PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Aamann, MD; Sorensen, MM; Hvitby, C; Berquist, BR; Muftuoglu, M; Tian, JY; de Souza-Pinto, NC; Scheibye-Knudsen, M; Wilson, DM; Stevnsner, T; Bohr, VA				Aamann, Maria D.; Sorensen, Martin M.; Hvitby, Christina; Berquist, Brian R.; Muftuoglu, Meltem; Tian, Jingyan; de Souza-Pinto, Nadja C.; Scheibye-Knudsen, Morten; Wilson, David M., III; Stevnsner, Tinna; Bohr, Vilhelm A.			Cockayne syndrome group B protein promotes mitochondrial DNA stability by supporting the DNA repair association with the mitochondrial membrane	FASEB JOURNAL			English	Article						base excision repair; BER; CSB; oxidative stress	BASE EXCISION-REPAIR; CELLULAR REPAIR; HELICASE DOMAIN; ATPASE DOMAIN; GENE-PRODUCT; DAMAGE; CSB; 8-OXOGUANINE; DEFICIENT; FORMAMIDOPYRIMIDINES	Cockayne syndrome (CS) is a human premature aging disorder associated with severe developmental deficiencies and neurodegeneration, and phenotypically it resembles some mitochondrial DNA (mtDNA) diseases. Most patients belong to complementation group B, and the CS group B (CSB) protein plays a role in genomic maintenance and transcriptome regulation. By immunocytochemistry, mitochondrial fractionation, and Western blotting, we demonstrate that CSB localizes to mitochondria in different types of cells, with increased mitochondrial distribution following menadione-induced oxidative stress. Moreover, our results suggest that CSB plays a significant role in mitochondrial base excision repair (BER) regulation. In particular, we find reduced 8-oxo-guanine, uracil, and 5-hydroxy-uracil BER incision activities in CSB-deficient cells compared to wild-type cells. This deficiency correlates with deficient association of the BER activities with the mitochondrial inner membrane, suggesting that CSB may participate in the anchoring of the DNA repair complex. Increased mutation frequency in mtDNA of CSB-deficient cells demonstrates functional significance of the presence of CSB in the mitochondria. The results in total suggest that CSB plays a direct role in mitochondrial BER by helping recruit, stabilize, and/or retain BER proteins in repair complexes associated with the inner mitochondrial membrane, perhaps providing a novel basis for understanding the complex phenotype of this debilitating disorder.-Aamann, M. D., Sorensen, M. M., Hvitby, C., Berquist, B. R., Muftuoglu, M., Tian, J., de Souza-Pinto, N. C., Scheibye-Knudsen, M., Wilson, D. M., III, Stevnsner, T., Bohr, V. A. Cockayne syndrome group B protein promotes mitochondrial DNA stability by supporting the DNA repair association with the mitochondrial membrane. FASEB J. 24, 2334-2346 (2010). www.fasebj.org	[Aamann, Maria D.; Sorensen, Martin M.; Berquist, Brian R.; Muftuoglu, Meltem; Tian, Jingyan; de Souza-Pinto, Nadja C.; Scheibye-Knudsen, Morten; Wilson, David M., III; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Aamann, Maria D.; Hvitby, Christina; Stevnsner, Tinna] Aarhus Univ, Danish Ctr Mol Gerontol, Aarhus, Denmark; [Aamann, Maria D.; Hvitby, Christina; Stevnsner, Tinna] Aarhus Univ, Dept Mol Biol, Danish Aging Res Ctr, DK-8000 Aarhus, Denmark	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Aarhus University; Aarhus University	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, Intramural Res Program, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	vbohr@nih.gov	Muftuoglu, Meltem/AAG-5004-2019; Bohr, Vilhelm/AAP-5931-2020; Souza-Pinto, Nadja/T-3050-2019; Souza-Pinto, Nadja C./C-3462-2013; Wilson, David M/AAK-5409-2021	Muftuoglu, Meltem/0000-0001-5372-4780; Souza-Pinto, Nadja/0000-0003-4206-964X; Souza-Pinto, Nadja C./0000-0003-4206-964X; Wilson, David M/0000-0002-8945-0395; Stevnsner, Tinna/0000-0003-1007-0427; Scheibye-Knudsen, Morten/0000-0002-6637-1280	National Institute of Health, National Institute on Aging; Danish Research Council [271-08-0697]; Velux Foundation [24715]; European Commission [LSHM-CT-2004-512020]; Danish Cancer Society [DP05118]; Lundbeck Foundation [4-55951-95094019]; NATIONAL INSTITUTE ON AGING [ZIAAG000722, ZIAAG000733, ZIAAG000723, ZIAAG000751, ZIAAG000727] Funding Source: NIH RePORTER; Lundbeck Foundation [R5-2006-128] Funding Source: researchfish	National Institute of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Danish Research Council(Det Frie Forskningsrad (DFF)); Velux Foundation(Velux Fonden); European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Lundbeck Foundation(Lundbeckfonden)	Alfred May and Ulla Henriksen provided excellent technical assistance. The authors thank John Vissing (Department of Neurology, Rigshospitalet, Copenhagen, Denmark) and co-workers for providing human muscle mitochondria. This research was supported by the Intramural Research Program of the National Institute of Health, National Institute on Aging, the Danish Research Council (grant 271-08-0697), the Velux Foundation (grant 24715), the European Commission (LSHM-CT-2004-512020), the Danish Cancer Society (DP05118), and the Lundbeck Foundation (4-55951-95094019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2007, NEUROSCIENCE, V145, P1201, DOI 10.1016/j.neuroscience.2006.10.010; ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348; Balajee AS, 1997, P NATL ACAD SCI USA, V94, P4306, DOI 10.1073/pnas.94.9.4306; Balajee AS, 2000, ONCOGENE, V19, P477, DOI 10.1038/sj.onc.1203372; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011; de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021; Dianov G, 1999, NUCLEIC ACIDS RES, V27, P1365, DOI 10.1093/nar/27.5.1365; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2; Flohr C, 2003, NUCLEIC ACIDS RES, V31, P5332, DOI 10.1093/nar/gkg715; Frossi B, 2002, J CELL PHYSIOL, V193, P180, DOI 10.1002/jcp.10159; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Griffiths LM, 2009, MOL CELL BIOL, V29, P794, DOI 10.1128/MCB.01357-08; Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Licht CL, 2003, AM J HUM GENET, V73, P1217, DOI 10.1086/380399; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; Loupatty FJ, 2007, AM J HUM GENET, V80, P195, DOI 10.1086/510725; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; MAYNE LV, 1986, EXP CELL RES, V162, P530, DOI 10.1016/0014-4827(86)90356-3; Mitra S, 2007, DNA REPAIR, V6, P461, DOI 10.1016/j.dnarep.2006.10.010; Muftuoglu M, 2002, GENE, V283, P27, DOI 10.1016/S0378-1119(01)00870-8; Muftuoglu M, 2009, J BIOL CHEM, V284, P9270, DOI 10.1074/jbc.M807006200; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Osenbroch PO, 2009, FEBS J, V276, P2811, DOI 10.1111/j.1742-4658.2009.07004.x; Osterod M, 2002, ONCOGENE, V21, P8232, DOI 10.1038/sj.onc.1206027; Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576; Scheibye-Knudsen M, 2009, EUR J APPL PHYSIOL, V105, P279, DOI 10.1007/s00421-008-0901-9; Selzer RR, 2002, NUCLEIC ACIDS RES, V30, P782, DOI 10.1093/nar/30.3.782; Shimomura Y, 2004, BIOCHEM BIOPH RES CO, V313, P381, DOI 10.1016/j.bbrc.2003.07.022; Stevnsner T, 2002, ONCOGENE, V21, P8675, DOI 10.1038/sj.onc.1205994; Stuart JA, 2005, NUCLEIC ACIDS RES, V33, P3722, DOI 10.1093/nar/gki683; Sunesen M, 2002, ONCOGENE, V21, P3571, DOI 10.1038/sj.onc.1205443; Thorslund T, 2005, MOL CELL BIOL, V25, P7625, DOI 10.1128/MCB.25.17.7625-7636.2005; Thorslund T, 2002, DNA REPAIR, V1, P261, DOI 10.1016/S1568-7864(02)00003-4; Trapp C, 2007, ONCOGENE, V26, P4044, DOI 10.1038/sj.onc.1210167; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tuo JS, 2003, FASEB J, V17, P668, DOI 10.1096/fj.02-0851com; Tuo JS, 2002, J BIOL CHEM, V277, P30832, DOI 10.1074/jbc.M204814200; Tuo JS, 2002, DNA REPAIR, V1, P913, DOI 10.1016/S1568-7864(02)00116-7; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; WALLACE DC, 1975, J CELL BIOL, V67, P174, DOI 10.1083/jcb.67.1.174; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Wong HK, 2007, NUCLEIC ACIDS RES, V35, P4103, DOI 10.1093/nar/gkm404; Wong HK, 2005, BIOCHEMISTRY-US, V44, P14335, DOI 10.1021/bi051161o	49	106	109	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2334	2346		10.1096/fj.09-147991	http://dx.doi.org/10.1096/fj.09-147991			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20181933	Green Published			2022-12-25	WOS:000279343600020
J	Hegge, S; Munter, S; Steinbuchel, M; Heiss, K; Engel, U; Matuschewski, K; Frischknecht, F				Hegge, Stephan; Muenter, Sylvia; Steinbuechel, Marion; Heiss, Kirsten; Engel, Ulrike; Matuschewski, Kai; Frischknecht, Friedrich			Multistep adhesion of Plasmodium sporozoites	FASEB JOURNAL			English	Article						flow chamber; malaria; TRAP; gliding motility	TRAP-LIKE PROTEIN; HEPARAN-SULFATE PROTEOGLYCANS; GLIDING MOTILITY; MALARIA PARASITES; CIRCUMSPOROZOITE PROTEIN; ACTIN CYTOSKELETON; STATISTICS NOTES; INVASION; CELLS; MOSQUITO	Adhesion of eukaryotic cells is a complex process during which interactions between extracellular ligands and cellular receptors on the plasma membrane modulate the organization of the cytoskeleton. Pathogens particularly rely often on adhesion to tissues or host cells in order to establish an infection. Here, we examined the adhesion of Plasmodium sporozoites, the motile form of the malaria parasite transmitted by the mosquito, to flat surfaces. Experiments using total internal reflection fluorescence microscopy and analysis of sporozoites under flow revealed a stepwise and developmentally regulated adhesion process. The sporozoite-specific transmembrane proteins TRAP and S6 were found to be important for initial adhesion. The structurally related protein TLP appears to play a specific role in adhesion under static conditions, as tlp(-) sporozoites move 4 times less efficiently than wild-type sporozoites. This likely reflects the decreased intradermal sporozoite movement of sporozoites lacking TLP. Further, these three sporozoite surface proteins also act in concert with actin filaments to organize efficient adhesion of the sporozoite prior to initiating motility and host cell invasion.-Hegge, S., Munter, S., Steinbuchel, M., Heiss, K., Engel, U., Matuschewski, K., Frischknecht, F. Multistep adhesion of Plasmodium sporozoites. FASEB J. 24, 2222-2234 (2010). www.fasebj.org	[Hegge, Stephan; Muenter, Sylvia; Steinbuechel, Marion; Heiss, Kirsten; Matuschewski, Kai; Frischknecht, Friedrich] Heidelberg Univ, Dept Parasitol, Inst Hyg, Sch Med, D-69120 Heidelberg, Germany; [Engel, Ulrike] BioQuant, Nikon Imaging Ctr, Heidelberg, Germany; [Matuschewski, Kai] Max Planck Inst Infect Biol, Dept Parasitol, Berlin, Germany	Ruprecht Karls University Heidelberg; Nikon Corporation; Ruprecht Karls University Heidelberg; Max Planck Society	Frischknecht, F (corresponding author), Heidelberg Univ, Dept Parasitol, Inst Hyg, Sch Med, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	freddy.frischknecht@med.uni-heidelberg.de	Engel, Ulrike/E-5456-2014; Engel, Ulrike/AAO-7719-2020	Engel, Ulrike/0000-0002-6953-6845; Frischknecht, Friedrich/0000-0002-8332-6668; Matuschewski, Kai/0000-0001-6147-8591	Federal German Ministry for Education and Research (BMBF-BioFuture); German Research Foundation [DFG-SFB 544]; European Network of Excellence BioMalPar; University of Heidelberg Medical School; Cluster of Excellence CellNetworks	Federal German Ministry for Education and Research (BMBF-BioFuture)(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); European Network of Excellence BioMalPar; University of Heidelberg Medical School; Cluster of Excellence CellNetworks	The authors thank Kai Uhrig for discussions and comments on the manuscript. The work was funded by grants from the Federal German Ministry for Education and Research (BMBF-BioFuture), the German Research Foundation (DFG-SFB 544), and the European Network of Excellence BioMalPar. The authors gratefully acknowledge support from the University of Heidelberg Medical School and the Cluster of Excellence CellNetworks. The authors thank Diana Schep-pan and Iris Arnold for mosquito infection, Jan-Peter Roderer for help with data analysis, and the Nikon Imaging Center at the University of Heidelberg for access to their microscopes. The authors declare no conflicts of interest.	Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Amino R, 2005, CURR OPIN MICROBIOL, V8, P407, DOI 10.1016/j.mib.2005.06.019; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Bland JM, 1998, BRIT MED J, V316, P129; Brennan JDG, 2000, P NATL ACAD SCI USA, V97, P13859, DOI 10.1073/pnas.250472597; BUBB MR, 1995, J BIOL CHEM, V270, P3463, DOI 10.1074/jbc.270.8.3463; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Combe A, 2009, INT J PARASITOL, V39, P489, DOI 10.1016/j.ijpara.2008.10.004; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Frevert U, 2006, CELL MICROBIOL, V8, P1537, DOI 10.1111/j.1462-5822.2006.00777.x; Frischknecht F, 2004, CELL MICROBIOL, V6, P687, DOI 10.1111/j.1462-5822.2004.00395.x; Gantt S, 2000, INFECT IMMUN, V68, P3667, DOI 10.1128/IAI.68.6.3667-3673.2000; Ghosh AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000265; Hegge Stephan, 2009, Biotechnology Journal, V4, P903, DOI 10.1002/biot.200900007; Heintzelman MB, 2006, INT REV CYTOL, V251, P79, DOI 10.1016/S0074-7696(06)51003-4; Heiss K, 2008, EUKARYOT CELL, V7, P1062, DOI 10.1128/EC.00089-08; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kebaier C, 2010, INT J PARASITOL, V40, P25, DOI 10.1016/j.ijpara.2009.06.011; Kerry SM, 1998, BMJ-BRIT MED J, V316, P54, DOI 10.1136/bmj.316.7124.54; Lacroix C, 2008, TRENDS PARASITOL, V24, P431, DOI 10.1016/j.pt.2008.07.003; Matuschewski K, 2002, EMBO J, V21, P1597, DOI 10.1093/emboj/21.7.1597; Matuschewski K, 2006, CELL MICROBIOL, V8, P1547, DOI 10.1111/j.1462-5822.2006.00778.x; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; Mizuno Y, 2002, PARASITOL RES, V88, P844, DOI 10.1007/s00436-002-0666-8; Morahan BJ, 2009, TRENDS PARASITOL, V25, P77, DOI 10.1016/j.pt.2008.11.004; Moreira CK, 2008, CELL MICROBIOL, V10, P1505, DOI 10.1111/j.1462-5822.2008.01143.x; Munter S, 2009, CELL HOST MICROBE, V6, P551, DOI 10.1016/j.chom.2009.11.007; Natarajan R, 2001, CELL MICROBIOL, V3, P371, DOI 10.1046/j.1462-5822.2001.00117.x; Pinzon-Ortiz C, 2001, J BIOL CHEM, V276, P26784, DOI 10.1074/jbc.M104038200; Poupel O, 1999, MICROBES INFECT, V1, P653, DOI 10.1016/S1286-4579(99)80066-5; Pradel G, 2002, MOL MICROBIOL, V45, P637, DOI 10.1046/j.1365-2958.2002.03057.x; Rathore D, 2002, J BIOL CHEM, V277, P7092, DOI 10.1074/jbc.M106862200; Saito S, 1998, J BIOCHEM-TOKYO, V123, P571; Sherman IW, 2003, MICROBES INFECT, V5, P897, DOI 10.1016/S1286-4579(03)00162-X; SIMONETTI AB, 1993, J EUKARYOT MICROBIOL, V40, P569, DOI 10.1111/j.1550-7408.1993.tb06109.x; Sinden RE, 2005, MOLECULAR APPROACHES TO MALARIA, P169; Starnes GL, 2009, CELL HOST MICROBE, V5, P353, DOI 10.1016/j.chom.2009.03.005; Steinbuechel M, 2009, CELL MICROBIOL, V11, P279, DOI 10.1111/j.1462-5822.2008.01252.x; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	48	60	60	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2222	2234		10.1096/fj.09-148700	http://dx.doi.org/10.1096/fj.09-148700			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20159960				2022-12-25	WOS:000279343600009
J	Lainez, S; Valente, P; Ontoria-Oviedo, I; Estevez-Herrera, J; Camprubi-Robles, M; Ferrer-Montiel, A; Planells-Cases, R				Lainez, S.; Valente, P.; Ontoria-Oviedo, I.; Estevez-Herrera, J.; Camprubi-Robles, M.; Ferrer-Montiel, A.; Planells-Cases, R.			GABA(A) receptor associated protein (GABARAP) modulates TRPV1 expression and channel function and desensitization	FASEB JOURNAL			English	Article						pain; analgesia; nociceptor; cytoskeleton; tubulin; inflammation	ROOT GANGLION NEURONS; PLASMA-MEMBRANE; GABA(A)-RECEPTOR-ASSOCIATED PROTEIN; VANILLOID RECEPTOR-1; BINDING; KINASE; IDENTIFICATION; INTERACTS; PHOSPHORYLATION; MICROTUBULES	Transient receptor potential vanilloid (TRPV1) transduces noxious chemical and physical stimuli in high-threshold nociceptors. The pivotal role of TRPV1 in the physiopathology of pain transduction has thrust the identification and characterization of interacting partners that modulate its cellular function. Here, we report that TRPV1 associates with gamma-amino butyric acid A-type (GABA(A)) receptor associated protein (GABARAP) in HEK293 cells and in neurons from dorsal root ganglia coexpressing both proteins. At variance with controls, GABARAP augmented TRPV1 expression in cotransfected cells and stimulated surface receptor clustering. Functionally, GABARAP expression attenuated voltage and capsaicin sensitivity of TRPV1 in the presence of extracellular calcium. Furthermore, the presence of the anchor protein GABARAP notably lengthened the kinetics of vanilloid-induced tachyphylaxia. Notably, the presence of GABARAP selectively increased the interaction of tubulin with the C-terminal domain of TRPV1. Disruption of tubulin cytoskeleton with nocodazole reduced capsaicin-evoked currents in cells expressing TRPV1 and GABARAP, without affecting the kinetics of vanilloid- induced desensitization. Taken together, these findings indicate that GABARAP is an important component of the TRPV1 signaling complex that contributes to increase the channel expression, to traffic and cluster it on the plasma membrane, and to modulate its functional activity at the level of channel gating and desensitization.-Lainez, S., Valente, P., Ontoria-Oviedo, I., Estevez-Herrera, J., Camprub Robles, M., Ferrer-Montiel, A. Planells-Cases, R. GABA(A) receptor associated protein (GABARAP) modulates TRPV1 expression and channel function and desensitization. FASEB J. 24, 1958-1970 (2010). www.fasebj.org	[Lainez, S.; Ontoria-Oviedo, I.; Estevez-Herrera, J.; Planells-Cases, R.] Ctr Invest Principe Felipe, Valencia 46012, Spain	Prince Felipe Research Center	Planells-Cases, R (corresponding author), Ctr Invest Principe Felipe, Av Autopista Saler 16, Valencia 46012, Spain.	rplanells@cipf.es	Ferrer-Montiel, Antonio/C-3072-2015; Valente, Pierluigi/AAF-2802-2021; Ontoria-Oviedo, Imelda/W-1069-2018; Estevez Herrera, Judith/R-5333-2018	Ferrer-Montiel, Antonio/0000-0002-2973-6607; Ontoria-Oviedo, Imelda/0000-0002-2497-1325; Estevez Herrera, Judith/0000-0001-8130-2294	Ministerio de Ciencia e Innovacion (MICINN) [SAF2006-2580, SAF2007-63193, CSD2008-00005]; la Fundacio La Marato de TV3; la Fundacion Emilio Botin	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); la Fundacio La Marato de TV3; la Fundacion Emilio Botin	This work was supported by grants from el Ministerio de Ciencia e Innovacion (MICINN; SAF2006-2580 to A.F.-M. and SAF2007-63193 to R.P.-C.); the Consolider-Ingenio 2010 (MICINN; CSD2008-00005 to A.F.-M and R.P.-C.), la Fundacio La Marato de TV3 (to A.F.-M and R.P.-C.), and la Fundacion Emilio Botin (to A.F.-M).	Alam J, 2010, REGUL PEPTIDES, V159, P78, DOI 10.1016/j.regpep.2009.09.002; Bavro VN, 2002, EMBO REP, V3, P183, DOI 10.1093/embo-reports/kvf026; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Cabedo H, 2004, J BIOL CHEM, V279, P33623, DOI 10.1074/jbc.M401962200; Camprubi-Robles M, 2009, FASEB J, V23, P3722, DOI 10.1096/fj.09-134346; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Chen L, 2000, P NATL ACAD SCI USA, V97, P11557, DOI 10.1073/pnas.190133497; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Cook JL, 2008, CIRC RES, V102, P1539, DOI 10.1161/CIRCRESAHA.108.176594; Coyle JE, 2003, NEUROSCIENTIST, V9, P205, DOI 10.1177/1073858403009003013; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Gonzalez MI, 2007, J NEUROCHEM, V103, P1917, DOI 10.1111/j.1471-4159.2007.04881.x; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Goswami C, 2006, J NEUROCHEM, V96, P254, DOI 10.1111/j.1471-4159.2005.03551.x; Goswami C, 2004, J NEUROCHEM, V91, P1092, DOI 10.1111/j.1471-4159.2004.02795.x; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Koplas PA, 1997, J NEUROSCI, V17, P3525; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Lilja J, 2007, J NEUROSCI RES, V85, P1413, DOI 10.1002/jnr.21255; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Mohrluder J, 2007, BIOCHEMISTRY-US, V46, P14537, DOI 10.1021/bi7018145; Molina ML, 2006, J BIOL CHEM, V281, P18837, DOI 10.1074/jbc.M600342200; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Reining SC, 2009, AM J PHYSIOL-RENAL, V296, pF1118, DOI 10.1152/ajprenal.90492.2008; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Sun H, 2008, J PHYSIOL-LONDON, V586, P751, DOI 10.1113/jphysiol.2007.136440; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang HB, 2000, J NEUROCHEM, V75, P644, DOI 10.1046/j.1471-4159.2000.0750644.x; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015	39	57	57	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2010	24	6					1958	1970		10.1096/fj.09-151472	http://dx.doi.org/10.1096/fj.09-151472			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20179142				2022-12-25	WOS:000278200000030
J	Liao, H; Hyman, MC; Baek, AE; Fukase, K; Pinsky, DJ				Liao, Hui; Hyman, Matthew C.; Baek, Amy E.; Fukase, Keigo; Pinsky, David J.			cAMP/CREB-mediated Transcriptional Regulation of Ectonucleoside Triphosphate Diphosphohydrolase 1 (CD39) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; RESPONSE ELEMENT; SIGNALING PATHWAYS; GENE-EXPRESSION; FACTOR CREB; CAMP-PKA; T-CELLS; C-JUN; PHOSPHORYLATION; ACTIVATION	CD39 is a transmembrane enzyme that inhibits platelet reactivity and inflammation by phosphohydrolyzing ATP and ADP to AMP. Cyclic AMP (cAMP), an essential second messenger, is particularly important in regulating genes controlling vascular homeostasis. These experiments test the hypothesis that cAMP might positively regulate the expression of CD39 and thereby modulate important vascular homeostatic properties. Cd39 mRNA was induced by 13.8- fold in RAW cells treated with a membrane-permeant cAMP analogue (8-bromo-cyclic AMP; 8-Br-cAMP), stimulation of adenylate cyclase, or prostanoids known to drive cAMP response. Fluorescence-activated cell sorting, immunofluorescence, and TLC assays demonstrated that both CD39 protein expression and enzymatic activity were increased in cells treated with 8-Br-cAMP but not in cells transfected with short hairpin RNA against CD39. This analogue drove a significant increase in transcriptional activity at the Cd39 promoter although not when the promoter's cAMP-response element sites were mutated. Pretreatment with cAMP-dependent protein kinase (PKA), phosphoinositide 3-kinase (PI3K), or ERK inhibitors nearly obliterated the cAMP-driven increase in Cd39 mRNA, protein expression, and promoter activity. 8-Br-cAMP greatly increased the phosphorylation of CREB1 (Ser(133)) and ATF2 (Thr(71)) in a PKA-, PI3K-, and ERK-dependent fashion. Chromatin immunoprecipitation assays demonstrated that binding of phosphorylated CREB1 and ATF2 to cAMP-response element-like sites was significantly increased with 8-Br-cAMP treatment and that binding was reduced with PKA, PI3K, and ERK inhibition, whereas transfection of Creb1 and Atf2 overexpression constructs enhanced cAMP-driven Cd39 mRNA expression. Transfection of RAW cells with mutated Creb1 (S133A) reduced cAMP-driven Cd39 mRNA expression. Furthermore, the cAMP-mediated induction of Cd39 mRNA, protein, and phosphohydrolytic activity was replicated in primary peritoneal macrophages. These data identify cAMP as a crucial regulator of macrophage CD39 expression and demonstrate that cAMP acts through the PKA/CREB, PKA/PI3K/ATF2, and PKA/ERK/ATF2 pathways to control a key vascular homeostatic mediator.	[Liao, Hui; Fukase, Keigo; Pinsky, David J.] Univ Michigan, Med Ctr, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Hyman, Matthew C.; Baek, Amy E.; Pinsky, David J.] Univ Michigan, Med Ctr, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pinsky, DJ (corresponding author), 7220 Med Sci Res Bldg 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	dpinsky@umich.edu	liao, hui/GSE-5758-2022	Hyman, Matthew/0000-0002-4050-6925	National Institutes of Health [R01HL085149, R01HL086676, R01HL055397, P01HL089407]; Taubman Medical Research Institute; Scleroderma Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086676, R01HL085149, R01HL055397, P01HL089407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taubman Medical Research Institute; Scleroderma Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL085149, R01HL086676, R01HL055397, and P01HL089407. This work was also supported by a Taubman Medical Research Institute Scholarship, the Ruth Professorship, and the Scleroderma Research Foundation.	Atkinson B, 2006, BLOOD CELL MOL DIS, V36, P217, DOI 10.1016/j.bcmd.2005.12.025; Buschmann T, 2000, J BIOL CHEM, V275, P16590, DOI 10.1074/jbc.M910045199; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chen KQ, 2005, CELL MOL IMMUNOL, V2, P241; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cosentino C, 2007, ONCOGENE, V26, P2095, DOI 10.1038/sj.onc.1210027; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; Dombrowski KE, 1998, IMMUNOL REV, V161, P111, DOI 10.1111/j.1600-065X.1998.tb01575.x; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; Freeland K, 2000, BIOCHEM J, V345, P233, DOI 10.1042/0264-6021:3450233; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; Gerlo S, 2006, CELL MOL LIFE SCI, V63, P92, DOI 10.1007/s00018-005-5433-4; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Hyman MC, 2009, J CLIN INVEST, V119, P1136, DOI 10.1172/JCI36433; Kang JH, 2007, AM J PHYSIOL-ENDOC M, V292, pE215, DOI 10.1152/ajpendo.00181.2006; KANSAS GS, 1991, J IMMUNOL, V146, P2235; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P5479, DOI 10.1128/MCB.13.9.5479; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Langston HP, 2003, J IMMUNOL, V170, P2962, DOI 10.4049/jimmunol.170.6.2962; Lawson CA, 1997, J CLIN INVEST, V99, P1729, DOI 10.1172/JCI119337; LEE KAW, 1993, BIOCHIM BIOPHYS ACTA, V1174, P221, DOI 10.1016/0167-4781(93)90191-F; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; Liao H, 2007, FASEB J, V21, P935, DOI 10.1096/fj.06-6285com; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcus A J, 2001, Ital Heart J, V2, P824; Marcus AJ, 2005, SEMIN THROMB HEMOST, V31, P234, DOI 10.1055/s-2005-869528; Marcus AJ, 2003, J THROMB HAEMOST, V1, P2497, DOI 10.1111/j.1538-7836.2003.00479.x; Marcus AJ, 2003, J PHARMACOL EXP THER, V305, P9, DOI 10.1124/jpet.102.043729; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; NAKAMURA T, 1995, EXP CELL RES, V216, P422, DOI 10.1006/excr.1995.1053; PINSKY D, 1993, J CLIN INVEST, V92, P2994, DOI 10.1172/JCI116922; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sperlagh B, 1999, J ENDOCRINOL, V160, P343, DOI 10.1677/joe.0.1600343; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vuchak LA, 2009, MOL PHARMACOL, V76, P1123, DOI 10.1124/mol.109.060129; Wang CY, 2000, CIRC RES, V86, P982, DOI 10.1161/01.RES.86.9.982; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YOON SO, 1992, NEURON, V9, P55, DOI 10.1016/0896-6273(92)90220-8; Zhang JL, 2009, INT J CLIN EXP MED, V2, P87	57	64	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14791	14805		10.1074/jbc.M110.116905	http://dx.doi.org/10.1074/jbc.M110.116905			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20178980	Green Published, hybrid			2022-12-25	WOS:000277299700076
J	Verbruggen, V; Ek, O; Georlette, D; Delporte, F; Von Berg, V; Detry, N; Biemar, F; Coutinho, P; Martial, JA; Voz, ML; Manfroid, I; Peers, B				Verbruggen, Vincianne; Ek, Olivier; Georlette, Daphne; Delporte, Francois; Von Berg, Virginie; Detry, Nathalie; Biemar, Frederic; Coutinho, Pedro; Martial, Joseph A.; Voz, Marianne L.; Manfroid, Isabelle; Peers, Bernard			The Pax6b Homeodomain Is Dispensable for Pancreatic Endocrine Cell Differentiation in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-EYE; EMBRYONIC-DEVELOPMENT; IN-VIVO; GENES; EXPRESSION; DROSOPHILA; OVEREXPRESSION; TRANSCRIPTION; VERTEBRATE; HUMANS	Pax6 is a well conserved transcription factor that contains two DNA-binding domains, a paired domain and a homeodomain, and plays a key role in the development of eye, brain, and pancreas in vertebrates. The recent identification of the zebrafish sunrise mutant, harboring a mutation in the pax6b homeobox and presenting eye abnormalities but no obvious pancreatic defects, raised a question about the role of pax6b in zebrafish pancreas. We show here that pax6b does play an essential role in pancreatic endocrine cell differentiation, as revealed by the phenotype of a novel zebrafish pax6b null mutant and of embryos injected with pax6b morpholinos. Pax6b-depleted embryos have almost no beta cells, a strongly reduced number of delta cells, and a significant increase of epsilon cells. Through the use of various morpholinos targeting intron-exon junctions, pax6b RNA splicing was perturbed at several sites, leading either to retention of intronic sequences or to deletion of exonic sequences in the pax6b transcript. By this strategy, we show that deletion of the Pax6b homeodomain in zebrafish embryos does not disturb pancreas development, whereas lens formation is strongly affected. These data thus provide the explanation for the lack of pancreatic defects in the sunrise pax6b mutants. In addition, partial reduction of Pax6b function in zebrafish embryos performed by injection of small amounts of pax6b morpholinos caused a clear rise in alpha cell number and in glucagon expression, emphasizing the importance of the fine tuning of the Pax6b level to its biological activity.	[Verbruggen, Vincianne; Ek, Olivier; Delporte, Francois; Von Berg, Virginie; Detry, Nathalie; Martial, Joseph A.; Voz, Marianne L.; Manfroid, Isabelle; Peers, Bernard] Univ Liege, Unit Mol Biol & Genet Engn, GIGA R, B-4000 Liege, Belgium; [Georlette, Daphne; Biemar, Frederic] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Coutinho, Pedro] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XV, Midlothian, Scotland	University of Liege; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Edinburgh	Peers, B (corresponding author), Univ Liege, Unit Mol Biol & Genet Engn, GIGA R, B34,Ave Hop 1, B-4000 Liege, Belgium.	bpeers@ulg.ac.be			Belgian State Program; European Union; Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture	Belgian State Program; European Union(European Commission); Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture(Fonds de la Recherche Scientifique - FNRS)	This work was funded by the Belgian State Program on "Interuniversity Poles of Attraction" and by the 6th European Union Framework Program (Beta Cell Therapy Integrated Project).; Recipient of a doctoral fellowship from the "Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture."	Argenton F, 1999, MECH DEVELOP, V87, P217, DOI 10.1016/S0925-4773(99)00151-3; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Delporte FM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-53; Devos N, 2002, MECH DEVELOP, V115, P133, DOI 10.1016/S0925-4773(02)00082-5; Ding J, 2009, ENDOCRINOLOGY, V150, P2136, DOI 10.1210/en.2008-1006; Dohrmann C, 2000, MECH DEVELOP, V92, P47, DOI 10.1016/S0925-4773(99)00324-X; Dong PDS, 2008, GENE DEV, V22, P1445, DOI 10.1101/gad.1663208; Favor J, 2001, GENETICS, V159, P1689; Godinho L, 2007, NEURON, V56, P597, DOI 10.1016/j.neuron.2007.09.036; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Heller RS, 2004, DEV BIOL, V268, P123, DOI 10.1016/j.ydbio.2003.12.008; Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kioussi C, 1999, P NATL ACAD SCI USA, V96, P14378, DOI 10.1073/pnas.96.25.14378; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Manuel M, 2005, BRAIN RES BULL, V66, P387, DOI 10.1016/j.brainresbull.2005.02.006; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; MATSUO T, 1993, NAT GENET, V3, P299, DOI 10.1038/ng0493-299; Milewski WM, 1998, ENDOCRINOLOGY, V139, P1440, DOI 10.1210/en.139.3.1440; Nomura T, 2004, DEVELOPMENT, V131, P787, DOI 10.1242/dev.00984; Nomura T, 2007, DEV GROWTH DIFFER, V49, P683, DOI 10.1111/j.1440-169x.2007.00965.x; Punzo C, 2001, GENE DEV, V15, P1716, DOI 10.1101/gad.196401; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Wen JH, 2009, DIABETOLOGIA, V52, P504, DOI 10.1007/s00125-008-1210-x; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yamaoka T, 2000, DIABETOLOGIA, V43, P332, DOI 10.1007/s001250050051	35	15	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13863	13873		10.1074/jbc.M110.108019	http://dx.doi.org/10.1074/jbc.M110.108019			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20177065	Green Published, hybrid			2022-12-25	WOS:000276987700061
J	Lee, BC; Kumauchi, M; Hoff, WD				Lee, Byoung-Chul; Kumauchi, Masato; Hoff, Wouter D.			Modulating Native-like Residual Structure in the Fully Denatured State of Photoactive Yellow Protein Affects Its Refolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HALOPHILIC PHOTOTROPHIC BACTERIUM; P-COUMARIC ACID; ECTOTHIORHODOSPIRA-HALOPHILA; UNFOLDED STATE; INTERMEDIATE; CHROMOPHORE; PHOTOCYCLE; NMR; THERMODYNAMICS; PHOTORECEPTOR	Residual structure in the fully unfolded state is a key element for understanding protein folding. We show that the residual structure in fully denatured photoactive yellow protein (PYP) is affected by isomerization of its p-coumaric acid (pCA) chromophore. The exposure of total surface area and hydrophobic surface area upon unfolding was quantified by denaturant m values and heat capacity changes (pCp), respectively. The exposure of the buried surface area upon the unfolding of the acid-denatured state of PYP containing trans-pCA is similar to 20% smaller than that of the native state. In contrast, for the partially unfolded pB photocycle intermediate containing cis-pCA, unfolding-induced exposure of the surface area is not decreased. These results show that pCA photoisomerization reduces residual structure in the fully unfolded state. Thus, residual structure in the fully unfolded state of PYP is under direct experimental control by photoexcitation. The sensitivity of the unfolded state to pCA isomerization provides a novel criterion that residual structure in the unfolded state of PYP is native-like, involving native-like protein-chromophore interactions. A largely untested prediction is that native-like residual structure facilitates the conformational search during folding. In the case of PYP, refolding from the less disordered fully unfolded state containing trans-pCA indeed is substantially accelerated. The burial of hydrophobic surface area in the fully unfolded state suggests that a significant part of the hydrophobic collapse process already has occurred in the denatured state.	[Lee, Byoung-Chul] Univ Calif Berkeley, Lawrence Berkeley Lab, Biol Nanostruct Facil, Berkeley, CA 94720 USA; [Lee, Byoung-Chul; Kumauchi, Masato; Hoff, Wouter D.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Oklahoma State University System; Oklahoma State University - Stillwater	Hoff, WD (corresponding author), 307 Life Sci E, Stillwater, OK 74078 USA.	wouter.hoff@okstate.edu			National Institutes of Health [GM063805]; United States Department of Energy [DE-AC02-05CH11231]; OCAST [HR07-135S]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); OCAST; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM063805 (to W.D.H.).; Both authors contributed equally to this work.; Supported by the Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231; Supported in part by OCAST Grant HR07-135S and by startup funds provided by Oklahoma State University. To whom correspondence should be addressed: 307 Life Sciences East, Stillwater, OK 74078. Tel.: 405-744-4449; Fax: 405-744-6790; E-mail: wouter. hoff@okstate.edu.	Bernard C, 2005, STRUCTURE, V13, P953, DOI 10.1016/j.str.2005.04.017; Craven CJ, 2000, BIOCHEMISTRY-US, V39, P14392, DOI 10.1021/bi001628p; DILL KA, 1995, PROTEIN SCI, V4, P561; FINK AL, 1993, PROTEIN SCI, V2, P1155, DOI 10.1002/pro.5560020710; Fitzkee NC, 2004, P NATL ACAD SCI USA, V101, P12497, DOI 10.1073/pnas.0404236101; Garcia P, 2001, PROTEIN SCI, V10, P1100, DOI 10.1110/ps.52701; HOFF WD, 1994, BIOCHEMISTRY-US, V33, P13959, DOI 10.1021/bi00251a001; Hoff WD, 1997, BBA-BIOENERGETICS, V1322, P151, DOI 10.1016/S0005-2728(97)00082-0; Hoff WD, 1999, BIOCHEMISTRY-US, V38, P1009, DOI 10.1021/bi980504y; Khan JS, 2006, J AM CHEM SOC, V128, P1002, DOI 10.1021/ja055584p; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Kort R, 1996, FEBS LETT, V382, P73, DOI 10.1016/0014-5793(96)00149-4; Lee BC, 2001, P NATL ACAD SCI USA, V98, P9062, DOI 10.1073/pnas.111153598; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Liu YF, 1996, BIOCHEMISTRY-US, V35, P3059, DOI 10.1021/bi952198j; McCarney ER, 2005, CRIT REV BIOCHEM MOL, V40, P181, DOI 10.1080/10409230591008143; MEYER TE, 1987, BIOCHEMISTRY-US, V26, P418, DOI 10.1021/bi00376a012; MEYER TE, 1985, BIOCHIM BIOPHYS ACTA, V806, P175, DOI 10.1016/0005-2728(85)90094-5; Mok KH, 2007, NATURE, V447, P106, DOI 10.1038/nature05728; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; Ohishi S, 2001, BIOCHEMISTRY-US, V40, P2854, DOI 10.1021/bi001846i; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Robic S, 2003, P NATL ACAD SCI USA, V100, P11345, DOI 10.1073/pnas.1635051100; Shortle D, 1996, FASEB J, V10, P27, DOI 10.1096/fasebj.10.1.8566543; Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438; SPRENGER WW, 1993, J BACTERIOL, V175, P3096, DOI 10.1128/JB.175.10.3096-3104.1993; Unno M, 2000, J AM CHEM SOC, V122, P4233, DOI 10.1021/ja000032m; van Gunsteren WF, 2001, ANGEW CHEM INT EDIT, V40, P351, DOI 10.1002/1521-3773(20010119)40:2<351::AID-ANIE351>3.0.CO;2-6; VanBrederode ME, 1996, BIOPHYS J, V71, P365, DOI 10.1016/S0006-3495(96)79234-2; Weinkam P, 2009, P NATL ACAD SCI USA, V106, P1796, DOI 10.1073/pnas.0813120106; Xie AH, 1996, BIOCHEMISTRY-US, V35, P14671, DOI 10.1021/bi9623035; Zhao JM, 2006, P NATL ACAD SCI USA, V103, P11561, DOI 10.1073/pnas.0601567103	34	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12579	12586		10.1074/jbc.M109.065821	http://dx.doi.org/10.1074/jbc.M109.065821			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178976	hybrid, Green Published			2022-12-25	WOS:000276787800015
J	Matei, E; Zheng, A; Furey, W; Rose, J; Aiken, C; Gronenborn, AM				Matei, Elena; Zheng, Andrew; Furey, William; Rose, Jeremy; Aiken, Christopher; Gronenborn, Angela M.			Anti-HIV Activity of Defective Cyanovirin-N Mutants Is Restored by Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN GP120; DOMAIN-SWAPPED DIMER; INACTIVATING PROTEIN; ANTIVIRAL ACTIVITY; BINDING-SITE; CONTAINS 2; X-RAY; NMR; 2G12	Cyanovirin-N (CV-N) is a two-domain, cyanobacterial protein that inhibits human immunodeficiency virus (HIV) at nano-molar concentrations by binding to high mannose sugars on the HIV envelope glycoprotein gp120. The wild type protein can exist as a monomer or a domain-swapped dimer with the monomer and dimer containing two or four sugar binding sites, respectively, one on each domain. Here we demonstrate that monomeric, single binding site mutants are completely inactive and that a single site, whether located on domain A or B, is insufficient to impart the antiviral activity. Linking inactive, monomeric proteins in a head-to-head fashion by an intermolecular disulfide bond or by creating an exclusively domain-swapped dimer via a hinge residue deletion restored antiviral activity to levels similar to that of wild type CV-N. These findings demonstrate unequivocally that multisite binding by CV-N type lectins is necessary for viral inhibition.	[Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Furey, William] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Furey, William] Vet Affairs Med Ctr, Biocrystallog Lab, Pittsburgh, PA 15240 USA; [Zheng, Andrew] Duke Univ, Dept Chem, Durham, NC 27708 USA; [Rose, Jeremy; Aiken, Christopher] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; Vanderbilt University	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 3501 5th Ave,BST3-Rm 1050, Pittsburgh, PA 15260 USA.	amg100@pitt.edu	Matei, Elena/AAP-8706-2020; Aiken, Christopher/Y-9252-2019; matei, elena/HHC-6815-2022	Gronenborn, Angela M/0000-0001-9072-3525; Matei, Elena/0000-0002-1625-2814	National Institutes of Health [RO1GM080642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM080642 (to A. M. G.).	Barrientos LG, 2006, PROTEIN ENG DES SEL, V19, P525, DOI 10.1093/protein/gzl040; Barrientos LG, 2004, J INFECT DIS, V189, P1440, DOI 10.1086/382658; Barrientos LG, 2002, STRUCTURE, V10, P673, DOI 10.1016/S0969-2126(02)00758-X; Barrientos LG, 2005, MINI-REV MED CHEM, V5, P21, DOI 10.2174/1389557053402783; Barrientos LG, 2002, BIOCHEM BIOPH RES CO, V298, P598, DOI 10.1016/S0006-291X(02)02489-0; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Bewley CA, 2001, J AM CHEM SOC, V123, P3892, DOI 10.1021/ja004040e; Bolmstedt AJ, 2001, MOL PHARMACOL, V59, P949, DOI 10.1124/mol.59.5.949; Botos I, 2002, BIOCHEM BIOPH RES CO, V294, P184, DOI 10.1016/S0006-291X(02)00455-2; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chang LC, 2002, J MOL BIOL, V318, P1, DOI 10.1016/S0022-2836(02)00045-1; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esser MT, 1999, J VIROL, V73, P4360, DOI 10.1128/JVI.73.5.4360-4371.1999; FESIK SW, 1990, Q REV BIOPHYS, V23, P97, DOI 10.1017/S0033583500005515; Fromme R, 2007, BIOCHEMISTRY-US, V46, P9199, DOI 10.1021/bi700666m; Grey MJ, 2003, J AM CHEM SOC, V125, P14324, DOI 10.1021/ja0367389; GRZESIEK S, 1993, J BIOMOL NMR, V3, P487; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kiessling L.L., 2008, GLYCOSCIENCE, P2483, DOI 10.1007/978-3-540-30429-6_64; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Matei E, 2008, STRUCTURE, V16, P1183, DOI 10.1016/j.str.2008.05.011; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; O'Keefe BR, 2003, ANTIMICROB AGENTS CH, V47, P2518, DOI 10.1128/AAC.47.8.2518-2525.2003; PATTERSON GML, 1993, J PHYCOL, V29, P125, DOI 10.1111/j.1529-8817.1993.tb00290.x; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Shenoy SR, 2002, CHEM BIOL, V9, P1109, DOI 10.1016/S1074-5521(02)00237-5; Shenoy SR, 2001, J PHARMACOL EXP THER, V297, P704; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Yang F, 1999, J MOL BIOL, V288, P403, DOI 10.1006/jmbi.1999.2693; Yang RF, 2007, J VIROL, V81, P3749, DOI 10.1128/JVI.02634-06	41	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13057	13065		10.1074/jbc.M109.094938	http://dx.doi.org/10.1074/jbc.M109.094938			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20147291	Green Published, hybrid			2022-12-25	WOS:000276787800063
J	Kwon, J; Cho, HJ; Han, SH; No, JG; Kwon, JY; Kim, H				Kwon, Junhye; Cho, Hyun Jung; Han, Seung Hun; No, Jin Gu; Kwon, Jae Young; Kim, Hongtae			A Novel LZAP-binding Protein, NLBP, Inhibits Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; NF-KAPPA-B; TUMOR-SUPPRESSOR; PROSTATE-CANCER; CDK5 ACTIVATOR; CHECKPOINT; LOCUS	LXXLL/leucine zipper-containing alternative reading frame (ARF)-binding protein (LZAP) was recently shown to function as a tumor suppressor through inhibition of the NF-kappa B signaling pathway. LZAP is also known as a negative regulator of cell invasion, and its expression was demonstrated to be reduced in several tumor tissues. However, the molecular mechanism of the negative effect of LZAP on cell invasion is unclear. In this study, we identify NLBP as a novel LZAP-binding protein using tandem affinity purification. We demonstrate the negative effects of NLBP on cell invasion and the NF-kappa B signaling pathway. NLBP expression was not detected in hepatocellular carcinoma cells with strong invasive activity, whereas its expression was detected in a hepatocellular carcinoma cell line with no invasive activity. We also demonstrate that these two proteins mutually affect the stability of each other by inhibiting ubiquitination of the other protein. Based on these results, we suggest that NLBP may act as a novel tumor suppressor by inhibiting cell invasion, blocking NF-kappa B signaling, and increasing stability of the LZAP protein.	[Cho, Hyun Jung; Han, Seung Hun; No, Jin Gu; Kwon, Jae Young; Kim, Hongtae] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Kwon, Junhye] Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea	Sungkyunkwan University (SKKU); Sookmyung Women's University	Kim, H (corresponding author), 300 Cheoncheon Dong, Suwon 440746, South Korea.	khtcat@skku.edu			Korean Government (MOEHRD) [2008-313-C00257]; Ministry of Education, Science and Technology [2009-0074228]	Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Korea Research Foundation Grant KRF-2008-313-C00257 funded by the Korean Government (MOEHRD, Basic Research Promotion Fund) (to H. K.) and Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (Grant 2009-0074228).	Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; HOFER B, 1994, GENE, V144, P9, DOI 10.1016/0378-1119(94)90196-1; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Jiang H, 2009, CELL RES, V19, P458, DOI 10.1038/cr.2009.14; Kasahara K, 2002, CANCER GENET CYTOGEN, V137, P59, DOI 10.1016/S0165-4608(02)00552-6; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kim HT, 2001, BIOCHEM BIOPH RES CO, V286, P886, DOI 10.1006/bbrc.2001.5496; Masumoto A, 1999, HEPATOLOGY, V29, P68, DOI 10.1002/hep.510290146; Park SG, 2006, J BIOL CHEM, V281, P31770, DOI 10.1074/jbc.M603194200; Saito S, 2006, ONCOL REP, V16, P949; Sun M, 2006, DNA CELL BIOL, V25, P597, DOI 10.1089/dna.2006.25.597; van Gils W, 2008, MELANOMA RES, V18, P10, DOI 10.1097/CMR.0b013e3282f1d4d9; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wang JL, 2006, BIOCHEM J, V393, P489, DOI 10.1042/BJ20050960; Wang XJ, 2000, J BIOL CHEM, V275, P31763, DOI 10.1074/jbc.M004358200; WIEDEMANN LM, 1992, EUR J CANCER, V28A, P248, DOI 10.1016/0959-8049(92)90425-2	17	46	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12232	12240		10.1074/jbc.M109.065920	http://dx.doi.org/10.1074/jbc.M109.065920			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164180	Green Published, hybrid			2022-12-25	WOS:000276787100052
J	Kim, HJ; Choi, MY; Kim, HJ; Llinas, M				Kim, Hyun Jin; Choi, Moo Young; Kim, Hyung J.; Llinas, Miguel			Conformational Dynamics and Ligand Binding in the Multi-Domain Protein PDC109	PLOS ONE			English	Article							BOVINE SEMINAL PLASMA; CATION-PI INTERACTIONS; BULL SPERM BINDING; MOLECULAR-DYNAMICS; FREE-ENERGY; OVIDUCTAL EPITHELIUM; MATRIX METALLOPROTEINASE-2; THERMAL-STABILITY; MAJOR PROTEINS; MEAN FORCE	PDC109 is a modular multi-domain protein with two fibronectin type II (Fn2) repeats joined by a linker. It plays a major role in bull sperm binding to the oviductal epithelium through its interactions with phosphorylcholines (PhCs), a head group of sperm cell membrane lipids. The crystal structure of the PDC109-PhC complex shows that each PhC binds to the corresponding Fn2 domain, while the two domains are on the same face of the protein. Long timescale explicit solvent molecular dynamics (MD) simulations of PDC109, in the presence and absence of PhC, suggest that PhC binding strongly correlates with the relative orientation of choline-phospholipid binding sites of the two Fn2 domains; unless the two domains tightly bind PhCs, they tend to change their relative orientation by deforming the flexible linker. The effective PDC109-PhC association constant of 28 M-1, estimated from their potential of mean force is consistent with the experimental result. Principal component analysis of the long timescale MD simulations was compared to the significantly less expensive normal mode analysis of minimized structures. The comparison indicates that difference between relative domain motions of PDC109 with bound and unbound PhC is captured by the first principal component in the principal component analysis as well as the three lowest normal modes in the normal mode analysis. The present study illustrates the use of detailed MD simulations to clarify the energetics of specific ligand-domain interactions revealed by a static crystallographic model, as well as their influence on relative domain motions in a multi-domain protein.	[Kim, Hyun Jin; Kim, Hyung J.; Llinas, Miguel] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [Choi, Moo Young] Seoul Natl Univ, Dept Phys, Seoul 151742, South Korea; [Choi, Moo Young] Seoul Natl Univ, Ctr Theoret Phys, Seoul, South Korea; [Kim, Hyung J.] Korea Inst Adv Study, Sch Computat Sci, Seoul, South Korea	Carnegie Mellon University; Seoul National University (SNU); Seoul National University (SNU); Korea Institute for Advanced Study (KIAS)	Kim, HJ (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA.	hjkim@cmu.edu; llinas@andrew.cmu.edu	Kim, Hyung/S-3066-2016	Kim, Hyung/0000-0003-4334-1879; Choi, MooYoung/0000-0001-8070-7716	National Science Foundation (NSF) Chemistry [(CHE)-0098062]; National Institutes of Health (NIH) [HL-29409, GM-067964]; Korea Science and Engineering Foundation (KOSEF); NSF through TeraGrid resources provided by Pittsburgh Supercomputing Center (PSC);  [MCB070055P];  [MCB090046P]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067964] Funding Source: NIH RePORTER	National Science Foundation (NSF) Chemistry(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); NSF through TeraGrid resources provided by Pittsburgh Supercomputing Center (PSC)(National Science Foundation (NSF)); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Science Foundation (NSF) Chemistry (CHE)-0098062, National Institutes of Health (NIH) HL-29409 and GM-067964, Korea Science and Engineering Foundation (KOSEF). NSF through TeraGrid resources provided by Pittsburgh Supercomputing Center (PSC), grant MCB070055P and MCB090046P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbazhagan V, 2005, FEBS LETT, V579, P2933, DOI 10.1016/j.febslet.2005.04.046; BANYAI L, 1990, EUR J BIOCHEM, V193, P801, DOI 10.1111/j.1432-1033.1990.tb19403.x; Braun T, 2009, NAT NANOTECHNOL, V4, P179, DOI [10.1038/NNANO.2008.398, 10.1038/nnano.2008.398]; Brewerton SC, 2008, CURR OPIN DRUG DISC, V11, P356; Briknarova K, 2001, J BIOL CHEM, V276, P27613, DOI 10.1074/jbc.M101105200; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CALVETE JJ, 1994, FEBS LETT, V350, P203, DOI 10.1016/0014-5793(94)00768-3; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chilkoti A, 1995, BIOPHYS J, V69, P2125, DOI 10.1016/S0006-3495(95)80083-4; Chipot C, 1996, J AM CHEM SOC, V118, P2998, DOI 10.1021/ja950302e; CONSTANTINE KL, 1992, J MOL BIOL, V223, P281, DOI 10.1016/0022-2836(92)90731-X; Cubero E, 1998, P NATL ACAD SCI USA, V95, P5976, DOI 10.1073/pnas.95.11.5976; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; De Los Rios P, 2005, BIOPHYS J, V89, P14, DOI 10.1529/biophysj.104.055004; Derrick TS, 2002, J MAGN RESON, V155, P217, DOI 10.1006/jmre.2002.2513; DESNOYERS L, 1992, J BIOL CHEM, V267, P10149; Douglas JT, 2002, BIOCHEMISTRY-US, V41, P3302, DOI 10.1021/bi016018j; EDDY T, 2009, J MOL STRUC-THEOCHEM, V898, P31; ESSMANN U, 1995, J COMP PHYS, V15, P8577; Felder C, 2001, J PHYS CHEM A, V105, P1326, DOI 10.1021/jp002933n; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gasset M, 1997, EUR J BIOCHEM, V250, P735, DOI 10.1111/j.1432-1033.1997.00735.x; Gasset M, 2000, ARCH BIOCHEM BIOPHYS, V374, P241, DOI 10.1006/abbi.1999.1593; Gerwig GJ, 1996, FEBS LETT, V387, P99, DOI 10.1016/0014-5793(96)00448-6; Greube A, 2001, BIOCHEMISTRY-US, V40, P8326, DOI 10.1021/bi010552+; Grubmuller H., SOLVATE 1 0; Gwathmey TM, 2006, BIOL REPROD, V75, P501, DOI 10.1095/biolreprod.106.053306; Gwathmey TM, 2003, BIOL REPROD, V69, P809, DOI 10.1095/biolreprod.102.010827; HART TN, 1992, PROTEINS, V13, P206, DOI 10.1002/prot.340130304; Hayward Steven, 2008, V443, P89, DOI 10.1007/978-1-59745-177-2_5; Henin J, 2004, J CHEM PHYS, V121, P2904, DOI 10.1063/1.1773132; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jelinkova P, 2004, COLLECT CZECH CHEM C, V69, P616, DOI 10.1135/cccc20040616; Jiao D, 2008, P NATL ACAD SCI USA, V105, P6290, DOI 10.1073/pnas.0711686105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lee MS, 2006, BIOPHYS J, V90, P864, DOI 10.1529/biophysj.105.071589; Lefebvre R, 1997, BIOL REPROD, V56, P1198, DOI 10.1095/biolreprod56.5.1198; LINSE P, 1993, J AM CHEM SOC, V115, P8793, DOI 10.1021/ja00072a037; LLINAS M, 1973, STRUCT BOND, V17, P135; MacKerell A. D., 1998, ENCY COMPUTATIONAL C, V1, P271; MANJUNATH P, 1994, BIOCHEM J, V303, P121, DOI 10.1042/bj3030121; MANJUNATH P, 1987, BIOCHEM J, V241, P685, DOI 10.1042/bj2410685; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McLaughlin SH, 2002, PROTEIN SCI, V11, P1926, DOI 10.1110/ps.5000102; Mecozzi S, 1996, P NATL ACAD SCI USA, V93, P10566, DOI 10.1073/pnas.93.20.10566; Michel J, 2006, J MED CHEM, V49, P7427, DOI 10.1021/jm061021s; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; Moreau R, 1999, BBA-MOL CELL BIOL L, V1438, P175, DOI 10.1016/S1388-1981(99)00049-9; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Muller P, 1998, EUR BIOPHYS J BIOPHY, V27, P33, DOI 10.1007/s002490050108; Pavani P, 2008, RES J BIOTECHNOL, V3, P18; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ramakrishnan M, 2001, BIOPHYS J, V81, P2215, DOI 10.1016/S0006-3495(01)75869-9; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; Roche O, 2001, J MED CHEM, V44, P3592, DOI 10.1021/jm000467k; Rodriguez-Gomez D, 2004, J CHEM PHYS, V120, P3563, DOI 10.1063/1.1642607; Romero A, 1997, PROTEINS, V28, P454, DOI 10.1002/(SICI)1097-0134(199707)28:3<454::AID-PROT14>3.0.CO;2-G; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shim Y, 2008, J PHYS CHEM B, V112, P2637, DOI 10.1021/jp710128p; SHOUP D, 1982, BIOPHYS J, V40, P33, DOI 10.1016/S0006-3495(82)84455-X; STRAATSMA TP, 1986, MOL PHYS, V57, P89, DOI 10.1080/00268978600100071; Suarez SS, 1998, BIOL REPROD, V59, P39, DOI 10.1095/biolreprod59.1.39; Sun Y, 1998, J COMPUT AID MOL DES, V12, P597, DOI 10.1023/A:1008036704754; Swamy MJ, 2004, CURR SCI INDIA, V87, P203; Tannert A, 2007, EUR BIOPHYS J BIOPHY, V36, P461, DOI 10.1007/s00249-006-0105-3; Thomas CJ, 2003, BIOPHYS J, V84, P3037, DOI 10.1016/S0006-3495(03)70029-0; Tillett ML, 1999, J BIOMOL NMR, V13, P223, DOI 10.1023/A:1008301324954; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Wah DA, 2002, STRUCTURE, V10, P505, DOI 10.1016/S0969-2126(02)00751-7; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Zavodszky MI, 2009, J COMPUT AID MOL DES, V23, P289, DOI 10.1007/s10822-008-9258-8	74	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9180	10.1371/journal.pone.0009180	http://dx.doi.org/10.1371/journal.pone.0009180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174627	Green Published, gold, Green Submitted			2022-12-25	WOS:000274654700006
J	Samuel, AS; Paldurai, A; Kumar, S; Collins, PL; Samal, SK				Samuel, Arthur S.; Paldurai, Anandan; Kumar, Sachin; Collins, Peter L.; Samal, Siba K.			Complete Genome Sequence of Avian Paramyxovirus (APMV) Serotype 5 Completes the Analysis of Nine APMV Serotypes and Reveals the Longest APMV Genome	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; UNTRANSLATED REGIONS; VIRUS M; RNA; PROTEIN; NEURAMINIDASE; REPLICATION; DOMAIN; RULE; GENE	Background: Avian paramyxoviruses (APMV) consist of nine known serotypes. The genomes of representatives of all APMV serotypes except APMV type 5 have recently been fully sequenced. Here, we report the complete genome sequence of the APMV-5 prototype strain budgerigar/Kunitachi/74. Methodology/Principal Findings: APMV-5 Kunitachi virus is unusual in that it lacks a virion hemagglutinin and does not grow in the allantoic cavity of embryonated chicken eggs. However, the virus grew in the amniotic cavity of embryonated chicken eggs and in twelve different established cell lines and two primary cell cultures. The genome is 17,262 nucleotides (nt) long, which is the longest among members of genus Avulavirus, and encodes six non-overlapping genes in the order of 3'N-P/V/W-M-F-HN-L-5' with intergenic regions of 4-57 nt. The genome length follows the 'rule of six' and contains a 55-nt leader sequence at the 3' end and a 552 nt trailer sequence at the 59 end. The phosphoprotein (P) gene contains a conserved RNA editing site and is predicted to encode P, V, and W proteins. The cleavage site of the F protein (G-K-R-K-K-R down arrow F) conforms to the cleavage site motif of the ubiquitous cellular protease furin. Consistent with this, exogenous protease was not required for virus replication in vitro. However, the intracerebral pathogenicity index of APMV-5 strain Kunitachi in one-day-old chicks was found to be zero, indicating that the virus is avirulent for chickens despite the presence of a polybasic F cleavage site. Conclusions/Significance: Phylogenetic analysis of the sequences of the APVM-5 genome and proteins versus those of the other APMV serotypes showed that APMV-5 is more closely related to APMV-6 than to the other APMVs. Furthermore, these comparisons provided evidence of extensive genome-wide divergence that supports the classification of the APMVs into nine separate serotypes. The structure of the F cleavage site does not appear to be a reliable indicator of virulence among APMV serotypes 2-9. The availability of sequence information for all known APMV serotypes will facilitate studies in epidemiology and vaccinology.	[Samuel, Arthur S.; Paldurai, Anandan; Kumar, Sachin; Samal, Siba K.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Collins, Peter L.] NIAID, Infect Dis Lab, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Samuel, AS (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	ssamal@umd.edu			National Institute of Allergy and Infectious Diseases (NIAID) [N01A060009]; NIAID; National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000938] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institute of Allergy and Infectious Diseases (NIAID) contract no. N01A060009 (85% support) and NIAID, National Institutes of Health (NIH) Intramural Research Program (15% support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DJ, 1982, AVIAN PATHOL, V11, P179, DOI 10.1080/03079458208436091; ALEXANDER DJ, 1982, WORLD POULTRY SCI J, V38, P97, DOI 10.1079/WPS19820008; ALEXANDER DJ, 2003, AVIAN PARAMYXOVIRUSE, P88; Anderson DE, 2008, J VIROL, V82, P10510, DOI 10.1128/JVI.01419-08; Beck I, 2003, VACCINE, V21, P1006, DOI 10.1016/S0264-410X(02)00552-2; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Chang PC, 2001, J GEN VIROL, V82, P2157, DOI 10.1099/0022-1317-82-9-2157; COLEMAN NA, 1993, VIROLOGY, V195, P596, DOI 10.1006/viro.1993.1411; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; de Almeida RS, 2009, VACCINE, V27, P3127, DOI 10.1016/j.vaccine.2009.03.076; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; GOUGH RE, 1993, VET REC, V133, P123, DOI 10.1136/vr.133.5.123-a; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; Jack PJM, 2005, J VIROL, V79, P10690, DOI 10.1128/JVI.79.16.10690-10700.2005; Jung A, 2009, J AVIAN MED SURG, V23, P205, DOI 10.1647/2008-022.1; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; Krishnamurthy S, 1998, J GEN VIROL, V79, P2419, DOI 10.1099/0022-1317-79-10-2419; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KUMAR S, 2008, VIRUS RES; Lamb R. A, 2005, VIRUS TAXONOMY CLASS, P655; LAMB RA, 1977, VIROLOGY, V81, P382, DOI 10.1016/0042-6822(77)90154-4; Langedijk JPM, 1997, J VIROL, V71, P6155, DOI 10.1128/JVI.71.8.6155-6167.1997; Li Z, 2006, VIROLOGY, V346, P219, DOI 10.1016/j.virol.2005.10.039; Lin Y, 2005, VIROLOGY, V338, P270, DOI 10.1016/j.virol.2005.05.014; Malur AG, 2002, J VIROL, V76, P8101, DOI 10.1128/JVI.76.16.8101-8109.2002; Miller PJ, 2003, VIROLOGY, V317, P330, DOI 10.1016/j.virol.2003.08.013; MIRZA AM, 1994, J VIROL, V68, P5093, DOI 10.1128/JVI.68.8.5093-5099.1994; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; MUSTAFFABABJEE A, 1974, AVIAN DIS, V18, P226, DOI 10.2307/1589130; Nayak B, 2008, VIROL J, V5, DOI [10.1186/1743-422X-5-124, 10.1186/1743-422x-5-124]; NEROME K, 1978, J GEN VIROL, V38, P293, DOI 10.1099/0022-1317-38-2-293; NYLUND S, 2007, VIROLOGY; Paldurai A, 2009, VIRUS RES, V142, P144, DOI 10.1016/j.virusres.2009.02.003; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; POCH O, 1990, J GEN VIROL, V71, P1153, DOI 10.1099/0022-1317-71-5-1153; PURCHASE HG, 1990, LAB MANUAL ISOLATION, P240; Samal SK, 1996, J VIROL, V70, P5075, DOI 10.1128/JVI.70.8.5075-5082.1996; Samuel AS, 2009, VIRUS RES, V142, P10, DOI 10.1016/j.virusres.2008.12.016; Schmitt AP, 2005, J VIROL, V79, P2988, DOI 10.1128/JVI.79.5.2988-2997.2005; Schnell MJ, 1995, VIROLOGY, V214, P522, DOI 10.1006/viro.1995.0063; SHIODA T, 1986, NUCLEIC ACIDS RES, V14, P1545, DOI 10.1093/nar/14.4.1545; Subbiah M, 2008, VIRUS RES, V137, P40, DOI 10.1016/j.virusres.2008.05.012; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; Takimoto T, 2000, VIROLOGY, V270, P208, DOI 10.1006/viro.2000.0263; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Weingartl HM, 2003, J CLIN MICROBIOL, V41, P1280, DOI 10.1128/JCM.41.3.1280-1284.2003; Xiao S, 2009, VIRUS RES, V145, P80, DOI 10.1016/j.virusres.2009.06.003; Yan YQ, 2009, J VIROL, V83, P5943, DOI 10.1128/JVI.00188-09; Yu M, 1998, J GEN VIROL, V79, P1775, DOI 10.1099/0022-1317-79-7-1775	50	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9269	10.1371/journal.pone.0009269	http://dx.doi.org/10.1371/journal.pone.0009269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174645	gold, Green Published, Green Submitted			2022-12-25	WOS:000274590600022
J	Khankin, EV; Mutter, WP; Tamez, H; Yuan, HT; Karumanchi, SA; Thadhani, R				Khankin, Eliyahu V.; Mutter, Walter P.; Tamez, Hector; Yuan, Hai-Tao; Karumanchi, S. Ananth; Thadhani, Ravi			Soluble Erythropoietin Receptor Contributes to Erythropoietin Resistance in End-Stage Renal Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INCIDENT HEMODIALYSIS-PATIENTS; TRANSFERRIN RECEPTOR; INDUCED DIFFERENTIATION; STIMULATING AGENTS; ANEMIA MANAGEMENT; ENDOTHELIAL-CELLS; DIALYSIS PATIENTS; EPOETIN-ALPHA; VITAMIN-D	Background: Erythropoietin is a growth factor commonly used to manage anemia in patients with chronic kidney disease. A significant clinical challenge is relative resistance to erythropoietin, which leads to use of successively higher erythropoietin doses, failure to achieve target hemoglobin levels, and increased risk of adverse outcomes. Erythropoietin acts through the erythropoietin receptor (EpoR) present in erythroblasts. Alternative mRNA splicing produces a soluble form of EpoR (sEpoR) found in human blood, however its role in anemia is not known. Methods and Findings: Using archived serum samples obtained from subjects with end stage kidney disease we show that sEpoR is detectable as a 27kDa protein in the serum of dialysis patients, and that higher serum sEpoR levels correlate with increased erythropoietin requirements. Soluble EpoR inhibits erythropoietin mediated signal transducer and activator of transcription 5 (Stat5) phosphorylation in cell lines expressing EpoR. Importantly, we demonstrate that serum from patients with elevated sEpoR levels blocks this phosphorylation in ex vivo studies. Finally, we show that sEpoR is increased in the supernatant of a human erythroleukaemia cell line when stimulated by inflammatory mediators such as interleukin-6 and tumor necrosis factor alpha implying a link between inflammation and erythropoietin resistance. Conclusions: These observations suggest that sEpoR levels may contribute to erythropoietin resistance in end stage renal disease, and that sEpoR production may be mediated by pro-inflammatory cytokines.	[Khankin, Eliyahu V.; Mutter, Walter P.; Tamez, Hector; Yuan, Hai-Tao; Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Khankin, Eliyahu V.; Mutter, Walter P.; Tamez, Hector; Yuan, Hai-Tao; Karumanchi, S. Ananth; Thadhani, Ravi] Harvard Univ, Sch Med, Boston, MA USA; [Thadhani, Ravi] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute	Khankin, EV (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	sananth@bidmc.harvard.edu	Karumanchi, Subbian Ananth/AAI-1694-2021; Khankin, Eli/M-7648-2013	Khankin, Eliyahu/0000-0002-1695-7267	Beth Israel Deaconess Medical Center; Massachusetts General Hospital; Satellite Research; Normon S. Coplon Grant	Beth Israel Deaconess Medical Center; Massachusetts General Hospital(General Electric); Satellite Research; Normon S. Coplon Grant	This work was supported by Department of Medicine seed funds from the Beth Israel Deaconess Medical Center and the Massachusetts General Hospital. S. A. K. is an investigator of the Howard Hughes Medical Institute. Work was also funded by Satellite Research, Normon S. Coplon Grant to W. P. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia N, 1997, AM J KIDNEY DIS, V30, P532, DOI 10.1016/S0272-6386(97)90313-9; Arcasoy MO, 2003, BIOCHEM BIOPH RES CO, V307, P999, DOI 10.1016/S0006-291X(03)01303-2; BARRON C, 1994, GENE, V147, P263, DOI 10.1016/0378-1119(94)90078-7; BAYNES RD, 1993, BLOOD, V82, P2088; Beleslin-Cokic BB, 2004, BLOOD, V104, P2073, DOI 10.1182/blood-2004-02-0744; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Brunelli SM, 2008, CLIN J AM SOC NEPHRO, V3, P1733, DOI 10.2215/CJN.02390508; Buck I, 2008, BIOCHEM PHARMACOL, V76, P1229, DOI 10.1016/j.bcp.2008.08.025; Chen CM, 2004, BLOOD, V104, P73, DOI 10.1182/blood-2003-04-1340; Chen CM, 2001, J BIOL CHEM, V276, P38518, DOI 10.1074/jbc.M105702200; Chen HH, 2008, J NEPHROL, V21, P543; Chiang WC, 2002, CLIN NEPHROL, V58, P363; Coyne DW, 2008, SEMIN DIALYSIS, V21, P212, DOI 10.1111/j.1525-139X.2008.00423.x; Daschner M, 1999, CLIN NEPHROL, V52, P246; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Eleftheriadis T, 2006, ACTA HAEMATOL-BASEL, V116, P238, DOI 10.1159/000095873; FERRO FE, 1993, J BIOL CHEM, V268, P5741; Goodnough LT, 2007, EXP HEMATOL, V35, P167, DOI 10.1016/j.exphem.2007.01.026; Greenwood RN, 2003, KIDNEY INT, V64, pS78, DOI 10.1046/j.1523-1755.64.s87.12.x; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Harris KW, 1996, AM J HEMATOL, V52, P8, DOI 10.1002/(SICI)1096-8652(199605)52:1<8::AID-AJH2>3.0.CO;2-Z; Horl WH, 2002, NEPHROL DIAL TRANSPL, V17, P35, DOI 10.1093/ndt/17.suppl_11.35; Hornig C, 2000, LAB INVEST, V80, P443, DOI 10.1038/labinvest.3780050; Johnson DW, 2007, NEPHROLOGY, V12, P321, DOI 10.1111/j.1440-1797.2007.00810.x; JONES SS, 1990, BLOOD, V76, P31; Joyeux-Faure M, 2007, J PHARMACOL EXP THER, V323, P759, DOI 10.1124/jpet.107.127357; Kalantar-Zadeh K, 2009, AM J KIDNEY DIS, V53, P823, DOI 10.1053/j.ajkd.2008.12.040; Kato A, 2008, AM J NEPHROL, V28, P115, DOI 10.1159/000109968; Kaysen GA, 2006, AM J KIDNEY DIS, V47, P157, DOI 10.1053/j.ajkd.2005.09.013; Keithi-Reddy SR, 2008, KIDNEY INT, V74, P782, DOI 10.1038/ki.2008.245; Krosl J, 1996, J BIOL CHEM, V271, P27432, DOI 10.1074/jbc.271.44.27432; Kubota Y, 2001, EMBO J, V20, P5666, DOI 10.1093/emboj/20.20.5666; KURAMOCHI H, 1990, CHEM PHARM BULL, V38, P123; Lacson E, 2008, AM J KIDNEY DIS, V52, P1104, DOI 10.1053/j.ajkd.2008.07.026; Lee PS, 2009, J AM SOC NEPHROL, V20, P1140, DOI 10.1681/ASN.2008091008; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Maruyama H, 2004, J GENE MED, V6, P228, DOI 10.1002/jgm.485; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; NAGAO M, 1992, BIOCHEM BIOPH RES CO, V188, P888, DOI 10.1016/0006-291X(92)91139-H; Navaneethan SD, 2006, J NEPHROL, V19, P640; Neumann D, 1996, BIOCHEM J, V313, P391, DOI 10.1042/bj3130391; Paoletti E, 2006, J AM SOC NEPHROL, V17, pS74, DOI 10.1681/ASN.2005121325; Pisoni RL, 2004, AM J KIDNEY DIS, V44, P94, DOI 10.1053/j.ajkd.2004.03.023; Priyadarshi A, 2006, SEMIN DIALYSIS, V19, P273, DOI 10.1111/j.1525-139X.2006.00172.x; Rossert J, 2005, NEPHROL DIAL TRANSPL, V20, P1025, DOI 10.1093/ndt/gfh800; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Soliz J, 2007, J PHYSIOL-LONDON, V583, P329, DOI 10.1113/jphysiol.2007.133454; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; Stenvinkel P, 2002, NEPHROL DIAL TRANSPL, V17, P32, DOI 10.1093/ndt/17.suppl_5.32; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003967.pub2; Tarng DC, 2002, NEPHROL DIAL TRANSPL, V17, P1063, DOI 10.1093/ndt/17.6.1063; TODOKORO K, 1991, GENE, V106, P283; Tsuchihashi D, 2008, THER APHER DIAL, V12, P226, DOI 10.1111/j.1744-9987.2008.00578.x; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Westphal G, 2002, CLIN EXP MED, V2, P45, DOI 10.1007/s102380200006; WINKELMANN JC, 1990, BLOOD, V76, P24; Wolf M, 2007, KIDNEY INT, V72, P1004, DOI 10.1038/sj.ki.5002451; Wolf M, 2008, J AM SOC NEPHROL, V19, P1379, DOI 10.1681/ASN.2007091002; YET MG, 1993, BLOOD, V82, P1713, DOI 10.1182/blood.V82.6.1713.bloodjournal8261713; Yoshida S, 1996, BLOOD, V88, P3246, DOI 10.1182/blood.V88.8.3246.bloodjournal8883246; Zhang Y, 2004, AM J KIDNEY DIS, V44, P866, DOI 10.1053/j.ajkd.2004.08.002	65	37	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9246	10.1371/journal.pone.0009246	http://dx.doi.org/10.1371/journal.pone.0009246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169072	gold, Green Published, Green Submitted			2022-12-25	WOS:000274590500024
J	Kostecki, JS; Li, HM; Turner, RJ; DeLisa, MP				Kostecki, Jan S.; Li, Haiming; Turner, Raymond J.; DeLisa, Matthew P.			Visualizing Interactions along the Escherichia coli Twin-Arginine Translocation Pathway Using Protein Fragment Complementation	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; FOLDING QUALITY-CONTROL; LEADER-BINDING PROTEIN; TRANSPORT SYSTEM; SIGNAL PEPTIDE; TATA COMPONENT; LIVING CELLS; DIFFERENTIAL INTERACTIONS; SECRETORY PATHWAY; COMMON PRINCIPLES	The twin-arginine translocation (Tat) pathway is well known for its ability to export fully folded substrate proteins out of the cytoplasm of Gram-negative and Gram-positive bacteria. Studies of this mechanism in Escherichia coli have identified numerous transient protein-protein interactions that guide export-competent proteins through the Tat pathway. To visualize these interactions, we have adapted bimolecular fluorescence complementation (BiFC) to detect protein-protein interactions along the Tat pathway of living cells. Fragments of the yellow fluorescent protein (YFP) were fused to soluble and transmembrane factors that participate in the translocation process including Tat substrates, Tat-specific proofreading chaperones and the integral membrane proteins TatABC that form the translocase. Fluorescence analysis of these YFP chimeras revealed a wide range of interactions such as the one between the Tat substrate dimethyl sulfoxide reductase (DmsA) and its dedicated proofreading chaperone DmsD. In addition, BiFC analysis illuminated homo- and hetero-oligomeric complexes of the TatA, TatB and TatC integral membrane proteins that were consistent with the current model of translocase assembly. In the case of TatBC assemblies, we provide the first evidence that these complexes are co-localized at the cell poles. Finally, we used this BiFC approach to capture interactions between the putative Tat receptor complex formed by TatBC and the DmsA substrate or its dedicated chaperone DmsD. Our results demonstrate that BiFC is a powerful approach for studying cytoplasmic and inner membrane interactions underlying bacterial secretory pathways.	[Kostecki, Jan S.; DeLisa, Matthew P.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Li, Haiming; Turner, Raymond J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY USA	Cornell University; University of Calgary; Cornell University	Kostecki, JS (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	md255@cornell.edu	DeLisa, Matthew/AAE-7361-2019; Turner, Raymond J./M-3961-2015	Turner, Raymond J./0000-0002-9263-0776; DeLisa, Matthew/0000-0003-3226-1566	Canadian Institutes of Health; National Science Foundation (NSF) [CBET 0448090]; New York State Foundation for Science, Technology and Innovation (NYSTAR)	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); National Science Foundation (NSF)(National Science Foundation (NSF)); New York State Foundation for Science, Technology and Innovation (NYSTAR)	This material is based upon work supported by a Canadian Institutes of Health Research Operating grant (to R.J.T.) and a National Science Foundation (NSF) CAREER Award (CBET 0448090) and a New York State Foundation for Science, Technology and Innovation (NYSTAR) James D. Watson Young Investigator Award (to M. P. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrett CML, 2005, J MOL BIOL, V347, P453, DOI 10.1016/j.jmb.2005.01.026; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Behrendt J, 2007, FEBS LETT, V581, P4085, DOI 10.1016/j.febslet.2007.07.045; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Berthelmann F, 2004, FEBS LETT, V569, P82, DOI 10.1016/j.febslet.2004.05.054; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Chan CS, 2008, BIOCHEMISTRY-US, V47, P2749, DOI 10.1021/bi702138a; Chan CS, 2009, J BACTERIOL, V191, P2091, DOI 10.1128/JB.00949-08; Chan CS, 2006, BIOCHEM BIOPH RES CO, V343, P244, DOI 10.1016/j.bbrc.2006.02.133; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Driessen AJM, 1998, CURR OPIN MICROBIOL, V1, P216, DOI 10.1016/S1369-5274(98)80014-3; Driessen AJM, 2001, NAT STRUCT BIOL, V8, P492, DOI 10.1038/88549; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Fisher AC, 2004, J BACTERIOL, V186, P7467, DOI 10.1128/JB.186.22.7467-7473.2004; Fisher AC, 2009, J MOL BIOL, V385, P299, DOI 10.1016/j.jmb.2008.10.051; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Graubner W, 2007, J BIOL CHEM, V282, P7116, DOI 10.1074/jbc.M608235200; Hatzixanthis K, 2005, P NATL ACAD SCI USA, V102, P8460, DOI 10.1073/pnas.0500737102; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; Ilbert M, 2004, MICROBIOL-SGM, V150, P935, DOI 10.1099/mic.0.26909-0; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Jack RL, 2005, BIOCHEM SOC T, V33, P105, DOI 10.1042/BST0330105; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lee PA, 2006, J BIOL CHEM, V281, P34072, DOI 10.1074/jbc.M607295200; Matos CFRO, 2008, EMBO J, V27, P2055, DOI 10.1038/emboj.2008.132; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Oresnik IJ, 2001, MOL MICROBIOL, V40, P323, DOI 10.1046/j.1365-2958.2001.02391.x; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Papish AL, 2003, J BIOL CHEM, V278, P32501, DOI 10.1074/jbc.M301076200; Perez-Rodriguez R, 2007, J MOL BIOL, V367, P715, DOI 10.1016/j.jmb.2007.01.027; Pommier J, 1998, J BIOL CHEM, V273, P16615, DOI 10.1074/jbc.273.26.16615; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Ray N, 2003, FEBS LETT, V534, P156, DOI 10.1016/S0014-5793(02)03839-5; Ribnicky B, 2007, J MOL BIOL, V369, P631, DOI 10.1016/j.jmb.2007.03.068; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Russell DW, 2001, MOL CLONING LAB MANU; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Santini CL, 2001, J BIOL CHEM, V276, P8159, DOI 10.1074/jbc.C000833200; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Shyu YJ, 2008, NAT PROTOC, V3, P1693, DOI 10.1038/nprot.2008.157; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Stuart RA, 2000, NATURE, V406, P575, DOI 10.1038/35020668; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vergnes A, 2006, J BIOL CHEM, V281, P2170, DOI 10.1074/jbc.M505902200; Waraho D, 2009, P NATL ACAD SCI USA, V106, P3692, DOI 10.1073/pnas.0704048106; Wehrman T, 2002, P NATL ACAD SCI USA, V99, P3469, DOI 10.1073/pnas.062043699; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255	70	33	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9225	10.1371/journal.pone.0009225	http://dx.doi.org/10.1371/journal.pone.0009225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169075	Green Published, Green Submitted, gold			2022-12-25	WOS:000274590500007
J	Fauque, P; Mondon, F; Letourneur, F; Ripoche, MA; Journot, L; Barbaux, S; Dandolo, L; Patrat, C; Wolf, JP; Jouannet, P; Jammes, H; Vaiman, D				Fauque, Patricia; Mondon, Francoise; Letourneur, Franck; Ripoche, Marie-Anne; Journot, Laurent; Barbaux, Sandrine; Dandolo, Luisa; Patrat, Catherine; Wolf, Jean-Philippe; Jouannet, Pierre; Jammes, Helene; Vaiman, Daniel			In Vitro Fertilization and Embryo Culture Strongly Impact the Placental Transcriptome in the Mouse Model	PLOS ONE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; INTRACYTOPLASMIC SPERM INJECTION; SILVER-RUSSELL-SYNDROME; ASSISTED REPRODUCTIVE TECHNOLOGIES; MAJOR BIRTH-DEFECTS; GENE-EXPRESSION; IMPRINTED GENES; CHILDREN BORN; CONGENITAL-MALFORMATIONS; DNA-METHYLATION	Background: Assisted Reproductive Technologies (ART) are increasingly used in humans; however, their impact is now questioned. At blastocyst stage, the trophectoderm is directly in contact with an artificial medium environment, which can impact placental development. This study was designed to carry out an in-depth analysis of the placental transcriptome after ART in mice. Methodology/Principal Findings: Blastocysts were transferred either (1) after in vivo fertilization and development (control group) or (2) after in vitro fertilization and embryo culture. Placentas were then analyzed at E10.5. Six percent of transcripts were altered at the two-fold threshold in placentas of manipulated embryos, 2/3 of transcripts being down-regulated. Strikingly, the X-chromosome harbors 11% of altered genes, 2/3 being induced. Imprinted genes were modified similarly to the X. Promoter composition analysis indicates that FOXA transcription factors may be involved in the transcriptional deregulations. Conclusions: For the first time, our study shows that in vitro fertilization associated with embryo culture strongly modify the placental expression profile, long after embryo manipulations, meaning that the stress of artificial environment is memorized after implantation. Expression of X and imprinted genes is also greatly modulated probably to adapt to adverse conditions. Our results highlight the importance of studying human placentas from ART.	[Fauque, Patricia; Patrat, Catherine; Wolf, Jean-Philippe; Jouannet, Pierre] Hop Cochin, Serv Histol Embryol, F-75674 Paris, France; [Fauque, Patricia; Mondon, Francoise; Letourneur, Franck; Ripoche, Marie-Anne; Barbaux, Sandrine; Dandolo, Luisa; Patrat, Catherine; Wolf, Jean-Philippe; Jouannet, Pierre; Jammes, Helene; Vaiman, Daniel] Univ Paris 05, Paris, France; [Fauque, Patricia; Mondon, Francoise; Ripoche, Marie-Anne; Barbaux, Sandrine; Dandolo, Luisa; Jammes, Helene; Vaiman, Daniel] CNRS, INSERM, Dept Genet & Dev, Inst Cochin,Equipe 21,U567,UMR 8104, Paris, France; [Journot, Laurent] Inst Genom Fonct, Montpellier, France; [Jammes, Helene] INRA, ENVA, UMR1198, Jouy En Josas, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Fauque, P (corresponding author), Hop Cochin, Serv Histol Embryol, 27 Rue Faubourg St Jacques, F-75674 Paris, France.	patricia.fauque@cch.aphp.fr	Journot, Laurent/T-9652-2018; Vaiman, Daniel/O-6030-2015; Barbaux, Sandrine C/B-2878-2019	Journot, Laurent/0000-0003-3499-8887; Vaiman, Daniel/0000-0002-1915-0717; Barbaux, Sandrine C/0000-0002-8204-1855	Fond d'Aide la Recherche d'Organon [ALA-570/06]; Agence de Biomedecine [06.21.DPM OMA 09]	Fond d'Aide la Recherche d'Organon; Agence de Biomedecine	Funding: This research was supported by grants from the "Fond d'Aide la Recherche d'Organon" (ALA-570/06) and from the "Agence de Biomedecine" (06.21.DPM OMA 09), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras Nagy M. G., 2003, MANIPULATING MOUSE E, V3rd; Beeson JG, 2005, CURR TOP MICROBIOL, V297, P187; Bliek J, 2006, AM J HUM GENET, V78, P604, DOI 10.1086/502981; Bowdin S, 2007, HUM REPROD, V22, P3237, DOI 10.1093/humrep/dem268; Buffat C, 2007, ENDOCRINOLOGY, V148, P5549, DOI 10.1210/en.2007-0765; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Corcoran D, 2006, REPRODUCTION, V131, P651, DOI 10.1530/rep.1.01015; Cox GF, 2002, AM J HUM GENET, V71, P162, DOI 10.1086/341096; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Douzgou S, 2008, PEDIATR DEVEL PATHOL, V11, P329, DOI 10.2350/08-04-0458.1; Ecker DJ, 2004, P NATL ACAD SCI USA, V101, P1595, DOI 10.1073/pnas.0306846101; El-Chaar D, 2009, FERTIL STERIL, V92, P1557, DOI 10.1016/j.fertnstert.2008.08.080; Fauque P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-116; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; Fortier AL, 2008, HUM MOL GENET, V17, P1653, DOI 10.1093/hmg/ddn055; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; Gicquel C, 2003, AM J HUM GENET, V72, P1338, DOI 10.1086/374824; Giritharan G, 2007, REPRODUCTION, V134, P63, DOI 10.1530/REP-06-0247; Gomes MV, 2007, AM J MED GENET A, V143A, P625, DOI 10.1002/ajmg.a.31628; Guerif F, 2007, HUM REPROD, V22, P1973, DOI 10.1093/humrep/dem100; Halliday J, 2004, AM J HUM GENET, V75, P526, DOI 10.1086/423902; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; Hansen M, 2005, HUM REPROD, V20, P328, DOI 10.1093/humrep/deh593; Hemberger M, 2007, CELL MOL LIFE SCI, V64, P2422, DOI 10.1007/s00018-007-7113-z; Hohn HP, 2002, CELLS TISSUES ORGANS, V172, P218, DOI 10.1159/000066965; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Husslein H, 2009, PLACENTA, V30, P284, DOI 10.1016/j.placenta.2008.12.002; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kagami M, 2007, J ASSIST REPROD GEN, V24, P131, DOI 10.1007/s10815-006-9096-3; Kallen B, 2005, BIRTH DEFECTS RES A, V73, P162, DOI 10.1002/bdra.20107; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; KATARI S, 2009, HUM MOL GENET; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; Kininis Miltiadis, 2008, Nucl Recept Signal, V6, pe005, DOI 10.1621/nrs.06005; Klemetti R, 2005, FERTIL STERIL, V84, P1300, DOI 10.1016/j.fertnstert.2005.03.085; Kovalevsky G, 2003, FERTIL STERIL, V79, P1270, DOI 10.1016/S0015-0282(03)00397-2; Lee JT, 2003, CURR BIOL, V13, pR242, DOI 10.1016/S0960-9822(03)00162-3; Li T, 2005, MOL HUM REPROD, V11, P631, DOI 10.1093/molehr/gah230; Ludwig Hans, 2005, Arch Gynecol Obstet, V271, P1, DOI 10.1007/s00404-004-0711-1; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Maher ER, 2003, J MED GENET, V40, P62, DOI 10.1136/jmg.40.1.62; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; Manning M, 2000, MOL HUM REPROD, V6, P1049, DOI 10.1093/molehr/6.11.1049; Marin JJG, 2003, PLACENTA, V24, P431, DOI 10.1053/plac.2002.0951; Marin JJG, 2008, LIVER INT, V28, P435, DOI 10.1111/j.1478-3231.2008.01680.x; Martin-de-Lara F, 2008, TRANSGENIC RES, V17, P1131, DOI 10.1007/s11248-008-9214-3; Meller M, 2005, PLACENTA, V26, P601, DOI 10.1016/j.placenta.2004.09.009; Merlob P, 2005, EUR J MED GENET, V48, P5, DOI 10.1016/j.ejmg.2005.01.019; Mondon F, 2005, PHYSIOL GENOMICS, V22, P99, DOI 10.1152/physiolgenomics.00276.2004; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Olson CK, 2005, FERTIL STERIL, V84, P1308, DOI 10.1016/j.fertnstert.2005.03.086; Orstavik KH, 2003, AM J HUM GENET, V72, P218, DOI 10.1086/346030; Polgar O, 2008, EXPERT OPIN DRUG MET, V4, P1, DOI 10.1517/17425255.4.1.1 ; Rinaudo P, 2004, REPRODUCTION, V128, P301, DOI 10.1530/rep.1.00297; Rinaudo PF, 2006, FERTIL STERIL, V86, P1252, DOI 10.1016/j.fertnstert.2006.05.017; Rivera RM, 2008, HUM MOL GENET, V17, P1, DOI 10.1093/hmg/ddm280; Rodriguez TA, 2004, MOL CELL BIOL, V24, P228, DOI 10.1128/MCB.24.1.228-244.2004; Sasaki H, 1995, DEVELOPMENT, V121, P4195; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; Stromberg B, 2002, LANCET, V359, P461, DOI 10.1016/S0140-6736(02)07674-2; TIERLING S, 2009, J MED GENET; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Wright Victoria Clay, 2008, Morbidity and Mortality Weekly Report, V57, P1	68	67	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9218	10.1371/journal.pone.0009218	http://dx.doi.org/10.1371/journal.pone.0009218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169163	Green Published, gold			2022-12-25	WOS:000274474700012
J	Molenaar, JJ; Ebus, ME; Koster, J; Santo, E; Geerts, D; Versteeg, R; Caron, HN				Molenaar, J. J.; Ebus, M. E.; Koster, J.; Santo, E.; Geerts, D.; Versteeg, R.; Caron, H. N.			Cyclin D1 is a direct transcriptional target of GATA3 in neuroblastoma tumor cells	ONCOGENE			English	Article						CCND1; ChIP; GATA3; microarray; neuroblastoma	ESTROGEN-RECEPTOR; BREAST-CANCER; AMPLIFICATION; HYDROXYLASE; EXPRESSION; FATE; GENE	Almost all neuroblastoma tumors express excess levels of Cyclin D1 (CCND1) compared to normal tissues and other tumor types. Only a small percentage of these neuroblastoma tumors have high-level amplification of the Cyclin D1 gene. The other neuroblastoma tumors have equally high Cyclin D1 expression without amplification. Silencing of Cyclin D1 expression was previously found to trigger differentiation of neuroblastoma cells. Overexpression of Cyclin D1 is therefore one of the most frequent mechanisms with a postulated function in neuroblastoma pathogenesis. The cause for the Cyclin D1 overexpression is unknown. Here we show that Cyclin D1 overexpression results from transcriptional upregulation. To identify upstream regulators, we searched in mRNA profiles of neuroblastoma tumor series for transcription factors with expression patterns correlating to Cyclin D1. GATA3 most consistently correlated to Cyclin D1 in four independent data sets. We identified a highly conserved GATA3 binding site 27 bp upstream of the Cyclin D1 transcriptional start. Chromatin immune precipitation confirmed binding of GATA3 to the Cyclin D1 promoter. Overexpression of GATA3 induced Cyclin D1 promoter activity, which decreased after site-directed mutagenesis of the GATA3 binding site in the Cyclin D1 promoter. Silencing of GATA3 resulted in reduced Cyclin D1 promoter activity and reduced Cyclin D1 mRNA and protein levels. Moreover, GATA3 silencing caused differentiation that was similar to that caused by Cyclin D1 inhibition. These finding implicate GATA3 in Cyclin D1 overexpression in neuroblastoma. Oncogene (2010) 29, 2739-2745; doi:10.1038/onc.2010.21; published online 15 February 2010	[Molenaar, J. J.; Ebus, M. E.; Koster, J.; Santo, E.; Geerts, D.; Versteeg, R.] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands; [Molenaar, J. J.; Caron, H. N.] Univ Amsterdam, Acad Med Ctr, Emma Kinderziekenhuis, Dept Pediat Oncol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Molenaar, JJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Human Genet, M1-132,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.molenaar@amc.uva.nl	Versteeg, Rogier/AAQ-1765-2020; Koster, Jan/C-5934-2008; Geerts, Dirk/K-8260-2015	Koster, Jan/0000-0002-0890-7585; Geerts, Dirk/0000-0002-6386-8187; Versteeg, Rogier/0000-0001-7172-0388	Stichting Koningin Wilhelmina Fonds; Stichting Kindergeneeskundig Kankeronderzoek; Kinderen Kankervrij	Stichting Koningin Wilhelmina Fonds; Stichting Kindergeneeskundig Kankeronderzoek; Kinderen Kankervrij	We kindly thank Dr RG Pestell for the full-length Cyclin D1 pA3 promoter construct that we used to generate our pGL3 Cyclin D1 promoter construct. The work was supported by Stichting Koningin Wilhelmina Fonds (KWF), Stichting Kindergeneeskundig Kankeronderzoek (SKK) and Kinderen Kankervrij (KiKa).	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Caren H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-353; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoch RV, 1999, INT J CANCER, V84, P122; Hong SJ, 2008, NEUROCHEM RES, V33, P1821, DOI 10.1007/s11064-008-9639-3; Hong SJ, 2006, J NEUROCHEM, V98, P773, DOI 10.1111/j.1471-4159.2006.03924.x; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Michels E, 2007, GENE CHROMOSOME CANC, V46, P1098, DOI 10.1002/gcc.20496; Molenaar JJ, 2008, CANCER RES, V68, P2599, DOI 10.1158/0008-5472.CAN-07-5032; Molenaar JJ, 2003, GENE CHROMOSOME CANC, V36, P242, DOI 10.1002/gcc.10166; Pei XH, 2009, CANCER CELL, V15, P389, DOI 10.1016/j.ccr.2009.03.004; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Tsarovina K, 2004, DEVELOPMENT, V131, P4775, DOI 10.1242/dev.01370; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Vallania F, 2009, P NATL ACAD SCI USA, V106, P5117, DOI 10.1073/pnas.0900473106; van Limpt V, 2004, ONCOGENE, V23, P9280, DOI 10.1038/sj.onc.1208157; van Noesel MM, 2004, GENE, V325, P1, DOI 10.1016/j.gene.2003.09.042; VANROY N, 1995, CANCER GENET CYTOGEN, V82, P151; Wilson BJ, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-49	23	30	32	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 6	2010	29	18					2739	2745		10.1038/onc.2010.21	http://dx.doi.org/10.1038/onc.2010.21			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	592DC	20154722				2022-12-25	WOS:000277354600013
J	Landau, G; Bercovich, Z; Park, MH; Kahana, C				Landau, Guy; Bercovich, Zippi; Park, Myung Hee; Kahana, Chaim			The Role of Polyamines in Supporting Growth of Mammalian Cells Is Mediated through Their Requirement for Translation Initiation and Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE; DEOXYHYPUSINE SYNTHASE; FACTOR 5A; HYPUSINE MODIFICATION; PROTEIN-SYNTHESIS; MESSENGER-RNA; INHIBITION; EIF5A; SPERMIDINE; ANTIZYME	Polyamines are essential cell constituents whose depletion results in growth cessation. Here we have investigated potential mechanisms of action of polyamines in supporting mammalian cell proliferation. We demonstrate that polyamines regulate translation both at the initiation and at the elongation steps. L-alpha-Difluoromethylornithine treatment resulting in polyamine depletion reduces protein synthesis via inhibition of translation initiation. N1-Guanyl-diaminoheptane (GC7), a spermidine analogue that inhibits eukaryotic initiation factor 5A (eIF5A) hypusination, also caused inhibition of translation initiation. In contrast, depletion of eIF5A by short hairpin RNA inhibits translation elongation as was recently demonstrated in yeast and Drosophila. These results suggest that in addition to competing with spermidine in the hypusination reaction, GC7 also competes with spermidine at yet undefined sites required for translation initiation. Finally, we show that either polyamine depletion or GC7 treatment induced eIF2 alpha phosphorylation and reduced phosphorylation of 4E-BP, thus setting the molecular basis for the observed inhibition of translation initiation.	[Landau, Guy; Bercovich, Zippi; Kahana, Chaim] Weizmann Inst Sci, Dept Mol Genet, IL-76199 Rehovot, Israel; [Park, Myung Hee] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Kahana, C (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76199 Rehovot, Israel.	chaim.kahana@weizmann.ac.il			M. D. Moross Institute for Cancer Research; Israel Science Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000608] Funding Source: NIH RePORTER	M. D. Moross Institute for Cancer Research; Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by a grant from the M. D. Moross Institute for Cancer Research at the Weizmann Institute and by the Israel Science Foundation.	BENNE R, 1978, J BIOL CHEM, V253, P3078; BITONTI AJ, 1985, BIOCHEM PHARMACOL, V34, P1773, DOI 10.1016/0006-2952(85)90648-3; Brostrom CO, 1996, J BIOL CHEM, V271, P24995, DOI 10.1074/jbc.271.40.24995; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; Chattopadhyay MK, 2008, P NATL ACAD SCI USA, V105, P6554, DOI 10.1073/pnas.0710970105; Chen KY, 1997, BIOL SIGNAL, V6, P105; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Christian BE, 2010, BIOCHEM BIOPH RES CO, V391, P942, DOI 10.1016/j.bbrc.2009.11.169; COOPER HL, 1983, P NATL ACAD SCI-BIOL, V80, P1854, DOI 10.1073/pnas.80.7.1854; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; GHODA L, 1990, J BIOL CHEM, V265, P11823; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Hyvonen MT, 2007, J BIOL CHEM, V282, P34700, DOI 10.1074/jbc.M704282200; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Iwata S, 1999, ONCOGENE, V18, P165, DOI 10.1038/sj.onc.1202275; JAKUS J, 1993, J BIOL CHEM, V268, P13151; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Lee Y, 2002, MOL CELL BIOCHEM, V237, P69, DOI 10.1023/A:1016535217038; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; MARTIN TE, 1970, J BIOL CHEM, V245, P1504; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Mitchell JLA, 2002, BIOCHEM J, V366, P663, DOI 10.1042/BJ20011612; Mize GJ, 2001, RNA, V7, P374, DOI 10.1017/S1355838201001972; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; OGASAWARA T, 1989, J BIOCHEM-TOKYO, V105, P164, DOI 10.1093/oxfordjournals.jbchem.a122633; PARK MH, 1994, J BIOL CHEM, V269, P27827; Park MH, 1997, BIOL SIGNAL, V6, P115; Patel PH, 2009, J CELL BIOL, V185, P1181, DOI 10.1083/jcb.200904161; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; Shi XP, 1996, BBA-MOL CELL RES, V1310, P119, DOI 10.1016/0167-4889(95)00165-4; Shimogori T, 1996, BIOCHEM BIOPH RES CO, V223, P544, DOI 10.1006/bbrc.1996.0931; Sivan G, 2007, MOL CELL BIOL, V27, P6639, DOI 10.1128/MCB.00798-07; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Zanelli CF, 2007, AMINO ACIDS, V33, P351, DOI 10.1007/s00726-007-0533-0	41	81	87	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12474	12481		10.1074/jbc.M110.106419	http://dx.doi.org/10.1074/jbc.M110.106419			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20181941	Green Published, hybrid			2022-12-25	WOS:000276787800003
J	Maruhashi, T; Kii, I; Saito, M; Kudo, A				Maruhashi, Takumi; Kii, Isao; Saito, Mitsuru; Kudo, Akira			Interaction between Periostin and BMP-1 Promotes Proteolytic Activation of Lysyl Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-1; GROWTH-FACTOR-BETA; PROCOLLAGEN C-PROTEINASE; HUMAN-LUNG FIBROBLASTS; SMOOTH-MUSCLE-CELLS; CROSS-LINKS; EXTRACELLULAR-MATRIX; COLLAGEN; EXPRESSION; METALLOPROTEINASES	Intra- and intermolecular covalent cross-linking between collagen fibrils, catalyzed by lysyl oxidase (LOX), determines the mechanical properties of connective tissues; however, mechanisms that regulate the collagen cross-linking according to tissue specificity are not well understood. Here we show that periostin, a secretory protein in the dense connective tissues, promotes the activation of LOX. Previous studies showed that periostin null mice exhibit reduced collagen cross-linking in their femurs, periosteum, infarcted myocardium, and tendons. Presently, we showed that active LOX protein, formed by cleavage of its propeptide by bone morphogenetic protein-1 (BMP-1), was decreased in calvarial osteoblast cells derived from periostin null mice. Overexpression of periostin promoted the proteolytic cleavage of the propeptide, which increased the amount of active LOX protein. The results of co-immunoprecipitation and solid phase binding assays revealed that periostin interacted with BMP-1. Furthermore, this interaction probably resulted in enhanced deposition of BMP-1 on the extracellular matrix, suggesting that this enhanced deposition would lead to cleavage of the propeptide of LOX. Thus, we demonstrated that periostin supported BMP-1-mediated proteolytic activation of LOX on the extracellular matrix, which promoted collagen cross-linking.	Tokyo Inst Technol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Saito, Mitsuru] Jikei Univ, Sch Med, Dept Orthopaed Surg, Minato Ku, Tokyo 1058461, Japan	Tokyo Institute of Technology; Jikei University	Kudo, A (corresponding author), 4259-B-33 Midori Ku, Yokohama, Kanagawa 2268501, Japan.	akudo@bio.titech.ac.jp	Kudo, Akira/C-7340-2015; KII, Isao/C-4117-2017	Kudo, Akira/0000-0001-6289-3391; KII, Isao/0000-0002-6153-6250; Maruhashi, Takumi/0000-0003-2944-1611	Ministry of Education, Science, Culture, and Sports of Japan; Japan Space Forum	Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Space Forum	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Culture, and Sports of Japan (to I. K. and A. K.) and by grants from the Ground-based Research Program for Space Utilization promoted by the Japan Space Forum (to A. K.).	ACIL Y, 1995, J AM ACAD DERMATOL, V33, P522, DOI 10.1016/0190-9622(95)91404-8; Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Atsawasuwan P, 2008, J BIOL CHEM, V283, P34229, DOI 10.1074/jbc.M803142200; Banse X, 2002, J BONE MINER RES, V17, P1621, DOI 10.1359/jbmr.2002.17.9.1621; BOAK AM, 1994, AM J RESP CELL MOL, V11, P751, DOI 10.1165/ajrcmb.11.6.7946403; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Feres EJ, 1995, J BIOL CHEM, V270, P30797, DOI 10.1074/jbc.270.51.30797; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Gacheru SN, 1997, J CELL BIOCHEM, V65, P395, DOI 10.1002/(SICI)1097-4644(19970601)65:3<395::AID-JCB9>3.0.CO;2-N; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Huang GR, 2009, J BIOL CHEM, V284, P25879, DOI 10.1074/jbc.M109.024125; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; KAGAN HM, 1979, BIOCHEM J, V177, P203, DOI 10.1042/bj1770203; Kaler SG, 1998, PEDIATR DEVEL PATHOL, V1, P85, DOI 10.1007/s100249900011; Kessler E, 2001, J BIOL CHEM, V276, P27051, DOI 10.1074/jbc.M102921200; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kim BY, 2009, J BIOL CHEM, V284, P19580, DOI 10.1074/jbc.M109.013607; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Li SW, 1996, P NATL ACAD SCI USA, V93, P5127, DOI 10.1073/pnas.93.10.5127; Liu GM, 1997, J BIOL CHEM, V272, P32370, DOI 10.1074/jbc.272.51.32370; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Medeck RJ, 2003, BIOCHEM J, V376, P361, DOI 10.1042/BJ20030894; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; ROBERTS CJ, 1988, J BIOL CHEM, V263, P4586; Roy R, 1996, J CELL BIOCHEM, V62, P411, DOI 10.1002/(SICI)1097-4644(199609)62:3<411::AID-JCB11>3.0.CO;2-L; Saito M, 1997, ANAL BIOCHEM, V253, P26, DOI 10.1006/abio.1997.2350; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Shanley CJ, 1997, J VASC SURG, V25, P446, DOI 10.1016/S0741-5214(97)70254-4; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Suzuki H, 2004, ANAT REC PART A, V281A, P1264, DOI 10.1002/ar.a.20080; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Takayama I, 2009, J BIOCHEM, V146, P713, DOI 10.1093/jb/mvp117; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; Wang DJ, 2003, HYPERTENSION, V42, P88, DOI 10.1161/01.HYP.0000074905.22908.A6	47	179	186	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13294	13303		10.1074/jbc.M109.088864	http://dx.doi.org/10.1074/jbc.M109.088864			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20181949	Green Published, hybrid			2022-12-25	WOS:000276787800084
J	Tseng, YT; Wang, SM; Huang, KJ; Lee, AIR; Chiang, CC; Wang, CT				Tseng, Ying-Tzu; Wang, Shiu-Mei; Huang, Kuo-Jung; Lee, Amber I-Ru; Chiang, Chien-Cheng; Wang, Chin-Tien			Self-assembly of Severe Acute Respiratory Syndrome Coronavirus Membrane Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL ENVELOPE PROTEIN; MOUSE HEPATITIS-VIRUS; MOLECULAR-BIOLOGY; GOLGI-COMPLEX; MURINE CORONAVIRUS; E1 GLYCOPROTEIN; LIPID RAFTS; PARTICLES; EXPRESSION; RETENTION	Coronavirus membrane (M) protein can form virus-like particles (VLPs) when coexpressed with nucleocapsid (N) or envelope (E) proteins, suggesting a pivotal role for M in virion assembly. Here we demonstrate the self-assembly and release of severe acute respiratory syndrome coronavirus (SARS-CoV) M protein in medium in the form of membrane-enveloped vesicles with densities lower than those of VLPs formed by M plus N. Although efficient N-N interactions require the presence of RNA, we found that M-M interactions were RNA-independent. SARS-CoV M was observed in both the Golgi area and plasma membranes of a variety of cells. Blocking M glycosylation does not appear to significantly affect M plasma membrane labeling intensity, M-containing vesicle release, or VLP formation. Results from a genetic analysis indicate involvement of the third transmembrane domain of M in plasma membrane-targeting signal. Fusion proteins containing M amino-terminal 50 residues encompassing the first transmembrane domain were found to be sufficient for membrane binding, multimerization, and Golgi retention. Surprisingly, we found that fusion proteins lacking all three transmembrane domains were still capable of membrane binding, Golgi retention, and interacting with M. The data suggest that multiple SARS-CoV M regions are involved in M self-assembly and subcellular localization.	[Wang, Chin-Tien] Natl Yang Ming Univ, Dept Med Res & Educ, Taipei Vet Gen Hosp, Sch Med, Taipei 11217, Taiwan; [Wang, Shiu-Mei; Lee, Amber I-Ru; Chiang, Chien-Cheng; Wang, Chin-Tien] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 11217, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Wang, CT (corresponding author), Natl Yang Ming Univ, Dept Med Res & Educ, Taipei Vet Gen Hosp, Sch Med, 201 Sec 2,Shih Pai Rd, Taipei 11217, Taiwan.	chintien@ym.edu.tw			Taipei Veterans General Hospital [V96C1-035]; National Science Council, Taiwan, Republic of China [NSC95-2320-B-010-041-MY2]; Ministry of Education	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education	This work was supported by Grant V96C1-035 from Taipei Veterans General Hospital, by Grant NSC95-2320-B-010-041-MY2 from the National Science Council, Taiwan, Republic of China, and by a grant from the Ministry of Education, Aim for the Top University Plan.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; ARMSTRONG J, 1990, J CELL SCI, V95, P191; Bai BK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002685; Baudoux P, 1998, J VIROL, V72, P8636, DOI 10.1128/JVI.72.11.8636-8643.1998; Baudoux P, 1998, ADV EXP MED BIOL, V440, P377; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bos ECW, 1996, VIROLOGY, V218, P52, DOI 10.1006/viro.1996.0165; Chan CM, 2007, ARCH BIOCHEM BIOPHYS, V459, P197, DOI 10.1016/j.abb.2007.01.012; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Choi KS, 2005, J VIROL, V79, P9862, DOI 10.1128/JVI.79.15.9862-9871.2005; Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000; de Haan CAM, 2000, J VIROL, V74, P4967, DOI 10.1128/JVI.74.11.4967-4978.2000; de Haan CAM, 1998, J VIROL, V72, P6838, DOI 10.1128/JVI.72.8.6838-6850.1998; de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7; Escors D, 2001, J VIROL, V75, P1312, DOI 10.1128/JVI.75.3.1312-1324.2001; Hatakeyama S, 2008, VIROLOGY, V380, P99, DOI 10.1016/j.virol.2008.07.012; Hsieh PK, 2005, J VIROL, V79, P13848, DOI 10.1128/JVI.79.22.13848-13855.2005; Huang Y, 2004, J VIROL, V78, P12557, DOI 10.1128/JVI.78.22.12557-12565.2004; Hurst KR, 2005, J VIROL, V79, P13285, DOI 10.1128/JVI.79.21.13285-13297.2005; JACOBSEGEELS HEL, 1983, J GEN VIROL, V64, P1859, DOI 10.1099/0022-1317-64-9-1859; KLUMPERMAN J, 1994, J VIROL, V68, P6523, DOI 10.1128/JVI.68.10.6523-6534.1994; KRIJNSELOCKER J, 1994, J CELL BIOL, V124, P55, DOI 10.1083/jcb.124.1.55; Kuo L, 2002, J VIROL, V76, P4987, DOI 10.1128/JVI.76.10.4987-4999.2002; Lai CW, 2006, FEBS LETT, V580, P3829, DOI 10.1016/j.febslet.2006.06.003; Lai M M, 1987, Adv Exp Med Biol, V218, P7; LAVIADA MD, 1990, VIRUS RES, V16, P247, DOI 10.1016/0168-1702(90)90051-C; Li GM, 2007, MICROBES INFECT, V9, P96, DOI 10.1016/j.micinf.2006.10.015; LOCKER JK, 1994, J BIOL CHEM, V269, P28263; Luo HB, 2006, INT J BIOCHEM CELL B, V38, P589, DOI 10.1016/j.biocel.2005.10.022; Ma HC, 2008, J BIOMED SCI, V15, P301, DOI 10.1007/s11373-008-9235-1; MACHAMER CE, 1987, J CELL BIOL, V105, P1205, DOI 10.1083/jcb.105.3.1205; MACHAMER CE, 1993, MOL BIOL CELL, V4, P695, DOI 10.1091/mbc.4.7.695; MACHAMER CE, 1990, P NATL ACAD SCI USA, V87, P6944, DOI 10.1073/pnas.87.18.6944; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.80671-0; Narayanan K, 2000, J VIROL, V74, P8127, DOI 10.1128/JVI.74.17.8127-8134.2000; Narayanan K, 2003, J VIROL, V77, P2922, DOI 10.1128/JVI.77.5.2922-2927.2003; Narayanan K, 2001, J VIROL, V75, P9059, DOI 10.1128/JVI.75.19.9059-9067.2001; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; PULFORD DJ, 1991, VIRUS RES, V18, P203, DOI 10.1016/0168-1702(91)90019-R; Risco C, 1996, J VIROL, V70, P4773, DOI 10.1128/JVI.70.7.4773-4777.1996; Sambrook J, 2001, MOL CLONING LAB MANU; Satija N, 2007, ANN NY ACAD SCI, V1102, P26, DOI 10.1196/annals.1408.002; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; STURMAN LS, 1980, J VIROL, V33, P449, DOI 10.1128/JVI.33.1.449-462.1980; Sun XJ, 2003, J VIROL, V77, P12543, DOI 10.1128/JVI.77.23.12543-12551.2003; SWIFT AM, 1991, J CELL BIOL, V115, P19, DOI 10.1083/jcb.115.1.19; TO LT, 1991, VET MICROBIOL, V29, P361, DOI 10.1016/0378-1135(91)90143-4; TOOZE J, 1984, EUR J CELL BIOL, V33, P281; TOOZE J, 1985, EUR J CELL BIOL, V37, P203; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; VO D, 2006, FEBS LETT, V580, P968; Wang CT, 1999, J MED VIROL, V59, P180; Wang SM, 2008, J BIOMED SCI, V15, P719, DOI 10.1007/s11373-008-9265-8; Wang SM, 2009, VIROLOGY, V388, P112, DOI 10.1016/j.virol.2009.03.010; Ziebuhr J, 2004, CURR OPIN MICROBIOL, V7, P412, DOI 10.1016/j.mib.2004.06.007	62	46	50	4	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12862	12872		10.1074/jbc.M109.030270	http://dx.doi.org/10.1074/jbc.M109.030270			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20154085	Green Published, hybrid			2022-12-25	WOS:000276787800044
J	Wang, HB; Mo, PL; Ren, SM; Yan, CH				Wang, Hongbo; Mo, Pingli; Ren, Shumei; Yan, Chunhong			Activating Transcription Factor 3 Activates p53 by Preventing E6-associated Protein from Binding to E6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; FACTOR ATF3; GENE; EXPRESSION; DEGRADATION; INHIBITION; APOPTOSIS; MDM2; ONCOPROTEIN; STABILITY	Genomic integration of human papillomavirus (HPV) DNA accounts for more than 90% of cervical cancers. High-risk genital HPVs encode E6 proteins that can interact with a cellular ubiquitin ligase E6-associated protein (E6AP) and target the tumor suppressor p53 for ubiquitin-mediated proteolysis. Currently, how this critical event is regulated is largely unknown. Here we report that activating transcription factor 3 (ATF3), a broad DNA damage sensor whose expression is frequently downregulated in cervical cancer, interacted with E6 and prevented p53 from ubiquitination and degradation mediated by the viral protein. Consistent with its role as a potent E6 antagonist, ATF3 expressed enforcedly in HPV-positive SiHa cells activated p53, leading to expression of p53-target genes (e. g. p21 and PUMA), cell cycle arrest and apoptotic cell death. The leucine zipper domain of ATF3 appears indispensable for these effects as an ATF3 mutant lacking this domain failed to interact with E6 and activate p53 in the cervical cancer cells. The prevention of p53 degradation was unlikely caused by binding of ATF3 to the tumor suppressor, but rather was a consequence of disruption of the E6-E6AP interaction by ATF3. These results indicate that ATF3 plays a key role in a mechanism defending against HPV-induced carcinogenesis, and could serve as a novel therapeutic target for HPV-positive cancers.	[Wang, Hongbo; Mo, Pingli; Ren, Shumei; Yan, Chunhong] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College	Yan, CH (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, MC-165,47 New Scotland Ave, Albany, NY 12208 USA.	yanc@mail.amc.edu	王, 洪波/A-6767-2019; Wang, Hongbo/AHC-7831-2022	王, 洪波/0000-0001-8530-2339; Wang, Hongbo/0000-0001-8530-2339; Yan, Chunhong/0000-0002-3974-7991	Department of Defense [PC061106]; NATIONAL CANCER INSTITUTE [R01CA139107] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Department of Defense Grant PC061106 (to C. Y.).	An J, 2008, CANCER CELL, V14, P394, DOI 10.1016/j.ccr.2008.10.007; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bohl J, 2000, VIROLOGY, V271, P163, DOI 10.1006/viro.2000.0316; Bottone FG, 2005, MOL CANCER THER, V4, P693, DOI 10.1158/1535-7163.MCT-04-0337; Boulet G, 2007, INT J BIOCHEM CELL B, V39, P2006, DOI 10.1016/j.biocel.2007.07.004; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Butz K, 2000, P NATL ACAD SCI USA, V97, P6693, DOI 10.1073/pnas.110538897; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Camus S, 2003, FEBS LETT, V536, P220, DOI 10.1016/S0014-5793(03)00054-1; Chen JJ, 1998, J BIOL CHEM, V273, P13537, DOI 10.1074/jbc.273.22.13537; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Chung CH, 2009, CLIN CANCER RES, V15, P6758, DOI 10.1158/1078-0432.CCR-09-0784; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Huibregtse JM, 1996, SEMIN CANCER BIOL, V7, P317, DOI 10.1006/scbi.1996.0041; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Ishiguro T, 1996, CANCER RES, V56, P875; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kitagawa M, 2008, MOL CELL, V29, P217, DOI 10.1016/j.molcel.2007.11.036; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Li XQ, 1996, J VIROL, V70, P4509, DOI 10.1128/JVI.70.7.4509-4516.1996; Liu YQ, 2008, FRONT BIOSCI-LANDMRK, V13, P121, DOI 10.2741/2664; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Nakamura S, 2002, ONCOGENE, V21, P2605, DOI 10.1038/sj.onc.1205343; Narisawa-Saito M, 2007, ONCOGENE, V26, P2988, DOI 10.1038/sj.onc.1210118; Oda H, 1999, P NATL ACAD SCI USA, V96, P9557, DOI 10.1073/pnas.96.17.9557; Oh YK, 2008, MOL CANCER RES, V6, P1232, DOI 10.1158/1541-7786.MCR-07-0297; Patel D, 1999, EMBO J, V18, P5061, DOI 10.1093/emboj/18.18.5061; Perez S, 2001, ONCOGENE, V20, P1135, DOI 10.1038/sj.onc.1204200; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Thomas M, 1998, ONCOGENE, V17, P2943, DOI 10.1038/sj.onc.1202223; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Tran N, 2007, HEAD NECK-J SCI SPEC, V29, P64, DOI 10.1002/hed.20460; Turnell AS, 2000, EMBO J, V19, P4759, DOI 10.1093/emboj/19.17.4759; Veldman T, 2001, J VIROL, V75, P4467, DOI 10.1128/JVI.75.9.4467-4472.2001; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vogt M, 2006, ONCOGENE, V25, P4009, DOI 10.1038/sj.onc.1209429; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; XU L, 1994, INT J CANCER, V59, P383, DOI 10.1002/ijc.2910590316; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan CH, 2005, MOL CANCER THER, V4, P233; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Yan CH, 2003, J BIOL CHEM, V278, P2309, DOI 10.1074/jbc.M210369200; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Zhang XY, 2005, J BIOL CHEM, V280, P33165, DOI 10.1074/jbc.M505124200; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	58	43	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13201	13210		10.1074/jbc.M109.058669	http://dx.doi.org/10.1074/jbc.M109.058669			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20167600	hybrid, Green Published			2022-12-25	WOS:000276787800075
J	Zhang, B; Hemann, CF; Hille, R				Zhang, Bo; Hemann, Craig F.; Hille, Russ			Kinetic and Spectroscopic Studies of the Molybdenum-Copper CO Dehydrogenase from Oligotropha carboxidovorans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON-MONOXIDE DEHYDROGENASE; ELECTRON-PARAMAGNETIC-RESONANCE; FLAVIN ADENINE-DINUCLEOTIDE; REDUCTIVE HALF-REACTION; XANTHINE-OXIDASE; PSEUDOMONAS-CARBOXYDOVORANS; ACTIVE-SITE; HYDROGENOPHAGA-PSEUDOFLAVA; MOLECULAR CHARACTERIZATION; SULFITE OXIDASE	Carbon monoxide dehydrogenase from the aerobic bacterium Oligotropha carboxidovorans catalyzes the oxidation of CO to CO2, yielding two electrons and two H+. The steady-state kinetics of the enzyme exhibit a pH optimum of 7.2 with a k(cat) of 93.3 s(-1) and K-m of 10.7 mu M at 25 degrees C. k(red) for the reductive half-reaction agrees well with k(cat) and exhibits a similar pH optimum, indicating that the rate-limiting step of overall turnover is likely in the reductive half-reaction. No dependence on CO concentration was observed in the rapid reaction kinetics, however, suggesting that CO initially binds rapidly to the enzyme, possibly at the Cu(I) of the active site, prior to undergoing oxidation. A Mo(V) species that exhibits strong coupling to the copper of the active center (I = 3/2) has been characterized by EPR. The signal is further split when [C-13] CO is used to generate it, demonstrating that substrate (or product) is a component of the signal-giving species. Finally, resonance Raman spectra of CODH reveal the presence of FAD, Fe/S clusters, and a [CuSMoO2] coordination in the active site, consistent with earlier x-ray absorption and crystallographic results.	[Zhang, Bo; Hemann, Craig F.; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	russ.hille@ucr.edu		Hemann, Craig/0000-0002-7380-4072	National Institutes of Health [075036]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 075036.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAY RC, 1978, BIOCHEM J, V171, P653, DOI 10.1042/bj1710653; BRAY RC, 1983, BIOCHEM J, V211, P687, DOI 10.1042/bj2110687; CYPIONKA H, 1983, J BACTERIOL, V156, P1178, DOI 10.1128/JB.156.3.1178-1187.1983; Dean J.A., 1972, LANGES HDB CHEM, V15; DILORIO, 1981, METHOD ENZYMOL, V76, P58; Dobbek H, 2002, P NATL ACAD SCI USA, V99, P15971, DOI 10.1073/pnas.212640899; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; Garton SD, 1997, J AM CHEM SOC, V119, P2590, DOI 10.1021/ja963931c; Gnida M, 2003, BIOCHEMISTRY-US, V42, P222, DOI 10.1021/bi026514n; Gourlay C, 2006, J AM CHEM SOC, V128, P2164, DOI 10.1021/ja056500f; Gremer L, 2000, J BIOL CHEM, V275, P1864, DOI 10.1074/jbc.275.3.1864; Hanzelmann P, 1998, EUR J BIOCHEM, V255, P755, DOI 10.1046/j.1432-1327.1998.2550755.x; Hanzelmann P, 2000, J MOL BIOL, V301, P1221, DOI 10.1006/jmbi.2000.4023; Hemann C, 2005, J AM CHEM SOC, V127, P16567, DOI 10.1021/ja0530873; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; HILLE R, 1991, BIOCHEMISTRY-US, V30, P8522, DOI 10.1021/bi00099a004; Hofmann M, 2005, J BIOL INORG CHEM, V10, P490, DOI 10.1007/s00775-005-0661-5; Johnson MK, 2004, PROG INORG CHEM, V52, P213; Kang BS, 1999, J BACTERIOL, V181, P5581, DOI 10.1128/JB.181.18.5581-5590.1999; Kim JH, 1996, J BIOL CHEM, V271, P6771, DOI 10.1074/jbc.271.12.6771; KRAUT M, 1989, ARCH MICROBIOL, V152, P335, DOI 10.1007/BF00425170; Leimkuhler S, 2004, J BIOL CHEM, V279, P40437, DOI 10.1074/jbc.M405778200; MCWHIRTER RB, 1991, J BIOL CHEM, V266, P23724; MEYER O, 1984, J BIOL CHEM, V259, P5612; MEYER O, 1978, ARCH MICROBIOL, V118, P35, DOI 10.1007/BF00406071; MEYER O, 1980, J BACTERIOL, V141, P74, DOI 10.1128/JB.141.1.74-80.1980; Meyer O, 2000, BIOL CHEM, V381, P865, DOI 10.1515/BC.2000.108; Moersdorf Gerhard, 1992, Biodegradation, V3, P61; OLSON JS, 1974, J BIOL CHEM, V249, P4363; PICK FM, 1969, BIOCHEM J, V114, P735, DOI 10.1042/bj1140735; Ragsdale SW, 1996, CHEM REV, V96, P2515, DOI 10.1021/cr950058+; Resch M, 2005, J BIOL INORG CHEM, V10, P518, DOI 10.1007/s00775-005-0006-4; Santiago B, 1999, GENE, V236, P115, DOI 10.1016/S0378-1119(99)00245-0; SCHUBEL U, 1995, J BACTERIOL, V177, P2197, DOI 10.1128/jb.177.8.2197-2203.1995; Siegbahn PEM, 2005, J COMPUT CHEM, V26, P888, DOI 10.1002/jcc.20230	36	52	52	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12571	12578		10.1074/jbc.M109.076851	http://dx.doi.org/10.1074/jbc.M109.076851			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178978	Green Published, hybrid			2022-12-25	WOS:000276787800014
J	Byla, P; Andersen, MH; Holtet, TL; Jacobsen, H; Munch, M; Gad, HH; Thogersen, HC; Hartmann, R				Byla, Povilas; Andersen, Mikkel H.; Holtet, Thor L.; Jacobsen, Helle; Munch, Mette; Gad, Hans Henrik; Thogersen, Hans Christian; Hartmann, Rune			Selection of a Novel and Highly Specific Tumor Necrosis Factor alpha (TNF alpha) Antagonist INSIGHT FROM THE CRYSTAL STRUCTURE OF THE ANTAGONIST-TNF alpha COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; LECTIN-LIKE DOMAIN; RHEUMATOID-ARTHRITIS; TETRANECTIN; BINDING; REFINEMENT; PROTEIN; CALCIUM; FORM	Inhibition of tumor necrosis factor alpha (TNF alpha) is a favorable way of treating several important diseases such as rheumatoid arthritis, Crohn disease, and psoriasis. Therefore, an extensive range of TNF alpha inhibitory proteins, most of them based upon an antibody scaffold, has been developed and used with variable success as therapeutics. We have developed a novel technology platform using C-type lectins as a vehicle for the creation of novel trimeric therapeutic proteins with increased avidity and unique properties as compared with current protein therapeutics. We chose human TNF alpha as a test target to validate this new technology because of the extensive experience available with protein-based TNF alpha antagonists. Here, we present a novel and highly specific TNF alpha antagonist developed using this technology. Furthermore, we have solved the three-dimensional structure of the antagonist-TNF alpha complex by x-ray crystallography, and this structure is presented here. The structure has given us a unique insight into how the selection procedure works at a molecular level. Surprisingly little change is observed in the C-type lectin-like domain structure outside of the randomized regions, whereas a substantial change is observed within the randomized loops. Thus, the overall integrity of the C-type lectin-like domain is maintained, whereas specificity and binding affinity are changed by the introduction of a number of specific contacts with TNF alpha.	[Byla, Povilas; Gad, Hans Henrik; Thogersen, Hans Christian; Hartmann, Rune] Aarhus Univ, Dept Mol Biol, Struct Biol Ctr, DK-8000 Aarhus C, Denmark; [Byla, Povilas; Andersen, Mikkel H.; Holtet, Thor L.; Jacobsen, Helle; Munch, Mette; Thogersen, Hans Christian] Borean Pharma AS, DK-8000 Aarhus C, Denmark	Aarhus University	Thogersen, HC (corresponding author), Aarhus Univ, Dept Mol Biol, Struct Biol Ctr, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	hct@mb.au.dk; rh@mb.au.dk		Hartmann, Rune/0000-0003-1159-066X; Gad, Hans Henrik/0000-0001-8449-1115	Novo Nordisk Foundation; The Danish Medical Research Council [22-04-0704]; The Carlsberg Foundation; Arne Hansen stipend	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); The Danish Medical Research Council(Danish Medical Research Council); The Carlsberg Foundation(Carlsberg Foundation); Arne Hansen stipend	This work was supported by a Novo Nordisk Foundation senior research grant and by grants from The Danish Medical Research Council (Grant 22-04-0704) and The Carlsberg Foundation and an Arne Hansen stipend (to R. H.).	Caterer NR, 2002, BIOL CHEM, V383, P1743, DOI 10.1515/BC.2002.195; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ECK MJ, 1988, J BIOL CHEM, V263, P12816; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Graversen JH, 1998, J BIOL CHEM, V273, P29241, DOI 10.1074/jbc.273.44.29241; HOGAN MM, 2001, CURRENT PROTOCOLS IM, P183; Holtet TL, 1997, PROTEIN SCI, V6, P1511, DOI 10.1002/pro.5560060715; Kastrup JS, 1998, ACTA CRYSTALLOGR D, V54, P757, DOI 10.1107/S0907444997016806; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mogues T, 2004, J BIOMED BIOTECHNOL, P73, DOI 10.1155/S1110724304307096; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielbo S, 2004, BIOCHEMISTRY-US, V43, P8636, DOI 10.1021/bi049570s; Nielsen BB, 1997, FEBS LETT, V412, P388, DOI 10.1016/S0014-5793(97)00664-9; Ursby T, 2004, AIP CONF PROC, V705, P1241, DOI 10.1063/1.1758025; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	19	17	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12096	12100		10.1074/jbc.M109.063305	http://dx.doi.org/10.1074/jbc.M109.063305			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20179326	Green Published, hybrid			2022-12-25	WOS:000276787100039
J	Durrnagel, S; Kuhn, A; Tsiairis, CD; Williamson, M; Kalbacher, H; Grimmelikhuijzen, CJP; Holstein, TW; Grunder, S				Duerrnagel, Stefan; Kuhn, Anne; Tsiairis, Charisios D.; Williamson, Michael; Kalbacher, Hubert; Grimmelikhuijzen, Cornelis J. P.; Holstein, Thomas W.; Gruender, Stefan			Three Homologous Subunits Form a High Affinity Peptide-gated Ion Channel in Hydra	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; HELISOMA-TRIVOLVIS; DEG/ENAC CHANNEL; SODIUM-CHANNEL; HELIX NEURONS; FMRFAMIDE; EXPRESSION; CLONING; SYSTEM; FAMILY	Recently, three ion channel subunits of the degenerin (DEG)/epithelial Na+ channel (ENaC) gene family have been cloned from the freshwater polyp Hydra magnipapillata, the Hydra Na+ channels (HyNaCs) 2-4. Two of them, HyNaC2 and HyNaC3, co-assemble to form an ion channel that is gated by the neuropeptides Hydra-RFamides I and II. The HyNaC2/3 channel is so far the only cloned ionotropic receptor from cnidarians and, together with the related ionotropic receptor FMRFamide-activated Na+ channel (FaNaC) from snails, the only known peptide-gated ionotropic receptor. The HyNaC2/3 channel has pore properties, like a low Na+ selectivity and a low amiloride affinity, that are different from other channels of the DEG/ENaC gene family, suggesting that a component of the native Hydra channel might still be lacking. Here, we report the cloning of a new ion channel subunit from Hydra, HyNaC5. The new subunit is closely related to HyNaC2 and -3 and co-localizes with HyNaC2 and -3 to the base of the tentacles. Coexpression in Xenopus oocytes of HyNaC5 with HyNaC2 and -3 largely increases current amplitude after peptide stimulation and affinity of the channel to Hydra-RFamides I and II. Moreover, the HyNaC2/3/5 channel has altered pore properties and amiloride affinity, more similarly to other DEG/ENaC channels. Collectively, our results suggest that the three homologous subunits HyNaC2,-3, and -5 form a peptide-gated ion channel in Hydra that could contribute to fast synaptic transmission.	[Gruender, Stefan] Rhein Westfal TH Aachen, Dept Physiol, D-52074 Aachen, Germany; [Kuhn, Anne; Tsiairis, Charisios D.; Holstein, Thomas W.] Heidelberg Inst Zool, Dept Mol Evolut & Genom, D-69120 Heidelberg, Germany; [Williamson, Michael; Grimmelikhuijzen, Cornelis J. P.] Univ Copenhagen, Dept Biol, Ctr Funct & Comparat Insect Genom, DK-2100 Copenhagen, Denmark; [Kalbacher, Hubert] Univ Tubingen, Interfak Inst Biochem, D-72074 Tubingen, Germany	RWTH Aachen University; University of Copenhagen; Eberhard Karls University of Tubingen	Grunder, S (corresponding author), Rhein Westfal TH Aachen, Dept Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.	sgruender@ukaachen.de	Gründer, Stefan/I-2495-2019; Tsiairis, Charisios/A-9145-2018	Gründer, Stefan/0000-0002-7635-9883; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046; Tsiairis, Charisios/0000-0002-9788-9875; Holstein, Thomas/0000-0003-0480-4674	Deutsche Forschungsgemeinschaft [SFB 488, SFB 685]; Danish Research Agency; Heidelberg Cluster of Excellence CellNetworks	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish Research Agency; Heidelberg Cluster of Excellence CellNetworks	This work was supported by the Deutsche Forschungsgemeinschaft SFB 488 (to T. W. H.), SFB 685 (to H. K.), the Danish Research Agency (to C. J. P. G.), and the Heidelberg Cluster of Excellence CellNetworks (to C. D. T.).	Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; COTTRELL GA, 1990, PFLUG ARCH EUR J PHY, V416, P612, DOI 10.1007/BF00382698; Davey F, 2001, J NEUROCYTOL, V30, P877, DOI 10.1023/A:1020656915810; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Green KA, 1999, J PHYSIOL-LONDON, V519, P47, DOI 10.1111/j.1469-7793.1999.0047o.x; Green KA, 2002, PFLUG ARCH EUR J PHY, V443, P813, DOI 10.1007/s00424-001-0750-4; Hansen GN, 2000, CELL TISSUE RES, V301, P245; HILLE B, 2001, ION CHANNELS EXCITAB, P471; Jeziorski MC, 2000, J PHYSIOL-LONDON, V526, P13, DOI 10.1111/j.1469-7793.2000.00013.x; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Lin HP, 2005, P NATL ACAD SCI USA, V102, P12831, DOI 10.1073/pnas.0506420102; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; LOOMIS WF, 1955, ANN NY ACAD SCI, V62, P211, DOI 10.1111/j.1749-6632.1955.tb35372.x; Martinez DE, 1997, DEV BIOL, V192, P523, DOI 10.1006/dbio.1997.8715; MEECH RW, 1995, J NEUROPHYSIOL, V74, P1662, DOI 10.1152/jn.1995.74.4.1662; Moosler A, 1996, BIOCHEM BIOPH RES CO, V229, P596, DOI 10.1006/bbrc.1996.1849; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Palmer LG, 1997, J GEN PHYSIOL, V109, P675, DOI 10.1085/jgp.109.6.675; Paukert M, 2004, J BIOL CHEM, V279, P18783, DOI 10.1074/jbc.M401477200; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0	28	47	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11958	11965		10.1074/jbc.M109.059998	http://dx.doi.org/10.1074/jbc.M109.059998			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20159980	Green Published, hybrid			2022-12-25	WOS:000276787100024
J	Chan, KT; Bennin, DA; Huttenlocher, A				Chan, Keefe T.; Bennin, David A.; Huttenlocher, Anna			Regulation of Adhesion Dynamics by Calpain-mediated Proteolysis of Focal Adhesion Kinase (FAK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEASE CALPAIN; CELL-MIGRATION; MYOBLAST MIGRATION; CLEAVAGE; SRC; APOPTOSIS; MOTILITY; TRANSFORMATION; PP125(FAK); PAXILLIN	The coordinated and dynamic regulation of adhesions is required for cell migration. We demonstrated previously that limited proteolysis of talin1 by the calcium-dependent protease calpain 2 plays a critical role in adhesion disassembly in fibroblasts (Franco, S.J., Rodgers, M. A., Perrin, B.J., Han, J., Bennin, D. A., Critchley, D. R., and Huttenlocher, A. (2004) Nat. Cell Biol. 6, 977-983). However, little is known about the contribution of other calpain substrates to the regulation of adhesion dynamics. We now provide evidence that calpain 2-mediated proteolysis of focal adhesion kinase (FAK) regulates adhesion dynamics in motile cells. We mapped the preferred calpain cleavage site between the two C-terminal proline-rich regions after Ser-745, resulting in a C-terminal fragment similar in size to the FAK-related non-kinase (FRNK). We generated mutant FAK with a point mutation (V744G) that renders FAK resistant to calpain proteolysis but retains other biochemical properties of FAK. Using time-lapse microscopy, we show that the dynamics of green fluorescent protein-talin1 are impaired in FAK-deficient cells. Expression of wild-type but not calpain-resistant FAK rescues talin dynamics in FAK-deficient cells. Taken together, our findings suggest a novel role for calpain proteolysis of FAK in regulating adhesion dynamics in motile cells.	[Chan, Keefe T.; Bennin, David A.; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Chan, Keefe T.] Univ Wisconsin, Dept Mol & Cellular Pharmacol, Madison, WI 53706 USA; [Chan, Keefe T.; Bennin, David A.; Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, 4225 Microbial Sci Bldg,1550 Linden Dr, Madison, WI 53706 USA.	huttenlocher@wisc.edu	Chan, Keefe/AAG-4153-2020	Chan, Keefe/0000-0001-6114-3724	National Institutes of Health [R01 CA085862-08]; NATIONAL CANCER INSTITUTE [R01CA085862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA085862-08 (to A.H.).	Barbero S, 2009, CANCER RES, V69, P3755, DOI 10.1158/0008-5472.CAN-08-3937; Bhatt A, 2002, J CELL SCI, V115, P3415; Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Carragher NO, 2002, MOL CELL BIOL, V22, P257, DOI 10.1128/MCB.22.1.257-269.2002; Carragher NO, 2001, J BIOL CHEM, V276, P4270, DOI 10.1074/jbc.M008972200; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Cooley MA, 2000, MOL BIOL CELL, V11, P3247, DOI 10.1091/mbc.11.9.3247; Cooray P, 1996, BIOCHEM J, V318, P41, DOI 10.1042/bj3180041; Dedieu S, 2003, BIOL CELL, V95, P615, DOI 10.1016/j.biolcel.2003.09.005; Dedieu S, 2004, EXP CELL RES, V292, P187, DOI 10.1016/j.yexcr.2003.08.014; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Gervais FG, 1998, J BIOL CHEM, V273, P17102, DOI 10.1074/jbc.273.27.17102; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Heidkamp MC, 2002, CIRC RES, V90, P1282, DOI 10.1161/01.RES.0000023201.41774.EA; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Libertini SJ, 2005, CANCER RES, V65, P10700, DOI 10.1158/0008-5472.CAN-05-1666; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Lokuta MA, 2007, MOL BIOL CELL, V18, P5069, DOI 10.1091/mbc.E07-05-0428; Mian MF, 2008, CHEM-BIOL INTERACT, V171, P57, DOI 10.1016/j.cbi.2007.08.009; Nolan K, 1999, MOL CELL BIOL, V19, P6120; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Palecek SP, 1998, J CELL SCI, V111, P929; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Sieg DJ, 1999, J CELL SCI, V112, P2677; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wen LP, 1997, J BIOL CHEM, V272, P26056, DOI 10.1074/jbc.272.41.26056; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Zamir E, 1999, J CELL SCI, V112, P1655	47	153	158	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11418	11426		10.1074/jbc.M109.090746	http://dx.doi.org/10.1074/jbc.M109.090746			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20150423	Green Published, hybrid			2022-12-25	WOS:000276286200048
J	Grigg, JC; Cooper, JD; Cheung, J; Heinrichs, DE; Murphy, MEP				Grigg, Jason C.; Cooper, John D.; Cheung, Johnson; Heinrichs, David E.; Murphy, Michael E. P.			The Staphylococcus aureus Siderophore Receptor HtsA Undergoes Localized Conformational Changes to Enclose Staphyloferrin A in an Arginine-rich Binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MEDIATED IRON ACQUISITION; TREPONEMA-PALLIDUM TROA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; BACILLUS-SUBTILIS; PROTEIN FHUD; ANTIBIOTIC ALBOMYCIN; MONOCLINIC CRYSTALS	Staphylococcus aureus uses several efficient iron acquisition strategies to overcome iron limitation. Recently, the genetic locus encoding biosynthetic enzymes for the iron chelating molecule, staphyloferrin A (SA), was determined. S. aureus synthesizes and secretes SA into its environment to scavenge iron. The membrane-anchored ATP binding cassette-binding protein, HtsA, receives the ferric-chelate for import into the cell. Recently, we determined the apoHtsA crystal structure, the first siderophore receptor from Gram-positive bacteria to be structurally characterized. Herein we present the x-ray crystal structure of the HtsA-ferric-SA complex. HtsA adopts a class III binding protein fold composed of separate N- and C-terminal domains bridged by a single alpha-helix. Recombinant HtsA can efficiently sequester ferric-SA from S. aureus culture supernatants where it is bound within the pocket formed between distinct N- and C-terminal domains. A basic patch composed mainly of six Arg residues contact the negatively charged siderophore, securing it within the pocket. The x-ray crystal structures from two different ligand-bound crystal forms were determined. The structures represent the first structural characterization of an endogenous alpha-hydroxycarboxylate-type siderophore-receptor complex. One structure is in an open form similar to apoHtsA, whereas the other is in a more closed conformation. The conformational change is highlighted by isolated movement of three loops within the C-terminal domain, a domain movement unique to known class III binding protein structures.	[Grigg, Jason C.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Cooper, John D.; Cheung, Johnson; Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada	University of British Columbia; Western University (University of Western Ontario)	Murphy, MEP (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada.	Michael.Murphy@ubc.ca	Heinrichs, David/ABD-5702-2021; Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014; Heinrichs, David/0000-0002-7217-2456	Canadian Institutes of Health [MOP-49597, MOP-38002]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grants MOP-49597 and MOP-38002 (to M. E. P. M. and D. E. H., respectively).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annamalai R, 2004, J BACTERIOL, V186, P3578, DOI 10.1128/JB.186.11.3578-3589.2004; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Beasley FC, 2010, J INORG BIOCHEM, V104, P282, DOI 10.1016/j.jinorgbio.2009.09.011; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Braun V, 2007, J BACTERIOL, V189, P6913, DOI 10.1128/JB.00884-07; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Cabrera G, 2001, APPL ENVIRON MICROB, V67, P1001, DOI 10.1128/AEM.67.2.1001-1003.2001; *CCPR, 1994, ACTA CRYSTALLOGR D, V50, P760; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Clarke TE, 2000, NAT STRUCT BIOL, V7, P287; Clarke TE, 2002, J BIOL CHEM, V277, P13966, DOI 10.1074/jbc.M109385200; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; Cobessi D, 2005, J MOL BIOL, V352, P893, DOI 10.1016/j.jmb.2005.08.004; Cobessi D, 2005, J MOL BIOL, V347, P121, DOI 10.1016/j.jmb.2005.01.021; Cotton JL, 2009, BIOCHEMISTRY-US, V48, P1025, DOI 10.1021/bi801844c; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DRECHSEL H, 1993, BIOMETALS, V6, P185; Drechsel H, 2005, BIOMETALS, V18, P75, DOI 10.1007/s10534-004-5774-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans W, 1997, CHEM BRIT, V33, P22; Ferguson AD, 2000, PROTEIN SCI, V9, P956, DOI 10.1110/ps.9.5.956; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; HAAG H, 1994, FEMS MICROBIOL LETT, V115, P125; Hamdane D, 2009, ACTA CRYSTALLOGR D, V65, P388, DOI 10.1107/S0907444909003382; Heitmann D, 2008, ACTA CRYSTALLOGR D, V64, P993, DOI 10.1107/S0907444908019197; Ho WW, 2007, J BIOL CHEM, V282, P35796, DOI 10.1074/jbc.M706761200; Hoegy FO, 2005, J BIOL CHEM, V280, P20222, DOI 10.1074/jbc.M500776200; Hoette TM, 2008, J AM CHEM SOC, V130, P17584, DOI 10.1021/ja8074665; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; KONETSCHNYRAPP S, 1990, EUR J BIOCHEM, V191, P65, DOI 10.1111/j.1432-1033.1990.tb19094.x; Krewulak KD, 2005, BIOMETALS, V18, P375, DOI 10.1007/s10534-005-3712-z; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; MEIWES J, 1990, FEMS MICROBIOL LETT, V67, P201, DOI 10.1111/j.1574-6968.1990.tb13863.x; Muller A, 2006, ANGEW CHEM INT EDIT, V45, P5132, DOI 10.1002/anie.200601198; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Peuckert F, 2009, ANGEW CHEM INT EDIT, V48, P7924, DOI 10.1002/anie.200902495; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Radtke AL, 2006, CELL MICROBIOL, V8, P1720, DOI 10.1111/j.1462-5822.2006.00795.x; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; ROHRBACH MR, 1995, J BACTERIOL, V177, P7186, DOI 10.1128/jb.177.24.7186-7193.1995; Sebulsky MT, 2000, J BACTERIOL, V182, P4394, DOI 10.1128/JB.182.16.4394-4400.2000; Sebulsky MT, 2004, J BIOL CHEM, V279, P53152, DOI 10.1074/jbc.M409793200; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Sebulsky MT, 2001, J BACTERIOL, V183, P4994, DOI 10.1128/JB.183.17.4994-5000.2001; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Shi R, 2009, PROTEINS, V75, P598, DOI 10.1002/prot.22272; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Speziali CD, 2006, J BACTERIOL, V188, P2048, DOI 10.1128/JB.188.6.2048-2055.2006; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Sultana A, 2007, ACTA CRYSTALLOGR D, V63, P149, DOI 10.1107/S0907444906044271; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Taylor JM, 2002, MOL MICROBIOL, V43, P1603, DOI 10.1046/j.1365-2958.2002.02850.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weems JJ, 2001, POSTGRAD MED, V110, P24, DOI 10.3810/pgm.2001.10.1042; Wittmann JG, 2007, ACTA CRYSTALLOGR D, V63, P744, DOI 10.1107/S0907444907016605; Zawadzka AM, 2009, P NATL ACAD SCI USA, V106, P21854, DOI 10.1073/pnas.0904793106; Zawadzka AM, 2009, BIOCHEMISTRY-US, V48, P3645, DOI 10.1021/bi8018674	83	57	59	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11162	11171		10.1074/jbc.M109.097865	http://dx.doi.org/10.1074/jbc.M109.097865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147287	Green Published, hybrid			2022-12-25	WOS:000276286200021
J	Dron, M; Moudjou, M; Chapuis, J; Salamat, MKF; Bernard, J; Cronier, S; Langevin, C; Laude, H				Dron, Michel; Moudjou, Mohammed; Chapuis, Jerome; Salamat, Muhammad Khalid Farooq; Bernard, Julie; Cronier, Sabrina; Langevin, Christelle; Laude, Hubert			Endogenous Proteolytic Cleavage of Disease-associated Prion Protein to Produce C2 Fragments Is Strongly Cell- and Tissue-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; SHEEP SCRAPIE; NEURONAL CELLS; CULTURED-CELLS; BIOCHEMICAL FINGERPRINTS; COPPER-BINDING; NORMAL BRAIN; MOUSE-BRAIN; PRPSC TYPES	The abnormally folded form of the prion protein (PrPSc) accumulating in nervous and lymphoid tissues of prion-infected individuals can be naturally cleaved to generate a N-terminaltruncated fragment called C2. Information about the identity of the cellular proteases involved in this process and its possible role in prion biology has remained limited and controversial. We investigated PrPSc N-terminal trimming in different cell lines and primary cultured nerve cells, and in the brain and spleen tissue from transgenic mice infected by ovine and mouse prions. We found the following: (i) the full-length to C2 ratio varies considerably depending on the infected cell or tissue. Thus, in primary neurons and brain tissue, PrPSc accumulated predominantly as untrimmed species, whereas efficient trimming occurred in Rov and MovS cells, and in spleen tissue. (ii) Although C2 is generally considered to be the counterpart of the PrPSc proteinase K-resistant core, the N termini of the fragments cleaved in vivo and in vitro can actually differ, as evidenced by a different reactivity toward the Pc248 anti-octarepeat antibody. (iii) In lysosome-impaired cells, the ratio of full-length versus C2 species dramatically increased, yet efficient prion propagation could occur. Moreover, cathepsin but not calpain inhibitors markedly inhibited C2 formation, and in vitro cleavage by cathepsins B and L produced PrPSc fragments lacking the Pc248 epitope, strongly arguing for the primary involvement of acidic hydrolases of the endolysosomal compartment. These findings have implications on the molecular analysis of PrPSc and cell pathogenesis of prion infection.	[Dron, Michel; Moudjou, Mohammed; Chapuis, Jerome; Salamat, Muhammad Khalid Farooq; Bernard, Julie; Cronier, Sabrina; Langevin, Christelle; Laude, Hubert] INRA, Virol Immunol Mol U892, F-78350 Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Laude, H (corresponding author), Batiment 440, F-78350 Jouy En Josas, France.	hubert.laude@jouy.inra.fr	DRON, Michel/M-7093-2017	Langevin, Christelle/0000-0002-6013-4460	Institut National de la Recherche Agronomique	Institut National de la Recherche Agronomique	This work was supported by the Institut National de la Recherche Agronomique.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Archer F, 2004, J VIROL, V78, P482, DOI 10.1128/JVI.78.1.482-490.2004; Arima K, 2005, J VIROL, V79, P7104, DOI 10.1128/JVI.79.11.7104-7112.2005; Arjona A, 2004, P NATL ACAD SCI USA, V101, P8768, DOI 10.1073/pnas.0400158101; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Cronier S, 2007, J VIROL, V81, P13794, DOI 10.1128/JVI.01502-07; Deslys JP, 2001, NATURE, V409, P476, DOI 10.1038/35054134; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Dron M, 2009, J GEN VIROL, V90, P2050, DOI 10.1099/vir.0.010082-0; Ecroyd H, 2004, BIOL REPROD, V71, P993, DOI 10.1095/biolreprod.104.029801; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Gielbert A, 2009, J MASS SPECTROM, V44, P384, DOI 10.1002/jms.1516; Hayashi HK, 2005, BIOCHEM BIOPH RES CO, V328, P1024, DOI 10.1016/j.bbrc.2005.01.065; HOPE J, 1988, EUR J BIOCHEM, V172, P271, DOI 10.1111/j.1432-1033.1988.tb13883.x; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; Howells LC, 2008, BIOMARKERS, V13, P393, DOI [10.1080/13547500801903719, 10.1080/13547500801903719 ]; Iwamaru Y, 2007, J VIROL, V81, P1524, DOI 10.1128/JVI.01379-06; Jeffrey M, 2007, NEUROPATH APPL NEURO, V33, P373, DOI 10.1111/j.1365-2990.2007.00868.x; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Jeffrey M, 2003, J GEN VIROL, V84, P1033, DOI 10.1099/vir.0.18825-0; Jeffrey M, 2009, BRAIN PATHOL, V19, P1, DOI 10.1111/j.1750-3639.2008.00150.x; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; JORDANS S, 2009, BMC BIOCH, V22, P10; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Luhr KM, 2004, NEUROREPORT, V15, P1663, DOI 10.1097/01.wnr.0000134931.81690.34; MCKINLEY MP, 1991, LAB INVEST, V65, P622; Moudjou M, 2004, J VIROL, V78, P9270, DOI 10.1128/JVI.78.17.9270-9276.2004; Moudjou M, 2001, J GEN VIROL, V82, P2017, DOI 10.1099/0022-1317-82-8-2017; Moudjou M, 2007, NEUROCHEM INT, V50, P689, DOI 10.1016/j.neuint.2007.01.001; Muller H, 2005, BIOCHEM J, V388, P371, DOI 10.1042/BJ20041291; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; Owen JP, 2007, J VIROL, V81, P10532, DOI 10.1128/JVI.00640-07; Owen JP, 2007, MOL BIOTECHNOL, V35, P161, DOI 10.1007/BF02686111; Pan T, 2005, J VIROL, V79, P934, DOI 10.1128/JVI.79.2.934-943.2005; Pan T, 2005, J NEUROCHEM, V92, P132, DOI 10.1111/j.1471-4159.2004.02859.x; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; Pimpinelli F, 2005, EUR J NEUROSCI, V21, P2063, DOI 10.1111/j.1460-9568.2005.04049.x; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qi YP, 1997, J NEUROSCI, V17, P1217; Sakudo A, 2005, BIOCHEM BIOPH RES CO, V333, P448, DOI 10.1016/j.bbrc.2005.05.128; Shaked Y, 2001, J VIROL, V75, P7872, DOI 10.1128/JVI.75.17.7872-7874.2001; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Taguchi Y, 2009, MOL BIOL CELL, V20, P233, DOI 10.1091/mbc.E08-06-0635; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001; Vincent B, 2001, J BIOL CHEM, V276, P37743; Wadsworth JDF, 2007, BBA-MOL BASIS DIS, V1772, P598, DOI 10.1016/j.bbadis.2007.02.010; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; Zanusso G, 2002, ELECTROPHORESIS, V23, P347, DOI 10.1002/1522-2683(200202)23:2<347::AID-ELPS347>3.0.CO;2-1; Zeng FN, 2003, J NEUROCHEM, V84, P480, DOI 10.1046/j.1471-4159.2003.01529.x	61	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10252	10264		10.1074/jbc.M109.083857	http://dx.doi.org/10.1074/jbc.M109.083857			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20154089	Green Published, hybrid			2022-12-25	WOS:000276264600009
J	Martz, JW; Parker, WG				Martz, Jeffrey W.; Parker, William G.			Revised Lithostratigraphy of the Sonsela Member (Chinle Formation, Upper Triassic) in the Southern Part of Petrified Forest National Park, Arizona	PLOS ONE			English	Article							COLORADO PLATEAU; NORTH-AMERICA; NEW-MEXICO; AGE; STRATIGRAPHY; SEQUENCE; STRATA; DOCKUM; USA	Background: Recent revisions to the Sonsela Member of the Chinle Formation in Petrified Forest National Park have presented a three-part lithostratigraphic model based on unconventional correlations of sandstone beds. As a vertebrate faunal transition is recorded within this stratigraphic interval, these correlations, and the purported existence of a depositional hiatus (the Tr-4 unconformity) at about the same level, must be carefully re-examined. Methodology/Principal Findings: Our investigations demonstrate the neglected necessity of walking out contacts and mapping when constructing lithostratigraphic models, and providing UTM coordinates and labeled photographs for all measured sections. We correct correlation errors within the Sonsela Member, demonstrate that there are multiple Flattops One sandstones, all of which are higher than the traditional Sonsela sandstone bed, that the Sonsela sandstone bed and Rainbow Forest Bed are equivalent, that the Rainbow Forest Bed is higher than the sandstones at the base of Blue Mesa and Agate Mesa, that strata formerly assigned to the Jim Camp Wash beds occur at two stratigraphic levels, and that there are multiple persistent silcrete horizons within the Sonsela Member. Conclusions/Significance: We present a revised five-part model for the Sonsela Member. The units from lowest to highest are: the Camp Butte beds, Lot's Wife beds, Jasper Forest bed (the Sonsela sandstone)/Rainbow Forest Bed, Jim Camp Wash beds, and Martha's Butte beds (including the Flattops One sandstones). Although there are numerous degradational/aggradational cycles within the Chinle Formation, a single unconformable horizon within or at the base of the Sonsela Member that can be traced across the entire western United States (the "Tr-4 unconformity") probably does not exist. The shift from relatively humid and poorly-drained to arid and well-drained climatic conditions began during deposition of the Sonsela Member (low in the Jim Camp Wash beds), well after the Carnian-Norian transition.	[Martz, Jeffrey W.; Parker, William G.] Petrified Forest Natl Pk, Div Resource Management, Petrified Forest, AZ USA		Martz, JW (corresponding author), Petrified Forest Natl Pk, Div Resource Management, Petrified Forest, AZ USA.	typothorax@gmail.com	Parker, William/AAV-8361-2021		Federal Lands Recreation Enhancement Act	Federal Lands Recreation Enhancement Act	The authors are currently employed by the National Park Service, and research was conducted during regular work hours. They therefore hold no copyright. Partial funding for this project was provided by the Federal Lands Recreation Enhancement Act. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERS JP, 1958, NEW MEXICO GEOLOGICA, V9, P88; Ash S., 2001, P 6 FOSS RES C NAT P, P3; ASH SR, 1992, PALAEOGEOGR PALAEOCL, V96, P299, DOI 10.1016/0031-0182(92)90107-G; ASH SR, 1987, PETRIFIED FOREST NAT, P405; Ash SR, 2005, MESA SW MUSEUM B, V9, P53; Axsmith BJ, 2009, INT J PLANT SCI, V170, P657, DOI 10.1086/597782; BAZARD DR, 1991, J GEOPHYS RES-SOLID, V96, P9847, DOI 10.1029/91JB00336; BEER JJ, 2005, THESIS U MINNESOTA D; Billingsley G, 1985, MUSEUM NO ARIZONA B, V54, P3; BILLINGSLEY GH, 1985, GEOLOGIC MAP PETRIFI; BILODEAU WL, 1986, J GEOL, V94, P724, DOI 10.1086/629077; Blakey R.C., 1983, MESOZOIC PALEOGEOGRA, P57; BLAKEY RC, 1984, SEDIMENT GEOL, V38, P51, DOI 10.1016/0037-0738(84)90074-5; BLAKEY RC, 1988, SEDIMENT GEOL, V56, P3, DOI 10.1016/0037-0738(88)90050-4; Blakey RC, 2008, SEDIMENT BASIN WORLD, V5, P245, DOI 10.1016/S1874-5997(08)00007-5; BOWN TM, 1987, J SEDIMENT PETROL, V57, P587; BUSBYSPERA CJ, 1988, GEOLOGY, V16, P1121, DOI 10.1130/0091-7613(1988)016<1121:STMFTE>2.3.CO;2; CAMP CL, 1930, MEM U CALIF, V10, P174; Channell JET, 2003, PALAEOGEOGR PALAEOCL, V191, P65, DOI 10.1016/S0031-0182(02)006545; Cleveland DM, 2007, J SEDIMENT RES, V77, P909, DOI 10.2110/jsr.2007.082; Cooley M.E., 1958, PLATEAU, V31, P7; Cooley M. E, 1957, THESIS U ARIZONA TUS; CREBER GT, 1990, REV PALAEOBOT PALYNO, V63, P189, DOI 10.1016/0034-6667(90)90099-5; DEACON M.W., 1990, THESIS NO ARIZONA U; Demko TM, 1998, GEOLOGY, V26, P1119, DOI 10.1130/0091-7613(1998)026<1119:PTIIVI>2.3.CO;2; DEMKO TM, 1995, FOSSILS ARIZONA, P37; DEMKO TM, 1995, THESIS U ARIZONA TUS; Dickinson W.R., 1981, ARIZ GEOL SOC DIG, V14, P113; DUBIEL R F, 1991, Palaios, V6, P347, DOI 10.2307/3514963; Dubiel R.F., 1987, Journal of the Arizona-Nevada Academy of Science, V22, P35; Dubiel R. F., 1989, DAWN AGE DINOSAURS A, P177; Dubiel R.F., 1994, MESOZOIC SYSTEMS ROC, P133; DUBIEL R.F., 1999, NPSNRGRDGRDTR9903, P78; DUBIEL RF, 1994, PETRIFIED FOREST NAT, P6; DUBIEL RF, 1993, NEW MEXICO MUSEUM NA, V3, P117; DUBIEL RF, SEPM SPECIA IN PRESS; DUNAY RE, 1974, REV PALAEOBOT PALYNO, V17, P179, DOI 10.1016/0034-6667(74)90099-2; ESPREGEN WA, 1985, THESIS NO ARIZONA U; Frehlier A. P., 1986, THESIS TEXAS TECH U; Furin S, 2006, GEOLOGY, V34, P1009, DOI 10.1130/G22967A.1; GEHRELS GE, 1995, AM J SCI, V295, P18, DOI 10.2475/ajs.295.1.18; GOEBEL LA, 1936, CORRELATION FO UNPUB; GOOD SC, 1998, EON EVOLUTION PALEOB, P223; GREGORY HE, 1950, 220 US GEOL SOC; GREGORY HE, 1917, 93 US GOL SUURV; Harshbarger JW, 1957, 291 US GEOL SURV; Hazel J.E., 1994, US GEOLOGICAL SURVEY, V2000; Heckert A. B., 2002, NEW MEXICO MUSEUM NA, V21, P37; Heckert A.B., 1996, N M GEOL, V18, P61; HECKERT AB, 1998, 9801 NPSNRGRDGRDTR, P129; HECKERT AB, 1998, 9801 NPSNRGRDGRDTR, P125; HECKERT AB, 1997, THESIS U NEW MEXICO; Heckert AB., 2009, GEOL SOC AM ABSTR, V41, P123; HERRICK AS, 1999, THESIS U RHODE ISLAN; HUNT A P., 2005, GEOLOGY CHAMA BASIN, P357; Hunt Adrian P., 1993, Journal of the Arizona-Nevada Academy of Science, V27, P89; HUNT AP, 1995, NPSNRPONRTR9516, P89; Irmis R, 2008, J VERTEBR PALEONTOL, V28, p95A; JOHNS ME, 1988, THESIS NO ARIZONA U; KIERSCH GA, 1956, METALLIFEROUS MINERA, V1; KRAUS MJ, 1987, GEOLOGY, V15, P18, DOI 10.1130/0091-7613(1987)15<18:DPABCI>2.0.CO;2; KUTZBACH JE, 1989, J GEOPHYS RES-ATMOS, V94, P3341, DOI 10.1029/JD094iD03p03341; Lawton T.F., 1994, MESOZOIC SYSTEMS ROC, P1; Lehman T, 2005, J EARTH SYST SCI, V114, P325, DOI 10.1007/BF02702953; LEHMAN TM, 1994, NEW MEXICO BUREAU MI, V150, P37; LITWIN RJ, 1991, REV PALAEOBOT PALYNO, V68, P269, DOI 10.1016/0034-6667(91)90028-2; Long R.A., 1986, P161; Long R. A., 1995, NEW MEXICO MUSEUM NA, V4, P254; Long R. A., 1985, MUS NORTH ARIZ BULL, V47, P45; LOVE SE, 1993, THESIS U ABERDEEN AB; Lucas S.G., 1993, NEW MEXICO MUSEUM NA, V3, P327; Lucas SG, 1998, PALAEOGEOGR PALAEOCL, V143, P345; LUCAS SG, 2000, ALBERTIANA, V24, P30; LUCAS SG, 1989, NEW MEX GEOL SOC GUI, P191; LUCAS SG, 1993, MUSEUM NO ARIZONA B, V59, P27; LUCAS SG, 2007, NEW MEXICO MUSEUM NA, V40, P189; LUCAS SG, 1991, ALBERTIANA, V4, P11; LUCAS SG, 1995, NATL PARK SERVICE PA, P102; LUPE R, 1985, CIRCUM PACIFIC COUNC, V1, P263; MAY BA, 1988, THESIS TEXAS TECH U; MORALES, 1993, NM MUS NAT HIST SCI, V3, P75; Murry P.A., 1989, P29; Murry P.A., 1989, P375; MURRY PA, 1990, J GEOL, V98, P780, DOI 10.1086/629441; Muttoni G, 2004, GEOL SOC AM BULL, V116, P1043, DOI 10.1130/B25326.1; Muttoni G, 2010, PALAEOGEOGR PALAEOCL, V285, P1, DOI 10.1016/j.palaeo.2009.10.014; NEAL JT, 1996, SOL MIN RES I M PAP; Ogg J.G., 2004, GEOLOGIC TIME SCALE, P271; Parker W.G., 2006, MUS NORTH ARIZ BULL, V62, P46; Parker W.G., 2005, MESA SW MUSEUM B, V11, P34; PARKER WG, 2006, MUSEUM NO ARIZONA B, V62, P126; Parker W, 2009, J VERTEBR PALEONTOL, V29, p162A; PARRISH JM, 1989, PALAEOGEOGR PALAEOCL, V72, P227; PARRISH JT, 1988, SEDIMENT GEOL, V56, P261, DOI 10.1016/0037-0738(88)90056-5; Pipiringos G.N., 1978, PRINCIPAL UNCONFORMI; RAUCCI JJ, 2006, MUSEUM NO ARIZONA B, V62, P157; REESIDE JB, 1957, GEOL SOC AM BULL, V68, P1451, DOI 10.1130/0016-7606(1957)68[1451:COTTFO]2.0.CO;2; REPENNING CA, 1969, 521 US GEOL SURV; Riggs NR, 2003, GEOL SOC AM BULL, V115, P1315, DOI 10.1130/B25254.1; Riggs NR, 1996, SCIENCE, V273, P97, DOI 10.1126/science.273.5271.97; Roadifer J.E, 1966, THESIS U ARIZONA TUS; SIMMS MJ, 1994, IN THE SHADOW OF THE DINOSAURS, P352; Smith D.G., 2001, PENNAKS FRESHWATER I; Stagner H. R., 1941, CARNEGIE I WASHINGTO, V526, P9; Stewart J.H., 1972, US GEOLOGICAL SURVEY, V690, P336; STEWART JH, 1986, GEOLOGY, V14, P567, DOI 10.1130/0091-7613(1986)14<567:LTPOTS>2.0.CO;2; Stewart JH, 1957, AAPG BULL, V41, P441; STEWART JH, 1972, MUSEUM NO ARIZONA B, V47, P75; STOCKER MR, 2008, THESIS U IOWA IOWA, P220; TANNER LH, 2003, GEOLOGY ZUNI PLATEAU, P269; Therrien F, 2000, PALAIOS, V15, P194, DOI 10.2307/3515642; THERRIEN F, 1999, NPSNRPOGRTR993, P101; West Texas Geological Society, 1949, E W CROSS SECTION SO; Wooden J.L., 2009, GEOLOGICAL SOC AM AB, V41, P540; Woody D.T., 2006, ARIZONA MUSEUM NO AR, V62, P17, DOI DOI 10.1007/S00114-007-0291-6; Woody D, 2004, J VERTEBR PALEONTOL, V24, p132A; WOODY DT, 2003, THESIS MUSEUM NO ARI	117	60	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9329	10.1371/journal.pone.0009329	http://dx.doi.org/10.1371/journal.pone.0009329			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174475	gold, Green Submitted, Green Published			2022-12-25	WOS:000274923700026
J	Zhang, H; Tully, DC; Hoffmann, FG; He, J; Kankasa, C; Wood, C				Zhang, Hong; Tully, Damien C.; Hoffmann, Federico G.; He, Jun; Kankasa, Chipepo; Wood, Charles			Restricted Genetic Diversity of HIV-1 Subtype C Envelope Glycoprotein from Perinatally Infected Zambian Infants	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TO-CHILD TRANSMISSION; NEUTRALIZING ANTIBODY-RESPONSES; AMINO-ACID SITES; VERTICAL TRANSMISSION; ESCAPE VARIANTS; DNA-SEQUENCES; ENV; SELECTION; RECOMBINATION	Background: Mother-to-child transmission of HIV-1 remains a significant problem in the resource-constrained settings where anti-retroviral therapy is still not widely available. Understanding the earliest events during HIV-1 transmission and characterizing the newly transmitted or founder virus is central to intervention efforts. In this study, we analyzed the viral env quasispecies of six mother-infant transmission pairs (MIPs) and characterized the genetic features of envelope glycoprotein that could influence HIV-1 subtype C perinatal transmission. Methodology and Findings: The V1-V5 region of env was amplified from 6 MIPs baseline samples and 334 DNA sequences in total were analyzed. A comparison of the viral population derived from the mother and infant revealed a severe genetic bottleneck occurring during perinatal transmission, which was characterized by low sequence diversity in the infant. Phylogenetic analysis indicates that most likely in all our infant subjects a single founder virus was responsible for establishing infection. Furthermore, the newly transmitted viruses from the infant had significantly fewer potential N-linked glycosylation sites in Env V1-V5 region and showed a propensity to encode shorter variable loops compared to the nontransmitted viruses. In addition, a similar intensity of selection was seen between mothers and infants with a higher rate of synonymous (dS) compared to nonsynonymous (dN) substitutions evident (dN/dS<1). Conclusions: Our results indicate that a strong genetic bottleneck occurs during perinatal transmission of HIV-1 subtype C. This is evident through population diversity and phylogenetic patterns where a single viral variant appears to be responsible for infection in the infants. As a result the newly transmitted viruses are less diverse and harbored significantly less glycosylated envelope. This suggests that viruses with the restricted glycosylation in envelope glycoprotein appeared to be preferentially transmitted during HIV-1 subtype C perinatal transmission. In addition, our findings also indicated that purifying selection appears to predominate in shaping the early intrahost evolution of HIV-1 subtype C envelope sequences.	[Zhang, Hong; Tully, Damien C.; Hoffmann, Federico G.; He, Jun; Wood, Charles] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Zhang, Hong; Tully, Damien C.; Hoffmann, Federico G.; He, Jun; Wood, Charles] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Kankasa, Chipepo] Univ Teaching Hosp, Dept Pediat, Lusaka, Zambia	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Zambia	Zhang, H (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA.	cwood@unlnotes.unl.edu	Wood, Charles/AAH-4536-2021; Hoffmann, Federico/B-7134-2009	Tully, Damien/0000-0002-7620-9340; Hoffmann, Federico/0000-0001-5056-4929; Wood, Charles/0000-0002-4256-1530	Public Health Service [CA75903]; Fogarty Training [TW001429]; NCRR COBRE [RR15635]; University of Nebraska-Lincoln;  [P20 RR15635]; NATIONAL CANCER INSTITUTE [R01CA075903] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Fogarty Training; NCRR COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Nebraska-Lincoln; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by Public Health Service grants CA75903, Fogarty Training grant TW001429 and NCRR COBRE grant RR15635 to C. W.; Layman Award from the University of Nebraska-Lincoln and P20 RR15635 to H. Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha A, 2009, J VIROL, V83, P5592, DOI 10.1128/JVI.02051-08; AHMAD N, 1995, J VIROL, V69, P1001, DOI 10.1128/JVI.69.2.1001-1012.1995; Anisimova M, 2003, GENETICS, V164, P1229; Buseyne F, 1998, VIROLOGY, V250, P316, DOI 10.1006/viro.1998.9373; Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dickover RE, 2001, J VIROL, V75, P2194, DOI 10.1128/JVI.75.5.2194-2203.2001; Dickover R, 2006, J VIROL, V80, P6525, DOI 10.1128/JVI.02658-05; Edwards CTT, 2006, GENETICS, V174, P1441, DOI 10.1534/genetics.105.052019; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Frost SDW, 2005, J VIROL, V79, P6523, DOI 10.1128/JVI.79.10.6523-6527.2005; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; KLIKS SC, 1994, JAMA-J AM MED ASSOC, V272, P467, DOI 10.1001/jama.272.6.467; Kong XH, 2008, J VIROL, V82, P11609, DOI 10.1128/JVI.00952-08; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LAMERS SL, 1994, J CLIN INVEST, V93, P380, DOI 10.1172/JCI116970; Leal E, 2007, INFECT GENET EVOL, V7, P694, DOI 10.1016/j.meegid.2007.07.008; Liu Y, 2008, VIROLOGY, V374, P229, DOI 10.1016/j.virol.2008.01.029; LUZURIAGA K, 1995, J IMMUNOL, V154, P433; Luzuriaga Katherine, 2002, AIDS Reviews, V4, P21; Mantina H, 2001, INT J CANCER, V94, P749, DOI 10.1002/ijc.1529; Ndung'u T, 2001, J VIROL, V75, P4964, DOI 10.1128/JVI.75.11.4964-4972.2001; Pasquier C, 1998, J VIROL, V72, P8493, DOI 10.1128/JVI.72.11.8493-8501.1998; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Rousseau CM, 2003, J INFECT DIS, V187, P741, DOI 10.1086/374273; Samleerat T, 2008, J INFECT DIS, V198, P868, DOI 10.1086/591251; Sandberg JK, 2003, J IMMUNOL, V170, P4403, DOI 10.4049/jimmunol.170.8.4403; SCARLATTI G, 1993, P NATL ACAD SCI USA, V90, P1721, DOI 10.1073/pnas.90.5.1721; SCARLATTI G, 1993, AIDS, V7, pS45, DOI 10.1097/00002030-199311002-00010; Scott ZA, 2001, J IMMUNOL, V167, P7134, DOI 10.4049/jimmunol.167.12.7134; Shriner D, 2003, GENET RES, V81, P115, DOI 10.1017/S0016672303006128; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tso FY, 2009, AIDS, V23, P1817, DOI 10.1097/QAD.0b013e32832f3da6; Verhofstede C, 2003, J VIROL, V77, P3050, DOI 10.1128/JVI.77.5.3050-3057.2003; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zhang H, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-67; Zhang H, 2002, AIDS RES HUM RETROV, V18, P1415, DOI 10.1089/088922202320935492; ZHANG H, 2009, VIROLOGY; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhang X, 2006, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/01/003	50	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9294	10.1371/journal.pone.0009294	http://dx.doi.org/10.1371/journal.pone.0009294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174636	Green Published, gold			2022-12-25	WOS:000274654700021
J	Maggini, J; Mirkin, G; Bognanni, I; Holmberg, J; Piazzon, IM; Nepomnaschy, I; Costa, H; Canones, C; Raiden, S; Vermeulen, M; Geffner, JR				Maggini, Julian; Mirkin, Gerardo; Bognanni, Ianina; Holmberg, Josefina; Piazzon, Isabel M.; Nepomnaschy, Irene; Costa, Hector; Canones, Cristian; Raiden, Silvina; Vermeulen, Monica; Geffner, Jorge R.			Mouse Bone Marrow-Derived Mesenchymal Stromal Cells Turn Activated Macrophages into a Regulatory-Like Profile	PLOS ONE			English	Article							IL-12 P40 HOMODIMER; STEM-CELLS; INTERFERON-GAMMA; APOPTOTIC CELLS; IFN-GAMMA; T-CELLS; ALTERNATIVE ACTIVATION; INTERLEUKIN (IL)-12; DENDRITIC CELLS; CHAGAS-DISEASE	In recent years it has become clear that the therapeutic properties of bone marrow-derived mesenchymal stromal cells (MSC) are related not only to their ability to differentiate into different lineages but also to their capacity to suppress the immune response. We here studied the influence of MSC on macrophage function. Using mouse thioglycolate-elicited peritoneal macrophages (M) stimulated with LPS, we found that MSC markedly suppressed the production of the inflammatory cytokines TNF-alpha, IL-6, IL-12p70 and interferon-gamma while increased the production of IL-10 and IL-12p40. Similar results were observed using supernatants from MSC suggesting that factor(s) constitutively released by MSC are involved. Supporting a role for PGE(2) we observed that acetylsalicylic acid impaired the ability of MSC to inhibit the production of inflammatory cytokines and to stimulate the production of IL-10 by LPS-stimulated M. Moreover, we found that MSC constitutively produce PGE(2) at levels able to inhibit the production of TNF-alpha and IL-6 by activated M. MSC also inhibited the up-regulation of CD86 and MHC class II in LPS-stimulated M impairing their ability to activate antigen-specific T CD4+ cells. On the other hand, they stimulated the uptake of apoptotic thymocytes by M. Of note, MSC turned M into cells highly susceptible to infection with the parasite Trypanosoma cruzi increasing more than 5-fold the rate of M infection. Using a model of inflammation triggered by s.c. implantation of glass cylinders, we found that MSC stimulated the recruitment of macrophages which showed a low expression of CD86 and the MHC class II molecule la(b) and a high ability to produce IL-10 and IL-12p40, but not IL-12 p70. In summary, our results suggest that MSC switch M into a regulatory profile characterized by a low ability to produce inflammatory cytokines, a high ability to phagocyte apoptotic cells, and a marked increase in their susceptibility to infection by intracellular pathogens.	[Maggini, Julian; Bognanni, Ianina; Holmberg, Josefina; Piazzon, Isabel M.; Nepomnaschy, Irene; Costa, Hector; Canones, Cristian; Raiden, Silvina; Vermeulen, Monica; Geffner, Jorge R.] Acad Nacl Med Buenos Aires, Inst Invest Hematol, Buenos Aires, DF, Argentina; [Mirkin, Gerardo; Geffner, Jorge R.] Univ Buenos Aires, Fac Med, Dept Microbiol Immunol & Parasitol, Buenos Aires, DF, Argentina; [Geffner, Jorge R.] Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; University of Buenos Aires; University of Buenos Aires	Geffner, JR (corresponding author), Acad Nacl Med Buenos Aires, Inst Invest Hematol, Buenos Aires, DF, Argentina.	geffnerj@fibertel.com.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas(CONICET); Buenos Aires University School of Medicine; Agencia Nacional de Promocion Cientifica y Tecnologica; Fundacion YPF (Argentina)	Consejo Nacional de Investigaciones Cientificas y Tecnicas(CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Buenos Aires University School of Medicine(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fundacion YPF (Argentina)	This study was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas(CONICET), the Buenos Aires University School of Medicine, the Agencia Nacional de Promocion Cientifica y Tecnologica, and Fundacion YPF (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Barrionuevo P, 2007, J IMMUNOL, V178, P436, DOI 10.4049/jimmunol.178.1.436; Bianco P, 2006, METHOD ENZYMOL, V419, P117, DOI 10.1016/S0076-6879(06)19006-0; Bogdan C, 2006, TRENDS IMMUNOL, V27, P282, DOI 10.1016/j.it.2006.04.004; CAPPA SMG, 1981, MEDICINA-BUENOS AIRE, V41, P119; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; COLIGAN JE, 1994, CURRENT PROTOCOLS IM, V3; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; DAIS F, 2007, CURR OPIN ONCOL, V19, P650; Darwich L, 2009, IMMUNOLOGY, V126, P386, DOI 10.1111/j.1365-2567.2008.02905.x; Dobreva ZG, 2008, CYTOKINE, V43, P76, DOI 10.1016/j.cyto.2008.04.003; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; GERMANN T, 1995, IMMUNOL TODAY, V16, P500, DOI 10.1016/0167-5699(95)80035-2; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Holscher C, 1998, INFECT IMMUN, V66, P1208; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Keating A, 2008, CELL STEM CELL, V2, P106, DOI 10.1016/j.stem.2008.01.007; Keating A, 2006, CURR OPIN HEMATOL, V13, P419, DOI 10.1097/01.moh.0000245697.54887.6f; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Li YP, 2008, J IMMUNOL, V180, P1598, DOI 10.4049/jimmunol.180.3.1598; Maccario R, 2005, HAEMATOLOGICA, V90, P516; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MIRKIN GA, 1994, CLIN IMMUNOL IMMUNOP, V73, P69, DOI 10.1006/clin.1994.1171; Moncayo A, 2006, ANN TROP MED PARASIT, V100, P663, DOI 10.1179/136485906X112248; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Oliveira AC, 2004, J IMMUNOL, V173, P5688, DOI 10.4049/jimmunol.173.9.5688; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Puddu P, 1997, J IMMUNOL, V159, P3490; Ramasamy R, 2007, TRANSPLANTATION, V83, P71, DOI 10.1097/01.tp.0000244572.24780.54; Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rossi AG, 1998, J IMMUNOL, V160, P3562; Sardinha LR, 2006, INFECT IMMUN, V74, P2031, DOI 10.1128/IAI.74.4.2031-2042.2006; Schleicher U, 2005, BLOOD, V105, P1319, DOI 10.1182/blood-2004-05-1749; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Stempin C, 2002, J LEUKOCYTE BIOL, V72, P727; Traggiai E, 2008, STEM CELLS, V26, P562, DOI 10.1634/stemcells.2007-0528; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Yang Yi-Wu, 2008, Zhonghua Xue Ye Xue Za Zhi, V29, P540	57	420	439	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9252	10.1371/journal.pone.0009252	http://dx.doi.org/10.1371/journal.pone.0009252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169081	Green Submitted, gold, Green Published			2022-12-25	WOS:000274590500027
J	Dahl, JA; Reiner, AH; Klungland, A; Wakayama, T; Collas, P				Dahl, John Arne; Reiner, Andrew H.; Klungland, Arne; Wakayama, Teruhiko; Collas, Philippe			Histone H3 Lysine 27 Methylation Asymmetry on Developmentally-Regulated Promoters Distinguish the First Two Lineages in Mouse Preimplantation Embryos	PLOS ONE			English	Article							CHROMATIN IMMUNOPRECIPITATION ASSAY; STEM-CELLS; NUCLEAR TRANSFER; GENE-EXPRESSION; HUMAN GENOME; CHIP-CHIP; MU-CHIP; PLURIPOTENT; FATE; DIFFERENTIATION	First lineage specification in the mammalian embryo leads to formation of the inner cell mass (ICM) and trophectoderm (TE), which respectively give rise to embryonic and extraembryonic tissues. We show here that this first differentiation event is accompanied by asymmetric distribution of trimethylated histone H3 lysine 27 (H3K27me3) on promoters of signaling and developmentally-regulated genes in the mouse ICM and TE. A genome-wide survey of promoter occupancy by H3K4me3 and H3K27me3 indicates that both compartments harbor promoters enriched in either modification, and promoters co-enriched in trimethylated H3K4 and H3K27 linked to developmental and signaling functions. The majority of H3K4/K27me3 co-enriched promoters are distinct between the two lineages, primarily due to differences in the distribution of H3K27me3. Derivation of embryonic stem cells leads to significant losses and gains of H3K4/K27me3 co-enriched promoters relative to the ICM, with distinct contributions of (de) methylation events on K4 and K27. Our results show histone trimethylation asymmetry on promoters in the first two developmental lineages, and highlight an epigenetic skewing associated with embryonic stem cell derivation.	[Dahl, John Arne; Reiner, Andrew H.; Collas, Philippe] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Dahl, John Arne; Reiner, Andrew H.; Collas, Philippe] Norwegian Ctr Stem Cell Res, Oslo, Norway; [Klungland, Arne] Oslo Univ Hosp, Inst Med Microbiol, Ctr Mol Biol & Neurosci, Oslo, Norway; [Wakayama, Teruhiko] RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan	University of Oslo; University of Oslo; RIKEN	Dahl, JA (corresponding author), Oslo Univ Hosp, Inst Med Microbiol, Ctr Mol Biol & Neurosci, Oslo, Norway.	philippe.collas@medisin.uio.no	Klungland, Arne/X-1233-2019	Klungland, Arne/0000-0001-7274-3661	Ministry of Education, Science, Sports, Culture and Technology of Japan [15080211]; Research Council of Norway	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Council of Norway(Research Council of Norway)	This work was funded by a Grant-in-Aid for Scientific Research in Priority Areas (15080211) from the Ministry of Education, Science, Sports, Culture and Technology of Japan (T. W.), and by the Research Council of Norway (P. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LG, 2008, CANCER RES, V68, P2641, DOI 10.1158/0008-5472.CAN-07-5590; Albert M, 2009, CURR OPIN GENET DEV, V19, P113, DOI 10.1016/j.gde.2009.03.004; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Collas P, 2008, FRONT BIOSCI-LANDMRK, V13, P929, DOI 10.2741/2733; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Dahl JA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r13; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Noer A, 2009, STEM CELLS DEV, V18, P725, DOI 10.1089/scd.2008.0189; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Reik W, 2003, PHILOS T R SOC B, V358, P1403, DOI 10.1098/rstb.2003.1326; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Sharov AA, 2007, CELL STEM CELL, V1, P237, DOI 10.1016/j.stem.2007.08.015; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Stewart S, 2009, P NATL ACAD SCI USA, V106, P19889, DOI 10.1073/pnas.0904132106; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; VerMilyea MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006086; Wakayama S, 2005, J REPROD DEVELOP, V51, P765, DOI 10.1262/jrd.17061; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	46	77	80	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9150	10.1371/journal.pone.0009150	http://dx.doi.org/10.1371/journal.pone.0009150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161773	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442700014
J	Ventura, E; Sassi, F; Parodi, A; Balza, E; Borsi, L; Castellani, P; Carnemolla, B; Zardi, L				Ventura, Elisa; Sassi, Francesca; Parodi, Arianna; Balza, Enrica; Borsi, Laura; Castellani, Patrizia; Carnemolla, Barbara; Zardi, Luciano			Alternative Splicing of the Angiogenesis Associated Extra-Domain B of Fibronectin Regulates the Accessibility of the B-C Loop of the Type III Repeat 8	PLOS ONE			English	Article							ED-B; MESSENGER-RNA; ONCOFETAL FIBRONECTIN; TARGETED DELIVERY; CRYPTIC SEQUENCE; ISOFORM; MARKER; ANTIBODIES; REGION; MOLECULE	Background: Fibronectin (FN) is a multi-domain molecule involved in many cellular processes, including tissue repair, embryogenesis, blood clotting, and cell migration/adhesion. The biological activities of FN are mediated by exposed loops located mainly at the interdomain interfaces that interact with various molecules such as, but not only, integrins. Different FN isoforms arise from the alternative splicing of the pre-mRNA. In malignancies, the splicing pattern of FN pre-mRNA is altered; in particular, the FN isoform containing the extra-domain B (ED-B), a complete FN type III repeat constituted by 91 residues, is undetectable in normal adult tissues, but exhibits a much greater expression in fetal and tumor tissues, and is accumulated around neovasculature during angiogenic processes, thus making ED-B one of the best markers and targets of angiogenesis. The functions of ED-B are still unclear; however, it has been postulated that the insertion of an extra-domain such as ED-B modifies the domain-domain interface and may unmask loops that are otherwise cryptic, thus giving FN new potential activities. Methodology: We used the mAb C6, which reacts with ED-B containing FN, but not with ED-B-free FN and various recombinant FN fragments containing mutations, to precisely localize the epitopes recognized by the mAb C6. Conclusion: We formally demonstrated that the inclusion of the alternatively spliced angiogenesis-associated ED-B leads to the unmasking of the FNIII 8 B-C loop that is cryptic in FN molecules lacking ED-B. Thus, the mAb C6, in addition to providing a new reagent for angiogenesis targeting, represents a new tool for the study of the potential biological functions of the B-C loop of the repeat FNIII 8 that is unmasked during angiogenic processes.	[Ventura, Elisa; Sassi, Francesca; Parodi, Arianna; Zardi, Luciano] CBA Adv Biotechnol Ctr, Lab Recombinant Therapeut Prot, Genoa, Italy; [Balza, Enrica; Borsi, Laura; Castellani, Patrizia] Ist Nazl Ric Canc, Cell Biol Lab, I-16132 Genoa, Italy; [Carnemolla, Barbara] Ist Nazl Ric Canc, Immunol Lab, I-16132 Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Ventura, E (corresponding author), CBA Adv Biotechnol Ctr, Lab Recombinant Therapeut Prot, Genoa, Italy.	zardi43@yahoo.it	Castellani, Patrizia/J-7333-2018	Castellani, Patrizia/0000-0002-6326-5853; Ventura, Elisa/0000-0002-5999-7613	LIMONTE, Regione Liguria and Piemonte, Genoa, Italy; European Union [LSHC-CT-2006-037489-ImmunoPDT]; Istituto Superiore della Sanita, Rome, Italy [ISS2006]; Italian Ministry of Health, Rome, Italy [RF-IST-2006-384590, RFSP-2006-3-339960]; Programma oncologico di medicina molecolare: i tumori femminili; Alleanza Contro il Cancro [ACC2007];  [IST/IEO 2007]	LIMONTE, Regione Liguria and Piemonte, Genoa, Italy; European Union(European Commission); Istituto Superiore della Sanita, Rome, Italy; Italian Ministry of Health, Rome, Italy(Ministry of Health, Italy); Programma oncologico di medicina molecolare: i tumori femminili; Alleanza Contro il Cancro; 	This research was supported by grants from: LIMONTE, Regione Liguria and Piemonte, Genoa, Italy (to L. Z.); European Union grant no. FP6 LSHC-CT-2006-037489-ImmunoPDT (to L. Z.); Istituto Superiore della Sanita, Rome, Italy grant no. ISS2006 Rare Diseases, (to B. C. and L. B.), Italian Ministry of Health, Rome, Italy grant no RF-IST-2006-384590 (to L. B.), grant no RFSP-2006-3-339960 (to B. C.) and grant no IST/IEO 2007(to L. B.) and Programma oncologico di medicina molecolare: i tumori femminili (to B. C.), and Alleanza Contro il Cancro grant no. ACC2007 (to L. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALZA E, 1988, FEBS LETT, V228, P42, DOI 10.1016/0014-5793(88)80580-5; Balza E, 2009, INT J CANCER, V125, P751, DOI 10.1002/ijc.24473; Bencharit S, 2007, J MOL BIOL, V367, P303, DOI 10.1016/j.jmb.2006.10.017; BORSI L, 1995, J BIOL CHEM, V270, P6243, DOI 10.1074/jbc.270.11.6243; Borsi L, 2003, BLOOD, V102, P4384, DOI 10.1182/blood-2003-04-1039; Borsi L, 2002, INT J CANCER, V102, P75, DOI 10.1002/ijc.10662; Carnemolla B, 2002, BLOOD, V99, P1659, DOI 10.1182/blood.V99.5.1659; CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139; Carnemolla B, 1996, INT J CANCER, V68, P397, DOI 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.3.CO;2-D; CARNEMOLLA B, 1992, J BIOL CHEM, V267, P24689; Castellani P, 2002, AM J PATHOL, V161, P1695, DOI 10.1016/S0002-9440(10)64446-X; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; Fattorusso R, 1999, STRUCTURE, V7, P381, DOI 10.1016/S0969-2126(99)80051-3; GUTMAN A, 1987, P NATL ACAD SCI USA, V84, P7179, DOI 10.1073/pnas.84.20.7179; Hynes RO, 1990, FIBRONECTINS; Kosmehl H, 1996, VIRCHOWS ARCH, V429, P311; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Mariani G, 1997, CANCER, V80, P2378, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2378::AID-CNCR7>3.0.CO;2-7; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Sauer S, 2009, BLOOD, V113, P2265, DOI 10.1182/blood-2008-06-160416; SCHWARZBAUER JE, 1987, EMBO J, V6, P2573, DOI 10.1002/j.1460-2075.1987.tb02547.x; Spitzfaden C, 1997, J MOL BIOL, V265, P565, DOI 10.1006/jmbi.1996.0736; Yamada K.M., 1996, MOL CELLULAR BIOL WO, P51; ZARDI L, 1982, EMBO J, V1, P929, DOI 10.1002/j.1460-2075.1982.tb01273.x; ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x	28	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9145	10.1371/journal.pone.0009145	http://dx.doi.org/10.1371/journal.pone.0009145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161770	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442700009
J	Abu-Hayyeh, S; Martinez-Becerra, P; Kadir, SHSA; Selden, C; Romero, MR; Rees, M; Marschall, HU; Marin, JJG; Williamson, C				Abu-Hayyeh, Shadi; Martinez-Becerra, Pablo; Kadir, Siti H. Sheikh Abdul; Selden, Clare; Romero, Marta R.; Rees, Myrddin; Marschall, Hanns-Ulrich; Marin, Jose J. G.; Williamson, Catherine			Inhibition of Na+-Taurocholate Co-transporting Polypeptide-mediated Bile Acid Transport by Cholestatic Sulfated Progesterone Metabolites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT EXPORT PUMP; INTRAHEPATIC CHOLESTASIS; COTRANSPORTING POLYPEPTIDE; ABCB4 GENE; PREGNANCY; HEPATOCYTES; RAT; DEXAMETHASONE; POLYMORPHISM; VARIANTS	Sulfated progesterone metabolite (P4-S) levels are raised in normal pregnancy and elevated further in intrahepatic cholestasis of pregnancy (ICP), a bile acid-liver disorder of pregnancy. ICP can be complicated by preterm labor and intrauterine death. The impact of P4-S on bile acid uptake was studied using two experimental models of hepatic uptake of bile acids, namely cultured primary human hepatocytes (PHH) and Na+-taurocholate co-transporting polypeptide (NTCP)-expressing Xenopus laevis oocytes. Two P4-S compounds, allopregnanolone-sulfate (PM4-S) and epiallopregnanolone-sulfate (PM5-S), reduced [H-3] taurocholate (TC) uptake in a dose-dependent manner in PHH, with both Na+-dependent and-independent bile acid uptake systems significantly inhibited. PM5-S-mediated inhibition of TC uptake could be reversed by increasing the TC concentration against a fixed PM5-S dose indicating competitive inhibition. Experiments using NTCP-expressing Xenopus oocytes confirmed that PM4-S/PM5-S are capable of competitively inhibiting NTCP-mediated uptake of [H-3]TC. Total serum PM4-S + PM5-S levels were measured in non-pregnant and third trimester pregnant women using liquid chromatography-electrospray tandem mass spectrometry and were increased in pregnant women, at levels capable of inhibiting TC uptake. In conclusion, pregnancy levels of P4-S can inhibit Na+-dependent and-independent influx of taurocholate in PHH and cause competitive inhibition of NTCP-mediated uptake of taurocholate in Xenopus oocytes.	[Williamson, Catherine] Univ London Imperial Coll Sci Technol & Med, Maternal & Fetal Dis Grp, Dept Surg & Canc, Inst Reprod & Dev Biol,Fac Med, London W12 0NN, England; [Martinez-Becerra, Pablo; Romero, Marta R.; Marin, Jose J. G.] Univ Salamanca, Lab Expt Hepatol & Drug Targeting, CIBERehd, Salamanca 37007, Spain; [Selden, Clare] Royal Free Campus Univ Coll London, Univ Coll Med Sch, Dept Med, Univ Coll London Ctr Hepatol, London NW3 2PF, England; [Rees, Myrddin] N Hampshire Hosp Natl Hlth Serv Trust, Basingstoke RG24 9NA, Hants, England; [Marschall, Hanns-Ulrich] Karolinska Inst, Dept Med, Karolinska Univ Hosp Huddinge, S-14186 Stockholm, Sweden	Imperial College London; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Salamanca; University of London; University College London; Karolinska Institutet; Karolinska University Hospital	Williamson, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Maternal & Fetal Dis Grp, Dept Surg & Canc, Inst Reprod & Dev Biol,Fac Med, Du Cane Rd, London W12 0NN, England.	catherine.williamson@imperial.ac.uk	Marschall, Hanns-Ulrich/K-8842-2017; Romero, Marta Rodriguez/B-1596-2017; Marin, Jose J. G./D-5017-2011; Sheikh Abdul Kadir, Siti Hamimah/ABA-7769-2021; IBSAL, Secretaría/H-3719-2011	Marschall, Hanns-Ulrich/0000-0001-7347-3085; Romero, Marta Rodriguez/0000-0001-6729-0215; Marin, Jose J. G./0000-0003-1186-6849; Sheikh Abdul Kadir, Siti Hamimah/0000-0002-1671-4839; Selden, Angela/0000-0003-2648-443X; Williamson, Catherine/0000-0002-6226-7611	Action Medical Research Grant [SP4005]; Women for Women Charity; Biomedical Research Centre at Imperial College Hospitals NHS Trust; Junta de Castilla y Leon (Spain) [GR75/2008, SA033A08, SA03508, SA03608, SAN 673/SA07/08]; Ministerio de Ciencia y Tecnologia; Plan Nacional de Investigacion Cientifica; Desarrollo e Innovacion Tecnologica (Spain) [BFU2006-12577, BFU2007-30688-E/BFI]	Action Medical Research Grant; Women for Women Charity; Biomedical Research Centre at Imperial College Hospitals NHS Trust; Junta de Castilla y Leon (Spain)(Junta de Castilla y Leon); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Plan Nacional de Investigacion Cientifica(Instituto de Salud Carlos IIIEuropean Commission); Desarrollo e Innovacion Tecnologica (Spain)	This work was supported in part by Action Medical Research Grant SP4005, Women for Women Charity, Biomedical Research Centre at Imperial College Hospitals NHS Trust, Junta de Castilla y Leon Grants GR75/2008, SA033A08, SA03508, SA03608, and SAN 673/SA07/08 (Spain), Ministerio de Ciencia y Tecnologia, Plan Nacional de Investigacion Cientifica, and Desarrollo e Innovacion Tecnologica Grants BFU2006-12577 and BFU2007-30688-E/BFI (Spain).	Arrese M, 2003, J HEPATOL, V38, P148, DOI 10.1016/S0168-8278(02)00379-3; Bacq Y, 1997, HEPATOLOGY, V26, P358, DOI 10.1002/hep.510260216; Briz O, 2002, MOL PHARMACOL, V61, P853, DOI 10.1124/mol.61.4.853; Castano G, 2006, CLIN SCI, V110, P459, DOI 10.1042/CS20050302; Crocenzi FA, 2003, AM J PHYSIOL-GASTR L, V285, pG449, DOI 10.1152/ajpgi.00508.2002; Diac M, 2006, J Obstet Gynaecol, V26, P110; Dixon PH, 2008, OBSTET MED, V1, P65, DOI 10.1258/om.2008.080010; Dixon PH, 2009, GUT, V58, P537, DOI 10.1136/gut.2008.159541; Dixon PH, 2000, HUM MOL GENET, V9, P1209, DOI 10.1093/hmg/9.8.1209; Eloranta JJ, 2006, MOL ENDOCRINOL, V20, P65, DOI 10.1210/me.2005-0159; GANGULY T, 1993, J PHARMACOL EXP THER, V267, P82; Geier A, 2003, BBA-BIOMEMBRANES, V1609, P87, DOI 10.1016/S0005-2736(02)00657-0; Glantz A, 2005, HEPATOLOGY, V42, P1399, DOI 10.1002/hep.20952; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Glantz A, 2008, HEPATOLOGY, V47, P544, DOI 10.1002/hep.21987; HIRVIOJA ML, 1992, BRIT J OBSTET GYNAEC, V99, P109, DOI 10.1111/j.1471-0528.1992.tb14465.x; Ho RH, 2004, J BIOL CHEM, V279, P7213, DOI 10.1074/jbc.M305782200; Kancheva R, 2007, J ENDOCRINOL, V195, P67, DOI 10.1677/JOE-06-0192; Kim RB, 1999, J PHARMACOL EXP THER, V291, P1204; Kullak-Ublick GA, 2000, CYTOTECHNOLOGY, V34, pB1, DOI 10.1023/A:1008152729133; Marschall HU, 2001, J LIPID RES, V42, P735; Meier Y, 2008, WORLD J GASTROENTERO, V14, P38, DOI 10.3748/wjg.14.38; Meng LJ, 1997, J HEPATOL, V27, P346, DOI 10.1016/S0168-8278(97)80181-X; Mullenbach R, 2005, GUT, V54, P829, DOI 10.1136/gut.2004.058115; Mullenbach R, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e70; Pascual MJ, 2002, CLIN SCI, V102, P587, DOI 10.1042/CS20010258; Pauli-Magnus C, 2004, PHARMACOGENETICS, V14, P91, DOI 10.1097/00008571-200402000-00003; SANDKER GW, 1994, BIOCHEM PHARMACOL, V47, P2193, DOI 10.1016/0006-2952(94)90255-0; Selden C, 2007, J GENE MED, V9, P67, DOI 10.1002/jgm.1000; SJOVALL J, 1970, Annals of Clinical Research, V2, P321; SJOVALL K, 1970, Annals of Clinical Research, V2, P393; Tagliacozzi D, 2003, CLIN CHEM LAB MED, V41, P1633, DOI 10.1515/CCLM.2003.247; Vallejo M, 2006, J HEPATOL, V44, P1150, DOI 10.1016/j.jhep.2005.09.017; Van Mil SWC, 2007, GASTROENTEROLOGY, V133, P507, DOI 10.1053/j.gastro.2007.05.015; Vicens M, 2007, BIOORGAN MED CHEM, V15, P2359, DOI 10.1016/j.bmc.2007.01.027; Wasmuth HE, 2007, GUT, V56, P265, DOI 10.1136/gut.2006.092742; Williamson C, 2004, BJOG-INT J OBSTET GY, V111, P676, DOI 10.1111/j.1471-0528.2004.00167.x; Yamamoto Y, 2006, J BIOL CHEM, V281, P16625, DOI 10.1074/jbc.M602723200; ZIMMERLI B, 1989, J PHARMACOL EXP THER, V250, P301	39	50	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16504	16512		10.1074/jbc.M109.072140	http://dx.doi.org/10.1074/jbc.M109.072140			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20177056	Green Published, hybrid			2022-12-25	WOS:000277982600012
J	Ran, FL; Gadura, N; Michels, CA				Ran, Fulai; Gadura, Nidhi; Michels, Corinne A.			Hsp90 Cochaperone Aha1 Is a Negative Regulator of the Saccharomyces MAL Activator and Acts Early in the Chaperone Activation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; QUALITY-CONTROL; ATPASE ACTIVITY; MOLECULAR CHAPERONES; CLIENT PROTEIN; MIDDLE DOMAIN; CDC37; CHIP; IDENTIFICATION; EXPRESSION	Aha1 is a ubiquitous cochaperone of the Hsp90/Hsp70 chaperone machine. It binds the middle domain of Hsp90 and stimulates ATPase activity, suggesting a function late in the chaperone pathway. Saccharomyces Mal63 MAL activator is a DNA-binding transcription factor and Hsp90 client protein. This study utilizes several MAL activator mutants to investigate Aha1functioninvivo. Deletion of AHA1 enhances induced Mal63-dependent maltase activity levels 2-fold, whereas overproduction of Aha1 represses expression. Maltase expression in strains carrying constitutive and super-inducible mutant activators with alterations near the C terminus (particularly residues 433-463) is unaffected by either aha1 Delta or Aha1 overproduction. However, another constitutive activator with alterations outside of this C-terminal region is sensitive to Aha1 regulation. Previously, we showed that in the absence of inducer, Mal63 forms a stable intermediate complex with Hsp70, Hsp90, and Sti1, whereas noninducible mutant activators bind only with Hsp70 in an apparent early complex. Here, we find that triple Myc-tagged Aha1/Myc3 copurifies with all noninducible Mal63 mutant activators tested. Aha1/Myc3 association with inducible Mal63 is observed only in a sti1 Delta strain, in which Hsp90 binding and intermediate complex formation are defective. Constitutive and super-inducible mutant activators with C-terminal alterations do not bind Aha1 even in a sti1 Delta strain. Mal63 binding to Hsp90 and Hsp70 is enhanced 3-fold by loss of Aha1. These results suggest an interaction between Aha1 and residues near the C terminus of Mal63 thereby regulating Hsp90 association. A novel mechanism for the negative regulation of the MAL activator by Aha1 cochaperone is proposed.	[Ran, Fulai; Michels, Corinne A.] CUNY Queens Coll, Dept Biol, Flushing, NY 11367 USA; [Ran, Fulai; Michels, Corinne A.] CUNY, Grad Sch, Ph D Program Biochem, New York, NY 10016 USA; [Gadura, Nidhi] CUNY Queensborough Community Coll, Dept Biol Sci & Geol, Bayside, NY 11364 USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System	Michels, CA (corresponding author), CUNY Queens Coll, Dept Biol, 65-30 Kissena Blvd, Flushing, NY 11367 USA.	corinne.michels@qc.cuny.edu			National Institutes of Health [GM28216]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM28216 (to C. A. M.).	Abbas-Terki T, 2002, BIOL CHEM, V383, P1335, DOI 10.1515/BC.2002.152; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bali M, 2003, J BIOL CHEM, V278, P47441, DOI 10.1074/jbc.M309536200; Barnett JA, 2005, YEAST, V22, P835, DOI 10.1002/yea.1249; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Caplan AJ, 2003, CELL STRESS CHAPERON, V8, P105, DOI 10.1379/1466-1268(2003)008<0105:WIAC>2.0.CO;2; Caplan Avrom J., 2003, EMBO Reports, V4, P126, DOI 10.1038/sj.embor.embor742; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; CHARRON MJ, 1987, GENETICS, V116, P23; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Danzi SE, 2003, CURR GENET, V44, P173, DOI 10.1007/s00294-003-0429-9; Danzi SE, 2000, CURR GENET, V38, P233, DOI 10.1007/s002940000161; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; DUBIN RA, 1985, J BACTERIOL, V164, P605, DOI 10.1128/JB.164.2.605-610.1985; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Gibson AW, 1997, GENETICS, V146, P1287; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; HU Z, 1995, CURR GENET, V28, P258, DOI 10.1007/BF00309785; Hu Z, 1999, CURR GENET, V36, P1, DOI 10.1007/s002940050466; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Lee P, 2004, MOL BIOL CELL, V15, P1785, DOI 10.1091/mbc.E03-07-0480; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Mandal AK, 2007, J CELL BIOL, V176, P319, DOI 10.1083/jcb.200604106; Martinez-Yamout MA, 2006, J BIOL CHEM, V281, P14457, DOI 10.1074/jbc.M601759200; Mayer MP, 2002, MOL CELL, V10, P1255, DOI 10.1016/S1097-2765(02)00793-1; McDowell CL, 2009, INT J BIOL MACROMOL, V45, P310, DOI 10.1016/j.ijbiomac.2009.06.012; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nathan DF, 1999, P NATL ACAD SCI USA, V96, P1409, DOI 10.1073/pnas.96.4.1409; Neckers L, 2009, NAT STRUCT MOL BIOL, V16, P235, DOI 10.1038/nsmb0309-235; Neckers L, 2009, TRENDS BIOCHEM SCI, V34, P223, DOI 10.1016/j.tibs.2009.01.006; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Ran F, 2008, GENETICS, V179, P331, DOI 10.1534/genetics.107.084921; Richter K, 2006, CELL, V127, P251, DOI 10.1016/j.cell.2006.10.004; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Tripathi V, 2007, J BIOL CHEM, V282, P28441, DOI 10.1074/jbc.M703698200; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Wang X, 2004, GENETICS, V168, P747, DOI 10.1534/genetics.104.029611; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	60	11	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13850	13862		10.1074/jbc.M109.040600	http://dx.doi.org/10.1074/jbc.M109.040600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20177068	hybrid, Green Published			2022-12-25	WOS:000276987700060
J	Piechota, J; Kolodziejczak, M; Juszczak, I; Sakamoto, W; Janska, H				Piechota, Janusz; Kolodziejczak, Marta; Juszczak, Ilona; Sakamoto, Wataru; Janska, Hanna			Identification and Characterization of High Molecular Weight Complexes Formed by Matrix AAA Proteases and Prohibitins in Mitochondria of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY SPASTIC PARAPLEGIA; MEMBRANE-PROTEIN DEGRADATION; CRISTAE MORPHOGENESIS; SUBUNIT COMPOSITION; CELL-PROLIFERATION; PLANT-MITOCHONDRIA; GENE-EXPRESSION; CHAPERONE; DEPENDS	We identify and characterize two matrix (m)-AAA proteases (AtFtsH3 and AtFtsH10) present in the mitochondria of Arabidopsis thaliana. AtFtsH3 is the predominant protease in leaves of wild type plants. Both proteases assemble with prohibitins (PHBs) into high molecular weight complexes (similar to 2 MDa), similarly to their yeast counterparts. A smaller PHB complex (similar to 1 MDa), without the m-AAA proteases, was also detected. Unlike in yeast, stable prohibitin-independent high molecular weight assemblies of m-AAA proteases could not be identified in A. thaliana. AtFtsH3 and AtFtsH10 form at least two types of m-AAA-PHB complexes in wild type plants. The one type contains PHBs and AtFtsH3, and the second one is composed of PHBs and both AtFtsH3 and AtFtsH10. Complexes composed of PHBs and AtFtsH10 were found in an Arabidopsis mutant lacking AtFtsH3 (ftsh3). Thus, both AtFtsH3 and AtFtsH10 may form hetero- and homo-oligomeric complexes with prohibitins. The increased level of AtFtsH10 observed in ftsh3 suggests that functions of the homo- and hetero-oligomeric complexes containing AtFtsH3 can be at least partially substituted by AtFtsH10 homo-oligomers. The steady-state level of the AtFtsH10 transcripts did not change in ftsh3 compared with wild type plants, but we found that almost twice more of the AtFtsH10 transcripts were associated with polysomes in ftsh3. Based on this result, we assume that the AtFtsH10 protein is synthesized at a higher rate in the ftsh3 mutant. Our results provide the first data on the composition of m-AAA and PHB complexes in plant mitochondria and suggest that the abundance of m-AAA proteases is regulated not only at the transcriptional but also at the translational level.	[Piechota, Janusz; Kolodziejczak, Marta; Juszczak, Ilona; Janska, Hanna] Univ Wroclaw, Dept Biotechnol, PL-51148 Wroclaw, Poland; [Sakamoto, Wataru] Okayama Univ, Bioresources Res Inst, Kurashiki, Okayama 7100046, Japan	University of Wroclaw; Okayama University	Janska, H (corresponding author), Univ Wroclaw, Dept Biotechnol, Przybyszewskiego 63-77 St, PL-51148 Wroclaw, Poland.	Hanna.Janska@ibmb.uni.wroc.pl	Sakamoto, Wataru/AAJ-9362-2020; SAKAMOTO, Wataru/B-2511-2011; Sakamoto, Wataru/J-5588-2015	Sakamoto, Wataru/0000-0001-9747-5042; SAKAMOTO, Wataru/0000-0001-9747-5042; Juszczak, Ilona/0000-0001-7592-8426; Janska, Hanna/0000-0002-6542-343X	Ministry of Science and Higher Education [N301 119 32/4116]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Grant N301 119 32/4116 from the Ministry of Science and Higher Education.	Arlt H, 1998, EMBO J, V17, P4837, DOI 10.1093/emboj/17.16.4837; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Chen JC, 2005, PLANT J, V44, P16, DOI 10.1111/j.1365-313X.2005.02505.x; Duvezin-Caubet S, 2007, MOL BIOL CELL, V18, P3582, DOI 10.1091/mbc.E07-02-0164; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; Gietz R.D., 1994, MOL GENETICS YEAST P, P121; Janska H, 2005, PHYSIOL PLANTARUM, V123, P399, DOI 10.1111/j.1399-3054.2004.00439.x; Kahlau S, 2008, PLANT CELL, V20, P856, DOI 10.1105/tpc.107.055202; Kaser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200; Kolodziejczak M, 2002, J BIOL CHEM, V277, P43792, DOI 10.1074/jbc.M203831200; Kolodziejczak M, 2007, PHYSIOL PLANTARUM, V129, P135, DOI 10.1111/j.1399-3054.2006.00835.x; Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06; Korbel D, 2004, EMBO REP, V5, P698, DOI 10.1038/sj.embor.7400186; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Sakamoto W, 2003, PLANT CELL, V15, P2843, DOI 10.1105/tpc.017319; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; Urantowka A, 2005, PLANT MOL BIOL, V59, P239, DOI 10.1007/s11103-005-8766-3; Van Aken O, 2007, PLANT J, V52, P850, DOI 10.1111/j.1365-313X.2007.03276.x; Yu F, 2004, PLANT J, V37, P864, DOI 10.1111/j.1365-313X.2003.02014.x; Zanetti ME, 2005, PLANT PHYSIOL, V138, P624, DOI 10.1104/pp.105.059477; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	32	54	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12512	12521		10.1074/jbc.M109.063644	http://dx.doi.org/10.1074/jbc.M109.063644			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20172857	hybrid, Green Published			2022-12-25	WOS:000276787800008
J	Hirayama, H; Seino, J; Kitajima, T; Jigami, Y; Suzuki, T				Hirayama, Hiroto; Seino, Junichi; Kitajima, Toshihiko; Jigami, Yoshifumi; Suzuki, Tadashi			Free Oligosaccharides to Monitor Glycoprotein Endoplasmic Reticulum-associated Degradation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; BETA-N-ACETYLGLUCOSAMINIDASE; ASPARAGINE-LINKED OLIGOSACCHARIDES; PERFORMANCE LIQUID-CHROMATOGRAPHY; POLYMANNOSE-TYPE OLIGOSACCHARIDES; VACUOLE TARGETING PATHWAY; UNFOLDED PROTEIN RESPONSE; OUTER CHAIN ELONGATION; QUALITY-CONTROL; ALPHA-MANNOSIDASE	In eukaryotic cells, N-glycosylation has been recognized as one of the mostcommonand functionally important co-or post-translational modifications of proteins. "Free" forms of N-glycans accumulate in the cytosol of mammalian cells, but the precise mechanism for their formation and degradation remains unknown. Here, we report a method for the isolation of yeast free oligosaccharides (fOSs) using endo-beta-1,6-glucanase digestion. fOSs were undetectable in cells lacking PNG1, coding the cytoplasmic peptide: N-glycanase gene, suggesting that almost all fOSs were formed from misfolded glycoproteins by Png1p. Structural studies revealed that the most abundant fOS was M8B, which is not recognized well by the endoplasmic reticulum-associated degradation (ERAD)-related lectin, Yos9p. In addition, we provide evidence that some of the ERAD substrates reached the Golgi apparatus prior to retrotranslocation to the cytosol. N-Glycan structures on misfolded glycoproteins in cells lacking the cytosol/vacuole alpha-mannosidase, Ams1p, was still quite diverse, indicating that processing of N-glycans on misfolded glycoproteins was more complex than currently envisaged. Under ER stress, an increase in fOSs was observed, whereas levels of M7C, a key glycan structure recognized by Yos9p, were unchanged. Our method can thus provide valuable information on the molecular mechanism of glycoprotein ERAD in Saccharomyces cerevisiae.	[Hirayama, Hiroto; Seino, Junichi; Suzuki, Tadashi] RIKEN Adv Sci Inst, Syst Glycobiol Res Grp, Glycometabolome Team, Wako, Saitama 3510198, Japan; [Kitajima, Toshihiko; Jigami, Yoshifumi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058566, Japan; [Suzuki, Tadashi] Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol, Kawaguchi, Saitama 3320012, Japan	RIKEN; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Suzuki, T (corresponding author), RIKEN Adv Sci Inst, Syst Glycobiol Res Grp, Glycometabolome Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp	hirayama, hiroto/HCH-9202-2022; Suzuki, Tadashi/AAX-5707-2021; Kitajima, Toshihiko/K-2894-2013; Suzuki, Tadashi/I-4536-2014; Kitajima, Toshihiko/D-2463-2016	Suzuki, Tadashi/0000-0003-1030-7631; Kitajima, Toshihiko/0000-0002-0202-5282; Kitajima, Toshihiko/0000-0001-9677-5086; Hirayama, Hiroto/0000-0003-1909-9488	Global Center of Excellence; RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Global Center of Excellence(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Global Center of Excellence Program, the RIKEN President's Discretionary Fund (Strategic Programs for R&D), and a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T.S.).	ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; BALLOU L, 1990, P NATL ACAD SCI USA, V87, P3368, DOI 10.1073/pnas.87.9.3368; BELARD M, 1988, BIOCHEM J, V255, P235; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; CHANG YH, 1989, J BIOL CHEM, V264, P6979; Chantret I, 2003, BIOCHEM J, V373, P901, DOI 10.1042/BJ20030384; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Coughlan CM, 2004, J BIOL CHEM, V279, P15289, DOI 10.1074/jbc.M309673200; CUEVA R, 1989, FEBS LETT, V259, P125, DOI 10.1016/0014-5793(89)81510-8; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; Haga Y, 2009, GLYCOBIOLOGY, V19, P987, DOI 10.1093/glycob/cwp075; HASE S, 1994, METHOD ENZYMOL, V230, P225; HASE S, 1992, BIOSCI BIOTECH BIOCH, V56, P1676, DOI 10.1271/bbb.56.1676; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hirayama H, 2008, J BIOCHEM, V143, P555, DOI 10.1093/jb/mvm249; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; HIURA N, 1987, AGR BIOL CHEM TOKYO, V51, P3315; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Iwai K, 1999, J BIOCHEM, V125, P70, DOI 10.1093/oxfordjournals.jbchem.a022270; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; Kapteyn JC, 1999, BBA-GEN SUBJECTS, V1426, P373, DOI 10.1016/S0304-4165(98)00137-8; Kario E, 2008, J BIOL CHEM, V283, P244, DOI 10.1074/jbc.M706237200; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Kato T, 1997, J BIOCHEM, V122, P1167, DOI 10.1093/oxfordjournals.jbchem.a021877; Kato T, 2007, J BIOL CHEM, V282, P22080, DOI 10.1074/jbc.M700805200; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kitajima T, 2006, FEBS J, V273, P5074, DOI 10.1111/j.1742-4658.2006.05505.x; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MOORE SEH, 1995, EMBO J, V14, P6034, DOI 10.1002/j.1460-2075.1995.tb00292.x; MOORE SEH, 1994, J BIOL CHEM, V269, P12715; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Mosse CA, 1998, J EXP MED, V187, P37, DOI 10.1084/jem.187.1.37; Munro S, 2001, FEBS LETT, V498, P223, DOI 10.1016/S0014-5793(01)02488-7; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Nakayama K, 1997, FEBS LETT, V412, P547, DOI 10.1016/S0014-5793(97)00634-0; Natsuka S, 2002, J BIOCHEM, V131, P807, DOI 10.1093/oxfordjournals.jbchem.a003169; Nikawa J, 1996, NUCLEIC ACIDS RES, V24, P4222, DOI 10.1093/nar/24.21.4222; Ohashi S, 1999, J BIOCHEM-TOKYO, V126, P852, DOI 10.1093/oxfordjournals.jbchem.a022526; Okamoto M, 2008, EUKARYOT CELL, V7, P310, DOI 10.1128/EC.00333-07; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Ostankovitch M, 2009, J IMMUNOL, V182, P4830, DOI 10.4049/jimmunol.0802902; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Oyama S, 2002, BIOSCI BIOTECH BIOCH, V66, P1378, DOI 10.1271/bbb.66.1378; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; SaintPol A, 1997, J CELL BIOL, V136, P45, DOI 10.1083/jcb.136.1.45; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; Spear ED, 2003, MOL BIOL CELL, V14, P2756, DOI 10.1091/mbc.E02-11-0717; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V302, P1, DOI 10.1016/S0006-291X(03)00052-4; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Suzuki T, 1997, P NATL ACAD SCI USA, V94, P6244, DOI 10.1073/pnas.94.12.6244; Suzuki T, 2008, ANAL BIOCHEM, V381, P224, DOI 10.1016/j.ab.2008.07.002; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; Suzuki T, 2006, GLYCOCONJUGATE J, V23, P291, DOI 10.1007/s10719-006-6975-x; Suzuki T, 2009, TRENDS GLYCOSCI GLYC, V21, P219, DOI 10.4052/tigg.21.219; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; TAKATSUKI A, 1971, J ANTIBIOT, V24, P215, DOI 10.7164/antibiotics.24.215; Tanabe K, 2006, METHOD ENZYMOL, V415, P46, DOI 10.1016/S0076-6879(06)15004-1; Taxis C, 2002, MOL BIOL CELL, V13, P1806, DOI 10.1091/mbc.01-08-0399; TKACZ JS, 1975, BIOCHEM BIOPH RES CO, V65, P248, DOI 10.1016/S0006-291X(75)80086-6; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; TRIMBLE RB, 1986, J BIOL CHEM, V261, P9815; TRUMBLY RJ, 1983, J BACTERIOL, V156, P36, DOI 10.1128/JB.156.1.36-48.1983; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Xie W, 2009, MOL BIOL CELL, V20, P3317, DOI 10.1091/mbc.E09-03-0231; Xu XH, 2004, FEBS LETT, V570, P155, DOI 10.1016/j.febslet.2004.06.039; YOSHIHISA T, 1989, BIOCHEM BIOPH RES CO, V163, P908, DOI 10.1016/0006-291X(89)92308-5; YOSHIHISA T, 1990, J BIOL CHEM, V265, P22418	89	72	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12390	12404		10.1074/jbc.M109.082081	http://dx.doi.org/10.1074/jbc.M109.082081			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20150426	hybrid, Green Published			2022-12-25	WOS:000276787100067
J	Miehe, S; Bieberstein, A; Arnould, I; Ihdene, O; Rutten, H; Strubing, C				Miehe, Susanne; Bieberstein, Andrea; Arnould, Isabelle; Ihdene, Orhia; Ruetten, Hartmut; Struebing, Carsten			The Phospholipid-binding Protein SESTD1 Is a Novel Regulator of the Transient Receptor Potential Channels TRPC4 and TRPC5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL-TRANSFER PROTEIN; STORE-OPERATED CHANNELS; SMOOTH-MUSCLE-CELLS; CALCIUM-ENTRY; SURFACE EXPRESSION; CATION CHANNELS; CA2+ CHANNEL; BRAIN; ACTIVATION; SIGNALS	TRPC4 and TRPC5 are two closely related members of the mammalian transient receptor potential cation channel family that have been implicated in important physiological functions, such as growth cone guidance and smooth muscle contraction. To further unravel the role of TRPC4 and TRPC5 in these processes in vivo, detailed information about the molecular composition of native channel complexes and their association with cellular signaling networks is needed. We therefore searched a human aortic cDNA library for novel TRPC4-interacting proteins using a modified yeast two-hybrid assay. This screen identified SESTD1, a previously uncharacterized protein containing a lipid-binding SEC14-like domain as well as spectrin-type cytoskeleton interaction domains. SESTD1 was found to associate with TRPC4 and TRPC5 via the channel's calmodulin-and inositol 1,4,5-trisphosphate receptor-binding domain. In functional studies, we demonstrate that SESTD1 binds several phospholipid species in vitro and is essential for efficient receptor-mediated activation of TRPC5. Notably, phospholipid binding to SESTD1 was Ca2+-dependent. Because TRPC4 and -5 conduct Ca2+, SESTD1-channel signaling may be bidirectional and also couple TRPC activity to lipid signaling through SESTD1. The modulation of TRPC channel function by specific lipid-binding proteins, such as SESTD1, adds another facet to the complex regulation of these channels complementary to the previously described effects of direct channel-phospholipid interaction.	[Miehe, Susanne; Bieberstein, Andrea; Ruetten, Hartmut; Struebing, Carsten] Sanofi Aventis Deutschland GmbH, Therapeut Dept Cardiovasc Dis, D-65926 Frankfurt, Germany; [Arnould, Isabelle; Ihdene, Orhia] Sanofi Aventis, Biol Sci, F-94403 Vitry Sur Seine, France	Sanofi-Aventis; Sanofi-Aventis; Sanofi France	Strubing, C (corresponding author), Sanofi Aventis Deutschland GmbH, Therapeut Dept Cardiovasc Dis, Ind Pk,Hoechst H824, D-65926 Frankfurt, Germany.	carsten.struebing@sanofi-aventis.com						Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Bankaitis VA, 2005, ADV ENZYME REGUL, V45, P155, DOI 10.1016/j.advenzreg.2005.02.014; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Cioffi DL, 2005, CIRC RES, V97, P1164, DOI 10.1161/01.RES.0000193597.65217.00; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; Flemming R, 2003, BRIT J PHARMACOL, V139, P955, DOI 10.1038/sj.bjp.0705327; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Goel M, 2005, PFLUG ARCH EUR J PHY, V451, P87, DOI 10.1007/s00424-005-1454-y; GRAZIANI A, 2010, BIOL CHEM, V285, P4213; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Griac P, 2006, BIOCHEM SOC T, V34, P377, DOI 10.1042/BST0340377; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hui H, 2006, J PHYSIOL-LONDON, V572, P165, DOI 10.1113/jphysiol.2005.102889; Lee KP, 2005, MOL CELLS, V20, P435; Mery L, 2002, J CELL SCI, V115, P3497; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Munsch T, 2003, P NATL ACAD SCI USA, V100, P16065, DOI 10.1073/pnas.2535311100; Odell AF, 2008, J BIOL CHEM, V283, P4395, DOI 10.1074/jbc.M709729200; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Schaefer M, 2002, J BIOL CHEM, V277, P3752, DOI 10.1074/jbc.M109850200; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Xu SZ, 2006, AM J PHYSIOL-HEART C, V291, pH2653, DOI 10.1152/ajpheart.00495.2006; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198	39	39	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12426	12434		10.1074/jbc.M109.068304	http://dx.doi.org/10.1074/jbc.M109.068304			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164195	hybrid, Green Published			2022-12-25	WOS:000276787100070
J	Wijeyewickrema, LC; Gardiner, EE; Gladigau, EL; Berndt, MC; Andrews, RK				Wijeyewickrema, Lakshmi C.; Gardiner, Elizabeth E.; Gladigau, Elsa L.; Berndt, Michael C.; Andrews, Robert K.			Nerve Growth Factor Inhibits Metalloproteinase-Disintegrins and Blocks Ectodomain Shedding of Platelet Glycoprotein VI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIN RECEPTOR P75(NTR); SNAKE-VENOM METALLOPROTEINASES; AMYLOID PRECURSOR PROTEIN; GAMMA-ESTERASE ACTIVITY; VON-WILLEBRAND-FACTOR; GPIB-IX-V; ALZHEIMERS-DISEASE; SUBUNIT INTERACTIONS; IB-ALPHA; IN-VITRO	Nerve growth factor (NGF) plays an important role in regulating mammalian neuronal/embryonic development, angiogenesis, and other physiological processes and has recently been investigated as a potential treatment for the neurodegenerative disorder, Alzheimer disease. In this study, we provide evidence that human NGF may also function as a metalloproteinase inhibitor, based on studies of NGF from snake venom. Originally, our aim was to isolate snake venom metalloproteinases targeting platelet receptors and/or ligands relevant to hemostasis and thrombosis, using Ni2+-agarose as a purification step based on the conserved metal ion-coordination motif in venom metalloproteinases. However, subsequent analysis of cobra (Naja kaouthia) venom led to the unexpected discovery that cobra venom NGF bound to Ni2+-agarose, eluting at similar to 15 mM imidazole, enabling a one-step purification. The identity of the purified protein was confirmed by mass spectrometry and N-terminal sequence analysis. Partial co-purification of NGF within metalloproteinase-enriched venom fractions led us to test whether NGF affected metalloproteinase activity. Venom NGF potently inhibited metalloproteinases isolated from the same or different venom and specifically bound to purified Nk metalloproteinase immobilized on agarose beads. Human NGF also interacted with human metalloproteinases because it blocked metalloproteinase-mediated shedding of the platelet collagen receptor, glycoprotein (GP) VI, and associated with recombinant ADAM10 by surface plasmon resonance. Together, these results suggest that NGF can function as a metalloproteinase inhibitor.	[Andrews, Robert K.] Monash Univ, AMREP, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	Monash University; Monash University	Andrews, RK (corresponding author), Monash Univ, AMREP, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia.	rob.andrews@med.monash.edu.au	Wijeyewickrema, Lakshmi/A-9676-2015; Gardiner, Elizabeth/E-7774-2011; Gardiner, Elizabeth/P-8716-2019; Berndt, Michael C/D-5580-2012	Wijeyewickrema, Lakshmi/0000-0001-6084-4887; Gardiner, Elizabeth/0000-0001-9453-9688; Andrews, Robert Keith/0000-0001-9577-8082	National Health and Medical Research Council of Australia; Monash University	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University)	This work was supported by grants from the National Health and Medical Research Council of Australia and Monash University.	Aktas B, 2005, J BIOL CHEM, V280, P39716, DOI 10.1074/jbc.M507762200; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Andrews RK, 2001, J BIOL CHEM, V276, P28092, DOI 10.1074/jbc.M011352200; ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8317, DOI 10.1021/bi00447a009; Andrews RK, 1998, BIOCHEMISTRY-US, V37, P638, DOI 10.1021/bi970893g; ANDREWS RK, 2004, HDB PROTEOLYTIC ENZY, P696; Andrews RK, 2007, ARTERIOSCL THROM VAS, V27, P1511, DOI 10.1161/ATVBAHA.107.141390; Arthur JF, 2005, THROMB HAEMOSTASIS, V93, P716, DOI 10.1160/TH04-09-0584; Bergmeier W, 2004, CIRC RES, V95, P677, DOI 10.1161/01.RES.0000143899.73453.11; Bergmeier W, 2003, BLOOD, V102, P4229, DOI 10.1182/blood-2003-04-1305; Berndt MC, 2007, J THROMB HAEMOST, V5, P212, DOI 10.1111/j.1538-7836.2007.02484.x; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; COHEN S, 1959, J BIOL CHEM, V234, P1129; Cohen S, 2004, ANN NY ACAD SCI, V1038, P98, DOI 10.1196/annals.1315.017; Colciaghi F, 2004, NEUROLOGY, V62, P498, DOI 10.1212/01.WNL.0000106953.49802.9C; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; DELUCA M, 1995, J BIOL CHEM, V270, P26734, DOI 10.1074/jbc.270.45.26734; Diaz-Rodriguez E, 2000, BIOCHEM J, V346, P359, DOI 10.1042/0264-6021:3460359; Evin G, 2003, J NEUROSCI RES, V74, P386, DOI 10.1002/jnr.10745; Freund-Michel V, 2008, PHARMACOL THERAPEUT, V117, P52, DOI 10.1016/j.pharmthera.2007.07.003; Gardiner EE, 2007, J THROMB HAEMOST, V5, P1530, DOI 10.1111/j.1538-7836.2007.02590.x; Gardiner EE, 2004, BLOOD, V104, P3611, DOI 10.1182/blood-2004-04-1549; Gardiner EE, 2008, BLOOD, V111, P165, DOI 10.1182/blood-2007-04-086983; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HOLLAND DR, 1994, J MOL BIOL, V239, P385, DOI 10.1006/jmbi.1994.1380; Huang KF, 1998, BIOCHEM BIOPH RES CO, V248, P562, DOI 10.1006/bbrc.1998.9017; Kamiguti AS, 2005, TOXICON, V45, P1041, DOI 10.1016/j.toxicon.2005.02.026; Kawamoto K, 2004, PROG BRAIN RES, V146, P369; Laske C, 2008, J PSYCHIATR RES, V42, P746, DOI 10.1016/j.jpsychires.2007.07.017; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; PALMER TE, 1980, J BIOL CHEM, V255, P5170; RAO AG, 1984, J BIOL CHEM, V259, P73; Salehi A, 2004, J NEURAL TRANSM, V111, P323, DOI 10.1007/s00702-003-0091-x; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Villoslada P, 2004, PROG BRAIN RES, V146, P403; Ward CM, 1996, BIOCHEMISTRY-US, V35, P4929, DOI 10.1021/bi952456c; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Wijeyewickrema LC, 2007, TOXICON, V50, P1064, DOI 10.1016/j.toxicon.2007.07.006; Wijeyewickrema LC, 2005, TOXICON, V45, P1051, DOI 10.1016/j.toxicon.2005.02.025	41	18	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11793	11799		10.1074/jbc.M110.100479	http://dx.doi.org/10.1074/jbc.M110.100479			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164177	Green Published, hybrid			2022-12-25	WOS:000276787100006
J	de Oliveira, T; Pillay, D; Gifford, RJ				de Oliveira, Tulio; Pillay, Deenan; Gifford, Robert J.		UK Collaborative Grp HIV Drug Resi	The HIV-1 Subtype C Epidemic in South America Is Linked to the United Kingdom	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; K65R RESISTANCE; HIGH-THROUGHPUT; BRAZIL; SURVEILLANCE; RECOMBINANTS; PREVALENCE; SEQUENCES	Background: The global spread of HIV-1 has been accompanied by the emergence of genetically distinct viral strains. Over the past two decades subtype C viruses, which predominate in Southern and Eastern Africa, have spread rapidly throughout parts of South America. Phylogenetic studies indicate that subtype C viruses were introduced to South America through a single founder event that occurred in Southern Brazil. However, the external route via which subtype C viruses spread to the South American continent has remained unclear. Methodology/Principal Findings: We used automated genotyping to screen 8,309 HIV-1 subtype C pol gene sequences sampled within the UK for isolates genetically linked to the subtype C epidemic in South America. Maximum likelihood and Bayesian approaches were used to explore the phylogenetic relationships between 54 sequences identified in this screen, and a set of globally sampled subtype C reference sequences. Phylogenetic trees disclosed a robustly supported relationship between sequences from Brazil, the UK and East Africa. A monophyletic cluster comprised exclusively of sequences from the UK and Brazil was identified and dated to approximately the early 1980s using a Bayesian coalescent-based method. A sub-cluster of 27 sequences isolated from homosexual men of UK origin was also identified and dated to the early 1990s. Conclusions: Phylogenetic, demographic and temporal data support the conclusion that the UK was a crucial staging post in the spread of subtype C from East Africa to South America. This unexpected finding demonstrates the role of diffuse international networks in the global spread of HIV-1 infection, and the utility of globally sampled viral sequence data in revealing these networks. Additionally, we show that subtype C viruses are spreading within the UK amongst men who have sex with men.	[de Oliveira, Tulio] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Africa Ctr Hlth & Populat Studies, Durban, South Africa; [Pillay, Deenan] UCL, Dept Infect, London, England; [Pillay, Deenan] Hlth Protect Agcy, Ctr Infect, Colindale, England; [Gifford, Robert J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Kwazulu Natal; University of London; University College London; Health Protection Agency; University of Oxford	de Oliveira, T (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Africa Ctr Hlth & Populat Studies, Durban, South Africa.	rgifford@adarc.org	Anderson, Jane/A-1632-2012	Anderson, Jane/0000-0001-5294-8707; Gifford, Robert/0000-0003-4028-9884; delpech, valerie/0000-0002-9952-8109; Kellam, Paul/0000-0003-3166-4734; Easterbrook, Philippa/0000-0002-2603-5418	Wellcome Trust [082384/Z/07/Z]; European Union [SANTE 2007 147-790]; MRC [G0900274] Funding Source: UKRI; Medical Research Council [G0900274] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Tulio de Oliveira is funded by the Wellcome Trust (082384/Z/07/Z) and the European Union (SANTE 2007 147-790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*BBC, 2005, PEOPL AR I PUBL POL; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Brigido LFM, 2007, AIDS RES HUM RETROV, V23, P1579, DOI 10.1089/aid.2007.0102; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Dougan S, 2005, BRIT MED J, V330, P1303, DOI 10.1136/bmj.38393.572188.EB; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EVANS Y, 2007, BRAZILIANS LONDON; Fontella R, 2008, AIDS, V22, P2001, DOI 10.1097/QAD.0b013e3283108f69; Gifford R, 2006, AIDS, V20, P1521, DOI 10.1097/01.aids.0000237368.64488.ae; Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Health Protection Agency (HPA), 2008, SEX TRANSM INF YOUNG; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu ZZ, 2005, AIDS RES HUM RETROV, V21, P1051, DOI 10.1089/aid.2005.21.1051; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Rambaut A, 2014, TRACER V1 6; Rogstad KE, 2004, BRIT MED J, V329, P214, DOI 10.1136/bmj.329.7459.214; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryan CE, 2007, AIDS RES HUM RETROV, V23, P941, DOI 10.1089/aid.2007.0043; Salemi M, 2005, J MOL EVOL, V60, P598, DOI 10.1007/s00239-004-0206-5; Salminen MO, 1996, AIDS RES HUM RETROV, V12, P1329, DOI 10.1089/aid.1996.12.1329; Santos AF, 2007, JAIDS-J ACQ IMM DEF, V45, P328; Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4; Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tatt ID, 2004, JAIDS-J ACQ IMM DEF, V36, P1092, DOI 10.1097/00126334-200408150-00013; Taylor BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMc086373; Thomson MM, 2005, AIDS REV, V7, P210; Turner D, 2009, J MED VIROL, V81, P1509, DOI 10.1002/jmv.21567; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390	37	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9311	10.1371/journal.pone.0009311	http://dx.doi.org/10.1371/journal.pone.0009311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174561	Green Published, gold, Green Submitted			2022-12-25	WOS:000274923700015
J	Tagmount, A; Wang, M; Lindquist, E; Tanaka, Y; Teranishi, KS; Sunagawa, S; Wong, M; Stillman, JH				Tagmount, Abderrahmane; Wang, Mei; Lindquist, Erika; Tanaka, Yoshihiro; Teranishi, Kristen S.; Sunagawa, Shinichi; Wong, Mike; Stillman, Jonathon H.			The Porcelain Crab Transcriptome and PCAD, the Porcelain Crab Microarray and Sequence Database	PLOS ONE			English	Article							THERMAL TOLERANCE LIMITS; GENUS PETROLISTHES; IMPLEMENTATION; IDENTIFICATION; ACCLIMATION; DAPHNIA; STRESS	Background: With the emergence of a completed genome sequence of the freshwater crustacean Daphnia pulex, construction of genomic-scale sequence databases for additional crustacean sequences are important for comparative genomics and annotation. Porcelain crabs, genus Petrolisthes, have been powerful crustacean models for environmental and evolutionary physiology with respect to thermal adaptation and understanding responses of marine organisms to climate change. Here, we present a large-scale EST sequencing and cDNA microarray database project for the porcelain crab Petrolisthes cinctipes. Methodology/Principal Findings: A set of similar to 30K unique sequences (UniSeqs) representing similar to 19K clusters were generated from similar to 98K high quality ESTs from a set of tissue specific non-normalized and mixed-tissue normalized cDNA libraries from the porcelain crab Petrolisthes cinctipes. Homology for each UniSeq was assessed using BLAST, InterProScan, GO and KEGG database searches. Approximately 66% of the UniSeqs had homology in at least one of the databases. All EST and UniSeq sequences along with annotation results and coordinated cDNA microarray datasets have been made publicly accessible at the Porcelain Crab Array Database (PCAD), a feature-enriched version of the Stanford and Longhorn Array Databases. Conclusions/Significance: The EST project presented here represents the third largest sequencing effort for any crustacean, and the largest effort for any crab species. Our assembly and clustering results suggest that our porcelain crab EST data set is equally diverse to the much larger EST set generated in the Daphnia pulex genome sequencing project, and thus will be an important resource to the Daphnia research community. Our homology results support the pancrustacea hypothesis and suggest that Malacostraca may be ancestral to Branchiopoda and Hexapoda. Our results also suggest that our cDNA microarrays cover as much of the transcriptome as can reasonably be captured in EST library sequencing approaches, and thus represent a rich resource for studies of environmental genomics.	[Tagmount, Abderrahmane; Tanaka, Yoshihiro; Teranishi, Kristen S.; Stillman, Jonathon H.] San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA USA; [Tagmount, Abderrahmane; Tanaka, Yoshihiro; Teranishi, Kristen S.; Stillman, Jonathon H.] San Francisco State Univ, Dept Biol, Tiburon, CA USA; [Wang, Mei; Lindquist, Erika] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Sunagawa, Shinichi] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Wong, Mike] San Francisco State Univ, Ctr Comp Life Sci, San Francisco, CA 94132 USA; [Stillman, Jonathon H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	California State University System; San Francisco State University; California State University System; San Francisco State University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Merced; California State University System; San Francisco State University; University of California System; University of California Berkeley	Tagmount, A (corresponding author), San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA USA.	stillmaj@sfsu.edu	Sunagawa, Shinichi/Q-5950-2019	Sunagawa, Shinichi/0000-0003-3065-0314; Stillman, Jonathon/0000-0002-4783-3830	National Science Foundation NSF-IOB [IOB 0533920]; San Francisco State University Center for Computing in the Life Sciences; San Francisco State University; University of California, Lawrence Livermore National Laboratory [W-7405-Eng-48]; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Los Alamos National Laboratory [W-7405-ENG-36]	National Science Foundation NSF-IOB(National Science Foundation (NSF)); San Francisco State University Center for Computing in the Life Sciences; San Francisco State University; University of California, Lawrence Livermore National Laboratory(University of California System); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory)	This work was supported by National Science Foundation NSF-IOB 0533920 to J.H.S. (http://www.nsf.gov), a San Francisco State University Center for Computing in the Life Sciences Mini-Grant to J.H.S. (http://cs.sfsu.edu/ccls/), a San Francisco State University Presidential Mini-Grant to J.H.S. (http://www.sfsu.edu), and DNA sequencing was performed as a part of a 2006 Community Sequencing Project (http://www.jgi.doe.gov/sequencing/cspseqplans2006.html), under the auspices of the US Department of Energy's Office of Science, Biological, and Environmental Research Program, and by the University of California, Lawrence Livermore National Laboratory under Contract No. W-7405-Eng-48, Lawrence Berkeley National Laboratory under Contract No. DE-AC02-05CH11231 and Los Alamos National Laboratory under Contract No. W-7405-ENG-36. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Ball CA, 2005, NUCLEIC ACIDS RES, V33, pD580; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Colbourne JK, 2005, INTEGR COMP BIOL, V45, P979; Colbourne JK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-217; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Forment J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-5; Gollub J, 2003, NUCLEIC ACIDS RES, V31, P94, DOI 10.1093/nar/gkg078; HAIG JANET, 1960, ALLAN HANCOCK PACIFIC EXPED, V24, P1; Heckmann LH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r40; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubble J, 2009, NUCLEIC ACIDS RES, V37, pD898, DOI 10.1093/nar/gkn786; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Killion PJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-32; Lenz PH, 2000, J COMP PHYSIOL A, V186, P337, DOI 10.1007/s003590050434; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nardi F, 2003, SCIENCE, V299, P1887, DOI 10.1126/science.1078607; Schaack S, 2008, MOL ECOL, V17, P1634, DOI 10.1111/j.1365-294X.2008.03698.x; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stillman JH, 2004, INT CONGR SER, V1275, P267, DOI 10.1016/j.ics.2004.09.034; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; Stillman JH, 1996, J EXP BIOL, V199, P1845; Stillman JH, 2001, MOL PHYLOGENET EVOL, V19, P236, DOI 10.1006/mpev.2001.0924; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; Stillman JH, 2006, INTEGR COMP BIOL, V46, P919, DOI 10.1093/icb/icl007; Stillman JH, 2009, MOL ECOL, V18, P4206, DOI 10.1111/j.1365-294X.2009.04354.x; Stillman JH, 2008, INTEGR COMP BIOL, V48, P852, DOI 10.1093/icb/icn096; Teranishi KS, 2007, COMP BIOCHEM PHYS D, V2, P53, DOI 10.1016/j.cbd.2006.11.002; Ungerer MC, 2008, HEREDITY, V100, P178, DOI 10.1038/sj.hdy.6800992; Waggett RJ, 2008, J EXP MAR BIOL ECOL, V361, P111, DOI 10.1016/j.jembe.2008.05.006	38	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9327	10.1371/journal.pone.0009327	http://dx.doi.org/10.1371/journal.pone.0009327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174471	gold, Green Published, Green Submitted			2022-12-25	WOS:000274923700025
J	Dong, X; Foteinou, PT; Calvano, SE; Lowry, SF; Androulakis, IP				Dong, Xu; Foteinou, Panagiota T.; Calvano, Steven E.; Lowry, Stephen F.; Androulakis, Ioannis P.			Agent-Based Modeling of Endotoxin-Induced Acute Inflammatory Response in Human Blood Leukocytes	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; TRANSLATIONAL SYSTEMS BIOLOGY; KINASE IKK; MACROPHAGES; SEPSIS; ACTIVATION; SIMULATION; EXPRESSION; SHOCK	Background: Inflammation is a highly complex biological response evoked by many stimuli. A persistent challenge in modeling this dynamic process has been the (nonlinear) nature of the response that precludes the single-variable assumption. Systems-based approaches offer a promising possibility for understanding inflammation in its homeostatic context. In order to study the underlying complexity of the acute inflammatory response, an agent-based framework is developed that models the emerging host response as the outcome of orchestrated interactions associated with intricate signaling cascades and intercellular immune system interactions. Methodology/Principal Findings: An agent-based modeling (ABM) framework is proposed to study the nonlinear dynamics of acute human inflammation. The model is implemented using NetLogo software. Interacting agents involve either inflammation-specific molecules or cells essential for the propagation of the inflammatory reaction across the system. Spatial orientation of molecule interactions involved in signaling cascades coupled with the cellular heterogeneity are further taken into account. The proposed in silico model is evaluated through its ability to successfully reproduce a self-limited inflammatory response as well as a series of scenarios indicative of the nonlinear dynamics of the response. Such scenarios involve either a persistent (non) infectious response or innate immune tolerance and potentiation effects followed by perturbations in intracellular signaling molecules and cascades. Conclusions/Significance: The ABM framework developed in this study provides insight on the stochastic interactions of the mediators involved in the propagation of endotoxin signaling at the cellular response level. The simulation results are in accordance with our prior research effort associated with the development of deterministic human inflammation models that include transcriptional dynamics, signaling, and physiological components. The hypothetical scenarios explored in this study would potentially improve our understanding of how manipulating the behavior of the molecular species could manifest into emergent behavior of the overall system.	[Dong, Xu; Foteinou, Panagiota T.; Androulakis, Ioannis P.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA; [Calvano, Steven E.; Lowry, Stephen F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Dong, X (corresponding author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA.	yannis@rci.rutgers.edu			National Science Foundation [0519563]; Environmental Protection Agency [GAD-R832721-010-RRA]; Busch Biomedical Research; National Institutes of Health [GM34695]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034695, R01GM034695] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency(United States Environmental Protection Agency); Busch Biomedical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D., P. T. F., and I. P. A. acknowledge support from the National Science Foundation grant 0519563, the Environmental Protection Agency grant GAD-R832721-010-RRA, and a Busch Biomedical Research grant. S. E. C. and S. F. L. are supported in part from National Institutes of Health GM34695. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An G, 2006, J CRIT CARE, V21, P105, DOI 10.1016/j.jcrc.2005.11.012; An G, 2001, SHOCK, V16, P266, DOI 10.1097/00024382-200116040-00006; An G, 2008, J BURN CARE RES, V29, P277, DOI 10.1097/BCR.0b013e31816677c8; An G, 2007, J CRIT CARE, V22, P169, DOI 10.1016/j.jcrc.2006.12.011; An G, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-11; Baldazzi V, 2006, CELL IMMUNOL, V244, P77, DOI 10.1016/j.cellimm.2006.12.006; Bauer AL, 2009, INFORM SCIENCES, V179, P1379, DOI 10.1016/j.ins.2008.11.012; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bosshart H, 2007, ANN NY ACAD SCI, V1096, P1, DOI 10.1196/annals.1397.064; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carre JE, 2008, BBA-BIOENERGETICS, V1777, P763, DOI 10.1016/j.bbabio.2008.04.024; Clermont G, 2004, CRIT CARE MED, V32, P2061, DOI 10.1097/01.CCM.0000142394.28791.C3; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Cook JA, 1998, ANN NY ACAD SCI, V851, P426, DOI 10.1111/j.1749-6632.1998.tb09020.x; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; ERMENTROUT GB, 1993, J THEOR BIOL, V160, P97, DOI 10.1006/jtbi.1993.1007; Fitting C, 2004, J INFECT DIS, V189, P1295, DOI 10.1086/382657; Folcik VA, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-39; FOTEINOU P, 2007, J CRITICAL CARE, V22, P337; Foteinou PT, 2009, CTS-CLIN TRANSL SCI, V2, P85, DOI 10.1111/j.1752-8062.2008.00051.x; Foteinou PT, 2009, MATH BIOSCI, V217, P27, DOI 10.1016/j.mbs.2008.09.003; Foteinou PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004706; Funk GA, 2005, J THEOR BIOL, V233, P221, DOI 10.1016/j.jtbi.2004.10.004; Gri G, 1998, J BIOL CHEM, V273, P6431, DOI 10.1074/jbc.273.11.6431; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Gupta S, 2005, INT J BIOCHEM CELL B, V37, P1034, DOI 10.1016/j.biocel.2004.08.013; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kataoka M, 2004, DIABETES RES CLIN PR, V64, P51, DOI 10.1016/j.diabres.2003.10.009; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kiehl TR, 2004, BIOINFORMATICS, V20, P316, DOI 10.1093/bioinformatics/btg409; Klaitman V, 2003, ISRAEL MED ASSOC J, V5, P51; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Louzoun Y, 2001, PHYSICA A, V297, P242, DOI 10.1016/S0378-4371(01)00201-1; Lowry SF, 2008, J LEUKOCYTE BIOL, V83, P553, DOI 10.1189/jlb.0607377; Mackay CR, 2000, J EXP MED, V192, pF31, DOI 10.1084/jem.192.11.F31; MacMaster JF, 2003, INFLAMM RES, V52, P508, DOI 10.1007/s00011-003-1206-4; MCKNIGHT AJ, 1994, J IMMUNOL, V152, P2172; Mi Q, 2007, WOUND REPAIR REGEN, V15, P671, DOI 10.1111/j.1524-475X.2007.00271.x; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Monick MM, 2002, EUR RESPIR J, V20, P210, DOI 10.1183/09031936.02.00252001; Munford RS, 2006, ANNU REV PATHOL-MECH, V1, P467, DOI 10.1146/annurev.pathol.1.110304.100200; Murai T, 1996, FEMS IMMUNOL MED MIC, V13, P269; Neugebauer EAM, 2001, SHOCK, V16, P252, DOI 10.1097/00024382-200116040-00003; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Pogson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002367; Protti A, 2007, NOVART FDN SYMP, V280, P160; Protti A, 2007, NOVART FDN SYMP, V280, P16; Protti Alessandro, 2007, Novartis Found Symp, V280, P7; Ramakrishnan N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000122; Romaschin Alexander D, 1998, Sepsis (Boston), V2, P119, DOI 10.1023/A:1009769923763; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Santoni D, 2008, BIOINFORMATICS, V24, P1374, DOI 10.1093/bioinformatics/btn135; Seely AJE, 2000, CRIT CARE MED, V28, P2193, DOI 10.1097/00003246-200007000-00003; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Tetta C, 2005, Crit Care Resusc, V7, P32; Ting AY, 2002, SCIENCE, V298, P1189, DOI 10.1126/science.1079331; VODOVOTZ Y, 2008, MATH BIOSCI; Vodovotz Y, 2006, SHOCK, V26, P235, DOI 10.1097/01.shk.0000225413.13866.fo; Vodovotz Yoram, 2004, Curr Opin Crit Care, V10, P383, DOI 10.1097/01.ccx.0000139360.30327.69; Vodovotz Y, 2009, MATH BIOSCI, V217, P1, DOI 10.1016/j.mbs.2008.07.013; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Wells CA, 2005, J LEUKOCYTE BIOL, V78, P9, DOI 10.1189/jlb.1204710; XING Z, 1994, AM J RESP CELL MOL, V10, P148, DOI 10.1165/ajrcmb.10.2.8110470; Yamakawa T, 1999, ENDOCRINOLOGY, V140, P3562, DOI 10.1210/en.140.8.3562; Yang E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-10; Zhang P, 2005, EMBO REP, V6, P531, DOI 10.1038/sj.embor.7400433; ZHOU YL, 1994, J LEUKOCYTE BIOL, V56, P507, DOI 10.1002/jlb.56.4.507	72	51	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9249	10.1371/journal.pone.0009249	http://dx.doi.org/10.1371/journal.pone.0009249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174629	gold, Green Published, Green Submitted			2022-12-25	WOS:000274654700009
J	Alves, NC; Bailey, CDC; Nashmi, R; Lambe, EK				Alves, Nyresa C.; Bailey, Craig D. C.; Nashmi, Raad; Lambe, Evelyn K.			Developmental Sex Differences in Nicotinic Currents of Prefrontal Layer VI Neurons in Mice and Rats	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; THALAMIC RETICULAR NUCLEUS; ACETYLCHOLINE-RECEPTORS; CEREBRAL-CORTEX; MESSENGER-RNA; FEMALE RATS; BRAIN; PLASTICITY; SUBUNIT; AGE	Background: There is a large sex difference in the prevalence of attention deficit disorder; yet, relatively little is known about sex differences in the development of prefrontal attention circuitry. In male rats, nicotinic acetylcholine receptors excite corticothalamic neurons in layer VI, which are thought to play an important role in attention by gating the sensitivity of thalamic neurons to incoming stimuli. These nicotinic currents in male rats are significantly larger during the first postnatal month when prefrontal circuitry is maturing. The present study was undertaken to investigate whether there are sex differences in the nicotinic currents in prefrontal layer VI neurons during development. Methodology/Principal Findings: Using whole cell recording in prefrontal brain slice, we examined the inward currents elicited by nicotinic stimulation in male and female rats and two strains of mice. We found a prominent sex difference in the currents during the first postnatal month when males had significantly greater nicotinic currents in layer VI neurons compared to females. These differences were apparent with three agonists: acetylcholine, carbachol, and nicotine. Furthermore, the developmental sex difference in nicotinic currents occurred despite male and female rodents displaying a similar pattern and proportion of layer VI neurons possessing a key nicotinic receptor subunit. Conclusions/Significance: This is the first illustration at a cellular level that prefrontal attention circuitry is differently affected by nicotinic receptor stimulation in males and females during development. This transient sex difference may help to define the cellular and circuit mechanisms that underlie vulnerability to attention deficit disorder.	[Alves, Nyresa C.; Bailey, Craig D. C.; Lambe, Evelyn K.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Nashmi, Raad] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Lambe, Evelyn K.] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of Toronto; University of Victoria; University of Toronto	Alves, NC (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	evelyn.lambe@utoronto.ca	Lambe, Evelyn K/K-3699-2015	Lambe, Evelyn K/0000-0002-5994-6090; Bailey, Craig/0000-0002-4320-6872; Nashmi, Raad/0000-0001-6596-2620	CIHR [MOP 89825]; Canadian Foundation for Innovation; Canada Research Chairs program	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chairs program(Canada Research Chairs)	This research was supported by grants to EKL from CIHR (MOP 89825), the Canadian Foundation for Innovation, and the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam L, 2007, NEUROSCIENCE, V144, P1347, DOI 10.1016/j.neuroscience.2006.11.011; BERTRAND D, 1991, NEUROREPORT, V2, P277, DOI 10.1097/00001756-199105000-00016; Brown RT, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e43; Chen XQ, 2005, J NEUROSCI RES, V79, P114, DOI 10.1002/jnr.20323; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Cuffe Steven P, 2005, J Atten Disord, V9, P392, DOI 10.1177/1087054705280413; Das A, 2001, LIFE SCI, V68, P1545, DOI 10.1016/S0024-3205(01)00950-X; Ernst M, 2001, J AM ACAD CHILD PSY, V40, P630, DOI 10.1097/00004583-200106000-00007; Espeseth T, 2007, NEUROSCIENCE, V147, P974, DOI 10.1016/j.neuroscience.2007.04.027; Fassbender C, 2009, BRAIN RES, V1273, P114, DOI 10.1016/j.brainres.2009.02.070; FUNG YK, 1989, PHARMACOL BIOCHEM BE, V33, P1, DOI 10.1016/0091-3057(89)90419-X; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Gaimarri A, 2007, BRAIN RES REV, V55, P134, DOI 10.1016/j.brainresrev.2007.02.005; Gan WQ, 2008, NICOTINE TOB RES, V10, P1293, DOI 10.1080/14622200802239132; HATCHELL PC, 1980, PSYCHOPHARMACOLOGY, V71, P45, DOI 10.1007/BF00433251; Heath CJ, 2009, NEUROPHARMACOLOGY, V56, P254, DOI 10.1016/j.neuropharm.2008.07.020; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; Jacobsen LK, 2007, NEUROPSYCHOPHARMACOL, V32, P2453, DOI 10.1038/sj.npp.1301398; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Kassam SM, 2008, J NEUROSCI, V28, P8756, DOI 10.1523/JNEUROSCI.2645-08.2008; KATO J, 1984, J STEROID BIOCHEM, V20, P147; King SL, 2003, J NEUROSCI, V23, P3837; Kohchi C, 1998, BRAIN RES, V801, P233, DOI 10.1016/S0006-8993(98)00585-X; Krain AL, 2006, CLIN PSYCHOL REV, V26, P433, DOI 10.1016/j.cpr.2006.01.005; KRISTT DA, 1991, BRAIN RES BULL, V26, P789, DOI 10.1016/0361-9230(91)90176-K; Kuczewski N, 2005, EUR J NEUROSCI, V21, P1807, DOI 10.1111/j.1460-9568.2005.04014.x; KYEREMATEN GA, 1988, DRUG METAB DISPOS, V16, P823; Lambers DS, 1996, SEMIN PERINATOL, V20, P115, DOI 10.1016/S0146-0005(96)80079-6; Langley K, 2005, Minerva Pediatr, V57, P359; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nishimura A, 2002, INT J DEV NEUROSCI, V20, P481, DOI 10.1016/S0736-5748(02)00078-3; Paxinos G., 2001, MOUSE BRAIN STEREOTA; REZVANI K, 2009, J MOL NEUROSCI; RIBARY U, 1989, J PHARMACOL EXP THER, V248, P786; Rigbi A, 2008, GENES BRAIN BEHAV, V7, P164, DOI 10.1111/j.1601-183X.2007.00329.x; Robertson RT, 1998, CEREB CORTEX, V8, P142, DOI 10.1093/cercor/8.2.142; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; ROSECRANS JA, 1972, ARCH INT PHARMACOD T, V196, P46; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Schmitz M, 2006, J AM ACAD CHILD PSY, V45, P1338, DOI 10.1097/S0890-8567(09)61916-X; Shacka JJ, 1998, DEV BRAIN RES, V109, P67, DOI 10.1016/S0165-3806(98)00058-3; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Sherman SM, 2006, TRENDS NEUROSCI, V29, P295, DOI 10.1016/j.tins.2006.05.005; Sherren N, 2005, NEUROSCIENCE, V136, P445, DOI 10.1016/j.neuroscience.2005.08.053; SHUGHRUE PJ, 1991, DEV BRAIN RES, V59, P143, DOI 10.1016/0165-3806(91)90094-Y; SHUGHRUE PJ, 1992, ENDOCRINOLOGY, V130, P3650, DOI 10.1210/en.130.6.3650; Smalley SL, 2007, J AM ACAD CHILD PSY, V46, P1575, DOI 10.1097/chi.0b013e3181573137; Sullivan RM, 2003, BEHAV BRAIN RES, V146, P43, DOI 10.1016/j.bbr.2003.09.015; Todd RD, 2003, MOL PSYCHIATR, V8, P103, DOI 10.1038/sj.mp.4001257; Tun PA, 2008, DEV PSYCHOL, V44, P1421, DOI 10.1037/a0012845; VALERA S, 1992, P NATL ACAD SCI USA, V89, P9949, DOI 10.1073/pnas.89.20.9949; Watson RE, 2006, BIRTH DEFECTS RES B, V77, P471, DOI 10.1002/bdrb.20090; Winzer-Serhan UH, 2005, J COMP NEUROL, V481, P19, DOI 10.1002/cne.20357; Zhang LM, 2004, J NEUROPHYSIOL, V91, P759, DOI 10.1152/jn.00624.2003; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843	57	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9261	10.1371/journal.pone.0009261	http://dx.doi.org/10.1371/journal.pone.0009261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174655	Green Published, gold, Green Submitted			2022-12-25	WOS:000274590600016
J	Ji, HZ; Masse, N; Tyler, S; Liang, B; Li, Y; Merks, H; Graham, M; Sandstrom, P; Brooks, J				Ji, Hezhao; Masse, Nathalie; Tyler, Shaun; Liang, Ben; Li, Yang; Merks, Harriet; Graham, Morag; Sandstrom, Paul; Brooks, James			HIV Drug Resistance Surveillance Using Pooled Pyrosequencing	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; VARIANTS	Background: Surveillance for HIV transmitted drug resistance (TDR) is performed using HIV genotype results from individual specimens. Pyrosequencing, through its massive parallel sequencing ability, can analyze large numbers of specimens simultaneously. Instead of using pyrosequencing conventionally, to sequence a population of viruses within an individual, we interrogated a single combined pool of surveillance specimens to demonstrate that it is possible to determine TDR rates in HIV protease from a population of individuals. Methodology/Principal Findings: The protease region from 96 treatment naive, HIV+ serum specimens was genotyped using standard Sanger sequencing method. The 462 bp protease amplicons from these specimens were pooled in equimolar concentrations and re-sequenced using the GS FLX Titanium system. The nucleotide (NT) and amino acid (AA) differences from the reference sequence, along with TDR mutations, detected by each method were compared. In the protease sequence, there were 212 nucleotide and 81 AA differences found using conventional sequencing and 345 nucleotide and 168 AA differences using pyrosequencing. All nucleotide and amino acid polymorphisms found at frequencies >= 5% in pyrosequencing were detected using both methods with the rates of variation highly correlated. Using Sanger sequencing, two TDR mutations, M46L and I84V, were each detected as mixtures at a frequency of 1.04% (1/96). These same TDR mutations were detected by pyrosequencing with a prevalence of 0.29% and 0.34% respectively. Phylogenetic analysis established that the detected low frequency mutations arose from the same single specimens that were found to contain TDR mutations by Sanger sequencing. Multiple clinical protease DR mutations present at higher frequencies were concordantly identified using both methods. Conclusions/Significance: We show that pyrosequencing pooled surveillance specimens can cost-competitively detect protease TDR mutations when compared with conventional methods. With few modifications, the method described here can be used to determine population rates of TDR in both protease and reverse transcriptase. Furthermore, this pooled pyrosequencing technique may be generalizable to other infectious agents where a survey of DR rates is required.	[Ji, Hezhao; Masse, Nathalie; Li, Yang; Merks, Harriet; Sandstrom, Paul; Brooks, James] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Natl Microbiol Lab, Ottawa, ON, Canada; [Tyler, Shaun; Graham, Morag] Publ Hlth Agcy Canada, Genom Core Facil, Natl Microbiol Lab, Winnipeg, MB, Canada; [Liang, Ben; Graham, Morag] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	Public Health Agency of Canada; Public Health Agency of Canada; University of Manitoba	Ji, HZ (corresponding author), Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Natl Microbiol Lab, Ottawa, ON, Canada.	james_brooks@phac-aspc.gc.ca	Liang, Binhua/ABN-9806-2022	liang, binhua/0000-0002-1108-6407; Ji, Hezhao/0000-0002-5451-6294	Government of Canada	Government of Canada(CGIAR)	This work funded by the Government of Canada through the Federal Initiative to Address HIV/AIDS in Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*454 LIF SCI CORP, 2009, TECHN B 454 LIF SCI; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2006, CURR OPIN INFECT DIS, V19, P607, DOI 10.1097/QCO.0b013e3280109ff1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Myatt M, 2008, ANTIVIR THER, V13, P37; Rozera G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-15; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	17	26	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9263	10.1371/journal.pone.0009263	http://dx.doi.org/10.1371/journal.pone.0009263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174661	gold, Green Published, Green Submitted			2022-12-25	WOS:000274590600018
J	Walsh, AW; Langley, DR; Colonno, RJ; Tenney, DJ				Walsh, Ann W.; Langley, David R.; Colonno, Richard J.; Tenney, Daniel J.			Mechanistic Characterization and Molecular Modeling of Hepatitis B Virus Polymerase Resistance to Entecavir	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REVERSE-TRANSCRIPTASE ACTIVITY; NUCLEOSIDE-NAIVE PATIENTS; IN-VITRO; WILD-TYPE; LAMIVUDINE RESISTANCE; DNA; REPLICATION; INHIBITION; MUTATIONS	Background: Entecavir (ETV) is a deoxyguanosine analog competitive inhibitor of hepatitis B virus (HBV) polymerase that exhibits delayed chain termination of HBV DNA. A high barrier to entecavir-resistance (ETVr) is observed clinically, likely due to its potency and a requirement for multiple resistance changes to overcome suppression. Changes in the HBV polymerase reverse-transcriptase (RT) domain involve lamivudine-resistance (LVDr) substitutions in the conserved YMDD motif (M204V/I +/- L180M), plus an additional ETV-specific change at residues T184, S202 or M250. These substitutions surround the putative dNTP binding site or primer grip regions of the HBV RT. Methods/Principal Findings: To determine the mechanistic basis for ETVr, wildtype, lamivudine-resistant (M204V, L180M) and ETVr HBVs were studied using in vitro RT enzyme and cell culture assays, as well as molecular modeling. Resistance substitutions significantly reduced ETV incorporation and chain termination in HBV DNA and increased the ETV-TP inhibition constant (K-i) for HBV RT. Resistant HBVs exhibited impaired replication in culture and reduced enzyme activity (k(cat)) in vitro. Molecular modeling of the HBV RT suggested that ETVr residue T184 was adjacent to and stabilized S202 within the LVDr YMDD loop. ETVr arose through steric changes at T184 or S202 or by disruption of hydrogen-bonding between the two, both of which repositioned the loop and reduced the ETV-triphosphate (ETV-TP) binding pocket. In contrast to T184 and S202 changes, ETVr at primer grip residue M250 was observed during RNA-directed DNA synthesis only. Experimentally, M250 changes also impacted the dNTP-binding site. Modeling suggested a novel mechanism for M250 resistance, whereby repositioning of the primer-template component of the dNTP-binding site shifted the ETV-TP binding pocket. No structural data are available to confirm the HBV RT modeling, however, results were consistent with phenotypic analysis of comprehensive substitutions of each ETVr position. Conclusions: Altogether, ETVr occurred through exclusion of ETV-TP from the dNTP-binding site, through different, novel mechanisms that involved lamivudine-resistance, ETV-specific substitutions, and the primer-template.	[Walsh, Ann W.; Langley, David R.; Colonno, Richard J.; Tenney, Daniel J.] Bristol Myers Squibb Inc, Res & Dev, Wallingford, CT USA	Bristol-Myers Squibb	Walsh, AW (corresponding author), Bristol Myers Squibb Inc, Res & Dev, Wallingford, CT USA.	david.langley@bms.com; daniel.tenney@bms.com		Langley, David/0000-0002-0820-3190	Bristol-Myers Squibb, Inc	Bristol-Myers Squibb, Inc(Bristol-Myers Squibb)	The work described in this paper was funded by Bristol-Myers Squibb, Inc. All authors were employees of Bristol-Myers Squibb at the time of the work and in this respect the company had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Baldick CJ, 2008, J HEPATOL, V48, P895, DOI 10.1016/j.jhep.2007.12.024; Baldick CJ, 2008, HEPATOLOGY, V47, P1473, DOI 10.1002/hep.22211; Bartholomeusz A, 2004, ANTIVIR THER, V9, P149; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231; Boyer PL, 2007, J MOL BIOL, V371, P873, DOI 10.1016/j.jmb.2007.05.043; Boyer PL, 2005, J MOL BIOL, V345, P441, DOI 10.1016/j.jmb.2004.10.021; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunelle MN, 2007, ANTIMICROB AGENTS CH, V51, P2240, DOI 10.1128/AAC.01440-06; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chin R, 2001, ANTIMICROB AGENTS CH, V45, P2495, DOI 10.1128/AAC.45.9.2495-2501.2001; Colonno RJ, 2006, HEPATOLOGY, V44, P1656, DOI 10.1002/hep.21422; Das K, 2001, J VIROL, V75, P4771, DOI 10.1128/JVI.75.10.4771-4779.2001; Domaoal RA, 2008, J BIOL CHEM, V283, P5452, DOI 10.1074/jbc.M707834200; Dominy BN, 1999, J PHYS CHEM B, V103, P3765, DOI 10.1021/jp984440c; FALLOWS DA, 1995, J VIROL, V69, P3067, DOI 10.1128/JVI.69.5.3067-3073.1995; Favre D, 2008, ALTEX-ALTERN TIEREXP, V25, P197; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Fung SK, 2005, J HEPATOL, V43, P937, DOI 10.1016/j.jhep.2005.05.037; Gaillard RK, 2002, ANTIMICROB AGENTS CH, V46, P1005, DOI 10.1128/AAC.46.4.1005-1013.2002; Hadziyannis SJ, 2005, NEW ENGL J MED, V352, P2673, DOI 10.1056/NEJMoa042957; HESS G, 1980, J MED VIROL, V5, P309, DOI 10.1002/1096-9071(1980)5:4&lt;309::AID-JMV1890050407&gt;3.0.CO;2-L; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Innaimo SF, 1997, ANTIMICROB AGENTS CH, V41, P1444, DOI 10.1128/AAC.41.7.1444; KAPLAN PM, 1976, J VIROL, V17, P885, DOI 10.1128/JVI.17.3.885-893.1976; LANFORD RE, 1995, J VIROL, V69, P4431, DOI 10.1128/JVI.69.7.4431-4439.1995; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; Levine S, 2002, ANTIMICROB AGENTS CH, V46, P2525, DOI 10.1128/AAC.46.8.2525-2532.2002; Lin PF, 2008, ANTIMICROB AGENTS CH, V52, P1759, DOI 10.1128/AAC.01313-07; Ling R, 1999, J GEN VIROL, V80, P601, DOI 10.1099/0022-1317-80-3-601; Ling R, 1996, HEPATOLOGY, V24, P711, DOI 10.1053/jhep.1996.v24.pm0008781347; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MCMILLAN JS, 1995, HEPATOLOGY, V22, P36, DOI 10.1016/0270-9139(95)90350-X; Melegari M, 1998, HEPATOLOGY, V27, P628, DOI 10.1002/hep.510270243; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; NILSSON L, 1986, J COMPUT CHEM, V7, P591, DOI 10.1002/jcc.540070502; NORDENFELT E, 1980, ACTA PATH MICRO IM B, V88, P169; OBERG B, 1989, PHARMACOL THERAPEUT, V40, P213, DOI 10.1016/0163-7258(89)90097-1; Ono-Nita SK, 1999, HEPATOLOGY, V29, P939, DOI 10.1002/hep.510290340; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; Seifer M, 1998, J VIROL, V72, P2765, DOI 10.1128/JVI.72.4.2765-2776.1998; Seifer M, 1998, ANTIMICROB AGENTS CH, V42, P3200, DOI 10.1128/AAC.42.12.3200; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Tatti KM, 2002, ANTIVIR RES, V55, P141, DOI 10.1016/S0166-3542(02)00019-0; Tchesnokov EP, 2008, J BIOL CHEM, V283, P34218, DOI 10.1074/jbc.M806797200; Tenney DJ, 2007, ANTIMICROB AGENTS CH, V51, P902, DOI 10.1128/AAC.00833-06; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; Tenney DJ, 2004, ANTIMICROB AGENTS CH, V48, P3498, DOI 10.1128/AAC.48.9.3498-3507.2004; TIDOR B, 1983, J BIOMOL STRUCT DYN, V1, P231, DOI 10.1080/07391102.1983.10507437; Tipples GA, 1996, HEPATOLOGY, V24, P714, DOI 10.1053/jhep.1996.v24.pm0008781348; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Urban S, 2001, P NATL ACAD SCI USA, V98, P4984, DOI 10.1073/pnas.091324398; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Villet S, 2008, J HEPATOL, V48, P747, DOI 10.1016/j.jhep.2008.01.027; Wilson JE, 1996, J BIOL CHEM, V271, P13656, DOI 10.1074/jbc.271.23.13656; Yadav V, 2004, BIOORG MED CHEM LETT, V14, P4313, DOI 10.1016/j.bmcl.2004.05.075	59	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9195	10.1371/journal.pone.0009195	http://dx.doi.org/10.1371/journal.pone.0009195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169198	gold, Green Submitted, Green Published			2022-12-25	WOS:000274474600015
J	Su, PT; Yen, PW; Wang, SH; Lin, CH; Chiou, A; Syu, WJ				Su, Pin-Tzu; Yen, Pei-Wen; Wang, Shao-Hung; Lin, Chi-Hung; Chiou, Arthur; Syu, Wan-Jr			Factors Affecting Daughter Cells' Arrangement during the Early Bacterial Divisions	PLOS ONE			English	Article							ESCHERICHIA-COLI; MEMBRANE; PROTEIN; LIPOPROTEIN; PAL; LIPOPOLYSACCHARIDE; CONTRIBUTE; REGULATOR; CURLI	On agar plates, daughter cells of Escherichia coli mutually slide and align side-by-side in parallel during the first round of binary fission. This phenomenon has been previously attributed to an elastic material that restricts apparently separated bacteria from being in string. We hypothesize that the interaction between bacteria and the underneath substratum may affect the arrangement of the daughter bacteria. To test this hypothesis, bacterial division on hyaluronic acid ( HA) gel, as an alternative substratum, was examined. Consistent with our proposition, the HA gel differs from agar by suppressing the typical side-by-side alignments to a rare population. Examination of bacterial surface molecules that may contribute to the daughter cells' arrangement yielded an observation that, with disrupted lpp, the E. coli daughter cells increasingly formed non-typical patterns, i.e. neither sliding side-by-side in parallel nor forming elongated strings. Therefore, our results suggest strongly that the early cell patterning is affected by multiple interaction factors. With oscillatory optical tweezers, we further demonstrated that the interaction force decreased in bacteria without Lpp, a result substantiating our notion that the side-by-side sliding phenomenon directly reflects the strength of in-situ interaction between bacteria and substratum.	[Su, Pin-Tzu; Wang, Shao-Hung; Lin, Chi-Hung; Syu, Wan-Jr] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Yen, Pei-Wen; Lin, Chi-Hung; Chiou, Arthur] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Su, PT (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	aechiou@ym.edu.tw; wjsyu@ym.edu.tw	wang, shaohung/E-4017-2015	wang, shaohung/0000-0002-6824-0372	Ministry of Education, Aim for the Top University Plan; National Science Council, Republic of China (Taiwan) [NSC98-2320-B-010-005-MY3;, NSC98-2627-M-010-003, NSC98-2627-M-010-002, NSC 97-2627-M-010-004]	Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); National Science Council, Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported in part by a grant from Ministry of Education, Aim for the Top University Plan and Grants NSC98-2320-B-010-005-MY3; (http://english.moe.gov.tw/) and NSC98-2627-M-010-003, NSC98-2627-M-010-002 and NSC 97-2627-M-010-004 from the National Science Council, Republic of China (Taiwan) (http://web1.nsc.gov.tw/).	Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Bian Z, 1997, EMBO J, V16, P5827, DOI 10.1093/emboj/16.19.5827; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Chattopadhyay S, 2006, P NATL ACAD SCI USA, V103, P13712, DOI 10.1073/pnas.0602043103; Clavel T, 1998, MOL MICROBIOL, V29, P359, DOI 10.1046/j.1365-2958.1998.00945.x; Clements A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003817; DONACHIE WD, 1970, NATURE, V227, P1220, DOI 10.1038/2271220a0; Fukuoka H, 2007, J MOL BIOL, V367, P692, DOI 10.1016/j.jmb.2007.01.015; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; GRAHAMSMITH GS, 1910, PARASITOLOGY, V3, P17; INOUYE M, 1972, J BIOL CHEM, V247, P8154; KEIJI S, 1997, APPL PHYS LETT, V71, P37; LEE DG, 2009, UROLOGY; Liu SL, 2007, OPT EXPRESS, V15, P2713, DOI 10.1364/OE.15.002713; Marolda CL, 2006, J BACTERIOL, V188, P5124, DOI 10.1128/JB.00461-06; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; Palmer J, 2007, J IND MICROBIOL BIOT, V34, P577, DOI 10.1007/s10295-007-0234-4; PARSONS CL, 1979, INFECT IMMUN, V24, P552, DOI 10.1128/IAI.24.2.552-557.1979; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Sha J, 2004, INFECT IMMUN, V72, P3987, DOI 10.1128/IAI.72.7.3987-4003.2004; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; SHAPIRO JA, 1995, BIOESSAYS, V17, P597, DOI 10.1002/bies.950170706; SHAPIRO JA, 1989, J BACTERIOL, V171, P5963, DOI 10.1128/jb.171.11.5963-5974.1989; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; SUZUKI H, 1978, MOL GEN GENET, V167, P1; Tomihata K, 1997, J BIOMED MATER RES, V37, P243; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; Veening JW, 2006, J BACTERIOL, V188, P3099, DOI 10.1128/JB.188.8.3099-3109.2006; Wei MT, 2008, OPT EXPRESS, V16, P8594, DOI 10.1364/OE.16.008594; Wei MT, 2007, OPT EXPRESS, V15, P11020, DOI 10.1364/OE.15.011020; Wei MT, 2005, OPT EXPRESS, V13, P5798, DOI 10.1364/OPEX.13.005798; Yona-Nadler C, 2003, MICROBIOL-SGM, V149, P877, DOI 10.1099/mic.0.25970-0; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	37	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9147	10.1371/journal.pone.0009147	http://dx.doi.org/10.1371/journal.pone.0009147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161768	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442700011
J	Aste-Amezaga, M; Zhang, NY; Lineberger, JE; Arnold, BA; Toner, TJ; Gu, MC; Huang, LY; Vitelli, S; Vo, KT; Haytko, P; Zhao, JZ; Baleydier, F; L'Heureux, S; Wang, HF; Gordon, WR; Thoryk, E; Andrawes, MB; Tiyanont, K; Stegmaier, K; Roti, G; Ross, KN; Franlin, LL; Wang, H; Wang, FB; Chastain, M; Bett, AJ; Audoly, LP; Aster, JC; Blacklow, SC; Huber, HE				Aste-Amezaga, Miguel; Zhang, Ningyan; Lineberger, Janet E.; Arnold, Beth A.; Toner, Timothy J.; Gu, Mingcheng; Huang, Lingyi; Vitelli, Salvatore; Vo, Kim T.; Haytko, Peter; Zhao, Jing Zhang; Baleydier, Frederic; L'Heureux, Sarah; Wang, Hongfang; Gordon, Wendy R.; Thoryk, Elizabeth; Andrawes, Marie Blanke; Tiyanont, Kittichoat; Stegmaier, Kimberly; Roti, Giovanni; Ross, Kenneth N.; Franlin, Laura L.; Wang, Hui; Wang, Fubao; Chastain, Michael; Bett, Andrew J.; Audoly, Laurent P.; Aster, Jon C.; Blacklow, Stephen C.; Huber, Hans E.			Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors	PLOS ONE			English	Article							GAMMA-SECRETASE INHIBITOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; BREAST-CANCER; PROTEOLYTIC ACTIVATION; THERAPEUTIC TARGET; PANCREATIC-CANCER; REGULATORY REGION; STRUCTURAL BASIS; MAMMALIAN NOTCH; MODIFIES NOTCH	Background: Notch receptors normally play a key role in guiding a variety of cell fate decisions during development and differentiation of metazoan organisms. On the other hand, dysregulation of Notch1 signaling is associated with many different types of cancer as well as tumor angiogenesis, making Notch1 a potential therapeutic target. Principal Findings: Here we report the in vitro activities of inhibitory Notch1 monoclonal antibodies derived from cell-based and solid-phase screening of a phage display library. Two classes of antibodies were found, one directed against the EGF-repeat region that encompasses the ligand-binding domain (LBD), and the second directed against the activation switch of the receptor, the Notch negative regulatory region (NRR). The antibodies are selective for Notch1, inhibiting Jag2-dependent signaling by Notch1 but not by Notch 2 and 3 in reporter gene assays, with EC50 values as low as 5 +/- 3 nM and 0.13 +/- 0.09 nM for the LBD and NRR antibodies, respectively, and fail to recognize Notch4. While more potent, NRR antibodies are incomplete antagonists of Notch1 signaling. The antagonistic activity of LBD, but not NRR, antibodies is strongly dependent on the activating ligand. Both LBD and NRR antibodies bind to Notch1 on human tumor cell lines and inhibit the expression of sentinel Notch target genes, including HES1, HES5, and DTX1. NRR antibodies also strongly inhibit ligand-independent signaling in heterologous cells transiently expressing Notch1 receptors with diverse NRR "class I" point mutations, the most common type of mutation found in human T-cell acute lymphoblastic leukemia (T-ALL). In contrast, NRR antibodies failed to antagonize Notch1 receptors bearing rare "class II" or "class III" mutations, in which amino acid insertions generate a duplicated or constitutively sensitive metalloprotease cleavage site. Signaling in T-ALL cell lines bearing class I mutations is partially refractory to inhibitory antibodies as compared to cell-penetrating gamma-secretase inhibitors. Conclusions/Significance: Antibodies that compete with Notch1 ligand binding or that bind to the negative regulatory region can act as potent inhibitors of Notch1 signaling. These antibodies may have clinical utility for conditions in which inhibition of signaling by wild-type Notch1 is desired, but are likely to be of limited value for treatment of T-ALLs associated with aberrant Notch1 activation.	[Aste-Amezaga, Miguel; Zhang, Ningyan; Lineberger, Janet E.; Arnold, Beth A.; Toner, Timothy J.; Gu, Mingcheng; Huang, Lingyi; Vitelli, Salvatore; Vo, Kim T.; Haytko, Peter; Zhao, Jing Zhang; Franlin, Laura L.; Wang, Hui; Wang, Fubao; Audoly, Laurent P.; Huber, Hans E.] Merck Res Labs, Dept Biol Res, West Point, PA 19486 USA; [Thoryk, Elizabeth; Bett, Andrew J.] Merck Res Labs, Dept Vaccines, West Point, PA USA; [Chastain, Michael] Merck Res Labs, Dept Mol Profiling & Pharmacol, West Point, PA USA; [Baleydier, Frederic; L'Heureux, Sarah; Wang, Hongfang; Gordon, Wendy R.; Andrawes, Marie Blanke; Tiyanont, Kittichoat; Aster, Jon C.; Blacklow, Stephen C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Stegmaier, Kimberly; Roti, Giovanni] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Stegmaier, Kimberly; Ross, Kenneth N.] Broad Inst, Canc Program, Cambridge, MA USA	Merck & Company; Merck & Company; Merck & Company; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Aste-Amezaga, M (corresponding author), Merck Res Labs, Dept Biol Res, West Point, PA 19486 USA.	jose_asteamezaga@merck.com	Roti, Giovanni/A-4234-2015; Baleydier, Frederic/AAX-2554-2020	Roti, Giovanni/0000-0002-8664-950X; Zhang, Ningyan/0000-0002-4348-2180; Gordon, Wendy/0000-0001-7696-5560	NIH (National Institutes of Health) [P01 119070, R01 CA092433]; Leukemia and Lymphoma Society; William Lawrence and Blanche Hughes Foundation; NATIONAL CANCER INSTITUTE [R01CA092433, P01CA119070, R56CA092433] Funding Source: NIH RePORTER	NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); William Lawrence and Blanche Hughes Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was supported in part by NIH (National Institutes of Health) grants P01 119070 and R01 CA092433 (JCA, SCB), a SCOR (Specialized Center of Research) award from the Leukemia and Lymphoma Society (JCA, SCB, KS), and the William Lawrence and Blanche Hughes Foundation (JCA, SCB, KS). WRG is a Leukemia and Lymphoma Society special fellow. The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Dickson BC, 2007, MODERN PATHOL, V20, P685, DOI 10.1038/modpathol.3800785; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dufraine J, 2008, ONCOGENE, V27, P5132, DOI 10.1038/onc.2008.227; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006613; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Houde C, 2004, BLOOD, V104, P3697, DOI 10.1182/blood-2003-12-4114; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Petcherski AG, 2000, CURR BIOL, V10, pR471, DOI 10.1016/S0960-9822(00)00577-7; Purow BW, 2008, CARCINOGENESIS, V29, P918, DOI 10.1093/carcin/bgn079; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; Rao SS, 2009, CANCER RES, V69, P3060, DOI 10.1158/0008-5472.CAN-08-4295; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; RECHSTEINER M, 1988, ADV ENZYME REGUL, V27, P135; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Reedijk M, 2008, BREAST CANCER RES TR, V111, P439, DOI 10.1007/s10549-007-9805-3; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Rizzo P, 2009, ADV ENZYME REGUL, V49, P134, DOI 10.1016/j.advenzreg.2009.01.008; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Sander GR, 2004, J HISTOCHEM CYTOCHEM, V52, P509, DOI 10.1177/002215540405200409; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; Shutter JR, 2000, GENE DEV, V14, P1313; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Sulis ML, 2008, BLOOD, V112, P733, DOI 10.1182/blood-2007-12-130096; TAMMAM J, 2009, BR J PHARM IN PRESS; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vardar D, 2003, BIOCHEMISTRY-US, V42, P7061, DOI 10.1021/bi034156y; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yu Hai, 2007, Ai Zheng, V26, P148	68	136	150	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9094	10.1371/journal.pone.0009094	http://dx.doi.org/10.1371/journal.pone.0009094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161710	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442500006
J	Zhang, ZY; Theler, D; Kaminska, KH; Hiller, M; de la Grange, P; Pudimat, R; Rafalska, I; Heinrich, B; Bujnicki, JM; Allain, FHT; Stamm, S				Zhang, Zhaiyi; Theler, Dominik; Kaminska, Katarzyna H.; Hiller, Michael; de la Grange, Pierre; Pudimat, Rainer; Rafalska, Ilona; Heinrich, Bettina; Bujnicki, Janusz M.; Allain, Frederic H.-T.; Stamm, Stefan			The YTH Domain Is a Novel RNA Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; PROTEIN; RECOGNITION; TRANSLATION; PREDICTION; SEQUENCES; SELECTION; DISPLAY; GENE	The YTH (YT521-B homology) domain was identified by sequence comparison and is found in 174 different proteins expressed in eukaryotes. It is characterized by 14 invariant residues within an alpha-helix/beta-sheet structure. Here we show that the YTH domain is a novel RNA binding domain that binds to a short, degenerated, single-stranded RNA sequence motif. The presence of the binding motif in alternative exons is necessary for YT521-B to directly influence splice site selection in vivo. Array analyses demonstrate that YT521-B predominantly regulates vertebrate-specific exons. An NMR titration experiment identified the binding surface for single-stranded RNA on the YTH domain. Structural analyses indicate that the YTH domain is related to the pseudouridine synthase and archaeosine transglycosylase (PUA) domain. Our data show that the YTH domain conveys RNA binding ability to a new class of proteins that are found in all eukaryotic organisms.	[Zhang, Zhaiyi; Stamm, Stefan] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Zhang, Zhaiyi; Rafalska, Ilona; Heinrich, Bettina] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Hiller, Michael; Pudimat, Rainer] Univ Freiburg, Bioinformat Grp, Inst Comp Sci, D-79110 Freiburg, Germany; [de la Grange, Pierre] Hop St Louis, Inst Univ Hematol, F-75010 Paris, France; [Theler, Dominik; Allain, Frederic H.-T.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Kaminska, Katarzyna H.; Bujnicki, Janusz M.] Int Inst Mol & Cell Biol, Lab Bioinformat & Prot Engn, PL-02109 Warsaw, Poland; [Kaminska, Katarzyna H.; Bujnicki, Janusz M.] Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, Bioinformat Lab, PL-61614 Poznan, Poland	University of Kentucky; University of Erlangen Nuremberg; University of Freiburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Swiss Federal Institutes of Technology Domain; ETH Zurich; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Adam Mickiewicz University	Stamm, S (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, B283 Biomed & Biol Sci Res Bldg,741 S Limestone, Lexington, KY 40536 USA.	stefan@stamms-lab.net	Kaminska, Katarzyna/C-8370-2011	Kaminska, Katarzyna/0000-0001-5726-6967	European Union; Deutsche Forschungsgemeinschaft; Swiss National Science Foundation National Center of Competence in Research Structural Biology	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation National Center of Competence in Research Structural Biology	This work was supported in part by the European Union (EURASNET) (to J. M. B., F.H.-T.A., and S. S.) and the Deutsche Forschungsgemeinschaft (to S. S.).; Supported by the Swiss National Science Foundation National Center of Competence in Research Structural Biology.	Arakaki T, 2006, ACTA CRYSTALLOGR F, V62, P175, DOI 10.1107/S1744309106005902; Aravind L, 1999, J MOL EVOL, V48, P291, DOI 10.1007/PL00006472; Auweter SD, 2007, J MOL BIOL, V367, P174, DOI 10.1016/j.jmb.2006.12.053; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Harfmann AM, 1999, MOL BIOL CELL, V10, P3909, DOI 10.1091/mbc.10.11.3909; Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Imai Y, 1998, MOL BRAIN RES, V53, P33, DOI 10.1016/S0169-328X(97)00262-3; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Li M, 2005, PROTEIN SCI, V14, P2895, DOI 10.1110/ps.051736805; Lie YS, 1999, DEVELOPMENT, V126, P1129; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Perez-Arellano I, 2007, FEBS J, V274, P4972, DOI 10.1111/j.1742-4658.2007.06031.x; Rafalska I, 2004, HUM MOL GENET, V13, P1535, DOI 10.1093/hmg/ddh167; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Stoilov P, 2002, TRENDS BIOCHEM SCI, V27, P495, DOI 10.1016/S0968-0004(02)02189-8; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4; Stoss O, 2001, J BIOL CHEM, V276, P8665, DOI 10.1074/jbc.M006851200; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; White EK, 2001, RNA, V7, P1855; Zuker M, 1994, Methods Mol Biol, V25, P267	30	161	170	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14701	14710		10.1074/jbc.M110.104711	http://dx.doi.org/10.1074/jbc.M110.104711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20167602	Green Published, hybrid			2022-12-25	WOS:000277299700068
J	Almeida-Souza, L; Goethals, S; de Winter, V; Dierick, I; Gallardo, R; Van Durme, J; Irobi, J; Gettemans, J; Rousseau, F; Schymkowitz, J; Timmerman, V; Janssens, S				Almeida-Souza, Leonardo; Goethals, Sofie; de Winter, Vicky; Dierick, Ines; Gallardo, Rodrigo; Van Durme, Joost; Irobi, Joy; Gettemans, Jan; Rousseau, Frederic; Schymkowitz, Joost; Timmerman, Vincent; Janssens, Sophie			Increased Monomerization of Mutant HSPB1 Leads to Protein Hyperactivity in Charcot-Marie-Tooth Neuropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; ALPHA-CRYSTALLIN DOMAIN; A-CRYSTALLIN; SUBUNIT INTERACTIONS; CHAPERONE ACTIVITY; B-CRYSTALLIN; IN-VIVO; HSP27; MUTATION; DISSOCIATION	Small heat shock proteins are molecular chaperones capable of maintaining denatured proteins in a folding-competent state. We have previously shown that missense mutations in the small heat shock protein HSPB1 (HSP27) cause distal hereditary motor neuropathy and axonal Charcot-Marie-Tooth disease. Here we investigated the biochemical consequences of HSPB1 mutations that are known to cause peripheral neuropathy. In contrast to other chaperonopathies, our results revealed that particular HSPB1 mutations presented higher chaperone activity compared with wild type. Hyperactivation of HSPB1 was accompanied by a change from its wild-type dimeric state to a monomer without dissociation of the 24-meric state. Purification of protein complexes from wild-type and HSPB1 mutants showed that the hyperactive isoforms also presented enhanced binding to client proteins. Furthermore, we show that the wildtype HSPB1 protein undergoes monomerization during heat-shock activation, strongly suggesting that the monomer is the active form of the HSPB1 protein.	[Timmerman, Vincent] Univ Antwerp, Peripheral Neuropathy Grp, VIB Dept Mol Genet, CDE, B-2610 Antwerp, Belgium; [Gallardo, Rodrigo; Van Durme, Joost; Rousseau, Frederic; Schymkowitz, Joost] Vrije Univ Brussel, VIB Switch Lab, B-1050 Brussels, Belgium; [Gettemans, Jan] Univ Ghent, VIB Dept Med Prot Res, B-9000 Ghent, Belgium; [Gettemans, Jan] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Almeida-Souza, Leonardo; Goethals, Sofie; de Winter, Vicky; Dierick, Ines; Irobi, Joy; Timmerman, Vincent; Janssens, Sophie] Inst Born Bunge, Neurogenet Lab, B-2610 Antwerp, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Timmerman, V (corresponding author), Univ Antwerp, Peripheral Neuropathy Grp, VIB Dept Mol Genet, CDE, Univ Pl 1,Bldg 5, B-2610 Antwerp, Belgium.	vincent.timmerman@molgen.vib-ua.be; sophie.janssens@molgen.vib-ua.be	Timmerman, Vincent/O-7283-2019; Rousseau, Frederic/J-9044-2016; Janssens, Sophie/HHN-1756-2022; Almeida-Souza, Leonardo/C-3437-2011; Schymkowitz, Joost/AAV-3680-2021; Schymkowitz, Joost/K-7764-2016	Timmerman, Vincent/0000-0002-2162-0933; Rousseau, Frederic/0000-0002-9189-7399; Almeida-Souza, Leonardo/0000-0002-7169-1238; Gallardo, Rodrigo/0000-0003-1584-3564; Schymkowitz, Joost/0000-0003-2020-0168	University of Antwerp; Fund for Scientific Research (FWO-Flanders); Medical Foundation Queen Elisabeth; Association Belge contre les Maladies Neuromusculaires; Belgian Federal Science Policy Office [P6/43]; Institute for Science and Technology	University of Antwerp; Fund for Scientific Research (FWO-Flanders)(FWO); Medical Foundation Queen Elisabeth; Association Belge contre les Maladies Neuromusculaires; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Institute for Science and Technology	This work was supported by the Methusalem program of the University of Antwerp, the Fund for Scientific Research (FWO-Flanders), the Medical Foundation Queen Elisabeth, the "Association Belge contre les Maladies Neuromusculaires," and the Interuniversity Attraction Poles P6/43 program of the Belgian Federal Science Policy Office.; Supported by a Ph.D. fellowship from the University of Antwerp.; Supported by a Ph.D. fellowship of the Institute for Science and Technology.; Postdoctoral researcher supported by the FWO-Flanders.	Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452; Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Barisic N, 2008, ANN HUM GENET, V72, P416, DOI 10.1111/j.1469-1809.2007.00412.x; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berengian AR, 1999, J BIOL CHEM, V274, P6305, DOI 10.1074/jbc.274.10.6305; Borrelli MJ, 2002, CELL STRESS CHAPERON, V7, P281, DOI 10.1379/1466-1268(2002)007<0281:SPBAFH>2.0.CO;2; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Bross P, 2008, J BIOL CHEM, V283, P15694, DOI 10.1074/jbc.M800548200; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; CHRETIEN P, 1988, J CELL PHYSIOL, V137, P157, DOI 10.1002/jcp.1041370119; Cobb BA, 2000, BIOCHEMISTRY-US, V39, P15791, DOI 10.1021/bi001453j; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Cuesta R, 2000, GENE DEV, V14, P1460; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; Dierick I, 2008, BRAIN, V131, P1217, DOI 10.1093/brain/awn029; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Franzmann TM, 2005, J MOL BIOL, V350, P1083, DOI 10.1016/j.jmb.2005.05.034; Guay J, 1997, J CELL SCI, V110, P357; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hilario E, 2006, ACTA CRYSTALLOGR F, V62, P446, DOI 10.1107/S174430910601219X; Houlden H, 2008, NEUROLOGY, V71, P1660, DOI 10.1212/01.wnl.0000319696.14225.67; Huot J, 1996, CANCER RES, V56, P273; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; LANDRY J, 1992, J BIOL CHEM, V267, P794; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Mchaourab HS, 1997, BIOCHEMISTRY-US, V36, P14627, DOI 10.1021/bi971700s; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Perng MD, 2004, CURR BIOL, V14, pR625, DOI 10.1016/j.cub.2004.07.047; SALMON P, 2006, CURRENT PROTOCOLS NE; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; Tang BS, 2005, ARCH NEUROL-CHICAGO, V62, P1201, DOI 10.1001/archneur.62.8.1201; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005	42	78	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12778	12786		10.1074/jbc.M109.082644	http://dx.doi.org/10.1074/jbc.M109.082644			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178975	Green Published, hybrid			2022-12-25	WOS:000276787800036
J	Luscieti, S; Santambrogio, P; d'Estaintot, BL; Granier, T; Cozzi, A; Poli, M; Gallois, B; Finazzi, D; Cattaneo, A; Levi, S; Arosio, P				Luscieti, Sara; Santambrogio, Paolo; d'Estaintot, Beatrice Langlois; Granier, Thierry; Cozzi, Anna; Poli, Maura; Gallois, Bernard; Finazzi, Dario; Cattaneo, Angela; Levi, Sonia; Arosio, Paolo			Mutant Ferritin L-chains That Cause Neurodegeneration Act in a Dominant-negative Manner to Reduce Ferritin Iron Incorporation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERFERRITINEMIA-CATARACT SYNDROME; LIGHT-POLYPEPTIDE GENE; H-CHAIN; HEREDITARY FERRITINOPATHY; ESCHERICHIA-COLI; CLINICAL-FEATURES; JAPANESE FAMILY; HELA-CELLS; MUTATION; NEUROFERRITINOPATHY	Nucleotide insertions that modify the C terminus of ferritin light chain (FTL) cause neurodegenerative movement disorders named neuroferritinopathies, which are inherited with dominant transmission. The disorders are characterized by abnormal brain iron accumulation. Here we describe the biochemical and crystallographic characterization of pathogenic FTL mutant p. Phe167SerfsX26 showing that it is a functional ferritin with an altered conformation of the C terminus. Moreover we analyze functional and stability properties of ferritin heteropolymers made of 20-23 H-chains and 1-4 L-chains with representative pathogenic mutations or the last 10-28 residues truncated. All the heteropolymers containing the pathogenic or truncated mutants had a strongly reduced capacity to incorporate iron, both when expressed in Escherichia coli, and in vitro when iron was supplied as Fe(III) in the presence of ascorbate. The mutations also reduced the physical stability of the heteropolymers. The data indicate that even a few mutated L-chains are sufficient to alter the permeability of 1-2 of the 6 hydrophobic channels and modify ferritin capacity to incorporate iron. The dominant-negative action of the mutations explains the dominant transmission of the disorder. The data support the hypothesis that hereditary ferritinopathies are due to alterations of ferritin functionality and provide new input on the mechanism of the function of isoferritins.	[Luscieti, Sara; Poli, Maura; Finazzi, Dario; Arosio, Paolo] Univ Brescia, Dipartimento Materno Infantile & Tecnol Biomed, I-25123 Brescia, Italy; [Santambrogio, Paolo; Cozzi, Anna; Levi, Sonia] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Cattaneo, Angela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [d'Estaintot, Beatrice Langlois; Granier, Thierry; Gallois, Bernard] Univ Bordeaux 1, UMR 5248, CNRS, F-33405 Talence, France; [Finazzi, Dario; Arosio, Paolo] AO Spedali Civili Brescia, Terzo Lab Anal Chim Clin, I-25123 Brescia, Italy; [Levi, Sonia] Univ Vita Salute San Raffaele, I-20132 Milan, Italy	University of Brescia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Hospital Spedali Civili Brescia; Vita-Salute San Raffaele University	Arosio, P (corresponding author), Univ Brescia, Dipartimento Materno Infantile & Tecnol Biomed, Viale Europa 11, I-25123 Brescia, Italy.	arosio@med.unibs.it	Luscieti, Sara/H-1324-2015; levi, sonia/A-3161-2015; finazzi, dario/GYV-1567-2022; Cozzi, Anna/AAN-3821-2020; arosio, paolo/E-6817-2010; arosio, paolo/S-3272-2019; Santambrogio, Paolo/AAN-3837-2020	Luscieti, Sara/0000-0002-3800-1303; levi, sonia/0000-0002-5092-0847; arosio, paolo/0000-0002-5343-8992; Santambrogio, Paolo/0000-0002-5481-2130; Finazzi, Dario/0000-0001-5176-2839	Telethon-Italia [GGP05141]; Fondazione [CARIPLO-2007]; European Community	Telethon-Italia(Fondazione Telethon); Fondazione(Fondazione CarifeFondazione Caritro); European Community(European Commission)	This work was supported in part by Telethon-Italia Grant GGP05141 (to S. L. and P. A.), Fondazione Grant CARIPLO-2007 (to S. L. and A. C.), and European Community Grant Euroiron1 (to P. A.).	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Baraibar MA, 2008, J BIOL CHEM, V283, P31679, DOI 10.1074/jbc.M805532200; Baraibar MA, 2010, J BIOL CHEM, V285, P1950, DOI 10.1074/jbc.M109.042986; Barbeito AG, 2009, J NEUROCHEM, V109, P1067, DOI 10.1111/j.1471-4159.2009.06028.x; BEAUMONT C, 1995, NAT GENET, V11, P444, DOI 10.1038/ng1295-444; Brooks DG, 2002, INVEST OPHTH VIS SCI, V43, P1121; Chinnery PF, 2007, BRAIN, V130, P110, DOI 10.1093/brain/awl319; CONNOR JR, 1994, J NEUROSCI RES, V37, P461, DOI 10.1002/jnr.490370405; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842; Cozzi A, 2006, NEUROBIOL DIS, V23, P644, DOI 10.1016/j.nbd.2006.05.004; Cozzi A, 2010, NEUROBIOL DIS, V37, P77, DOI 10.1016/j.nbd.2009.09.009; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; Darshan D, 2009, HEPATOLOGY, V50, P852, DOI 10.1002/hep.23058; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Gerardi G, 2005, BLOOD CELL MOL DIS, V35, P177, DOI 10.1016/j.bcmd.2005.06.002; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Infante AA, 2007, EXP CELL RES, V313, P1602, DOI 10.1016/j.yexcr.2007.02.021; Ingrassia R, 2006, J BIOCHEM, V139, P881, DOI 10.1093/jb/mvj101; JAPPELLI R, 1992, J MOL BIOL, V227, P532, DOI 10.1016/0022-2836(92)90905-Y; Kubota A, 2009, MOVEMENT DISORD, V24, P441, DOI 10.1002/mds.22435; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LEVI S, 1994, J BIOL CHEM, V269, P30334; Levi S, 1998, BLOOD, V91, P4180, DOI 10.1182/blood.V91.11.4180.411k38_4180_4187; LEVI S, 1988, J BIOL CHEM, V263, P18086; LEVI S, 1989, BIOCHEM J, V264, P381, DOI 10.1042/bj2640381; LUZZAGO A, 1989, EMBO J, V8, P569, DOI 10.1002/j.1460-2075.1989.tb03411.x; Maciel P, 2005, NEUROLOGY, V65, P603, DOI 10.1212/01.wnl.0000178224.81169.c2; Mancuso M, 2005, J NEUROPATH EXP NEUR, V64, P280, DOI 10.1093/jnen/64.4.280; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohta E, 2008, NEUROLOGY, V70, P1493, DOI 10.1212/01.wnl.0000310428.74624.95; Rucker P, 1997, PROTEIN ENG, V10, P967, DOI 10.1093/protein/10.8.967; SANTAMBROGIO P, 1992, J BIOL CHEM, V267, P14077; Santambrogio P, 1997, BIOCHEM J, V322, P461, DOI 10.1042/bj3220461; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; Santambrogio P, 2000, PROTEIN EXPRES PURIF, V19, P212, DOI 10.1006/prep.2000.1212; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P363, DOI 10.1093/jnen/63.4.363; Vidal R, 2003, J NEUROL SCI, V207, P110, DOI 10.1016/S0022-510X(02)00435-5; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Wang ZM, 2006, ACTA CRYSTALLOGR D, V62, P800, DOI 10.1107/S0907444906018294	48	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11948	11957		10.1074/jbc.M109.096404	http://dx.doi.org/10.1074/jbc.M109.096404			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20159981	Green Published, hybrid			2022-12-25	WOS:000276787100023
J	Buttar, NS; DeMars, CJ; Lomberk, G; Rizvi, S; Bonilla-Velez, J; Achra, S; Rashtak, S; Wang, KK; Fernandez-Zapico, ME; Urrutia, R				Buttar, Navtej S.; DeMars, Cathrine J.; Lomberk, Gwen; Rizvi, Sumera; Bonilla-Velez, Juliana; Achra, Shalini; Rashtak, Shahrooz; Wang, Kenneth K.; Fernandez-Zapico, Martin E.; Urrutia, Raul			Distinct Role of Kruppel-like Factor 11 in the Regulation of Prostaglandin E-2 Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); NONSTEROIDAL ANTIINFLAMMATORY DRUGS; APC(DELTA-716) KNOCKOUT MICE; COLON-CANCER CELLS; BARRETTS-ESOPHAGUS; TRANSCRIPTIONAL REPRESSION; INTESTINAL POLYPOSIS; CARDIOVASCULAR RISK; COX-2 INHIBITORS; CYCLOOXYGENASE-2	Kruppel-like factor (KLF) proteins are emerging as key regulators of lipid metabolism, diabetes, and the biosynthesis of immunological cytokines. However, their role in the synthesis of prostaglandins, widely known biochemical mediators that act in a myriad of cell biological processes remain poorly understood. Consequently, in this study a comprehensive investigation at the cellular, biochemical, and molecular levels reveal that KLF11 inhibits prostaglandin E-2 synthesis via transcriptional silencing of the promoter of its biosynthetic enzyme, cytosolic phospholipase A2 alpha. Mechanistically, KLF11 accomplishes this function by binding to the promoter via specific GC-rich sites and recruiting the Sin3-histone deacetylase chromatin remodeling complex. Further functional characterization reveals that this function of KLF11 can be reversed by epidermal growth factor receptor-AKT-mediated post-translational modification of threonine 56, a residue within its Sin3-binding domain. This is the first evidence supporting a relevant role for any KLF protein in doing both: transcriptionally inhibiting prostaglandin biosynthesis and its reversibility by an epidermal growth factor receptor-AKT signaling-mediated posttranslational mechanisms.	[Buttar, Navtej S.; DeMars, Cathrine J.; Lomberk, Gwen; Rizvi, Sumera; Bonilla-Velez, Juliana; Achra, Shalini; Rashtak, Shahrooz; Wang, Kenneth K.; Fernandez-Zapico, Martin E.; Urrutia, Raul] Mayo Clin, Div Gastroenterol, Rochester, MN 55902 USA; [Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55902 USA	Mayo Clinic; Mayo Clinic	Buttar, NS (corresponding author), Guggenheim 10,200 1st St SW, Rochester, MN 55902 USA.	buttar.navtej@mayo.edu	Lomberk, Gwen/AAL-8490-2020	Lomberk, Gwen/0000-0001-5463-789X	National Institutes of Health [CA110022-01, DK076845-01, CA125127, CA136526, DK52913]; Mayo Foundation; NATIONAL CANCER INSTITUTE [R03CA125127, R01CA136526, R03CA110022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052913, K08DK076845, R01DK052913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA110022-01 and DK076845-01 (to N.S.B.), CA125127 and CA136526 (to M.E.F.-Z.), and DK52913 (to R. U.) and by the Mayo Foundation.	Anderson LA, 2006, CANCER RES, V66, P4975, DOI 10.1158/0008-5472.CAN-05-4253; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Baltus GA, 2009, J BIOL CHEM, V284, P6998, DOI 10.1074/jbc.M807670200; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Brien TP, 2000, HUM PATHOL, V31, P35, DOI 10.1016/S0046-8177(00)80195-1; Buttar NS, 2004, NAT CLIN PRACT GASTR, V1, P106, DOI 10.1038/ncpgasthep0057; Buttar NS, 2002, JNCI-J NATL CANCER I, V94, P422; Buttar NS, 2002, GASTROENTEROLOGY, V122, P1101, DOI 10.1053/gast.2002.32371; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Coffey RJ, 1997, P NATL ACAD SCI USA, V94, P657, DOI 10.1073/pnas.94.2.657; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Das A, 2006, J BIOL CHEM, V281, P39105, DOI 10.1074/jbc.M607720200; Diaz BL, 2003, PROSTAG LEUKOTR ESS, V69, P87, DOI 10.1016/S0952-3278(03)00069-3; Ellenrieder V, 2002, EMBO J, V21, P2451, DOI 10.1093/emboj/21.10.2451; Emlet DR, 2006, BRIT J CANCER, V94, P1144, DOI 10.1038/sj.bjc.6603078; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gammon MD, 2004, CANCER EPIDEM BIOMAR, V13, P34, DOI 10.1158/1055-9965.EPI-03-0198; Ghosh M, 2004, AM J RESP CELL MOL, V30, P91, DOI 10.1165/rcmb.2003-0005OC; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hong KH, 2001, P NATL ACAD SCI USA, V98, P3935, DOI 10.1073/pnas.051635898; Hormi-Carver K, 2009, CANCER RES, V69, P672, DOI 10.1158/0008-5472.CAN-08-3703; Kaur BS, 2002, GASTROENTEROLOGY, V123, P60, DOI 10.1053/gast.2002.34244; Kuwata H, 1998, J BIOL CHEM, V273, P1733, DOI 10.1074/jbc.273.3.1733; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Markowitz SD, 2007, NEW ENGL J MED, V356, P2195, DOI 10.1056/NEJMe078044; Minuz P, 2008, J AM COLL CARDIOL, V52, P1637, DOI 10.1016/j.jacc.2008.08.042; Morgan S, 2009, EXP CELL RES, V315, P572, DOI 10.1016/j.yexcr.2008.08.009; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Naraba H, 1998, J IMMUNOL, V160, P2974; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Pawliczak R, 2004, J BIOL CHEM, V279, P48550, DOI 10.1074/jbc.M408926200; Poortinga G, 1998, EMBO J, V17, P2067, DOI 10.1093/emboj/17.7.2067; Psaty BM, 2005, NEW ENGL J MED, V352, P1133, DOI 10.1056/NEJMe058042; Rogers AB, 2004, AM J PHYSIOL-GASTR L, V286, pG361, DOI 10.1152/ajpgi.00499.2003; Rustgi AK, 2006, SEMIN ONCOL, V33, pS57, DOI 10.1053/j.seminoncol.2006.10.013; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Souza RF, 2000, CANCER RES, V60, P5767; Spindler KLG, 2006, INT J ONCOL, V29, P1159; Takaku K, 2000, J BIOL CHEM, V275, P34013, DOI 10.1074/jbc.C000586200; Trebino CE, 2005, J BIOL CHEM, V280, P16579, DOI 10.1074/jbc.M412075200; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200; Vadlamudi R, 1999, ONCOGENE, V18, P305, DOI 10.1038/sj.onc.1202307; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wick MJ, 2005, BIOCHEM J, V387, P239, DOI 10.1042/BJ20041458; Wild CP, 2003, NAT REV CANCER, V3, P676, DOI 10.1038/nrc1166; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wilson KT, 1998, CANCER RES, V58, P2929; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001	64	33	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11433	11444		10.1074/jbc.M109.077065	http://dx.doi.org/10.1074/jbc.M109.077065			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154088	hybrid, Green Published			2022-12-25	WOS:000276286200050
J	Parlakian, A; Gomaa, I; Solly, S; Arandel, L; Mahale, A; Born, G; Marazzi, G; Sassoon, D				Parlakian, Ara; Gomaa, Iman; Solly, Sounkary; Arandel, Ludovic; Mahale, Alka; Born, Gustav; Marazzi, Giovanna; Sassoon, David			Skeletal Muscle Phenotypically Converts and Selectively Inhibits Metastatic Cells in Mice	PLOS ONE			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; A3 ADENOSINE RECEPTOR; MELANOMA-CELLS; MALIGNANT-MELANOMA; STEM-CELLS; CANCER METASTASIS; TRANSFORMATION EFFECTOR; ORGAN MICROENVIRONMENT; CUTANEOUS MELANOMA; ADHESION MOLECULE	Skeletal muscle is rarely a site of malignant metastasis; the molecular and cellular basis for this rarity is not understood. We report that myogenic cells exert pronounced effects upon co-culture with metastatic melanoma (B16-F10) or carcinoma (LLC1) cells including conversion to the myogenic lineage in vitro and in vivo, as well as inhibition of melanin production in melanoma cells coupled with cytotoxic and cytostatic effects. No effect is seen with non-tumorigenic cells. Tumor suppression assays reveal that the muscle-mediated tumor suppressor effects do not generate resistant clones but function through the down-regulation of the transcription factor MiTF, a master regulator of melanocyte development and a melanoma oncogene. Our findings point to skeletal muscle as a source of therapeutic agents in the treatment of metastatic cancers.	[Parlakian, Ara; Gomaa, Iman; Solly, Sounkary; Arandel, Ludovic; Marazzi, Giovanna; Sassoon, David] Univ Paris 06, INSERM, UMR S 787, Myol Grp, Paris, France; [Born, Gustav] Univ London, William Harvey Res Inst, London, England; [Mahale, Alka] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; Queen Mary University London; Icahn School of Medicine at Mount Sinai	Parlakian, A (corresponding author), Univ Paris 06, INSERM, UMR S 787, Myol Grp, Paris, France.	david.a.sassoon@gmail.com	SASSOON, David A/G-2502-2013	SASSOON, David A/0000-0001-6074-048X; Gomaa, Iman/0000-0003-0295-2518; Marazzi, giovanna/0000-0002-5388-1038; ARA, PARLAKIAN/0000-0002-0928-2185	National Institutes of Health [PO1 CA80058]; French Ministry of Research 'Chaire d'Excellence'; Weston Foundation Fellowship; Association Francaise contre les Myopathies (AFM); NATIONAL CANCER INSTITUTE [P01CA080058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Ministry of Research 'Chaire d'Excellence'; Weston Foundation Fellowship; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health (National Cancer Institute PO1 CA80058) and the French Ministry of Research 'Chaire d'Excellence' to D. S. A. P. is the recipient of a Weston Foundation Fellowship. The Myology Group is the beneficiary of a Strategic Plan Support from the Association Francaise contre les Myopathies (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiou G, 2000, ONCOLOGY-BASEL, V58, P83, DOI 10.1159/000012083; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bar-Yehuda S, 2001, NEOPLASIA, V3, P125, DOI 10.1038/sj.neo.7900138; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; BERTRAM JS, 1980, CANCER LETT, V11, P63, DOI 10.1016/0304-3835(80)90130-5; BOYLAN MO, 1991, J CELL BIOCHEM, V46, P199, DOI 10.1002/jcb.240460303; Brooks SV, 2003, ADV PHYSIOL EDUC, V27, P171, DOI [10.1152/advan.00025.2003, 10.1152/advan.2003.27.4.171]; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; BYSTRYN JC, 1987, ARCH DERMATOL, V123, P1053, DOI 10.1001/archderm.123.8.1053; Capkovic KL, 2008, EXP CELL RES, V314, P1553, DOI 10.1016/j.yexcr.2008.01.021; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Constant JS, 2000, WOUND REPAIR REGEN, V8, P353, DOI 10.1046/j.1524-475x.2000.00353.x; CRISSMAN JD, 1986, PATHOL ANNU, V21, P29; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Djaldetti M, 1996, CLIN EXP METASTAS, V14, P189; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Dubey RK, 1997, CIRCULATION, V96, P2656, DOI 10.1161/01.CIR.96.8.2656; Dynek JN, 2008, CANCER RES, V68, P3124, DOI 10.1158/0008-5472.CAN-07-6622; Ehrhardt J, 2005, CURR OPIN NEUROL, V18, P548, DOI 10.1097/01.wco.0000177382.62156.82; Ewing J., 1928, METASTASIS NEOPLASTI; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fidler IJ, 1999, CANCER CHEMOTH PHARM, V43, pS3, DOI 10.1007/s002800051091; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fidler IJ, 2002, DIFFERENTIATION, V70, P498, DOI 10.1046/j.1432-0436.2002.700904.x; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; FIDLER IJ, PRINCIPLES CANC BIOL; FIGARELLABRANGER D, 1990, J NEUROL SCI, V98, P21, DOI 10.1016/0022-510X(90)90179-Q; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Fishman P, 1998, CANCER RES, V58, P3181; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; GREIG RG, 1986, CANCER METAST REV, V5, P3, DOI 10.1007/BF00049527; Grichnik JM, 2006, J INVEST DERMATOL, V126, P1214, DOI 10.1038/sj.jid.5700240; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hendrix MJC, 2003, ONCOGENE, V22, P3070, DOI 10.1038/sj.onc.1206447; Herring CL, 1998, CLIN ORTHOP RELAT R, P272; Ibrahim N, 2009, ANNU REV PATHOL-MECH, V4, P551, DOI 10.1146/annurev.pathol.3.121806.151541; Inoue-Narita T, 2008, CANCER RES, V68, P5760, DOI 10.1158/0008-5472.CAN-08-0889; Jackson KA, 2004, STEM CELLS, V22, P180, DOI 10.1634/stemcells.22-2-180; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; King R, 1999, AM J PATHOL, V155, P731, DOI 10.1016/S0002-9440(10)65172-3; KIZAKI H, 1988, J IMMUNOL, V141, P1652; Klein CA, 2004, CELL CYCLE, V3, P29; KLEIN CA, 2008, EUR J CANC; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Kulesa PM, 2006, P NATL ACAD SCI USA, V103, P3752, DOI 10.1073/pnas.0506977103; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Luo CH, 2002, CHINESE MED J-PEKING, V115, P1645; McGary EC, 2002, CANCER BIOL THER, V1, P459, DOI 10.4161/cbt.1.5.158; MCGEACHIE JK, 1987, CELL TISSUE RES, V248, P125, DOI 10.1007/BF01239972; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; MOULY V, 1993, NEUROMUSCULAR DISORD, V3, P371, DOI 10.1016/0960-8966(93)90080-4; Nakamura K, 2002, LIFE SCI, V70, P791, DOI 10.1016/S0024-3205(01)01454-0; NETLAND PA, 1984, SCIENCE, V224, P1113, DOI 10.1126/science.6372098; NETLAND PA, 1985, J CELL BIOL, V101, P720, DOI 10.1083/jcb.101.3.720; NORDLUND JJ, 1983, J AM ACAD DERMATOL, V9, P689, DOI 10.1016/S0190-9622(83)70182-9; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Reilly FM, 2001, J AM ACAD DERMATOL, V45, P414, DOI 10.1067/mjd.2001.117526; Obata H, 2002, CLIN ORTHOP RELAT R, P212; Ohana G, 2001, J CELL PHYSIOL, V186, P19, DOI 10.1002/1097-4652(200101)186:1<19::AID-JCP1011>3.0.CO;2-3; Olie RA, 2001, DRUG RESIST UPDATE, V4, P9, DOI 10.1054/drup.2001.0181; Paget S, 1889, LANCET, V133, P571, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Plaza JA, 2008, CANCER-AM CANCER SOC, V112, P193, DOI 10.1002/cncr.23151; Plummer RS, 2008, MODERN PATHOL, V21, P525, DOI 10.1038/modpathol.3801019; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Poser I, 2004, ONCOGENE, V23, P6115, DOI 10.1038/sj.onc.1207797; POSTE G, 1980, CANCER RES, V40, P1636; Pouyssegur J, 2001, Novartis Found Symp, V240, P186; Rambow F, 2008, PIGM CELL MELANOMA R, V21, P147, DOI 10.1111/j.1755-148X.2008.00442.x; Razak Albiruni Ryan Abdul, 2007, MedGenMed, V9, P20; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Salti GI, 2000, CANCER RES, V60, P5012; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Schriek G, 2005, MELANOMA RES, V15, P225, DOI 10.1097/00008390-200508000-00001; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; SEELY S, 1980, MED HYPOTHESES, V6, P133, DOI 10.1016/0306-9877(80)90079-1; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SUDO A, 1993, CLIN ORTHOP RELAT R, P213; Tatzel J, 2005, PIGM CELL RES, V18, P92, DOI 10.1111/j.1600-0749.2005.00212.x; Thune I, 1997, NEW ENGL J MED, V336, P1269, DOI 10.1056/NEJM199705013361801; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Wang E, 2006, J INVEST DERMATOL, V126, P1372, DOI 10.1038/sj.jid.5700193; WEISS L, 1989, CELL BIOPHYS, V14, P187, DOI 10.1007/BF02797133; Willis RA, 1973, SPREAD TUMOURS HUMAN, P279; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465; ZARBL H, 1991, ENVIRON HEALTH PERSP, V93, P83, DOI 10.2307/3431174; Zhang WH, 2006, NEOPLASIA, V8, P543, DOI 10.1593/neo.05655; Zhao Wanzhou, 2001, Cancer Letters, V162, pS49, DOI 10.1016/S0304-3835(00)00656-X; ZHU DZ, 1991, P NATL ACAD SCI USA, V88, P9568, DOI 10.1073/pnas.88.21.9568	102	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9299	10.1371/journal.pone.0009299	http://dx.doi.org/10.1371/journal.pone.0009299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174581	Green Published, Green Submitted, gold			2022-12-25	WOS:000274654700023
J	Brolund, A; Sundqvist, M; Kahlmeter, G; Grape, M				Brolund, Alma; Sundqvist, Martin; Kahlmeter, Gunnar; Grape, Malin			Molecular Characterisation of Trimethoprim Resistance in Escherichia coli and Klebsiella pneumoniae during a Two Year Intervention on Trimethoprim Use	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; ANTIMICROBIAL RESISTANCE; GENE CASSETTES; DFR GENES; SULFONAMIDE RESISTANCE; INTEGRONS; SUSCEPTIBILITY; PREVALENCE; PLASMIDS; BACTERIA	Background: Trimethoprim resistance is increasing in Enterobacteriaceae. In 2004-2006 an intervention on trimethoprim use was conducted in Kronoberg County, Sweden, resulting in 85% reduction in trimethoprim prescriptions. We investigated the distribution of dihydrofolate reductase (dfr) genes and integrons in Escherichia coli and Klebsiella pneumoniae and the effect of the intervention on this distribution. Methodology/Principal Findings: Consecutively isolated E. coli (n = 320) and K. pneumoniae (n = 54) isolates phenotypicaly resistant to trimethoprim were studied. All were investigated for the presence of dfrA1, dfrA5, dfrA7, dfrA8, dfrA12, dfrA14, dfrA17 and integrons class I and II. Isolates negative for the seven dfr genes (n = 12) were also screened for dfr2d, dfrA3, dfrA9, dfrA10, dfrA24 and dfrA26. These genes accounted for 96% of trimethoprim resistance in E. coli and 69% in K. pneumoniae. The most prevalent was dfrA1 in both species. This was followed by dfrA17 in E. coli which was only found in one K. pneumoniae isolate. Class I and II Integrons were more common in E. coli (85%) than in K. pneumoniae (57%). The distribution of dfr-genes did not change during the course of the 2-year intervention. Conclusions/Significance: The differences observed between the studied species in terms of dfr gene and integron prevalence indicated a low rate of dfr gene transfer between these two species and highlighted the possible role of narrow host range plasmids in the spread of trimethoprim resistance. The stability of dfr genes, despite large changes in the selective pressure, indirectly suggests a low fitness cost of dfr gene carriage.	[Brolund, Alma; Grape, Malin] Karolinska Inst, Div Clin Microbiol, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Sundqvist, Martin; Kahlmeter, Gunnar] Cent Hosp Vaxjo, Dept Clin Microbiol, Vaxjo, Sweden; [Sundqvist, Martin] Uppsala Univ, Dept Med Sci, Div Infect Dis, Uppsala, Sweden; [Kahlmeter, Gunnar] Uppsala Univ, Dept Med Sci, Div Clin Bacteriol, Uppsala, Sweden	Karolinska Institutet; Uppsala University; Uppsala University	Brolund, A (corresponding author), Karolinska Inst, Div Clin Microbiol, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	alma.brolund@smi.se			Research and Development Unit; Kronoberg County Council; Scandinavian Society of Antimicrobial Chemotherapy	Research and Development Unit; Kronoberg County Council; Scandinavian Society of Antimicrobial Chemotherapy	This work was partly financed by nonrestricted grants from the Research and Development Unit, Kronoberg County Council and The Scandinavian Society of Antimicrobial Chemotherapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram Mohammed, 2007, Ann Clin Microbiol Antimicrob, V6, P4, DOI 10.1186/1476-0711-6-4; Blahna MT, 2006, J ANTIMICROB CHEMOTH, V57, P666, DOI 10.1093/jac/dkl020; Butler CC, 2006, BRIT J GEN PRACT, V56, P686; Dionisio F, 2002, GENETICS, V162, P1525; Grape M, 2007, CLIN MICROBIOL INFEC, V13, P1112, DOI 10.1111/j.1469-0691.2007.01807.x; Grape M, 2007, ANTIMICROB AGENTS CH, V51, P1863, DOI 10.1128/AAC.01273-06; Grape M, 2005, CLIN MICROBIOL INFEC, V11, P185, DOI 10.1111/j.1469-0691.2004.01059.x; HUOVINEN P, 1995, ANTIMICROB AGENTS CH, V39, P279, DOI 10.1128/AAC.39.2.279; Joneberg J, 2003, INT J ANTIMICROB AG, V21, P525, DOI 10.1016/S0924-8579(03)00053-0; Kadlec K, 2008, J ANTIMICROB CHEMOTH, V62, P469, DOI 10.1093/jac/dkn233; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V52, P128, DOI 10.1093/jac/dkg280; KARAH N, 2008, 18 ECCMID BARC; Kerrn MB, 2002, J ANTIMICROB CHEMOTH, V50, P513, DOI 10.1093/jac/dkf164; Lee JC, 2001, J ANTIMICROB CHEMOTH, V47, P599, DOI 10.1093/jac/47.5.599; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; OLSSONLILJEQUIS.B, 2008, REPORT SWEDISH ANTIM; Randrianirina F, 2007, J ANTIMICROB CHEMOTH, V59, P309, DOI 10.1093/jac/dkl466; Schjorring S, 2008, J ANTIMICROB CHEMOTH, V62, P1086, DOI 10.1093/jac/dkn323; Skold O, 2001, VET RES, V32, P261, DOI 10.1051/vetres:2001123; Sundqvist M, 2009, J ANTIMICROB CHEMOTH; White PA, 2000, FEMS MICROBIOL LETT, V182, P265, DOI 10.1111/j.1574-6968.2000.tb08906.x; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001; Wise R, 1998, BMJ-BRIT MED J, V317, P609, DOI 10.1136/bmj.317.7159.609; Yu HS, 2004, J ANTIMICROB CHEMOTH, V53, P445, DOI 10.1093/jac/dkh097	24	54	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9233	10.1371/journal.pone.0009233	http://dx.doi.org/10.1371/journal.pone.0009233			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169085	gold, Green Submitted, Green Published			2022-12-25	WOS:000274590500015
J	Barth, M; Schultze, M; Schuster, CM; Strauss, R				Barth, Martin; Schultze, Michael; Schuster, Christoph M.; Strauss, Roland			Circadian Plasticity in Photoreceptor Cells Controls Visual Coding Efficiency in Drosophila melanogaster	PLOS ONE			English	Article							LIGHT-INDUCED DEGRADATION; OPTIC LOBE; LAMINA GANGLIONARIS; RHYTHMIC CHANGES; CLOCKS; OSCILLATOR; TIMELESS; MUTANTS; NEURONS; GENE	In the fly Drosophila melanogaster, neuronal plasticity of synaptic terminals in the first optic neuropil, or lamina, depends on early visual experience within a critical period after eclosion [1]. The current study revealed two additional and parallel mechanisms involved in this type of synaptic terminal plasticity. First, an endogenous circadian rhythm causes daily oscillations in the volume of photoreceptor cell terminals. Second, daily visual experience precisely modulates the circadian time course and amplitude of the volume oscillations that the photoreceptor-cell terminals undergo. Both mechanisms are separable in their molecular basis. We suggest that the described neuronal plasticity in Drosophila ensures continuous optimal performance of the visual system over the course of a 24 h-day. Moreover, the sensory system of Drosophila cannot only account for predictable, but also for acute, environmental changes. The volumetric changes in the synaptic terminals of photoreceptor cells are accompanied by circadian and light-induced changes of presynaptic ribbons as well as extensions of epithelial glial cells into the photoreceptor terminals, suggesting that the architecture of the lamina is altered by both visual exposure and the circadian clock. Clock-mutant analysis and the rescue of PER protein rhythmicity exclusively in all R1-6 cells revealed that photoreceptor-cell plasticity is autonomous and sufficient to control visual behavior. The strength of a visually guided behavior, the optomotor turning response, co-varies with synaptic-terminal volume oscillations of photoreceptor cells when elicited at low light levels. Our results show that behaviorally relevant adaptive processing of visual information is performed, in part, at the level of visual input level.	[Barth, Martin; Schultze, Michael; Schuster, Christoph M.; Strauss, Roland] Max Planck Soc MPG, Friedrich Miescher Lab, Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society	Barth, M (corresponding author), Max Planck Soc MPG, Friedrich Miescher Lab, Tubingen, Germany.	rstrauss@uni-mainz.de			Max-Planck-Society; BMBF [FKZ 0311855]; Deutsche Forschungsgemeinschaft	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was supported by the Max-Planck-Society, a BMBF Biofuture grant to R. S. (FKZ 0311855), and a Deutsche Forschungsgemeinschaft grant to M. B. http://www.bmbf.de/, http://www.dfg.de/, http://www.mpg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth M, 1997, J NEUROSCI, V17, P1493; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BULT R, 1993, J BIOL RHYTHM, V8, P311, DOI 10.1177/074873049300800404; BURNSIDE B, 1993, EXP EYE RES, V57, P709, DOI 10.1006/exer.1993.1179; CHAMBERLAIN SC, 1979, SCIENCE, V206, P361, DOI 10.1126/science.482946; Cheng YZ, 1998, J NEUROSCI, V18, P741; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Giebultowicz JM, 2001, PHILOS T R SOC B, V356, P1791, DOI 10.1098/rstb.2001.0960; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; GOTZ KG, 1979, BIOL CYBERN, V35, P101, DOI 10.1007/BF00337435; Hausen K., 1984, PHOTORECEPTION VISIO, P523, DOI [10.1007/978-1-4613-2743-1_15, DOI 10.1007/978-1-4613-2743-1_15]; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Mayhew TM, 1996, J NEUROCYTOL, V25, P793, DOI 10.1007/BF02284842; Meinertzhagen IA, 1996, TRENDS NEUROSCI, V19, P285, DOI 10.1016/S0166-2236(96)10033-3; Meinertzhagen IA, 2001, ADV INSECT PHYSIOL, V28, P84, DOI 10.1016/S0065-2806(01)28009-6; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Peschel N, 2006, P NATL ACAD SCI USA, V103, P17313, DOI 10.1073/pnas.0606675103; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Pyza E, 2004, J NEUROBIOL, V59, P205, DOI 10.1002/neu.10307; Pyza E, 1999, J NEUROBIOL, V40, P77, DOI 10.1002/(SICI)1097-4695(199907)40:1<77::AID-NEU7>3.0.CO;2-0; Rieger D, 2007, J BIOL RHYTHM, V22, P387, DOI 10.1177/0748730407306198; Rybak J, 1997, EUR J NEUROSCI, V9, P319, DOI 10.1111/j.1460-9568.1997.tb01402.x; SAINTMARIE RL, 1983, J NEUROCYTOL, V12, P213, DOI 10.1007/BF01148463; SAINTMARIE RL, 1983, J NEUROCYTOL, V12, P243, DOI 10.1007/BF01148464; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; Strauss R, 2001, J COMP PHYSIOL A, V187, P617, DOI 10.1007/s003590100234; Taghert PH, 2006, J BIOL RHYTHM, V21, P445, DOI 10.1177/0748730406293910; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; ZERR DM, 1990, J NEUROSCI, V10, P2749	37	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9217	10.1371/journal.pone.0009217	http://dx.doi.org/10.1371/journal.pone.0009217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169158	Green Submitted, Green Published, gold			2022-12-25	WOS:000274474700011
J	Janic, B; Guo, AM; Iskander, ASM; Varma, NRS; Scicli, AG; Arbab, AS				Janic, Branislava; Guo, Austin M.; Iskander, A. S. M.; Varma, Nadimpalli Ravi S.; Scicli, Alfonso G.; Arbab, Ali S.			Human Cord Blood-Derived AC133+Progenitor Cells Preserve Endothelial Progenitor Characteristics after Long Term In Vitro Expansion	PLOS ONE			English	Article							HEMATOPOIETIC STEM; CD34(+) CELLS; DIFFERENTIATION; ANGIOGENESIS; NEOVASCULARIZATION; IDENTIFICATION; TRAFFICKING; HIERARCHY; CULTURES; AC133	Background: Stem cells/progenitors are central to the development of cell therapy approaches for vascular ischemic diseases. The crucial step in rescuing tissues from ischemia is improvement of vascularization that can be achieved by promoting neovascularization. Endothelial progenitor cells (EPCs) are the best candidates for developing such an approach due to their ability to self-renew, circulate and differentiate into mature endothelial cells (ECs). Studies showed that intravenously administered progenitors isolated from bone marrow, peripheral or cord blood home to ischemic sites. However, the successful clinical application of such transplantation therapy is limited by low quantities of EPCs that can be generated from patients. Hence, the ability to amplify the numbers of autologous EPCs by long term in vitro expansion while preserving their angiogenic potential is critically important for developing EPC based therapies. Therefore, the objective of this study was to evaluate the capacity of cord blood (CB)-derived AC133+ cells to differentiate, in vitro, towards functional, mature endothelial cells (ECs) after long term in vitro expansion.	[Janic, Branislava; Iskander, A. S. M.; Varma, Nadimpalli Ravi S.; Arbab, Ali S.] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA; [Guo, Austin M.] Henry Ford Hosp, Dept Womens Hlth Serv, Detroit, MI 48202 USA; [Scicli, Alfonso G.] Henry Ford Hosp, Dept Eye Care Serv Res, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Janic, B (corresponding author), Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	bjanic@rad.hfh.edu	Arbab, Ali/AAS-1933-2020		National Institutes of Health (NIH) [R21NS058589, R21CA129801, R01CA122031]; American Heart Association [09SDG2230011]; NATIONAL CANCER INSTITUTE [R01CA122031, R21CA129801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058589] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by National Institutes of Health (NIH) grant R21NS058589, National Institutes of Health (NIH) grant R21CA129801, National Institutes of Health (NIH) grant R01CA122031 and American Heart Association 09SDG2230011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbab AS, 2008, FASEB J, V22, P3234, DOI 10.1096/fj.07-105676; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bonanno G, 2007, TRANSFUSION, V47, P280, DOI 10.1111/j.1537-2995.2007.01104.x; Burciaga-Nava JA, 2009, IN VITRO CELL DEV-AN, V45, P15, DOI 10.1007/s11626-008-9146-5; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Duan Hua-Xin, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P387; Eggermann J, 2003, CARDIOVASC RES, V58, P478, DOI 10.1016/S0008-6363(03)00252-9; Fibbe WE, 2001, ANN NY ACAD SCI, V938, P9; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE; Gehling UM, 2000, BLOOD, V95, P3106; Goussetis E, 2000, J HEMATOTH STEM CELL, V9, P827, DOI 10.1089/152581600750062255; Gross P, 2004, Rocz Akad Med Bialymst, V49, P174; Handgretinger R, 2003, ANN NY ACAD SCI, V996, P141, DOI 10.1111/j.1749-6632.2003.tb03242.x; HAO QL, 1995, BLOOD, V86, P3745, DOI 10.1182/blood.V86.10.3745.bloodjournal86103745; HLADOVEC J, 1978, KLIN WOCHENSCHR, V56, P1033, DOI 10.1007/BF01476669; HLADOVEC J, 1978, PHYSIOL BOHEMOSLOV, V27, P140; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Janic B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005873; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kawamoto A, 2001, CIRCULATION, V103, P634; Khakoo AY, 2005, ANNU REV MED, V56, P79, DOI 10.1146/annurev.med.56.090203.104149; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Krenning G, 2009, TRENDS MOL MED, V15, P180, DOI 10.1016/j.molmed.2009.02.001; Kuci S, 2008, CELL PROLIFERAT, V41, P12, DOI 10.1111/j.1365-2184.2007.00502.x; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Ma Gang, 2008, Zhonghua Zheng Xing Wai Ke Za Zhi, V24, P144; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Moise KJ, 2005, OBSTET GYNECOL, V106, P1393, DOI 10.1097/01.AOG.0000188388.84901.e4; Neumuller J, 2006, HISTOCHEM CELL BIOL, V126, P649, DOI 10.1007/s00418-006-0201-6; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; RISAU W, 1988, DEVELOPMENT, V102, P471; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; SCOTT SM, 1994, J VASC SURG, V19, P585, DOI 10.1016/S0741-5214(94)70030-3; Senegaglia AC, 2008, REV BRAS CIR CARDIOV, V23, P467, DOI 10.1590/S0102-76382008000400003; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; SOWEMIMOCOKER SO, 1989, AM J HEMATOL, V31, P263, DOI 10.1002/ajh.2830310409; STEIN O, 1980, BIOCHIM BIOPHYS ACTA, V620, P631, DOI 10.1016/0005-2760(80)90155-1; TERRANOVA VP, 1985, J CELL BIOL, V101, P2330, DOI 10.1083/jcb.101.6.2330; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Werner C, 2008, BIOCHEM BIOPH RES CO, V377, P331, DOI 10.1016/j.bbrc.2008.09.081; Yang C, 2004, THROMB HAEMOSTASIS, V91, P1202, DOI 10.1160/TH03-06-0378; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zangiacomi V, 2008, STEM CELLS DEV, V17, P1005, DOI 10.1089/scd.2007.0248	51	38	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9173	10.1371/journal.pone.0009173	http://dx.doi.org/10.1371/journal.pone.0009173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161785	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442800019
J	Zimmermann, B; Gesell, T; Chen, D; Lorenz, C; Schroeder, R				Zimmermann, Bob; Gesell, Tanja; Chen, Doris; Lorenz, Christina; Schroeder, Renee			Monitoring Genomic Sequences during SELEX Using High-Throughput Sequencing: Neutral SELEX	PLOS ONE			English	Article							RNA SECONDARY STRUCTURES; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; NONCODING RNAS; DINUCLEOTIDE; APTAMERS; BINDING; TRANSLATION; EXPRESSION; STABILITY	Background: SELEX is a well established in vitro selection tool to analyze the structure of ligand-binding nucleic acid sequences called aptamers. Genomic SELEX transforms SELEX into a tool to discover novel, genomically encoded RNA or DNA sequences binding a ligand of interest, called genomic aptamers. Concerns have been raised regarding requirements imposed on RNA sequences undergoing SELEX selection. Methodology/Principal Findings: To evaluate SELEX and assess the extent of these effects, we designed and performed a Neutral SELEX experiment omitting the selection step, such that the sequences are under the sole selective pressure of SELEX's amplification steps. Using high-throughput sequencing, we obtained thousands of full-length sequences from the initial genomic library and the pools after each of the 10 rounds of Neutral SELEX. We compared these to sequences obtained from a Genomic SELEX experiment deriving from the same initial library, but screening for RNAs binding with high affinity to the E. coli regulator protein Hfq. With each round of Neutral SELEX, sequences became less stable and changed in nucleotide content, but no sequences were enriched. In contrast, we detected substantial enrichment in the Hfq-selected set with enriched sequences having structural stability similar to the neutral sequences but with significantly different nucleotide selection. Conclusions/Significance: Our data indicate that positive selection in SELEX acts independently of the neutral selective requirements imposed on the sequences. We conclude that Genomic SELEX, when combined with high-throughput sequencing of positively and neutrally selected pools, as well as the gnomic library, is a powerful method to identify genomic aptamers.	[Zimmermann, Bob; Gesell, Tanja; Chen, Doris; Lorenz, Christina; Schroeder, Renee] Univ Vienna, Max F Perutz Labs, Dept Biochem, Vienna, Austria; [Gesell, Tanja] Med Univ Vienna, Univ Vienna, Max F Perutz Labs, Ctr Integrat Bioinformat Vienna, Vienna, Austria; [Gesell, Tanja] Univ Vet Med, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Veterinary Medicine Vienna	Zimmermann, B (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Biochem, Vienna, Austria.	renee.schroeder@univie.ac.at		Chen, Doris/0000-0001-8835-0280; Gesell, Tanja/0000-0002-0733-7605	Bundesministerium fur Wissenschaft und Forschung program Genomforschung in Osterreich	Bundesministerium fur Wissenschaft und Forschung program Genomforschung in Osterreich	This work was supported by funding from the Bundesministerium fur Wissenschaft und Forschung program Genomforschung in Osterreich (http://www.gen-au.at/) [projects noncoding RNA and Bioinformatics Integration Network III to T.G., R.S. and Arndt von Haeseler, project RNomics to D.C.]; Wiener Wissenschafts-, Forschungs- and Technologiefonds(http://www.wwtf.at/) [to T.G. and Arndt von Haessler]; and Fonds zur Forderung der wissenschaftlichen Forschung (http://www.fwf.ac.at/) [W1207 RNA Biologie to B.Z. and 17 SFB to D.C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; ALTSCHUL SF, 1985, MOL BIOL EVOL, V2, P526; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bejerano G, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/bth946; BENSON D, 1993, NUCLEIC ACIDS RES, V21, P2963, DOI 10.1093/nar/21.13.2963; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; BORER PN, 1974, J MOL BIOL, V86, P843, DOI 10.1016/0022-2836(74)90357-X; CHEN JH, 1990, COMPUT APPL BIOSCI, V6, P7; Clote P, 2005, RNA, V11, P578, DOI 10.1261/rna.7220505; Gesell T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-248; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Hallegger M, 2006, RNA, V12, P1993, DOI 10.1261/rna.125506; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; LE SY, 1989, NUCLEIC ACIDS RES, V17, P6143, DOI 10.1093/nar/17.15.6143; LORENZ C, 2010, NUCL ACIDS IN PRESS; Lorenz C, 2006, NAT PROTOC, V1, P2204, DOI 10.1038/nprot.2006.372; Meyers LA, 2004, J MOL EVOL, V58, P681, DOI 10.1007/s00239-004-2590-2; R_Development_Core_Team, 2008, R FDN STAT COMP; Suess B, 2003, NUCLEIC ACIDS RES, V31, P1853, DOI 10.1093/nar/gkg285; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Weigand JE, 2008, RNA, V14, P89, DOI 10.1261/rna.772408	24	62	65	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9169	10.1371/journal.pone.0009169	http://dx.doi.org/10.1371/journal.pone.0009169			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161784	Green Published, gold			2022-12-25	WOS:000274442800015
J	Li, GQ; Wang, ZQ; Miskimen, KL; Zhang, Y; Tse, W; Bunting, KD				Li, Geqiang; Wang, Zhengqi; Miskimen, Kristy L.; Zhang, Yi; Tse, William; Bunting, Kevin D.			Gab2 Promotes Hematopoietic Stem Cell Maintenance and Self-Renewal Synergistically with STAT5	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; BONE-MARROW; EXPRESSION; THROMBOPOIETIN; QUIESCENCE; CYTOKINE; DEFECTS; PATHWAY; SHP-2; RESPONSIVENESS	Background: Grb2-associated binding (Gab) adapter proteins play major roles in coordinating signaling downstream of hematopoietic cytokine receptors. In hematopoietic cells, Gab2 can modulate phosphatidylinositol-3 kinase and mitogen associated protein kinase activities and regulate the long-term multilineage competitive repopulating activity of hematopoietic stem cells (HSCs). Gab2 may also act in a linear pathway upstream or downstream of signal transducer and activator of transcription-5 (STAT5), a major positive regulator of HSC function. Therefore, we aimed to determine whether Gab2 and STAT5 function in hematopoiesis in a redundant or non-redundant manner. Methodology/Principal Findings: To do this we generated Gab2 mutant mice with heterozygous and homozygous deletions of STAT5. In heterozygous STAT5 mutant mice, deficiencies in HSC/multipotent progenitors were reflected by decreased long-term repopulating activity. This reduction in repopulation function was mirrored in the reduced growth response to early-acting cytokines from sorted double mutant c-Kit(+)Lin(-)Sca-1(+) (KLS) cells. Importantly, in non-ablated newborn mice, the host steady-state engraftment ability was impaired by loss of Gab2 in heterozygous STAT5 mutant background. Fetal liver cells isolated from homozygous STAT5 mutant mice lacking Gab2 showed significant reduction in HSC number (KLS CD150(+)CD48(-)), reduced HSC survival, and dramatic loss of self-renewal potential as measured by serial transplantation. Conclusions/Significance: These data demonstrate new functions for Gab2 in hematopoiesis in a manner that is non-redundant with STAT5. Furthermore, important synergy between STAT5 and Gab2 was observed in HSC self-renewal, which might be exploited to optimize stem cell-based therapeutics.	[Li, Geqiang; Wang, Zhengqi; Miskimen, Kristy L.; Zhang, Yi; Tse, William; Bunting, Kevin D.] Case Western Reserve Univ, Dept Med, Div Hematol Oncol, Cleveland, OH 44106 USA; [Li, Geqiang; Wang, Zhengqi; Miskimen, Kristy L.; Tse, William; Bunting, Kevin D.] Ctr Stem Cell & Regenerat Med, Cleveland, OH USA; [Bunting, Kevin D.] Case Comprehens Canc Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University	Li, GQ (corresponding author), Case Western Reserve Univ, Dept Med, Div Hematol Oncol, Cleveland, OH 44106 USA.	kdb10@case.edu			National Institutes of Health (NIH) [R01DK059380]; Center for Stem Cell and Regenerative Medicine; Flow Cytometry and Radiation Resources Core Facilities of the Case Comprehensive Cancer Center [P30CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059380] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Stem Cell and Regenerative Medicine; Flow Cytometry and Radiation Resources Core Facilities of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) R01DK059380, http://www2.niddk.nih.gov/ (K. D. Bunting), The Center for Stem Cell and Regenerative Medicine, and the Flow Cytometry and Radiation Resources Core Facilities of the Case Comprehensive Cancer Center (P30CA43703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud M, 2004, J IMMUNOL, V173, P3962, DOI 10.4049/jimmunol.173.6.3962; Barnstein BO, 2006, J IMMUNOL, V177, P3421, DOI 10.4049/jimmunol.177.5.3421; Bradley HL, 2004, BLOOD, V103, P2965, DOI 10.1182/blood-2003-08-2963; Bradley HL, 2002, BLOOD, V100, P3983, DOI 10.1182/blood-2002-05-1602; Bunting KD, 2002, BLOOD, V99, P479, DOI 10.1182/blood.V99.2.479; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; Couldrey C, 2005, BLOOD, V105, P1476, DOI 10.1182/blood-2004-06-2302; Crouin C, 2001, FEBS LETT, V495, P148, DOI 10.1016/S0014-5793(01)02373-0; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Iyer J, 2008, FASEB J, V22, P391, DOI 10.1096/fj.07-8965com; Janzen V, 2008, CELL STEM CELL, V2, P584, DOI 10.1016/j.stem.2008.03.012; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Kirito K, 2002, J BIOL CHEM, V277, P8329, DOI 10.1074/jbc.M109824200; Liu G, 2007, EXP HEMATOL, V35, P1684, DOI 10.1016/j.exphem.2007.08.026; Lockyer HM, 2007, J IMMUNOL, V179, P5301, DOI 10.4049/jimmunol.179.8.5301; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Miyamoto K, 2008, BLOOD, V112, P4485, DOI 10.1182/blood-2008-05-159848; Moon JJ, 2004, J BIOL CHEM, V279, P5520, DOI 10.1074/jbc.M308998200; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Scherr M, 2006, BLOOD, V107, P3279, DOI 10.1182/blood-2005-08-3087; Shelburne CP, 2003, BLOOD, V102, P1290, DOI 10.1182/blood-2002-11-3490; Snow JW, 2002, BLOOD, V99, P95, DOI 10.1182/blood.V99.1.95; Sun JM, 2008, J BIOL CHEM, V283, P27444, DOI 10.1074/jbc.M709703200; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Um M, 2006, J BIOL CHEM, V281, P5648, DOI 10.1074/jbc.M510943200; Wang ZQ, 2009, BLOOD, V113, P4856, DOI 10.1182/blood-2008-09-181107; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Yu WM, 2002, BLOOD, V99, P2351, DOI 10.1182/blood.V99.7.2351; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang YD, 2007, J COMPUT NONLIN DYN, V2, P124, DOI 10.1115/1.2447190	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9152	10.1371/journal.pone.0009152	http://dx.doi.org/10.1371/journal.pone.0009152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161778	gold, Green Submitted, Green Published			2022-12-25	WOS:000274442700016
J	Lee, HS; Kim, EY; Kim, KH; Moon, J; Park, KS; Kim, KS; Lee, KA				Lee, Hyun-Seo; Kim, Eun-Young; Kim, Kyeoung-Hwa; Moon, Jisook; Park, Kyung-Soon; Kim, Kwang-Soo; Lee, Kyung-Ah			Obox4 critically regulates cAMP-dependent meiotic arrest and MI-MII transition in oocytes	FASEB JOURNAL			English	Article						oocyte maturation; GV arrest; RNA interference; overexpression	MOUSE OOCYTES; FOLLICULAR DEVELOPMENT; TRANSCRIPTION FACTORS; SPINDLE CHECKPOINT; EMBRYO DEVELOPMENT; CELL-INTERACTIONS; GENE-EXPRESSION; HOMEOBOX GENES; GERM-CELLS; IN-VITRO	Extra follicular oocytes spontaneously resume meiosis in vitro, but the intact germinal vesicle (GV) is retained if the oocytes are cultured in medium containing phosphodiesterase (PDE) inhibitors or cAMP analogues. On the basis of our finding that Obox4 is prominently expressed in oocytes, the present study was conducted to determine the functional role of the homeodomain-containing factor Obox4 during in vitro oocyte maturation. After microinjection of Obox4 dsRNA into the cytoplasm of GV oocytes cultured in M16 medium, oocytes were arrested at metaphase I (MI, 77.7%) and metaphase II (MII, 22.3%). Surprisingly, however, 89% of Obox4 RNAi-treated oocytes resumed meiosis and developed to MI and MII when cultured in medium containing 0.2 mM 3-isobutyl-1-metyl-xanthine (IBMX), in which untreated oocytes maintain intact GVs. Spindles were aberrant, and chromosomes were severely aggregated with decreased MPF and MAP kinase activities in arrested MI oocytes after exposure to Obox4 RNAi. Oocytes overexpressing Obox4 retained intact GVs when cultured in M16 medium. Taken together, for the first time to our knowledge, these findings indicate that Obox4 plays a key role in the cAMP-dependent signaling cascades that maintain GV arrest. Oocytes not expressing Obox4 failed to maintain intact GVs in IBMX-supplemented medium, while GVs remained intact when oocytes were kept in plain medium and overexpressing Obox4, suggesting that Obox4 plays a critical role in cAMP-dependent cascade for maintaining intact GVs.-Lee, H.-S., Kim, E.-Y., Kim, K.-H., Moon, J., Park, K.-S., Kim, K.-S., Lee, K.-A. Obox4 critically regulates cAMP-dependent meiotic arrest and MI-MII transition in oocytes. FASEB J. 24, 2314-2324 (2010). www.fasebj.org	[Lee, Hyun-Seo; Kim, Eun-Young; Kim, Kyeoung-Hwa; Moon, Jisook; Park, Kyung-Soon; Lee, Kyung-Ah] CHA Univ, Dept Biomed Sci, Coll Life Sci, Seoul 135081, South Korea; [Moon, Jisook; Park, Kyung-Soon; Kim, Kwang-Soo; Lee, Kyung-Ah] CHA Univ, CHA Stem Cell Inst, Seoul 135081, South Korea; [Kim, Kwang-Soo] Harvard Univ, Sch Med, Mol Neurobiol Lab, McLean Hosp, Boston, MA USA	Pochon Cha University; Pochon Cha University; Harvard University; Harvard Medical School; McLean Hospital	Lee, KA (corresponding author), CHA Univ, Dept Biomed Sci, Coll Life Sci, 606-13 Yeoksam 1 Dong, Seoul 135081, South Korea.	leeka@ovary.co.kr			Ministry of Science and Technology, Republic of Korea [SC4021]	Ministry of Science and Technology, Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by a grant (SC4021) from the Stem Cell Research Center of the 21st Century Frontier Research Program, funded by the Ministry of Science and Technology, Republic of Korea.	Anger M, 2005, BIOL REPROD, V72, P188, DOI 10.1095/biolreprod.104.035451; Barnes FL, 2000, SEMIN REPROD MED, V18, P123, DOI 10.1055/s-2000-12551; Cao YK, 2005, REPRODUCTION, V130, P431, DOI 10.1530/rep.1.00391; CHO WK, 1974, J EXP ZOOL, V187, P383, DOI 10.1002/jez.1401870307; Conti M, 2002, MOL CELL ENDOCRINOL, V187, P153, DOI 10.1016/S0303-7207(01)00686-4; Conti M, 2002, BIOL REPROD, V67, P1653, DOI 10.1095/biolreprod.102.004952; FULKA J, 1993, MOL REPROD DEV, V34, P427, DOI 10.1002/mrd.1080340412; Fulka J, 2004, TRENDS BIOTECHNOL, V22, P279, DOI 10.1016/j.tibtech.2004.04.002; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Juengel JL, 2002, BIOL REPROD, V67, P1777, DOI 10.1095/biolreprod.102.007146; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Kezele P, 2002, FRONT BIOSCI-LANDMRK, V7, pD1990, DOI 10.2741/kezele; Kim KH, 2008, BIOL REPROD, V79, P1192, DOI 10.1095/biolreprod.108.068478; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Ledan E, 2001, DEV BIOL, V232, P400, DOI 10.1006/dbio.2001.0188; LEVINE M, 1988, CELL, V55, P537, DOI 10.1016/0092-8674(88)90209-7; Mannervik M, 1999, BIOESSAYS, V21, P267, DOI 10.1002/(SICI)1521-1878(199904)21:4<267::AID-BIES1>3.3.CO;2-3; Park CE, 2004, MOL REPROD DEV, V69, P365, DOI 10.1002/mrd.20179; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; PETERS H, 1969, ACTA ENDOCRINOL-COP, V62, P98, DOI 10.1530/acta.0.0620098; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Rajkovic A, 2002, GENOMICS, V79, P711, DOI 10.1006/geno.2002.6759; SCHULTZ RM, 1977, P NATL ACAD SCI USA, V74, P538, DOI 10.1073/pnas.74.2.538; Svingen T, 2007, SEX DEV, V1, P12, DOI 10.1159/000096235; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Svoboda P, 2000, DEVELOPMENT, V127, P4147; THIBAULT C, 1977, J REPROD FERTIL, V51, P1; Thomas FH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-19; Tsafriri A, 1996, DEV BIOL, V178, P393, DOI 10.1006/dbio.1996.0226; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Yoon SJ, 2006, FERTIL STERIL, V86, P1129, DOI 10.1016/j.fertnstert.2006.02.105; Yoon SJ, 2009, BIOL REPROD, V81, P497, DOI 10.1095/biolreprod.108.073759; Yoon SJ, 2005, FERTIL STERIL, V83, P1293, DOI 10.1016/j.fertnstert.2004.09.037	34	11	11	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2314	2324		10.1096/fj.09-147314	http://dx.doi.org/10.1096/fj.09-147314			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20154267				2022-12-25	WOS:000279343600018
J	Alvaro-Benito, M; Polo, A; Gonzalez, B; Fernandez-Lobato, M; Sanz-Aparicio, J				Alvaro-Benito, Miguel; Polo, Aitana; Gonzalez, Beatriz; Fernandez-Lobato, Maria; Sanz-Aparicio, Julia			Structural and Kinetic Analysis of Schwanniomyces occidentalis Invertase Reveals a New Oligomerization Pattern and the Role of Its Supplementary Domain in Substrate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; BETA-FRUCTOSIDASE; ALPHA-AMYLASE; PROTEIN; EXPRESSION; PURIFICATION; YEAST; GLYCOSYLATION; ENZYMES	Schwanniomyces occidentalis invertase is an extracellular enzyme that hydrolizes sucrose and releases beta-fructose from various oligosaccharides and essential storage fructan polymers such as inulin. We report here the three-dimensional structure of Sw. occidentalis invertase at 2.9 angstrom resolution and its complex with fructose at 1.9 angstrom resolution. The monomer presents a bimodular arrangement common to other GH32 enzymes, with an N-terminal 5-fold beta-propeller catalytic domain and a C-terminal beta-sandwich domain for which the function has been unknown until now. However, the dimeric nature of Sw. occidentalis invertase reveals a unique active site cleft shaped by both subunits that may be representative of other yeast enzymes reported to be multimeric. Binding of the tetrasaccharide nystose and the polymer inulin was explored by docking analysis, which suggested that medium size and long substrates are recognized by residues from both subunits. The identified residues were mutated, and the enzymatic activity of the mutants against sucrose, nystose, and inulin were investigated by kinetic analysis. The replacements that showed the largest effect on catalytic efficiency were Q228V, a residue putatively involved in nystose and inulin binding, and S281I, involved in a polar link at the dimer interface. Moreover, a significant decrease in catalytic efficiency against inulin was observed in the mutants Q435A and Y462A, both located in the beta-sandwich domain of the second monomer. This highlights the essential function that oligomerization plays in substrate specificity and assigns, for the first time, a direct catalytic role to the supplementary domain of a GH32 enzyme.	[Polo, Aitana; Gonzalez, Beatriz; Sanz-Aparicio, Julia] CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estruct, Madrid 28006, Spain; [Alvaro-Benito, Miguel; Fernandez-Lobato, Maria] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Dept Biol Mol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Sanz-Aparicio, J (corresponding author), CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estruct, Serrano 119, Madrid 28006, Spain.	xjulia@iqfr.csic.es	Gonzalez, Beatriz/M-1219-2014; Lobato, Maria Fernandez/F-1338-2016; Alvaro-Benito, Miguel/AAC-9704-2022; Sanz-Aparicio, Julia/F-6201-2013	Gonzalez, Beatriz/0000-0002-0710-0202; Lobato, Maria Fernandez/0000-0003-0778-7443; Alvaro-Benito, Miguel/0000-0002-6019-3567; Sanz-Aparicio, Julia/0000-0002-6849-8621	Ministerio de Educacion y Ciencia, Spain [BIO2007-67708-C04-04, BIO2007-67708-C04-03, BIO2004-67708-C04-04, BIO2004-67708-C04-03]; Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa; Spanish Comunidad de Madrid Program	Ministerio de Educacion y Ciencia, Spain(Spanish Government); Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa; Spanish Comunidad de Madrid Program	This work was supported by Grants BIO2007-67708-C04-04, BIO2007-67708-C04-03, BIO2004-67708-C04-04, and BIO2004-67708-C04-03 from the Ministerio de Educacion y Ciencia, Spain, and by an institutional grant from the Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa.; Supported by the Spanish Comunidad de Madrid Program.	ABARCA D, 1989, FEBS LETT, V255, P455, DOI 10.1016/0014-5793(89)81144-5; ABARCA D, 1991, FEBS LETT, V279, P41, DOI 10.1016/0014-5793(91)80245-X; Alberto F, 2006, BIOCHEM J, V395, P457, DOI [10.1042/BJ20051936, 10.1042/Bj20051936]; Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Alvaro-Benito M, 2007, J BIOTECHNOL, V132, P75, DOI 10.1016/j.jbiotec.2007.07.939; Andre I, 1996, MACROMOLECULES, V29, P4626, DOI 10.1021/ma951799f; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; Burke D., 2000, METHODS YEAST GENETI; Coutinho PM, 1999, ROY SOC CH, P3; Dai JY, 2004, CELL, V116, P649, DOI 10.1016/S0092-8674(04)00172-2; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DEIBEL MR, 1988, PREP BIOCHEM, V18, P77, DOI 10.1080/00327488808062514; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DOHMEN RJ, 1990, GENE, V95, P111, DOI 10.1016/0378-1119(90)90421-M; Ghazi I, 2007, J BIOTECHNOL, V128, P204, DOI 10.1016/j.jbiotec.2006.09.017; Holm L, 1998, CURR OPIN STRUC BIOL, V8, P372, DOI 10.1016/S0959-440X(98)80072-9; Isorna P, 2007, J MOL BIOL, V371, P1204, DOI 10.1016/j.jmb.2007.05.082; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEIN RD, 1989, PREP BIOCHEM, V19, P293, DOI 10.1080/10826068908544919; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, CRYSTALLOGRAPHIC COM, V5, P39; Matrai J, 2008, PROTEINS, V71, P552, DOI 10.1002/prot.21700; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Naumoff DG, 2001, PROTEINS, V42, P66, DOI 10.1002/1097-0134(20010101)42:1<66::AID-PROT70>3.0.CO;2-4; OKUYAMA K, 1993, B CHEM SOC JPN, V66, P374, DOI 10.1246/bcsj.66.374; Polo A, 2009, ACTA CRYSTALLOGR F, V65, P1162, DOI 10.1107/S1744309109039384; Pons T, 2004, PROTEINS, V54, P424, DOI 10.1002/prot.10604; REDDY AV, 1990, BIOCHEMISTRY-US, V29, P2482, DOI 10.1021/bi00462a007; Sangeetha PT, 2005, PROCESS BIOCHEM, V40, P1085, DOI 10.1016/j.procbio.2004.03.009; Schmidt A, 1999, BIOCHEMISTRY-US, V38, P2403, DOI 10.1021/bi982108l; TAMMI M, 1987, J BIOL CHEM, V262, P4395; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Verhaest M, 2005, PLANT J, V41, P400, DOI 10.1111/j.1365-313X.2004.02304.x; Verhaest M, 2007, NEW PHYTOL, V174, P90, DOI 10.1111/j.1469-8137.2007.01988.x; Verhaest M, 2006, ACTA CRYSTALLOGR D, V62, P1555, DOI 10.1107/S0907444906044489; Wang TT, 1999, CRIT REV BIOTECHNOL, V19, P113, DOI 10.1080/0738-859991229215; WILLIAMS RS, 1985, J BIOL CHEM, V260, P3334; Yanez E, 1998, BIOCHEM J, V329, P65, DOI 10.1042/bj3290065; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	45	63	65	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13930	13941		10.1074/jbc.M109.095430	http://dx.doi.org/10.1074/jbc.M109.095430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20181943	Green Published, hybrid			2022-12-25	WOS:000276987700067
J	Bairwa, NK; Zzaman, S; Mohanty, BK; Bastia, D				Bairwa, Narendra K.; Zzaman, Shamsu; Mohanty, Bidyut K.; Bastia, Deepak			Replication Fork Arrest and rDNA Silencing Are Two Independent and Separable Functions of the Replication Terminator Protein Fob1 of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL DNA REPEATS; YEAST; RECOMBINATION; COMPLEX; POLYMERASES; REQUIREMENT; PROGRESSION; EXPANSION; HELICASE; BARRIER	The replication terminator protein Fob1 of Saccharomyces cerevisiae is multifunctional, and it not only promotes polar replication fork arrest at the tandem Ter sites located in the intergenic spacer region of rDNA but also loads the NAD-dependent histone deacetylase Sir2 at Ter sites via a protein complex called RENT (regulator of nucleolar silencing and telophase exit). Sir2 is a component of the RENT complex, and its loading not only silences intrachromatid recombination in rDNA but also RNA polymerase II-catalyzed transcription. Here, we present three lines of evidence showing that the two aforementioned activities of Fob1 are independent of each other as well as functionally separable. First, a Fob1 ortholog of Saccharomyces bayanus expressed in a fob1 Delta strain of S. cerevisiae restored polar fork arrest at Ter but not rDNA silencing. Second, a mutant form (I407T) of S. cerevisiae Fob1 retained normal fork arresting activity but was partially defective in rDNA silencing. We further show that the silencing defect of S. bayanus Fob1 and the I407T mutant of S. cerevisiae Fob1 were caused by the failure of the proteins to interact with two members of the S. cerevisiae RENT complex, namely S. cerevisiae Sir2 and S. cerevisiae Net1. Third, deletions of the intra-S phase checkpoint proteins Tof1 and Csm3 abolished fork arrest by Fob1 at Ter without causing loss of silencing. Taken together, the data support the conclusion that unlike some other functions of Fob1, rDNA silencing at Ter is independent of fork arrest.	[Bairwa, Narendra K.; Zzaman, Shamsu; Mohanty, Bidyut K.; Bastia, Deepak] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Mohanty, BK (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	mohanty@musc.edu; bastia@musc.edu			NIGMS [GM049264]; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049264] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant GM049264 from the NIGMS, National Institutes of Health (to D.B.).	BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Chen XW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001562; Cuperus G, 2000, EMBO J, V19, P2641, DOI 10.1093/emboj/19.11.2641; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Garcia SN, 2002, GENETICS, V162, P721; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; James P, 1996, GENETICS, V144, P1425; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Kobayashi T, 2001, MOL CELL BIOL, V21, P136, DOI 10.1128/MCB.21.1.136-147.2001; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; Kobayashi T, 2003, MOL CELL BIOL, V23, P9178, DOI 10.1128/MCB.23.24.9178-9188.2003; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mohanty BK, 2009, EUKARYOT CELL, V8, P487, DOI 10.1128/EC.00382-08; Mohanty BK, 2006, P NATL ACAD SCI USA, V103, P897, DOI 10.1073/pnas.0506540103; Mohanty BK, 2004, J BIOL CHEM, V279, P1932, DOI 10.1074/jbc.M309078200; PETES TD, 1979, P NATL ACAD SCI USA, V76, P410, DOI 10.1073/pnas.76.1.410; Serizawa N, 2004, GENES CELLS, V9, P305, DOI 10.1111/j.1356-9597.2004.00729.x; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sinclair DA, 1998, TRENDS BIOCHEM SCI, V23, P131, DOI 10.1016/S0968-0004(98)01188-8; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Stegmeier F, 2004, CURR BIOL, V14, P467, DOI 10.1016/j.cub.2004.03.009; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Szyjka SJ, 2005, MOL CELL, V19, P691, DOI 10.1016/j.molcel.2005.06.037; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Tsang E, 2008, DNA REPAIR, V7, P1613, DOI 10.1016/j.dnarep.2008.06.010; Ward TR, 2000, MOL CELL BIOL, V20, P4948, DOI 10.1128/MCB.20.13.4948-4957.2000	38	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12612	12619		10.1074/jbc.M109.082388	http://dx.doi.org/10.1074/jbc.M109.082388			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20179323	Green Published, hybrid			2022-12-25	WOS:000276787800019
J	Kondo, K; Obitsu, S; Ohta, S; Matsunami, K; Otsuka, H; Teshima, R				Kondo, Kazunari; Obitsu, Saemi; Ohta, Sayaka; Matsunami, Katsuyoshi; Otsuka, Hideaki; Teshima, Reiko			Poly(ADP-ribose) Polymerase (PARP)-1-independent Apoptosis-inducing Factor (AIF) Release and Cell Death Are Induced by Eleostearic Acid and Blocked by alpha-Tocopherol and MEK Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATED TRIENE SYSTEM; FOCAL CEREBRAL-ISCHEMIA; BCL-2 PROTEIN FAMILY; ERK ACTIVATION; NEURONAL DEATH; PAR POLYMER; BRAIN; SUPPRESSION; PROTECTION; TRANSIENT	Poly(ADP-ribose) polymerase-1 (PARP-1) is thought to be required for apoptosis-inducing factor (AIF) release from mitochondria in caspase-independent apoptosis. The mechanism by which AIF is released through PARP-1 remains unclear. Here, we provide evidence that PARP-1-independent AIF release and cell death are induced by a trienoic fatty acid, alpha-eleostearic acid (alpha-ESA). alpha-ESA induced the caspase-independent and AIF-initiated apoptotic death of neuronal cell lines, independently of PARP-1 activation. The cell death was inhibited by the MEK inhibitor U0126 and by knockdown of MEK using small interfering RNA. However, inhibitors for JNK, p38 inhibitors, calpain, phospholipase A(2), and phosphatidylinositol 3-kinase, did not block cell death. AIF was translocated to the nucleus after the induction of apoptosis by alpha-ESA in differentiated PC12 cells without activating caspase-3 and PARP-1. The alpha-ESA-mediated cell death was not inhibited by PARP inhibitor 3,4-dihydro- 5-[4-(1-piperidinyl) butoxyl]-1(2H)-isoquinoline and by knockdown of PARP-1 using small interfering RNA. Unlike N-methyl-N'-nitro-N-nitrosoguanidine treatment, histone-phosphorylated histone 2AX was not phosphorylated by alpha-ESA, which suggests no DNA damage. Overexpression of Bcl-2 did not inhibit the cell death. alpha-ESA caused a small quantity of superoxide production in the mitochondria, resulting in the reduction of mitochondrial membrane potential, both of which were blocked by a trace amount of alpha-tocopherol localized in the mitochondria. Our results demonstrate that alpha-ESA induces PARP-1-independent AIF release and cell death without activating Bax, cytochrome c, and caspase-3. MEK is also a key molecule, although the link between ERK, AIF release, and cell death remains unknown. Finding molecules that regulate AIF release may be an important therapeutic target for the treatment of neuronal injury.	[Kondo, Kazunari; Obitsu, Saemi; Ohta, Sayaka; Teshima, Reiko] Natl Inst Hlth Sci, Div Novel Food & Immunochem, Setagaya Ku, Tokyo 1588501, Japan; [Matsunami, Katsuyoshi; Otsuka, Hideaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pharmacognosy, Minami Ku, Hiroshima 7348553, Japan	National Institute of Health Sciences - Japan; Hiroshima University	Kondo, K (corresponding author), Natl Inst Hlth Sci, Div Novel Food & Immunochem, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	kondo@nihs.go.jp	kondo, kazunari/AGE-0558-2022; Matsunami, Katsuyoshi/AHC-4234-2022	kondo, kazunari/0000-0002-2662-4626; Matsunami, Katsuyoshi/0000-0002-8034-0253	Ministry of Health, Labor, and Welfare of Japan; Japan Health Sciences Foundation; Grant-in-aid for Scientific Research [20590132]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; Grant-in-aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Health, Labor, and Welfare of Japan, the Japan Health Sciences Foundation, and Grant-in-aid for Scientific Research 20590132 (to K. K.).	Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Chen J, 1998, J NEUROSCI, V18, P4914; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; EGUCHI Y, 1992, NUCLEIC ACIDS RES, V20, P4187, DOI 10.1093/nar/20.16.4187; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; Hara C, 2006, BRAIN CELL BIOL, V35, P229, DOI 10.1007/s11068-008-9021-z; Igarashi M, 2000, CANCER LETT, V148, P173, DOI 10.1016/S0304-3835(99)00332-8; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Maeda H, 2005, J AM CHEM SOC, V127, P68, DOI 10.1021/ja047018k; Maeda H, 2007, CHEM-EUR J, V13, P1946, DOI 10.1002/chem.200600522; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Numakawa Y, 2006, J NEUROCHEM, V97, P1191, DOI 10.1111/j.1471-4159.2006.03827.x; Okuno S, 1998, J BIOL CHEM, V273, P34272, DOI 10.1074/jbc.273.51.34272; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Tsuzuki T, 2004, CARCINOGENESIS, V25, P1417, DOI 10.1093/carcin/bgh109; Tsuzuki T, 2008, CARCINOGENESIS, V29, P797, DOI 10.1093/carcin/bgm298; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang YF, 2009, J NEUROCHEM, V110, P687, DOI 10.1111/j.1471-4159.2009.06167.x; YANG J, 1997, SCIENCE, V275, P1132; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; Zhu C, 2007, CELL DEATH DIFFER, V14, P775, DOI 10.1038/sj.cdd.4402053; Zhu CL, 2003, J NEUROCHEM, V86, P306, DOI 10.1046/j.1471-4159.2003.01832.x	44	32	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13079	13091		10.1074/jbc.M109.044206	http://dx.doi.org/10.1074/jbc.M109.044206			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177052	Green Published, hybrid			2022-12-25	WOS:000276787800065
J	Lebbink, JHG; Fish, A; Reumer, A; Natrajan, G; Winterwerp, HHK; Sixma, TK				Lebbink, Joyce H. G.; Fish, Alexander; Reumer, Annet; Natrajan, Ganesh; Winterwerp, Herrie H. K.; Sixma, Titia K.			Magnesium Coordination Controls the Molecular Switch Function of DNA Mismatch Repair Protein MutS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; GUANINE-NUCLEOTIDE EXCHANGE; GTP-BINDING PROTEINS; ESCHERICHIA-COLI; ATPASE ACTIVITY; GDP/GTP EXCHANGE; FLUORESCENCE POLARIZATION; RECOGNITION COMPLEX; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE	The DNA mismatch repair protein MutS acts as a molecular switch. It toggles between ADP and ATP states and is regulated by mismatched DNA. This is analogous to G-protein switches and the regulation of their "on" and "off" states by guanine exchange factors. Although GDP release in monomeric GTPases is accelerated by guanine exchange factor-induced removal of magnesium from the catalytic site, we found that release of ADP from MutS is not influenced by the metal ion in this manner. Rather, ADP release is induced by the binding of mismatched DNA at the opposite end of the protein, a long-range allosteric response resembling the mechanism of activation of heterotrimeric GTPases. Magnesium influences switching in MutS by inducing faster and tighter ATP binding, allowing rapid downstream responses. MutS mutants with decreased affinity for the metal ion are impaired in fast switching and in vivo mismatch repair. Thus, the G-proteins and MutS conceptually employ the same efficient use of the high energy cofactor: slow hydrolysis in the absence of a signal and fast conversion to the active state when required.	[Lebbink, Joyce H. G.] Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands; [Lebbink, Joyce H. G.] Erasmus MC, Dept Radiat Oncol, NL-3000 CA Rotterdam, Netherlands; [Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Sixma, Titia K.] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Netherlands Cancer Institute; Netherlands Cancer Institute	Lebbink, JHG (corresponding author), Erasmus MC, Dept Cell Biol & Genet, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.lebbink@erasmusmc.nl; t.sixma@nki.nl		Sixma, Titia K/0000-0001-6180-0632	European Community [223545]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen [VENI 700.53.407]; Koningin Wilhelmina Fonds [04-3084]; Center for Biomedical Genetics	European Community(European Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen; Koningin Wilhelmina Fonds; Center for Biomedical Genetics	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant 223545 "mismatch2model," the Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen (VENI 700.53.407 to J. H. G. L.), the Koningin Wilhelmina Fonds (Project 04-3084), and the Center for Biomedical Genetics. Author's Choice-Final version full access.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Antony E, 2006, DNA REPAIR, V5, P153, DOI 10.1016/j.dnarep.2005.08.016; Antony E, 2004, BIOCHEMISTRY-US, V43, P13115, DOI 10.1021/bi049010t; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Bjornson KP, 2003, J BIOL CHEM, V278, P34667, DOI 10.1074/jbc.M305513200; Bjornson KP, 2003, J BIOL CHEM, V278, P18557, DOI 10.1074/jbc.M301101200; Bjornson KP, 2000, BIOCHEMISTRY-US, V39, P3176, DOI 10.1021/bi992286u; Blackwell LJ, 2001, J BIOL CHEM, V276, P34339, DOI 10.1074/jbc.M104256200; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BROSH RM, 1995, J BACTERIOL, V177, P5612, DOI 10.1128/jb.177.19.5612-5621.1995; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FENG G, 1995, BIOTECHNIQUES, V19, P956; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hutchinson JP, 2000, BIOCHEMISTRY-US, V39, P11348, DOI 10.1021/bi0007573; Iaccarino I, 2000, J BIOL CHEM, V275, P2080, DOI 10.1074/jbc.275.3.2080; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jacobs-Palmer E, 2007, J MOL BIOL, V366, P1087, DOI 10.1016/j.jmb.2006.11.092; Jameson DM, 1999, METHODS, V19, P222, DOI 10.1006/meth.1999.0853; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; JOHN J, 1993, J BIOL CHEM, V268, P923; Junop MS, 2003, DNA REPAIR, V2, P387, DOI 10.1016/S1568-7864(02)00245-8; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; KINOSIAN HJ, 1993, J BIOL CHEM, V268, P8683; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lamers MH, 2004, J BIOL CHEM, V279, P43879, DOI 10.1074/jbc.M406380200; Lamers MH, 2003, EMBO J, V22, P746, DOI 10.1093/emboj/cdg064; Lebbink JHG, 2006, EMBO J, V25, P409, DOI 10.1038/sj.emboj.7600936; Lebbink JHG, 2005, STRUCTURE, V13, P498, DOI 10.1016/j.str.2005.03.003; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Lobau S, 1997, J BIOL CHEM, V272, P3648, DOI 10.1074/jbc.272.6.3648; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Muradov KG, 2000, BIOCHEMISTRY-US, V39, P3937, DOI 10.1021/bi992156l; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natrajan G, 2003, NUCLEIC ACIDS RES, V31, P4814, DOI 10.1093/nar/gkg677; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pan JY, 1996, J BIOL CHEM, V271, P1322, DOI 10.1074/jbc.271.3.1322; Pan JY, 1998, BIOESSAYS, V20, P516, DOI 10.1002/(SICI)1521-1878(199806)20:6<516::AID-BIES11>3.0.CO;2-3; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Schofield MJ, 2001, J BIOL CHEM, V276, P45505, DOI 10.1074/jbc.C100449200; Selmane T, 2003, J MOL BIOL, V334, P949, DOI 10.1016/j.jmb.2003.10.010; Shim KS, 2006, DNA REPAIR, V5, P704, DOI 10.1016/j.dnarep.2006.03.004; Shimizu T, 2000, J BIOL CHEM, V275, P18311, DOI 10.1074/jbc.M910274199; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STEWART FM, 1994, GENETICS, V137, P1139; Stricher F, 2005, BIOCHEM J, V390, P29, DOI 10.1042/BJ20041953; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Wu TH, 1999, J BIOL CHEM, V274, P5948, DOI 10.1074/jbc.274.9.5948; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200; 1994, ACTA CRYSTALLOGR, V50, P760	74	41	41	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13131	13141		10.1074/jbc.M109.066001	http://dx.doi.org/10.1074/jbc.M109.066001			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20167596	Green Published, hybrid			2022-12-25	WOS:000276787800069
J	Novikova, M; Kazakov, T; Vondenhoff, GH; Semenova, E; Rozenski, J; Metlytskaya, A; Zukher, I; Tikhonov, A; Van Aerschot, A; Severinov, K				Novikova, Maria; Kazakov, Teymur; Vondenhoff, Gaston H.; Semenova, Ekaterina; Rozenski, Jef; Metlytskaya, Anastasija; Zukher, Inna; Tikhonov, Anton; Van Aerschot, Arthur; Severinov, Konstantin			MccE Provides Resistance to Protein Synthesis Inhibitor Microcin C by Acetylating the Processed Form of the Antibiotic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; MATURATION; C51; GENES; H22	The heptapeptide-nucleotide microcin C (McC) is a potent inhibitor of enteric bacteria growth. McC is excreted from producing cells by the MccC transporter. The residual McC that remains in the producing cell can be processed by cellular amino-peptidases with the release of a non-hydrolyzable aspartyl-adenylate, a strong inhibitor of aspartyl-tRNA synthetase. Accumulation of processed McC inside producing cells should therefore lead to translation inhibition and cessation of growth. Here, we show that a product of another gene of the McC biosynthetic cluster, mccE, acetylates processed McC and converts it into a non-toxic compound. MccE also makes Escherichia coli resistant to albomycin, a Trojan horse inhibitor unrelated to McC that, upon processing, gives rise to a serine coupled to a thioxylofuranosyl pyrimidine, an inhibitor of seryl-tRNA synthetase. We speculate that MccE and related cellular acetyltransferases of the Rim family may detoxify various aminoacyl-nucleotides, either exogenous or those generated inside the cell.	[Kazakov, Teymur; Vondenhoff, Gaston H.; Semenova, Ekaterina; Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Novikova, Maria; Kazakov, Teymur; Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Vondenhoff, Gaston H.; Rozenski, Jef; Van Aerschot, Arthur] Katholieke Univ Leuven, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium; [Severinov, Konstantin] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Metlytskaya, Anastasija; Zukher, Inna; Tikhonov, Anton; Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Rutgers State University New Brunswick; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; KU Leuven; Rutgers State University New Brunswick; Russian Academy of Sciences	Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu	Novikova, Mariia/AAL-1120-2020; Severinov, Konstantin/C-8545-2016	Rozenski, Jef/0000-0001-9624-5536; Van Aerschot, Arthur/0000-0003-3528-8588	National Institutes of Health; NIAID [U54 AI057158]; Russian Academy of Sciences; Rutgers University Technology Commercialization Fund; Russian Foundation for Basic Research [06-04-48865, 09-04-13825]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Russian Academy of Sciences(Russian Academy of Sciences); Rutgers University Technology Commercialization Fund; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, North Eastern Biodefense Center Grant U54 AI057158.This work was also supported by the Burroughs Wellcome Career Award, a Russian Academy of Sciences Presidium program in Molecular and Cellular Biology new groups grant, a Rutgers University Technology Commercialization Fund Grant (to K.S.), and Russian Foundation for Basic Research Grants 06-04-48865 (to A.M.) and 09-04-13825 (to K.S.).	BAQUERO F, 1978, J BACTERIOL, V135, P342, DOI 10.1128/JB.135.2.342-347.1978; BAQUERO F, 1984, FEMS MICROBIOL LETT, V23, P117; BENZ G, 1982, ANGEW CHEM INT EDIT, V21, P527, DOI 10.1002/anie.198205271; BODE R, 1993, ARCH MICROBIOL, V160, P397; BRAUN V, 1983, J BACTERIOL, V156, P308, DOI 10.1128/JB.156.1.308-315.1983; Cursino L, 2006, J APPL MICROBIOL, V100, P821, DOI 10.1111/j.1365-2672.2006.02834.x; Destoumieux-Garzon D, 2002, BIOCHIMIE, V84, P511, DOI 10.1016/S0300-9084(02)01411-6; Finking R, 2003, CHEMBIOCHEM, V4, P903, DOI 10.1002/cbic.200300666; Fomenko D, 2001, RES MICROBIOL, V152, P469, DOI 10.1016/S0923-2508(01)01220-7; Fomenko DE, 2003, ANTIMICROB AGENTS CH, V47, P2868, DOI 10.1128/AAC.47.9.2868-2874.2003; GONZALEZPASTOR JE, 1994, NATURE, V369, P281, DOI 10.1038/369281a0; GUIJARRO JI, 1995, J BIOL CHEM, V270, P23520, DOI 10.1074/jbc.270.40.23520; Kazakov T, 2007, J BACTERIOL, V189, P2114, DOI 10.1128/JB.01609-06; Kazakov T, 2008, J BACTERIOL, V190, P2607, DOI 10.1128/JB.01956-07; Metlitskaya A, 2006, J BIOL CHEM, V281, P18033, DOI 10.1074/jbc.M513174200; Metlitskaya A, 2009, J BACTERIOL, V191, P2380, DOI 10.1128/JB.00999-08; METLITSKAYA AZ, 1995, FEBS LETT, V357, P235, DOI 10.1016/0014-5793(94)01345-2; Moreno F, 2002, BIOCHIMIE, V84, P521, DOI 10.1016/S0300-9084(02)01452-9; Reader JS, 2005, SCIENCE, V309, P1533, DOI 10.1126/science.1116841; Regni CA, 2009, EMBO J, V28, P1953, DOI 10.1038/emboj.2009.146; Roush RF, 2008, J AM CHEM SOC, V130, P3603, DOI 10.1021/ja7101949; Severinov K, 2007, MOL MICROBIOL, V65, P1380, DOI 10.1111/j.1365-2958.2007.05874.x; Smajs D, 2008, PLASMID, V59, P1, DOI 10.1016/j.plasmid.2007.08.002; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/jbc.M502401200; Zeng Y, 2009, ANTIMICROB AGENTS CH, V53, P4619, DOI 10.1128/AAC.00782-09	25	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12662	12669		10.1074/jbc.M109.080192	http://dx.doi.org/10.1074/jbc.M109.080192			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20159968	Green Published, hybrid			2022-12-25	WOS:000276787800025
J	Borikova, AL; Dibble, CF; Sciaky, N; Welch, CM; Abell, AN; Bencharit, S; Johnson, GL				Borikova, Asya L.; Dibble, Christopher F.; Sciaky, Noah; Welch, Christopher M.; Abell, Amy N.; Bencharit, Sompop; Johnson, Gary L.			Rho Kinase Inhibition Rescues the Endothelial Cell Cerebral Cavernous Malformation Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; INTEGRITY; GTPASES; FASUDIL; PATHWAY; CCM1	Cerebral cavernous malformations (CCM) are vascular lesions causing seizures and stroke. Mutations causing inactivation of one of three genes, ccm1, -2, or -3, are sufficient to induce vascular endothelial cell defects resulting in CCM. Herein, we show that loss of expression of the CCM1, -2, or -3 proteins causes a marked increase in expression of the GTPase RhoA. Live cell imaging with a RhoA-specific biosensor demonstrates increased RhoA activity with loss of CCM1, -2, or -3, with an especially pronounced RhoA activation in both the cytosol and the nucleus with loss of CCM1 expression. Increased RhoA activation was associated with Rho kinase-dependent phosphorylation of myosin light chain 2. Functionally, loss of CCM1, -2, or -3 inhibited endothelial cell vessel-like tube formation and extracellular matrix invasion, each of which is rescued by chemical inhibition or short hairpin RNA knockdown of Rho kinase. The findings, for the first time, define a signaling network for CCM1, -2, and -3 in CCM pathology, whereby loss of CCM1, -2, or -3 protein expression results in increased RhoA activity, with the activation of Rho kinase responsible for endothelial cell dysregulation. The results define Rho kinase as a therapeutic target to rescue endothelial cells from loss of CCM protein function.	[Johnson, Gary L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Borikova, Asya L.; Dibble, Christopher F.; Sciaky, Noah; Welch, Christopher M.; Abell, Amy N.; Johnson, Gary L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Bencharit, Sompop] Univ N Carolina, Sch Dent, Dept Prosthodont, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Johnson, GL (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Campus Box 7365, Chapel Hill, NC 27599 USA.	glj@med.unc.edu	Bencharit, Sompop/AAO-8563-2020		National Institutes of Health [GM068820, GM068820-S1, HL092338, T32GM80079, HL094020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092338, F30HL108598, F30HL094020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080079, R01GM068820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068820 (to G. L. J.), GM068820-S1 and HL092338 (to S. B.), T32GM80079 (to C. F. D. and C. M. W.), and HL094020 (to C. M. W.).	Awad IA, 2005, SURG NEUROL, V63, P317, DOI 10.1016/j.surneu.2004.12.032; Chrissobolis S, 2006, STROKE, V37, P2174, DOI 10.1161/01.STR.0000231647.41578.df; Crose LES, 2009, J BIOL CHEM, V284, P13301, DOI 10.1074/jbc.C900009200; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Inan SY, 2008, BRIT J PHARMACOL, V155, P44, DOI 10.1038/bjp.2008.225; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jiang XS, 2010, HUM MOL GENET, V19, P1347, DOI 10.1093/hmg/ddq011; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Plummer Nicholas W, 2005, Curr Neurol Neurosci Rep, V5, P391, DOI 10.1007/s11910-005-0063-7; Suzuki Y, 2008, NEUROL MED-CHIR, V48, P241, DOI 10.2176/nmc.48.241; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256	19	99	104	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11760	11764		10.1074/jbc.C109.097220	http://dx.doi.org/10.1074/jbc.C109.097220			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20181950	Green Published, hybrid			2022-12-25	WOS:000276787100002
J	Fernandez-Alvarez, A; Alvarez, MS; Cucarella, C; Casado, M				Fernandez-Alvarez, Ana; Soledad Alvarez, Maria; Cucarella, Carme; Casado, Marta			Characterization of the Human Insulin-induced Gene 2 (INSIG2) Promoter THE ROLE OF Ets-BINDING MOTIFS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY COMPLEX FACTORS; FATTY-ACID SYNTHESIS; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; RESPONSE FACTOR; FACTORS ELK-1; ELEMENT; LIVER; OBESITY; CHOLESTEROL	Insulin-induced gene 2 (INSIG2) and its homolog INSIG1 encode closely related endoplasmic reticulum proteins that regulate the proteolytic activation of sterol regulatory element-binding proteins, transcription factors that activate the synthesis of cholesterol and fatty acids in animal cells. Several studies have been carried out to identify INSIG2 genetic variants associated with metabolic diseases. However, few data have been published regarding the regulation of INSIG2 gene expression. Two Insig2 transcripts have been described in rodents through the use of different promoters that produce different noncoding first exons that splice into a common second exon. Herein we report the cloning and characterization of the human INSIG2 promoter and the detection of an INSIG2-specific transcript homologous to the Insig2b mouse variant in human liver. Deletion analyses on 3 kb of 5'-flanking DNA of the human INSIG2 gene revealed the functional importance of a 350-bp region upstream of the transcription start site. Mutated analyses, chromatin immunoprecipitation assays, and RNA interference analyses unveiled the significance of an Ets-consensus motif in the proximal region and the interaction of the Ets family member SAP1a (serum response factor (SRF) accessory protein-1a) with this region of the human INSIG2 promoter. Moreover, our findings suggest that insulin activated the human INSIG2 promoter in a process mediated by phosphorylated SAP1a. Overall, these results map the functional elements in the human INSIG2 promoter sequence and suggest an unexpected regulation of INSIG2 gene expression in human liver.	[Fernandez-Alvarez, Ana; Soledad Alvarez, Maria; Cucarella, Carme; Casado, Marta] IBV CSIC, Valencia 46010, Spain; [Casado, Marta] CIBERehd, Barcelona 08036, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Casado, M (corresponding author), IBV CSIC, Jaime Roig 11, Valencia 46010, Spain.	mcasado@ibv.csic.es	Casado, Marta/L-2078-2014	Casado, Marta/0000-0001-6457-4650; Fernandez-Alvarez, Ana/0000-0002-5296-5678	Ministry of Science and Innovation [SAF2006-06760]; Carlos III Health Institute (Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA) [RD06/0014/0025]; Spanish Ministry of Education and Science [BES-2004-6151]; Consejo Superior de Investigaciones Cientificas	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Carlos III Health Institute (Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA)(Instituto de Salud Carlos III); Spanish Ministry of Education and Science(Spanish Government); Consejo Superior de Investigaciones Cientificas	This work was supported by Ministry of Science and Innovation Grant SAF2006-06760 and the Carlos III Health Institute (Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA) RD06/0014/0025).; Supported by Spanish Ministry of Education and Science Fellowship BES-2004-6151.; Supported by Consejo Superior de Investigaciones Cientificas Fellowship JAE-predoc.	Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Boros J, 2009, NUCLEIC ACIDS RES, V37, P7368, DOI 10.1093/nar/gkp804; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Casado M, 2001, FASEB J, V15, P2016, DOI 10.1096/fj.01-0158fje; Cervino AC, 2005, GENOMICS, V86, P505, DOI 10.1016/j.ygeno.2005.07.010; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Cheverud JM, 2004, DIABETES, V53, P3328, DOI 10.2337/diabetes.53.12.3328; Clarkson RWE, 1999, MOL ENDOCRINOL, V13, P619, DOI 10.1210/me.13.4.619; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; DIAMOND RH, 1993, J BIOL CHEM, V268, P15185; Fernandez-Alvarez A, 2008, FEBS LETT, V582, P177, DOI 10.1016/j.febslet.2007.11.083; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; JACOB KK, 1995, J BIOL CHEM, V270, P27773, DOI 10.1074/jbc.270.46.27773; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; JOLLIFF K, 1991, NUCLEIC ACIDS RES, V19, P2267, DOI 10.1093/nar/19.9.2267; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; MYERS MG, 1994, TRENDS BIOCHEM SCI, V19, P289, DOI 10.1016/0968-0004(94)90007-8; Nilsson M, 2007, NUCLEIC ACIDS RES, V35, P4858, DOI 10.1093/nar/gkm492; Oliva JL, 2004, J BIOL CHEM, V279, P33480, DOI 10.1074/jbc.M404058200; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Sewter C, 2002, DIABETES, V51, P1035, DOI 10.2337/diabetes.51.4.1035; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Strahl T, 1996, P NATL ACAD SCI USA, V93, P11563, DOI 10.1073/pnas.93.21.11563; Tobe K, 2001, J BIOL CHEM, V276, P38337, DOI 10.1074/jbc.C100160200; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; Watson DK, 1997, ONCOGENE, V14, P213, DOI 10.1038/sj.onc.1200839; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; Yamazaki Y, 2003, J BIOL CHEM, V278, P30642, DOI 10.1074/jbc.M212242200; Yellaturu CR, 2009, J BIOL CHEM, V284, P31726, DOI 10.1074/jbc.M109.050914; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036	41	19	20	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11765	11774		10.1074/jbc.M109.067447	http://dx.doi.org/10.1074/jbc.M109.067447			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20145255	Green Published, hybrid			2022-12-25	WOS:000276787100003
J	Li, SJ; Zhao, Q; Zhou, QJ; Unno, H; Zhai, YJ; Sun, F				Li, Shu Jie; Zhao, Qing; Zhou, Qiangjun; Unno, Hideaki; Zhai, Yujia; Sun, Fei			The Role and Structure of the Carboxyl-terminal Domain of the Human Voltage-gated Proton Channel Hv1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-ION CURRENTS; ALVEOLAR EPITHELIAL-CELLS; NADPH OXIDASE; HUMAN-NEUTROPHILS; PH; PROTEIN; CONDUCTANCE; SNAIL	The voltage-gated proton channel Hv1 has a voltage sensor domain but lacks a pore domain. Although the C-terminal domain of Hv1 is known to be responsible for dimeric architecture of the channel, its role and structure are not known. We report that the full-length Hv1 is mainly localized in intracellular compartment membranes rather than the plasma membrane. Truncation of either the N or C terminus alone or both together revealed that the N-terminal deletion did not alter localization, but deletion of the C terminus either alone or together with the N terminus resulted in expression throughout the cell. These results indicate that the C terminus is essential for Hv1 localization but not the N terminus. In the 2.0 angstrom structure of the C-terminal domain, the two monomers form a dimer via a parallel C-helical coiled-coil, in which one chloride ion binds with the N eta atom of Arg(264). A pH-dependent structural change of the protein has been observed, but it remains a dimer irrespective of pH value.	[Li, Shu Jie; Zhao, Qing] Nankai Univ, Key Lab Bioact Mat, Minist Educ, Coll Phys Sci, Tianjin 300071, Peoples R China; [Zhou, Qiangjun; Zhai, Yujia; Sun, Fei] Chinese Acad Sci, Lab Biol Electron Microscopy & Struct Biol, Inst Biophys, Beijing 100101, Peoples R China; [Zhou, Qiangjun; Zhai, Yujia; Sun, Fei] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China; [Unno, Hideaki] Nagasaki Univ, Dept Appl Chem, Fac Engn, Nagasaki 8528521, Japan	Nankai University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Nagasaki University	Li, SJ (corresponding author), Nankai Univ, Key Lab Bioact Mat, Minist Educ, Coll Phys Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.	shujieli@nankai.edu.cn; feisun@ibp.ac.cn	Sun, Fei/C-4190-2015; Hideaki, UNNO/ABG-9471-2020	Sun, Fei/0000-0002-0351-5144; Hideaki, UNNO/0000-0001-5917-269X; Zhou, Qiangjun/0000-0002-7768-0249; Zhou, Qiangjun/0000-0003-1789-9588	National Natural Science Foundation of China [30840028, 30970579, 30623005]; Chinese Ministry of Science and Technology [2006AA02Z173]; Basic Science and Advance Technology Research Program of Tianjin [08JCY-BJC25800]; Ministry of Education of China [200800551035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Basic Science and Advance Technology Research Program of Tianjin; Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grants 30840028, 30970579, and 30623005; "863" program from the Chinese Ministry of Science and Technology Grant 2006AA02Z173; Basic Science and Advance Technology Research Program of Tianjin Grant 08JCY-BJC25800; and Ph.D. Program Foundation of the Ministry of Education of China Grant 200800551035.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BYERLY L, 1984, J PHYSIOL-LONDON, V351, P199, DOI 10.1113/jphysiol.1984.sp015241; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; CHERNY VV, 1995, J GEN PHYSIOL, V105, P861, DOI 10.1085/jgp.105.6.861; CLARK RA, 1987, J BIOL CHEM, V262, P4065; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DECOURSEY TE, 1991, BIOPHYS J, V60, P1243, DOI 10.1016/S0006-3495(91)82158-0; DECOURSEY TE, 1994, J MEMBRANE BIOL, V141, P203; Eder C, 2001, PROG NEUROBIOL, V64, P277, DOI 10.1016/S0301-0082(00)00062-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; KAPUS A, 1993, J GEN PHYSIOL, V102, P729, DOI 10.1085/jgp.102.4.729; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Li SJ, 2009, ACTA CRYSTALLOGR F, V65, P279, DOI 10.1107/S1744309109003777; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Morgan D, 2005, J PHYSIOL-LONDON, V569, P419, DOI 10.1113/jphysiol.2005.094748; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; SAXENA VP, 1971, P NATL ACAD SCI USA, V68, P969, DOI 10.1073/pnas.68.5.969; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200	30	53	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12047	12054		10.1074/jbc.M109.040360	http://dx.doi.org/10.1074/jbc.M109.040360			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20147290	Green Published, hybrid			2022-12-25	WOS:000276787100033
J	Toffalini, F; Hellberg, C; Demoulin, JB				Toffalini, Federica; Hellberg, Carina; Demoulin, Jean-Baptiste			Critical Role of the Platelet-derived Growth Factor Receptor (PDGFR) beta Transmembrane Domain in the TEL-PDGFR beta Cytosolic Oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOMONOCYTIC LEUKEMIA; WW-LIKE DOMAIN; TYROSINE KINASE; R FUSION; ERYTHROPOIETIN RECEPTOR; PRODUCTIVE INTERACTION; STRUCTURAL BASIS; ACTIVATION; JUXTAMEMBRANE; GENE	The fusion of TEL with platelet-derived growth factor receptor (PDGFR) beta (TP beta) is found in a subset of patients with atypical myeloid neoplasms associated with eosinophilia and is the archetype of a larger group of hybrid receptors that are produced by rearrangements of PDGFR genes. TP beta is activated by oligomerization mediated by the pointed domain of TEL/ETV6, leading to constitutive activation of the PDGFR beta kinase domain. The receptor transmembrane (TM) domain is retained in TP beta and in most of the described PDGFR beta hybrids. Deletion of the TM domain (Delta TM-TP beta) strongly impaired the ability of TP beta to sustain growth factor-independent cell proliferation. We confirmed that TP beta resides in the cytosol, indicating that the PDGFR beta TM domain does not act as a transmembrane domain in the context of the hybrid receptor but has a completely different function. The Delta TM-TP beta protein was expressed at a lower level because of increased degradation. It could form oligomers, was phosphorylated at a slightly higher level, co-immunoprecipitated with the p85 adaptor protein, but showed a much reduced capacity to activate STAT5 and ERK1/2 in Ba/F3 cells, compared with TP beta. Inanin vitro kinase assay, Delta TM-TP beta was more active than TP beta and less sensitive to imatinib, a PDGFR inhibitor. In conclusion, we show that the TM domain is required for TP beta-mediated signaling and proliferation, suggesting that the activation of the PDGFR beta kinase domain is not enough for cell transformation.	[Demoulin, Jean-Baptiste] Catholic Univ Louvain, de Duve Inst, Unite MEXP UCL 74 30, BE-1200 Brussels, Belgium; [Hellberg, Carina] Ludwig Inst Canc Res, S-75124 Uppsala, Sweden	Universite Catholique Louvain; Ludwig Institute for Cancer Research	Demoulin, JB (corresponding author), Catholic Univ Louvain, de Duve Inst, Unite MEXP UCL 74 30, Ave Hippocrate 75, BE-1200 Brussels, Belgium.	jb.demoulin@uclouvain.be	Demoulin, Jean-Baptiste/E-5847-2010	Demoulin, Jean-Baptiste/0000-0002-8016-6689	Bekales Foundation; Salus Sanguinis Foundation, Belgium	Bekales Foundation; Salus Sanguinis Foundation, Belgium	This work was supported by grants from the Bekales Foundation, from Action de Recherche Concertee (Communaute Francaise de Belgique), and from the Salus Sanguinis Foundation, Belgium.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Cain JA, 2007, BLOOD, V109, P3906, DOI 10.1182/blood-2006-07-036335; Carroll M, 1996, P NATL ACAD SCI USA, V93, P14845, DOI 10.1073/pnas.93.25.14845; Chang PM, 2003, MOL CELL BIOL, V23, P3067, DOI 10.1128/MCB.23.9.3067-3078.2003; Chiara F, 2004, J BIOL CHEM, V279, P19732, DOI 10.1074/jbc.M314070200; Classen JF, 2009, ARTHRITIS RHEUM-US, V60, P1137, DOI 10.1002/art.24381; Demoulin JB, 2000, FEBS LETT, V482, P200, DOI 10.1016/S0014-5793(00)02059-7; Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200; Demoulin JB, 2003, BIOCHEM J, V376, P505, DOI 10.1042/BJ20030385; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; Demoulin JB, 2006, GROWTH FACTORS, V24, P184, DOI 10.1080/08977190600696430; Dobbin E, 2009, EXP HEMATOL, V37, P111, DOI 10.1016/j.exphem.2008.09.012; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eriksson A, 1992, GROWTH FACTORS, V6, DOI 10.3109/08977199209008867; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Gotlib J, 2008, LEUKEMIA, V22, P1999, DOI 10.1038/leu.2008.287; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; GULLICK WJ, 1992, EMBO J, V11, P43, DOI 10.1002/j.1460-2075.1992.tb05025.x; Hellberg C, 2009, MOL BIOL CELL, V20, P2856, DOI 10.1091/mbc.E08-12-1228; Irusta PM, 1998, EMBO J, V17, P6912, DOI 10.1093/emboj/17.23.6912; Irusta PM, 2002, J BIOL CHEM, V277, P38627, DOI 10.1074/jbc.M204890200; Jones AV, 2004, CELL MOL LIFE SCI, V61, P2912, DOI 10.1007/s00018-004-4272-z; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; MEDVES S, 2010, LEUKEMIA IN PRESS; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Nakao M, 1996, LEUKEMIA, V10, P1911; Nappi VM, 2002, J BIOL CHEM, V277, P47149, DOI 10.1074/jbc.M209582200; OATES J, 2009, BIOCHIM BIOPHYS ACTA, V1798, P605; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Petti LM, 1997, J VIROL, V71, P7318, DOI 10.1128/JVI.71.10.7318-7327.1997; Poirel H, 1997, ONCOGENE, V14, P349, DOI 10.1038/sj.onc.1200829; Roth L, 2008, MOL BIOL CELL, V19, P646, DOI 10.1091/mbc.E07-06-0625; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Sjoblom T, 1999, ONCOGENE, V18, P7055, DOI 10.1038/sj.onc.1203190; SORKIN A, 1991, J CELL BIOL, V112, P469, DOI 10.1083/jcb.112.3.469; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Sternberg DW, 2001, BLOOD, V98, P3390, DOI 10.1182/blood.V98.12.3390; Stover EH, 2006, P NATL ACAD SCI USA, V103, P8078, DOI 10.1073/pnas.0601192103; Toffalini F, 2009, HAEMATOL-HEMATOL J, V94, P1085, DOI 10.3324/haematol.2008.001149; Tomasson MH, 2000, J CLIN INVEST, V105, P423, DOI 10.1172/JCI8902; Valgeirsdottir S, 1998, ONCOGENE, V16, P505, DOI 10.1038/sj.onc.1201555; Walz C, 2007, HAEMATOLOGICA, V92, P163, DOI 10.3324/haematol.10980; Yang Y, 2008, P NATL ACAD SCI USA, V105, P7681, DOI 10.1073/pnas.0802896105; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	49	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12268	12278		10.1074/jbc.M109.076638	http://dx.doi.org/10.1074/jbc.M109.076638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164181	Green Published, hybrid			2022-12-25	WOS:000276787100056
J	Weatherill, DB; Dyer, J; Sossin, WS				Weatherill, Daniel B.; Dyer, John; Sossin, Wayne S.			Ribosomal Protein S6 Kinase Is a Critical Downstream Effector of the Target of Rapamycin Complex 1 for Long-term Facilitation in Aplysia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-DEPENDENT TRANSLATION; MESSENGER-RNA TRANSLATION; INITIATION-FACTOR 4E; MAMMALIAN TARGET; SYNAPTIC PLASTICITY; SIGNALING PATHWAYS; SENSITIVE MANNER; NERVOUS-SYSTEM; RHEB BINDS; PHOSPHORYLATION	Long-term facilitation (LTF) in Aplysia is a leading cellular model for elucidating the biochemical mechanisms of synaptic plasticity underlying learning. In Aplysia, LTF requires translational control downstream of the target of rapamycin (TOR) complex 1 (TORC1). The major known downstream targets of TORC1 are 4E binding protein (4E-BP) and S6 kinase (S6K). By removing the site within these regulators required for their interaction with TORC1, we have generated dominant negative proteins that disrupt specific pathways downstream of TORC1. Expression of dominant negative S6K, but not dominant negative 4E-BP, in Aplysia sensory neurons (SNs) blocked 24-h LTF. TORC1 is directly activated by the small GTP-binding protein, Ras homologue enriched in brain (Rheb). To determine the effects of TORC1 activation on translation in Aplysia neurons, we have examined the effects of expressing a constitutively active form of the Aplysia orthologue of Rheb, ApRheb (ApRheb(Q63L)). Expression of ApRheb(Q63L) increased 4E-BP phosphorylation and the level of general, cap-dependent translation within the SN cell soma in a rapamycin-sensitive manner. This increase in cap-dependent translation was blocked neither by dominant negative 4E-BP nor dominant negative S6K. Thus, we demonstrate that S6K is an important downstream target of TORC1 in Aplysia and that it is necessary for 24-h LTF, but not for TORC1-mediated increases in somatic cap-dependent translation.	[Weatherill, Daniel B.; Dyer, John; Sossin, Wayne S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Sossin, WS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Rm BT 110,3801 Univ St, Montreal, PQ H3A 2B4, Canada.	wayne.sossin@mcgill.ca			Canadian Institutes of Health Research [MOP 15121]; Fonds de la Recherche en Sante du Quebec (FRSQ)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by Canadian Institutes of Health Research Grant MOP 15121 (to W. S. S.).; Recipient of a studentship from the Fonds de la Recherche en Sante du Quebec (FRSQ).	Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Antion MD, 2008, MOL CELL BIOL, V28, P2996, DOI 10.1128/MCB.00201-08; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Banko JL, 2008, PROG BRAIN RES, V169, P59, DOI 10.1016/S0079-6123(07)00004-0; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; BARZILAI A, 1989, NEURON, V2, P1577, DOI 10.1016/0896-6273(89)90046-9; Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Carroll M, 2004, J NEUROCHEM, V90, P1464, DOI 10.1111/j.1471-4159.2004.02634.x; Carroll M, 2006, MOL CELL BIOL, V26, P8586, DOI 10.1128/MCB.00955-06; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Dyer JR, 2003, NAT NEUROSCI, V6, P219, DOI 10.1038/nn1018; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Giustetto M, 2003, P NATL ACAD SCI USA, V100, P13680, DOI 10.1073/pnas.1835674100; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hu JY, 2006, J NEUROSCI, V26, P1026, DOI 10.1523/JNEUROSCI.4258-05.2006; Hu JY, 2004, NEURON, V43, P373, DOI 10.1016/j.neuron.2004.07.011; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Khan A, 2001, J NEUROSCI, V21, P382, DOI 10.1523/JNEUROSCI.21-02-00382.2001; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manseau F, 2001, J NEUROSCI, V21, P1247; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MOSER BK, 1992, AM STAT, V46, P19, DOI 10.2307/2684403; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; PAINTER SD, 1989, J COMP NEUROL, V287, P515, DOI 10.1002/cne.902870409; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Ross G, 2006, J NEUROCHEM, V97, P79, DOI 10.1111/j.1471-4159.2006.03704.x; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; SCHACHER S, 1983, J NEUROSCI, V3, P2403; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shama Silvian, 1995, Gene Expression, V4, P241; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; STANTON PK, 1984, J NEUROSCI, V4, P3080; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; TERADA N, 1994, P NATL ACAD SCI USA, V91, P11477, DOI 10.1073/pnas.91.24.11477; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Yanow SK, 1998, J NEUROCHEM, V70, P572; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Zimmerman DW, 2004, BRIT J MATH STAT PSY, V57, P173, DOI 10.1348/000711004849222	62	24	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12255	12267		10.1074/jbc.M109.071142	http://dx.doi.org/10.1074/jbc.M109.071142			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177060	hybrid, Green Published			2022-12-25	WOS:000276787100055
J	Yu, QJ; Schaub, P; Ghisla, S; Al-Babili, S; Krieger-Liszkay, A; Beyer, P				Yu, Qiuju; Schaub, Patrick; Ghisla, Sandro; Al-Babili, Salim; Krieger-Liszkay, Anja; Beyer, Peter			The Lycopene Cyclase CrtY from Pantoea ananatis (Formerly Erwinia uredovora) Catalyzes an FAD(red)-dependent Non-redox Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOPENTENYL DIPHOSPHATE ISOMERASE; IN-VITRO CHARACTERIZATION; BETA-CAROTENE; RETINAL BIOSYNTHESIS; NEOXANTHIN SYNTHASE; FAD SYNTHETASE; FLAVIN; IDENTIFICATION; PATHWAY; MECHANISM	The cyclization of lycopene generates provitamin A carotenoids such as beta-carotene and paves the way toward the formation of cyclic xanthophylls playing distinct roles in photosynthesis and as precursors for regulatory molecules in plants and animals. The biochemistry of lycopene cyclization has been enigmatic, as the previously proposed acid-base catalysis conflicted with the possibility of redox catalysis as predicted by the presence of a dinucleotide binding site. We show that reduced FAD is the essential lycopene cyclase (CrtY) cofactor. Using flavin analogs, mass spectrometry, and mutagenesis, evidence was obtained based on which a catalytic mechanism relying on cryptic (net) electron transfer can be refuted. The role of reduced FAD is proposed to reside in the stabilization of a transition state carrying a (partial) positive charge or of a positively charged intermediate via a charge transfer interaction, acid-base catalysis serving as the underlying catalytic principle. Lycopene cyclase, thus, ranks among the novel class of non-redox flavoproteins, such as isopentenyl diphosphate: dimethylallyl diphosphate isomerase type 2 (IDI-2) that requires the reduced form of the cofactor.	[Yu, Qiuju; Schaub, Patrick; Al-Babili, Salim; Beyer, Peter] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Ghisla, Sandro] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Krieger-Liszkay, Anja] CEA, Inst Biol & Technol Saclay, CNRS, Serv Bioenerget Biol Struct & Mecanisme,URA 2096, F-91191 Gif Sur Yvette, France	University of Freiburg; University of Konstanz; CEA; Centre National de la Recherche Scientifique (CNRS)	Beyer, P (corresponding author), Univ Freiburg, Fac Biol, Schanzlestr 1, D-79104 Freiburg, Germany.	peter.beyer@biologie.uni-freiburg.de	Schaub, Patrick/C-8358-2018	Krieger-Liszkay, Anja/0000-0001-7141-4129; Al-Babili, Salim/0000-0003-4823-2882	The German-Israel Foundation; German Federal and State Governments [EXC 294]	The German-Israel Foundation; German Federal and State Governments	This work was supported by The German-Israel Foundation and by the Excellence Initiative of the German Federal and State Governments (EXC 294).	Al-Babili S, 2000, FEBS LETT, V485, P168, DOI 10.1016/S0014-5793(00)02193-1; Arigoni D, 1999, P NATL ACAD SCI USA, V96, P1309, DOI 10.1073/pnas.96.4.1309; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; Bartley GE, 1999, EUR J BIOCHEM, V259, P396, DOI 10.1046/j.1432-1327.1999.00051.x; BEYER P, 1991, J BIOL CHEM, V266, P17072; BEYER P, 1989, EUR J BIOCHEM, V184, P141, DOI 10.1111/j.1432-1033.1989.tb15000.x; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bornemann S, 2002, NAT PROD REP, V19, P761, DOI 10.1039/b108916c; Bouvier F, 1997, ARCH BIOCHEM BIOPHYS, V346, P53, DOI 10.1006/abbi.1997.0278; BOUVIER F, 1994, PLANT J, V6, P45, DOI 10.1046/j.1365-313X.1994.6010045.x; Bouvier F, 2000, EUR J BIOCHEM, V267, P6346, DOI 10.1046/j.1432-1327.2000.01722.x; Bouwmeester HJ, 2007, TRENDS PLANT SCI, V12, P224, DOI 10.1016/j.tplants.2007.03.009; BRITTON G, 1977, FEBS LETT, V79, P281, DOI 10.1016/0014-5793(77)80803-X; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cunningham FX, 1996, PLANT CELL, V8, P1613, DOI 10.2307/3870254; D'Ambrosio C, 2004, PLANT SCI, V166, P207, DOI 10.1016/j.plantsci.2003.09.015; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; ECKSTEIN JW, 1993, BIOCHEMISTRY-US, V32, P404, DOI 10.1021/bi00053a004; Edge R, 1999, ADV PHOTOSYNTH, V8, P223; Edmondson D, 1999, METH MOL B, V131, P157; Efimov I, 1998, BIOCHEMISTRY-US, V37, P9716, DOI 10.1021/bi972817j; Estrada AF, 2009, FUNGAL GENET BIOL, V46, P803, DOI 10.1016/j.fgb.2009.06.011; Faller P, 2005, ADV PHOTO RESPIRAT, V22, P347; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frago S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-160; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; HALL LH, 1987, BIOCHEMISTRY-US, V26, P7401, DOI 10.1021/bi00397a031; Hornero-Mendez D, 2002, FEBS LETT, V515, P133, DOI 10.1016/S0014-5793(02)02453-5; Husain M, 1978, Methods Enzymol, V53, P429; Isaacson T, 2004, PLANT PHYSIOL, V136, P4246, DOI 10.1104/pp.104.052092; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Kittleman W, 2007, BIOCHEMISTRY-US, V46, P8401, DOI 10.1021/bi700286a; Krubasik P, 2000, BIOCHEM SOC T, V28, P806, DOI 10.1042/BST0280806; KUSHWAHA SC, 1969, J BIOL CHEM, V244, P3635; Laupitz R, 2004, EUR J BIOCHEM, V271, P2658, DOI 10.1111/j.1432-1033.2004.04194.x; Lee JK, 2007, J BACTERIOL, V189, P8556, DOI 10.1128/JB.01050-07; Maresca JA, 2007, P NATL ACAD SCI USA, V104, P11784, DOI 10.1073/pnas.0702984104; Mayer JE, 2008, CURR OPIN PLANT BIOL, V11, P166, DOI 10.1016/j.pbi.2008.01.007; MCCORMICK DB, 1967, EUR J BIOCHEM, V2, P387, DOI 10.1111/j.1432-1033.1967.tb00150.x; Morstadt L, 2002, PLANTA, V215, P134, DOI 10.1007/s00425-001-0724-y; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Prado-Cabrero A, 2007, EUKARYOT CELL, V6, P650, DOI 10.1128/EC.00392-06; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Rosati C, 2000, PLANT J, V24, P413, DOI 10.1046/j.1365-313x.2000.00880.x; Rothman SC, 2008, J AM CHEM SOC, V130, P4906, DOI 10.1021/ja7108954; Rothman SC, 2007, BIOCHEMISTRY-US, V46, P5437, DOI 10.1021/bi0616347; Ruch S, 2005, MOL MICROBIOL, V55, P1015, DOI 10.1111/j.1365-2958.2004.04460.x; Schaub P, 2005, PLANT PHYSIOL, V138, P441, DOI 10.1104/pp.104.057927; Scherzinger D, 2006, BIOCHEM J, V398, P361, DOI 10.1042/BJ20060592; Schnurr G, 1996, BIOCHEM J, V315, P869, DOI 10.1042/bj3150869; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; SPENCER R, 1977, BIOCHEMISTRY-US, V16, P3594, DOI 10.1021/bi00635a015; SPENCER R, 1977, BIOCHEMISTRY-US, V16, P3586, DOI 10.1021/bi00635a014; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Telfer A, 2005, PHOTOCH PHOTOBIO SCI, V4, P950, DOI 10.1039/b507888c; Thibodeaux CJ, 2008, BIOCHEMISTRY-US, V47, P2547, DOI 10.1021/bi701467g; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; UNDEN G, 2008, ECOSAL MODULE 3 2 2; Unno H, 2009, J BIOL CHEM, V284, P9160, DOI 10.1074/jbc.M808438200; Unversucht S, 2005, ADV SYNTH CATAL, V347, P1163, DOI 10.1002/adsc.200505029; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; WALSH C, 1978, BIOCHEMISTRY-US, V17, P1942, DOI 10.1021/bi00603a022; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008	65	42	47	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12109	12120		10.1074/jbc.M109.091843	http://dx.doi.org/10.1074/jbc.M109.091843			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20178989	hybrid, Green Published			2022-12-25	WOS:000276787100041
J	Iyer, RR; Pluciennik, A; Genschel, J; Tsai, MS; Beese, LS; Modrich, P				Iyer, Ravi R.; Pluciennik, Anna; Genschel, Jochen; Tsai, Miaw-Sheue; Beese, Lorena S.; Modrich, Paul			MutL alpha and Proliferating Cell Nuclear Antigen Share Binding Sites on MutS beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA MISMATCH REPAIR; INTERSTRAND CROSS-LINKS; RECOGNITION COMPLEX; HMUTS-ALPHA; EXCISION; MSH2-MSH6; PROTEINS; INTERACT; SYSTEM; RECONSTITUTION	MutS beta (MSH2-MSH3) mediates repair of insertion-deletion heterologies but also triggers triplet repeat expansions that cause neurological diseases. Like other DNA metabolic activities, MutS beta interacts with proliferating cell nuclear antigen (PCNA) via a conserved motif (QXX(L/I)XXFF). We demonstrate that MutS beta-PCNA complex formation occurs with an affinity of similar to 0.1 mu M and a preferred stoichiometry of 1:1. However, up to 20% of complexes are multivalent under conditions where MutS beta is in molar excess over PCNA. Conformational studies indicate that the two proteins associate in an end-to-end fashion in solution. Surprisingly, mutation of the PCNA-binding motif of MutS beta not only abolishes PCNA binding, but unlike MutS beta, also dramatically attenuates MutS beta-MutL alpha interaction, MutL alpha endonuclease activation, and bidirectional mismatch repair. As predicted by these findings, PCNA competes with MutL alpha for binding to MutS beta, an effect that is blocked by the cell cycle regulator p21(CIP1). We propose that MutS beta-MutL alpha interaction is mediated in part by residues ((L/I)SRFF) embedded within the MSH3 PCNA-binding motif. To our knowledge this is the first case where residues important for PCNA binding also mediate interaction with a second protein. These findings also indicate that MutS beta- and MutS alpha-initiated repair events differ in fundamental ways.	[Iyer, Ravi R.; Pluciennik, Anna; Genschel, Jochen; Beese, Lorena S.; Modrich, Paul] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Tsai, Miaw-Sheue] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Canc & DNA Damage Responses, Berkeley, CA 94720 USA	Duke University; Duke University; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Modrich, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	modrich@biochem.duke.edu	Classen, Scott/AAY-8176-2020; beese, lorena/G-4993-2010	Modrich, Paul/0000-0001-8708-9885	National Institutes of Health [R01 GM45190, P01 CA92584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM45190 and P01 CA92584.	Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Brouwer JR, 2009, BIOESSAYS, V31, P71, DOI 10.1002/bies.080122; Charbonneau N, 2009, CANCER BIOL THER, V8, P1411, DOI 10.4161/cbt.8.14.8886; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Dherin C, 2009, MOL CELL BIOL, V29, P907, DOI 10.1128/MCB.00945-08; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Drummond JT, 1997, P NATL ACAD SCI USA, V94, P10144, DOI 10.1073/pnas.94.19.10144; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Galio L, 1999, NUCLEIC ACIDS RES, V27, P2325, DOI 10.1093/nar/27.11.2325; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2006, METHOD ENZYMOL, V408, P273, DOI 10.1016/S0076-6879(06)08017-7; Genschel J, 2009, J BIOL CHEM, V284, P21536, DOI 10.1074/jbc.M109.021287; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Guinier A., 1955, SMALL ANGLE SCATTERI; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Iyer RR, 2008, J BIOL CHEM, V283, P13310, DOI 10.1074/jbc.M800606200; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; KRATKY O, 1963, PROG BIOPHYS MOL BIO, V13, P105, DOI 10.1016/S0079-6107(63)80015-2; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Plotz G, 2006, NUCLEIC ACIDS RES, V34, P6574, DOI 10.1093/nar/gkl944; Raschle M, 2002, J BIOL CHEM, V277, P21810, DOI 10.1074/jbc.M108787200; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Zhang NX, 2002, MOL CELL BIOL, V22, P2388, DOI 10.1128/MCB.22.7.2388-2397.2002; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zhao JH, 2009, NUCLEIC ACIDS RES, V37, P4420, DOI 10.1093/nar/gkp399	49	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11730	11739		10.1074/jbc.M110.104125	http://dx.doi.org/10.1074/jbc.M110.104125			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154325	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000276286200076
J	You, JJ; Lin-Chao, S				You, Jhong-Jhe; Lin-Chao, Sue			Gas7 Functions with N-WASP to Regulate the Neurite Outgrowth of Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; DEMYELINATING PERIPHERAL NEUROPATHY; ACTIN-DEPOLYMERIZING PROTEIN; ARREST-SPECIFIC PROTEIN; ARP2/3 COMPLEX; GROWTH-ARREST; PC12 CELLS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MEMBRANE INVAGINATION; MICROSPIKE FORMATION	Neuritogenesis, or neurite outgrowth, is a critical process for neuronal differentiation and maturation in which growth cones are formed from highly dynamic actin structures. Gas7 ( growth arrest-specific gene 7), a new member of the PCH( Pombe Cdc15 homology) protein family, is predominantly expressed in neurons and is required for the maturation of primary cultured Purkinje neurons as well as the neuron-like differentiation of PC12 cells upon nerve growth factor stimulation. We report that Gas7 co-localizes and physically interacts with N-WASP, a key regulator of Arp2/3 complex-mediated actin polymerization, in the cortical region of Gas7-transfected Neuro-2a cells and growth cones of hippocampal neurons. The interaction between Gas7 and N-WASP is mediated by WW-Prodomains, which is unique in the PCH protein family, where most interactions are of the SH3-Pro kind. The interaction contributes to the formation of membrane protrusions and processes by recruiting the Arp2/3 complex in a Cdc42-independent manner. Importantly, specific interaction between Gas7 and N-WASP is required for regular neurite outgrowth of hippocampal neurons. The data demonstrate an essential role of Gas7 through its interaction with N-WASP during neuronal maturation/differentiation.	[Lin-Chao, Sue] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10002, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Lin-Chao, S (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan.	mbsue@gate.sinica.edu.tw	Lin-Chao, Sue/AAZ-8246-2021; Lin-Chao, Sue/AGI-2030-2022	Lin-Chao, Sue/0000-0002-8415-9304; Lin-Chao, Sue/0000-0002-8415-9304	Academia Sinica [AS-95-TP-B04]; National Science Council of Taiwan	Academia Sinica(Academia Sinica - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by an intramural fund and Program Project Grant AS-95-TP-B04 from Academia Sinica and by grants from the National Science Council of Taiwan. This work fulfilled in part the requirements for the Ph.D. thesis of J.-J. You, Graduate Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taiwan.	Abe T, 2003, J CELL SCI, V116, P155, DOI 10.1242/jcs.00208; ADLKOFER K, 1995, NAT GENET, V11, P274, DOI 10.1038/ng1195-274; Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Banzai Y, 2000, J BIOL CHEM, V275, P11987, DOI 10.1074/jbc.275.16.11987; Bompard G, 2004, J CELL BIOL, V166, P957, DOI 10.1083/jcb.200403127; BRANCOLINI C, 1992, J CELL BIOL, V117, P1251, DOI 10.1083/jcb.117.6.1251; BRENNER DG, 1989, P NATL ACAD SCI USA, V86, P5517, DOI 10.1073/pnas.86.14.5517; Carlier MF, 2000, J BIOL CHEM, V275, P21946, DOI 10.1074/jbc.M000687200; Chao CCK, 2005, J NEUROSCI RES, V81, P153, DOI 10.1002/jnr.20552; Chao CCK, 2003, J NEUROSCI RES, V74, P248, DOI 10.1002/jnr.10763; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Dent EW, 2003, NEUROSCIENTIST, V9, P343, DOI 10.1177/1073858403252683; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; FABBRETTI E, 1995, GENE DEV, V9, P1846, DOI 10.1101/gad.9.15.1846; Fukuoka M, 2001, J CELL BIOL, V152, P471, DOI 10.1083/jcb.152.3.471; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lazakovitch EM, 1999, GENOMICS, V61, P298, DOI 10.1006/geno.1999.5964; Lee KKH, 1999, DEV BIOL, V207, P14; Lih CJ, 1996, P NATL ACAD SCI USA, V93, P4617, DOI 10.1073/pnas.93.10.4617; Lippincott J, 2000, MICROSC RES TECHNIQ, V49, P168, DOI 10.1002/(SICI)1097-0029(20000415)49:2<168::AID-JEMT9>3.0.CO;2-T; Lortie K, 2005, BRAIN RES, V1036, P27, DOI 10.1016/j.brainres.2004.12.024; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; MIKI H, 1994, J BIOL CHEM, V269, P5489; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Miura K, 1996, BIOCHEM J, V316, P639, DOI 10.1042/bj3160639; Mizutani K, 2004, BIOCHEM BIOPH RES CO, V313, P468, DOI 10.1016/j.bbrc.2003.11.139; Moorthy PP, 2005, STEM CELLS DEV, V14, P664, DOI 10.1089/scd.2005.14.664; Purpura D P, 1982, Brain Res, V281, P287; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; She BR, 2002, EXP CELL RES, V273, P34, DOI 10.1006/excr.2001.5435; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; So CW, 2003, CANCER CELL, V4, P99, DOI 10.1016/S1535-6108(03)00188-0; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Su WB, 2009, POMBE CDC15 HOMOLOGY; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Takenawa T, 2005, NOVART FDN SYMP, V269, P10; Takenawa Tadaomi, 2005, Novartis Found Symp, V269, P3; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tomasevic N, 2007, BIOCHEMISTRY-US, V46, P3494, DOI 10.1021/bi062152y; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; WISNIEWSKI KE, 1991, AM J MED GENET, V38, P476, DOI 10.1002/ajmg.1320380267; Yamaguchi H, 2000, P NATL ACAD SCI USA, V97, P12631, DOI 10.1073/pnas.190351397; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0	57	37	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11652	11666		10.1074/jbc.M109.051094	http://dx.doi.org/10.1074/jbc.M109.051094			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20150425	Green Published, hybrid			2022-12-25	WOS:000276286200070
J	Eliasz, S; Liang, S; Chen, Y; De Marco, MA; Machek, O; Skucha, S; Miele, L; Bocchetta, M				Eliasz, S.; Liang, S.; Chen, Y.; De Marco, M. A.; Machek, O.; Skucha, S.; Miele, L.; Bocchetta, M.			Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway	ONCOGENE			English	Article						notch signaling; lung cancer; hypoxia; IGF-1R; cancer cell survival	CANCER STEM-CELLS; FACTOR-I GENE; PROTEIN-KINASE; GROWTH; INSULIN; EXPRESSION; TRANSCRIPTION; RESISTANCE; MAINTENANCE; INHIBITION	Hypoxic microenvironment supports cancer stem cell survival, causes poor response to anticancer therapy and tumor recurrence. Inhibition of Notch-1 signaling in adenocarcinoma of the lung (ACL) cells causes apoptosis ifically under hypoxia. Here, we found that Akt-1 activation is a key mediator of Notch-1 pro-survival effects under hypoxia. Notch-1 activates Akt-1 through repression of phosphatase and tensin (PTEN) homolog expression and induction of the insulin-like growth factor 1 receptor (IGF-1R). The latter seems to be the major determinant of Akt-1 stimulation, as Notch-1 signaling affects Akt-1 activation in PTEN-/- ACL cells. Both downregulation of insulin receptor substrate 1 (IRS-1) and dominant-negative IGF-1R sensitized ACL cells to c-secretase inhibitor (GSI)-induced apoptosis. Conversely, overexpression of IGF-1R protected ACL cells from GSI toxicity. Inhibition of Notch-1 caused reduced IGF-1R expression, whereas forced Notch-1 expression yielded opposite effects. Chromatin immunoprecipitation experiments suggested Notch-1 direct regulation of the IGF-1R promoter. Experiments in which human ACL cells were injected in mice confirmed elevated and specific co-expression of Notch-1IC, IGF-1R and pAkt-1 in hypoxic tumor areas. Our data provide a mechanistic explanation for Notch-1-mediated pro-survival function in hypoxic ACL tumor microenvironment. The results identify additional targets that may synergize with Notch-1 inhibition for ACL treatment. Oncogene (2010) 29, 2488-2498; doi:10.1038/onc.2010.7; published online 15 February 2010	[Eliasz, S.; Liang, S.; De Marco, M. A.; Machek, O.; Skucha, S.; Bocchetta, M.] Loyola Univ Chicago, Cardinal Bernardin Canc Ctr, Inst Oncol, 2160 S 1st Ave,Bldg 112,Room 204, Maywood, IL 60153 USA; [Chen, Y.] NYU, Dept Surg, Langone Med Ctr, New York, NY 10016 USA; [Miele, L.] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA	Loyola University Chicago; New York University; NYU Langone Medical Center; University of Mississippi; University of Mississippi Medical Center	Bocchetta, M (corresponding author), Loyola Univ Chicago, Cardinal Bernardin Canc Ctr, Inst Oncol, 2160 S 1st Ave,Bldg 112,Room 204, Maywood, IL 60153 USA.	mbocche@lumc.edu	Machek, Ondrej/L-4203-2018	Machek, Ondrej/0000-0003-3955-7853; Miele, Lucio/0000-0002-5853-7287	American Cancer Society [RSG-05-077-MBC]; National Cancer Institute [RO1 CA134503]; Riviera Country Club and Sport Center; NATIONAL CANCER INSTITUTE [R01CA134503] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Riviera Country Club and Sport Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Patricia Simms for help with FACS analyses. Merck & CO., Inc. (Whitehouse Station, NJ, USA) kindly provided the MRK-003 compound. We thank Dr Michele Carbone for critical review of this paper. This work was supported by grants from the American Cancer Society RSG-05-077-MBC, Award Number RO1 CA134503 from the National Cancer Institute and by a grant from the Riviera Country Club and Sport Center. Financial support was from American Cancer Society grant RSG-05-077-MBC, Award Number RO1 CA134503 from the National Cancer Institute and by a grant by the Riviera Country Club and Sport Center (M Bocchetta). Merck Inc. provided the drug MRK-003.	Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Behrooz A, 1999, NEWS PHYSIOL SCI, V14, P105; Belfiore A, 2007, CURR PHARM DESIGN, V13, P671, DOI 10.2174/138161207780249173; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bocchetta M, 2008, CANCER RES, V68, P1022, DOI 10.1158/0008-5472.CAN-07-5203; Carelli S, 2006, J CELL PHYSIOL, V208, P354, DOI 10.1002/jcp.20670; Chen Delphine L, 2005, Proc Am Thorac Soc, V2, P541, DOI 10.1513/pats.200507-075DS; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Chen YB, 2007, CANCER RES, V67, P7954, DOI 10.1158/0008-5472.CAN-07-1229; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Graziani I, 2008, CANCER RES, V68, P9678, DOI 10.1158/0008-5472.CAN-08-0969; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; HEUSON JC, 1972, CANCER RES, V32, P226; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Korkaya H, 2009, CLIN CANCER RES, V15, P1845, DOI 10.1158/1078-0432.CCR-08-3087; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; McLellan AS, 2006, AM J PHYSIOL-CELL PH, V291, pC300, DOI 10.1152/ajpcell.00345.2005; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Milas L, 2009, SEMIN RADIAT ONCOL, V19, P96, DOI 10.1016/j.semradonc.2008.11.004; Moromisato DY, 1996, CRIT CARE MED, V24, P919, DOI 10.1097/00003246-199606000-00008; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Ouellet J, 2008, DEVELOPMENT, V135, P2583, DOI 10.1242/dev.012435; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Romanelli RJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704309200; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Schuurbiers OCJ, 2009, J THORAC ONCOL, V4, P761, DOI 10.1097/JTO.0b013e3181a1084f; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; SHEMER J, 1992, ENDOCRINOLOGY, V131, P2793, DOI 10.1210/en.131.6.2793; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Treins C, 2005, MOL ENDOCRINOL, V19, P1304, DOI 10.1210/me.2004-0239; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Valentinis, 1997, BIOCHIM BIOPHYS ACTA, V1332, P105; Venkateswaran V, 2007, J NATL CANCER I, V99, P1793, DOI 10.1093/jnci/djm231; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; YOYOSHIMA Y, 2008, ENDOCRINOLOGY, V149, P5996	51	128	133	0	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	17					2488	2498		10.1038/onc.2010.7	http://dx.doi.org/10.1038/onc.2010.7			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	589RB	20154720	Green Accepted			2022-12-25	WOS:000277169400004
J	Szmaragd, C; Wilson, AJ; Carpenter, S; Wood, JLN; Mellor, PS; Gubbins, S				Szmaragd, Camille; Wilson, Anthony J.; Carpenter, Simon; Wood, James L. N.; Mellor, Philip S.; Gubbins, Simon			The Spread of Bluetongue Virus Serotype 8 in Great Britain and Its Control by Vaccination	PLOS ONE			English	Article							TRANSMISSION; INFECTION; EPIDEMIC; EUROPE; SHEEP	Background: Bluetongue (BT) is a viral disease of ruminants transmitted by Culicoides biting midges and has the ability to spread rapidly over large distances. In the summer of 2006, BTV serotype 8 (BTV-8) emerged for the first time in northern Europe, resulting in over 2000 infected farms by the end of the year. The virus subsequently overwintered and has since spread across much of Europe, causing tens of thousands of livestock deaths. In August 2007, BTV-8 reached Great Britain (GB), threatening the large and valuable livestock industry. A voluntary vaccination scheme was launched in GB in May 2008 and, in contrast with elsewhere in Europe, there were no reported cases in GB during 2008. Methodology/Principal Findings: Here, we use carefully parameterised mathematical models to investigate the spread of BTV in GB and its control by vaccination. In the absence of vaccination, the model predicted severe outbreaks of BTV, particularly for warmer temperatures. Vaccination was predicted to reduce the severity of epidemics, with the greatest reduction achieved for high levels (95%) of vaccine uptake. However, even at this level of uptake the model predicted some spread of BTV. The sensitivity of the predictions to vaccination parameters (time to full protection in cattle, vaccine efficacy), the shape of the transmission kernel and temperature dependence in the transmission of BTV between farms was assessed. Conclusions/Significance: A combination of lower temperatures and high levels of vaccine uptake (>80%) in the previously-affected areas are likely to be the major contributing factors in the control achieved in England in 2008. However, low levels of vaccination against BTV-8 or the introduction of other serotypes could result in further, potentially severe outbreaks in future.	[Szmaragd, Camille; Wilson, Anthony J.; Carpenter, Simon; Mellor, Philip S.; Gubbins, Simon] Inst Anim Hlth, Div Epidemiol, Pirbright Lab, Surrey, England; [Wood, James L. N.] Univ Cambridge, Dept Vet Med, Cambridge Infect Dis Consortium, Cambridge, Cambs, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Cambridge	Szmaragd, C (corresponding author), Univ Bristol, Sch Clin Vet Sci, Lower Langford, Somerset, England.	Camille.Szmaragd@bristol.ac.uk	Carpenter, Simon T/C-2718-2013; Wood, James/A-1626-2008	Carpenter, Simon T/0000-0001-5775-045X; Wood, James/0000-0002-0258-3188; Wilson, Anthony/0000-0002-2000-2914; Gubbins, Simon/0000-0003-0538-4173	Biotechnology and Biological Sciences Research Council (BBSRC [BBS/B/00603]; Department for Environment, Food and Rural Affairs (Defra [SE4104]; BBSRC [IAH1320]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001320, BBS/E/I/00001409, BBS/B/00603] Funding Source: researchfish; BBSRC [BBS/E/I/00001320, BBS/E/I/00001409] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs (Defra(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC; grant number BBS/B/00603) and the Department for Environment, Food and Rural Affairs (Defra; grant number SE4104) through the Combating Viral Diseases of Livestock (CVDL) initiative. SG also acknowledges additional funding from BBSRC (grant number IAH1320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; Carpenter S, 2006, J MED ENTOMOL, V43, P73, DOI 10.1603/0022-2585(2006)043[0073:OSTBVO]2.0.CO;2; Carpenter S, 2008, J APPL ECOL, V45, P1237, DOI 10.1111/j.1365-2664.2008.01511.x; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Darpel KE, 2009, EMERG INFECT DIS, V15, P2025, DOI 10.3201/eid1512.090788; De Clercq K, 2008, TRANSBOUND EMERG DIS, V55, P352, DOI 10.1111/j.1865-1682.2008.01044.x; De Clercq K, 2008, VET REC, V162, P564, DOI 10.1136/vr.162.17.564; *DEP ENV FOOD RUR, DECL PROT ZON SURV Z; *DEP ENV FOOD RUR, UK BLUET VACC ROLL O; *DEP ENV FOOD RUR, 2008, REP DISTR BLUET INF; Elbers ARW, 2008, PREV VET MED, V87, P31, DOI 10.1016/j.prevetmed.2008.06.003; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Hamers C, 2009, VET REC, V165, P369, DOI 10.1136/vr.165.13.369; Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS, 2009, BIOL ANIM INFECT, P1; Menzies FD, 2008, VET REC, V163, P203, DOI 10.1136/vr.163.7.203; OURA C, 2009, VACCINE IN PRESS; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Ster IC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000502; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; *UK MET OFF, 2009, MIDAS LAND SURF STAT; Wilson A, 2008, PLOS BIOL, V6, P1612, DOI 10.1371/journal.pbio.0060210; Wilson A, 2008, PARASITOL RES, V103, pS69, DOI 10.1007/s00436-008-1053-x	25	54	54	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9353	10.1371/journal.pone.0009353	http://dx.doi.org/10.1371/journal.pone.0009353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179768	Green Published, Green Submitted, gold			2022-12-25	WOS:000274923900017
J	Dejean, A; Fisher, BL; Corbara, B; Rarevohitra, R; Randrianaivo, R; Rajemison, B; Leponce, M				Dejean, Alain; Fisher, Brian L.; Corbara, Bruno; Rarevohitra, Raymond; Randrianaivo, Richard; Rajemison, Balsama; Leponce, Maurice			Spatial Distribution of Dominant Arboreal Ants in a Malagasy Coastal Rainforest: Gaps and Presence of an Invasive Species	PLOS ONE			English	Article							COMPETITIVE ABILITY; SUPERCOLONIES; AGGRESSION; DIVERSITY; ABUNDANCE; SEX	We conducted a survey along three belt transects located at increasing distances from the coast to determine whether a non-random arboreal ant assemblage, such as an ant mosaic, exists in the rainforest on the Masoala Peninsula, Madagascar. In most tropical rainforests, very populous colonies of territorially dominant arboreal ant species defend absolute territories distributed in a mosaic pattern. Among the 29 ant species recorded, only nine had colonies large enough to be considered potentially territorially dominant; the remaining species had smaller colonies and were considered non-dominant. Nevertheless, the null-model analyses used to examine the spatial structure of their assemblages did not reveal the existence of an ant mosaic. Inland, up to 44% of the trees were devoid of dominant arboreal ants, something not reported in other studies. While two Crematogaster species were not associated with one another, Brachymyrmex cordemoyi was positively associated with Technomyrmex albipes, which is considered an invasive species-a non-indigenous species that has an adverse ecological effect on the habitats it invades. The latter two species and Crematogaster ranavalonae were mutually exclusive. On the other hand, all of the trees in the coastal transect and at least 4 km of coast were occupied by T. albipes, and were interconnected by columns of workers. Technomyrmex albipes workers collected from different trees did not attack each other during confrontation tests, indicating that this species has formed a supercolony along the coast. Yet interspecific aggressiveness did occur between T. albipes and Crematogaster ranavalonae, a native species which is likely territorially dominant based on our intraspecific confrontation tests. These results suggest that the Masoala rainforest is threatened by a potential invasion by T. albipes, and that the penetration of this species further inland might be facilitated by the low density of native, territorially dominant arboreal ants normally able to limit its progression.	[Dejean, Alain] CNRS, Unite Mixte Rech 8172, Kourou, France; [Fisher, Brian L.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA; [Corbara, Bruno] Univ Blaise Pascal, CNRS, Lab Microorganismes Genome & Environm, Unite Mixte Rech 6023, Aubiere, France; [Rarevohitra, Raymond] Dept Rech Forestieres & Piscicoles, Antananarivo, Madagascar; [Leponce, Maurice] Inst Royal Sci Nat Belgique, Biol Evaluat Sect, B-1040 Brussels, Belgium	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; California Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Dejean, A (corresponding author), CNRS, Unite Mixte Rech 8172, Campus Agron,BP 709, Kourou, France.	alain.dejean@wanadoo.fr		CORBARA, Bruno/0000-0003-4232-8234; Dejean, Alain/0000-0002-3561-2248; Fisher, Brian/0000-0002-4653-3270	Solvay S.A.; Direct For Biological Sciences [0842395] Funding Source: National Science Foundation	Solvay S.A.(Solvay SA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was conducted during the 5th Operation canopee as part of a project set up by Pro-Natura International and Ocean Vert sponsored by Solvay S.A. through the SolVin-Bretzel programme. We would also like to thank Francis Halle and Olivier Pascal for inviting us to participate in this operation. We are grateful to Nicolas Lochu and Jean-Yves Serein who gathered samples from the canopy using the single rope technique and to Andrea Dejean for proofreading the first version of the manuscript.	Abbott KL, 2007, BIOL INVASIONS, V9, P453, DOI 10.1007/s10530-006-9052-2; Abbott KL, 2006, DIVERS DISTRIB, V12, P101, DOI 10.1111/j.1366-9516.2006.00193.x; Basset Y, 2003, ARTHROPODS TROPICAL, P474; Bluthgen N, 2007, AUSTRAL ECOL, V32, P93, DOI 10.1111/j.1442-9993.2007.01744.x; Bluthgen N, 2003, OECOLOGIA, V137, P426, DOI 10.1007/s00442-003-1347-8; Bolton Barry, 2007, Contributions of the American Entomological Institute, V35, P1; BOOSMA JJ, 2003, GENES BEHAV EVOLUTIO, P131; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Davidson DW, 1998, ECOL ENTOMOL, V23, P484, DOI 10.1046/j.1365-2311.1998.00145.x; Dejean A., 2007, FUNCT ECOSYST COMMUN, V1, P105, DOI DOI 10.1515/CCLM.2008.220; Dejean A, 2008, BASIC APPL ECOL, V9, P316, DOI 10.1016/j.baae.2007.03.001; DJIETOLORDON C, 2005, BIOTROPICA, V37, P420; Fadamiro HY, 2009, ECOL ENTOMOL, V34, P427, DOI 10.1111/j.1365-2311.2009.01102.x; Foucaud J, 2007, MOL BIOL EVOL, V24, P2465, DOI 10.1093/molbev/msm180; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2000, ECOSIM NULL MODELS S; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; Holway DA, 2004, OECOLOGIA, V138, P216, DOI 10.1007/s00442-003-1414-1; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Hunt JH, 2003, SCIENCE, V300, P916, DOI 10.1126/science.1085065; Kenne M, 2003, J ECON ENTOMOL, V96, P251, DOI 10.1603/0022-0493-96.2.251; Le Breton J, 2005, J TROP ECOL, V21, P93, DOI 10.1017/S0266467404002019; LESTON D, 1973, PANS (PEST ARTIC NEWS SUMM), V19, P311; Majer Jonathan D., 1993, P115; Pedersen JS, 2006, EVOLUTION, V60, P782, DOI 10.1111/j.0014-3820.2006.tb01156.x; Pfeiffer M, 2008, ECOGRAPHY, V31, P21, DOI 10.1111/j.2007.0906-7590.05172.x; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Suarez Andrew V., 1999, Biological Invasions, V1, P43, DOI 10.1023/A:1010038413690; Sulaiman SFM, 1997, ACTA HORTIC, P475, DOI 10.17660/ActaHortic.1997.425.51; Tanner CJ, 2006, P ROY SOC B-BIOL SCI, V273, P2737, DOI 10.1098/rspb.2006.3626; ter Steege H, 1998, BIOTROPICA, V30, P496, DOI 10.1111/j.1744-7429.1998.tb00087.x; TERAYAMA M, 1989, B TOHO GAKUEN, V3, P1; TSUJI K, 1994, BEHAV ECOL SOCIOBIOL, V34, P157, DOI 10.1007/BF00167740; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Tsutsui ND, 2003, P NATL ACAD SCI USA, V100, P1078, DOI 10.1073/pnas.0234412100	38	29	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9319	10.1371/journal.pone.0009319	http://dx.doi.org/10.1371/journal.pone.0009319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174474	Green Published, gold, Green Submitted			2022-12-25	WOS:000274923700021
J	Rorie, AE; Gao, J; McClelland, JL; Newsome, WT				Rorie, Alan E.; Gao, Juan; McClelland, James L.; Newsome, William T.			Integration of Sensory and Reward Information during Perceptual Decision-Making in Lateral Intraparietal Cortex (LIP) of the Macaque Monkey	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; SACCADIC EYE-MOVEMENTS; VISUAL AREA MT; DISCRIMINATION TASK; SUPERIOR COLLICULUS; MOTION PERCEPTION; SPATIAL ATTENTION; MATCHING BEHAVIOR; STOCHASTIC-MODELS; NEURONAL-ACTIVITY	Single neurons in cortical area LIP are known to carry information relevant to both sensory and value-based decisions that are reported by eye movements. It is not known, however, how sensory and value information are combined in LIP when individual decisions must be based on a combination of these variables. To investigate this issue, we conducted behavioral and electrophysiological experiments in rhesus monkeys during performance of a two-alternative, forced-choice discrimination of motion direction (sensory component). Monkeys reported each decision by making an eye movement to one of two visual targets associated with the two possible directions of motion. We introduced choice biases to the monkeys' decision process (value component) by randomly interleaving balanced reward conditions (equal reward value for the two choices) with unbalanced conditions (one alternative worth twice as much as the other). The monkeys' behavior, as well as that of most LIP neurons, reflected the influence of all relevant variables: the strength of the sensory information, the value of the target in the neuron's response field, and the value of the target outside the response field. Overall, detailed analysis and computer simulation reveal that our data are consistent with a two-stage drift diffusion model proposed by Diederich and Bussmeyer [1] for the effect of payoffs in the context of sensory discrimination tasks. Initial processing of payoff information strongly influences the starting point for the accumulation of sensory evidence, while exerting little if any effect on the rate of accumulation of sensory evidence.	[Rorie, Alan E.; Newsome, William T.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Rorie, Alan E.; Newsome, William T.] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Gao, Juan; McClelland, James L.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Rorie, AE (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	bill@monkeybiz.stanford.edu	McClelland, James L/F-6004-2011; Newsome, William T./W-7171-2019	McClelland, James/0000-0002-8217-405X	Air Force Research Laboratory [FA9550-07-1-0537]; Howard Hughes Medical Institute (HHMI)	Air Force Research Laboratory; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	The research was funded by the Air Force Research Laboratory, under agreement number FA9550-07-1-0537, and by the Howard Hughes Medical Institute (HHMI). WN is an HHMI Investigator. AR was supported by an HHMI predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Balleine BW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P367, DOI 10.1016/B978-0-12-374176-9.00024-5; Bendiksby MS, 2006, NEUROPSYCHOLOGIA, V44, P2411, DOI 10.1016/j.neuropsychologia.2006.04.011; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Cavanaugh J, 2006, J NEUROSCI, V26, P11347, DOI 10.1523/JNEUROSCI.2376-06.2006; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corrado GS, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P463, DOI 10.1016/B978-0-12-374176-9.00030-0; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; Diederich A, 1997, J MATH PSYCHOL, V41, P260, DOI 10.1006/jmps.1997.1167; Diederich A, 2008, PERCEPT PSYCHOPHYS, V70, P229, DOI 10.3758/PP.70.2.229; Diederich A, 2006, PERCEPT PSYCHOPHYS, V68, P194, DOI 10.3758/BF03193669; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; Ditterich J, 2006, EUR J NEUROSCI, V24, P3628, DOI 10.1111/j.1460-9568.2006.05221.x; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; Feng S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000284; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P503, DOI 10.1016/B978-0-12-374176-9.00032-4; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldberg ME, 2006, PROG BRAIN RES, V155, P157, DOI 10.1016/S0079-6123(06)55010-1; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Gottlieb J, 2009, NEUROBIOL LEARN MEM, V91, P121, DOI 10.1016/j.nlm.2008.09.013; Green D. M., 1966, SIGNAL DETECTION PSY; Grossberg S, 2008, VISION RES, V48, P1345, DOI 10.1016/j.visres.2008.02.019; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hays AV, 1982, WESCON C P, V2, P1; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Ipata AE, 2009, EXP BRAIN RES, V192, P479, DOI 10.1007/s00221-008-1557-8; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; Kusunoki M, 2000, VISION RES, V40, P1459, DOI 10.1016/S0042-6989(99)00212-6; Laming DR, 1968, INFORM THEORY CHOICE; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Lee D, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P481, DOI 10.1016/B978-0-12-374176-9.00031-2; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Moore T, 2006, CURR OPIN NEUROBIOL, V16, P159, DOI 10.1016/j.conb.2006.03.009; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Platt M, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P441, DOI 10.1016/B978-0-12-374176-9.00029-4; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rangel A, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P425, DOI 10.1016/B978-0-12-374176-9.00028-2; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ratcliff R, 2007, J NEUROPHYSIOL, V97, P1756, DOI 10.1152/jn.00393.2006; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Vickers D., 2000, NONLINEAR DYNAMICS P, V4, P1, DOI DOI 10.1023/A:1009571011764; Vickers D., 1979, DECISION PROCESSES V; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Wong KF, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.006.2007; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	81	135	135	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9308	10.1371/journal.pone.0009308	http://dx.doi.org/10.1371/journal.pone.0009308			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174574	gold, Green Published			2022-12-25	WOS:000274923700012
J	Verykokakis, M; Boos, MD; Bendelac, A; Adams, EJ; Pereira, P; Kee, BL				Verykokakis, Mihalis; Boos, Markus D.; Bendelac, Albert; Adams, Erin J.; Pereira, Pablo; Kee, Barbara L.			Inhibitor of DNA Binding 3 Limits Development of Murine Slam-Associated Adaptor Protein-Dependent "Innate'' gamma delta T cells	PLOS ONE			English	Article							LOOP-HELIX PROTEIN; TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; TEC FAMILY KINASES; TCR-ALPHA-BETA; LYMPHOCYTE DEVELOPMENT; THYMOCYTE DEVELOPMENT; LINEAGE COMMITMENT; ADULT MICE; V(D)J RECOMBINATION; POSITIVE SELECTION	Background: Id3 is a dominant antagonist of E protein transcription factor activity that is induced by signals emanating from the alpha beta and gamma delta T cell receptor (TCR). Mice lacking Id3 were previously shown to have subtle defects in positive and negative selection of TCR alpha beta(+) T lymphocytes. More recently, Id3(-/-) mice on a C57BL/6 background were shown to have a dramatic expansion of gamma delta T cells. Methodology/Principal Findings: Here we report that mice lacking Id3 have reduced thymocyte numbers but increased production of gamma delta T cells that express a V gamma 1.1(+)V delta 6.3(+) receptor with restricted junctional diversity. These V gamma 1.1(+)V delta 6.3(+) T cells have multiple characteristics associated with "innate'' lymphocytes such as natural killer T (NKT) cells including an activated phenotype, expression of the transcription factor PLZF, and rapid production of IFNg and interleukin-4. Moreover, like other "innate'' lymphocyte populations, development of Id3(-/-) V gamma 1.1(+)V delta 6.3(+) T cells requires the signaling adapter protein SAP. Conclusions: Our data provide novel insight into the requirements for development of V gamma 1.1(+)V delta 6.3(+) T cells and indicate a role for Id3 in repressing the response of "innate'' gamma delta T cells to SAP-mediated expansion or survival.	[Verykokakis, Mihalis; Bendelac, Albert; Kee, Barbara L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Verykokakis, Mihalis; Boos, Markus D.; Bendelac, Albert; Adams, Erin J.; Kee, Barbara L.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Bendelac, Albert] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Adams, Erin J.] Univ Chicago, Dept Biochem, Chicago, IL 60637 USA; [Pereira, Pablo] Inst Pasteur, Unite Dev Lymphocytes, Paris, France; [Pereira, Pablo] INSERM, U668, Paris, France	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Verykokakis, M (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bkee@bsd.uchicago.edu	Pereira, Pablo/M-7224-2014	Pereira, Pablo/0000-0003-1784-2776	National Institutes of Health [R01 CA099978, R01 AI073922, T32 GM07281]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA099978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (R01 CA099978, R01 AI073922 and T32 GM07281) and a Leukemia and Lymphoma Society Scholar Award (http://www.lls.org/hm_lls). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 2007, IMMUNITY, V27, P871, DOI 10.1016/j.immuni.2007.11.015; Alonzo ES, 2009, J IMMUNOL; Aono A, 2000, IMMUNOLOGY, V99, P489, DOI 10.1046/j.1365-2567.2000.00987.x; ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; Azuara V, 1997, EUR J IMMUNOL, V27, P544, DOI 10.1002/eji.1830270228; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Bain G, 1998, SEMIN IMMUNOL, V10, P143, DOI 10.1006/smim.1998.0116; Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1034/j.1600-065X.2000.017518.x; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; CAPONE M, 1995, J IMMUNOL, V154, P5165; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Felices M, 2009, P NATL ACAD SCI USA, V106, P8308, DOI 10.1073/pnas.0808459106; GARMAN RD, 1986, P NATL ACAD SCI USA, V83, P3987, DOI 10.1073/pnas.83.11.3987; Gerber DJ, 1999, J IMMUNOL, V163, P3076; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Grigoriadou K, 2003, J IMMUNOL, V171, P2413, DOI 10.4049/jimmunol.171.5.2413; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Horai R, 2007, IMMUNITY, V27, P775, DOI 10.1016/j.immuni.2007.09.012; ITOHARA S, 1989, P NATL ACAD SCI USA, V86, P5094, DOI 10.1073/pnas.86.13.5094; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; Lauritsen JPH, 2009, IMMUNITY, V31, P565, DOI 10.1016/j.immuni.2009.07.010; Li W, 2007, IMMUNITY, V27, P763, DOI 10.1016/j.immuni.2007.10.008; Lucas JA, 2002, J IMMUNOL, V168, P6142, DOI 10.4049/jimmunol.168.12.6142; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; O'Brien RL, 2007, IMMUNOL REV, V215, P77, DOI 10.1111/j.1600-065X.2006.00477.x; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Pereira P, 2000, EUR J IMMUNOL, V30, P1988, DOI 10.1002/1521-4141(200007)30:7<1988::AID-IMMU1988>3.0.CO;2-W; Prince Amanda L, 2009, Immunol Rev, V228, P115, DOI 10.1111/j.1600-065X.2008.00746.x; Qi Q, 2009, BLOOD, V114, P564, DOI 10.1182/blood-2008-12-196345; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stewart CA, 2007, EUR J IMMUNOL, V37, P1442, DOI 10.1002/eji.200737354; Taghon T, 2008, SEMIN IMMUNOPATHOL, V30, P383, DOI 10.1007/s00281-008-0134-3; UEDAHAYAKAWA I, 2009, J IMMUNOL IN PRESS; von Boehmer H, 1998, IMMUNOL REV, V165, P111; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008; Xiong N, 2007, IMMUNOL REV, V215, P15, DOI 10.1111/j.1600-065X.2006.00478.x	63	70	70	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9303	10.1371/journal.pone.0009303	http://dx.doi.org/10.1371/journal.pone.0009303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174563	gold, Green Submitted, Green Published			2022-12-25	WOS:000274923700010
J	Chaudhary, N; Staab, JF; Marr, KA				Chaudhary, Neelkamal; Staab, Janet F.; Marr, Kieren A.			Healthy Human T-Cell Responses to Aspergillus fumigatus Antigens	PLOS ONE			English	Article							INVASIVE ASPERGILLOSIS; GENERATION; EXPRESSION; SUSCEPTIBILITY; INVOLVEMENT; GLIOTOXIN; IMMUNITY; PROTEIN; EPITOPE; MICE	Background: Aspergillus fumigatus is associated with both invasive and allergic pulmonary diseases, in different hosts. The organism is inhaled as a spore, which, if not cleared from the airway, germinates into hyphal morphotypes that are responsible for tissue invasion and resultant inflammation. Hyphae secrete multiple products that function as antigens, evoking both a protective (T(H)1-T(H)17) and destructive allergic (T(H)2) immunity. How Aspergillus allergens (Asp f proteins) participate in the development of allergic sensitization is unknown. Methodology/Principal Findings: To determine whether Asp f proteins are strictly associated with T(H)2 responses, or represent soluble hyphal products recognized by healthy hosts, human T cell responses to crude and recombinant products were characterized by ELISPOT. While responses (number of spots producing IFN-gamma, IL-4 or IL-17) to crude hyphal antigen preparations were weak, responses to recombinant Asp f proteins were higher. Recombinant allergens stimulated cells to produce IFN-gamma more so than IL-4 or IL-17. Volunteers exhibited a diverse CD4+ and CD8+ T cell antigen recognition profile, with prominent CD4 T(H)1-responses to Asp f3 (a putative peroxismal membrane protein), Asp f9/16 (cell wall glucanase), Asp f11 (cyclophilin type peptidyl-prolyl isomerase) and Asp f22 (enolase). Strong IFN-gamma responses were reproduced in most subjects tested over 6 month intervals. Conclusions: Products secreted after conidial germination into hyphae are differentially recognized by protective T cells in healthy, non-atopic individuals. Defining the specificity of the human T cell repertoire, and identifying factors that govern early responses may allow for development of novel diagnostics and therapeutics for both invasive and allergic Aspergillus diseases.	[Chaudhary, Neelkamal; Staab, Janet F.; Marr, Kieren A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Marr, Kieren A.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Chaudhary, N (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	kmarr4@jhmi.edu			National Institutes of Health [R01 AI067710]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant R01 AI067710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, CHEST, V135, P805, DOI 10.1378/chest.08-2586; Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Banerjee B, 2003, FRONT BIOSCI-LANDMRK, V8, pS128, DOI 10.2741/982; Banerjee B, 2001, CLIN EXP ALLERGY, V31, P761, DOI 10.1046/j.1365-2222.2001.01076.x; Beck O, 2008, J IMMUNOL METHODS, V335, P41, DOI 10.1016/j.jim.2008.02.014; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Bozza S, 2002, MICROBES INFECT, V4, P1281, DOI 10.1016/S1286-4579(02)00007-2; Braun RP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-54; Bretz C, 2008, INFECT IMMUN, V76, P952, DOI 10.1128/IAI.00927-07; Chauhan B, 2000, J ALLERGY CLIN IMMUN, V106, P723, DOI 10.1067/mai.2000.109913; Chauhan B, 1996, J CLIN INVEST, V97, P2324, DOI 10.1172/JCI118675; COLIGAN J, CURRENT PROTOCOLS PR; CRAMERI R, 1994, EUR J BIOCHEM, V226, P53, DOI 10.1111/j.1432-1033.1994.tb20025.x; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Gigliotti F, 2006, INFECT IMMUN, V74, P6310, DOI 10.1128/IAI.00668-06; Hebart H, 2002, BLOOD, V100, P4521, DOI 10.1182/blood-2002-01-0265; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Ito JI, 2006, INFECT IMMUN, V74, P5075, DOI 10.1128/IAI.00815-06; Knutsen AP, 2004, ALLERGY, V59, P198, DOI 10.1046/j.1398-9995.2003.00310.x; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Lehrnbecher T, 2009, MED MYCOL, V47, pS170, DOI 10.1080/13693780802169120; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Lindell DM, 2005, J IMMUNOL, V174, P7920, DOI 10.4049/jimmunol.174.12.7920; Montagnoli C, 2004, MED MYCOL, V42, P319, DOI 10.1080/13693780310001644653; Nickel P, 2009, TRANSPL IMMUNOL, V20, P238, DOI 10.1016/j.trim.2008.11.002; Nierman WC, 2005, MED MYCOL, V43, pS3, DOI 10.1080/13693780400029049; Ohnishi M, 2005, BRIT J HAEMATOL, V131, P472, DOI 10.1111/j.1365-2141.2005.05800.x; Orciuolo E, 2007, J LEUKOCYTE BIOL, V82, P839, DOI 10.1189/jlb.0207090; Orsborn KI, 2006, INFECT IMMUN, V74, P1865, DOI 10.1128/IAI.74.3.1865-1872.2006; Pahl HL, 1996, J EXP MED, V183, P1829, DOI 10.1084/jem.183.4.1829; Potenza L, 2007, LEUKEMIA, V21, P578, DOI 10.1038/sj.leu.2404504; Priyadarsiny P, 2003, MOL CELL BIOCHEM, V252, P157, DOI 10.1023/A:1025594620152; Ramadan G, 2005, CLIN EXP IMMUNOL, V139, P257, DOI 10.1111/j.1365-2249.2005.02699.x; Ramadan G, 2005, CLIN EXP IMMUNOL, V140, P81, DOI 10.1111/j.1365-2249.2005.02738.x; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Sainz J, 2007, HUM IMMUNOL, V68, P41, DOI 10.1016/j.humimm.2006.10.011; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shimizu K, 2001, GENETICS, V157, P591; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Stanzani M, 2005, BLOOD, V105, P2258, DOI 10.1182/blood-2004-09-3421; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Tramsen L, 2009, BONE MARROW TRANSPL, V43, P13, DOI 10.1038/bmt.2008.271; van Deventer Hanneke J., 1996, Clin Microbiol Infect, V2, P36; Vodisch M, 2009, PROTEOMICS, V9, P1407, DOI 10.1002/pmic.200800394; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	46	75	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9036	10.1371/journal.pone.0009036	http://dx.doi.org/10.1371/journal.pone.0009036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174463	Green Published, Green Submitted, gold			2022-12-25	WOS:000274590600002
J	Hasegawa, K; Miwa, S; Tsutsumiuchi, K; Miwa, J				Hasegawa, Koichi; Miwa, Satsuki; Tsutsumiuchi, Kaname; Miwa, Johji			Allyl Isothiocyanate that Induces GST and UGT Expression Confers Oxidative Stress Resistance on C. elegans, as Demonstrated by Nematode Biosensor	PLOS ONE			English	Article							LIFE-SPAN; RESPONSIVE GENES; INNATE IMMUNITY; CAENORHABDITIS; SULFORAPHANE; ACRYLAMIDE; INDUCTION; ENZYMES; CELLS; DETOXIFICATION	Background: Electrophilic xenobiotics and endogenous products from oxidative stresses induce the glutathione S-transferases (GSTs), which form a large family within the phase II enzymes over both animal and plant kingdoms. The GSTs thus induced in turn detoxify these external as well as internal stresses. Because these stresses are often linked to ageing and damage to health, the induction of phase II enzymes without causing adverse effects would be beneficial in slowing down ageing and keeping healthy conditions. Methodology/Principal Findings: We have tested this hypothesis by choosing allyl isothiocyanate (AITC), a functional ingredient in wasabi, as a candidate food ingredient that induces GSTs without causing adverse effects on animals' lives. To monitor the GST induction, we constructed a gst::gfp fusion gene and used it to transform Caenorhabditis elegans for use as a nematode biosensor. With the nematode biosensor, we found that AITC induced GST expression and conferred tolerance on the nematode against various oxidative stresses. We also present evidence that the transcription factor SKN-1 is involved in regulating the GST expression induced by AITC. Conclusions/Significance: We show the applicability of the nematode biosensor for discovering and evaluating functional food substances and chemicals that would provide anti-ageing or healthful benefits.	[Hasegawa, Koichi; Miwa, Satsuki; Tsutsumiuchi, Kaname; Miwa, Johji] Chubu Univ, Coll Biosci & Biotechnol, Aichi, Japan	Chubu University	Hasegawa, K (corresponding author), Chubu Univ, Coll Biosci & Biotechnol, Aichi, Japan.	miwa@isc.chubu.ac.jp			Japan Science and Technology (JST); Japan Society for the Promotion of Science (JSPS); Japanese Ministry of Education, Culture, Sports, Science and Technology; Chubu University	Japan Science and Technology (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chubu University	This work was supported by a Japan Science and Technology (JST) research fund to J. M., a Japan Society for the Promotion of Science (JSPS) research fund to K. H. of the Japanese Ministry of Education, Culture, Sports, Science and Technology, and a Chubu University Special Fund to J. M.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Angeloni C, 2009, J AGR FOOD CHEM, V57, P5615, DOI 10.1021/jf900549c; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; Bock KW, 2003, BIOCHEM PHARMACOL, V66, P691, DOI 10.1016/S0006-2952(03)00296-X; Borek V, 1998, J AGR FOOD CHEM, V46, P5318, DOI 10.1021/jf9805754; BRENNER S, 1974, GENETICS, V77, P71; Brown MK, 2006, PHARMACOL BIOCHEM BE, V85, P620, DOI 10.1016/j.pbb.2006.10.017; Buskov S, 2002, J AGR FOOD CHEM, V50, P690, DOI 10.1021/jf010470s; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Evason K, 2008, AGING CELL, V7, P305, DOI 10.1111/j.1474-9726.2008.00375.x; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Gao XQ, 2001, P NATL ACAD SCI USA, V98, P15221, DOI 10.1073/pnas.261572998; Hasegawa K, 2004, TOXICOL LETT, V152, P183, DOI 10.1016/j.toxlet.2004.04.037; Hasegawa K, 2008, TOXICOL SCI, V101, P215, DOI 10.1093/toxsci/kfm276; Hasegawa K, 2007, TOXICOL LETT, V175, P82, DOI 10.1016/j.toxlet.2007.09.013; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; HUNDLE BS, 1992, P NATL ACAD SCI USA, V89, P9321, DOI 10.1073/pnas.89.19.9321; *IARC, 1999, IARC MON EV CARC RIS, V73, P37; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; KAMPKOTTER A, 2006, PHARM RES, V55, P139; Kim DH, 2005, CURR OPIN IMMUNOL, V17, P4, DOI 10.1016/j.coi.2004.11.007; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kurz CL, 2004, AGING CELL, V3, P185, DOI 10.1111/j.1474-9728.2004.00108.x; Kushad MM, 1999, J AGR FOOD CHEM, V47, P1541, DOI 10.1021/jf980985s; Leiers BR, 2003, FREE RADICAL BIO MED, V34, P1405, DOI 10.1016/S0891-5849(03)00102-3; Lindblom TH, 2006, J EXP ZOOL PART A, V305A, P720, DOI 10.1002/jez.a.324; Maduro M, 1996, GENE, V183, P77, DOI 10.1016/S0378-1119(96)00491-X; Masutomi N, 2001, TOXICOL PATHOL, V29, P617, DOI 10.1080/019262301753385942; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Munday R, 2004, J AGR FOOD CHEM, V52, P1867, DOI 10.1021/jf030549s; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; RIDDLE D.L., 1997, C ELEGANS, P1; Stiernagle T., 1999, C ELEGANS PRACTICAL, P51; Tawe WN, 1998, NUCLEIC ACIDS RES, V26, P1621, DOI 10.1093/nar/26.7.1621; Wiegant FAC, 2009, BIOGERONTOLOGY, V10, P27, DOI 10.1007/s10522-008-9151-9; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Zhang LZ, 2009, FREE RADICAL BIO MED, V46, P414, DOI 10.1016/j.freeradbiomed.2008.10.041; Zhang YS, 2006, J AGR FOOD CHEM, V54, P9370, DOI 10.1021/jf062109h; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P71, DOI 10.1007/s12012-008-9016-0	48	32	38	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9267	10.1371/journal.pone.0009267	http://dx.doi.org/10.1371/journal.pone.0009267			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174640	Green Published, Green Submitted, gold			2022-12-25	WOS:000274590600020
J	Katare, RG; Ando, M; Kakinuma, Y; Sato, T				Katare, Rajesh G.; Ando, Motonori; Kakinuma, Yoshihiko; Sato, Takayuki			Engineered Heart Tissue: A Novel Tool to Study the Ischemic Changes of the Heart In Vitro	PLOS ONE			English	Article							PERMEABILITY TRANSITION-PORE; PROTECTS; INHIBITION	Background: Understanding the basic mechanisms and prevention of any disease pattern lies mainly on development of a successful experimental model. Recently, engineered heart tissue (EHT) has been demonstrated to be a useful tool in experimental transplantation. Here, we demonstrate a novel function for the spontaneously contracting EHT as an experimental model in studying the acute ischemia-induced changes in vitro. Methodology/Principal Findings: EHT was constructed by mixing cardiomyocytes isolated from the neonatal rats and cultured in a ring-shaped scaffold for five days. This was followed by mechanical stretching of the EHT for another one week under incubation. Fully developed EHT was subjected to hypoxia with 1% O-2 for 6 hours after treating them with cell protective agents such as cyclosporine A (CsA) and acetylcholine (ACh). During culture, EHT started to show spontaneous contractions that became more synchronous following mechanical stretching. This was confirmed by the increased expression of gap junctional protein connexin 43 and improved action potential recordings using an optical mapping system after mechanical stretching. When subjected to hypoxia, EHT demonstrated conduction defects, dephosphorylation of connexin-43, and down-regulation of cell survival proteins identical to the adult heart. These effects were inhibited by treating the EHT with cell protective agents. Conclusions/Significance: Under hypoxic conditions, the EHT responds similarly to the adult myocardium, thus making EHT a promising material for the study of cardiac functions in vitro.	[Katare, Rajesh G.; Ando, Motonori; Kakinuma, Yoshihiko; Sato, Takayuki] Kochi Med Sch, Dept Cardiovasc Control, Nankoku, Kochi, Japan	Kochi University	Katare, RG (corresponding author), Univ Bristol, Bristol Heart Inst, Bristol, Avon, England.	katarerajesh@yahoo.com		Katare, Rajesh/0000-0001-5419-7935; Kakinuma, Yoshihiko/0000-0001-5470-9128	Ministry of Health, Labor, and Welfare of Japan [H14-NANO-002, H16-NANO-005]; Ministry of Education, Science, Sports, and Culture of Japan [15300165, 17790892]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labor Sciences Research Grant (H14-NANO-002, H16-NANO-005) from the Ministry of Health, Labor, and Welfare of Japan, and by a Grant-in-Aid for Scientific Research (15300165, 17790892) from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RE, 2002, CIRC RES, V90, P120, DOI 10.1161/res.90.2.120; Ando M, 2005, CIRCULATION, V112, P164, DOI 10.1161/CIRCULATIONAHA.104.525493; Bailey B, 2009, REGEN MED, V4, P823, DOI [10.2217/rme.09.51, 10.2217/RME.09.51]; Hasenfuss G, 1998, CARDIOVASC RES, V39, P60, DOI 10.1016/S0008-6363(98)00110-2; Kakinuma Y, 2005, FEBS LETT, V579, P2111, DOI 10.1016/j.febslet.2005.02.065; Katare RG, 2009, J THORAC CARDIOV SUR, V137, P223, DOI 10.1016/j.jtcvs.2008.08.020; Katare RG, 2007, CAN J PHYSIOL PHARM, V85, P979, DOI 10.1139/Y07-071; Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193; LESMAN A, 2009, TISSUE ENG A; Lin JW, 2008, AM J PHYSIOL-HEART C, V294, pH58, DOI 10.1152/ajpheart.00631.2007; Migneco F, 2008, REGEN MED, V3, P399, DOI 10.2217/17460751.3.3.399; Naito H, 2006, CIRCULATION, V114, pI72, DOI 10.1161/CIRCULATIONAHA.105.001560; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Rajesh KG, 2003, TRANSPLANTATION, V76, P1314, DOI 10.1097/01.TP.0000085660.93090.79; Rajesh KG, 2003, CARDIOVASC RES, V59, P297, DOI 10.1016/S0008-6363(03)00358-4; Shimizu T, 2009, CURR PHARM DESIGN, V15, P2807, DOI 10.2174/138161209788923822; SILL B, 2009, J VIS EXP; SONG H, 2009, P NATL ACAD SCI US; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394; Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106	22	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9275	10.1371/journal.pone.0009275	http://dx.doi.org/10.1371/journal.pone.0009275			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174664	gold, Green Submitted, Green Published			2022-12-25	WOS:000274590600028
J	Patnaik, SK; Kannisto, E; Yendamuri, S				Patnaik, Santosh Kumar; Kannisto, Eric; Yendamuri, Sai			Overexpression of MicroRNA miR-30a or miR-191 in A549 Lung Cancer or BEAS-2B Normal Lung Cell Lines Does Not Alter Phenotype	PLOS ONE			English	Article							SOLID TUMORS; EXPRESSION; IDENTIFICATION; PROGNOSIS; TARGETS; ADENOCARCINOMA; ESTABLISHMENT; SIGNATURES; PROFILES; GENES	Background: MicroRNAs (miRNAs) are small, noncoding RNAs (ribonucleic acids) that regulate translation. Several miRNAs have been shown to be altered in whole cancer tissue compared to normal tissue when quantified by microarray. Based on previous such evidence of differential expression, we chose to study the functional significance of miRNAs miR-30a and -191 alterations in human lung cancer. Methodology/Principal Findings: The functional significance of miRNAs miR-30a and -191 was studied by creating stable transfectants of the lung adenocarcinoma cell line A549 and the immortalized bronchial epithelial cell line BEAS-2B with modest overexpression of miR-30a or -191 using a lentiviral system. When compared to the corresponding controls, both cell lines overexpressing miR-30a or -191 do not demonstrate any significant changes in cell cycle distribution, cell proliferation, adherent colony formation, soft agar colony formation, xenograft formation in a subcutaneous SCID mouse model, and drug sensitivity to doxorubicin and cisplatin. There is a modest increase in cell migration in cell lines overexpressing miR-30a compared to their controls. Conclusions/Significance: Overexpression of miR-30a or -191 does not lead to an alteration in cell cycle, proliferation, xenograft formation, and chemosensitivity of A549 and BEAS-2B cell lines. Using microarray data from whole tumors to select specific miRNAs for functional study may be a suboptimal strategy.	[Patnaik, Santosh Kumar; Kannisto, Eric; Yendamuri, Sai] Roswell Pk Canc Inst, Dept Thorac Surg, Buffalo, NY 14263 USA; [Yendamuri, Sai] SUNY Buffalo, Dept Surg, Buffalo, NY 14260 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Patnaik, SK (corresponding author), Roswell Pk Canc Inst, Dept Thorac Surg, Buffalo, NY 14263 USA.	sai.yendamuri@roswellpark.org		Yendamuri, Sai/0000-0001-6654-3487	Thoracic Surgery Foundation for Research and Education; Cancer and Leukemia Group B; Buswell Foundation; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Thoracic Surgery Foundation for Research and Education; Cancer and Leukemia Group B; Buswell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work is supported by research grants from the Thoracic Surgery Foundation for Research and Education and the Cancer and Leukemia Group B; SY is supported by a fellowship from the Buswell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; KE Y, 1989, AM J PATHOL, V134, P979; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	18	31	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9219	10.1371/journal.pone.0009219	http://dx.doi.org/10.1371/journal.pone.0009219			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169152	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474700013
J	Gwinn, DM; Asara, JM; Shaw, RJ				Gwinn, Dana M.; Asara, John M.; Shaw, Reuben J.			Raptor is Phosphorylated by cdc2 during Mitosis	PLOS ONE			English	Article							CELL-CYCLE; MAMMALIAN TARGET; PROTEIN-KINASE; RAPAMYCIN MTOR; S6 KINASE-1; COMPLEX; GROWTH; 4E-BP1; TRANSLATION; INHIBITOR	Background: The appropriate control of mitotic entry and exit is reliant on a series of interlocking signaling events that coordinately drive the biological processes required for accurate cell division. Overlaid onto these signals that promote orchestrated cell division are checkpoints that ensure appropriate mitotic spindle formation, a lack of DNA damage, kinetochore attachment, and that each daughter cell has the appropriate complement of DNA. We recently discovered that AMP-activated protein kinase (AMPK) modulates the G2/M phase of cell cycle progression in part through its suppression of mammalian target of rapamycin (mTOR) signaling. AMPK directly phosphorylates the critical mTOR binding partner raptor inhibiting mTORC1 (mTOR-raptor rapamycin sensitive mTOR kinase complex 1). As mTOR has been previously tied to mitotic control, we examined further how raptor may contribute to this process. Methodology/Principal Findings: We have discovered that raptor becomes highly phosphorylated in cells in mitosis. Utilizing tandem mass spectrometry, we identified a number of novel phosphorylation sites in raptor, and using phosphospecific antibodies demonstrated that raptor becomes phosphorylated on phospho-serine/threonine-proline sites in mitosis. A combination of site-directed mutagenesis in a tagged raptor cDNA and analysis with a series of new phosphospecific antibodies generated against different sites in raptor revealed that Serine 696 and Threonine 706 represent two key sites in raptor phosphorylated in mitosis. We demonstrate that the mitotic cyclin-dependent kinase cdc2/CDK1 is the kinase responsible for phosphorylating these sites, and its mitotic partner Cyclin B efficiently coimmunoprecipitates with raptor in mitotic cells. Conclusions/Significance: This study demonstrates that the key mTOR binding partner raptor is directly phosphorylated during mitosis by cdc2. This reinforces previous studies suggesting that mTOR activity is highly regulated and important for mitotic progression, and points to a direct modulation of the mTORC1 complex during mitosis.	[Gwinn, Dana M.; Shaw, Reuben J.] Dulbecco Ctr Canc Res, Mol & Cell Biol Lab, La Jolla, CA USA; [Shaw, Reuben J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Howard Hughes Medical Institute; Salk Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Gwinn, DM (corresponding author), Dulbecco Ctr Canc Res, Mol & Cell Biol Lab, La Jolla, CA USA.	shaw@salk.edu			National Institutes of Health [P01 CA120964, R01 DK080425]; American Cancer Society; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported in part from grants from the National Institutes of Health to R.J.S. and J.M.A. (P01 CA120964), and to R.J.S. (R01 DK080425); and from the American Cancer Society (R.J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; FOSTER KG, 2009, J BIOL CHEM; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Greenberg VL, 2005, ONCOGENE, V24, P4851, DOI 10.1038/sj.onc.1208624; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Heesom KJ, 2001, CURR BIOL, V11, P1374, DOI 10.1016/S0960-9822(01)00422-5; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hou ZB, 2007, J BIOL CHEM, V282, P6922, DOI 10.1074/jbc.M607836200; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nakashima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002223; Papst PJ, 1998, J BIOL CHEM, V273, P15077, DOI 10.1074/jbc.273.24.15077; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shah OJ, 2003, J BIOL CHEM, V278, P16433, DOI 10.1074/jbc.M300435200; Smith EM, 2008, EMBO J, V27, P1005, DOI 10.1038/emboj.2008.39; THOREEN CC, 2009, J BIOL CHEM; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vazquez-Martin A, 2009, CELL CYCLE, V8, P2385, DOI 10.4161/cc.8.15.9082; Wang X, 2009, TRENDS CELL BIOL, V19, P260, DOI 10.1016/j.tcb.2009.03.005; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	33	49	51	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9197	10.1371/journal.pone.0009197	http://dx.doi.org/10.1371/journal.pone.0009197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169205	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474600017
J	Touboul, J; Destexhe, A				Touboul, Jonathan; Destexhe, Alain			Can Power-Law Scaling and Neuronal Avalanches Arise from Stochastic Dynamics?	PLOS ONE			English	Article							DISTRIBUTIONS; TESTS	The presence of self-organized criticality in biology is often evidenced by a power-law scaling of event size distributions, which can be measured by linear regression on logarithmic axes. We show here that such a procedure does not necessarily mean that the system exhibits self-organized criticality. We first provide an analysis of multisite local field potential (LFP) recordings of brain activity and show that event size distributions defined as negative LFP peaks can be close to power-law distributions. However, this result is not robust to change in detection threshold, or when tested using more rigorous statistical analyses such as the Kolmogorov-Smirnov test. Similar power-law scaling is observed for surrogate signals, suggesting that power-law scaling may be a generic property of thresholded stochastic processes. We next investigate this problem analytically, and show that, indeed, stochastic processes can produce spurious power-law scaling without the presence of underlying self-organized criticality. However, this power-law is only apparent in logarithmic representations, and does not survive more rigorous analysis such as the Kolmogorov-Smirnov test. The same analysis was also performed on an artificial network known to display self-organized criticality. In this case, both the graphical representations and the rigorous statistical analysis reveal with no ambiguity that the avalanche size is distributed as a power-law. We conclude that logarithmic representations can lead to spurious power-law scaling induced by the stochastic nature of the phenomenon. This apparent power-law scaling does not constitute a proof of self-organized criticality, which should be demonstrated by more stringent statistical tests.	[Touboul, Jonathan] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Touboul, Jonathan] Rockefeller Univ, Phys Math Lab, New York, NY USA; [Destexhe, Alain] CNRS, UPR 2191, UNIC, Gif Sur Yvette, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rockefeller University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Touboul, J (corresponding author), Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA.	jonathan.touboul@rockefeller.edu		Destexhe, Alain/0000-0001-7405-0455	National Science Foundation (NSF) [DMS0817131]; Centre National de la Recherche Scientifique (CNRS); National Research Agency (ANR); European Community (FACETS project)	National Science Foundation (NSF)(National Science Foundation (NSF)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); National Research Agency (ANR)(French National Research Agency (ANR)); European Community (FACETS project)(European Commission)	This work was funded by the National Science Foundation (NSF) grant DMS0817131 and the Centre National de la Recherche Scientifique (CNRS), National Research Agency (ANR) (grant HR-CORTEX) and the European Community (FACETS project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alili A, 2005, STOCH MODELS, V21, P967, DOI 10.1080/15326340500294702; Arnold BC., 1983, PARETO DISTRIBUTIONS; Bak P., 1996, NATURE WORKS SCI SEL; Barndorff-Nielsen O.E., 1995, INFERENCE ASYMPTOTIC; Bauke H, 2007, EUR PHYS J B, V58, P167, DOI 10.1140/epjb/e2007-00219-y; Bedard C, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051911; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Billingsley Patrick, 1999, CONVERGENCE PROBABIL, V2nd; Boes, 1963, INTRO THEORY STAT; Clauset A, 2007, J CONFLICT RESOLUT, V51, P58, DOI 10.1177/0022002706296157; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Grunwald P. D., 2007, MINIMUM DESCRIPTION; HENNIG M, 2009, J NEUROSCIENCE, V29; Jensen H., 1998, SELF ORGANIZED CRITI; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Levina A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118110; Muniruzzaman A, 1957, B CALCUTTA STAT ASS, V7, P115; Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009; PETERMANN T, 2009, P NATL ACAD SCI, V106; PLESSER HE, 1999, THESIS G AUGUST U GO; Schrodinger E, 1915, PHYS Z, V16, P289; STERIADE M, 2001, J NEUROPHYSIOLOGY, V86; STOEV S, 2006, MATHST0609163 ARXIV; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; Touboul J, 2007, J PHYSIOL-PARIS, V101, P78, DOI 10.1016/j.jphysparis.2007.10.008; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557	28	117	117	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e8982	10.1371/journal.pone.0008982	http://dx.doi.org/10.1371/journal.pone.0008982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161798	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000274442800002
J	Gruber, A; Manimekalai, MSS; Balakrishna, AM; Hunke, C; Jeyakanthan, J; Preiser, PR; Gruber, G				Grueber, Ardina; Manimekalai, Malathy S. S.; Balakrishna, Asha M.; Hunke, Cornelia; Jeyakanthan, Jeyaraman; Preiser, Peter R.; Grueber, Gerhard			Structural Determination of Functional Units of the Nucleotide Binding Domain (NBD94) of the Reticulocyte Binding Protein Py235 of Plasmodium yoelii	PLOS ONE			English	Article							RED-BLOOD-CELLS; SECONDARY STRUCTURE; CIRCUMSPOROZOITE PROTEIN; ERYTHROCYTE INVASION; PHENOTYPIC VARIATION; RHOPTRY-PROTEIN; ATP SYNTHASE; SUBUNIT-A; PARASITE; VIVAX	Background: Invasion of the red blood cells (RBC) by the merozoite of malaria parasites involves a large number of receptor ligand interactions. The reticulocyte binding protein homologue family (RH) plays an important role in erythrocyte recognition as well as virulence. Recently, it has been shown that members of RH in addition to receptor binding may also have a role as ATP/ADP sensor. A 94 kDa region named Nucleotide-Binding Domain 94 (NBD94) of Plasmodium yoelii YM, representative of the putative nucleotide binding region of RH, has been demonstrated to bind ATP and ADP selectively. Binding of ATP or ADP induced nucleotide-dependent structural changes in the C-terminal hinge-region of NBD94, and directly impacted on the RBC binding ability of RH. Methodology/Principals Findings: In order to find the smallest structural unit, able to bind nucleotides, and its coupling module, the hinge region, three truncated domains of NBD94 have been generated, termed NBD94(444-547), NBD94(566-663) and NBD94(674-793), respectively. Using fluorescence correlation spectroscopy NBD94(444-547) has been identified to form the smallest nucleotide binding segment, sensitive for ATP and ADP, which became inhibited by 4-Chloro-7-nitrobenzofurazan. The shape of NBD94(444-547) in solution was calculated from small-angle X-ray scattering data, revealing an elongated molecule, comprised of two globular domains, connected by a spiral segment of about 73.1 angstrom in length. The high quality of the constructs, forming the hinge-region, NBD94(566-663) and NBD94(674-793) enabled to determine the first crystallographic and solution structure, respectively. The crystal structure of NBD94(566-663) consists of two helices with 97.8 angstrom and 48.6 angstrom in length, linked by a loop. By comparison, the low resolution structure of NBD94(674-793) in solution represents a chair-like shape with three architectural segments. Conclusions: These structures give the first insight into how nucleotide binding impacts on the overall structure of RH and demonstrates the potential use of this region as a novel drug target.	[Grueber, Ardina; Manimekalai, Malathy S. S.; Balakrishna, Asha M.; Hunke, Cornelia; Preiser, Peter R.; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Jeyakanthan, Jeyaraman] Natl Synchrotron Radiat Res Ctr, Hsinchu, Taiwan	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Synchrotron Radiation Research Center	Gruber, A (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	ggrueber@ntu.edu.sg	Manikkoth Balakrishna, Asha/AFP-1973-2022; Preiser, Peter R/A-2201-2011	Manikkoth Balakrishna, Asha/0000-0001-5239-9015; , Peter/0000-0003-4331-7000; Jeyakanthan, Jeyaraman/0000-0002-4594-9610	A*STAR BMRC [06/1/22/19/456, 06/1/22/19/467]	A*STAR BMRC(Agency for Science Technology & Research (A*STAR))	This research was supported by A*STAR BMRC (06/1/22/19/456 and 06/1/22/19/467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOULIN C, 1986, NUCL INSTRUM METH A, V249, P399, DOI 10.1016/0168-9002(86)90694-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DLUZEWSKI AR, 1983, PARASITOLOGY, V87, P429, DOI 10.1017/S0031182000082950; DLUZEWSKI AR, 1983, MOL BIOCHEM PARASIT, V9, P145, DOI 10.1016/0166-6851(83)90106-8; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Ellsworth ML, 2004, MED SCI SPORT EXER, V36, P35, DOI 10.1249/01.MSS.0000106284.80300.B2; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREEMAN RR, 1980, NATURE, V284, P366, DOI 10.1038/284366a0; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Galinski MR, 1996, PARASITOL TODAY, V12, P20, DOI 10.1016/0169-4758(96)80641-7; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; GOLENDA CF, 1990, J HISTOCHEM CYTOCHEM, V38, P475, DOI 10.1177/38.4.2181019; Gruber G, 2002, BIOCHEM BIOPH RES CO, V298, P383, DOI 10.1016/S0006-291X(02)02468-3; Gruner AC, 2004, MICROBES INFECT, V6, P864, DOI 10.1016/j.micinf.2004.04.004; Guinier A., 1955, SMALL ANGLE SCATTERI; Holder AA, 1981, NATURE, V294, P361, DOI 10.1038/294361a0; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; HUBER M, 1991, P NATL ACAD SCI USA, V88, P2807, DOI 10.1073/pnas.88.7.2807; Hunke C, 2007, PROTEIN EXPRES PURIF, V53, P378, DOI 10.1016/j.pep.2007.01.009; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Iyer JK, 2007, MOL MICROBIOL, V65, P333, DOI 10.1111/j.1365-2958.2007.05786.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MEIS JFGM, 1992, PARASITOL RES, V78, P165, DOI 10.1007/BF00931660; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; OGUN SA, 1994, EXP PARASITOL, V79, P270, DOI 10.1006/expr.1994.1090; Ogun SA, 2000, EXP PARASITOL, V95, P187, DOI 10.1006/expr.2000.4535; OLSON JA, 1982, J CELL BIOL, V95, P757, DOI 10.1083/jcb.95.3.757; Orriss GL, 1998, STRUCT FOLD DES, V6, P831, DOI 10.1016/S0969-2126(98)00085-9; OSIPCHUK Y, 1992, NATURE, V359, P241, DOI 10.1038/359241a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Preiser P, 2000, MICROBES INFECT, V2, P1461, DOI 10.1016/S1286-4579(00)01301-0; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Ramalingam JK, 2008, J BIOL CHEM, V283, P36386, DOI 10.1074/jbc.M803102200; RANGACHARI K, 1989, MOL BIOCHEM PARASIT, V34, P63, DOI 10.1016/0166-6851(89)90020-0; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rodriguez LE, 2008, CHEM REV, V108, P3656, DOI 10.1021/cr068407v; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; Schafer HJ, 2001, BIOCHEM BIOPH RES CO, V286, P1218, DOI 10.1006/bbrc.2001.5502; Schafer IB, 2006, J MOL BIOL, V358, P725, DOI 10.1016/j.jmb.2006.02.057; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Snounou G, 2000, PARASITOL TODAY, V16, P28, DOI 10.1016/S0169-4758(99)01546-X; Sprague RS, 1996, AM J PHYSIOL-HEART C, V271, pH2717, DOI 10.1152/ajpheart.1996.271.6.H2717; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; SUTTON R, 1985, EUR J BIOCHEM, V148, P551, DOI 10.1111/j.1432-1033.1985.tb08875.x; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Svergun DI, 2000, BIOCHEMISTRY-US, V39, P10677, DOI 10.1021/bi000865p; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TRIGLIA T, 2009, CELL MICROB IN PRESS; VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x	67	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9146	10.1371/journal.pone.0009146	http://dx.doi.org/10.1371/journal.pone.0009146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161776	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442700010
J	Uys, C; Hamer, M; Slotow, R				Uys, Charmaine; Hamer, Michelle; Slotow, Rob			Step Process for Selecting and Testing Surrogates and Indicators of Afrotemperate Forest Invertebrate Diversity	PLOS ONE			English	Article							BIODIVERSITY ASSESSMENT; AGRICULTURAL LANDSCAPES; EPIGAEIC INVERTEBRATES; HABITAT DISTURBANCE; SPECIES RICHNESS; TAXA; CONSERVATION; ASSEMBLAGES; SCORPIONIDA; STRATEGIES	Background: The diversity and complexity of invertebrate communities usually result in their exclusion from conservation activities. Here we provide a step process for assessing predominantly ground-dwelling Afrotemperate forest invertebrates' (earthworms, centipedes, millipedes, ants, molluscs) potential as surrogates for conservation and indicators for monitoring. We also evaluated sampling methods (soil and litter samples, pitfall traps, active searching quadrats and tree beating) and temporal (seasonal) effects. Methodology/Principal Findings: Lack of congruence of species richness across taxa indicated poor surrogacy potential for any of the focus taxa. Based on abundance and richness, seasonal stability, and ease of sampling, molluscs were the most appropriate taxon for use in monitoring of disturbance impacts. Mollusc richness was highest in March (Antipodal late summer wet season). The most effective and efficient methods were active searching quadrats and searching litter samples. We tested the effectiveness of molluscs as indicators for monitoring by contrasting species richness and community structure in burned relative to unburned forests. Both species richness and community structure changed significantly with burning. Some mollusc species (e. g. Macroptychia africana) showed marked negative responses to burning, and these species have potential for use as indicators. Conclusions/Significance: Despite habitat type (i.e., Afrotemperate forest) being constant, species richness and community structure varied across forest patches. Therefore, in conservation planning, setting targets for coarse filter features (e. g., habitat type) requires fine filter features (e. g., localities for individual species). This is especially true for limited mobility taxa such as those studied here. Molluscs have high potential for indicators for monitoring, and this requires broader study.	[Uys, Charmaine; Hamer, Michelle; Slotow, Rob] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Pietermaritzburg, Kwazulunatal, South Africa	University of Kwazulu Natal	Uys, C (corresponding author), Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, Western Cape, South Africa.	slotow@ukzn.ac.za	Slotow, Rob/AAM-9053-2020	Slotow, Rob/0000-0001-9469-1508	National Research Foundation	National Research Foundation	Financial support for this study was provided by the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSTI D, 2005, ANTBASE; Andersen AN, 1999, J INSECT CONSERV, V3, P61; Andersen AN, 2004, AUSTRAL ECOL, V29, P87, DOI 10.1111/j.1442-9993.2004.01362.x; Andersen AN, 2004, FRONT ECOL ENVIRON, V2, P291; Billeter R, 2008, J APPL ECOL, V45, P141, DOI 10.1111/j.1365-2664.2007.01393.x; Bilton DT, 2006, FRESHWATER BIOL, V51, P578, DOI 10.1111/j.1365-2427.2006.01505.x; CLARKE KR, 2001, PRIMER VERSION 5; Didham RK, 2003, ARTHROPODS OF TROPICAL FORESTS, P28; Druce D, 2004, AFR ZOOL, V39, P293; Druce D, 2007, AFR ZOOL, V42, P204, DOI 10.3377/1562-7020(2007)42[204:POMDCC]2.0.CO;2; Emberton KC, 1996, MALACOLOGIA, V38, P203; Fontaine B, 2007, DIVERS DISTRIB, V13, P725, DOI 10.1111/j.1472-4642.2007.00376.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GOVENDER V, 2009, THESIS U KWAZULU NAT; Hamer M. L., 1997, Annals of the Natal Museum, V38, P283; Hamer M. L., 1998, Annals of the Natal Museum, V39, P11; Hamer ML, 2002, AFR ENTOMOL, V10, P29; Hemp A, 2009, AFR J ECOL, V47, P3, DOI 10.1111/j.1365-2028.2008.01043.x; Herbert D, 2004, FIELD GUIDE LAND SNA; HORN JL, 2007, AFRICAN ZOOLOGY, V42, P171; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Hurlbert SH, 2004, OIKOS, V104, P591, DOI 10.1111/j.0030-1299.2004.12752.x; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Kati V, 2004, CONSERV BIOL, V18, P667, DOI 10.1111/j.1523-1739.2004.00465.x; Kotze DJ, 1999, J INSECT CONSERV, V3, P125, DOI 10.1023/A:1009660601372; KREMEN C, 1993, CONSERV BIOL, V7, P796, DOI 10.1046/j.1523-1739.1993.740796.x; Lawes MJ, 2005, BIOTROPICA, V37, P109, DOI 10.1111/j.1744-7429.2005.04054.x; LAWES MJ, 1990, J BIOGEOGR, V17, P669, DOI 10.2307/2845148; Lawrence R. F., 1984, CENTIPEDES MILLIPEDE; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lindenmayer DB, 2006, BIOL CONSERV, V131, P433, DOI 10.1016/j.biocon.2006.02.019; Lombard AT, 1995, S AFR J ZOOL, V30, P145; Longino JT, 1997, ECOL APPL, V7, P1263, DOI 10.1890/1051-0761(1997)007[1263:BAUSIC]2.0.CO;2; LOVELL S, 2010, AUSTR ECOLO IN PRESS; Lovell S, 2007, BIOL CONSERV, V139, P113, DOI 10.1016/j.biocon.2007.06.008; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; MESIBOV R, 1995, BIODIVERS CONSERV, V4, P429, DOI 10.1007/BF00058426; MUCINA L, 2006, VEGETATION S AFRICA, V19, pCH12; New TR, 2000, J INSECT CONSERV, V4, P153, DOI 10.1023/A:1009668817271; New TR, 1999, J INSECT CONSERV, V3, P251, DOI 10.1023/A:1009697104759; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Parr CL, 2002, AFR ENTOMOL, V10, P101; Pickford G. E., 1937, MONOGRAPH ACANTHODRI; Plisko Jadwiga Danuta, 2003, African Invertebrates, V44, P279; Pocock MJO, 2008, J APPL ECOL, V45, P151, DOI 10.1111/j.1365-2664.2007.01361.x; Ponder W. F., 1999, OTHER 99 CONSERVATIO; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Ricketts TH, 2002, BIOL CONSERV, V103, P361, DOI 10.1016/S0006-3207(01)00147-1; Rohr JR, 2007, CONSERV BIOL, V21, P422, DOI 10.1111/j.1523-1739.2006.00578.x; Sauberer N, 2004, BIOL CONSERV, V117, P181, DOI 10.1016/S0006-3207(03)00291-X; Schulze RE., 1997, S AFRICAN ATLAS AGRO; Scott WA, 2003, BIOL CONSERV, V110, P197, DOI 10.1016/S0006-3207(02)00189-1; Slotow R, 2000, S AFR J SCI, V96, P222; Stanisic J, 2007, MALACOLOGIA, V49, P445, DOI 10.4002/0076-2997-49.2.445; Summerville KS, 2004, BIOL CONSERV, V116, P9, DOI 10.1016/S0006-3207(03)00168-X; Underwood EC, 2006, BIOL CONSERV, V132, P166, DOI 10.1016/j.biocon.2006.03.022; Uys C, 2009, AFR J ECOL, V47, P341, DOI 10.1111/j.1365-2028.2008.00968.x; Ward DF, 2004, NEW ZEAL J ECOL, V28, P151	59	15	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9100	10.1371/journal.pone.0009100	http://dx.doi.org/10.1371/journal.pone.0009100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161757	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442600007
J	Wiley, JC; Meabon, JS; Frankowski, H; Smith, EA; Schecterson, LC; Bothwell, M; Ladiges, WC				Wiley, Jesse C.; Meabon, James S.; Frankowski, Harald; Smith, Elise A.; Schecterson, Leslayann C.; Bothwell, Mark; Ladiges, Warren C.			Phenylbutyric Acid Rescues Endoplasmic Reticulum Stress-Induced Suppression of APP Proteolysis and Prevents Apoptosis in Neuronal Cells	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE COMPLEX; ALZHEIMERS-DISEASE; INTRACELLULAR DOMAIN; BETA-SECRETASE; MOUSE MODEL; PRESENILIN MUTATIONS; ALPHA-SECRETASE; ER STRESS; IN-VIVO	Background: The familial and sporadic forms of Alzheimer's disease (AD) have an identical pathology with a severe disparity in the time of onset [1]. The pathological similarity suggests that epigenetic processes may phenocopy the Familial Alzheimer's disease (FAD) mutations within sporadic AD. Numerous groups have demonstrated that FAD mutations in presenilin result in 'loss of function' of gamma-secretase mediated APP cleavage [2,3,4,5]. Accordingly, ER stress is prominent within the pathologically impacted brain regions in AD patients [6] and is reported to inhibit APP trafficking through the secretory pathway [7,8]. As the maturation of APP and the cleaving secretases requires trafficking through the secretory pathway [9,10,11], we hypothesized that ER stress may block trafficking requisite for normal levels of APP cleavage and that the small molecular chaperone 4-phenylbutyrate (PBA) may rescue the proteolytic deficit. Methodology/Principal Findings: The APP-Gal4VP16/Gal4-reporter screen was stably incorporated into neuroblastoma cells in order to assay gamma-secretase mediated APP proteolysis under normal and pharmacologically induced ER stress conditions. Three unrelated pharmacological agents (tunicamycin, thapsigargin and brefeldin A) all repressed APP proteolysis in parallel with activation of unfolded protein response (UPR) signaling-a biochemical marker of ER stress. Co-treatment of the gamma-secretase reporter cells with PBA blocked the repressive effects of tunicamycin and thapsigargin upon APP proteolysis, UPR activation, and apoptosis. In unstressed cells, PBA stimulated gamma-secretase mediated cleavage of APP by 8-10 fold, in the absence of any significant effects upon amyloid production, by promoting APP trafficking through the secretory pathway and the stimulation of the non-pathogenic alpha/gamma-cleavage. Conclusions/Significance: ER stress represses gamma-secretase mediated APP proteolysis, which replicates some of the proteolytic deficits associated with the FAD mutations. The small molecular chaperone PBA can reverse ER stress induced effects upon APP proteolysis, trafficking and cellular viability. Pharmaceutical agents, such as PBA, that stimulate alpha/gamma-cleavage of APP by modifying intracellular trafficking should be explored as AD therapeutics.	[Wiley, Jesse C.; Smith, Elise A.; Ladiges, Warren C.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Meabon, James S.; Frankowski, Harald; Schecterson, Leslayann C.; Bothwell, Mark] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wiley, JC (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.	jwiley@u.washington.edu	Longo, Kenneth A/A-5631-2010	SCHECTERSON, LESLAYANN/0000-0002-3896-998X; Bothwell, Mark/0000-0001-5423-2702	Alzheimer's Association [NIRG-07-59865]	Alzheimer's Association(Alzheimer's Association)	This work was funded by a New Investigator Award from the Alzheimer's Association (NIRG-07-59865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BASSERI S, 2009, J LIPID RES; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Domingues SCTS, 2007, ANN NY ACAD SCI, V1096, P184, DOI 10.1196/annals.1397.085; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hu QB, 2005, J BIOL CHEM, V280, P12548, DOI 10.1074/jbc.M411855200; HUNZIKER W, 1992, FEBS LETT, V307, P93, DOI 10.1016/0014-5793(92)80908-Y; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Jung M, 2001, CURR MED CHEM, V8, P1505, DOI 10.2174/0929867013372058; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kim I, 2009, J BIOL CHEM, V284, P1593, DOI 10.1074/jbc.M807308200; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Kim ML, 2008, J NEUROSCI, V28, P12052, DOI 10.1523/JNEUROSCI.2913-08.2008; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kinoshita A, 2002, J BIOL CHEM, V277, P28530, DOI 10.1074/jbc.M203372200; Kudo T, 2006, BIOCHEM BIOPH RES CO, V344, P525, DOI 10.1016/j.bbrc.2006.03.173; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Nakayama K, 2008, NEUROSCI LETT, V444, P127, DOI 10.1016/j.neulet.2008.08.034; Nishitsuji K, 2009, AM J PATHOL, V174, P957, DOI 10.2353/ajpath.2009.080480; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; OZAKI T, 2006, BIOCH BIOPHYS RES CO; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; RICOBARAZA A, 2009, NEUROPSYCHOPHARMACOL; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Scheper W, 2009, CURR MED CHEM, V16, P615, DOI 10.2174/092986709787458506; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroeder A, 2009, J ALZHEIMERS DIS, V16, P309, DOI 10.3233/JAD-2009-0952; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; van den Brandt J, 2004, EUR J IMMUNOL, V34, P1405, DOI 10.1002/eji.200324735; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vilatoba M, 2005, SURGERY, V138, P342, DOI 10.1016/j.surg.2005.04.019; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wiley JC, 2005, J NEUROCHEM, V94, P1189, DOI 10.1111/j.1471-4159.2005.03266.x; Wiley JC, 2007, J BIOL CHEM, V282, P33313, DOI 10.1074/jbc.M706024200; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Yang Z, 2006, J BIOL CHEM, V281, P4207, DOI 10.1074/jbc.M508445200	59	60	65	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9135	10.1371/journal.pone.0009135	http://dx.doi.org/10.1371/journal.pone.0009135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161760	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442600031
J	Weisfelt, M; de Gans, J; van der Ende, A; van de Beek, D				Weisfelt, Martijn; de Gans, Jan; van der Ende, Arie; van de Beek, Diederik			Community-Acquired Bacterial Meningitis in Alcoholic Patients	PLOS ONE			English	Article							PRACTICE GUIDELINES; CLINICAL-FEATURES; ADULTS; CONSUMPTION; DEXAMETHASONE; DAMAGE	Background: Alcoholism is associated with susceptibility to infectious disease, particularly bacterial pneumonia. In the present study we described characteristics in alcoholic patients with bacterial meningitis and delineate the differences with findings in non-alcoholic adults with bacterial meningitis. Methods and Principal Findings: This was a prospective nationwide observational cohort study including patients aged > 16 years who had bacterial meningitis confirmed by culture of cerebrospinal fluid (696 episodes of bacterial meningitis occurring in 671 patients). Alcoholism was present in 27 of 686 recorded episodes of bacterial meningitis (4%) and alcoholics were more often male than non-alcoholics (82% vs 48%, P = 0.001). A higher proportion of alcoholics had underlying pneumonia (41% vs 11% P < 0.001). Alcoholics were more likely to have meningitis due to infection with Streptococcus pneumoniae (70% vs 50%, P = 0.01) and Listeria monocytogenes (19% vs 4%, P = 0.005), whereas Neisseria meningitidis was more common in non-alcoholic patients (39% vs 4%, P = 0.01). A large proportion of alcoholics developed complications during clinical course (82% vs 62%, as compared with non-alcoholics; P = 0.04), often cardiorespiratory failure (52% vs 28%, as compared with non-alcoholics; P = 0.01). Alcoholic patients were at risk for unfavourable outcome (67% vs 33%, as compared with non-alcoholics; P < 0.001). Conclusions and Significance: Alcoholic patients are at high risk for complications resulting in high morbidity and mortality. They are especially at risk for cardiorespiratory failure due to underlying pneumonia, and therefore, aggressive supportive care may be crucial in the treatment of these patients.	[Weisfelt, Martijn] Kennemer Gasthuis, Dept Neurol, Haarlem, Netherlands; [de Gans, Jan] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, Dept Neurol,Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie; van de Beek, Diederik] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, Dept Microbiol,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands	Spaarne Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Weisfelt, M (corresponding author), Kennemer Gasthuis, Dept Neurol, Haarlem, Netherlands.	D.vandeBeek@amc.uva.nl	van der Ende, Arie/A-4346-2012; van de Beek, Diederik/Y-2713-2019; van de beek, diederik/A-2935-2010	van de Beek, Diederik/0000-0002-4571-044X; van der Ende, Arie/0000-0003-1298-3086	Roche Pharmaceuticals, The Netherlands	Roche Pharmaceuticals, The Netherlands(Netherlands GovernmentRoche Holding)	Funding: The Dutch Meningitis Cohort Study was in part supported by a research grant of Roche Pharmaceuticals, The Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batty GD, 2009, J PSYCHOSOM RES, V66, P317, DOI 10.1016/j.jpsychores.2008.09.021; Brand RM, 2009, J IMMUNOL, V182; Cook RT, 1998, ALCOHOL CLIN EXP RES, V22, P1927, DOI 10.1097/00000374-199812000-00007; Culebras A, 1997, STROKE, V28, P1480, DOI 10.1161/01.STR.28.7.1480; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Delgado-Rodriguez M, 2003, BRIT J SURG, V90, P1287, DOI 10.1002/bjs.4186; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; ENZMANN DR, 1983, RADIOLOGY, V146, P703, DOI 10.1148/radiology.146.3.6828685; Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399; JENNETT B, 1975, LANCET, V1, P480; Lau A, 2009, ANESTH ANALG, V108, P916, DOI 10.1213/ane.0b013e318193fd89; MANDEL G, 2005, PRINCIPLES PRACTICE; McMillan DA, 2001, CLIN INFECT DIS, V33, P969, DOI 10.1086/322612; MOORE RD, 1989, JAMA-J AM MED ASSOC, V261, P403, DOI 10.1001/jama.261.3.403; *NETH REF LAB BACT, 2005, BACT MEN NETH ANN RE; *NIAAA, STRAT PLAN RES 2006; Pauwels A, 1997, J HEPATOL, V27, P830, DOI 10.1016/S0168-8278(97)80320-0; PILLAI R, 1990, ALCOHOL ALCOHOLISM, V25, P711, DOI 10.1093/oxfordjournals.alcalc.a045069; ROORD JJ, 1997, CONSENSUS BIJEENKOMS; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; TUNKEL AR, 2001, BACTERIAL MENINGITIS; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2004, LANCET INFECT DIS, V4, P139, DOI 10.1016/S1473-3099(04)00937-5; van de Beek D, 2002, J ANTIMICROB CHEMOTH, V49, P661, DOI 10.1093/jac/49.4.661; van de Beek D, 2004, ANN INTERN MED, V141, P327, DOI 10.7326/0003-4819-141-4-200408170-00028; van de Beek D, 2006, NAT CLIN PRACT NEURO, V2, P504, DOI 10.1038/ncpneuro0265; Weisfelt M, 2006, LANCET NEUROL, V5, P123, DOI 10.1016/S1474-4422(05)70288-X; Weisfelt M, 2007, EXPERT OPIN PHARMACO, V8, P1493, DOI 10.1517/14656566.8.10.1493	31	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9102	10.1371/journal.pone.0009102	http://dx.doi.org/10.1371/journal.pone.0009102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161709	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442500009
J	Mizuno, Y; Chang, H; Umeda, K; Niwa, A; Iwasa, T; Awaya, T; Fukada, S; Yamamoto, H; Yamanaka, S; Nakahata, T; Heike, T				Mizuno, Yuta; Chang, Hsi; Umeda, Katsutsugu; Niwa, Akira; Iwasa, Toru; Awaya, Tomonari; Fukada, So-ichiro; Yamamoto, Hiroshi; Yamanaka, Shinya; Nakahata, Tatsutoshi; Heike, Toshio			Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells	FASEB JOURNAL			English	Article						Duchenne muscular dystrophy; Pax7; long-term engraftment; no teratoma formation; high engraftment efficiency	BONE-MARROW; DYSTROPHIN EXPRESSION; SATELLITE CELLS; MOUSE; REGENERATION; FIBROBLASTS; PROGENITORS; CULTURE; MDX	Induced pluripotent stem (iPS) cells, which are a type of pluripotent stem cell generated from reprogrammed somatic cells, are expected to have potential for patient-oriented disease investigation, drug screening, toxicity tests, and transplantation therapies. Here, we demonstrated that murine iPS cells have the potential to develop in vitro into skeletal muscle stem/progenitor cells, which are almost equivalent to murine embryonic stem cells. Cells with strong in vitro myogenic potential effectively were enriched by fluorescence-activated cell sorting using the anti-satellite cell antibody SM/C-2.6. Furthermore, on transplantation into mdx mice, SM/C-2.6(+) cells exerted sustained myogenic lineage differentiation in injured muscles, while providing long-lived muscle stem cell support. Our data suggest that iPS cells have the potential to be used in clinical treatment of muscular dystrophies.-Mizuno, Y., Chang, H., Umeda, K., Niwa, A., Iwasa, T., Awaya, T., Fukada, S., Yamamoto, H., Yamanaka, S., Nakahata, T., Heike, T. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J. 24, 2245-2253 (2010). www.fasebj.org	[Heike, Toshio] Kyoto Univ, Dept Pediat, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan; [Yamanaka, Shinya] Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Yamanaka, Shinya; Nakahata, Tatsutoshi] Kyoto Univ, Ctr iPS Cell Res & Applicat, Inst Integrated Cell Mat Sci, Kyoto 6068507, Japan; [Fukada, So-ichiro; Yamamoto, Hiroshi] Osaka Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Osaka, Japan; [Yamanaka, Shinya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Kyoto University; Kyoto University; Kyoto University; Osaka University; Japan Science & Technology Agency (JST)	Heike, T (corresponding author), Kyoto Univ, Dept Pediat, Grad Sch Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	heike@kuhp.kyoto-u.ac.jp	Fukada, So-ichiro/AAI-9151-2020; Awaya, Tomonari/O-2757-2015	Fukada, So-ichiro/0000-0003-4051-5108; Awaya, Tomonari/0000-0002-9004-3172	Japan Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [22249042] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Ministry of Education, Culture, Sports, Science, and Technology.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Baba S, 2007, STEM CELLS, V25, P1375, DOI 10.1634/stemcells.2006-0574; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Bhagavati S, 2005, BIOCHEM BIOPH RES CO, V333, P644, DOI 10.1016/j.bbrc.2005.05.135; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chang H, 2009, FASEB J, V23, P1907, DOI 10.1096/fj.08-123661; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Harris JB, 2003, TOXICON, V42, P933, DOI 10.1016/j.toxicon.2003.11.011; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PARTRIDGE TA, 1991, MUSCLE NERVE, V14, P197, DOI 10.1002/mus.880140302; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Sakurai H, 2008, STEM CELLS, V26, P1865, DOI 10.1634/stemcells.2008-0173; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; SMITH TH, 1993, DEVELOPMENT, V117, P1125; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Tsuchiya A, 2007, STEM CELLS, V25, P895, DOI 10.1634/stemcells.2006-0558; WALLACE GQ, 2008, ANN REV PHYSL; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	45	119	135	2	46	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2245	2253		10.1096/fj.09-137174	http://dx.doi.org/10.1096/fj.09-137174			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20181939				2022-12-25	WOS:000279343600011
J	Premkumar, L; Bobkov, AA; Patel, M; Jaroszewski, L; Bankston, LA; Stec, B; Vuori, K; Cote, JF; Liddington, RC				Premkumar, Lakshmanane; Bobkov, Andrey A.; Patel, Manishha; Jaroszewski, Lukasz; Bankston, Laurie A.; Stec, Boguslaw; Vuori, Kristiina; Cote, Jean-Francois; Liddington, Robert C.			Structural Basis of Membrane Targeting by the Dock180 Family of Rho Family Guanine Exchange Factors (Rho-GEFs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; NUCLEOTIDE-EXCHANGE; C2 DOMAIN; CELL-MIGRATION; MYOBLAST CITY; CRKII/DOCK180/RAC PATHWAY; APOPTOTIC CELLS; CDC42 ACTIVATOR; BINDING; PROTEIN	The Dock180 family of atypical Rho family guanine nucleotide exchange factors (Rho-GEFs) regulate a variety of processes involving cellular or subcellular polarization, including cell migration and phagocytosis. Each contains a Dock homology region-1 (DHR-1) domain that is required to localize its GEF activity to a specific membrane compartment where levels of phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P-3) are up-regulated by the local activity of PtdIns 3-kinase. Here we define the structural and energetic bases of phosphoinositide specificity by the DHR-1 domain of Dock1 (a GEF for Rac1), and show that DHR-1 utilizes a C2 domain scaffold and surface loops to create a basic pocket on its upper surface for recognition of the PtdIns(3,4,5)P-3 head group. The pocket has many of the characteristics of those observed in pleckstrin homology domains. We show that point mutations in the pocket that abolish phospholipid binding in vitro ablate the ability of Dock1 to induce cell polarization, and propose a model that brings together recent mechanistic and structural studies to rationalize the central role of DHR-1 in dynamic membrane targeting of the Rho-GEF activity of Dock180.	[Stec, Boguslaw; Liddington, Robert C.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Bobkov, Andrey A.; Jaroszewski, Lukasz; Vuori, Kristiina] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA 92037 USA; [Patel, Manishha; Cote, Jean-Francois] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Liddington, RC (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@burnham.org		Stec, Boguslaw/0000-0002-8696-0349	National Institutes of Health NIGMS Cell Migration Consortium [U54 GM06346]; Canadian Institute of Health Research; IRCM Training Program in Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health NIGMS Cell Migration Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); IRCM Training Program in Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS Cell Migration Consortium Grant U54 GM06346 (to R. C. L.) and the Canadian Institute of Health Research (to J.-F.C.).; Supported by a Canadian Institute of Health Research award from the IRCM Training Program in Cancer Research.; Holds a Canadian Institute of Health Research New Investigator award.	Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Balagopalan L, 2006, MOL CELL BIOL, V26, P9442, DOI 10.1128/MCB.00016-06; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cadmel B, 2008, J PROTEOME RES, V7, P5295, DOI 10.1021/pr800540h; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; Cullen PJ, 2001, CURR BIOL, V11, pR882, DOI 10.1016/S0960-9822(01)00523-1; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Grobler JA, 1996, NAT STRUCT BIOL, V3, P788, DOI 10.1038/nsb0996-788; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Handa Y, 2007, NAT CELL BIOL, V9, P121, DOI 10.1038/ncb1526; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kanai A, 2008, IUBMB LIFE, V60, P467, DOI 10.1002/iub.67; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Kobayashi S, 2001, BIOCHEM J, V354, P73, DOI 10.1042/0264-6021:3540073; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Kuramoto K, 2009, J NEUROSCI RES, V87, P1794, DOI 10.1002/jnr.21997; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Matsuda M, 1996, J BIOL CHEM, V271, P14468, DOI 10.1074/jbc.271.24.14468; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Meller N, 2004, J BIOL CHEM, V279, P37470, DOI 10.1074/jbc.M404535200; Meller N, 2008, BIOCHEM J, V409, P525, DOI 10.1042/BJ20071263; Moore CA, 2007, DEVELOPMENT, V134, P3145, DOI 10.1242/dev.001214; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narayan K, 2006, METHODS, V39, P122, DOI 10.1016/j.ymeth.2006.05.006; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Omi N, 2008, EXP EYE RES, V86, P828, DOI 10.1016/j.exer.2008.02.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Para A, 2009, MOL BIOL CELL, V20, P699, DOI 10.1091/mbc.E08-09-0899; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sanchez-Bautista S, 2006, J MOL BIOL, V362, P901, DOI 10.1016/j.jmb.2006.07.093; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Schwarzenbacher R, 2008, ACTA CRYSTALLOGR D, V64, P133, DOI 10.1107/S0907444907050111; Skowronek KR, 2004, J BIOL CHEM, V279, P37895, DOI 10.1074/jbc.M312677200; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Wohlwend D, 2007, J MOL BIOL, V374, P1129, DOI 10.1016/j.jmb.2007.09.065; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468	86	44	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13211	13222		10.1074/jbc.M110.102517	http://dx.doi.org/10.1074/jbc.M110.102517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20167601	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000276787800076
J	Zhou, MX; Zhu, F; Dong, SL; Pritchard, DG; Wu, H				Zhou, Meixian; Zhu, Fan; Dong, Shengli; Pritchard, David G.; Wu, Hui			A Novel Glucosyltransferase Is Required for Glycosylation of a Serine-rich Adhesin and Biofilm Formation by Streptococcus parasanguinis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIMBRIAE-ASSOCIATED ADHESIN; BINDING-PROTEIN GSPB; ACCESSORY SEC SYSTEM; STAPHYLOCOCCUS-AUREUS; SURFACE PROTEIN; HUMAN PLATELETS; SANGUIS FW213; FAP1; GLYCOPROTEIN; GLYCOSYLTRANSFERASES	Fap1-like serine-rich glycoproteins are conserved in streptococci, staphylococci, and lactobacilli, and are required for bacterial biofilm formation and pathogenesis. Glycosylation of Fap1 is mediated by a gene cluster flanking the fap1 locus. The key enzymes responsible for the first step of Fap1 glycosylation are glycosyltransferases Gtf1 and Gtf2. They form a functional enzyme complex that catalyzes the transfer of N-acetylglucosamine (GlcNAc) residues to the Fap1 polypeptide. However, until now nothing was known about the subsequent step in Fap1 glycosylation. Here, we show that the second step in Fap1 glycosylation is catalyzed by nucleotide-sugar synthetase-like (Nss) protein. The nss gene located upstream of fap1 is also highly conserved in streptococci and lactobacilli. Nss-deficient mutants failed to catalyze the second step of Fap1 glycosylation in vivo in Streptococcus parasanguinis and in a recombinant Fap1 glycosylation system. Nss catalyzed the direct transfer of the glucosyl residue to the GlcNAc-modified Fap1 substrate in vitro, demonstrating that Nss is a glucosyltransferase. Thus we renamed Nss as glucosyltransferase 3 (Gtf3). A gtf3 mutant exhibited a biofilm defect. Taken together, we conclude that this new glucosyltransferase mediates the second step of Fap1 glycosylation and is required for biofilm formation.	[Wu, Hui] Univ Alabama, Dept Pediat Dent, Sch Dent, Birmingham, AL 35244 USA; [Dong, Shengli; Pritchard, David G.] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35244 USA; [Wu, Hui] Univ Alabama, Dept Microbiol, Birmingham, AL 35244 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wu, H (corresponding author), Univ Alabama, Dept Pediat Dent, Sch Dent, 802 SDB, Birmingham, AL 35244 USA.	hwu@uab.edu			National Institutes of Health [R01 DE011000]; NIDCR [DE017954]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DE011000 and DE017954 from the NIDCR (to H.W.).	Banerjee A, 2002, J EXP MED, V196, P147, DOI 10.1084/jem.20012022; Belyi Y, 2010, BBA-GEN SUBJECTS, V1800, P134, DOI 10.1016/j.bbagen.2009.07.022; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2004, J BACTERIOL, V186, P638, DOI 10.1128/JB.186.3.638-645.2004; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bu S, 2008, J BACTERIOL, V190, P1256, DOI 10.1128/JB.01078-07; BURNETTECURLEY D, 1995, INFECT IMMUN, V63, P4669, DOI 10.1128/IAI.63.12.4669-4674.1995; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; COLE RM, 1976, J DENT RES, V55, pA142, DOI 10.1177/002203457605500106011; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Drickamer K, 1998, TRENDS BIOCHEM SCI, V23, P321, DOI 10.1016/S0968-0004(98)01246-8; ELDER BL, 1986, INFECT IMMUN, V54, P421, DOI 10.1128/IAI.54.2.421-427.1986; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; FIVESTAYLOR PM, 1985, INFECT IMMUN, V47, P752, DOI 10.1128/IAI.47.3.752-759.1985; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; HAMADEH RM, 1995, INFECT IMMUN, V63, P4900, DOI 10.1128/IAI.63.12.4900-4906.1995; Handley PS, 2005, ORAL MICROBIOL IMMUN, V20, P131, DOI 10.1111/j.1399-302X.2004.00190.x; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Kremer BHA, 2001, J BACTERIOL, V183, P2543, DOI 10.1128/JB.183.8.2543-2552.2001; Leipold MD, 2007, J BIOL CHEM, V282, P26786, DOI 10.1074/jbc.M704131200; Li YR, 2008, MOL MICROBIOL, V70, P1094, DOI 10.1111/j.1365-2958.2008.06456.x; Mendez C, 2001, TRENDS BIOTECHNOL, V19, P449, DOI 10.1016/S0167-7799(01)01765-6; Moens S, 1997, ARCH MICROBIOL, V168, P169, DOI 10.1007/s002030050484; Oberthur M, 2005, J AM CHEM SOC, V127, P10747, DOI 10.1021/ja052945s; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Orihuela CJ, 2009, J INFECT DIS, V200, P1180, DOI 10.1086/605649; Peng Z, 2008, ORAL MICROBIOL IMMUN, V23, P70, DOI 10.1111/j.1399-302X.2007.00401.x; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Stephenson AE, 2002, MOL MICROBIOL, V43, P147, DOI 10.1046/j.1365-2958.2002.02725.x; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Takeuchi F, 2005, J BACTERIOL, V187, P7292, DOI 10.1128/JB.187.21.7292-7308.2005; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Truman AW, 2009, CHEM BIOL, V16, P676, DOI 10.1016/j.chembiol.2009.04.013; Upreti RK, 2003, PROTEOMICS, V3, P363, DOI 10.1002/pmic.200390052; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Wu H, 1999, MOL MICROBIOL, V34, P1070, DOI 10.1046/j.1365-2958.1999.01670.x; Wu H, 1998, MOL MICROBIOL, V28, P487, DOI 10.1046/j.1365-2958.1998.00805.x; Wu H, 2007, INFECT IMMUN, V75, P2181, DOI 10.1128/IAI.01544-06; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Zhou MX, 2008, INFECT IMMUN, V76, P5624, DOI 10.1128/IAI.00534-08; Zhou M, 2008, J MICROBIOL METH, V72, P249, DOI 10.1016/j.mimet.2007.12.002; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	52	39	40	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12140	12148		10.1074/jbc.M109.066928	http://dx.doi.org/10.1074/jbc.M109.066928			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164186	hybrid, Green Published			2022-12-25	WOS:000276787100044
J	Field, JR; Henry, LK; Blakely, RD				Field, Julie R.; Henry, L. Keith; Blakely, Randy D.			Transmembrane Domain 6 of the Human Serotonin Transporter Contributes to an Aqueously Accessible Binding Pocket for Serotonin and the Psychostimulant 3,4-Methylene Dioxymethamphetamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT NEUROTRANSMITTER TRANSPORTERS; SUBSTITUTED-CYSTEINE ACCESSIBILITY; HIGH-AFFINITY RECOGNITION; DOPAMINE TRANSPORTER; NOREPINEPHRINE TRANSPORTER; SUBSTRATE RECOGNITION; SCANNING MUTAGENESIS; MOLECULAR-MECHANISM; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE	The plasma membrane serotonin (5-HT) transporter (SERT, SLC6A4) clears 5-HT after release at nerve termini and is targeted by both antidepressant medications and psychostimulants (e. g. MDMA, cocaine). Homology modeling of human SERT (hSERT), based on high resolution structures of the microbial SLC6 family member LeuT(Aa), along with biochemical studies of wild type and mutant transporters, predicts transmembrane (TM) domains 1, 3, 6, and 8 comprise the 5-HT-binding pocket. We utilized the substituted cysteine accessibility method along with surface and site-specific biotinylation to probe TM6 for aqueous accessibility and differential interactions with 5-HT and psychostimulants. Our results are consistent with TM6 being composed of an aqueous-accessible, alpha-helical extracellular domain (TM6a) that is separated by a central, unwound section from a cytoplasmically localized domain (TM6b) with limited aqueous accessibility. The substitution G338C appears to lock hSERT in an outward-facing conformation that, although accessible to aminoethylmethanethio-sulfonate-biotin, 5-HT, and citalopram, is incapable of inward 5-HT transport. Transport of 5-HT by G338C can be partially restored by the TM1 mutation Y95F. With regard to methanethiosulfonate (MTS) inactivation of uptake, TM6a Cys mutants demonstrate Na+-dependent [2-(trimethylammonium)ethyl]MTS sensitivity. Studies with the centrally located substitution S336C reveal features of acommonbinding pocket for 5-HT and 3,4-methylenedioxymethamphetamine (MDMA). Interestingly, the substitution I333C reveals an MDMA-induced conformation not observed with 5-HT. In the context of prior studies on TM1, our findings document shared and unique features of TM6 contributing to hSERT aqueous accessibility, ligand recognition, and conformational dynamics.	[Blakely, Randy D.] Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Sch Med, Nashville, TN 37232 USA; [Field, Julie R.; Blakely, Randy D.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Blakely, Randy D.] Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN 37232 USA; [Henry, L. Keith] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of North Dakota Grand Forks	Blakely, RD (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Sch Med, Nashville, TN 37232 USA.	randy.blakely@vanderbilt.edu			National Institutes of Health [DA07390, DA022378, DA23337]; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA023337, R01DA007390, K01DA022378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA07390 (to R. D. B.), DA022378 (to L. K. H.), and DA23337 (to J.R.F.).	Adams SV, 2003, BIOPHYS J, V85, P1548, DOI 10.1016/S0006-3495(03)74587-1; Adams SV, 2002, BIOPHYS J, V83, P3268, DOI 10.1016/S0006-3495(02)75328-9; Adkins EM, 2001, MOL PHARMACOL, V59, P514, DOI 10.1124/mol.59.3.514; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Androutsellis-Theotokis A, 2002, J NEUROSCI, V22, P8370; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Cooper J.R., 2003, BIOCH BASIS NEUROPHA, Veighth, P271; Dodd JR, 2005, J BIOL CHEM, V280, P32649, DOI 10.1074/jbc.M506723200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gu HH, 1996, J BIOL CHEM, V271, P6911, DOI 10.1074/jbc.271.12.6911; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Henry LK, 2007, MOL INTERV, V7, P306, DOI 10.1124/mi.7.6.4; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Horschitz S, 2008, NEUROCHEM INT, V52, P770, DOI 10.1016/j.neuint.2007.09.005; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jayanthi LD, 2005, AAPS J, V7, pE728, DOI 10.1208/aapsj070373; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P827, DOI 10.1002/cmdc.200600243; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P815, DOI 10.1002/cmdc.200600242; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; Kaplan RS, 2000, J BIOL CHEM, V275, P12009, DOI 10.1074/jbc.275.16.12009; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lill H, 1998, METHOD ENZYMOL, V296, P425; McCauley JL, 2004, AM J MED GENET B, V127B, P104, DOI 10.1002/ajmg.b.20151; Melikian HE, 1996, MOL PHARMACOL, V50, P266; Parnas ML, 2008, MOL PHARMACOL, V73, P1141, DOI 10.1124/mol.107.043679; Prasad HC, 2009, PHILOS T R SOC B, V364, P163, DOI 10.1098/rstb.2008.0143; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; Rudnick G, 1998, METHOD ENZYMOL, V296, P233; SAIER MH, 2002, TRANSMEMBRANE TRANSP, P1; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sitte HH, 2000, J NEUROCHEM, V74, P1317; Sitte HH, 2001, MOL PHARMACOL, V59, P1129, DOI 10.1124/mol.59.5.1129; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; TATE CG, 1994, J BIOL CHEM, V269, P26303; Vaughan RA, 2007, J BIOL CHEM, V282, P8915, DOI 10.1074/jbc.M610633200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200	58	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11270	11280		10.1074/jbc.M109.093658	http://dx.doi.org/10.1074/jbc.M109.093658			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20159976	hybrid, Green Published			2022-12-25	WOS:000276286200033
J	Kock, K; Koenen, A; Giese, B; Fraunholz, M; May, K; Siegmund, W; Hammer, E; Volker, U; Jedlitschky, G; Kroemer, HK; Grube, M				Koeck, Kathleen; Koenen, Anna; Giese, Bernd; Fraunholz, Martin; May, Karen; Siegmund, Werner; Hammer, Elke; Voelker, Uwe; Jedlitschky, Gabriele; Kroemer, Heyo K.; Grube, Markus			Rapid Modulation of the Organic Anion Transporting Polypeptide 2B1 (OATP2B1, SLCO2B1) Function by Protein Kinase C-mediated Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; BREAST-CANCER; HUMAN PLACENTA; PHOSPHORYLATION SITES; DOPAMINE TRANSPORTER; STEROID-HORMONES; DOWN-REGULATION; CACO-2 CELLS; HUMAN HEART; CLATHRIN	Members of the organic anion transporting polypeptide (OATP) family are involved in various pharmacological, pathophysiological, and physiological processes, such as hepatic drug uptake, progress of cancer, or transport of hormones. Although variability in expression and function of OATPs has been investigated in detail, data concerning regulation are rather limited. Here, we report a novel mechanism for rapid regulation of OATP2B1 mediated by protein kinase C (PKC) resulting in significant changes of transport activity. PKC activation by the phorbol ester (phorbol 12-myristate 13-acetate, PMA) resulted in increased phosphorylation of OATP2B1 as well as reduced OATP2B1 transport activity with a decrease in V-max of E1S uptake (288 +/- 21 (control) versus 165 +/- 16 pmol/min/mg of protein (PMA)). This effect was sensitive to the PKC inhibitor bisindolylmaleimide I (BIM-I). Confocal microscopy, fluorescence-based internalization assay, and live-cell imaging using green fluorescent protein-tagged OATP2B1 revealed that transport inhibition was due to internalization of the transporter. Furthermore, colocalization with LAMP-2 and chloroquine-sensitive degradation of OATP2B1 suggest that the internalized protein is targeted to a lysosomal degradation pathway. With regard to the underlying mechanism inhibition of caveolin/lipid raft-mediated endocytosis failed to prevent OATP2B1 internalization, whereas inhibition of clathrin-mediated processes blocked OATP2B1 sequestration. However, small interfering RNA-mediated clathrin knock-down affected general trafficking of OATP2B1 and resulted in intracellular accumulation in the absence of PMA. In conclusion, our data demonstrate that OATP2B1 function is regulated by PKC-mediated, clathrin-dependent internalization and followed by lysosomal degradation. Furthermore, internalization could be shown in an ex vivo placenta perfusion. Our findings represent a new, rapid mechanism in regulation of human OATPs.	[Koeck, Kathleen; Koenen, Anna; May, Karen; Siegmund, Werner; Jedlitschky, Gabriele; Kroemer, Heyo K.; Grube, Markus] Ernst Moritz Arndt Univ Greifswald, Res Ctr Pharmacol & Expt Therapeut, Dept Pharmacol, D-17487 Greifswald, Germany; [Giese, Bernd; Fraunholz, Martin] Ernst Moritz Arndt Univ Greifswald, Competence Ctr Funct Gen, D-17487 Greifswald, Germany; [Hammer, Elke; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Gen, D-17487 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Kroemer, HK (corresponding author), Friedrich Loeffler Str 23D, D-17487 Greifswald, Germany.	kroemer@uni-greifswald.de		Hammer, Elke/0000-0002-1507-0402; Volker, Uwe/0000-0002-5689-3448; Fraunholz, Martin/0000-0002-4581-6244	Deutsche Forschungsgemeinschaft [GR 3375/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant GR 3375/1-1.	Al Sarakbi W, 2006, ANTICANCER RES, V26, P4985; Ali AS, 2009, CANCER TREAT REV, V35, P1, DOI 10.1016/j.ctrv.2008.07.006; Alzamora R, 2008, STEROIDS, V73, P885, DOI 10.1016/j.steroids.2008.01.001; Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Assender JW, 2007, J CLIN PATHOL, V60, P1216, DOI 10.1136/jcp.2006.041616; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cheng XG, 2005, DRUG METAB DISPOS, V33, P1276, DOI 10.1124/dmd.105.003988; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; Crocenzi FA, 2008, HEPATOLOGY, V48, P1885, DOI 10.1002/hep.22532; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Deng JW, 2008, PHARMACOGENET GENOM, V18, P424, DOI 10.1097/FPC.0b013e3282fb02a3; GOODE NT, 1995, J BIOL CHEM, V270, P2669, DOI 10.1074/jbc.270.6.2669; Graf P, 2001, BRIT J PHARMACOL, V132, P1193, DOI 10.1038/sj.bjp.0703921; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Grube M, 2006, CIRCULATION, V113, P1114, DOI 10.1161/CIRCULATIONAHA.105.586107; Grube M, 2007, DRUG METAB DISPOS, V35, P30, DOI 10.1124/dmd.106.011411; Grube M, 2006, CLIN PHARMACOL THER, V80, P607, DOI 10.1016/j.clpt.2006.09.010; Grube M, 2006, MOL PHARMACOL, V70, P1735, DOI 10.1124/mol.106.026450; Guo GL, 2001, J PHARMACOL EXP THER, V299, P551; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hamada A, 2008, CLIN CANCER RES, V14, P3312, DOI 10.1158/1078-0432.CCR-07-4118; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; HEPLER JR, 1988, J BIOL CHEM, V263, P7610; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iwai M, 2004, PHARMACOGENETICS, V14, P749, DOI 10.1097/00008571-200411000-00006; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jigorel E, 2006, DRUG METAB DISPOS, V34, P1756, DOI 10.1124/dmd.106.010033; Kobayashi D, 2003, J PHARMACOL EXP THER, V306, P703, DOI 10.1124/jpet.103.051300; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Lee W, 2008, CANCER RES, V68, P10315, DOI 10.1158/0008-5472.CAN-08-1984; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; LIE SO, 1973, BIOCHEM PHARMACOL, V22, P3109, DOI 10.1016/0006-2952(73)90197-4; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; May K, 2008, DRUG METAB DISPOS, V36, P740, DOI 10.1124/dmd.107.019448; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Niemi M, 2006, CLIN PHARMACOL THER, V80, P356, DOI 10.1016/j.clpt.2006.06.010; Niessen J, 2009, DRUG METAB DISPOS, V37, P1129, DOI 10.1124/dmd.108.024570; Nozawa T, 2004, J PHARMACOL EXP THER, V308, P438, DOI 10.1124/jpet.103.060194; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Pizzagalli F, 2003, J CLIN ENDOCR METAB, V88, P3902, DOI 10.1210/jc.2003-030174; Rost D, 2005, EUR J CLIN INVEST, V35, P635, DOI 10.1111/j.1365-2362.2005.01556.x; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; ROTHMAN JE, 1980, P NATL ACAD SCI-BIOL, V77, P780, DOI 10.1073/pnas.77.2.780; Sai Y, 2006, DRUG METAB DISPOS, V34, P1423, DOI 10.1124/dmd.106.009530; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; Satoh H, 2005, DRUG METAB DISPOS, V33, P518, DOI 10.1124/dmd.104.002337; Seithel A, 2006, EUR J PHARM SCI, V28, P291, DOI 10.1016/j.ejps.2006.03.003; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; St-Pierre MV, 2002, J CLIN ENDOCR METAB, V87, P1856, DOI 10.1210/jc.87.4.1856; Stedman CAM, 2005, P NATL ACAD SCI USA, V102, P2063, DOI 10.1073/pnas.0409794102; Sun AQ, 2008, PHARM RES-DORDR, V25, P463, DOI 10.1007/s11095-007-9399-9; Tachibana-Iimori Rieko, 2004, Drug Metab Pharmacokinet, V19, P375, DOI 10.2133/dmpk.19.375; Tamai I, 2001, PHARMACEUT RES, V18, P1262, DOI 10.1023/A:1013077609227; Tirona RG, 2001, J BIOL CHEM, V276, P35669, DOI 10.1074/jbc.M103792200; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Vaidyanathan S, 2008, J CLIN PHARMACOL, V48, P1323, DOI 10.1177/0091270008323258; VOUTILAINEN R, 1986, J CLIN ENDOCR METAB, V63, P1145, DOI 10.1210/jcem-63-5-1145; Wlcek K, 2008, CANCER BIOL THER, V7, P1452, DOI 10.4161/cbt.7.9.6282; Wolff NA, 2003, J AM SOC NEPHROL, V14, P1959, DOI 10.1097/01.ASN.0000079040.55124.25; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhang Q, 2008, J BIOL CHEM, V283, P32570, DOI 10.1074/jbc.M800298200	63	73	74	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11336	11347		10.1074/jbc.M109.056457	http://dx.doi.org/10.1074/jbc.M109.056457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20159975	Green Published, hybrid			2022-12-25	WOS:000276286200040
J	Muller, T; Stein, U; Poletti, A; Garzia, L; Rothley, M; Plaumann, D; Thiele, W; Bauer, M; Galasso, A; Schlag, P; Pankratz, M; Zollo, M; Sleeman, JP				Mueller, T.; Stein, U.; Poletti, A.; Garzia, L.; Rothley, M.; Plaumann, D.; Thiele, W.; Bauer, M.; Galasso, A.; Schlag, P.; Pankratz, M.; Zollo, M.; Sleeman, J. P.			ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients	ONCOGENE			English	Article						ASAP1; metastasis; ARF-GAP; motility; invasion	GTPASE-ACTIVATING PROTEIN; SMOOTH-MUSCLE-CELLS; PODOSOME FORMATION; BINDING-PROTEIN; EXPRESSION; SRC; PHOSPHORYLATION; INVASION; ARF1; GAP	We have previously performed an unbiased screen to identify genes whose expression is associated with the metastatic phenotype. Secondary screening of these genes using custom microarray chips identified ASAP1, a multidomain adaptor protein with ADP-ribosylation factor-GAP activity, as being potentially involved in tumor progression. Here, we show that at least three different splice forms of ASAP1 are upregulated in rodent tumor models in a manner that correlates with metastatic potential. In human cancers, we found that ASAP1 expression is strongly upregulated in a variety of tumors in comparison with normal tissue and that this expression correlates with poor metastasis-free survival and prognosis in colorectal cancer patients. Using loss and gain of function approaches, we were able to show that ASAP1 promotes metastasis formation in vivo and stimulates tumor cell motility, invasiveness, and adhesiveness in vitro. Furthermore, we show that ASAP1 interacts with the metastasis-promoting protein h-prune and stimulates its phosphodiesterase activity. In addition, ASAP1 binds to the SH3 domains of several proteins, including SLK with which it co-immunoprecipitates. These data support the notion that ASAP1 can contribute to the dissemination of a variety of tumor types and represent a potential target for cancer therapy. Oncogene (2010) 29, 2393-2403; doi:10.1038/onc.2010.6; published online 15 February 2010	[Poletti, A.; Rothley, M.; Thiele, W.; Sleeman, J. P.] Univ Heidelberg, Univ Med Mannheim, D-68167 Mannheim, Germany; [Mueller, T.; Rothley, M.; Plaumann, D.; Thiele, W.; Bauer, M.; Pankratz, M.; Sleeman, J. P.] Forschungszentrum Karlsruhe, Inst Genet, D-76021 Karlsruhe, Germany; [Stein, U.] Max Delbruck Ctr Mol Med, Charite Univ Med Berlin, Expt & Clin Res Ctr, Berlin, Germany; [Garzia, L.; Galasso, A.; Zollo, M.] Ctr Ingn Genet & Biotecnol Avanzate CEINGE, Naples, Italy; [Schlag, P.] Charite Comprehens Canc Ctr, Berlin, Germany; [Zollo, M.] Univ Naples Federico 2, Fac Biotechnol Sci, Dipartimento Biochim & Biotecnol Med, Naples, Italy	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; CEINGE Biotecnologie Avanzate; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Naples Federico II	Sleeman, JP (corresponding author), Univ Heidelberg, Univ Med Mannheim, Ludolf Krehl Str 13-17, D-68167 Mannheim, Germany.	sleeman@medma.uni-heidelberg.de	Sleeman, Jonathan P/H-2515-2013; Thiele, Wilko/AAF-7856-2020	Sleeman, Jonathan P/0000-0003-1718-7687; Thiele, Wilko/0000-0002-8978-4192; Stein, Ulrike/0000-0001-7006-282X; Galasso, Alessia/0000-0001-7110-9925	BMBF; European Union [LSHC-CT-2004-503224]; AIRC [2007-2010]; Association for International Cancer Research (AICR) [08-0015]	BMBF(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); AIRC(Fondazione AIRC per la ricerca sul cancro); Association for International Cancer Research (AICR)	This work was supported by grants to JPS and US from the BMBF NGFN2 CancerNet Program, to JPS from the European Union (FP6 STREP project BRECOSM, contract no. LSHC-CT-2004-503224), to MZ from AIRC 2007-2010 and to JPS and MZ from the Association for International Cancer Research (AICR, grant no. 08-0015). We thank Norma Howells and Selma Huber for animal care and Paul Randazzo, Craig Furman, and Margaret Frame for providing expression contructs. The contribution of Franziska Arlt Pia Hermann and Markus Niederstrasser is also gratefully acknowledged.	Andreev J, 1999, MOL CELL BIOL, V19, P2338; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Buffart TE, 2005, CELL ONCOL, V27, P57; Cougoule C, 2005, TRAFFIC, V6, P682, DOI 10.1111/j.1600-0854.2005.00307.x; D'Angelo A, 2004, CANCER CELL, V5, P137, DOI 10.1016/S1535-6108(04)00021-2; Ehlers JP, 2005, CLIN CANCER RES, V11, P3609, DOI 10.1158/1078-0432.CCR-04-1941; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Furman C, 2002, J BIOL CHEM, V277, P7962, DOI 10.1074/jbc.M109149200; Harlow E., 1988, ANTIBODIES LAB MANUA; Hashimoto S, 2006, P NATL ACAD SCI USA, V103, P7036, DOI 10.1073/pnas.0509166103; Hofmann M, 1998, J CELL SCI, V111, P1673; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Kowanetz K, 2004, MOL BIOL CELL, V15, P3155, DOI 10.1091/mbc.E03-09-0683; Kruljac-Letunic A, 2003, J BIOL CHEM, V278, P29560, DOI 10.1074/jbc.M302278200; Lin D, 2008, CANCER RES, V68, P4352, DOI 10.1158/0008-5472.CAN-07-5237; Liu YH, 2005, J BIOL CHEM, V280, P8884, DOI 10.1074/jbc.M412200200; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; Marino N, 2007, CLIN EXP METASTAS, V24, P637, DOI 10.1007/s10585-007-9109-3; Mengwasser J, 2004, ONCOGENE, V23, P7430, DOI 10.1038/sj.onc.1207987; Nam JM, 2007, EMBO J, V26, P647, DOI 10.1038/sj.emboj.7601534; Nestl A, 2001, CANCER RES, V61, P1569; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Niebuhr K, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P398; Oda A, 2003, J BIOL CHEM, V278, P6456, DOI 10.1074/jbc.M210817200; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Oshiro T, 2002, J BIOL CHEM, V277, P38618, DOI 10.1074/jbc.M203453200; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Stein U, 2002, J CLIN ONCOL, V20, P3282, DOI 10.1200/JCO.2002.01.003; Wagner S, 2002, J BIOL CHEM, V277, P37685, DOI 10.1074/jbc.M205899200; Webb BA, 2005, AM J PHYSIOL-CELL PH, V289, pC898, DOI 10.1152/ajpcell.00095.2005; Zhou ST, 2006, AM J PHYSIOL-CELL PH, V290, pC463, DOI 10.1152/ajpcell.00350.2005	37	65	68	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	16					2393	2403		10.1038/onc.2010.6	http://dx.doi.org/10.1038/onc.2010.6			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	586YK	20154719				2022-12-25	WOS:000276951500008
J	Collins, SH; Kuo, AD				Collins, Steven H.; Kuo, Arthur D.			Recycling Energy to Restore Impaired Ankle Function during Human Walking	PLOS ONE			English	Article							GENERATING ELECTRICITY; MECHANICAL WORK; FOOT; COST; OPTIMIZATION; EXPENDITURE; ENERGETICS; LOCOMOTION; ECONOMY; FORCE	Background: Humans normally dissipate significant energy during walking, largely at the transitions between steps. The ankle then acts to restore energy during push-off, which may be the reason that ankle impairment nearly always leads to poorer walking economy. The replacement of lost energy is necessary for steady gait, in which mechanical energy is constant on average, external dissipation is negligible, and no net work is performed over a stride. However, dissipation and replacement by muscles might not be necessary if energy were instead captured and reused by an assistive device. Methodology/Principal Findings: We developed a microprocessor-controlled artificial foot that captures some of the energy that is normally dissipated by the leg and "recycles'' it as positive ankle work. In tests on subjects walking with an artificially-impaired ankle, a conventional prosthesis reduced ankle push-off work and increased net metabolic energy expenditure by 23% compared to normal walking. Energy recycling restored ankle push-off to normal and reduced the net metabolic energy penalty to 14%. Conclusions/Significance: These results suggest that reduced ankle push-off contributes to the increased metabolic energy expenditure accompanying ankle impairments, and demonstrate that energy recycling can be used to reduce such cost.	[Collins, Steven H.] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands; [Kuo, Arthur D.] Univ Michigan, Dept Mech, Ann Arbor, MI 48109 USA; [Kuo, Arthur D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	Delft University of Technology; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Collins, SH (corresponding author), Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands.	s.h.collins@tudelft.nl	Kuo, Arthur/L-3359-2013	Kuo, Arthur/0000-0001-5233-9709; Collins, Steve/0000-0002-3997-3374	National Institutes of Health and the Department of Veterans Affairs	National Institutes of Health and the Department of Veterans Affairs	This work was supported by grants from the National Institutes of Health and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk PG, 2006, J EXP BIOL, V209, P3953, DOI 10.1242/jeb.02455; ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Au SK, 2009, IEEE T ROBOT, V25, P51, DOI 10.1109/TRO.2008.2008747; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Collins SH, 2009, GAIT POSTURE, V29, P59, DOI 10.1016/j.gaitpost.2008.06.010; Dean JC, 2009, J R SOC INTERFACE, V6, P561, DOI 10.1098/rsif.2008.0415; Doke J, 2005, J EXP BIOL, V208, P439, DOI 10.1242/jeb.01408; Donelan JM, 2008, SCIENCE, V319, P807, DOI 10.1126/science.1149860; Donelan JM, 2002, J EXP BIOL, V205, P3717; Donelan JM, 2002, J BIOMECH, V35, P117, DOI 10.1016/S0021-9290(01)00169-5; Geil MD, 2000, J BIOMECH, V33, P1745, DOI 10.1016/S0021-9290(00)00102-0; GOLDMAN RF, 1962, J APPL PHYSIOL, V17, P675, DOI 10.1152/jappl.1962.17.4.675; Hsu MJ, 2006, ARCH PHYS MED REHAB, V87, P123, DOI 10.1016/j.apmr.2005.07.310; Inman V., 1981, HUMAN WALKING; JOHNSON CL, 2001, Patent No. 6238437; KAZEROONI H, P IEEE INT C ROB AUT, P4353; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Kuo AD, 2005, SCIENCE, V309, P1686, DOI 10.1126/science.1118058; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; LEHMANN JF, 1993, ARCH PHYS MED REHAB, V74, P1225; Margaria R, 1968, Int Z Angew Physiol, V25, P339; Prince F., 1994, IEEE Transactions on Rehabilitation Engineering, V2, P247, DOI 10.1109/86.340873; Roberts TJ, 1997, SCIENCE, V275, P1113, DOI 10.1126/science.275.5303.1113; Rome LC, 2005, SCIENCE, V309, P1725, DOI 10.1126/science.1111063; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; Sawicki GS, 2008, J EXP BIOL, V211, P1402, DOI 10.1242/jeb.009241; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; TORBURN L, 1995, J REHABIL RES DEV, V32, P111; Vanderpool MT, 2008, GAIT POSTURE, V28, P427, DOI 10.1016/j.gaitpost.2008.01.016; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; Whittle M.W, 2014, GAIT ANAL INTRO; Winter DA., 1987, BIOMECHANICS MOTOR C; ZARRUGH MY, 1974, EUR J APPL PHYSIOL O, V33, P293, DOI 10.1007/BF00430237	33	136	138	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9307	10.1371/journal.pone.0009307	http://dx.doi.org/10.1371/journal.pone.0009307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174659	gold, Green Published			2022-12-25	WOS:000274590600031
J	Falkenberg, G; Fleissner, G; Schuchardt, K; Kuehbacher, M; Thalau, P; Mouritsen, H; Heyers, D; Wellenreuther, G; Fleissner, G				Falkenberg, Gerald; Fleissner, Gerta; Schuchardt, Kirsten; Kuehbacher, Markus; Thalau, Peter; Mouritsen, Henrik; Heyers, Dominik; Wellenreuther, Gerd; Fleissner, Guenther			Avian Magnetoreception: Elaborate Iron Mineral Containing Dendrites in the Upper Beak Seem to Be a Common Feature of Birds	PLOS ONE			English	Article							LIGHT-DEPENDENT MAGNETORECEPTION; MAGNETIC COMPASS; BIOGENIC MAGNETITE; TRIGEMINAL MEDIATION; ORIENTATION; ORGANIZATION; NAVIGATION; SYSTEM; RESPONSES; BEHAVIOR	The magnetic field sensors enabling birds to extract orientational information from the Earth's magnetic field have remained enigmatic. Our previously published results from homing pigeons have made us suggest that the iron containing sensory dendrites in the inner dermal lining of the upper beak are a candidate structure for such an avian magnetometer system. Here we show that similar structures occur in two species of migratory birds (garden warbler, Sylvia borin and European robin, Erithacus rubecula) and a non-migratory bird, the domestic chicken (Gallus gallus). In all these bird species, histological data have revealed dendrites of similar shape and size, all containing iron minerals within distinct subcellular compartments of nervous terminals of the median branch of the Nervus ophthalmicus. We also used microscopic X-ray absorption spectroscopy analyses to identify the involved iron minerals to be almost completely Fe III-oxides. Magnetite (Fe II/III) may also occur in these structures, but not as a major Fe constituent. Our data suggest that this complex dendritic system in the beak is a common feature of birds, and that it may form an essential sensory basis for the evolution of at least certain types of magnetic field guided behavior.	[Falkenberg, Gerald; Wellenreuther, Gerd] DESY, Hamburger Synchrotronstrahlungslab HASYLAB, D-2000 Hamburg, Germany; [Fleissner, Gerta; Schuchardt, Kirsten; Thalau, Peter; Fleissner, Guenther] Goethe Univ Frankfurt, Inst Zellbiol & Neurowissensch, Frankfurt, Germany; [Kuehbacher, Markus] Helmholtz Ctr Berlin Mat & Energy, Abt Elementanalyt, Berlin, Germany; [Mouritsen, Henrik; Heyers, Dominik] Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Goethe University Frankfurt; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Carl von Ossietzky Universitat Oldenburg	Falkenberg, G (corresponding author), DESY, Hamburger Synchrotronstrahlungslab HASYLAB, Notkestr 85, D-2000 Hamburg, Germany.	fleissner@bio.uni-frankfurt.de	Heyers, Dominik/D-3885-2015; Mouritsen, Henrik/A-5401-2010	Heyers, Dominik/0000-0002-2831-6985; Mouritsen, Henrik/0000-0001-7082-4839	Deutsche Forschungsgemeinschaft [Fl 177/15-1, Fl 177/16-1]; HASYLAB at DESY, Hamburg [I-05-095, II-20060167]; Stiftung Polytechnische Gesellschaft, Frankfurt; Gemeinnutzige Hertie-Stiftung, Berlin; Alumni of the Goethe-University, Frankfurt; Volkswagenstiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); HASYLAB at DESY, Hamburg; Stiftung Polytechnische Gesellschaft, Frankfurt; Gemeinnutzige Hertie-Stiftung, Berlin; Alumni of the Goethe-University, Frankfurt; Volkswagenstiftung(Volkswagen)	The project is supported by grants from the Deutsche Forschungsgemeinschaft (Fl 177/15-1 and 16-1), http://www.dfg.de; from HASYLAB at DESY, Hamburg (I-05-095, II-20060167), http://www.desy.de; from the Stiftung Polytechnische Gesellschaft, Frankfurt a. M., http://www.sptg.de/; from the Gemeinnutzige Hertie-Stiftung, Berlin: ZEN-program, http://www.ghst.de; from the Alumni of the Goethe-University, Frankfurt a. M., http://www.vff.unifrankfurt.de; from the Volkswagenstiftung (Heisenberg-Professorship to H. M.), http://www.volkswagen-stiftung.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEASON RC, 1987, NEUROSCI LETT, V80, P229, DOI 10.1016/0304-3940(87)90659-8; Beason RC, 1996, J EXP BIOL, V199, P1241; Beck W., 1988, P1955; Boles LC, 2003, NATURE, V421, P60, DOI 10.1038/nature01226; Cain SD, 2005, INTEGR COMP BIOL, V45, P539, DOI 10.1093/icb/45.3.539; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Dennis TE, 2007, P ROY SOC B-BIOL SCI, V274, P1153, DOI 10.1098/rspb.2007.3768; Diebel CE, 2000, NATURE, V406, P299, DOI 10.1038/35018561; Dubbeldam JL, 1998, ARCH PHYSIOL BIOCHEM, V106, P338, DOI 10.1076/apab.106.5.338.4367; DUBBELDAM JL, 1998, CENTRAL NERVOUS SYST, V3, P1525; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; EVANS LA, 1990, PHILOS T ROY SOC B, V329, P87, DOI 10.1098/rstb.1990.0153; FALKENBERG G, 2008, J PHYS C SE IN PRESS; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; FLEISSNER GE, 2008, HASYLAB ANN REPORT 2; Fleissner G, 2007, J ORNITHOL, V148, pS643, DOI 10.1007/s10336-007-0229-y; Fleissner G, 2007, NATURWISSENSCHAFTEN, V94, P631, DOI 10.1007/s00114-007-0236-0; Fransson T, 2001, NATURE, V414, P35, DOI 10.1038/35102115; Hanzlik M, 2000, BIOMETALS, V13, P325, DOI 10.1023/A:1009214526685; Hautot D, 2003, P ROY SOC B-BIOL SCI, V270, pS62, DOI 10.1098/rsbl.2003.0012; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Holland RA, 2006, NATURE, V444, P702, DOI 10.1038/444702b; HSU CY, 1994, SCIENCE, V265, P95, DOI 10.1126/science.265.5168.95; HUBER J, 2004, THESIS JL U GIESSEN; Janssens K.H.A., 2000, MICROSCOPIC XRAY FLU; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; KIRSCHVINK JL, 1992, P NATL ACAD SCI USA, V89, P7683, DOI 10.1073/pnas.89.16.7683; LIU Y., 2003, PIGMENT CELL RES, V16, P597, DOI [DOI 10.1034/J.1600-0749.2003.08378.X, 10.1034/j.1600-0749.2003.08378.x]; Lohmann KJ, 2004, NATURE, V428, P909, DOI 10.1038/428909a; MANN S, 1988, J EXP BIOL, V140, P35; Marhold S, 1997, NATURWISSENSCHAFTEN, V84, P421, DOI 10.1007/s001140050422; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Phillips JB, 2006, ANIMAL SPATIAL COGNI; Schofield RMS, 2001, SCORPION BIOLOGY AND RESEARCH, P234; Schultheiss-Grassi PP, 1999, BBA-GEN SUBJECTS, V1426, P212, DOI 10.1016/S0304-4165(98)00160-3; SEMM P, 1990, BRAIN RES BULL, V25, P735, DOI 10.1016/0361-9230(90)90051-Z; Solov'yov IA, 2007, BIOPHYS J, V93, P1493, DOI 10.1529/biophysj.107.105098; STAHL B, 2005, HASYLAB ANN REPORT 2; STAHL B, 2006, P 4 FALL C MET MET H, P63; Thalau P, 2007, NATURWISSENSCHAFTEN, V94, P813, DOI 10.1007/s00114-007-0259-6; Tian LX, 2007, BIOMETALS, V20, P197, DOI 10.1007/s10534-006-9027-x; Vacha M, 2006, J EXP BIOL, V209, P3882, DOI 10.1242/jeb.02456; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; WILD JM, 1980, J COMP NEUROL, V192, P175, DOI 10.1002/cne.901920112; Wilke M, 2001, AM MINERAL, V86, P714; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R, 2008, J EXP BIOL, V211, P3344, DOI 10.1242/jeb.020313; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Wiltschko W, 2004, NATURWISSENSCHAFTEN, V91, P130, DOI 10.1007/s00114-003-0500-x; Wiltschko W, 1971, Vogelwarte, V26, P245; Wiltschko W, 2007, J EXP BIOL, V210, P2300, DOI 10.1242/jeb.004853; Wiltschko W, 2009, P ROY SOC B-BIOL SCI, V276, P2227, DOI 10.1098/rspb.2009.0050; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	57	101	107	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9231	10.1371/journal.pone.0009231	http://dx.doi.org/10.1371/journal.pone.0009231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169083	Green Published, gold, Green Submitted			2022-12-25	WOS:000274590500013
J	Trimborn, M; Ghani, M; Walther, DJ; Dopatka, M; Dutrannoy, V; Busche, A; Meyer, F; Nowak, S; Nowak, J; Zabel, C; Klose, J; Esquitino, V; Garshasbi, M; Kuss, AW; Ropers, HH; Mueller, S; Poehlmann, C; Gavvovidis, I; Schindler, D; Sperling, K; Neitzel, H				Trimborn, Marc; Ghani, Mahdi; Walther, Diego J.; Dopatka, Monika; Dutrannoy, Veronique; Busche, Andreas; Meyer, Franziska; Nowak, Stefanie; Nowak, Jean; Zabel, Claus; Klose, Joachim; Esquitino, Veronica; Garshasbi, Masoud; Kuss, Andreas W.; Ropers, Hans-Hilger; Mueller, Susanne; Poehlmann, Charlotte; Gavvovidis, Ioannis; Schindler, Detlev; Sperling, Karl; Neitzel, Heidemarie			Establishment of a Mouse Model with Misregulated Chromosome Condensation due to Defective Mcph1 Function	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DNA-DAMAGE RESPONSE; MICROCEPHALIN; PROTEIN; CHECKPOINT; REPAIR; BRIT1/MCPH1; MUTATIONS; PHENOTYPE; SUGGEST	Mutations in the human gene MCPH1 cause primary microcephaly associated with a unique cellular phenotype with premature chromosome condensation (PCC) in early G2 phase and delayed decondensation post-mitosis (PCC syndrome). The gene encodes the BRCT-domain containing protein microcephalin/BRIT1. Apart from its role in the regulation of chromosome condensation, the protein is involved in the cellular response to DNA damage. We report here on the first mouse model of impaired Mcph1-function. The model was established based on an embryonic stem cell line from BayGenomics (RR0608) containing a gene trap in intron 12 of the Mcph1 gene deleting the C-terminal BRCT-domain of the protein. Although residual wild type allele can be detected by quantitative real-time PCR cell cultures generated from mouse tissues bearing the homozygous gene trap mutation display the cellular phenotype of misregulated chromosome condensation that is characteristic for the human disorder, confirming defective Mcph1 function due to the gene trap mutation. While surprisingly the DNA damage response (formation of repair foci, chromosomal breakage, and G2/M checkpoint function after irradiation) appears to be largely normal in cell cultures derived from Mcph1(gt/gt) mice, the overall survival rates of the Mcph1(gt/gt) animals are significantly reduced compared to wild type and heterozygous mice. However, we could not detect clear signs of premature malignant disease development due to the perturbed Mcph1 function. Moreover, the animals show no obvious physical phenotype and no reduced fertility. Body and brain size are within the range of wild type controls. Gene expression on RNA and protein level did not reveal any specific pattern of differentially regulated genes. To the best of our knowledge this represents the first mammalian transgenic model displaying a defect in mitotic chromosome condensation and is also the first mouse model for impaired Mcph1-function.	[Trimborn, Marc; Busche, Andreas; Meyer, Franziska] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Ghani, Mahdi; Dutrannoy, Veronique; Nowak, Stefanie; Nowak, Jean; Zabel, Claus; Klose, Joachim; Esquitino, Veronica; Poehlmann, Charlotte; Sperling, Karl; Neitzel, Heidemarie] Charite, Inst Human Genet, D-13353 Berlin, Germany; [Walther, Diego J.; Dopatka, Monika; Garshasbi, Masoud; Kuss, Andreas W.; Ropers, Hans-Hilger] Max Planck Inst Mol Genet, Berlin, Germany; [Mueller, Susanne] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Gavvovidis, Ioannis; Schindler, Detlev] Univ Wurzburg, Inst Human Genet, Wurzburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg	Trimborn, M (corresponding author), Charite, Inst Med Genet, D-13353 Berlin, Germany.	heidemarie.neitzel@charite.de		Garshasbi, Masoud/0000-0002-5508-7903; Ghani, Mahdi/0000-0001-6455-7199; Gavvovidis, Ioannis/0000-0001-5644-9788; Busche, Andreas/0000-0003-1787-767X; Mueller, Susanne/0000-0002-5053-2211; Kuss, Andreas/0000-0002-9401-4627	Deutsche Forschungsgemeinschaft [NE 531/5-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by funding from the Deutsche Forschungsgemeinschaft (NE 531/5-3) to H. N. and K. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Berth M, 2007, APPL MICROBIOL BIOT, V76, P1223, DOI 10.1007/s00253-007-1128-0; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brunk K, 2007, J CELL SCI, V120, P3578, DOI 10.1242/jcs.014290; Chaplet M, 2006, CELL CYCLE, V5, P2579, DOI 10.4161/cc.5.22.3471; Diedrich M, 2008, PROTEOMICS, V8, P1266, DOI 10.1002/pmic.200700754; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Hartl D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002759; Huyton T, 2000, MUTAT RES-DNA REPAIR, V460, P319, DOI 10.1016/S0921-8777(00)00034-3; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Klose J, 1999, METH MOL B, V112, P147; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Mao L, 2008, J PROTEOME RES, V7, P3968, DOI 10.1021/pr800245x; Mao L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001218; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Neitzel H, 2002, AM J HUM GENET, V70, P1015, DOI 10.1086/339518; O'Driscoll M, 2006, CELL CYCLE, V5, P2339, DOI 10.4161/cc.5.20.3358; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; Ponting C, 2005, CURR OPIN GENET DEV, V15, P241, DOI 10.1016/j.gde.2005.04.009; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rickmyre JL, 2007, J CELL SCI, V120, P3565, DOI 10.1242/jcs.016626; Singh AP, 2000, CYTOGENET CELL GENET, V91, P253, DOI 10.1159/000056854; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Trimborn M, 2006, CELL CYCLE, V5, P322, DOI 10.4161/cc.5.3.2412; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Wu XL, 2009, CANCER RES, V69, P5531, DOI 10.1158/0008-5472.CAN-08-4834; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128; Zabel C, 2006, J PROTEOME RES, V5, P1948, DOI 10.1021/pr0601077; Zabel C, 2009, MOL CELL PROTEOMICS, V8, P720, DOI 10.1074/mcp.M800277-MCP200; Zhong XY, 2006, CELL CYCLE, V5, P457, DOI 10.4161/cc.5.4.2481	36	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9242	10.1371/journal.pone.0009242	http://dx.doi.org/10.1371/journal.pone.0009242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169082	Green Published, gold, Green Submitted			2022-12-25	WOS:000274590500021
J	Yoder, L				Yoder, Lane			Explicit Logic Circuits Predict Local Properties of the Neocortex's Physiology and Anatomy	PLOS ONE			English	Article								Background: Two previous articles proposed an explicit model of how the brain processes information by its organization of synaptic connections. The family of logic circuits was shown to generate neural correlates of complex psychophysical phenomena in different sensory systems. Methodology/Principal Findings: Here it is shown that the most cost-effective architectures for these networks produce correlates of electrophysiological brain phenomena and predict major aspects of the anatomical structure and physiological organization of the neocortex. The logic circuits are markedly efficient in several respects and provide the foundation for all of the brain's combinational processing of information. Conclusions/Significance: At the local level, these networks account for much of the physical structure of the neocortex as well its organization of synaptic connections. Electronic implementations of the logic circuits may be more efficient than current electronic logic arrays in generating both Boolean and fuzzy logic.	Univ Hawaii, Dept Math, Honolulu, HI 96822 USA	University of Hawaii System	Yoder, L (corresponding author), Univ Hawaii, Dept Math, Honolulu, HI 96822 USA.	LDYoder@gmail.com						DUDEL J, 1983, HUMAN PHYSL, P177; Hales TC, 2005, ANN MATH, V162, P1065, DOI 10.4007/annals.2005.162.1065; HEIDEMANN SR, 1997, CELL BIOCHEM BIOPHYS, V27, P1085; Heimer L., 1994, HUMAN BRAIN SPINAL C; JONES EG, 1986, CEREB CORTEX, V5, P118; KANDEL ER, 2000, PRINCIPLES NEURAL SC, P327; Kepler J., 1966, NIVE SEXANGULA; Yoder L, 2005, COLOR RES APPL, V30, P252, DOI 10.1002/col.20121; Yoder L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004154	9	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9227	10.1371/journal.pone.0009227	http://dx.doi.org/10.1371/journal.pone.0009227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169077	gold, Green Published, Green Submitted			2022-12-25	WOS:000274590500009
J	Yamasaki, A; Saleh, A; Koussih, L; Muro, S; Halayko, AJ; Gounni, AS				Yamasaki, Akira; Saleh, Ali; Koussih, Latifa; Muro, Shigeo; Halayko, Andrew J.; Gounni, Abdelilah S.			IL-9 Induces CCL11 Expression via STAT3 Signalling in Human Airway Smooth Muscle Cells	PLOS ONE			English	Article							SERINE PHOSPHORYLATION; TRANSGENIC MICE; GENE-REGULATION; DNA-BINDING; INFLAMMATION; ACTIVATION; HYPERRESPONSIVENESS; TRANSFORMATION; RECEPTOR; TYROSINE	Background: Previous findings support the concept that IL-9 may play a significant role in mediating both pro-inflammatory and changes in airway responsiveness that characterizes the atopic asthmatic state. We previously demonstrated that human airway smooth muscle (ASM) cells express a functional IL-9R that mediate CCL11 expression. However, the signaling pathway governing this effect is not well understood. Methodology/Principal Findings: In this study, we showed that IL-9 mediated CCL11 expression in ASM cells does not rely on STAT6 or STAT5 but on STAT3 pathway. IL-9 induced rapid STAT3 activation in primary ASM cells that was not observed in case of STAT6 or STAT5. STAT3 binding to CCL11 promoter was also observed in vivo upon IL-9 stimulation of ASM cells. Disruption of STAT3 activity with SH2 domain binding inhibitory peptide results in significant reduction of IL-9 mediated CCL11 promoter activity. DN STAT3b over-expression in ASM cells, but not Ser 727 STAT3 or STAT6 DN, abolishes IL-9 mediated CCL11 promoter activity. Finally, STAT3 but not STAT6 silenced ASM cells showed significant reduction in IL-9 mediated CCL11 promoter activity and mRNA expression. Conclusion/Significance: Taken together, our results indicate that IL-9 mediated CCL11 via STAT3 signalling pathway may play a crucial role in airway inflammatory responses.	[Yamasaki, Akira; Saleh, Ali; Koussih, Latifa; Gounni, Abdelilah S.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Yamasaki, Akira; Halayko, Andrew J.] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Halayko, Andrew J.] Univ Manitoba, Resp Sect, Winnipeg, MB, Canada; [Muro, Shigeo] Kyoto Univ Hosp, Dept Resp Med, Sakyo Ku, Kyoto 606, Japan	University of Manitoba; University of Manitoba; University of Manitoba; Kyoto University	Yamasaki, A (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	gounni@cc.umanitoba.ca	Gounni, Abdelilah Soussi/AAH-3456-2020	Gounni, Abdelilah/0000-0003-1265-6560; Halayko, Andrew/0000-0002-7865-4552; Soussi Gounni, Abdelilah/0000-0002-7282-0388	Canadian Institutes of Health Research (CIHR) [MOP 5314]; Manitoba Health Research Council (MHRC) Research Chair; CIHR-National Training program in Allergy and Asthma	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council (MHRC) Research Chair; CIHR-National Training program in Allergy and Asthma(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) grant # MOP 5314 and Manitoba Health Research Council (MHRC) Research Chair to ASG. AY was supported by the CIHR-National Training program in Allergy and Asthma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pinheiro AAD, 2007, J LEUKOCYTE BIOL, V81, P1102, DOI 10.1189/jlb.0906583; Alvarez de Morales M., 1999, ELECTRON T NUMER ANA, V9, P1; Baraldo S, 2003, AM J PHYSIOL-LUNG C, V284, pL1093, DOI 10.1152/ajplung.00300.2002; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; DAMERA G, 2008, PULM PHARM THER; Demoulin J B, 1998, Int Rev Immunol, V16, P345, DOI 10.3109/08830189809043001; Demoulin JB, 2000, FEBS LETT, V482, P200, DOI 10.1016/S0014-5793(00)02059-7; Demoulin JB, 2000, CANCER RES, V60, P3971; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Faffe DS, 2005, J ALLERGY CLIN IMMUN, V115, P514, DOI 10.1016/j.jaci.2004.11.033; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Ghaffar O, 1999, AM J RESP CRIT CARE, V159, P1933, DOI 10.1164/ajrccm.159.6.9805039; Gounni AS, 2004, J IMMUNOL, V173, P2771, DOI 10.4049/jimmunol.173.4.2771; Hamann KJ, 2000, AM J PHYSIOL-LUNG C, V278, pL618, DOI 10.1152/ajplung.2000.278.3.L618; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Kung SKP, 2000, J VIROL, V74, P3668, DOI 10.1128/JVI.74.8.3668-3681.2000; Laporte JC, 2001, AM J RESP CRIT CARE, V164, P141, DOI 10.1164/ajrccm.164.1.2008060; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; McLane MP, 1998, AM J RESP CELL MOL, V19, P713, DOI 10.1165/ajrcmb.19.5.3457; Oliver Brian G, 2006, Allergol Int, V55, P215, DOI 10.2332/allergolint.55.215; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577; Rolling C, 1996, FEBS LETT, V393, P53, DOI 10.1016/0014-5793(96)00835-6; Saleh A, 2009, J IMMUNOL, V182, P3357, DOI 10.4049/jimmunol.0801882; Shen YH, 2004, MOL CELL BIOL, V24, P407, DOI 10.1128/MCB.24.1.407-419.2004; Simeone-Penney MC, 2007, J IMMUNOL, V178, P6191, DOI 10.4049/jimmunol.178.10.6191; Soussi-Gounni A, 2001, J ALLERGY CLIN IMMUN, V107, P575, DOI 10.1067/mai.2001.114238; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Ulbrecht M, 1997, J ALLERGY CLIN IMMUN, V99, P828, DOI 10.1016/S0091-6749(97)80018-8; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062	38	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9178	10.1371/journal.pone.0009178	http://dx.doi.org/10.1371/journal.pone.0009178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169197	gold, Green Submitted, Green Published			2022-12-25	WOS:000274474600003
J	Miller, G; Neilan, M; Chia, R; Gheryani, N; Holt, N; Charbit, A; Wells, S; Tucci, V; Lalanne, Z; Denny, P; Fisher, EMC; Cheeseman, M; Askew, GN; Dear, TN				Miller, Gaynor; Neilan, Monica; Chia, Ruth; Gheryani, Nabeia; Holt, Natalie; Charbit, Annabelle; Wells, Sara; Tucci, Valter; Lalanne, Zuzanne; Denny, Paul; Fisher, Elizabeth M. C.; Cheeseman, Michael; Askew, Graham N.; Dear, T. Neil			ENU Mutagenesis Reveals a Novel Phenotype of Reduced Limb Strength in Mice Lacking Fibrillin 2	PLOS ONE			English	Article							MARFAN-SYNDROME; EXTRACELLULAR MICROFIBRILS; SKELETAL-MUSCLES; MOUSE; GENE; MUTATIONS; DRIVEN; SCREENS; FBN2; SY	Background: Fibrillins 1 (FBN1) and 2 (FBN2) are components of microfibrils, microfilaments that are present in many connective tissues, either alone or in association with elastin. Marfan's syndrome and congenital contractural arachnodactyly (CCA) result from dominant mutations in the genes FBN1 and FBN2 respectively. Patients with both conditions often present with specific muscle atrophy or weakness, yet this has not been reported in the mouse models. In the case of Fbn1, this is due to perinatal lethality of the homozygous null mice making measurements of strength difficult. In the case of Fbn2, four different mutant alleles have been described in the mouse and in all cases syndactyly was reported as the defining phenotypic feature of homozygotes. Methodology/Principal Findings: As part of a large-scale N-ethyl-N-nitrosourea (ENU) mutagenesis screen, we identified a mouse mutant, Mariusz, which exhibited muscle weakness along with hindlimb syndactyly. We identified an amber nonsense mutation in Fbn2 in this mouse mutant. Examination of a previously characterised Fbn2-null mutant, Fbn2(fp), identified a similar muscle weakness phenotype. The two Fbn2 mutant alleles complement each other confirming that the weakness is the result of a lack of Fbn2 activity. Skeletal muscle from mutants proved to be abnormal with higher than average numbers of fibres with centrally placed nuclei, an indicator that there are some regenerating muscle fibres. Physiological tests indicated that the mutant muscle produces significantly less maximal force, possibly as a result of the muscles being relatively smaller in Mariusz mice. Conclusions: These findings indicate that Fbn2 is involved in integrity of structures required for strength in limb movement. As human patients with mutations in the fibrillin genes FBN1 and FBN2 often present with muscle weakness and atrophy as a symptom, Fbn2-null mice will be a useful model for examining this aspect of the disease process further.	[Miller, Gaynor; Neilan, Monica; Gheryani, Nabeia; Dear, T. Neil] Univ Sheffield, Sch Med, Mammalian Genet Dis Unit, Sheffield, S Yorkshire, England; [Chia, Ruth; Charbit, Annabelle; Fisher, Elizabeth M. C.] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Holt, Natalie; Askew, Graham N.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Wells, Sara; Tucci, Valter; Lalanne, Zuzanne; Denny, Paul; Cheeseman, Michael; Dear, T. Neil] MRC, Mary Lyon Ctr, Harwell, Berks, England; [Wells, Sara; Tucci, Valter; Lalanne, Zuzanne; Denny, Paul; Cheeseman, Michael; Dear, T. Neil] MRC, Mammalian Genet Unit, Harwell, Berks, England; [Dear, T. Neil] St James Univ Hosp, Leeds Inst Mol Med, Leeds, W Yorkshire, England	University of Sheffield; University of London; University College London; University of Leeds; Saint James's University Hospital; University of Leeds	Miller, G (corresponding author), Univ Sheffield, Sch Med, Mammalian Genet Dis Unit, Sheffield, S Yorkshire, England.	t.n.dear@leeds.ac.uk	Miller, Gaynor/G-8917-2014; Fisher, Elizabeth MC/C-2168-2008; Chia, Ruth/AAF-4900-2021; Holt, Natalie/T-4685-2019	Fisher, Elizabeth MC/0000-0003-2850-9936; Chia, Ruth/0000-0002-4709-7423; Holt, Natalie/0000-0003-0006-1279; Tucci, Valter/0000-0002-3796-3826; Denny, Paul/0000-0003-4659-6893; Miller, Gaynor/0000-0003-4527-3814	MRC [G0500288, MC_UP_1502/1, MC_U142670371, MC_U142684172, MC_U142684175] Funding Source: UKRI; Medical Research Council [MC_U142684172, MC_UP_1502/1, MC_U142684175, G0500288, MC_U142670371] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Askew GN, 1997, J EXP BIOL, V200, P3119; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Barbaric I, 2007, ENVIRON MOL MUTAGEN, V48, P124, DOI 10.1002/em.20286; Behan WMH, 2003, J NEUROL NEUROSUR PS, V74, P633, DOI 10.1136/jnnp.74.5.633; Boregowda R, 2008, MATRIX BIOL, V27, P661, DOI 10.1016/j.matbio.2008.09.579; Browning VL, 2001, GENOMICS, V73, P291, DOI 10.1006/geno.2001.6523; Chaudhry SS, 2001, HUM MOL GENET, V10, P835, DOI 10.1093/hmg/10.8.835; Dean JCS, 2007, EUR J HUM GENET, V15, P724, DOI 10.1038/sj.ejhg.5201851; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Farah S, 1997, CLIN NEUROL NEUROSUR, V99, P66, DOI 10.1016/S0303-8467(96)00596-3; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Johnson KR, 1998, MAMM GENOME, V9, P889, DOI 10.1007/s003359900889; Keays DA, 2007, MAMM GENOME, V18, P123, DOI 10.1007/s00335-006-0065-z; Krebs HA, 1932, H-S Z PHYSIOL CHEM, V210, P33, DOI 10.1515/bchm2.1932.210.1-2.33; Mallon AM, 2008, NUCLEIC ACIDS RES, V36, pD715, DOI 10.1093/nar/gkm728; MARSH RL, 1986, J EXP BIOL, V126, P63; MENDEZ J, 1960, METABOLISM, V9, P184; Percheron G, 2007, RHEUMATOLOGY, V46, P957, DOI 10.1093/rheumatology/kel450; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Rafael JA, 2000, MAMM GENOME, V11, P725, DOI 10.1007/s003350010149; Ramirez F, 2009, J BIOL CHEM, V284, P14677, DOI 10.1074/jbc.R900004200; Ritty TM, 2002, ANAT RECORD, V268, P430, DOI 10.1002/ar.10175; Scola RH, 2001, ARQ NEURO-PSIQUIAT, V59, P259, DOI 10.1590/S0004-282X2001000200022; Stratil A, 2008, ANIM GENET, V39, P204, DOI 10.1111/j.1365-2052.2007.01678.x; Tucci V, 2007, NEUROSCIENCE, V147, P573, DOI 10.1016/j.neuroscience.2007.04.034; VILJOEN D, 1994, J MED GENET, V31, P640, DOI 10.1136/jmg.31.8.640	30	18	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9137	10.1371/journal.pone.0009137	http://dx.doi.org/10.1371/journal.pone.0009137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161761	Green Accepted, Green Published, gold			2022-12-25	WOS:000274442600033
J	Mao, DQ; Hinds, PW				Mao, Daqin; Hinds, Philip W.			p35 Is Required for CDK5 Activation in Cellular Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; ONCOGENE-INDUCED SENESCENCE; RETINOBLASTOMA PROTEIN; TUMOR-CELLS; DNA-DAMAGE; P53; EXPRESSION; ARREST; RAS; ROLES	The retinoblastoma tumor suppressor gene (RB-1) is a key regulator of cellular senescence. Expression of the retinoblastoma protein (pRB) in human tumor cells that lack it results in senescence-like changes. The induction of the senescent phenotype by pRB requires the postmitotic kinase CDK5, the best known function of which is in neuronal development and postmitotic neuronal activities. Activation of CDK5 in neurons depends on its activators p35 and p39; however, little is known about how CDK5 is activated in non-neuronal senescent cells. Here we report that p35 is required for the activation ofCDK5in the process of cellular senescence. We demonstrate that: (i) p35 is expressed in osteosarcoma cells, (ii) p35 is required for CDK5 activation induced by pRB during senescence, (iii) p35 is required for the senescent morphological changes in which CDK5 is known to be involved as well as for expression of the senescence secretome, and (iv) p35 is up-regulated in senescing cells. Taken together, these results suggest that p35 is at least one of the activators of CDK5 that is mobilized in the process of cellular senescence, which may provide insight into cancer cell proliferation and future cancer therapeutics.	[Mao, Daqin; Hinds, Philip W.] Tufts Univ, Sch Med, Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Mao, Daqin] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University	Hinds, PW (corresponding author), Tufts Univ, Sch Med, Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St 5609, Boston, MA 02111 USA.	phinds@tuftsmedicalcenter.org			National Institutes of Health [CA104322, AG020208]; NATIONAL CANCER INSTITUTE [R01CA104322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020208] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA104322 and AG020208 (to P. W. H.).	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Alexander K, 2004, MOL CELL BIOL, V24, P2808, DOI 10.1128/MCB.24.7.2808-2819.2004; Alexander K, 2001, MOL CELL BIOL, V21, P3616, DOI 10.1128/MCB.21.11.3616-3631.2001; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang BD, 1999, CANCER RES, V59, P3761; Chen F, 2004, CANCER RES, V64, P5425, DOI 10.1158/0008-5472.CAN-04-0806; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Dai CY, 2000, ONCOGENE, V19, P1613, DOI 10.1038/sj.onc.1203438; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dulic V, 2000, MOL CELL BIOL, V20, P6741, DOI 10.1128/MCB.20.18.6741-6754.2000; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Lazaro JB, 1997, J CELL SCI, V110, P1251; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mathon NE, 2001, NAT REV CANCER, V1, P203, DOI 10.1038/35106045; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; MITTNACHT S, 1991, CELL, V65, P381, DOI 10.1016/0092-8674(91)90456-9; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Rosales JL, 2006, BIOESSAYS, V28, P1023, DOI 10.1002/bies.20473; Sarker KP, 2004, ONCOGENE, V23, P6064, DOI 10.1038/sj.onc.1207819; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Stein GH, 1999, MOL CELL BIOL, V19, P2109; STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342; te Poele RH, 2002, CANCER RES, V62, P1876; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Xu HJ, 1997, ONCOGENE, V15, P2589, DOI 10.1038/sj.onc.1201446; Yang HS, 2006, CANCER RES, V66, P2708, DOI 10.1158/0008-5472.CAN-05-3141; Yang HS, 2003, MOL CELL, V11, P1163, DOI 10.1016/S1097-2765(03)00135-7; Zheng M, 1998, J NEUROBIOL, V35, P141, DOI 10.1002/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4	51	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14671	14680		10.1074/jbc.M109.066118	http://dx.doi.org/10.1074/jbc.M109.066118			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20181942	Green Published, hybrid			2022-12-25	WOS:000277299700065
J	Hu, TH; Li, CX; Cao, Z; Van Raay, TJ; Smith, JG; Willert, K; Solnica-Krezel, L; Coffey, RJ				Hu, Tianhui; Li, Cunxi; Cao, Zheng; Van Raay, Terence J.; Smith, Jason G.; Willert, Karl; Solnica-Krezel, Lila; Coffey, Robert J.			Myristoylated Naked2 Antagonizes Wnt-beta-Catenin Activity by Degrading Dishevelled-1 at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-ALPHA; SUBCELLULAR-LOCALIZATION; EXOCYTIC VESICLES; CELL POLARITY; MDCK CELLS; PROTEIN; DEGRADATION; ZEBRAFISH; PATHWAYS; POSTERIORIZATION	In Drosophila, naked cuticle is an inducible antagonist of the Wnt-beta-catenin pathway, likely acting at the level of Dishevelled (Dsh/Dvl), an essential component of this pathway. The mechanism by which naked cuticle and its two vertebrate orthologs, Naked1 (NKD1) and Naked2 (NKD2), inhibit Dvl function is unknown. NKD2 is myristoylated, a co-translational modification that leads to its plasma membrane localization. In contrast, myristoylation-deficient G2A NKD2 is cytoplasmic. Herein we show that the ability of Nkd2/NKD2 to antagonize Wnt-beta-catenin activity during zebrafish embryonic development and in mammalian HEK293cells is myristoylation-dependent. NKD2 and Dvl-1 interact and co-localize at the lateral membrane of polarized epithelial cells. In reciprocal overexpression and siRNA knockdown experiments, NKD2 and Dvl-1 destabilize each other via enhanced polyubiquitylation; this effect is also dependent upon Naked2 myristoylation. Cell fractionation and ubiquitylation assays indicate that endogenous NKD2 interacts with a slower migrating, ubiquitylated form of Dvl-1 in plasma membrane fractions. These results provide a mechanism by which NKD2 antagonizes Wnt signaling: myristoylated NKD2 interacts with Dvl-1 at the plasma membrane, and this interaction leads to their mutual ubiquitin-mediated proteasomal degradation.	[Hu, Tianhui; Li, Cunxi; Cao, Zheng; Van Raay, Terence J.; Smith, Jason G.; Coffey, Robert J.] Vanderbilt Univ, Sch Med, Dept Med & Cell & Dev Biol, Nashville, TN 37232 USA; [Van Raay, Terence J.; Solnica-Krezel, Lila] Vanderbilt Univ, Sch Med, Dept Biol Sci, Nashville, TN 37232 USA; [Willert, Karl] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Coffey, Robert J.] Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA; [Hu, Tianhui] Xiamen Univ, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China; [Hu, Tianhui] Xiamen Univ, Coll Med, Canc Res Ctr, Xiamen 361005, Peoples R China	Vanderbilt University; Vanderbilt University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Xiamen University; Xiamen University	Coffey, RJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Med & Cell & Dev Biol, 10415-E MRB 4,2213 Garland Ave, Nashville, TN 37232 USA.	robert.coffey@vanderbilt.edu	Van Raay, Terry/AAA-7342-2021; Hu, T/G-3381-2010	Van Raay, Terence/0000-0003-0196-1041	National Institutes of Health [5R01CA046413, 5P50CA095103, 5T32HL007751]; Ministry of Science and Technology [2009CB522200, 2006AA02A303]; Ministry of Education for Cell Biology and Tumor Cell Engineering, Xiamen University [2009102]; NATIONAL CANCER INSTITUTE [U01CA084239, R01CA046413, P50CA095103] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education for Cell Biology and Tumor Cell Engineering, Xiamen University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01CA046413 and 5P50CA095103 ( to R.J.C.) and 5T32HL007751. This work was also supported by Project Grant 985 from Xiamen University, Ministry of Science and Technology Grants 2009CB522200 and 2006AA02A303, and Research Grant 2009102 from the Key Laboratory of the Ministry of Education for Cell Biology and Tumor Cell Engineering, Xiamen University ( to T. H.).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cao Z, 2008, MOL CELL PROTEOMICS, V7, P1651, DOI 10.1074/mcp.M700155-MCP200; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Chung EK, 2005, EXP CELL RES, V309, P149, DOI 10.1016/j.yexcr.2005.05.012; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; Ding W, 2008, P NATL ACAD SCI USA, V105, P13433, DOI 10.1073/pnas.0806298105; Erter CE, 2001, DEVELOPMENT, V128, P3571; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; KELLY GM, 1995, DEVELOPMENT, V121, P1787; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lee YN, 2008, CELL SIGNAL, V20, P443, DOI 10.1016/j.cellsig.2007.11.005; Li CX, 2007, MOL BIOL CELL, V18, P3081, DOI 10.1091/mbc.E07-02-0172; Li CX, 2004, P NATL ACAD SCI USA, V101, P5571, DOI 10.1073/pnas.0401294101; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nusse R, 1997, COLD SPRING HARB SYM, V62, P185; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Polakis P, 2000, GENE DEV, V14, P1837; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rhinn M, 2005, DEVELOPMENT, V132, P1261, DOI 10.1242/dev.01685; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Van Raay TJ, 2007, DEV BIOL, V309, P151, DOI 10.1016/j.ydbio.2007.04.018; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	40	40	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13561	13568		10.1074/jbc.M109.075945	http://dx.doi.org/10.1074/jbc.M109.075945			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20177058	Green Published, hybrid			2022-12-25	WOS:000276987700029
J	Glazer, L; Shechter, A; Tom, M; Yudkovski, Y; Weil, S; Aflalo, ED; Pamuru, RR; Khalaila, I; Bentov, S; Berman, A; Sagi, A				Glazer, Lilah; Shechter, Assaf; Tom, Moshe; Yudkovski, Yana; Weil, Simy; Aflalo, Eliahu David; Pamuru, Ramachandra Reddy; Khalaila, Isam; Bentov, Shmuel; Berman, Amir; Sagi, Amir			A Protein Involved in the Assembly of an Extracellular Calcium Storage Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAYFISH CHERAX-QUADRICARINATUS; PROCAMBARUS-CLARKII; MOLT CYCLE; CUTICULAR PROTEINS; ORGANIC MATRIX; GEL-ELECTROPHORESIS; SKELETAL STRUCTURES; VIRILIS HAGEN; EXOSKELETON; EXPRESSION	Gastroliths, the calcium storage organs of crustaceans, consist of chitin-protein-mineral complexes in which the mineral component is stabilized amorphous calcium carbonate. To date, only three proteins, GAP 65, gastrolith matrix protein (GAMP), and orchestin, have been identified in gastroliths. Here, we report a novel protein, GAP 10, isolated from the gastrolith of the crayfish Cherax quadricarinatus and specifically expressed in its gastrolith disc. The encoding gene was cloned by partial sequencing of the protein extracted from the gastrolith matrix. Based on an assembled microarray cDNA chip, GAP 10 transcripts were found to be highly (12-fold) up-regulated in premolt gastrolith disc and significantly down-regulated in the hypodermis at the same molt stage. The deduced protein sequence of GAP 10 lacks chitin-binding domains and does not show homology to known proteins in the GenBank (TM) data base. It does, however, have an amino acid composition that has similarity to proteins extracted from invertebrate and ascidian-calcified extracellular matrices. The GAP 10 sequence contains a predicted signal peptide and predicted phosphorylation sites. In addition, the protein is phosphorylated and exhibits calcium-binding ability. Repeated daily injections of GAP 10 double strand RNA to premolt C. quadricarinatus resulted in a prolonged premolt stage and in the development of gastroliths with irregularly rough surfaces. These findings suggest that GAP 10 may be involved in the assembly of the gastrolith chitin-protein-mineral complex, particularly in the deposition of amorphous calcium carbonate.	[Bentov, Shmuel; Sagi, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Glazer, Lilah; Shechter, Assaf; Aflalo, Eliahu David; Berman, Amir; Sagi, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Khalaila, Isam; Berman, Amir] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel; [Tom, Moshe; Yudkovski, Yana] Israel Oceanog & Limnol Res, IL-31096 Haifa, Israel; [Pamuru, Ramachandra Reddy] Yogi Vemana Univ, Dept Biochem, Kadapa 516003, Andhra Pradesh, India	Ben Gurion University; Ben Gurion University; Ben Gurion University; Israel Oceanographic & Limnological Research Institute; Yogi Vemana University	Sagi, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, POB 653, IL-84105 Beer Sheva, Israel.	sagia@bgu.ac.il	Pamuru, Ramachandra Reddy/K-3509-2019; Pamuru, Ramachandra Reddy/B-3782-2015; Aflalo, Eliahu/F-1484-2012; khalaila, Isam/F-1498-2012; Berman, Amir/F-1870-2012	Pamuru, Ramachandra Reddy/0000-0002-9017-974X; khalaila, Isam/0000-0003-3250-5778; Sagi, Amir/0000-0002-4229-1059; berman, amir/0000-0001-7359-9016; Aflalo, Eli/0000-0003-1385-2387	Israel Science Foundation [1080/05]; German Israel Foundation [950-9.5/2007]; Amorphical Ltd.	Israel Science Foundation(Israel Science Foundation); German Israel Foundation(German-Israeli Foundation for Scientific Research and Development); Amorphical Ltd.	This work was supported in part by Israel Science Foundation Grant 1080/05, by German Israel Foundation Grant 950-9.5/2007, and by a grant from Amorphical Ltd.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Aizenberg J, 2002, J AM CHEM SOC, V124, P32, DOI 10.1021/ja016990l; ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Arnott D, 1998, ANAL BIOCHEM, V258, P1, DOI 10.1006/abio.1998.2566; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENSON SC, 1986, J CELL BIOL, V102, P1878, DOI 10.1083/jcb.102.5.1878; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Gayathri S, 2007, CHEM-EUR J, V13, P3262, DOI 10.1002/chem.200600825; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; GREENAWAY P, 1985, BIOL REV, V60, P425, DOI 10.1111/j.1469-185X.1985.tb00424.x; HALLORAN BA, 1995, COMP BIOCHEM PHYS B, V111, P221, DOI 10.1016/0305-0491(94)00245-P; Hecker A, 2003, FEBS LETT, V535, P49, DOI 10.1016/S0014-5793(02)03856-5; Inoue H, 2003, COMP BIOCHEM PHYS B, V136, P755, DOI 10.1016/S1096-4959(03)00210-0; Inoue H, 2004, BIOCHEM BIOPH RES CO, V318, P649, DOI 10.1016/j.bbrc.2004.04.075; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; Ishii K, 1998, BIOSCI BIOTECH BIOCH, V62, P291, DOI 10.1271/bbb.62.291; Ishii K, 1996, BIOSCI BIOTECH BIOCH, V60, P1479, DOI 10.1271/bbb.60.1479; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; Kuballa AV, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-45; LAEMMLI UK, 1970, NATURE, V227, P685; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; Magkrioti CK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-138; Marie B, 2007, FEBS J, V274, P2933, DOI 10.1111/j.1742-4658.2007.05825.x; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x; Pratoomchat B, 2002, J EXP ZOOL, V293, P414, DOI 10.1002/jez.90002; Raz S, 2003, ADV FUNCT MATER, V13, P480, DOI 10.1002/adfm.200304285; ROER R, 1984, AM ZOOL, V24, P893; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Shechter A, 2005, BIOL REPROD, V73, P72, DOI 10.1095/biolreprod.104.038554; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Shechter A, 2008, BIOL BULL-US, V214, P122, DOI 10.2307/25066669; Shechter A, 2007, J EXP BIOL, V210, P3525, DOI 10.1242/jeb.006791; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Sugawara A, 2006, ANGEW CHEM INT EDIT, V45, P2876, DOI 10.1002/anie.200503800; Takagi Y, 2000, ZOOL SCI, V17, P179, DOI 10.2108/zsj.17.179; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Testeniere O, 2002, BIOCHEM J, V361, P327, DOI 10.1042/0264-6021:3610327; TRAVIS DF, 1960, BIOL BULL, V118, P137, DOI 10.2307/1539064; TRAVIS DF, 1963, J ULTRA MOL STRUCT R, V9, P285, DOI 10.1016/S0022-5320(63)80008-8; Tsutsui N, 1999, ZOOL SCI, V16, P619, DOI 10.2108/zsj.16.619; UENO M, 1980, J EXP ZOOL, V213, P161, DOI 10.1002/jez.1402130202; Ventura T, 2009, ENDOCRINOLOGY, V150, P1278, DOI 10.1210/en.2008-0906; Watanabe T, 2000, COMP BIOCHEM PHYS B, V125, P127, DOI 10.1016/S0305-0491(99)00153-4; Wynn A, 2005, COMP BIOCHEM PHYS B, V141, P294, DOI 10.1016/j.cbpc.2005.04.002; YANO I, 1975, B JPN SOC SCI FISH, V41, P1079; Yudkovski Y, 2007, INSECT MOL BIOL, V16, P661, DOI 10.1111/j.1365-2583.2007.00762.x; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	51	40	40	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12831	12839		10.1074/jbc.M109.071068	http://dx.doi.org/10.1074/jbc.M109.071068			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20150428	Green Published, hybrid			2022-12-25	WOS:000276787800041
J	Pozzi, A; Popescu, V; Yang, SL; Mei, SJ; Shi, MJ; Puolitaival, SM; Caprioli, RM; Capdevila, JH				Pozzi, Ambra; Popescu, Vlad; Yang, Shilin; Mei, Shaojun; Shi, Mingjian; Puolitaival, Satu M.; Caprioli, Richard M.; Capdevila, Jorge H.			The Anti-tumorigenic Properties of Peroxisomal Proliferator-activated Receptor alpha Are Arachidonic Acid Epoxygenase-mediated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; SOLUBLE EPOXIDE HYDROLASE; EPOXYEICOSATRIENOIC ACIDS; PPAR-ALPHA; SPECIES-DIFFERENCES; CARCINOMA-CELLS; DOWN-REGULATION; LUNG-CANCER; IN-VIVO; ANGIOGENESIS	Prevalence and mortality make cancer a health challenge in need of effective and better tolerated therapeutic approaches, with tumor angiogenesis identified as a promising target for drug development. The epoxygenase products, the epoxyeicosatrienoic acids, are pro-angiogenic, and down-regulation of their biosynthesis by peroxisomal proliferator-activated receptor alpha (PPAR alpha) ligands reduces tumor angiogenesis and growth. Endothelial cells lacking a Cyp2c44 epoxygenase, a PPAR alpha target, show reduced proliferative and tubulogenic activities that are reversed by the enzyme's metabolites. In a mouse xenograft model of tumorigenesis, disruption of the host Cyp2c44 gene causes marked reductions in tumor volume, mass, and vascularization. The relevance of these studies to human cancer is indicated by the demonstration that: (a) activation of human PPAR alpha down-regulates endothelial cell CYP2C9 epoxygenase expression and blunts proliferation and tubulogenesis, (b) in a PPAR alpha-humanized mouse model, activation of the receptor inhibits tumor angiogenesis and growth, and (c) the CYP2C9 epoxygenase is expressed in the vasculature of human tumors. The identification of anti-angiogenic/anti-tumorigenic properties of PPAR alpha points to a role for the receptor and its epoxygenase regulatory target in the pathophysiology of cancer, and for its ligands as candidates for the development of a new generation of safer and better tolerated anti-cancer drugs.	[Pozzi, Ambra; Popescu, Vlad; Yang, Shilin; Mei, Shaojun; Shi, Mingjian; Capdevila, Jorge H.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Puolitaival, Satu M.] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37232 USA; [Caprioli, Richard M.; Capdevila, Jorge H.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Puolitaival, Satu M.; Caprioli, Richard M.] Vanderbilt Univ, Sch Med, Ctr Mass Spectrometry Res, Nashville, TN 37232 USA; [Pozzi, Ambra] Vet Affairs Hosp, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Capdevila, JH (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Med Ctr N S 3223, Nashville, TN 37232 USA.	jorge.capdevila@vanderbilt.edu		Shi, Mingjian/0000-0003-1569-9822	National Institutes of Health [DK 5P01-038226, GM 5R01-037922, DK R01-065123]; Department of Veterans Affairs; Vanderbilt University Cancer Center [CA-68485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK065123, P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058008, R01GM037922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Vanderbilt University Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 5P01-038226 and GM 5R01-037922 (to J. H. C.), DK R01-065123 (to A. P.), and GM5R01-58008 (to R. M. C.). This work was also supported by a Department of Veterans Affairs Merit Award (to A. P.). Mass Spectrometric analyses were done with support from the Vanderbilt University Cancer Center Grant CA-68485.	Capdevila JH, 2007, KIDNEY INT, V72, P683, DOI 10.1038/sj.ki.5002394; CAPDEVILA JH, 1991, METHOD ENZYMOL, V206, P441; Capdevila JH, 2002, PROSTAG OTH LIPID M, V68-9, P325, DOI 10.1016/S0090-6980(02)00038-2; Chen JK, 2002, P NATL ACAD SCI USA, V99, P6029, DOI 10.1073/pnas.092671899; Chen XW, 2005, INT J CANCER, V116, P52, DOI 10.1002/ijc.20997; Cheranov SY, 2008, BLOOD, V111, P5581, DOI 10.1182/blood-2007-11-126680; Chiamvimonvat N, 2007, J CARDIOVASC PHARM, V50, P225, DOI 10.1097/FJC.0b013e3181506445; Chung EK, 2008, CLIN GENITOURIN CANC, V6, pS22, DOI 10.3816/CGC.2008.s.004; Corton JC, 1998, MOL PHARMACOL, V54, P463, DOI 10.1124/mol.54.3.463; Dellavalle RP, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003697.pub2; DeLozier TC, 2004, J PHARMACOL EXP THER, V310, P845, DOI 10.1124/jpet.104.067819; Fernando NT, 2008, CLIN CANCER RES, V14, P1529, DOI 10.1158/1078-0432.CCR-07-4126; Fleming I, 2006, HYPERTENSION, V47, P629, DOI 10.1161/01.HYP.0000208597.87957.89; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gauthier KM, 2007, J CARDIOVASC PHARM, V50, P601, DOI 10.1097/FJC.0b013e318159cbe3; Golembesky AK, 2008, CARCINOGENESIS, V29, P1944, DOI 10.1093/carcin/bgn154; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Grabacka M, 2006, CLIN CANCER RES, V12, P3028, DOI 10.1158/1078-0432.CCR-05-2556; Hardesty WM, 2008, ANAL BIOANAL CHEM, V391, P899, DOI 10.1007/s00216-008-1972-5; Jiang JG, 2005, CANCER RES, V65, P4707, DOI 10.1158/0008-5472.CAN-04-4173; Jiang JG, 2007, CANCER RES, V67, P6665, DOI 10.1158/0008-5472.CAN-06-3643; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; KARARA A, 1992, BIOCHEM BIOPH RES CO, V182, P1320, DOI 10.1016/0006-291X(92)91877-S; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Kuhn H, 2007, CURR MED CHEM, V14, P3157, DOI 10.2174/092986707782793907; Medhora M, 2003, AM J PHYSIOL-HEART C, V284, pH215, DOI 10.1152/ajpheart.01118.2001; Michaelis UR, 2003, FASEB J, V17, P770, DOI 10.1096/fj.02-0640fje; Nie DT, 2000, BLOOD, V95, P2304, DOI 10.1182/blood.V95.7.2304.007k23_2304_2311; Obhrai JS, 2008, KIDNEY INT, V74, P685, DOI 10.1038/ki.2008.288; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Pozzi A, 2005, J BIOL CHEM, V280, P27138, DOI 10.1074/jbc.M501730200; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Pozzi A, 2007, J BIOL CHEM, V282, P17685, DOI 10.1074/jbc.M701429200; Pozzi A, 2008, PPAR RES, V2008, DOI 10.1155/2008/906542; Press MF, 2007, DRUGS, V67, P2045, DOI 10.2165/00003495-200767140-00006; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; ROBERTS WC, 1989, CARDIOLOGY, V76, P169, DOI 10.1159/000174488; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Savas U, 1999, MOL PHARMACOL, V56, P851, DOI 10.1124/mol.56.5.851; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Shah YA, 2007, MOL CELL BIOL, V27, P4238, DOI 10.1128/MCB.00317-07; Sivanandam VG, 2008, J GENE MED, V10, P1083, DOI 10.1002/jgm.1244; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Steinhoff M, 2008, J AM ACAD DERMATOL, V58, pS88, DOI 10.1016/j.jaad.2007.07.012; Strakova N, 2005, NEOPLASMA, V52, P126; Tenenbaum A, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-18; Tsubouchi Y, 2000, BIOCHEM BIOPH RES CO, V270, P400, DOI 10.1006/bbrc.2000.2436; Urbanska K, 2008, INT J CANCER, V123, P1015, DOI 10.1002/ijc.23588; Veeravagu A, 2007, RECENT PAT ANTI-CANC, V2, P59, DOI 10.2174/157489207779561426; Wang DZ, 2008, PPAR RES, V2008, DOI 10.1155/2008/931074; Webler AC, 2008, AM J PHYSIOL-CELL PH, V295, pC1292, DOI 10.1152/ajpcell.00230.2008; Wu CW, 2009, ONCOL REP, V22, P451, DOI 10.3892/or_00000456; Yang Q, 2008, TOXICOL SCI, V101, P132, DOI 10.1093/toxsci/kfm206; Yang SL, 2009, ARCH BIOCHEM BIOPHYS, V489, P82, DOI 10.1016/j.abb.2009.05.006; Yang WQ, 2008, J PHARMACOL EXP THER, V324, P1019, DOI 10.1124/jpet.107.129577; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V322, P76, DOI 10.1006/abbi.1995.1438	58	61	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12840	12850		10.1074/jbc.M109.081554	http://dx.doi.org/10.1074/jbc.M109.081554			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178979	Green Published, hybrid			2022-12-25	WOS:000276787800042
J	Crozet, P; Jammes, F; Valot, B; Ambard-Bretteville, F; Nessler, S; Hodges, M; Vidal, J; Thomas, M				Crozet, Pierre; Jammes, Fabien; Valot, Benoit; Ambard-Bretteville, Francoise; Nessler, Sylvie; Hodges, Michael; Vidal, Jean; Thomas, Martine			Cross-phosphorylation between Arabidopsis thaliana Sucrose Nonfermenting 1-related Protein Kinase 1 (AtSnRK1) and Its Activating Kinase (AtSnAK) Determines Their Catalytic Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UPSTREAM KINASE; YEAST SNF1; IN-VITRO; ENERGY; SNRK1; EXPRESSION; REGULATORS; REDUCTASE; BETA; LOOP	Arabidopsis thaliana sucrose nonfermenting 1-related protein kinase 1 complexes belong to the SNF1/AMPK/SnRK1 protein kinase family that shares an ancestral function as central regulators of metabolism. In A. thaliana, the products of AtSnAK1 and AtSnAK2, orthologous to yeast genes, have been shown to autophosphorylate and to phosphorylate/activate the AtSnRK1.1 catalytic subunit on Thr(175). The phosphorylation of these kinases has been investigated by site-directed mutagenesis and tandem mass spectrometry. The autophosphorylation site of AtSnAK2 was identified as Thr(154), and it was shown to be required for AtSnAK catalytic activity. Interestingly, activated AtSnRK1 exerted a negative feedback phosphorylation on AtSnAK2 at Ser(261) (Ser(260) of AtSnAK1) that was dependent on AtSnAK autophosphorylation. The dynamics of these reciprocal phosphorylation events on the different kinases was established, and structural modeling allowed clarification of the topography of the AtSnAK phosphorylation sites. A mechanism is proposed to explain the observed changes in the enzymatic properties of each kinase triggered by these phosphorylation events.	[Crozet, Pierre; Jammes, Fabien; Ambard-Bretteville, Francoise; Hodges, Michael; Vidal, Jean; Thomas, Martine] Univ Paris 11, Lab Signalisat & Regulat Metab, Inst Biol Plantes, CNRS,UMR 8618, F-91405 Orsay, France; [Valot, Benoit] Univ Paris 11, UMR Genet Vegetale INRA, CNRS, INA PG, F-91190 Gif Sur Yvette, France; [Nessler, Sylvie] CNRS, Lab Enzymol & Biochim Struct, UPR 3082, CNRS, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Thomas, M (corresponding author), Univ Paris 11, Lab Signalisat & Regulat Metab, Inst Biol Plantes, CNRS,UMR 8618, Batiment 630, F-91405 Orsay, France.	martine.thomas@u-psud.fr	Hodges, Michael/A-8883-2008; Valot, Benoit BV/G-3521-2018; Crozet, Pierre/M-4306-2013; Jammes, Fabien/AAB-6235-2020; Nessler, Sylvie/R-4296-2016	Crozet, Pierre/0000-0001-5113-2407; Nessler, Sylvie/0000-0003-4973-9941	French Ministere de l'Enseignement Superieur et de la Recherche (MENRT)	French Ministere de l'Enseignement Superieur et de la Recherche (MENRT)	Supported by a fellowship from the French Ministere de l'Enseignement Superieur et de la Recherche (MENRT).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Cai XJ, 2009, MOL PHARMACOL, V75, P626, DOI 10.1124/mol.108.050278; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Harthill JE, 2006, PLANT J, V47, P211, DOI 10.1111/j.1365-313X.2006.02780.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hey S, 2007, J BIOL CHEM, V282, P10472, DOI 10.1074/jbc.M611244200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; LAEMMLI UK, 1970, NATURE, V227, P685; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Polge C, 2007, TRENDS PLANT SCI, V12, P20, DOI 10.1016/j.tplants.2006.11.005; Shen W, 2006, PLANT PHYSIOL, V142, P1642, DOI 10.1104/pp.106.088476; Shen W, 2009, PLANT PHYSIOL, V150, P996, DOI 10.1104/pp.108.132787; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sugden C, 1999, PLANT J, V19, P433, DOI 10.1046/j.1365-313X.1999.00532.x; Sugden C, 1999, PLANT PHYSIOL, V120, P257, DOI 10.1104/pp.120.1.257; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031	24	54	59	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12071	12077		10.1074/jbc.M109.079194	http://dx.doi.org/10.1074/jbc.M109.079194			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164192	hybrid, Green Published			2022-12-25	WOS:000276787100036
J	de la Vega, M; Burrows, JF; McFarlane, C; Govender, U; Scott, CJ; Johnston, JA				de la Vega, Michelle; Burrows, James F.; McFarlane, Cheryl; Govender, Ureshnie; Scott, Christopher J.; Johnston, James A.			The Deubiquitinating Enzyme USP17 Blocks N-Ras Membrane Trafficking and Activation but Leaves K-Ras Unaffected	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; GOLGI-COMPLEX; H-RAS; B-RAF; CANCER; CELL; TRANSFORMATION; PROLIFERATION; PATHWAY; FAMILY	The proto-oncogenic Ras isoforms (H, N, and K) have a C-terminal CAAX motif and undergo the same post-translational processing steps, although they traffic to the plasma membrane through different routes. Previously, we have shown that overexpression of the deubiquitinating enzyme USP17 inhibits H-Ras localization to the plasma membrane. Now we report that whereas H-Ras and N-Ras were unable to localize to the plasma membrane in the presence of USP17, K-Ras4b localization was unaffected. EGF stimulation was unable to induce N-Ras membrane localization in USP17-expressing cells. In addition, N-Ras activity and downstream signaling through the MAPK MEK/ERK and PI3K/JNK pathways were blunted. However, we still detected abundant N-Ras localization at the ER and Golgi in USP17-expressing cells. Collectively, our data showed that the deubiquitinating enzyme USP17 blocks EGF-induced N-Ras membrane trafficking and activation, but left K-Ras unaffected.	[de la Vega, Michelle; Burrows, James F.; McFarlane, Cheryl; Govender, Ureshnie; Johnston, James A.] Queens Univ Belfast, Ctr Infect & Immun, Sch Med Dent & Biomed Sci, Belfast BT9 7BL, Antrim, North Ireland; [Burrows, James F.; Scott, Christopher J.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Johnston, JA (corresponding author), Rm 330,Whitla Med Bldg,97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	jim.johnston@qub.ac.uk						Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Ballard-Croft C, 2006, AM J PHYSIOL-HEART C, V291, pH658, DOI 10.1152/ajpheart.01354.2005; Bannykh SI, 2005, TRAFFIC, V6, P803, DOI 10.1111/j.1600-0854.2005.00319.x; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2002, MOL CELL BIOL, V22, P171, DOI 10.1128/MCB.22.1.171-181.2002; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; Burrows JF, 2009, J BIOL CHEM, V284, P9587, DOI 10.1074/jbc.M807216200; Burrows JF, 2005, GENOMICS, V85, P524, DOI 10.1016/j.ygeno.2004.11.013; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Ibiza S, 2008, P NATL ACAD SCI USA, V105, P10507, DOI 10.1073/pnas.0711062105; Inder K, 2008, MOL BIOL CELL, V19, P4776, DOI 10.1091/mbc.E08-04-0407; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Liu L, 2009, BBA-PROTEINS PROTEOM, V1794, P1485, DOI 10.1016/j.bbapap.2009.06.016; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Nakamura K, 2008, ONCOGENE, V27, P2961, DOI 10.1038/sj.onc.1210956; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rotblat B, 2006, CANCER RES, V66, P1974, DOI 10.1158/0008-5472.CAN-05-3791; Saxena N, 2008, CANCER INVEST, V26, P948, DOI 10.1080/07357900802087275; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sousa SF, 2008, CURR MED CHEM, V15, P1478, DOI 10.2174/092986708784638825; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Wong KK, 2009, RECENT PAT ANTI-CANC, V4, P28, DOI 10.2174/157489209787002461; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Zheng H, 2007, J BIOL CHEM, V282, P25760, DOI 10.1074/jbc.M700437200	38	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12028	12036		10.1074/jbc.M109.081448	http://dx.doi.org/10.1074/jbc.M109.081448			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20147298	Green Published, hybrid			2022-12-25	WOS:000276787100031
J	El Mortaji, L; Terrasse, R; Dessen, A; Vernet, T; Di Guilmi, AM				El Mortaji, Lamya; Terrasse, Remi; Dessen, Andrea; Vernet, Thierry; Di Guilmi, Anne Marie			Stability and Assembly of Pilus Subunits of Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROCOCCUS-FAECALIS; ISOPEPTIDE BONDS; HUG MODEL; SORTASE; COLLAGEN; SURFACE; BINDING; AGALACTIAE; ADHESIN; PROTEIN	Pili are surface-exposed virulence factors involved in bacterial adhesion to host cells. The Streptococcus pneumoniae pilus is composed of three structural proteins, RrgA, RrgB, and RrgC and three transpeptidase enzymes, sortases SrtC-1, SrtC-2, and SrtC-3. To gain insights into the mechanism of pilus formation we have exploited biochemical approaches using recombinant proteins expressed in Escherichia coli. Using site-directed mutagenesis, mass spectrometry, limited proteolysis, and thermal stability measurements, we have identified isopeptide bonds in RrgB and RrgC and demonstrate their role in protein stabilization. Co-expression in E. coli of RrgB together with RrgC and SrtC-1 leads to the formation of a covalent RrgB-RrgC complex. Inactivation of SrtC-1 by mutation of the active site cysteine impairs RrgB-RrgC complex formation, indicating that the association between RrgB and RrgC is specifically catalyzed by SrtC-1. Mass spectrometry analyses performed on purified samples of the RrgB-RrgC complex show that the complex has 1: 1 stoichiometry. The deletion of the IPQTG RrgB sorting signal, but not the corresponding sequence in RrgC, abolishes complex formation, indicating that SrtC-1 recognizes exclusively the sorting motif of RrgB. Finally, we show that the intramolecular bonds that stabilize RrgB may play a role in its efficient recognition by SrtC-1. The development of a methodology to generate covalent pilin complexes in vitro, facilitating the study of sortase specificity and the importance of isopeptide bond formation for pilus biogenesis, provide key information toward the understanding of this complex macromolecular process.	UJF, CNRS, CEA,UMR 5075, Inst Biol Struct Jean Pierre Ebel,Lab Ingn Macrom, F-38027 Grenoble, France; [Dessen, Andrea] UJF, CNRS, CEA,UMR 5075, Inst Biol Struct Jean Pierre Ebel,Bacterial Patho, F-38027 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA		diguilmi@ibs.fr	Vernet, Thierry/G-1118-2012	Dessen, Andrea/0000-0001-6487-4020; Di Guilmi, Anne Marie/0000-0001-7335-3470	EC [LSHM-CT-2004-512138]; ANR [05-JC-JC-0049]	EC(European CommissionEuropean Commission Joint Research Centre); ANR(French National Research Agency (ANR))	This work was supported in part by EC Grant LSHM-CT-2004-512138 and ANR Grant 05-JC-JC-0049.	Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Budzik JM, 2009, J BIOL CHEM, V284, P12989, DOI 10.1074/jbc.M900927200; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Dramsi S, 2008, FEMS MICROBIOL REV, V32, P307, DOI 10.1111/j.1574-6976.2008.00102.x; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Kline KA, 2009, J BACTERIOL, V191, P3237, DOI 10.1128/JB.01837-08; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Liu Q, 2007, J BIOL CHEM, V282, P19629, DOI 10.1074/jbc.M611137200; Manzano C, 2009, BIOCHEMISTRY-US, V48, P10549, DOI 10.1021/bi901261y; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	30	31	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12405	12415		10.1074/jbc.M109.082776	http://dx.doi.org/10.1074/jbc.M109.082776			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20147289	Green Published, hybrid			2022-12-25	WOS:000276787100068
J	Lin, JJ; Hemenway, CS				Lin, Jeffrey J.; Hemenway, Charles S.			Hsp90 Directly Modulates the Spatial Distribution of AF9/MLLT3 and Affects Target Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MLL FUSION PARTNER; TRANSCRIPTIONAL ELONGATION; CHROMOSOMAL TRANSLOCATION; NUCLEAR IMPORT; LEUKEMIA; INTERACTS; CHAPERONE; CHROMATIN; COMPLEXES; BINDING	AF9/MLLT3 contributes to the regulation of the gene encoding the epithelial sodium channel alpha, ENaC alpha, in renal tubular cells. Specifically, increases in AF9 protein lead to a reduction in ENaC alpha expression and changes in AF9 activity appear to be an important component of aldosterone signaling in the kidney. Whereas AF9 is found in the nucleus where it interacts with the histone H3 lysine 79 methyltransferase, Dot1, AF9 is also present in the cytoplasm. Data presented in this report indicate that the heat shock protein Hsp90 directly and specifically interacts with AF9 as part of an Hsp90-Hsp70-p60/Hop chaperone complex. Experimental manipulation of Hsp90 function by the inhibitor novobiocin, but not 17-AAG, results in redistribution of AF9 from a primarily nuclear to cytoplasmic location. Knockdown of Hsp90 with siRNA mimics the effect elicited by novobiocin. As expected, a shift in AF9 from the nucleus to the cytoplasm in response to Hsp90 interference leads to increased ENaC alpha expression. This is accompanied by a decrease in AF9 occupancy at the ENaC alpha promoter. Our data suggest that the interaction of Hsp90, Hsp70, and p60/Hop with AF9 is necessary for the proper subnuclear localization and activity of AF9. AF9 is among a growing number of nuclear proteins recognized to rely on the Hsp90 complex for nuclear targeting.	[Hemenway, Charles S.] Loyola Univ Chicago, Stritch Sch Med, Dept Pediat, Maywood, IL 60153 USA; [Hemenway, Charles S.] Loyola Univ Chicago, Stritch Sch Med, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA; Tulane Univ, Sch Med, Dept Biochem, New Orleans, LA 70112 USA	Loyola University Chicago; Loyola University Chicago; Tulane University	Hemenway, CS (corresponding author), 2160 S 1st Ave, Maywood, IL 60153 USA.	chemenway@lumc.edu			National Institutes of Health [CA098459]; Cardinal Bernardin Cancer Center; NATIONAL CANCER INSTITUTE [R01CA098459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardinal Bernardin Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA098459. This work was also supported by funds from the Cardinal Bernardin Cancer Center.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; BLATCH GL, 2007, NETWORKING CHAPERONE, V55; Bushnell DA, 1996, J BIOL CHEM, V271, P20170, DOI 10.1074/jbc.271.33.20170; Cairns BR, 1996, MOL CELL BIOL, V16, P3308; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; Collins EC, 2002, MOL CELL BIOL, V22, P7313, DOI 10.1128/MCB.22.20.7313-7324.2002; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; DeZwaan DC, 2008, CELL CYCLE, V7, P1006, DOI 10.4161/cc.7.8.5723; DiMartino JF, 2000, BLOOD, V96, P3887, DOI 10.1182/blood.V96.12.3887.h8003887_3887_3893; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Gooljarsingh LT, 2006, P NATL ACAD SCI USA, V103, P7625, DOI 10.1073/pnas.0602650103; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Hemenway CS, 2001, ONCOGENE, V20, P3798, DOI 10.1038/sj.onc.1204478; ISSACS JS, 2003, CANCER CELL, V3, P23; Kamphausen T, 2002, PLANT J, V32, P263, DOI 10.1046/j.1365-313X.2002.01420.x; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Longshaw VM, 2009, EUR J CELL BIOL, V88, P153, DOI 10.1016/j.ejcb.2008.09.003; Ma YS, 2000, BBA-PROTEIN STRUCT M, V1476, P300, DOI 10.1016/S0167-4838(99)00250-2; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Nie ZQ, 2003, MOL CELL BIOL, V23, P2942, DOI 10.1128/MCB.23.8.2942-2952.2003; Pare JM, 2009, MOL BIOL CELL, V20, P3273, DOI 10.1091/mbc.E09-01-0082; Pina C, 2008, CELL STEM CELL, V2, P264, DOI 10.1016/j.stem.2008.01.013; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Selkirk James K., 1994, Applied and Theoretical Electrophoresis, V4, P89; Srinivasan RS, 2003, ONCOGENE, V22, P3395, DOI 10.1038/sj.onc.1206361; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; Truman AW, 2006, EUKARYOT CELL, V5, P1914, DOI 10.1128/EC.00263-06; Wayne N, 2007, J BIOL CHEM, V282, P35386, DOI 10.1074/jbc.M703844200; Zeng Y, 2003, BLOOD, V101, P4485, DOI 10.1182/blood-2002-10-3108; Zhang DY, 2009, KIDNEY INT, V75, P260, DOI 10.1038/ki.2008.475; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200	39	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11966	11973		10.1074/jbc.M110.101642	http://dx.doi.org/10.1074/jbc.M110.101642			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20159978	Green Published, hybrid			2022-12-25	WOS:000276787100025
J	Gould, AD; Shilton, BH				Gould, Alister D.; Shilton, Brian H.			Studies of the Maltose Transport System Reveal a Mechanism for Coupling ATP Hydrolysis to Substrate Translocation without Direct Recognition of Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DEPENDENT TRANSPORT; BINDING-PROTEIN; ESCHERICHIA-COLI; ABC-TRANSPORTER; MEMBRANE-COMPONENTS; ACTIVE-TRANSPORT; LIGAND-BINDING; EVOLUTION; MALFGK(2); INTERACTS	The ATPase activity of the maltose transporter (MalFGK2) is dependent on interactions with the maltose-binding protein (MBP). To determine whether direct interactions between the translocated sugar and MalFGK2 are important for the regulation of ATP hydrolysis, we used an MBP mutant (sMBP) that is able to bind either maltose or sucrose. We observed that maltose-and sucrose-bound sMBP stimulate equal levels of MalFGK2 ATPase activity. Therefore, the ATPase activity of MalFGK2 is coupled to translocation of maltose solely by interactions between MalFGK2 and MBP. For both maltose and sucrose, the ability of sMBP to stimulate the MalFGK2 ATPase was greatly reduced compared with wild-type MBP, indicating that the mutations in sMBP have interfered with important interactions between MBP and MalFGK2. High resolution crystal structure analysis of sMBP shows that in the closed conformation with bound sucrose, three of four mutations are buried, and the fourth causes only a minor change in the accessible surface. In contrast, in the open form of sMBP, all of the mutations are accessible, and the main chain of Tyr(62)-Gly(69) is destabilized and occupies an alternative conformation due to the W62Y mutation. On this basis, the compromised ability of sMBP to stimulate ATP hydrolysis by MalFGK2 is most likely due to a disruption of interactions between MalFGK2 and the open, rather than the closed, conformation of sMBP. Modeling the open sMBP structure bound to MalFGK2 in the transition state for ATP hydrolysis points to an important site of interaction and suggests a mechanism for coupling ATP hydrolysis to substrate translocation that is independent of the exact structure of the substrate.	[Gould, Alister D.; Shilton, Brian H.] Univ Western Ontario, Dept Biochem, London, ON N6B 2G3, Canada	Western University (University of Western Ontario)	Shilton, BH (corresponding author), Univ Western Ontario, Dept Biochem, 1151 Richmond St, London, ON N6B 2G3, Canada.	bshilton@uwo.ca	Shilton, Brian H/A-6667-2011		Natural Sciences and Engineering Research Council of Canada [217494-2008]; Natural Sciences and Engineering Research Council of Canada; National Research Council; Canadian Institutes of Health Research; University of Saskatchewan; United States Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; National Institutes of Health Research [RR-08630]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Discovery Grant 217494-2008 from the Natural Sciences and Engineering Research Council of Canada.; We thank Lee-Ann Briere and Dr. Stanley Nithianantham for help with crystallization and data collection, and Dr. Marc Ostermeier for providing the expression construct for sMBP. Crystallographic data were collected at the Canadian Light Source, which is supported by Natural Sciences and Engineering Research Council of Canada, National Research Council, Canadian Institutes of Health Research, and the University of Saskatchewan. Use of the Advanced Photon Source is supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-ENG-38, and BioCAT is supported by National Institutes of Health Research Grant RR-08630.	Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; BOHL E, 1995, J THEOR BIOL, V172, P83, DOI 10.1006/jtbi.1995.0006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Daus ML, 2009, J BACTERIOL, V191, P754, DOI 10.1128/JB.01439-08; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; DeLano WL, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gould AD, 2009, BIOCHEMISTRY-US, V48, P8051, DOI 10.1021/bi9007066; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; Guntas G, 2005, P NATL ACAD SCI USA, V102, P11224, DOI 10.1073/pnas.0502673102; Hall JA, 1997, J BIOL CHEM, V272, P17610, DOI 10.1074/jbc.272.28.17610; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; HOR LI, 1993, J MOL BIOL, V233, P659, DOI 10.1006/jmbi.1993.1543; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Merino G, 1997, J BACTERIOL, V179, P7687, DOI 10.1128/jb.179.24.7687-7694.1997; Nelson BD, 1998, J BACTERIOL, V180, P2507, DOI 10.1128/JB.180.9.2507-2514.1998; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Shilton BH, 2008, BBA-BIOMEMBRANES, V1778, P1772, DOI 10.1016/j.bbamem.2007.09.005; SHUMAN HA, 1982, J BIOL CHEM, V257, P5455; TREPTOW NA, 1988, J MOL BIOL, V202, P809, DOI 10.1016/0022-2836(88)90560-8	25	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11290	11296		10.1074/jbc.M109.089078	http://dx.doi.org/10.1074/jbc.M109.089078			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147285	hybrid, Green Published			2022-12-25	WOS:000276286200035
J	Laurent, M; Deschatrette, J; Wolfrom, CM				Laurent, Michel; Deschatrette, Jean; Wolfrom, Claire M.			Unmasking Chaotic Attributes in Time Series of Living Cell Populations	PLOS ONE			English	Article							HEPATOMA-CELLS; DYNAMICS; PROLIFERATION; OSCILLATIONS; TELOMERASE; RESISTANCE; GEOMETRY; MODEL	Background: Long-range oscillations of the mammalian cell proliferation rate are commonly observed both in vivo and in vitro. Such complicated dynamics are generally the result of a combination of stochastic events and deterministic regulation. Assessing the role, if any, of chaotic regulation is difficult. However, unmasking chaotic dynamics is essential for analysis of cellular processes related to proliferation rate, including metabolic activity, telomere homeostasis, gene expression, and tumor growth. Methodology/Principal Findings: Using a simple, original, nonlinear method based on return maps, we previously found a geometrical deterministic structure coordinating such fluctuations in populations of various cell types. However, nonlinearity and determinism are only necessary conditions for chaos; they do not by themselves constitute a proof of chaotic dynamics. Therefore, we used the same analytical method to analyze the oscillations of four well-known, low--dimensional, chaotic oscillators, originally designed in diverse settings and all possibly well-adapted to model the fluctuations of cell populations: the Lorenz, Rossler, Verhulst and Duffing oscillators. All four systems also display this geometrical structure, coordinating the oscillations of one or two variables of the oscillator. No such structure could be observed in periodic or stochastic fluctuations. Conclusion/Significance: Theoretical models predict various cell population dynamics, from stable through periodically oscillating to a chaotic regime. Periodic and stochastic fluctuations were first described long ago in various mammalian cells, but by contrast, chaotic regulation had not previously been evidenced. The findings with our nonlinear geometrical approach are entirely consistent with the notion that fluctuations of cell populations can be chaotically controlled.	[Laurent, Michel; Deschatrette, Jean; Wolfrom, Claire M.] Univ Paris 11, CNRS, INSERM,Unite Mixte Rech 8080, Lab Dynam Cellulaires & Modelisat,Unite Mixte Rec, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Laurent, M (corresponding author), Univ Paris 11, CNRS, INSERM,Unite Mixte Rech 8080, Lab Dynam Cellulaires & Modelisat,Unite Mixte Rec, F-91405 Orsay, France.	claire.wolfrom@u-psud.fr			Centre National de la Recherche Scientifique (CNRS); University Paris-Sud Orsay; Association Biologie du Cancer et Dynamiques complexes	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paris-Sud Orsay; Association Biologie du Cancer et Dynamiques complexes	This work was supported by funding from the Centre National de la Recherche Scientifique (CNRS), University Paris-Sud Orsay, and the Association Biologie du Cancer et Dynamiques complexes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhalla US, 2001, CHAOS, V11, P221, DOI 10.1063/1.1350440; Chau NP, 2005, ANTICANCER RES, V25, P3279; DEMENEZES MA, 2001, INT J MOD PHYS C, V12, P1; DEMONGEOT J, 1987, LIFE SCI SERIES, V138, P255; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Deschatrette J., 2003, ComPlexUs, V1, P134, DOI 10.1159/000076101; Deschatrette J, 2004, ANTI-CANCER DRUG, V15, P671, DOI 10.1097/01.cad.0000136879.96680.bc; FRANCHIMONT C, 1982, BRIT J DERMATOL, V106, P305, DOI 10.1111/j.1365-2133.1982.tb01728.x; GATTI RA, 1973, BLOOD, V41, P771, DOI 10.1182/blood.V41.6.771.771; Haurie C, 1999, EXP HEMATOL, V27, P401, DOI 10.1016/S0301-472X(98)00061-7; Kaplan DT, 1997, STUD HEALTH TECHNOL, V35, P15; KHOKHA MK, 1994, DEV BIOL, V165, P545, DOI 10.1006/dbio.1994.1274; Lampl M, 2003, AM J HUM BIOL, V15, P667, DOI 10.1002/ajhb.10204; Letaief N, 1995, J PHYS II, V5, P1883, DOI 10.1051/jp2:1995218; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; MACKEY MC, 2003, NONLINEAR DYNAMICS P, pCH9; Maigne J, 1998, IN VITRO CELL DEV-AN, V34, P163; MAUGHAN WZ, 1973, BLOOD, V41, P85, DOI 10.1182/blood.V41.1.85.85; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Ostby I, 2004, J MATH BIOL, V49, P501, DOI 10.1007/s00285-004-0274-6; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Popivanov D, 1999, MATH BIOSCI, V157, P303, DOI 10.1016/S0025-5564(98)10088-3; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; VANCE RR, 1978, AM NAT, V112, P797, DOI 10.1086/283324; Verhulst P., 1845, ACAD R SCI METR BR 2, V18, P1; Wolfrom C, 2004, EXP HEMATOL, V32, P822, DOI 10.1016/j.exphem.2004.06.005; Wolfrom C, 2000, J CELL SCI, V113, P1069; WOLFROM C, 2010, CELL PROLIF IN PRESS; Wolfrom C, 2007, FEBS LETT, V581, P125, DOI 10.1016/j.febslet.2006.12.007	31	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9346	10.1371/journal.pone.0009346	http://dx.doi.org/10.1371/journal.pone.0009346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179755	Green Published, Green Submitted, gold			2022-12-25	WOS:000274923900012
J	Gustafsson, M; Hornquist, M				Gustafsson, Mika; Hornquist, Michael			Gene Expression Prediction by Soft Integration and the Elastic Net-Best Performance of the DREAM3 Gene Expression Challenge	PLOS ONE			English	Article							EFFECTIVE DIMENSIONALITY; REGULATORY ASSOCIATIONS; NETWORK; REGRESSION; INFERENCE; SELECTION; DATABASE; SYSTEMS; LASSO; TOOLS	Background: To predict gene expressions is an important endeavour within computational systems biology. It can both be a way to explore how drugs affect the system, as well as providing a framework for finding which genes are interrelated in a certain process. A practical problem, however, is how to assess and discriminate among the various algorithms which have been developed for this purpose. Therefore, the DREAM project invited the year 2008 to a challenge for predicting gene expression values, and here we present the algorithm with best performance. Methodology/Principal Findings: We develop an algorithm by exploring various regression schemes with different model selection procedures. It turns out that the most effective scheme is based on least squares, with a penalty term of a recently developed form called the "elastic net". Key components in the algorithm are the integration of expression data from other experimental conditions than those presented for the challenge and the utilization of transcription factor binding data for guiding the inference process towards known interactions. Of importance is also a cross-validation procedure where each form of external data is used only to the extent it increases the expected performance. Conclusions/Significance: Our algorithm proves both the possibility to extract information from large-scale expression data concerning prediction of gene levels, as well as the benefits of integrating different data sources for improving the inference. We believe the former is an important message to those still hesitating on the possibilities for computational approaches, while the latter is part of an important way forward for the future development of the field of computational systems biology.	[Gustafsson, Mika; Hornquist, Michael] Linkoping Univ, Dept Sci & Technol, Norrkoping, Sweden	Linkoping University	Gustafsson, M (corresponding author), Linkoping Univ, Dept Sci & Technol, Norrkoping, Sweden.	michael.hornquist@liu.se			Center for Industrial Information Technology at Linkoping University [03.02]	Center for Industrial Information Technology at Linkoping University	This work was funded by Center for Industrial Information Technology at Linkoping University (http://www.isy.liu.se/ceniit/) under grant number 03.02. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Brazhnik P, 2002, TRENDS BIOTECHNOL, V20, P467, DOI 10.1016/S0167-7799(02)02053-X; Cho KH, 2007, IET SYST BIOL, V1, P149, DOI 10.1049/iet-syb:20060075; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dewey T. Gregory, 2001, Functional and Integrative Genomics, V1, P269, DOI 10.1007/s101420000035; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Draper N.R., 1998, APPL REGRESSION ANAL; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FRIEDMAN J, J STAT SOFT IN PRESS; Gustafsson M, 2005, IEEE ACM T COMPUT BI, V2, P254, DOI 10.1109/TCBB.2005.35; Gustafsson M, 2009, IET SYST BIOL, V3, P219, DOI 10.1049/iet-syb.2008.0112; GUSTAFSSON M, 2009, COMPUTATIONAL METHOD, P476; Gustafsson M, 2009, ANN NY ACAD SCI, V1158, P265, DOI 10.1111/j.1749-6632.2008.03764.x; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hornquist M, 2003, BIOSYSTEMS, V71, P311, DOI 10.1016/S0303-2647(03)00128-X; Hornquist M, 2002, BIOSYSTEMS, V65, P147, DOI 10.1016/S0303-2647(02)00011-4; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; NARULA SC, 1982, INT STAT REV, V50, P317, DOI 10.2307/1402501; Ruan JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008944; STOLOVITZKY G, 2009, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0009202; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Thorsson V, 2005, STAT APPL GENET MOL, V4; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tibshirani RJ, 2009, ANN APPL STAT, V3, P822, DOI 10.1214/08-AOAS224; WANG L, 2007, P IEEE INT C DAT MIN, P690; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	34	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9134	10.1371/journal.pone.0009134	http://dx.doi.org/10.1371/journal.pone.0009134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169069	Green Published, Green Submitted, gold			2022-12-25	WOS:000274590500002
J	Jenkins, HE; Woodroffe, R; Donnelly, CA				Jenkins, Helen E.; Woodroffe, Rosie; Donnelly, Christl A.			The Duration of the Effects of Repeated Widespread Badger Culling on Cattle Tuberculosis Following the Cessation of Culling	PLOS ONE			English	Article							BOVINE TUBERCULOSIS; MYCOBACTERIUM-BOVIS; IMPACT; REMOVAL; IRELAND; WELFARE; TB	Background: In the British Isles, control of cattle tuberculosis (TB) is hindered by persistent infection of wild badger (Meles meles) populations. A large-scale field trial-the Randomised Badger Culling Trial (RBCT)-previously showed that widespread badger culling produced modest reductions in cattle TB incidence during culling, which were offset by elevated TB risks for cattle on adjoining lands. Once culling was halted, beneficial effects inside culling areas increased, while detrimental effects on adjoining lands disappeared. However, a full assessment of the utility of badger culling requires information on the duration of culling effects. Methodology/Principal Findings: We monitored cattle TB incidence in and around RBCT areas after culling ended. We found that benefits inside culled areas declined over time, and were no longer detectable by three years post-culling. On adjoining lands, a trend suggesting beneficial effects immediately after the end of culling was insignificant, and disappeared after 18 months post-culling. From completion of the first cull to the loss of detectable effects (an average five-year culling period plus 2.5 years post-culling), cattle TB incidence was 28.7% lower (95% confidence interval [CI] 20.7 to 35.8% lower) inside ten 100 km(2) culled areas than inside ten matched no-culling areas, and comparable (11.7% higher, 95% CI: 13.0% lower to 43.4% higher, p = 0.39) on lands <= 2 km outside culled and no-culling areas. The financial costs of culling an idealized 150 km(2) area would exceed the savings achieved through reduced cattle TB, by factors of 2 to 3.5. Conclusions/Significance: Our findings show that the reductions in cattle TB incidence achieved by repeated badger culling were not sustained in the long term after culling ended and did not offset the financial costs of culling. These results, combined with evaluation of alternative culling methods, suggest that badger culling is unlikely to contribute effectively to the control of cattle TB in Britain.	[Jenkins, Helen E.; Donnelly, Christl A.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Woodroffe, Rosie] Zool Soc London, Inst Zool, London NW1 4RY, England	Imperial College London; Zoological Society of London	Jenkins, HE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	c.donnelly@imperial.ac.uk		Donnelly, Christl/0000-0002-0195-2463; Jenkins, Helen/0000-0003-4749-1591	United Kingdom Department of Environment, Food and Rural Affairs; Medical Research Council [G0600719B] Funding Source: researchfish	United Kingdom Department of Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge the support of the United Kingdom Department of Environment, Food and Rural Affairs (Defra; http://www.defra.gov.uk/index.htm) for this work. CAD thanks the United Kingdom Medical Research Council (http://www.mrc.ac.uk/index.htm) for Centre funding. HEJ thanks the Medical Research Council for a studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Randomised Badger Culling Trial was implemented by the staff of Defra and its associated agencies. Defra funds the ongoing collection and storage of routine surveillance data, which were utilized in this study. Defra officials commented on a near-final draft of this manuscript.	Bourne J., 2007, BOVINE TB SCI EVIDEN; BOURNE J, 1998, 1 MIN AGR FISH FOOD; Cheeseman C.L., 1993, P78; CLIFTONHADLEY RS, 1995, EPIDEMIOL INFECT, V114, P179, DOI 10.1017/S0950268800052031; *DEFR, 2005, COST BEN AN BADG MAN; *DEFRA, 2009, MONTHL PUBL NAT STAT; Defra, 2006, PUBL CONS CONTR SPRE; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Donnelly CA, 2007, INT J INFECT DIS, V11, P300, DOI 10.1016/j.ijid.2007.04.001; Evans JT, 2007, LANCET, V369, P1270, DOI 10.1016/S0140-6736(07)60598-4; FERA, 2009, ASS REL LANDSC IS BA; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Jenkins HE, 2008, INT J INFECT DIS, V12, P457, DOI 10.1016/j.ijid.2008.04.001; Kelly GE, 2008, EPIDEMIOL INFECT, V136, P1362, DOI 10.1017/S0950268807000027; KIRKWOOD JK, 2000, HUMANENESS MAFFS BAD; Krebs J., 1997, PB3423 HMSO; MacDonald DW, 2006, BIOL CONSERV, V131, P268, DOI 10.1016/j.biocon.2006.05.006; McGrath G, 2009, IRISH VET J, V62, P192, DOI 10.1186/2046-0481-62-3-192; MORRIS RS, 1994, VET MICROBIOL, V40, P153, DOI 10.1016/0378-1135(94)90053-1; Pope LC, 2007, MOL ECOL, V16, P4919, DOI 10.1111/j.1365-294X.2007.03553.x; *WELSH ASS GOV, 2009, STRAT COSTS TB COMP; Wilkinson D, 2009, J WILDLIFE DIS, V45, P1062, DOI 10.7589/0090-3558-45.4.1062; Woodroffe R, 2008, J ZOOL, V274, P28, DOI 10.1111/j.1469-7998.2007.00353.x; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; Woodroffe R, 2005, ANIM WELFARE, V14, P19; Woodroffe R, 2005, ANIM WELFARE, V14, P11; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103; Woodroffe R, 2009, J WILDLIFE DIS, V45, P128, DOI 10.7589/0090-3558-45.1.128	29	74	76	0	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9090	10.1371/journal.pone.0009090	http://dx.doi.org/10.1371/journal.pone.0009090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161769	Green Published, gold			2022-12-25	WOS:000274442700004
J	Thuny, F; Richet, H; Casalta, JP; Angelakis, E; Habib, G; Raoult, D				Thuny, Franck; Richet, Herve; Casalta, Jean-Paul; Angelakis, Emmanouil; Habib, Gilbert; Raoult, Didier			Vancomycin Treatment of Infective Endocarditis Is Linked with Recently Acquired Obesity	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; GUT MICROBIOTA; GROWTH; LACTOBACILLUS; ANTIBIOTICS; PROBIOTICS; PROMOTERS; AVOPARCIN; INFANT; HEALTH	Background: Gut microbiota play a major role in digestion and energy conversion of nutrients. Antibiotics, such as avoparcin (a vancomycin analogue), and probiotics, such as Lactobacillus species, have been used to increase weight in farm animals. We tested the effect of antibiotics given for infective endocarditis (IE) on weight gain (WG). Methodology/Principal Findings: Forty-eight adults with a definite diagnosis of bacterial IE (antibiotic group) were compared with forty-eight age-matched controls without IE. Their body mass index (BMI) was collected at one month before the first symptoms and one year after hospital discharge. The BMI increased significantly and strongly in vancomycinplus-gentamycin-treated patients (mean [+/- SE] kg/m(2), + 2.3 [0.9], p = 0.03), but not in controls or in patients treated with other antibiotics. Seventeen patients had a BMI increase of >= 10%, and five of the antibiotic group developed obesity. The treatment by vancomycin-plus-gentamycin was an independent predictor of BMI increase of >= 10% (adjusted OR, 6.7; 95% CI, 1.37-33.0; p = 0.02), but not treatment with other antibiotics. Weight gain was particularly high in male patients older than 65 who did not undergo cardiac surgery. Indeed, all three vancomycin-treated patients with these characteristics developed obesity. Conclusions/Significance: A major and significant weight gain can occur after a six-week intravenous treatment by vancomycin plus gentamycin for IE with a risk of obesity, especially in males older than 65 who have not undergone surgery. We speculate on the role of the gut colonization by Lactobacillus sp, a microorganism intrinsically resistant to vancomycin, used as a growth promoter in animals, and found at a high concentration in the feces of obese patients. Thus, nutritional programs and weight follow-up should be utilized in patients under such treatment.	[Thuny, Franck; Richet, Herve; Angelakis, Emmanouil; Raoult, Didier] Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, Marseille, France; [Thuny, Franck; Habib, Gilbert] Hop La Timone, Serv Cardiol, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Thuny, F (corresponding author), Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, Marseille, France.	didier.raoult@gmail.com	Thuny, Franck/ABC-7157-2020; RAOULT, Didier/A-8434-2008; Thuny, Franck/GSD-2668-2022; Thuny, Franck/ABB-2408-2021; Angelakis, Emmanouil/A-9873-2015; Angelakis, Emmanouil/D-8039-2013	RAOULT, Didier/0000-0002-0633-5974; Thuny, Franck/0000-0002-8727-7154; Thuny, Franck/0000-0002-8727-7154; Angelakis, Emmanouil/0000-0001-7327-5441				Abe F, 1995, J DAIRY SCI, V78, P2838, DOI 10.3168/jds.S0022-0302(95)76914-4; Acar J, 2000, CLIN MICROBIOL INFEC, V6, P477, DOI 10.1046/j.1469-0691.2000.00128.x; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bax JJ, 2006, J AM COLL CARDIOL, V48, P754, DOI 10.1016/j.jacc.2006.04.077; Botelho-Nevers E, 2009, ARCH INTERN MED, V169, P1290, DOI 10.1001/archinternmed.2009.192; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chiofalo V, 2004, REPROD NUTR DEV, V44, P449, DOI 10.1051/rnd:2004051; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Delgado S, 2005, CURR MICROBIOL, V50, P202, DOI 10.1007/s00284-004-4431-3; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; DYER IA, 1980, J ANIM SCI, V51, P843, DOI 10.2527/jas1980.514843x; Eckel RH, 2004, CIRCULATION, V110, P2968, DOI 10.1161/01.CIR.0000140086.88453.9A; FEIGHNER SD, 1987, APPL ENVIRON MICROB, V53, P331, DOI 10.1128/AEM.53.2.331-336.1987; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Friedman JM, 2009, NATURE, V459, P340, DOI 10.1038/459340a; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Han E, 2009, INT J OBESITY, V33, P249, DOI 10.1038/ijo.2008.193; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Khan M, 2007, BRIT POULTRY SCI, V48, P732, DOI 10.1080/00071660701716222; LEY R, 2006, NATURE, V444, P1023; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Mudd AJ, 1996, LANCET, V348, P1454, DOI 10.1016/S0140-6736(04)70103-8; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Raoult D, 2008, EUR J CLIN MICROBIOL, V27, P631, DOI 10.1007/s10096-008-0490-x; Raoult D, 2008, NATURE, V454, P690, DOI 10.1038/454690c; ROSENBERG IH, 1974, AM J CLIN NUTR, V27, P304, DOI 10.1093/ajcn/27.3.304; Ammor MS, 2007, FOOD MICROBIOL, V24, P559, DOI 10.1016/j.fm.2006.11.001; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Ternak G, 2005, MED HYPOTHESES, V64, P14, DOI 10.1016/j.mehy.2004.08.003; Timmerman HM, 2005, J DAIRY SCI, V88, P2154, DOI 10.3168/jds.S0022-0302(05)72891-5; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vendt N, 2006, J HUM NUTR DIET, V19, P51, DOI 10.1111/j.1365-277X.2006.00660.x	38	108	111	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9074	10.1371/journal.pone.0009074	http://dx.doi.org/10.1371/journal.pone.0009074			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161775	Green Submitted, gold, Green Published			2022-12-25	WOS:000274442700003
J	Biswas, S; Reinhard, J; Oakeshott, J; Russell, R; Srinivasan, MV; Claudianos, C				Biswas, Sunita; Reinhard, Judith; Oakeshott, John; Russell, Robyn; Srinivasan, Mandyam V.; Claudianos, Charles			Sensory Regulation of Neuroligins and Neurexin I in the Honeybee Brain	PLOS ONE			English	Article							MUSHROOM BODIES; NEURAL LATERALIZATION; HEMISPHERE ADVANTAGE; INHIBITORY SYNAPSES; ALPHA-NEUREXINS; APIS-MELLIFERA; PLASTICITY; MEMORY; EXPERIENCE; DROSOPHILA	Background: Neurexins and neuroligins, which have recently been associated with neurological disorders such as autism in humans, are highly conserved adhesive proteins found on synaptic membranes of neurons. These binding partners produce a trans-synaptic bridge that facilitates maturation and specification of synapses. It is believed that there exists an optimal spatio-temporal code of neurexin and neuroligin interactions that guide synapse formation in the postnatal developing brain. Therefore, we investigated whether neuroligins and neurexin are differentially regulated by sensory input using a behavioural model system with an advanced capacity for sensory processing, learning and memory, the honeybee. Methodology/Principal Findings: Whole brain expression levels of neuroligin 1-5 (NLG1-5) and neurexin I (NrxI) were estimated by qRT-PCR analysis in three different behavioural paradigms: sensory deprivation, associative scent learning, and lateralised sensory input. Sensory deprived bees had a lower level of NLG1 expression, but a generally increased level of NLG2-5 and NrxI expression compared to hive bees. Bees that had undergone associative scent training had significantly increased levels of NrxI, NLG1 and NLG3 expression compared to untrained control bees. Bees that had lateralised sensory input after antennal amputation showed a specific increase in NLG1 expression compared to control bees, which only happened over time. Conclusions/Significance: Our results suggest that (1) there is a lack of synaptic pruning during sensory deprivation; (2) NLG1 expression increases with sensory stimulation; (3) concomitant changes in gene expression suggests NrxI interacts with all neuroligins; (4) there is evidence for synaptic compensation after lateralised injury.	[Biswas, Sunita; Reinhard, Judith; Srinivasan, Mandyam V.; Claudianos, Charles] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Biswas, Sunita] Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT 2601, Australia; [Biswas, Sunita; Oakeshott, John; Russell, Robyn; Claudianos, Charles] Commonwealth Sci & Ind Res Org Entomol, Canberra, ACT, Australia; [Srinivasan, Mandyam V.] Australian Natl Univ, Australian Res Council, Ctr Excellence Vis Sci, Canberra, ACT, Australia; [Srinivasan, Mandyam V.] Univ Queensland, Sch Informat Technol & Elect Engn, St Lucia, Qld, Australia	University of Queensland; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; University of Queensland	Biswas, S (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	c.claudianos@uq.edu.au	Srinivasan, Mandyam V/G-5571-2010; Oakeshott, John G/B-5365-2009; Russell, Robyn/C-5449-2008	Oakeshott, John G/0000-0001-8324-7874; Russell, Robyn/0000-0001-5600-3305; Claudianos, Charles/0000-0002-9799-9572; Muthukumarasamy, Srinivasan/0000-0002-2948-6206	Australian National University PhD Scholarship	Australian National University PhD Scholarship(Australian National University)	S. Biswas was supported by an Australian National University PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitz M, 2007, CEREB CORTEX, V17, P2573, DOI 10.1093/cercor/bhl163; ANDREW RJ, 1984, NEUROPSYCHOLOGIA, V22, P503, DOI 10.1016/0028-3932(84)90045-9; Barrow SL, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-17; BENSON TE, 1984, J NEUROSCI, V4, P638; BICKER G, 1988, J NEUROSCI, V8, P2108; Biswas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003542; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; BRADSHAW JL, 1981, BEHAV BRAIN SCI, V4, P51, DOI 10.1017/S0140525X00007548; Brown SM, 2004, J NEUROBIOL, V60, P40, DOI 10.1002/neu.20002; Bruel-Jungerman E, 2007, NEUROSCIENTIST, V13, P492, DOI 10.1177/1073858407302725; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Collins AM, 2004, INSECT MOL BIOL, V13, P141, DOI 10.1111/j.0962-1075.2004.00469.x; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Corballis MC, 2003, P BRIT ACAD, V106, P137; DAHLHAUS R, 2009, HIPPOCAMPUS; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DENENBERG VH, 1978, SCIENCE, V201, P1150, DOI 10.1126/science.684436; Devaud JM, 2003, J NEUROBIOL, V56, P1, DOI 10.1002/neu.10216; Devaud JM, 2003, J NEUROBIOL, V56, P13, DOI 10.1002/neu.10215; DURST C, 1994, BEHAV NEURAL BIOL, V62, P259, DOI 10.1016/S0163-1047(05)80025-1; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Fahrbach SE, 1998, LEARN MEMORY, V5, P115; Fahrbach SE, 2003, J NEUROBIOL, V57, P141, DOI 10.1002/neu.10256; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Frings H, 1944, J EXP ZOOL, V97, P123, DOI 10.1002/jez.1400970203; Funada M, 2004, NEUROSCI LETT, V359, P190, DOI 10.1016/j.neulet.2004.02.004; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Groh C, 2006, BRAIN BEHAV EVOLUT, V68, P1, DOI 10.1159/000092309; Grubb MS, 2004, CURR OPIN NEUROBIOL, V14, P503, DOI 10.1016/j.conb.2004.06.006; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Hellstern F, 1998, LEARN MEMORY, V4, P429, DOI 10.1101/lm.4.5.429; Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; IFUNE CK, 1984, BEHAV NEURAL BIOL, V41, P231, DOI 10.1016/S0163-1047(84)90639-3; KANO M, 2009, CURR OPIN NEUROBIOL; Kucharski R., 2007, Invertebrate Neuroscience, V7, P99, DOI 10.1007/s10158-007-0045-3; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Kuwabara M., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P458; Letzkus P, 2008, BIOL LETTERS, V4, P16, DOI 10.1098/rsbl.2007.0466; Letzkus P, 2006, CURR BIOL, V16, P1471, DOI 10.1016/j.cub.2006.05.060; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Libersat F, 2003, J COMP PHYSIOL A, V189, P497, DOI 10.1007/s00359-003-0432-0; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mizunami M, 1998, J COMP NEUROL, V402, P520; MORRIS RD, 1993, J CLIN EXP NEUROPSYC, V15, P487, DOI 10.1080/01688639308402573; NOTTEBOHM F, 1971, J EXP ZOOL, V177, P229, DOI 10.1002/jez.1401770210; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Reinhard J, 2004, NATURE, V427, P411, DOI 10.1038/427411a; Rogers LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002340; Rose JK, 2005, J NEUROSCI, V25, P7159, DOI 10.1523/JNEUROSCI.1833-05.2005; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 2001, MOL CLONING LAB MANU; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; VALLORTIGARA G, 1992, NEUROPSYCHOLOGIA, V30, P761, DOI 10.1016/0028-3932(92)90080-6; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; WITHERS GS, 2007, DEV NEUROBIOL; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068	69	48	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9133	10.1371/journal.pone.0009133	http://dx.doi.org/10.1371/journal.pone.0009133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161754	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442600030
J	Friesen, RHE; Koudstaal, W; Koldijk, MH; Weverling, GJ; Brakenhoff, JPJ; Lenting, PJ; Stittelaar, KJ; Osterhaus, ADME; Kompier, R; Goudsmit, J				Friesen, Robert H. E.; Koudstaal, Wouter; Koldijk, Martin H.; Weverling, Gerrit Jan; Brakenhoff, Just P. J.; Lenting, Peter J.; Stittelaar, Koert J.; Osterhaus, Albert D. M. E.; Kompier, Ronald; Goudsmit, Jaap			New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets	PLOS ONE			English	Article							A H5N1 VIRUS; INFECTION; RESISTANCE; TRANSMISSION	Background: The urgent medical need for innovative approaches to control influenza is emphasized by the widespread resistance of circulating subtype H1N1 viruses to the leading antiviral drug oseltamivir, the pandemic threat posed by the occurrences of human infections with highly pathogenic avian H5N1 viruses, and indeed the evolving swine-origin H1N1 influenza pandemic. A recently discovered class of human monoclonal antibodies with the ability to neutralize a broad spectrum of influenza viruses (including H1, H2, H5, H6 and H9 subtypes) has the potential to prevent and treat influenza in humans. Here we report the latest efficacy data for a representative antibody of this novel class. Methodology/Principal Findings: We evaluated the prophylactic and therapeutic efficacy of the human monoclonal antibody CR6261 against lethal challenge with the highly pathogenic avian H5N1 virus in ferrets, the optimal model of human influenza infection. Survival rates, clinically relevant disease signs such as changes in body weight and temperature, virus replication in lungs and upper respiratory tract, as well as macro- and microscopic pathology were investigated. Prophylactic administration of 30 and 10 mg/kg CR6261 prior to viral challenge completely prevented mortality, weight loss and reduced the amount of infectious virus in the lungs by more than 99.9%, abolished shedding of virus in pharyngeal secretions and largely prevented H5N1-induced lung pathology. When administered therapeutically 1 day after challenge, 30 mg/kg CR6261 prevented death in all animals and blunted disease, as evidenced by decreased weight loss and temperature rise, reduced lung viral loads and shedding, and less lung damage. Conclusions/Significance: These data demonstrate the prophylactic and therapeutic efficacy of this new class of human monoclonal antibodies in a highly stringent and clinically relevant animal model of influenza and justify clinical development of this approach as intervention for both seasonal and pandemic influenza.	[Friesen, Robert H. E.; Koudstaal, Wouter; Koldijk, Martin H.; Weverling, Gerrit Jan; Brakenhoff, Just P. J.; Lenting, Peter J.; Kompier, Ronald; Goudsmit, Jaap] Crucell Holland BV, Leiden, Netherlands; [Stittelaar, Koert J.; Osterhaus, Albert D. M. E.] ViroClin BV, Rotterdam, Netherlands; [Osterhaus, Albert D. M. E.] ErasmusMC, Dept Virol, Rotterdam, Netherlands	Johnson & Johnson; Erasmus University Rotterdam; Erasmus MC	Friesen, RHE (corresponding author), Crucell Holland BV, Leiden, Netherlands.	robert.friesen@crucell.com	Lenting, Peter/F-8269-2013; Lenting, Peter/AAH-5663-2019	Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429; Osterhaus, Albert/0000-0002-6074-1172	Crucell Holland BV	Crucell Holland BV	Funding: This work was funded by Crucell Holland BV (http://www.crucell.com). The funder had a role in study design, data analysis, decision to publish and preparation of the manuscript, but not in execution of the experiments and collection of the data.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; BARNARD DL, 2009, ANTIVIRAL RES; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; *CDC, 2008, MMWR-MORBID MORTAL W, V57, P393; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P44; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; EKIERT DC, 2009, SCIENCE; Enserink M, 2009, SCIENCE, V323, P1162, DOI 10.1126/science.323.5918.1162; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hampson AW, 2006, J INFECT DIS, V194, P143, DOI 10.1086/505229; He GM, 2008, ANTIVIR RES, V77, P72, DOI 10.1016/j.antiviral.2007.08.007; Hoelscher M, 2008, EXPERT OPIN DRUG DEL, V5, P1139, DOI 10.1517/17425247.5.10.1139 ; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Lowen AC, 2009, J VIROL, V83, P2803, DOI 10.1128/JVI.02424-08; Moscona A, 2008, ANNU REV MED, V59, P397, DOI 10.1146/annurev.med.59.061506.213121; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Ng WF, 2006, HUM PATHOL, V37, P381, DOI 10.1016/j.humpath.2006.01.015; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Salzberg S, 2008, NATURE, V454, P160, DOI 10.1038/454160a; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; ter Meulen J, 2004, LANCET, V363, P2139, DOI 10.1016/S0140-6736(04)16506-9; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tran TT, 2008, INT J BIOCHEM CELL B, V40, P2671, DOI 10.1016/j.biocel.2008.05.019; Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; *WHO, 2009, 211 WHO; World Health Organization, 2009, WORLD NOW START 2009	34	83	93	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9106	10.1371/journal.pone.0009106	http://dx.doi.org/10.1371/journal.pone.0009106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161706	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442500013
J	Oliveira-Martins, JB; Yusa, SI; Calella, AM; Bridel, C; Baumann, F; Dametto, P; Aguzzi, A				Oliveira-Martins, Jose B.; Yusa, Sei-ichi; Calella, Anna Maria; Bridel, Claire; Baumann, Frank; Dametto, Paolo; Aguzzi, Adriano			Unexpected Tolerance of alpha-Cleavage of the Prion Protein to Sequence Variations	PLOS ONE			English	Article							CREUTZFELDT-JAKOB DISEASE; NEURONAL CELL-LINE; NEUROBLASTOMA-CELLS; PROTEOLYTIC CLEAVAGE; IN-VIVO; SCRAPIE; PRP; MUTATION; DOMAINS; GENE	The cellular form of the prion protein, PrPC, undergoes extensive proteolysis at the alpha site (109K down arrow H110). Expression of non-cleavable PrPC mutants in transgenic mice correlates with neurotoxicity, suggesting that alpha-cleavage is important for PrPC physiology. To gain insights into the mechanisms of alpha-cleavage, we generated a library of PrPC mutants with mutations in the region neighbouring the alpha-cleavage site. The prevalence of C1, the carboxy adduct of alpha-cleavage, was determined for each mutant. In cell lines of disparate origin, C1 prevalence was unaffected by variations in charge and hydrophobicity of the region neighbouring the alpha-cleavage site, and by substitutions of the residues in the palindrome that flanks this site. Instead, alpha-cleavage was size-dependently impaired by deletions within the domain 106-119. Almost no cleavage was observed upon full deletion of this domain. These results suggest that alpha-cleavage is executed by an alpha-PrPase whose activity, despite surprisingly limited sequence specificity, is dependent on the size of the central region of PrPC.	[Oliveira-Martins, Jose B.; Yusa, Sei-ichi; Calella, Anna Maria; Bridel, Claire; Baumann, Frank; Dametto, Paolo; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Oliveira-Martins, JB (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Baumann, Frank/F-7737-2016; Aguzzi, Adriano/A-3351-2008	Aguzzi, Adriano/0000-0002-0344-6708	Swiss National Foundation; European Union; National Competence Center on Neural Plasticity and Repair; Stammbach foundation; Novartis Foundation; European Research Council; Portuguese Foundation for Science and Technology; Instituto Gulbenkian de Ciencia	Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Union(European Commission); National Competence Center on Neural Plasticity and Repair; Stammbach foundation; Novartis Foundation(Novartis); European Research Council(European Research Council (ERC)European Commission); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Instituto Gulbenkian de Ciencia	Funding: This work was supported by the Swiss National Foundation, European Union contracts (PRIORITY and LUPAS), the National Competence Center on Neural Plasticity and Repair, the Stammbach foundation, and the Novartis Foundation. AA is the recipient of an Advanced Investigator Grant of the European Research Council. JBOM was supported by the Portuguese Foundation for Science and Technology and the Instituto Gulbenkian de Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Baumann F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006707; Baumann G, 2002, J ENDOCRINOL, V174, P361, DOI 10.1677/joe.0.1740361; Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BREMER J, 2010, NAT NEUROSC IN PRESS; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; GEY GO, 1952, CANCER RES, V12, P264; GOLDFARB LG, 1991, EUR J EPIDEMIOL, V7, P477, DOI 10.1007/BF00143125; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kim Y, 2008, TRANSBOUND EMERG DIS, V55, P105, DOI 10.1111/j.1865-1682.2007.00997.x; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kornblatt JA, 2003, BIOCHEM BIOPH RES CO, V305, P518, DOI 10.1016/S0006-291X(03)00804-0; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Mayer BJ, 2001, J CELL SCI, V114, P1253; MEDORI R, 1992, NEUROLOGY, V42, P669, DOI 10.1212/WNL.42.3.669; Nishimura T, 2007, MICROBIOL IMMUNOL, V51, P457, DOI 10.1111/j.1348-0421.2007.tb03920.x; Ott D, 2008, PROTEIN ENG DES SEL, V21, P623, DOI 10.1093/protein/gzn042; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Rutishauser D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004446; Sakudo A, 2005, BIOCHEM BIOPH RES CO, V326, P600, DOI 10.1016/j.bbrc.2004.11.092; Schlondorff J, 1999, J CELL SCI, V112, P3603; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tveit H, 2005, BIOCHEM BIOPH RES CO, V337, P232, DOI 10.1016/j.bbrc.2005.09.031; van Rheede T, 2003, MOL BIOL EVOL, V20, P111, DOI 10.1093/molbev/msg014; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Vincent B, 2001, J BIOL CHEM, V276, P37743; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Wang XD, 2002, J BIOL CHEM, V277, P50510, DOI 10.1074/jbc.M208738200; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; Wegner C, 2002, J GEN VIROL, V83, P1237, DOI 10.1099/0022-1317-83-5-1237; Zhao HX, 2006, VIRUS RES, V115, P43, DOI 10.1016/j.virusres.2005.07.004	54	41	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9107	10.1371/journal.pone.0009107	http://dx.doi.org/10.1371/journal.pone.0009107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161712	Green Submitted, Green Published, gold			2022-12-25	WOS:000274442500014
J	Visschedyk, DD; Perieteanu, AA; Turgeon, ZJ; Fieldhouse, RJ; Dawson, JF; Merrill, AR				Visschedyk, Danielle D.; Perieteanu, Alexandru A.; Turgeon, Zachari J.; Fieldhouse, Robert J.; Dawson, John F.; Merrill, A. Rod			Photox, a Novel Actin-targeting Mono-ADP-ribosyltransferase from Photorhabdus luminescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGENS IOTA-TOXIN; CLOSTRIDIUM-BOTULINUM; RIBOSYLATING TOXIN; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; PROTEIN; VIRULENCE; MECHANISM; EXOENZYME; CLASSIFICATION	Photorhabdus luminescens is a pathogenic bacterium that produces many toxic proteins. The mono-ADP-ribosyltransferases (mARTs) are an enzyme class produced by numerous pathogenic bacteria and participate in disease in plants and animals, including humans. Herein we report a novel mART from P. luminescens called Photox. This 46-kDa toxin shows high homology to other actin-targeting mARTs in hallmark catalytic regions and a similar core catalytic fold. Furthermore, Photox shows in vivo cytotoxic activity against yeast, with protection occurring when catalytic residues are substituted with alanine. In vitro, enzymatic activity (k(cat), 1680 +/- 75 min(-1)) is higher than that of the related iota toxin, and diminishes by nearly 14,000-fold following substitution of the catalytic Glu (E355A). This toxin specifically ADP-ribosylates monomeric alpha-skeletal actin and nonmuscle beta- and alpha-actin at Arg(177), inhibiting regular polymerization of actin filaments. These results indicate that Photox is indeed an ADP-ribosyltransferase, making it the newest member of the actin-targeting mART family.	[Visschedyk, Danielle D.; Perieteanu, Alexandru A.; Turgeon, Zachari J.; Fieldhouse, Robert J.; Dawson, John F.; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Merrill, Rod/M-8313-2014; Dawson, John/HDM-6702-2022	Turgeon, Zachari/0000-0002-0883-8292	Ontario Graduate Scholarship; National Sciences and Engineering Research Council of Canada (NSERC) [250118]; Canadian Cystic Fibrosis Foundation (CCFF); Canadian Institutes of Health Research; Human Frontier Science Program	Ontario Graduate Scholarship(Ontario Graduate Scholarship); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Cystic Fibrosis Foundation (CCFF); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program(Human Frontier Science Program)	Supported by pre-doctoral fellowships from Ontario Graduate Scholarship and National Sciences and Engineering Research Council of Canada (NSERC).; Supported by a summer studentship from the Canadian Cystic Fibrosis Foundation (CCFF) and a NSERC fellowship.; Supported by pre-doctoral fellowships from OGS and NSERC.; Supported by NSERC Grant 250118.; Supported by grants from CCFF, Canadian Institutes of Health Research, and Human Frontier Science Program.	AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Arnoldo A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000005; Barth H, 1998, J BIOL CHEM, V273, P29506, DOI 10.1074/jbc.273.45.29506; Browne SH, 2008, FEMS IMMUNOL MED MIC, V52, P194, DOI 10.1111/j.1574-695X.2007.00364.x; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Coye LH, 2004, MOL MICROBIOL, V54, P89, DOI 10.1111/j.1365-2958.2004.04262.x; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Ehlers RU, 2001, APPL MICROBIOL BIOT, V56, P623, DOI 10.1007/s002530100711; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fehr D, 2007, J BIOL CHEM, V282, P28843, DOI 10.1074/jbc.M704797200; ffrench-Constant RH, 2000, CELL MOL LIFE SCI, V57, P828, DOI 10.1007/s000180050044; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Fischer-Le Saux M, 1999, INT J SYST BACTERIOL, V49, P1645, DOI 10.1099/00207713-49-4-1645; GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Hochmann H, 2006, BIOCHEMISTRY-US, V45, P1271, DOI 10.1021/bi051810w; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Li M, 1996, P NATL ACAD SCI USA, V93, P6902, DOI 10.1073/pnas.93.14.6902; Margarit SM, 2006, STRUCTURE, V14, P1219, DOI 10.1016/j.str.2006.05.022; McGuffin LJ, 2004, NUCLEIC ACIDS RES, V32, pD196, DOI 10.1093/nar/gkh043; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otto H, 2000, MOL MICROBIOL, V37, P1106, DOI 10.1046/j.1365-2958.2000.02064.x; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; POPOFF MR, 1988, BIOCHEM BIOPH RES CO, V152, P1361, DOI 10.1016/S0006-291X(88)80435-2; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Sakurai J, 2003, ADV ENZYME REGUL, V43, P361, DOI 10.1016/S0065-2571(02)00044-4; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Sun JJ, 2004, NAT STRUCT MOL BIOL, V11, P868, DOI 10.1038/nsmb818; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Turgeon Z, 2009, FEMS MICROBIOL LETT, V300, P97, DOI 10.1111/j.1574-6968.2009.01777.x; VANDEKERCKHOVE J, 1987, FEBS LETT, V225, P48, DOI 10.1016/0014-5793(87)81129-8; Vilches S, 2008, MICROB PATHOGENESIS, V44, P1, DOI 10.1016/j.micpath.2007.06.004; Vogelsgesang M, 2006, BIOCHEMISTRY-US, V45, P1017, DOI 10.1021/bi052253g; Wallner B, 2007, NUCLEIC ACIDS RES, V35, pW369, DOI 10.1093/nar/gkm319; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3; Yates SP, 2007, ARCH BIOCHEM BIOPHYS, V466, P58, DOI 10.1016/j.abb.2007.07.018	50	40	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13525	13534		10.1074/jbc.M109.077339	http://dx.doi.org/10.1074/jbc.M109.077339			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20181945	Green Published, hybrid			2022-12-25	WOS:000276987700025
J	Guo, XM; Williams, JG; Schug, TT; Li, XL				Guo, Xiumei; Williams, Jason G.; Schug, Thaddeus T.; Li, Xiaoling			DYRK1A and DYRK3 Promote Cell Survival through Phosphorylation and Activation of SIRT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE DYRK1A; SUBSTRATE-SPECIFICITY; TRANSCRIPTION FACTORS; DEACETYLASE ACTIVITY; DUAL-SPECIFICITY; DNA-DAMAGE; STRESS; FAMILY; REGULATOR; P53	DYRK1A (the dual specificity tyrosine phosphorylation-regulated kinase 1A) plays an important role in body growth and brain physiology. Overexpression of this kinase has been associated with the development of Down syndrome in both human and animal models, whereas single copy loss-of-function of DYRK1A leads to increased apoptosis and decreased brain size. Although more than a dozen of DYRK1A targets have been identified, the molecular basis of its involvement in neuronal development remains unclear. Here we show that DYRK1A and another pro-survival member of the DYRK family, DYRK3, promote cell survival through phosphorylation and activation of SIRT1, an NAD(+)-dependent protein deacetylase that is essential in a variety of physiological processes including stress response and energy metabolism. DYRK1A and DYRK3 directly phosphorylate SIRT1 at Thr(522), promoting deacetylation of p53. A SIRT1 phosphorylation mimetic (SIRT1 T522D) displays elevated deacetylase activity, thus inhibiting cell apoptosis. Conversely, a SIRT1 dephosphorylation mimetic (SIRT1 T522V) fails to mediate DYRK-induced deacetylation of p53 and cell survival. We show that knockdown of endogenous DYRK1A and DYRK3 leads to hypophosphorylation of SIRT1, sensitizing cells to DNA damage-induced cell death. We also provide evidence that phosphorylation of Thr(522) activates SIRT1 by promoting product release, thereby increasing its enzymatic turnover. Taken together, our findings provide a novel mechanism by which two anti-apoptotic DYRK members promote cell survival through direct modification of SIRT1. These findings may have important implications in understanding the molecular mechanisms of tumorigenesis, Down syndrome, and aging.	NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Williams, Jason G.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)		lix3@niehs.nih.gov	Li, Xiaoling/A-2994-2015	Li, Xiaoling/0000-0001-5920-7784	National Institutes of Health [Z01 ES102205]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102205, ZICES102488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01 ES102205 ( to X. L.).	Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Chang HS, 2007, INT J CANCER, V120, P2377, DOI 10.1002/ijc.22573; Delabar JM, 2006, THESCIENTIFICWORLDJO, V6, P1945, DOI 10.1100/tsw.2006.322; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Geiger JN, 2001, BLOOD, V97, P901, DOI 10.1182/blood.V97.4.901; Guarente L, 2000, GENE DEV, V14, P1021; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lord KA, 2000, BLOOD, V95, P2838, DOI 10.1182/blood.V95.9.2838.009k29_2838_2846; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978; Zhao KH, 2003, STRUCTURE, V11, P1403, DOI 10.1016/j.str.2003.09.016; Zschoernig B, 2008, BIOCHEM BIOPH RES CO, V376, P251, DOI 10.1016/j.bbrc.2008.08.137	45	166	177	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13223	13232		10.1074/jbc.M110.102574	http://dx.doi.org/10.1074/jbc.M110.102574			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20167603	hybrid, Green Published			2022-12-25	WOS:000276787800077
J	Mendillo, ML; Putnam, CD; Mo, AO; Jamison, JW; Li, S; Woods, VL; Kolodner, RD				Mendillo, Marc L.; Putnam, Christopher D.; Mo, Ashley O.; Jamison, Jonathan W.; Li, Sheng; Woods, Virgil L., Jr.; Kolodner, Richard D.			Probing DNA- and ATP-mediated Conformational Changes in the MutS Family of Mispair Recognition Proteins Using Deuterium Exchange Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; ESCHERICHIA-COLI MUTS; MISMATCH-REPAIR; DOMINANT MUTATIONS; CRYSTAL-STRUCTURE; BINDING; COMPLEX; MSH6; HYDROLYSIS; GENE	We have performed deuterium exchange mass spectrometry (DXMS) to probe the conformational changes that the bacterial MutS homodimer and the homologous eukaryotic heterodimer Msh2-Msh6 undergo when binding to ATP or DNA. The DXMS data support the view that high affinity binding to mispair-containing DNA and low affinity binding to fully base-paired DNA both involve forming rings by MutS protein family dimers around the DNA; however, mispair binding protects additional regions from deuterium exchange. DXMS also reveals two distinct conformations upon binding one or two ATP molecules and that binding of two ATP molecules propagates conformational changes to other regions of the protein complexes. The regions showing major changes in deuterium exchange upon ATP binding tend to occur in regions distinct from those involved in DNA binding, suggesting that although communication occurs between DNA and nucleotide binding, sliding clamps formed by binding both ATP and mispairs could result from the simultaneous action of two independent conformational changes.	[Putnam, Christopher D.; Mo, Ashley O.; Jamison, Jonathan W.; Li, Sheng; Woods, Virgil L., Jr.; Kolodner, Richard D.] Univ Calif San Diego, San Diego Sch Med, Dept Med, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, San Diego Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, San Diego Sch Med, Ctr Canc, La Jolla, CA 92093 USA; [Mendillo, Marc L.; Putnam, Christopher D.; Kolodner, Richard D.] Univ Calif San Diego, San Diego Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Woods, VL (corresponding author), Univ Calif San Diego, San Diego Sch Med, Dept Med, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; rkolodner@ucsd.edu	Classen, Scott/AAY-8176-2020	Putnam, Christopher/0000-0002-6145-1265; Mendillo, Marc/0000-0001-8128-0128	National Institutes of Health [GM50006, CA92584, AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, GM066170]; Innovative Technologies for the Molecular Analysis of Cancer Program [CA099835, CA118595]; University of California Industry [UC10591]; BiogenIDEC corporate; NATIONAL CANCER INSTITUTE [R33CA099835, R21CA118595, P01CA092584, R21CA099835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081982, P01AI068730, R01AI072106, R21AI076961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020501, R01GM066170, R01GM020501, R01GM050006, R01GM037684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Innovative Technologies for the Molecular Analysis of Cancer Program; University of California Industry; BiogenIDEC corporate; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM50006 and CA92584 (to R. D. K.), AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, and GM066170 (to V. L. W.), and Grants CA099835 and CA118595 from Innovative Technologies for the Molecular Analysis of Cancer Program (to V. L. W.). This work was also supported by Discovery Grant UC10591 from the University of California Industry-University Cooperative Research Program, BiogenIDEC corporate sponsor (to V. L. W.).	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Alani E, 2003, J BIOL CHEM, V278, P16088, DOI 10.1074/jbc.M213193200; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Bai YW, 1995, METHOD ENZYMOL, V259, P344; Biswas I, 2001, J MOL BIOL, V305, P805, DOI 10.1006/jmbi.2000.4367; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Blackwell LJ, 2001, J BIOL CHEM, V276, P34339, DOI 10.1074/jbc.M104256200; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; DeLano WL, 2002, PYMOL USERS MANUAL; Drotschmann K, 2001, J BIOL CHEM, V276, P46225, DOI 10.1074/jbc.C100450200; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; ENGLANDER SW, 1994, METHOD ENZYMOL, V232, P26; FENG G, 1995, BIOTECHNIQUES, V19, P956; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Hess MT, 2006, P NATL ACAD SCI USA, V103, P558, DOI 10.1073/pnas.0510078103; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hsu S, 2009, BIOCHEMISTRY-US, V48, P9891, DOI 10.1021/bi9008853; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lamers MH, 2004, J BIOL CHEM, V279, P43879, DOI 10.1074/jbc.M406380200; Lamers MH, 2003, EMBO J, V22, P746, DOI 10.1093/emboj/cdg064; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mendillo ML, 2007, J BIOL CHEM, V282, P16345, DOI 10.1074/jbc.M700858200; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Selmane T, 2003, J MOL BIOL, V334, P949, DOI 10.1016/j.jmb.2003.10.010; Shell SS, 2007, P NATL ACAD SCI USA, V104, P10956, DOI 10.1073/pnas.0704148104; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Yamamoto A, 2000, NUCLEIC ACIDS RES, V28, P3564, DOI 10.1093/nar/28.18.3564	50	35	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13170	13182		10.1074/jbc.M110.108894	http://dx.doi.org/10.1074/jbc.M110.108894			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20181951	hybrid, Green Published			2022-12-25	WOS:000276787800072
J	Ushiki-Kaku, Y; Endo, R; Iwamaru, Y; Shimizu, Y; Imamura, M; Masujin, K; Yamamoto, T; Hattori, S; Itohara, S; Irie, S; Yokoyama, T				Ushiki-Kaku, Yuko; Endo, Ryo; Iwamaru, Yoshifumi; Shimizu, Yoshihisa; Imamura, Morikazu; Masujin, Kentaro; Yamamoto, Takuji; Hattori, Shunji; Itohara, Shigeyoshi; Irie, Shinkichi; Yokoyama, Takashi			Tracing Conformational Transition of Abnormal Prion Proteins during Interspecies Transmission by Using Novel Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; SCRAPIE AGENT; STRAIN VARIATION; MINK ENCEPHALOPATHY; MONOCLONAL-ANTIBODY; MOLECULAR ANALYSIS; BSE; PRP; TISSUE; CONVERSION	Conformational differences in abnormal prion proteins (PrPSc) have been postulated to produce different prion phenotypes. During the interspecies transmission of prions, the conformation of PrPSc may change with passage; however, little is known about the mechanism of PrPSc transition. In this study, novel PrPSc-specific monoclonal antibodies (mAbs) were developed that could detect the PrPSc of mouse but not that of sheep. By using these mAbs, we attempted to examine PrPSc accumulated in mice inoculated with sheep scrapie serially up to five passages. The presence of PrPSc in the mice was confirmed at all passages; however, mAb-bound PrPSc conformer was detected only from the third passage onward. The generated mAb enabled tracing of a particular conformer during adaptation in sheep-to-mice transmission of prion, suggesting that the conformational transition of PrPSc was caused by propagation of this conformer. Such mAbs capable of discriminating conformational differences may allow us to address questions concerning PrPSc conformation and strain diversity.	[Itohara, Shigeyoshi] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Ushiki-Kaku, Yuko; Yamamoto, Takuji; Hattori, Shunji; Irie, Shinkichi] Nippi Res Inst Biomatrix, Toride, Ibaraki 3020017, Japan; [Endo, Ryo; Iwamaru, Yoshifumi; Shimizu, Yoshihisa; Imamura, Morikazu; Masujin, Kentaro; Yokoyama, Takashi] Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan	RIKEN; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Yokoyama, T (corresponding author), 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	tyoko@affrc.go.jp	Itohara, Shigeyoshi/I-8769-2012	Itohara, Shigeyoshi/0000-0002-2410-9989	Ministry of Agriculture, Forestry, and Fisheries of Japan	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by grants from the Ministry of Agriculture, Forestry, and Fisheries of Japan.	Baron TGM, 2001, J VIROL, V75, P107, DOI 10.1128/JVI.75.1.107-114.2001; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; Beringue V, 2008, VET RES, V39, DOI 10.1051/vetres:2008024; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BOLTON DC, 1987, ARCH BIOCHEM BIOPHYS, V258, P579, DOI 10.1016/0003-9861(87)90380-8; Bruce ME, 2002, J GEN VIROL, V83, P695, DOI 10.1099/0022-1317-83-3-695; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Caughey B, 1999, MOL BIOTECHNOL, V13, P45, DOI 10.1385/MB:13:1:45; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Hayashi H, 2004, J VET MED SCI, V66, P515, DOI 10.1292/jvms.66.515; Hayashi HK, 2005, BIOCHEM BIOPH RES CO, V328, P1024, DOI 10.1016/j.bbrc.2005.01.065; Iwamaru Y, 2007, J VIROL, V81, P1524, DOI 10.1128/JVI.01379-06; KIMBERLIN RH, 1991, CURR T VET, V55, P137; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kuczius T, 1999, MOL MED, V5, P406, DOI 10.1007/BF03402129; Lane A, 2003, CLIN CHEM, V49, P1774, DOI 10.1373/49.10.1774; Masujin K, 2007, MICROBIOL IMMUNOL, V51, P1039, DOI 10.1111/j.1348-0421.2007.tb03988.x; Morel N, 2004, J BIOL CHEM, V279, P30143, DOI 10.1074/jbc.M403896200; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; OSTERMAN DG, 1985, J CELL BIOCHEM, V29, P57, DOI 10.1002/jcb.240290202; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; PRUSINER SB, 1991, CURR TOP MICROBIOL, P233; Serbec VC, 2004, J BIOL CHEM, V279, P3694, DOI 10.1074/jbc.M310868200; Shimada K, 2005, MICROBIOL IMMUNOL, V49, P801, DOI 10.1111/j.1348-0421.2005.tb03660.x; SHINAGAWA M, 1985, MICROBIOL IMMUNOL, V29, P543, DOI 10.1111/j.1348-0421.1985.tb00856.x; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; YOKOYAMA T, 1995, CLIN DIAGN LAB IMMUN, V2, P172, DOI 10.1128/CDLI.2.2.172-176.1995; Yokoyama T, 2001, J BIOL CHEM, V276, P11265, DOI 10.1074/jbc.M008734200	35	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11931	11936		10.1074/jbc.M109.058859	http://dx.doi.org/10.1074/jbc.M109.058859			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177064	hybrid, Green Published			2022-12-25	WOS:000276787100021
J	Guo, JH; Cheng, P; Liu, Y				Guo, Jinhu; Cheng, Ping; Liu, Yi			Functional Significance of FRH in Regulating the Phosphorylation and Stability of Neurospora Circadian Clock Protein FRQ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEEDBACK LOOPS; FREQUENCY; MULTIPLE; LIGHT; DEGRADATION; COMPLEX; EXOSOME; KINASE; TRANSCRIPTION; MECHANISM	FREQUENCY (FRQ) is the central component of the Neurospora circadian clock. All FRQ proteins form the FFC complex with FRH (FRQ-interacting RNA helicase) that acts as the negative element in the circadian negative feedback loop by repressing frq mRNA levels. To understand the function of the FRQ-FRH interaction, we mapped and identified the minimal FRQ region that is required for FRQ-FRH interaction. We demonstrated that the FRQ-FRH complex formation is required for the interaction between FRQ and the White Collar Complex (WCC) and clock function. On the other hand, in the FRQ-FRH complex, FRQ is also required for the FRH-WCC interaction. Disruption of FRQ-FRH interaction or down-regulation of FRH results in hypophosphorylation, rapid degradation of FRQ, as well as low levels of WHITE COLLAR-1 and WHITE COLLAR-2. Furthermore, we showed that the rapid FRQ degradation in the absence of FRH is independent of FWD-1, the ubiquitin E3 ligase of FRQ under normal conditions, thus uncovering an alternative pathway for FRQ degradation.	[Guo, Jinhu; Cheng, Ping; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, ND13-214A,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Yi.Liu@UTsouthwestern.edu			National Institutes of Health [GM068496, GM062591]; The Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068496, R01GM062591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068496 and GM062591 (to Y.L.). This work was also supported by The Welch Foundation (to Y.L.).	ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; ARPAIA G, 1993, PLANT PHYSIOL, V102, P1299, DOI 10.1104/pp.102.4.1299; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Cha J, 2007, COLD SPRING HARB SYM, V72, P185, DOI 10.1101/sqb.2007.72.010; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2003, P NATL ACAD SCI USA, V100, P5938, DOI 10.1073/pnas.1031791100; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Dunlap JC, 1999, GENES CELLS, V4, P1, DOI 10.1046/j.1365-2443.1999.00239.x; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; He Q, 2005, BIOCHEM SOC T, V33, P953, DOI 10.1042/BST0330953; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Yang YH, 2003, MOL CELL BIOL, V23, P6221, DOI 10.1128/MCB.23.17.6221-6228.2003; Yang YH, 2001, J BIOL CHEM, V276, P41064, DOI 10.1074/jbc.M106905200; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	34	44	45	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11508	11515		10.1074/jbc.M109.071688	http://dx.doi.org/10.1074/jbc.M109.071688			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20159972	hybrid, Green Published			2022-12-25	WOS:000276286200057
J	Volkov, A; Liavonchanka, A; Kamneva, O; Fiedler, T; Goebel, C; Kreikemeyer, B; Feussner, I				Volkov, Anton; Liavonchanka, Alena; Kamneva, Olga; Fiedler, Tomas; Goebel, Cornelia; Kreikemeyer, Bernd; Feussner, Ivo			Myosin Cross-reactive Antigen of Streptococcus pyogenes M49 Encodes a Fatty Acid Double Bond Hydratase That Plays a Role in Oleic Acid Detoxification and Bacterial Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENOYL-COA HYDRATASE; ESCHERICHIA-COLI; LINOLEIC-ACID; SEQUENCE; MECHANISM; BIOHYDROGENATION; INHIBITION; BINDING; GROWTH; GENE	The myosin cross-reactive antigen (MCRA) protein family is highly conserved among different bacterial species ranging from Gram-positive to Gram-negative bacteria. Besides their ubiquitous occurrence, knowledge about the biochemical and physiological function of MCRA proteins is scarce. Here, we show that MCRA protein from Streptococcus pyogenes M49 is a FAD enzyme, which acts as hydratase on (9Z)- and (12Z)-double bonds of C-16, C-18 non-esterified fatty acids. Products are 10-hydroxy and 10,13-dihydroxy fatty acids. Kinetic analysis suggests that FAD rather stabilizes the active conformation of the enzyme and is not directly involved in catalysis. Analysis of S. pyogenes M49 grown in the presence of either oleic or linoleic acid showed that 10-hydroxy and 10,13-dihydroxy derivatives were the only products. No further metabolism of these hydroxy fatty acids was detected. Deletion of the hydratase gene caused a 2-fold decrease in minimum inhibitory concentration against oleic acid but increased survival of the mutant strain in whole blood. Adherence and internalization properties to human keratinocytes were reduced in comparison with the wild type. Based on these results, we conclude that the previously identified MCRA protein can be classified as a FAD-containing double bond hydratase, within the carbon-oxygen lyase family, that plays a role in virulence of at least S. pyogenes M49.	[Volkov, Anton; Liavonchanka, Alena; Goebel, Cornelia; Feussner, Ivo] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, D-37077 Gottingen, Germany; [Fiedler, Tomas; Kreikemeyer, Bernd] Univ Hosp Rostock, Inst Med Microbiol Virol & Hyg, D-18057 Rostock, Germany; [Kamneva, Olga] Univ Wyoming, Coll Agr, Dept Mol Biol, Laramie, WY 82072 USA	University of Gottingen; University of Rostock; University of Wyoming	Feussner, I (corresponding author), Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Justus von Liebig Weg 11, D-377077 Gottingen, Germany.	ifeussn@uni-goettingen.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003; Fiedler, Tomas/0000-0001-6717-1865; Kreikemeyer, Bernd/0000-0001-9527-5098	Molecular Sciences and Biotechnology of Crop Plants	Molecular Sciences and Biotechnology of Crop Plants	Supported by the Ph.D. program "Molecular Sciences and Biotechnology of Crop Plants."	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bevers LE, 2009, J BACTERIOL, V191, P5010, DOI 10.1128/JB.00306-09; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CROMARTIE TH, 1976, J BIOL CHEM, V251, P329; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Duggleby RG, 2000, J BIOCHEM MOL BIOL, V33, P1; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; FEUSSNER I, 2008, Patent No. 119735; GREENWAY DLA, 1979, J GEN MICROBIOL, V115, P233, DOI 10.1099/00221287-115-1-233; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KAUPPINEN S, 1988, CARLSBERG RES COMMUN, V53, P357, DOI 10.1007/BF02983311; KEPLER CR, 1970, J BIOL CHEM, V245, P3612; KEPLER CR, 1967, J BIOL CHEM, V242, P5686; KEPLER CR, 1966, J BIOL CHEM, V241, P1350; KIL KS, 1994, INFECT IMMUN, V62, P2440, DOI 10.1128/IAI.62.6.2440-2449.1994; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Kleinfeld AM, 1996, AM J CARDIOL, V78, P1350, DOI 10.1016/S0002-9149(96)00651-0; Kreikemeyer B, 2001, MOL MICROBIOL, V39, P392, DOI 10.1046/j.1365-2958.2001.02226.x; Liavonchanka A, 2006, P NATL ACAD SCI USA, V103, P2576, DOI 10.1073/pnas.0510144103; Liavonchanka A, 2008, CHEMBIOCHEM, V9, P1867, DOI 10.1002/cbic.200800141; Liavonchanka A, 2009, J BIOL CHEM, V284, P8005, DOI 10.1074/jbc.M809060200; Maia MRG, 2007, ANTON LEEUW INT J G, V91, P303, DOI 10.1007/s10482-006-9118-2; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; RAYCHOWDHURY MK, 1985, J APPL BACTERIOL, V59, P183, DOI 10.1111/j.1365-2672.1985.tb03319.x; RICHIERI GV, 1995, J LIPID RES, V36, P229; ROSSON RA, 2004, Patent No. 6743609; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stenz L, 2008, FEMS MICROBIOL LETT, V287, P149, DOI 10.1111/j.1574-6968.2008.01316.x; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ValentinWeigand P, 1996, INFECT IMMUN, V64, P2467, DOI 10.1128/IAI.64.7.2467-2473.1996; VARGO D, 1981, J BIOL CHEM, V256, P6027; VERBRUGH HA, 1985, IMMUNOLOGY, V54, P643; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zheng CJ, 2005, FEBS LETT, V579, P5157, DOI 10.1016/j.febslet.2005.08.028	47	91	98	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10353	10361		10.1074/jbc.M109.081851	http://dx.doi.org/10.1074/jbc.M109.081851			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20145247	Green Published, hybrid			2022-12-25	WOS:000276264600020
J	Bertolino, A; Taurisano, P; Pisciotta, NM; Blasi, G; Fazio, L; Romano, R; Gelao, B; Lo Bianco, L; Lozupone, M; Di Giorgio, A; Caforio, G; Sambataro, F; Niccoli-Asabella, A; Papp, A; Ursini, G; Sinibaldi, L; Popolizio, T; Sadee, W; Rubini, G				Bertolino, Alessandro; Taurisano, Paolo; Pisciotta, Nicola Marco; Blasi, Giuseppe; Fazio, Leonardo; Romano, Raffaella; Gelao, Barbara; Lo Bianco, Luciana; Lozupone, Madia; Di Giorgio, Annabella; Caforio, Grazia; Sambataro, Fabio; Niccoli-Asabella, Artor; Papp, Audrey; Ursini, Gianluca; Sinibaldi, Lorenzo; Popolizio, Teresa; Sadee, Wolfgang; Rubini, Giuseppe			Genetically Determined Measures of Striatal D2 Signaling Predict Prefrontal Activity during Working Memory Performance	PLOS ONE			English	Article							DOPAMINE TRANSPORTER FUNCTION; VAL(108/158) MET GENOTYPE; RECEPTOR GENE; PARKINSONS-DISEASE; D-2 RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; N-ACETYLASPARTATE; SPECT MEASUREMENT; CEREBRAL-CORTEX; FUNCTIONAL MRI	Background: Variation of the gene coding for D2 receptors (DRD2) has been associated with risk for schizophrenia and with working memory deficits. A functional intronic SNP (rs1076560) predicts relative expression of the two D2 receptors isoforms, D2S (mainly pre-synaptic) and D2L (mainly post-synaptic). However, the effect of functional genetic variation of DRD2 on striatal dopamine D2 signaling and on its correlation with prefrontal activity during working memory in humans is not known. Methods: Thirty-seven healthy subjects were genotyped for rs1076560 (G>T) and underwent SPECT with [I-123]IBZM (which binds primarily to post-synaptic D2 receptors) and with [I-123]FP-CIT (which binds to pre-synaptic dopamine transporters, whose activity and density is also regulated by pre-synaptic D2 receptors), as well as BOLD fMRI during N-Back working memory. Results: Subjects carrying the T allele (previously associated with reduced D2S expression) had striatal reductions of [I-123]IBZM and of [I-123]FP-CIT binding. DRD2 genotype also differentially predicted the correlation between striatal dopamine D2 signaling (as identified with factor analysis of the two radiotracers) and activity of the prefrontal cortex during working memory as measured with BOLD fMRI, which was positive in GG subjects and negative in GT. Conclusions: Our results demonstrate that this functional SNP within DRD2 predicts striatal binding of the two radiotracers to dopamine transporters and D2 receptors as well as the correlation between striatal D2 signaling with prefrontal cortex activity during performance of a working memory task. These data are consistent with the possibility that the balance of excitatory/inhibitory modulation of striatal neurons may also affect striatal outputs in relationship with prefrontal activity during working memory performance within the cortico-striatal-thalamic-cortical pathway.	[Bertolino, Alessandro; Taurisano, Paolo; Blasi, Giuseppe; Fazio, Leonardo; Romano, Raffaella; Gelao, Barbara; Lo Bianco, Luciana; Lozupone, Madia; Di Giorgio, Annabella; Caforio, Grazia; Ursini, Gianluca] Univ Bari, Dept Neurol & Psychiat Sci, Psychiat Neurosci Grp, Bari, Italy; [Bertolino, Alessandro; Fazio, Leonardo; Popolizio, Teresa] IRCCS Casa Sollievo Sofferenza, Dept Neuroradiol, San Giovanni Rotondo, Italy; [Pisciotta, Nicola Marco; Niccoli-Asabella, Artor; Rubini, Giuseppe] Univ Bari, Dept Internal Med & Publ Med, Nucl Med Unit, Bari, Italy; [Sambataro, Fabio] NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; [Papp, Audrey; Sadee, Wolfgang] Ohio State Univ, Coll Med, Dept Pharmacol, Program Pharmacogenom, Columbus, OH 43210 USA; [Papp, Audrey; Sadee, Wolfgang] Ohio State Univ, Div Biostat, Coll Publ Hlth, Columbus, OH 43210 USA; [Ursini, Gianluca; Sinibaldi, Lorenzo] IRCCS CSS Mendel Inst, Rome, Italy; [Sinibaldi, Lorenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	Universita degli Studi di Bari Aldo Moro; IRCCS Casa Sollievo Della Sofferenza; Universita degli Studi di Bari Aldo Moro; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome	Bertolino, A (corresponding author), Univ Bari, Dept Neurol & Psychiat Sci, Psychiat Neurosci Grp, Bari, Italy.	a.bertolino@psichiat.uniba.it	Taurisano, Paolo/AID-5342-2022; Lozupone, Madia/F-7262-2018; Bertolino, Alessandro/O-6352-2016; Sambataro, Fabio/E-3426-2010; Blasi, Giuseppe/HHS-5404-2022; Ursini, Gianluca/AAA-8242-2019; Taurisano, Paolo/U-1828-2017; Sinibaldi, Lorenzo/HFZ-8860-2022; Fazio, Leonardo/J-4570-2012; Di Giorgio, Annabella/D-7353-2017; Di Giorgio, Annabella/AAS-1137-2020; Picchioni, Marco M/E-3300-2010; Di Giorgio, Annabella/AAI-5367-2020; Asabella, Artor Niccoli/M-1745-2015	Taurisano, Paolo/0000-0001-6140-9326; Lozupone, Madia/0000-0002-1674-9724; Bertolino, Alessandro/0000-0002-1251-1380; Sambataro, Fabio/0000-0003-2102-416X; Taurisano, Paolo/0000-0001-6140-9326; Sinibaldi, Lorenzo/0000-0002-1371-936X; Fazio, Leonardo/0000-0003-4000-974X; Di Giorgio, Annabella/0000-0001-7876-3495; Picchioni, Marco M/0000-0001-6681-147X; Di Giorgio, Annabella/0000-0001-7876-3495; Asabella, Artor Niccoli/0000-0002-1227-029X; Blasi, Giuseppe/0000-0003-0878-1131; Rubini, Giuseppe/0000-0003-1972-3308; Ursini, Gianluca/0000-0002-4733-5196	National Institutes of Health (NIH) [DA022199]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022199] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Part of this work was supported by a National Institutes of Health (NIH) grant DA022199 (W.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Bertolino A, 1999, BIOL PSYCHIAT, V45, P660, DOI 10.1016/S0006-3223(98)00380-1; Bertolino A, 2000, NEUROPSYCHOPHARMACOL, V22, P125, DOI 10.1016/S0893-133X(99)00096-2; Bertolino A, 2004, BIOL PSYCHIAT, V56, P190, DOI 10.1016/j.biopsych.2004.04.009; Bertolino A, 2004, AM J PSYCHIAT, V161, P1798, DOI 10.1176/appi.ajp.161.10.1798; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Bertolino A, 2006, PSYCHIAT RES-NEUROIM, V147, P221, DOI 10.1016/j.pscychresns.2006.04.001; Bertolino A, 2009, BRAIN, V132, P417, DOI 10.1093/brain/awn248; Bertolino A, 2009, J NEUROSCI, V29, P1224, DOI 10.1523/JNEUROSCI.4858-08.2009; Betcheva ET, 2009, J HUM GENET, V54, P98, DOI 10.1038/jhg.2008.14; Beukers RJ, 2009, EUR J NUCL MED MOL I, V36, P269, DOI 10.1007/s00259-008-0924-9; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Booij J, 2001, SYNAPSE, V39, P101, DOI 10.1002/1098-2396(200102)39:2<101::AID-SYN1>3.3.CO;2-T; Booij J, 1999, J NUCL MED, V40, P753; BRUCKE T, 1991, J CEREBR BLOOD F MET, V11, P220; Caceres A, 2009, NEUROIMAGE, V45, P758, DOI 10.1016/j.neuroimage.2008.12.035; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Carlsson Arvid, 2006, Dialogues Clin Neurosci, V8, P137; Catafau AM, 2004, MOVEMENT DISORD, V19, P1175, DOI 10.1002/mds.20112; Catafau AM, 2008, SYNAPSE, V62, P62, DOI 10.1002/syn.20465; Centonze D, 2004, NEUROSCIENCE, V129, P157, DOI 10.1016/j.neuroscience.2004.07.043; Chen PS, 2005, PSYCHOL MED, V35, P197, DOI 10.1017/S0033291704003101; Curtis CE, 2004, J NEUROSCI, V24, P3944, DOI 10.1523/JNEUROSCI.5640-03.2004; Dickinson SD, 1999, J NEUROCHEM, V72, P148, DOI 10.1046/j.1471-4159.1999.0720148.x; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Frankle WG, 2004, PSYCHOPHARMACOLOGY, V175, P473, DOI 10.1007/s00213-004-1852-4; Glatt SJ, 2003, MOL PSYCHIATR, V8, P911, DOI 10.1038/sj.mp.4001321; GLATT SJ, 2008, MOL PSYCHIAT; Glickstein SB, 2002, J NEUROSCI, V22, P5619; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; GUO N, 2009, NEUROPSYCHOPHARMACOL; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hill T., 2006, STAT METHODS APPL CO; Hirvonen J, 2005, ARCH GEN PSYCHIAT, V62, P371, DOI 10.1001/archpsyc.62.4.371; HIRVONEN MM, 2009, IN VIVO MOL IMAGING; Howes OD, 2009, ARCH GEN PSYCHIAT, V66, P13, DOI 10.1001/archgenpsychiatry.2008.514; Huttunen J, 2008, BIOL PSYCHIAT, V63, P114, DOI 10.1016/j.biopsych.2007.04.017; Ishikawa T, 1996, J NUCL MED, V37, P1760; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Jonsson EG, 1999, SCHIZOPHR RES, V40, P31, DOI 10.1016/S0920-9964(99)00033-X; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kegeles LS, 1999, SYNAPSE, V31, P302; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kimberg DY, 2001, HUM BRAIN MAPP, V12, P246, DOI 10.1002/1097-0193(200104)12:4<246::AID-HBM1019>3.0.CO;2-9; Kimmel HL, 2001, J PHARMACOL EXP THER, V298, P129; KUNG HF, 1990, J NUCL MED, V31, P573; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Landau SM, 2009, CEREB CORTEX, V19, P445, DOI 10.1093/cercor/bhn095; Laruelle M, 1994, NIDA Res Monogr, V138, P131; Laruelle M, 1997, NEUROPSYCHOPHARMACOL, V17, P162, DOI 10.1016/S0893-133X(97)00043-2; LARUELLE M, 1993, SYNAPSE, V13, P295, DOI 10.1002/syn.890130402; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Lee FJS, 2007, EMBO J, V26, P2127, DOI 10.1038/sj.emboj.7601656; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; LIDOW MS, 1989, P NATL ACAD SCI USA, V86, P6412, DOI 10.1073/pnas.86.16.6412; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Manoach DS, 2004, NEUROIMAGE, V21, P894, DOI 10.1016/j.neuroimage.2003.10.025; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; Manoach DS, 2001, AM J PSYCHIAT, V158, P955, DOI 10.1176/appi.ajp.158.6.955; Mehta MA, 2003, NEUROIMAGE, V20, P1982, DOI 10.1016/j.neuroimage.2003.08.007; Mehta MA, 2004, PSYCHOPHARMACOLOGY, V176, P331, DOI 10.1007/s00213-004-1899-2; MEIERGERD SM, 1993, J NEUROCHEM, V61, P764; Meyer PT, 2008, NEUROIMAGE, V42, P548, DOI 10.1016/j.neuroimage.2008.05.023; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Meyer-Lindenberg A, 2008, NEUROIMAGE, V40, P655, DOI 10.1016/j.neuroimage.2007.11.058; Mortensen OV, 2003, EUR J PHARMACOL, V479, P159, DOI 10.1016/j.ejphar.2003.08.066; Nyberg L, 2009, NEUROIMAGE, V46, P1194, DOI 10.1016/j.neuroimage.2009.03.035; O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242; Papp AC, 2003, BIOTECHNIQUES, V34, P1068, DOI 10.2144/03345dd03; PARSONS LH, 1993, J NEUROCHEM, V60, P376, DOI 10.1111/j.1471-4159.1993.tb05864.x; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Rakshi JS, 1999, BRAIN, V122, P1637, DOI 10.1093/brain/122.9.1637; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Scheffel U, 1997, SYNAPSE, V25, P345, DOI 10.1002/(SICI)1098-2396(199704)25:4<345::AID-SYN5>3.3.CO;2-Z; Scherfler C, 2005, BRAIN, V128, P1605, DOI 10.1093/brain/awh485; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seibyl J, 2005, Q J NUCL MED MOL IM, V49, P215; SEIBYL JP, 1992, J NUCL MED, V33, P1964; Seidman LJ, 2006, SCHIZOPHR RES, V85, P58, DOI 10.1016/j.schres.2006.03.019; Sesack S R, 1998, Adv Pharmacol, V42, P171; Soret M, 2003, J NUCL MED, V44, P1184; Tan HY, 2007, J NEUROSCI, V27, P13393, DOI 10.1523/JNEUROSCI.4041-07.2007; Tatsch K, 2002, EUR J NUCL MED MOL I, V29, pBP23; Tsuchida T, 2004, ANN NUCL MED, V18, P609, DOI 10.1007/BF02984583; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; VERHOEFF NPLG, 1993, J NUCL MED, V34, P2076; Volkow ND, 1996, PSYCHIAT RES-NEUROIM, V67, P11, DOI 10.1016/0925-4927(96)02809-0; Volkow ND, 1998, AM J PSYCHIAT, V155, P344; Volkow ND, 1996, J NUCL MED, V37, P554; Watanabe K, 2009, J NEUROPHYSIOL, V101, P665, DOI 10.1152/jn.90806.2008; Wei XC, 2004, NEUROIMAGE, V21, P1000, DOI 10.1016/j.neuroimage.2003.10.039; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Williams GV, 2006, NEUROSCIENCE, V139, P263, DOI 10.1016/j.neuroscience.2005.09.028; Zhang Y, 2005, J BIOL CHEM, V280, P32618, DOI 10.1074/jbc.M504942200; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104	103	70	72	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9348	10.1371/journal.pone.0009348	http://dx.doi.org/10.1371/journal.pone.0009348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179754	gold, Green Submitted, Green Published			2022-12-25	WOS:000274923900014
J	Dubois, A; Raymond, O; Maene, M; Baudino, S; Langlade, NB; Boltz, V; Vergne, P; Bendahmane, M				Dubois, Annick; Raymond, Olivier; Maene, Marion; Baudino, Sylvie; Langlade, Nicolas B.; Boltz, Veronique; Vergne, Philippe; Bendahmane, Mohammed			Tinkering with the C-Function: A Molecular Frame for the Selection of Double Flowers in Cultivated Roses	PLOS ONE			English	Article							MADS-BOX GENES; EVOLUTION; PETAL; IDENTITY; DOMESTICATION; ASSOCIATION; CHIMERISM; MASAKO-C1; GENETICS	Background: Roses have been cultivated for centuries and a number of varieties have been selected based on flower traits such as petal form, color, and number. Wild-type roses have five petals (simple flowers), whereas high numbers of petals (double flowers) are typical attributes of most of the cultivated roses. Here, we investigated the molecular mechanisms that could have been selected to control petal number in roses. Methodology/Principal Findings: We have analyzed the expression of several candidate genes known to be involved in floral organ identity determination in roses from similar genetic backgrounds but exhibiting contrasting petal numbers per flower. We show that the rose ortholog of AGAMOUS (RhAG) is differentially expressed in double flowers as compared to simple flowers. In situ hybridization experiments confirm the differential expression of RhAG and demonstrate that in the double-flower roses, the expression domain of RhAG is restricted toward the center of the flower. Conversely, in simple-flower roses, RhAG expression domain is wider. We further show that the border of RhAG expression domain is labile, which allows the selection of rose flowers with increased petal number. Double-flower roses were selected independently in the two major regions for domestication, China and the peri-Mediterranean areas. Comparison of RhAG expression in the wildtype ancestors of cultivated roses and their descendants both in the European and Chinese lineages corroborates the correlation between the degree of restriction of RhAG expression domain and the number of petals. Our data suggests that a restriction of RhAG expression domain is the basis for selection of double flowers in both the Chinese and peri-Mediterranean centers of domestication. Conclusions/Significance: We demonstrate that a shift in RhAG expression domain boundary occurred in rose hybrids, causing double-flower phenotype. This molecular event was selected independently during rose domestication in Europe/Middle East and in China.	[Dubois, Annick; Raymond, Olivier; Maene, Marion; Boltz, Veronique; Vergne, Philippe; Bendahmane, Mohammed] Univ Lyon, Reprod & Dev Plantes, Lyon, France; [Baudino, Sylvie] Univ St Etienne, Lab Biotechnol Vegetales Appl Plantes Aromat & Me, St Etienne, France; [Langlade, Nicolas B.] INRA, Castanet Tolosan, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; INRAE	Dubois, A (corresponding author), Univ Lyon, Reprod & Dev Plantes, Lyon, France.	mohammed.bendahmane@ens-lyon.fr	Dubois, Annick/AAX-2219-2021; Langlade, Nicolas/C-6191-2008; Bendahmane, Mohammed/AAX-1296-2020; Raymond, Olivier/AAO-5868-2020	Dubois, Annick/0000-0002-3646-3811; Langlade, Nicolas/0000-0002-5651-1446; Bendahmane, Mohammed/0000-0003-1661-1060; Raymond, Olivier/0000-0002-9664-5377; Baudino, Sylvie/0000-0002-3367-172X	Biologie Vegetale Department of the French Institut National de la Recherche Agronomique; Region Rhone-Alpes/Cluster 9; Region Rhone-Alpes	Biologie Vegetale Department of the French Institut National de la Recherche Agronomique; Region Rhone-Alpes/Cluster 9(Region Auvergne-Rhone-Alpes); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was funded by the Biologie Vegetale Department of the French Institut National de la Recherche Agronomique and by funds from the Region Rhone-Alpes/Cluster 9. MM was supported by a PhD fellowship Prospective from Region Rhone-Alpes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergougnoux V, 2007, PLANTA, V226, P853, DOI 10.1007/s00425-007-0531-1; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; Bowman J L, 1991, Symp Soc Exp Biol, V45, P89; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Burke JM, 2007, CURR OPIN GENET DEV, V17, P525, DOI 10.1016/j.gde.2007.09.003; CAIRNS T, 2000, MODERN ROSES, V11; Causier B, 2005, CURR BIOL, V15, P1508, DOI 10.1016/j.cub.2005.07.063; Cherri-Martin M, 2007, SCI HORTIC-AMSTERDAM, V113, P177, DOI 10.1016/j.scienta.2007.03.002; Darwin C. S., 1859, ORIGIN SPECIES MEANS; Davies B, 1999, EMBO J, V18, P4023, DOI 10.1093/emboj/18.14.4023; Fernandez L, 2006, GENOME, V49, P721, DOI 10.1139/G06-034; Ferrario S, 2004, CURR OPIN PLANT BIOL, V7, P84, DOI 10.1016/j.pbi.2003.11.003; Franks T, 2002, THEOR APPL GENET, V104, P192, DOI 10.1007/s001220100683; Glemin S, 2009, NEW PHYTOL, V183, P273, DOI 10.1111/j.1469-8137.2009.02884.x; Gregory T.R., 2009, EVOLUTION, V2, P5, DOI [DOI 10.1007/S12052-008-0114-Z, 10.1007/s12052-008-0114-z]; Grison-Pige L, 2002, J CHEM ECOL, V28, P283, DOI 10.1023/A:1017930023741; Hibino Y, 2006, PLANT SCI, V170, P778, DOI 10.1016/j.plantsci.2005.11.010; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kitahara K, 2004, PLANT SCI, V166, P1245, DOI 10.1016/j.plantsci.2003.12.040; Kitahara K, 2000, PLANT SCI, V151, P121, DOI 10.1016/S0168-9452(99)00206-X; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; KRUSSMANN G, 1981, COMPLETE BOOK ROSES, P436; Langlade NB, 2005, P NATL ACAD SCI USA, V102, P10221, DOI 10.1073/pnas.0504210102; Li Wanlong, 2006, Functional & Integrative Genomics, V6, P300, DOI 10.1007/s10142-005-0015-y; Lijavetzky D, 2006, MOL GENET GENOMICS, V276, P427, DOI 10.1007/s00438-006-0149-1; Lohmann JU, 2002, DEV CELL, V2, P135, DOI 10.1016/S1534-5807(02)00122-3; Lu SH, 2007, EVOL DEV, V9, P92, DOI 10.1111/j.1525-142X.2006.00140.x; Ma N, 2008, PLANT PHYSIOL, V148, P894, DOI 10.1104/pp.108.120154; Martin M, 2001, THEOR APPL GENET, V102, P398, DOI 10.1007/s001220051660; Melzer R, 2009, NUCLEIC ACIDS RES, V37, P144, DOI 10.1093/nar/gkn900; MIZUKAMI Y, 1995, PLANT MOL BIOL, V28, P767, DOI 10.1007/BF00042064; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Roeder AHK, 2001, DEV CELL, V1, P4, DOI 10.1016/S1534-5807(01)00013-2; Saedler H, 2001, ACTA BIOCHIM POL, V48, P351; Soltis DE, 2007, TRENDS PLANT SCI, V12, P358, DOI 10.1016/j.tplants.2007.06.012; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker AR, 2006, PLANT MOL BIOL, V62, P623, DOI 10.1007/s11103-006-9043-9; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435	41	69	86	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9288	10.1371/journal.pone.0009288	http://dx.doi.org/10.1371/journal.pone.0009288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174587	Green Published, gold			2022-12-25	WOS:000274654700018
J	Valensi-Kurtz, M; Lefler, S; Cohen, MA; Aharonowiz, M; Cohen-Kupiec, R; Sheinin, A; Ashery, U; Reubinoff, B; Weil, M				Valensi-Kurtz, Moran; Lefler, Sharon; Cohen, Malkiel A.; Aharonowiz, Michal; Cohen-Kupiec, Rachel; Sheinin, Anton; Ashery, Uri; Reubinoff, Benjamin; Weil, Miguel			Enriched Population of PNS Neurons Derived from Human Embryonic Stem Cells as a Platform for Studying Peripheral Neuropathies	PLOS ONE			English	Article							VESICULAR ACETYLCHOLINE TRANSPORTER; NEURAL CREST CELLS; FAMILIAL DYSAUTONOMIA; IN-VITRO; DIRECTED DIFFERENTIATION; SYMPATHETIC NEURONS; CHOLINERGIC NEURONS; GENERATION; SPECIFICATION; PRECURSORS	Background: The absence of a suitable cellular model is a major obstacle for the study of peripheral neuropathies. Human embryonic stem cells hold the potential to be differentiated into peripheral neurons which makes them a suitable candidate for this purpose. However, so far the potential of hESC to differentiate into derivatives of the peripheral nervous system (PNS) was not investigated enough and in particular, the few trials conducted resulted in low yields of PNS neurons. Here we describe a novel hESC differentiation method to produce enriched populations of PNS mature neurons. By plating 8 weeks hESC derived neural progenitors (hESC-NPs) on laminin for two weeks in a defined medium, we demonstrate that over 70% of the resulting neurons express PNS markers and 30% of these cells are sensory neurons. Methods/Findings: Our method shows that the hNPs express neuronal crest lineage markers in a temporal manner, and by plating 8 weeks hESC-NPs into laminin coated dishes these hNPs were promoted to differentiate and give rise to homogeneous PNS neuronal populations, expressing several PNS lineage-specific markers. Importantly, these cultures produced functional neurons with electrophysiological activities typical of mature neurons. Moreover, supporting this physiological capacity implantation of 8 weeks old hESC-NPs into the neural tube of chick embryos also produced human neurons expressing specific PNS markers in vivo in just a few days. Having the enriched PNS differentiation system in hand, we show for the first time in human PNS neurons the expression of IKAP/hELP1 protein, where a splicing mutation on the gene encoding this protein causes the peripheral neuropathy Familial Dysautonomia. Conclusions/Significance: We conclude that this differentiation system to produce high numbers of human PNS neurons will be useful for studying PNS related neuropathies and for developing future drug screening applications for these diseases.	[Valensi-Kurtz, Moran; Lefler, Sharon; Cohen-Kupiec, Rachel; Weil, Miguel] Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Cohen, Malkiel A.; Aharonowiz, Michal; Reubinoff, Benjamin] Tel Aviv Univ, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Sheinin, Anton; Ashery, Uri] Hadassah Univ Hosp, Dept Gynecol, IL-91120 Jerusalem, Israel	Tel Aviv University; Tel Aviv University; Hebrew University of Jerusalem	Valensi-Kurtz, M (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	miguelw@tauex.tau.ac.il	Cohen, Malkiel/AAE-1115-2020	Ashery, Uri/0000-0001-6338-7888; Reubinoff, Benjamin/0000-0003-0353-1299; Cohen, Malkiel/0000-0002-4187-691X	Familial Dysautonomia-Hope Foundation in the United States; Tel Aviv University Reccanati Fund	Familial Dysautonomia-Hope Foundation in the United States; Tel Aviv University Reccanati Fund	This work was supported by the Familial Dysautonomia-Hope Foundation (http://www.fdhope.org/) in the United States and by The Tel Aviv University Reccanati Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Arvidsson U, 1997, J COMP NEUROL, V378, P454; Baker CVH, 2002, DEV BIOL, V249, P219, DOI 10.1006/dbio.2002.0767; Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; BROKHMAN I, 2007, DIFFERENTIATION; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Cohen M. A., 2007, CURR PROTOC CELL BIO; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Harris ML, 2007, DEV DYNAM, V236, P1, DOI 10.1002/dvdy.20919; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; JIANG X, 2008, STEM CELLS DEV; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Koblar SA, 1999, J NEUROSCI RES, V56, P518, DOI 10.1002/(SICI)1097-4547(19990601)56:5<518::AID-JNR7>3.3.CO;2-#; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Le Douarin NM, 1999, NEURAL CREST, V2; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Leyne M, 2003, AM J MED GENET A, V118A, P305, DOI 10.1002/ajmg.a.20052; MAAYAN C, 1987, CLIN GENET, V32, P106; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pomp O, 2005, STEM CELLS, V23, P923, DOI 10.1634/stemcells.2005-0038; Pomp O, 2008, BRAIN RES, V1230, P50, DOI 10.1016/j.brainres.2008.07.029; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; RILEY CM, 1949, PEDIATRICS, V3, P468; Schafer MKH, 1998, NEUROSCIENCE, V84, P361, DOI 10.1016/S0306-4522(97)80196-0; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; SWEENEY TM, 1990, LAMININ POTENTIATES; Zeng X, 2007, NEUROSCIENCE, V145, P1348, DOI 10.1016/j.neuroscience.2006.09.017; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	40	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9290	10.1371/journal.pone.0009290	http://dx.doi.org/10.1371/journal.pone.0009290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174633	Green Submitted, gold, Green Published			2022-12-25	WOS:000274654700019
J	Savic, I; Berglund, H				Savic, Ivanka; Berglund, Hans			Androstenol - a Steroid Derived Odor Activates the Hypothalamus in Women	PLOS ONE			English	Article							PUTATIVE PHEROMONES; BRAIN ACTIVATION; 16-ANDROSTENES; EXPOSURE; HORMONE; HUMANS; SWEAT; MOOD	Background: Whether pheromone signaling exists in humans is still a matter of intense discussion. In the present study we tested if smelling of Androstenol, a steroid produced by the human body and reported to affect human behavior, may elicit cerebral activation. A further issue was to evaluate whether the pattern of activation resembles the pattern of common odors. Methodology: PET measurements of regional cerebral blood flow (rCBF) were conducted in 16 healthy heterosexual women during passive smelling of Androstenol, four ordinary odors (OO), and odorless air (the base line condition). Principal findings: Smelling Androstenol caused activation of a portion of the hypothalamus, which according to animal data mediates the pheromone triggered mating behavior. Smelling of OO, on the other hand, engaged only the classical olfactory regions (the piriform cortex, lateral amygdala, anterior insular and anterior cingulate cortex). Conclusions: The observed pattern of activation is very similar to the pattern previously detected with 4,16-androstadien-3-one in heterosexual females. It suggests that several compounds released by human body may activate cerebral networks involved in human reproduction.	[Savic, Ivanka] Karolinska Inst, Stockholm Brain Inst, Dept Clin Neurosci, Stockholm, Sweden; [Berglund, Hans] Karolinska Univ Hosp, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Savic, I (corresponding author), Karolinska Inst, Stockholm Brain Inst, Dept Clin Neurosci, Stockholm, Sweden.	ivanka.savic-berglund@ki.se			Osher Pro Suecia Foundation; Swedish Research Council	Osher Pro Suecia Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by the Osher Pro Suecia Foundation and Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensafi A, 2004, BEHAV BRAIN RES, V152, P11, DOI 10.1016/j.bbr.2003.09.009; Bensafi M, 2004, PSYCHONEUROENDOCRINO, V29, P1290, DOI 10.1016/j.psyneuen.2004.03.007; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; COWLEY JJ, 1991, J STEROID BIOCHEM, V39, P647, DOI 10.1016/0960-0760(91)90264-6; GOWER DB, 1993, J ENDOCRINOL, V137, P167, DOI 10.1677/joe.0.1370167; GOWER DB, 1994, J STEROID BIOCHEM, V48, P409, DOI 10.1016/0960-0760(94)90082-5; Jacob S, 2002, HORM BEHAV, V42, P274, DOI 10.1006/hbeh.2002.1826; Kaminski RM, 2005, EPILEPSIA, V46, P819, DOI 10.1111/j.1528-1167.2005.00705.x; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Lundstrom JN, 2003, HORM BEHAV, V44, P395, DOI 10.1016/j.yhbeh.2003.06.004; McCluskey JJ, 2005, J AGR RESOUR ECON, V30, P1; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2002, CURR OPIN NEUROBIOL, V12, P455, DOI 10.1016/S0959-4388(02)00346-X; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Shinohara K, 2000, CHEM SENSES, V25, P465, DOI 10.1093/chemse/25.4.465; Sobel N, 1998, J NEUROSCI, V18, P8990; Sobel N, 1999, BRAIN, V122, P209, DOI 10.1093/brain/122.2.209; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0	20	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e8651	10.1371/journal.pone.0008651	http://dx.doi.org/10.1371/journal.pone.0008651			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174662	gold, Green Published, Green Submitted			2022-12-25	WOS:000274590600001
J	Katsuragawa, TH; Gil, LHS; Tada, MS; Silva, ADE; Costa, JDN; Araujo, MD; Escobar, AL; da Silva, LHP				Katsuragawa, Tony Hiroshi; Soares Gil, Luiz Herman; Tada, Mauro Shugiro; de Almeida e Silva, Alexandre; Neves Costa, Joana D'Arc; Araujo, Maisa da Silva; Escobar, Ana Lucia; Pereira da Silva, Luiz Hildebrando			The Dynamics of Transmission and Spatial Distribution of Malaria in Riverside Areas of Porto Velho, Rondonia, in the Amazon Region of Brazil	PLOS ONE			English	Article							COMPARATIVE SUSCEPTIBILITY; PLASMODIUM-FALCIPARUM; ASYMPTOMATIC CARRIERS; ANOPHELINE MOSQUITOS; HYPOENDEMIC MALARIA; HIGH PREVALENCE; ENDEMIC AREAS; URBAN; INFECTION; GAMBIAE	The study area in Rondonia was the site of extensive malaria epidemic outbreaks in the 19(th) and 20(th) centuries related to environmental impacts, with large immigration flows. The present work analyzes the transmission dynamics of malaria in these areas to propose measures for avoiding epidemic outbreaks due to the construction of two Hydroelectric Power Plants. A population based baseline demographic census and a malaria prevalence follow up were performed in two river side localities in the suburbs of Porto Velho city and in its rural vicinity. The quantification and nature of malaria parasites in clinical patients and asymptomatic parasite carriers were performed using microscopic and Real Time PCR methodologies. Anopheles densities and their seasonal variation were done by monthly captures for defining HBR (hourly biting rate) values. Main results: (i) malaria among residents show the riverside profile, with population at risk represented by children and young adults; (ii) asymptomatic vivax and falciparum malaria parasite carriers correspond to around 15% of adults living in the area; (iii) vivax malaria relapses were responsible for 30% of clinical cases; (iv) malaria risk for the residents was evaluated as 20-25% for vivax and 5-7% for falciparum malaria; (v) anopheline densities shown outdoors HBR values 5 to 10 fold higher than indoors and reach 10.000 bites/person/year; (vi) very high incidence observed in one of the surveyed localities was explained by a micro epidemic outbreak affecting visitors and temporary residents. Temporary residents living in tents or shacks are accessible to outdoors transmission. Seasonal fishermen were the main group at risk in the study and were responsible for a 2.6 fold increase in the malaria incidence in the locality. This situation illustrates the danger of extensive epidemic outbreaks when thousands of workers and secondary immigrant population will arrive attracted by opportunities opened by the Hydroelectric Power Plants constructions.	[Katsuragawa, Tony Hiroshi] Inst Pesquisas Patol Tropicais, Lab Epidemiol, Porto Velho, Rondonia, Brazil; [Soares Gil, Luiz Herman; de Almeida e Silva, Alexandre; Araujo, Maisa da Silva] Inst Pesquisas Patol Tropicais, Entomol Lab, Porto Velho, Rondonia, Brazil; [Neves Costa, Joana D'Arc; Pereira da Silva, Luiz Hildebrando] Inst Pesquisas Patol Tropicais, Mol Parasitol Lab, Porto Velho, Rondonia, Brazil; [Tada, Mauro Shugiro] Res Ctr Trop Med, Porto Velho, Rondonia, Brazil; [de Almeida e Silva, Alexandre] Fed Univ Rondonia, Dept Biol, Nucleo Ciencias & Tecnol, Porto Velho, Rondonia, Brazil; [Escobar, Ana Lucia] Fed Univ Rondonia, Dept Med, Nucleo Saude, Porto Velho, Rondonia, Brazil	Universidade Federal de Rondonia; Universidade Federal de Rondonia	Katsuragawa, TH (corresponding author), Inst Pesquisas Patol Tropicais, Lab Epidemiol, Porto Velho, Rondonia, Brazil.	hildebrando.pereira@yahoo.com.br	Silva, Alexandre A./A-6768-2008; Araujo, Maisa/AAJ-8827-2020; de Almeida e Silva, Alexandre/C-2597-2018; Costa, Joana D'Arc Neves/AAO-2140-2020	de Almeida e Silva, Alexandre/0000-0002-6500-0402; Neves Costa, Joana D'Arc/0000-0003-3675-742X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [410509/2006-0, 475097/2006]; Ministerio de Ciencia e Tecnologia, Brasil; Odebrecht Engenharia e Construcao	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio de Ciencia e Tecnologia, Brasil; Odebrecht Engenharia e Construcao	The present work was funded by contracts numbers 410509/2006-0 and 475097/2006 from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Ministerio de Ciencia e Tecnologia, Brasil, and funds from Odebrecht Engenharia e Construcao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; CAMARGO L, THESIS U DADE SAO PA; Camargo LMA, 1999, ACTA TROP, V72, P1, DOI 10.1016/S0001-706X(98)00082-5; Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS, P190; CONSTANTINI C, 1998, AM J TROP MED HYG, V58, P56; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; Deane L., 1992, REV SOC BRAS MED TRO, V25, P12; DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002; FORATTINI OP, 2002, CULICIDOLOGIA MED, V2, P139; Gil LHS, 2003, J MED ENTOMOL, V40, P636, DOI 10.1603/0022-2585-40.5.636; Katsuragawa Tony Hiroshi, 2008, Estud. av., V22, P111, DOI 10.1590/S0103-40142008000300008; Klein T.A., 1991, Revista da Sociedade Brasileira de Medicina Tropical, V24, P13, DOI 10.1590/S0037-86821991000100003; KLEIN TA, 1991, AM J TROP MED HYG, V44, P598, DOI 10.4269/ajtmh.1991.44.598; KLEIN TA, 1991, AM J TROP MED HYG, V45, P463, DOI 10.4269/ajtmh.1991.45.463; KLEIN TA, 1990, J AM MOSQUITO CONTR, V6, P700; LOURENCODEOLIVEIRA R, 1989, MEM I OSWALDO CRUZ, V84, P501, DOI 10.1590/S0074-02761989000400008; LourencodeOliveira R, 1996, MEM I OSWALDO CRUZ, V91, P687, DOI 10.1590/S0074-02761996000600005; MARCELO L, 1994, AM J TROP MED HYG, V51, P16, DOI 10.4269/ajtmh.1994.51.16; *MIN SAUD, 2008, GRUP TRAB CAPT MOSQ; Ministerio da Saude, 2006, AC CONTR MAL MAN PRO; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; SAWYER D R, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P342; Sawyer DR, 1988, FRONTIER MALARIA AMA; Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Gil LHS, 2007, MEM I OSWALDO CRUZ, V102, P271, DOI 10.1590/S0074-02762007005000013; Tada MS, 2007, MEM I OSWALDO CRUZ, V102, P263, DOI 10.1590/S0074-02762007005000012; Tadei Wanderli Pedro, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P87, DOI 10.1590/S0036-46652000000200005; TADEI WP, 1988, REV I MED TROP, V30, P221, DOI 10.1590/S0036-46651988000300017; TADEI WP, 1988, C SOC BRASILEIRA MED, V24, P26; TADEI WP, 1986, ACTA AMAZON, V16, P151; Tadei WP, 1993, BASES CIENTIFICAS ES, P167; VILLALOBOSSALCE.JM, 2000, MEM I O CRUZ, V95, P139; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191	37	34	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9245	10.1371/journal.pone.0009245	http://dx.doi.org/10.1371/journal.pone.0009245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169070	gold, Green Published, Green Submitted			2022-12-25	WOS:000274590500023
J	Starck, CS; Sutherland-Smith, AJ				Starck, Carlene S.; Sutherland-Smith, Andrew J.			Cytotoxic Aggregation and Amyloid Formation by the Myostatin Precursor Protein	PLOS ONE			English	Article							INCLUSION-BODY MYOSITIS; ENDOPLASMIC-RETICULUM STRESS; SKELETAL-MUSCLE; FIBRIL FORMATION; THIOFLAVIN-T; MYOBLAST PROLIFERATION; DEGENERATIVE DISEASES; MISFOLDING DISEASES; NEGATIVE REGULATOR; CRYSTAL-STRUCTURE	Myostatin, a negative regulator of muscle growth, has been implicated in sporadic inclusion body myositis (sIBM). sIBM is the most common age-related muscle-wastage disease with a pathogenesis similar to that of amyloid disorders such as Alzheimer's and Parkinson's diseases. Myostatin precursor protein (MstnPP) has been shown to associate with large molecular weight filamentous inclusions containing the Alzheimer's amyloid beta peptide in sIBM tissue, and MstnPP is upregulated following ER stress. The mechanism for how MstnPP contributes to disease pathogenesis is unknown. Here, we show for the first time that MstnPP is capable of forming amyloid fibrils in vitro. When MstnPP-containing Escherichia coli inclusion bodies are refolded and purified, a proportion of MstnPP spontaneously misfolds into amyloid-like aggregates as characterised by electron microscopy and binding of the amyloid-specific dye thioflavin T. When subjected to a slightly acidic pH and elevated temperature, the aggregates form straight and unbranched amyloid fibrils 15 nm in diameter and also exhibit higher order amyloid structures. Circular dichroism spectroscopy reveals that the amyloid fibrils are dominated by beta-sheet and that their formation occurs via a conformational change that occurs at a physiologically relevant temperature. Importantly, MstnPP aggregates and protofibrils have a negative effect on the viability of myoblasts. These novel results show that the myostatin precursor protein is capable of forming amyloid structures in vitro with implications for a role in sIBM pathogenesis.	[Starck, Carlene S.; Sutherland-Smith, Andrew J.] Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand	Massey University	Starck, CS (corresponding author), Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand.	A.J.Sutherland-Smith@massey.ac.nz	Sutherland-Smith, Andrew/F-1813-2011	Sutherland-Smith, Andrew/0000-0001-9485-1428	Tertiary Education Commission Top Achiever Doctoral and New Zealand Neuromuscular Alliance Henry Kelsey Scholarships; Massey University Research Fund; Palmerston North Medical Research Foundation	Tertiary Education Commission Top Achiever Doctoral and New Zealand Neuromuscular Alliance Henry Kelsey Scholarships; Massey University Research Fund; Palmerston North Medical Research Foundation	This work was funded by Tertiary Education Commission Top Achiever Doctoral and New Zealand Neuromuscular Alliance Henry Kelsey Scholarships to C.S.S. and grants from the Massey University Research Fund and the Palmerston North Medical Research Foundation to A.J.S.-S.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; Amthor H, 2006, DEV DYNAM, V235, P672, DOI 10.1002/dvdy.20680; Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Askanas V, 2008, ACTA NEUROPATHOL, V116, P583, DOI 10.1007/s00401-008-0449-0; Badtke MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.280pe43; Berry C, 2002, AM J PHYSIOL-CELL PH, V283, pC135, DOI 10.1152/ajpcell.00458.2001; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Bourhim M, 2007, J NEUROSCI METH, V160, P264, DOI 10.1016/j.jneumeth.2006.09.013; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calloni G, 2008, J AM CHEM SOC, V130, P13040, DOI 10.1021/ja8029224; Cash JN, 2009, EMBO J, V28, P2662, DOI 10.1038/emboj.2009.205; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; Durieux AC, 2007, ENDOCRINOLOGY, V148, P3140, DOI 10.1210/en.2006-1500; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; Funkenstein B, 2007, PROTEIN EXPRES PURIF, V54, P54, DOI 10.1016/j.pep.2007.02.002; Garlepp MJ, 2008, CURR OPIN RHEUMATOL, V20, P662, DOI 10.1097/BOR.0b013e328313644c; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Goda S, 2000, PROTEIN SCI, V9, P369; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004; Hartley DM, 2008, J BIOL CHEM, V283, P16790, DOI 10.1074/jbc.M802215200; Heiring C, 2001, PROTEIN ENG, V14, P183, DOI 10.1093/protein/14.3.183; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Jansen R, 2005, BIOPHYS J, V88, P1344, DOI 10.1529/biophysj.104.048843; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Jin HJ, 2004, PROTEIN EXPRES PURIF, V35, P1, DOI 10.1016/j.pep.2004.01.001; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Joulia-Ekaza D, 2006, EXP CELL RES, V312, P3458, DOI 10.1016/j.yexcr.2006.07.010; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Karpati G, 2009, ANN NEUROL, V65, P7, DOI 10.1002/ana.21622; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kumar S, 2007, J MOL BIOL, V367, P1186, DOI 10.1016/j.jmb.2007.01.039; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lee SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001628; Lee SJ, 2007, TRENDS GENET, V23, P475, DOI 10.1016/j.tig.2007.08.008; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x; Malisauskas M, 2005, J BIOL CHEM, V280, P6269, DOI 10.1074/jbc.M407273200; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; Marshall KE, 2009, BIOCHEM SOC T, V37, P671, DOI 10.1042/BST0370671; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; McNally EM, 2004, NEW ENGL J MED, V350, P2642, DOI 10.1056/NEJMp048124; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Meredith SC, 2005, ANN NY ACAD SCI, V1066, P181, DOI 10.1196/annals.1363.030; Mittl PRE, 1996, PROTEIN SCI, V5, P1261, DOI 10.1002/pro.5560050705; Nogalska A, 2007, EXP NEUROL, V204, P610, DOI 10.1016/j.expneurol.2006.12.014; Paschen W, 2003, CELL CALCIUM, V34, P365, DOI 10.1016/S0143-4160(03)00139-8; Patel K, 2005, NEUROMUSCULAR DISORD, V15, P117, DOI 10.1016/j.nmd.2004.10.018; Picotti P, 2007, J MOL BIOL, V367, P1237, DOI 10.1016/j.jmb.2007.01.072; Pratico D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Reumers J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S9; Rezaei-Ghaleh N, 2009, BIOPOLYMERS, V91, P28, DOI 10.1002/bip.21079; Sabate R, 2008, J STRUCT BIOL, V162, P387, DOI 10.1016/j.jsb.2008.02.002; Schreuder H, 2005, BIOCHEM BIOPH RES CO, V329, P1076, DOI 10.1016/j.bbrc.2005.02.078; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; SOTO C, 1995, J BIOL CHEM, V270, P3063, DOI 10.1074/jbc.270.7.3063; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Svane ASP, 2008, BIOPHYS J, V95, P366, DOI 10.1529/biophysj.107.122895; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Tobin JF, 2005, CURR OPIN PHARMACOL, V5, P328, DOI 10.1016/j.coph.2005.01.011; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Vattemi G, 2009, ACTA NEUROPATHOL, V117, P569, DOI 10.1007/s00401-009-0511-6; WAGNER K, 2002, ANN NEUROL, V52; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Wojcik S, 2007, NEUROPATH APPL NEURO, V33, P238, DOI 10.1111/j.1365-2990.2006.00821.x; Wojcik S, 2005, ACTA NEUROPATHOL, V110, P173, DOI 10.1007/s00401-005-1035-3; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525; [No title captured]	82	14	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9170	10.1371/journal.pone.0009170	http://dx.doi.org/10.1371/journal.pone.0009170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161792	Green Submitted, Green Published, gold			2022-12-25	WOS:000274442800016
J	Yuan, P; Kadara, H; Behrens, C; Tang, XM; Woods, D; Solis, LM; Huang, JT; Spinola, M; Dong, WL; Yin, GS; Fujimoto, J; Kim, E; Xie, Y; Girard, L; Moran, C; Hong, WK; Minna, JD; Wistuba, II				Yuan, Ping; Kadara, Humam; Behrens, Carmen; Tang, Ximing; Woods, Denise; Solis, Luisa M.; Huang, Jiaoti; Spinola, Monica; Dong, Wenli; Yin, Guosheng; Fujimoto, Junya; Kim, Edward; Xie, Yang; Girard, Luc; Moran, Cesar; Hong, Waun Ki; Minna, John D.; Wistuba, Ignacio I.			Sex Determining Region Y-Box 2 (SOX2) Is a Potential Cell-Lineage Gene Highly Expressed in the Pathogenesis of Squamous Cell Carcinomas of the Lung	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; BRANCHING MORPHOGENESIS; STEM-CELLS; CANCER; ONCOGENE	Background: Non-small cell lung cancer (NSCLC) represents the majority (85%) of lung cancers and is comprised mainly of adenocarcinomas and squamous cell carcinomas (SCCs). The sequential pathogenesis of lung adenocarcinomas and SCCs occurs through dissimilar phases as the former tumors typically arise in the lung periphery whereas the latter normally arise near the central airway. Methodology/Principal Findings: We assessed the expression of SOX2, an embryonic stem cell transcriptional factor that also plays important roles in the proliferation of basal tracheal cells and whose expression is restricted to the main and central airways and bronchioles of the developing and adult mouse lung, in NSCLC by various methodologies. Here, we found that SOX2 mRNA levels, from various published datasets, were significantly elevated in lung SCCs compared to adenocarcinomas (all p < 0.001). Moreover, a previously characterized OCT4/SOX2/NANOG signature effectively separated lung SCCs from adenocarcinomas in two independent publicly available datasets which correlated with increased SOX2 mRNA in SCCs. Immunohistochemical analysis of various histological lung tissue specimens demonstrated marked nuclear SOX2 protein expression in all normal bronchial epithelia, alveolar bronchiolization structures and premalignant lesions in SCC development (hyperplasia, dysplasia and carcinoma in situ) and absence of expression in all normal alveoli and atypical adenomatous hyperplasias. Moreover, SOX2 protein expression was greatly higher in lung SCCs compared to adenocarcinomas following analyses in two independent large TMA sets (TMA set I, n = 287; TMA set II, n = 511 both p < 0.001). Furthermore, amplification of SOX2 DNA was detected in 20% of lung SCCs tested (n = 40) and in none of the adenocarcinomas (n = 17). Conclusions/Significance: Our findings highlight a cell-lineage gene expression pattern for the stem cell transcriptional factor SOX2 in the pathogenesis of lung SCCs and suggest a differential activation of stem cell-related pathways between squamous cell carcinomas and adenocarcinomas of the lung.	[Yuan, Ping; Woods, Denise; Solis, Luisa M.; Moran, Cesar; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Kadara, Humam; Behrens, Carmen; Tang, Ximing; Fujimoto, Junya; Kim, Edward; Hong, Waun Ki; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Dong, Wenli; Yin, Guosheng] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Spinola, Monica; Girard, Luc; Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA; [Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Biostat, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yuan, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	iiwistuba@mdanderson.org	Yin, Guosheng/D-3214-2009	Yin, Guosheng/0000-0003-3276-1392; Huang, Jiaoti/0000-0003-1195-1998	Department of Defense [W81XWH-04-1-0142, W81XWH-07-1-03060]; Specialized Program of Research Excellence in Lung Cancer [P50CA70907]; National Cancer Institute [CA-16672]; NATIONAL CANCER INSTITUTE [P50CA070907, P30CA016672] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Specialized Program of Research Excellence in Lung Cancer; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by grants from the Department of Defense (W81XWH-04-1-0142 and W81XWH-07-1-03060 to W. K. H., J. D. M., I. I. W.) and by the Specialized Program of Research Excellence in Lung Cancer Grant P50CA70907 (J. D. M., I. I. W.) and Cancer Center Support Grant CA-16672 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Behrens C, 2008, CLIN CANCER RES, V14, P6014, DOI 10.1158/1078-0432.CCR-08-0167; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Simon R, 2007, CANCER INFORM, V3, P11; Tang XM, 2008, CANCER PREV RES, V1, P192, DOI 10.1158/1940-6207.CAPR-08-0032; Westra WH, 1996, CANCER RES, V56, P2224; Wistuba II, 2006, ANNU REV PATHOL-MECH, V1, P331, DOI 10.1146/annurev.pathol.1.110304.100103	20	103	105	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9112	10.1371/journal.pone.0009112	http://dx.doi.org/10.1371/journal.pone.0009112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161759	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442600010
J	Iwata, A; Morgan-Stevenson, V; Schwartz, B; Liu, L; Tupper, J; Zhu, XD; Harlan, J; Winn, R				Iwata, Akiko; Morgan-Stevenson, Vicki; Schwartz, Barbara; Liu, Li; Tupper, Joan; Zhu, Xiaodong; Harlan, John; Winn, Robert			Extracellular BCL2 Proteins Are Danger-Associated Molecular Patterns That Reduce Tissue Damage in Murine Models of Ischemia-Reperfusion Injury	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; BH4 DOMAIN; ANTIAPOPTOTIC PROTEIN; CEREBROSPINAL-FLUID; HEPATIC ISCHEMIA; CELL-DEATH; APOPTOSIS; EXPRESSION; SERUM; PEPTIDE	Background: Ischemia-reperfusion (I/R) injury contributes to organ dysfunction in a variety of clinical disorders, including myocardial infarction, stroke, organ transplantation, and hemorrhagic shock. Recent investigations have demonstrated that apoptosis as an important mechanism of cell death leading to organ dysfunction following I/R. Intracellular danger-associated molecular patterns (DAMPs) released during cell death can activate cytoprotective responses by engaging receptors of the innate immune system. Methodology/Principal Findings: Ischemia was induced in the mouse hind limb by tourniquet or in the heart by coronary artery ligation. Reperfusion injury of skeletal or cardiac muscle was markedly reduced by intraperitoneal or subcutaneous injection of recombinant human (rh)BCL2 protein or rhBCL2-related protein A1 (BCL2A1) (50 ng/g) given prior to ischemia or at the time of reperfusion. The cytoprotective activity of extracellular rhBCL2 or rhBCL2A1 protein was mapped to the BH4 domain, as treatment with a mutant BCL2 protein lacking the BH4 domain was not protective, whereas peptides derived from the BH4 domain of BCL2 or the BH4-like domain of BCL2A1 were. Protection by extracellular rhBCL2 or rhBCL2A1 was associated with a reduction in apoptosis in skeletal and cardiac muscle following I/R, concomitant with increased expression of endogenous mouse BCL2 (mBCL2) protein. Notably, treatment with rhBCL2A1 protein did not protect mice deficient in toll-like receptor-2 (TLR2) or the adaptor protein, myeloid differentiation factor-88 (MyD88). Conclusions/Significance: Treatment with cytokine-like doses of rhBCL2 or rhBCL2A1 protein or BH4-domain peptides reduces apoptosis and tissue injury following I/R by a TLR2-MyD88-dependent mechanism. These findings establish a novel extracellular cytoprotective activity of BCL2 BH4-domain proteins as potent cytoprotective DAMPs.	[Iwata, Akiko; Morgan-Stevenson, Vicki; Winn, Robert] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Schwartz, Barbara; Liu, Li; Tupper, Joan; Zhu, Xiaodong; Harlan, John] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Iwata, A (corresponding author), Univ Washington, Dept Surg, Seattle, WA 98195 USA.	jharlan@u.washington.edu			Seredigm Corporation; National Institutes of Health [GM66197, GM42686, GM071398, HL72262]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL072262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042686, R01GM071398, R01GM066197] Funding Source: NIH RePORTER	Seredigm Corporation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: Seredigm Corporation and National Institutes of Health grants GM66197 (RW), GM42686 (RW), GM071398 (JH), and HL72262 (JH) supported this work. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aprahamian CJ, 2008, PEDIATR CRIT CARE ME, V9, P105, DOI 10.1097/01.PCC.0000288717.44702.C0; Arumugam TV, 2009, SHOCK, V32, P4, DOI 10.1097/SHK.0b013e318193e333; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bilbao G, 1999, ANN SURG, V230, P185, DOI 10.1097/00000658-199908000-00008; Brocheriou V, 2000, J GENE MED, V2, P326, DOI 10.1002/1521-2254(200009/10)2:5<326::AID-JGM133>3.0.CO;2-1; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Camlica H, 2008, AM J CLIN ONCOL-CANC, V31, P585, DOI 10.1097/COC.0b013e318174dbd2; Cantara S, 2004, J VASC RES, V41, P202, DOI 10.1159/000077408; Cao YJ, 2002, GENE THER, V9, P415, DOI 10.1038/sj.gt.3301676; Carter WO, 1998, J APPL PHYSIOL, V85, P1676, DOI 10.1152/jappl.1998.85.5.1676; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; CHOI SS, 1995, ONCOGENE, V11, P1693; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Coopersmith CM, 1999, AM J PHYSIOL-GASTR L, V276, pG677, DOI 10.1152/ajpgi.1999.276.3.G677; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Fathi NA, 2006, CLIN EXP IMMUNOL, V146, P339, DOI 10.1111/j.1365-2249.2006.03219.x; FERRERA R, 1993, J MOL CELL CARDIOL, V25, P1091, DOI 10.1006/jmcc.1993.1121; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Hirotani M, 1999, J BIOL CHEM, V274, P20415, DOI 10.1074/jbc.274.29.20415; Hotchkiss RS, 2006, J IMMUNOL, V176, P5471, DOI 10.4049/jimmunol.176.9.5471; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Hua F, 2008, J NEUROIMMUNOL, V199, P75, DOI 10.1016/j.jneuroim.2008.05.009; Hua F, 2009, BRAIN RES, V1262, P100, DOI 10.1016/j.brainres.2009.01.018; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Iwata A, 2002, BLOOD, V100, P2077, DOI 10.1182/blood-2002-03-0752; Izuishi K, 2006, J IMMUNOL, V176, P7154, DOI 10.4049/jimmunol.176.12.7154; Karsan A, 1996, BLOOD, V87, P3089, DOI 10.1182/blood.V87.8.3089.bloodjournal8783089; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Klein D, 2004, BIOCHEM BIOPH RES CO, V323, P473, DOI 10.1016/j.bbrc.2004.08.116; Klune JR, 2008, J LEUKOCYTE BIOL, V83, P558, DOI 10.1189/jlb.0607406; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kyriakides C, 2000, J TRAUMA, V48, P32, DOI 10.1097/00005373-200001000-00006; Li CF, 2004, CARDIOVASC RES, V61, P538, DOI 10.1016/j.cardiores.2003.09.007; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; LIN EY, 1993, J IMMUNOL, V151, P1979; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Ono M, 2005, EUR J CARDIO-THORAC, V27, P117, DOI 10.1016/j.ejcts.2004.09.025; Oshiro T, 2002, J SURG RES, V103, P30, DOI 10.1006/jsre.2001.6313; Osman H G, 2007, Indian J Med Microbiol, V25, P323; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Protopsaltis J, 2007, MED PRIN PRACT, V16, P222, DOI 10.1159/000100394; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Rouhiainen A, 2007, J LEUKOCYTE BIOL, V81, P49, DOI 10.1189/jlb.0306200; Sakai T, 1999, J INTERF CYTOK RES, V19, P999, DOI 10.1089/107999099313208; Selzner M, 2002, J HEPATOL, V36, P218, DOI 10.1016/S0168-8278(01)00259-8; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Sugioka R, 2003, ONCOGENE, V22, P8432, DOI 10.1038/sj.onc.1207180; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Zhang H, 2000, J BIOL CHEM, V275, P11092, DOI 10.1074/jbc.275.15.11092	59	30	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9103	10.1371/journal.pone.0009103	http://dx.doi.org/10.1371/journal.pone.0009103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161703	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442500010
J	Nehra, R; Riggins, RB; Shajahan, AN; Zwart, A; Crawford, AC; Clarke, R				Nehra, Ruchi; Riggins, Rebecca B.; Shajahan, Ayesha N.; Zwart, Alan; Crawford, Anatasha C.; Clarke, Robert			BCL2 and CASP8 regulation by NF-kappa B differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells	FASEB JOURNAL			English	Article						apoptosis; autophagy; breast neoplasms; RELA; selective estrogen receptor modulators; tamoxifen	CYTOCHROME-C RELEASE; ESTROGEN-RECEPTOR; ACQUIRED-RESISTANCE; THERAPY RESISTANCE; FACTOR-I; ACTIVATION; EXPRESSION; APOPTOSIS; AUTOPHAGY; MCF-7	Resistance to endocrine therapies remains a major problem in the management of estrogen receptor-alpha (ER)-positive breast cancer. We show that inhibition of NF-kappa B (p65/RELA), either by overexpression of a mutant I kappa B (I kappa BSR) or a small-molecule inhibitor of NF-kappa B (parthenolide; IC50=500 nM in tamoxifen-resistant cells), synergistically restores sensitivity to 4-hydroxytamoxifen (4HT) in resistant MCF7/RR and MCF7/LCC9 cells and further sensitizes MCF-7 and MCF7/LCC1 control cells to 4HT. These effects are independent of changes in either cell cycle distribution or in the level of autophagy measured by inhibition of p62/SQSTM1 expression and cleavage of LC3. NF-kappa B inhibition restores the ability of 4HT to decrease BCL2 expression, increase mitochondrial membrane permeability, and induce a caspase-dependent apoptotic cell death in resistant cells. Each of these effects is reversed by a caspase 8 (CASP8)-specific inhibitor that blocks enzyme-substrate binding. Thus, increased activation of NF-kappa B can alter sensitivity to tamoxifen by modulating CASP8 activity, with consequent effects on BCL2 expression, mitochondrial function, and apoptosis. These data provide significant new insights into how molecular signaling affects antiestrogen responsiveness and strongly suggest that a combination of parthenolide and tamoxifen may offer a novel therapeutic approach to the management of some ER-positive breast cancers.-Nehra, R., Riggins, R. B., Shajahan, A. N., Zwart, A., Crawford, A. C., Clarke, R. BCL2 and CASP8 regulation by NF-kappa B differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells. FASEB J. 24, 2040-2055 (2010). www.fasebj.org	[Nehra, Ruchi; Riggins, Rebecca B.; Shajahan, Ayesha N.; Zwart, Alan; Crawford, Anatasha C.; Clarke, Robert] Georgetown Univ, Dept Oncol, Sch Med, Washington, DC 20057 USA; [Nehra, Ruchi; Riggins, Rebecca B.; Shajahan, Ayesha N.; Zwart, Alan; Crawford, Anatasha C.; Clarke, Robert] Georgetown Univ, Lombardi Comprehens Canc Ctr, Sch Med, Washington, DC 20057 USA; [Clarke, Robert] Georgetown Univ, Dept Physiol & Biophys, Sch Med, Washington, DC 20057 USA	Georgetown University; Georgetown University; Georgetown University	Clarke, R (corresponding author), Georgetown Univ, Dept Oncol, Sch Med, Rm W405A Res Bldg,3970 Reservoir Rd NW, Washington, DC 20057 USA.	clarker@georgetown.edu	Riggins, Rebecca/GQH-4466-2022; Clarke, Robert/A-6485-2008	Clarke, Robert/0000-0002-9278-0854; Riggins, Rebecca/0000-0002-1555-4431; Shajahan-Haq, Ayesha/0000-0001-7616-320X; Zwart, Alan/0000-0001-6834-9290	U.S. Army [W81XWH-04-1-0378, W81XWH-04-1-0570]; U.S. Department of Health and Human Services, National Institutes of Health [R01-CA131465, R21-CA139246]; NATIONAL CANCER INSTITUTE [R01CA131465, R21CA139246] Funding Source: NIH RePORTER	U.S. Army(United States Department of DefenseUnited States Army); U.S. Department of Health and Human Services, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Department of Defense Awards W81XWH-04-1-0378 and W81XWH-04-1-0570 from the U.S. Army Medical Research and Materiel Command and R01-CA131465 and R21-CA139246 from the U.S. Department of Health and Human Services, National Institutes of Health. Technical services were provided by the Lombardi Comprehensive Cancer Center Flow Cytometry and Cell Sorting and Macromolecular Shared Resources. The authors thank Dr. Marty Mayo (University of Virginia, Charlottesville, VA, USA) for providing the empty pCMV4 and the S32/36A mutant pCMV4-FLAG I kappa B alpha (I kappa BSR) plasmids. The authors also thank Drs. Stephen Byers, Dean Rosenthal, Thomas G. Sherman, and Bassem R. Haddad for thoughtful comments in carrying out this research.	Bachleitner-Hofmann T, 2002, CLIN CANCER RES, V8, P3427; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Bouker KB, 2004, CANCER RES, V64, P4030, DOI 10.1158/0008-5472.CAN-03-3602; BRUNNER N, 1993, CANCER RES, V53, P3229; Brunner N, 1997, CANCER RES, V57, P3486; BRUNNER N, 1993, CANCER RES, V53, P283; BUTLER WB, 1992, CANCER RES, V52, P6164; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Clarke R, 2001, PHARMACOL REV, V53, P25; Clarke R, 2009, J STEROID BIOCHEM, V114, P8, DOI 10.1016/j.jsbmb.2008.12.023; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Crawford AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008604; Curry EA, 2004, INVEST NEW DRUG, V22, P299, DOI 10.1023/B:DRUG.0000026256.38560.be; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Drew PD, 1995, J INTERF CYTOK RES, V15, P1037, DOI 10.1089/jir.1995.15.1037; ENCARNACION CA, 1993, BREAST CANCER RES TR, V26, P237, DOI 10.1007/BF00665801; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Goonesinghe A, 2005, BIOCHEM J, V387, P109, DOI 10.1042/BJ20041389; Gu ZP, 2002, CANCER RES, V62, P3428; Hehner SP, 1998, J BIOL CHEM, V273, P1288, DOI 10.1074/jbc.273.3.1288; HOWELL A, 1995, LANCET, V345, P29, DOI 10.1016/S0140-6736(95)91156-1; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kim DW, 2000, CARCINOGENESIS, V21, P871, DOI 10.1093/carcin/21.5.871; Kim KY, 2008, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2008/01/002; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuske B, 2006, ENDOCR-RELAT CANCER, V13, P1121, DOI 10.1677/erc.1.01257; Kuukasjarvi T, 1996, J CLIN ONCOL, V14, P2584, DOI 10.1200/JCO.1996.14.9.2584; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lilling G, 2000, CANCER LETT, V161, P27, DOI 10.1016/S0304-3835(00)00579-6; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Nakshatri H, 2004, ONCOGENE, V23, P7330, DOI 10.1038/sj.onc.1207995; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Patel NM, 2000, ONCOGENE, V19, P4159, DOI 10.1038/sj.onc.1203768; Pratt MAC, 2003, MOL CELL BIOL, V23, P6887, DOI 10.1128/MCB.23.19.6887-6900.2003; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; Riggins RB, 2005, VITAM HORM, V71, P201, DOI 10.1016/S0083-6729(05)71007-4; Riggins RB, 2005, MOL CANCER THER, V4, P33; Romanelli S, 1998, CANCER CHEMOTH PHARM, V41, P385, DOI 10.1007/s002800050755; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; TAYLOR IW, 1983, CANCER RES, V43, P4007; TEIXEIRA C, 1995, CANCER RES, V55, P3902; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Viatour P, 2003, LEUKEMIA, V17, P1349, DOI 10.1038/sj.leu.2402982; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Wen J, 2002, J BIOL CHEM, V277, P38954, DOI 10.1074/jbc.M203842200; Zhou F, 2007, IET RADAR SONAR NAV, V1, P59, DOI 10.1049/iet-rsn:20060040	52	66	71	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					2040	2055		10.1096/fj.09-138305	http://dx.doi.org/10.1096/fj.09-138305			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20154269	Green Published			2022-12-25	WOS:000278200000038
J	Gustafson, B; Smith, U				Gustafson, Birgit; Smith, Ulf			Activation of Canonical Wingless-type MMTV Integration Site Family (Wnt) Signaling in Mature Adipocytes Increases beta-Catenin Levels and Leads to Cell Dedifferentiation and Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; MESENCHYMAL STEM-CELLS; TNF-ALPHA; RECEPTOR-GAMMA; PPAR-GAMMA; GENE-EXPRESSION; BONE MASS; DIFFERENTIATION; ADIPOGENESIS; PATHWAY	Canonical Wnt ligands are secreted by several cell types in the adipose tissue. We examined if mature adipocytes can also be target cells and found that canonical Wnt activation by Wnt3a induced a marked dedifferentiation of both 3T3-L1 and human adipocytes. Typical adipogenic markers were reduced while undifferentiated cell markers like Pref-1/Dlk1, Wnt10b, and Gata2 were increased. The cells also became insulin-resistant with impaired upstream insulin signaling and reduced glucose uptake. Wnt3a stabilized beta-catenin in the absence of the LRP6 receptor and with maintained axin and Dickkopf-1 protein expression. PPAR gamma was repressed and PPAR gamma ligands could not restore the adipogenic markers or reduce the beta-catenin levels. The dedifferentiated adipocytes expressed the myofibroblast marker alpha-smooth muscle actin and were also susceptible to osteogenic transdifferentiation. These results identify a novel pathway in mature adipose cells that is critical for maintaining the normal adipocyte phenotype and insulin sensitivity.	[Gustafson, Birgit; Smith, Ulf] Gothenburg Univ, Lundberg Lab Diabet Res, Ctr Excellence Metab & Cardiovasc Res, Dept Mol & Clin Med,Sahlgrenska Acad, S-41345 Gothenburg, Sweden	University of Gothenburg	Smith, U (corresponding author), Sahlgrens Univ Hosp, Dept Mol & Clin Med, Vita Straket 12 L, S-41345 Gothenburg, Sweden.	ulf.smith@medic.gu.se			Swedish Research Council; Swedish Diabetes Association; Novo Nordisk Foundation; Swedish Foundation for Strategic Research; Torsten and Ragnar Sorderberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Torsten and Ragnar Sorderberg Foundation	This work was supported by the Swedish Research Council, the Swedish Diabetes Association, the Novo Nordisk Foundation, the Swedish Foundation for Strategic Research, and the Torsten and Ragnar Sorderberg Foundation.	Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bowers RR, 2007, CELL CYCLE, V6, P385, DOI 10.4161/cc.6.4.3804; Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Chen SQ, 2007, J CELL COMMUN SIGNAL, V1, P175, DOI 10.1007/s12079-007-0015-x; Dubois SG, 2006, OBESITY, V14, P1543, DOI 10.1038/oby.2006.178; Fujishiro M, 2003, MOL ENDOCRINOL, V17, P487, DOI 10.1210/me.2002-0131; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gregory CA, 2005, ANN NY ACAD SCI, V1049, P97, DOI 10.1196/annals.1334.010; Guo YF, 2006, J MED GENET, V43, P798, DOI 10.1136/jmg.2006.041715; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Hammarstedt A, 2007, BIOCHEM BIOPH RES CO, V357, P700, DOI 10.1016/j.bbrc.2007.03.202; Hirobe T, 2010, J DERMATOL SCI, V57, P123, DOI 10.1016/j.jdermsci.2009.11.006; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Huang XY, 2008, DIABETES, V57, P77, DOI 10.2337/db07-0599; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jansson EA, 2005, P NATL ACAD SCI USA, V102, P1460, DOI 10.1073/pnas.0405928102; Jansson PA, 2003, FASEB J, V17, P1434, DOI 10.1096/fj.02-1132com; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Katoh M, 2005, ONCOL REP, V14, P1583; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kim SE, 2007, CELL SIGNAL, V19, P511, DOI 10.1016/j.cellsig.2006.08.008; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Maeda S, 2002, J CELL PHYSIOL, V193, P73, DOI 10.1002/jcp.10151; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Prins JB, 1997, DIABETES, V46, P1939, DOI 10.2337/diabetes.46.12.1939; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; Sharma C, 2004, J BIOL CHEM, V279, P16927, DOI 10.1074/jbc.M309045200; Smas CM, 1998, J BIOL CHEM, V273, P31751, DOI 10.1074/jbc.273.48.31751; STEPHENS JM, 1992, J BIOL CHEM, V267, P13580; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tickenbrock L, 2006, J LEUKOCYTE BIOL, V79, P1306, DOI 10.1189/jlb.0905539; Vertino AM, 2005, MOL BIOL CELL, V16, P2039, DOI 10.1091/mbc.E04-08-0720; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 2002, ENDOCRINOLOGY, V143, P1502, DOI 10.1210/en.143.4.1502; Yang XL, 2004, BIOCHEM BIOPH RES CO, V317, P1045, DOI 10.1016/j.bbrc.2004.03.152; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3	49	62	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					14031	14041		10.1074/jbc.M110.102855	http://dx.doi.org/10.1074/jbc.M110.102855			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20179324	hybrid, Green Published			2022-12-25	WOS:000276987700076
J	Qiu, JM; Xiao, JF; Han, CF; Li, N; Shen, X; Jiang, HL; Cao, XT				Qiu, Jianming; Xiao, Jianfeng; Han, Chaofeng; Li, Nan; Shen, Xu; Jiang, Hualiang; Cao, Xuetao			Potentiation of Tumor Necrosis Factor-alpha-induced Tumor Cell Apoptosis by a Small Molecule Inhibitor for Anti-apoptotic Protein hPEBP4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN; TRAIL-INDUCED APOPTOSIS; BREAST-CANCER CELLS; NF-KAPPA-B; SIGNAL-TRANSDUCTION; TNF SUPERFAMILY; DRUG DISCOVERY; IN-VITRO; ACTIVATION; PATHWAYS	hPEBP4 (human phosphatidylethanolamine-binding protein 4) has been identified to be able to potentiate the resistance of breast, prostate, and ovarian cancers, with the preferential expression of hPEBP4, to tumor necrosis factor-alpha (TNF-alpha) or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis, suggesting that inhibitors targeting the anti-apoptotic protein hPEBP4 may be useful to increase the sensitivity of hPEBP4-expressing cancer cells to TNF-alpha or TRAIL-induced apoptosis. By structure-based virtual screening and following surface plasmon resonance-based binding assay, seven small compounds were found to potently bind with hPEBP4. The hit compounds were further functionally screened for their ability to inhibit cancer cell growth, and one small compound, IOI-42, was identified to be able to promote TNF-alpha-mediated growth inhibition of MCF-7 breast cancer cells. IOI-42 could potentiate TNF-alpha-induced apoptosis of MCF-7 cells by inhibiting hPEBP4 and could suppress anchorage-independent cell growth of MCF-7 cells. We further demonstrated that IOI-42 could reduce the endogenous association of hPEBP4 with Raf-1/MEK1 and enhance the activation of ERK1/2 and JNK while inhibiting Akt activation. Furthermore, IOI-42 also promoted TRAIL-induced cell apoptosis of prostate cancer cells. Taken together, our data suggest that IOI-42, as the first chemical inhibitor of anti-apoptotic protein hPEBP4, may serve as a potential anti-tumor drug by sensitizing tumor cells to apoptotic inducers.	[Xiao, Jianfeng; Shen, Xu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Qiu, Jianming; Han, Chaofeng; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Qiu, Jianming; Han, Chaofeng; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Qiu, Jianming; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Naval Medical University; Naval Medical University; Zhejiang University	Jiang, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China.	hljiang@mail.shcnc.ac.cn; caoxt@immunol.org			National High Biotechnology Development Program of China [2009ZX09503-003, 2009AA02Z101, 2006AA02A305]; National Natural Science Foundation of China [30721091, 30772504]; National Key Basic Research Program of China [2010CB911903]; Shanghai Committee of Science and Technology [09QH1402800, 09SG35]	National High Biotechnology Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by grants from the National High Biotechnology Development Program of China (2009ZX09503-003, 2009AA02Z101, and 2006AA02A305), the National Natural Science Foundation of China (30721091 and 30772504), the National Key Basic Research Program of China (2010CB911903), and the Shanghai Committee of Science and Technology (09QH1402800 and 09SG35).	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal Bharat B., 2002, Current Drug Targets - Inflammation and Allergy, V1, P327, DOI 10.2174/1568010023344571; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Banfield MJ, 1998, STRUCTURE, V6, P1245, DOI 10.1016/S0969-2126(98)00125-7; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chen LL, 2005, J VIROL, V79, P7095, DOI 10.1128/JVI.79.11.7095-7103.2005; Cooper MA, 2002, NAT REV DRUG DISCOV, V1, P515, DOI 10.1038/nrd838; Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann D, 1999, J MED CHEM, V42, P4422, DOI 10.1021/jm991090p; Jana S, 2007, CURR MED CHEM, V14, P2369, DOI 10.2174/092986707781745569; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Lejeune Ferdy J, 2006, Cancer Immun, V6, P6; Li HZ, 2007, J BIOL CHEM, V282, P4943, DOI 10.1074/jbc.M609494200; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li N, 2007, CANCER RES, V67, P11176, DOI 10.1158/0008-5472.CAN-07-2333; Li N, 2009, J BIOL CHEM, V284, P3021, DOI 10.1074/jbc.M805483200; Li P, 2006, INT J MOL MED, V18, P505; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Park H, 2006, PROTEINS, V65, P549, DOI 10.1002/prot.21183; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi RX, 2004, ONCOGENE, V23, P7712, DOI 10.1038/sj.onc.1208046; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Van Molle W, 2002, IMMUNITY, V16, P685, DOI 10.1016/S1074-7613(02)00310-2; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang CM, 2008, J BIOL CHEM, V283, P11565, DOI 10.1074/jbc.M800436200; Wang XJ, 2005, CLIN CANCER RES, V11, P7545, DOI 10.1158/1078-0432.CCR-05-0879; Wang XJ, 2004, J BIOL CHEM, V279, P45855, DOI 10.1074/jbc.M405147200; Zhang YY, 2007, INT J MOL MED, V19, P55; Zheng SX, 2005, J CHEM INF MODEL, V45, P856, DOI 10.1021/ci050031j	38	25	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12241	12247		10.1074/jbc.M110.111898	http://dx.doi.org/10.1074/jbc.M110.111898			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177075	Green Published, hybrid			2022-12-25	WOS:000276787100053
J	Hanson, KA; Kim, SH; Wassarman, DA; Tibbetts, RS				Hanson, Keith A.; Kim, Sang Hwa; Wassarman, David A.; Tibbetts, Randal S.			Ubiquilin Modifies TDP-43 Toxicity in a Drosophila Model of Amyotrophic Lateral Sclerosis (ALS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; FUNCTIONAL IMPLICATIONS; MUTATIONS; NEURODEGENERATION; PROTEASOME; PROTEINS; PHOSPHORYLATION; IDENTIFICATION; PRESENILIN; MOUSE	TDP-43 (43-kDa TAR DNA-binding protein) is a major constituent of ubiquitin-positive cytosolic aggregates present in neurons of patients with amyotrophic lateral sclerosis (ALS) and ubiquitin-positive fronto-temporal lobar degeneration (FTLD-U). Inherited mutations in TDP-43 have been linked to familial forms of ALS, indicating a key role for TDP-43 in disease pathogenesis. Here, we describe a Drosophila melanogaster model of TDP-43 proteinopathy. Expression of wild-type human TDP-43 protein in Drosophila motor neurons led to motor dysfunction and dramatic reduction of life span. Interestingly, coexpression of ubiquilin 1, a previously identified TDP-43-interacting protein with suspected functions in autophagy and proteasome targeting, reduced steady-state TDP-43 expression but enhanced the severity of TDP-43 phenotypes. Finally, ectopically expressed TDP-43 was largely localized to motor neuron nuclei, suggesting that expression of wild-type TDP-43 alone is detrimental even in the absence of cytosolic aggregation. Our findings demonstrate that TDP-43 exerts cell-autonomous neurotoxicity in Drosophila and further imply that dose-dependent alterations of TDP-43 nuclear function may underlie motor neuron death in ALS.	[Hanson, Keith A.; Kim, Sang Hwa; Wassarman, David A.; Tibbetts, Randal S.] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	National Institutes of Health [CA124722, NS059001]; American Cancer Society; Greater Milwaukee Foundation; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Greater Milwaukee Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA124722 (to R. S. T.) and NS059001 (to D. A. W.). This work was also supported by grants from the American Cancer Society and a Shaw Scientist Award from the Greater Milwaukee Foundation (to R. S. T.).	Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Banks GT, 2008, MAMM GENOME, V19, P299, DOI 10.1007/s00335-008-9117-x; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Ganguly A, 2008, HUM MOL GENET, V17, P293, DOI 10.1093/hmg/ddm305; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kim SH, 2009, J BIOL CHEM, V284, P8083, DOI 10.1074/jbc.M808064200; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Mitsumoto H., 1998, AMYOTROPHIC LATERAL; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; R Development Core Team, 2009, R FDN STAT COMP; Rasband W, 2009, IMAGEJ; Rimkus SA, 2008, GENE DEV, V22, P1205, DOI 10.1101/gad.1639608; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; THERNEAU T, 2009, SURVIVAL R PACKAGE V; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930	31	107	108	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11068	11072		10.1074/jbc.C109.078527	http://dx.doi.org/10.1074/jbc.C109.078527			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154090	hybrid, Green Published			2022-12-25	WOS:000276286200009
J	Kee, Y; Yang, KL; Cohn, MA; Haas, W; Gygi, SP; D'Andrea, AD				Kee, Younghoon; Yang, Kailin; Cohn, Martin A.; Haas, Wilhelm; Gygi, Steven P.; D'Andrea, Alan D.			WDR20 Regulates Activity of the USP12 center dot UAF1 Deubiquitinating Enzyme Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FANCONI-ANEMIA PATHWAY; PROTEASOME; UCH37; SUBUNIT	The UAF1 (Usp1-associated factor 1) protein binds and stimulates three deubiquitinating enzymes: USP1, USP12, and USP46. Although the USP1 center dot UAF1 complex is required for regulation of the Fanconi anemia (FA) DNA repair pathway, less is known about the USP12 center dot UAF1 and the USP46 center dot UAF1 complexes. To understand further the nature of the USP12 and USP46 complexes, we attempted to identify proteins that interact with the USP12 and USP46 deubiquitinating enzyme complexes. We identified WDR20, a WD40-repeat containing protein, as a common binding partner of UAF1, USP12, and USP46. Further analysis showed that WDR20 associates exclusively with USP12 and USP46, not with USP1. Furthermore, we demonstrate the purification of a ternary USP12 center dot UAF1 center dot WDR20 complex. Interestingly, and consistent with the binding assays, WDR20 stimulated the enzymatic activity of USP12 center dot UAF1, but not of USP1 center dot UAF1. Consistent with our previous report that USP12 and USP46 do not regulate the FA pathway, small interference RNA-mediated depletion of WDR20 protein did not affect the FA pathway or DNA damage responses. We provide a model in which WDR20 serves as a stimulatory subunit for preserving and regulating the activity of the subset of the UAF1 center dot USP complexes.	[Kee, Younghoon; Yang, Kailin; Cohn, Martin A.; D'Andrea, Alan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Yang, Kailin] Harvard Univ, Sch Med, Leder Human Biol Program, Biol & Biomed Sci Program, Boston, MA 02115 USA; [Haas, Wilhelm; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	D'Andrea, AD (corresponding author), 44 Binney St, Boston, MA 02115 USA.	alan_dandrea@dfci.harvard.edu	Classen, Scott/AAY-8176-2020; Yang, Kailin/L-2205-2013; Yang, Kailin/D-7966-2013; Kee, Younghoon/J-4107-2019	Yang, Kailin/0000-0001-5968-6738; Cohn, Martin/0000-0002-2988-3009	National Institutes of Health [R01DK43889, R01HL52725, P01CA092584, U19A1067751]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL052725, R01HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK43889, R01HL52725, P01CA092584, and U19A1067751.	Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; KON N, 2009, ONCOGENE        1130, DOI DOI 10.1038/ONC.2009.427; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lockington RA, 2002, MOL MICROBIOL, V43, P1173, DOI 10.1046/j.1365-2958.2002.02811.x; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460	21	71	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11252	11257		10.1074/jbc.M109.095141	http://dx.doi.org/10.1074/jbc.M109.095141			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147737	Green Published, hybrid			2022-12-25	WOS:000276286200031
J	D'Amato, M; Zucchelli, M; Seddighzadeh, M; Anedda, F; Lindblad, S; Kere, J; Alfredsson, L; Klareskog, L; Padyukov, L				D'Amato, Mauro; Zucchelli, Marco; Seddighzadeh, Maria; Anedda, Francesca; Lindblad, Staffan; Kere, Juha; Alfredsson, Lars; Klareskog, Lars; Padyukov, Leonid			Analysis of Neuropeptide S Receptor Gene (NPSR1) Polymorphism in Rheumatoid Arthritis	PLOS ONE			English	Article							ASSOCIATION; SUSCEPTIBILITY; POPULATION; DISEASE; LOCUS; 6Q23; RISK	Background: Polymorphism in the neuropeptide S receptor gene NPSR1 is associated with asthma and inflammatory bowel disease. NPSR1 is expressed in the brain, where it modulates anxiety and responses to stress, but also in other tissues and cell types including lymphocytes, the lungs, and the intestine, where it appears to be up-regulated in inflammation. We sought to determine whether genetic variability at the NPSR1 locus influences the susceptibility and clinical manifestation of rheumatoid arthritis (RA). Methodology/Principal Findings: From the Epidemiological Investigation of Rheumatoid Arthritis (EIRA) case-control study, 1,888 rheumatoid arthritis patients and 888 controls were genotyped for 19 single-nucleotide polymorphisms (SNPs) spanning the entire NPSR1 gene and 220 KB of DNA on chromosome 7p14. The association between individual genetic markers and their haplotypic combinations, respectively, and diagnosis of RA, presence of autoantibodies to citrullinated proteins (ACPA), and disease activity score based on 28 joints (DAS28) was tested. There was no association between diagnosis of RA and NPSR1 variants. However, several associations of nominal significance were detected concerning susceptibility to ACPA-negative RA and disease activity measures (DAS28). Among these, the association of SNP rs324987 with ACPA-negative RA [(p = 0.004, OR = 0.674 (95% CI 0.512-0.888)] and that of SNP rs10263447 with DAS28 [p = 0.0002, OR = 0.380 (95% CI 0.227-0.635)] remained significant after correction for multiple comparisons. Conclusions/Significance: NPSR1 polymorphism may be relevant to RA susceptibility and its clinical manifestation. Specific alleles at the NPSR1 locus may represent common risk factors for chronic inflammatory diseases, including RA.	[D'Amato, Mauro; Zucchelli, Marco; Anedda, Francesca; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, S-10401 Stockholm, Sweden; [Seddighzadeh, Maria; Lindblad, Staffan; Klareskog, Lars; Padyukov, Leonid] Karolinska Inst, Dept Med, S-10401 Stockholm, Sweden; [Anedda, Francesca] CNR, Inst Neurogenet & Neuropharmacol, Monserrato, Italy; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Consiglio Nazionale delle Ricerche (CNR); Karolinska Institutet	D'Amato, M (corresponding author), Karolinska Inst, Dept Biosci & Nutr, S-10401 Stockholm, Sweden.	leonid.padyukov@ki.se	D'Amato, Mauro/B-5050-2019; Alfredsson, Lars/AAC-9007-2019; D'Amato, Mauro/F-2450-2010; Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021; Padyukov, Leonid/A-4890-2009	D'Amato, Mauro/0000-0003-2743-5197; Alfredsson, Lars/0000-0003-1688-6697; D'Amato, Mauro/0000-0003-2743-5197; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Padyukov, Leonid/0000-0003-2950-5670; Klareskog, Lars/0000-0001-9601-6186	Swedish Medical Research Council; Swedish Rheumatism Foundation; AFA Insurance; National Institutes of Allergy and Infectious Diseases [AI067152]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152] Funding Source: NIH RePORTER	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Rheumatism Foundation; AFA Insurance; National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Swedish Medical Research Council, the Swedish Rheumatism Foundation, AFA Insurance, and the National Institutes of Allergy and Infectious Diseases (AI067152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bernier V, 2006, J BIOL CHEM, V281, P24704, DOI 10.1074/jbc.M603691200; D'Amato M, 2007, GASTROENTEROLOGY, V133, P808, DOI 10.1053/j.gastro.2007.06.012; Feng Y, 2006, J ALLERGY CLIN IMMUN, V117, P612, DOI 10.1016/j.jaci.2005.11.045; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Lorentzen JC, 2007, ARTHRITIS RHEUM-US, V56, P2620, DOI 10.1002/art.22813; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Pulkkinen V, 2006, HUM MOL GENET, V15, P1667, DOI 10.1093/hmg/ddl090; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Reinscheid Rainer K., 2008, V46, P145, DOI 10.1007/400_2007_051; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Sigurdsson S, 2007, ARTHRITIS RHEUM-US, V56, P2202, DOI 10.1002/art.22704; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; van der Helm-van Mil AHM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2384; Vendelin J, 2006, HUM MOL GENET, V15, P2923, DOI 10.1093/hmg/ddl234; Verpoort KN, 2005, ARTHRITIS RHEUM, V52, P3058, DOI 10.1002/art.21302	19	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9315	10.1371/journal.pone.0009315	http://dx.doi.org/10.1371/journal.pone.0009315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179762	Green Published, Green Submitted, gold			2022-12-25	WOS:000274923900004
J	Pan, RK; Chatterjee, N; Sinha, S				Pan, Raj Kumar; Chatterjee, Nivedita; Sinha, Sitabhra			Mesoscopic Organization Reveals the Constraints Governing Caenorhabditis elegans Nervous System	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SMALL-WORLD; HIERARCHICAL ORGANIZATION; MODULAR ORGANIZATION; CONNECTIVITY; NETWORKS; INTEGRATION; NEMATODE; OPTIMIZATION; CENTRALITY	One of the biggest challenges in biology is to understand how activity at the cellular level of neurons, as a result of their mutual interactions, leads to the observed behavior of an organism responding to a variety of environmental stimuli. Investigating the intermediate or mesoscopic level of organization in the nervous system is a vital step towards understanding how the integration of micro-level dynamics results in macro-level functioning. The coordination of many different co-occurring processes at this level underlies the command and control of overall network activity. In this paper, we have considered the somatic nervous system of the nematode Caenorhabditis elegans, for which the entire neuronal connectivity diagram is known. We focus on the organization of the system into modules, i.e., neuronal groups having relatively higher connection density compared to that of the overall network. We show that this mesoscopic feature cannot be explained exclusively in terms of considerations such as, optimizing for resource constraints (viz., total wiring cost) and communication efficiency (i.e., network path length). Even including information about the genetic relatedness of the cells cannot account for the observed modular structure. Comparison with other complex networks designed for efficient transport (of signals or resources) implies that neuronal networks form a distinct class. This suggests that the principal function of the network, viz., processing of sensory information resulting in appropriate motor response, may be playing a vital role in determining the connection topology. Using modular spectral analysis we make explicit the intimate relation between function and structure in the nervous system. This is further brought out by identifying functionally critical neurons purely on the basis of patterns of intra-and inter-modular connections. Our study reveals how the design of the nervous system reflects several constraints, including its key functional role as a processor of information.	[Pan, Raj Kumar; Sinha, Sitabhra] Inst Math Sci, Madras 600113, Tamil Nadu, India; [Chatterjee, Nivedita] Sankara Nethralaya, Vis Res Fdn, Madras, Tamil Nadu, India	Institute of Mathematical Sciences (IMSc) India	Pan, RK (corresponding author), Inst Math Sci, Madras 600113, Tamil Nadu, India.	sitabhra@imsc.res.in	Pan, Raj Kumar/B-4352-2010	Pan, Raj Kumar/0000-0001-9803-6332; Sinha, Sitabhra/0000-0002-3004-1079	Complex Systems Project (XI Plan); Department of Atomic Energy, Government of India	Complex Systems Project (XI Plan); Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	This work was funded by the Complex Systems Project (XI Plan), Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2006, PHYSICA A, V367, P531, DOI 10.1016/j.physa.2005.12.013; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arenas A, 2008, LECT NOTES COMPUT SC, V5151, P9; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Bany IA, 2003, J NEUROSCI, V23, P8060; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cancho RFI, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046119; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chatterjee N, 2008, PROG BRAIN RES, V168, P145, DOI 10.1016/S0079-6123(07)68012-1; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; Costa LD, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-16; Daniels SA, 2000, GENETICS, V156, P123; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; DEPPE U, 1978, P NATL ACAD SCI USA, V75, P376, DOI 10.1073/pnas.75.1.376; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Franks Christopher J., 2006, Invertebrate Neuroscience, V6, P105, DOI 10.1007/s10158-006-0023-1; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.017101; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hobert O, 2005, SPECIFICATION NERVOU; HOFMAN MA, 1988, BRAIN BEHAV EVOLUT, V32, P17, DOI 10.1159/000116529; Horwitz B, 1995, NEUROREPORT, V6, P2287, DOI 10.1097/00001756-199511270-00005; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Itzkovitz S, 2008, P NATL ACAD SCI USA, V105, P9278, DOI 10.1073/pnas.0712207105; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kim BJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.045101; Klemm K, 2005, P NATL ACAD SCI USA, V102, P18414, DOI 10.1073/pnas.0509132102; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Kuncheva LI, 2004, IEEE SYS MAN CYBERN, P1214; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Morris R., 2007, HIPPOCAMPUS BOOK; Muller-Linow M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000190; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Pan RK, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.045103; Pan RK, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/68006; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Perez-Escudero A, 2007, P NATL ACAD SCI USA, V104, P17180, DOI 10.1073/pnas.0703183104; Reigl M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-25; RIDDLE DL, C ELEGANS, V2; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Sawin E. R., 1996, THESIS MIT CAMBRIDGE; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; Schnabel R, 1997, SEMIN CELL DEV BIOL, V8, P341, DOI 10.1006/scdb.1997.0158; Schwarz AJ, 2008, MAGN RESON IMAGING, V26, P914, DOI 10.1016/j.mri.2008.01.048; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; SHEPHERD GM, SYNAPTIC ORG BRAIN; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Vazquez A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066130; Waggoner LE, 1998, NEURON, V21, P203, DOI 10.1016/S0896-6273(00)80527-9; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; Wicks SR, 1996, J COMP PHYSIOL A, V179, P675, DOI 10.1007/BF00216131; YOUNG MP, 1993, P ROY SOC B-BIOL SCI, V252, P13, DOI 10.1098/rspb.1993.0040; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	85	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9240	10.1371/journal.pone.0009240	http://dx.doi.org/10.1371/journal.pone.0009240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179757	Green Submitted, Green Published, gold			2022-12-25	WOS:000274923900002
J	Snyder, BR; Chiu, AM; Prockop, DJ; Chan, AWS				Snyder, Brooke R.; Chiu, Andrew M.; Prockop, Darwin J.; Chan, Anthony W. S.			Human Multipotent Stromal Cells (MSCs) Increase Neurogenesis and Decrease Atrophy of the Striatum in a Transgenic Mouse Model for Huntington's Disease	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; STEM/PROGENITOR CELLS; SUBEPENDYMAL LAYER; ACID; TRANSPLANTATION; MICROSPHERES; PROGENITORS; NEURONS; REPAIR	Background: Implantation of human multipotent stromal cells from bone marrow (hMSCs) into the dentate gyrus of the hippocampus of mice was previously shown to stimulate proliferation, migration and neural differentiation of endogenous neural stem cells. We hypothesized that hMSCs would be beneficial in a mouse model of Huntington disease (HD) due to these neurogenic effects. Results: We implanted hMSCs into the striatum of transgenic mice (N171-82Q) that are a model for HD. The implanted hMSCs rapidly disappeared over 3 to 15 days. However, they increased proliferation and neural differentiation of endogenous neural stem cells for up to 30 days. They also increased neurotrophic signaling and decreased atrophy of the striatum in 3-month old HD mice implanted with hMSCs one month earlier. Conclusions: The results therefore suggested that neural implantation of hMSCs may be of benefit in HD but a number of parameters of dose, treatment schedule, and route of administration need to be optimized.	[Snyder, Brooke R.; Chiu, Andrew M.; Chan, Anthony W. S.] Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Chan, Anthony W. S.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Snyder, Brooke R.; Prockop, Darwin J.] Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, New Orleans, LA 70118 USA	Emory University; Tulane University	Snyder, BR (corresponding author), Yerkes Natl Primate Res Ctr, Atlanta, GA USA.	Prockop@medicine.tamhsc.edu; awchan@emory.edu			National Center for Research Resources (NCRR)/National Institutes of Health (NIH) [RR-00165, RR018827]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR018827, P51RR000165] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Center for Research Resources (NCRR)/National Institutes of Health (NIH) grants RR-00165 and RR018827. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista CMC, 2006, J NEUROSCI, V26, P10452, DOI 10.1523/JNEUROSCI.2850-06.2006; Bjugstad KB, 2001, J INHERIT METAB DIS, V24, P631, DOI 10.1023/A:1012706908779; Caplan AI, 2000, CLIN ORTHOP RELAT R, pS67; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Coyne TM, 2007, TRANSPLANTATION, V84, P1507, DOI 10.1097/01.tp.0000288185.09601.4d; Curtis MA, 2005, J CHEM NEUROANAT, V30, P55, DOI 10.1016/j.jchemneu.2005.05.001; Curtis MA, 2005, NEUROSCIENCE, V132, P777, DOI 10.1016/j.neuroscience.2004.12.051; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Dezawa M, 2008, MED MOL MORPHOL, V41, P14, DOI 10.1007/s00795-007-0389-0; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Emerich DF, 1998, CELL TRANSPLANT, V7, P213, DOI 10.1016/S0963-6897(97)00163-2; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gouhier C, 2000, NEUROSCI LETT, V288, P71, DOI 10.1016/S0304-3940(00)01172-1; Hardy SA, 2008, CURR STEM CELL RES T, V3, P43; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Joel D, 2001, MOVEMENT DISORD, V16, P407, DOI 10.1002/mds.1096; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lescaudron L, 2003, INT J NEUROSCI, V113, P945, DOI 10.1080/00207450390207759; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; McBride C, 2003, CYTOTHERAPY, V5, P7, DOI 10.1080/14653240310000038; Menei P, 2000, EXP NEUROL, V161, P259, DOI 10.1006/exnr.1999.7253; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; MYERS RH, 1982, NEW ENGL J MED, V307, P561; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; OWEN M, 1988, CIBA F SYMP, V136, P42; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Prockop DJ, 2007, CLIN PHARMACOL THER, V82, P241, DOI 10.1038/sj.clpt.6100313; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; ROOS RAC, 1993, J NEUROL NEUROSUR PS, V56, P98, DOI 10.1136/jnnp.56.1.98; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Tattersfield AS, 2004, NEUROSCIENCE, V127, P319, DOI 10.1016/j.neuroscience.2004.04.061; Vassos E, 2007, BIOL PSYCHIAT, V62, P1347, DOI 10.1016/j.biopsych.2006.12.016; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975	36	65	68	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9347	10.1371/journal.pone.0009347	http://dx.doi.org/10.1371/journal.pone.0009347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179764	Green Published, gold, Green Submitted			2022-12-25	WOS:000274923900013
J	Nougairede, A; Ninove, L; Zandotti, C; de Lamballerie, X; Gazin, C; Drancourt, M; La Scola, B; Raoult, D; Charrel, RN				Nougairede, Antoine; Ninove, Laetitia; Zandotti, Christine; de Lamballerie, Xavier; Gazin, Celine; Drancourt, Michel; La Scola, Bernard; Raoult, Didier; Charrel, Remi N.			Point of Care Strategy for Rapid Diagnosis of Novel A/H1N1 Influenza Virus	PLOS ONE			English	Article							INFECTIONS	Background: Within months of the emergence of the novel A/H1N1 pandemic influenza virus (nA/H1N1v), systematic screening for the surveillance of the pandemic was abandoned in France and in some other countries. At the end of June 2009, we implemented, for the public hospitals of Marseille, a Point Of Care (POC) strategy for rapid diagnosis of the novel A/H1N1 influenza virus, in order to maintain local surveillance and to evaluate locally the kinetics of the pandemic. Methodology/Principal Findings: Two POC laboratories, located in strategic places, were organized to receive and test samples 24 h/24. POC strategy consisted of receiving and processing naso-pharyngeal specimens in preparation for the rapid influenza diagnostic test (RIDT) and real-time RT-PCR assay (rtRT-PCR). This strategy had the theoretical capacity of processing up to 36 samples per 24 h. When the flow of samples was too high, the rtRT-PCR test was abandoned in the POC laboratories and transferred to the core virology laboratory. Confirmatory diagnosis was performed in the core virology laboratory twice a day using two distinct rtRT-PCR techniques that detect either influenza A virus or nA/N1N1v. Over a period of three months, 1974 samples were received in the POC laboratories, of which 111 were positive for nA/H1N1v. Specificity and sensitivity of RIDT were 100%, and 57.7% respectively. Positive results obtained using RIDT were transmitted to clinical practitioners in less than 2 hours. POC processed rtRT-PCR results were available within 7 hours, and rtRT-PCR confirmation within 24 hours. Conclusions/Significance: The POC strategy is of benefit, in all cases (with or without rtRT-PCR assay), because it provides continuous reception/processing of samples and reduction of the time to provide consolidated results to the clinical practitioners. We believe that implementation of the POC strategy for the largest number of suspect cases may improve the quality of patient care and our knowledge of the epidemiology of the pandemic.	[Nougairede, Antoine; Ninove, Laetitia; Zandotti, Christine; de Lamballerie, Xavier; Gazin, Celine; Drancourt, Michel; La Scola, Bernard; Raoult, Didier; Charrel, Remi N.] Assistance Publ Hop Marseille, Marseille, France; [Nougairede, Antoine; Ninove, Laetitia; de Lamballerie, Xavier; Charrel, Remi N.] Univ Mediterranee, UMR Emergence Pathol Virales 190, Unite Virus Emergents, Marseille, France; [Nougairede, Antoine; Ninove, Laetitia; de Lamballerie, Xavier; Charrel, Remi N.] Inst Rech Dev, Marseille, France; [Drancourt, Michel; La Scola, Bernard; Raoult, Didier] Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, UMR 6236, CNRS,Fac Med,IFR 48,IRD 3R198, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Nougairede, A (corresponding author), Assistance Publ Hop Marseille, Marseille, France.	remi.charrel@univmed.fr	RAOULT, Didier/A-8434-2008; LA SCOLA, Bernard/P-6477-2016	RAOULT, Didier/0000-0002-0633-5974; LA SCOLA, Bernard/0000-0001-8006-7704; Charrel, Remi/0000-0002-7675-8251	AP-HM Public Hospital [228292]	AP-HM Public Hospital	This study was partly funded by AP-HM Public Hospital system and by the FP7 European project n<SUP>o</SUP>228292 European Virus Archive (EVA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgian working group on influenza A(H1N1), 2009, EUROSURVEILLANCE, V14; Enserink M, 2009, SCIENCE, V323, P700, DOI 10.1126/science.323.5915.700; Follin P, 2009, EUROSURVEILLANCE, V14; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; LEVYBRUHL D, 2009, EURO SURVEILL, V14; Lytras T, 2009, EUROSURVEILLANCE, V14, P6; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; NINOVE L, 2009, VECTOR BORNE ZOONOTI; NINOVE L, 2009, CLIN MICROB IN PRESS; Raoult D, 2004, NAT REV MICROBIOL, V2, P151, DOI 10.1038/nrmicro820; Rizzo C, 2009, EURO SURVEILL, V14; *VS I, 2009, B EP GRIPP A H1N1 20; Woo PCY, 1997, J CLIN MICROBIOL, V35, P1579, DOI 10.1128/JCM.35.6.1579-1581.1997; World Health Organization, 2009, COMMUNICATION	16	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9215	10.1371/journal.pone.0009215	http://dx.doi.org/10.1371/journal.pone.0009215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174646	gold, Green Submitted, Green Published			2022-12-25	WOS:000274590600007
J	Al Tanoury, Z; Schaffner-Reckinger, E; Halavatyi, A; Hoffmann, C; Moes, M; Hadzic, E; Catillon, M; Yatskou, M; Friederich, E				Al Tanoury, Ziad; Schaffner-Reckinger, Elisabeth; Halavatyi, Aliaksandr; Hoffmann, Celine; Moes, Michele; Hadzic, Ermin; Catillon, Marie; Yatskou, Mikalai; Friederich, Evelyne			Quantitative Kinetic Study of the Actin-Bundling Protein L-Plastin and of Its Impact on Actin Turn-Over	PLOS ONE			English	Article							FILAMENT CROSS-LINKING; KINASE-C ISOZYMES; F-ACTIN; HUMAN NEUTROPHILS; NEOPLASTIC-CELLS; PHORBOL ESTER; SMOOTH-MUSCLE; CANCER-CELLS; IN-VITRO; PHOSPHORYLATION	Background: Initially detected in leukocytes and cancer cells derived from solid tissues, L-plastin/fimbrin belongs to a large family of actin crosslinkers and is considered as a marker for many cancers. Phosphorylation of L-plastin on residue Ser5 increases its F-actin binding activity and is required for L-plastin-mediated cell invasion. Methodology/Principal Findings: To study the kinetics of L-plastin and the impact of L-plastin Ser5 phosphorylation on L-plastin dynamics and actin turn-over in live cells, simian Vero cells were transfected with GFP-coupled WT-L-plastin, Ser5 substitution variants (S5/A, S5/E) or actin and analyzed by fluorescence recovery after photobleaching (FRAP). FRAP data were explored by mathematical modeling to estimate steady-state reaction parameters. We demonstrate that in Vero cell focal adhesions L-plastin undergoes rapid cycles of association/dissociation following a two-binding-state model. Phosphorylation of L-plastin increased its association rates by two-fold, whereas dissociation rates were unaffected. Importantly, L-plastin affected actin turn-over by decreasing the actin dissociation rate by four-fold, increasing thereby the amount of F-actin in the focal adhesions, all these effects being promoted by Ser5 phosphorylation. In MCF-7 breast carcinoma cells, phorbol 12-myristate 13-acetate (PMA) treatment induced L-plastin translocation to de novo actin polymerization sites in ruffling membranes and spike-like structures and highly increased its Ser5 phosphorylation. Both inhibition studies and siRNA knock-down of PKC isozymes pointed to the involvement of the novel PKC-delta isozyme in the PMA-elicited signaling pathway leading to L-plastin Ser5 phosphorylation. Furthermore, the L-plastin contribution to actin dynamics regulation was substantiated by its association with a protein complex comprising cortactin, which is known to be involved in this process. Conclusions/Significance: Altogether these findings quantitatively demonstrate for the first time that L-plastin contributes to the fine-tuning of actin turn-over, an activity which is regulated by Ser5 phosphorylation promoting its high affinity binding to the cytoskeleton. In carcinoma cells, PKC-delta signaling pathways appear to link L-plastin phosphorylation to actin polymerization and invasion.	[Al Tanoury, Ziad; Schaffner-Reckinger, Elisabeth; Halavatyi, Aliaksandr; Moes, Michele; Hadzic, Ermin; Catillon, Marie; Yatskou, Mikalai; Friederich, Evelyne] Univ Luxembourg, Life Sci Res Unit, Lab Cytoskeleton & Cell Plast, Luxembourg, Luxembourg; [Hoffmann, Celine] Publ Res Ctr Hlth CRP Sante, Plant Mol Biol Lab, Strassen, Luxembourg	University of Luxembourg; Luxembourg Institute of Health	Al Tanoury, Z (corresponding author), Univ Luxembourg, Life Sci Res Unit, Lab Cytoskeleton & Cell Plast, Luxembourg, Luxembourg.	Evelyne.Friederich@uni.lu	Hoffmann, Céline/F-3741-2016	Hoffmann, Céline/0000-0002-7564-2329	Ministere de la Culture, de l'Enseignement Superieur et de la Recherche, Luxembourg; Fonds National de la Recherche, Luxembourg; Human Frontier Science Program [RGP0058/2005]	Ministere de la Culture, de l'Enseignement Superieur et de la Recherche, Luxembourg; Fonds National de la Recherche, Luxembourg(Luxembourg National Research Fund); Human Frontier Science Program(Human Frontier Science Program)	Funding: Ziad Al Tanoury, Aliaksandr Halavatyi and Ermin Hadzic were supported by fellowships from the Ministere de la Culture, de l'Enseignement Superieur et de la Recherche, Luxembourg, and from the Fonds National de la Recherche, Luxembourg. This work was supported by a grant of the Human Frontier Science Program (RGP0058/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS AEM, 1995, MOL CELL BIOL, V15, P69, DOI 10.1128/MCB.15.1.69; ARPIN M, 1994, J CELL BIOL, V127, P1995, DOI 10.1083/jcb.127.6.1995; Babb SG, 1997, CELL MOTIL CYTOSKEL, V37, P308; Basu A, 2001, BIOCHEM BIOPH RES CO, V280, P883, DOI 10.1006/bbrc.2000.4209; BRETSCHER A, 1981, P NATL ACAD SCI-BIOL, V78, P6849, DOI 10.1073/pnas.78.11.6849; Chen CL, 2007, J CELL SCI, V120, P1157, DOI 10.1242/jcs.03408; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; DELANOTE V, 2009, FASEB J; Fidler IJ, 1999, CANCER CHEMOTH PHARM, V43, pS3, DOI 10.1007/s002800051091; Friederich E, 1999, J BIOL CHEM, V274, P26751, DOI 10.1074/jbc.274.38.26751; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; Giganti A, 2005, J CELL SCI, V118, P1255, DOI 10.1242/jcs.01698; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; GOLDSTEIN D, 1985, CANCER RES, V45, P5643; Hai CM, 2002, EXP CELL RES, V280, P64, DOI 10.1006/excr.2002.5592; Hiroyama M, 2005, J CELL PHYSIOL, V202, P608, DOI 10.1002/jcp.20156; Hofmann WA, 2006, J CELL BIOL, V172, P495, DOI 10.1083/jcb.200601095; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; JANJI B, 2009, J CELL MOL MED; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Jones SL, 1996, J BIOL CHEM, V271, P14623, DOI 10.1074/jbc.271.24.14623; Klein MG, 2004, STRUCTURE, V12, P999, DOI 10.1016/j.str.2004.04.010; Klemke M, 2007, INT J CANCER, V120, P2590, DOI 10.1002/ijc.22589; Lacroix M, 2004, ONCOL REP, V12, P701; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Lapillonne A, 2000, ANTICANCER RES, V20, P3177; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lebart MC, 2004, BIOCHEMISTRY-US, V43, P2428, DOI 10.1021/bi030151p; Lee SO, 2008, BIOCHEM BIOPH RES CO, V366, P1019, DOI 10.1016/j.bbrc.2007.12.068; Liedtke CM, 2003, AM J PHYSIOL-CELL PH, V284, pC487, DOI 10.1152/ajpcell.00357.2002; LIN CS, 1993, J BIOL CHEM, V268, P2793; LIN CS, 1993, J BIOL CHEM, V268, P2781; Lin CS, 1998, DNA CELL BIOL, V17, P1041, DOI 10.1089/dna.1998.17.1041; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; MATSUSHIMA K, 1988, BIOCHEMISTRY-US, V27, P3765, DOI 10.1021/bi00410a037; MESSIER JM, 1993, CELL MOTIL CYTOSKEL, V25, P223, DOI 10.1002/cm.970250303; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; Paclet MH, 2004, BIOCHEM J, V377, P469, DOI 10.1042/BJ20031114; PARK TS, 1994, CANCER RES, V54, P1775; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Sharma CP, 2004, CELL BIOL INT, V28, P935, DOI 10.1016/j.cellbi.2004.09.006; SHINOMIYA H, 1995, J IMMUNOL, V154, P3471; SHIROO M, 1990, Cytokine, V2, P13, DOI 10.1016/1043-4666(90)90038-U; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; TONEGUZZO F, 1986, MOL CELL BIOL, V6, P703, DOI 10.1128/MCB.6.2.703; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wang J, 1999, J BIOL CHEM, V274, P24349, DOI 10.1074/jbc.274.34.24349; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Weisswange I, 2009, NATURE, V458, P87, DOI 10.1038/nature07773; Woodsome TP, 2001, J PHYSIOL-LONDON, V535, P553, DOI 10.1111/j.1469-7793.2001.t01-1-00553.x; Zhou LY, 1996, J INVEST DERMATOL, V107, P248, DOI 10.1111/1523-1747.ep12329733	59	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9210	10.1371/journal.pone.0009210	http://dx.doi.org/10.1371/journal.pone.0009210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169155	Green Published, gold			2022-12-25	WOS:000274474700008
J	Gupta, V; Gupta, RK; Khare, G; Salunke, DM; Surolia, A; Tyagi, AK				Gupta, Vibha; Gupta, Rakesh K.; Khare, Garima; Salunke, Dinakar M.; Surolia, Avadhesha; Tyagi, Anil K.			Structural Ordering of Disordered Ligand-Binding Loops of Biotin Protein Ligase into Active Conformations as a Consequence of Dehydration	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURES; DIFFRACTION; CARBOXYLASE; SPECIFICITY; DOMAINS; CRYSTALLIZATION; BIOTINYLATION; DIMERIZATION; RESOLUTION	Mycobacterium tuberculosis (Mtb), a dreaded pathogen, has a unique cell envelope composed of high fatty acid content that plays a crucial role in its pathogenesis. Acetyl Coenzyme A Carboxylase (ACC), an important enzyme that catalyzes the first reaction of fatty acid biosynthesis, is biotinylated by biotin acetyl-CoA carboxylase ligase (BirA). The ligand-binding loops in all known apo BirAs to date are disordered and attain an ordered structure only after undergoing a conformational change upon ligand-binding. Here, we report that dehydration of Mtb-BirA crystals traps both the apo and active conformations in its asymmetric unit, and for the first time provides structural evidence of such transformation. Recombinant Mtb-BirA was crystallized at room temperature, and diffraction data was collected at 295 K as well as at 120 K. Transfer of crystals to paraffin and paratone-N oil (cryoprotectants) prior to flash-freezing induced lattice shrinkage and enhancement in the resolution of the X-ray diffraction data. Intriguingly, the crystal lattice rearrangement due to shrinkage in the dehydrated Mtb-BirA crystals ensued structural order of otherwise flexible ligand-binding loops L4 and L8 in apo BirA. In addition, crystal dehydration resulted in a shift of similar to 3.5 angstrom in the flexible loop L6, a proline-rich loop unique to Mtb complex as well as around the L11 region. The shift in loop L11 in the C-terminal domain on dehydration emulates the action responsible for the complex formation with its protein ligand biotin carboxyl carrier protein (BCCP) domain of ACCA3. This is contrary to the involvement of loop L14 observed in Pyrococcus horikoshii BirA-BCCP complex. Another interesting feature that emerges from this dehydrated structure is that the two subunits A and B, though related by a noncrystallographic twofold symmetry, assemble into an asymmetric dimer representing the ligand-bound and ligand-free states of the protein, respectively. In-depth analyses of the sequence and the structure also provide answers to the reported lower affinities of Mtb-BirA toward ATP and biotin substrates. This dehydrated crystal structure not only provides key leads to the understanding of the structure/function relationships in the protein in the absence of any ligand-bound structure, but also demonstrates the merit of dehydration of crystals as an inimitable technique to have a glance at proteins in action.	[Gupta, Vibha; Gupta, Rakesh K.; Khare, Garima; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India; [Gupta, Rakesh K.] Univ Delhi, Dept Microbiol, New Delhi, India; [Salunke, Dinakar M.; Surolia, Avadhesha] Natl Inst Immunol, New Delhi 110067, India	University of Delhi; University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Gupta, V (corresponding author), Univ Delhi, Dept Biochem, New Delhi, India.	aniltyagi@south.du.ac.in			Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	Funding: This work was supported by the financial grants received from the Department of Biotechnology, Government of India. G. K. is grateful to the Council of Scientific and Industrial Research, India, for a fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2007, ACTA CRYSTALLOGR D, V63, P1194, DOI 10.1107/S0907444907046148; Akiva E, 2008, P NATL ACAD SCI USA, V105, P13292, DOI 10.1073/pnas.0801207105; Bagautdinov B, 2005, J MOL BIOL, V353, P322, DOI 10.1016/j.jmb.2005.08.032; Bagautdinov B, 2008, J BIOL CHEM, V283, P14739, DOI 10.1074/jbc.M709116200; Beckett D, 2007, ANNU REV GENET, V41, P443, DOI 10.1146/annurev.genet.41.042007.170450; Beckett D, 2009, J NUTR, V139, P167, DOI 10.3945/jn.108.095760; Bell JA, 1999, PROTEIN SCI, V8, P2033, DOI 10.1110/ps.8.10.2033; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; Dams T, 2000, J MOL BIOL, V297, P659, DOI 10.1006/jmbi.2000.3570; Daniel J, 2007, J BACTERIOL, V189, P911, DOI 10.1128/JB.01019-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Gupta V, 2008, ACTA CRYSTALLOGR F, V64, P524, DOI 10.1107/S1744309108012475; Harata K, 2007, ACTA CRYSTALLOGR D, V63, P1016, DOI 10.1107/S0907444907031319; Heras B, 2003, STRUCTURE, V11, P139, DOI 10.1016/S0969-2126(03)00005-4; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Kuo A, 2003, J STRUCT BIOL, V141, P97, DOI 10.1016/S1047-8477(02)00633-0; Kwon K, 2000, PROTEIN SCI, V9, P1530, DOI 10.1110/ps.9.8.1530; Kwon K, 2000, J MOL BIOL, V304, P821, DOI 10.1006/jmbi.2000.4249; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mukhopadhyay B, 2001, J BACTERIOL, V183, P3804, DOI 10.1128/JB.183.12.3804-3810.2001; Naganathan S, 2007, J MOL BIOL, V373, P96, DOI 10.1016/j.jmb.2007.07.020; Nagendra HG, 1998, PROTEINS, V32, P229, DOI 10.1002/(SICI)1097-0134(19980801)32:2<229::AID-PROT9>3.0.CO;2-F; Parrish NM, 2001, ANTIMICROB AGENTS CH, V45, P1143, DOI 10.1128/AAC.45.4.1143-1150.2001; Polyak SW, 2001, J BIOL CHEM, V276, P3037, DOI 10.1074/jbc.M003968200; Purushothaman S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002320; Rodionov DA, 2002, GENOME RES, V12, P1507, DOI 10.1101/gr.314502; SALUNKE DM, 1985, ACTA CRYSTALLOGR B, V41, P431, DOI 10.1107/S0108768185002415; Tron CM, 2009, J MOL BIOL, V387, P129, DOI 10.1016/j.jmb.2008.12.086; Vijayalakshmi L, 2008, PROTEINS, V71, P241, DOI 10.1002/prot.21695; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; Wood ZA, 2006, J MOL BIOL, V357, P509, DOI 10.1016/j.jmb.2005.12.066; Zhao HY, 2009, J MOL BIOL, V389, P336, DOI 10.1016/j.jmb.2009.04.009	36	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9222	10.1371/journal.pone.0009222	http://dx.doi.org/10.1371/journal.pone.0009222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169168	Green Published, gold			2022-12-25	WOS:000274474700016
J	Spanholtz, J; Tordoir, M; Eissens, D; Preijers, F; van der Meer, A; Joosten, I; Schaap, N; de Witte, TM; Dolstra, H				Spanholtz, Jan; Tordoir, Marleen; Eissens, Diana; Preijers, Frank; van der Meer, Arnold; Joosten, Irma; Schaap, Nicolaas; de Witte, Theo M.; Dolstra, Harry			High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy	PLOS ONE			English	Article							EX-VIVO EXPANSION; NK CELLS; IN-VIVO; BONE-MARROW; STEM-CELLS; TRANSPLANTATION; DIFFERENTIATION; PROGENITORS; MELANOMA; IDENTIFICATION	Immunotherapy based on natural killer (NK) cell infusions is a potential adjuvant treatment for many cancers. Such therapeutic application in humans requires large numbers of functional NK cells that have been selected and expanded using clinical grade protocols. We established an extremely efficient cytokine-based culture system for ex vivo expansion of NK cells from hematopoietic stem and progenitor cells from umbilical cord blood (UCB). Systematic refinement of this two-step system using a novel clinical grade medium resulted in a therapeutically applicable cell culture protocol. CD56(+)CD3(-) NK cell products could be routinely generated from freshly selected CD34(+) UCB cells with a mean expansion of > 15,000 fold and a nearly 100% purity. Moreover, our protocol has the capacity to produce more than 3-log NK cell expansion from frozen CD34(+) UCB cells. These ex vivo-generated cell products contain NK cell subsets differentially expressing NKG2A and killer immunoglobulin-like receptors. Furthermore, UCB-derived CD56(+) NK cells generated by our protocol uniformly express high levels of activating NKG2D and natural cytotoxicity receptors. Functional analysis showed that these ex vivo-generated NK cells efficiently target myeloid leukemia and melanoma tumor cell lines, and mediate cytolysis of primary leukemia cells at low NK-target ratios. Our culture system exemplifies a major breakthrough in producing pure NK cell products from limited numbers of CD34(+) cells for cancer immunotherapy.	[Spanholtz, Jan; Tordoir, Marleen; Preijers, Frank; de Witte, Theo M.; Dolstra, Harry] Radboud Univ Nijmegen, Hematol Lab, Dept Lab Med, Nijmegen Ctr Mol Life Sci,Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Schaap, Nicolaas; de Witte, Theo M.] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, Lab Med Immunol,Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Eissens, Diana] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Med Immunol,Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Spanholtz, J (corresponding author), Radboud Univ Nijmegen, Hematol Lab, Dept Lab Med, Nijmegen Ctr Mol Life Sci,Med Ctr, NL-6525 ED Nijmegen, Netherlands.	h.dolstra@chl.umcn.nl	Preijers, Frank/L-4586-2015; van der Meer, Arnold/M-1693-2016; de Witte, T.J.M./L-4762-2015; Dolstra, H./L-4276-2015; Schaap, Nicolaas/L-4625-2015; Joosten, Irma/N-4418-2013	van der Meer, Arnold/0000-0001-8274-414X; Dolstra, H./0000-0002-3998-687X; Schaap, Nicolaas/0000-0001-7696-4752; Joosten, Irma/0000-0003-2950-4977; Spanholtz, Jan/0000-0001-7152-6956	Radboud University Nijmegen Medical Centre; Glycostem Therapeutics	Radboud University Nijmegen Medical Centre; Glycostem Therapeutics	Funding: This work was financially supported by the Radboud University Nijmegen Medical Centre and Glycostem Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Arai S, 2008, CYTOTHERAPY, V10, P625, DOI 10.1080/14653240802301872; Carayol G, 1998, EUR J IMMUNOL, V28, P1991, DOI 10.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO;2-7; Carlens S, 2001, HUM IMMUNOL, V62, P1092, DOI 10.1016/S0198-8859(01)00313-5; Cooley S, 2007, BLOOD, V110, P578, DOI 10.1182/blood-2006-07-036228; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Iyengar R, 2003, CYTOTHERAPY, V5, P479, DOI 10.1080/14653240310003558; Kao IT, 2007, STEM CELLS DEV, V16, P1043, DOI 10.1089/scd.2007.0033; Klingemann HG, 2004, CYTOTHERAPY, V6, P15, DOI 10.1080/14653240310004548; Koehl U, 2005, KLIN PADIATR, V217, P345, DOI 10.1055/s-2005-872520; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; LOTZOVA E, 1993, J IMMUNOL, V150, P5263; McKenna DH, 2007, TRANSFUSION, V47, P520, DOI 10.1111/j.1537-2995.2006.01145.x; Meyer-Monard S, 2009, TRANSFUSION, V49, P362, DOI 10.1111/j.1537-2995.2008.01969.x; MILLER JS, 1992, BLOOD, V80, P2182; MILLER JS, 1994, BLOOD, V83, P2594; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Mrozek E, 1996, BLOOD, V87, P2632, DOI 10.1182/blood.V87.7.2632.bloodjournal8772632; Overes IM, 2008, BRIT J HAEMATOL, V141, P799, DOI 10.1111/j.1365-2141.2008.07125.x; Passweg JR, 2006, BEST PRACT RES CL HA, V19, P811, DOI 10.1016/j.beha.2006.06.004; Passweg JR, 2005, BONE MARROW TRANSPL, V35, P637, DOI 10.1038/sj.bmt.1704810; Perez SA, 2003, BLOOD, V101, P3444, DOI 10.1182/blood-2002-05-1501; Pietra G, 2009, INT IMMUNOL, V21, P793, DOI 10.1093/intimm/dxp047; Punzel M, 1999, LEUKEMIA, V13, P1079, DOI 10.1038/sj.leu.2401432; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Shilling HG, 2003, BLOOD, V101, P3730, DOI 10.1182/blood-2002-08-2568; SIEGLER U, 2008, ASH ANN M, V112, P3893; Vitale C, 2008, INT IMMUNOL, V20, P565, DOI 10.1093/intimm/dxn014; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Woll PS, 2009, BLOOD, V113, P6094, DOI 10.1182/blood-2008-06-165225; Yu Y, 2001, J IMMUNOL, V166, P1590, DOI 10.4049/jimmunol.166.3.1590	34	119	130	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9221	10.1371/journal.pone.0009221	http://dx.doi.org/10.1371/journal.pone.0009221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169160	Green Published, gold			2022-12-25	WOS:000274474700015
J	Davis, J; Metzger, JM				Davis, Jennifer; Metzger, Joseph M.			Combinatorial Effects of Double Cardiomyopathy Mutant Alleles in Rodent Myocytes: A Predictive Cellular Model of Myofilament Dysregulation in Disease	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; BINDING-PROTEIN-C; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; ADULT CARDIAC MYOCYTES; SKELETAL TROPONIN-I; THIN FILAMENT; GENE-TRANSFER; COOPERATIVE INTERACTIONS; MECHANICAL-PROPERTIES; TROPOMYOSIN MICE	Inherited cardiomyopathy (CM) represents a diverse group of cardiac muscle diseases that present with a broad spectrum of symptoms ranging from benign to highly malignant. Contributing to this genetic complexity and clinical heterogeneity is the emergence of a cohort of patients that are double or compound heterozygotes who have inherited two different CM mutant alleles in the same or different sarcomeric gene. These patients typically have early disease onset with worse clinical outcomes. Little experimental attention has been directed towards elucidating the physiologic basis of double CM mutations at the cellular-molecular level. Here, dual gene transfer to isolated adult rat cardiac myocytes was used to determine the primary effects of co-expressing two different CM-linked mutant proteins on intact cardiac myocyte contractile physiology. Dual expression of two CM mutants, that alone moderately increase myofilament activation, tropomyosin mutant A63V and cardiac troponin mutant R146G, were shown to additively slow myocyte relaxation beyond either mutant studied in isolation. These results were qualitatively similar to a combination of moderate and strong activating CM mutant alleles aTmA63V and cTnI R193H, which approached a functional threshold. Interestingly, a combination of a CM myofilament deactivating mutant, troponin C G159D, together with an activating mutant, cTnIR193H, produced a hybrid phenotype that blunted the strong activating phenotype of cTnIR193H alone. This is evidence of neutralizing effects of activating/deactivating mutant alleles in combination. Taken together, this combinatorial mutant allele functional analysis lends molecular insight into disease severity and forms the foundation for a predictive model to deconstruct the myriad of possible CM double mutations in presenting patients.	[Davis, Jennifer; Metzger, Joseph M.] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Davis, J (corresponding author), Childrens Hosp, Med Ctr, Dept Mol Cardiovasc Biol, Cincinnati, OH 45229 USA.	metzgerj@umn.edu		DAVIS, JENNIFER/0000-0003-2380-1321	NIH; American Heart Association's Greater Midwest Predoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059301] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association's Greater Midwest Predoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH and American Heart Association's Greater Midwest Predoctoral Fellowship. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Alpert NR, 2005, AM J PHYSIOL-HEART C, V288, pH1097, DOI 10.1152/ajpheart.00650.2004; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Blumenschein TMA, 2006, BIOPHYS J, V90, P2436, DOI 10.1529/biophysj.105.076216; BRANDT PW, 1987, J MOL BIOL, V195, P885, DOI 10.1016/0022-2836(87)90492-X; BRANDT PW, 1990, J MOL BIOL, V212, P473, DOI 10.1016/0022-2836(90)90326-H; Braunwald E, 2002, CIRCULATION, V106, P1312, DOI 10.1161/01.CIR.0000030314.11999.6A; Coutu P, 2005, AM J PHYSIOL-HEART C, V288, pH601, DOI 10.1152/ajpheart.00424.2004; Coutu P, 2004, CIRC RES, V94, P1235, DOI 10.1161/01.RES.0000126923.46786.FD; Davis J, 2008, PHYSIOL REV, V88, P1567, DOI 10.1152/physrev.00039.2007; Davis J, 2008, J MOL CELL CARDIOL, V44, P891, DOI 10.1016/j.yjmcc.2008.02.274; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Day S, 2006, ANN NY ACAD SCI, V1080, P437, DOI 10.1196/annals.1380.033; Day SM, 2006, NAT MED, V12, P181, DOI 10.1038/nm1346; Doolan Alessandra, 2004, Heart Lung Circ, V13, P15, DOI 10.1016/j.hlc.2004.01.026; DWECK D, 2008, J BIOL CHEM; EATON BL, 1975, BIOCHEMISTRY-US, V14, P2718, DOI 10.1021/bi00683a025; Epstein ND, 1998, ADV EXP MED BIOL, V453, P105; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Fatkin D, 2002, PHYSIOL REV, V82, P945, DOI 10.1152/physrev.00012.2002; Frazier A, 2008, PEDIATR CARDIOL, V29, P846, DOI 10.1007/s00246-007-9177-9; Garcia-Castro M, 2005, INT J CARDIOL, V102, P501, DOI 10.1016/j.ijcard.2004.05.060; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Gomes AV, 2004, ANN NY ACAD SCI, V1015, P214, DOI 10.1196/annals.1302.018; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P99, DOI 10.1023/B:MCBI.0000041852.42291.aa; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Herron TJ, 2007, CIRC RES, V100, P1182, DOI 10.1161/01.RES.0000264102.00706.4e; Hilario E, 2004, EUR J BIOCHEM, V271, P4132, DOI 10.1111/j.1432-1033.2004.04351.x; Ho CY, 2000, CIRCULATION, V102, P1950, DOI 10.1161/01.CIR.102.16.1950; Ingles J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033886; Kim SJ, 1999, AM J PHYSIOL-HEART C, V276, pH1780, DOI 10.1152/ajpheart.1999.276.5.H1780; Lim CC, 2008, BIOPHYS J, V94, P3577, DOI 10.1529/biophysj.107.112896; Lin TL, 2000, CARDIOLOGY, V93, P155, DOI 10.1159/000007020; Lindhout DA, 2005, BIOCHEMISTRY-US, V44, P14750, DOI 10.1021/bi051580l; Marian AJ, 2002, CURR OPIN CARDIOL, V17, P242, DOI 10.1097/00001573-200205000-00006; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; MARTIN AF, 1981, J BIOL CHEM, V256, P964; McConnell BK, 1999, J CLIN INVEST, V104, P1771, DOI 10.1172/JCI7377C1; MEHEGAN JP, 1991, J BIOL CHEM, V266, P966; Metzger JM, 2003, J BIOL CHEM, V278, P13118, DOI 10.1074/jbc.M212601200; METZGER JM, 1995, BIOPHYS J, V68, P1430, DOI 10.1016/S0006-3495(95)80316-4; Michele DE, 1999, NAT MED, V5, P1413; Michele DE, 1999, J CELL BIOL, V145, P1483, DOI 10.1083/jcb.145.7.1483; Michele DE, 2002, CIRC RES, V91, P255, DOI 10.1161/01.RES.0000027530.58419.82; Michele DE, 2002, PHYSIOL GENOMICS, V9, P103, DOI 10.1152/physiolgenomics.00099.2001; Miller T, 2001, J BIOL CHEM, V276, P3743, DOI 10.1074/jbc.M006746200; Mohiddin SA, 2003, GENET TEST, V7, P21, DOI 10.1089/109065703321560895; MOSS RL, 1992, CIRC RES, V70, P865, DOI 10.1161/01.RES.70.5.865; MOSS RL, 1986, J GEN PHYSIOL, V87, P761, DOI 10.1085/jgp.87.5.761; Nanni L, 2003, BIOCHEM BIOPH RES CO, V309, P391, DOI 10.1016/j.bbrc.2003.08.014; *NHLBI PROGR GEN A, GEN CARD DEV AD REM; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Palmer BM, 2004, AM J PHYSIOL-HEART C, V287, pH91, DOI 10.1152/ajpheart.01015.2003; Preston LC, 2007, PFLUG ARCH EUR J PHY, V453, P771, DOI 10.1007/s00424-006-0161-7; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Richard P, 1999, J MED GENET, V36, P542; Richard P, 2000, J MOL CELL CARDIOL, V32, P1575, DOI 10.1006/jmcc.2000.1193; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Rust EM, 1998, MOL CELL BIOCHEM, V181, P143, DOI 10.1023/A:1006802719136; Semsarian C, 2002, J CLIN INVEST, V109, P1013, DOI 10.1172/JCI200214677; Semsarian C, 2001, J MOL CELL CARDIOL, V33, P2055, DOI 10.1006/jmcc.2001.1466; Solaro RJ, 1996, J MOL CELL CARDIOL, V28, P217; SWARTZ DR, 1992, J BIOL CHEM, V267, P20497; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Tsoutsman T, 2008, CLIN EXP PHARMACOL P, V35, P1349, DOI 10.1111/j.1440-1681.2008.05037.x; Tsoutsman T, 2008, CIRCULATION, V117, P1820, DOI 10.1161/CIRCULATIONAHA.107.755777; Tsoutsman T, 2006, J MOL CELL CARDIOL, V41, P623, DOI 10.1016/j.yjmcc.2006.07.016; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; Van Driest SL, 2002, CIRCULATION, V106, P3085, DOI 10.1161/01.CIR.0000042675.59901.14; Westfall MV, 1997, P NATL ACAD SCI USA, V94, P5444, DOI 10.1073/pnas.94.10.5444; Westfall MV, 2000, CIRC RES, V86, P470, DOI 10.1161/01.RES.86.4.470; Westfall MV, 2002, CIRC RES, V91, P525, DOI 10.1161/01.RES.0000034710.46739.C0; Westfall MV, 1997, METHOD CELL BIOL, V52, P307, DOI 10.1016/S0091-679X(08)60385-4; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031	76	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9140	10.1371/journal.pone.0009140	http://dx.doi.org/10.1371/journal.pone.0009140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161772	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442700006
J	Martin, RA; Pfennig, DW				Martin, Ryan A.; Pfennig, David W.			Maternal Investment Influences Expression of Resource Polymorphism in Amphibians: Implications for the Evolution of Novel Resource-Use Phenotypes	PLOS ONE			English	Article							DEVELOPMENTAL PLASTICITY; CHARACTER DISPLACEMENT; EGG SIZE; OVUM SIZE; POPULATION DIVERGENCE; ADAPTIVE SIGNIFICANCE; TROPHIC POLYMORPHISM; FROG; POLYPHENISM; SALAMANDER	Maternal effects-where an individual's phenotype is influenced by the phenotype or environment of its mother-are taxonomically and ecologically widespread. Yet, their role in the origin of novel, complex traits remains unclear. Here we investigate the role of maternal effects in influencing the induction of a novel resource-use phenotype. Spadefoot toad tadpoles, Spea multiplicata, often deviate from their normal development and produce a morphologically distinctive carnivore-morph phenotype, which specializes on anostracan fairy shrimp. We evaluated whether maternal investment influences expression of this novel phenotype. We found that larger females invested in larger eggs, which, in turn, produced larger tadpoles. Such larger tadpoles are better able to capture the shrimp that induce carnivores. By influencing the expression of novel resource-use phenotypes, maternal effects may play a largely underappreciated role in the origins of novelty.	[Martin, Ryan A.; Pfennig, David W.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Martin, RA (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	martinra@email.unc.edu	Martin, Ryan A/D-8945-2011; Martin, Ryan/AAF-1314-2019	Martin, Ryan/0000-0002-7448-5907	National Science Foundation [DEB-0640026]	National Science Foundation(National Science Foundation (NSF))	This work was funded by a National Science Foundation grant DEB-0640026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, NATURE, V401, P60, DOI 10.1038/43425; Badyaev AV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-3; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; Badyaev AV, 2002, SCIENCE, V295, P316, DOI 10.1126/science.1066651; Baldwin JM, 1896, AM NAT, V30, P441, DOI DOI 10.1086/276408; Bernardo J, 1996, AM ZOOL, V36, P216; Bragg AN, 1965, GNOMES NIGHT SPADEFO; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; COLLINS JP, 1983, AM ZOOL, V23, P77; Frankino WA, 2001, EVOL ECOL RES, V3, P939; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; Gomez-Mestre I, 2006, P NATL ACAD SCI USA, V103, P19021, DOI 10.1073/pnas.0603562103; Gosner K. L., 1960, Herpetologica, V16, P183; GROSS MR, 1985, AM ZOOL, V25, P807; Hamilton W.D., 1979, P167; Hoffman EA, 1999, ECOLOGY, V80, P1076, DOI 10.2307/177041; JORGENSEN CB, 1982, J EXP ZOOL, V224, P437, DOI 10.1002/jez.1402240317; KAPLAN RH, 1992, ECOLOGY, V73, P280, DOI 10.2307/1938739; Kaplan RH, 2006, EVOLUTION, V60, P142; KAPLAN RH, 1979, COPEIA, P348; KAPLAN RH, 1987, OECOLOGIA, V71, P273, DOI 10.1007/BF00377295; KAPLAN RH, 1989, FUNCT ECOL, V3, P597, DOI 10.2307/2389574; KAPLAN RH, 1979, AM NAT, V113, P671, DOI 10.1086/283425; Kaplan RH, 1997, HERPETOLOGICA, V53, P149; Kaplan RH, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P244; King EG, 1997, J HERPETOL, V31, P299, DOI 10.2307/1565402; Ledon-Rettig CC, 2008, EVOL DEV, V10, P316, DOI 10.1111/j.1525-142X.2008.00240.x; Linksvayer TA, 2005, Q REV BIOL, V80, P317, DOI 10.1086/432266; LOEB MLG, 1994, FUNCT ECOL, V8, P151, DOI 10.2307/2389898; Loman J, 2002, J ZOOL, V257, P93, DOI 10.1017/S0952836902000687; MARET TJ, 1994, OECOLOGIA, V100, P279, DOI 10.1007/BF00316955; Martin RA, 2009, AM NAT, V174, P268, DOI 10.1086/600090; Michimae H, 2002, EVOLUTION, V56, P2029; Michimae H, 2009, OECOLOGIA, V160, P601, DOI 10.1007/s00442-009-1319-8; Moczek AP, 2008, BIOESSAYS, V30, P432, DOI 10.1002/bies.20754; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nishihara A, 1996, COPEIA, P478, DOI 10.2307/1446871; PARICHY DM, 1995, FUNCT ECOL, V9, P606, DOI 10.2307/2390151; PARICHY DM, 1992, OECOLOGIA, V91, P579, DOI 10.1007/BF00650334; PFENNIG D, 1990, OECOLOGIA, V85, P101, DOI 10.1007/BF00317349; Pfennig DW, 2007, EVOLUTION, V61, P257, DOI 10.1111/j.1558-5646.2007.00034.x; Pfennig DW, 2009, EVOLUTION, V63, P898, DOI 10.1111/j.1558-5646.2008.00544.x; PFENNIG DW, 1993, NATURE, V362, P836, DOI 10.1038/362836a0; Pfennig DW, 2000, EVOLUTION, V54, P1738; Pfennig DW, 2006, ECOLOGY, V87, P769, DOI 10.1890/05-0787; Pfennig DW, 1999, P ROY SOC B-BIOL SCI, V266, P57, DOI 10.1098/rspb.1999.0604; PFENNIG DW, 1992, EVOLUTION, V46, P1408, DOI 10.1111/j.1558-5646.1992.tb01133.x; Pfennig DW, 2002, EVOLUTION, V56, P1217; Pfennig DW, 1997, EVOLUTION, V51, P1993, DOI 10.1111/j.1558-5646.1997.tb05120.x; PFENNIG DW, 2009, PHILOS T B IN PRESS; Pfennig KS, 2005, EVOLUTION, V59, P2200; Pfenning DW, 2000, AM NAT, V155, P335, DOI 10.1086/303329; Plaistow SJ, 2006, AM NAT, V167, P206, DOI 10.1086/499380; POMEROY LV, 1981, THESIS U CALIFORNIA; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Rasanen K, 2003, EVOLUTION, V57, P363, DOI 10.1554/0014-3820(2003)057[0363:GVIAST]2.0.CO;2; RASBAND WS, 1996, IMAGEJ; ROBINSON BW, 1994, AM NAT, V144, P596, DOI 10.1086/285696; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Schmalhausen I. I., 1949, FACTORS OF EVOLUTION; SINERVO B, 1990, EVOLUTION, V44, P279, DOI 10.1111/j.1558-5646.1990.tb05198.x; Skulason S, 1999, EVOLUTION OF BIOLOGICAL DIVERSITY, P70; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Stebbins R. C., 2003, FIELD GUIDE W REPTIL; Storz BL, 2004, OECOLOGIA, V141, P402, DOI 10.1007/s00442-004-1672-6; Storz Brian L., 2007, TSW Development & Embryology, V2, P60; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; WAINWRIGHT PC, 1991, FUNCT ECOL, V5, P40, DOI 10.2307/2389554; WALLS SC, 1993, OECOLOGIA, V96, P162, DOI 10.1007/BF00317728; West-Eberhard Mary Jane, 2003, pi; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341	73	35	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9117	10.1371/journal.pone.0009117	http://dx.doi.org/10.1371/journal.pone.0009117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161745	gold, Green Submitted, Green Published			2022-12-25	WOS:000274442600015
J	Reinhard, J; Sinclair, M; Srinivasan, MV; Claudianos, C				Reinhard, Judith; Sinclair, Michael; Srinivasan, Mandyam V.; Claudianos, Charles			Honeybees Learn Odour Mixtures via a Selection of Key Odorants	PLOS ONE			English	Article							OILSEED RAPE VOLATILES; APIS-MELLIFERA L; ANTENNAL LOBE; BEHAVIORAL ASSAY; OLFACTORY CUES; MANDUCA-SEXTA; DISCRIMINATION; BEE; REPRESENTATIONS; RECOGNITION	Background: The honeybee has to detect, process and learn numerous complex odours from her natural environment on a daily basis. Most of these odours are floral scents, which are mixtures of dozens of different odorants. To date, it is still unclear how the bee brain unravels the complex information contained in scent mixtures. Methodology/Principal Findings: This study investigates learning of complex odour mixtures in honeybees using a simple olfactory conditioning procedure, the Proboscis-Extension-Reflex (PER) paradigm. Restrained honeybees were trained to three scent mixtures composed of 14 floral odorants each, and then tested with the individual odorants of each mixture. Bees did not respond to all odorants of a mixture equally: They responded well to a selection of key odorants, which were unique for each of the three scent mixtures. Bees showed less or very little response to the other odorants of the mixtures. The bees' response to mixtures composed of only the key odorants was as good as to the original mixtures of 14 odorants. A mixture composed of the other, non-key-odorants elicited a significantly lower response. Neither an odorant's volatility or molecular structure, nor learning efficiencies for individual odorants affected whether an odorant became a key odorant for a particular mixture. Odorant concentration had a positive effect, with odorants at high concentration likely to become key odorants. Conclusions/Significance: Our study suggests that the brain processes complex scent mixtures by predominantly learning information from selected key odorants. Our observations on key odorant learning lend significant support to previous work on olfactory learning and mixture processing in honeybees.	[Reinhard, Judith; Srinivasan, Mandyam V.; Claudianos, Charles] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Sinclair, Michael] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Srinivasan, Mandyam V.] Australian Natl Univ, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia; [Srinivasan, Mandyam V.] Univ Queensland, Sch Informat Technol & Elect Engn, St Lucia, Qld, Australia	University of Queensland; University of Queensland; Australian National University; University of Queensland	Reinhard, J (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	j.reinhard@uq.edu.au	Srinivasan, Mandyam V/G-5571-2010	Claudianos, Charles/0000-0002-9799-9572; Muthukumarasamy, Srinivasan/0000-0002-2948-6206	Commonwealth Scientific and Industrial Research Organisation Food Futures Flagship Collaborative Research Fund [CBR3_45865_9W2003]	Commonwealth Scientific and Industrial Research Organisation Food Futures Flagship Collaborative Research Fund	Funding: This work was supported by a grant from the Commonwealth Scientific and Industrial Research Organisation Food Futures Flagship Collaborative Research Fund (CBR3_45865_9W2003, http://www.csiro.au/org/FoodFuturesFlagship.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD G, 1985, CELL TISSUE RES, V242, P593, DOI 10.1007/BF00225425; Brunke EJ, 1994, FLAVOUR FRAG J, V9, P59, DOI 10.1002/ffj.2730090205; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; Deisig N, 2006, EUR J NEUROSCI, V24, P1161, DOI 10.1111/j.1460-9568.2006.04959.x; Dudareva N, 2006, BIOLOGY OF FLORAL SCENT, P55; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Fernandez PC, 2009, J NEUROSCI, V29, P10191, DOI 10.1523/JNEUROSCI.1874-09.2009; FLANAGAN D, 1989, INT J INSECT MORPHOL, V18, P145, DOI 10.1016/0020-7322(89)90023-8; Galizia CG, 2004, J COMP PHYSIOL A, V190, P21, DOI 10.1007/s00359-003-0469-0; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; HEISENBERG M, 2004, NATURE, V4, P266; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Kelber C, 2006, J COMP NEUROL, V496, P395, DOI 10.1002/cne.20930; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Kuwabara M., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P458; Laloi D, 1999, J INSECT BEHAV, V12, P585, DOI 10.1023/A:1020919501871; Laloi D, 2000, J CHEM ECOL, V26, P2307, DOI 10.1023/A:1005522826673; Laska M, 1999, CHEM SENSES, V24, P263, DOI 10.1093/chemse/24.3.263; Laska M, 2001, BEHAV NEUROSCI, V115, P632, DOI 10.1037/0735-7044.115.3.632; Lei H, 2008, J CHEM ECOL, V34, P915, DOI 10.1007/s10886-008-9487-2; LeMetayer M, 1997, CHEM SENSES, V22, P391, DOI 10.1093/chemse/22.4.391; Livermore A, 1998, PERCEPT PSYCHOPHYS, V60, P650, DOI 10.3758/BF03206052; PHAMDELEGUE MH, 1993, CHEM SENSES, V18, P483, DOI 10.1093/chemse/18.5.483; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Rao BRR, 2000, FLAVOUR FRAG J, V15, P105, DOI 10.1002/(SICI)1099-1026(200003/04)15:2&lt;105::AID-FFJ875&gt;3.0.CO;2-G; Reinhard J, 2009, CONTEMP TOP ENTOMOL, P165; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Silbering AF, 2007, J NEUROSCI, V27, P11966, DOI 10.1523/JNEUROSCI.3099-07.2007; Smith BH, 1998, PHYSIOL BEHAV, V65, P397, DOI 10.1016/S0031-9384(98)00142-5; SMITH BH, 1994, J EXP BIOL, V195, P91; Strausfeld NJ, 1999, CURR OPIN NEUROBIOL, V9, P634, DOI 10.1016/S0959-4388(99)00019-7; WADHAMS LJ, 1994, J CHEM ECOL, V20, P3221, DOI 10.1007/BF02033722; Wright GA, 2005, J COMP PHYSIOL A, V191, P105, DOI 10.1007/s00359-004-0576-6; Wright GA, 2004, CHEM SENSES, V29, P127, DOI 10.1093/chemse/bjh016; Wright GA, 2004, P ROY SOC B-BIOL SCI, V271, P147, DOI 10.1098/rspb.2003.2590	41	69	69	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9110	10.1371/journal.pone.0009110	http://dx.doi.org/10.1371/journal.pone.0009110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161714	gold, Green Submitted, Green Published			2022-12-25	WOS:000274442500016
J	Repellin, CE; Tsimbouri, PM; Philbey, AW; Wilson, JB				Repellin, Claire E.; Tsimbouri, Penelope M.; Philbey, Adrian W.; Wilson, Joanna B.			Lymphoid Hyperplasia and Lymphoma in Transgenic Mice Expressing the Small Non-Coding RNA, EBER1 of Epstein-Barr Virus	PLOS ONE			English	Article							ENCODED SMALL RNAS; BURKITTS-LYMPHOMA; PROTEIN-KINASE; MALIGNANT-TRANSFORMATION; GROWTH TRANSFORMATION; (EBV)-ENCODED RNA; NUCLEAR ANTIGEN-1; INDUCED APOPTOSIS; MICRORNAS; CELLS	Background: Non-coding RNAs have critical functions in diverse biological processes, particularly in gene regulation. Viruses, like their host cells, employ such functional RNAs and the human cancer associated Epstein-Barr virus (EBV) is no exception. Nearly all EBV associated tumours express the EBV small, non-coding RNAs (EBERs) 1 and 2, however their role in viral pathogenesis remains largely obscure. Methodology/Principal Findings: To investigate the action of EBER1 in vivo, we produced ten transgenic mouse lines expressing EBER1 in the lymphoid compartment using the mouse immunoglobulin heavy chain intronic enhancer E mu. Mice of several of these E mu EBER1 lines developed lymphoid hyperplasia which in some cases proceeded to B cell malignancy. The hallmark of the transgenic phenotype is enlargement of the spleen and mesenteric lymph nodes and in some cases enlargement of the thymus, liver and peripheral lymph nodes. The tumours were found to be of B cell origin and showed clonal IgH rearrangements. In order to explore if EBER1 would cooperate with c-Myc (deregulated in Burkitt's lymphoma) to accelerate lymphomagenesis, a cross-breeding study was undertaken with EmEBER1 and E mu Myc mice. While no significant reduction in latency to lymphoma onset was observed in bi-transgenic mice, c-Myc induction was detected in some EmEBER1 single transgenic tumours, indicative of a functional cooperation. Conclusions/Significance: This study is the first to describe the in vivo expression of a polymerase III, non-coding viral gene and demonstrate its oncogenic potential. The data suggest that EBER1 plays an oncogenic role in EBV associated malignant disease.	[Repellin, Claire E.; Tsimbouri, Penelope M.; Wilson, Joanna B.] Univ Glasgow, Fac Biomed & Life Sci, Div Mol & Cellular Biol, Glasgow, Lanark, Scotland; [Philbey, Adrian W.] Univ Glasgow, Sch Vet, Div Pathol Sci, Inst Comparat Med, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Repellin, CE (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Div Mol & Cellular Biol, Glasgow, Lanark, Scotland.	Joanna.Wilson@bio.gla.ac.uk	Wilson, Joanna B/B-4466-2009	Tsimbouri, Penelope/0000-0001-5124-7458	Wellcome Trust [065530, 078519]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: Wellcome Trust #065530 and #078519 (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ARRAND JR, 1982, J VIROL, V41, P376, DOI 10.1128/JVI.41.2.376-389.1982; ARRAND JR, 1989, J VIROL, V63, P983, DOI 10.1128/JVI.63.2.983-986.1989; Charalambous CT, 2007, CARCINOGENESIS, V28, P1839, DOI 10.1093/carcin/bgm055; Clemens MJ, 2006, INT J BIOCHEM CELL B, V38, P164, DOI 10.1016/j.biocel.2005.09.014; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; DILDROP R, 1989, EMBO J, V8, P1121, DOI 10.1002/j.1460-2075.1989.tb03482.x; Eilebrecht Sebastian, 2008, BMC Res Notes, V1, P100, DOI 10.1186/1756-0500-1-100; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; GLICKMAN JN, 1988, J VIROL, V62, P902, DOI 10.1128/JVI.62.3.902-911.1988; Grey F, 2008, MED MICROBIOL IMMUN, V197, P261, DOI 10.1007/s00430-007-0070-1; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; HOWE JG, 1989, CELL, V57, P825, DOI 10.1016/0092-8674(89)90797-6; HOWE JG, 1988, J VIROL, V62, P2790, DOI 10.1128/JVI.62.8.2790-2798.1988; Iwakiri D, 2005, ONCOGENE, V24, P1767, DOI 10.1038/sj.onc.1208357; JAT P, 1982, NUCLEIC ACIDS RES, V10, P3407, DOI 10.1093/nar/10.11.3407; KHAN G, 1992, J CLIN PATHOL, V45, P616, DOI 10.1136/jcp.45.7.616; Kitagawa N, 2000, EMBO J, V19, P6742, DOI 10.1093/emboj/19.24.6742; Komano J, 1999, J VIROL, V73, P9827, DOI 10.1128/JVI.73.12.9827-9831.1999; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; Laing KG, 2002, VIROLOGY, V297, P253, DOI 10.1006/viro.2002.1354; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Lu CC, 2004, J GEN VIROL, V85, P2755, DOI 10.1099/vir.0.80239-0; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; Nanbo A, 2002, EMBO J, V21, P954, DOI 10.1093/emboj/21.5.954; Niller HH, 2003, MED SCI MONITOR, V9, pHY1; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; ROSA MD, 1981, MOL CELL BIOL, V1, P785, DOI 10.1128/MCB.1.9.785; Ruf IK, 2000, J VIROL, V74, P10223, DOI 10.1128/JVI.74.21.10223-10228.2000; Ruf IK, 2005, J VIROL, V79, P14562, DOI 10.1128/JVI.79.23.14562-14569.2005; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Sano M, 2006, FEBS LETT, V580, P1553, DOI 10.1016/j.febslet.2006.01.085; SHARP TV, 1993, NUCLEIC ACIDS RES, V21, P4483, DOI 10.1093/nar/21.19.4483; Stevenson D, 2005, CANCER RES, V65, P8826, DOI 10.1158/0008-5472.CAN-05-0591; Wilson JB, 1996, EMBO J, V15, P3117, DOI 10.1002/j.1460-2075.1996.tb00674.x; WILSON JB, 1990, CELL, V61, P1315, DOI 10.1016/0092-8674(90)90695-B; Wu Y, 2007, J VIROL, V81, P11236, DOI 10.1128/JVI.00579-07; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Yajima M, 2005, J VIROL, V79, P4298, DOI 10.1128/JVI.79.7.4298-4307.2005; Yamamoto N, 2000, FEBS LETT, V484, P153, DOI 10.1016/S0014-5793(00)02145-1; Yang LX, 2004, CANCER RES, V64, P5332, DOI 10.1158/0008-5472.CAN-04-0733; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	44	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9092	10.1371/journal.pone.0009092	http://dx.doi.org/10.1371/journal.pone.0009092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161707	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000274442500004
J	Choi, LJ; Jenikova, G; Hanson, E; Spehlmann, ME; Boehling, NS; Kirstein, SL; Bundey, RA; Smith, JR; Insel, PA; Eckmann, L				Choi, Lillian J.; Jenikova, Gabriela; Hanson, Elaine; Spehlmann, Martina E.; Boehling, Nicholas S.; Kirstein, Shelli L.; Bundey, Richard A.; Smith, Jennifer R.; Insel, Paul A.; Eckmann, Lars			Coordinate Down-regulation of Adenylyl Cyclase Isoforms and the Stimulatory G Protein (G(s)) in Intestinal Epithelial Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CHLORIDE SECRETION; PROSTAGLANDIN E-2; RETINOIC ACID; MESSENGER-RNA; COLON; RAT; CRYPT; CAMP; QUANTIFICATION	The intestinal epithelium is dynamic, with proliferation of undifferentiated crypt cells balanced by terminal differentiation and cell death at the colon surface or small intestinal villus tips. Cyclic AMP, induced by agonists such as prostaglandin E-2 and vasoactive intestinal polypeptide, promotes proliferation and ion secretion and suppresses apoptosis in intestinal epithelial cells. Here, we show that cell differentiation in a model intestinal epithelium leads to attenuation of cAMP production in response to G protein-coupled receptor and receptor-independent agonists. Concomitantly, key components of the cAMP cascade, the alpha subunit of the stimulatory G protein, G(s), and adenylyl cyclase (AC) isoforms 3, 4, 6, and 7 are down-regulated. By contrast, AC1, AC2, AC8, and AC9, and the receptors for prostaglandin E2 and vasoactive intestinal polypeptide, are not expressed or not affected by differentiation. We confirmed key findings in normal murine colon epithelium, in which the major AC isoforms and G(s)alpha are markedly down-regulated in differentiated surface cells. Suppression of AC isoforms and G(s)alpha is functionally important, because their constitutive expression completely reverses differentiation-induced cAMP attenuation. Thus, down-regulation of AC isoforms and G(s)alpha is an integral part of the intestinal epithelial differentiation program, perhaps serving to release cells from cAMP-promoted anti-apoptosis as a prerequisite for cell death upon terminal differentiation.	[Choi, Lillian J.; Jenikova, Gabriela; Hanson, Elaine; Spehlmann, Martina E.; Smith, Jennifer R.; Insel, Paul A.; Eckmann, Lars] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Boehling, Nicholas S.; Kirstein, Shelli L.; Bundey, Richard A.; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Eckmann, L (corresponding author), Univ Calif San Diego, Dept Med 0063, 9500 Gilman Dr, La Jolla, CA 92093 USA.	leckmann@ucsd.edu	Jenikova, Gabriela/G-6196-2014	Jenikova, Gabriela/0000-0002-1847-5456	National Institutes of Health [DK035108, HL066941, GM066232, T32 DK007202]; Digestive Diseases Research Development Center [DK80506]; Ellison Medical Foundation; Mucosaimmunologie gemeinnutzige Forschungsgesellschaft Educative Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066941, T32HL007444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, T32DK007202, P01DK035108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Development Center; Ellison Medical Foundation(Lawrence Ellison Foundation); Mucosaimmunologie gemeinnutzige Forschungsgesellschaft Educative Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK035108 (to L.E.), HL066941 (to P.A.I.), GM066232 (to P.A.I.), and Digestive Diseases Research Development Center Grant DK80506. This work was also supported by grants from the Ellison Medical Foundation (to P.A I.). 1 Supported by National Institutes of Health Training Grant T32 DK007202. 2 Supported by a fellowship from the Mucosaimmunologie gemeinnutzige Forschungsgesellschaft Educative Science.	Alrefai WA, 2007, AM J PHYSIOL-GASTR L, V293, pG923, DOI 10.1152/ajpgi.00029.2007; Amelsberg M, 1996, SCAND J GASTROENTERO, V31, P233, DOI 10.3109/00365529609004872; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Belley A, 1999, GASTROENTEROLOGY, V117, P1352, DOI 10.1016/S0016-5085(99)70285-4; BRAY P, 1986, P NATL ACAD SCI USA, V83, P8893, DOI 10.1073/pnas.83.23.8893; Bundey RA, 2003, ANAL BIOCHEM, V319, P318, DOI 10.1016/S0003-2697(03)00325-7; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Dudeja PK, 1996, AM J PHYSIOL-GASTR L, V271, pG483, DOI 10.1152/ajpgi.1996.271.3.G483; Freeman SL, 2004, GUT, V53, P214, DOI 10.1136/gut.2003.023895; Gao MH, 1998, P NATL ACAD SCI USA, V95, P1038, DOI 10.1073/pnas.95.3.1038; Guo J, 2009, J BIOL CHEM, V284, P134, DOI 10.1074/jbc.M806133200; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hanoune J, 1997, MOL CELL ENDOCRINOL, V128, P179, DOI 10.1016/S0303-7207(97)04013-6; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; Izu LT, 2002, J MEMBRANE BIOL, V186, P145, DOI 10.1007/s00232-001-0145-7; Jourdan KB, 2001, AM J PHYSIOL-LUNG C, V280, pL1359, DOI 10.1152/ajplung.2001.280.6.L1359; Kolachala V, 2005, J BIOL CHEM, V280, P4048, DOI 10.1074/jbc.M409577200; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Krupinski John, 1998, Advances in Second Messenger and Phosphoprotein Research, V32, P53; Lipskaia L, 1997, FEBS LETT, V415, P275, DOI 10.1016/S0014-5793(97)01001-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; Marnett LJ, 2002, ANNU REV PHARMACOL, V42, P55, DOI 10.1146/annurev.pharmtox.42.082301.164620; Matthews JB, 1998, J CLIN INVEST, V101, P2072, DOI 10.1172/JCI1042; Milligan G, 1996, CELL SIGNAL, V8, P87, DOI 10.1016/0898-6568(95)02034-9; Morimoto K, 1997, AM J PHYSIOL-GASTR L, V272, pG681, DOI 10.1152/ajpgi.1997.272.3.G681; Mutoh M, 2002, CANCER RES, V62, P28; Nishihara H, 2003, P NATL ACAD SCI USA, V100, P8921, DOI 10.1073/pnas.1533221100; Nlend MC, 2007, FEBS LETT, V581, P3241, DOI 10.1016/j.febslet.2007.06.015; Olsen L, 2005, AM J PHYSIOL-GASTR L, V289, pG220, DOI 10.1152/ajpgi.00449.2004; Ostrom RS, 2000, J PHARMACOL EXP THER, V294, P407; POST SR, 1995, BIOCHEM J, V311, P75, DOI 10.1042/bj3110075; QUILL H, 1975, GASTROENTEROLOGY, V69, P470; Resta-Lenert S, 2001, AM J PHYSIOL-CELL PH, V281, pC1837, DOI 10.1152/ajpcell.2001.281.6.C1837; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Sheng HM, 1998, CANCER RES, V58, P362; Strazzabosco M, 2009, HEPATOLOGY, V50, P244, DOI 10.1002/hep.22926; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Tabuchi Y, 2002, BIOCHEM BIOPH RES CO, V293, P1287, DOI 10.1016/S0006-291X(02)00365-0; Takahashi H, 1998, ARCH DERMATOL RES, V290, P407, DOI 10.1007/s004030050327; TRABER PG, 1992, AM J PHYSIOL, V262, pG123, DOI 10.1152/ajpgi.1992.262.1.G123; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004	47	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12504	12511		10.1074/jbc.M109.059741	http://dx.doi.org/10.1074/jbc.M109.059741			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20157112	hybrid, Green Published			2022-12-25	WOS:000276787800007
J	Veyron-Churlet, R; Zanella-Cleon, I; Cohen-Gonsaud, M; Molle, V; Kremer, L				Veyron-Churlet, Romain; Zanella-Cleon, Isabelle; Cohen-Gonsaud, Martin; Molle, Virginie; Kremer, Laurent			Phosphorylation of the Mycobacterium tuberculosis beta-Ketoacyl-Acyl Carrier Protein Reductase MabA Regulates Mycolic Acid Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASES/REDUCTASES; SYNTHASE-III MTFABH; CELL-DIVISION; BIOCHEMICAL-CHARACTERIZATION; SERINE/THREONINE KINASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; FAS-II; PKNA; IDENTIFICATION	Mycolic acids are key cell wall components for the survival, pathogenicity, and antibiotic resistance of the human tubercle bacillus. Although it was thought that Mycobacterium tuberculosis tightly regulates their production to adapt to prevailing environmental conditions, the molecular mechanisms governing mycolic acid biosynthesis remained extremely obscure. Meromycolic acids, the direct precursors of mycolic acids, are synthesized by a type II fatty acid synthase from acyl carrier protein-bound substrates that are extended iteratively, with a reductive cycle in each round of extension, the second step of which is catalyzed by the essential beta-ketoacyl-acyl carrier protein reductase, MabA. In this study, we investigated whether post-translational modifications of MabA might represent a strategy employed by M. tuberculosis to regulate mycolic acid biosynthesis. Indeed, we show here that MabA was efficiently phosphorylated in vitro by several M. tuberculosis Ser/Thr protein kinases, including PknB, as well as in vivo in mycobacteria. Mass spectrometric analyses using LC-ESI/MS/MS and site-directed mutagenesis identified three phosphothreonines, with Thr(191) being the primary phosphor-acceptor. A MabA_T191D mutant, designed to mimic constitutive phosphorylation, exhibited markedly decreased ketoacyl reductase activity compared with the wild-type protein, as well as impaired binding of the NADPH cofactor, as demonstrated by fluorescence spectroscopy. The hypothesis that phosphorylation of Thr(191) alters the enzymatic activity of MabA, and subsequently mycolic acid biosynthesis, was further supported by the fact that constitutive overexpression of the mabA_T191D allele in Mycobacterium bovis BCG strongly impaired mycobacterial growth. Importantly, conditional expression of the phosphomimetic MabA_T191D led to a significant inhibition of de novo biosynthesis of mycolic acids. This study provides the first information on the molecular mechanism(s) involved in mycolic acid regulation through Ser/Thr protein kinase-dependent phosphorylation of a type II fatty acid synthase enzyme.	[Zanella-Cleon, Isabelle; Molle, Virginie] Univ Lyon 1, CNRS, IBCP UMR 5086, Biosci IFR128, F-69367 Lyon 07, France; [Veyron-Churlet, Romain; Kremer, Laurent] Univ Montpellier 1, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Veyron-Churlet, Romain; Kremer, Laurent] Univ Montpellier 2, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Cohen-Gonsaud, Martin] INSERM, U554, F-34090 Montpellier, France; [Cohen-Gonsaud, Martin] Univ Montpellier I & II, Ctr Biochim Struct, UMR 5048, CNRS, F-34093 Montpellier, France; [Kremer, Laurent] INSERM, DIMNP, F-34095 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Molle, V (corresponding author), Univ Lyon 1, CNRS, IBCP UMR 5086, Biosci IFR128, 7 Passage Vercors, F-69367 Lyon 07, France.	vmolle@ibcp.fr; laurent.kremer@univ-montp2.fr	Veyron-Churlet, Romain/J-4254-2019; Kremer, Laurent/M-4935-2017; MOLLE, Virginie/D-4050-2019	Veyron-Churlet, Romain/0000-0001-6902-5917; Kremer, Laurent/0000-0002-6604-4458; MOLLE, Virginie/0000-0002-6573-3411; Cohen-Gonsaud, Martin/0000-0002-0150-9912	National Research Agency [ANR-06-MIME-027-01, ANR-JC07_203251]	National Research Agency(French National Research Agency (ANR))	This work was supported by National Research Agency Grants ANR-06- MIME-027-01 (to V. M. and L. K.) and ANR-JC07_203251 (to M. C.-G.).	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Banerjee A, 1998, MICROBIOL-SGM, V144, P2697, DOI 10.1099/00221287-144-10-2697; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Bloch K, 1975, Methods Enzymol, V35, P84, DOI 10.1016/0076-6879(75)35141-0; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brown AK, 2005, J BIOL CHEM, V280, P32539, DOI 10.1074/jbc.M413216200; Brown AK, 2007, MICROBIOL-SGM, V153, P4166, DOI 10.1099/mic.0.2007/012419-0; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Choi KH, 2000, J BIOL CHEM, V275, P28201; Cohen-Gonsaud M, 2005, PROTEINS, V60, P392, DOI 10.1002/prot.20494; Cohen-Gonsaud M, 2002, J MOL BIOL, V320, P249, DOI 10.1016/S0022-2836(02)00463-1; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Daugelat S, 2003, MICROBES INFECT, V5, P1082, DOI 10.1016/S1286-4579(03)00205-3; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Gupta M, 2009, J BIOL CHEM, V284, P34723, DOI 10.1074/jbc.M109.058834; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kremer L, 2003, J BIOL CHEM, V278, P20547, DOI 10.1074/jbc.M302435200; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Marrakchi H, 2002, MICROBIOL-SGM, V148, P951, DOI 10.1099/00221287-148-4-951; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2008, BIOCHEM J, V410, P309, DOI 10.1042/BJ20071384; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Oppermann UCT, 2001, CHEM-BIOL INTERACT, V130, P699, DOI 10.1016/S0009-2797(00)00301-X; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Parish T, 2007, J BACTERIOL, V189, P3721, DOI 10.1128/JB.01740-06; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Scarsdale JN, 2001, J BIOL CHEM, V276, P20516, DOI 10.1074/jbc.M010762200; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Zimhony O, 2004, J BACTERIOL, V186, P4051, DOI 10.1128/JB.186.13.4051-4055.2004	59	60	63	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12714	12725		10.1074/jbc.M110.105189	http://dx.doi.org/10.1074/jbc.M110.105189			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178986	Green Published, hybrid			2022-12-25	WOS:000276787800030
J	Huo, JX; Xu, SL; Lam, KP				Huo, Jianxin; Xu, Shengli; Lam, Kong-Peng			Fas Apoptosis Inhibitory Molecule Regulates T Cell Receptor-mediated Apoptosis of Thymocytes by Modulating Akt Activation and Nur77 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN STEROID-RECEPTOR; NEGATIVE SELECTION; SIGNAL-TRANSDUCTION; IMMATURE THYMOCYTES; DEATH; FAIM; COMPLEX; ANTIGEN; REQUIREMENT; LYMPHOCYTES	Fas apoptosis inhibitory molecule (FAIM) has been demonstrated to confer resistance to Fas-induced apoptosis of lymphocytes and hepatocytes in vitro and in vivo. Here, we show that FAIM is up-regulated in thymocytes upon T cell receptor (TCR) engagement and that faim(-/-) thymocytes are highly susceptible to TCR-mediated apoptosis with increased activation of caspase-8 and -9. Furthermore, injection of anti-CD3 antibodies leads to augmented depletion of CD4(+)CD8(+)T cells in the thymus of faim(-/-) mice compared with wild-type control, suggesting that FAIM plays a role in thymocyte apoptosis. Cross-linking of the TCR on faim(-/-) thymocytes leads to an elevated protein level of the orphan nuclear receptor Nur77, which plays a role in thymocyte apoptosis. Interestingly, in the absence of FAIM, there are reduced ubiquitination and degradation of the Nur77 protein. Faim(-/-) thymocytes also exhibit a defective TCR-induced activation of Akt whose activity we now show is required for Nur77 ubiquitination. Further analyses utilizing FAIM-deficient primary thymocytes and FAIM-overexpressing DO-11.10 T cells indicate that FAIM acts upstream of Akt during TCR signaling and influences the localization of Akt to lipid rafts, hence affecting its activation. Taken together, our study defined a TCR-induced FAIM/Akt/Nur77 signaling axis that is critical for modulating the apoptosis of developing thymocytes.	[Huo, Jianxin; Xu, Shengli; Lam, Kong-Peng] Agcy Sci Technol & Res, Bioproc Technol Inst, Immunol Grp, Singapore 138668, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI)	Lam, KP (corresponding author), 20 Biopolis Way,06-01 Ctr, Singapore 138668, Singapore.	lam_kong_peng@bti.a-star.edu.sg	HUO, JIANXIN/GXH-0232-2022; Lam, Kong-Peng/G-5374-2012	HUO, JIANXIN/0000-0003-2913-6537; Lam, Kong-Peng/0000-0002-1316-4333	Biomedical Research Council of the Agency for Science, Technology and Research, Singapore	Biomedical Research Council of the Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of the Agency for Science, Technology and Research, Singapore.	Alam A, 1997, J EXP MED, V186, P1503, DOI 10.1084/jem.186.9.1503; CALNAN BJ, 1995, IMMUNITY, V3, P273; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Huo J, 2009, CELL DEATH DIFFER, V16, P1062, DOI 10.1038/cdd.2009.26; Jiang D, 1999, CELL DEATH DIFFER, V6, P402, DOI 10.1038/sj.cdd.4400513; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Luciano F, 2007, BLOOD, V109, P3849, DOI 10.1182/blood-2006-11-056879; Masuyama N, 2001, J BIOL CHEM, V276, P32799, DOI 10.1074/jbc.M105431200; MCCONKEY DJ, 1989, J IMMUNOL, V143, P1801; Moulian N, 1998, SEMIN IMMUNOL, V10, P449, DOI 10.1006/smim.1998.0155; Na SY, 2003, J IMMUNOL, V171, P1285, DOI 10.4049/jimmunol.171.3.1285; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Pekarsky Y, 2001, P NATL ACAD SCI USA, V98, P3690, DOI 10.1073/pnas.051003198; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Rathmell JC, 2002, CELL, V109, pS97, DOI 10.1016/S0092-8674(02)00704-3; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schneider TJ, 1999, J EXP MED, V189, P949, DOI 10.1084/jem.189.6.949; SHI YF, 1991, J IMMUNOL, V146, P3340; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; Sohn SJ, 2003, CURR OPIN IMMUNOL, V15, P209, DOI 10.1016/S0952-7915(03)00004-9; Sole C, 2004, J CELL BIOL, V167, P479, DOI 10.1083/jcb.200403093; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Weih F, 1996, P NATL ACAD SCI USA, V93, P5533, DOI 10.1073/pnas.93.11.5533; Weissman AM, 1997, IMMUNOL TODAY, V18, P189, DOI 10.1016/S0167-5699(97)84666-X; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005; Yoder J, 2001, SCIENCE, V291, P1987, DOI 10.1126/science.1057176; Zhong XM, 2001, MOL IMMUNOL, V38, P65, DOI 10.1016/S0161-5890(01)00035-9	41	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11827	11835		10.1074/jbc.M109.072744	http://dx.doi.org/10.1074/jbc.M109.072744			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20178987	hybrid, Green Published			2022-12-25	WOS:000276787100010
J	Wang, F; Robbins, S; Guo, JT; Shen, WJ; Schultz, PG				Wang, Feng; Robbins, Scott; Guo, Jiantao; Shen, Weijun; Schultz, Peter G.			Genetic Incorporation of Unnatural Amino Acids into Proteins in Mycobacterium tuberculosis	PLOS ONE			English	Article							CODE	New tools are needed to study the intracellular pathogen Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), to facilitate new drug discovery and vaccine development. We have developed methodology to genetically incorporate unnatural amino acids into proteins in Mycobacterium smegmatis, BCG and Mtb, grown both extracellularly in culture and inside host cells. Orthogonal mutant tRNA(Tyr)/tyrosyl-tRNA synthetase pairs derived from Methanococcus jannaschii and evolved in Escherichia coli incorporate a variety of unnatural amino acids (including photocrosslinking, chemically reactive, heavy atom containing, and immunogenic amino acids) into proteins in response to the amber nonsense codon. By taking advantage of the fidelity and suppression efficiency of the MjtRNA/pIpaRS pair in mycobacteria, we are also able to use p-iodophenylalanine to induce the expression of proteins in mycobacteria both extracellularly in culture and inside of mammalian host cells. This provides a new approach to regulate the expression of reporter genes or mycobacteria endogenous genes of interest. The establishment of the unnatural amino acid expression system in Mtb, an intracellular pathogen, should facilitate studies of TB biology and vaccine development.	[Wang, Feng; Guo, Jiantao; Shen, Weijun; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Wang, Feng; Guo, Jiantao; Shen, Weijun; Schultz, Peter G.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Robbins, Scott; Schultz, Peter G.] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Scripps Research Institute; Scripps Research Institute; Novartis	Wang, F (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	schultz@scripps.edu	Guo, Jiantao/O-1776-2016	Guo, Jiantao/0000-0001-6983-9953; Shen, Weijun/0000-0001-8388-729X; Wang, Feng/0000-0003-2980-4646	NIH [R01GM62159]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH R01GM62159. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brustad E, 2008, ANGEW CHEM INT EDIT, V47, P8220, DOI 10.1002/anie.200803240; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Deiters A, 2003, J AM CHEM SOC, V125, P11782, DOI 10.1021/ja0370037; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Gruenewald J, 2008, P NATL ACAD SCI USA, V105, P11276, DOI 10.1073/pnas.0804157105; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Lee HS, 2009, J AM CHEM SOC, V131, P12921, DOI 10.1021/ja904896s; Lee HS, 2009, J AM CHEM SOC, V131, P2481, DOI 10.1021/ja808340b; Liu CC, 2006, NAT BIOTECHNOL, V24, P1436, DOI 10.1038/nbt1254; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Vasanthakrishna M, 1997, MICROBIOL-SGM, V143, P3591, DOI 10.1099/00221287-143-11-3591; Wang JY, 2006, J AM CHEM SOC, V128, P8738, DOI 10.1021/ja062666k; Wang L, 2001, CHEM BIOL, V8, P883, DOI 10.1016/S1074-5521(01)00063-1; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2000, J AM CHEM SOC, V122, P5010, DOI 10.1021/ja000595y; Xie JM, 2007, ANGEW CHEM INT EDIT, V46, P9239, DOI 10.1002/anie.200703397	19	45	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9354	10.1371/journal.pone.0009354	http://dx.doi.org/10.1371/journal.pone.0009354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179771	Green Published, Green Submitted, gold			2022-12-25	WOS:000274923900018
J	Dumortier, A; Durham, AD; Di Piazza, M; Vauclair, S; Koch, U; Ferrand, G; Ferrero, I; Demehri, S; Song, LL; Farr, AG; Leonard, WJ; Kopan, R; Miele, L; Hohl, D; Finke, D; Radtke, F				Dumortier, Alexis; Durham, Andre-Dante; Di Piazza, Matteo; Vauclair, Sophie; Koch, Ute; Ferrand, Gisele; Ferrero, Isabel; Demehri, Shadmehr; Song, Lynda Li; Farr, Andrew G.; Leonard, Warren J.; Kopan, Raphael; Miele, Lucio; Hohl, Daniel; Finke, Daniela; Radtke, Freddy			Atopic Dermatitis-Like Disease and Associated Lethal Myeloproliferative Disorder Arise from Loss of Notch Signaling in the Murine Skin	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; HUMAN EPITHELIAL-CELLS; IGM(+) B-CELLS; T-CELL; MOUSE KERATINOCYTES; IN-VITRO; EXPRESSION; INFLAMMATION; GROWTH; MICE	Background: The Notch pathway is essential for proper epidermal differentiation during embryonic skin development. Moreover, skin specific loss of Notch signaling in the embryo results in skin barrier defects accompanied by a B-lymphoproliferative disease. However, much less is known about the consequences of loss of Notch signaling after birth. Methodology and Principal Findings: To study the function of Notch signaling in the skin of adult mice, we made use of a series of conditional gene targeted mice that allow inactivation of several components of the Notch signaling pathway specifically in the skin. We demonstrate that skin-specific inactivation of Notch1 and Notch2 simultaneously, or RBP-J, induces the development of a severe form of atopic dermatitis (AD), characterized by acanthosis, spongiosis and hyperkeratosis, as well as a massive dermal infiltration of eosinophils and mast cells. Likewise, patients suffering from AD, but not psoriasis or lichen planus, have a marked reduction of Notch receptor expression in the skin. Loss of Notch in keratinocytes induces the production of thymic stromal lymphopoietin (TSLP), a cytokine deeply implicated in the pathogenesis of AD. The AD-like associated inflammation is accompanied by a myeloproliferative disorder (MPD) characterized by an increase in immature myeloid populations in the bone marrow and spleen. Transplantation studies revealed that the MPD is cell non-autonomous and caused by dramatic microenvironmental alterations. Genetic studies demontrated that G-CSF mediates the MPD as well as changes in the bone marrow microenvironment leading to osteopenia. Significance: Our data demonstrate a critical role for Notch in repressing TSLP production in keratinocytes, thereby maintaining integrity of the skin and the hematopoietic system.	[Dumortier, Alexis; Durham, Andre-Dante; Di Piazza, Matteo; Vauclair, Sophie; Koch, Ute; Ferrand, Gisele; Radtke, Freddy] Ecole Polytech Fed Lausanne, SV, ISREC, CH-1015 Lausanne, Switzerland; [Ferrero, Isabel] Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; [Demehri, Shadmehr; Kopan, Raphael] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Demehri, Shadmehr; Kopan, Raphael] Washington Univ, Sch Med, Div Dermatol, St Louis, MO 63110 USA; [Song, Lynda Li; Miele, Lucio] Loyola Univ, Breast Canc Program, Cardinal Bernardin Canc Ctr, Chicago, IL 60611 USA; [Farr, Andrew G.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Farr, Andrew G.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Hohl, Daniel] CHU Vaudois, Dept Dermatol, Lausanne, Switzerland; [Finke, Daniela] Univ Basel, Ctr Biomed, Dept Clin & Biol Sci DKBW, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Ludwig Institute for Cancer Research; University of Lausanne; Washington University (WUSTL); Washington University (WUSTL); Loyola University Chicago; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel	Dumortier, A (corresponding author), Ecole Polytech Fed Lausanne, SV, ISREC, CH-1015 Lausanne, Switzerland.	Freddy.Radtke@epfl.ch	Kopan, Raphael/AFG-3275-2022; Demehri, Shadmehr/N-5732-2019; Hohl, Daniel M/N-7554-2016; Leonard, Warren/AAA-1397-2022; Radtke, Freddy/Q-3198-2017; Durham, Andre/AAC-1020-2019; Kopan, Raphael/AAF-1357-2022	Radtke, Freddy/0000-0003-4315-4045; Durham, Andre/0000-0002-5875-0301; Koch, Ute/0000-0001-7914-7061; Miele, Lucio/0000-0002-5853-7287; Kopan, Raphael/0000-0002-0350-2730	Swiss Cancer League [OCS-01560-08-2004]; Swiss National Science Foundation [FNS: 3236B0-111292 (ADD), PPOOA-68855 (DF)]; Eurosystems, Optistem; Division of Intramural Research, National Heart, Lung and Blood Institute, NIH (WJL); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005409] Funding Source: NIH RePORTER	Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Eurosystems, Optistem; Division of Intramural Research, National Heart, Lung and Blood Institute, NIH (WJL)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was in part supported by the Swiss Cancer League (OCS-01560-08-2004) and the Swiss National Science Foundation (FNS: 3236B0-111292 (ADD), and PPOOA-68855 (DF)), Eurosystems, Optistem, and the Division of Intramural Research, National Heart, Lung and Blood Institute, NIH (WJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Arellano FM, 2007, J INVEST DERMATOL, V127, P808, DOI 10.1038/sj.jid.5700622; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Astrakhan A, 2007, NAT IMMUNOL, V8, P522, DOI 10.1038/ni1452; Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Caruso R, 2009, NAT MED, V15, P1013, DOI 10.1038/nm.1995; Chappaz S, 2007, BLOOD, V110, P3862, DOI 10.1182/blood-2007-02-074245; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Dumortier A, 2003, BLOOD, V101, P2219, DOI 10.1182/blood-2002-05-1336; Eichenfield Lawrence F, 2003, J Am Acad Dermatol, V49, P1088, DOI 10.1016/S0190-9622(03)02539-8; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Guttman-Yassky E, 2008, J IMMUNOL, V181, P7420, DOI 10.4049/jimmunol.181.10.7420; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Levin SD, 1999, J IMMUNOL, V162, P677; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Natalija Novak, 2003, J ALLERGY CLIN IMMUN, V112, pS128, DOI DOI 10.1016/j.jaci.2003.09.032; Nichols AM, 2004, GENESIS, V40, P40, DOI 10.1002/gene.20061; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Osborn MJ, 2004, BLOOD, V103, P843, DOI 10.1182/blood-2003-05-1557; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ray RJ, 1996, EUR J IMMUNOL, V26, P10, DOI 10.1002/eji.1830260103; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Rochman I, 2007, J IMMUNOL, V178, P6720, DOI 10.4049/jimmunol.178.11.6720; Rochman Y, 2008, J IMMUNOL, V181, P7699, DOI 10.4049/jimmunol.181.11.7699; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; Sinke JD, 2002, VET IMMUNOL IMMUNOP, V87, P351, DOI 10.1016/S0165-2427(02)00066-1; Soderberg KC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-51; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Toda M, 2003, J ALLERGY CLIN IMMUN, V111, P875, DOI 10.1067/mai.2003.1414; Uyttendaele H, 2004, DIFFERENTIATION, V72, P396, DOI 10.1111/j.1432-0436.2004.07208006.x; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Vosshenrich CAJ, 2003, NAT IMMUNOL, V4, P773, DOI 10.1038/ni956; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wang H, 2006, BRIT J DERMATOL, V154, P205, DOI 10.1111/j.1365-2133.2005.07077.x; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhang YW, 2004, CANCER CAUSE CONTROL, V15, P419, DOI 10.1023/B:CACO.0000027506.55846.5d; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	71	132	133	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9258	10.1371/journal.pone.0009258	http://dx.doi.org/10.1371/journal.pone.0009258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174635	Green Published, gold, Green Submitted			2022-12-25	WOS:000274654700010
J	Denecke, C; Bedi, DS; Ge, XP; Kim, IKE; Jurisch, A; Weiland, A; Habicht, A; Li, XC; Tullius, SG				Denecke, Christian; Bedi, Damanpreet Singh; Ge, Xupeng; Kim, Irene Kyung-eun; Jurisch, Anke; Weiland, Anne; Habicht, Antje; Li, Xian C.; Tullius, Stefan G.			Prolonged Graft Survival in Older Recipient Mice Is Determined by Impaired Effector T-Cell but Intact Regulatory T-Cell Responses	PLOS ONE			English	Article							AGE-RELATED-CHANGES; TRANSGENIC MODEL; IN-VIVO; ACTIVATION; REJECTION	Elderly organ transplant recipients represent a fast growing segment of patients on the waiting list. We examined age-dependent CD4(+) T-cell functions in a wild-type (WT) and a transgenic mouse transplant model and analyzed the suppressive function of old regulatory T-cells. We found that splenocytes of naive old B6 mice contained significantly higher frequencies of T-cells with an effector/memory phenotype (CD4(+)CD44(high)CD62L(low)). However, in-vitro proliferation (MLR) and IFN gamma-production (ELISPOT) were markedly reduced with increasing age. Likewise, skin graft rejection was significantly delayed in older recipients and fewer graft infiltrating CD4(+) T-cells were observed. Old CD4(+) T-cells demonstrated a significant impaired responsiveness as indicated by diminished proliferation and activation. In contrast, old alloantigen-specific CD4(+)CD25(+)FoxP3(+) T-cells demonstrated a dose-dependent well-preserved suppressor function. Next, we examined characteristics of 18-month old alloreactive T-cells in a transgenic adoptive transfer model. Adoptively transferred old T-cells proliferated significantly less in response to antigen. Skin graft rejection was significantly delayed in older recipients, and graft infiltrating cells were reduced. In summary, advanced recipient age was associated with delayed acute rejection and impaired CD4(+) T-cell function and proliferation while CD4(+)CD25(+)FoxP3(+) T-cells (Tregs) showed a well-preserved function.	[Denecke, Christian; Bedi, Damanpreet Singh; Ge, Xupeng; Kim, Irene Kyung-eun; Jurisch, Anke; Weiland, Anne; Tullius, Stefan G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Transplant Surg, Boston, MA 02115 USA; [Denecke, Christian; Bedi, Damanpreet Singh; Ge, Xupeng; Kim, Irene Kyung-eun; Jurisch, Anke; Weiland, Anne; Tullius, Stefan G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Transplant Surg Res Lab, Boston, MA 02115 USA; [Habicht, Antje] Brigham & Womens Hosp, Transplantat Res Ctr, Boston, MA 02115 USA; [Habicht, Antje] Childrens Hosp, Boston, MA 02115 USA; [Li, Xian C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Transplant Res Ctr, Sch Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Denecke, C (corresponding author), Univ Hosp Berlin, Dept Gen Transplant & Visceral Surg, Charite, Berlin, Germany.	stullius@partners.org		Li, Xian Chang/0000-0002-5981-2762	Deutsche Forschungsgemeinschaft (DFG) [DE 1452/1-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	C. Denecke was supported by a Deutsche Forschungsgemeinschaft (DFG) Grant DE 1452/1-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Elrefaei M, 2002, VIROLOGY, V299, P8, DOI 10.1006/viro.2002.1367; Fritsche L, 2003, AM J TRANSPLANT, V3, P1434, DOI 10.1046/j.1600-6135.2003.00251.x; Gregg R, 2005, CLIN EXP IMMUNOL, V140, P540, DOI 10.1111/j.1365-2249.2005.02798.x; Habicht A, 2006, J IMMUNOL, V176, P36, DOI 10.4049/jimmunol.176.1.36; Haynes L, 1997, MECH AGEING DEV, V93, P95, DOI 10.1016/S0047-6374(96)01826-X; Haynes L, 2003, P NATL ACAD SCI USA, V100, P15053, DOI 10.1073/pnas.2433717100; Jassal S V, 1997, Geriatr Nephrol Urol, V7, P157, DOI 10.1023/A:1008246129084; Junt T, 2004, J IMMUNOL, V173, P6684, DOI 10.4049/jimmunol.173.11.6684; Kozlowska E, 2007, IMMUNOLOGY, V122, P445, DOI 10.1111/j.1365-2567.2007.02667.x; Linton PJ, 1996, J EXP MED, V184, P1891, DOI 10.1084/jem.184.5.1891; Lufft V, 2000, TRANSPLANTATION, V69, P790; Meier-Kriesche HU, 2000, TRANSPLANTATION, V70, P306, DOI 10.1097/00007890-200007270-00012; Messaoudi I, 2004, J EXP MED, V200, P1347, DOI 10.1084/jem.20040437; Ming JK, 2003, J IMMUNOL, V170, P1556, DOI 10.4049/jimmunol.170.3.1556; Mu XY, 1999, J GERONTOL A-BIOL, V54, pB116, DOI 10.1093/gerona/54.3.B116; Pascher A, 2003, TRANSPLANTATION, V76, P1560, DOI 10.1097/01.TP.0000090161.79609.D3; ROSENBERG AS, 1994, EUR J IMMUNOL, V24, P1312, DOI 10.1002/eji.1830240611; Sandner SE, 2003, AM J TRANSPLANT, V3, P1242, DOI 10.1046/j.1600-6143.2003.00220.x; Sharma S, 2006, J IMMUNOL, V177, P8348, DOI 10.4049/jimmunol.177.12.8348; Shen XH, 2009, CELL STEM CELL, V4, P1, DOI 10.1016/j.stem.2008.12.006; Sun YM, 2004, CELL MOL IMMUNOL, V1, P440; Tesar BM, 2009, AM J TRANSPLANT, V9, P54, DOI 10.1111/j.1600-6143.2008.02458.x; Uppaluri R, 2008, TRANSPLANTATION, V86, P137, DOI 10.1097/TP.0b013e31817b8e4b	24	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9232	10.1371/journal.pone.0009232	http://dx.doi.org/10.1371/journal.pone.0009232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169060	Green Published, Green Submitted, gold			2022-12-25	WOS:000274590500014
J	Chang, TC; Chen, YC; Yang, MH; Chen, CH; Hsing, EW; Ko, BS; Liou, JY; Wu, KK				Chang, Tzu-Ching; Chen, Yen-Chung; Yang, Ming-Hua; Chen, Chien-Hung; Hsing, En-Wei; Ko, Bor-Sheng; Liou, Jun-Yang; Wu, Kenneth K.			Rho Kinases Regulate the Renewal and Neural Differentiation of Embryonic Stem Cells in a Cell Plating Density-Dependent Manner	PLOS ONE			English	Article							SIGNALING PATHWAY; BETA-CATENIN; ROCK; PROTEINS; GTPASES; PHOSPHORYLATION; CYTOKINESIS; MAINTENANCE; COMMITMENT; INHIBITOR	Background: Rho kinases (ROCKs) mediate cell contraction, local adhesion, and cell motility, which are considered to be important in cell differentiation. We postulated that ROCKs are involved in controlling embryonic stem (ES) cell renewal and differentiation. Methodology/Principal Findings: CCE, a murine ES cell, was treated with Y-27632 for 48 to 96 hours and colony formation was evaluated. Y-27632 blocked CCE colony formation and induced CCE to grow as individual cells, regardless of the initial seeding cell density either at 10(4)/cm(2) ("high'' seeding density) or 2 x 10(3)/cm(2) ("low'' density). However, at high seeding density, Y-27632-treated cells exhibited reduction of alkaline phosphatase (AP) staining and Oct3/4 expression. They expressed SOX-1, nestin, and MAP2c, but not beta III-tubulin or NG-2. They did not express endoderm or mesoderm lineage markers. After removal of Y-27632, the cells failed to form colonies or regain undifferentiated state. Silencing of ROCK-1 or ROCK-2 with selective small interference RNA induced CCE morphological changes similar to Y-27632. Silencing of ROCK-1 or ROCK-2 individually was sufficient to cause reduction of AP and Oct3/4, and expression of SOX-1, nestin, and MAP2c; and combined silencing of both ROCKs did not augment the effects exerted by individual ROCK siRNA. Y-27632-treated CCE cells seeded at 2 x 10(3) or 6.6 x 10(3) cells/cm(2) did not lose renewal factors or express differentiation markers. Furthermore, they were able to form AP-positive colonies after removal of Y-27632 and reseeding. Similar to ROCK inhibition by Y-27632, silencing of ROCK-1 or ROCK-2 in cells seeded at 2 x 10(3)/cm(2) did not change renewal factors. Conclusions/Significance: We conclude that ROCKs promote ES cell colony formation, maintain them at undifferentiated state, and prevent them from neural differentiation at high seeding density. ROCK inhibition represents a new strategy for preparing large numbers of neural progenitor cells.	[Chang, Tzu-Ching; Chen, Yen-Chung; Yang, Ming-Hua; Chen, Chien-Hung; Hsing, En-Wei; Liou, Jun-Yang; Wu, Kenneth K.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Ko, Bor-Sheng; Wu, Kenneth K.] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Wu, Kenneth K.] Univ Texas Hlth Sci Ctr, Houston, TX USA	National Health Research Institutes - Taiwan; National Taiwan University; University of Texas System; University of Texas Health Science Center Houston	Chang, TC (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	kkgo@nhri.org.tw	Liou, Jun-Yang/B-1065-2010; Wu, Kenneth Kun-Yu/B-1070-2010	KO, BOR-SHENG/0000-0002-7965-7579	National Science Council, Taiwan; National Health Research Institutes, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by a Stem Cell Flagship Center grant from the National Science Council, Taiwan, and intramural funding from the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Castellani L, 2006, J BIOL CHEM, V281, P15249, DOI 10.1074/jbc.M601390200; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Dietrich C, 2002, BIOCHEM BIOPH RES CO, V292, P195, DOI 10.1006/bbrc.2002.6625; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Liou JY, 2007, STEM CELLS, V25, P1096, DOI 10.1634/stemcells.2006-0505; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMullan R, 2003, CURR BIOL, V13, P2185, DOI 10.1016/S0960-9822(03)00906-0; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Pacary E, 2007, MOL CELL NEUROSCI, V35, P409, DOI 10.1016/j.mcn.2007.04.002; Pacary E, 2006, J CELL SCI, V119, P2667, DOI 10.1242/jcs.03004; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Pelosi M, 2007, MOL CELL BIOL, V27, P6163, DOI 10.1128/MCB.01735-06; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249	30	26	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9187	10.1371/journal.pone.0009187	http://dx.doi.org/10.1371/journal.pone.0009187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169147	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474600008
J	Clarkson, BK; Gilbert, WV; Doudna, JA				Clarkson, Bryan K.; Gilbert, Wendy V.; Doudna, Jennifer A.			Functional Overlap between eIF4G Isoforms in Saccharomyces cerevisiae	PLOS ONE			English	Article							CAP-INDEPENDENT TRANSLATION; INITIATION-FACTOR EIF4G; RIBOSOMAL-RNA SYNTHESIS; FACTOR 4G EIF4G; MESSENGER-RNA; EUKARYOTIC TRANSLATION; PROTEIN-SYNTHESIS; HELICASE ACTIVITY; INTERNAL INITIATION; FEEDBACK-REGULATION	Initiation factor eIF4G is a key regulator of eukaryotic protein synthesis, recognizing proteins bound at both ends of an mRNA to help recruit messages to the small (40S) ribosomal subunit. Notably, the genomes of a wide variety of eukaryotes encode multiple distinct variants of eIF4G. We found that deletion of eIF4G1, but not eIF4G2, impairs growth and global translation initiation rates in budding yeast under standard laboratory conditions. Not all mRNAs are equally sensitive to loss of eIF4G1; genes that encode messages with longer poly(A) tails are preferentially affected. However, eIF4G1-deletion strains contain significantly lower levels of total eIF4G, relative to eIF4G2-delete or wild type strains. Homogenic strains, which encode two copies of either eIF4G1 or eIF4G2 under native promoter control, express a single isoform at levels similar to the total amount of eIF4G in a wild type cell and have a similar capacity to support normal translation initiation rates. Polysome microarray analysis of these strains and the wild type parent showed that translationally active mRNAs are similar. These results suggest that total eIF4G levels, but not isoform-specific functions, determine mRNA-specific translational efficiency.	[Clarkson, Bryan K.; Gilbert, Wendy V.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Clarkson, BK (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu		/0000-0003-2807-9657	NIH [K99]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM081399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a program grant from the NIH (JAD), a K99 award from the NIH (WVG) and an NIH training grant (BKC). JAD is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON RD, 1988, J BIOL CHEM, V263, P6016; Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; [Anonymous], SACCHAROMYCES GENOME; Arava Y, 2005, NUCLEIC ACIDS RES, V33, P2421, DOI 10.1093/nar/gki331; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; Baker CC, 2007, DEVELOPMENT, V134, P2863, DOI 10.1242/dev.003764; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Berset C, 2003, RNA, V9, P871, DOI 10.1261/rna.5380903; Bovee ML, 1998, VIROLOGY, V245, P241, DOI 10.1006/viro.1998.9172; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brachmann CB, 1998, YEAST, V14, P115; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; BROWNING KS, 1992, J BIOL CHEM, V267, P10096; Bushell M, 2002, J CELL BIOL, V158, P395, DOI 10.1083/jcb.200205044; Castello A, 2006, J BIOL CHEM, V281, P33206, DOI 10.1074/jbc.M604340200; Coldwell MJ, 2006, MOL CELL BIOL, V26, P8448, DOI 10.1128/MCB.01248-06; COLE JR, 1987, J MOL BIOL, V198, P383, DOI 10.1016/0022-2836(87)90288-9; Contreras V, 2008, CELL DEATH DIFFER, V15, P1232, DOI 10.1038/cdd.2008.46; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Dominguez D, 1999, J BIOL CHEM, V274, P26720, DOI 10.1074/jbc.274.38.26720; Dominguez D, 2001, BIOCHEM J, V355, P223, DOI 10.1042/0264-6021:3550223; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Franklin-Dumont TM, 2007, DEVELOPMENT, V134, P2851, DOI 10.1242/dev.003517; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gentleman R, 2005, BIOINFORMATICS COMPU, p[xix, 473]; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Glanville JG, 2007, NUCLEIC ACIDS RES, V35, pW27, DOI 10.1093/nar/gkm325; GOYER C, 1993, MOL CELL BIOL, V13, P4860, DOI 10.1128/MCB.13.8.4860; Gradi A, 1998, MOL CELL BIOL, V18, P334, DOI 10.1128/MCB.18.1.334; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Guthrie C., 2002, GUIDE YEAST GENETICS; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hundsdoerfer P, 2005, P NATL ACAD SCI USA, V102, P13421, DOI 10.1073/pnas.0506536102; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kuhn KM, 2001, MOL CELL BIOL, V21, P916, DOI 10.1128/MCB.21.3.916-927.2001; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; LANKER S, 1992, J BIOL CHEM, V267, P21167; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Lee SH, 2006, EMBO J, V25, P4008, DOI 10.1038/sj.emboj.7601268; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li L, 2005, EUKARYOT CELL, V4, P948, DOI 10.1128/EC.4.5.948-959.2005; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marintchev A, 2005, BIOCHEMISTRY-US, V44, P12265, DOI 10.1021/bi051271v; MATHEWS M, 2007, TRANSLATIONAL CONTRO, pR10; MERRICK WC, 2000, CURRENT PROTOCOLS CE; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ng WL, 2003, J BACTERIOL, V185, P359, DOI 10.1128/JB.185.1.359-370.2003; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Rasband W., 2006, IMAGEJ; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Sabina J, 2003, J BACTERIOL, V185, P6158, DOI 10.1128/JB.185.20.6158-6170.2003; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Searfoss AW, 2000, P NATL ACAD SCI USA, V97, P9133, DOI 10.1073/pnas.97.16.9133; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Smirnova JB, 2005, MOL CELL BIOL, V25, P9340, DOI 10.1128/MCB.25.21.9340-9349.2005; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; SPELLMAN PT, 1998, MOL BIOL CELL; Svitkin YV, 1999, J VIROL, V73, P3467, DOI 10.1128/JVI.73.4.3467-3472.1999; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Tuteja Renu, 2009, Communicative & Integrative Biology, V2, P245; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x; von der Haar T, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-87; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; YAMAGISHI M, 1987, J MOL BIOL, V198, P547, DOI 10.1016/0022-2836(87)90299-3; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106	90	45	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9114	10.1371/journal.pone.0009114	http://dx.doi.org/10.1371/journal.pone.0009114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161741	gold, Green Submitted, Green Published			2022-12-25	WOS:000274442600012
J	Zha, WB; Liang, G; Xiao, J; Studer, EJ; Hylemon, PB; Pandak, WM; Wang, GJ; Li, XK; Zhou, HP				Zha, Weibin; Liang, Guang; Xiao, Jian; Studer, Elaine J.; Hylemon, Phillip B.; Pandak, William M., Jr.; Wang, Guangji; Li, Xiaokun; Zhou, Huiping			Berberine Inhibits HIV Protease Inhibitor-Induced Inflammatory Response by Modulating ER Stress Signaling Pathways in Murine Macrophages	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA STABILITY; INFECTED PATIENTS; NATURAL-PRODUCTS; IL-6 EXPRESSION; TNF-ALPHA; KINASE; TRISTETRAPROLIN; MEDICINE; ACTIVATE	Background: HIV protease inhibitor (PI)-induced inflammatory response plays an important role in HIV PI-associated dyslipidemia and cardiovascular complications. This study examined the effect of berberine, a traditional herb medicine, on HIV PI-induced inflammatory response and further investigated the underlying cellular/molecular mechanisms in macrophages. Methodology and Principal Findings: Cultured mouse J774A.1 macrophages and primary mouse macrophages were used in this study. The expression of TNF-alpha and IL-6 were detected by real-time RT-PCR and ELISA. Activations of ER stress and ERK signaling pathways were determined by Western blot analysis. Immunofluorescent staining was used to determine the intracellular localization of RNA binding protein HuR. RNA-pull down assay was used to determine the association of HuR with endogenous TNF-alpha and IL-6. Berberine significantly inhibited HIV PI-induced TNF-alpha and IL-6 expression by modulating ER stress signaling pathways and subsequent ERK activation, in turn preventing the accumulation of the RNA binding protein HuR in cytosol and inhibiting the binding of HuR to the 3'-UTRs of TNF-alpha and IL-6 in macrophages. Conclusions and Significance: Inhibition of ER stress represents a key mechanism by which berberine prevents HIV PI-induced inflammatory response. Our findings provide a new insight into the molecular mechanisms of berberine and show the potential application of berberine as a complimentary therapeutic agent for HIV infection.	[Zha, Weibin; Liang, Guang; Xiao, Jian; Studer, Elaine J.; Hylemon, Phillip B.; Pandak, William M., Jr.; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol & Internal Med Gastroent, Richmond, VA 23284 USA; [Zha, Weibin; Liang, Guang; Xiao, Jian; Studer, Elaine J.; Hylemon, Phillip B.; Pandak, William M., Jr.; Zhou, Huiping] Virginia Commonwealth Univ, McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Zha, Weibin] China Pharmaceut Univ, Nanjing 210009, Peoples R China; [Liang, Guang; Xiao, Jian; Wang, Guangji; Li, Xiaokun; Zhou, Huiping] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China	Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; China Pharmaceutical University; Wenzhou Medical University	Zha, WB (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol & Internal Med Gastroent, Richmond, VA 23284 USA.	wangguangji01@gmail.com; hzhou@vcu.edu	Zhou, Huiping/H-6875-2019; Zhou, Huiping/J-3639-2015	Zhou, Huiping/0000-0002-0050-372X; 	NIH [R01AT004148, R21AI068432, R01AI057189, P01DK38030]; Wenzhou Medical College Key Project fund; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057189, R21AI068432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038030] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenzhou Medical College Key Project fund; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH Grants R01AT004148, R21AI068432, R01AI057189, and P01DK38030. A. D. William fund, and Wenzhou Medical College Key Project fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi P, 2005, ARTERIOSCL THROM VAS, V25, P2170, DOI 10.1161/01.ATV.0000181761.16341.2b; Asztalos BF, 2006, ATHEROSCLEROSIS, V184, P72, DOI 10.1016/j.atherosclerosis.2005.04.013; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chen L, 2009, BIOCHEM PHARMACOL, V78, P70, DOI 10.1016/j.bcp.2009.03.022; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Clevenbergh P, 2003, HIV CLIN TRIALS, V4, P330, DOI 10.1310/8TXF-P814-8JPF-7TRY; Cohen Calvin J, 2005, AIDS Read, V15, P528; Cooper EL, 2005, EVID-BASED COMPL ALT, V2, P125, DOI 10.1093/ecam/neh094; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hotamisligil GS, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.238; Imanshahidi M, 2008, PHYTOTHER RES, V22, P999, DOI 10.1002/ptr.2399; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim S, 2008, PHYTOMEDICINE, V15, P340, DOI 10.1016/j.phymed.2007.09.011; Kim WS, 2009, AM J PHYSIOL-ENDOC M, V296, pE812, DOI 10.1152/ajpendo.90710.2008; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002; Lau CW, 2001, CARDIOVASC DRUG REV, V19, P234; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Lu JY, 2004, J BIOL CHEM, V279, P12974, DOI 10.1074/jbc.M310433200; Martinet W, 2004, Verh K Acad Geneeskd Belg, V66, P61; Newman DJ, 2000, NAT PROD REP, V17, P215, DOI 10.1039/a902202c; Palmerini CA, 2008, J BIOCHEM MOL TOXIC, V22, P35, DOI 10.1002/jbt.20211; Parker RA, 2005, MOL PHARMACOL, V67, P1909, DOI 10.1124/mol.104.010165; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; RASHEVA VI, 2009, APOPTOSIS; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Spector AA, 2006, ARTERIOSCL THROM VAS, V26, P7, DOI 10.1161/01.ATV.0000198749.28422.29; Yeni P, 2006, J HEPATOL, V44, pS100, DOI 10.1016/j.jhep.2005.11.021; Yin Jun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P99, DOI 10.2174/187153008784534330; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898; Zhou Huiping, 2007, Atherosclerosis, V195, pe134, DOI 10.1016/j.atherosclerosis.2007.04.008; Zhou HP, 2006, AM J PHYSIOL-GASTR L, V291, pG1071, DOI 10.1152/ajpgi.00182.2006; Zhu XZ, 2004, EUR J PHARMACOL, V500, P221, DOI 10.1016/j.ejphar.2004.07.027	36	54	59	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9069	10.1371/journal.pone.0009069	http://dx.doi.org/10.1371/journal.pone.0009069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161729	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442600004
J	Loayza-Puch, F; Yoshida, Y; Matsuzaki, T; Takahashi, C; Kitayama, H; Noda, M				Loayza-Puch, F.; Yoshida, Y.; Matsuzaki, T.; Takahashi, C.; Kitayama, H.; Noda, M.			Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs	ONCOGENE			English	Article						RECK; invasion; metastasis; MMP; hypoxia; RAS	GENE-EXPRESSION; MESENCHYMAL TRANSITION; INVASION; MIR-21; METASTASIS; INVOLVEMENT; GROWTH; INHIBITION; APOPTOSIS; CELLS	Cancer cells show characteristic gene expression profiles. Recent studies support the potential importance of microRNA (miRNA) expression signatures as biomarkers and therapeutic targets. The membrane-anchored protease regulator RECK is downregulated in many cancers, and forced expression of RECK in tumor cells results in decreased malignancy in animal models. RECK is also essential for mammalian development. In this study, we found that RECK is a target of at least three groups of miRNAs (miR-15b/16, miR-21 and miR-372/373); that RECK mutants lacking the target sites for these miRNA show augmented tumor/metastasis-suppressor activities; and that miR-372/373 are upregulated in response to hypoxia through HIF1 alpha and TWIST1, whereas miR-21 is upregulated by RAS/ERK signaling. These data indicate that the hypoxia- and RAS-signaling pathways converge on RECK through miRNAs, cooperatively downregulating this tumor suppressor and thereby promoting malignant cell behavior. Oncogene (2010) 29, 2638-2648; doi:10.1038/onc.2010.23; published online 15 February 2010	[Noda, M.] Kyoto Univ, Dept Mol Oncol, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Noda, M (corresponding author), Kyoto Univ, Dept Mol Oncol, Grad Sch Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	mnoda@virus.kyoto-u.ac.jp		Loayza-Puch, Fabricio/0000-0002-2999-8594	JSPS; MEXT; Grants-in-Aid for Scientific Research [22501010] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Takao Miki, EPS Chandana and Awad Shamma for valuable discussion; Masahiro Sonoshita for advice on animal experiments; Aiko Nishimoto and Hai-Ou Gu for technical support; Aki Miyazaki for secretarial assistance and David B Alexander and Oana Maria Cusen for critical reading of the paper. This work was supported by a Grant-in-Aid for Creative Scientific Research from JSPS. FL has been supported by fellowships from MEXT and the Global COE Program, JSPS.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hill RP, 2009, SEMIN RADIAT ONCOL, V19, P106, DOI 10.1016/j.semradonc.2008.12.002; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Hsu MC, 2006, J BIOL CHEM, V281, P4718, DOI 10.1074/jbc.M510937200; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Morioka Y, 2009, ONCOGENE, V28, P1454, DOI 10.1038/onc.2008.486; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Noda M, 2007, CANCER SCI, V98, P1659, DOI 10.1111/j.1349-7006.2007.00588.x; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Paumelle R, 2002, ONCOGENE, V21, P2309, DOI 10.1038/sj.onc.1205297; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sasahara RM, 1999, BIOCHEM BIOPH RES CO, V264, P668, DOI 10.1006/bbrc.1999.1552; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; WANG GL, 1993, BLOOD, V82, P3610; Yang L, 2008, WD SCI P COMP ENG, V1, P295, DOI 10.1142/9789812799470_0048; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	43	90	93	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2010	29	18					2638	2648		10.1038/onc.2010.23	http://dx.doi.org/10.1038/onc.2010.23			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	592DC	20154725	Green Submitted			2022-12-25	WOS:000277354600004
J	Chevalier, C; Al Bazzal, A; Vidic, J; Fevrier, V; Bourdieu, C; Bouguyon, E; Le Goffic, R; Vautherot, JF; Bernard, J; Moudjou, M; Noinville, S; Chich, JF; Da Costa, B; Rezaei, H; Delmas, B				Chevalier, Christophe; Al Bazzal, Ali; Vidic, Jasmina; Fevrier, Vincent; Bourdieu, Christiane; Bouguyon, Edwige; Le Goffic, Ronan; Vautherot, Jean-Francois; Bernard, Julie; Moudjou, Mohammed; Noinville, Sylvie; Chich, Jean-Francois; Da Costa, Bruno; Rezaei, Human; Delmas, Bernard			PB1-F2 Influenza A Virus Protein Adopts a beta-Sheet Conformation and Forms Amyloid Fibers in Membrane Environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE; MITOCHONDRIAL PROTEIN; MISFOLDING DISEASES; ALZHEIMERS-DISEASE; UNFOLDED PROTEINS; THIOFLAVINE-T; PEPTIDES; BINDING; DOMAIN; GENE	The influenza A virus PB1-F2 protein, encoded by an alternative reading frame in the PB1 polymerase gene, displays a high sequence polymorphism and is reported to contribute to viral pathogenesis in a sequence-specific manner. To gain insights into the functions of PB1-F2, the molecular structure of several PB1-F2 variants produced in Escherichia coli was investigated in different environments. Circular dichroism spectroscopy shows that all variants have a random coil secondary structure in aqueous solution. When incubated in trifluoroethanol polar solvent, all PB1-F2 variants adopt an alpha-helix-rich structure, whereas incubated in acetonitrile, a solvent of medium polarity mimicking the membrane environment, they display beta-sheet secondary structures. Incubated with asolectin liposomes and SDS micelles, PB1-F2 variants also acquire a beta-sheet structure. Dynamic light scattering revealed that the presence of beta-sheets is correlated with an oligomerization/aggregation of PB1-F2. Electron microscopy showed that PB1-F2 forms amorphous aggregates in acetonitrile. In contrast, at low concentrations of SDS, PB1-F2 variants exhibited various abilities to form fibers that were evidenced as amyloid fibers in a thioflavin T assay. Using a recombinant virus and its PB1-F2 knock-out mutant, we show that PB1-F2 also forms amyloid structures in infected cells. Functional membrane permeabilization assays revealed that the PB1-F2 variants can perforate membranes at nanomolar concentrations but with activities found to be sequence-dependent and not obviously correlated with their differential ability to form amyloid fibers. All of these observations suggest that PB1-F2 could be involved in physiological processes through different pathways, permeabilization of cellular membranes, and amyloid fiber formation.	[Chevalier, Christophe; Al Bazzal, Ali; Vidic, Jasmina; Fevrier, Vincent; Bourdieu, Christiane; Bouguyon, Edwige; Le Goffic, Ronan; Bernard, Julie; Moudjou, Mohammed; Noinville, Sylvie; Chich, Jean-Francois; Da Costa, Bruno; Rezaei, Human; Delmas, Bernard] INRA, Ctr Rech Jouy En Josas, Unite Virol & Immunol Mol, UR892, F-78350 Jouy En Josas, France; [Vautherot, Jean-Francois] INRA, Unite Infectiol Anim & Sante Publ, UR1282, Ctr Tours, F-37380 Nouzilly, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Chevalier, C (corresponding author), INRA Jouy En Josas, Ctr Rech, Equipe Virus Influenza, Unite VIM, Batiment 440, F-78350 Jouy En Josas, France.	christophe.chevalier@jouy.inra.fr	LE GOFFIC, Ronan/B-7649-2008; Chevalier, Christophe/AAW-5560-2020; LE GOFFIC, Ronan/M-3099-2019; Vidic, Jasmina/AFP-6747-2022; Noinville, Sylvie/S-8318-2019; Chevalier, Christophe/AAK-4461-2020; Chevalier, Christophe/C-2575-2009; Noinville, Sylvie/B-1086-2009	LE GOFFIC, Ronan/0000-0002-2012-0064; LE GOFFIC, Ronan/0000-0002-2012-0064; Vidic, Jasmina/0000-0002-8549-8199; Noinville, Sylvie/0000-0002-8320-9488; Chevalier, Christophe/0000-0003-3231-9027; 				BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Basler CF, 2008, ANTIVIR RES, V79, P166, DOI 10.1016/j.antiviral.2008.04.006; Bruns K, 2007, J BIOL CHEM, V282, P353, DOI 10.1074/jbc.M606494200; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Chang DK, 1997, J VIROL, V71, P6593, DOI 10.1128/JVI.71.9.6593-6602.1997; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2007, CELL HOST MICROBE, V2, P207, DOI 10.1016/j.chom.2007.09.010; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Engel MFM, 2009, CHEM PHYS LIPIDS, V160, P1, DOI 10.1016/j.chemphyslip.2009.03.008; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Freire E, 2008, PROTEINS, V70, P450, DOI 10.1002/prot.21580; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Henklein P, 2005, J PEPT SCI, V11, P481, DOI 10.1002/psc.641; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; KAMLET MJ, 1977, J AM CHEM SOC, V99, P6027, DOI 10.1021/ja00460a031; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Lamb RA, 2001, NAT MED, V7, P1286, DOI 10.1038/nm1201-1286; Lashuel HA., 2005, SCI AGING KNOWLEDGE; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004; Lowy RJ, 2003, INT REV IMMUNOL, V22, P425, DOI 10.1080/08830180305216; Mazur I, 2008, CELL MICROBIOL, V10, P1140, DOI 10.1111/j.1462-5822.2008.01116.x; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McLean JE, 2009, J VIROL, V83, P8233, DOI 10.1128/JVI.02672-08; Montserret R, 1999, BIOCHEMISTRY-US, V38, P6479, DOI 10.1021/bi9900222; Montserret R, 2000, BIOCHEMISTRY-US, V39, P8362, DOI 10.1021/bi000208x; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Najbar LV, 1997, BIOCHEMISTRY-US, V36, P11525, DOI 10.1021/bi970730s; PALESE P, 1977, CELL, V10, P1, DOI 10.1016/0092-8674(77)90133-7; Pancucharova H, 2006, ACTA VIROL, V50, P269; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Pulliam L, 2009, J NEUROIMMUNE PHARM, V4, P213, DOI 10.1007/s11481-009-9151-9; Roder R, 2008, J PEPT SCI, V14, P954, DOI 10.1002/psc.1031; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sun AY, 2002, J HISTOCHEM CYTOCHEM, V50, P463, DOI 10.1177/002215540205000403; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Wetzler DE, 2007, PROTEIN SCI, V16, P744, DOI 10.1110/ps.062594007; Wojtowicz WM, 2002, J BIOL CHEM, V277, P35019, DOI 10.1074/jbc.M203518200; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0; Zell R, 2006, EMERG INFECT DIS, V12, P1607, DOI 10.3201/eid1210.060511; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462	56	52	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13233	13243		10.1074/jbc.M109.067710	http://dx.doi.org/10.1074/jbc.M109.067710			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20172856	Green Published, hybrid			2022-12-25	WOS:000276787800078
J	Hoshino, T; Matsuda, M; Yamashita, Y; Takehara, M; Fukuya, M; Mineda, K; Maji, D; Ihn, H; Adachi, H; Sobue, G; Funasaka, Y; Mizushima, T				Hoshino, Tatsuya; Matsuda, Minoru; Yamashita, Yasuhiro; Takehara, Masaya; Fukuya, Masayo; Mineda, Kazutaka; Maji, Daisuke; Ihn, Hironobu; Adachi, Hiroaki; Sobue, Gen; Funasaka, Yoko; Mizushima, Tohru			Suppression of Melanin Production by Expression of HSP70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; INDUCED GASTRIC-LESIONS; HUMAN SKIN PIGMENTATION; CELL-LINE; IN-VITRO; ULTRAVIOLET-RADIATION; GENETIC-EVIDENCE; EXCISION-REPAIR; INDUCED COLITIS; PROTECTIVE ROLE	Skin hyperpigmentation disorders due to abnormal melanin production induced by ultraviolet (UV) irradiation are both a clinical and cosmetic problem. UV irradiation stimulates melanin production in melanocytes by increasing intracellular cAMP. Expression of heat shock proteins (HSPs), especially HSP70, is induced by various stressors, including UV irradiation, to provide cellular resistance to such stressors. In this study we examined the effect of expression of HSP70 on melanin production both in vitro and in vivo. 3-Isobutyl-1-methylxanthine (IBMX), a cAMP-elevating agent, stimulated melanin production in cultured mouse melanoma cells, and this stimulation was suppressed in cells overexpressing HSP70. IBMX-dependent transcriptional activation of the tyrosinase gene was also suppressed in HSP70-overexpressing cells. Expression of microphthalmia-associated transcription factor (MITF), which positively regulates transcription of the tyrosinase gene, was up-regulated by IBMX; however, this up-regulation was not suppressed in HSP70-overexpressing cells. On the other hand, immunoprecipitation and immunostaining analyses revealed a physical interaction between and co-localization of MITF and HSP70, respectively. Furthermore, the transcription of tyrosinase gene in nuclear extract was inhibited by HSP70. In vivo, UV irradiation of wild-type mice increased the amount of melanin in the basal layer of the epidermis, and this increase was suppressed in transgenic mice expressing HSP70. This study provides the first evidence of an inhibitory effect of HSP70 on melanin production both in vitro and in vivo. This effect seems to be mediated by modulation of MITF activity through a direct interaction between HSP70 and MITF.	[Hoshino, Tatsuya; Matsuda, Minoru; Yamashita, Yasuhiro; Takehara, Masaya; Fukuya, Masayo; Ihn, Hironobu; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan; [Mineda, Kazutaka; Maji, Daisuke] Saishunkan Pharmaceut Co Ltd, Kumamoto 8612201, Japan; [Adachi, Hiroaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Funasaka, Yoko] Kobe Univ, Grad Sch Med, Kobe, Hyogo 6500017, Japan	Kumamoto University; Nagoya University; Kobe University	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp	Adachi, Hiroaki/AAM-7812-2020	Adachi, Hiroaki/0000-0002-9302-4663	Ministry of Health, Labour, and Welfare of Japan; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Health, Labour, and Welfare of Japan as well as the Japan Science and Technology Agency and grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Agar N, 2005, MUTAT RES-FUND MOL M, V571, P121, DOI 10.1016/j.mrfmmm.2004.11.016; Allanson M, 2004, J INVEST DERMATOL, V122, P1030, DOI 10.1111/j.0022-202X.2004.22421.x; Ando H, 2007, J INVEST DERMATOL, V127, P751, DOI 10.1038/sj.jid.5700683; Asano T, 2009, J PHARMACOL EXP THER, V330, P458, DOI 10.1124/jpet.109.152181; Bases R, 2006, CELL STRESS CHAPERON, V11, P240, DOI 10.1379/CSC-185R.1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; BUSTAMANTE J, 1993, PIGM CELL RES, V6, P348, DOI 10.1111/j.1600-0749.1993.tb00612.x; Costin GE, 2007, FASEB J, V21, P976, DOI 10.1096/fj.06-6649rev; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Douki T, 2003, BIOCHEMISTRY-US, V42, P9221, DOI 10.1021/bi034593c; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gutsmann-Conrad A, 1998, EXP CELL RES, V241, P404, DOI 10.1006/excr.1998.4069; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Ito T, 2005, BRIT J DERMATOL, V152, P623, DOI 10.1111/j.1365-2133.2005.06453.x; Jonak C., 2006, International Journal of Cosmetic Science, V28, P233, DOI 10.1111/j.1467-2494.2006.00327.x; Kim DS, 2007, ARCH PHARM RES, V30, P581, DOI 10.1007/BF02977652; Kim DS, 2005, CELL SIGNAL, V17, P1023, DOI 10.1016/j.cellsig.2004.11.020; Kim KS, 2006, PIGM CELL RES, V19, P90, DOI 10.1111/j.1600-0749.2005.00281.x; Kimura K, 2007, J BIOL CHEM, V282, P5910, DOI 10.1074/jbc.M609025200; Kobayashi N, 1998, J INVEST DERMATOL, V110, P806, DOI 10.1046/j.1523-1747.1998.00178.x; Kwon SB, 2002, J DERMATOL SCI, V28, P144, DOI 10.1016/S0923-1811(01)00156-6; Lei TC, 2002, ANAL BIOCHEM, V305, P260, DOI 10.1006/abio.2002.5665; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Matsuda M, 2010, J BIOL CHEM, V285, P5848, DOI 10.1074/jbc.M109.063453; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; MAYTIN EV, 1994, J INVEST DERMATOL, V103, P547, DOI 10.1111/1523-1747.ep12396274; McMillan TJ, 2008, J PHARM PHARMACOL, V60, P969, DOI 10.1211/jpp.60.8.0004; Mima S, 2005, CANCER RES, V65, P1868, DOI 10.1158/0008-5472.CAN-04-2770; Miyamura Y, 2007, PIGM CELL RES, V20, P2, DOI 10.1111/j.1600-0749.2006.00358.x; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Morris SD, 2002, CLIN EXP DERMATOL, V27, P220, DOI 10.1046/j.1365-2230.2002.01012.x; Murakami M, 2007, MOL CELL BIOCHEM, V303, P251, DOI 10.1007/s11010-007-9474-x; Namba T, 2009, J BIOL CHEM, V284, P4158, DOI 10.1074/jbc.M806051200; Ohkawara T, 2005, SCAND J GASTROENTERO, V40, P1049, DOI 10.1080/00365520510023161; Ohkawara T, 2006, INT J MOL MED, V17, P229; Park HY, 2006, BIOCHEM J, V395, P571, DOI 10.1042/BJ20051388; Park KC, 2000, ARCH DERMATOL RES, V292, P482, DOI 10.1007/s004030000173; Rabe JH, 2006, J AM ACAD DERMATOL, V55, P1, DOI 10.1016/j.jaad.2005.05.010; Rattan SIS, 1998, BIOCHEM MOL BIOL INT, V45, P753; Shorrocks J, 2008, J INVEST DERMATOL, V128, P685, DOI 10.1038/sj.jid.5701037; SIMON MM, 1995, J CLIN INVEST, V95, P926, DOI 10.1172/JCI117800; Sturm RA, 2003, PIGM CELL RES, V16, P266, DOI 10.1034/j.1600-0749.2003.00041.x; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; Svobodova Alena, 2006, Biomedical Papers (Olomouc), V150, P25; Takehara M, 2008, BIOCHEM J, V413, P535, DOI 10.1042/BJ20070484; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; Tanaka KI, 2007, MOL PHARMACOL, V71, P985, DOI 10.1124/mol.106.033282; Trautinger F, 1996, J INVEST DERMATOL, V107, P442, DOI 10.1111/1523-1747.ep12365498; TRAUTINGER F, 1995, J INVEST DERMATOL, V105, P160, DOI 10.1111/1523-1747.ep12317003; Trautinger F, 1999, EXP DERMATOL, V8, P187, DOI 10.1111/j.1600-0625.1999.tb00369.x; Trautinger F, 2001, J PHOTOCH PHOTOBIO B, V63, P70, DOI 10.1016/S1011-1344(01)00203-2; Wilson N, 2000, J CUTAN PATHOL, V27, P176, DOI 10.1034/j.1600-0560.2000.027004176.x; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; YAMASHITA Y, 2010, EXP DERMATO IN PRESS; Yang JY, 2006, ACTA PHARMACOL SIN, V27, P1467, DOI 10.1111/j.1745-7254.2006.00435.x; Zou Y, 1998, J BIOL CHEM, V273, P12887, DOI 10.1074/jbc.273.21.12887	62	36	38	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13254	13263		10.1074/jbc.M110.103051	http://dx.doi.org/10.1074/jbc.M110.103051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177067	Green Published, hybrid			2022-12-25	WOS:000276787800080
J	Swift, S; Xu, J; Trivedi, V; Austin, KM; Tressel, SL; Zhang, L; Covic, L; Kuliopulos, A				Swift, Steven; Xu, Jian; Trivedi, Vishal; Austin, Karyn M.; Tressel, Sarah L.; Zhang, Lei; Covic, Lidija; Kuliopulos, Athan			A Novel Protease-activated Receptor-1 Interactor, Bicaudal D1, Regulates G Protein Signaling and Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN RECEPTOR; BETA-ARRESTINS; DOWN-REGULATION; PAR1; TERMINATION; KINASE; DYNEIN; DESENSITIZATION; INHIBITION; MECHANISM	Protease-activated receptor-1 (PAR1) is a G protein-coupled receptor that plays critical roles in cancer, angiogenesis, inflammation, and thrombosis. Proteolytic cleavage of the extracellular domain of PAR1 generates a tethered ligand that activates PAR1 in an unusual intramolecular mode. The signal emanating from the irreversibly cleaved PAR1 is terminated by G protein uncoupling and internalization; however, the mechanisms of PAR1 signal shut off still remain unclear. Using a yeast two-hybrid screen, we identified Bicaudal D1 (BicD1) as a direct interactor with the C-terminal cytoplasmic domain of PAR1. BICD was originally identified as an essential developmental gene associated with mRNA and Golgi-endoplasmic reticulum transport. We discovered a novel function of BicD1 in the modulation of G protein signaling, cell proliferation, and endocytosis downstream of PAR1. BicD1 and its C-terminal CC3 domain inhibited PAR1 signaling to G(q)-phospholipase C-beta through coiled-coil interactions with the cytoplasmic 8th helix of PAR1. Unexpectedly, BicD1 was also found to be a potent suppressor of PAR1-driven proliferation of breast carcinoma cells. The growth-suppressing effects of BicD1 required the ability to interact with the 8th helix of PAR1. Silencing of BicD1 expression impaired endocytosis of PAR1, and BicD1 co-localized with PAR1 and tubulin, implicating BicD1 as an important adapter protein involved in the transport of PAR1 from the plasma membrane to endosomal vesicles. Together, these findings provide a link between PAR1 signal termination and internalization through the non-G protein effector, BicD1.	[Kuliopulos, Athan] Tufts Univ, Sch Med, Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University	Kuliopulos, A (corresponding author), Tufts Univ, Sch Med, Tufts Med Ctr, Mol Oncol Res Inst, Box 7510,750 Washington St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu		Swift, Steven/0000-0002-3840-4401	National Institutes of Health [F32 HL10296, T32 CA65441, R01-HL64701, R01-CA122992, R01-HL57905]; Susan G. Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA122992, T32CA065441] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057905, R01HL064701, F32HL010296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 HL10296 (to S. S.), T32 CA65441 (to L.Z.), and R01-HL64701, R01-CA122992, and R01-HL57905 (to A. K.). This work was also supported by the Susan G. Komen Breast Cancer Foundation (A. K.).	Baens M, 1997, GENOMICS, V45, P601, DOI 10.1006/geno.1997.4971; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Brzostowski JA, 2001, TRENDS BIOCHEM SCI, V26, P291, DOI 10.1016/S0968-0004(01)01804-7; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; Claussen M, 2005, ANN ANAT, V187, P539, DOI 10.1016/j.aanat.2005.07.004; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dhanasekaran N, 1998, ONCOGENE, V17, P1383, DOI 10.1038/sj.onc.1202242; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Hammes SR, 1999, BIOCHEMISTRY-US, V38, P2486, DOI 10.1021/bi982527i; Holland PM, 2002, J BIOL CHEM, V277, P16229, DOI 10.1074/jbc.M108662200; Houalla T, 2005, MECH DEVELOP, V122, P97, DOI 10.1016/j.mod.2004.08.005; ISHII K, 1994, J BIOL CHEM, V269, P1125; Kamath L, 2001, CANCER RES, V61, P5933; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Luttrell LM, 2002, J CELL SCI, V115, P455; Mach JM, 1997, GENE DEV, V11, P423, DOI 10.1101/gad.11.4.423; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; McLaughlin JN, 2005, J BIOL CHEM, V280, P25048, DOI 10.1074/jbc.M414090200; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Paing MM, 2004, J BIOL CHEM, V279, P21938, DOI 10.1074/jbc.M401672200; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Pawlinski R, 2007, CIRCULATION, V116, P2298, DOI 10.1161/CIRCULATIONAHA.107.692764; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Rothwell SW, 1997, THROMB HAEMOSTASIS, V78, P910; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Stuurman N, 1999, EUR J CELL BIOL, V78, P278, DOI 10.1016/S0171-9335(99)80061-2; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Tiruppathi C, 2000, P NATL ACAD SCI USA, V97, P7440, DOI 10.1073/pnas.97.13.7440; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; VanObberghenSchilling E, 1995, ANN NY ACAD SCI, V766, P431, DOI 10.1111/j.1749-6632.1995.tb26692.x; VOURETCRAVIARI V, 1992, MOL BIOL CELL, V3, P95, DOI 10.1091/mbc.3.1.95; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wang YJ, 2002, MOL BIOL CELL, V13, P1965, DOI 10.1091/mbc.E01-11-0131; WHARTON RP, 1989, CELL, V59, P881, DOI 10.1016/0092-8674(89)90611-9; Zain J, 2000, BLOOD, V95, P3133	40	24	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11402	11410		10.1074/jbc.M110.105403	http://dx.doi.org/10.1074/jbc.M110.105403			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20164183	Green Published, hybrid			2022-12-25	WOS:000276286200046
J	Bouzigues, C; Holcman, D; Dahan, M				Bouzigues, Cedric; Holcman, David; Dahan, Maxime			A Mechanism for the Polarity Formation of Chemoreceptors at the Growth Cone Membrane for Gradient Amplification during Directional Sensing	PLOS ONE			English	Article							CELL POLARITY; DICTYOSTELIUM-DISCOIDEUM; EUKARYOTIC CHEMOTAXIS; MOLECULAR GRADIENTS; GABA(A) RECEPTOR; GUIDANCE CUES; AXONS; DYNAMICS; PROTEIN; POLARIZATION	Accurate response to external directional signals is essential for many physiological functions such as chemotaxis or axonal guidance. It relies on the detection and amplification of gradients of chemical cues, which, in eukaryotic cells, involves the asymmetric relocalization of signaling molecules. How molecular events coordinate to induce a polarity at the cell level remains however poorly understood, particularly for nerve chemotaxis. Here, we propose a model, inspired by single-molecule experiments, for the membrane dynamics of GABA chemoreceptors in nerve growth cones (GCs) during directional sensing. In our model, transient interactions between the receptors and the microtubules, coupled to GABA-induced signaling, provide a positive-feedback loop that leads to redistribution of the receptors towards the gradient source. Using numerical simulations with parameters derived from experiments, we find that the kinetics of polarization and the steady-state polarized distribution of GABA receptors are in remarkable agreement with experimental observations. Furthermore, we make predictions on the properties of the GC seen as a sensing, amplification and filtering module. In particular, the growth cone acts as a low-pass filter with a time constant,10 minutes determined by the Brownian diffusion of chemoreceptors in the membrane. This filtering makes the gradient amplification resistent to rapid fluctuations of the external signals, a beneficial feature to enhance the accuracy of neuronal wiring. Since the model is based on minimal assumptions on the receptor/cytoskeleton interactions, its validity extends to polarity formation beyond the case of GABA gradient sensing. Altogether, it constitutes an original positive-feedback mechanism by which cells can dynamically adapt their internal organization to external signals.	[Bouzigues, Cedric] Ecole Polytech, CNRS, INSERM, Lab Opt & Biosci,U696, F-7645 Palaiseau, France; [Holcman, David; Dahan, Maxime] Ecole Normale Super, Dept Biol, F-75231 Paris, France; [Dahan, Maxime] Univ Paris 06, CNRS, Ecole Normale Super, Lab Kastler Brossel,UMR 8552, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS)	Bouzigues, C (corresponding author), Ecole Polytech, CNRS, INSERM, Lab Opt & Biosci,U696, F-7645 Palaiseau, France.	cedric.bouzigues@polytechnique.edu	Holcman, David/L-9243-2013; Dahan, Maxime/F-1740-2010	holcman, david/0000-0001-9854-5014; Dahan, Maxime/0000-0002-4943-2491	Fondation pour la recherche medicale; Fondation Pierre-Gilles de Gennes	Fondation pour la recherche medicale(Fondation pour la Recherche Medicale); Fondation Pierre-Gilles de Gennes	Sources of funding: Fondation pour la recherche medicale (www.frm.org) - Fondation Pierre-Gilles de Gennes (www.fondation-pgg.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Bak M, 2003, DEVELOPMENT, V130, P4999, DOI 10.1242/dev.00713; BOUZIGUES C, 2007, BIOPHYSICAL J, V92; Bouzigues Cedric, 2007, Methods Mol Biol, V374, P81; Bouzigues C, 2007, P NATL ACAD SCI USA, V104, P11251, DOI 10.1073/pnas.0702536104; Bray D, 1998, ANNU REV BIOPH BIOM, V27, P59, DOI 10.1146/annurev.biophys.27.1.59; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; CARUNCHO HJ, 1995, NEUROSCIENCE, V67, P583, DOI 10.1016/0306-4522(95)00065-Q; Causin P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000479; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; de Keijzer S, 2008, J CELL SCI, V121, P1750, DOI 10.1242/jcs.030692; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; EDIDIN M, 1994, P NATL ACAD SCI USA, V91, P1378; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; FLYVBJERG H, 1994, PHYS REV LETT, V73, P2372, DOI 10.1103/PhysRevLett.73.2372; Franca-Koh J, 2004, PHYSIOLOGY, V19, P300, DOI 10.1152/physiol.00017.2004; Fukura H, 1996, J NEUROCHEM, V67, P1426; Gamba A, 2005, P NATL ACAD SCI USA, V102, P16927, DOI 10.1073/pnas.0503974102; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; Huberman AD, 2007, CURR OPIN NEUROBIOL, V17, P73, DOI 10.1016/j.conb.2007.01.005; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Karsenti E, 2006, NAT CELL BIOL, V8, P1204, DOI 10.1038/ncb1498; Kulkarni RP, 2007, P NATL ACAD SCI USA, V104, P1207, DOI 10.1073/pnas.0610142104; LEUNG KM, 2006, NAT NEUROSCI, V9, P1201; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Ma L, 2004, BIOPHYS J, V87, P3764, DOI 10.1529/biophysj.104.045484; Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Meinhardt H, 1999, J CELL SCI, V112, P2867; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Morel M, 2009, LAB CHIP, V9, P1011, DOI 10.1039/b819090a; Mortimer D, 2008, TRENDS NEUROSCI, V31, P90, DOI 10.1016/j.tins.2007.11.008; Mortimer D, 2009, P NATL ACAD SCI USA, V106, P10296, DOI 10.1073/pnas.0900715106; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; POSTMA M, 2001, BIOPHYS J, V81, P612; Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Singer A, 2006, J STAT PHYS, V122, P437, DOI 10.1007/s10955-005-8026-6; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stepanova T, 2003, J NEUROSCI, V23, P2655; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Suter DM, 2004, CURR BIOL, V14, P1194, DOI 10.1016/j.cub.2004.06.049; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; von Philipsborn A, 2007, INT REV CYTOL, V263, P1, DOI 10.1016/S0074-7696(07)63001-0; Wang CJ, 2008, LAB CHIP, V8, P227, DOI 10.1039/b713945d; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	59	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9243	10.1371/journal.pone.0009243	http://dx.doi.org/10.1371/journal.pone.0009243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179770	Green Published, gold			2022-12-25	WOS:000274923900003
J	Sammons, MA; Antons, AK; Bendjennat, M; Udd, B; Krahe, R; Link, AJ				Sammons, Morgan A.; Antons, Amanda K.; Bendjennat, Mourad; Udd, Bjarne; Krahe, Ralf; Link, Andrew J.			ZNF9 Activation of IRES-Mediated Translation of the Human ODC mRNA Is Decreased in Myotonic Dystrophy Type 2	PLOS ONE			English	Article							EXPANDED-REPEAT TRANSCRIPTS; TRANS-ACTING FACTORS; MASS-SPECTROMETRY; T-CELLS; IN-VIVO; PROTEIN TRANSLATION; CUG REPEATS; LA PROTEIN; DM2; EXPRESSION	Myotonic dystrophy types 1 and 2 (DM1 and DM2) are forms of muscular dystrophy that share similar clinical and molecular manifestations, such as myotonia, muscle weakness, cardiac anomalies, cataracts, and the presence of defined RNA-containing foci in muscle nuclei. DM2 is caused by an expansion of the tetranucleotide CCTG repeat within the first intron of ZNF9, although the mechanism by which the expanded nucleotide repeat causes the debilitating symptoms of DM2 is unclear. Conflicting studies have led to two models for the mechanisms leading to the problems associated with DM2. First, a gain-of-function disease model hypothesizes that the repeat expansions in the transcribed RNA do not directly affect ZNF9 function. Instead repeat-containing RNAs are thought to sequester proteins in the nucleus, causing misregulation of normal cellular processes. In the alternative model, the repeat expansions impair ZNF9 function and lead to a decrease in the level of translation. Here we examine the normal in vivo function of ZNF9. We report that ZNF9 associates with actively translating ribosomes and functions as an activator of cap-independent translation of the human ODC mRNA. This activity is mediated by direct binding of ZNF9 to the internal ribosome entry site sequence (IRES) within the 5'UTR of ODC mRNA. ZNF9 can activate IRES-mediated translation of ODC within primary human myoblasts, and this activity is reduced in myoblasts derived from a DM2 patient. These data identify ZNF9 as a regulator of cap-independent translation and indicate that ZNF9 activity may contribute mechanistically to the myotonic dystrophy type 2 phenotype.	[Sammons, Morgan A.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Udd, Bjarne] Univ Helsinki, Dept Med Genet, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; [Udd, Bjarne] Tampere Univ Hosp & Med Sch, Neuromuscular Res Unit, Tampere, Finland; [Udd, Bjarne] Vasa Cent Hosp, Dept Neurol, Vaasa, Finland; [Krahe, Ralf] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Antons, Amanda K.; Bendjennat, Mourad; Link, Andrew J.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA	Vanderbilt University; University of Helsinki; Tampere University; Tampere University Hospital; Vaasa Central Hospital; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University	Sammons, MA (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	andrew.link@vanderbilt.edu			National Institutes of Health (NIH) [AR055231, GM064779]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR055231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064779] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.J.L. was supported by National Institutes of Health (NIH) grants AR055231 and GM064779. M. A. S. was supported by National Institutes of Health (NIH) grant AR055231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2006, DEV BIOL, V295, P116, DOI 10.1016/j.ydbio.2006.03.012; Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; Amack JD, 2002, J CELL BIOL, V159, P419, DOI 10.1083/jcb.200206020; Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Botta A, 2006, BBA-MOL BASIS DIS, V1762, P329, DOI 10.1016/j.bbadis.2005.11.004; Cardinali B, 2003, J BIOL CHEM, V278, P35145, DOI 10.1074/jbc.M300722200; Chen W, 2003, DEVELOPMENT, V130, P1367, DOI 10.1242/dev.00349; Chen W, 2007, J MOL BIOL, V368, P8, DOI 10.1016/j.jmb.2007.01.088; Cho DH, 2007, BBA-MOL BASIS DIS, V1772, P195, DOI 10.1016/j.bbadis.2006.05.013; Crosio C, 2000, NUCLEIC ACIDS RES, V28, P2927, DOI 10.1093/nar/28.15.2927; Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9; de Haro M, 2006, HUM MOL GENET, V15, P2138, DOI 10.1093/hmg/ddl137; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Gerbasi VR, 2007, MOL CELL PROTEOMICS, V6, P1049, DOI 10.1074/mcp.M600384-MCP200; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Huichalaf C, 2009, J NEUROSCI, V29, P9042, DOI 10.1523/JNEUROSCI.1983-09.2009; Link AJ, 2005, METHODS, V35, P274, DOI 10.1016/j.ymeth.2004.08.019; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Margolis JM, 2006, HUM MOL GENET, V15, P1808, DOI 10.1093/hmg/ddl103; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Motsinger A, 2002, J EXP MED, V195, P869, DOI 10.1084/jem.20011712; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; Pellizzoni L, 1998, J MOL BIOL, V281, P593, DOI 10.1006/jmbi.1998.1961; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Ranum Laura P W, 2002, Curr Neurol Neurosci Rep, V2, P465, DOI 10.1007/s11910-002-0074-6; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; RICKER K, 1994, NEUROLOGY, V44, P1448, DOI 10.1212/WNL.44.8.1448; Salisbury E, 2009, AM J PATHOL, V175, P748, DOI 10.2353/ajpath.2009.090047; Sallinen R, 2004, NEUROMUSCULAR DISORD, V14, P274, DOI 10.1016/j.nmd.2004.01.002; Scheper GC, 2006, TRENDS MOL MED, V12, P159, DOI 10.1016/j.molmed.2006.02.006; Semler BL, 2008, TRENDS MICROBIOL, V16, P1, DOI 10.1016/j.tim.2007.11.001; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Sundrud MS, 2003, J IMMUNOL, V171, P3542, DOI 10.4049/jimmunol.171.7.3542; Udd B, 2006, Neuromuscul Disord, V16, P403, DOI 10.1016/j.nmd.2006.03.010; Vihola A, 2003, NEUROLOGY, V60, P1854, DOI 10.1212/01.WNL.0000065898.61358.09; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Weiner AMJ, 2007, J CELL BIOCHEM, V102, P1553, DOI 10.1002/jcb.21380; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601	51	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9301	10.1371/journal.pone.0009301	http://dx.doi.org/10.1371/journal.pone.0009301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174632	Green Published, gold, Green Submitted			2022-12-25	WOS:000274654700025
J	Amrouni, D; Gautier-Sauvigne, S; Meiller, A; Vincendeau, P; Bouteille, B; Buguet, A; Cespuglio, R				Amrouni, Donia; Gautier-Sauvigne, Sabine; Meiller, Anne; Vincendeau, Philippe; Bouteille, Bernard; Buguet, Alain; Cespuglio, Raymond			Cerebral and Peripheral Changes Occurring in Nitric Oxide (NO) Synthesis in a Rat Model of Sleeping Sickness: Identification of Brain iNOS Expressing Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SYNTHASE; IL-10; INFECTION; STATES	Background: The implication of nitric oxide (NO) in the development of human African trypanosomiasis (HAT) using an animal model, was examined. The manner by which the trypanocidal activity of NO is impaired in the periphery and in the brain of rats infected with Trypanosoma brucei brucei (T. b. brucei) was analyzed through: (i) the changes occurring in NO concentration in both peripheral (blood) and cerebral compartments; (ii) the activity of nNOS and iNOS enzymes; (iii) identification of the brain cell types in which the NO-pathways are particularly active during the time-course of the infection. Methodology/Principal Findings: NO concentration (direct measures by voltammetry) was determined in central (brain) and peripheral (blood) compartments in healthy and infected animals at various days post-infection: D5, D10, D16 and D22. Opposite changes were observed in the two compartments. NO production increased in the brain (hypothalamus) from D10 (+32%) to D16 (+71%), but decreased in the blood from D10 (222%) to D16 (246%) and D22 (260%). In parallel with NO measures, cerebral iNOS activity increased and peaked significantly at D16 (up to +700%). However, nNOS activity did not vary. Immunohistochemical staining confirmed iNOS activation in several brain regions, particularly in the hypothalamus. In peritoneal macrophages, iNOS activity decreased from D10 (283%) to D16 (265%) and D22 (274%) similarly to circulating NO. Conclusion/Significance: The NO changes observed in our rat model were dependent on iNOS activity in both peripheral and central compartments. In the periphery, the NO production decrease may reflect an arginase-mediated synthesis of polyamines necessary to trypanosome growth. In the brain, the increased NO concentration may result from an enhanced activity of iNOS present in neurons and glial cells. It may be regarded as a marker of deleterious inflammatory reactions.	[Amrouni, Donia; Gautier-Sauvigne, Sabine; Meiller, Anne; Buguet, Alain; Cespuglio, Raymond] Univ Lyon, Fac Med, EA Lab Free Rad Energy Substrates & Cerebral Phys, Lyon, France; [Vincendeau, Philippe] Univ Bordeaux 2, EA Lab Parasitol 3677, F-33076 Bordeaux, France; [Bouteille, Bernard] Univ Limoges, EA Lab Trop & Compared Neuroepidemiol 3174, Limoges, France; [Bouteille, Bernard] Fac Med Limoges, IFR GEIST 145, F-87025 Limoges, France	UDICE-French Research Universities; Universite de Bordeaux; Universite de Limoges	Amrouni, D (corresponding author), Univ Lyon, Fac Med, EA Lab Free Rad Energy Substrates & Cerebral Phys, Lyon, France.	cespuglio@univ-lyon1.fr	Buguet, Alain/W-1610-2019; Bouteille, Bernard/T-6519-2019; Bouteille, Bernard/M-4547-2018	Bouteille, Bernard/0000-0001-9661-0302; CESPUGLIO, Raymond/0000-0003-2246-8643; MEILLER, Anne/0000-0001-5546-3035	INSERM; Claude Bernard University Lyon 1	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Claude Bernard University Lyon 1	This work was supported by INSERM, Claude Bernard University Lyon 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Antoine-Moussiaux N, 2008, TRENDS PARASITOL, V24, P411, DOI 10.1016/j.pt.2008.05.010; Boger RH, 2004, J NUTR, V134, p2842S, DOI 10.1093/jn/134.10.2842S; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buguet A, 2001, SLEEP MED REV, V5, P139, DOI 10.1053/smrv.2000.0130; Buguet A, 1996, CR ACAD SCI III-VIE, V319, P201; Buguet A., 2002, ADAPTATION BIOL MED, V3, P222; Burlet S, 1997, NEUROSCI LETT, V226, P131, DOI 10.1016/S0304-3940(97)00247-4; CESPUGLIO R, 2004, J SLEEP RES S1, V13, P131; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Chevrier C, 2005, ACTA TROP, V95, P33, DOI 10.1016/j.actatropica.2005.04.011; Clarencon D, 1999, INT J RADIAT BIOL, V75, P201, DOI 10.1080/095530099140654; Clement P, 2005, NEUROSCIENCE, V135, P347, DOI 10.1016/j.neuroscience.2005.05.064; Clement P, 2003, NEUROSCIENCE, V116, P863, DOI 10.1016/S0306-4522(02)00761-3; Cua DJ, 2001, J IMMUNOL, V166, P602, DOI 10.4049/jimmunol.166.1.602; Darsaud A, 2003, EXP BIOL MED, V228, P1355, DOI 10.1177/153537020322801114; Darsaud A, 2004, TROP MED INT HEALTH, V9, P83, DOI 10.1046/j.1365-3156.2003.01154.x; Dauvilliers Y, 2008, SLEEP, V31, P348, DOI 10.1093/sleep/31.3.348; De Baetselier P, 2001, INT J PARASITOL, V31, P575, DOI 10.1016/S0020-7519(01)00170-9; Duleu S, 2004, J IMMUNOL, V172, P6298, DOI 10.4049/jimmunol.172.10.6298; Gautier-Sauvigne S, 2005, SLEEP MED REV, V9, P101, DOI 10.1016/j.smrv.2004.07.004; Girard M, 2000, PARASITE IMMUNOL, V22, P7, DOI 10.1046/j.1365-3024.2000.00264.x; Gobert AP, 2000, INFECT IMMUN, V68, P4653, DOI 10.1128/IAI.68.8.4653-4657.2000; Keita M, 2000, EXP PARASITOL, V95, P19, DOI 10.1006/expr.2000.4505; Kennedy PGE, 2006, INT J PARASITOL, V36, P505, DOI 10.1016/j.ijpara.2006.01.012; Munder M, 1998, J IMMUNOL, V160, P5347; Ohno K, 2008, FRONT NEUROENDOCRIN, V29, P70, DOI 10.1016/j.yfrne.2007.08.001; OSWALD IP, 1994, COMP BIOCHEM PHYS C, V108, P11, DOI 10.1016/1367-8280(94)90083-3; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rhind SG, 1997, CLIN IMMUNOL IMMUNOP, V83, P185, DOI 10.1006/clin.1997.4350; Rodgers J, 2009, BRAIN, V132, P1259, DOI 10.1093/brain/awp074; Rodgers J, 2009, J NEUROIMMUNOL, V211, P16, DOI 10.1016/j.jneuroim.2009.02.007; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; SCHULTZBERG M, 1988, J NEUROSCI RES, V21, P56, DOI 10.1002/jnr.490210109; Sternberg JM, 2005, J NEUROIMMUNOL, V167, P81, DOI 10.1016/j.jneuroim.2005.06.017; Taylor K, 1998, PARASITE IMMUNOL, V20, P421, DOI 10.1046/j.1365-3024.1998.00165.x; Vincendeau P, 2006, AN ACAD BRAS CIENC, V78, P645, DOI 10.1590/S0001-37652006000400004; Viswambharan H, 2003, INT J PARASITOL, V33, P1099, DOI 10.1016/S0020-7519(03)00180-2	38	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9211	10.1371/journal.pone.0009211	http://dx.doi.org/10.1371/journal.pone.0009211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169057	Green Published, gold			2022-12-25	WOS:000274590500004
J	Druzhinina, IS; Komon-Zelazowska, M; Atanasova, L; Seidl, V; Kubicek, CP				Druzhinina, Irina S.; Komon-Zelazowska, Monika; Atanasova, Lea; Seidl, Verena; Kubicek, Christian P.			Evolution and Ecophysiology of the Industrial Producer Hypocrea jecorina (Anamorph Trichoderma reesei) and a New Sympatric Agamospecies Related to It	PLOS ONE			English	Article							PHYLOGENETIC SPECIES RECOGNITION; REPRODUCTIVE ISOLATION; FUSARIUM-GRAMINEARUM; SPECIATION; PHOTOSTIMULATION; LONGIBRACHIATUM; STRATEGIES; DIVERSITY; CELLULASE; STRAINS	Background: Trichoderma reesei, a mitosporic green mould, was recognized during the WW II based on a single isolate from the Solomon Islands and since then used in industry for production of cellulases. It is believed to be an anamorph (asexual stage) of the common pantropical ascomycete Hypocrea jecorina. Methodology/Principal Findings: We combined molecular evolutionary analysis and multiple methods of phenotype profiling in order to reveal the genetic relationship of T. reesei to H. jecorina. The resulting data show that the isolates which were previously identified as H. jecorina by means of morphophysiology and ITS1 and 2 (rRNA gene cluster) barcode in fact comprise several species: i) H. jecorina/T. reesei sensu stricto which contains most of the teleomorphs (sexual stages) found on dead wood and the wild-type strain of T. reesei QM 6a; ii) T. parareesei nom. prov., which contains all strains isolated as anamorphs from soil; iii) and two other hypothetical new species for which only one or two isolates are available. In silico tests for recombination and in vitro mating experiments revealed a history of sexual reproduction for H. jecorina and confirmed clonality for T. parareesei nom. prov. Isolates of both species were consistently found worldwide in pantropical climatic zone. Ecophysiological comparison of H. jecorina and T. parareesei nom. prov. revealed striking differences in carbon source utilization, conidiation intensity, photosensitivity and mycoparasitism, thus suggesting adaptation to different ecological niches with the high opportunistic potential for T. parareesei nom. prov. Conclusions: Our data prove that T. reesei belongs to a holomorph H. jecorina and displays a history of worldwide gene flow. We also show that its nearest genetic neighbour - T. parareesei nom. prov., is a cryptic phylogenetic agamospecies which inhabits the same biogeographic zone. These two species thus provide a so far rare example of sympatric speciation within saprotrophic fungi, with divergent ecophysiological adaptations and reproductive strategies.	[Druzhinina, Irina S.; Komon-Zelazowska, Monika; Atanasova, Lea; Seidl, Verena; Kubicek, Christian P.] Vienna Univ Technol, Inst Chem Engn, Res Area Gene Technol & Appl Biochem, A-1040 Vienna, Austria	Technische Universitat Wien	Druzhinina, IS (corresponding author), Vienna Univ Technol, Inst Chem Engn, Res Area Gene Technol & Appl Biochem, A-1040 Vienna, Austria.	druzhini@mail.zserv.tuwien.ac.at	Atanasova, Lea/AAK-4479-2021; Druzhinina, Irina S./AAK-7054-2021	Atanasova, Lea/0000-0002-1751-277X; Druzhinina, Irina S./0000-0003-2821-5268	Austrian Science Fund [P-19340-MOB, P17859-B06]	Austrian Science Fund(Austrian Science Fund (FWF))	This research has been supported by the Austrian Science Fund grants FWF (www.fwf.ac.at) P-19340-MOB to C. P. K. and P17859-B06 to I. S. D. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BISBY G. R., 1939, TRANS BRIT MYCOL SOC, V23, P149; BISSETT J, 1984, CAN J BOT, V62, P924, DOI 10.1139/b84-131; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Chaverri P, 2003, MOL PHYLOGENET EVOL, V27, P302, DOI 10.1016/S1055-7903(02)00400-1; Dettman JR, 2007, NATURE, V447, P585, DOI 10.1038/nature05856; Dettman JR, 2006, MYCOLOGIA, V98, P436, DOI 10.3852/mycologia.98.3.436; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; DOSEFF AI, 1997, GENETICS, V147, P857; Druzhinina IS, 2008, MICROBIOL-SGM, V154, P3447, DOI 10.1099/mic.0.2008/021196-0; Druzhinina IS, 2006, APPL ENVIRON MICROB, V72, P2126, DOI 10.1128/AEM.72.3.2126-2133.2006; Druzhinina IS, 2005, FUNGAL GENET BIOL, V42, P813, DOI 10.1016/j.fgb.2005.06.007; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Friedl MA, 2008, MICROBIOL-SGM, V154, P1229, DOI 10.1099/mic.0.2007/014175-0; Friedl MA, 2008, APPL ENVIRON MICROB, V74, P245, DOI 10.1128/AEM.02068-07; Giraud T, 2008, FUNGAL GENET BIOL, V45, P791, DOI 10.1016/j.fgb.2008.02.001; Harman G. E., 1998, TRICHODERMA GLIOCLAD, V2, P393; HOYOSCARVAJAL L, 2009, FUNGAL GENE IN PRESS; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Komon-Zelazowska M, 2007, APPL ENVIRON MICROB, V73, P7415, DOI 10.1128/AEM.01059-07; KUBICEK CP, 1981, EUR J APPL MICROBIOL, V13, P226, DOI 10.1007/BF00500103; Kubicek CP, 2003, FUNGAL GENET BIOL, V38, P310, DOI 10.1016/S1087-1845(02)00583-2; KUBICEK CP, 2009, BIOTECHNOL IN PRESS; Kuhls K, 1996, P NATL ACAD SCI USA, V93, P7755, DOI 10.1073/pnas.93.15.7755; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Lieckfeldt E, 2000, MYCOLOGIA, V92, P374, DOI 10.2307/3761493; MANDELS M, 1985, BIOCHEM SOC T, V13, P414, DOI 10.1042/bst0130414; Nicholas KB., 1997, GENEDOC TOOL EDITING; NYLANDER JA, 1981, AWTY SYSTEM GRAPHICA, P581; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; Posada D., 2003, CURRENT PROTOCOLS BI; REESE E. T., 1950, FARLOWIA, V4, P45; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Rice WR, 1987, EVOL ECOL, V1, P301, DOI 10.1007/BF02071555; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Samuels GJ, 2006, STUD MYCOL, P67, DOI 10.3114/sim.2006.56.03; SAMUELS GJ, 1994, MYCOLOGIA, V86, P421, DOI 10.2307/3760575; Samuels GJ, 1998, STUD MYCOL, P1; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schuster A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-449; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; SEIDL V, 2009, P NATL ACAD IN PRESS; SIMMONS EG, 1977, IND MYC C, P618; SMITH JM, 1992, J MOL EVOL, V34, P126; Steenkamp ET, 2002, MYCOLOGIA, V94, P1032, DOI 10.2307/3761868; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	54	51	54	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9191	10.1371/journal.pone.0009191	http://dx.doi.org/10.1371/journal.pone.0009191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169200	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474600012
J	Lonergan, KM; Chari, R; Coe, BP; Wilson, IM; Tsao, MS; Ng, RT; MacAulay, C; Lam, S; Lam, WL				Lonergan, Kim M.; Chari, Raj; Coe, Bradley P.; Wilson, Ian M.; Tsao, Ming-Sound; Ng, Raymond T.; MacAulay, Calum; Lam, Stephen; Lam, Wan L.			Transcriptome Profiles of Carcinoma-in-Situ and Invasive Non-Small Cell Lung Cancer as Revealed by SAGE	PLOS ONE			English	Article							PANCREATIC STELLATE CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; MICROFIBRILLAR PROTEINS MAGP-1; PROLINE-RICH PROTEIN; G HLA-G; BRONCHIAL EPITHELIUM; TARGETED THERAPIES; EPIDERMAL DIFFERENTIATION; CARDIAC-HYPERTROPHY; GENOMIC IMBALANCES	Background: Non-small cell lung cancer (NSCLC) presents as a progressive disease spanning precancerous, preinvasive, locally invasive, and metastatic lesions. Identification of biological pathways reflective of these progressive stages, and aberrantly expressed genes associated with these pathways, would conceivably enhance therapeutic approaches to this devastating disease. Methodology/Principal Findings: Through the construction and analysis of SAGE libraries, we have determined transcriptome profiles for preinvasive carcinoma-in-situ (CIS) and invasive squamous cell carcinoma (SCC) of the lung, and compared these with expression profiles generated from both bronchial epithelium, and precancerous metaplastic and dysplastic lesions using Ingenuity Pathway Analysis. Expression of genes associated with epidermal development, and loss of expression of genes associated with mucociliary biology, are predominant features of CIS, largely shared with precancerous lesions. Additionally, expression of genes associated with xenobiotic metabolism/detoxification is a notable feature of CIS, and is largely maintained in invasive cancer. Genes related to tissue fibrosis and acute phase immune response are characteristic of the invasive SCC phenotype. Moreover, the data presented here suggests that tissue remodeling/fibrosis is initiated at the early stages of CIS. Additionally, this study indicates that alteration in copy-number status represents a plausible mechanism for differential gene expression in CIS and invasive SCC. Conclusions/Significance: This study is the first report of large-scale expression profiling of CIS of the lung. Unbiased expression profiling of these preinvasive and invasive lesions provides a platform for further investigations into the molecular genetic events relevant to early stages of squamous NSCLC development. Additionally, up-regulated genes detected at extreme differences between CIS and invasive cancer may have potential to serve as biomarkers for early detection.	[Lonergan, Kim M.; Chari, Raj; Coe, Bradley P.; Wilson, Ian M.; Ng, Raymond T.; Lam, Wan L.] British Columbia Canc Res Ctr, Genet Unit, Vancouver, BC V5Z 1L3, Canada; [MacAulay, Calum; Lam, Stephen] British Columbia Canc Res Ctr, Imaging Unit, Vancouver, BC V5Z 1L3, Canada; [Tsao, Ming-Sound] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Ng, Raymond T.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of British Columbia	Lonergan, KM (corresponding author), British Columbia Canc Res Ctr, Genet Unit, Vancouver, BC V5Z 1L3, Canada.	klonergan@bccrc.ca	Chari, Raj/G-3285-2019; Coe, Bradley/A-2878-2009; Tsao, Ming-Sound/M-3503-2017; Tsao, Ming Sound/AFQ-7332-2022; MacAulay, Calum/K-1795-2016; Chari, Rajagopal/B-6980-2008	Tsao, Ming Sound/0000-0002-9160-5405; MacAulay, Calum/0000-0003-4440-2792; Coe, Bradley/0000-0001-8471-4016	Genome Canada/Genome British Columbia, Canadian Cancer Society Research Institute; Canadian Cancer Society Research Institute [CCS 20485]; Canadian Institutes of Health Canada [MOP200113, MOP 86731]	Genome Canada/Genome British Columbia, Canadian Cancer Society Research Institute(Genome Canada); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by funding from Genome Canada/Genome British Columbia, Canadian Cancer Society Research Institute (CCS#20485) and the Canadian Institutes of Health Canada (MOP200113 and MOP 86731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Apte MV, 2004, DIGEST DIS, V22, P273, DOI 10.1159/000082799; Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Atzori L, 2009, INT J BIOCHEM CELL B, V41, P1639, DOI 10.1016/j.biocel.2009.03.001; Auberger J, 2006, CURR CANCER DRUG TAR, V6, P271, DOI 10.2174/156800906777441780; Aviel-Ronen S, 2008, P NATL ACAD SCI USA, V105, P10155, DOI 10.1073/pnas.0709618105; Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704; Bachem MG, 2008, LANGENBECK ARCH SURG, V393, P891, DOI 10.1007/s00423-008-0279-5; Baldwin C, 2005, CANCER RES, V65, P7561, DOI 10.1158/0008-5472.CAN-05-1513; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bazzi H, 2007, DEV DYNAM, V236, P961, DOI 10.1002/dvdy.21099; Beyer C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2598; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blaine SA, 2009, AM J PHYSIOL-GASTR L, V297, pG434, DOI 10.1152/ajpgi.00152.2009; Boon K, 2002, P NATL ACAD SCI USA, V99, P11287, DOI 10.1073/pnas.152324199; Bota S, 2001, AM J RESP CRIT CARE, V164, P1688, DOI 10.1164/ajrccm.164.9.2012147; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; Buys TPH, 2009, J THORAC ONCOL, V4, P227, DOI 10.1097/JTO.0b013e3181952678; Capdevila J, 2009, CANCER TREAT REV, V35, P354, DOI 10.1016/j.ctrv.2009.02.001; Cascone T, 2007, CURR OPIN ONCOL, V19, P98, DOI 10.1097/CCO.0b013e328011beec; Chanas SA, 2002, BIOCHEM J, V365, P405, DOI 10.1042/BJ20020320; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chari R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-297; Chari R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-324; Chari R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-422; Chen ZS, 2007, FASEB J, V21, P2931, DOI 10.1096/fj.07-8073com; Cimmino F, 2009, ONCOGENE, V28, P2015, DOI 10.1038/onc.2009.70; Dawn B, 2005, AM J PHYSIOL-HEART C, V289, pH522, DOI 10.1152/ajpheart.00274.2005; Deleeuw RJ, 2007, GASTROENTEROLOGY, V132, P1902, DOI 10.1053/j.gastro.2007.03.036; Di Maio M, 2005, J CELL PHYSIOL, V205, P355, DOI 10.1002/jcp.20402; Eferl R, 2008, P NATL ACAD SCI USA, V105, P10525, DOI 10.1073/pnas.0801414105; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Ermakov A, 2009, DEV DYNAM, V238, P581, DOI 10.1002/dvdy.21874; Florin L, 2006, J INVEST DERMATOL, V126, P902, DOI 10.1038/sj.jid.5700123; Fraga CH, 1998, J UROLOGY, V159, P270, DOI 10.1016/S0022-5347(01)64080-1; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; Fu ZM, 2009, CIRC RES, V104, P1337, DOI 10.1161/CIRCRESAHA.108.187088; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Garnis C, 2006, INT J CANCER, V118, P1556, DOI 10.1002/ijc.21491; Garnis C, 2005, ONCOGENE, V24, P4806, DOI 10.1038/sj.onc.1208643; Garnis C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-50; Gazdar AF, 2004, CHEST, V125, p97S, DOI 10.1378/chest.125.5_suppl.97S-a; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Gresner P, 2007, LUNG CANCER, V57, P1, DOI 10.1016/j.lungcan.2007.02.002; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Guarino M, 2009, HUM PATHOL, V40, P1365, DOI 10.1016/j.humpath.2009.02.020; Hayashi T, 2008, AM J PHYSIOL-HEART C, V294, pH2197, DOI 10.1152/ajpheart.91496.2007; Hefler-Frischmuth K, 2009, EUR J OBSTET GYN R B, V147, P65, DOI 10.1016/j.ejogrb.2009.06.010; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; Higgins DF, 2008, CELL CYCLE, V7, P1128, DOI 10.4161/cc.7.9.5804; Hirsch FR, 2003, LUNG CANCER, V41, pS29, DOI 10.1016/S0169-5002(03)00137-5; Hofmann HS, 2006, ONCOL REP, V16, P587; IE MS, 2007, HUM IMMUNOL, V68, P272; Inada R, 2000, AM J PATHOL, V157, P1875, DOI 10.1016/S0002-9440(10)64826-2; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishkanian AS, 2009, PROSTATE, V69, P1091, DOI 10.1002/pros.20959; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Isobe T, 2005, SEMIN ONCOL, V32, P315, DOI 10.1053/j.seminoncol.2005.02.016; Janne PA, 2006, CLIN CANCER RES, V12, p4416S, DOI 10.1158/1078-0432.CCR-06-0555; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jie G, 2007, INT J CLIN PRACT, V61, P1523, DOI 10.1111/j.1742-1241.2006.01033.x; Jinushi M, 2008, CANCER RES, V68, P8889, DOI 10.1158/0008-5472.CAN-08-2147; Jong K, 2004, BIOINFORMATICS, V20, P3636, DOI 10.1093/bioinformatics/bth355; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kashimaa TG, 2009, HUM PATHOL, V40, P226, DOI 10.1016/j.humpath.2008.07.008; Kerr KM, 2001, J CLIN PATHOL, V54, P257, DOI 10.1136/jcp.54.4.257; Khojasteh M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-274; Kimoto Y, 1998, GENE CHROMOSOME CANC, V22, P83, DOI 10.1002/(SICI)1098-2264(1998)22:1<83::AID-GCC12>3.0.CO;2-O; Kimura K, 2008, AM J PHYSIOL-RENAL, V295, pF1023, DOI 10.1152/ajprenal.90209.2008; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kong WY, 2003, J BIOL CHEM, V278, P22781, DOI 10.1074/jbc.M210488200; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuroishi S, 2009, RESPIROLOGY, V14, P828, DOI 10.1111/j.1440-1843.2009.01561.x; Lam S, 1998, CHEST, V113, P696, DOI 10.1378/chest.113.3.696; Lam S, 2000, CANCER-AM CANCER SOC, V89, P2468; Lee SH, 2003, BIOCHEM BIOPH RES CO, V303, P954, DOI 10.1016/S0006-291X(03)00448-0; Lee WH, 2005, J INVEST DERMATOL, V125, P995, DOI 10.1111/j.0022-202X.2005.23887.x; Li QT, 2005, P NATL ACAD SCI USA, V102, P15977, DOI 10.1073/pnas.0508310102; Lonergan KM, 2006, AM J RESP CELL MOL, V35, P651, DOI 10.1165/rcmb.2006-0056OC; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Maione P, 2006, ONCOLOGIST, V11, P274, DOI 10.1634/theoncologist.11-3-274; Malik Manzoor A, 2009, J Gastrointest Cancer, V40, P26, DOI 10.1007/s12029-009-9072-0; Marenholz I, 2001, GENOME RES, V11, P341, DOI 10.1101/gr.114801; Marshall D, 2001, P NATL ACAD SCI USA, V98, P13031, DOI 10.1073/pnas.231489198; Martin HJ, 2009, CHEM-BIOL INTERACT, V178, P145, DOI 10.1016/j.cbi.2008.10.021; Mastracci TL, 2006, GENE CHROMOSOME CANC, V45, P1007, DOI 10.1002/gcc.20368; Matsui T, 2004, GENOMICS, V84, P384, DOI 10.1016/j.ygeno.2004.03.010; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Moffatt P, 2004, GENE, V334, P123, DOI 10.1016/j.gene.2004.03.010; Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008; Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Nozaki I, 2005, LAB INVEST, V85, P109, DOI 10.1038/labinvest.3700213; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Olson P, 2009, SCIENCE, V324, P1400, DOI 10.1126/science.1175940; Oomizu S, 2000, GENE, V256, P19, DOI 10.1016/S0378-1119(00)00357-7; Ouyang GL, 2009, CANCER LETT, V281, P213, DOI 10.1016/j.canlet.2009.02.030; Paramio JM, 2001, J BIOL CHEM, V276, P44203, DOI 10.1074/jbc.M105650200; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; Pei JM, 2001, GENE CHROMOSOME CANC, V31, P282, DOI 10.1002/gcc.1145; Qian J, 2008, J THORAC ONCOL, V3, P212, DOI 10.1097/JTO.0b013e3181663544; Qiu XY, 2003, CANCER RES, V63, P6488; Quinn AM, 2008, CHEM RES TOXICOL, V21, P1086, DOI 10.1021/tx700345v; Reade CA, 2009, BIOL-TARGETS THER, V3, P215; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; SALONEN EM, 1984, J BIOL CHEM, V259, P1496; Scharpfenecker M, 2009, RADIOTHER ONCOL, V92, P484, DOI 10.1016/j.radonc.2009.06.013; Segade F, 2002, J BIOL CHEM, V277, P11050, DOI 10.1074/jbc.M110347200; Singh A, 2006, AM J RESP CELL MOL, V35, P639, DOI 10.1165/rcmb.2005-0325OC; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Stawowy P, 2004, CARDIOVASC RES, V63, P87, DOI 10.1016/j.cardiores.2004.03.010; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Svensson S, 2003, CANCER RES, V63, P1737; Tanney A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-20; Taylor RC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000166; Trask BC, 2000, MOL BIOL CELL, V11, P1499, DOI 10.1091/mbc.11.5.1499; Tsilidis KK, 2008, INT J CANCER, V123, P1133, DOI 10.1002/ijc.23606; Tsuchida S, 2004, J INVEST DERMATOL, V122, P1225, DOI 10.1111/j.0022-202X.2004.22511.x; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Venmans BJW, 2000, CHEST, V117, P1572, DOI 10.1378/chest.117.6.1572; Vermeer PD, 2006, AM J PHYSIOL-LUNG C, V291, pL175, DOI 10.1152/ajplung.00547.2005; Vijayachandra K, 2009, MOL CARCINOGEN, V48, P181, DOI 10.1002/mc.20472; Vokes Everett E, 2006, Oncology (Williston Park), V20, P15; Vonlaufen A, 2008, CANCER RES, V68, P7707, DOI 10.1158/0008-5472.CAN-08-1132; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Wallingford JB, 2006, HUM MOL GENET, V15, pR227, DOI 10.1093/hmg/ddl216; Watson SK, 2007, HUM GENET, V120, P795, DOI 10.1007/s00439-006-0251-9; Wei Q, 2008, P NATL ACAD SCI USA, V105, P19738, DOI 10.1073/pnas.0810676105; Wells RG, 2008, CLIN LIVER DIS, V12, P759, DOI 10.1016/j.cld.2008.07.008; Wistuba II, 2006, ANNU REV PATHOL-MECH, V1, P331, DOI 10.1146/annurev.pathol.1.110304.100103; Woenckhaus M, 2006, J PATHOL, V210, P192, DOI 10.1002/path.2039; Yagihara H, 2009, VET J, V180, P348, DOI 10.1016/j.tvjl.2008.01.006; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yie SM, 2007, AM J CLIN PATHOL, V128, P1002, DOI 10.1309/JNCW1QLDFB6AM9WE; Yie SM, 2007, LUNG CANCER, V58, P267, DOI 10.1016/j.lungcan.2007.06.011; Yie SM, 2007, ANN SURG ONCOL, V14, P2721, DOI 10.1245/s10434-007-9464-y; Yoneda K, 2009, INT J ONCOL, V35, P33, DOI 10.3892/ijo_00000310; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zang XP, 2009, ANTICANCER RES, V29, P3417; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zienolddiny S, 2008, CARCINOGENESIS, V29, P1164, DOI 10.1093/carcin/bgn020	149	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9162	10.1371/journal.pone.0009162	http://dx.doi.org/10.1371/journal.pone.0009162			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161782	Green Submitted, gold, Green Published			2022-12-25	WOS:000274442800008
J	Wen, J; Ronn, T; Olsson, A; Yang, Z; Lu, B; Du, YP; Groop, L; Ling, C; Hu, RM				Wen, Jie; Ronn, Tina; Olsson, Anders; Yang, Zhen; Lu, Bin; Du, Yieping; Groop, Leif; Ling, Charlotte; Hu, Renming			Investigation of Type 2 Diabetes Risk Alleles Support CDKN2A/B, CDKAL1, and TCF7L2 As Susceptibility Genes in a Han Chinese Cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FTO GENE; COMMON VARIANTS; FAT MASS; LOCI; REPLICATION; POLYMORPHISMS; IGF2BP2; OBESITY; HHEX	Background: Recent genome-wide association studies (GWASs) have reported several genetic variants to be reproducibly associated with type 2 diabetes. Additional variants have also been detected from a metaanalysis of three GWASs, performed in populations of European ancestry. In the present study, we evaluated the influence of 17 genetic variants from 15 candidate loci, identified in type 2 diabetes GWASs and the metaanalysis, in a Han Chinese cohort. Methodology/Principal Findings: Selected type 2 diabetes-associated genetic variants were genotyped in 1,165 type 2 diabetic patients and 1,136 normoglycemic control individuals of Southern Han Chinese ancestry. The OR for risk of developing type 2 diabetes was calculated using a logistic regression model adjusted for age, sex, and BMI. Genotype-phenotype associations were tested using a multivariate linear regression model. Genetic variants in CDKN2A/B, CDKAL1, TCF7L2, TCF2, MC4R, and PPARG showed a nominal association with type 2 diabetes (P <= 0.05), of whom the three first would stand correction for multiple testing: CDKN2A/B rs10811661, OR: 1.26 (1.12-1.43) P = 1.8* 10(-4); CDKAL1 rs10946398, OR: 1.23 (1.09-1.39); P = 7.1* 10(-4), and TCF7L2 rs7903146, OR: 1.61 (1.19-2.18) P = 2.3* 10(-3). Only nominal phenotype associations were observed, notably for rs8050136 in FTO and fasting plasma glucose (P = 0.002), postprandial plasma glucose (P = 0.002), and fasting C-peptide levels (P = 0.006) in the diabetic patients, and with BMI in controls (P = 0.033). Conclusions/Significance: We have identified significant association between variants in CDKN2A/B, CDKAL1 and TCF7L2, and type 2 diabetes in a Han Chinese cohort, indicating these genes as strong candidates conferring susceptibility to type 2 diabetes across different ethnicities.	[Wen, Jie; Yang, Zhen; Lu, Bin; Du, Yieping; Hu, Renming] Fudan Univ, Shanghai Med Coll, Dept Endocrinol, Shanghai 200433, Peoples R China; [Ronn, Tina; Olsson, Anders; Groop, Leif; Ling, Charlotte] Lund Univ, Ctr Diabet, Dept Clin Sci, Malmo, Sweden	Fudan University; Lund University	Wen, J (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Endocrinol, Shanghai 200433, Peoples R China.	Renminghu@Fudan.edu.cn	Ling, Charlotte/Q-2432-2015	Ling, Charlotte/0000-0003-0587-7154; Ronn, Tina/0000-0001-7622-800X	Swedish Research Council; Wallenberg foundation; Novo Nordisk; Bergvall; Pahlsson; Nilsson-Ehle; Tore Nilsson; Ake Wiberg; Soderbergs; Crafoord; Swedish Diabetes Association; National Science Foundation of China [30230380]; National Nature Science foundation of China [30670999, 30711120573, 3030770854]; National Key Basic Research and Development Program [2002 CB713703]; Key Project of Shanghai Commission for Science and Technology [04dz19504]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Wallenberg foundation(European Commission); Novo Nordisk(Novo Nordisk); Bergvall; Pahlsson; Nilsson-Ehle; Tore Nilsson; Ake Wiberg; Soderbergs; Crafoord; Swedish Diabetes Association; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program(National Basic Research Program of China); Key Project of Shanghai Commission for Science and Technology	This study was supported by grants from the Swedish Research Council, the Wallenberg foundation, Novo Nordisk, Bergvall, Pahlsson, Nilsson-Ehle, Tore Nilsson, Ake Wiberg, Soderbergs, Crafoord, and the Swedish Diabetes Association. This study was also supported by research grants (to RH) from the Key Project of National Science Foundation of China (30230380), the National Nature Science foundation of China (30670999, 30711120573, 3030770854), the National Key Basic Research and Development Program (2002 CB713703), and the Key Project of Shanghai Commission for Science and Technology (04dz19504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Cauchi S, 2006, DIABETES, V55, P2903, DOI 10.2337/db06-0474; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chang YC, 2007, DIABETES, V56, P2631, DOI 10.2337/db07-0421; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hayashi T, 2007, DIABETOLOGIA, V50, P980, DOI 10.1007/s00125-007-0618-z; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Humphries SE, 2006, J MOL MED, V84, P1005, DOI 10.1007/s00109-006-0108-7; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Liu Y, 2008, DIABETOLOGIA, V51, P2134, DOI 10.1007/s00125-008-1141-6; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ng MCY, 2007, J CLIN ENDOCR METAB, V92, P3733, DOI 10.1210/jc.2007-0849; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ren Q, 2008, DIABETOLOGIA, V51, P1146, DOI 10.1007/s00125-008-1039-3; Ronn T., 2009, DIABETOLOGIA; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang CL, 2006, DIABETES, V55, P2645, DOI 10.2337/db06-0643	37	103	109	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9153	10.1371/journal.pone.0009153	http://dx.doi.org/10.1371/journal.pone.0009153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161779	gold, Green Submitted, Green Published			2022-12-25	WOS:000274442700017
J	Carr, KA; Janes, BK; Hanna, PC				Carr, Katherine A.; Janes, Brian K.; Hanna, Philip C.			Role of the gerP Operon in Germination and Outgrowth of Bacillus anthracis Spores	PLOS ONE			English	Article							GENOME SEQUENCE; IN-VITRO; SUBTILIS; PROTEINS; CEREUS; SPORULATION; ENDOSPORES; LOCALIZATION; SUPEROXIDE; RESISTANCE	Germination of Bacillus anthracis spores occurs when nutrients such as amino acids or purine nucleosides stimulate specific germinant receptors located in the spore inner membrane. The gerP(ABCDEF) operon has been suggested to play a role in facilitating the interaction between germinants and their receptors in spores of Bacillus subtilis and Bacillus cereus. B. anthracis mutants containing deletions in each of the six genes belonging to the orthologue of the gerP(ABCDEF) operon, or deletion of the entire operon, were tested for their ability to germinate. Deletion of the entire gerP operon resulted in a significant delay in germination in response to nutrient germinants. These spores eventually germinated to levels equivalent to wild-type, suggesting that an additional entry point for nutrient germinants may exist. Deletions of each individual gene resulted in a similar phenotype, with the exception of Delta gerPF, which showed no obvious defect. The removal of two additional gerPF-like orthologues was necessary to achieve the germination defect observed for the other mutants. Upon physical removal of the spore coat, the mutant lacking the full gerP operon no longer exhibited a germination defect, suggesting that the GerP proteins play a role in spore coat permeability. Additionally, each of the gerP mutants exhibited a severe defect in calcium-dipicolinic acid (Ca-DPA)-dependent germination, suggesting a role for the GerP proteins in this process. Collectively, these data implicate all GerP proteins in the early stages of spore germination.	[Carr, Katherine A.; Janes, Brian K.; Hanna, Philip C.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Carr, KA (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	pchanna@umich.edu			Health and Human Services [N266200400059C/N01-AI-40059]; Southeast Regional Centers of Excellence for Biodefense and Emerging Infections	Health and Human Services; Southeast Regional Centers of Excellence for Biodefense and Emerging Infections	This work was supported in part by Health and Human Services contract N266200400059C/N01-AI-40059 and by the Great Lakes and the Southeast Regional Centers of Excellence for Biodefense and Emerging Infections. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagyan I, 2002, J BACTERIOL, V184, P1219, DOI 10.1128/jb.184.4.1219-1224.2002; Baillie L, 2005, FEMS MICROBIOL LETT, V245, P33, DOI 10.1016/j.femsle.2005.02.016; Behravan J, 2000, J BACTERIOL, V182, P1987, DOI 10.1128/JB.182.7.1987-1994.2000; Bergman NH, 2007, APPL ENVIRON MICROB, V73, P846, DOI 10.1128/AEM.01686-06; Bergman NH, 2006, J BACTERIOL, V188, P6092, DOI 10.1128/JB.00723-06; BETTY JM, 1970, J APPL MICROBIOL, V33, P103; Bozue J, 2007, INFECT IMMUN, V75, P4498, DOI 10.1128/IAI.00434-07; Brahmbhatt TN, 2007, INFECT IMMUN, V75, P5233, DOI 10.1128/IAI.00660-07; BROWN WC, 1982, J BACTERIOL, V149, P969, DOI 10.1128/JB.149.3.969-976.1982; DANIEL JR, 2003, FEMS MICROBIOL LETT, V221, P103; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Fisher N, 2005, J BACTERIOL, V187, P8055, DOI 10.1128/JB.187.23.8055-8062.2005; GOULD GW, 1977, J APPL BACTERIOL, V42, P297, DOI 10.1111/j.1365-2672.1977.tb00697.x; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Ireland JAW, 2002, J BACTERIOL, V184, P1296, DOI 10.1128/JB.184.5.1296-1303.2002; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; JENKINSON HF, 1980, J BACTERIOL, V141, P793, DOI 10.1128/JB.141.2.793-805.1980; KIM HU, 1974, J APPL BACTERIOL, V37, P265, DOI 10.1111/j.1365-2672.1974.tb00438.x; Klobutcher LA, 2006, P NATL ACAD SCI USA, V103, P165, DOI 10.1073/pnas.0507121102; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lee JY, 2007, J BACTERIOL, V189, P1698, DOI 10.1128/JB.01526-06; MCCORMIC.NG, 1965, J BACTERIOL, V89, P1180, DOI 10.1128/JB.89.5.1180-1185.1965; Mesnage S, 1999, J APPL MICROBIOL, V87, P256, DOI 10.1046/j.1365-2672.1999.00880.x; Moir A, 2003, TRENDS MICROBIOL, V11, P452, DOI 10.1016/j.tim.2003.08.001; Paidhungat M, 2001, J BACTERIOL, V183, P4886, DOI 10.1128/JB.183.16.4886-4893.2001; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Paidhungat M, 2001, J BACTERIOL, V183, P3982, DOI 10.1128/JB.183.13.3982-3990.2001; Paidhungat M., 2002, BACILLUS SUBTILIS IT, P537, DOI DOI 10.1128/9781555817992.CH37; Passalacqua KD, 2006, J BACTERIOL, V188, P3837, DOI 10.1128/JB.00239-06; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Popham DL, 2002, CELL MOL LIFE SCI, V59, P426, DOI 10.1007/s00018-002-8435-5; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Setlow B, 2001, J BACTERIOL, V183, P4894, DOI 10.1128/JB.183.16.4894-4899.2001; SETLOW P, 1995, ANNU REV MICROBIOL, V49, P29, DOI 10.1146/annurev.mi.49.100195.000333; STERNE MAX, 1939, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V13, P313; Todd SJ, 2003, J BACTERIOL, V185, P3373, DOI 10.1128/JB.185.11.3373-3378.2003; Weiner M, 2003, J BACTERIOL, V185, P1462, DOI 10.1128/JB.185.4.1462-1464.2003	38	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9128	10.1371/journal.pone.0009128	http://dx.doi.org/10.1371/journal.pone.0009128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161744	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442600025
J	Gakhar, L; Bartlett, JA; Penterman, J; Mizrachi, D; Singh, PK; Mallampalli, RK; Ramaswamy, S; McCray, PB				Gakhar, Lokesh; Bartlett, Jennifer A.; Penterman, Jon; Mizrachi, Dario; Singh, Pradeep K.; Mallampalli, Rama K.; Ramaswamy, S.; McCray, Paul B., Jr.			PLUNC Is a Novel Airway Surfactant Protein with Anti-Biofilm Activity	PLOS ONE			English	Article							NASAL LAVAGE FLUID; IN-VITRO MODEL; PSEUDOMONAS-AERUGINOSA; HOST-DEFENSE; PULMONARY SURFACTANT; LIQUID VOLUME; HORSE SWEAT; LUNG; LIPOPOLYSACCHARIDE; BIOSURFACTANTS	Background: The PLUNC (``Palate, lung, nasal epithelium clone'') protein is an abundant secretory product of epithelia present throughout the conducting airways of humans and other mammals, which is evolutionarily related to the lipid transfer/lipopolysaccharide binding protein (LT/LBP) family. Two members of this family - the bactericidal/permeability increasing protein (BPI) and the lipopolysaccharide binding protein (LBP) - are innate immune molecules with recognized roles in sensing and responding to Gram negative bacteria, leading many to propose that PLUNC may play a host defense role in the human airways. Methodology/Principal Findings: Based on its marked hydrophobicity, we hypothesized that PLUNC may be an airway surfactant. We found that purified recombinant human PLUNC greatly enhanced the ability of aqueous solutions to spread on a hydrophobic surface. Furthermore, we discovered that PLUNC significantly reduced surface tension at the air-liquid interface in aqueous solutions, indicating novel and biologically relevant surfactant properties. Of note, surface tensions achieved by adding PLUNC to solutions are very similar to measurements of the surface tension in tracheobronchial secretions from humans and animal models. Because surfactants of microbial origin can disperse matrix-encased bacterial clusters known as biofilms [1], we hypothesized that PLUNC may also have anti-biofilm activity. We found that, at a physiologically relevant concentration, PLUNC inhibited biofilm formation by the airway pathogen Pseudomonas aeruginosa in an in vitro model. Conclusions/Significance: Our data suggest that the PLUNC protein contributes to the surfactant properties of airway secretions, and that this activity may interfere with biofilm formation by an airway pathogen.	[Gakhar, Lokesh; Ramaswamy, S.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Gakhar, Lokesh; Ramaswamy, S.] Univ Iowa, Prot Crystallog Facil, Iowa City, IA 52242 USA; [Bartlett, Jennifer A.; McCray, Paul B., Jr.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Penterman, Jon; Singh, Pradeep K.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Penterman, Jon; Singh, Pradeep K.] Univ Washington, Dept Med, Seattle, WA USA; [Mizrachi, Dario] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Mallampalli, Rama K.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Iowa	Gakhar, L (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	paul-mccray@uiowa.edu	Gakhar, Lokesh/F-2113-2010; Gakhar, Lokesh/P-8356-2019; Subramanian, Ramaswamy/Q-8671-2019; Bartlett, Jennifer/AAH-4532-2020	Gakhar, Lokesh/0000-0002-3319-1902; Gakhar, Lokesh/0000-0002-3319-1902; Subramanian, Ramaswamy/0000-0002-6709-190X; McCray, Paul/0000-0002-4067-577X	National Institutes of Health [P50 HL-61234, P01 HL-091842]; National Institute for Environmental Health Sciences Research Center [P30 ES05605]; NIH Ruth L. Kirschstein National Research Service Award [GM087635]; Cystic Fibrosis Foundation; Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL061234, P01HL091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Environmental Health Sciences Research Center; NIH Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the support of the National Institutes of Health (http://www.nih.gov/) grants NIH P50 HL-61234 and P01 HL-091842 (PBM), as well as the Roy J. Carver Charitable Trust (https://www.carvertrust.org) (PBM). In addition, this research was funded by the National Institute for Environmental Health Sciences Research Center (http://www.niehs.nih.gov), NIEHS/NIH P30 ES05605 (JAB). JP is supported by a NIH Ruth L. Kirschstein National Research Service Award (GM087635) (http://www.nih.gov/). PS is supported by grants from the National Institutes of Health (http://www.nih.gov/), the Cystic Fibrosis Foundation (http://www.cff.org/), and the Burroughs Wellcome Fund (http://www.bwfund.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tahhan RA, 2000, APPL ENVIRON MICROB, V66, P3262, DOI 10.1128/AEM.66.8.3262-3268.2000; ALLEGRA L, 1985, EUR J RESPIR DIS S, V142, P71; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Banerjee R, 2000, J BIOMATER APPL, V14, P243, DOI 10.1106/9D4B-L6PP-7CTF-BY8G; Bartlett JA, 2008, J LEUKOCYTE BIOL, V83, P1201, DOI 10.1189/jlb.0507302; BEELEY JG, 1986, BIOCHEM J, V235, P645, DOI 10.1042/bj2350645; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernhard W, 1997, AM J RESP CELL MOL, V17, P41, DOI 10.1165/ajrcmb.17.1.2594; Bingle CD, 2004, INT J BIOCHEM CELL B, V36, P2144, DOI 10.1016/j.biocel.2004.05.002; Bingle CD, 2004, PROTEIN SCI, V13, P422, DOI 10.1110/ps.03332704; Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937; Boles BR, 2005, MOL MICROBIOL, V57, P1210, DOI 10.1111/j.1365-2958.2005.04743.x; Botros HG, 2001, EUR J BIOCHEM, V268, P3126, DOI 10.1046/j.1432-1327.2001.02217.x; Campos MA, 2004, AM J RESP CELL MOL, V30, P184, DOI 10.1165/rcmb.2003-0142OC; Chu HW, 2007, J IMMUNOL, V179, P3995, DOI 10.4049/jimmunol.179.6.3995; Deziel E, 2003, MICROBIOL-SGM, V149, P2005, DOI 10.1099/mic.0.26154-0; Di YP, 2003, J BIOL CHEM, V278, P1165, DOI 10.1074/jbc.M210523200; ENHORNING G, 1977, J APPL PHYSIOL, V43, P198, DOI 10.1152/jappl.1977.43.2.198; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Garcia-Caballero A, 2009, P NATL ACAD SCI USA, V106, P11412, DOI 10.1073/pnas.0903609106; Geiser M, 2003, J APPL PHYSIOL, V94, P1793, DOI 10.1152/japplphysiol.00514.2002; Ghafouri B, 2006, J PROTEOME RES, V5, P330, DOI 10.1021/pr050341h; Ghafouri B, 2004, BBA-PROTEINS PROTEOM, V1699, P57, DOI 10.1016/j.bbapap.2004.01.001; Ghafouri B, 2003, BIOCHEM SOC T, V31, P810, DOI 10.1042/BST0310810; Ghafouri B, 2002, PROTEOMICS, V2, P112, DOI 10.1002/1615-9861(200201)2:1<112::AID-PROT112>3.0.CO;2-N; GIL J, 1971, ANAT REC, V169, P185, DOI 10.1002/ar.1091690205; Hof VI, 1997, RESP PHYSIOL, V109, P81, DOI 10.1016/S0034-5687(97)84032-7; Irie Y, 2005, FEMS MICROBIOL LETT, V250, P237, DOI 10.1016/j.femsle.2005.07.012; KAKUTA Y, 1991, RESP PHYSIOL, V83, P313, DOI 10.1016/0034-5687(91)90050-S; Karp Philip H, 2002, Methods Mol Biol, V188, P115; KHOOR A, 1994, J HISTOCHEM CYTOCHEM, V42, P1187, DOI 10.1177/42.9.8064126; Kuiper I, 2004, MOL MICROBIOL, V51, P97, DOI 10.1046/j.1365-2958.2003.03751.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LeClair EE, 2003, J DENT RES, V82, P944, DOI 10.1177/154405910308201202; Lindahl M, 2001, ELECTROPHORESIS, V22, P1795, DOI 10.1002/1522-2683(200105)22:9<1795::AID-ELPS1795>3.0.CO;2-J; McDonald RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005726; MERELO JJ, 1994, NEUROCOMPUTING, V6, P443, DOI 10.1016/0925-2312(94)90021-3; Mireles JR, 2001, J BACTERIOL, V183, P5848, DOI 10.1128/JB.183.20.5848-5854.2001; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; O'Toole GA, 2005, NAT BIOTECHNOL, V23, P1378, DOI 10.1038/nbt1105-1378; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Possmayer F, 2001, COMP BIOCHEM PHYS A, V129, P209, DOI 10.1016/S1095-6433(01)00317-8; Rachana, 2004, COLLOID SURFACE B, V34, P95, DOI 10.1016/j.colsurfb.2003.12.001; Ron EZ, 2001, ENVIRON MICROBIOL, V3, P229, DOI 10.1046/j.1462-2920.2001.00190.x; Scheetz TE, 2004, PHYSIOL GENOMICS, V17, P69, DOI 10.1152/physiolgenomics.00188.2003; SCHURCH S, 1990, RESP PHYSIOL, V80, P17, DOI 10.1016/0034-5687(90)90003-H; Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Singh PK, 2000, AM J PHYSIOL-LUNG C, V279, pL799, DOI 10.1152/ajplung.2000.279.5.L799; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Vitorino R, 2004, PROTEOMICS, V4, P1109, DOI 10.1002/pmic.200300638; Walencka E, 2008, FOLIA MICROBIOL, V53, P61, DOI 10.1007/s12223-008-0009-y; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; WEISS J, 1978, J BIOL CHEM, V253, P2664; Weiss J, 2003, BIOCHEM SOC T, V31, P785, DOI 10.1042/BST0310785; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387	58	95	99	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9098	10.1371/journal.pone.0009098	http://dx.doi.org/10.1371/journal.pone.0009098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161732	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442600006
J	Nicolas, L; Martinez, C; Baro, C; Rodriguez, M; Baroja-Mazo, A; Sole, F; Flores, JM; Ampurdanes, C; Dantzer, F; Martin-Caballero, J; Aparicio, P; Yelamos, J				Nicolas, L.; Martinez, C.; Baro, C.; Rodriguez, M.; Baroja-Mazo, A.; Sole, F.; Flores, J. M.; Ampurdanes, C.; Dantzer, F.; Martin-Caballero, J.; Aparicio, P.; Yelamos, J.			Loss of poly(ADP-ribose) polymerase-2 leads to rapid development of spontaneous T-cell lymphomas in p53-deficient mice	ONCOGENE			English	Article						Parp-2; p53; tumour development; thymocytes; V(D)J recombination; double-strand breaks	DOUBLE-STRAND BREAKS; DNA-DAMAGE; CHROMOSOMAL-ABERRATIONS; GENOMIC STABILITY; REPAIR; P53; RECOMBINATION; TUMORIGENESIS; INHIBITION; DEFICIENCY	Poly(ADP-ribose) polymerase-2 (Parp-2) belongs to a family of enzymes that catalyse poly(ADP-ribosyl) ation of proteins. Parp-2 deficiency in mice (Parp-2(-/-)) results in reduced thymic cellularity associated with increased apoptosis in thymocytes, defining Parp-2 as an important mediator of T-cell survival during thymopoiesis. To determine whether there is a link between Parp-2 and the p53 DNA-damage-dependent apoptotic response, we have generated Parp-2/p53-double-null mutant mice. We found that p53(-/-) backgrounds completely restored the survival and development of Parp-2(-/-) thymocytes. However, Parp-2-deficient thymocytes accumulated high levels of DNA double-strand breaks (DSB), independently of the p53 status, in line with a function of Parp-2 as a caretaker promoting genomic stability during thymocytes development. Although Parp-2(-/-) mice do not have spontaneous tumours, Parp-2 deficiency accelerated spontaneous tumour development in p53-null mice, mainly T-cell lymphomas. These data suggest a synergistic interaction between Parp-2 and p53 in tumour suppression through the role of Parp-2 in DNA-damage response and genome integrity surveillance, and point to the potential importance of examining human tumours for the status of both genes. Oncogene (2010) 29, 2877-2883; doi: 10.1038/onc.2010.11; published online 15 February 2010	[Nicolas, L.; Ampurdanes, C.; Martin-Caballero, J.; Yelamos, J.] IMIM Hosp Mar, Barcelona Biomed Res Pk PRBB, Dept Immunol, Barcelona 08003, Spain; [Nicolas, L.; Aparicio, P.] Univ Murcia, Dept Biochem Mol Biol & Immunol, Sch Med, Murcia, Spain; [Martinez, C.; Baroja-Mazo, A.] Univ Murcia, Dept Surg, CIBERehd, Univ Hosp Virgen de la Arrixaca, Murcia, Spain; [Baro, C.; Rodriguez, M.; Sole, F.] IMIM Hosp Mar, Barcelona Biomed Res Pk, Dept Pathol, Barcelona 08003, Spain; [Flores, J. M.] Univ Complutense, Dept Anim Surg & Med, Sch Vet, E-28040 Madrid, Spain; [Dantzer, F.] ESBS, IREBS FRE3211, Strasbourg, France	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; University of Murcia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Complutense University of Madrid	Yelamos, J (corresponding author), IMIM Hosp Mar, Barcelona Biomed Res Pk PRBB, Dept Immunol, C Dr Aiguader,88, Barcelona 08003, Spain.	jyelamos@imim.es	Solé, Francesc/K-8373-2012; Dantzer, Françoise/O-2126-2016; sole, francesc/A-2430-2011; Baroja-Mazo, Alberto/E-6270-2016; Martinez, Carlos M./E-4986-2016; Yelamos, Jose/N-2842-2016	Solé, Francesc/0000-0002-3251-2161; Baroja-Mazo, Alberto/0000-0001-5212-5006; Martinez, Carlos M./0000-0003-3307-1326; Aparicio, Pedro/0000-0001-9162-1563; Yelamos, Jose/0000-0003-1195-1496; Dantzer, Francoise/0000-0003-0945-8483	Spanish Ministerio de Ciencia e Innovacion [SAF2008-01572]; Generalitat de Catalunya [2009/SGR/524]; Instituto de Salud Carlos III [PI081150]; Fundacion Seneca [08643/PI/08]; Centre National de la Recherche Scientifique, Association pour la Recherche contre le Cancer, Electricite de France, Comite du Haut-Rhin de la Ligue Nationale Contre le Cancer and Commissariat a l'Energie Atomique; Spanish Ministerio de Ciencia e Innovacion; Instituto de Salud Carlos III (Madrid, Spain); FFIS (Murcia, Spain)	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Seneca(Fundacion Seneca); Centre National de la Recherche Scientifique, Association pour la Recherche contre le Cancer, Electricite de France, Comite du Haut-Rhin de la Ligue Nationale Contre le Cancer and Commissariat a l'Energie Atomique(Centre National de la Recherche Scientifique (CNRS)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III (Madrid, Spain)(Instituto de Salud Carlos III); FFIS (Murcia, Spain)	We thank Katherine Papageorgiou for assistance with handling the mice and Sergi Mojal for statistical analysis support. This work was supported by Spanish Ministerio de Ciencia e Innovacion (Grant SAF2008-01572 to JY); Generalitat de Catalunya (Grant 2009/SGR/524 to JY); Instituto de Salud Carlos III (Grant PI081150 to PA); Fundacion Seneca (Grant 08643/PI/08 to PA); and funds from Centre National de la Recherche Scientifique, Association pour la Recherche contre le Cancer, Electricite de France, Comite du Haut-Rhin de la Ligue Nationale Contre le Cancer and Commissariat a l'Energie Atomique (VS, FD). LN is supported by the Spanish Ministerio de Ciencia e Innovacion and AB-M is supported by Instituto de Salud Carlos III (Madrid, Spain) and the FFIS (Murcia, Spain).	Bai P, 2007, J BIOL CHEM, V282, P37738, DOI 10.1074/jbc.M701021200; Bassing CH, 2008, BLOOD, V111, P2163, DOI 10.1182/blood-2007-08-104760; Beneke R, 2001, ONCOGENE, V20, P8136, DOI 10.1038/sj.onc.1205056; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Conde C, 2001, EMBO J, V20, P3535, DOI 10.1093/emboj/20.13.3535; Dantzer F, 2006, P NATL ACAD SCI USA, V103, P14854, DOI 10.1073/pnas.0604252103; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Hawwari A, 2005, NAT IMMUNOL, V6, P481, DOI 10.1038/ni1189; Huber A, 2004, DNA REPAIR, V3, P1103, DOI 10.1016/j.dnarep.2004.06.002; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robert I, 2009, J EXP MED, V206, P1047, DOI 10.1084/jem.20082468; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rooney S, 2004, P NATL ACAD SCI USA, V101, P2410, DOI 10.1073/pnas.0308757101; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Tentori L, 2008, EUR J CANCER, V44, P1302, DOI 10.1016/j.ejca.2008.03.019; Tong WM, 2007, ONCOGENE, V26, P3857, DOI 10.1038/sj.onc.1210156; Tong WM, 2001, MOL CELL BIOL, V21, P4046, DOI 10.1128/MCB.21.12.4046-4054.2001; Tong WM, 2003, AM J PATHOL, V162, P343, DOI 10.1016/S0002-9440(10)63825-4; Tong WM, 2002, CANCER RES, V62, P6990; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Xu M, 2008, MOL CELL BIOL, V28, P1713, DOI 10.1128/MCB.01360-07; Yelamos J, 2008, TRENDS MOL MED, V14, P169, DOI 10.1016/j.molmed.2008.02.003; Yelamos J, 2006, EMBO J, V25, P4350, DOI 10.1038/sj.emboj.7601301	39	44	45	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	19					2877	2883		10.1038/onc.2010.11	http://dx.doi.org/10.1038/onc.2010.11			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	595DW	20154718				2022-12-25	WOS:000277591900012
J	Lampl, N; Budai-Hadrian, O; Davydov, O; Joss, TV; Harrop, SJ; Curmi, PMG; Roberts, TH; Fluhr, R				Lampl, Nardy; Budai-Hadrian, Ofra; Davydov, Olga; Joss, Tom V.; Harrop, Stephen J.; Curmi, Paul M. G.; Roberts, Thomas H.; Fluhr, Robert			Arabidopsis AtSerpin1, Crystal Structure and in Vivo Interaction with Its Target Protease RESPONSIVE TO DESICCATION-21 (RD21)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; VACUOLAR PROCESSING ENZYME; PROTEINASE-INHIBITORS SERPINS; SEED STORAGE PROTEINS; CYSTEINE PROTEASES; REACTIVE CENTERS; GRAIN; ACTIVATION; EXPRESSION; MECHANISM	In animals, protease inhibitors of the serpin family are associated with many physiological processes, including blood coagulation and innate immunity. Serpins feature a reactive center loop (RCL), which displays a protease target sequence as a bait. RCL cleavage results in an irreversible, covalent serpin-protease complex. AtSerpin1 is an Arabidopsis protease inhibitor that is expressed ubiquitously throughout the plant. The x-ray crystal structure of recombinant AtSerpin1 in its native stressed conformation was determined at 2.2 A. The electrostatic surface potential below the RCL was found to be highly positive, whereas the breach region critical for RCL insertion is an unusually open structure. AtSerpin1 accumulates in plants as a full-length and a cleaved form. Fractionation of seedling extracts by nonreducing SDS-PAGE revealed the presence of an additional slower migrating complex that was absent when leaves were treated with the specific cysteine protease inhibitor L-trans-epoxysuccinyl-L-leucylamido (4-guanidino) butane. Significantly, RESPONSIVE TO DESICCATION-21 (RD21) was the major protease labeled with the L-trans-epoxysuccinyl-L-leucylamido (4-guanidino) butane derivative DCG-04 in wild type extracts but not in extracts of mutant plants constitutively overexpressing AtSerpin1, indicating competition. Fractionation by nonreducing SDS-PAGE followed by immunoblotting with RD21-specific antibody revealed that the protease accumulated both as a free enzyme and in a complex with AtSerpin1. Importantly, both RD21 and AtSerpin1 knock-out mutants lacked the serpin-protease complex. The results establish that the major Arabidopsis plant serpin interacts with RD21. This is the first report of the structure and in vivo interaction of a plant serpin with its target protease.	[Lampl, Nardy; Budai-Hadrian, Ofra; Davydov, Olga; Fluhr, Robert] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Joss, Tom V.; Roberts, Thomas H.] Macquarie Univ N Ryde, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Harrop, Stephen J.; Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; [Curmi, Paul M. G.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia	Weizmann Institute of Science; Macquarie University; University of New South Wales Sydney; St Vincents Hospital Sydney	Fluhr, R (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	robert.fluhr@weizmann.ac.il	Roberts, Thomas H/H-2071-2012; Curmi, Paul/G-7185-2011	Roberts, Thomas H/0000-0003-3831-3240; Curmi, Paul/0000-0001-5762-7638	Israel Science Foundation, Macquarie University [1306/06]; Australian Research Council	Israel Science Foundation, Macquarie University(Israel Science Foundation); Australian Research Council(Australian Research Council)	This work was supported by Grant 1306/06 (to R. F.) by the Israel Science Foundation, Macquarie University funding (to T. H. R.), and Australian Research Council funding (to P. M. G. C.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahn JW, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-52; Al-Ayyoubi M, 2004, J BIOL CHEM, V279, P55540, DOI 10.1074/jbc.M409957200; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Belenghi B, 2003, EUR J BIOCHEM, V270, P2593, DOI 10.1046/j.1432-1033.2003.03630.x; Bonneau L, 2008, J EXP BOT, V59, P491, DOI 10.1093/jxb/erm352; Bosch M, 2007, P NATL ACAD SCI USA, V104, P18327, DOI 10.1073/pnas.0705826104; Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Chichkova NV, 2004, PLANT CELL, V16, P157, DOI 10.1105/tpc.017889; Chuang YJ, 1999, J BIOL CHEM, V274, P28142, DOI 10.1074/jbc.274.40.28142; Dahl SW, 1996, J BIOL CHEM, V271, P25083, DOI 10.1074/jbc.271.41.25083; del Pozo O, 1998, CURR BIOL, V8, P1129, DOI 10.1016/S0960-9822(98)70469-5; Elbaz M, 2002, CELL DEATH DIFFER, V9, P726, DOI 10.1038/sj.cdd.4401030; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fass E, 2002, J BIOL CHEM, V277, P30921, DOI 10.1074/jbc.M112250200; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fu YP, 2007, J PLANT RES, V120, P465, DOI 10.1007/s10265-007-0080-5; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Gruis D, 2002, PLANT CELL, V14, P2863, DOI 10.1105/tpc.005009; Harp JM, 1998, ACTA CRYSTALLOGR D, V54, P622, DOI 10.1107/S0907444997019008; Harrop SJ, 1999, STRUCTURE, V7, P43, DOI 10.1016/S0969-2126(99)80008-2; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Hayashi Y, 2001, PLANT CELL PHYSIOL, V42, P894, DOI 10.1093/pcp/pce144; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; Hejgaard J, 2001, FEBS LETT, V488, P149, DOI 10.1016/S0014-5793(00)02425-X; Hejgaard J, 2002, PHYSIOL PLANTARUM, V116, P155, DOI 10.1034/j.1399-3054.2002.1160204.x; Hejgaard J, 2007, MOL CELLULAR ASPECTS, P279; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Kehr J, 2006, J EXP BOT, V57, P767, DOI 10.1093/jxb/erj087; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; Kuroyanagi M, 2005, J BIOL CHEM, V280, P32914, DOI 10.1074/jbc.M504476200; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nielsen HM, 2007, NEUROLOGY, V69, P1569, DOI 10.1212/01.wnl.0000271077.82508.a0; Ondzighi CA, 2008, PLANT CELL, V20, P2205, DOI 10.1105/tpc.108.058339; Ostergaard H, 2000, J BIOL CHEM, V275, P33272, DOI 10.1074/jbc.M004633200; Otegui MS, 2006, PLANT CELL, V18, P2567, DOI 10.1105/tpc.106.040931; Patston PA, 2004, METHODS, V32, P93, DOI 10.1016/S1046-2023(03)00201-9; Petersen ML, 2005, J EXP BOT, V56, P3111, DOI 10.1093/jxb/eri308; Piszczek E, 2007, ACTA PHYSIOL PLANT, V29, P391, DOI 10.1007/s11738-007-0086-6; Roberts TH, 2003, J EXP BOT, V54, P2251, DOI 10.1093/jxb/erg248; Roberts TH, 2008, FUNCT INTEGR GENOMIC, V8, P1, DOI 10.1007/s10142-007-0059-2; Rojo E, 2003, P NATL ACAD SCI USA, V100, P7389, DOI 10.1073/pnas.1230987100; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; Simonovic I, 2000, BBA-PROTEIN STRUCT M, V1481, P97, DOI 10.1016/S0167-4838(00)00115-1; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; Szepessy E, 2006, FEBS J, V273, P2942, DOI 10.1111/j.1742-4658.2006.05305.x; van der Hoorn RAL, 2004, PLANT PHYSIOL, V135, P1170, DOI 10.1104/pp.104.041467; van Gent D, 2003, INT J BIOCHEM CELL B, V35, P1536, DOI 10.1016/S1357-2725(03)00134-1; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Wang Z, 2008, NAT CHEM BIOL, V4, P557, DOI 10.1038/nchembio.104; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; WOLTERING EJ, 2008, J BIOL CHEM, V283, P774; Yamada K, 2001, PLANT PHYSIOL, V127, P1626, DOI 10.1104/pp.010551; Yamada T, 2000, PLANT CELL PHYSIOL, V41, P185, DOI 10.1093/pcp/41.2.185; Yoo BC, 2000, J BIOL CHEM, V275, P35122, DOI 10.1074/jbc.M006060200; Zhang HD, 1998, P NATL ACAD SCI USA, V95, P14202, DOI 10.1073/pnas.95.24.14202; ZHOU J, 1993, J BIOL CHEM, V268, P10863	72	62	66	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13550	13560		10.1074/jbc.M109.095075	http://dx.doi.org/10.1074/jbc.M109.095075			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20181955	Green Published, hybrid			2022-12-25	WOS:000276987700028
J	Li, YF; Hao, B				Li, Yunfeng; Hao, Bing			Structural Basis of Dimerization-dependent Ubiquitination by the SCFFbx4 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX; CYCLIN D1; SCF; ACTIVATION; INSIGHTS; COMPLEX; BINDING; FORM; RECOGNITION; ORIENTATION	The F-box proteins are the substrate recognition subunits of the SCF (Skp1-Cul1-Rbx1-F-box protein) ubiquitin ligase complexes that control the stability of numerous regulators in eukaryotic cells. Here we show that dimerization of the F-box protein Fbx4 is essential for SCFFbx4 (the superscript denotes the F-box protein) ubiquitination activity toward the telomere regulator Pin2 (also known as TRF1). The crystal structure of Fbx4 in complex with an adaptor protein Skp1 reveals an anti-parallel dimer configuration in which the linker domain of Fbx4 interacts with the C-terminal substrate-binding domain of the other protomer, whereas the C-terminal domain of the protein adopts a compact alpha/beta fold distinct from those of known F-box proteins. Biochemical studies indicate that both the N-terminal domain and a loop connecting the linker and C-terminal domain of Fbx4 are critical for the dimerization and activation of the protein. Our findings provide a framework for understanding the role of F-box dimerization in the SCF-mediated ubiquitination reaction.			Hao, B (corresponding author), 263 Farmington Ave, Farmington, CT 06030 USA.	bhao@uchc.edu		Li, Yunfeng/0000-0001-6501-9093	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NIBIB NIH HHS [P30 EB009998] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbash O, 2008, CELL CYCLE, V7, P2983, DOI 10.4161/cc.7.19.6775; Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dixon C, 2003, EUKARYOT CELL, V2, P123, DOI 10.1128/EC.2.1.123-133.2003; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Mizushima T, 2004, NAT STRUCT MOL BIOL, V11, P365, DOI 10.1038/nsmb732; Mizushima T, 2007, P NATL ACAD SCI USA, V104, P5777, DOI 10.1073/pnas.0610312104; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	50	31	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13896	13906		10.1074/jbc.M110.111518	http://dx.doi.org/10.1074/jbc.M110.111518			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20181953	Green Published, hybrid			2022-12-25	WOS:000276987700064
J	Mandriota, SJ; Buser, R; Lesne, L; Stouder, C; Favaudon, V; Maechler, P; Bena, F; Clement, V; Ruegg, C; Montesano, R; Sappino, AP				Mandriota, Stefano J.; Buser, Raphaele; Lesne, Laurence; Stouder, Christelle; Favaudon, Vincent; Maechler, Pierre; Bena, FredeRique; Clement, Virginie; Rueegg, Curzio; Montesano, Roberto; Sappino, Andre-Pascal			Ataxia Telangiectasia Mutated (ATM) Inhibition Transforms Human Mammary Gland Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; MUTATIONS; GENE; LINE; IMMORTALIZATION; HETEROZYGOSITY; SECRETION	Carriers of mutations in the cell cycle checkpoint protein kinase ataxia telangiectasia mutated (ATM), which represent 1-2% of the general population, have an increased risk of breast cancer. However, experimental evidence that ATM deficiency contributes to human breast carcinogenesis is lacking. We report here that in MCF-10A and MCF-12A cells, which are well established normal human mammary gland epithelial cell models, partial or almost complete stable ATM silencing or pharmacological inhibition resulted in cellular transformation, genomic instability, and formation of dysplastic lesions in NOD/SCID mice. These effects did not require the activity of exogenous DNA-damaging agents and were preceded by an unsuspected and striking increase in cell proliferation also observed in primary human mammary gland epithelial cells. Increased proliferation correlated with a dramatic, transient, and proteasome dependent reduction of p21(WAF1/CIP1) and p27(KIP1) protein levels, whereas little or no effect was observed on p(21WAF1/CIP1) or p27(KIP1) mRNAs. p21(WAF1/CIP1) silencing also increased MCF-10A cell proliferation, thus identifying p21(WAF1/CIP1) down-regulation as a mediator of the proliferative effect of ATM inhibition. Our findings provide the first experimental evidence that ATMis a human breast tumor suppressor. In addition, they mirror the sensitivity of ATM tumor suppressor function and unveil a new mechanism by which ATM might prevent human breast tumorigenesis, namely a direct inhibitory effect on the basal proliferation of normal mammary epithelial cells.	Univ Geneva, Ctr Oncol, CH-1206 Geneva, Switzerland; [Stouder, Christelle; Bena, FredeRique] Univ Geneva, Dept Genet Med & Dev, CH-1206 Geneva, Switzerland; [Maechler, Pierre; Montesano, Roberto] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, CH-1206 Geneva, Switzerland; [Clement, Virginie] Univ Hosp Geneva, Dept Clin Neurosci & Neurosurg, CH-1205 Geneva, Switzerland; [Rueegg, Curzio] Ctr Pluridisciplinaire Oncol, Div Expt Oncol, CH-1066 Epalinges, Switzerland; [Favaudon, Vincent] Inst Curie, INSERM, F-91405 Orsay, France	University of Geneva; University of Geneva; University of Geneva; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie		stefano.mandriota@unige.ch	Montesano, Roberto/AAV-3192-2020	Maechler, Pierre/0000-0002-2005-1433	Ligue Genevoise Contre le Cancer; Fondation pour la Lutte contre le Cancer et pour des Recherches Medico-Biologiques; Fondation Gustave et Simone Prevot; Fondation Ritva Meier; Swiss National Science Foundation [310030-120584, 3100A0-113832/1, 3100A0-118079]; Medic Foundation	Ligue Genevoise Contre le Cancer; Fondation pour la Lutte contre le Cancer et pour des Recherches Medico-Biologiques; Fondation Gustave et Simone Prevot; Fondation Ritva Meier; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medic Foundation	This work was supported by grants from the Ligue Genevoise Contre le Cancer, from the Fondation pour la Lutte contre le Cancer et pour des Recherches Medico-Biologiques, from the Fondation Gustave et Simone Prevot, and from the Fondation Ritva Meier (to S. J. M. and/or A. P. S.); from the Swiss National Science Foundation (Grant 310030-120584 to P. M.), Grant 3100A0-113832/1 (to R. M.), and Grant 3100A0-118079 (to C. R.)); and from the Medic Foundation (to C. R.).	Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Broeks A, 2000, AM J HUM GENET, V66, P494, DOI 10.1086/302746; Camacho-Vanegas O, 2007, INT J CANCER, V121, P1390, DOI 10.1002/ijc.22809; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; FAVAUDON V, 1983, BIOCHIMIE, V65, P593; Forsyth NR, 2004, NEOPLASIA, V6, P258, DOI 10.1593/neo.04103; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hall J, 2005, CANCER LETT, V227, P105, DOI 10.1016/j.canlet.2004.12.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jones A, 2008, J PATHOL, V214, P533, DOI 10.1002/path.2320; Khanna KK, 2004, J MAMMARY GLAND BIOL, V9, P247, DOI 10.1023/B:JOMG.0000048772.92326.a1; KOJIS TL, 1991, CANCER GENET CYTOGEN, V56, P143, DOI 10.1016/0165-4608(91)90164-P; Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Maillet P, 2002, J MED GENET, V39, P751, DOI 10.1136/jmg.39.10.751; Mao X, 2005, CANCER GENET CYTOGEN, V160, P141, DOI 10.1016/j.cancergencyto.2004.12.018; Montesano R, 2005, J CELL SCI, V118, P3487, DOI 10.1242/jcs.02467; Montesano R, 2009, AM J PHYSIOL-RENAL, V296, pF446, DOI 10.1152/ajprenal.90415.2008; PAINE TM, 1992, INT J CANCER, V50, P463, DOI 10.1002/ijc.2910500323; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sabourin M, 2008, TRENDS CELL BIOL, V18, P337, DOI 10.1016/j.tcb.2008.04.004; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Soukupova J, 2008, ONCOL REP, V19, P1505; SOULE HD, 1990, CANCER RES, V50, P6075; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; TAIT L, 1990, CANCER RES, V50, P6087; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weil MM, 2001, ONCOGENE, V20, P4409, DOI 10.1038/sj.onc.1204589; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622	39	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13092	13106		10.1074/jbc.M109.078360	http://dx.doi.org/10.1074/jbc.M109.078360			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177072	Green Published, hybrid			2022-12-25	WOS:000276787800066
J	Ren, JQ; Wang, YQ; Liang, YH; Zhang, YQ; Bao, SL; Xu, ZH				Ren, Jinqi; Wang, Yaqing; Liang, Yuheng; Zhang, Yongqing; Bao, Shilai; Xu, Zhiheng			Methylation of Ribosomal Protein S10 by Protein-arginine Methyltransferase 5 Regulates Ribosome Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC ANALYSIS; FISSION YEAST; HUMAN HOMOLOG; PRMT5; NUCLEOPHOSMIN; COMPLEX; SKB1; IDENTIFICATION; METHYLOSOME; ACTIVATION	Modulation of ribosomal assembly is a fine tuning mechanism for cell number and organ size control. Many ribosomal proteins undergo post-translational modification, but their exact roles remain elusive. Here, we report that ribosomal protein s10 (RPS10) is a novel substrate of an oncoprotein, protein-arginine methyltransferase 5 (PRMT5). We show that PRMT5 interacts with RPS10 and catalyzes its methylation at the Arg(158) and Arg(160) residues. The methylation of RPS10 at Arg(158) and Arg(160) plays a role in the proper assembly of ribosomes, protein synthesis, and optimal cell proliferation. The RPS10-R158K/R160K mutant is not efficiently assembled into ribosomes and is unstable and prone to degradation by the proteasomal pathway. In nucleoli, RPS10 interacts with nucleophosmin/B23 and is predominantly concentrated in the granular component region, which is required for ribosome assembly. The RPS10 methylation mutant interacts weakly with nucleophosmin/B23 and fails to concentrate in the granular component region. Our results suggest that PRMT5 is likely to regulate cell proliferation through the methylation of ribosome proteins, and thus reveal a novel mechanism for PRMT5 in tumorigenesis.	[Ren, Jinqi; Wang, Yaqing; Liang, Yuheng; Zhang, Yongqing; Bao, Shilai; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Xu, ZH (corresponding author), 1 W Beichen Rd, Beijing 100101, Peoples R China.	zhxu@genetics.ac.cn	Ren, Jinqi/D-5545-2015	Ren, Jinqi/0000-0001-7461-0491; Xu, Zhiheng/0000-0002-4809-2851	Ministry of Science and Technology of China [2007CB947202, 2006CB500701, 2006AA02Z173, 2006AA02Z140, 2009DFA32450]; National Science Foundation of China [30970580, 30725007, 30670663, 30870527, 30670479]; Chinese Academy of Sciences [KSCX1-YW-R-62/84]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by the Ministry of Science and Technology of China "973" program (2007CB947202/2006CB500701), "863" program (2006AA02Z173/Z140), and 2009DFA32450; the National Science Foundation of China (30970580/30725007/30670663/30870527/30670479); and the Chinese Academy of Sciences (Bairen plan and KSCX1-YW-R-62/84).	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Bachand F, 2006, MOL CELL BIOL, V26, P1731, DOI 10.1128/MCB.26.5.1731-1742.2006; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bao SL, 2001, J BIOL CHEM, V276, P14549, DOI 10.1074/jbc.C100096200; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Castro ME, 2008, CARCINOGENESIS, V29, P1343, DOI 10.1093/carcin/bgm302; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Gilbreth M, 1998, P NATL ACAD SCI USA, V95, P14781, DOI 10.1073/pnas.95.25.14781; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hasegawa H, 1999, LUPUS, V8, P439, DOI 10.1177/096120339900800605; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kim JM, 2005, CLIN CANCER RES, V11, P473; Kruger T, 2007, J CELL BIOL, V177, P573, DOI 10.1083/jcb.200612048; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; LHOEST J, 1984, EUR J BIOCHEM, V141, P585, DOI 10.1111/j.1432-1033.1984.tb08233.x; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Louie DF, 1996, J BIOL CHEM, V271, P28189, DOI 10.1074/jbc.271.45.28189; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Pelletier CL, 2007, CANCER RES, V67, P1609, DOI 10.1158/0008-5472.CAN-06-2875; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; SCOLNIK P, 1979, EUR J BIOCHEM, V101, P93, DOI 10.1111/j.1432-1033.1979.tb04220.x; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Shin HS, 2009, BIOCHEM BIOPH RES CO, V385, P273, DOI 10.1016/j.bbrc.2009.05.055; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Xu ZH, 2003, EMBO J, V22, P252, DOI 10.1093/emboj/cdg021; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yu YH, 2005, PROTEIN SCI, V14, P1438, DOI 10.1110/ps.041293005; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006; Zieve GW, 2003, AUTOIMMUN REV, V2, P235, DOI 10.1016/S1568-9972(03)00018-1	50	98	107	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12695	12705		10.1074/jbc.M110.103911	http://dx.doi.org/10.1074/jbc.M110.103911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20159986	Green Published, hybrid			2022-12-25	WOS:000276787800028
J	Herman, BD; Votruba, I; Holy, A; Sluis-Cremer, N; Balzarini, J				Herman, Brian D.; Votruba, Ivan; Holy, Antonin; Sluis-Cremer, Nicolas; Balzarini, Jan			The Acyclic 2,4-Diaminopyrimidine Nucleoside Phosphonate Acts as a Purine Mimetic in HIV-1 Reverse Transcriptase DNA Polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL ACTIVITY; IN-VITRO; KINETIC-ANALYSIS; MECHANISM; DERIVATIVES; POLYMERASE; RESISTANCE; CIDOFOVIR; MUTATION; ANALOGS	The acyclic pyrimidine nucleoside phosphonate (ANP) phosphonylmethoxyethoxydiaminopyrimidine (PMEO-DA-Pym) differs from other ANPs in that the aliphatic alkyloxy linker is bound to the C-6 of the 2,4-diaminopyrimidine base through an ether bond, instead of the traditional alkyl linkage to the N-1 or N-9 of the pyrimidine or purine base. In this study, we have analyzed the molecular interactions between PMEO-DA-Pym-diphosphate (PMEO-DAPym-pp) and the active sites of wild-type (WT) and drug-resistant HIV-1 reverse transcriptase (RT). Pre-steady-state kinetic analyses revealed that PMEO-DAPym-pp is a good substrate for WT HIV-1 RT: its catalytic efficiency of incorporation (k(pol)/K-d) is only 2- to 3-fold less than that of the corresponding prototype purine nucleotide analogs PMEA-pp or (R) PMPA-pp. HIV-1 RT recognizes PMEO-DAPym-pp as a purine base instead of a pyrimidine base and incorporates it opposite to thymine (in DNA) or uracil (in RNA). Molecular modeling demonstrates that PMEO-DAPym-pp fits into the active site of HIV-1 RT without significant perturbation of key amino acid residues and mimics an open incomplete purine ring that allows the canonical Watson-Crick base pairing to be maintained. PMEO-DAPym-pp is incorporated more efficiently than (R) PMPA-pp by mutant K65R HIV-1 RT and is not as efficiently excised as (R) PMPA by HIV-1RT containing thymidine analog mutations. Overall, the data revealed that PMEO-DAPym represents the prototype compound of a novel class of pyrimidine acyclic nucleoside phosphonates that are recognized as a purine nucleotide and should form the rational basis for the design and development of novel purine nucleo(s)(t)ide mimetics as potential antiviral or antimetabolic agents.	[Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; [Herman, Brian D.; Sluis-Cremer, Nicolas] Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA 15261 USA; [Votruba, Ivan; Holy, Antonin] Acad Sci Czech Republic, Inst Organ Chem & Biochem, CZ-16610 Prague, Czech Republic	KU Leuven; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Balzarini, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Louvain, Belgium.	jan.balzarini@rega.kuleuven.be			National Institutes of Health [R01 AI081571]; KU Leuven [GOA Krediet 05/19]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KU Leuven(KU Leuven); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI081571 (to N.S.-C.). This work was also supported by KU Leuven Grant GOA Krediet 05/19 (to J.B.).	Balzarini J, 2002, ANTIMICROB AGENTS CH, V46, P2185, DOI 10.1128/AAC.46.7.2185-2193.2002; BALZARINI J, 1993, ANTIMICROB AGENTS CH, V37, P332, DOI 10.1128/AAC.37.2.332; BALZARINI J, 1991, P NATL ACAD SCI USA, V88, P4961, DOI 10.1073/pnas.88.11.4961; Balzarini J, 2007, J ANTIMICROB CHEMOTH, V59, P80, DOI 10.1093/jac/dkl454; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Cherrington JM, 1996, ANTIMICROB AGENTS CH, V40, P2212, DOI 10.1128/AAC.40.9.2212; De Clercq E, 2007, BIOCHEM PHARMACOL, V73, P911, DOI 10.1016/j.bcp.2006.09.014; DECLERCQ E, 1987, ANTIVIR RES, V8, P261; DECLERCQ E, 1986, NATURE, V323, P464, DOI 10.1038/323464a0; Deval J, 2004, J BIOL CHEM, V279, P509, DOI 10.1074/jbc.M308806200; GU ZX, 1995, ANTIMICROB AGENTS CH, V39, P1888, DOI 10.1128/AAC.39.8.1888; Hockova D, 2003, J MED CHEM, V46, P5064, DOI 10.1021/jm030932o; Holy A, 2002, J MED CHEM, V45, P1918, DOI 10.1021/jm011095y; HOLY A, 1990, ANTIVIR RES, V13, P295, DOI 10.1016/0166-3542(90)90014-X; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Magee WC, 2008, ANTIMICROB AGENTS CH, V52, P586, DOI 10.1128/AAC.01172-07; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; MUL YM, 1989, NUCLEIC ACIDS RES, V17, P8917, DOI 10.1093/nar/17.22.8917; Parikh UM, 2007, AIDS, V21, P1405, DOI 10.1097/QAD.0b013e3281ac229b; PAUWELS R, 1988, ANTIMICROB AGENTS CH, V32, P1025, DOI 10.1128/AAC.32.7.1025; Sluis-Cremer N, 2005, J BIOL CHEM, V280, P29047, DOI 10.1074/jbc.M503166200; Sluis-Cremer N, 2007, ANTIMICROB AGENTS CH, V51, P48, DOI 10.1128/AAC.00683-06; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; Xiong XF, 1997, ANTIMICROB AGENTS CH, V41, P594, DOI 10.1128/AAC.41.3.594; Xiong XF, 1996, BIOCHEM PHARMACOL, V51, P1563, DOI 10.1016/0006-2952(96)00100-1; Ying C, 2005, ANTIMICROB AGENTS CH, V49, P1177, DOI 10.1128/AAC.49.3.1177-1180.2005; ZINNEN S, 1994, J BIOL CHEM, V269, P24195	29	25	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12101	12108		10.1074/jbc.M109.096529	http://dx.doi.org/10.1074/jbc.M109.096529			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164190	Green Published, hybrid			2022-12-25	WOS:000276787100040
J	Luo, SL; Akondi, KB; Zhangsun, DT; Wu, Y; Zhu, XP; Hu, YY; Christensen, S; Dowell, C; Daly, NL; Craik, DJ; Wang, CIA; Lewis, RJ; Alewood, PF; McIntosh, JM				Luo, Sulan; Akondi, Kalyana Bharati; Zhangsun, Dongting; Wu, Yong; Zhu, Xiaopeng; Hu, Yuanyan; Christensen, Sean; Dowell, Cheryl; Daly, Norelle L.; Craik, David J.; Wang, Ching-I. Anderson; Lewis, Richard J.; Alewood, Paul F.; McIntosh, J. Michael			Atypical alpha-Conotoxin LtIA from Conus litteratus Targets a Novel Microsite of the alpha 3 beta 2 Nicotinic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; NACHR SUBTYPE SELECTIVITY; ACETYLCHOLINE-RECEPTORS; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; BINDING PROTEIN; HOMOLOG ACHBP; CDNA CLONING; PEPTIDE; SUBUNIT	Different nicotinic acetylcholine receptor (nAChR) subtypes are implicated in learning, pain sensation, and disease states, including Parkinson disease and nicotine addiction. alpha-Conotoxins are among the most selective nAChR ligands. Mechanistic insights into the structure, function, and receptor interaction of alpha-conotoxins may serve as a platform for development of new therapies. Previously characterized alpha-conotoxins have a highly conserved Ser-Xaa-Pro motif that is crucial for potent nAChR interaction. This study characterized the novel alpha-conotoxin LtIA, which lacks this highly conserved motif but potently blocked alpha 3 beta 2 nAChRs with a 9.8 nM IC50 value. The off-rate of LtIA was rapid relative to Ser-Xaa-Pro-containing alpha-conotoxin MII. Nevertheless, pre-blockof alpha 3 beta 2 nAChRs with LtIA prevented the slowly reversible block associated with MII, suggesting overlap in their binding sites. nAChR beta subunit ligand-binding interface mutations were used to examine the > 1000-fold selectivity difference of LtIA for alpha 3 beta 2 versus alpha 3 beta 4 nAChRs. Unlike MII, LtIA had a > 900-fold increased IC50 value on alpha 3 beta 2(F119Q) versus wild type nAChRs, whereas T59K and V111I beta 2 mutants had little effect. Molecular docking simulations suggested that LtIA had a surprisingly shallow binding site on the alpha 3 beta 2 nAChR that includes beta 2 Lys-79. The K79A mutant disrupted LtIA binding but was without effect on an LtIA analog where the Ser-Xaa-Pro motif is present, consistent with distinct binding modes.	[Luo, Sulan] Hainan Univ, Ctr Expt Biotechnol, Ocean Coll, Coll Mat & Chem Engn,Minist Educ,Key Lab Trop Bio, Haikou Hainan 570228, Peoples R China; [Akondi, Kalyana Bharati; Daly, Norelle L.; Craik, David J.; Wang, Ching-I. Anderson; Lewis, Richard J.; Alewood, Paul F.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Akondi, Kalyana Bharati; Daly, Norelle L.; Craik, David J.; Wang, Ching-I. Anderson; Lewis, Richard J.; Alewood, Paul F.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Christensen, Sean; Dowell, Cheryl; McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Christensen, Sean; Dowell, Cheryl; McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA	Hainan University; University of Queensland; University of Queensland; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Luo, SL (corresponding author), Hainan Univ, Ctr Expt Biotechnol, Ocean Coll, Coll Mat & Chem Engn,Minist Educ,Key Lab Trop Bio, Haikou Hainan 570228, Peoples R China.	luosulan2003@163.com	Daly, Norelle L/D-4302-2013; Craik, David/B-1695-2010; Lewis, Richard J/E-8674-2013; Lewis, Richard/T-8763-2019; Alewood, Paul F/J-2412-2014	Daly, Norelle L/0000-0002-4697-6602; Craik, David/0000-0003-0007-6796; Lewis, Richard J/0000-0003-3470-923X; Lewis, Richard/0000-0003-3470-923X; Alewood, Paul/0000-0001-7454-6522	Ministry of Science and Technology of China [2007AA02Z114]; Major New Drug Discovery [2009ZX09103-644]; International Key Project of Science and Technology Collaboration [2005DFA30600]; National Natural Science Foundation of China [30860368]; Key Scientific and Technical Innovation Project; Ministry of Education of China [705043]; National Institutes of Health [MH53631, GM48677]; Australian Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053631, R29MH053631] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Major New Drug Discovery; International Key Project of Science and Technology Collaboration; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific and Technical Innovation Project; Ministry of Education of China(Ministry of Education, China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by State High Tech Research and Development Project (863) of the Ministry of Science and Technology of China Grant 2007AA02Z114, Major New Drug Discovery Project 2009ZX09103-644, International Key Project of Science and Technology Collaboration Grant 2005DFA30600, National Natural Science Foundation of China Grant 30860368, Cultivation Fund of the Key Scientific and Technical Innovation Project, and Ministry of Education of China Grant 705043. This work was also supported by National Institutes of Health Grants MH53631 and GM48677 (to J. M. M.), and Australian Research Council grants (to P. F. A., D. J. C., and N. L. D.). A preliminary account of part of this work was presented in the patent literature (Chinese Patents CN ZL200410103563. X (November 5, 2008) and CN 200810182970.2-A (December 12, 2008)).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armishaw CJ, 2005, CURR PROTEIN PEPT SC, V6, P221, DOI 10.2174/1389203054065437; Azam L, 2008, J BIOL CHEM, V283, P11625, DOI 10.1074/jbc.M710288200; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chi SW, 2006, BIOCHEM BIOPH RES CO, V345, P248, DOI 10.1016/j.bbrc.2006.04.099; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Craik DJ, 2007, ACS CHEM BIOL, V2, P457, DOI 10.1021/cb700091j; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dowell C, 2003, J NEUROSCI, V23, P8445; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutertre S, 2004, J MOL RECOGNIT, V17, P339, DOI 10.1002/jmr.683; Dutertre S, 2004, EUR J BIOCHEM, V271, P2327, DOI 10.1111/j.1432-1033.2004.04147.x; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Ellison M, 2007, CHEM REC, V7, P341, DOI 10.1002/tcr.20131; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; Gotti C, 2006, CURR PHARM DESIGN, V12, P407, DOI 10.2174/138161206775474486; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hill JM, 1998, BIOCHEMISTRY-US, V37, P15621, DOI 10.1021/bi981535w; Hogg RC, 1999, J BIOL CHEM, V274, P36559, DOI 10.1074/jbc.274.51.36559; Jin AH, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-28; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lopez-Vera E, 2007, FEBS J, V274, P3972, DOI 10.1111/j.1742-4658.2007.05931.x; Loughnan M, 1998, J BIOL CHEM, V273, P15667, DOI 10.1074/jbc.273.25.15667; Loughnan ML, 2004, J MED CHEM, V47, P1234, DOI 10.1021/jm031010o; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Luo SQ, 1998, J NEUROSCI, V18, P8571; Luo SL, 2006, PEPTIDES, V27, P2640, DOI 10.1016/j.peptides.2006.05.002; Luo S, 2006, J PEPT SCI, V12, P693, DOI 10.1002/psc.781; McIntosh JM, 2005, J BIOL CHEM, V280, P30107, DOI 10.1074/jbc.M504102200; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; McIntosh JM, 2002, J BIOL CHEM, V277, P33610, DOI 10.1074/jbc.M205102200; Olivera BM, 2008, CHANNELS, V2, P143, DOI 10.4161/chan.2.2.6276; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; Peng C, 2008, PEPTIDES, V29, P1700, DOI 10.1016/j.peptides.2008.05.028; Quiram PA, 2000, J BIOL CHEM, V275, P4889, DOI 10.1074/jbc.275.7.4889; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Shiembob DL, 2006, BIOCHEMISTRY-US, V45, P11200, DOI 10.1021/bi0611715; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wonnacott S, 2006, J MOL NEUROSCI, V30, P137, DOI 10.1385/JMN:30:1:137; Zhangsun D, 2006, CHEM BIOL DRUG DES, V68, P256, DOI 10.1111/j.1747-0285.2006.00443.x	57	48	59	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12355	12366		10.1074/jbc.M109.079012	http://dx.doi.org/10.1074/jbc.M109.079012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20145249	Green Published, hybrid			2022-12-25	WOS:000276787100064
J	Li, J; Lu, Y; Zhang, J; Kang, H; Qin, Z; Chen, C				Li, J.; Lu, Y.; Zhang, J.; Kang, H.; Qin, Z.; Chen, C.			PI4KII alpha is a novel regulator of tumor growth by its action on angiogenesis and HIF-1 alpha regulation	ONCOGENE			English	Article						phosphatidylinositol 4-kinase type II alpha (PI4KII alpha); tumor; angiogenesis; hypoxia-inducible factor-1 alpha (HIF-1 alpha)	HYPOXIA-INDUCIBLE FACTOR; II PHOSPHATIDYLINOSITOL 4-KINASE; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; NITRIC-OXIDE; FACTOR-1; PATHWAY; ALPHA; PROGRESSION; MODULATION	Tumor growth is the orchestration of various oncogenes and tumor suppressors, and the regulation of these genes offers a rational therapeutic approach to cancer treatment. In this study, we found a new regulator of tumor growth, phosphatidylinositol 4-kinase type II alpha (PI4KII alpha), the mechanism of which is involved in angiogenesis and hypoxia-inducible factor HIF-1 alpha regulation. Results obtained from a human cancer tissue microarray showed that PI4KII alpha protein expression increases markedly in seven types of cancers compared with normal tissues. Suppression of PI4KII alpha leads to retarded tumor growth in nude mice. Downregulation of PI4KII alpha in cancer cells eliminates tumor cell-induced endothelial cell tubulogenesis and migration, and results in impaired angiogenesis. Further investigation showed that PI4KII alpha can directly regulate HIF-1 alpha expression and that the expression of these two proteins is correlated in vivo. At the same time, downregulation of PI4KII alpha markedly reduces HER-2 autophosphorylation, and PI4KII alpha specifically triggers HIF-1 alpha accumulation through a phosphatidylinositol 3-kinase (PI3K)- and extracellular signal-regulated protein kinase (ERK)-dependent pathway, suggesting that PI4KII alpha may regulate HIF-1 alpha through the HER-2/PI3K, ERK cascade. In summary, we discovered a pivotal role for PI4KII alpha in the regulation of tumor growth. Our results shed new light on understanding the novel functions of PI4KII alpha in cancer and suggest that PI4KII alpha may be a promising specific target for tumor therapy. Oncogene (2010) 29, 2550 - 2559; doi:10.1038/onc.2010.14; published online 15 February 2010	[Li, J.; Lu, Y.; Zhang, J.; Qin, Z.; Chen, C.] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China; [Lu, Y.; Zhang, J.; Qin, Z.] Chinese Acad Sci, Univ Tokyo Joint Lab Struct Virol & Immunol, Inst Biophys, Beijing, Peoples R China; [Kang, H.] Capital Med Univ, Dept Gen Surg, Xuanwu Hosp, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Capital Medical University	Chen, C (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	zhihai@ibp.ac.cn; changchen@moon.ibp.ac.cn		Zhang, Jinhua/0000-0001-8957-8893	'863' National High-Technology Development Program of China [0A200202D03]; National Basic Research Program of China [2006CB911001, 2005CB522804]; National Natural Science Foundation of China [90606020, 30770512]	'863' National High-Technology Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Shane Minogue and Konstantin V Kandror for gifted plasmids and Pietro De Camilli for PI4KII alpha antibody, Wei Liang, Xiyun Yan and Yi Zhu for sharing materials, and Guoheng Xu and Qinwei Yin for valuable discussions. We are grateful to Nanping Wang for his great support. We also thank Junfeng Hao and Xudong Zhao for technical assistance. The work was supported by the '863' National High-Technology Development Program of China (0A200202D03), the National Basic Research Program of China (2006CB911001, 2005CB522804) and the National Natural Science Foundation of China (90606020, 30770512).	Craige B, 2008, MOL BIOL CELL, V19, P1415, DOI 10.1091/mbc.E07-12-1239; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DRABKIN DL, 1949, AM J MED SCI, V217, P710; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Garcia-Cardena G, 1998, J NATL CANCER I, V90, P560, DOI 10.1093/jnci/90.8.560; Gehrmann T, 1998, EUR J BIOCHEM, V253, P357, DOI 10.1046/j.1432-1327.1998.2530357.x; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; GRANT DS, 1992, J CELL PHYSIOL, V153, P614, DOI 10.1002/jcp.1041530324; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Heilmeyer LMG, 2003, IUBMB LIFE, V55, P59, DOI 10.1080/1521654031000090896; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; HSUAN JJ, 1993, ANTICANCER RES, V13, P2521; Huang LE, 2003, J BIOL CHEM, V278, P19575, DOI 10.1074/jbc.R200030200; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; KAUFFMANNZEH A, 1994, J BIOL CHEM, V269, P31243; Koesters R, 2003, CANCER LETT, V198, P123, DOI 10.1016/S0304-3835(03)00367-7; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; MELILLO G, 1995, J EXP MED, V182, P1683, DOI 10.1084/jem.182.6.1683; Minogue S, 2006, J CELL SCI, V119, P571, DOI 10.1242/jcs.02752; Minogue S, 2001, J BIOL CHEM, V276, P16635, DOI 10.1074/jbc.M100982200; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Qin YB, 2009, J BIOL CHEM, V284, P22544, DOI 10.1074/jbc.M109.014399; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V319, P1, DOI 10.1016/j.bbrc.2004.04.150; Salazar G, 2009, J BIOL CHEM, V284, P1790, DOI 10.1074/jbc.M805991200; SCOTT GK, 1991, J BIOL CHEM, V266, P14300; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Simonton DK, 2009, PERSPECT PSYCHOL SCI, V4, P2, DOI 10.1111/j.1745-6924.2009.01093.x; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Waugh MG, 2003, BIOCHEM J, V373, P57, DOI 10.1042/BJ20030089; Weber G, 1996, ANTICANCER RES, V16, P3271; Xu Z, 2006, MOL ENDOCRINOL, V20, P2890, DOI 10.1210/me.2006-0193; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Zhong H, 2000, CANCER RES, V60, P1541	41	40	43	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	17					2550	2559		10.1038/onc.2010.14	http://dx.doi.org/10.1038/onc.2010.14			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	589RB	20154717				2022-12-25	WOS:000277169400010
J	Piper, KE; Fernandez-Sampedro, M; Steckelberg, KE; Mandrekar, JN; Karau, MJ; Steckelberg, JM; Berbari, EF; Osmon, DR; Hanssen, AD; Lewallen, DG; Cofield, RH; Sperling, JW; Sanchez-Sotelo, J; Huddleston, PM; Dekutoski, MB; Yaszemski, M; Currier, B; Patel, R				Piper, Kerryl E.; Fernandez-Sampedro, Marta; Steckelberg, Kathryn E.; Mandrekar, Jayawant N.; Karau, Melissa J.; Steckelberg, James M.; Berbari, Elie F.; Osmon, Douglas R.; Hanssen, Arlen D.; Lewallen, David G.; Cofield, Robert H.; Sperling, John W.; Sanchez-Sotelo, Joaquin; Huddleston, Paul M.; Dekutoski, Mark B.; Yaszemski, Michael; Currier, Bradford; Patel, Robin			C-Reactive Protein, Erythrocyte Sedimentation Rate and Orthopedic Implant Infection	PLOS ONE			English	Article							TOTAL KNEE ARTHROPLASTY; TOTAL HIP-ARTHROPLASTY; PERI-PROSTHETIC INFECTION; JOINT INFECTION; DIAGNOSIS; SURGERY; REPLACEMENT; SONICATION; VALUES; LEVEL	Background: C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) have been shown to be useful for diagnosis of prosthetic hip and knee infection. Little information is available on CRP and ESR in patients undergoing revision or resection of shoulder arthroplasties or spine implants. Methods/Results: We analyzed preoperative CRP and ESR in 636 subjects who underwent knee (n = 297), hip (n = 221) or shoulder (n = 64) arthroplasty, or spine implant (n = 54) removal. A standardized definition of orthopedic implant-associated infection was applied. Receiver operating curve analysis was used to determine ideal cutoff values for differentiating infected from non-infected cases. ESR was significantly different in subjects with aseptic failure infection of knee (median 11 and 53.5 mm/h, respectively, p = <0.0001) and hip (median 11 and 30 mm/h, respectively, p = <0.0001) arthroplasties and spine implants (median 10 and 48.5 mm/h, respectively, p = 0.0033), but not shoulder arthroplasties (median 10 and 9 mm/h, respectively, p = 0.9883). Optimized ESR cutoffs for knee, hip and shoulder arthroplasties and spine implants were 19, 13, 26, and 45 mm/h, respectively. Using these cutoffs, sensitivity and specificity to detect infection were 89 and 74% for knee, 82 and 60% for hip, and 32 and 93% for shoulder arthroplasties, and 57 and 90% for spine implants. CRP was significantly different in subjects with aseptic failure and infection of knee (median 4 and 51 mg/l, respectively, p < 0.0001), hip (median 3 and 18 mg/l, respectively, p < 0.0001), and shoulder (median 3 and 10 mg/l, respectively, p = 0.01) arthroplasties, and spine implants (median 3 and 20 mg/l, respectively, p = 0.0011). Optimized CRP cutoffs for knee, hip, and shoulder arthroplasties, and spine implants were 14.5, 10.3, 7, and 4.6 mg/l, respectively. Using these cutoffs, sensitivity and specificity to detect infection were 79 and 88% for knee, 74 and 79% for hip, and 63 and 73% for shoulder arthroplasties, and 79 and 68% for spine implants. Conclusion: CRP and ESR have poor sensitivity for the diagnosis of shoulder implant infection. A CRP of 4.6 mg/l had a sensitivity of 79 and a specificity of 68% to detect infection of spine implants.	[Piper, Kerryl E.; Fernandez-Sampedro, Marta; Steckelberg, Kathryn E.; Karau, Melissa J.; Steckelberg, James M.; Berbari, Elie F.; Osmon, Douglas R.; Patel, Robin] Mayo Clin, Coll Med, Dept Med, Div Infect Dis, Rochester, MN 55905 USA; [Mandrekar, Jayawant N.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Patel, Robin] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN USA; [Hanssen, Arlen D.; Lewallen, David G.; Cofield, Robert H.; Sperling, John W.; Sanchez-Sotelo, Joaquin; Huddleston, Paul M.; Dekutoski, Mark B.; Yaszemski, Michael; Currier, Bradford] Mayo Clin, Coll Med, Dept Orthoped Surg, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Piper, KE (corresponding author), Mayo Clin, Coll Med, Dept Med, Div Infect Dis, Rochester, MN 55905 USA.	patel.robin@mayo.edu	Huddleston, Paul/ABI-6836-2020; Sanchez-Sotelo, Joaquin/AAJ-1248-2021	Huddleston, Paul/0000-0002-8665-3787; 				AALTO K, 1984, CLIN ORTHOP RELAT R, P118; Austin MS, 2008, J ARTHROPLASTY, V23, P65, DOI 10.1016/j.arth.2007.09.005; Bare J, 2006, CLIN ORTHOP RELAT R, P40, DOI 10.1097/01.blo.0000218727.14097.d5; Bernard L, 2004, SCAND J INFECT DIS, V36, P410, DOI 10.1080/00365540410015240; Bilgen OF, 2001, J INT MED RES, V29, P7, DOI 10.1177/147323000102900102; Bottner F, 2007, J BONE JOINT SURG BR, V89B, P94, DOI 10.1302/0301-620X.89B1.17485; CHOUDHRY RR, 1992, J BONE JOINT SURG BR, V74, P523, DOI 10.1302/0301-620X.74B4.1624508; DELPOZO JL, 2009, NEW ENGL J MED, V361, P43; Feldman DS, 1995, J BONE JOINT SURG AM, V77A, P1807, DOI 10.2106/00004623-199512000-00003; Fink B, 2008, J BONE JOINT SURG BR, V90B, P874, DOI 10.1302/0301-620X.90B7.20417; Greidanus NV, 2007, J BONE JOINT SURG AM, V89A, P1409, DOI 10.2106/JBJS.D.02602; Hahn F, 2005, EUR SPINE J, V14, P783, DOI 10.1007/s00586-004-0854-6; JONSSON B, 1991, SPINE, V16, P1049; Kanafani ZA, 2009, CLIN INFECT DIS, V49, P1083, DOI 10.1086/605577; Kowalski TJ, 2007, AM J NEURORADIOL, V28, P693; Laiho K, 2001, ANN RHEUM DIS, V60, P275, DOI 10.1136/ard.60.3.275; LARSSON S, 1992, CLIN ORTHOP RELAT R, P237; LEVIN BR, 1991, TRENDS ECOL EVOL, V6, P237, DOI 10.1016/0169-5347(91)90067-8; Moreschini O, 2001, INT J TISSUE REACT, V23, P151; Muller Michael, 2008, J Orthop Surg Res, V3, P31, DOI 10.1186/1749-799X-3-31; Niskanen RO, 1996, J BONE JOINT SURG BR, V78B, P431, DOI 10.1302/0301-620X.78B3.0780431; Piper KE, 2009, J CLIN MICROBIOL, V47, P1878, DOI 10.1128/JCM.01686-08; SAMPEDRO MF, SPINE IN PRESS; Schinsky MF, 2008, J BONE JOINT SURG AM, V90A, P1869, DOI 10.2106/JBJS.G.01255; SHIH LY, 1987, CLIN ORTHOP RELAT R, P238; Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Virolainen P, 2002, Scand J Surg, V91, P178; White J, 1998, J BONE JOINT SURG BR, V80B, P909, DOI 10.1302/0301-620X.80B5.8708	29	122	130	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9358	10.1371/journal.pone.0009358	http://dx.doi.org/10.1371/journal.pone.0009358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179760	Green Published, gold			2022-12-25	WOS:000274923900019
J	Zhang, H; Wang, P; Papangelopoulos, N; Xu, Y; Sette, A; Bourne, PE; Lund, O; Ponomarenko, J; Nielsen, M; Peters, B				Zhang, Hao; Wang, Peng; Papangelopoulos, Nikitas; Xu, Ying; Sette, Alessandro; Bourne, Philip E.; Lund, Ole; Ponomarenko, Julia; Nielsen, Morten; Peters, Bjoern			Limitations of Ab Initio Predictions of Peptide Binding to MHC Class II Molecules	PLOS ONE			English	Article							FREE-ENERGY DECOMPOSITION; STRUCTURAL PREDICTION; PROTEIN; COMPLEX; SEQUENCE; RECEPTOR; DYNAMICS; NETMHCPAN; POCKETS; SERVER	Successful predictions of peptide MHC binding typically require a large set of binding data for the specific MHC molecule that is examined. Structure based prediction methods promise to circumvent this requirement by evaluating the physical contacts a peptide can make with an MHC molecule based on the highly conserved 3D structure of peptide: MHC complexes. While several such methods have been described before, most are not publicly available and have not been independently tested for their performance. We here implemented and evaluated three prediction methods for MHC class II molecules: statistical potentials derived from the analysis of known protein structures; energetic evaluation of different peptide snapshots in a molecular dynamics simulation; and direct analysis of contacts made in known 3D structures of peptide: MHC complexes. These methods are ab initio in that they require structural data of the MHC molecule examined, but no specific peptide: MHC binding data. Moreover, these methods retain the ability to make predictions in a sufficiently short time scale to be useful in a real world application, such as screening a whole proteome for candidate binding peptides. A rigorous evaluation of each methods prediction performance showed that these are significantly better than random, but still substantially lower than the best performing sequence based class II prediction methods available. While the approaches presented here were developed independently, we have chosen to present our results together in order to support the notion that generating structure based predictions of peptide: MHC binding without using binding data is unlikely to give satisfactory results.	[Zhang, Hao; Lund, Ole; Nielsen, Morten] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Wang, Peng; Sette, Alessandro; Peters, Bjoern] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Papangelopoulos, Nikitas; Bourne, Philip E.; Ponomarenko, Julia] Univ Calif San Diego, San Diego Supercomp Ctr, San Diego, CA 92103 USA; [Papangelopoulos, Nikitas; Bourne, Philip E.; Ponomarenko, Julia] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA; [Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Inst Bioinformat, Athens, GA 30602 USA	Technical University of Denmark; La Jolla Institute for Immunology; University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Georgia; University of Georgia	Zhang, H (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark.	bpeters@liai.org	Ponomarenko, Julia/K-8105-2015; Nielsen, Morten/E-7754-2011; Sette, Alessandro/AFO-8916-2022; Bourne, Philip E/C-2073-2008; Lund, Ole/F-4437-2014; Nielsen, Morten/AAL-8700-2020	Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Nielsen, Morten/0000-0001-7885-4311; Ponomarenko, Julia/0000-0002-1477-9444	National Institutes of Health [HHSN26620040006C, HHSN266200400083C, HHSN266200400025C]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health contracts HHSN26620040006C, HHSN266200400083C and HHSN266200400025C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia Y, 2004, METHODS, V34, P454, DOI 10.1016/j.ymeth.2004.06.008; ALTUVIA Y, 1995, J MOL BIOL, V249, P244, DOI 10.1006/jmbi.1995.0293; Altuvia Y, 1997, HUM IMMUNOL, V58, P1, DOI 10.1016/S0198-8859(97)00210-3; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brusic V, 2002, IMMUNOL CELL BIOL, V80, P280, DOI 10.1046/j.1440-1711.2002.01088.x; Bui HH, 2006, PROTEINS, V63, P43, DOI 10.1002/prot.20870; Davies MN, 2003, MOL MED, V9, P220, DOI 10.2119/2003-00032.Sansom; Doytchinova IA, 2004, J IMMUNOL, V172, P7495, DOI 10.4049/jimmunol.172.12.7495; Fagerberg T, 2006, J MOL BIOL, V356, P521, DOI 10.1016/j.jmb.2005.11.059; Godkin AJ, 2001, J IMMUNOL, V166, P6720, DOI 10.4049/jimmunol.166.11.6720; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Guan PP, 2003, NUCLEIC ACIDS RES, V31, P3621, DOI 10.1093/nar/gkg510; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Jojic N, 2006, BIOINFORMATICS, V22, pE227, DOI 10.1093/bioinformatics/btl255; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lovitch SB, 2006, J IMMUNOL, V176, P2958, DOI 10.4049/jimmunol.176.5.2958; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Moreira IS, 2007, J COMPUT CHEM, V28, P644, DOI 10.1002/jcc.20566; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; *RDC T, 2006, R LANG ENV STAT COMP; Richards MW, 2009, MOL CELL, V36, P560, DOI 10.1016/j.molcel.2009.09.038; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Schafroth HD, 2004, PROTEINS, V54, P534, DOI 10.1002/prot.10608; SIDNEY JS, 1998, MEASUREMENT MHC PEPT; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Singh SP, 2008, BIOINFORMATION, V3, P72, DOI 10.6026/97320630003072; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Zaitlen N, 2008, J COMPUT BIOL, V15, P927, DOI 10.1089/cmb.2007.0183; Zhang C, 2004, PROTEIN SCI, V13, P400, DOI 10.1110/ps.03348304; Zhang H, 2009, BIOINFORMATICS, V25, P1293, DOI 10.1093/bioinformatics/btp137; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	49	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9272	10.1371/journal.pone.0009272	http://dx.doi.org/10.1371/journal.pone.0009272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174654	Green Submitted, Green Published, gold			2022-12-25	WOS:000274590600025
J	Bouamrani, A; Ramus, C; Gay, E; Pelletier, L; Cubizolles, M; Brugiere, S; Wion, D; Berger, F; Issartel, JP				Bouamrani, Ali; Ramus, Claire; Gay, Emmanuel; Pelletier, Laurent; Cubizolles, Myriam; Brugiere, Sabine; Wion, Didier; Berger, Francois; Issartel, Jean-Paul			Increased Phosphorylation of Vimentin in Noninfiltrative Meningiomas	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; RHEUMATOID-ARTHRITIS; BRAIN-TUMORS; EXPRESSION; KINASE; CANCER; CELLS; CARCINOMA; CYTOSKELETON; PROSTATE	Background: Tissue invasion or tissue infiltration are clinical behaviors of a poor-prognosis subset of meningiomas. We carried out proteomic analyses of tissue extracts to discover new markers to accurately distinguish between infiltrative and noninfiltrative meningiomas. Methodology/Principal Findings: Protein lysates of 64 different tissue samples (including two brain-invasive and 32 infiltrative tumors) were submitted to SELDI-TOF mass spectrometric analysis. Mass profiles were used to build up both unsupervised and supervised hierarchical clustering. One marker was found at high levels in noninvasive and noninfiltrative tumors and appeared to be a discriminative marker for clustering infiltrative and/or invasive meningiomas versus noninvasive meningiomas in two distinct subsets. Sensitivity and specificity were 86.7% and 100%, respectively. This marker was purified and identified as a multiphosphorylated form of vimentin, a cytoskeletal protein expressed in meningiomas. Conclusions/Significance: Specific forms of vimentin can be surrogate molecular indicators of the invasive/infiltrative phenotype in tumors.	[Bouamrani, Ali; Ramus, Claire; Pelletier, Laurent; Wion, Didier; Berger, Francois; Issartel, Jean-Paul] Univ Grenoble 1, INSERM, U836, Grenoble Inst Neurosci, Grenoble, France; [Gay, Emmanuel] CHU Grenoble, Dept Neurosurg & Pathol, F-38043 Grenoble, France; [Cubizolles, Myriam] Ciphergen Inc, Fremont, CA USA; [Brugiere, Sabine] CEA, Grenoble, France; [Issartel, Jean-Paul] CNRS, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Bouamrani, A (corresponding author), Univ Grenoble 1, INSERM, U836, Grenoble Inst Neurosci, Grenoble, France.	jean-paul.issartel@ujf-grenoble.fr	Cubizolles, Myriam/AAZ-7719-2021; ISSARTEL, Jean-Paul/B-8727-2014; Wion, Didier/M-7045-2018	Wion, Didier/0000-0001-7144-6470; Sabine, BRUGIERE/0000-0002-0757-0968	Region Rhne-Alpes; Ligue contre le Cancer; Lyon, Auvergne, Rhne-Alpes Canceropole; Institut National du Cancer	Region Rhne-Alpes; Ligue contre le Cancer(Ligue nationale contre le cancer); Lyon, Auvergne, Rhne-Alpes Canceropole; Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by grants from the Region Rhne-Alpes; the Ligue contre le Cancer; the Lyon, Auvergne, Rhne-Alpes Canceropole and the Institut National du Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO S, 1989, BIOCHEMISTRY-US, V28, P2974, DOI 10.1021/bi00433a035; ANDO S, 1991, BIOCHEM BIOPH RES CO, V175, P955, DOI 10.1016/0006-291X(91)91658-Y; Bang H, 2007, ARTHRITIS RHEUM-US, V56, P2503, DOI 10.1002/art.22817; BLACK PM, 1993, NEUROSURGERY, V32, P643, DOI 10.1227/00006123-199304000-00023; Bonam-Rani A, 2006, CLIN CHEM, V52, P2103, DOI 10.1373/clinchem.2006.070979; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; CHAMBERLAIN MC, 2004, CURR TREAT OPTION NE, V26, P297; Cheng TJ, 2003, J CELL BIOCHEM, V89, P589, DOI 10.1002/jcb.10511; CHOU YH, 1991, J BIOL CHEM, V266, P7325; Chu YW, 1996, AM J PATHOL, V148, P63; Diamandis EP, 2003, CLIN CHEM, V49, P1272, DOI 10.1373/49.8.1272; DONHUIJSEN K, 1989, PATHOL RES PRACT, V184, P287, DOI 10.1016/S0344-0338(89)80088-3; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gilles C, 1999, J CELL SCI, V112, P4615; HEATLEY M, 1995, J CLIN PATHOL, V48, P1031, DOI 10.1136/jcp.48.11.1031; Hong SH, 2006, BIOMARK INSIGHTS, V1, P175; HUANG TJ, 1994, J PROTEIN CHEM, V13, P517, DOI 10.1007/BF01901533; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Li Zu-mao, 2008, Zhonghua Zhong Liu Za Zhi, V30, P408; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Matsuzawa K, 1997, BIOCHEM BIOPH RES CO, V234, P621, DOI 10.1006/bbrc.1997.6669; Nakamura Y, 2000, GENES CELLS, V5, P823, DOI 10.1046/j.1365-2443.2000.00372.x; Nakamura Y, 2009, INT J CANCER, V124, P2512, DOI 10.1002/ijc.24229; Paradis V, 2005, HEPATOLOGY, V41, P40, DOI 10.1002/hep.20505; Perry A, 1999, CANCER, V85, P2046, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M; Petricoin EF, 2004, CURR OPIN BIOTECH, V15, P24, DOI 10.1016/j.copbio.2004.01.005; RAYMOND WA, 1989, J PATHOL, V158, P107, DOI 10.1002/path.1711580205; Schwartz SA, 2004, CLIN CANCER RES, V10, P981, DOI 10.1158/1078-0432.CCR-0927-3; SCHWECHHEIMER K, 1984, LAB INVEST, V51, P584; Seshadri R, 1996, INT J CANCER, V67, P353; Singh S, 2003, CANCER RES, V63, P2306; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Trog D, 2008, AMINO ACIDS, V34, P539, DOI 10.1007/s00726-007-0007-4; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149; Whipple RA, 2008, CANCER RES, V68, P5678, DOI 10.1158/0008-5472.CAN-07-6589; Wiesner A, 2004, CURR PHARM BIOTECHNO, V5, P45, DOI 10.2174/1389201043489675; YANG HY, 1994, MOL CHEM NEUROPATHOL, V21, P155, DOI 10.1007/BF02815349; YUNG WKA, 1985, J NEURO-ONCOL, V3, P35; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746	42	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9238	10.1371/journal.pone.0009238	http://dx.doi.org/10.1371/journal.pone.0009238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169076	Green Published, gold			2022-12-25	WOS:000274590500019
J	Xue, L; Chiang, L; He, B; Zhao, YY; Winoto, A				Xue, Ling; Chiang, Leslie; He, Bo; Zhao, You-Yang; Winoto, Astar			FoxM1, a Forkhead Transcription Factor Is a Master Cell Cycle Regulator for Mouse Mature T Cells but Not Double Positive Thymocytes	PLOS ONE			English	Article							BOX M1; NEGATIVE SELECTION; FACTOR TRIDENT; APOPTOSIS; MITOSIS; CANCER; PROLIFERATION; HOMEOSTASIS; PROGRESSION; INHIBITOR	FoxM1 is a forkhead box transcription factor and a known master regulator required for different phases of the cell cycle. In cell lines, FoxM1 deficient cells exhibit delayed S phase entry, aneuploidy, polyploidy and can't complete mitosis. In vivo, FoxM1 is expressed mostly in proliferating cells but is surprisingly also found in non-proliferating CD4(+)CD8(+) double positive thymocytes. Here, we addressed the role of FoxM1 in T cell development by generating and analyzing two different lines of T-cell specific FoxM1 deficient mice. As expected, FoxM1 is required for proliferation of early thymocytes and activated mature T cells. Defective expression of many cell cycle proteins was detected, including cyclin A, cyclin B1, cdc2, cdk2, p27 and the Rb family members p107 and p130 but surprisingly not survivin. Unexpectedly, loss of FoxM1 only affects a few cell cycle proteins in CD4(+)CD8(+) thymocytes and has little effect on their sensitivity to apoptosis and the subsequent steps of T cell differentiation. Thus, regulation of cell cycle genes by FoxM1 is stage-and context-dependent.	[Xue, Ling; Chiang, Leslie; He, Bo; Winoto, Astar] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Xue, Ling; Chiang, Leslie; He, Bo; Winoto, Astar] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Zhao, You-Yang] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL USA; [Zhao, You-Yang] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Xue, L (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	winoto@berkeley.edu		ZHAO, YOU-YANG/0000-0002-0041-0339	National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA066236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JM, 2004, CURR OPIN CELL BIOL, V16, P634, DOI 10.1016/j.ceb.2004.09.010; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Korver W, 1997, IMMUNOBIOLOGY, V198, P157, DOI 10.1016/S0171-2985(97)80036-8; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Krutzik PO, 2005, J IMMUNOL, V175, P2357, DOI 10.4049/jimmunol.175.4.2357; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; MYATT SS, 2007, NATUER REV CANC, V7; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Pellicciari C, 1996, EXP CELL RES, V229, P370, DOI 10.1006/excr.1996.0382; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sohn SJ, 2007, CURR OPIN IMMUNOL, V19, P510, DOI 10.1016/j.coi.2007.06.001; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tait ED, 2009, NAT IMMUNOL, V10, P457, DOI 10.1038/ni0509-457; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; WANG XD, 2005, J ORGAN DYSFUNCT, V1, P2; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Xue L, 2008, P NATL ACAD SCI USA, V105, P2022, DOI 10.1073/pnas.0712059105; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	36	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9229	10.1371/journal.pone.0009229	http://dx.doi.org/10.1371/journal.pone.0009229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169079	gold, Green Published, Green Submitted			2022-12-25	WOS:000274590500011
J	Kadota, M; Yang, HH; Gomez, B; Sato, M; Clifford, RJ; Meerzaman, D; Dunn, BK; Wakefield, LM; Lee, MP				Kadota, Mitsutaka; Yang, Howard H.; Gomez, Bianca; Sato, Misako; Clifford, Robert J.; Meerzaman, Daoud; Dunn, Barbara K.; Wakefield, Lalage M.; Lee, Maxwell P.			Delineating Genetic Alterations for Tumor Progression in the MCF10A Series of Breast Cancer Cell Lines	PLOS ONE			English	Article							EPITHELIAL-CELLS; EXPRESSION; MODEL; IMMORTALIZATION; SUPPRESSOR; RECEPTOR; PIK3CA	To gain insight into the role of genomic alterations in breast cancer progression, we conducted a comprehensive genetic characterization of a series of four cell lines derived from MCF10A. MCF10A is an immortalized mammary epithelial cell line (MEC); MCF10AT is a premalignant cell line generated from MCF10A by transformation with an activated HRAS gene; MCF10CA1h and MCF10CA1a, both derived from MCF10AT xenografts, form well-differentiated and poorly-differentiated malignant tumors in the xenograft models, respectively. We analyzed DNA copy number variation using the Affymetrix 500 K SNP arrays with the goal of identifying gene-specific amplification and deletion events. In addition to a previously noted deletion in the CDKN2A locus, our studies identified MYC amplification in all four cell lines. Additionally, we found intragenic deletions in several genes, including LRP1B in MCF10CA1h and MCF10CA1a, FHIT and CDH13 in MCF10CA1h, and RUNX1 in MCF10CA1a. We confirmed the deletion of RUNX1 in MCF10CA1a by DNA and RNA analyses, as well as the absence of the RUNX1 protein in that cell line. Furthermore, we found that RUNX1 expression was reduced in high-grade primary breast tumors compared to low/mid-grade tumors. Mutational analysis identified an activating PIK3CA mutation, H1047R, in MCF10CA1h and MCF10CA1a, which correlates with an increase of AKT1 phosphorylation at Ser473 and Thr308. Furthermore, we showed increased expression levels for genes located in the genomic regions with copy number gain. Thus, our genetic analyses have uncovered sequential molecular events that delineate breast tumor progression. These events include CDKN2A deletion and MYC amplification in immortalization, HRAS activation in transformation, PIK3CA activation in the formation of malignant tumors, and RUNX1 deletion associated with poorly-differentiated malignant tumors.	[Kadota, Mitsutaka; Yang, Howard H.; Gomez, Bianca; Clifford, Robert J.; Meerzaman, Daoud; Lee, Maxwell P.] NCI, Lab Populat Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Sato, Misako; Wakefield, Lalage M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Dunn, Barbara K.] NCI, Basic Prevent Sci Res Grp, Canc Prevent Div, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kadota, M (corresponding author), NCI, Lab Populat Genet, Ctr Canc Res, Bethesda, MD 20892 USA.	leemax@mail.nih.gov	Kadota, Mitsutaka/AAF-2652-2019; Wakefield, Lalage M/M-1963-2017	Kadota, Mitsutaka/0000-0002-1674-6697; Wakefield, Lalage M/0000-0003-4124-5250	NIH; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011253, ZIABC005785, ZIABC011250, ZIABC011252, ZIABC010986] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This research was supported by the Intramural Research Program of the NIH and the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima Y, 2008, CANCER RES, V68, P5104, DOI 10.1158/0008-5472.CAN-07-5680; Choong LY, 2007, MOL CANCER THER, V6, P2828, DOI 10.1158/1535-7163.MCT-06-0809; Cowell JK, 2005, CANCER GENET CYTOGEN, V163, P23, DOI 10.1016/j.cancergencyto.2005.04.019; Dawson PJ, 1996, AM J PATHOL, V148, P313; Friedman AD, 2009, J CELL PHYSIOL, V219, P520, DOI 10.1002/jcp.21738; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Kadota M, 2009, CANCER RES, V69, P7357, DOI 10.1158/0008-5472.CAN-09-0064; Kim IY, 2009, CANCER LETT, V275, P227, DOI 10.1016/j.canlet.2008.10.013; Kim SH, 2009, INT J CANCER, V124, P2813, DOI 10.1002/ijc.24278; Marella NV, 2009, CANCER RES, V69, P5946, DOI 10.1158/0008-5472.CAN-09-0420; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Shekhar PVM, 1998, INT J ONCOL, V13, P907; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; SOULE HD, 1990, CANCER RES, V50, P6075; Strickland LB, 2000, BREAST CANCER RES TR, V64, P235, DOI 10.1023/A:1026562720218; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Worsham MJ, 2006, BREAST CANCER RES TR, V96, P177, DOI 10.1007/s10549-005-9077-8; Wu GJ, 2005, BREAST CANCER RES, V7, pR609, DOI 10.1186/bcr1262; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101	22	108	110	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9201	10.1371/journal.pone.0009201	http://dx.doi.org/10.1371/journal.pone.0009201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169162	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474700005
J	Hohm, T; Zitzler, E; Simon, R				Hohm, Tim; Zitzler, Eckart; Simon, Ruediger			A Dynamic Model for Stem Cell Homeostasis and Patterning in Arabidopsis Meristems	PLOS ONE			English	Article							SHOOT MERISTEM; GENE ENCODES; WUSCHEL; FATE; EXPRESSION; KINASE; LOOP	Plants maintain stem cells in their meristems as a source for new undifferentiated cells throughout their life. Meristems are small groups of cells that provide the microenvironment that allows stem cells to prosper. Homeostasis of a stem cell domain within a growing meristem is achieved by signalling between stem cells and surrounding cells. We have here simulated the origin and maintenance of a defined stem cell domain at the tip of Arabidopsis shoot meristems, based on the assumption that meristems are self-organizing systems. The model comprises two coupled feedback regulated genetic systems that control stem cell behaviour. Using a minimal set of spatial parameters, the mathematical model allows to predict the generation, shape and size of the stem cell domain, and the underlying organizing centre. We use the model to explore the parameter space that allows stem cell maintenance, and to simulate the consequences of mutations, gene misexpression and cell ablations.	[Hohm, Tim] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Hohm, Tim] Univ Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland; [Hohm, Tim; Zitzler, Eckart] Comp Engn & Networks Lab, Zurich, Switzerland; [Simon, Ruediger] Univ Dusseldorf, Inst Genet, Dusseldorf, Germany	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Heinrich Heine University Dusseldorf	Hohm, T (corresponding author), Univ Lausanne, Dept Med Genet, Lausanne, Switzerland.	ruediger.simon@uni-duesseldorf.de	Hohm, Tim/D-8593-2015; Simon, Rudiger/T-6755-2018	Hohm, Tim/0000-0003-0935-9784; Simon, Rudiger/0000-0002-1317-7716	European Commission [5336]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the European Commission under the Marie Curie Research Training Network SY-STEM, Project 5336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand U, 2002, PLANT PHYSIOL, V129, P565, DOI 10.1104/pp.001867; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Foster JA, 2001, NAT REV GENET, V2, P428, DOI 10.1038/35076523; Geier F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003553; Gordon SP, 2007, DEVELOPMENT, V134, P3539, DOI 10.1242/dev.010298; Gross-Hardt R, 2002, GENE DEV, V16, P1129, DOI 10.1101/gad.225202; Han P, 2008, PLANT CELL, V20, P1482, DOI 10.1105/tpc.108.058867; Hohm T, 2007, LECT NOTES COMPUT SC, V4447, P102; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Jonsson H, 2005, BIOINFORMATICS, V21, pI232, DOI 10.1093/bioinformatics/bti1036; Jonsson H, 2003, SIGNALLING MULTICELL, P156; KOCH AJ, 1994, REV MOD PHYS, V66, P1481, DOI 10.1103/RevModPhys.66.1481; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Kwon CS, 2005, GENE DEV, V19, P992, DOI 10.1101/gad.1276305; Laux T, 1996, DEVELOPMENT, V122, P87; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Muller R, 2006, PLANT CELL, V18, P1188, DOI 10.1105/tpc.105.040444; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Reinhardt D, 2003, DEVELOPMENT, V130, P4073, DOI 10.1242/dev.00596; Ruuth SJ, 1995, J MATH BIOL, V34, P148, DOI 10.1007/BF00178771; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Stahl Y, 2005, INT J DEV BIOL, V49, P479, DOI 10.1387/ijdb.041929ys; Tomlin CJ, 2007, NAT REV GENET, V8, P331, DOI 10.1038/nrg2098; TUCKER MR, 2008, DEVELOPMENT; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Zhao YX, 2004, PLANT CELL, V16, P2586, DOI 10.1105/tpc.104.024869	33	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9189	10.1371/journal.pone.0009189	http://dx.doi.org/10.1371/journal.pone.0009189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169148	Green Published, gold			2022-12-25	WOS:000274474600010
J	Menke, SB; Booth, W; Dunn, RR; Schal, C; Vargo, EL; Silverman, J				Menke, Sean B.; Booth, Warren; Dunn, Robert R.; Schal, Coby; Vargo, Edward L.; Silverman, Jules			Is It Easy to Be Urban? Convergent Success in Urban Habitats among Lineages of a Widespread Native Ant	PLOS ONE			English	Article							ODOROUS HOUSE ANT; ARGENTINE ANTS; LINEPITHEMA-HUMILE; EVOLUTION; COMMUNITIES; INVASION; CONSERVATION; GENETICS; BIOLOGY; SUPERCOLONIES	The most rapidly expanding habitat globally is the urban habitat, yet the origin and life histories of the populations of native species that inhabit this habitat remain poorly understood. We use DNA barcoding of the COI gene in the widespread native pest ant Tapinoma sessile to test two hypotheses regarding the origin of urban populations and traits associated with their success. First, we determine if urban samples of T. sessile have a single origin from natural populations by looking at patterns of haplotype clustering fromacross their range. Second, we examine whether polygynous colony structure - a trait associated with invasion success - is correlated with urban environments, by studying the lineage dependence of colony structure. Our phylogenetic analysis of 49 samples identified four well supported geographic clades. Within clades, Kimura-2 parameter pairwise genetic distances revealed <2.3% variation; however, between clade genetic distances were 7.5-10.0%, suggesting the possibility of the presence of cryptic species. Our results indicate that T. sessile has successfully colonized urban environments multiple times. Additionally, polygynous colony structure is a highly plastic trait across habitat, clade, and haplotype. In short, T. sessile has colonized urban habitats repeatedly and appears to do so using life history strategies already present in more natural populations. Whether similar results hold for other species found in urban habitats has scarcely begun to be considered.	[Menke, Sean B.; Booth, Warren; Schal, Coby; Vargo, Edward L.; Silverman, Jules] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Menke, Sean B.; Dunn, Robert R.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Menke, Sean B.; Booth, Warren; Dunn, Robert R.; Schal, Coby; Vargo, Edward L.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Menke, SB (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	sean_menke@ncsu.edu	Vargo, Edward/D-1097-2010; Schal, Coby/A-8717-2010; Dunn, Robert/B-1360-2013	Vargo, Edward/0000-0002-8712-1248; Schal, Coby/0000-0001-7195-6358; Dunn, Robert/0000-0002-6030-4837	Pest Management Foundation; Blanton J. Whitmire endowment; Department of Energy (DOE) Program for Ecosystem Research (PER) [DE-FG02-08ER64510]; National Aeronautics and Space Administration (NASA) Biodiversity Grant	Pest Management Foundation; Blanton J. Whitmire endowment; Department of Energy (DOE) Program for Ecosystem Research (PER)(United States Department of Energy (DOE)); National Aeronautics and Space Administration (NASA) Biodiversity Grant(National Aeronautics & Space Administration (NASA))	This research was funded by the Pest Management Foundation (http://npmapestworld.org/PMFoundation/), the Blanton J. Whitmire endowment, Department of Energy (DOE) Program for Ecosystem Research (PER) DE-FG02-08ER64510 (http://per. ornl. gov/), and a National Aeronautics and Space Administration (NASA) Biodiversity Grant (http://www. nasa. gov/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascunce MS, 2008, J ECON ENTOMOL, V101, P1443, DOI 10.1603/0022-0493(2008)101[1443:MNVIIP]2.0.CO;2; Avise JC, 1999, P NATL ACAD SCI USA, V96, P992, DOI 10.1073/pnas.96.3.992; BARBANI LE, 2003, FORAGING ACTIVITY FO; BRISTOW CM, 1984, J ANIM ECOL, V53, P715, DOI 10.2307/4654; Buczkowski G, 2006, INSECT SOC, V53, P282, DOI 10.1007/s00040-006-0870-0; Buczkowski G, 2008, ECOL ENTOMOL, V33, P780, DOI 10.1111/j.1365-2311.2008.01034.x; Chapman RE, 2001, ECOL LETT, V4, P650, DOI 10.1046/j.1461-0248.2001.00253.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Copren KA, 2005, MOL PHYLOGENET EVOL, V35, P689, DOI 10.1016/j.ympev.2005.03.002; Cremer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003838; Dunn RR, 2006, CONSERV BIOL, V20, P1814, DOI 10.1111/j.1523-1739.2006.00533.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELLERS JH, 1987, ECOLOGY, V68, P1466, DOI 10.2307/1939230; FELLERS JH, 1989, OECOLOGIA, V78, P69, DOI 10.1007/BF00377199; Fisher B. L., 2007, ANTS N AM GUIDE GENE; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; FOUCAUD J, 2009, MOL ECOLOGY; Foucaud J, 2007, MOL BIOL EVOL, V24, P2465, DOI 10.1093/molbev/msm180; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Gotzek D, 2007, Q REV BIOL, V82, P201, DOI 10.1086/519965; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HAMM CA, 2008, PHYLOGEOGRAPHY TAPIN; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hedges S. A., 1998, FIELD GUIDE MANAGEME; HEDGES SA, 2000, COAST TO COAST; Hegglin D, 2007, FUNCT ECOL, V21, P552, DOI 10.1111/j.1365-2435.2007.01257.x; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; HOLLDOBLER B, 1977, NATURWISSENSCHAFTEN, V64, P8, DOI 10.1007/BF00439886; Holway DA, 2004, OECOLOGIA, V138, P216, DOI 10.1007/s00442-003-1414-1; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Huang J, 2007, PEDOBIOLOGIA, V51, P301, DOI 10.1016/j.pedobi.2007.05.003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Keller L, 2007, AM NAT, V169, P1, DOI 10.1086/509938; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; La Sorte FA, 2005, J BIOGEOGR, V32, P1151, DOI 10.1111/j.1365-2699.2005.01271.x; Landry B, 1999, ANN ENTOMOL SOC AM, V92, P40, DOI 10.1093/aesa/92.1.40; Lockwood JL, 2007, INVASION ECOLOGY; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Lundholm J. T., 2006, Urban Ecosystems, V9, P139, DOI 10.1007/s11252-006-8587-4; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McGowan KJ, 2001, AVIAN ECOLOGY CONSER, P332, DOI [10.1007/978-1-4615-1531-9_16, DOI 10.1007/978-1-4615-1531-9_16]; Menke SB, 2007, ECOLOGY, V88, P3164, DOI 10.1890/07-0122.1; Milford ER, 1999, SOUTHWEST NAT, V44, P278; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Novak SJ, 2007, P NATL ACAD SCI USA, V104, P3671, DOI 10.1073/pnas.0700224104; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Ross KG, 1996, P NATL ACAD SCI USA, V93, P3021, DOI 10.1073/pnas.93.7.3021; Roura-Pascual N, 2004, P ROY SOC B-BIOL SCI, V271, P2527, DOI 10.1098/rspb.2004.2898; Sanford MP, 2009, CONSERV BIOL, V23, P131, DOI 10.1111/j.1523-1739.2008.01040.x; Scharf ME, 2004, J ECON ENTOMOL, V97, P601, DOI 10.1603/0022-0493-97.2.601; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; SMALLWOOD J, 1982, INSECT SOC, V29, P138, DOI 10.1007/BF02228747; SMITH MA, 2005, RAPID ASSESSMENT ANT; SMITH MARION R., 1928, ANN ENT SOC AMER, V21, P307, DOI 10.1093/aesa/21.2.307; SMITH MR, 1965, HOUSE INFESTING ANTS; Suarez AV, 2008, AM NAT, V172, pS72, DOI 10.1086/588638; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1992, GENETICS, V132, P619; Thomas ML, 2006, MOL ECOL, V15, P4303, DOI 10.1111/j.1365-294X.2006.03038.x; Thompson Bill, 2007, Urban Ecosystems, V10, P43, DOI 10.1007/s11252-006-0013-4; Thompson K, 2008, J ECOL, V96, P853, DOI 10.1111/j.1365-2745.2008.01383.x; Tschinkel WR, 2006, FIRE ANTS; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Tsutsui ND, 2003, P NATL ACAD SCI USA, V100, P1078, DOI 10.1073/pnas.0234412100; Tsutsui ND, 2001, MOL ECOL, V10, P2151, DOI 10.1046/j.0962-1083.2001.01363.x; *UN, 2007, AFF UDOEAS; Vargo EL, 2009, ANNU REV ENTOMOL, V54, P379, DOI 10.1146/annurev.ento.54.110807.090443; Vogt JT, 2004, J ENTOMOL SCI, V39, P444, DOI 10.18474/0749-8004-39.3.444; Walters AC, 2005, AUSTRAL ECOL, V30, P395, DOI 10.1111/j.1442-9993.2005.01481.x; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wilcox TP, 1997, MOL PHYLOGENET EVOL, V7, P208, DOI 10.1006/mpev.1996.0388; Wild AL, 2009, SYST ENTOMOL, V34, P49, DOI 10.1111/j.1365-3113.2008.00435.x; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	80	38	42	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9194	10.1371/journal.pone.0009194	http://dx.doi.org/10.1371/journal.pone.0009194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169204	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474600014
J	Domenici, E; Wille, DR; Tozzi, F; Prokopenko, I; Miller, S; McKeown, A; Brittain, C; Rujescu, D; Giegling, I; Turck, CW; Holsboer, F; Bullmore, ET; Middleton, L; Merlo-Pich, E; Alexander, RC; Muglia, P				Domenici, Enrico; Wille, David R.; Tozzi, Federica; Prokopenko, Inga; Miller, Sam; McKeown, Astrid; Brittain, Claire; Rujescu, Dan; Giegling, Ina; Turck, Christoph W.; Holsboer, Florian; Bullmore, Edward T.; Middleton, Lefkos; Merlo-Pich, Emilio; Alexander, Robert C.; Muglia, Pierandrea			Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; EPIDERMAL-GROWTH-FACTOR; LONG-TERM POTENTIATION; MAJOR DEPRESSION; NEUROTROPHIC FACTOR; INSULIN-RESISTANCE; TREATMENT RESPONSE; MATRIX METALLOPROTEINASES; RECEPTOR ANTAGONIST; SERUM-LEVELS	Despite significant research efforts aimed at understanding the neurobiological underpinnings of psychiatric disorders, the diagnosis and the evaluation of treatment of these disorders are still based solely on relatively subjective assessment of symptoms. Therefore, biological markers which could improve the current classification of psychiatry disorders, and in perspective stratify patients on a biological basis into more homogeneous clinically distinct subgroups, are highly needed. In order to identify novel candidate biological markers for major depression and schizophrenia, we have applied a focused proteomic approach using plasma samples from a large case-control collection. Patients were diagnosed according to DSM criteria using structured interviews and a number of additional clinical variables and demographic information were assessed. Plasma samples from 245 depressed patients, 229 schizophrenic patients and 254 controls were submitted to multi analyte profiling allowing the evaluation of up to 79 proteins, including a series of cytokines, chemokines and neurotrophins previously suggested to be involved in the pathophysiology of depression and schizophrenia. Univariate data analysis showed more significant p-values than would be expected by chance and highlighted several proteins belonging to pathways or mechanisms previously suspected to be involved in the pathophysiology of major depression or schizophrenia, such as insulin and MMP-9 for depression, and BDNF, EGF and a number of chemokines for schizophrenia. Multivariate analysis was carried out to improve the differentiation of cases from controls and identify the most informative panel of markers. The results illustrate the potential of plasma biomarker profiling for psychiatric disorders, when conducted in large collections. The study highlighted a set of analytes as candidate biomarker signatures for depression and schizophrenia, warranting further investigation in independent collections.	[Domenici, Enrico; Merlo-Pich, Emilio; Alexander, Robert C.; Muglia, Pierandrea] GlaxoSmithKline R&D, Neurosci Ctr Excellence Drug Discovery, Verona, Italy; [Wille, David R.; Miller, Sam; Brittain, Claire] GlaxoSmithKline R&D, Discovery Stat Europe, Harlow, Essex, England; [Tozzi, Federica] GlaxoSmithKline R&D, Quantitat Sci, Verona, Italy; [Prokopenko, Inga] GlaxoSmithKline R&D, Div Genet, Drug Discovery, Verona, Italy; [McKeown, Astrid; Bullmore, Edward T.] Addenbrookes Hosp, GSK Clin Units, Cambridge, England; [Rujescu, Dan; Giegling, Ina] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Turck, Christoph W.; Holsboer, Florian] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Bullmore, Edward T.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Middleton, Lefkos] GlaxoSmithKline R&D, Div Genet, Drug Discovery, Greenford, Middx, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Munich; Max Planck Society; University of Cambridge; GlaxoSmithKline	Domenici, E (corresponding author), GlaxoSmithKline R&D, Neurosci Ctr Excellence Drug Discovery, Verona, Italy.	enrico.h.domenici@gsk.com	Bullmore, Ed/C-1706-2012; Rujescu, Dan/GRS-3875-2022; Giegling, Ina/ABA-3677-2021; Domenici, Enrico/K-8194-2016; Prokopenko, Inga/H-3241-2014; Tozzi, Federica/AAP-5462-2021; Muglia, Pierandrea/ABD-9235-2020; Prokopenko, Inga/AAU-9895-2020	Bullmore, Ed/0000-0002-8955-8283; Domenici, Enrico/0000-0001-7436-6919; Prokopenko, Inga/0000-0003-1624-7457; Tozzi, Federica/0000-0002-3536-2920; Muglia, Pierandrea/0000-0002-3973-8606; 	Max-Planck Institute; Ludwig-Maximilian University; GSK; Medical Research Council [G0001354, G0001354B] Funding Source: researchfish	Max-Planck Institute(Foundation CELLEX); Ludwig-Maximilian University; GSK(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Munich patients collection at Max-Planck Institute and the Ludwig-Maximilian University were funded by GSK. GSK supported the biomarker data collection and analysis and approved the publication of the results.	Alesci S, 2005, J CLIN ENDOCR METAB, V90, P2522, DOI 10.1210/jc.2004-1667; Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brietzke E, 2009, BRAIN BEHAV IMMUN, V23, P1079, DOI 10.1016/j.bbi.2009.04.008; Chaillan FA, 2006, BEHAV BRAIN RES, V173, P191, DOI 10.1016/j.bbr.2006.06.020; Chowdhury F, 2009, J IMMUNOL METHODS, V340, P55, DOI 10.1016/j.jim.2008.10.002; CONNOR TJ, 2004, HDB EXPT PHARM ANTID, V157, P117; Domenici Enrico, 2007, Expert Opin Med Diagn, V1, P235, DOI 10.1517/17530059.1.2.235; Dunbar JA, 2008, DIABETES CARE, V31, P2368, DOI 10.2337/dc08-0175; Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Futamura T, 2002, MOL PSYCHIATR, V7, P673, DOI 10.1038/sj.mp.4001081; GAMA CS, 2007, NEUROSCI LETT; Goncalves FM, 2009, CLIN CHIM ACTA, V403, P173, DOI 10.1016/j.cca.2009.02.013; Grassi-Oliveira R, 2009, PSYCHIAT CLIN NEUROS, V63, P202, DOI 10.1111/j.1440-1819.2008.01918.x; Grillo RW, 2007, J PSYCHIAT RES, V41, P31, DOI 10.1016/j.jpsychires.2006.01.005; Hashimoto K, 2005, PSYCHIAT RES, V135, P257, DOI 10.1016/j.psychres.2003.11.006; Hestad KA, 2003, J ECT, V19, P183, DOI 10.1097/00124509-200312000-00002; Himmerich H, 2008, EUR PSYCHIAT, V23, P421, DOI 10.1016/j.eurpsy.2008.03.013; Himmerich H, 2006, EUR CYTOKINE NETW, V17, P196, DOI 10.1684/ecn.2006.0037; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Ikeda Y, 2008, SCHIZOPHR RES, V101, P58, DOI 10.1016/j.schres.2008.01.017; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; Katon WJ, 2008, AM J MED, V121, P8, DOI 10.1016/j.amjmed.2008.09.008; Krishhan VV, 2009, CRIT REV BIOTECHNOL, V29, P29, DOI 10.1080/07388550802688847; Kubera M, 2000, POL J PHARMACOL, V52, P237; Lanquillon S, 2000, NEUROPSYCHOPHARMACOL, V22, P370, DOI 10.1016/S0893-133X(99)00134-7; Lee BH, 2009, NEUROPSYCHOBIOLOGY, V59, P51, DOI 10.1159/000205518; Lorenzl S, 2008, INT PSYCHOGERIATR, V20, P67, DOI 10.1017/S1041610207005790; Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238; MAES M, 1995, J AFFECT DISORDERS, V34, P301, DOI 10.1016/0165-0327(95)00028-L; MAES M, 1995, J AFFECT DISORDERS, V34, P61, DOI 10.1016/0165-0327(94)00106-J; Mikova O, 2001, EUR NEUROPSYCHOPHARM, V11, P203, DOI 10.1016/S0924-977X(01)00081-5; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Narita K, 2006, PROG NEURO-PSYCHOPH, V30, P1159, DOI 10.1016/j.pnpbp.2006.03.030; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Okamura F, 2000, METABOLISM, V49, P1255, DOI 10.1053/meta.2000.9515; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Shimizu E, 2003, NEUROSCI LETT, V351, P111, DOI 10.1016/j.neulet.2003.08.004; Simon NM, 2008, EUR NEUROPSYCHOPHARM, V18, P230, DOI 10.1016/j.euroneuro.2007.06.004; Tashiro A, 1997, DIABETES CARE, V20, P1924, DOI 10.2337/diacare.20.12.1924; Teixeira AL, 2008, PROG NEURO-PSYCHOPH, V32, P710, DOI 10.1016/j.pnpbp.2007.11.019; Tuglu C, 2003, PSYCHOPHARMACOLOGY, V170, P429, DOI 10.1007/s00213-003-1566-z; Van den Oord EJCG, 2006, SCHIZOPHR RES, V82, P213, DOI 10.1016/j.schres.2005.09.002; VAN HF, 1996, PSYCHIAT RES, V65, P159; Weber B, 2000, EXP CLIN ENDOCR DIAB, V108, P187, DOI 10.1055/s-2000-7742; WINOKUR A, 1988, AM J PSYCHIAT, V145, P325; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095	55	255	274	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9166	10.1371/journal.pone.0009166	http://dx.doi.org/10.1371/journal.pone.0009166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161799	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442800012
J	Quan, FS; Vunnava, A; Compans, RW; Kang, SM				Quan, Fu-Shi; Vunnava, Aswani; Compans, Richard W.; Kang, Sang-Moo			Virus-Like Particle Vaccine Protects against 2009 H1N1 Pandemic Influenza Virus in Mice	PLOS ONE			English	Article							IMMUNE-RESPONSES; HETEROSUBTYPIC IMMUNITY; IMMUNOGENICITY; IMMUNIZATION; INDUCTION; EMERGENCE; ANTIBODY; HUMANS	Background: The 2009 influenza pandemic and shortages in vaccine supplies worldwide underscore the need for new approaches to develop more effective vaccines. Methodology/Principal Findings: We generated influenza virus-like particles (VLPs) containing proteins derived from the A/California/04/2009 virus, and tested their efficacy as a vaccine in mice. A single intramuscular vaccination with VLPs provided complete protection against lethal challenge with the A/California/04/2009 virus and partial protection against A/PR/8/1934 virus, an antigenically distant human isolate. VLP vaccination induced predominant IgG2a antibody responses, high hemagglutination inhibition (HAI) titers, and recall IgG and IgA antibody responses. HAI titers after VLP vaccination were equivalent to those observed after live virus infection. VLP immune sera also showed HAI responses against diverse geographic pandemic isolates. Notably, a low dose of VLPs could provide protection against lethal infection. Conclusion/Significance: This study demonstrates that VLP vaccination provides highly effective protection against the 2009 pandemic influenza virus. The results indicate that VLPs can be developed into an effective vaccine, which can be rapidly produced and avoid the need to isolate high growth reassortants for egg-based production.	[Quan, Fu-Shi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA	Emory University; Emory University	Quan, FS (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rompan@emory.edu; skang2@emory.edu	Compans, Richard W/I-4087-2013; Quan, Fu-Shi/V-1826-2019	Compans, Richard W/0000-0003-2360-335X; 	National Institute of Allergy and Infectious Diseases [R01AI0680003, 3R01AI068003-04S1]; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068003] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by Award Numbers R01AI0680003 (R.W.C.), 3R01AI068003-04S1 (R.W.C.) from the National Institute of Allergy and Infectious Diseases, and partially by the fund from the Georgia Research Alliance (S.M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI [10.1586/erv.09.19, 10.1586/ERV.09.19]; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chang LY, 2009, J FORMOS MED ASSOC, V108, P526, DOI 10.1016/S0929-6646(09)60369-7; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gluck R, 2000, J INFECT DIS, V181, P1129, DOI 10.1086/315337; Glueck R, 2001, ADV DRUG DELIVER REV, V51, P203, DOI 10.1016/S0169-409X(01)00174-0; Hagenaars N, 2008, VACCINE, V26, P6555, DOI 10.1016/j.vaccine.2008.09.057; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Itoh Y, 2009, NATURE; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Kang SM, 2009, VIRUS RES, V143, P140, DOI 10.1016/j.virusres.2009.04.005; Kang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004667; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mozdzanowska K, 2006, VIROLOGY, V352, P418, DOI 10.1016/j.virol.2006.05.008; Naffakh N, 2009, MICROBES INFECT, V11, P725, DOI 10.1016/j.micinf.2009.05.002; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Perrone LA, 2009, J VIROL, V83, P5726, DOI 10.1128/JVI.00207-09; Quan FS, 2008, VACCINE, V26, P3352, DOI 10.1016/j.vaccine.2008.03.055; Quan FS, 2009, J VIROL, V83, P4489, DOI 10.1128/JVI.02035-08; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SOLOVYOV A, 2009, EURO SURVEILL, V14; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Wang BZ, 2008, J VIROL, V82, P11813, DOI 10.1128/JVI.01076-08	31	70	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9161	10.1371/journal.pone.0009161	http://dx.doi.org/10.1371/journal.pone.0009161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161790	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442800007
J	Straschewski, S; Warmer, M; Frascaroli, G; Hohenberg, H; Mertens, T; Winkler, M				Straschewski, Sarah; Warmer, Martin; Frascaroli, Giada; Hohenberg, Heinrich; Mertens, Thomas; Winkler, Michael			Human Cytomegaloviruses Expressing Yellow Fluorescent Fusion Proteins - Characterization and Use in Antiviral Screening	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; PSEUDORABIES VIRUS; POTENT INHIBITORS; ESCHERICHIA-COLI; LATE TIMES; RECOMBINANT; GENE; TEGUMENT; REPLICATION; GROWTH	Recombinant viruses labelled with fluorescent proteins are useful tools in molecular virology with multiple applications (e.g., studies on intracellular trafficking, protein localization, or gene activity). We generated by homologous recombination three recombinant cytomegaloviruses carrying the enhanced yellow fluorescent protein (EYFP) fused with the viral proteins IE-2, ppUL32 (pp150), and ppUL83 (pp65). In growth kinetics, the three viruses behaved all like wild type, even at low multiplicity of infection (MOI). The expression of all three fusion proteins was detected, and their respective localizations were the same as for the unmodified proteins in wild-type virus-infected cells. We established the in vivo measurement of fluorescence intensity and used the recombinant viruses to measure inhibition of viral replication by neutralizing antibodies or antiviral substances. The use of these viruses in a pilot screen based on fluorescence intensity and high-content analysis identified cellular kinase inhibitors that block viral replication. In summary, these viruses with individually EYFP-tagged proteins will be useful to study antiviral substances and the dynamics of viral infection in cell culture.	[Straschewski, Sarah; Frascaroli, Giada; Mertens, Thomas; Winkler, Michael] Ulm Univ Hosp, Inst Virol, Ulm, Germany; [Winkler, Michael] Univ Klinikum Schleswig Holstein, Inst Infect Med, Kiel, Germany; [Warmer, Martin; Hohenberg, Heinrich] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-2000 Hamburg, Germany	Ulm University; University of Kiel; Schleswig Holstein University Hospital; Heinrich Pette Institute; University of Hamburg	Straschewski, S (corresponding author), Ulm Univ Hosp, Inst Virol, Ulm, Germany.	winkler@infmed.uni-kiel.de	Mertens, Thomas M/E-9826-2013	Mayer, Sarah/0000-0002-9667-1794; Winkler, Michael/0000-0002-6198-554X	Deutsche Forschungsgemeinschaft [WI 1725]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (WI 1725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AuCoin DP, 2006, J VIROL, V80, P8199, DOI 10.1128/JVI.00457-06; Baxter MK, 2001, J VIROL, V75, P6865, DOI 10.1128/JVI.75.15.6865-6873.2001; BEVILACQUA F, 1995, J GEN VIROL, V76, P1927, DOI 10.1099/0022-1317-76-8-1927; BILDER GE, 1991, AM J PHYSIOL, V260, pC721, DOI 10.1152/ajpcell.1991.260.4.C721; BOGNER E, 1992, ARCH VIROL, V126, P67, DOI 10.1007/BF01309685; Bresnahan WA, 1997, VIROLOGY, V231, P239, DOI 10.1006/viro.1997.8489; Bresnahan WA, 2000, P NATL ACAD SCI USA, V97, P14506, DOI 10.1073/pnas.97.26.14506; BRITT WJ, 1987, J GEN VIROL, V68, P1897, DOI 10.1099/0022-1317-68-7-1897; CHEE M, 1989, J VIROL, V63, P1345, DOI 10.1128/JVI.63.3.1345-1353.1989; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chevillotte M, 2009, J VIROL, V83, P2480, DOI 10.1128/JVI.01818-08; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Dal Pozzo F, 2008, J VIROL METHODS, V151, P66, DOI 10.1016/j.jviromet.2008.03.025; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Elliott G, 1999, J VIROL, V73, P4110, DOI 10.1128/JVI.73.5.4110-4119.1999; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Frommolt P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-475; Goodrum FD, 2002, P NATL ACAD SCI USA, V99, P16255, DOI 10.1073/pnas.252630899; Heider JA, 2002, J VIROL, V76, P928, DOI 10.1128/JVI.76.2.928-932.2002; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Iwata M, 1999, BLOOD, V94, P572, DOI 10.1182/blood.V94.2.572.414k18_572_578; Jons A, 1997, J VIROL METHODS, V66, P283, DOI 10.1016/S0166-0934(97)00065-7; Kerman IA, 2003, J NEUROSCI, V23, P4657; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; Leost M, 2000, EUR J BIOCHEM, V267, P5983, DOI 10.1046/j.1432-1327.2000.01673.x; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; Marschall M, 2000, ANTIMICROB AGENTS CH, V44, P1588, DOI 10.1128/AAC.44.6.1588-1597.2000; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Meyer HH, 1997, J GEN VIROL, V78, P2621, DOI 10.1099/0022-1317-78-10-2621; Michel D, 2006, CYTOMEGALOVIRUSES: MOLECULAR BIOLOGY AND IMMUNOLOGY, P573; Mocarski E.S., 2001, FIELDS VIROLOGY, V4th Edn, P2629; Mocarski ES, 1996, P NATL ACAD SCI USA, V93, P11321, DOI 10.1073/pnas.93.21.11321; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Murphy EA, 2000, J VIROL, V74, P7108, DOI 10.1128/JVI.74.15.7108-7118.2000; Muyrers JPP, 2001, TRENDS BIOCHEM SCI, V26, P325, DOI 10.1016/S0968-0004(00)01757-6; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; PASS RF, 2001, FIELDS VIROLOGY, P2675; Patterson G, 2001, J CELL SCI, V114, P837; PLACHTER B, 1993, VIROLOGY, V193, P642, DOI 10.1006/viro.1993.1172; PLACHTER B, 1992, J CLIN MICROBIOL, V30, P201, DOI 10.1128/JCM.30.1.201-206.1992; Potel C, 2002, J VIROL METHODS, V105, P13, DOI 10.1016/S0166-0934(02)00027-7; Pyner S, 2001, EXP PHYSIOL, V86, P695, DOI 10.1111/j.1469-445X.2001.tb00034.x; Reeves M, 2006, J VIROL, V80, P9998, DOI 10.1128/JVI.01297-06; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sampaio KL, 2005, J VIROL, V79, P2754, DOI 10.1128/JVI.79.5.2754-2767.2005; Sanchez V, 2000, J VIROL, V74, P975, DOI 10.1128/JVI.74.2.975-986.2000; Sanchez V, 2002, J VIROL, V76, P2973, DOI 10.1128/JVI.76.6.2973-2989.2002; Sanchez V, 2007, J VIROL, V81, P11730, DOI 10.1128/JVI.02760-06; Schierling K, 2005, J VIROL, V79, P3084, DOI 10.1128/JVI.79.5.3084-3096.2005; SCHMOLKE S, 1995, J VIROL, V69, P5959, DOI 10.1128/JVI.69.10.5959-5968.1995; SCHMOLKE S, 1995, J VIROL, V69, P1071, DOI 10.1128/JVI.69.2.1071-1078.1995; Sinzger C, 2008, J GEN VIROL, V89, P359, DOI 10.1099/vir.0.83286-0; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Soroceanu L, 2008, NATURE, V455, P391, DOI 10.1038/nature07209; UTZ U, 1989, J VIROL, V63, P1995, DOI 10.1128/JVI.63.5.1995-2001.1989; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Wagner M, 1999, J VIROL, V73, P7056, DOI 10.1128/JVI.73.8.7056-7060.1999; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; WATHEN MW, 1982, J VIROL, V41, P462, DOI 10.1128/JVI.41.2.462-477.1982; White EA, 2004, J VIROL, V78, P1817, DOI 10.1128/JVI.78.4.1817-1830.2004; WINKLER M, 1994, J VIROL, V68, P3943, DOI 10.1128/JVI.68.6.3943-3954.1994; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100; YURA Y, 1995, ARCH VIROL, V140, P1181, DOI 10.1007/BF01322745; Zaharevitz DW, 1999, CANCER RES, V59, P2566; Zimmermann A, 2000, ANTIVIR RES, V48, P49, DOI 10.1016/S0166-3542(00)00118-2	69	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9174	10.1371/journal.pone.0009174	http://dx.doi.org/10.1371/journal.pone.0009174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161802	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442800020
J	Talman, AM; Blagborough, AM; Sinden, RE				Talman, Arthur M.; Blagborough, Andrew M.; Sinden, Robert E.			A Plasmodium falciparum Strain Expressing GFP throughout the Parasite's Life-Cycle	PLOS ONE			English	Article							MALARIA PARASITES; PHYLOGENY	The human malaria parasite Plasmodium falciparum is responsible for the majority of malaria-related deaths. Tools allowing the study of the basic biology of P. falciparum throughout the life cycle are critical to the development of new strategies to target the parasite within both human and mosquito hosts. We here present 3D7HT-GFP, a strain of P. falciparum constitutively expressing the Green Fluorescent Protein (GFP) throughout the life cycle, which has retained its capacity to complete sporogonic development. The GFP expressing cassette was inserted in the Pf47 locus. Using this transgenic strain, parasite tracking and population dynamics studies in mosquito stages and exo-erythrocytic schizogony is greatly facilitated. The development of 3D7HT-GFP will permit a deeper understanding of the biology of parasite-host vector interactions, and facilitate the development of high-throughput malaria transmission assays and thus aid development of new intervention strategies against both parasite and mosquito.	[Talman, Arthur M.; Blagborough, Andrew M.; Sinden, Robert E.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England	Imperial College London	Talman, AM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England.	arthur.talman@imperial.ac.uk	Talman, Arthur/GMW-9116-2022	Talman, Arthur/0000-0003-2584-3672	EU BioMalPar Network of Excellence; BBSRC; Wellcome Trust; EU-funded Marie Curie Action MalParTraining [MEST-CT-2005-020492]	EU BioMalPar Network of Excellence; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EU-funded Marie Curie Action MalParTraining	This work was supported by research grants from the EU BioMalPar Network of Excellence, BBSRC and the Wellcome Trust for research funds. AMT is a recipient of support from the EU-funded Marie Curie Action MalParTraining (MEST-CT-2005-020492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANO P, 1990, ANNU REV MICROBIOL, V44, P429, DOI 10.1146/annurev.mi.44.100190.002241; Alavi Y, 2004, INT J PARASITOL, V34, P245, DOI 10.1016/j.ijpara.2003.05.001; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Dube A, 2009, TRENDS PARASITOL, V25, P432, DOI 10.1016/j.pt.2009.06.006; Dunachie SJ, 2006, VACCINE, V24, P2850, DOI 10.1016/j.vaccine.2005.12.041; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Garnham PCC, 1966, MALARIA PARASITES OT; HOPPE HC, 1991, EXP PARASITOL, V72, P464, DOI 10.1016/0014-4894(91)90093-C; JANSE CJ, 1988, PARASITOLOGY, V96, P1, DOI 10.1017/S0031182000081609; KAUSHAL DC, 1980, NATURE, V286, P490, DOI 10.1038/286490a0; Ono T, 2007, EXP PARASITOL, V115, P310, DOI 10.1016/j.exppara.2006.09.008; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Schaijk BCL, 2006, MOL BIOCHEM PARASIT, V149, P216, DOI 10.1016/j.molbiopara.2006.05.015; Vaughan JA, 2007, TRENDS PARASITOL, V23, P63, DOI 10.1016/j.pt.2006.12.009; Waterkeyn JG, 1999, INT J PARASITOL, V29, P945, DOI 10.1016/S0020-7519(99)00047-8	18	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9156	10.1371/journal.pone.0009156	http://dx.doi.org/10.1371/journal.pone.0009156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161781	Green Submitted, Green Published, gold			2022-12-25	WOS:000274442700018
J	Vu, GTH; Dear, PH; Caligari, PDS; Wilkinson, MJ				Vu, Giang T. H.; Dear, Paul H.; Caligari, Peter D. S.; Wilkinson, Mike J.			BAC-HAPPY Mapping (BAP Mapping): A New and Efficient Protocol for Physical Mapping	PLOS ONE			English	Article							GENOME; MAP; SEQUENCE; PCR	Physical and linkage mapping underpin efforts to sequence and characterize the genomes of eukaryotic organisms by providing a skeleton framework for whole genome assembly. Hitherto, linkage and physical "contig" maps were generated independently prior to merging. Here, we develop a new and easy method, BAC HAPPY MAPPING (BAP mapping), that utilizes BAC library pools as a HAPPY mapping panel together with an Mbp-sized DNA panel to integrate the linkage and physical mapping efforts into one pipeline. Using Arabidopsis thaliana as an exemplar, a set of 40 Sequence Tagged Site (STS) markers spanning similar to 10% of chromosome 4 were simultaneously assembled onto a BAP map compiled using both a series of BAC pools each comprising 0.7x genome coverage and dilute (0.7x genome) samples of sheared genomic DNA. The resultant BAP map overcomes the need for polymorphic loci to separate genetic loci by recombination and allows physical mapping in segments of suppressed recombination that are difficult to analyze using traditional mapping techniques. Even virtual "BAC-HAPPY-mapping" to convert BAC landing data into BAC linkage contigs is possible.	[Vu, Giang T. H.; Wilkinson, Mike J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Dear, Paul H.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Caligari, Peter D. S.] Sumatra Biosci, Singapore, Singapore; [Caligari, Peter D. S.] BioHybrids Int, Woodley, England	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); MRC Laboratory Molecular Biology	Vu, GTH (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	jjw@aber.ac.uk	Dear, Paul H/A-1162-2012; Caligari, Peter/B-1298-2008; Vu, Giang/D-7928-2016	Caligari, Peter/0000-0003-1223-7833; Vu, Giang/0000-0001-8394-9067; Wilkinson, Michael/0000-0002-9881-6993	Biohybrids International; Sumatra Biosciences; Medical Research Council [MC_U105131672] Funding Source: researchfish; MRC [MC_U105131672] Funding Source: UKRI	Biohybrids International; Sumatra Biosciences; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: Biohybrids International and Sumatra Biosciences funded this work. Other than the input of one author in the wording of the manuscript, and in providing materials and approving permission to publish freely, the sponsors had no direct role in the conception of the method (except to define the need), the study design, data collection, or analysis.	Cai WW, 2001, GENOME RES, V11, P1619, DOI 10.1101/gr.198101; DEAR PH, 1989, NUCLEIC ACIDS RES, V17, P6795, DOI 10.1093/nar/17.17.6795; Dear PH, 1998, GENOMICS, V48, P232, DOI 10.1006/geno.1997.5140; DEAR PH, 1993, NUCLEIC ACIDS RES, V21, P13, DOI 10.1093/nar/21.1.13; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Konfortov BA, 2000, GENOME RES, V10, P1737, DOI 10.1101/gr.141700; Kunzel G, 2000, GENETICS, V154, P397; LEWIN HA, 2009, EVERY GENOME SEQUENC; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Mueller LA, 2005, COMP FUNCT GENOM, V6, P153, DOI 10.1002/cfg.468; NEWELL WR, 1995, GENOMICS, V30, P59, DOI 10.1006/geno.1995.0009; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Piper MB, 1998, GENOME RES, V8, P1299, DOI 10.1101/gr.8.12.1299; Snelling WM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r165; Stanley KK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni182; Thangavelu M, 2003, PLANT BIOTECHNOL J, V1, P23, DOI 10.1046/j.1467-7652.2003.00001.x; Wiley G., 2009, CURR PROTOC HUM GENE; Xu JC, 1998, P NATL ACAD SCI USA, V95, P5661, DOI 10.1073/pnas.95.10.5661; YAOGUANG L, 1995, PLANT J, V7, P351; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-371; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	27	4	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9089	10.1371/journal.pone.0009089	http://dx.doi.org/10.1371/journal.pone.0009089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161702	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442500003
J	Huang, MC; Patel, K; Taub, DD; Longo, DL; Goetzl, EJ				Huang, Mei-Chuan; Patel, Kalpesh; Taub, Dennis D.; Longo, Dan L.; Goetzl, Edward J.			Human CD4(-)8(-) T cells are a distinctive immunoregulatory subset	FASEB JOURNAL			English	Article						cytokines; autoimmunity; immunosenescence	MIGRATION INHIBITORY FACTOR; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; LYMPHOCYTE APOPTOSIS; IN-VITRO; MICE; ACTIVATION; RECEPTOR; ALPHA; EXPRESS	Human CD4(-)8(-) T cells are a minor subset quantitatively but potentially important in immunity because they are predominantly distributed at body surfaces, and their number and activities increase in autoimmune diseases and decrease with aging. Distinguishing characteristics of CD4(-)8(-) T cells are found to include a unique profile of cytokines, including Serpin E1, which is not generated by other T cells, MIF, and TGF-beta. At 2-5% of the total in mixtures with CD4 + CD8 T cells, CD4(-)8(-) T cells enhance the generation of IFN-gamma and IL-17 by up to 12- and 5-fold, respectively, without contributing either cytokine or affecting cytokine production by NK/NKT cells. CD4(-)8(-) T cell-derived MIF is their major enhancer and TGF beta their principal inhibitor of CD4 and CD8 T cell cytokine production. Decreases in CD4(-)8(-) T cell effects may diminish protective immunity in aging, whereas increases may augment the severity of autoimmune diseases.-Huang, M.-C., Patel, K., Taub, D. D., Longo, D. L., Goetzl, E.J. Human CD4(-)8(-) T cells are a distinctive immunoregulatory subset. FASEB J. 24, 2558-2566 (2010). www.fasebj.org	[Goetzl, Edward J.] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA 94143 USA; [Huang, Mei-Chuan; Goetzl, Edward J.] Univ Calif San Francisco, Dept Microbiol Immunol, San Francisco, CA 94143 USA; [Patel, Kalpesh; Taub, Dennis D.; Longo, Dan L.] NIA, NIH, Baltimore, MD 21224 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Goetzl, EJ (corresponding author), Univ Calif San Francisco, Med Ctr, Dept Med, Room UB8B,UC Box 0711,533 Parnassus & 4th Ave, San Francisco, CA 94143 USA.	edward.goetzl@ucsf.edu	Longo, Dan L./F-6022-2011; Patel, Kalpesh/G-6685-2012	Patel, Kalpesh/0000-0002-2952-6773	Kenneth Rainin Foundation; U.S. National Institutes of Health [HL31809]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000104] Funding Source: NIH RePORTER	Kenneth Rainin Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a grant from the Kenneth Rainin Foundation and by U.S. National Institutes of Health RO-1 grant HL31809. The authors are grateful to Judith H. Goetzl for preparation of the figures and tables. The authors declare no conflicts of interest. Authors' contributions: D.D.T., D.L.L., and E.J.G. designed research; M.-C.H., K.P., and E.J.G. performed research and analyzed data; E.J.G., M.-C.H., and D.L.L. wrote the paper.	Anand A, 2002, LUPUS, V11, P493, DOI 10.1191/0961203302lu235oa; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Bernhagen J, 1996, J EXP MED, V183, P277, DOI 10.1084/jem.183.1.277; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chen M, 2006, LETT MATH PHYS, V75, P1, DOI 10.1007/s11005-005-0041-7; Cowley SC, 2005, J EXP MED, V202, P309, DOI 10.1084/jem.20050569; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Dixit VD, 2007, J CLIN INVEST, V117, P2778, DOI 10.1172/JCI30248; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Haque MA, 1998, IMMUNOLOGY, V94, P536; Hernandez-Pigeon H, 2007, J BIOL CHEM, V282, P8157, DOI 10.1074/jbc.M607436200; Kowalewska Anita, 2006, Pol Arch Med Wewn, V115, P197; KOYAMADA N, 1993, CELL IMMUNOL, V149, P107, DOI 10.1006/cimm.1993.1140; LANIER LL, 1986, J EXP MED, V164, P339, DOI 10.1084/jem.164.1.339; Larson DF, 2006, CRIT CARE, V10, DOI 10.1186/cc4899; Liao H, 2007, FASEB J, V21, P935, DOI 10.1096/fj.06-6285com; LONDEI M, 1989, P NATL ACAD SCI USA, V86, P8502, DOI 10.1073/pnas.86.21.8502; Makino Y, 2002, CLIN IMMUNOL, V102, P302, DOI 10.1006/clim.2001.5178; MATTEI M, 1994, INT J IMMUNOPHARMACO, V16, P651, DOI 10.1016/0192-0561(94)90138-4; Metz CN, 1997, ADV IMMUNOL, V66, P197, DOI 10.1016/S0065-2776(08)60598-2; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Ngiam N, 2007, AM J PHYSIOL-LUNG C, V293, pL1089, DOI 10.1152/ajplung.00265.2007; PAWANKAR R, 1993, ALLERGY, V48, P99, DOI 10.1111/j.1398-9995.1993.tb00693.x; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Renckens R, 2006, J IMMUNOL, V177, P8171, DOI 10.4049/jimmunol.177.11.8171; Sejima T, 2005, J IMMUNOL, V174, P8135, DOI 10.4049/jimmunol.174.12.8135; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; Straus SE, 1999, ANN INTERN MED, V130, P591, DOI 10.7326/0003-4819-130-7-199904060-00020; Taub DD, 1996, J IMMUNOL, V156, P2095; THOMSSEN H, 1995, IMMUNOLOGY, V85, P33; Wadgaonkar R, 2008, J CELL BIOCHEM, V105, P1279, DOI 10.1002/jcb.21928; Zhang XH, 2002, J EXP MED, V195, P283, DOI 10.1084/jem.20011267	32	10	10	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2010	24	7					2558	2566		10.1096/fj.09-153148	http://dx.doi.org/10.1096/fj.09-153148			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20154266	Green Published			2022-12-25	WOS:000279343600042
J	Lin, ZC; Zhao, Y; Chung, CY; Zhou, YH; Xiong, NA; Glatt, CE; Isacson, O				Lin, Zhicheng; Zhao, Ying; Chung, Chee Yeun; Zhou, Yanhong; Xiong, Nian; Glatt, Charles E.; Isacson, Ole			High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life	FASEB JOURNAL			English	Article						human; promoter haplotypes; evolution; signaling cascades; transcription	DOPAMINE TRANSPORTER; TRANSCRIPTION FACTOR; IN-VIVO; EXPRESSION; PROMOTER; PATHWAY; VMAT2; RAT; SCHIZOPHRENIA; HAPLOTYPES	SLC18A2 encodes the vesicular monoamine transporter 2 protein that regulates neurotransmission and reduces cytosolic toxicity of monoamines. Deletion of this gene causes lethality in mice, and DNA sequence variation in this gene is associated with alcoholism and Parkinson's disease, among other disorders. The Caucasian SLC18A2 promoter has at least 20 haplotypes (A-T), with A representing two-thirds of 1460 chromosomes. It is not known why A is selected in the human lineage. To understand the selection, here we took a functional approach by investigating the regulations of 4 representative haplotypes (A, C, G, and T) by 17 agents. We show that 76.5% of the agents were able to regulate A but only 11.8-23.5% of them regulated the 3 other infrequent ones, observing a positive correlation between haplotype frequency and regulatability. Pathway and molecular analyses revealed five signaling hubs that regulate the four haplotypes differentially, probably through targeting the polymorphic core promoter region. These findings suggest that greater diversity of transcriptional regulations is the driving force for the haplotype selection in SLC18A2.-Lin, Z., Zhao, Y., Chung, C. Y., Zhou, Y., Xiong, N., Glatt, C. E., Isacson, O. High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life. FASEB J. 24, 2191-2200 (2010). www.fasebj.org	[Lin, Zhicheng; Zhao, Ying; Zhou, Yanhong; Xiong, Nian] McLean Hosp, Div Alcohol & Drug Abuse, Belmont, MA 02478 USA; [Chung, Chee Yeun; Isacson, Ole] McLean Hosp, Ctr Neuroregenerat Res, Belmont, MA 02478 USA; [Lin, Zhicheng; Zhao, Ying; Zhou, Yanhong; Xiong, Nian] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Chung, Chee Yeun; Isacson, Ole] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Glatt, Charles E.] Cornell Univ, Dept Psychiat, Weill Med Coll, New York, NY 10021 USA	Harvard University; McLean Hospital; Harvard University; McLean Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Cornell University	Lin, ZC (corresponding author), McLean Hosp, Div Alcohol & Drug Abuse, 115 Mill St, Belmont, MA 02478 USA.	zhicheng_lin@hms.harvard.edu		Isacson, Ole/0000-0001-8091-8302	U.S. National Institutes of Health [P50-NS039793, P01-ES016732, R01-DA021409]; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021409] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by grants from the U.S. National Institutes of Health (P50-NS039793 to O.I., P01-ES016732 to C. E. G., and R01-DA021409 to Z.L.) and by a Michael J. Fox Foundation Award (to Z.L.).	Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Ekins S, 2007, METH MOL B, V356, P319; Gainetdinov RR, 1998, J NEUROCHEM, V70, P1973; Glatt CE, 2006, HUM MOL GENET, V15, P299, DOI 10.1093/hmg/ddi445; GUILLOT T, 2006, 82416BB27 SOC NEUR; Guillot TS, 2008, NEUROPEPTIDES, V42, P423, DOI 10.1016/j.npep.2008.04.003; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P620, DOI 10.1038/sj.npp.1300070; Kalueff AV, 2007, TRENDS PHARMACOL SCI, V28, P122, DOI 10.1016/j.tips.2007.01.002; Lebrand C, 1998, J COMP NEUROL, V401, P506; LIN Z, 2003, INFO ORG DESIGN SER, V3, P1; Lin ZC, 2005, HUM MOL GENET, V14, P1393, DOI 10.1093/hmg/ddi148; Lin ZC, 1999, MOL PHARMACOL, V56, P434, DOI 10.1124/mol.56.2.434; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Nikoshkov A, 2008, P NATL ACAD SCI USA, V105, P786, DOI 10.1073/pnas.0710902105; PETER D, 1995, J NEUROSCI, V15, P6179; Pfeffer M, 2009, J NEUROSCI, V29, P6114, DOI 10.1523/JNEUROSCI.0275-09.2009; Pothos EN, 2000, J NEUROSCI, V20, P7297; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Rehavi M, 2002, EUR NEUROPSYCHOPHARM, V12, P261, DOI 10.1016/S0924-977X(02)00021-4; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Richardson JR, 2004, TOXICOL LETT, V148, P29, DOI 10.1016/j.toxlet.2003.12.006; Rusnak M, 2001, BRAIN RES, V899, P20, DOI 10.1016/S0006-8993(01)02126-6; Schwab SG, 2005, NEUROPSYCHOPHARMACOL, V30, P2263, DOI 10.1038/sj.npp.1300809; Schwarz J, 2006, FASEB J, V20, P935, DOI 10.1096/fj.05-5497com; Takahashi N, 1997, P NATL ACAD SCI USA, V94, P9938, DOI 10.1073/pnas.94.18.9938; Talkowski ME, 2008, HUM MOL GENET, V17, P747, DOI 10.1093/hmg/ddm347; Taylor SF, 2000, NEUROPSYCHOPHARMACOL, V23, P667, DOI 10.1016/S0893-133X(00)00165-2; Towers E, 2009, NUCLEIC ACIDS RES, V37, P3044, DOI 10.1093/nar/gkp175; Tseng PC, 2008, BIOCHEM PHARMACOL, V76, P1121, DOI 10.1016/j.bcp.2008.08.023; Wang GY, 2006, FASEB J, V20, P2639, DOI 10.1096/fj.06-6315fje; Watson F, 2001, J BIOL CHEM, V276, P7661, DOI 10.1074/jbc.M006697200; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106; Zanotto E, 2007, NUCLEIC ACIDS RES, V35, P664, DOI 10.1093/nar/gkl1037; Zubieta JK, 2001, BIOL PSYCHIAT, V49, P110, DOI 10.1016/S0006-3223(00)00981-1; Zucker M, 2002, EUR NEUROPSYCHOPHARM, V12, P343, DOI 10.1016/S0924-977X(02)00041-X	36	16	16	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2191	2200		10.1096/fj.09-140368	http://dx.doi.org/10.1096/fj.09-140368			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20181938	Green Published			2022-12-25	WOS:000279343600006
J	Di Giovanni, S; Eleuteri, S; Paleologou, KE; Yin, GW; Zweckstetter, M; Carrupt, PA; Lashuel, HA				Di Giovanni, Saviana; Eleuteri, Simona; Paleologou, Katerina E.; Yin, Guowei; Zweckstetter, Markus; Carrupt, Pierre-Alain; Lashuel, Hilal A.			Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of alpha-Synuclein and beta-Amyloid and Protect against Amyloid-induced Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-DEATH; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; IN-VITRO; CEREBROSPINAL-FLUID; INCLUSION FORMATION; CAFFEIC ACID; AGGREGATION; DOPAMINE; FIBRILLIZATION	Parkinson disease (PD) is the second most common neurodegenerative disorder after Alzheimer disease (AD). There is considerable consensus that the increased production and/or aggregation of alpha-synuclein (alpha-syn) plays a central role in the pathogenesis of PD and related synucleinopathies. Current therapeutic strategies for treating PD offer mainly transient symptomatic relief and aim at the restitution of dopamine levels to counterbalance the loss of dopaminergic neurons. Therefore, the identification and development of drug-like molecules that block alpha-synuclein aggregation and prevent the loss of dopaminergic neurons are desperately needed to treat or slow the progression of PD. Here, we show that entacapone and tolcapone are potent inhibitors of alpha-syn and beta-amyloid (A beta) oligomerization and fibrillogenesis, and they also protect against extracellular toxicity induced by the aggregation of both proteins. Comparison of the anti-aggregation properties of entacapone and tolcapone with the effect of five other catechol-containing compounds, dopamine, pyrogallol, gallic acid, caffeic acid, and quercetin on the oligomerization and fibrillization of alpha-syn and A beta, demonstrate that the catechol moiety is essential for the anti-amyloidogenic activity. Our findings present the first characterization of the anti-amyloidogenic properties of tolcapone and entacapone against both alpha-synuclein and A beta 42 and highlight the potential of this class of nitro-catechol compounds as anti-amyloidogenic agents. Their inhibitory properties, mode of action, and structural properties suggest that they constitute promising lead compounds for further optimization.	[Di Giovanni, Saviana; Eleuteri, Simona; Paleologou, Katerina E.; Lashuel, Hilal A.] Swiss Fed Inst Technol, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland; [Eleuteri, Simona] Univ Bologna, Dipartimento Biol Evoluzionist Sperimentale, I-40126 Bologna, Italy; [Yin, Guowei; Zweckstetter, Markus] Max Planck Inst Biophys Chem, NMR Based Struct Biol, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Deutsch Forsch Sgemeinschaft Res Ctr Mol Physiol, Gottingen, Germany; [Carrupt, Pierre-Alain] Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva 4, Switzerland; [Carrupt, Pierre-Alain] Univ Lausanne, CH-1211 Geneva 4, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bologna; Max Planck Society; University of Geneva; University of Lausanne	Lashuel, HA (corresponding author), Swiss Fed Inst Technol, Lab Mol Neurobiol & Neuroprote, SV BMI LMNN AI2351, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Carrupt, Pierre-Alain/C-4854-2008; Lashuel, Hilal/M-3500-2017	Zweckstetter, Markus/0000-0002-2536-6581	Swiss Federal Institute of Technology Lausanne; Swiss National Science Foundation; Strauss Foundation; Max Planck Society; Deutsche Forschungsgemeinschaft Heisenberg Scholarship [ZW 71/2-1, 3-1]	Swiss Federal Institute of Technology Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Strauss Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft Heisenberg Scholarship(German Research Foundation (DFG))	This work was supported by the Swiss Federal Institute of Technology Lausanne, grants from the Swiss National Science Foundation and the Strauss Foundation, and by the Max Planck Society and through Deutsche Forschungsgemeinschaft Heisenberg Scholarship ZW 71/2-1 and 3-1 ( to M.Z.).	Ahn KJ, 2006, J NEUROCHEM, V97, P265, DOI 10.1111/j.1471-4159.2006.03731.x; Albani D, 2004, FASEB J, V18, P1713, DOI 10.1096/fj.04-1621fje; Ansari MA, 2009, J NUTR BIOCHEM, V20, P269, DOI 10.1016/j.jnutbio.2008.03.002; Antonini Angelo, 2008, Neuropsychiatr Dis Treat, V4, P1; Armagan A, 2008, HUM EXP TOXICOL, V27, P547, DOI 10.1177/0960327108092293; Assal F, 1998, LANCET, V352, P958, DOI 10.1016/S0140-6736(05)61511-5; Ban JY, 2008, BIOL PHARM BULL, V31, P149, DOI 10.1248/bpb.31.149; Bastianetto S, 2006, EUR J NEUROSCI, V23, P55, DOI 10.1111/j.1460-9568.2005.04532.x; Bertolini F, 2007, J PHARM SCI-US, V96, P2931, DOI 10.1002/jps.20881; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Boelsterli UA, 2006, CURR DRUG METAB, V7, P715, DOI 10.2174/138920006778520606; Bonifacio MJ, 2007, CNS DRUG REV, V13, P352, DOI 10.1111/j.1527-3458.2007.00020.x; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chung KKK, 2003, J NEUROL, V250, P15, DOI 10.1007/s00415-003-1304-9; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Craik D J, 1997, Methods Mol Biol, V60, P195; Damier P, 2008, EUR J NEUROL, V15, P643, DOI 10.1111/j.1468-1331.2008.02165.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Di Stefano A, 2009, EXPERT OPIN DRUG DEL, V6, P389, DOI [10.1517/17425240902870405, 10.1517/17425240902870405 ]; Dodo K, 2008, BIOORGAN MED CHEM, V16, P7975, DOI 10.1016/j.bmc.2008.07.063; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; El-Agnaf OMA, 1998, NEUROREPORT, V9, P3925, DOI 10.1097/00001756-199812010-00029; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Feng Y, 2009, NEUROTOXICOLOGY, V30, P986, DOI 10.1016/j.neuro.2009.08.013; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Forloni G, 2000, ANN NEUROL, V47, P632, DOI 10.1002/1531-8249(200005)47:5<632::AID-ANA11>3.3.CO;2-E; Forsberg M, 2003, J PHARMACOL EXP THER, V304, P498, DOI 10.1124/jpet.102.042846; Fradinger EA, 2008, P NATL ACAD SCI USA, V105, P14175, DOI 10.1073/pnas.0807163105; Goddard T. D, 2003, SPARKY, V3; Grimminger-Marquardt V, 2010, BIOPOLYMERS, V93, P252, DOI 10.1002/bip.21301; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Haefeli WE, 2007, J NEUROL, V254, P29, DOI 10.1007/s00415-007-4006-x; Han YH, 2008, INT J MOL MED, V21, P721; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Herrera FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003394; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Johnson KS, 2005, J AGR FOOD CHEM, V53, P10120, DOI 10.1021/jf051942w; Klegeris A, 2008, NEUROBIOL AGING, V29, P739, DOI 10.1016/j.neurobiolaging.2006.11.013; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lapish CC, 2009, PSYCHOPHARMACOLOGY, V202, P521, DOI 10.1007/s00213-008-1342-1; Lashuel HA, 2002, J BIOL CHEM, V277, P42881, DOI 10.1074/jbc.M206593200; Learmonth DA, 2004, J MED CHEM, V47, P6207, DOI 10.1021/jm040848o; Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lees AJ, 2007, J NEUROL NEUROSUR PS, V78, P944, DOI 10.1136/jnnp.2006.097154; Li HT, 2005, FEBS J, V272, P3661, DOI 10.1111/j.1742-4658.2005.04792.x; Li J, 2004, FASEB J, V18, P962, DOI 10.1096/fj.03-0770fje; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Losic D, 2006, J STRUCT BIOL, V155, P104, DOI 10.1016/j.jsb.2006.02.013; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; Morgan C, 2004, PROG NEUROBIOL, V74, P323, DOI 10.1016/j.pneurobio.2004.10.004; Naiki H, 1996, LAB INVEST, V74, P374; NISSINEN E, 1992, N-S ARCH PHARMACOL, V346, P262; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Novaroli L, 2006, HELV CHIM ACTA, V89, P144, DOI 10.1002/hlca.200690007; Novaroli L, 2005, CHIMIA, V59, P315, DOI 10.2533/000942905777676407; Ono K, 2007, J NEUROSCI RES, V85, P1547, DOI 10.1002/jnr.21271; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Recchia A, 2004, FASEB J, V18, P617, DOI 10.1096/fj.03-0338rev; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; Sommer David B, 2008, Expert Rev Neurother, V8, P1829, DOI 10.1586/14737175.8.12.1829; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sul D, 2009, LIFE SCI, V84, P257, DOI 10.1016/j.lfs.2008.12.001; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Truong DD, 2009, CLIN INTERV AGING, V4, P109; Wang YJ, 2009, NEUROTOX RES, V15, P3, DOI 10.1007/s12640-009-9000-x; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yamin G, 2005, BIOCHEMISTRY-US, V44, P9096, DOI 10.1021/bi048778a; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	91	96	98	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14941	14954		10.1074/jbc.M109.080390	http://dx.doi.org/10.1074/jbc.M109.080390			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20150427	hybrid, Green Published			2022-12-25	WOS:000277399000015
J	Caccamo, A; Majumder, S; Richardson, A; Strong, R; Oddo, S				Caccamo, Antonella; Majumder, Smita; Richardson, Arlan; Strong, Randy; Oddo, Salvatore			Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-beta, and Tau EFFECTS ON COGNITIVE IMPAIRMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; TRIPLE-TRANSGENIC MODEL; P70 S6 KINASE; ALZHEIMERS-DISEASE; A-BETA; LIFE-SPAN; SIGNALING PATHWAY; PROTEIN-TAU; GLYCOPROTEIN COMPLEX; INDUCED APOPTOSIS	Accumulation of amyloid-beta (A beta) and Tau is an invariant feature of Alzheimer disease (AD). The upstream role of A beta accumulation in the disease pathogenesis is widely accepted, and there is strong evidence showing that A beta accumulation causes cognitive impairments. However, the molecular mechanisms linking A beta to cognitive decline remain to be elucidated. Here we show that the buildup of A beta increases the mammalian target of rapamycin (mTOR) signaling, whereas decreasing mTOR signaling reduces A beta levels, thereby highlighting an interrelation between mTOR signaling and A beta. The mTOR pathway plays a central role in controlling protein homeostasis and hence, neuronal functions; indeed mTOR signaling regulates different forms of learning and memory. Using an animal model of AD, we show that pharmacologically restoring mTOR signaling with rapamycin rescues cognitive deficits and ameliorates A beta and Tau pathology by increasing autophagy. Indeed, we further show that autophagy induction is necessary for the rapamycin mediated reduction in A beta levels. The results presented here provide a molecular basis for the A beta-induced cognitive deficits and, moreover, show that rapamycin, an FDA approved drug, improves learning and memory and reduces A beta and Tau pathology.	[Caccamo, Antonella; Majumder, Smita; Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78245 USA; [Caccamo, Antonella; Majumder, Smita; Richardson, Arlan; Strong, Randy; Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78245 USA; [Strong, Randy] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78245 USA; [Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78245 USA; [Richardson, Arlan; Strong, Randy] S Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Richardson, Arlan; Strong, Randy] S Texas Vet Hlth Care Syst, Res Serv, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Oddo, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	oddo@uthscsa.edu		Oddo, Salvatore/0000-0001-7304-7430	NIA [AG29729-4]; San Antonio Nathan Shock Aging Center [1P30-AG-13319]; Department of Veterans Affairs; NATIONAL INSTITUTE ON AGING [R00AG029729, K99AG029729, P30AG013319] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); San Antonio Nathan Shock Aging Center; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG29729-4 from the NIA (to S. O.), San Antonio Nathan Shock Aging Center Grant 1P30-AG-13319, and a grant from the Department of Veterans Affairs Enhancement Award Program.	An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Bhaskar K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-14; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Cao RF, 2009, J NEUROSCI, V29, P12372, DOI 10.1523/JNEUROSCI.3486-09.2009; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Castedo M, 2001, J EXP MED, V194, P1097, DOI 10.1084/jem.194.8.1097; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Ferri KF, 2000, CELL DEATH DIFFER, V7, P1137, DOI 10.1038/sj.cdd.4400748; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Ito S, 2007, EXP GERONTOL, V42, P532, DOI 10.1016/j.exger.2006.11.012; Ito S, 2006, NEUROSCI RES, V56, P294, DOI 10.1016/j.neures.2006.07.009; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KOO EH, 1994, J BIOL CHEM, V269, P17386; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Lafay-Chebassier C, 2005, J NEUROCHEM, V94, P215, DOI 10.1111/j.1471-4159.2005.03187.x; Lafay-Chebassier C, 2006, J NEUROSCI RES, V84, P1323, DOI 10.1002/jnr.21039; Ling DJ, 2009, AUTOPHAGY, V5, P738, DOI 10.4161/auto.5.5.8626; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lopes JP, 2009, CURR ALZHEIMER RES, V6, P205, DOI 10.2174/156720509788486590; Martin D, 2001, J NEUROCHEM, V78, P1000, DOI 10.1046/j.1471-4159.2001.00472.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Meske V, 2008, J BIOL CHEM, V283, P100, DOI 10.1074/jbc.M704292200; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Oddo S, 2005, P NATL ACAD SCI USA, V102, P3046, DOI 10.1073/pnas.0408500102; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Oddo S, 2007, J NEUROCHEM, V102, P1053, DOI 10.1111/j.1471-4159.2007.04607.x; Oddo S, 2008, J NEUROSCI, V28, P12163, DOI 10.1523/JNEUROSCI.2464-08.2008; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Onuki R, 2004, EMBO J, V23, P959, DOI 10.1038/sj.emboj.7600049; Peel AL, 2003, NEUROBIOL DIS, V14, P52, DOI 10.1016/S0969-9961(03)00086-X; Pei JJ, 2008, J ALZHEIMERS DIS, V14, P385; Pei JJ, 2008, J CELL MOL MED, V12, P2525, DOI 10.1111/j.1582-4934.2008.00509.x; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tischmeyer W, 2003, EUR J NEUROSCI, V18, P942, DOI 10.1046/j.1460-9568.2003.02820.x; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009	76	631	677	0	70	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13107	13120		10.1074/jbc.M110.100420	http://dx.doi.org/10.1074/jbc.M110.100420			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178983	hybrid, Green Published			2022-12-25	WOS:000276787800067
J	Nishida, M; Watanabe, K; Sato, Y; Nakaya, M; Kitajima, N; Ide, T; Inoue, R; Kurose, H				Nishida, Motohiro; Watanabe, Kenta; Sato, Yoji; Nakaya, Michio; Kitajima, Naoyuki; Ide, Tomomi; Inoue, Ryuji; Kurose, Hitoshi			Phosphorylation of TRPC6 Channels at Thr(69) Is Required for Anti-hypertrophic Effects of Phosphodiesterase 5 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR POTENTIAL CHANNELS; INDUCED CARDIAC-HYPERTROPHY; VASCULAR SMOOTH-MUSCLE; PROTEIN-KINASE-G; CATION CHANNELS; HEART-FAILURE; B-LYMPHOCYTES; CA2+ RELEASE; ACTIVATION; CELLS	Activation of Ca2+ signaling induced by receptor stimulation and mechanical stress plays a critical role in the development of cardiac hypertrophy. A canonical transient receptor potential protein subfamily member, TRPC6, which is activated by diacylglycerol and mechanical stretch, works as an upstream regulator of the Ca2+ signaling pathway. Although activation of protein kinase G (PKG) inhibits TRPC6 channel activity and cardiac hypertrophy, respectively, it is unclear whether PKG suppresses cardiac hypertrophy through inhibition of TRPC6. Here, we show that inhibition of cGMP-selective PDE5 (phosphodiesterase 5) suppresses endothelin-1-,diacylglycerol analog-, and mechanical stretch-induced hypertrophy through inhibition of Ca2+ influx in rat neonatal cardiomyocytes. Inhibition of PDE5 suppressed the increase in frequency of Ca2+ spikes induced by agonists or mechanical stretch. However, PDE5 inhibition did not suppress the hypertrophic responses induced by high KCl or the activation of protein kinase C, suggesting that PDE5 inhibition suppresses Ca2+ influx itself or molecule(s) upstream of Ca2+ influx. PKG activated by PDE5 inhibition phosphorylated TRPC6 proteins at Thr(69) and prevented TRPC6-mediated Ca2+ influx. Substitution of Ala for Thr(69) in TRPC6 abolished the anti-hypertrophic effects of PDE5 inhibition. In addition, chronic PDE5 inhibition by oral sildenafil treatment actually induced TRPC6 phosphorylation in mouse hearts. Knockdown of RGS2 (regulator of G protein signaling 2) and RGS4, both of which are activated by PKG to reduce G alpha(q)-mediated signaling, did not affect the suppression of receptor-activated Ca2+ influx by PDE5 inhibition. These results suggest that phosphorylation and functional suppression of TRPC6 underlie prevention of pathological hypertrophy by PDE5 inhibition.	[Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Higashi Ku, Fukuoka 8128582, Japan; [Ide, Tomomi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Higashi Ku, Fukuoka 8128582, Japan; [Sato, Yoji] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan; [Inoue, Ryuji] Fukuoka Univ, Sch Med, Dept Physiol, Jyonan Ku, Fukuoka 8140180, Japan	Kyushu University; Kyushu University; National Institute of Health Sciences - Japan; Fukuoka University	Kurose, H (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Higashi Ku, Fukuoka 8128582, Japan.	kurose@phar.kyushu-u.ac.jp		Nishida, Motohiro/0000-0002-2587-5458	Ministry of Education, Culture, Sports, Science, and Technology of Japan; grant-in-aid for scientific research on Innovative Areas; grant-in-aid for scientific research on Priority Areas; Naito Foundation; Nakatomi Foundation; Sapporo Bioscience Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); grant-in-aid for scientific research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); grant-in-aid for scientific research on Priority Areas; Naito Foundation(Naito Memorial Foundation); Nakatomi Foundation; Sapporo Bioscience Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. Nishida, M. Nakaya, and H. Kurose), a grant-in-aid for scientific research on Innovative Areas (to M. Nishida), a grant-in-aid for scientific research on Priority Areas (H. Kurose), and grants from the Naito Foundation, the Nakatomi Foundation, the Sapporo Bioscience Foundation (M. Nishida), and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to M. Nakaya).	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Colella M, 2008, P NATL ACAD SCI USA, V105, P2859, DOI 10.1073/pnas.0712316105; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Fiedler B, 2002, P NATL ACAD SCI USA, V99, P11363, DOI 10.1073/pnas.162100799; Frey N, 2000, NAT MED, V6, P1221, DOI 10.1038/81321; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hsu S, 2009, CARDIOVASC RES, V81, P301, DOI 10.1093/cvr/cvn324; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Kass DA, 2007, CIRC RES, V101, P1084, DOI 10.1161/CIRCRESAHA.107.162511; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Kwan HY, 2004, P NATL ACAD SCI USA, V101, P2625, DOI 10.1073/pnas.0304471101; Large WA, 2002, J CARDIOVASC ELECTR, V13, P493, DOI 10.1046/j.1540-8167.2002.00493.x; Lewis GD, 2007, CIRCULATION, V115, P59, DOI 10.1161/CIRCULATIONAHA.106.626226; Liao XD, 2003, BIOCHEM BIOPH RES CO, V310, P405, DOI 10.1016/j.bbrc.2003.09.023; Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Mori Y, 2002, J EXP MED, V195, P673, DOI 10.1084/jem.20011758; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Nishida M, 2005, J BIOL CHEM, V280, P18434, DOI 10.1074/jbc.M409710200; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; Nishida M, 2008, N-S ARCH PHARMACOL, V378, P395, DOI 10.1007/s00210-008-0321-8; Nishida M, 2007, J BIOL CHEM, V282, P23117, DOI 10.1074/jbc.M611780200; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Ramirez MT, 1997, J BIOL CHEM, V272, P31203, DOI 10.1074/jbc.272.49.31203; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tokudome T, 2008, CIRCULATION, V117, P2329, DOI 10.1161/CIRCULATIONAHA.107.732990; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Yao XQ, 2005, CIRC RES, V97, P853, DOI 10.1161/01.RES.0000187473.85419.3e; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200	46	77	80	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13244	13253		10.1074/jbc.M109.074104	http://dx.doi.org/10.1074/jbc.M109.074104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177073	Green Published, hybrid			2022-12-25	WOS:000276787800079
J	Gruber, A; Cornaciu, I; Lass, A; Schweiger, M; Poeschl, M; Eder, C; Kumari, M; Schoiswohl, G; Wolinski, H; Kohlwein, SD; Zechner, R; Zimmermann, R; Oberer, M				Gruber, Astrid; Cornaciu, Irina; Lass, Achim; Schweiger, Martina; Poeschl, Margret; Eder, Christina; Kumari, Manju; Schoiswohl, Gabriele; Wolinski, Heimo; Kohlwein, Sepp D.; Zechner, Rudolf; Zimmermann, Robert; Oberer, Monika			The N-terminal Region of Comparative Gene Identification-58 (CGI-58) Is Important for Lipid Droplet Binding and Activation of Adipose Triglyceride Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANARIN-DORFMAN-SYNDROME; PROTEIN TRAFFICKING; 3T3-L1 ADIPOCYTES; LAMELLAR GRANULES; STORAGE DISEASE; PERILIPIN; LIPOLYSIS; HYDROLASE; CELLS; MOBILIZATION	In mammals, excess energy is stored in the form of triacylglycerol primarily in lipid droplets of white adipose tissue. The first step of lipolysis (i.e. the mobilization of fat stores) is catalyzed by adipose triglyceride lipase (ATGL). The enzymatic activity of ATGL is strongly enhanced by CGI-58 (comparative gene identification-58), and the loss of either ATGL or CGI-58 function causes systemic triglyceride accumulation in humans and mice. However, the mechanism by which CGI-58 stimulates ATGL activity is unknown. To gain insight into CGI-58 function using structural features of the protein, we generated a three-dimensional homology model based on sequence similarity with other proteins. Interestingly, the model of CGI-58 revealed that the N terminus forms an extension of the otherwise compact structure of the protein. This N-terminal region (amino acids 1-30) harbors a lipophilic tryptophan-rich stretch, which affects the localization of the protein. H-1 NMR experiments revealed strong interaction between the N-terminal peptide and dodecylphosphocholine micelles as a lipid droplet-mimicking system. A role for this N-terminal region of CGI-58 in lipid droplet binding was further strengthened by localization studies in cultured cells. Although wild-type CGI-58 localizes to the lipid droplet, the N-terminally truncated fragments of CGI-58 are dispersed in the cytoplasm. Moreover, CGI-58 lacking the N-terminal extension loses the ability to stimulate ATGL, implying that the ability of CGI-58 to activate ATGL is linked to correct localization. In summary, our study shows that the N-terminal, Trp-rich region of CGI-58 is essential for correct localization and ATGL-activating function of CGI-58.	[Gruber, Astrid; Cornaciu, Irina; Lass, Achim; Schweiger, Martina; Poeschl, Margret; Eder, Christina; Kumari, Manju; Schoiswohl, Gabriele; Wolinski, Heimo; Kohlwein, Sepp D.; Zechner, Rudolf; Zimmermann, Robert; Oberer, Monika] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	University of Graz	Oberer, M (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50-3, A-8010 Graz, Austria.	m.oberer@uni-graz.at	Lass, Achim/C-3332-2008	Lass, Achim/0000-0002-8190-7151; Zechner, Rudolf/0000-0001-5483-1182; Paar, Margret/0000-0001-5494-8890; Oberer, Monika/0000-0003-2525-9513; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Schweiger, Martina/0000-0002-3419-1007; Schoiswohl, Gabriele/0000-0002-7346-2834; Zimmermann, Robert/0000-0002-7354-870X; Wolinski, Heimo/0000-0002-1583-6092	GEN-AU Genome Research in Austria; Austrian Federal Ministry of Science and Research; Austrian Science Fund [FWF W901-B05]; Austrian Science Fund (FWF) [F 3002, F 3005, W 901, Z 136, P 22170] Funding Source: researchfish	GEN-AU Genome Research in Austria; Austrian Federal Ministry of Science and Research; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from "GOLD: Genomics of Lipid-Associated Disorders," which is part of the Austrian Genome Project "GEN-AU Genome Research in Austria" and is funded by the Austrian Federal Ministry of Science and Research and DK Molecular Enzymology, which is funded by Austrian Science Fund Grant FWF W901-B05.	Akiyama M, 2003, J INVEST DERMATOL, V121, P1029, DOI 10.1046/j.1523-1747.2003.12520.x; Akiyama M, 2008, AM J PATHOL, V173, P1349, DOI 10.2353/ajpath.2008.080005; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bai JN, 1997, BIOCHEMISTRY-US, V36, P8840, DOI 10.1021/bi970145r; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Brown JM, 2007, J LIPID RES, V48, P2295, DOI 10.1194/jlr.M700279-JLR200; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Gelb MH, 1999, CURR OPIN STRUC BIOL, V9, P428, DOI 10.1016/S0959-440X(99)80059-1; Ghosh AK, 2008, J BIOL CHEM, V283, P24525, DOI 10.1074/jbc.M801783200; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Montero-Moran G, 2010, J LIPID RES, V51, P709, DOI 10.1194/jlr.M001917; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Yamaguchi T, 2009, BBA-MOL CELL BIOL L, V1791, P519, DOI 10.1016/j.bbalip.2008.10.012; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zou JY, 2000, STRUCTURE, V8, P111, DOI 10.1016/S0969-2126(00)00087-3; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	40	83	89	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12289	12298		10.1074/jbc.M109.064469	http://dx.doi.org/10.1074/jbc.M109.064469			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164531	Green Published, hybrid			2022-12-25	WOS:000276787100058
J	Lu, QW; Hinken, AC; Patrick, SE; Solaro, RJ; Kobayashi, T				Lu, Qun-Wei; Hinken, Aaron C.; Patrick, Stacey E.; Solaro, R. John; Kobayashi, Tomoyoshi			Phosphorylation of Cardiac Troponin I at Protein Kinase C Site Threonine 144 Depresses Cooperative Activation of Thin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORDERED PHOSPHORYLATION; MYOCARDIAL-FUNCTION; CROSSBRIDGE CYCLE; FORCE DEVELOPMENT; CALCIUM-BINDING; ATPASE ACTIVITY; HEART-FAILURE; MUSCLE-FIBERS; CA2+ AFFINITY; CROSS-BRIDGE	There is evidence for PKC-dependent multisite phosphorylation of cardiac troponin I (cTnI) at Ser-23 and Ser-24 (also PKA sites) in the cardiac-specific N-terminal extension and at Thr-144, a unique residue in the inhibitory region. The functional effect of these phosphorylations in combination is of interest in view of data indicating intramolecular interaction between the N-terminal extension and the inhibitory region of cTnI. To determine the role of PKC-dependent phosphorylation of cTnI on sarcomeric function, we measured contractile regulation at multiple levels of complexity. Ca2+ binding to thin filaments reconstituted with either cTnI(wild-type) or pseudo-phosphorylated cTnI(S23D/S24D), cTnI(T144E), and cTnI(S23D/S24D/T144E) was determined. Compared with controls regulated by cTnI(wild-type), thin filaments with cTnI(S23D/S24D) and cTnI(S23D/S24D/T144E) exhibited decreased Ca2+ sensitivity. In contrast, there was no significant difference between Ca2+ binding to thin filaments with cTnI(wild-type) and with cTnI(T144E). Studies of the pCa-force relations in skinned papillary fibers regulated by these forms of cTnI yielded similar results. However, in both the Ca2+ binding measurements and the skinned fiber tension measurements, the presence of cTnI(S23D/S24D/T144E) induced a much lower Hill coefficient than either wild type, S23D/S24D, or T144E. These data highlight the importance of thin filament-based cooperative mechanisms in cardiac regulation, with implications for mechanisms of control of function in normal and pathological hearts.	[Kobayashi, Tomoyoshi] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; Univ Illinois, Cardiovasc Res Ctr, Coll Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kobayashi, T (corresponding author), Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott Ave M-C 901, Chicago, IL 60612 USA.	tkoba@uic.edu			National Institutes of Health [R01HL082923, R01HL022231, P01HL062426, T32HL07692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692, P01HL062426, R01HL022231, R01HL082923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL082923, R01HL022231, P01HL062426, and T32HL07692.	Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; DANTZIG JA, 1992, J PHYSIOL-LONDON, V451, P247, DOI 10.1113/jphysiol.1992.sp019163; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Deng Y, 2001, BIOCHEMISTRY-US, V40, P14593, DOI 10.1021/bi0115232; Dohet C, 1995, FEBS LETT, V377, P131, DOI 10.1016/0014-5793(95)01319-9; Finley NL, 2004, J BIOL CHEM, V279, P54833, DOI 10.1074/jbc.M408304200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Hanft LM, 2008, CARDIOVASC RES, V77, P627, DOI 10.1093/cvr/cvm099; Hinken AC, 2004, AM J PHYSIOL-CELL PH, V287, pC500, DOI 10.1152/ajpcell.00049.2004; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Hunlich M, 2005, J MOL CELL CARDIOL, V38, P119, DOI 10.1016/j.yjmcc.2004.10.005; Keane NE, 1997, EUR J BIOCHEM, V248, P329, DOI 10.1111/j.1432-1033.1997.00329.x; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kobayashi T, 2005, J MOL CELL CARDIOL, V38, P213, DOI 10.1016/j.yjmcc.2004.10.014; Kobayashi T, 2009, J BIOL CHEM, V284, P20052, DOI 10.1074/jbc.M109.001396; Lu QW, 2003, J MOL CELL CARDIOL, V35, P1421, DOI 10.1016/j.yjmcc.2003.09.003; Mathur MC, 2008, BIOPHYS J, V94, P542, DOI 10.1529/biophysj.107.113944; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; MITTMANN K, 1992, FEBS LETT, V302, P133, DOI 10.1016/0014-5793(92)80423-E; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; NAGASHIMA H, 1982, J MOL BIOL, V155, P409, DOI 10.1016/0022-2836(82)90479-X; Noguchi T, 2004, CIRCULATION, V110, P982, DOI 10.1161/01.CIR.0000139334.43109.F9; NOLAND TA, 1995, J BIOL CHEM, V270, P25445, DOI 10.1074/jbc.270.43.25445; NOLAND TA, 1989, J BIOL CHEM, V264, P20778; ONISHI H, 1995, P NATL ACAD SCI USA, V92, P704, DOI 10.1073/pnas.92.3.704; PAN BS, 1987, J BIOL CHEM, V262, P7839; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Phan TT, 2009, J AM COLL CARDIOL, V54, P402, DOI 10.1016/j.jacc.2009.05.012; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Pi YQ, 2002, CIRC RES, V90, P649, DOI 10.1161/01.RES.0000014080.82861.5F; Rarick HM, 1996, J BIOL CHEM, V271, P27039, DOI 10.1074/jbc.271.43.27039; Regnier M, 2004, BIOPHYS J, V87, P1815, DOI 10.1529/biophysj.103.039123; Reiffert SU, 1996, FEBS LETT, V384, P43, DOI 10.1016/0014-5793(96)00274-8; Sadayappan S, 2008, FASEB J, V22, P1246, DOI 10.1096/fj.07-9458com; Sleep J, 2005, J PHYSIOL-LONDON, V563, P671, DOI 10.1113/jphysiol.2004.078873; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Steffen W, 2004, P NATL ACAD SCI USA, V101, P12904, DOI 10.1073/pnas.0400227101; Sumandea MP, 2008, J BIOL CHEM, V283, P22680, DOI 10.1074/jbc.M802396200; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; Tachampa K, 2007, CIRC RES, V101, P1081, DOI 10.1161/CIRCRESAHA.107.165258; Takeda S, 1997, EUR J BIOCHEM, V246, P611, DOI 10.1111/j.1432-1033.1997.00611.x; Takimoto E, 2004, CIRC RES, V94, P496, DOI 10.1161/01.RES.0000117307.57798.F5; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; TOBACMAN LS, 1990, J BIOL CHEM, V265, P931; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; Warren CM, 2009, J BIOL CHEM, V284, P14258, DOI 10.1074/jbc.M807621200; Westfall MV, 2005, J BIOL CHEM, V280, P41324, DOI 10.1074/jbc.M506043200; Yasuda SI, 2007, CIRC RES, V101, P377, DOI 10.1161/CIRCRESAHA.106.145557; Zabrouskov V, 2008, MOL CELL PROTEOMICS, V7, P1838, DOI 10.1074/mcp.M700524-MCP200; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773	55	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11810	11817		10.1074/jbc.M109.055657	http://dx.doi.org/10.1074/jbc.M109.055657			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164197	Green Published, hybrid			2022-12-25	WOS:000276787100008
J	Meena, N; Kaur, H; Mondal, AK				Meena, Netrapal; Kaur, Harsimran; Mondal, Alok K.			Interactions among HAMP Domain Repeats Act as an Osmosensing Molecular Switch in Group III Hybrid Histidine Kinases from Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; SEVERE OSMOTIC-STRESS; NEUROSPORA-CRASSA; CANDIDA-ALBICANS; DEBARYOMYCES-HANSENII; HYPHAL DEVELOPMENT; SACCHAROMYCES-CEREVISIAE; PROTEIN INTERACTIONS; YEAST OSMOSENSOR; DRUG-SENSITIVITY	The members of group III hybrid histidine kinases (HHK) are ubiquitous in fungi. Group III HHK have been implicated to function as osmosensors in the high osmolarity glycerol (HOG) pathway that is essential for fungal survival under high osmolarity stress. Recent literature suggests that group III HHK are also involved in conidia formation, virulence in several filamentous fungi, and are an excellent molecular target for antifungal agents. Thus, group III HHK constitute a very important group of sensor kinases. Structurally, group III HHK are distinct from Sln1p, the osmosensing HHK that regulates the HOG pathway in Saccharomyces cerevisiae. Group III HHK lack any transmembrane domain and typically contain HAMP domain repeats at the N terminus. Until now, it is not clear how group III HHK function as an osmosensor to regulate the HOG pathway. To investigate this, we undertook molecular characterization of DhNIK1, an ortholog from osmotolerant yeast Debaryomyces hansenii. We show here that DhNIK1 could complement sln1 mutation in S. cerevisiae thereby confirming its role as a bona fide osmosensor. We further investigated the role of HAMP domains by deleting them systematically. Our results clearly indicate that the HAMP4 domain is crucial for osmosensing by DhNik1p. Most importantly, we also show that the alternative interaction among the HAMP domains regulates the activity of DhNik1p like an "on-off switch" and thus provides, for the first time, an insight into the molecular mechanism of osmosensing by this group of HHKs.	[Meena, Netrapal; Kaur, Harsimran; Mondal, Alok K.] Inst Microbial Technol, Sector 39A, Council Sci & Ind Res, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Mondal, AK (corresponding author), Inst Microbial Technol, Sector 39A, Council Sci & Ind Res, Chandigarh 160036, India.	alok@imtech.res.in		Meena, Netra/0000-0003-1898-4530	Department of Biotechnology, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported in part by a grant from Department of Biotechnology, India.	Aggarwal M, 2006, EUKARYOT CELL, V5, P262, DOI 10.1128/EC.5.2.262-271.2006; Alex LA, 1998, P NATL ACAD SCI USA, V95, P7069, DOI 10.1073/pnas.95.12.7069; Alex LA, 1996, P NATL ACAD SCI USA, V93, P3416, DOI 10.1073/pnas.93.8.3416; Appleman JA, 2003, J BACTERIOL, V185, P4872, DOI 10.1128/JB.185.16.4872-4882.2003; Appleman JA, 2003, J BACTERIOL, V185, P89, DOI 10.1128/JB.185.1.89-97.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; Avenot H, 2005, CURR GENET, V47, P234, DOI 10.1007/s00294-005-0568-2; Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Bahn YS, 2006, MOL BIOL CELL, V17, P3122, DOI 10.1091/mbc.E06-02-0113; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Chapeland-Leclerc F, 2007, EUKARYOT CELL, V6, P1782, DOI 10.1128/EC.00155-07; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cui W, 2002, FUNGAL GENET BIOL, V36, P187, DOI 10.1016/S1087-1845(02)00009-9; De Nadal E, 2007, TRENDS CELL BIOL, V17, P571, DOI 10.1016/j.tcb.2007.10.001; Dongo A, 2009, APPL ENVIRON MICROB, V75, P127, DOI 10.1128/AEM.00993-08; Germino FJ, 1999, METHOD ENZYMOL, V303, P422; Golemis EA, 1997, YEAST 2 HYBRID SYSTE, P43; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Kruppa M, 2006, FEMS YEAST RES, V6, P149, DOI 10.1111/j.1567-1364.2006.00024.x; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Miller TK, 2002, FUNGAL GENET BIOL, V35, P147, DOI 10.1006/fgbi.2001.1306; Motoyama T, 2005, FUNGAL GENET BIOL, V42, P200, DOI 10.1016/j.fgb.2004.11.002; Nagahashi S, 1998, MICROBIOL-UK, V144, P425, DOI 10.1099/00221287-144-2-425; Nemecek JC, 2006, SCIENCE, V312, P583, DOI 10.1126/science.1124105; Ochiai N, 2001, PEST MANAG SCI, V57, P437, DOI 10.1002/ps.302; Oshima Michiyo, 2006, Journal of General Plant Pathology, V72, P65, DOI 10.1007/s10327-005-0247-7; Ostrander DB, 1999, J BACTERIOL, V181, P2527, DOI 10.1128/JB.181.8.2527-2534.1999; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Prista C, 2005, FEMS YEAST RES, V5, P693, DOI 10.1016/j.femsyr.2004.12.009; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; SANTOS JL, 2001, SCI STKE, pRE1, DOI DOI 10.1126/J.STKE.2001.98.RE1; Schumacher MM, 1997, CURR MICROBIOL, V34, P340, DOI 10.1007/s002849900193; Sharma P, 2005, CURR GENET, V48, P162, DOI 10.1007/s00294-005-0010-9; Srikantha T, 1998, MICROBIOL-SGM, V144, P2715, DOI 10.1099/00221287-144-10-2715; Stephens DJ, 2000, TRAFFIC, V1, P763, DOI 10.1034/j.1600-0854.2000.011003.x; Swain KE, 2007, BIOCHEMISTRY-US, V46, P13684, DOI 10.1021/bi701832b; Tao W, 2002, MOL MICROBIOL, V43, P459, DOI 10.1046/j.1365-2958.2002.02757.x; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Wuytswinkel O, 2000, MOL MICROBIOL, V37, P382, DOI 10.1046/j.1365-2958.2000.02002.x; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Viaud M, 2006, MOL PLANT MICROBE IN, V19, P1042, DOI 10.1094/MPMI-19-1042; Yamada-Okabe T, 1999, J BACTERIOL, V181, P7243, DOI 10.1128/JB.181.23.7243-7247.1999; Yoshimi A, 2004, MOL GENET GENOMICS, V271, P228, DOI 10.1007/s00438-003-0974-4	48	54	54	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12121	12132		10.1074/jbc.M109.075721	http://dx.doi.org/10.1074/jbc.M109.075721			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164185	Green Published, hybrid			2022-12-25	WOS:000276787100042
J	Cui, M; Tang, XN; Christian, WV; Yoon, Y; Tieu, K				Cui, Mei; Tang, Xiangna; Christian, Whitney V.; Yoon, Yisang; Tieu, Kim			Perturbations in Mitochondrial Dynamics Induced by Human Mutant PINK1 Can Be Rescued by the Mitochondrial Division Inhibitor mdivi-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY-ONSET PARKINSONISM; UBIQUITIN LIGASE; INDEPENDENT UBIQUITINATION; RECESSIVE PARKINSONISM; OXIDATIVE STRESS; MAMMALIAN-CELLS; DISEASE; MUTATIONS; PROTEIN; DEGRADATION	Mutations in the mitochondrial encoded protein PTEN-induced putative kinase 1 (PINK1) cause autosomal recessive Parkinson disease (PD). In mammalian cells, mutant PINK1 has been reported to promote fission or inhibit fusion in mitochondria; however, the mechanism by which this process occurs remains elusive. Using an ecdysone-inducible expression system in mammalian dopaminergic neuronal cells, we report here that human mutant PINK1 (L347P and W437X) mediates an overall fission effect by increasing the ratio of mitochondrial fission over fusion proteins, leading to excessive dysfunctional fragmented mitochondria. Knocking down endogenous Pink1 produces similar effects. In contrast, overexpressing human wild type PINK1 produces a pro-fusion effect by increasing the ratio of mitochondrial fusion/fission proteins without resulting in functionally compromised mitochondria. Parkin knockdown blocks the imbalance in fission/fusion proteins. Furthermore, overexpressing parkin and ubiquitin increases degradation of the mitochondrial fission hFis1 protein, suggesting PINK1 and parkin maintain proper mitochondrial function and integrity via the fission/fusion machinery. Through genetic manipulations and treatment with the small molecule mitochondrial division inhibitor (mdivi-1), which inhibits DLP1/Drp1, both structural and functional mitochondrial defects induced by mutant PINK1 were attenuated, highlighting a potential novel therapeutic avenue for Parkinson disease.	[Tieu, Kim] Univ Rochester, Sch Med, Dept Neurol, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Christian, Whitney V.; Tieu, Kim] Univ Rochester, Sch Med, Dept Environm Med, Rochester, NY 14642 USA; [Yoon, Yisang] Univ Rochester, Sch Med, Dept Anesthesiol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Tieu, K (corresponding author), Univ Rochester, Sch Med, Dept Neurol, Ctr Translat Neuromed, 575 Elmwood Ave,Box 645, Rochester, NY 14642 USA.	kim_tieu@urmc.rochester.edu	Yoon, Yisang/AAJ-7910-2020; Tieu, Kim/F-5426-2012; Tieu, Kim/AAG-7336-2019	Tieu, Kim/0000-0001-6606-4371; Tieu, Kim/0000-0001-6606-4371; Yoon, Yisang/0000-0002-1618-5439	National Institutes of Health [ES014899, ES17470, DK078618, DK061991, P30 ES01247, T32 ES07026]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061991, R01DK078618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247, T32ES007026, R01ES014899, R21ES017470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES014899 and ES17470 (to K.T.), DK078618 and DK061991 (to Y.Y.), and P30 ES01247 and T32 ES07026.	Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Criscuolo C, 2006, MOVEMENT DISORD, V21, P1265, DOI 10.1002/mds.20933; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Halterman MW, 2009, J NEUROSCI METH, V177, P348, DOI 10.1016/j.jneumeth.2008.10.023; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hatano Y, 2004, ANN NEUROL, V56, P424, DOI 10.1002/ana.20251; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Mills RD, 2008, J NEUROCHEM, V105, P18, DOI 10.1111/j.1471-4159.2008.05249.x; Mopert K, 2009, EXP CELL RES, V315, P2165, DOI 10.1016/j.yexcr.2009.04.016; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; PRASAD KN, 1994, IN VITRO CELL DEV-AN, V30A, P596; Prasad KN, 1998, MOL GENET METAB, V65, P1, DOI 10.1006/mgme.1998.2726; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Rogaeva E, 2004, ARCH NEUROL-CHICAGO, V61, P1898, DOI 10.1001/archneur.61.12.1898; Rohe CF, 2004, ANN NEUROL, V56, P427, DOI 10.1002/ana.20247; Rojo M, 2002, J CELL SCI, V115, P1663; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Volonte MG, 2004, J PHARMACEUT BIOMED, V35, P647, DOI 10.1016/j.jpba.2004.02.002; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	52	145	149	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11740	11752		10.1074/jbc.M109.066662	http://dx.doi.org/10.1074/jbc.M109.066662			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20164189	hybrid, Green Published			2022-12-25	WOS:000276286200077
J	Gurgul-Convey, E; Lenzen, S				Gurgul-Convey, Ewa; Lenzen, Sigurd			Protection against Cytokine Toxicity through Endoplasmic Reticulum and Mitochondrial Stress Prevention by Prostacyclin Synthase Overexpression in Insulin-producing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; PANCREATIC BETA-CELLS; FACTOR-KAPPA-B; TUMOR-NECROSIS-FACTOR; BERAPROST SODIUM; RINM5F CELLS; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); CYCLOPENTENONE PROSTAGLANDINS; PROINFLAMMATORY CYTOKINES; ENDOGENOUS PROSTACYCLIN	Proinflammatory cytokines play a crucial role in the pathogenesis of type 1 diabetes mellitus. One of the cytokine-regulated pathways mediating inflammation in this autoimmune disease is the arachidonic acid metabolism pathway, comprising both the induction of cyclooxygenases and the production of different prostaglandins. Cytokine toxicity is mediated in many cell types, including pancreatic beta cells through this pathway. Interestingly, some cell types have been shown to be insensitive to such toxicity, and this correlated with a high expression of prostacyclin synthase (PGIS). Using insulin-producing RINm5F cells as a model for pancreatic beta cells, PGIS was overexpressed and exhibited a large protective effect against cytokine toxicity. This protective effect of PGIS against cytokine toxicity correlated with a decreased activation of the transcription factor NF kappa B and the inducible NO synthase promoter as well as a reduced inducible NO synthase protein expression and nitrite production. A reduction in the cytokine-stimulated endoplasmic reticulum and mitochondrial stress was also found in the PGIS-overexpressing cells. Moreover, cytokine-induced caspase-3 activation and reduction of glucose oxidation and cell proliferation were suppressed. Thus, PGIS overexpression apparently protects insulin-producing cells against cytokine toxicity via suppression of endoplasmic reticulum and mitochondrial stress-mediated cell death pathways.	[Gurgul-Convey, Ewa; Lenzen, Sigurd] Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany	Hannover Medical School	Gurgul-Convey, E (corresponding author), Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany.	Gurgul-Convey.Ewa@mh-hannover.de		Gurgul-Convey, Ewa/0000-0002-9269-266X	European Union [LSHM-CT-2006-036903]; German Foundation Das Zuckerkranke Kind	European Union(European Commission); German Foundation Das Zuckerkranke Kind	This work was supported by European Union Grant STREP SaveBeta LSHM-CT-2006-036903 in Framework Programme 6 of the European Community) (to S. L.) and by a grant from the German Foundation Das Zuckerkranke Kind (to E. G.- C.).	Arita S, 1999, PANCREAS, V19, P289, DOI 10.1097/00006676-199910000-00010; Arita S, 2001, PANCREAS, V23, P62, DOI 10.1097/00006676-200107000-00009; Arita S, 1998, TRANSPLANT P, V30, P366, DOI 10.1016/S0041-1345(97)01310-9; Arita S, 1997, TRANSPLANT P, V29, P1977, DOI 10.1016/S0041-1345(97)00190-5; Azevedo-Martins AK, 2003, DIABETES, V52, P93, DOI 10.2337/diabetes.52.1.93; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bast A, 2002, DIABETOLOGIA, V45, P867, DOI 10.1007/s00125-002-0846-1; Chambers KT, 2008, DIABETES, V57, P124, DOI 10.2337/db07-0944; Chambers KT, 2007, AM J PHYSIOL-ENDOC M, V292, pE1052, DOI 10.1152/ajpendo.00274.2006; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Darville MI, 1998, DIABETOLOGIA, V41, P1101, DOI 10.1007/s001250051036; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; EIZIRIK DL, 1991, ENDOCRINOLOGY, V128, P1611, DOI 10.1210/endo-128-3-1611; EIZIRIK DL, 1988, ACTA ENDOCRINOL-COP, V119, P321, DOI 10.1530/acta.0.1190321; EIZIRIK DL, 1991, AUTOIMMUNITY, V10, P107, DOI 10.3109/08916939109004814; Eizirik DL, 1996, HORM METAB RES, V28, P302, DOI 10.1055/s-2007-979799; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; EIZIRIK DL, 1994, DIABETES METAB, V20, P116; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Elsner M, 2002, DIABETOLOGIA, V45, P1542, DOI 10.1007/s00125-002-0955-x; Flodstrom M, 1996, FEBS LETT, V385, P4, DOI 10.1016/0014-5793(96)00337-7; Flodstrom M, 1999, DIABETES, V48, P706, DOI 10.2337/diabetes.48.4.706; Gurgul E, 2004, DIABETES, V53, P2271, DOI 10.2337/diabetes.53.9.2271; Hatae T, 2001, J BIOL CHEM, V276, P46260, DOI 10.1074/jbc.M107180200; Heitmeier MR, 2004, J BIOL CHEM, V279, P53145, DOI 10.1074/jbc.M410978200; Jobin C, 1998, IMMUNOLOGY, V95, P537; Kunugiza Y, 2006, GENE THER, V13, P1143, DOI 10.1038/sj.gt.3302767; Kwon G, 1998, DIABETES, V47, P583, DOI 10.2337/diabetes.47.4.583; LENZEN S, 1980, BIOCHEM J, V186, P135, DOI 10.1042/bj1860135; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Liou JY, 2006, ARTERIOSCL THROM VAS, V26, P1481, DOI 10.1161/01.ATV.0000223875.14120.93; Lortz S, 2000, DIABETES, V49, P1123, DOI 10.2337/diabetes.49.7.1123; Lortz S, 2005, DIABETOLOGIA, V48, P1541, DOI 10.1007/s00125-005-1822-3; Lortz S, 2003, FREE RADICAL BIO MED, V34, P683, DOI 10.1016/S0891-5849(02)01371-0; Maggi LB, 2000, DIABETES, V49, P346, DOI 10.2337/diabetes.49.3.346; Mandrup-Poulsen T, 2003, ANN NY ACAD SCI, V1005, P32, DOI 10.1196/annals.1288.005; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; MARNETT LJ, 1982, DRUG METAB REV, V13, P235, DOI 10.3109/03602538209029998; Marnett LJ, 2000, E SCHERING RES FDN W, V31, P65; McDaniel ML, 1996, P SOC EXP BIOL MED, V211, P24; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Pakrasi PL, 2007, LIFE SCI, V80, P1503, DOI 10.1016/j.lfs.2007.01.044; Pakrasi PL, 2008, PROSTAG LEUKOTR ESS, V79, P27, DOI 10.1016/j.plefa.2008.07.006; PAOLISSO G, 1995, DIABETES CARE, V18, P200, DOI 10.2337/diacare.18.2.200; PAOLISSO G, 1995, EUR J CLIN PHARMACOL, V48, P333; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; Ronn SG, 2007, DIABETES, V56, P541, DOI 10.2337/db06-1068; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; Sandler S, 1992, Lakartidningen, V89, P1777; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; SCHEEREN T, 1994, J CRIT CARE, V9, P175, DOI 10.1016/0883-9441(94)90014-0; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Siegle I, 2000, J HISTOCHEM CYTOCHEM, V48, P631, DOI 10.1177/002215540004800507; Sorli CH, 1998, P NATL ACAD SCI USA, V95, P1788, DOI 10.1073/pnas.95.4.1788; Souza KLA, 2008, J ENDOCRINOL, V197, P139, DOI 10.1677/JOE-07-0638; Storling J, 2005, DIABETOLOGIA, V48, P2039, DOI 10.1007/s00125-005-1912-2; Suarez-Pinzon WL, 2001, J AUTOIMMUN, V16, P449, DOI 10.1006/jaut.2001.0507; Tabatabaie T, 2003, DIABETES, V52, P1994, DOI 10.2337/diabetes.52.8.1994; Tiedge M, 1999, DIABETOLOGIA, V42, P849, DOI 10.1007/s001250051237; Tonnesen MF, 2009, ENDOCRINOLOGY, V150, P4094, DOI 10.1210/en.2009-0029; Tran POT, 2002, DIABETES, V51, P1772, DOI 10.2337/diabetes.51.6.1772; Tran POT, 1999, J BIOL CHEM, V274, P31245, DOI 10.1074/jbc.274.44.31245; Weber SM, 2004, AM J PHYSIOL-ENDOC M, V287, pE1171, DOI 10.1152/ajpendo.00331.2004; Weber SM, 2003, AM J PHYSIOL-ENDOC M, V284, pE883, DOI 10.1152/ajpendo.00515.2002; Wu KK, 2005, BIOCHEM BIOPH RES CO, V338, P45, DOI 10.1016/j.bbrc.2005.08.021; Yang ZD, 2005, AM J TRANSPLANT, V5, P475, DOI 10.1111/j.1600-6143.2005.00707.x; YEGEN C, 1994, PROSTAG LEUKOTR ESS, V51, P257, DOI 10.1016/0952-3278(94)90189-9	71	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11121	11128		10.1074/jbc.M109.054775	http://dx.doi.org/10.1074/jbc.M109.054775			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20159982	hybrid, Green Published			2022-12-25	WOS:000276286200017
J	Guttridge, TL; Gruber, SH; Krause, J; Sims, DW				Guttridge, Tristan L.; Gruber, Samuel H.; Krause, Jens; Sims, David W.			Novel Acoustic Technology for Studying Free-Ranging Shark Social Behaviour by Recording Individuals' Interactions	PLOS ONE			English	Article							JUVENILE LEMON SHARKS; SCALLOPED HAMMERHEAD SHARK; SEXUAL SEGREGATION; NEGAPRION-BREVIROSTRIS; PATTERNS; CONSERVATION; STRATEGIES; PROXIMITY; NETWORKS; TRACKING	Group behaviours are widespread among fish but comparatively little is known about the interactions between free-ranging individuals and how these might change across different spatio-temporal scales. This is largely due to the difficulty of observing wild fish groups directly underwater over long enough time periods to quantify group structure and individual associations. Here we describe the use of a novel technology, an animal-borne acoustic proximity receiver that records close-spatial associations between free-ranging fish by detection of acoustic signals emitted from transmitters on other individuals. Validation trials, held within enclosures in the natural environment, on juvenile lemon sharks Negaprion brevirostris fitted with external receivers and transmitters, showed receivers logged interactions between individuals regularly when sharks were within 4 m (similar to 4 body lengths) of each other, but rarely when at 10 m distance. A field trial lasting 17 days with 5 juvenile lemon sharks implanted with proximity receivers showed one receiver successfully recorded association data, demonstrating this shark associated with 9 other juvenile lemon sharks on 128 occasions. This study describes the use of acoustic underwater proximity receivers to quantify interactions among wild sharks, setting the scene for new advances in understanding the social behaviours of marine animals.	[Guttridge, Tristan L.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Guttridge, Tristan L.; Gruber, Samuel H.] Bimini Biol Field Stn, S Bimini, Bahamas; [Gruber, Samuel H.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA; [Krause, Jens] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; [Sims, David W.] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England; [Sims, David W.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Inst Marine, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England	University of Leeds; University of Miami; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Marine Biological Association United Kingdom; University of Plymouth	Guttridge, TL (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England.	tristanguttridge@gmail.com	Krause, Jens/C-2750-2011; Krause, Jens/J-4381-2013	Krause, Jens/0000-0002-1289-2857; Sims, David/0000-0002-0916-7363	Bimini Biological Field Station; Lacy Hoover; Earthwatch Institute; National Science Foundation [NSF-OCE 97-12793]; Department of Education, State of Florida [FLORIDA 8749703000001]; Leverhulme Trust; Engineering and Physical Sciences Research Council [GR/T11241/01(P)]; Natural Environment Research Council [NE/D011035/1]; Natural Environment Research Council; MBA Senior Research Fellowship; NERC [MBA010001] Funding Source: UKRI; Natural Environment Research Council [MBA010001] Funding Source: researchfish	Bimini Biological Field Station; Lacy Hoover; Earthwatch Institute; National Science Foundation(National Science Foundation (NSF)); Department of Education, State of Florida; Leverhulme Trust(Leverhulme Trust); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MBA Senior Research Fellowship; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study would not have been possible without financial support from the Bimini Biological Field Station, Lacy Hoover, Earthwatch Institute, National Science Foundation (NSF-OCE 97-12793) and Department of Education, State of Florida (FLORIDA 8749703000001). T. L. G. was supported by a Leverhulme Trust study aboard studentship for postgraduate work. J.K. was funded by grants from the Engineering and Physical Sciences Research Council (GR/T11241/01(P)) and the Natural Environment Research Council (NE/D011035/1). D. W. S. was supported by the Natural Environment Research Council Oceans 2025 Strategic Research Programme (www.oceans2025.org) and by an MBA Senior Research Fellowship (www.mba.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; BRES M, 1993, REV FISH BIOL FISHER, V3, P133, DOI 10.1007/BF00045229; Cooke Steven J., 2008, Endangered Species Research, V4, P165, DOI 10.3354/esr00063; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Croft DP, 2004, P ROY SOC B-BIOL SCI, V271, pS516, DOI 10.1098/rsbl.2004.0206; EBERT DA, 1991, S AFR J MARINE SCI, V11, P455, DOI 10.2989/025776191784287637; FRANKS BR, 2007, THESIS DREXEL U US; Gibbons JW, 2004, BIOSCIENCE, V54, P447, DOI 10.1641/0006-3568(2004)054[0447:PTSTAI]2.0.CO;2; Gleiss AC, 2009, FISH RES, V97, P11, DOI 10.1016/j.fishres.2008.12.012; GRUBER S H, 1982, Florida Scientist, V45, P46; GRUBER SH, 1988, B MAR SCI, V43, P61; GUTTRIDGE, 2009, THESIS U LEEDS UK; Guttridge TL, 2009, ANIM BEHAV, V78, P543, DOI 10.1016/j.anbehav.2009.06.009; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Heupel MR, 2005, MAR BIOL, V147, P1239, DOI 10.1007/s00227-005-0004-7; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; HOLLAND KN, 1992, AUST J MAR FRESH RES, V43, P61; HOLLAND KN, 2009, ENDANGER SPECIES RES, V10, P287, DOI DOI 10.3354/ESR00226; Ji WH, 2005, J APPL ECOL, V42, P595, DOI 10.1111/j.1365-2664.2005.01026.x; KLIMLEY AP, 1981, FISH B-NOAA, V79, P356; Klimley AP, 2001, MAR BIOL, V138, P429, DOI 10.1007/s002270000394; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Krause J, 2000, BIOL REV, V75, P477; Krause J., 2002, LIVING GROUPS; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; MORRISSEY JF, 1993, COPEIA, P425; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; MYRBERG AA, 1974, COPEIA, P358; Parrish J., 1997, ANIMAL GROUPS 3 DIME; PITCHER TJ, 1993, LONDON BEHAV TELEOST, P363; Prange S, 2006, WILDLIFE SOC B, V34, P1333, DOI 10.2193/0091-7648(2006)34[1333:NRFTDO]2.0.CO;2; Pratt HL, 2001, ENVIRON BIOL FISH, V60, P157; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Sims DW, 2001, MAR BIOL, V139, P1165; Sims DW, 2000, P ROY SOC B-BIOL SCI, V267, P1897, DOI 10.1098/rspb.2000.1227; SIMS DW, 2010, BIOL SHARKS THEIR RE, V2, P341; Springer S, 1967, SHARKS SKATES RAYS, P149, DOI DOI 10.1111/J.1095-8649.2012.03244.X; Strier KB, 2002, BEHAVIOUR, V139, P315, DOI 10.1163/156853902760102690; Sundstrom LF, 2002, J FISH BIOL, V61, P834, DOI 10.1006/jfbi.2002.2058; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Wetherbee BM, 2007, MAR ECOL PROG SER, V343, P283, DOI 10.3354/meps06920; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001	43	42	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9324	10.1371/journal.pone.0009324	http://dx.doi.org/10.1371/journal.pone.0009324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174465	Green Published, Green Submitted, gold			2022-12-25	WOS:000274923700022
J	Bogdarina, I; Haase, A; Langley-Evans, S; Clark, AJL				Bogdarina, Irina; Haase, Andrea; Langley-Evans, Simon; Clark, Adrian J. L.			Glucocorticoid Effects on the Programming of AT1b Angiotensin Receptor Gene Methylation and Expression in the Rat	PLOS ONE			English	Article							LOW-PROTEIN DIET; ISCHEMIC-HEART-DISEASE; ADULT-BLOOD PRESSURE; PRENATAL EXPOSURE; DIFFERENTIAL EXPRESSION; EPIGENETIC MODIFICATION; INDUCED HYPERTENSION; LATER LIFE; FETAL; CONSEQUENCES	Adverse events in pregnancy may 'programme' offspring for the later development of cardiovascular disease and hypertension. Previously, using a rodent model of programmed hypertension we have demonstrated the role of the renin-angiotensin system in this process. More recently we showed that a maternal low protein diet resulted in undermethylation of the At1b angiotensin receptor promoter and the early overexpression of this gene in the adrenal of offspring. Here, we investigate the hypothesis that maternal glucocorticoid modulates this effect on fetal DNA methylation and gene expression. We investigated whether treatment of rat dams with the 11 beta-hydroxylase inhibitor metyrapone, could prevent the epigenetic and gene expression changes we observed. Offspring of mothers subjected to a low protein diet in pregnancy showed reduced adrenal Agtr1b methylation and increased adrenal gene expression as we observed previously. Treatment of mothers with metyrapone for the first 14 days of pregnancy reversed these changes and prevented the appearance of hypertension in the offspring at 4 weeks of age. As a control for non-specific effects of programmed hypertension we studied offspring of mothers treated with dexamethasone from day 15 of pregnancy and showed that, whilst they had raised blood pressure, they failed to show any evidence of Agtr1b methylation or increase in gene expression. We conclude that maternal glucocorticoid in early pregnancy may induce changes in methylation and expression of the Agtr1b gene as these are clearly reversed by an 11 beta-hydroxylase inhibitor. However in later pregnancy a converse effect with dexamethasone could not be demonstrated and this may reflect either an alternative mechanism of this glucocorticoid or a stage-specific influence.	[Bogdarina, Irina; Clark, Adrian J. L.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Endocrinol, London, England; [Haase, Andrea; Langley-Evans, Simon] Univ Nottingham, Div Nutr Sci, Loughborough, Leics, England	University of London; Queen Mary University London; University of Nottingham	Bogdarina, I (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Endocrinol, London, England.	a.j.clark@qmul.ac.uk	Langley-Evans, Simon C/F-3564-2012; Langley-Evans, Simon/AAR-4181-2020	Langley-Evans, Simon C/0000-0002-1969-8416; 	British Heart Foundation	British Heart Foundation(British Heart Foundation)	This work was funded by the British Heart Foundation (http://www.bhf.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAM TZ, 1990, LIFE SCI, V47, P485, DOI 10.1016/0024-3205(90)90607-S; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; BENEDIKTSSON R, 1993, LANCET, V341, P339, DOI 10.1016/0140-6736(93)90138-7; Bertram CE, 2002, REPRODUCTION, V124, P459, DOI 10.1530/rep.0.1240459; Bertram CE, 2001, BRIT MED BULL, V60, P103, DOI 10.1093/bmb/60.1.103; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Bogdarina IG, 2009, J MOL ENDOCRINOL, V43, P73, DOI 10.1677/JME-09-0036; Burns SP, 1997, J CLIN INVEST, V100, P1768, DOI 10.1172/JCI119703; BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260; Desai M, 1996, BRIT J NUTR, V76, P591, DOI 10.1079/BJN19960065; DLUHY RG, 1975, STEROID THERAPY, P1; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; FALL CHD, 1992, BRIT MED J, V304, P801, DOI 10.1136/bmj.304.6830.801; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Gardner DS, 1997, HYPERTENSION, V30, P1525, DOI 10.1161/01.HYP.30.6.1525; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; GOLDBERG GR, 1994, NUTR REV, V52, P191, DOI 10.1111/j.1753-4887.1994.tb01420.x; GUO DF, 1994, BBA-GENE STRUCT EXPR, V1218, P91, DOI 10.1016/0167-4781(94)90105-8; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Johren O, 2003, HYPERTENSION, V41, P984, DOI 10.1161/01.HYP.0000062466.38314.B7; Kwong WY, 2000, DEVELOPMENT, V127, P4195; LangleyEvans SC, 1996, CLIN SCI, V91, P607, DOI 10.1042/cs0910607; LangleyEvans SC, 1997, LIFE SCI, V60, P1213, DOI 10.1016/S0024-3205(96)00611-X; LangleyEvans SC, 1996, J NUTR BIOCHEM, V7, P173, DOI 10.1016/0955-2863(95)00197-2; Law CM, 2001, INT J EPIDEMIOL, V30, P52, DOI 10.1093/ije/30.1.52; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; McMullen S, 2005, AM J PHYSIOL-REG I, V288, pR85, DOI 10.1152/ajpregu.00435.2004; McMullen S, 2004, BRIT J NUTR, V91, P133, DOI 10.1079/BJN20031029; Ozanne SE, 1999, P NUTR SOC, V58, P615, DOI 10.1017/S0029665199000804; Pladys P, 2005, AM J PHYSIOL-REG I, V289, pR1580, DOI 10.1152/ajpregu.00031.2005; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sherman RC, 2000, CLIN SCI, V98, P269, DOI 10.1042/CS19990275; Sherman RC, 1998, CLIN SCI, V94, P373, DOI 10.1042/cs0940373; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Stein CE, 1996, LANCET, V348, P1269, DOI 10.1016/S0140-6736(96)04547-3; Vasanthi D, 2008, J GENET GENOMICS, V35, P413, DOI 10.1016/S1673-8527(08)60059-4; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Woods LL, 2004, KIDNEY INT, V65, P1339, DOI 10.1111/j.1523-1755.2004.00511.x; Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR955, DOI 10.1152/ajpregu.00455.2004; Woods LL, 2006, AM J PHYSIOL-REG I, V291, pR1069, DOI 10.1152/ajpregu.00753.2005; Zhang TY, 2004, ANN NY ACAD SCI, V1032, P85, DOI 10.1196/annals.1314.007	48	69	74	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9237	10.1371/journal.pone.0009237	http://dx.doi.org/10.1371/journal.pone.0009237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169056	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000274590500018
J	Stucken, K; John, U; Cembella, A; Murillo, AA; Soto-Liebe, K; Fuentes-Valdes, JJ; Friedel, M; Plominsky, AM; Vasquez, M; Glockner, G				Stucken, Karina; John, Uwe; Cembella, Allan; Murillo, Alejandro A.; Soto-Liebe, Katia; Fuentes-Valdes, Juan J.; Friedel, Maik; Plominsky, Alvaro M.; Vasquez, Monica; Gloeckner, Gernot			The Smallest Known Genomes of Multicellular and Toxic Cyanobacteria: Comparison, Minimal Gene Sets for Linked Traits and the Evolutionary Implications	PLOS ONE			English	Article							SP STRAIN PCC-7120; HETEROCYST PATTERN-FORMATION; FRESH-WATER CYANOBACTERIUM; ANABAENA SP PCC-7120; CYLINDROSPERMOPSIS-RACIBORSKII; 1ST REPORT; DIFFERENTIATION; SAXITOXIN; IDENTIFICATION; EXPRESSION	Cyanobacterial morphology is diverse, ranging from unicellular spheres or rods to multicellular structures such as colonies and filaments. Multicellular species represent an evolutionary strategy to differentiate and compartmentalize certain metabolic functions for reproduction and nitrogen (N-2) fixation into specialized cell types (e.g. akinetes, heterocysts and diazocytes). Only a few filamentous, differentiated cyanobacterial species, with genome sizes over 5 Mb, have been sequenced. We sequenced the genomes of two strains of closely related filamentous cyanobacterial species to yield further insights into the molecular basis of the traits of N-2 fixation, filament formation and cell differentiation. Cylindrospermopsis raciborskii CS-505 is a cylindrospermopsin-producing strain from Australia, whereas Raphidiopsis brookii D9 from Brazil synthesizes neurotoxins associated with paralytic shellfish poisoning (PSP). Despite their different morphology, toxin composition and disjunct geographical distribution, these strains form a monophyletic group. With genome sizes of approximately 3.9 (CS-505) and 3.2 (D9) Mb, these are the smallest genomes described for free-living filamentous cyanobacteria. We observed remarkable gene order conservation (synteny) between these genomes despite the difference in repetitive element content, which accounts for most of the genome size difference between them. We show here that the strains share a specific set of 2539 genes with >90% average nucleotide identity. The fact that the CS-505 and D9 genomes are small and streamlined compared to those of other filamentous cyanobacterial species and the lack of the ability for heterocyst formation in strain D9 allowed us to define a core set of genes responsible for each trait in filamentous species. We presume that in strain D9 the ability to form proper heterocysts was secondarily lost together with N2 fixation capacity. Further comparisons to all available cyanobacterial genomes covering almost the entire evolutionary branch revealed a common minimal gene set for each of these cyanobacterial traits.	[Stucken, Karina; John, Uwe; Cembella, Allan] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Murillo, Alejandro A.; Soto-Liebe, Katia; Fuentes-Valdes, Juan J.; Plominsky, Alvaro M.; Vasquez, Monica] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Mol Genet & Microbiol, Santiago, Chile; [Stucken, Karina; Murillo, Alejandro A.; Soto-Liebe, Katia; Fuentes-Valdes, Juan J.; Plominsky, Alvaro M.; Vasquez, Monica] Millenium Nucleus EMBA, Santiago, Chile; [Friedel, Maik; Gloeckner, Gernot] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Gloeckner, Gernot] Univ Cologne, Inst Biochem 1, Cologne, Germany; [Gloeckner, Gernot] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Pontificia Universidad Catolica de Chile; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Cologne; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Stucken, K (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	mvasquez@bio.puc.cl; gloeckner@igb-berlin.de	Murillo, Alejandro A./AAY-5276-2020; Stucken, Karina/AAI-8343-2021; john, uwe/S-3009-2016; Glöckner, Gernot/A-7800-2010	Murillo, Alejandro A./0000-0003-3553-1330; Stucken, Karina/0000-0002-2783-4342; john, uwe/0000-0002-1297-4086; Glöckner, Gernot/0000-0002-9061-1061; Cembella, Allan/0000-0002-1297-2240; M. Plominsky, Alvaro/0000-0003-0816-8580	Fondecyt, Chile [1050433, 1080075]; Fondef, Chile [MR07I1005]; Millennium Nucleus [EMBA P04/007]; Programa de Cooperacion Cientifica Internacional (PCCI) CONICYT/DFG; EU [GOCE CT-2004-511154]; Alfred Wegener Institute (Helmholtz Society)	Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondef, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); Millennium Nucleus; Programa de Cooperacion Cientifica Internacional (PCCI) CONICYT/DFG(German Research Foundation (DFG)Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); EU(European Commission); Alfred Wegener Institute (Helmholtz Society)(Helmholtz Association)	Financial support for this work was provided by Grants from Chile (to M. V.): Fondecyt 1050433 and 1080075; Fondef MR07I1005; Millennium Nucleus EMBA P04/007; and Programa de Cooperacion Cientifica Internacional (PCCI) CONICYT/DFG between the P. Universidad Catolica de Chile and the Alfred Wegener Institute for Polar and Marine Research (Helmholtz Foundation). Additional operational support was obtained from the EU-project ESTTAL (GOCE CT-2004-511154) (to A. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The first author (K. S.) received a scholarship from the Alfred Wegener Institute (Helmholtz Society) under the MARCOPOLI program in Earth and Environment and is a member of the MarMic program administered from the MPI for Marine Microbiology.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Awai K, 2007, FEMS MICROBIOL LETT, V266, P98, DOI 10.1111/j.1574-6968.2006.00512.x; BOLHUIS H, 2009, ISME J; BUIKEMA WJ, 1991, GENE DEV, V5, P321, DOI 10.1101/gad.5.2.321; Callahan SM, 2001, MOL MICROBIOL, V40, P941, DOI 10.1046/j.1365-2958.2001.02437.x; Campbell EL, 2007, J BACTERIOL, V189, P5247, DOI 10.1128/JB.00360-07; Castro D, 2004, TOXICON, V44, P483, DOI 10.1016/j.toxicon.2004.06.005; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Des Marais DJ, 2000, SCIENCE, V289, P1703; Ehira S, 2003, DNA RES, V10, P97, DOI 10.1093/dnares/10.3.97; Ehira S, 2006, MOL MICROBIOL, V59, P1692, DOI 10.1111/j.1365-2958.2006.05049.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Falconer IR, 2006, ENVIRON TOXICOL, V21, P299, DOI 10.1002/tox.20194; Fan Q, 2005, MOL MICROBIOL, V58, P227, DOI 10.1111/j.1365-2958.2005.04818.x; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Gugger MF, 2004, INT J SYST EVOL MICR, V54, P349, DOI 10.1099/ijs.0.02744-0; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Honda D, 1999, J MOL EVOL, V48, P723, DOI 10.1007/PL00006517; Huang G, 2005, J BACTERIOL, V187, P1114, DOI 10.1128/JB.187.3.1114-1123.2005; Jones KM, 2003, J BACTERIOL, V185, P2306, DOI 10.1128/JB.185.7.2306-2314.2003; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kellmann R, 2008, J MOL EVOL, V67, P526, DOI 10.1007/s00239-008-9169-2; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; Khudyakov IY, 2004, P NATL ACAD SCI USA, V101, P16040, DOI 10.1073/pnas.0405572101; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Lagos N, 1999, TOXICON, V37, P1359, DOI 10.1016/S0041-0101(99)00080-X; LANDER E S, 1988, Genomics, V2, P231; Li RH, 2001, J PHYCOL, V37, P1121, DOI 10.1046/j.1529-8817.2001.01075.x; LIANG J, 1992, P NATL ACAD SCI USA, V89, P5655, DOI 10.1073/pnas.89.12.5655; Liu DA, 2002, J BACTERIOL, V184, P6873, DOI 10.1128/JB.184.24.6873-6881.2002; Llewellyn LE, 2006, NAT PROD REP, V23, P200, DOI 10.1039/b501296c; Mihali Troco K, 2009, BMC Biochem, V10, P8, DOI 10.1186/1471-2091-10-8; Mihali TK, 2008, APPL ENVIRON MICROB, V74, P716, DOI 10.1128/AEM.01988-07; Miyagishima SY, 2005, MOL MICROBIOL, V56, P126, DOI 10.1111/j.1365-2958.2005.04548.x; Mohamed ZA, 2007, FEMS MICROBIOL ECOL, V59, P749, DOI 10.1111/j.1574-6941.2006.00226.x; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Namikoshi M, 2003, TOXICON, V42, P533, DOI 10.1016/S0041-0101(03)00233-2; Padisak J., 1997, ARCH HYDROBIOL, V4, P563; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Saker ML, 1999, J PHYCOL, V35, P599, DOI 10.1046/j.1529-8817.1999.3530599.x; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Sivonen K, 1999, TOXIC CYANOBACTERIA, P41, DOI DOI 10.4324/9780203478073; Stucken K, 2009, SYST APPL MICROBIOL, V32, P37, DOI 10.1016/j.syapm.2008.10.002; Swingley WD, 2008, MOL BIOL EVOL, V25, P643, DOI 10.1093/molbev/msn034; Tamagnini P, 2007, FEMS MICROBIOL REV, V31, P692, DOI 10.1111/j.1574-6976.2007.00085.x; Thiel T, 1997, J BACTERIOL, V179, P5222, DOI 10.1128/jb.179.16.5222-5225.1997; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; Xu XD, 2001, J BACTERIOL, V183, P393, DOI 10.1128/JB.183.1.393-396.2001; Yoon HS, 1998, SCIENCE, V282, P935, DOI 10.1126/science.282.5390.935; Yoshimura H, 2007, DNA RES, V14, P13, DOI 10.1093/dnares/dsm003; Yunes JS, 2009, J PHYCOL, V45, P585, DOI 10.1111/j.1529-8817.2009.00673.x; Zhang CC, 2006, MOL MICROBIOL, V59, P367, DOI 10.1111/j.1365-2958.2005.04979.x; Zhang JY, 2009, MICROBIOL-SGM, V155, P1418, DOI 10.1099/mic.0.027540-0; Zhang W, 2007, MOL MICROBIOL, V66, P1429, DOI 10.1111/j.1365-2958.2007.05997.x; Zhao YH, 2005, P NATL ACAD SCI USA, V102, P5744, DOI 10.1073/pnas.0501782102	58	139	148	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9235	10.1371/journal.pone.0009235	http://dx.doi.org/10.1371/journal.pone.0009235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169071	Green Published, gold, Green Submitted			2022-12-25	WOS:000274590500017
J	Zhu, HP; Qian, H; Li, GP				Zhu, Huaiping; Qian, Hong; Li, Guangpu			Delayed Onset of Positive Feedback Activation of Rab5 by Rabex-5 and Rabaptin-5 in Endocytosis	PLOS ONE			English	Article							EXCHANGE FACTOR RABEX-5; NUCLEOTIDE EXCHANGE; STRUCTURAL BASIS; DOMAIN; GTPASES; CELL	Background: Rabex-5 is a guanine nucleotide exchange factor (GEF) that specifically activates Rab5, i.e., converting Rab5-GDP to Rab5-GTP, through two distinct pathways to promote endosome fusion and endocytosis. The direct pathway involves a pool of membrane-associated Rabex-5 that targets to the membrane via an early endosomal targeting (EET) domain. The indirect pathway, on the other hand, involves a cytosolic pool of Rabex-5/Rabaptin-5 complex. The complex is recruited to the membrane via Rabaptin-5 binding to Rab5-GTP, suggesting a positive feedback mechanism. The relationship of these two pathways for Rab5 activation in the cell is unclear. Methodology/Principal Findings: We dissect the relative contribution of each pathway to Rab5 activation via mathematical modeling and kinetic analysis in the cell. These studies show that the indirect pathway constitutes a positive feedback loop for converting Rab5-GDP to Rab5-GTP on the endosomal membrane and allows sensitive regulation of endosome fusion activity by the levels of Rab5 and Rabex-5 in the cell. The onset of this positive feedback effect, however, contains a threshold, which requires above endogenous levels of Rab5 or Rabex-5 in the cell. We term this novel phenomenon "delayed response". The presence of the direct pathway reduces the delay by increasing the basal level of Rab5-GTP, thus facilitates the function of the Rabex-5/Rabaptin-5-mediated positive feedback loop. Conclusion: Our data support the mathematical model. With the model's guidance, the data reveal the affinity of Rabex-5/Rabaptin-5/Rab5-GTP interaction in the cell, which is quantitatively related to the Rabex-5 concentration for the onset of the indirect positive feedback pathway. The presence of the direct pathway and increased Rab5 concentration can reduce the Rabex-5 concentration required for the onset of the positive feedback loop. Thus the direct and indirect pathways cooperate in the regulation of early endosome fusion.	[Zhu, Huaiping; Li, Guangpu] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Qian, Hong] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Washington; University of Washington Seattle	Zhu, HP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	guangpu-li@ouhsc.edu	Li, Guangpu/GRS-5397-2022		National Institutes of Health (NIH) [R01 GM074692]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074692] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the National Institutes of Health (NIH) grant R01 GM074692 (to GL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Goryachev AB, 2006, PLOS COMPUT BIOL, V2, P1511, DOI 10.1371/journal.pcbi.0020172; Hassler Christopher, 2005, Am J Cardiovasc Drugs, V5, P7, DOI 10.2165/00129784-200505010-00002; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Kalesnikoff J, 2007, BLOOD, V109, P5308, DOI 10.1182/blood-2007-01-067363; Li GP, 2004, J MOL BIOL, V340, P921, DOI 10.1016/j.jmb.2004.06.007; LI GP, 1994, J BIOL CHEM, V269, P14631; Li GP, 2001, BIOCHEM J, V355, P681, DOI 10.1042/bj3550681; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Tam SY, 2004, NAT IMMUNOL, V5, P844, DOI 10.1038/ni1093; Zhu GY, 2004, NAT STRUCT MOL BIOL, V11, P975, DOI 10.1038/nsmb832; Zhu HP, 2007, MOL BIOL CELL, V18, P4119, DOI 10.1091/mbc.E07-02-0100; Zhu HP, 2009, MOL BIOL CELL, V20, P4720, DOI 10.1091/mbc.E09-06-0453	20	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9226	10.1371/journal.pone.0009226	http://dx.doi.org/10.1371/journal.pone.0009226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169068	Green Published, gold, Green Submitted			2022-12-25	WOS:000274590500008
J	Cerami, E; Demir, E; Schultz, N; Taylor, BS; Sander, C				Cerami, Ethan; Demir, Emek; Schultz, Nikolaus; Taylor, Barry S.; Sander, Chris			Automated Network Analysis Identifies Core Pathways in Glioblastoma	PLOS ONE			English	Article							INTEGRATED ANALYSIS; FUNCTIONAL MODULES; PROTEIN INTERACTIONS; PIKE-A; AMPLIFICATION; ORGANIZATION; TOPOLOGY; PATTERNS; REVEALS; GLIOMAS	Background: Glioblastoma multiforme (GBM) is the most common and aggressive type of brain tumor in humans and the first cancer with comprehensive genomic profiles mapped by The Cancer Genome Atlas (TCGA) project. A central challenge in large-scale genome projects, such as the TCGA GBM project, is the ability to distinguish cancer-causing "driver'' mutations from passively selected "passenger'' mutations. Principal Findings: In contrast to a purely frequency based approach to identifying driver mutations in cancer, we propose an automated network-based approach for identifying candidate oncogenic processes and driver genes. The approach is based on the hypothesis that cellular networks contain functional modules, and that tumors target specific modules critical to their growth. Key elements in the approach include combined analysis of sequence mutations and DNA copy number alterations; use of a unified molecular interaction network consisting of both protein-protein interactions and signaling pathways; and identification and statistical assessment of network modules, i.e. cohesive groups of genes of interest with a higher density of interactions within groups than between groups. Conclusions: We confirm and extend the observation that GBM alterations tend to occur within specific functional modules, in spite of considerable patient-to-patient variation, and that two of the largest modules involve signaling via p53, Rb, PI3K and receptor protein kinases. We also identify new candidate drivers in GBM, including AGAP2/CENTG1, a putative oncogene and an activator of the PI3K pathway; and, three additional significantly altered modules, including one involved in microtubule organization. To facilitate the application of our network-based approach to additional cancer types, we make the method freely available as part of a software tool called NetBox.	[Cerami, Ethan; Demir, Emek; Schultz, Nikolaus; Taylor, Barry S.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Cerami, Ethan] Tri Inst Training Program Computat Biol & Med, New York, NY USA	Memorial Sloan Kettering Cancer Center	Cerami, E (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, 1275 York Ave, New York, NY 10021 USA.	gbm-network@cbio.mskcc.org	Schultz, Nikolaus/ABE-6347-2020; Sander, Chris/H-1452-2011	Sander, Chris/0000-0001-6059-6270; Schultz, Nikolaus/0000-0002-0131-4904; Demir, Emek/0000-0002-3663-7113	National Cancer Institute [1R21CA135870-01, U24CA126543]; National Human Genome Research Institute [1P41HG004118-01A1]; Tri-Institutional Training Program; NATIONAL CANCER INSTITUTE [U24CA126543, R21CA135870] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004118] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Tri-Institutional Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Support for this work was provided by National Cancer Institute grants (1R21CA135870-01, A Computational Platform for Analyzing and Visualizing Integrated TCGA Data in the Context of Biological Pathways; and U24CA126543, TCGA Cancer Genome Characterization Center). Support for Pathway Commons and BioPAX tools was provided by an National Human Genome Research Institute grant (1P41HG004118-01A1, Pathway Commons: Research Resource For Biological Pathways). Additional support was provided by the Tri-Institutional Training Program in Computational Biology and Medicine. The National Institutes of Health did have a role in the study design and data collection of the original TCGA GBM study, but it and other funders had no role in the network analysis presented here, decision to publish, or preparation of the manuscript.	Ahn JY, 2004, P NATL ACAD SCI USA, V101, P6993, DOI 10.1073/pnas.0400921101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaschke C, 2001, COMP FUNCT GENOM, V2, P196, DOI 10.1002/cfg.91; Blom T, 2008, INT J CANCER, V123, P793, DOI 10.1002/ijc.23576; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Costello JF, 1997, CANCER RES, V57, P1250; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; DEMIR E, 2009, PAXTOOLS LIB ACCESSI; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Durek P, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-100; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gomes AL, 2007, CELL ONCOL, V29, P399; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HENSON JW, 1994, ANN NEUROL, V36, P714, DOI 10.1002/ana.410360505; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Holopainen T, 2009, CANCER RES, V69, P4656, DOI 10.1158/0008-5472.CAN-08-4654; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; JAMES CD, 1988, CANCER RES, V48, P5546; *JUNG, 2009, JUNG JAV UN NETW GRA; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Knobbe CB, 2005, NEUROPATH APPL NEURO, V31, P486, DOI 10.1111/j.1365-2990.2005.00660.x; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Liu X, 2007, ONCOGENE, V26, P4918, DOI 10.1038/sj.onc.1210290; Loffler H, 2006, EXP CELL RES, V312, P2633, DOI 10.1016/j.yexcr.2006.06.008; Lu HC, 2006, BIOCHEM BIOPH RES CO, V345, P302, DOI 10.1016/j.bbrc.2006.04.088; Marks PW, 1998, J CELL SCI, V111, P2129; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mischel PS, 2003, BRAIN PATHOL, V13, P52; *MSKCC, 2009, SIF INT RUL; *MSKCC, 2009, CBIO CANC GEN DAT PO; *NCT, 2009, TCGA DAT PORT; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pereira-Leal JB, 2004, PROTEINS, V54, P49, DOI 10.1002/prot.10505; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; REIFENBERGER G, 1994, CANCER RES, V54, P4299; Reis RM, 2005, CELL ONCOL, V27, P319; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; TORKAMANI A, 2009, GENOME RES; Velculescu VE, 2008, CARCINOGENESIS, V29, P1087, DOI 10.1093/carcin/bgn096; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Yamada T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-130; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001	59	256	264	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e8918	10.1371/journal.pone.0008918	http://dx.doi.org/10.1371/journal.pone.0008918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169195	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474600001
J	Ying, HY; Shen, X; Park, B; Yue, BYJT				Ying, Hongyu; Shen, Xiang; Park, BumChan; Yue, Beatrice Y. J. T.			Posttranslational Modifications, Localization, and Protein Interactions of Optineurin, the Product of a Glaucoma Gene	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NF-KAPPA-B; ENHANCER-BLOCKING ACTIVITY; RETINAL GANGLION-CELLS; TRABECULAR MESHWORK; MYOSIN-VI; IN-VITRO; INHIBITION; EXPRESSION; DISEASE	Background: Glaucoma is a major blinding disease. The most common form of this disease, primary open angle glaucoma (POAG), is genetically heterogeneous. One of the candidate genes, optineurin, is linked principally to normal tension glaucoma, a subtype of POAG. The present study was undertaken to illustrate the basic characteristics of optineurin. Methodology/Principal Findings: Lysates from rat retinal ganglion RGC5 cells were subjected to N- or O-deglycosylation or membrane protein extraction. The phosphorylation status was evaluated after immunoprecipitation. It was found that while phosphorylated, optineurin was neither N- nor O-glycosylated, and was by itself not a membrane protein. RGC5 and human retinal pigment epithelial cells were double stained with anti-optineurin and anti-GM130. The endogenous optineurin exhibited a diffuse, cytoplasmic distribution, but a population of the protein was associated with the Golgi apparatus. Turnover experiments showed that the endogenous optineurin was relatively short-lived, with a half-life of approximately 8 hours. Native blue gel electrophoresis revealed that the endogenous optineurin formed homohexamers. Optineurin also interacted with molecules including Rab8, myosin VI, and transferrin receptor to assemble into supermolecular complexes. When overexpressed, optineurin-green fluorescence protein (GFP) fusion protein formed punctate structures termed "foci'' in the perinuclear region. Treatment of nocadazole resulted in dispersion of the optineurin foci. In addition, tetracycline-regulated optineurin-GFPs expressing RGC5 stable cell lines were established for the first time. Conclusions/Significance: The present study provides new information regarding basic characteristics of optineurin that are important for future efforts in defining precisely how optineurin functions normally and how mutations may result in pathology. The inducible optineurin-GFP-expressing cell lines are also anticipated to facilitate in-depth studies of optineurin. Furthermore, the demonstrations that optineurin is an aggregation-prone protein and that the foci formation is microtubule-dependent bear similarities to features documented in neurodegenerative diseases, supporting a neurodegenerative paradigm for glaucoma.	[Ying, Hongyu; Shen, Xiang; Park, BumChan; Yue, Beatrice Y. J. T.] Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ying, HY (corresponding author), Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60680 USA.	beatyue@uic.edu			National Eye Institute [EY018828, EY005628, EY003890, EY01792]; National Institutes of Health; American Health Assistance Foundation; NATIONAL EYE INSTITUTE [R01EY003890, R01EY005628, R01EY018828, P30EY001792] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants EY018828, EY005628, and EY003890 (to B.Y.J.T.Y.); by Core Grant EY01792 from the National Eye Institute, National Institutes of Health (www.nei.nih.gov; Bethesda, Maryland); and by a grant from the American Health Assistance Foundation (www.ahaf.org; Clarksburg, Maryland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Arnaud L, 2006, NEURODEGENER DIS, V3, P313, DOI 10.1159/000095638; Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; Aung T, 2005, INVEST OPHTH VIS SCI, V46, P2816, DOI 10.1167/iovs.04-1133; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chalasani ML, 2008, EXP EYE RES, V87, P1, DOI 10.1016/j.exer.2007.10.021; Chibalina MV, 2008, METHOD ENZYMOL, V438, P11, DOI 10.1016/S0076-6879(07)38002-6; Choi J, 2005, INVEST OPHTH VIS SCI, V46, P214, DOI 10.1167/iovs.04-0765; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Fan BJ, 2006, CLIN BIOCHEM, V39, P249, DOI 10.1016/j.clinbiochem.2005.11.001; Franch HA, 2001, J BIOL CHEM, V276, P19126, DOI 10.1074/jbc.M101777200; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; Fu NY, 2007, P NATL ACAD SCI USA, V104, P10051, DOI 10.1073/pnas.0700007104; Gallagher PG, 2009, BLOOD, V113, P1547, DOI 10.1182/blood-2008-06-164954; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; HANAWA H, 2009, MOL THER; Harvey R, 2007, INVEST OPHTH VIS SCI, V48, P1884, DOI 10.1167/iovs.06-0990; Hashimoto M, 2004, J MOL NEUROSCI, V24, P343, DOI 10.1385/JMN:24:3:343; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Hauser MA, 2006, J GLAUCOMA, V15, P358, DOI 10.1097/01.ijg.0000212255.17950.42; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kroeber M, 2006, EXP EYE RES, V82, P1075, DOI 10.1016/j.exer.2005.11.004; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; McKinnon SJ, 2003, FRONT BIOSCI-LANDMRK, V8, pS1140, DOI 10.2741/1172; Moreland RJ, 2000, NUCLEIC ACIDS RES, V28, P1986, DOI 10.1093/nar/28.9.1986; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Obazawa M, 2004, INVEST OPHTH VIS SCI, V45, P2652, DOI 10.1167/iovs.03-0572; Park BC, 2007, GENES CELLS, V12, P969, DOI 10.1111/j.1365-2443.2007.01102.x; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Pradere JP, 2007, BBA-MOL CELL BIOL L, V1771, P93, DOI 10.1016/j.bbalip.2006.11.010; Recillas-Targa F, 1999, P NATL ACAD SCI USA, V96, P14354, DOI 10.1073/pnas.96.25.14354; Rezaie T, 2005, GENOMICS, V85, P131, DOI 10.1016/j.ygeno.2004.10.011; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Schwechter BR, 2007, INVEST OPHTH VIS SCI, V48, P2845, DOI 10.1167/iovs.06-1364; SPIRO RG, 1974, J BIOL CHEM, V249, P5704; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; TAYLOR CR, 1994, HUM PATHOL, V25, P263, DOI 10.1016/0046-8177(94)90198-8; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Yang C, 2009, INVEST OPHTH VIS SCI, V50, P1290, DOI 10.1167/iovs.08-1920; Zhou B, 2004, FEBS LETT, V576, P401, DOI 10.1016/j.febslet.2004.09.039; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	55	47	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9168	10.1371/journal.pone.0009168	http://dx.doi.org/10.1371/journal.pone.0009168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161783	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442800014
J	Jee, MK; Kim, JH; Han, YM; Jung, SJ; Kang, KS; Kim, DW; Kang, SK				Jee, Min Ki; Kim, Ji Hoon; Han, Yong Man; Jung, Sung Jun; Kang, Kyung Sun; Kim, Dong Wook; Kang, Soo Kyung			DHP-Derivative and Low Oxygen Tension Effectively Induces Human Adipose Stromal Cell Reprogramming	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; RADIAL GLIA; STEM-CELL; CEREBRAL-ISCHEMIA; PLANT-CELLS; ADULT-RATS; DEDIFFERENTIATION; PLASTICITY; TRANSFORMATION; IMPROVEMENT	Background and Methods: In this study, we utilized a combination of low oxygen tension and a novel anti-oxidant, 4-(3,4-dihydroxy- phenyl)-derivative (DHP-d) to directly induce adipose tissue stromal cells (ATSC) to de-differentiate into more primitive stem cells. De-differentiated ATSCs was overexpress stemness genes, Rex-1, Oct-4, Sox-2, and Nanog. Additionally, demethylation of the regulatory regions of Rex-1, stemnesses, and HIF1 alpha and scavenging of reactive oxygen species were finally resulted in an improved stem cell behavior of de-differentiate ATSC (de-ATSC). Proliferation activity of ATSCs after dedifferentiation was induced by REX1, Oct4, and JAK/STAT3 directly or indirectly. De-ATSCs showed increased migration activity that mediated by P38/JUNK and ERK phosphorylation. Moreover, regenerative efficacy of de-ATSC engrafted spinal cord-injured rats and chemical-induced diabetes animals were significantly restored their functions. Conclusions/Significance: Our stem cell remodeling system may provide a good model which would provide insight into the molecular mechanisms underlying ATSC proliferation and transdifferentiation. Also, these multipotent stem cells can be harvested may provide us with a valuable reservoir of primitive and autologous stem cells for use in a broad spectrum of regenerative cell-based disease therapy.	[Jee, Min Ki; Kang, Soo Kyung] Seoul Natl Univ, Coll Vet Med, Dept Biotechnol, Seoul, South Korea; [Kim, Ji Hoon; Han, Yong Man] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kang, Kyung Sun] Seoul Natl Univ, Coll Vet Med, Dept Vet Publ Hlth, Lab Stem Cell & Tumor Biol, Seoul, South Korea; [Kim, Dong Wook] Yonsei Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Jung, Sung Jun] Han Yang Univ, Coll Med, Dept Physiol, Seoul, South Korea	Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Yonsei University; Yonsei University Health System; Hanyang University	Jee, MK (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Biotechnol, Seoul, South Korea.	sookang@snu.ac.kr	Han, Yong-Mahn/C-1652-2011	Dong-Wook, Kim/0000-0002-5025-1532	21st Century Frontier/Stem Cell Research Committee [SC5110, SC5112]; Korean Science and Engineering Foundation; South Korean government [M10841000109-08N4100-10910]	21st Century Frontier/Stem Cell Research Committee; Korean Science and Engineering Foundation(Korea Science and Engineering Foundation); South Korean government(Korean Government)	This work was supported by the 21st Century Frontier/Stem Cell Research Committee (SC5110, SC5112) and was also supported by a Korean Science and Engineering Foundation grant funded by the South Korean government (MOST, No. M10841000109-08N4100-10910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2004, INT J RADIAT BIOL, V80, P483, DOI 10.1080/09553000410001725107; Alves JAJ, 2002, J NEUROBIOL, V52, P251, DOI 10.1002/neu.10087; Avivi Y, 2004, DEV DYNAM, V230, P12, DOI 10.1002/dvdy.20006; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Goodell MA, 2003, CURR OPIN HEMATOL, V10, P208, DOI 10.1097/00062752-200305000-00003; Grafi G, 2004, DEV BIOL, V268, P1, DOI 10.1016/j.ydbio.2003.12.027; Grafi G, 2007, DEV BIOL, V306, P838, DOI 10.1016/j.ydbio.2007.03.023; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; HATTEN ME, 1984, DEV BRAIN RES, V13, P309, DOI 10.1016/0165-3806(84)90166-4; HUNTER KE, 1995, P NATL ACAD SCI USA, V92, P2061, DOI 10.1073/pnas.92.6.2061; Huttmann K, 2003, EUR J NEUROSCI, V18, P2769, DOI 10.1111/j.1460-9568.2003.03002.x; Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X; Kang SK, 2004, J CELL SCI, V117, P4289, DOI 10.1242/jcs.01264; Kang SK, 2006, PROTEOMICS, V6, P2797, DOI 10.1002/pmic.200500621; Kim JH, 2008, STEM CELLS, V26, P2724, DOI 10.1634/stemcells.2008-0184; Lennmyr F, 2002, ACTA NEUROL SCAND, V106, P333, DOI 10.1034/j.1600-0404.2002.01313.x; Ng DCH, 2000, J BIOL CHEM, V275, P40856, DOI 10.1074/jbc.M004639200; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; ROSEN GD, 1994, DEV BRAIN RES, V82, P127, DOI 10.1016/0165-3806(94)90155-4; ROSEN GD, 1992, J NEUROPATH EXP NEUR, V51, P601, DOI 10.1097/00005072-199211000-00005; Shibuya S, 2002, NEUROSCIENCE, V114, P905, DOI 10.1016/S0306-4522(02)00323-8; TAKEBE I, 1971, NATURWISSENSCHAFTEN, V58, P318, DOI 10.1007/BF00624737; Valente P, 1998, PLANT SCI, V134, P207, DOI 10.1016/S0168-9452(98)00062-4; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Yaccoby S, 2005, CLIN CANCER RES, V11, P7599, DOI 10.1158/1078-0432.CCR-05-0523; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200	32	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9026	10.1371/journal.pone.0009026	http://dx.doi.org/10.1371/journal.pone.0009026			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161735	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442600001
J	de Barros, APDN; Takiya, CM; Garzoni, LR; Leal-Ferreira, ML; Dutra, HS; Chiarini, LB; Meirelles, MN; Borojevic, R; Rossi, MID				de Barros, Ana Paula D. N.; Takiya, Christina M.; Garzoni, Luciana R.; Leal-Ferreira, Mona Lisa; Dutra, Helio S.; Chiarini, Luciana B.; Meirelles, Maria Nazareth; Borojevic, Radovan; Rossi, Maria Isabel D.			Osteoblasts and Bone Marrow Mesenchymal Stromal Cells Control Hematopoietic Stem Cell Migration and Proliferation in 3D In Vitro Model	PLOS ONE			English	Article							PROGENITOR CELLS; NICHE; MICROENVIRONMENT; HYPOXIA; BLOOD; OSTEOPONTIN; MAINTENANCE; TRAFFICKING; COMPONENT; SYSTEM	Background: Migration, proliferation, and differentiation of hematopoietic stem cells (HSCs) are dependent upon a complex three-dimensional (3D) bone marrow microenvironment. Although osteoblasts control the HSC pool, the subendosteal niche is complex and its cellular composition and the role of each cell population in HSC fate have not been established. In vivo models are complex and involve subtle species-specific differences, while bidimensional cultures do not reflect the 3D tissue organization. The aim of this study was to investigate in vitro the role of human bone marrow-derived mesenchymal stromal cells (BMSC) and active osteoblasts in control of migration, lodgment, and proliferation of HSCs. Methodology/Principal Findings: A complex mixed multicellular spheroid in vitro model was developed with human BMSC, undifferentiated or induced for one week into osteoblasts. A clear limit between the two stromal cells was established, and deposition of extracellular matrix proteins fibronectin, collagens I and IV, laminin, and osteopontin was similar to the observed in vivo. Noninduced BMSC cultured as spheroid expressed higher levels of mRNA for the chemokine CXCL12, and the growth factors Wnt5a and Kit ligand. Cord blood and bone marrow CD34(+) cells moved in and out the spheroids, and some lodged at the interface of the two stromal cells. Myeloid colony-forming cells were maintained after seven days of coculture with mixed spheroids, and the frequency of cycling CD34(+) cells was decreased. Conclusions/Significance: Undifferentiated and one-week osteo-induced BMSC self-assembled in a 3D spheroid and formed a microenvironment that is informative for hematopoietic progenitor cells, allowing their lodgment and controlling their proliferation.	[de Barros, Ana Paula D. N.; Takiya, Christina M.; Dutra, Helio S.; Borojevic, Radovan; Rossi, Maria Isabel D.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil; [Garzoni, Luciana R.; Meirelles, Maria Nazareth] Inst Oswaldo Cruz, Dept Ultrastruct & Biol Celular, BR-20001 Rio De Janeiro, Brazil; [Leal-Ferreira, Mona Lisa; Chiarini, Luciana B.] Univ Fed Rio de Janeiro, Inst Biofis, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	de Barros, APDN (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.	idrossi@hucff.ufrj.br	Rossi, Maria Isabel D/J-4802-2012; Takiya, Christina/AAU-5959-2021; Borojevic, Radovan/V-8500-2019; Chiarini, Luciana B/J-3644-2015	Rossi, Maria Isabel D/0000-0003-3432-8453; Takiya, Christina/0000-0002-8019-628X; Borojevic, Radovan/0000-0002-2393-7280; 	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Pesquisa; Coordenacao de Aperfeicaoamento de Pessoal de Nivel Superior; Associacao e Programa de Biologia Celular Aplicada a Medicina	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Pesquisa; Coordenacao de Aperfeicaoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Associacao e Programa de Biologia Celular Aplicada a Medicina	Funding: This work was supported by grants of the Brazilian agencies Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Pesquisa, Coordenacao de Aperfeicaoamento de Pessoal de Nivel Superior, and Associacao e Programa de Biologia Celular Aplicada a Medicina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Askenasy N, 2003, BRIT J HAEMATOL, V120, P505, DOI 10.1046/j.1365-2141.2003.04114.x; Askmyr M, 2009, TRENDS ENDOCRIN MET, V20, P303, DOI 10.1016/j.tem.2009.03.004; Balduino A, 2005, CELL TISSUE RES, V319, P255, DOI 10.1007/s00441-004-1006-3; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Bug G, 2002, J LEUKOCYTE BIOL, V72, P837; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; deCarvalho HF, 1996, HISTOCHEM CELL BIOL, V106, P587, DOI 10.1007/s004180050080; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; Garzoni LR, 2009, EXP CELL RES, V315, P3406, DOI 10.1016/j.yexcr.2009.09.016; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Kalajzic Z, 2008, BONE, V43, P501, DOI 10.1016/j.bone.2008.04.023; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Kunz-Schughart LA, 2001, EXP CELL RES, V266, P74, DOI 10.1006/excr.2001.5210; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Larsson J, 2008, CELL STEM CELL, V3, P221, DOI 10.1016/j.stem.2008.06.005; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mendes SC, 2005, DEVELOPMENT, V132, P1127, DOI 10.1242/dev.01615; Miura Y, 2006, STEM CELLS, V24, P2428, DOI 10.1634/stemcells.2006-0089; Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311; Nilsson SK, 2006, EXP HEMATOL, V34, P123, DOI 10.1016/j.exphem.2005.08.006; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Remy-Martin JP, 1999, EXP HEMATOL, V27, P1782, DOI 10.1016/S0301-472X(99)00122-8; Rogers HM, 2008, EXP HEMATOL, V36, P17, DOI 10.1016/j.exphem.2007.08.014; Rossi MID, 2001, J IMMUNOL, V167, P3033, DOI 10.4049/jimmunol.167.6.3033; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; SKAWINA A, 1994, J ANAT, V185, P369; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Timmins Nicholas E., 2004, Angiogenesis, V7, P97, DOI 10.1007/s10456-004-8911-7; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; WEISS L, 1976, ANAT RECORD, V186, P161, DOI 10.1002/ar.1091860204; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yao LB, 2005, BLOOD, V106, P4093, DOI 10.1182/blood-2005-02-0671; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	65	77	79	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9093	10.1371/journal.pone.0009093	http://dx.doi.org/10.1371/journal.pone.0009093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161704	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442500005
J	Layden, BT; Newman, M; Chen, F; Fisher, A; Lowe, WL				Layden, Brian T.; Newman, Marsha; Chen, Fei; Fisher, Amanda; Lowe, William L., Jr.			G Protein Coupled Receptors in Embryonic Stem Cells: A Role for Gs-Alpha Signaling	PLOS ONE			English	Article							SELF-RENEWAL; DIFFERENTIATION; GROWTH; PROLIFERATION; PROGENITORS; EXPRESSION; MEDICINE; BIOLOGY; MODELS	Background: Identification of receptor mediated signaling pathways in embryonic stem (ES) cells is needed to facilitate strategies for cell replacement using ES cells. One large receptor family, largely uninvestigated in ES cells, is G protein coupled receptors (GPCRs). An important role for these receptors in embryonic development has been described, but little is known about GPCR expression in ES cells. Methodology/Principal Findings: We have examined the expression profile of 343 different GPCRs in mouse ES cells demonstrating for the first time that a large number of GPCRs are expressed in undifferentiated and differentiating ES cells, and in many cases at high levels. To begin to define a role for GPCR signaling in ES cells, the impact of activating Gs-alpha, one of the major alpha subunits that couples to GPCRs, was investigated. Gs-alpha activation resulted in larger embryoid bodies (EBs), due, in part, to increased cell proliferation and prevented the time-related decline in expression of transcription factors important for maintaining ES cell pluripotency. Significance/Conclusions: These studies suggest that Gs-alpha signaling contributes to ES cell proliferation and pluripotency and provide a framework for further investigation of GPCRs in ES cells.	[Layden, Brian T.; Newman, Marsha; Chen, Fei; Fisher, Amanda; Lowe, William L., Jr.] Northwestern Univ, Dept Med, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Layden, BT (corresponding author), Northwestern Univ, Dept Med, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA.	wlowe@northwestern.edu			Butz Foundation; Northwestern Memorial Foundation	Butz Foundation; Northwestern Memorial Foundation	Funding: This work was supported by grants from the Butz Foundation and Northwestern Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams G.B., 2009, NATURE; Anisimov SV, 2002, GENOMICS, V79, P169, DOI 10.1006/geno.2002.6687; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI [10.1002/0471142727.mb2303s51, 10.1002/0471142727.mb2302s51]; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Faherty S, 2007, IN VITRO CELL DEV-AN, V43, P37, DOI 10.1007/s11626-006-9001-5; Feng GS, 2007, CELL RES, V17, P37, DOI 10.1038/sj.cr.7310140; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Hamm HE, 1996, CURR OPIN CELL BIOL, V8, P189, DOI 10.1016/S0955-0674(96)80065-2; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Matteson PG, 2008, P NATL ACAD SCI USA, V105, P2088, DOI 10.1073/pnas.0705657105; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Okoye Ujunwa C, 2008, J Mol Signal, V3, P16, DOI 10.1186/1750-2187-3-16; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Trounson A, 2007, CURR OPIN BIOTECH, V18, P432, DOI 10.1016/j.copbio.2007.10.003; Wang X, 2008, J VIS EXP; Weinstein LS, 2007, PHARMACOL THERAPEUT, V115, P271, DOI 10.1016/j.pharmthera.2007.03.013; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zeng XXI, 2007, DEV CELL, V12, P391, DOI 10.1016/j.devcel.2007.01.011	35	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9105	10.1371/journal.pone.0009105	http://dx.doi.org/10.1371/journal.pone.0009105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161705	gold, Green Submitted, Green Published			2022-12-25	WOS:000274442500012
J	Romanenko, VG; Catalan, MA; Brown, DA; Putzier, I; Hartzell, HC; Marmorstein, AD; Gonzalez-Begne, M; Rock, JR; Harfe, BD; Melvin, JE				Romanenko, Victor G.; Catalan, Marcelo A.; Brown, David A.; Putzier, Ilva; Hartzell, H. Criss; Marmorstein, Alan D.; Gonzalez-Begne, Mireya; Rock, Jason R.; Harfe, Brian D.; Melvin, James E.			Tmem16A Encodes the Ca2+-activated Cl- Channel in Mouse Submandibular Salivary Gland Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CHLORIDE CHANNEL; REGULATED ANION CHANNELS; FLUID SECRETION; PROTEIN-KINASE; DUCT CELLS; FAMILY; BESTROPHIN; CONDUCTANCE; EXPRESSION; VOLUME	Activation of an apical Ca2+-dependent Cl- channel (CaCC) is the rate-limiting step for fluid secretion in many exocrine tissues. Here, we compared the properties of native CaCC in mouse submandibular salivary gland acinar cells to the Ca2+-gated Cl- currents generated by Tmem16A and Best2, members from two distinct families of Ca2+-activated Cl-channels found in salivary glands. Heterologous expression of Tmem16A and Best2 transcripts in HEK293 cells produced Ca2+-activated Cl-currents with time and voltage dependence and inhibitor sensitivity that resembled the Ca2+-activated Cl- current found in native salivary acinar cells. Best2(-/-) and Tmem16A(-/-) mice were used to further characterize the role of these channels in the exocrine salivary gland. The amplitude and the biophysical footprint of the Ca2+-activated Cl- current in submandibular gland acinar cells from Best2-deficient mice were the same as in wild type cells. Consistent with this observation, the fluid secretion rate in Best2 null mice was comparable with that in wild type mice. In contrast, submandibular gland acinar cells from Tmem16A(-/-) mice lacked a Ca2+-activated Cl-current and a Ca2+-mobilizing agonist failed to stimulate Cl-efflux, requirements for fluid secretion. Furthermore, saliva secretion was abolished by the CaCC inhibitor niflumic acid in wild type and Best2(-/-) mice. Our results demonstrate that both Tmem16A and Best2 generate Ca2+-activated Cl-current in vitro with similar properties to those expressed in native cells, yet only Tmem16A appears to be a critical component of the acinar Ca2+-activated Cl- channel complex that is essential for saliva production by the submandibular gland.	[Melvin, James E.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Gonzalez-Begne, Mireya] Univ Rochester, Ctr Oral Biol, Rochester, NY 14642 USA; [Putzier, Ilva; Hartzell, H. Criss; Melvin, James E.] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Marmorstein, Alan D.] Univ Arizona, Coll Opt Sci, Tucson, AZ 85711 USA; [Marmorstein, Alan D.] Univ Arizona, Dept Ophthalmol & Vis Sci, Tucson, AZ 85711 USA; [Rock, Jason R.; Harfe, Brian D.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA	University of Rochester; University of Rochester; Emory University; University of Arizona; University of Arizona; State University System of Florida; University of Florida	Melvin, JE (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Box 711,601 Elmwood Ave, Rochester, NY 14642 USA.	james_melvin@urmc.rochester.edu	Catalan, Marcelo/ABE-7044-2021; Catalan, Marcelo/AAW-3848-2020	Catalan, Marcelo/0000-0003-3544-2821	National Institutes of Health [DE09692, DE08921, GM060448, EY13160]; Macular Vision Research Foundation; NIDCR [DE07202]; NATIONAL EYE INSTITUTE [R01EY014852, R56EY013160, R01EY013160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE008921, ZIADE000738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE008921, T32DE007202, R01DE009692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macular Vision Research Foundation; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DE09692 and DE08921 (to J. E. M.), GM060448 (to H. C. H.), and EY13160 (to A. D. M.). This work was also supported by the Macular Vision Research Foundation (to A. D. M.) and an unrestricted grant to the Department of Ophthalmology and Vision Science at the University of Arizona from Research to Prevent Blindness (to A. D. M.).; Supported by National Institutes of Health Training Grant DE07202 from NIDCR (to J. E. M.)	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; Bakall B, 2008, INVEST OPHTH VIS SCI, V49, P1563, DOI 10.1167/iovs.07-1338; Brown DA, 2007, BBA-MOL CELL RES, V1773, P166, DOI 10.1016/j.bbamcr.2006.09.020; Bullard T, 2008, DEV BIOL, V320, P72, DOI 10.1016/j.ydbio.2008.04.018; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Catalan MA, 2010, J PHYSIOL-LONDON, V588, P713, DOI 10.1113/jphysiol.2009.183541; COOK DIV, 1994, SECRETION MAJOR SALI, P1061; Droogmans G, 1999, BRIT J PHARMACOL, V128, P35, DOI 10.1038/sj.bjp.0702770; Duta V, 2004, FEBS LETT, V577, P551, DOI 10.1016/j.febslet.2004.10.068; Duta V, 2006, J MEMBRANE BIOL, V213, P165, DOI 10.1007/s00232-006-0062-x; Eggermont J, 2001, CELL BIOCHEM BIOPHYS, V35, P263, DOI 10.1385/CBB:35:3:263; EVANS MG, 1986, J PHYSIOL-LONDON, V378, P437, DOI 10.1113/jphysiol.1986.sp016229; FOSKETT JK, 1990, AM J PHYSIOL, V259, pC998; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Gruber AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1261; HANCOCK AA, 1988, TRENDS PHARMACOL SCI, V9, P29, DOI 10.1016/0165-6147(88)90239-8; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; HILLE B, 1992, IONIC CHANNELS EXCIT, P344; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Ishikawa T, 1996, J MEMBRANE BIOL, V153, P147, DOI 10.1007/s002329900118; Kramer F, 2004, CYTOGENET GENOME RES, V105, P107, DOI 10.1159/000078016; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; Lee MG, 1999, J BIOL CHEM, V274, P14670, DOI 10.1074/jbc.274.21.14670; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Nakamoto T, 2008, AM J PHYSIOL-CELL PH, V294, pC810, DOI 10.1152/ajpcell.00511.2007; Nakamoto T, 2007, AM J PHYSIOL-REG I, V292, pR2380, DOI 10.1152/ajpregu.00591.2006; Nakamoto T, 2009, J BIOL CHEM, V284, P4815, DOI 10.1074/jbc.M808597200; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Qiang Z, 2007, J BIOL CHEM, V282, P17460, DOI 10.1074/jbc.M701043200; Qu ZQ, 2008, AM J PHYSIOL-CELL PH, V294, pC1371, DOI 10.1152/ajpcell.00398.2007; Qu ZQ, 2006, J NEUROSCI, V26, P5411, DOI 10.1523/JNEUROSCI.5500-05.2006; Qu ZQ, 2006, FEBS LETT, V580, P2141, DOI 10.1016/j.febslet.2006.03.025; Qu ZQ, 2004, J GEN PHYSIOL, V124, P371, DOI 10.1085/jgp.200409108; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Rock JR, 2008, DEV DYNAM, V237, P2566, DOI 10.1002/dvdy.21676; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Romanenko VG, 2008, AM J PHYSIOL-GASTR L, V295, pG1058, DOI 10.1152/ajpgi.90384.2008; Romanenko VG, 2007, J PHYSIOL-LONDON, V581, P801, DOI 10.1113/jphysiol.2006.127498; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Soria RB, 2009, J BIOL CHEM, V284, P29405, DOI 10.1074/jbc.M605716200; Srivastava A, 2008, J MEMBRANE BIOL, V222, P43, DOI 10.1007/s00232-008-9098-4; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Stohr H, 2002, EUR J HUM GENET, V10, P281, DOI 10.1038/sj.ejhg.5200796; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Suzuki M, 2006, CELL MOL LIFE SCI, V63, P12, DOI 10.1007/s00018-005-5336-4; Suzuki M, 2004, J BIOL CHEM, V279, P22461, DOI 10.1074/jbc.M313813200; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zeng WZ, 1997, J BIOL CHEM, V272, P32956, DOI 10.1074/jbc.272.52.32956; Zeng WZ, 1997, AM J PHYSIOL-CELL PH, V273, pC442, DOI 10.1152/ajpcell.1997.273.2.C442	56	148	152	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12990	13001		10.1074/jbc.M109.068544	http://dx.doi.org/10.1074/jbc.M109.068544			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177062	Green Published, hybrid			2022-12-25	WOS:000276787800057
J	Taylor, AH; Medina, FS; Holzhaider, JC; Hearne, LJ; Hunt, GR; Gray, RD				Taylor, Alex H.; Medina, Felipe S.; Holzhaider, Jennifer C.; Hearne, Lindsay J.; Hunt, Gavin R.; Gray, Russell D.			An Investigation into the Cognition Behind Spontaneous String Pulling in New Caledonian Crows	PLOS ONE			English	Article							BIRDS; PASSERIFORMES; MANUFACTURE; RAVENS; BRAIN; TOOLS	The ability of some bird species to pull up meat hung on a string is a famous example of spontaneous animal problem solving. The "insight'' hypothesis claims that this complex behaviour is based on cognitive abilities such as mental scenario building and imagination. An operant conditioning account, in contrast, would claim that this spontaneity is due to each action in string pulling being reinforced by the meat moving closer and remaining closer to the bird on the perch. We presented experienced and naive New Caledonian crows with a novel, visually restricted string-pulling problem that reduced the quality of visual feedback during string pulling. Experienced crows solved this problem with reduced efficiency and increased errors compared to their performance in standard string pulling. Naive crows either failed or solved the problem by trial and error learning. However, when visual feedback was available via a mirror mounted next to the apparatus, two naive crows were able to perform at the same level as the experienced group. Our results raise the possibility that spontaneous string pulling in New Caledonian crows may not be based on insight but on operant conditioning mediated by a perceptual-motor feedback cycle.	[Taylor, Alex H.; Medina, Felipe S.; Holzhaider, Jennifer C.; Hearne, Lindsay J.; Hunt, Gavin R.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland, New Zealand	University of Auckland	Taylor, AH (corresponding author), Univ Auckland, Dept Psychol, Auckland, New Zealand.	alexhtaylor@gmail.com; rd.gray@auckland.ac.nz	Gray, Russell/H-2078-2015; Taylor, Alex H/D-6428-2012	Gray, Russell/0000-0002-9858-0191; Taylor, Alex/0000-0003-3492-7667	Commonwealth Doctoral Scholarship; CONCICYT [26080006]; New Zealand Marsden Fund	Commonwealth Doctoral Scholarship; CONCICYT; New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	The work was supported by a Commonwealth Doctoral Scholarship (A.H.T.), CONCICYT 26080006 (F. M.) and a grant from the New Zealand Marsden Fund (G.R.H. and R.D.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN DR, 1962, AM J PSYCHOL, V75, P144, DOI 10.2307/1419554; DUCKER G, 1977, BEHAVIOUR, V62, P164, DOI 10.1163/156853977X00081; Emery Nathan J., 2004, P3; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Gibbs R., 2006, EMBODIMENT COGNITIVE; Hauser MD, 1997, COGNITION, V64, P285, DOI 10.1016/S0010-0277(97)00028-0; Heinrich B, 2005, ETHOLOGY, V111, P962, DOI 10.1111/j.1439-0310.2005.01133.x; Heinrich B, 1995, AUK, V112, P994, DOI 10.2307/4089030; Heinrich Bernd, 2000, P289; Hunt GR, 2000, P ROY SOC B-BIOL SCI, V267, P403, DOI 10.1098/rspb.2000.1015; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; KIRSH D, 1994, COGNITIVE SCI, V18, P513, DOI 10.1207/s15516709cog1804_1; KOHLER W, 1959, AM PSYCHOL, V14, P727; Osthaus B, 2005, ANIM COGN, V8, P37, DOI 10.1007/s10071-004-0230-2; Pepperberg IM, 2004, ANIM COGN, V7, P263, DOI 10.1007/s10071-004-0218-y; Perrins C., 1994, HDB BIRDS MIDDLE E N, V8; Piaget J., 1936, NAISSANCE INTELLIGEN; Plinius C., 1554, HIST MUNDI LIBRI 37, VXXXVII; REHKAMPER G, 1991, BRAIN BEHAV EVOLUT, V37, P125, DOI 10.1159/000114353; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Seibt U, 2006, ETHOLOGY, V112, P493, DOI 10.1111/j.1439-0310.2005.01172.x; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; Taylor Alex, 2009, Communicative & Integrative Biology, V2, P311; Taylor AH, 2007, CURR BIOL, V17, P1504, DOI 10.1016/j.cub.2007.07.057; VINCE M. A., 1961, BEHAVIOUR, V17, P103, DOI 10.1163/156853961X00033; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Weir AAS, 2006, ANIM COGN, V9, P317, DOI 10.1007/s10071-006-0052-5; Werdenich D, 2006, ANIM BEHAV, V71, P855, DOI 10.1016/j.anbehav.2005.06.018; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322	29	81	81	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9345	10.1371/journal.pone.0009345	http://dx.doi.org/10.1371/journal.pone.0009345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560SU	20179759	gold, Green Published, Green Submitted			2022-12-25	WOS:000274923900011
J	Solovey, G; Dawson, SP				Solovey, Guillermo; Dawson, Silvina Ponce			Intra-Cluster Percolation of Calcium Signals	PLOS ONE			English	Article							INOSITOL TRISPHOSPHATE; IP3 RECEPTORS; CA2+ RELEASE; SINGLE; OSCILLATIONS; MODEL; PUFFS; MODULATION; DYNAMICS; BUFFERS	Calcium signals are involved in a large variety of physiological processes. Their versatility relies on the diversity of spatio-temporal behaviors that the calcium concentration can display. Calcium entry through inositol 1,4,5-trisphosphate (IP3) receptors (IP3R's) is a key component that participates in both local signals such as "puffs'' and in global waves. IP3R's are usually organized in clusters on the membrane of the endoplasmic reticulum and their spatial distribution has important effects on the resulting signal. Recent high resolution observations [1] of Ca2+ puffs offer a window to study intra-cluster organization. The experiments give the distribution of the number of IP3R's that open during each puff without much processing. Here we present a simple model with which we interpret the experimental distribution in terms of two stochastic processes: IP3 binding and unbinding and Ca2+-mediated inter-channel coupling. Depending on the parameters of the system, the distribution may be dominated by one or the other process. The transition between both extreme cases is similar to a percolation process. We show how, from an analysis of the experimental distribution, information can be obtained on the relative weight of the two processes. The largest distance over which Ca2+-mediated coupling acts and the density of IP3-bound IP3R's of the cluster can also be estimated. The approach allows us to infer properties of the interactions among the channels of the cluster from statistical information on their emergent collective behavior.	[Solovey, Guillermo; Dawson, Silvina Ponce] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina	University of Buenos Aires	Solovey, G (corresponding author), Rockefeller Univ, Phys Math Lab, 1230 York Ave, New York, NY 10021 USA.	gsolovey@df.uba.ar		Ponce Dawson, Silvina/0000-0001-6550-4267	Proyecto de Investigacion Cientifica y Tecnologica (PICT) [17-21001]; Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT]; Proyecto de Investigacion Plurianual (PIP) [112-200801-01612]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Proyecto de Investigacion Cientifica y Tecnologica (PICT)(ANPCyT); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Proyecto de Investigacion Plurianual (PIP); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Proyecto de Investigacion Cientifica y Tecnologica (PICT) 17-21001 granted by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, http://www.agencia.gov.ar/), and by Proyecto de Investigacion Plurianual (PIP) 112-200801-01612 granted by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) UBA (http://www.uba.ar/secyt/subsidios/index.php), Santa Fe Institute (http://www.santafe.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Bar M, 2000, PHYS REV LETT, V84, P5664, DOI 10.1103/PhysRevLett.84.5664; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bootman MD, 1997, CELL, V91, P367, DOI 10.1016/S0092-8674(00)80420-1; BRUNO L, 2009, CELL CALCIU IN PRESS; Bugrim AE, 1997, BIOPHYS J, V73, P2897, DOI 10.1016/S0006-3495(97)78318-8; Callamaras N, 1998, J PHYSIOL-LONDON, V509, P81, DOI 10.1111/j.1469-7793.1998.081bo.x; Dawson SP, 1999, P NATL ACAD SCI USA, V96, P6060, DOI 10.1073/pnas.96.11.6060; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Falcke M, 2003, BIOPHYS J, V84, P28, DOI 10.1016/S0006-3495(03)74830-9; Falcke M, 2003, BIOPHYS J, V84, P42, DOI 10.1016/S0006-3495(03)74831-0; Falcke M, 2009, CHAOS, V19, DOI 10.1063/1.3234259; Fraiman D, 2004, CELL CALCIUM, V35, P403, DOI 10.1016/j.ceca.2003.10.004; Fraiman D, 2006, BIOPHYS J, V90, P3897, DOI 10.1529/biophysj.105.075911; Parker I, 1996, J PHYSIOL-LONDON, V491, P663, DOI 10.1113/jphysiol.1996.sp021247; Pencea CS, 2000, PHYS REV E, V62, P8420, DOI 10.1103/PhysRevE.62.8420; Perc M, 2006, CHEM PHYS LETT, V421, P106, DOI 10.1016/j.cplett.2006.01.065; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; Perc M, 2007, CHEM PHYS LETT, V437, P143, DOI 10.1016/j.cplett.2007.02.003; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Shuai J W, 2002, Phys Rev Lett, V88, P068102; Shuai JW, 2008, BIOPHYS J, V95, P3738, DOI 10.1529/biophysj.108.137182; Shuai JW, 2007, BIOPHYS J, V93, P1151, DOI 10.1529/biophysj.107.108795; Shuai JW, 2006, BIOPHYS J, V91, P4033, DOI 10.1529/biophysj.106.088880; Shuai JW, 2003, P NATL ACAD SCI USA, V100, P506, DOI 10.1073/pnas.0236032100; Skupin A, 2008, BIOPHYS J, V94, P2404, DOI 10.1529/biophysj.107.119495; Smith IF, 2009, P NATL ACAD SCI USA, V106, P6404, DOI 10.1073/pnas.0810799106; Smith IF, 2009, CELL CALCIUM, V45, P65, DOI 10.1016/j.ceca.2008.06.001; Sun XP, 1998, J PHYSIOL-LONDON, V509, P67, DOI 10.1111/j.1469-7793.1998.067bo.x; Swillens S, 1999, P NATL ACAD SCI USA, V96, P13750, DOI 10.1073/pnas.96.24.13750; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Timofeeva Y, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.062901; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538; Zeller S, 2009, BIOPHYS J, V97, P992, DOI 10.1016/j.bpj.2009.05.050	34	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e8997	10.1371/journal.pone.0008997	http://dx.doi.org/10.1371/journal.pone.0008997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174630	Green Published, gold, Green Submitted			2022-12-25	WOS:000274654700003
J	Gache, V; Waridel, P; Winter, C; Juhem, A; Schroeder, M; Shevchenko, A; Popov, AV				Gache, Vincent; Waridel, Patrice; Winter, Christof; Juhem, Aurelie; Schroeder, Michael; Shevchenko, Andrej; Popov, Andrei V.			Xenopus Meiotic Microtubule-Associated Interactome	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; GENOME-WIDE ANALYSIS; MITOTIC SPINDLE; IN-VITRO; MASS-SPECTROMETRY; CELL-DIVISION; MOUSE OOCYTES; SUBCELLULAR-LOCALIZATION; INTERACTION NETWORK; BINDING PROTEINS	In metazoan oocytes the assembly of a microtubule-based spindle depends on the activity of a large number of accessory non-tubulin proteins, many of which remain unknown. In this work we isolated the microtubule-bound proteins from Xenopus eggs. Using mass spectrometry we identified 318 proteins, only 43 of which are known to bind microtubules. To integrate our results, we compiled for the first time a network of the meiotic microtubule-related interactome. The map reveals numerous interactions between spindle microtubules and the newly identified non-tubulin spindle components and highlights proteins absent from the mitotic spindle proteome. To validate newly identified spindle components, we expressed as GFP-fusions nine proteins identified by us and for first time demonstrated that Mgc68500, Loc398535, Nif3l1bp1/THOC7, LSM14A/RAP55A, TSGA14/CEP41, Mgc80361 and Mgc81475 are associated with spindles in egg extracts or in somatic cells. Furthermore, we showed that transfection of HeLa cells with siRNAs, corresponding to the human orthologue of Mgc81475 dramatically perturbs spindle formation in HeLa cells. These results show that our approach to the identification of the Xenopus microtubule-associated proteome yielded bona fide factors with a role in spindle assembly.	[Gache, Vincent; Juhem, Aurelie; Popov, Andrei V.] CEA Grenoble, INSERM, U366, DRDC CS, Grenoble, France; [Waridel, Patrice; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Winter, Christof; Schroeder, Michael] Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society; Technische Universitat Dresden	Gache, V (corresponding author), Univ Paris 06, INSERM, Myol Grp, Inst Myol,UMR S 787, Paris, France.	andrei.popov@ujf-grenoble.fr	Schroeder, Michael/A-3040-2010; GACHE, vincent/L-1990-2019; Winter, Christof/A-1887-2011; Winter, Christof/AAF-1860-2020; GACHE, Vincent/M-9556-2015	GACHE, vincent/0000-0002-2928-791X; Winter, Christof/0000-0002-0253-9056; Winter, Christof/0000-0002-0253-9056; GACHE, Vincent/0000-0002-2928-791X	Inserm; French Research Ministry [BCM0210]; Bundesministerium fur Bildung und Forschung (BMBF) [PTJ-BIO/0313130]; National Institute of Health, National Institute of General Medical Sciences (NIH NIGMS) [1R01GM070986-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070986] Funding Source: NIH RePORTER	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Research Ministry(Ministry of Research, France); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); National Institute of Health, National Institute of General Medical Sciences (NIH NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in the group of A. P. was supported by the Avenir grant of Inserm, "Action Concertee Incitative'' (ACI) "Biologie cellulaire, moleculaire et structurale'' (BCMS) 2003 of the French Research Ministry (project BCM0210), equipment grant of the "La Ligue contre le Cancer'' (Comite de l'Isere), equipment grant "Emergence 2004'' of the Department de Rhone-Alpes and equipment grant of the "Association pour la Recherche sur le Cancer (project 7833). Work in Shevchenko lab was supported by grants PTJ-BIO/0313130 from Bundesministerium fur Bildung und Forschung (BMBF) and 1R01GM070986-01A1 from National Institute of Health, National Institute of General Medical Sciences (NIH NIGMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Battaglia DE, 1996, HUM REPROD, V11, P2217; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; BONIFACINO JS, CURRENT PROTOCOLS CE; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Casaletto JB, 2005, J CELL BIOL, V169, P61, DOI 10.1083/jcb.200411056; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Castedo Maria, 2004, Journal de la Societe de Biologie, V198, P97; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Cha BJ, 1999, J CELL SCI, V112, P4337; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Cukurcam S, 2004, MUTAT RES-GEN TOX EN, V564, P165, DOI 10.1016/j.mrgentox.2004.08.008; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dumont J, 2007, J CELL BIOL, V176, P295, DOI 10.1083/jcb.200605199; Eichenmuller B, 2003, CELL MOTIL CYTOSKEL, V56, P225, DOI 10.1002/cm.10147; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Frank A, 2005, ANAL CHEM, V77, P964, DOI 10.1021/ac048788h; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; GACHE V, 2007, METHODS MOL MED MICR, P29; Gassmann R, 2005, CHROMOSOMA, V113, P385, DOI 10.1007/s00412-004-0326-0; Groen AC, 2004, CURR BIOL, V14, P1801, DOI 10.1016/j.cub.2004.10.002; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Habermann B, 2004, MOL CELL PROTEOMICS, V3, P238, DOI 10.1074/mcp.M300073-MCP200; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Hitzler JK, 2005, NAT REV CANCER, V5, P11, DOI 10.1038/nrc1525; Huang L, 2000, J BIOL CHEM, V275, P29829, DOI 10.1074/jbc.M002737200; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; LAJOIEMAZENC I, 1994, J CELL SCI, V107, P2825; Lamb NE, 1997, HUM MOL GENET, V6, P1391, DOI 10.1093/hmg/6.9.1391; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Liska AJ, 2004, PROTEOMICS, V4, P2707, DOI 10.1002/PMIC.200300813; Liu J, 2005, P NATL ACAD SCI USA, V102, P1927, DOI 10.1073/pnas.0409472102; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Mailhes JB, 2004, MUTAT RES-GEN TOX EN, V559, P153, DOI 10.1016/j.mrgentox.2004.01.001; Maresca TJ, 2005, CURR BIOL, V15, P1755, DOI 10.1016/j.cub.2005.08.049; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; MILLER L, 1977, IN VITRO CELL DEV B, V13, P557; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; MOREJOHN LC, 1994, PLANT CELL, V6, P1696, DOI 10.2307/3869900; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nicolaidis P, 1998, HUM REPROD, V13, P313, DOI 10.1093/humrep/13.2.313; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849; Pellestor F, 2003, HUM GENET, V112, P195, DOI 10.1007/s00439-002-0852-x; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Popov AV, 2001, EMBO J, V20, P397, DOI 10.1093/emboj/20.3.397; RAFFERTY KA, 1969, BIOL AMPHIBIAN TUMOR, P52; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shevchenko Anna, 2003, Methods Mol Biol, V211, P221; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Simerly C, 2003, SCIENCE, V300, P297, DOI 10.1126/science.1082091; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Simpson JC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-222; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; SLOBODA RD, 1975, P NATL ACAD SCI USA, V72, P177, DOI 10.1073/pnas.72.1.177; Spike CA, 2001, MOL CELL BIOL, V21, P4985, DOI 10.1128/MCB.21.15.4985-4995.2001; SUPRENANT KA, 1993, J CELL SCI, V104, P445; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; Wang S, 2004, J BIOL CHEM, V279, P35958, DOI 10.1074/jbc.M313778200; Wang WH, 2006, FRONT BIOSCI-LANDMRK, V11, P620, DOI 10.2741/1822; Waridel P, 2007, PROTEOMICS, V7, P2318, DOI 10.1002/pmic.200700003; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; YOSHIDA S, 1994, MOL CELL BIOCHEM, V138, P39, DOI 10.1007/BF00928441; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	95	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9248	10.1371/journal.pone.0009248	http://dx.doi.org/10.1371/journal.pone.0009248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174651	Green Published, gold			2022-12-25	WOS:000274590600009
J	Chintagari, NR; Mishra, A; Su, LJ; Wang, Y; Ayalew, S; Hartson, SD; Liu, L				Chintagari, Narendranath Reddy; Mishra, Amarjit; Su, Lijing; Wang, Yang; Ayalew, Sahlu; Hartson, Steven D.; Liu, Lin			Vacuolar ATPase Regulates Surfactant Secretion in Rat Alveolar Type II Cells by Modulating Lamellar Body Calcium	PLOS ONE			English	Article							LUNG PHOSPHOLIPID-METABOLISM; LIPID RAFT MICRODOMAINS; RENAL TUBULAR-ACIDOSIS; H+-ATPASE; V-ATPASE; PROTEOMIC ANALYSIS; GRANULAR PNEUMOCYTES; EPITHELIAL-CELLS; INTRACELLULAR PH; PROTON PUMPS	Lung surfactant reduces surface tension and maintains the stability of alveoli. How surfactant is released from alveolar epithelial type II cells is not fully understood. Vacuolar ATPase (V-ATPase) is the enzyme responsible for pumping H(+) into lamellar bodies and is required for the processing of surfactant proteins and the packaging of surfactant lipids. However, its role in lung surfactant secretion is unknown. Proteomic analysis revealed that vacuolar ATPase (V-ATPase) dominated the alveolar type II cell lipid raft proteome. Western blotting confirmed the association of V-ATPase a1 and B1/2 subunits with lipid rafts and their enrichment in lamellar bodies. The dissipation of lamellar body pH gradient by Bafilomycin A1 (Baf A1), an inhibitor of V-ATPase, increased surfactant secretion. Baf A1-stimulated secretion was blocked by the intracellular Ca(2+) chelator, BAPTA-AM, the protein kinase C (PKC) inhibitor, staurosporine, and the Ca(2+)/calmodulin-dependent protein kinase II (CaMKII), KN-62. Baf A1 induced Ca(2+) release from isolated lamellar bodies. Thapsigargin reduced the Baf A1-induced secretion, indicating cross-talk between lamellar body and endoplasmic reticulum Ca(2+) pools. Stimulation of type II cells with surfactant secretagogues dissipated the pH gradient across lamellar bodies and disassembled the V-ATPase complex, indicating the physiological relevance of the V-ATPase-mediated surfactant secretion. Finally, silencing of V-ATPase a1 and B2 subunits decreased stimulated surfactant secretion, indicating that these subunits were crucial for surfactant secretion. We conclude that V-ATPase regulates surfactant secretion via an increased Ca(2+) mobilization from lamellar bodies and endoplasmic reticulum, and the activation of PKC and CaMKII. Our finding revealed a previously unrealized role of V-ATPase in surfactant secretion.	[Chintagari, Narendranath Reddy; Mishra, Amarjit; Su, Lijing; Wang, Yang; Liu, Lin] Oklahoma State Univ, Dept Physiol Sci, Lundberg Kienlen Lung Biol & Toxicol Lab, Stillwater, OK 74078 USA; [Ayalew, Sahlu] Oklahoma State Univ, Dept Pathobiol, Stillwater, OK 74078 USA; [Hartson, Steven D.] Oklahoma State Univ, Dept Mol Biol & Biochem, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Chintagari, NR (corresponding author), Oklahoma State Univ, Dept Physiol Sci, Lundberg Kienlen Lung Biol & Toxicol Lab, Stillwater, OK 74078 USA.	lin.liu@okstate.edu	Wang, Yang/G-4496-2014; MISHRA, AMARJIT/I-4928-2019; MISHRA, AMARJIT/D-7504-2016	Wang, Yang/0000-0002-2626-478X; MISHRA, AMARJIT/0000-0002-3777-0338; MISHRA, AMARJIT/0000-0002-3777-0338	NIH [R01 HL-052146, R01 HL-071628, R01 HL-083188]; Center for Veterinary Health Sciences, Oklahoma State University; American Heart Association [0810016Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071628, R01HL052146, R01HL083188] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Veterinary Health Sciences, Oklahoma State University; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH R01 HL-052146, R01 HL-071628 and R01 HL-083188 (LL) and a Student Seed Grant from Center for Veterinary Health Sciences, Oklahoma State University (NRC). YW was supported by a pre-doctoral fellowship from the American Heart Association (0810016Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonyo BO, 2004, BIOCHEMISTRY-US, V43, P3499, DOI 10.1021/bi036338y; Abonyo BO, 2003, AM J RESP CELL MOL, V29, P273, DOI 10.1165/rcmb.2002-0189OC; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Beers MF, 1996, J BIOL CHEM, V271, P14361, DOI 10.1074/jbc.271.24.14361; Berkane AA, 2007, BIOCHEM BIOPH RES CO, V355, P813, DOI 10.1016/j.bbrc.2007.02.037; Bini L, 2003, BIOCHEM J, V369, P301, DOI 10.1042/BJ20020503; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Brisseau GF, 1996, J BIOL CHEM, V271, P2005, DOI 10.1074/jbc.271.4.2005; CHANDER A, 1986, J BIOL CHEM, V261, P6126; CHANDER A, 1982, BIOCHEM J, V208, P651, DOI 10.1042/bj2080651; Chander A, 1996, BIOCHEM J, V318, P271, DOI 10.1042/bj3180271; CHANDER A, 1989, AM J PHYSIOL, V257, pL354, DOI 10.1152/ajplung.1989.257.6.L354; Chintagari NR, 2008, CELL RES, V18, P701, DOI 10.1038/cr.2008.55; Chintagari NR, 2006, AM J RESP CELL MOL, V34, P677, DOI 10.1165/rcmb.2005-0418OC; Christensen KA, 2002, J CELL SCI, V115, P599; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; ECKENHOFF RG, 1988, AM J PHYSIOL, V254, pC614, DOI 10.1152/ajpcell.1988.254.5.C614; Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200; Fisher AB, 1996, J LIPID RES, V37, P1057; Fisher AB, 2006, BBA-MOL CELL BIOL L, V1761, P785, DOI 10.1016/j.bbalip.2006.05.009; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Galli T, 1996, J BIOL CHEM, V271, P2193, DOI 10.1074/jbc.271.4.2193; GOU D, 2004, ANNEXINS, V1, P31; Gou DM, 2007, J GENE MED, V9, P751, DOI 10.1002/jgm.1080; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; HILDEBRAN JN, 1981, J APPL PHYSIOL, V51, P905, DOI 10.1152/jappl.1981.51.4.905; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; JONES PG, 1994, BIOCHEMISTRY-US, V33, P8180, DOI 10.1021/bi00193a003; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Li N, 2004, PROTEOMICS, V4, P3156, DOI 10.1002/pmic.200400832; Liu L, 1996, AM J PHYSIOL-LUNG C, V270, pL668, DOI 10.1152/ajplung.1996.270.4.L668; Liu L, 1999, J CELL BIOCHEM, V72, P103, DOI 10.1002/(SICI)1097-4644(19990101)72:1<103::AID-JCB11>3.0.CO;2-5; MacLellan DL, 2005, PROTEOMICS, V5, P4733, DOI 10.1002/pmic.200500044; Mason RJ, 2002, AM J PHYSIOL-LUNG C, V282, pL249, DOI 10.1152/ajplung.00027.2001; Morel N, 2001, J NEUROCHEM, V79, P485, DOI 10.1046/j.1471-4159.2001.00611.x; MYERS M, 1993, J BIOL CHEM, V268, P9184; Nguyen HTT, 2006, BIOCHEM BIOPH RES CO, V342, P236, DOI 10.1016/j.bbrc.2006.01.141; NICHOLAS TE, 1983, RESP PHYSIOL, V52, P69, DOI 10.1016/0034-5687(83)90137-8; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishiguchi M, 2003, NEUROCHEM INT, V42, P493, DOI 10.1016/S0197-0186(02)00139-0; NORDSTROM T, 1995, J BIOL CHEM, V270, P2203, DOI 10.1074/jbc.270.5.2203; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Razzaq TM, 2004, IMMUNOLOGY, V113, P413, DOI 10.1111/j.1365-2567.2004.01998.x; Salaun B, 2004, AM J PATHOL, V164, P861, DOI 10.1016/S0002-9440(10)63174-4; Salaun C, 2004, TRAFFIC, V5, P255, DOI 10.1111/j.1600-0854.2004.0162.x; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Sleight SB, 2005, BIOL REPROD, V73, P721, DOI 10.1095/biolreprod.105.041533; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Sprenger Richard R, 2007, Methods Mol Biol, V357, P199; Strayer DS, 1999, BIOCHEM J, V344, P39, DOI 10.1042/0264-6021:3440039; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Sundler R, 1997, ACTA PHYSIOL SCAND, V161, P553, DOI 10.1046/j.1365-201X.1997.00262.x; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; Taupenot L, 2005, J BIOL CHEM, V280, P3885, DOI 10.1074/jbc.M408197200; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wadsworth SJ, 1997, AM J PHYSIOL-LUNG C, V273, pL427, DOI 10.1152/ajplung.1997.273.2.L427; Weaver TE, 2002, SEMIN CELL DEV BIOL, V13, P263, DOI 10.1016/S1084952102000551; Yamada H, 2001, DIABETES, V50, P1012, DOI 10.2337/diabetes.50.5.1012; Yanagida M, 2007, PROTEOMICS, V7, P2398, DOI 10.1002/pmic.200700056; Zaas DW, 2005, BBA-MOL CELL RES, V1746, P305, DOI 10.1016/j.bbamcr.2005.10.003	67	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9228	10.1371/journal.pone.0009228	http://dx.doi.org/10.1371/journal.pone.0009228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169059	gold, Green Published, Green Submitted			2022-12-25	WOS:000274590500010
J	Rinaudo, CD; Rosini, R; Galeotti, CL; Berti, F; Necchi, F; Reguzzi, V; Ghezzo, C; Telford, JL; Grandi, G; Maione, D				Rinaudo, Cira Daniela; Rosini, Roberto; Galeotti, Cesira L.; Berti, Francesco; Necchi, Francesca; Reguzzi, Valerio; Ghezzo, Claudia; Telford, John Laird; Grandi, Guido; Maione, Domenico			Specific Involvement of Pilus Type 2a in Biofilm Formation in Group B Streptococcus	PLOS ONE			English	Article							BACTERIAL BIOFILMS; CELL-ADHESION; AGALACTIAE; INFECTIONS; PYOGENES; IDENTIFICATION; COLONIZATION; PNEUMONIAE; PROTEINS; VACCINE	Streptococcus agalactiae is the primary colonizer of the anogenital mucosa of up to 30% of healthy women and can infect newborns during delivery and cause severe sepsis and meningitis. Persistent colonization usually involves the formation of biofilm and increasing evidences indicate that in pathogenic streptococci biofilm formation is mediated by pili. Recently, we have characterized pili distribution and conservation in 289 GBS clinical isolates and we have shown that GBS has three pilus types, 1, 2a and 2b encoded by three corresponding pilus islands, and that each strain carries one or two islands. Here we have investigated the capacity of these strains to form biofilms. We have found that most of the biofilm-formers carry pilus 2a, and using insertion and deletion mutants we have confirmed that pilus type 2a, but not pilus types 1 and 2b, confers biofilm-forming phenotype. We also show that deletion of the major ancillary protein of type 2a did not impair biofilm formation while the inactivation of the other ancillary protein and of the backbone protein completely abolished this phenotype. Furthermore, antibodies raised against pilus components inhibited bacterial adherence to solid surfaces, offering new strategies to prevent GBS infection by targeting bacteria during their initial attachment to host epithelial cells.	[Rinaudo, Cira Daniela; Rosini, Roberto; Galeotti, Cesira L.; Berti, Francesco; Necchi, Francesca; Reguzzi, Valerio; Ghezzo, Claudia; Telford, John Laird; Grandi, Guido; Maione, Domenico] Novartis Vaccines & Diagnost, Siena, Italy	Novartis	Rinaudo, CD (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	domenico.maione@novartis.com	Telford, John Laird/ABG-8144-2020	Grandi, Guido/0000-0001-9724-2185	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	Funding: This work was supported by internal funding from Novartis Vaccines and Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Brodeur BR, 2000, INFECT IMMUN, V68, P5610, DOI 10.1128/IAI.68.10.5610-5618.2000; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Courtney HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004166; Doern CD, 2009, MICROBIOL-SGM, V155, P46, DOI 10.1099/mic.0.021048-0; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Edwards MS, 2005, CLIN INFECT DIS, V40, P352, DOI 10.1086/426820; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Gibbs RS, 2004, OBSTET GYNECOL, V104, P1062, DOI 10.1097/01.AOG.0000144128.03913.c2; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hansen SM, 2004, J CLIN MICROBIOL, V42, P83, DOI 10.1128/JCM.42.1.83-89.2004; Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Kaur H, 2009, MICROB PATHOGENESIS, V46, P321, DOI 10.1016/j.micpath.2009.04.004; Keefe GP, 1997, CAN VET J, V38, P429; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; MARRIE TJ, 1983, ARCH INTERN MED, V143, P1135, DOI 10.1001/archinte.143.6.1135; Melchior MB, 2006, VET J, V171, P398, DOI 10.1016/j.tvjl.2005.01.006; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Olson ME, 2002, CAN J VET RES, V66, P86; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; WESSELS MR, 1993, INFECT IMMUN, V61, P4760, DOI 10.1128/IAI.61.11.4760-4766.1993	43	81	86	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9216	10.1371/journal.pone.0009216	http://dx.doi.org/10.1371/journal.pone.0009216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169161	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474700010
J	Soubry, A; Staes, K; Parthoens, E; Noppen, S; Stove, C; Bogaert, P; van Hengel, J; van Roy, F				Soubry, Adelheid; Staes, Katrien; Parthoens, Eef; Noppen, Sam; Stove, Christophe; Bogaert, Pieter; van Hengel, Jolanda; van Roy, Frans			The Transcriptional Repressor Kaiso Localizes at the Mitotic Spindle and Is a Constituent of the Pericentriolar Material	PLOS ONE			English	Article							GAMMA-TUBULIN COMPLEXES; DNA-BINDING PROTEIN; P120 CATENIN; NUCLEAR-LOCALIZATION; CENTROSOMAL PROTEINS; MICROTUBULE-BINDING; MAMMALIAN-CELLS; PARTNER KAISO; P120(CTN); ORGANIZATION	Kaiso is a BTB/POZ zinc finger protein known as a transcriptional repressor. It was originally identified through its in vitro association with the Armadillo protein p120ctn. Subcellular localization of Kaiso in cell lines and in normal and cancerous human tissues revealed that its expression is not restricted to the nucleus. In the present study we monitored Kaiso's subcellular localization during the cell cycle and found the following: (1) during interphase, Kaiso is located not only in the nucleus, but also on microtubular structures, including the centrosome; (2) at metaphase, it is present at the centrosomes and on the spindle microtubules; (3) during telophase, it accumulates at the midbody. We found that Kaiso is a genuine PCM component that belongs to a pericentrin molecular complex. We analyzed the functions of different domains of Kaiso by visualizing the subcellular distribution of GFP-tagged Kaiso fragments throughout the cell cycle. Our results indicate that two domains are responsible for targeting Kaiso to the centrosomes and microtubules. The first domain, designated SA1 for spindle-associated domain 1, is located in the center of the Kaiso protein and localizes at the spindle microtubules and centrosomes; the second domain, SA2, is an evolutionarily conserved domain situated just before the zinc finger domain and might be responsible for localizing Kaiso towards the centrosomal region. Constructs containing both SA domains and Kaiso's aminoterminal BTB/POZ domain triggered the formation of abnormal centrosomes. We also observed that overexpression of longer or full-length Kaiso constructs led to mitotic cell arrest and frequent cell death. Knockdown of Kaiso accelerated cell proliferation. Our data reveal a new target for Kaiso at the centrosomes and spindle microtubules during mitosis. They also strongly imply that Kaiso's function as a transcriptional regulator might be linked to the control of the cell cycle and to cell proliferation in cancer.	[Soubry, Adelheid; Staes, Katrien; Parthoens, Eef; Noppen, Sam; Stove, Christophe; Bogaert, Pieter; van Hengel, Jolanda; van Roy, Frans] VIB, Dept Mol Biomed Res, Ghent, Belgium; [Soubry, Adelheid; Staes, Katrien; Parthoens, Eef; Noppen, Sam; Stove, Christophe; Bogaert, Pieter; van Hengel, Jolanda; van Roy, Frans] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Soubry, A (corresponding author), Duke Univ, Dept Cell Biol, Durham, NC 27710 USA.	F.Vanroy@dmbr.VIB-UGent.be	Noppen, Sam/F-8681-2018; van Roy, Frans M/C-6123-2009; Stove, Christophe/B-6057-2008	Noppen, Sam/0000-0002-2831-5042; van Roy, Frans M/0000-0003-4358-1039; Stove, Christophe/0000-0001-7126-348X	Ghent University [BOF09/01M00709]; Belgian Federation against Cancer - Stichting tegen Kanker; Research Foundation Flanders (FWO)	Ghent University(Ghent University); Belgian Federation against Cancer - Stichting tegen Kanker; Research Foundation Flanders (FWO)(FWO)	Funding: This project was supported by a Special Research Grant (BOF: Bijzonder Onderzoeksfonds) from Ghent University (http://www.ugent.be/en/research/opportunities), a Ghent University Methusalem (BOF09/01M00709) grant (http://www.ugent.be/en/news/bulletin/methusalem.htm/), a research grant from the Belgian Federation against Cancer - Stichting tegen Kanker (http://www.kanker.be/), and a research grant from the Research Foundation Flanders (FWO; http://www.fwo.be/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008-5472.CAN-05-1947; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Caballero IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004315; Chartier NT, 2007, CANCER RES, V67, P9781, DOI 10.1158/0008-5472.CAN-07-0233; DAI SD, 2009, LUNG CANC; Dai SD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-178; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2001, HYBRIDOMA, V20, P159, DOI 10.1089/027245701750293484; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Defossez PA, 2005, J BIOL CHEM, V280, P43017, DOI 10.1074/jbc.M510802200; DELAVAL B, 2009, J CELL BIOL; Dionne MA, 1999, CELL MOTIL CYTOSKEL, V42, P189, DOI 10.1002/(SICI)1097-0169(1999)42:3<189::AID-CM3>3.0.CO;2-X; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Fant X, 2004, INT REV CYTOL, V238, P1, DOI 10.1016/S0074-7696(04)38001-0; Flory MR, 2003, GENOMICS, V82, P401, DOI 10.1016/S0888-7543(03)00119-8; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gunawardane RN, 2000, CURR TOP DEV BIOL, V49, P55; JULIAN M, 1993, J CELL SCI, V105, P145; Kantidze OL, 2009, CELL CYCLE, V8, P2303, DOI 10.4161/cc.8.14.8944; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kelly KF, 2004, J CELL SCI, V117, P6143, DOI 10.1242/jcs.01541; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Keryer G, 2003, MOL BIOL CELL, V14, P4260, DOI 10.1091/mbc.E02-11-0773; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Kisurina-Evgenieva O, 2004, J CELL SCI, V117, P6391, DOI 10.1242/jcs.01568; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; OEGEMA K, 1995, J CELL BIOL, V131, P1261, DOI 10.1083/jcb.131.5.1261; Ogden SR, 2008, MOL BIOL CELL, V19, P4110, DOI 10.1091/mbc.E08-03-0283; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Popov AV, 2001, EMBO J, V20, P397, DOI 10.1093/emboj/20.3.397; Prokhortchouk A, 2006, MOL CELL BIOL, V26, P199, DOI 10.1128/MCB.26.1.199-208.2006; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Ruzov A, 2004, DEVELOPMENT, V131, P6185, DOI 10.1242/dev.01549; Ruzov A, 2009, DEVELOPMENT, V136, P723, DOI 10.1242/dev.025577; Sansom OJ, 2007, NAT CLIN PRACT ONCOL, V4, P305, DOI 10.1038/ncponc0812; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Schatten H, 2008, HISTOCHEM CELL BIOL, V129, P667, DOI 10.1007/s00418-008-0427-6; Sillibourne JE, 2007, MOL BIOL CELL, V18, P3667, DOI 10.1091/mbc.E06-07-0604; Soubry A, 2005, CANCER RES, V65, P2224, DOI 10.1158/0008-5472.CAN-04-2020; Spring CM, 2005, EXP CELL RES, V305, P253, DOI 10.1016/j.yexcr.2005.01.007; Stove V, 2005, J VIROL, V79, P11422, DOI 10.1128/JVI.79.17.11422-11433.2005; TOBEY RA, 1972, EXP CELL RES, V75, P460, DOI 10.1016/0014-4827(72)90453-3; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; van Hengel J, 2007, BBA-MOL CELL RES, V1773, P78, DOI 10.1016/j.bbamcr.2006.08.033; van Roy FM, 2005, NAT REV CANCER, V5, P956, DOI 10.1038/nrc1752; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; WHITFIELD WGF, 1995, J CELL SCI, V108, P3377; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang ZH, 1997, J CELL BIOL, V137, P657, DOI 10.1083/jcb.137.3.657; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zeng CQ, 2000, MICROSC RES TECHNIQ, V49, P467, DOI 10.1002/(SICI)1097-0029(20000601)49:5<467::AID-JEMT9>3.3.CO;2-M; Zhang R, 2004, EXP CELL RES, V294, P86, DOI 10.1016/j.yexcr.2003.11.015; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	68	21	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9203	10.1371/journal.pone.0009203	http://dx.doi.org/10.1371/journal.pone.0009203			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169156	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474700006
J	Negi, VD; Nagarajan, AG; Chakravortty, D				Negi, Vidya Devi; Nagarajan, Arvindhan G.; Chakravortty, Dipshikha			A Safe Vaccine (DV-STM-07) against Salmonella Infection Prevents Abortion and Confers Protective Immunity to the Pregnant and New Born Mice	PLOS ONE			English	Article							AMNIOTIC-FLUID; POLYSACCHARIDE VACCINE; TYPHIMURIUM INFECTION; IFN-GAMMA; RESISTANCE; CYTOKINES; TYPHI; EXPRESSION; RESPONSES; TH1	Pregnancy is a transient immuno-compromised condition which has evolved to avoid the immune rejection of the fetus by the maternal immune system. The altered immune response of the pregnant female leads to increased susceptibility to invading pathogens, resulting in abortion and congenital defects of the fetus and a subnormal response to vaccination. Active vaccination during pregnancy may lead to abortion induced by heightened cell mediated immune response. In this study, we have administered the highly attenuated vaccine strain delta pmrG-HM-D (DV-STM-07) in female mice before the onset of pregnancy and followed the immune reaction against challenge with virulent S. Typhimurium in pregnant mice. Here we demonstrate that DV-STM-07 vaccine gives protection against Salmonella in pregnant mice and also prevents Salmonella induced abortion. This protection is conferred by directing the immune response towards Th2 activation and Th1 suppression. The low Th1 response prevents abortion. The use of live attenuated vaccine just before pregnancy carries the risk of transmission to the fetus. We have shown that this vaccine is safe as the vaccine strain is quickly eliminated from the mother and is not transmitted to the fetus. This vaccine also confers immunity to the new born mice of vaccinated mothers. Since there is no evidence of the vaccine candidate reaching the new born mice, we hypothesize that it may be due to trans-colostral transfer of protective anti-Salmonella antibodies. These results suggest that our vaccine DV-STM-07 can be very useful in preventing abortion in the pregnant individuals and confer immunity to the new born. Since there are no such vaccine candidates which can be given to the new born and to the pregnant women, this vaccine holds a very bright future to combat Salmonella induced pregnancy loss.	[Negi, Vidya Devi] Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India; Indian Inst Sci, Dept Microbiol & Cell Biol, Biosafety Labs, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Negi, VD (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India.	dipa@mcbl.iisc.ernet.in	chakravortty, dipshikha/A-9492-2009; Chakravortty, Dipshikha/AAI-4448-2020; Negi, Vidya Devi/AAY-6756-2021	Negi, Vidya Devi/0000-0001-6835-556X; Chakravortty, Dipshikha/0000-0002-7838-5145	ICMR (Center for Advanced Study in Molecular Medicine); DST (FIST); UGC; Director of Indian Institute of Science, Bangalore, India [191/MCB]; Department of Biotechnology [DBT 197, DBT 172]; Council of Scientific and Industrial Research (CSIR)	ICMR (Center for Advanced Study in Molecular Medicine)(Indian Council of Medical Research (ICMR)); DST (FIST)(Department of Science & Technology (India)); UGC(University Grants Commission, India); Director of Indian Institute of Science, Bangalore, India; Department of Biotechnology; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Infrastructure support from ICMR (Center for Advanced Study in Molecular Medicine), DST (FIST) and UGC (special assistance) is acknowledged. The authors would also like to thank the Central Animal Facility (CAF) for providing the mice. This work was supported by the grant, Provision (2A) Tenth Plan (191/MCB) from the Director of Indian Institute of Science, Bangalore, India, and Department of Biotechnology (DBT 197 and DBT 172) to D. C. V. D. N. acknowledges the Council of Scientific and Industrial Research (CSIR) for fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Arya SC, 1999, VACCINE, V17, P1015; Arya SC, 1997, VACCINE, V15, P244, DOI 10.1016/S0264-410X(96)00168-5; Ashkar AA, 1999, BIOL REPROD, V61, P493, DOI 10.1095/biolreprod61.2.493; AWADALLA SG, 1985, OBSTET GYNECOL, V65, pS30; Bennett W A, 1997, Early Pregnancy, V3, P190; Cagiola M, 2007, VET MICROBIOL, V121, P330, DOI 10.1016/j.vetmic.2006.12.018; Chau TT, 2007, ANTIMICROB AGENTS CH, V51, P4315, DOI 10.1128/AAC.00294-07; Clark RG, 2007, NEW ZEAL VET J, V55, P356, DOI 10.1080/00480169.2007.36794; Kohn William G, 2003, MMWR Recomm Rep, V52, P1; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; DALAKER K, 1988, ACTA OBSTET GYN SCAN, V67, P185, DOI 10.3109/00016348809004197; Daniel Y, 1998, AM J REPROD IMMUNOL, V39, P376; Dietz HH, 2006, CAN VET J, V47, P1201; Dubinsky V, 2008, AM J REPROD IMMUNOL, V60, P197, DOI 10.1111/j.1600-0897.2008.00614.x; Fievet N, 2001, J INFECT DIS, V183, P1530, DOI 10.1086/320201; GORHAM JR, 1949, AM J VET RES, V10, P183; HASHIMOTO Y, 1991, FEMS MICROBIOL LETT, V90, P53, DOI 10.1016/0378-1097(91)90645-Q; HILL JA, 1995, JAMA-J AM MED ASSOC, V273, P1933, DOI 10.1001/jama.273.24.1933; HINTON M, 1973, J HYG-CAMBRIDGE, V71, P459, DOI 10.1017/S0022172400046441; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; Kaaja RJ, 2005, JAMA-J AM MED ASSOC, V294, P2751, DOI 10.1001/jama.294.21.2751; KENT ASH, 1994, J REPROD FERTIL, V100, P81; KILLAR LM, 1985, INFECT IMMUN, V47, P605, DOI 10.1128/IAI.47.3.605-612.1985; Krishnan L, 1996, J IMMUNOL, V156, P644; LUFT BJ, 1982, INFECT IMMUN, V38, P1164, DOI 10.1128/IAI.38.3.1164-1171.1982; Luque I, 2009, VET MICROBIOL, V134, P396, DOI 10.1016/j.vetmic.2008.08.015; Madic J, 1997, EQUINE VET J, V29, P230, DOI 10.1111/j.2042-3306.1997.tb01674.x; MASTROENI PSC, 2000, J IMMUNOL, V15, P1648; MENON R, 1995, AM J OBSTET GYNECOL, V172, P493, DOI 10.1016/0002-9378(95)90562-6; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; Mizuno Y, 2003, CLIN EXP IMMUNOL, V131, P111, DOI 10.1046/j.1365-2249.2003.02060.x; Mukkur TKS, 1998, COMP IMMUNOL MICROB, V21, P327, DOI 10.1016/S0147-9571(97)00021-0; Nahum R, 2004, HUM REPROD, V19, P715, DOI 10.1093/humrep/deh099; Naleway AL, 2006, EPIDEMIOL REV, V28, P47, DOI 10.1093/epirev/mxj002; Negi VD, 2007, VACCINE, V25, P5315, DOI 10.1016/j.vaccine.2007.05.015; Orsi NA, 2007, J REPROD IMMUNOL, V75, P97, DOI 10.1016/j.jri.2007.03.002; Pejcic-Karapetrovic B, 2007, J IMMUNOL, V179, P6088, DOI 10.4049/jimmunol.179.9.6088; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; ROBBINS JD, 1984, J INFECT DIS, V150, P436, DOI 10.1093/infdis/150.3.436; SALERNOGONCALVE.RP, 2002, J IMMUNOL, V169; SALERNOGONCALVE.RW, 2003, J IMMUNOL; Salzman NH, 2003, INFECT IMMUN, V71, P1109, DOI 10.1128/IAI.71.3.1109-1115.2003; SILVER RM, 1993, AM J OBSTET GYNECOL, V169, P1101, DOI 10.1016/0002-9378(93)90263-I; Sin JI, 1998, EUR J IMMUNOL, V28, P3530, DOI 10.1002/(SICI)1521-4141(199811)28:11<3530::AID-IMMU3530>3.0.CO;2-C; STOCKER BAD, 1982, DEV BIOLOGICALS, V53, P47; THOMAS GW, 1993, IMMUNOL TODAY, V14, P353; Veith GL, 1999, GYNECOL OBSTET INVES, V48, P163, DOI 10.1159/000010165; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4	49	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9139	10.1371/journal.pone.0009139	http://dx.doi.org/10.1371/journal.pone.0009139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161765	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442700005
J	Kleinau, G; Haas, AK; Neumann, S; Worth, CL; Hoyer, I; Furkert, J; Rutz, C; Gershengorn, MC; Schulein, R; Krause, G				Kleinau, Gunnar; Haas, Ann-Karin; Neumann, Susanne; Worth, Catherine L.; Hoyer, Inna; Furkert, Jens; Rutz, Claudia; Gershengorn, Marvin C.; Schuelein, Ralf; Krause, Gerd			Signaling-sensitive amino acids surround the allosteric ligand binding site of the thyrotropin receptor	FASEB JOURNAL			English	Article						allosteric small molecules; glycoprotein hormone receptors; constitutively activating mutations; activation mechanisms	PROTEIN-COUPLED RECEPTORS; STIMULATING-HORMONE-RECEPTOR; TSH RECEPTOR; CONSTITUTIVE ACTIVITY; TRANSMEMBRANE DOMAIN; CRYSTAL-STRUCTURES; MUTATIONS; GPCR; PATHOPHYSIOLOGY; ACTIVATION	The thyrotropin receptor [thyroid-stimulating hormone receptor (TSHR)], a G-protein-coupled receptor (GPCR), is endogenously activated by thyrotropin, which binds to the extracellular region of the receptor. We previously identified a low-molecular-weight (LMW) agonist of the TSHR and predicted its allosteric binding pocket within the receptor's transmembrane domain. Because binding of the LMW agonist probably disrupts interactions or leads to formation of new interactions among amino acid residues surrounding the pocket, we tested whether mutation of residues at these positions would lead to constitutive signaling activity. Guided by molecular modeling, we performed site-directed mutagenesis of 24 amino acids in this spatial region, followed by functional characterization of the mutant receptors in terms of expression and signaling, measured as cAMP accumulation. We found that mutations V421I, Y466A, T501A, L587V, M637C, M637W, S641A, Y643F, L645V, and Y667A located in several helices exhibit constitutive activity. Of note is mutation M637W at position 6.48 in transmembrane helix 6, which has a significant effect on the interaction of the receptor with the LMW agonist. In summary, we found that a high proportion of residues in several helices surrounding the allosteric binding site of LMW ligands in the TSHR when mutated lead to constitutively active receptors. Our findings of signaling-sensitive residues in this region of the transmembrane bundle may be of general importance as this domain appears to be evolutionarily retained among GPCRs.-Kleinau, G., Haas, A.-K., Neumann, S., Worth, C. L., Hoyer, I., Furkert, J., Rutz, Gershengorn, M. C., Schulein, R., Krause, G. Signaling-sensitive amino acids surround the allosteric ligand binding site of the thyrotropin receptor. FASEB J. 24, 2347-2354 (2010). www.fasebj.org	[Kleinau, Gunnar; Haas, Ann-Karin; Worth, Catherine L.; Hoyer, Inna; Furkert, Jens; Rutz, Claudia; Schuelein, Ralf; Krause, Gerd] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Neumann, Susanne; Gershengorn, Marvin C.] NIDDK, NIH, Clin Endocrinol Branch, Bethesda, MD USA	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Krause, G (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	gkrause@fmp-berlin.de	Kleinau, Gunnar/GPX-6330-2022	Worth, Catherine/0000-0002-1796-9606	Deutsche Forschungsgemeinschaft [KR1273/4-1]; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK011006] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Elena Eliseeva for her excellent technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (KR1273/4-1) and by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.	Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Deflorian F, 2008, PROTEINS, V71, P783, DOI 10.1002/prot.21763; Gozu HI, 2006, EUR J ENDOCRINOL, V155, P535, DOI 10.1530/eje.1.02253; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Heitman LH, 2008, MED RES REV, V28, P975, DOI 10.1002/med.20129; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Jaschke H, 2006, J BIOL CHEM, V281, P9841, DOI 10.1074/jbc.C600014200; Kleinau G, 2008, CELL MOL LIFE SCI, V65, P3664, DOI 10.1007/s00018-008-8450-2; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau G, 2007, MOL ENDOCRINOL, V21, P574, DOI 10.1210/me.2006-0309; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Konopka JB, 1996, P NATL ACAD SCI USA, V93, P6764, DOI 10.1073/pnas.93.13.6764; Kosugi S, 1996, ENDOCR J, V43, P595, DOI 10.1507/endocrj.43.595; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lodowski DT, 2009, PHOTOCHEM PHOTOBIOL, V85, P425, DOI 10.1111/j.1751-1097.2008.00516.x; Moore S, 2006, J MED CHEM, V49, P3888, DOI 10.1021/jm060247s; Neumann S, 2009, P NATL ACAD SCI USA, V106, P12471, DOI 10.1073/pnas.0904506106; Neumann S, 2008, ENDOCRINOLOGY, V149, P5945, DOI 10.1210/en.2008-0836; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Rodien P, 2003, ANN ENDOCRINOL-PARIS, V64, P12; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; SMITH BJ, 1993, APPL BIOCHEM BIOTECH, V41, P189, DOI 10.1007/BF02916422; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006	36	34	36	3	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2347	2354		10.1096/fj.09-149146	http://dx.doi.org/10.1096/fj.09-149146			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20179143	Green Published			2022-12-25	WOS:000279343600021
J	Abrass, CK; Hansen, KM				Abrass, Christine K.; Hansen, Kim M.			Insulin-like Growth Factor-binding Protein-5-induced Laminin gamma 1 Transcription Requires Filamin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSING RECEPTOR; RAT MESANGIAL CELLS; ANDROGEN RECEPTOR; DEPENDENT ACTIVATION; EXPRESSION; IGFBP-5; DOMAINS; GTPASES; RHO; PHOSPHORYLATION	Insulin-like growth factor-binding protein-5 (IGFBP-5) has IGF-1-independent intranuclear effects that are poorly defined. Treatment of cells with IGFBP-5 induces migration, prevents apoptosis, and leads to increased laminin subunit transcription. Similarly, filamin A (FLNa), an actin-binding protein that participates in cell attachment, plays important additional roles in signal transduction and modulation of transcriptional responses. In this report, we show that IGFBP-5 leads to dephosphorylation of FLNa with subsequent FLNa cleavage. Following cleavage, there is enhanced recruitment of Smad3/4 to a C-terminal FLNa fragment with nuclear translocation and subsequent binding to the promoter region of the laminin gamma 1 (lamc1) gene. FLNa knockdown prevents IGFBP-5-mediated increases in lamc1 transcription. These data indicate that IGFBP-5 induces formation of a FLNa-based nuclear shuttle that recruits transcription factors and regulates transcription of IGFBP-5 target genes. These studies provide new insights into the mechanisms whereby IGFBP-5 and FLNa exert intranuclear effects.	[Abrass, Christine K.; Hansen, Kim M.] Univ Washington, Dept Med, Allergy & Inflammat Program, Sch Med, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle	Abrass, CK (corresponding author), UW Med S Lake Union, 815 Mercer St, Seattle, WA 98109 USA.	cabrass@u.washington.edu			National Institutes of Health [R01 DK 49771]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK 49771 (to C. K. A.).	ABRASS CK, 1994, KIDNEY INT, V46, P613, DOI 10.1038/ki.1994.313; Abrass CK, 1997, AM J PHYSIOL-RENAL, V273, pF899, DOI 10.1152/ajprenal.1997.273.6.F899; ABRASS CK, 1995, KIDNEY INT, V47, P25, DOI 10.1038/ki.1995.3; Akkiprik M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2116; Akkiprik M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-103; Amaar YG, 2002, J BIOL CHEM, V277, P12053, DOI 10.1074/jbc.M110872200; Andress DL, 1998, AM J PHYSIOL-ENDOC M, V274, pE744, DOI 10.1152/ajpendo.1998.274.4.E744; Anilkumar G, 2003, CANCER RES, V63, P2645; Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Beekman JM, 2008, J IMMUNOL, V180, P3938, DOI 10.4049/jimmunol.180.6.3938; Berfield AK, 2000, KIDNEY INT, V57, P1991, DOI 10.1046/j.1523-1755.2000.00049.x; Berfield AK, 2006, AM J PHYSIOL-CELL PH, V291, pC589, DOI 10.1152/ajpcell.00623.2005; Berry FB, 2005, MOL CELL BIOL, V25, P1415, DOI 10.1128/MCB.25.4.1415-1424.2005; BOOTH BA, 1995, GROWTH REGULAT, V5, P1; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; CHANT J, 1995, CELL, V81, P1, DOI 10.1016/0092-8674(95)90363-1; Coughlin MF, 2006, BIOPHYS J, V90, P2199, DOI 10.1529/biophysj.105.061267; Culig Z, 2004, J STEROID BIOCHEM, V92, P265, DOI 10.1016/j.jsbmb.2004.10.003; Garcia E, 2006, ARCH BIOCHEM BIOPHYS, V446, P140, DOI 10.1016/j.abb.2005.12.006; Goda N, 2008, EXP CELL RES, V314, P2352, DOI 10.1016/j.yexcr.2008.05.008; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Hastie LE, 1998, J CELL BIOCHEM, V68, P511, DOI 10.1002/(SICI)1097-4644(19980315)68:4<511::AID-JCB10>3.0.CO;2-C; He HJ, 2003, J BIOL CHEM, V278, P27096, DOI 10.1074/jbc.M301003200; Hjalm G, 2001, J BIOL CHEM, V276, P34880, DOI 10.1074/jbc.M100784200; HOCK RS, 1990, BIOCHEMISTRY-US, V29, P9441, DOI 10.1021/bi00492a019; Huang CF, 2006, FEBS LETT, V580, P1795, DOI 10.1016/j.febslet.2006.02.035; Huang C, 2007, J CELL MOL MED, V11, P923, DOI 10.1111/j.1582-4934.2007.00114.x; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kawata Y, 2002, J BIOL CHEM, V277, P11375, DOI 10.1074/jbc.M111284200; Khazenzon NM, 2003, MOL CANCER THER, V2, P985; Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280; KREISBERG JI, 1983, KIDNEY INT, V23, P439, DOI 10.1038/ki.1983.40; Leal SM, 1999, J BIOL CHEM, V274, P6711, DOI 10.1074/jbc.274.10.6711; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; Mukherjee A, 2008, MOL ENDOCRINOL, V22, P206, DOI 10.1210/me.2007-0336; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Nagano T, 2002, NAT CELL BIOL, V4, P495, DOI 10.1038/ncb808; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ohta Y, 1996, J BIOL CHEM, V271, P11858, DOI 10.1074/jbc.271.20.11858; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618; Parker A, 1996, J BIOL CHEM, V271, P13523, DOI 10.1074/jbc.271.23.13523; Perks CM, 2000, J CELL BIOCHEM, V80, P248; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Ravid D, 2008, EXP CELL RES, V314, P2762, DOI 10.1016/j.yexcr.2008.06.004; Sasaki A, 2001, J BIOL CHEM, V276, P17871, DOI 10.1074/jbc.M008422200; Schedlich LJ, 1998, J BIOL CHEM, V273, P18347, DOI 10.1074/jbc.273.29.18347; Schedlich LJ, 2007, ARCH BIOCHEM BIOPHYS, V465, P359, DOI 10.1016/j.abb.2007.06.013; Schneider MR, 2002, J ENDOCRINOL, V172, P423, DOI 10.1677/joe.0.1720423; Shand JH, 2003, J BIOL CHEM, V278, P17859, DOI 10.1074/jbc.M300526200; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Sprenger CCT, 2008, NEOPLASIA, V10, P1350, DOI 10.1593/neo.08746; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Uribe R, 2009, MOL BIOL REP, V36, P121, DOI 10.1007/s11033-007-9159-2; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vainionpaa N, 2007, LAB INVEST, V87, P780, DOI 10.1038/labinvest.3700592; Wang Q, 1996, J CELL BIOCHEM, V62, P383, DOI 10.1002/(SICI)1097-4644(199609)62:3<383::AID-JCB8>3.0.CO;2-N; Wang Y, 2007, ONCOGENE, V26, P6061, DOI 10.1038/sj.onc.1210435; WEIHING RR, 1985, CAN J BIOCHEM CELL B, V63, P397, DOI 10.1139/o85-059; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xu QJ, 2004, CIRC RES, V94, pE46, DOI 10.1161/01.RES.0000124761.62846.DF; Zhao Y, 2006, J BIOL CHEM, V281, P14184, DOI 10.1074/jbc.M506941200; Zhou X, 2007, TRENDS CARDIOVAS MED, V17, P222, DOI 10.1016/j.tcm.2007.08.001	68	10	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12925	12934		10.1074/jbc.M109.061754	http://dx.doi.org/10.1074/jbc.M109.061754			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20167606	Green Published, hybrid			2022-12-25	WOS:000276787800051
J	Barko, S; Bugyi, B; Carlier, MF; Gombos, R; Matusek, T; Mihaly, J; Nyitrai, M				Barko, Szilvia; Bugyi, Beata; Carlier, Marie-France; Gombos, Rita; Matusek, Tamas; Mihaly, Jozsef; Nyitrai, Miklos			Characterization of the Biochemical Properties and Biological Function of the Formin Homology Domains of Drosophila DAAM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAPHANOUS-RELATED FORMINS; ACTIN-FILAMENT ELONGATION; RABBIT SKELETAL-MUSCLE; BARBED END ELONGATION; CAPPING PROTEIN; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; MAMMALIAN FORMINS; BUNDLING ACTIVITY; ARP2/3 COMPLEX	We characterized the properties of Drosophila melanogaster DAAM-FH2 and DAAM-FH1-FH2 fragments and their interactions with actin and profilin by using various biophysical methods and in vivo experiments. The results show that although the DAAM-FH2 fragment does not have any conspicuous effect on actin assembly in vivo, in cells expressing the DAAM-FH1-FH2 fragment, a profilin-dependent increase in the formation of actin structures is observed. The trachea-specific expression of DAAM-FH1-FH2 also induces phenotypic effects, leading to the collapse of the tracheal tube and lethality in the larval stages. In vitro, both DAAM fragments catalyze actin nucleation but severely decrease both the elongation and depolymerization rate of the filaments. Profilin acts as a molecular switch in DAAM function. DAAM-FH1-FH2, remaining bound to barbed ends, drives processive assembly of profilin-actin, whereas DAAM-FH2 forms an abortive complex with barbed ends that does not support profilin-actin assembly. Both DAAM fragments also bind to the sides of the actin filaments and induce actin bundling. These observations show that the D. melanogaster DAAM formin represents an extreme class of barbed end regulators gated by profilin.	[Barko, Szilvia; Bugyi, Beata; Nyitrai, Miklos] Univ Pecs, Fac Med, Dept Biophys, H-7624 Pecs, Hungary; [Bugyi, Beata; Carlier, Marie-France] CNRS, Lab Enzymol & Biochem Struct, F-91198 Gif Sur Yvette, France; [Gombos, Rita; Matusek, Tamas; Mihaly, Jozsef] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6726 Szeged, Hungary	University of Pecs; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Nyitrai, M (corresponding author), Univ Pecs, Fac Med, Dept Biophys, Szigeti Str 12, H-7624 Pecs, Hungary.	miklos.nyitrai@aok.pte.hu		Nyitrai, Miklos/0000-0002-6229-4337; Mihaly, Jozsef/0000-0003-3399-2424	Hungarian Science Foundation [K60968, K77840]; Hungarian National Office for Research and Technology [GVOP-3.2.1-2004-04-0190/3.0, GVOP-3.2.1-2004-04-0228/3.0]; Science, Please! Research Team on Innovation [SROP-4.2.2/08/1/2008-0011]; European Molecular Biology Organization [ALTF 626-2006]; La Ligue Nationale Contre le Cancer; ANR-PCV [2006-2009]; European STREP	Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Office for Research and Technology(National Office for Research and Technology); Science, Please! Research Team on Innovation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); ANR-PCV(French National Research Agency (ANR)); European STREP(European Commission)	This work was supported by grants from the Hungarian Science Foundation (OTKA Grants K60968 and K77840 (to M. N.)) and from the Hungarian National Office for Research and Technology (Grants GVOP-3.2.1-2004-04-0190/3.0 and GVOP-3.2.1-2004-04-0228/3.0). This work was also supported by "Science, Please! Research Team on Innovation" Grant SROP-4.2.2/08/1/2008-0011.; Supported by European Molecular Biology Organization "Long-Term Fellowship" ALTF 626-2006 and by La Ligue Contre le Cancer" Allocation Post-doctorale pour Jeune Chercheur Confirme."; Supported in part by La Ligue Nationale Contre le Cancer, ANR-PCV 2006-2009, and the European STREP "BIOMICS."	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Bubb MR, 2003, J BIOL CHEM, V278, P24629, DOI 10.1074/jbc.M302796200; Bugyi B, 2006, J BIOL CHEM, V281, P10727, DOI 10.1074/jbc.M510252200; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Didry D, 1998, J BIOL CHEM, V273, P25602, DOI 10.1074/jbc.273.40.25602; ELZINGA M, 1973, P NATL ACAD SCI USA, V70, P2687, DOI 10.1073/pnas.70.9.2687; Esue O, 2008, J MOL BIOL, V384, P324, DOI 10.1016/j.jmb.2008.09.043; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Franch-Marro X, 2006, DEVELOPMENT, V133, P785, DOI 10.1242/dev.02260; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gutsche-Perelroizen I, 1999, J BIOL CHEM, V274, P6234, DOI 10.1074/jbc.274.10.6234; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Harris ES, 2006, METHOD ENZYMOL, V406, P190, DOI 10.1016/S0076-6879(06)06015-0; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Kida Y, 2004, DEV BRAIN RES, V153, P143, DOI 10.1016/j.devbrainres.2004.07.014; Kida YS, 2007, P NATL ACAD SCI USA, V104, P6708, DOI 10.1073/pnas.0608946104; Kinosian HJ, 2002, BIOCHEMISTRY-US, V41, P6734, DOI 10.1021/bi016083t; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, NAT CELL BIOL, V6, P1158, DOI 10.1038/ncb1204-1158; Kupi T, 2009, BIOPHYS J, V96, P2901, DOI 10.1016/j.bpj.2008.11.058; Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Le Clainche C., 2004, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb1207s24, DOI 10.1002/0471143030.CB1207S24]; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Nakaya MA, 2004, GENE EXPR PATTERNS, V5, P97, DOI 10.1016/j.modgep.2004.06.001; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Papp G, 2006, BIOPHYS J, V91, P2564, DOI 10.1529/biophysj.106.087775; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Schirenbeck A, 2005, BIOCHEM SOC T, V33, P1256, DOI 10.1042/BST0331256; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; WEGNER A, 1983, P NATL ACAD SCI-BIOL, V80, P4922, DOI 10.1073/pnas.80.16.4922; Wen KK, 2009, J BIOL CHEM, V284, P16776, DOI 10.1074/jbc.M109.006981; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	71	28	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13154	13169		10.1074/jbc.M109.093914	http://dx.doi.org/10.1074/jbc.M109.093914			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177055	Green Published, hybrid			2022-12-25	WOS:000276787800071
J	Nieves, EC; Manchanda, N				Nieves, Evelyn C.; Manchanda, Naveen			A Cleavage-resistant Urokinase Plasminogen Activator Receptor Exhibits Dysregulated Cell-surface Clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; VITRONECTIN-BINDING; ENDOCYTIC RECEPTOR; THYROID-CELLS; UPAR; MIGRATION; COMPLEXES; EXPRESSION; PROTEIN; INTERNALIZATION	Urokinase plasminogen activator receptor (u-PAR) binds urokinase plasminogen activator (u-PA) and participates in plasminogen activation in addition to modulating several cellular processes such as adhesion, proliferation, and migration. u-PAR is susceptible to proteolysis by its cognate ligand and several other proteases. To elucidate the biological significance of receptor cleavage by u-PA, we engineered and expressed a two-chain urokinase plasminogen activator (tcu-PA) cleavageresistant u-PAR (cr-u-PAR). This mutated receptor was similar to wild-type u-PAR in binding u-PA and initiating plasminogen activation. However, cr-u-PAR exhibited accelerated internalization and resurfacing due to direct association with the endocytic receptor alpha(2)-macroglobulin receptor/low density lipoprotein receptor-related protein in the absence of the enzyme inhibitor complex of tcu-PA and plasminogen activator inhibitor-1 (tcu-PA.PAI-1). cr-u-PAR-expressing cells had enhanced migration compared with wild-type u-PAR-expressing cells, and cr-u-PAR was less sensitive to chymotrypsin cleavage as compared with wt u-PAR. Our studies suggest that these mutations in the linker region result in a rearrangement within the cr-u-PAR structure that makes it resemble its ligand-bound form. This constitutively active variant may mimic highly glycosylated cleavage-resistant u-PAR expressed in certain highly malignant cancer-cells.	[Nieves, Evelyn C.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Manchanda, Naveen] Univ Illinois, Dept Internal Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nieves, EC (corresponding author), 1500 E Med Ctr Dr,6420 Comprehens Canc Ctr, Ann Arbor, MI 48109 USA.	ecnieves@gmail.com						ANDREASEN PA, 1994, FEBS LETT, V338, P239, DOI 10.1016/0014-5793(94)80276-9; ANDREW SM, 2001, CURR PROTOC IMMU MAY, pCH16; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Beaufort N, 2004, J IMMUNOL, V172, P540, DOI 10.4049/jimmunol.172.1.540; Behrendt N, 1996, J BIOL CHEM, V271, P22885, DOI 10.1074/jbc.271.37.22885; BEHRENDT N, 1990, J BIOL CHEM, V265, P6453; BERKENPAS MB, 1995, EMBO J, V14, P2969, DOI 10.1002/j.1460-2075.1995.tb07299.x; Bernstein AM, 2007, MOL BIOL CELL, V18, P2716, DOI 10.1091/mbc.E06-10-0912; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; BLASI F, 1986, J CELL BIOCHEM, V32, P179, DOI 10.1002/jcb.240320303; BLASI F, 1990, CELL DIFFER DEV, V32, P247, DOI 10.1016/0922-3371(90)90037-W; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Chapman HA, 1999, THROMB HAEMOSTASIS, V82, P291; Chapman HA, 2001, THROMB HAEMOSTASIS, V86, P124; CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609; Cortese K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003730; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; ELLIS V, 1991, J BIOL CHEM, V266, P12752; Ellis V, 1999, BIOCHEMISTRY-US, V38, P651, DOI 10.1021/bi981714d; ESTREICHER A, 1989, J BIOL CHEM, V264, P1180; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; FIORE MM, 1992, BLOOD, V80, P3127; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; GRIFFITH MJ, 1985, J CLIN INVEST, V75, P4, DOI 10.1172/JCI111694; Henic E, 2006, GYNECOL ONCOL, V101, P28, DOI 10.1016/j.ygyno.2005.09.038; Hoyer-Hansen G, 1997, FEBS LETT, V420, P79, DOI 10.1016/S0014-5793(97)01491-9; Hoyer-Hansen G, 2001, BIOCHEM J, V358, P673, DOI 10.1042/0264-6021:3580673; HoyerHansen G, 1997, EUR J BIOCHEM, V243, P21, DOI 10.1111/j.1432-1033.1997.0021a.x; HOYERHANSEN G, 1992, J BIOL CHEM, V267, P18224; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Jo M, 2009, AM J PATHOL, V175, P190, DOI 10.2353/ajpath.2009.081053; KETTNER C, 1979, BIOCHIM BIOPHYS ACTA, V569, P31, DOI 10.1016/0005-2744(79)90078-0; LI H, 1994, J BIOL CHEM, V269, P8153; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; MANCHANDA N, 1991, J BIOL CHEM, V266, P14580; Mannari C, 2008, INT J IMMUNOPATH PH, V21, P651, DOI 10.1177/039463200802100319; Mazzieri R, 2006, MOL BIOL CELL, V17, P367, DOI 10.1091/mbc.E05-07-0635; MOLLER LB, 1993, J BIOL CHEM, V268, P11152; Montuori N, 1999, FEBS LETT, V460, P32, DOI 10.1016/S0014-5793(99)01314-9; Montuori N, 2000, FEBS LETT, V476, P166, DOI 10.1016/S0014-5793(00)01713-0; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Nykjaer A, 1997, EMBO J, V16, P2610, DOI 10.1093/emboj/16.10.2610; NYKJAER A, 1994, J BIOL CHEM, V269, P25668; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; PICONE R, 1989, J CELL BIOL, V108, P693, DOI 10.1083/jcb.108.2.693; Ploug M, 1998, J BIOL CHEM, V273, P13933, DOI 10.1074/jbc.273.22.13933; PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411; Ragno P, 1998, CANCER RES, V58, P1315; Rasch MG, 2008, FRONT BIOSCI-LANDMRK, V13, P6752, DOI 10.2741/3186; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; SCHWARTZ BS, 1988, BLOOD, V71, P734; STOPPELLI MP, 1985, P NATL ACAD SCI USA, V82, P4939, DOI 10.1073/pnas.82.15.4939; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wu LH, 2005, J CELL BIOCHEM, V96, P1021, DOI 10.1002/jcb.20596	59	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12595	12603		10.1074/jbc.M109.008581	http://dx.doi.org/10.1074/jbc.M109.008581			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177061	Green Published, hybrid			2022-12-25	WOS:000276787800017
J	Beleford, D; Rattan, R; Chien, J; Shridhar, V				Beleford, Daniah; Rattan, Ramandeep; Chien, Jeremy; Shridhar, Viji			High Temperature Requirement A3 (HtrA3) Promotes Etoposide- and Cisplatin-induced Cytotoxicity in Lung Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE OMI/HTRA2; OVARIAN-CANCER; APOPTOSIS; INHIBITOR; PROTEINS; DEATH; XIAP; IDENTIFICATION; MITOCHONDRIA; CHEMOTHERAPY	Lung cancer is the leading cause of cancer-related deaths worldwide. Here we show for the first time that HtrA3 is a mitochondrial stress-response factor that promotes cytotoxicity to etoposide and cisplatin in lung cancer cell lines. Exogenous expression of wild type HtrA3 domain variants significantly attenuated cell survival with etoposide and cisplatin treatment in lung cancer cell lines H157 and A549 compared with expression of protease inactive mutants (S305A) or vector control. Conversely, HtrA3 suppression promoted cell survival with etoposide and cisplatin treatment in lung cancer cell lines Hop62 and HCC827. Survival was attenuated by re-expression of wild type HtrA3 variants during treatment but not by protease inactive mutants or vector control. HtrA3 also co-fractionated and co-localized with mitochondrial markers with both endogenous and exogenous expression in normal lung and lung cancer cell lines but was translocated from mitochondria following etoposide treatment. Moreover, HtrA3 translocation from mitochondria correlated with an increase in cell death that was attenuated by either HtrA3 suppression or Bcl-2 overexpression. Taken together, these results suggest that HtrA3 may be a previously uncharacterized mitochondrial cell death effector whose serine protease function may be crucial to modulating etoposide-and cisplatin-induced cytotoxicity in lung cancer cell lines.	[Beleford, Daniah; Rattan, Ramandeep; Chien, Jeremy; Shridhar, Viji] Mayo Clin, Coll Med, Dept Expt Pathol, Rochester, MN 55905 USA	Mayo Clinic	Shridhar, V (corresponding author), Mayo Clin, Coll Med, Dept Expt Pathol, Stabile 2-47,200 1st St SW, Rochester, MN 55905 USA.	shridhar.vijayalakshmi@mayo.edu	Seal, Sudipta/A-7698-2012; Chien, Jeremy/AID-8939-2022	Chien, Jeremy/0000-0003-4744-8374	Edith and Bernard Waterman Foundation; Mayo Foundation	Edith and Bernard Waterman Foundation; Mayo Foundation	This work was supported by the Edith and Bernard Waterman Foundation and the Mayo Foundation (to V. S.).	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Bunn Paul A Jr, 2004, Clin Lung Cancer, V6, P85; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Cilenti L, 2005, AM J PHYSIOL-RENAL, V288, pF371, DOI 10.1152/ajprenal.00154.2004; Ciombor Kristen Keon, 2006, Curr Treat Options Oncol, V7, P59, DOI 10.1007/s11864-006-0032-7; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Damiani LA, 2008, CANCER RES, V68, P9005, DOI 10.1158/0008-5472.CAN-08-1276; Dinser R, 2009, J TISSUE ENG REGEN M, V3, P124, DOI 10.1002/term.148; Ferraldeschi R, 2007, DRUGS, V67, P2135, DOI 10.2165/00003495-200767150-00003; Fischer B, 2008, REV RECENT CLIN TRIA, V3, P40, DOI 10.2174/157488708783330503; Gallego MA, 2008, ONCOGENE, V27, P1981, DOI 10.1038/sj.onc.1210833; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Gibson TJ, 1996, TRENDS NEUROSCI, V19, P465, DOI 10.1016/S0166-2236(96)20054-2; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hann CL, 2008, ONCOLOGY-NY, V22, P1486; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Hirsch FR, 2005, J CLIN ONCOL, V23, P3186, DOI 10.1200/JCO.2005.14.209; James R, 2004, MOL CELL NEUROSCI, V26, P112, DOI 10.1016/j.mcn.2004.01.013; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Li CX, 2007, MOL BIOL CELL, V18, P3081, DOI 10.1091/mbc.E07-02-0172; Li YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001397; Lingle WL, 2000, CURR TOP DEV BIOL, V49, P313; Machtay M, 2004, J THORAC CARDIOV SUR, V127, P108, DOI 10.1016/j.jtcvs.2003.07.027; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Martins LM, 2002, CELL DEATH DIFFER, V9, P699, DOI 10.1038/sj.cdd.4401044; Meng XW, 2006, CURR OPIN CELL BIOL, V18, P668, DOI 10.1016/j.ceb.2006.10.008; Millar JK, 2005, MOL CELL NEUROSCI, V30, P477, DOI 10.1016/j.mcn.2005.08.021; MINNA J, 2008, HARRISONS PRINCIPLES; Murwantoko, 2004, BIOCHEM J, V381, P895, DOI 10.1042/BJ20040435; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nie GY, 2003, BIOCHEM J, V371, P39, DOI 10.1042/BJ20021569; Rosell R, 2006, CURR OPIN PHARMACOL, V6, P323, DOI 10.1016/j.coph.2006.01.011; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Sanborn Rachel E, 2008, Thorac Surg Clin, V18, P423, DOI 10.1016/j.thorsurg.2008.08.004; Seong YM, 2004, J BIOL CHEM, V279, P37588, DOI 10.1074/jbc.M401408200; Srinivasula SM, 2003, J BIOL CHEM, V278, P31469, DOI 10.1074/jbc.C300240200; Staub J, 2007, ONCOGENE, V26, P4969, DOI 10.1038/sj.onc.1210300; Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; van Loo G, 2002, CELL DEATH DIFFER, V9, P20, DOI 10.1038/sj.cdd.4400970; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Yang QH, 2003, GENE DEV, V17, P1487, DOI 10.1101/gad.1097903; Zhang JM, 2009, AM J RESP CELL MOL, V40, P135, DOI 10.1165/rcmb.2007-0277OC	58	42	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12011	12027		10.1074/jbc.M109.097790	http://dx.doi.org/10.1074/jbc.M109.097790			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20154083	Green Published, hybrid			2022-12-25	WOS:000276787100030
J	Pioszak, AA; Harikumar, KG; Parker, NR; Miller, LJ; Xu, HE				Pioszak, Augen A.; Harikumar, Kaleeckal G.; Parker, Naomi R.; Miller, Laurence J.; Xu, H. Eric			Dimeric Arrangement of the Parathyroid Hormone Receptor and a Structural Mechanism for Ligand-induced Dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; SECRETIN RECEPTOR; BINDING DOMAIN; MOLECULAR RECOGNITION; OLIGOMERIC COMPLEXES; EXTRACELLULAR DOMAIN; GPCR OLIGOMERIZATION; CRYSTAL-STRUCTURE; PTH RECEPTOR; LIVING CELLS	The parathyroid hormone receptor (PTH1R) is a class B G protein-coupled receptor that is activated by parathyroid hormone (PTH) and PTH-related protein (PTHrP). Little is known about the oligomeric state of the receptor and its regulation by hormone. The crystal structure of the ligand-free PTH1R extracellular domain (ECD) reveals an unexpected dimer in which the C-terminal segment of both ECD protomers forms an alpha-helix that mimics PTH/PTHrP by occupying the peptide binding groove of the opposing protomer. ECD-mediated oligomerization of intact PTH1R was confirmed in living cells by bioluminescence and fluorescence resonance energy transfer experiments. As predicted by the structure, PTH binding disrupted receptor oligomerization. A receptor rendered monomeric by mutations in the ECD retained wild-type PTH binding and cAMP signaling ability. Our results are consistent with the hypothesis that PTH1R forms constitutive dimers that are dissociated by ligand binding and that monomeric PTH1R is capable of activating G protein.	[Pioszak, Augen A.; Parker, Naomi R.; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Harikumar, Kaleeckal G.; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Van Andel Institute; Mayo Clinic; Mayo Clinic Phoenix	Pioszak, AA (corresponding author), Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA.	augie.pioszak@vai.org; eric.xu@vai.org	Xu, H. Eric/ABD-7487-2021	Xu, H. Eric/0000-0002-6829-8144; Harikumar, Kaleeckal/0000-0003-0411-5334	National Institutes of Health [GM087413, DK46577]; Jay and Betty Van Andel Foundation; Fiterman Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046577, R56DK046577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; Fiterman Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM087413 (to H.E.X.) and DK46577 (to L.J.M.). This work was also supported in part by the Jay and Betty Van Andel Foundation (to H.E.X.) and the Fiterman Foundation (to L.J.M.).	Angers S, 2001, LIFE SCI, V68, P2243, DOI 10.1016/S0024-3205(01)01012-8; [Anonymous], ACTA CRYSTALLOGR D, V50, P760; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Carter PH, 1999, J BIOL CHEM, V274, P31955, DOI 10.1074/jbc.274.45.31955; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gardella T J, 2000, Rev Endocr Metab Disord, V1, P317, DOI 10.1023/A:1026522619828; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2008, J MOL NEUROSCI, V36, P279, DOI 10.1007/s12031-008-9060-z; Harikumar KG, 2006, MOL PHARMACOL, V69, P363, DOI 10.1124/mol.105.015776; Harikurnar KG, 2008, BBA-BIOMEMBRANES, V1778, P2555, DOI 10.1016/j.bbamem.2008.07.008; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P569, DOI 10.1210/jc.2002-021122; Jin L, 2000, J BIOL CHEM, V275, P27238; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kraetke O, 2005, J RECEPT SIG TRANSD, V25, P251, DOI 10.1080/10799890500468838; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lisenbee CS, 2006, BIOCHEMISTRY-US, V45, P8216, DOI 10.1021/bi060494y; Luck MD, 1999, MOL ENDOCRINOL, V13, P670, DOI 10.1210/me.13.5.670; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Patel RC, 2002, P NATL ACAD SCI USA, V99, P3294, DOI 10.1073/pnas.042705099; Pellegrini M, 1998, BIOCHEMISTRY-US, V37, P12737, DOI 10.1021/bi981265h; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Pioszak AA, 2009, J BIOL CHEM, V284, P28382, DOI 10.1074/jbc.M109.022905; Potts JT, 2007, ANN NY ACAD SCI, V1117, P196, DOI 10.1196/annals.1402.088; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Seck T, 2003, J BIOL CHEM, V278, P23085, DOI 10.1074/jbc.M211280200; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhou AT, 1997, P NATL ACAD SCI USA, V94, P3644, DOI 10.1073/pnas.94.8.3644	61	44	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12435	12444		10.1074/jbc.M109.093138	http://dx.doi.org/10.1074/jbc.M109.093138			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20172855	Green Published, hybrid			2022-12-25	WOS:000276787100071
J	Hui, XY; Li, HY; Zhou, ZG; Lam, KSL; Xiao, Y; Wu, DH; Ding, K; Wang, Y; Vanhoutte, PM; Xu, AM				Hui, Xiaoyan; Li, Huiying; Zhou, Zhiguang; Lam, Karen S. L.; Xiao, Yang; Wu, Donghai; Ding, Ke; Wang, Yu; Vanhoutte, Paul M.; Xu, Aimin			Adipocyte Fatty Acid-binding Protein Modulates Inflammatory Responses in Macrophages through a Positive Feedback Loop Involving c-Jun NH2-terminal Kinases and Activator Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; HORMONE-SENSITIVE LIPASE; HUMAN THP-1 MACROPHAGES; FOAM CELL-FORMATION; INSULIN-RESISTANCE; SIGNAL-TRANSDUCTION; METABOLIC SYNDROME; MAP KINASES; OBESITY; AP2	Adipocyte fatty acid-binding protein (A-FABP) has emerged as an important mediator of inflammation in macrophages. Macrophage-selective ablation of A-FABP alone is sufficient to prevent the development of high cholesterol diet-induced atherosclerosis in apoE-deficient mice. However, the precise mechanisms whereby A-FABP modulates inflammation remain elusive. Here, we report that A-FABP forms a finely tuned positive loop between JNK and activator protein-1 (AP-1) to exacerbate lipopolysaccharide (LPS)-induced inflammatory responses in macrophages. Real time PCR and luciferase reporter analysis showed that LPS induced A-FABP expression through transcriptional activation. This effect was mediated by JNK, which promoted the recruitment of c-Jun to a highly conserved AP-1 consensus binding motif located within the proximal region of the A-FABP promoter. LPS-induced transactivation of the A-FABP gene was diminished by either pharmacological inhibition of JNK or knocking down c-Jun or by mutating the AP-1 recognition site within the proximal region (-122 to -116 bp) of the A-FABP promoter. Conversely, the LPS-evoked phosphorylation of JNK, activation of AP-1, and production of pro-inflammatory cytokines were markedly attenuated by pharmacological or genetic suppression of A-FABP in macrophages. Furthermore, the LPS-induced elevation in A-FABP expression could also be prevented by the selective A-FABP inhibitor BMS309403. These findings support the notion that pharmacological inhibition of A-FABP represents a valid strategy for treating inflammation-related disorders such as atherosclerosis.	[Hui, Xiaoyan; Lam, Karen S. L.; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Li, Huiying; Wang, Yu; Vanhoutte, Paul M.; Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Hui, Xiaoyan; Li, Huiying; Lam, Karen S. L.; Wang, Yu; Vanhoutte, Paul M.; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Zhou, Zhiguang; Xiao, Yang] Cent S Univ, Xiangya Hosp 2, Inst Metab & Endocrinol, Metab Syndrome Res Ctr,Diabet Ctr, Changsha 410011, Peoples R China; [Wu, Donghai; Ding, Ke] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Central South University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Xu, AM (corresponding author), L8-40,New Lab Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	amxu@hkucc.hku.hk	Ding, Ke/B-3257-2010; Xu, Aimin/D-3291-2013; HUI, Xiaoyan Hannah/M-5175-2019	Xu, Aimin/0000-0002-0668-033X; HUI, Xiaoyan Hannah/0000-0002-7525-5812; Ding, Ke/0000-0001-9016-812X; wang, yu/0000-0001-8697-2940; Zhou, Zhiguang/0000-0002-0374-1838; ding, ke/0000-0001-8167-0476	Research Grants Council of Hong Kong; National Natural Science Foundation of China [N_HKU 735/08, 30831160518]; Collaborative Research Fund [HKU 2/07C]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Research Fund	This work was supported by Research Grants Council of Hong Kong, the National Natural Science Foundation of China Joint Research Scheme (Projects N_HKU 735/08 and 30831160518), and the Collaborative Research Fund (HKU 2/07C) from the Research Grants Council of Hong Kong.	Bennett BL, 2003, CURR OPIN PHARMACOL, V3, P420, DOI 10.1016/S1471-4892(03)00068-7; Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6; CABRE A, 2009, J LIPID RES     0411, DOI DOI 10.1194/JLR.M800626-JLR200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng WG, 2003, J IMMUNOL, V171, P6581, DOI 10.4049/jimmunol.171.12.6581; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Fu YC, 2002, ATHEROSCLEROSIS, V165, P259, DOI 10.1016/S0021-9150(02)00305-2; Fu YC, 2000, J LIPID RES, V41, P2017; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Hertzel AV, 2009, J MED CHEM, V52, P6024, DOI 10.1021/jm900720m; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Jenkins-Kruchten AE, 2003, J BIOL CHEM, V278, P47636, DOI 10.1074/jbc.M307680200; Kazemi MR, 2005, ARTERIOSCL THROM VAS, V25, P1220, DOI 10.1161/01.ATV.0000159163.52632.1b; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Milner KL, 2009, HEPATOLOGY, V49, P1926, DOI 10.1002/hep.22896; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; Reynolds JM, 2007, J IMMUNOL, V179, P313, DOI 10.4049/jimmunol.179.1.313; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Thompson BR, 2009, J BIOL CHEM, V284, P13473, DOI 10.1074/jbc.M900075200; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Vigouroux C, 2003, AIDS, V17, P1503, DOI 10.1097/00002030-200307040-00011; WAHLI B, 2002, GUT, V50, P658; Wang QF, 2000, MOL CELL BIOL, V20, P9203, DOI 10.1128/MCB.20.24.9203-9211.2000; Wu Kenneth K., 2006, V338, P281; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Xu AM, 2004, FEBS LETT, V572, P129, DOI 10.1016/j.febslet.2004.07.020; Yeung DCY, 2009, DIABETES CARE, V32, P132, DOI 10.2337/dc08-1333; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966	48	122	138	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10273	10280		10.1074/jbc.M109.097907	http://dx.doi.org/10.1074/jbc.M109.097907			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20145251	Green Published, hybrid			2022-12-25	WOS:000276264600011
J	Iwai, K; Naganuma, A; Kuge, S				Iwai, Kenta; Naganuma, Akira; Kuge, Shusuke			Peroxiredoxin Ahp1 Acts as a Receptor for Alkylhydroperoxides to Induce Disulfide Bond Formation in the Cad1 Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; SACCHAROMYCES-CEREVISIAE; 2-CYS PEROXIREDOXIN; OXIDATIVE STRESS; THIOL PEROXIDASE; YAP1; PROTEIN; OXYR; ACTIVATION	Reactive oxygen species (ROS) generated during cellular metabolism are toxic to cells. As a result, cells must be able to identify ROS as a stress signal and induce stress response pathways that protect cells from ROS toxicity. Recently, peroxiredoxin (Prx)-induced relays of disulfide bond formation have been identified in budding yeast, namely the disulfide bond formation of Yap1, a crucial transcription factor for oxidative stress response, by a specific Prx Gpx3 and by a major Prx Tsa1. Here, we show that an atypical-type Prx Ahp1 can act as a receptor for alkylhydroperoxides, resulting in activation of the Cad1 transcription factor that is homologous to Yap1. We demonstrate that Ahp1 is required for the formation of intermolecular Cad1 disulfide bond(s) in both an in vitro redox system and in cells treated with alkylhydroperoxide. Furthermore, we found that Cad1-dependent transcriptional activation of the HSP82 gene is dependent on Ahp1. Our results suggest that, although the Gpx3-Yap1 pathway contributes more strongly to resistance than the Ahp1-Cad1 pathway, the Ahp1-induced activation of Cad1 can function as a defense system against stress induced by alkylhydroperoxides, possibly including lipid peroxides. Thus, the Prx family of proteins have an important role in determining peroxide response signals and in transmitting the signals to specific target proteins by inducing disulfide bond formation.	[Iwai, Kenta; Naganuma, Akira; Kuge, Shusuke] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Biochem Toxicol, Sendai, Miyagi 9800861, Japan	Tohoku University	Kuge, S (corresponding author), Tohoku Pharmaceut Univ, Dept Microbiol, Aoba Ku, 4-4-1 Komatsujima, Sendai, Miyagi 9818558, Japan.	skuge@mail.pharm.tohoku.ac.jp	NAGANUMA, AKIRA/V-2918-2019		Ministry of Education, Culture, Sports, Science, and Technology, Japan [20059003, 21200069]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Exploratory Research, a Grant-in-aid for Scientific Research on Priority Areas (Life of Proteins, KAKENHI 20059003), and a Grant-in-aid for Scientific Research on Innovative Areas (KAKENHI 21200069) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Avery AM, 2004, J BIOL CHEM, V279, P46652, DOI 10.1074/jbc.M408340200; Azevedo D, 2007, FEBS LETT, V581, P187, DOI 10.1016/j.febslet.2006.11.083; Bilsland E, 2004, MOL MICROBIOL, V53, P1743, DOI 10.1111/j.1365-2958.2004.04238.x; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Cohen BA, 2002, MOL BIOL CELL, V13, P1608, DOI 10.1091/mbc.01-10-0472; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; DUNN B, 1997, CURRENT PROTOCOLS MO; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Frankel EN, 1996, J AGR FOOD CHEM, V44, P131, DOI 10.1021/jf950374p; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lee J, 1999, J BIOL CHEM, V274, P4537, DOI 10.1074/jbc.274.8.4537; Lee SY, 2008, BIOCHEM BIOPH RES CO, V367, P67, DOI 10.1016/j.bbrc.2007.12.105; Okazaki S, 2005, ANTIOXID REDOX SIGN, V7, P327, DOI 10.1089/ars.2005.7.327; Okazaki S, 2007, MOL CELL, V27, P675, DOI 10.1016/j.molcel.2007.06.035; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Tachibana T, 2009, J BIOL CHEM, V284, P4464, DOI 10.1074/jbc.M807583200; Tanaka T, 2005, J BIOL CHEM, V280, P42078, DOI 10.1074/jbc.M508622200; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	27	29	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10597	10604		10.1074/jbc.M109.090142	http://dx.doi.org/10.1074/jbc.M109.090142			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20145245	Green Published, hybrid			2022-12-25	WOS:000276264600047
J	Banning, C; Votteler, J; Hoffmann, D; Koppensteiner, H; Warmer, M; Reimer, R; Kirchhoff, F; Schubert, U; Hauber, J; Schindler, M				Banning, Carina; Votteler, Joerg; Hoffmann, Dirk; Koppensteiner, Herwig; Warmer, Martin; Reimer, Rudolph; Kirchhoff, Frank; Schubert, Ulrich; Hauber, Joachim; Schindler, Michael			A Flow Cytometry-Based FRET Assay to Identify and Analyse Protein-Protein Interactions in Living Cells	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; VIRUS TYPE-1 NEF; VPU PROTEIN; FLUORESCENT PROTEIN; DOWN-MODULATION; HIV-1 VPU; ACTIVATION; DEGRADATION; EXPRESSION; BINDS	Background: Forsters resonance energy transfer (FRET) microscopy is widely used for the analysis of protein interactions in intact cells. However, FRET microscopy is technically challenging and does not allow assessing interactions in large cell numbers. To overcome these limitations we developed a flow cytometry-based FRET assay and analysed interactions of human and simian immunodeficiency virus (HIV and SIV) Nef and Vpu proteins with cellular factors, as well as HIV Rev multimer-formation. Results: Amongst others, we characterize the interaction of Vpu with CD317 (also termed Bst-2 or tetherin), a host restriction factor that inhibits HIV release from infected cells and demonstrate that the direct binding of both is mediated by the Vpu membrane-spanning region. Furthermore, we adapted our assay to allow the identification of novel protein interaction partners in a high-throughput format. Conclusion: The presented combination of FRET and FACS offers the precious possibility to discover and define protein interactions in living cells and is expected to contribute to the identification of novel therapeutic targets for treatment of human diseases.	[Banning, Carina; Hoffmann, Dirk; Koppensteiner, Herwig; Warmer, Martin; Reimer, Rudolph; Hauber, Joachim; Schindler, Michael] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-2000 Hamburg, Germany; [Votteler, Joerg; Schubert, Ulrich] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Erlangen, Germany; [Kirchhoff, Frank] Univ Ulm, Inst Virol, Ulm, Germany	Heinrich Pette Institute; University of Hamburg; University of Erlangen Nuremberg; Ulm University	Banning, C (corresponding author), Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Martinistr 52, D-2000 Hamburg, Germany.	michael.schindler@hpi.uni-hamburg.de	Schindler, Michael/C-1647-2015; Kirchhoff, Frank/O-8367-2018	Schindler, Michael/0000-0001-8989-5813; Kirchhoff, Frank/0000-0002-7052-2360	Deutsche Forschungsgemeinschaft (DFG); EU; NIH [R01, AI067057]; DFG [HA2580/2-2, SCHI1073/2-1]; Stiftung fuer neurovirale Erkrankungen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067057] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EU(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); Stiftung fuer neurovirale Erkrankungen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	F.K. is supported by the Deutsche Forschungsgemeinschaft (DFG), the EU and NIH R01 grant AI067057. J. H. is supported by the DFG grant HA2580/2-2. This work was funded by grants to M.S. from the DFG (SCHI1073/2-1) and the Stiftung fuer neurovirale Erkrankungen (NVE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Binette Julie, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P297, DOI 10.2174/1568008043339695; BOUR S, 1995, J VIROL, V69, P1510, DOI 10.1128/JVI.69.3.1510-1520.1995; Chan FKM, 2001, CYTOMETRY, V44, P361, DOI 10.1002/1097-0320(20010801)44:4<361::AID-CYTO1128>3.0.CO;2-3; D'haeseleer P, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P216; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; DOUGLAS JL, 2009, J VIROL; DUBE M, 2009, J VIROL; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Greenway AL, 2002, J VIROL, V76, P2692, DOI 10.1128/JVI.76.6.2692-2702.2002; Hachet-Haas M, 2006, MICROSC RES TECHNIQ, V69, P941, DOI 10.1002/jemt.20376; He LS, 2004, J BIOL CHEM, V279, P55855, DOI 10.1074/jbc.M407284200; He LS, 2003, CYTOM PART A, V55A, P71, DOI 10.1002/cyto.a.10073; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Nomaguchi M, 2008, MICROBES INFECT, V10, P960, DOI 10.1016/j.micinf.2008.07.006; Piehler J, 2005, CURR OPIN STRUC BIOL, V15, P4, DOI 10.1016/j.sbi.2005.01.008; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Ptak RG, 2008, AIDS RES HUM RETROV, V24, P1497, DOI 10.1089/aid.2008.0113; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Schaefer TM, 2002, VIROLOGY, V302, P106, DOI 10.1006/viro.2002.1628; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; SCHUBERT U, 1994, J MOL BIOL, V236, P16, DOI 10.1006/jmbi.1994.1114; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; SIEGEL RM, 2000, SCI STKE, pPL1; Swanson CM, 2004, EMBO J, V23, P2632, DOI 10.1038/sj.emboj.7600270; Thomas SL, 1998, J VIROL, V72, P2935, DOI 10.1128/JVI.72.4.2935-2944.1998; Wu XD, 2007, DEV NEUROBIOL, V67, P483, DOI 10.1002/dneu.20357; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Yan YL, 2003, CURR OPIN CHEM BIOL, V7, P635, DOI 10.1016/j.cbpa.2003.08.017; You X, 2006, P NATL ACAD SCI USA, V103, P18458, DOI 10.1073/pnas.0605422103	40	112	114	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9344	10.1371/journal.pone.0009344	http://dx.doi.org/10.1371/journal.pone.0009344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179761	Green Published, gold, Green Submitted			2022-12-25	WOS:000274923900010
J	Smith, ER; Cai, KQ; Smedberg, JL; Ribeiro, MM; Rula, ME; Slater, C; Godwin, AK; Xu, XX				Smith, Elizabeth R.; Cai, Kathy Qi; Smedberg, Jennifer L.; Ribeiro, Melina M.; Rula, Malgorzata E.; Slater, Carolyn; Godwin, Andrew K.; Xu, Xiang-Xi			Nuclear Entry of Activated MAPK Is Restricted in Primary Ovarian and Mammary Epithelial Cells	PLOS ONE			English	Article							DEVELOPING DROSOPHILA EYE; SURFACE EPITHELIUM; PROTEIN-KINASE; GENE-EXPRESSION; TRANSLOCATION; TRANSPORT; GROWTH; PHOSPHORYLATION; IMPORT; ERK2	Background: The MAPK/ERK1/2 serine kinases are primary mediators of the Ras mitogenic signaling pathway. Phosphorylation by MEK activates MAPK/ERK in the cytoplasm, and phospho-ERK is thought to enter the nucleus readily to modulate transcription. Principal Findings: Here, however, we observe that in primary cultures of breast and ovarian epithelial cells, phosphorylation and activation of ERK1/2 are disassociated from nuclear translocalization and transcription of downstream targets, such as c-Fos, suggesting that nuclear translocation is limited in primary cells. Accordingly, in import assays in vitro, primary cells showed a lower import activity for ERK1/2 than cancer cells, in which activated MAPK readily translocated into the nucleus and activated c-Fos expression. Primary cells express lower levels of nuclear pore complex proteins and the nuclear transport factors, importin B1 and importin 7, which may explain the limiting ERK1/2 import found in primary cells. Additionally, reduction in expression of nucleoporin 153 by siRNA targeting reduced ERK1/2 nuclear activity in cancer cells. Conclusion: ERK1/2 activation is dissociated from nuclear entry, which is a rate limiting step in primary cells and in vivo, and the restriction of nuclear entry is disrupted in transformed cells by the increased expression of nuclear pores and/or nuclear transport factors.	[Smith, Elizabeth R.; Ribeiro, Melina M.; Xu, Xiang-Xi] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Smith, Elizabeth R.; Ribeiro, Melina M.; Xu, Xiang-Xi] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Cai, Kathy Qi; Smedberg, Jennifer L.; Rula, Malgorzata E.; Slater, Carolyn; Godwin, Andrew K.] Fox Chase Canc Ctr, Dept Med Oncol, Ovarian Canc Program, Philadelphia, PA 19111 USA; [Cai, Kathy Qi; Smedberg, Jennifer L.; Rula, Malgorzata E.; Slater, Carolyn; Godwin, Andrew K.] Fox Chase Canc Ctr, Dept Med Oncol, Tumor Cell Biol Program, Philadelphia, PA 19111 USA	University of Miami; University of Miami; Fox Chase Cancer Center; Fox Chase Cancer Center	Smith, ER (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.	esmith@med.miami.edu			National Cancer Institute [R01CA099471, R01CA79716, R01CA75389]; Marsha Rivkin Ovarian Cancer Research Center and DOD Ovarian Concept [W81XWH-07-1-0303]; NATIONAL CANCER INSTITUTE [R01CA075389, R01CA099471, R01CA079716] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Marsha Rivkin Ovarian Cancer Research Center and DOD Ovarian Concept; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grants R01CA099471, R01CA79716, and R01CA75389 (to X-XX). E. R. S. received support from the Marsha Rivkin Ovarian Cancer Research Center and DOD Ovarian Concept W81XWH-07-1-0303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; BERCHUCK A, 1991, AM J OBSTET GYNECOL, V164, P669, DOI 10.1016/S0002-9378(11)80044-X; BRONDELLO JM, 1995, ONCOGENE, V10, P1895; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Cai KQ, 2007, MOL CARCINOGEN, V46, P130, DOI 10.1002/mc.20273; Capo-Chichi CD, 2002, CANCER-AM CANCER SOC, V95, P1802, DOI 10.1002/cncr.10870; Chakraborty P, 2008, DEV CELL, V15, P657, DOI 10.1016/j.devcel.2008.08.020; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Dyck HG, 1996, INT J CANCER, V69, P429, DOI 10.1002/(SICI)1097-0215(19961220)69:6<429::AID-IJC1>3.0.CO;2-6; FELDHERR CM, 1991, J CELL BIOL, V115, P933, DOI 10.1083/jcb.115.4.933; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Gaytan M, 2005, REPRODUCTION, V129, P311, DOI 10.1530/rep.1.00401; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GILLET JY, 1980, BIOL OVARY, P86; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; James BP, 2007, MOL BIOL CELL, V18, P4190, DOI 10.1091/mbc.E06-07-0659; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; KRUK PA, 1990, LAB INVEST, V63, P132; Kumar JP, 2003, DEVELOPMENT, V130, P3703, DOI 10.1242/dev.00556; Kumar JP, 1998, DEVELOPMENT, V125, P3875; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lorenzen JA, 2001, DEVELOPMENT, V128, P1403; Lyman SK, 2001, J CELL BIOL, V154, P17, DOI 10.1083/jcb.200106071; Mackay DR, 2009, MOL BIOL CELL, V20, P1652, DOI 10.1091/mbc.E08-08-0883; MARAIS R, 1993, CELL, V65, P663; Marenda DR, 2006, DEVELOPMENT, V133, P43, DOI 10.1242/dev.02168; Martinez N, 1999, CANCER RES, V59, P5408; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Pouton CW, 2007, ADV DRUG DELIVER REV, V59, P698, DOI 10.1016/j.addr.2007.06.010; Ranganathan A, 2006, J BIOL CHEM, V281, P15645, DOI 10.1074/jbc.M513866200; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; SIEMENS CH, 1988, J CELL PHYSIOL, V134, P347, DOI 10.1002/jcp.1041340305; Smith ER, 2004, J CELL BIOL, V164, P689, DOI 10.1083/jcb.200312028; SOULE HD, 1986, IN VITRO CELL DEV B, V22, P6, DOI 10.1007/BF02623435; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Tresini M, 2001, EXP CELL RES, V269, P287, DOI 10.1006/excr.2001.5334; Vrailas AD, 2006, DEVELOPMENT, V133, P1485, DOI 10.1242/dev.02334; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Whitehurst AW, 2004, J BIOL CHEM, V279, P12840, DOI 10.1074/jbc.M310031200; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Yang SH, 1999, EMBO J, V18, P5666, DOI 10.1093/emboj/18.20.5666; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200	55	32	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9295	10.1371/journal.pone.0009295	http://dx.doi.org/10.1371/journal.pone.0009295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174585	Green Published, gold, Green Submitted			2022-12-25	WOS:000274654700022
J	Rato, S; Maia, S; Brito, PM; Resende, L; Pereira, CF; Moita, C; Freitas, RP; Moniz-Pereira, J; Hacohen, N; Moita, LF; Goncalves, J				Rato, Sylvie; Maia, Sara; Brito, Paula M.; Resende, Leonor; Pereira, Carina F.; Moita, Catarina; Freitas, Rui P.; Moniz-Pereira, Jose; Hacohen, Nir; Moita, Luis Ferreira; Goncalves, Joao			Novel HIV-1 Knockdown Targets Identified by an Enriched Kinases/Phosphatases shRNA Library Using a Long-Term Iterative Screen in Jurkat T-Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LENTIVIRAL VECTORS; DRUGGABLE GENOME; HUMAN HOMOLOG; TAT PROTEIN; EED; REPLICATION; KINASES; DRUG; VPR	HIV-1 is a complex retrovirus that uses host machinery to promote its replication. Understanding cellular proteins involved in the multistep process of HIV-1 infection may result in the discovery of more adapted and effective therapeutic targets. Kinases and phosphatases are a druggable class of proteins critically involved in regulation of signal pathways of eukaryotic cells. Here, we focused on the discovery of kinases and phosphatases that are essential for HIV-1 replication but dispensable for cell viability. We performed an iterative screen in Jurkat T-cells with a short-hairpin-RNA (shRNA) library highly enriched for human kinases and phosphatases. We identified 14 new proteins essential for HIV-1 replication that do not affect cell viability. These proteins are described to be involved in MAPK, JNK and ERK pathways, vesicular traffic and DNA repair. Moreover, we show that the proteins under study are important in an early step of HIV-1 infection before viral integration, whereas some of them affect viral transcription/translation. This study brings new insights for the complex interplay of HIV1/host cell and opens new possibilities for antiviral strategies.	[Rato, Sylvie; Maia, Sara; Brito, Paula M.; Resende, Leonor; Pereira, Carina F.; Moniz-Pereira, Jose; Goncalves, Joao] Univ Lisbon, Fac Farm, URIA Ctr Patogenese Mol, P-1699 Lisbon, Portugal; [Rato, Sylvie; Maia, Sara; Brito, Paula M.; Resende, Leonor; Pereira, Carina F.; Moita, Catarina; Freitas, Rui P.; Moita, Luis Ferreira; Goncalves, Joao] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Charlestown, MA USA; [Hacohen, Nir] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Hacohen, Nir] MIT, Cambridge, MA 02139 USA	Universidade de Lisboa; Universidade de Lisboa; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Rato, S (corresponding author), Univ Lisbon, Fac Farm, URIA Ctr Patogenese Mol, P-1699 Lisbon, Portugal.	joao.goncalves@ff.ul.pt	Moita, Luis F./L-1296-2013; iMed.ULisboa, M2B/B-5277-2014; Moita, Luis/HCI-2793-2022; Brito, Paula/H-3693-2013; Maia, Sara/B-2513-2013; Goncalves, Joao/B-2013-2008	Moita, Luis F./0000-0003-0707-315X; iMed.ULisboa, M2B/0000-0002-1245-3715; Moita, Luis/0000-0003-0707-315X; Brito, Paula/0000-0002-0105-6968; Maia, Sara/0000-0001-8638-0566; Goncalves, Joao/0000-0002-1245-3715; /0000-0002-8779-2017; Ferreira Moita, Catarina/0000-0002-9910-2343; Rato, Sylvie/0000-0002-0204-0335	Fundacao para Ciencia e Tecnologia [PTDC/SAU-MII/65346/2006, PTDC/SAU-MII/69280/2006, PTDC/SAU-MII/78333/2006]	Fundacao para Ciencia e Tecnologia(Portuguese Foundation for Science and Technology)	This work was supported by Fundacao para Ciencia e Tecnologia (PTDC/SAU-MII/65346/2006, PTDC/SAU-MII/69280/2006 and PTDC/SAU-MII/78333/2006)(www.fct.mctes.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bristow CL, 2003, BLOOD, V102, P4479, DOI 10.1182/blood-2003-05-1635; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Dayton AI, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-15; Devroe E, 2005, VIROLOGY, V331, P181, DOI 10.1016/j.virol.2004.10.023; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; Flexner C, 2007, NAT REV DRUG DISCOV, V6, P959, DOI 10.1038/nrd2336; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Goff SP, 2008, CELL, V135, P417, DOI 10.1016/j.cell.2008.10.007; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gragerov A, 1998, VIROLOGY, V245, P323, DOI 10.1006/viro.1998.9138; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Greenway AL, 2003, J BIOSCIENCES, V28, P323, DOI 10.1007/BF02970151; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hui B, 2006, J NEUROCHEM, V97, P334, DOI 10.1111/j.1471-4159.2006.03698.x; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jacque JM, 1998, EMBO J, V17, P2607, DOI 10.1093/emboj/17.9.2607; Kok KH, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-78; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mammano F, 2000, J VIROL, V74, P8524, DOI 10.1128/JVI.74.18.8524-8531.2000; Mischiati C, 1999, AIDS, V13, P1637, DOI 10.1097/00002030-199909100-00006; Mishra S, 2007, J BIOL CHEM, V282, P4288, DOI 10.1074/jbc.M608307200; Muthumani K, 2005, CELL DEATH DIFFER, V12, P962, DOI 10.1038/sj.cdd.4401583; Nekhai S, 2007, CURR HIV RES, V5, P3, DOI 10.2174/157016207779316279; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Peytavi R, 1999, J BIOL CHEM, V274, P1635, DOI 10.1074/jbc.274.3.1635; Popik W, 2000, VIROLOGY, V276, P1, DOI 10.1006/viro.2000.0581; Rakotobe D, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-37; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Schafer EA, 2006, ANTIVIR RES, V72, P224, DOI 10.1016/j.antiviral.2006.06.008; Stevenson M, 2008, SCI AM, V299, P78, DOI 10.1038/scientificamerican1108-78; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; van Hoffen A, 2003, TOXICOLOGY, V193, P79, DOI 10.1016/j.tox.2003.06.001; Violot S, 2003, J VIROL, V77, P12507, DOI 10.1128/JVI.77.23.12507-12522.2003; WithersWard ES, 1997, J VIROL, V71, P9732, DOI 10.1128/JVI.71.12.9732-9742.1997; Witte V, 2004, MOL CELL, V13, P179, DOI 10.1016/S1097-2765(04)00004-8; Yang XY, 1999, J BIOL CHEM, V274, P27981, DOI 10.1074/jbc.274.39.27981; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	47	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9276	10.1371/journal.pone.0009276	http://dx.doi.org/10.1371/journal.pone.0009276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174665	Green Submitted, Green Published, gold			2022-12-25	WOS:000274590600029
J	Huijgen, R; Kindt, I; Verhoeven, SBJ; Sijbrands, EJG; Vissers, MN; Kastelein, JJP; Hutten, BA				Huijgen, Roeland; Kindt, Iris; Verhoeven, Sjoerd B. J.; Sijbrands, Eric J. G.; Vissers, Maud N.; Kastelein, John J. P.; Hutten, Barbara A.			Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment Goal	PLOS ONE			English	Article							RANDOMIZED-TRIALS; EFFICACY; STATINS; METAANALYSIS; NETHERLANDS; MUTATIONS; SAFETY; RISK	Background: The risk of premature cardiovascular disease in patients with familial hypercholesterolemia (FH) can be profoundly reduced by cholesterol-lowering therapy, and current guidelines for FH advocate ambitious low-density lipoprotein cholesterol (LDL-C) goals. In the present study, we determined whether these goals are reflected in current clinical practice once FH has been diagnosed. Methodology/Principal Findings: In 2008, we sent questionnaires to all subjects (aged 18-65 years) who were molecularly diagnosed with FH in the year 2006 through the screening program in the Netherlands. Of these 1062 subjects, 781 completed the questionnaire (46% males; mean age: 42 +/- 12 years; mean LDL-C at molecular diagnosis (baseline): 4.1 +/- 1.3 mmol/L). The number of persons that used cholesterol-lowering therapy increased from 397 (51%) at baseline to 636 (81%) after diagnosis. Mean treated LDL-C levels decreased significantly to 3.2 +/- 1.1 mmol/L two years after diagnosis. Only 22% achieved the LDL-C target level of <= 2.5 mmol/L. Conclusions/Significance: The proportion of patients using cholesterol-lowering medication was significantly increased after FH diagnosis through genetic cascade screening. The attained LDL-C levels were lower than those reported in previous surveys on medication use in FH, which could reflect the effect of more stringent lipid target levels. However, only a minority of the medication users reached the LDL-C target.	[Huijgen, Roeland; Verhoeven, Sjoerd B. J.; Vissers, Maud N.; Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Kindt, Iris] Fdn Identificat Persons Inherited Hypercholestero, Amsterdam, Netherlands; [Sijbrands, Eric J. G.] Erasmus MC, Dept Cardiovasc Genet, Rotterdam, Netherlands; [Sijbrands, Eric J. G.] Erasmus MC, Dept Pharmacol Vasc & Metab Dis, Rotterdam, Netherlands; [Hutten, Barbara A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam	Huijgen, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.huijgen@amc.uva.nl	Kastelein, John/AAF-7950-2020; Sijbrands, Eric/A-1065-2009	Sijbrands, Eric/0000-0001-8857-7389	AstraZeneca; Pfizer; Roche; Novartis; Merck; Merck-Schering-Plough; Isis; Genzyme; Sanofi-Aventis; Ministry of Health of the Dutch Government	AstraZeneca(AstraZeneca); Pfizer(Pfizer); Roche(Roche Holding); Novartis(Novartis); Merck(Merck & Company); Merck-Schering-Plough(Merck & CompanySchering Plough Corporation); Isis; Genzyme(Sanofi-AventisGenzyme Corporation); Sanofi-Aventis(Sanofi-Aventis); Ministry of Health of the Dutch Government	Funding: J.J.P.K. received grant support from AstraZeneca, Pfizer, Roche, Novartis, Merck, Merck-Schering-Plough, Isis, Genzyme, and Sanofi-Aventis; lecture fees from AstraZeneca, GlaxoSmithKline, Pfizer, Novartis, Merck-Schering-Plough, Roche, Isis, and Boehringer Ingelheim; and consulting fees from AstraZeneca, Abbott, Pfizer, Isis, Genzyme, Roche, Novartis, Merck, Merck-Schering-Plough, and Sanofi-Aventis. The FH screening program itself is financed by the Ministry of Health of the Dutch Government. Although no specific additional funding was required for the author's survey, the authors state that the funders of the screening program had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abifadel M, 2009, HUM MUTAT, V30, pE682, DOI 10.1002/humu.21002; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Fouchier Sigrid W, 2004, Semin Vasc Med, V4, P259, DOI 10.1055/s-2004-861493; Fouchier SW, 2005, HUM MUTAT, V26, P550, DOI 10.1002/humu.20256; Fouchier SW, 2009, ATHEROSCLEROSIS SUPP, V10, pP870; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; GOTTO AM, 1984, CIRCULATION, V69, pA1065; Hadfield SG, 2008, ANN CLIN BIOCHEM, V45, P199, DOI 10.1258/acb.2007.007078; HUIJGEN R, 2009, ATHEROSCLEROSIS SUPP, V10, pP841; Huijgen Roeland, 2008, Expert Rev Cardiovasc Ther, V6, P567, DOI 10.1586/14779072.6.4.567; Josan K, 2008, CAN MED ASSOC J, V178, P576, DOI 10.1503/cmaj.070675; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Leren TP, 2008, COMMUNITY GENET, V11, P26, DOI 10.1159/000111637; Neil HAW, 2004, HEART, V90, P1431, DOI 10.1136/hrt.2003.022764; Neil HAW, 2000, BRIT MED J, V321, P148, DOI 10.1136/bmj.321.7254.148; PIJLMAN AH, 2009, ATHEROSCLER IN PRESS; Robinson JG, 2005, J AM COLL CARDIOL, V46, P1855, DOI 10.1016/j.jacc.2005.05.085; SLACK J, 1969, LANCET, V2, P1380; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; Souverein OW, 2007, EUR HEART J, V28, P299, DOI 10.1093/eurheartj/ehl366; Umans-Eckenhausen MAW, 2003, ARCH INTERN MED, V163, P65, DOI 10.1001/archinte.163.1.65; Umans-Eckenhausen MAW, 2002, CIRCULATION, V106, P3031, DOI 10.1161/01.CIR.0000041253.61683.08; Umans-Eckenhausen MAW, 2001, LANCET, V357, P165, DOI 10.1016/S0140-6736(00)03587-X; van der Graaf A, 2008, ANN INTERN MED, V148, P712, DOI 10.7326/0003-4819-148-9-200805060-00022; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; Walma E P, 2006, Ned Tijdschr Geneeskd, V150, P18; Wierzbicki AS, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1095	27	100	104	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9220	10.1371/journal.pone.0009220	http://dx.doi.org/10.1371/journal.pone.0009220			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169164	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474700014
J	van Woesik, R; Shiroma, K; Koksal, S				van Woesik, Robert; Shiroma, Kazuyo; Koksal, Semen			Phenotypic Variance Predicts Symbiont Population Densities in Corals: A Modeling Approach	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PHOTOCHEMICAL EFFICIENCY; LANDSCAPE ECOLOGY; DIURNAL CHANGES; PHOTOSYSTEM-II; CLIMATE-CHANGE; ZOOXANTHELLAE; DIVERSITY; EVOLUTION; PATTERNS	Background: We test whether the phenotypic variance of symbionts (Symbiodinium) in corals is closely related with the capacity of corals to acclimatize to increasing seawater temperatures. Moreover, we assess whether more specialist symbionts will increase within coral hosts under ocean warming. The present study is only applicable to those corals that naturally have the capacity to support more than one type of Symbiodinium within the lifetime of a colony; for example, Montastraea annularis and Montastraea faveolata. Methodology/Principal Findings: The population dynamics of competing Symbiodinium symbiont populations were projected through time in coral hosts using a novel, discrete time optimal-resource model. Models were run for two Atlantic Ocean localities. Four symbiont populations, with different environmental optima and phenotypic variances, were modeled to grow, divide, and compete in the corals under seasonal fluctuations in solar insolation and seawater temperature. Elevated seawater temperatures were input into the model 1.5 degrees C above the seasonal summer average, and the symbiont population response was observed for each location. The models showed dynamic fluctuations in Symbiodinium populations densities within corals. Population density predictions for Lee Stocking Island, the Bahamas, where temperatures were relatively homogenous throughout the year, showed a dominance of both type 2, with high phenotypic variance, and type 1, a high-temperature and high-insolation specialist. Whereas the densities of Symbiodinium types 3 and 4, a high-temperature, low-insolation specialist, and a high-temperature, low-insolation generalist, remained consistently low. Predictions for Key Largo, Florida, where environmental conditions were more seasonally variable, showed the coexistence of generalists (types 2 and 4) and low densities of specialists (types 1 and 3). When elevated temperatures were input into the model, population densities in corals at Lee Stocking Island showed an emergence of high-temperature specialists. However, even under high temperatures, corals in the Florida Keys were dominated by generalists. Conclusions/Significance: Predictions at higher seawater temperatures showed endogenous shuffling and an emergence of the high-temperature Symbiodinium specialists, even though their phenotypic variance was low. The model shows that sustaining these "hidden'' specialists becomes advantageous under thermal stress conditions, and shuffling symbionts may increase the corals' capacity to acclimatize but not adapt to climatechange-induced ocean warming.	[van Woesik, Robert; Shiroma, Kazuyo] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; [Koksal, Semen] Florida Inst Technol, Dept Math Sci, Melbourne, FL 32901 USA	Florida Institute of Technology; Florida Institute of Technology	van Woesik, R (corresponding author), Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA.	rvw@fit.edu			Okinawa International Exchange & Human Resources Development Foundation; World Bank; Global Environmental Facility; Coral Bleaching; Local Environmental Responses working group	Okinawa International Exchange & Human Resources Development Foundation; World Bank(The World Bank India); Global Environmental Facility; Coral Bleaching; Local Environmental Responses working group	Funding for study to KS was provided by the Okinawa International Exchange & Human Resources Development Foundation. This research was supported in part by the World Bank and the Global Environmental Facility through the Coral Reef Targeted Research and Capacity Building for Management program, Coral Bleaching and Local Environmental Responses working group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; Berkelmans R, 2002, MAR ECOL PROG SER, V229, P73, DOI 10.3354/meps229073; BRADSHAW AD, 1991, PHILOS T R SOC B, V333, P289, DOI 10.1098/rstb.1991.0079; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Brown BE, 1999, CORAL REEFS, V18, P99; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Chen CA, 2005, MAR ECOL PROG SER, V295, P113, DOI 10.3354/meps295113; Day T, 2008, AM NAT, V171, pE72, DOI 10.1086/524956; Dunn SR, 2002, J EXP MAR BIOL ECOL, V272, P29, DOI 10.1016/S0022-0981(02)00036-9; Fagoonee I, 1999, SCIENCE, V283, P843, DOI 10.1126/science.283.5403.843; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Fitt WK, 2001, MAR BIOL, V139, P507; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Gingerich PD, 2000, J THEOR BIOL, V204, P201, DOI 10.1006/jtbi.2000.2008; GLYNN PW, 1991, TRENDS ECOL EVOL, V6, P175, DOI 10.1016/0169-5347(91)90208-F; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Hellmann JJ, 2007, BIOL CONSERV, V137, P599, DOI 10.1016/j.biocon.2007.03.018; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hubbell S.P., 2001, MG POP BIOL, V32; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Hutchinson GE, 1941, AM NAT, V75, P406, DOI 10.1086/280983; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jones RJ, 1997, PHILOS T ROY SOC B, V352, P457, DOI 10.1098/rstb.1997.0033; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; McClanahan T, 2002, AMBIO, V31, P543, DOI 10.1639/0044-7447(2002)031[0543:EOTCME]2.0.CO;2; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; Pillay RM, 2005, SYMBIOSIS, V38, P209; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; ROWAN R, 1992, P NATL ACAD SCI USA, V89, P3639, DOI 10.1073/pnas.89.8.3639; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Santos SR, 2004, J PHYCOL, V40, P395, DOI 10.1111/j.1529-8817.2004.03186.x; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Stimson J, 1997, J EXP MAR BIOL ECOL, V214, P35, DOI 10.1016/S0022-0981(96)02753-0; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Taylor DL, 1974, SYMBIOSIS SEA, P245; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Thornhill DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006262; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Toller WW, 2001, BIOL BULL, V201, P348, DOI 10.2307/1543613; van Woesik R, 2006, ECOL LETT, V9, P390, DOI 10.1111/j.1461-0248.2006.00886.x; van Woesik R., 2002, Comments on Theoretical Biology, V7, P201, DOI 10.1080/08948550214054; VANWOESIK R, 2006, COASTAL ESTUARINE ST, V61, P129; Wagner D, 2008, B MAR SCI, V83, P553; Ware JR, 1996, ECOL MODEL, V84, P199, DOI 10.1016/0304-3800(94)00132-4; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Warner ME, 2002, MAR BIOL, V141, P31, DOI 10.1007/s00227-002-0807-8	66	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9185	10.1371/journal.pone.0009185	http://dx.doi.org/10.1371/journal.pone.0009185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169202	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474600006
J	De Kroon, MLA; Renders, CM; Van Wouwe, JP; Van Buuren, S; Hirasing, RA				De Kroon, Marlou L. A.; Renders, Carry M.; Van Wouwe, Jacobus P.; Van Buuren, Stef; Hirasing, Remy A.			The Terneuzen Birth Cohort: BMI Changes between 2 and 6 Years Correlate Strongest with Adult Overweight	PLOS ONE			English	Article							BODY-MASS INDEX; WEIGHT-GAIN; CHILDHOOD GROWTH; YOUNG ADULTHOOD; OBESITY; CHILDREN; INFANT; SIZE; ADOLESCENCE; AGE	Background: Complications of overweight amplify with age, and irreversible damage already exists in young persons. Identifying the most sensitive age interval(s) for adult overweight is relevant for primary prevention. The aim of the study was to assess the relative contribution of body mass index (BMI) changes between 0 and 18 years to adult overweight, and to identify the earliest critical growth period. Methods and Findings: Data from 762 subjects in the Terneuzen Birth Cohort with an average of 21 growth measurements per subject from birth until 18 years were used. The main outcome measure was the BMI standard deviation score (SDS) at young adulthood. For each subject BMI SDS was fitted by a piecewise linear model at eight different ages and correlated to adult BMI SDS. The age intervals in between are considered critical according to three criteria, tested by respectively Students' t-tests, multiple linear regression analyses and Pearson's correlation tests. In the age intervals 4 months(m) -1 year(y), 2-6 y, 6-10 y and 10-18 y the BMI SDS change differs between adults with and without overweight (P <= 0.001). The age intervals 2-6 y and 10-18 y also meet the second criterion, implying that the BMI change during this period has a predictive value for adult BMI SDS in addition to BMI SDS at the end of the period. The largest rise in correlation between estimated BMI SDS and measured adult BMI SDS occurs during the period 2-6 y (from 0.36 to 0.63), which results in a high sensitivity (0.6) and specificity (0.8) by the age of 6 y. Conclusions/Significance: The age interval from 2 y to 6 y is the earliest and most critical growth period for adult overweight. Therefore, primary prevention of adult overweight seems most likely to be successful if targeted at this specific age interval. By identifying those with an upwards centile crossing between 2 and 6 years, the development towards adult overweight might be reversed.	[De Kroon, Marlou L. A.; Renders, Carry M.; Hirasing, Remy A.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Van Wouwe, Jacobus P.; Van Buuren, Stef] TNO Qual Life Prevent & Hlth Care, Netherlands Org Appl Sci Res, Leiden, Netherlands; [Van Buuren, Stef] Univ Utrecht, Dept Methodol & Stat, Fac Social Sci, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research; Utrecht University	De Kroon, MLA (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.	ml.dekroon@vumc.nl	de Kroon, Marlou MLA/M-4040-2014; Van Wouwe, Jacobus P/D-5549-2018	Van Wouwe, Jacobus P/0000-0001-9273-6258; van Buuren, Stef/0000-0003-1098-2119; de Kroon, Marlou/0000-0003-1730-4994; Renders, Carry/0000-0001-6688-1312	Health Research and Development Council of the Netherlands [2100.0092]; Municipal Health Services of Terneuzen (GGD Zeeland)	Health Research and Development Council of the Netherlands; Municipal Health Services of Terneuzen (GGD Zeeland)	This study received a grant from the Health Research and Development Council of the Netherlands (ZONMw Grants no. 2100.0092). The funders had no role in study desigh, data collection and analysis, decision to publish or preparation of the manuscript.; We gratefully thank all participants for their time, the assistants for their contribution in the field work, the laboratory of the Community Hospital in the city of Terneuzen, especially Ruud Muusze, PhD, the Municipal Health Services of Terneuzen (GGD Zeeland) for support and cooperation, and Guus A. de Jonge, PhD, professor emeritus, for laying the foundations of this study in 1977-1986.	Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Blair NJ, 2007, ARCH DIS CHILD, V92, P866, DOI 10.1136/adc.2007.116855; Botton J, 2008, AM J CLIN NUTR, V87, P1760, DOI 10.1093/ajcn/87.6.1760; Cole T J, 2004, BMC Pediatr, V4, P6; Corvalan C, 2007, INT J EPIDEMIOL, V36, P550, DOI 10.1093/ije/dym010; DEKROON ML, 2008, EUR J PUBLIC HEALTH, V6, P656; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Eriksson J, 2003, INT J OBESITY, V27, P722, DOI 10.1038/sj.ijo.0802278; Euser AM, 2005, AM J CLIN NUTR, V81, P480; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Freedman DS, 2009, ARCH PEDIAT ADOL MED, V163, P805, DOI 10.1001/archpediatrics.2009.104; Jones HE, 2009, STAT MED, V28, P1645, DOI 10.1002/sim.3583; Kindblom JM, 2009, DIABETES, V58, P867, DOI 10.2337/db08-0606; Kvaavik E, 2003, ARCH PEDIAT ADOL MED, V157, P1212, DOI 10.1001/archpedi.157.12.1212; Lagstrom H, 2008, PEDIATRICS, V122, pE876, DOI 10.1542/peds.2007-2354; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; MARTORELL R, 1995, J NUTR, V125, pS1127, DOI 10.1093/jn/125.suppl_4.1127S; McCarthy A, 2007, AM J CLIN NUTR, V86, P907, DOI 10.1093/ajcn/86.4.907; Monteiro POA, 2003, INT J OBESITY, V27, P1274, DOI 10.1038/sj.ijo.0802409; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Oren A, 2003, INT J OBESITY, V27, P1383, DOI 10.1038/sj.ijo.0802404; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Scholtens S, 2007, AM J EPIDEMIOL, V165, P919, DOI 10.1093/aje/kwk083; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Snijders T, 1999, MULTILEVEL ANAL; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; Stettler N, 2005, CIRCULATION, V111, P1897, DOI 10.1161/01.CIR.0000161797.67671.A7; Taylor RW, 2005, CURR OPIN CLIN NUTR, V8, P607, DOI 10.1097/01.mco.0000168391.60884.93; Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4; Vogels N, 2006, AM J CLIN NUTR, V84, P717, DOI 10.1093/ajcn/84.4.717; Wells JCK, 2007, P NUTR SOC, V66, P423, DOI 10.1017/S0029665107005691; WHITAKER RC, 1998, PEDIATRICS, V101, P1	34	52	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9155	10.1371/journal.pone.0009155	http://dx.doi.org/10.1371/journal.pone.0009155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161800	Green Published, gold			2022-12-25	WOS:000274442800003
J	Gordienko, R; Ohno, H; Singh, VK; Jia, ZC; Ripmeester, JA; Walker, VK				Gordienko, Raimond; Ohno, Hiroshi; Singh, Vinay K.; Jia, Zongchao; Ripmeester, John A.; Walker, Virginia K.			Towards a Green Hydrate Inhibitor: Imaging Antifreeze Proteins on Clathrates	PLOS ONE			English	Article							KINETIC INHIBITORS; GAS; GROWTH; CRYSTAL; MELT	The formation of hydrate plugs in oil and gas pipelines is a serious industrial problem and recently there has been an increased interest in the use of alternative hydrate inhibitors as substitutes for thermodynamic inhibitors like methanol. We show here that antifreeze proteins (AFPs) possess the ability to modify structure II (sII) tetrahydrofuran (THF) hydrate crystal morphologies by adhering to the hydrate surface and inhibiting growth in a similar fashion to the kinetic inhibitor poly-N-vinylpyrrolidone (PVP). The effects of AFPs on the formation and growth rate of high-pressure sII gas mix hydrate demonstrated that AFPs are superior hydrate inhibitors compared to PVP. These results indicate that AFPs may be suitable for the study of new inhibitor systems and represent an important step towards the development of biologically-based hydrate inhibitors.	[Gordienko, Raimond; Ohno, Hiroshi; Walker, Virginia K.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Singh, Vinay K.; Jia, Zongchao] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Ohno, Hiroshi; Ripmeester, John A.] Natl Res Council Canada, Mat Struct & Funct Grp, Ottawa, ON, Canada	Queens University - Canada; Queens University - Canada; National Research Council Canada	Gordienko, R (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	walkervk@queensu.ca	Ripmeester, John A/G-1950-2011		Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Natural Sciences and Engineering Research Council of Canada (NSERC) Strategic and Discovery grants: http://www.nserc-crsng.gc.ca/Professors-Professeurs/RPP- PP/SNG-SRS_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett J, 2001, INT J BIOCHEM CELL B, V33, P105, DOI 10.1016/S1357-2725(00)00083-2; CHAKRABARTTY A, 1991, EUR J BIOCHEM, V202, P1057, DOI 10.1111/j.1432-1033.1991.tb16470.x; Davies SR, 2006, AICHE J, V52, P4016, DOI 10.1002/aic.11005; Gilbert JA, 2005, FEMS MICROBIOL LETT, V245, P67, DOI 10.1016/j.femsle.2005.02.022; GORDON MS, 1962, BIOL BULL, V122, P52, DOI 10.2307/1539321; Huo Z, 2001, CHEM ENG SCI, V56, P4979, DOI 10.1016/S0009-2509(01)00188-9; Kennedy J.L., 1993, OIL GAS PIPELINE FUN; Knight CA, 2002, PHILOS MAG A, V82, P1609, DOI 10.1080/01418610210128159; Koh CA, 2002, FLUID PHASE EQUILIBR, V194, P143, DOI 10.1016/S0378-3812(01)00660-4; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; Larsen R, 1998, FLUID PHASE EQUILIBR, V150, P353, DOI 10.1016/S0378-3812(98)00335-5; Lederhos JP, 1996, CHEM ENG SCI, V51, P1221, DOI 10.1016/0009-2509(95)00370-3; Lee JD, 2005, CHEM ENG SCI, V60, P5323, DOI 10.1016/j.ces.2005.05.023; Makogon TY, 1997, J CRYST GROWTH, V179, P258, DOI 10.1016/S0022-0248(97)00118-8; MATERER N, 1995, J PHYS CHEM-US, V99, P6267, DOI 10.1021/j100017a002; MEHTA A, 2006, ANN NY ACAD SCI, V912, P366; Middleton AJ, 2009, FEBS LETT, V583, P815, DOI 10.1016/j.febslet.2009.01.035; Pudney PDA, 2003, ARCH BIOCHEM BIOPHYS, V410, P238, DOI 10.1016/S0003-9861(02)00697-5; Scotter AJ, 2006, CRYOBIOLOGY, V53, P229, DOI 10.1016/j.cryobiol.2006.06.006; Seo YT, 2005, ENVIRON SCI TECHNOL, V39, P2315, DOI 10.1021/es049269z; Sloan ED, 2003, NATURE, V426, P353, DOI 10.1038/nature02135; Smith J.M., 2001, INTRO CHEM ENG THERM; Tyshenko MG, 1997, NAT BIOTECHNOL, V15, P887, DOI 10.1038/nbt0997-887; Zeng H, 2006, J AM CHEM SOC, V128, P2844, DOI 10.1021/ja0548182; Zeng H, 2003, CAN J PHYS, V81, P17, DOI 10.1139/P03-001; Zeng H., 2007, ANGEW CHEM, V119, P5498; Zeng H, 2006, AICHE J, V52, P3304, DOI 10.1002/aic.10929	27	74	77	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e8953	10.1371/journal.pone.0008953	http://dx.doi.org/10.1371/journal.pone.0008953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161789	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442800001
J	Nemolato, S; Cabras, T; Cau, F; Fanari, MU; Fanni, D; Manconi, B; Messana, I; Castagnola, M; Faa, G				Nemolato, Sonia; Cabras, Tiziana; Cau, Flaviana; Fanari, Mattia Umberto; Fanni, Daniela; Manconi, Barbara; Messana, Irene; Castagnola, Massimo; Faa, Gavino			Different Thymosin Beta 4 Immunoreactivity in Foetal and Adult Gastrointestinal Tract	PLOS ONE			English	Article							ACTIN; CELLS; EXPRESSION; INSIGHTS; BIOLOGY; SWITCH	Background: Thymosin beta 4 (T beta(4)) is a member of beta-thymosins, a family of peptides that play essential roles in many cellular functions. A recent study from our group suggested a role for T beta(4) in the development of human salivary glands. The aim of this study was to analyze the expression of T beta(4) in the human gut during development, and in the adult. Methodology/Principal Findings: Immunolocalization of T beta(4) was studied in autoptic samples of tongue, oesophagus, stomach, ileum, colon, liver and pancreas obtained from two human foetuses and two adults. T beta(4) appeared unevenly distributed, with marked differences between foetuses and adults. In the stomach, superficial epithelium was positive in foetuses and negative in adults. Ileal enterocytes were strongly positive in the adult and weakly positive in the foetuses. An increase in reactivity for T beta(4) was observed in superficial colon epithelium of adults as compared with the foetuses. Striking differences were found between foetal and adult liver: the former showed a very low reactivity for T beta(4) while in the adult we observed a strong reactivity in the vast majority of the hepatocytes. A peculiar pattern was found in the pancreas, with the strongest reactivity observed in foetal and adult islet cells. Significance: Our data show a strong expression of T beta(4) in the human gut and in endocrine pancreas during development. The observed differential expression of T beta(4) suggests specific roles of the peptide in the gut of foetuses and adults. The observed heterogeneity of T beta(4) expression in the foetal life, ranging from a very rare detection in liver cells up to a diffuse reactivity in endocrine pancreas, should be taken into account when the role of T beta(4) in the development of human embryo is assessed. Future studies are needed to shed light on the link between T beta(4) and organogenesis.	[Nemolato, Sonia; Cau, Flaviana; Fanari, Mattia Umberto; Fanni, Daniela; Faa, Gavino] Univ Cagliari, Dipartimento Citomorfol, Div Anat Patol, Cagliari, Italy; [Cabras, Tiziana; Manconi, Barbara; Messana, Irene] Univ Cagliari, Dipartimento Sci Applicate Biosistemi, Cagliari, Italy; [Castagnola, Massimo] Univ Cattolica, Ist Biochim & Biochim Clin, Rome, Italy; [Castagnola, Massimo] Int ISI, Ist Sci, Ist Chim Riconoscimento Mol, CNR, Rome, Italy	University of Cagliari; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Nemolato, S (corresponding author), Univ Cagliari, Dipartimento Citomorfol, Div Anat Patol, Cagliari, Italy.	gavinofaa@gmail.com	Cabras, Tiziana/AAF-6231-2020; Castagnola, Massimo/AAM-6355-2021; Messana, Irene/L-2478-2019; Castagnola, Massimo/AAB-2825-2019; Fanni, Daniela/ABD-9643-2020; Fanni, Daniela/N-5669-2016	Messana, Irene/0000-0002-1436-6105; Castagnola, Massimo/0000-0002-0959-7259; Fanni, Daniela/0000-0003-2797-8343; Fanni, Daniela/0000-0003-2797-8343; cau, flaviana/0000-0001-6205-4555; Faa, Gavino/0000-0002-6129-0975	Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy	Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy(Fondazione Banco di Sardegna)	The authors acknowledge the financial support of Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet D, 1996, EXP HEMATOL, V24, P776; De La Cruz EM, 2001, SCIENCE, V293, P616, DOI 10.1126/science.1063558; Dominguez R, 2007, ANN NY ACAD SCI, V1112, P86, DOI 10.1196/annals.1415.011; Girardi M, 2003, IMMUNOLOGY, V109, P1, DOI 10.1046/j.1365-2567.2003.01616.x; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; GomezMarquez J, 1996, BBA-GENE STRUCT EXPR, V1306, P187, DOI 10.1016/0167-4781(96)00003-6; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Kupatt C, 2005, FASEB J, V19, P1576, DOI 10.1096/fj.04-3282fje; Lee SJ, 2008, FEBS LETT, V582, P2161, DOI 10.1016/j.febslet.2008.03.058; LIN SC, 1990, J MOL NEUROSCI, V2, P35, DOI 10.1007/BF02896924; LOW TLK, 1979, J BIOL CHEM, V254, P981; Moon HS, 2006, EXP CELL RES, V312, P3425, DOI 10.1016/j.yexcr.2006.07.021; Nemolato S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005109; Philp D, 2003, FASEB J, V17, P385, DOI 10.1096/fj.03-0244fje; Safer D, 1997, BIOCHEMISTRY-US, V36, P5806, DOI 10.1021/bi970185v; SAFER D, 1990, P NATL ACAD SCI USA, V87, P2536, DOI 10.1073/pnas.87.7.2536; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Smart Nicola, 2007, Angiogenesis, V10, P229, DOI 10.1007/s10456-007-9077-x; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2002, MECH DEVELOP, V119, pS65, DOI 10.1016/S0925-4773(03)00093-5; Sosne G, 2002, EXP EYE RES, V74, P293, DOI 10.1006/exer.2001.1125; Stossel TP, 2006, J CELL SCI, V119, P3261, DOI 10.1242/jcs.02994; SUN HQ, 1995, CURR OPIN CELL BIOL, V7, P102, DOI 10.1016/0955-0674(95)80051-4; Sun W, 2007, ANN NY ACAD SCI, V1112, P210, DOI 10.1196/annals.1415.013; von Kodpolitsch Y, 2004, Z KARDIOL, V93, P929, DOI 10.1007/s00392-004-0152-7; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Young JD, 1999, NAT MED, V5, P1424	28	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9111	10.1371/journal.pone.0009111	http://dx.doi.org/10.1371/journal.pone.0009111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161756	Green Submitted, Green Published, gold			2022-12-25	WOS:000274442600009
J	Miralem, T; Gibbs, PEM; Revert, F; Saus, J; Maines, MD				Miralem, Tihomir; Gibbs, Peter E. M.; Revert, Fernando; Saus, Juan; Maines, Mahin D.			Human Biliverdin Reductase Suppresses Goodpasture Antigen-binding Protein (GPBP) Kinase Activity THE REDUCTASE REGULATES TUMOR NECROSIS FACTOR-alpha-NF-kappa B-DEPENDENT GPBP EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE-1; OXIDATIVE STRESS; IV COLLAGEN; CRYSTAL-STRUCTURE; GENE-EXPRESSION; BILIRUBIN; IDENTIFICATION; PHOSPHORYLATION; ACTIVATION; INDUCTION	The Ser/Thr/Tyr kinase activity of human biliverdin reductase (hBVR) and the expression of Goodpasture antigen-binding protein (GPBP), a nonconventional Ser/Thr kinase for the type IV collagen of basement membrane, are regulated by tumor necrosis factor (TNF-alpha). The pro-inflammatory cytokine stimulates kinase activity of hBVR and activates NF-kappa B, a transcriptional regulator of GPBP mRNA. Increased GPBP activity is associated with several autoimmune conditions, including Goodpasture syndrome. Here we show that in HEK293A cells hBVR binds to GPBP and down-regulates its TNF-alpha-stimulated kinase activity; this was not due to a decrease in GPBP expression. Findings with small interfering RNA to hBVR and to the p65 regulatory subunit of NF-kappa B show the hBVRrole in the initial stimulation of GPBP expression by TNF-alpha activated NF-kappa B; hBVR was not a factor in mediating GPBP mRNA stability. The interacting domain was mapped to the (CX10C)-C-281 motif in the C-terminal 24 residues of hBVR. A 7-residue peptide, KKRILHC281, corresponding to the core of the consensus D(delta)-Box motif in the interacting domain, was as effective as the intact 296-residue hBVR polypeptide in inhibiting GPBP kinase activity. GPBP neither regulated hBVR expression nor TNF-alpha dependent NF-kappa B expression. Collectively, our data reveal that hBVR is a regulator of the TNF-alpha GPBP-collagen type IV signaling cascade and uncover a novel biological interaction that may be of relevance in autoimmune pathogenesis.	[Miralem, Tihomir; Gibbs, Peter E. M.; Maines, Mahin D.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Revert, Fernando; Saus, Juan] Ctr Invest Principe Felipe, Valencia 46012, Spain; [Saus, Juan] Univ Valencia, Dept Bioquim & Biol Mol, Valencia 46010, Spain	University of Rochester; Prince Felipe Research Center; University of Valencia	Maines, MD (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA.	mahin_maines@urmc.rochester.edu	REVERT, FERNANDO/ABF-8171-2021; Miralem, Tihomir/F-7576-2013	REVERT, FERNANDO/0000-0002-7304-5846; Saus, Juan/0000-0003-2082-1597; Miralem, Tihomir/0000-0001-7705-0442	National Institutes of Health [ES04066, ES12187]; SAF [2006-12520-C02-01]; Ministerio de Educacion y Ciencia; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004066, R01ES012187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SAF; Ministerio de Educacion y Ciencia(Spanish Government); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES04066 and ES12187 (to M.D.M.). This work was also supported by SAF 2006-12520-C02-01 from the Plan Nacional I + D of the Ministerio de Educacion y Ciencia and Prometeo/2009/065 from Generalitat Valenciana, of Spain (to J.S.).	BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; C J, 2008, AM J PHYSIOL-LUNG C, V295, pL624; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Gibbs PEM, 2007, INT J CANCER, V121, P2567, DOI 10.1002/ijc.22978; Graham B, 2005, CELL CYCLE, V4, P1342, DOI 10.4161/cc.4.10.2047; Granero F, 2005, FEBS J, V272, P5291, DOI 10.1111/j.1742-4658.2005.04925.x; Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147; HUBBARD SR, 1991, SCIENCE, V254, P1776; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hunter T, 1998, Harvey Lect, V94, P81; Immenschuh S, 2005, CELL MOL BIOL, V51, P471, DOI 10.1170/T652; Jacobs JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P8, DOI 10.1006/abbi.1999.1416; Juan SH, 2005, BIOCHEM PHARMACOL, V69, P41, DOI 10.1016/j.bcp.2004.09.015; Kalluri R, 2000, J BIOL CHEM, V275, P20027, DOI 10.1074/jbc.M904549199; Kapitulnik J, 2009, TRENDS PHARMACOL SCI, V30, P129, DOI 10.1016/j.tips.2008.12.003; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kasza A, 2005, J BIOL CHEM, V280, P1149, DOI 10.1074/jbc.M411161200; Kikuchi A, 2001, NAT STRUCT BIOL, V8, P221, DOI 10.1038/84955; Kravets A, 2004, J BIOL CHEM, V279, P19916, DOI 10.1074/jbc.M314251200; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Lerner-Marmarosh N, 2008, P NATL ACAD SCI USA, V105, P6870, DOI 10.1073/pnas.0800750105; Lerner-Marmarosh N, 2007, FASEB J, V21, P3949, DOI 10.1096/fj.07-8544com; LITERSKY JM, 1992, J BIOL CHEM, V267, P1563; Maghzal GJ, 2009, J BIOL CHEM, V284, P29251, DOI 10.1074/jbc.M109.037119; Maines MD, 2007, J BIOL CHEM, V282, P8110, DOI 10.1074/jbc.M513427200; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; MAINES MD, 1993, ARCH BIOCHEM BIOPHYS, V300, P320, DOI 10.1006/abbi.1993.1044; Maines MD, 1996, EUR J BIOCHEM, V235, P372, DOI 10.1111/j.1432-1033.1996.00372.x; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Mancuso C, 2006, REDOX REP, V11, P207, DOI 10.1179/135100006X154978; MCCOUBREY WK, 1995, BIOL REPROD, V53, P1330, DOI 10.1095/biolreprod53.6.1330; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Miralem T, 2005, J BIOL CHEM, V280, P17084, DOI 10.1074/jbc.M413121200; Naidu S, 2008, J IMMUNOL, V181, P4113, DOI 10.4049/jimmunol.181.6.4113; Nath KA, 2001, KIDNEY INT, V59, P106, DOI 10.1046/j.1523-1755.2001.00471.x; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; QUINONES S, 1992, J BIOL CHEM, V267, P19780; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Revert F, 2008, J BIOL CHEM, V283, P30246, DOI 10.1074/jbc.M805026200; Revert F, 2007, AM J PATHOL, V171, P1419, DOI 10.2353/ajpath.2007.070205; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; SAUS J, 1998, ENCY IMMUNOLOGY, P1005; Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tudor C, 2008, BIOCHEM J, V413, P405, DOI 10.1042/BJ20080018; Whitby FG, 2002, J MOL BIOL, V319, P1199, DOI 10.1016/S0022-2836(02)00383-2	51	13	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12551	12558		10.1074/jbc.M109.032771	http://dx.doi.org/10.1074/jbc.M109.032771			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177069	hybrid, Green Published			2022-12-25	WOS:000276787800012
J	Barreteau, H; Bouhss, A; Gerard, F; Duche, D; Boussaid, B; Blanot, D; Lloubes, R; Mengin-Lecreulx, D; Touze, T				Barreteau, Helene; Bouhss, Ahmed; Gerard, Fabien; Duche, Denis; Boussaid, Boubekeur; Blanot, Didier; Lloubes, Roland; Mengin-Lecreulx, Dominique; Touze, Thierry			Deciphering the Catalytic Domain of Colicin M, a Peptidoglycan Lipid II-degrading Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; IMMUNITY PROTEIN; BIOSYNTHESIS; ACQUISITION; EXPRESSION; INHIBITOR; MECHANISM; BINDING; GENES; CELLS	Colicin M inhibits Escherichia coli peptidoglycan synthesis through cleavage of its lipid-linked precursors. It has a compact structure, whereas other related toxins are organized in three independent domains, each devoted to a particular function: translocation through the outer membrane, receptor binding, and toxicity, from the N to the C termini, respectively. To establish whether colicin M displays such an organization despite its structural characteristics, protein dissection experiments were performed, which allowed us to delineate an independent toxicity domain encompassing exactly the C-terminal region conserved among colicin M-like proteins and covering about half of colicin M( residues 124-271). Surprisingly, the in vitro activity of the isolated domain was 45-fold higher than that of the full-length protein, suggesting a mechanism by which the toxicity of this domain is revealed following primary protein maturation. In vivo, the isolated toxicity domain appeared as toxic as the full-length protein under conditions where the reception and translocation steps were by-passed. Contrary to the full-length colicin M, the isolated domain did not require the presence of the periplasmic FkpA protein to be toxic under these conditions, demonstrating that FkpA is involved in the maturation process. Mutational analysis further identified five residues that are essential for cytotoxicity as well as in vitro lipid II-degrading activity: Asp-229, His-235, Asp-226, Tyr-228, and Arg-236. Most of these residues are surface-exposed and located relatively close to each other, hence suggesting they belong to the colicin M active site.	[Touze, Thierry] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, Lab Enveloppes Bacteriennes & Antibiot,UMR 8619, F-91405 Orsay, France; [Duche, Denis; Lloubes, Roland] Aix Marseille Univ, CNRS, Lab Ingn Syst Macromol, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Touze, T (corresponding author), Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, Lab Enveloppes Bacteriennes & Antibiot,UMR 8619, Batiment 430, F-91405 Orsay, France.	thierry.touze@u-psud.fr	Touzé, Thierry/GLT-1308-2022	MENGIN-LECREULX, Dominique/0000-0003-3205-0275; Duche, Denis/0000-0002-4208-6661; LLOUBES, Roland/0000-0002-9520-1053; Touze, Thierry/0000-0002-2176-6537	Agence Nationale de la Recherche [ANR-07-MIME-020]; CNRS [UMR 8619]	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the Agence Nationale de la Recherche (PEPGLYCOL project, ANR-07-MIME-020) and the CNRS (UMR 8619).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barreteau H, 2009, J BACTERIOL, V191, P3657, DOI 10.1128/JB.01824-08; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN V, 1994, ARCH MICROBIOL, V161, P199, DOI 10.1007/s002030050042; BRAUN V, 1980, J BACTERIOL, V142, P162, DOI 10.1128/JB.142.1.162-168.1980; BRAUN V, 1973, BIOCHIM BIOPHYS ACTA, V323, P87, DOI 10.1016/0005-2736(73)90433-1; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chavan M, 2005, J MOL EVOL, V60, P546, DOI 10.1007/s00239-004-0263-9; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; EICKHELMERICH K, 1989, J BACTERIOL, V171, P5117, DOI 10.1128/jb.171.9.5117-5126.1989; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; FEHRST A, 1977, ENZYME STRUCTURE MEC; HARKNESS RE, 1989, J BIOL CHEM, V264, P6177; Hullmann J, 2008, MOL MICROBIOL, V69, P926, DOI 10.1111/j.1365-2958.2008.06327.x; JAKES KS, 1988, J BACTERIOL, V170, P4231, DOI 10.1128/jb.170.9.4231-4238.1988; JOHNSON KA, 1990, ENZYMES, V19, P159; Kageyama M, 1996, J BACTERIOL, V178, P103, DOI 10.1128/jb.178.1.103-110.1996; KOCK J, 1987, J BACTERIOL, V169, P3358; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Mavrodi DV, 2002, APPL ENVIRON MICROB, V68, P5170, DOI 10.1128/AEM.68.10.5170-5176.2002; MILLER JH, 1972, COLD SPRING HARBOR L, P431; OLSCHLAGER T, 1991, MOL MICROBIOL, V5, P1105, DOI 10.1111/j.1365-2958.1991.tb01883.x; OLSCHLAGER T, 1987, J BACTERIOL, V169, P4765, DOI 10.1128/jb.169.10.4765-4769.1987; OLSCHLAGER T, 1984, MOL GEN GENET, V196, P482, DOI 10.1007/BF00436196; PILSL H, 1993, MOL GEN GENET, V240, P103, DOI 10.1007/BF00276889; Press WH, 1986, NUMERICAL RECIPES AR, P521; PUGSLEY AP, 1984, MICROBIOL SCI, V1, P203; PUGSLEY AP, 1984, MICROBIOL SCI, V1, P168; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Saul FA, 2004, J MOL BIOL, V335, P595, DOI 10.1016/j.jmb.2003.10.056; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; SCHALLER K, 1982, J BACTERIOL, V152, P994; SHIMIZU K, 1979, MOL GEN GENET, V168, P37, DOI 10.1007/BF00267931; TOUZE T, 2008, UNDECAPRENYL PHOSPHA; van Dam V, 2007, MOL MICROBIOL, V64, P1105, DOI 10.1111/j.1365-2958.2007.05722.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200	41	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12378	12389		10.1074/jbc.M109.093583	http://dx.doi.org/10.1074/jbc.M109.093583			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20159977	Green Published, hybrid			2022-12-25	WOS:000276787100066
J	Phillips, NB; Wan, ZI; Whittaker, L; Hu, SQ; Huang, K; Hua, QX; Whittaker, J; Ismail-Beigi, F; Weiss, MA				Phillips, Nelson B.; Wan, Zhu-Ii; Whittaker, Linda; Hu, Shi-Quan; Huang, Kun; Hua, Qing-xin; Whittaker, Jonathan; Ismail-Beigi, Faramarz; Weiss, Michael A.			Supramolecular Protein Engineering DESIGN OF ZINC-STAPLED INSULIN HEXAMERS AS A LONG ACTING DEPOT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-BINDING SITES; RECEPTOR-BINDING; CRYSTAL-STRUCTURE; ANALOGS; GLARGINE; RECOGNITION; INTERFACE; THERAPY	Bottom-up control of supramolecular protein assembly can provide a therapeutic nanobiotechnology. We demonstrate that the pharmacological properties of insulin can be enhanced by design of "zinc staples" between hexamers. Paired (i, i+4) His substitutions were introduced at an alpha-helical surface. The crystal structure contains both classical axial zinc ions and novel zinc ions at hexamer-hexamer interfaces. Although soluble at pH 4, the combined electrostatic effects of the substitutions and bridging zinc ions cause isoelectric precipitation at neutral pH. Following subcutaneous injection in a diabetic rat, the analog effected glycemic control with a time course similar to that of long acting formulation Lantus (R). Relative to Lantus, however, the analog discriminates at least 30-fold more stringently between the insulin receptor and mitogenic insulin-like growth factor receptor. Because aberrant mitogenic signaling may be associated with elevated cancer risk, such enhanced specificity may improve safety. Zinc stapling provides a general strategy to modify the pharmacokinetic and biological properties of a subcutaneous protein depot.	[Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Hu, Shi-Quan; Huang, Kun; Hua, Qing-xin; Whittaker, Jonathan] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA.	michael.weiss@case.edu	Huang, Kun/H-4427-2012		National Institutes of Health [DK069764]; American Diabetes Association; Dietrich Diabetes Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074176, R01DK069764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Dietrich Diabetes Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK069764 (to M. A. W.). This work was also supported by grants from the American Diabetes Association (to N. B. P. and M. A. W.) and Dietrich Diabetes Research Institute (to N. B. P. and F. I.-B.). This article is a contribution from the Cleveland Center for Membrane and Structural Biology. M. A. W. is a founding shareholder of Thermalin Diabetes, Inc. (Cleveland, OH).	Albrecht M, 2007, NATURWISSENSCHAFTEN, V94, P951, DOI 10.1007/s00114-007-0282-7; Asuri P, 2006, CURR OPIN BIOTECH, V17, P562, DOI 10.1016/j.copbio.2006.09.002; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Baxter MA, 2008, ACTA DIABETOL, V45, P253, DOI 10.1007/s00592-008-0052-9; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brange J, 1997, Pharm Biotechnol, V10, P343; BRANGE J, 1987, GALENICS INSULIN, P18; Campbell RK, 2001, CLIN THER, V23, P1938, DOI 10.1016/S0149-2918(01)80148-X; CISZAK E, 1994, BIOCHEMISTRY-US, V33, P1512, DOI 10.1021/bi00172a030; DeFelippis MR, 2001, CRIT REV THER DRUG, V18, P201; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; DODSON GG, 1993, BIOCHEM SOC T, V21, P609, DOI 10.1042/bst0210609; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Kohn WD, 2007, PEPTIDES, V28, P935, DOI 10.1016/j.peptides.2007.01.012; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kuerzel GU, 2003, CURR MED RES OPIN, V19, P34, DOI 10.1185/030079902125001416; Le Roith D, 2007, DIABETES-METAB RES, V23, P593, DOI 10.1002/dmrr.776; Lu Y, 2001, CHEM REV, V101, P3047, DOI 10.1021/cr0000574; Mayer Doris, 2008, Archives of Physiology and Biochemistry, V114, P38, DOI [10.1080/13813450801900645, 10.1080/13813450801900645 ]; Pocock SJ, 2009, LANCET, V374, P511, DOI 10.1016/S0140-6736(09)61307-6; Raskin P, 2007, ENDOCRIN METAB CLIN, V36, P21, DOI 10.1016/S0889-8529(07)80005-3; REGAN L, 1993, ANNU REV BIOPH BIOM, V22, P257, DOI 10.1146/annurev.bb.22.060193.001353; Saker F, 1998, AM J PHYSIOL-ENDOC M, V274, pE984, DOI 10.1152/ajpendo.1998.274.6.E984; Schneider S, 2004, ARZNEIMITTELFORSCH, V54, P842; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Wan ZL, 2008, J BIOL CHEM, V283, P21198, DOI 10.1074/jbc.M800235200; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Wan ZL, 2003, BIOCHEMISTRY-US, V42, P12770, DOI 10.1021/bi034430o; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872; Zhao M, 2009, J BIOL CHEM, V284, P32178, DOI 10.1074/jbc.M109.028399	33	25	54	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11755	11759		10.1074/jbc.C110.105825	http://dx.doi.org/10.1074/jbc.C110.105825			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20181952	Green Published, hybrid			2022-12-25	WOS:000276787100001
J	Wu, M; Kang, MM; Schoene, NW; Cheng, WH				Wu, Min; Kang, Mandy M.; Schoene, Norberta W.; Cheng, Wen-Hsing			Selenium Compounds Activate Early Barriers of Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; PROSTATE-CANCER; OXIDATIVE STRESS; GENOMIC INSTABILITY; VITAMIN-E; DEPENDENT PHOSPHORYLATION; TRIGGERS SENESCENCE; INDUCED APOPTOSIS; LUNG-CANCER; IN-VITRO	Selenium chemoprevention by apoptosis has been well studied, but it is not clear whether selenium can activate early barriers of tumorigenesis, namely senescence and DNA damage response. To test this hypothesis, we treated normal and cancerous cells with a gradient concentration of sodium selenite, methylseleninic acid and methylselenocysteine for 48 h, followed by a recovery of 1-7 days. Here we show that selenium compounds at doses of <= LD50 can induce cellular senescence, as evidenced by the expression of senescence-associated beta-galactosidase and 5-bromo-2-deoxyuridine incorporation, in normal but not cancerous cells. In response to clastogens, the ataxia telangiectasia mutated (ATM) protein is rapidly activated, which in turn initiates a cascade of DNA damage response. We found that the ATM pathway is activated by the selenium compounds, and the kinase activity is required for the selenium-induced senescence response. Pretreatment of the MRC-5 non-cancerous cells with the antioxidant N-acetylcysteine or 2,2,6,6-tetramethylpiperidine-1-oxyl suppresses the selenium-induced ATM activation and senescence. Taken together, the results suggest a novel role of selenium in the activation of early tumorigenesis barriers specific in non-cancerous cells, whereby selenium induces an ATM-dependent senescence response that depends on reactive oxygen species.	[Wu, Min; Kang, Mandy M.; Cheng, Wen-Hsing] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Schoene, Norberta W.] USDA, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, Beltsville, MD 20705 USA	University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA)	Cheng, WH (corresponding author), Univ Maryland, Dept Nutr & Food Sci, 3107B Skinner Bldg, College Pk, MD 20742 USA.	whcheng@umd.edu			General Research Board, the University of Maryland at College Park; United States Department of Agriculture Agricultural Research Service [1235-51530-052-00D]	General Research Board, the University of Maryland at College Park; United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported in part by an award from the General Research Board, the University of Maryland at College Park (to W.-H. C.), and United States Department of Agriculture Agricultural Research Service Project 1235-51530-052-00D (to N.W.S.). Downloaded from www.jbc.org at ISI, Thomson Scientific, on April 19, 2010	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Camphausen K, 2004, MOL CANCER THER, V3, P409; Carlson BA, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-57; Cheng WH, 2008, MOL BIOL CELL, V19, P3923, DOI 10.1091/mbc.E07-07-0698; Cheng WH, 2009, ENVIRON MOL MUTAGEN, V50, P349, DOI 10.1002/em.20489; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Duensing S, 2004, INT J CANCER, V109, P157, DOI 10.1002/ijc.11691; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hu HB, 2006, MOL CANCER THER, V5, P1873, DOI 10.1158/1535-7163.MCT-06-0063; HURST R, 2009, JAMA-J AM MED ASSOC, V301, P1877; Hurst R, 2009, JAMA-J AM MED ASSOC, V301, P1876, DOI 10.1001/jama.2009.626; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Li GX, 2007, INT J CANCER, V120, P2034, DOI 10.1002/ijc.22480; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lippman SM, 2005, JNCI-J NATL CANCER I, V97, P94, DOI 10.1093/jnci/dji009; Liu N, 2005, LAB INVEST, V85, P1471, DOI 10.1038/labinvest.3700354; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Marshall JR, 2006, CANCER EPIDEM BIOMAR, V15, P1479, DOI 10.1158/1055-9965.EPI-05-0585; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Ravizza R, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-92; Rayman MP, 2009, JAMA-J AM MED ASSOC, V301, P1876, DOI 10.1001/jama.2009.625; Reid ME, 2002, CANCER EPIDEM BIOMAR, V11, P1285; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; SHAMBERGER RJ, 1969, CAN MED ASSOC J, V100, P682; Shen CL, 2001, CANCER EPIDEM BIOMAR, V10, P385; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Spallholz JE, 2001, NUTR CANCER, V40, P34, DOI 10.1207/S15327914NC401_8; Stewart MS, 1999, FREE RADICAL BIO MED, V26, P42, DOI 10.1016/S0891-5849(98)00147-6; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; te Poele RH, 2002, CANCER RES, V62, P1876; Thompson IM, 2007, J UROLOGY, V178, pS9, DOI 10.1016/j.juro.2007.03.138; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; von Kobbe C, 2004, FASEB J, V18, P1970, DOI 10.1096/fj.04-1895fje; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Waters DJ, 2005, CARCINOGENESIS, V26, P1256, DOI 10.1093/carcin/bgi077; Zhao R, 2006, MOL CANCER THER, V5, P3275, DOI 10.1158/1535-7163.MCT-06-0400; Zhou N, 2003, J BIOL CHEM, V278, P29532, DOI 10.1074/jbc.M301877200; Zhou XZ, 2003, J CELL BIOCHEM, V89, P19, DOI 10.1002/jcb.10496; Zhuo HJ, 2004, CANCER EPIDEM BIOMAR, V13, P771	51	54	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12055	12062		10.1074/jbc.M109.088781	http://dx.doi.org/10.1074/jbc.M109.088781			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20157118	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000276787100034
J	Nguyen, JT; Hoopes, JD; Le, MH; Smee, DF; Patick, AK; Faix, DJ; Blair, PJ; de Jong, MD; Prichard, MN; Went, GT				Nguyen, Jack T.; Hoopes, Justin D.; Le, Minh H.; Smee, Donald F.; Patick, Amy K.; Faix, Dennis J.; Blair, Patrick J.; de Jong, Menno D.; Prichard, Mark N.; Went, Gregory T.			Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro	PLOS ONE			English	Article							CELL-CULTURE; HEMAGGLUTININ; INFECTIONS; SURVEILLANCE; MECHANISM; THERAPY	The rapid emergence and subsequent spread of the novel 2009 Influenza A/H1N1 virus (2009 H1N1) has prompted the World Health Organization to declare the first pandemic of the 21(st) century, highlighting the threat of influenza to public health and healthcare systems. Widespread resistance to both classes of influenza antivirals (adamantanes and neuraminidase inhibitors) occurs in both pandemic and seasonal viruses, rendering these drugs to be of marginal utility in the treatment modality. Worldwide, virtually all 2009 H1N1 and seasonal H3N2 strains are resistant to the adamantanes (rimantadine and amantadine), and the majority of seasonal H1N1 strains are resistant to oseltamivir, the most widely prescribed neuraminidase inhibitor (NAI). To address the need for more effective therapy, we evaluated the in vitro activity of a triple combination antiviral drug (TCAD) regimen composed of drugs with different mechanisms of action against drug-resistant seasonal and 2009 H1N1 influenza viruses. Amantadine, ribavirin, and oseltamivir, alone and in combination, were tested against amantadine-and oseltamivir-resistant influenza A viruses using an in vitro infection model in MDCK cells. Our data show that the triple combination was highly synergistic against drug-resistant viruses, and the synergy of the triple combination was significantly greater than the synergy of any double combination tested (P < 0.05), including the combination of two NAIs. Surprisingly, amantadine and oseltamivir contributed to the antiviral activity of the TCAD regimen against amantadine-and oseltamivir-resistant viruses, respectively, at concentrations where they had no activity as single agents, and at concentrations that were clinically achievable. Our data demonstrate that the TCAD regimen composed of amantadine, ribavirin, and oseltamivir is highly synergistic against resistant viruses, including 2009 H1N1. The TCAD regimen overcomes baseline drug resistance to both classes of approved influenza antivirals, and thus may represent a highly active antiviral therapy for seasonal and pandemic influenza.	[Nguyen, Jack T.; Le, Minh H.; Patick, Amy K.; Went, Gregory T.] Adamas Pharmaceut Inc, Emeryville, CA USA; [Hoopes, Justin D.; Smee, Donald F.] Utah State Univ, Logan, UT 84322 USA; [Faix, Dennis J.; Blair, Patrick J.] USN, Hlth Res Ctr, San Diego, CA 92152 USA; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Prichard, Mark N.] Univ Alabama Birmingham, Birmingham, AL USA	Utah System of Higher Education; Utah State University; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); University of Amsterdam; Academic Medical Center Amsterdam; University of Alabama System; University of Alabama Birmingham	Nguyen, JT (corresponding author), Adamas Pharmaceut Inc, Emeryville, CA USA.	jnguyen@adamaspharma.com; gwent@adamaspharma.com		Prichard, Mark/0000-0002-2720-6661	Adamas Pharmaceuticals	Adamas Pharmaceuticals	Funding for this study was provided by Adamas Pharmaceuticals. Authors from Adamas Pharmaceuticals participated in the design of the studies, analysis of the data, and preparing the manuscript.	Abed Y, 2005, ANTIMICROB AGENTS CH, V49, P556, DOI 10.1128/AAC.49.2.556-559.2005; Adinolfi LE, 2003, GUT, V52, P701, DOI 10.1136/gut.52.5.701; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; BROWNE MJ, 1979, ANTIMICROB AGENTS CH, V15, P747, DOI 10.1128/AAC.15.6.747; Cameron CE, 2001, CURR OPIN INFECT DIS, V14, P757, DOI 10.1097/00001432-200112000-00015; *CDC, 2009, FLUVIEW 2009 2010 IN; *CDC, 2008, FLUVIEW 2008 2009 IN; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; Chan M, 2009, SWINE INFLUENZA; Chan M., 2009, WORLD NOW START 2009; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; *END PHARM INC, 2007, SYMM PACK INS; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Govorkova EA, 2004, ANTIMICROB AGENTS CH, V48, P4855, DOI 10.1128/AAC.48.12.4855-4863.2004; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V18, P536, DOI 10.1128/AAC.18.4.536; HAYDEN FG, 1984, ANTIMICROB AGENTS CH, V25, P53, DOI 10.1128/AAC.25.1.53; Ilyushina NA, 2008, ANTIMICROB AGENTS CH, V52, P3889, DOI 10.1128/AAC.01579-07; Ilyushina NA, 2007, J GEN VIROL, V88, P1266, DOI 10.1099/vir.0.82256-0; Ilyushina NA, 2006, ANTIVIR RES, V70, P121, DOI 10.1016/j.antiviral.2006.01.012; JOHNSON CE, 2009, DETERMINATION PUBLIC; MADREN LK, 1995, ANTIVIR CHEM CHEMOTH, V6, P109, DOI 10.1177/095632029500600205; Masihi KN, 2007, J CHEMOTHERAPY, V19, P295, DOI 10.1179/joc.2007.19.3.295; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Mishin VP, 2005, ANTIMICROB AGENTS CH, V49, P4515, DOI 10.1128/AAC.49.11.4515-4520.2005; Morrison D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001305; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Nguyen JT, 2009, ANTIMICROB AGENTS CH, V53, P4115, DOI 10.1128/AAC.00476-09; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; PRICHARD MN, 1993, ANTIMICROB AGENTS CH, V37, P540, DOI 10.1128/AAC.37.3.540; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; *ROCH LAB INC, 2008, TAM PACK INS; *SCHER CORP, 2008, REB OFF FDA INF; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Smee DF, 2002, CHEMOTHERAPY, V48, P88, DOI 10.1159/000057668; Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001; Smee DF, 2009, ANTIMICROB AGENTS CH, V53, P2120, DOI 10.1128/AAC.01012-08; STEINHAUER DA, 1991, P NATL ACAD SCI USA, V88, P11525, DOI 10.1073/pnas.88.24.11525	40	124	135	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9332	10.1371/journal.pone.0009332	http://dx.doi.org/10.1371/journal.pone.0009332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179772	Green Published, gold, Green Submitted			2022-12-25	WOS:000274923900006
J	Mishto, M; Bellavista, E; Ligorio, C; Textoris-Taube, K; Santoro, A; Giordano, M; D'Alfonso, S; Listi, F; Nacmias, B; Cellini, E; Leone, M; Grimaldi, LME; Fenoglio, C; Esposito, F; Martinelli-Boneschi, F; Galimberti, D; Scarpini, E; Seifert, U; Amato, MP; Caruso, C; Foschini, MP; Kloetzel, PM; Franceschi, C				Mishto, Michele; Bellavista, Elena; Ligorio, Claudia; Textoris-Taube, Kathrin; Santoro, Aurelia; Giordano, Mara; D'Alfonso, Sandra; Listi, Florinda; Nacmias, Benedetta; Cellini, Elena; Leone, Maurizio; Grimaldi, Luigi M. E.; Fenoglio, Chiara; Esposito, Federica; Martinelli-Boneschi, Filippo; Galimberti, Daniela; Scarpini, Elio; Seifert, Ulrike; Amato, Maria Pia; Caruso, Calogero; Foschini, Maria P.; Kloetzel, Peter M.; Franceschi, Claudio			Immunoproteasome LMP2 60HH Variant Alters MBP Epitope Generation and Reduces the Risk to Develop Multiple Sclerosis in Italian Female Population	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; CD8(+) T-CELLS; BLOOD-BRAIN-BARRIER; INTERFERON-GAMMA; ENDOTHELIAL-CELLS; IN-VITRO; PROTEASOME; POLYMORPHISM; INDUCTION; RESPONSES	Background: Albeit several studies pointed out the pivotal role that CD4+T cells have in Multiple Sclerosis, the CD8+ T cells involvement in the pathology is still in its early phases of investigation. Proteasome degradation is the key step in the production of MHC class I-restricted epitopes and therefore its activity could be an important element in the activation and regulation of autoreactive CD8+ T cells in Multiple Sclerosis. Methodology/Principal Findings: Immunoproteasomes and PA28-alpha beta regulator are present in MS affected brain area and accumulated in plaques. They are expressed in cell types supposed to be involved in MS development such as neurons, endothelial cells, oligodendrocytes, macrophages/macroglia and lymphocytes. Furthermore, in a genetic study on 1262 Italian MS cases and 845 controls we observed that HLA-A*02+ female subjects carrying the immunoproteasome LMP2 codon 60HH variant have a reduced risk to develop MS. Accordingly, immunoproteasomes carrying the LMP2 60H allele produce in vitro a lower amount of the HLA-A*0201 restricted immunodominant epitope MBP111-119. Conclusion/Significance: The immunoproteasome LMP2 60HH variant reduces the risk to develop MS amongst Italian HLA-A*02+ females. We propose that such an effect is mediated by the altered proteasome-dependent production of a specific MBP epitope presented on the MHC class I. Our observations thereby support the hypothesis of an involvement of immunoproteasome in the MS pathogenesis.	[Mishto, Michele; Santoro, Aurelia; Franceschi, Claudio] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy; [Mishto, Michele; Bellavista, Elena; Santoro, Aurelia; Franceschi, Claudio] Interdept Ctr Studies Biophys Bioinformat & Bioco, Bologna, Italy; [Mishto, Michele; Textoris-Taube, Kathrin; Seifert, Ulrike; Kloetzel, Peter M.] Fac Med Charite, Inst Biochem, Berlin, Germany; [Ligorio, Claudia; Foschini, Maria P.] Univ Bologna, Dept Hematol & Oncol, Sect Anat Pathol, Bologna, Italy; [Ligorio, Claudia; Foschini, Maria P.] Bellaria Hosp, Bologna, Italy; [Giordano, Mara; D'Alfonso, Sandra] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy; [Giordano, Mara; D'Alfonso, Sandra] Univ Piemonte Orientale, IRCAD, Novara, Italy; [Listi, Florinda; Caruso, Calogero] Univ Palermo, Dept Biopathol & Biomed Methodol, Palermo, Italy; [Nacmias, Benedetta; Cellini, Elena; Amato, Maria Pia] Univ Florence, Dept Neurol & Psychiat Sci, Florence, Italy; [Leone, Maurizio] Osped Maggiore La Carita, Neurol Clin, Novara, Italy; [Grimaldi, Luigi M. E.] Ist San Raffaele G Giglio Cefalu, UO Neurol Fdn, Cefalu, PA, Italy; [Fenoglio, Chiara; Galimberti, Daniela; Scarpini, Elio] Univ Milan, Dept Neurol Sci, IRCCS Fdn, Osped Maggiore Policlin, Milan, Italy; [Esposito, Federica; Martinelli-Boneschi, Filippo] Ist Sci San Raffaele, Inst Expt Neurol INSPE, I-20132 Milan, Italy; [Esposito, Federica; Martinelli-Boneschi, Filippo] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy	University of Bologna; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bologna; AUSL di Bologna; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Palermo; University of Florence; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Mishto, M (corresponding author), Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.	michele.mishto@charite.de	Leone, Maurizio A./J-4130-2016; Boneschi, Filippo Martinelli/H-8592-2012; Amato, Maria Pia/AAC-5940-2022; amato, Maria Pia/AAL-5998-2020; D'Alfonso, Sandra/K-7295-2014; Franceschi, Claudio/L-4484-2017; Esposito, Federica/K-6537-2016; mishto, michele/A-5592-2010; Cellini, Elena/J-4031-2018; GIORDANO, Mara/AAB-1379-2019; Nacmias, Benedetta/J-5084-2018; Galimberti, Daniela/N-7209-2019; Grimaldi, Luigi/L-2614-2019; Scarpini, Elio/K-6547-2016; Foschini, Maria P./A-6306-2016	Leone, Maurizio A./0000-0002-6339-5738; amato, Maria Pia/0000-0003-3325-3760; D'Alfonso, Sandra/0000-0002-3983-9925; Franceschi, Claudio/0000-0001-9841-6386; Esposito, Federica/0000-0003-2550-0805; mishto, michele/0000-0003-3042-2792; Cellini, Elena/0000-0001-7597-940X; GIORDANO, Mara/0000-0001-6686-4600; Nacmias, Benedetta/0000-0001-9338-9040; Galimberti, Daniela/0000-0002-9284-5953; Scarpini, Elio/0000-0002-6395-2119; Rapa, Anna/0000-0002-5523-5224; Foschini, Maria P./0000-0001-7079-7260; Santoro, Aurelia/0000-0002-7187-1116; martinelli boneschi, filippo/0000-0002-9955-1368	Italian Ministry of Health; European Commission [FP6]; Fondazione Italiana Sclerosi Multipla (FISM) [2003/R26]; BioPharmaNet [2002/R/40, 2005/R/10, 2008/R/11]; University of Bologna (FRO); Regione Piemonte; Sonderforschungsbereich [SFB-507, SFB-421]; Neurocure; A. V. Humboldt PostDoc fellowship;  [TR43]	Italian Ministry of Health(Ministry of Health, Italy); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); BioPharmaNet; University of Bologna (FRO); Regione Piemonte(Regione Piemonte); Sonderforschungsbereich(German Research Foundation (DFG)); Neurocure; A. V. Humboldt PostDoc fellowship(Alexander von Humboldt Foundation); 	This work was financed in part by the grant Giovani Ricercatori 2007 from Italian Ministry of Health to MM, DG and FMB, by a grant from the European Commission Integrated Project PROTEOMAGE (FP6) to CF, by the finalized projects of Fondazione Italiana Sclerosi Multipla (FISM) cod. 2003/R26 and BioPharmaNet to CF and 2002/R/40 and 2005/R/10, 2008/R/11 (Genoa) to SD'A, by the University of Bologna (FRO) to MPF, by the Regione Piemonte (Ricerca Sanitaria Finalizzata Project and Ricerca Sanitaria Applicata-CIPE Project) to SD'A, by Associazione Amici del Centro Dino Ferrari and IRCCS Ospedale Maggiore Policlinico, Milano to DG and by the grants Sonderforschungsbereich (SFB-507, SFB-421) to PMK and US, the grants TR43 and Neurocure to PMK. MM benefited from the A. V. Humboldt PostDoc fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BERGAMASCHI L, 2009, GENES IMMUN; BOURDOULOUS S, 1995, EUR J IMMUNOL, V25, P1176, DOI 10.1002/eji.1830250507; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; D'Alfonso S, 2008, GENES IMMUN, V9, P7, DOI 10.1038/sj.gene.6364437; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; El-Etr M, 2005, J NEUROL SCI, V233, P49, DOI 10.1016/j.jns.2005.03.004; Friese MA, 2005, BRAIN, V128, P1747, DOI 10.1093/brain/awh578; Friese MA, 2008, NAT MED, V14, P1227, DOI 10.1038/nm.1881; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Fugger L, 2009, NAT REV IMMUNOL; Galea I, 2007, J EXP MED, V204, P2023, DOI 10.1084/jem.20070064; Giovannoni G, 2007, CURR OPIN NEUROL, V20, P261, DOI 10.1097/WCO.0b013e32815610c2; Jurewicz A, 1998, J IMMUNOL, V160, P3056; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kloss A, 2010, CARDIOVASC RES, V85, P367, DOI 10.1093/cvr/cvp217; Kraemer U, 2007, GENES IMMUN, V8, P513, DOI 10.1038/sj.gene.6364404; KUCKELKORN U, 1995, EUR J IMMUNOL, V25, P2605, DOI 10.1002/eji.1830250930; Kuhn DJ, 2009, BLOOD, V113, P4667, DOI 10.1182/blood-2008-07-171637; LEWONTIN RC, 1988, THEOR POPUL BIOL, V34, P177, DOI 10.1016/0040-5809(88)90041-X; Liu T, 2007, J PROTEOME RES, V6, P2565, DOI 10.1021/pr070012k; Macagno A, 1999, EUR J IMMUNOL, V29, P4037, DOI 10.1002/(SICI)1521-4141(199912)29:12<4037::AID-IMMU4037>3.0.CO;2-T; Maksymowych WP, 2000, J RHEUMATOL, V27, P183; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Meuth SG, 2008, J NEUROL, V255, P93, DOI 10.1007/s00415-008-6017-7; Mishto M, 2006, BIOL CHEM, V387, P417, DOI 10.1515/BC.2006.056; Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004; Mishto M, 2003, AGEING RES REV, V2, P419, DOI 10.1016/S1568-1637(03)00030-8; Mishto M, 2002, EXP GERONTOL, V37, P301, DOI 10.1016/S0531-5565(01)00196-6; MISHTO M, 2009, UBIQUITIN PROTEASOME; Mishto M, 2008, J MOL BIOL, V377, P1607, DOI 10.1016/j.jmb.2008.01.086; Moldovan IR, 2008, J NEUROIMMUNOL, V193, P161, DOI 10.1016/j.jneuroim.2007.10.010; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Papenfuss Tracey L, 2007, ScientificWorldJournal, V7, P112; Pastorino R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006526; Pelfrey CM, 2005, J NEUROIMMUNOL, V167, P190, DOI 10.1016/j.jneuroim.2005.06.014; Perchellet A, 2004, NAT IMMUNOL, V5, P606, DOI 10.1038/ni1073; Perchellet A, 2008, P NATL ACAD SCI USA, V105, P14040, DOI 10.1073/pnas.0804970105; RISAU W, 1990, J CELL BIOL, V110, P1757, DOI 10.1083/jcb.110.5.1757; Silva AM, 2009, MULT SCLER, V15, P771, DOI 10.1177/1352458509104588; Stohwasser R, 2000, GLIA, V29, P355, DOI 10.1002/(SICI)1098-1136(20000215)29:4<355::AID-GLIA6>3.0.CO;2-4; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Textoris-Taube K, 2007, J BIOL CHEM, V282, P12749, DOI 10.1074/jbc.M611644200; TSUCHIDA T, 1994, P NATL ACAD SCI USA, V91, P10859, DOI 10.1073/pnas.91.23.10859; Valmori D, 1998, J IMMUNOL, V160, P1750; Vargas-Alarcon G, 2004, HUM IMMUNOL, V65, P1437, DOI 10.1016/j.humimm.2004.09.007; Wehenkel M, 2008, MOL BIOSYST, V4, P280, DOI 10.1039/b716221a; WILCOX CE, 1989, IMMUNOLOGY, V67, P435; Zang YCQ, 2004, J IMMUNOL, V172, P5120, DOI 10.4049/jimmunol.172.8.5120	52	51	57	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9287	10.1371/journal.pone.0009287	http://dx.doi.org/10.1371/journal.pone.0009287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174631	gold, Green Published			2022-12-25	WOS:000274654700017
J	Sahini, L; Tempczyk-Russell, A; Agarwal, R				Sahini, Leepakshi; Tempczyk-Russell, Anna; Agarwal, Ritu			Large-Scale Sequence Analysis of Hemagglutinin of Influenza A Virus Identifies Conserved Regions Suitable for Targeting an Anti-Viral Response	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; MEMBRANE GLYCOPROTEIN; ANTIGENIC STRUCTURE; IMMUNE RECOGNITION; STRUCTURAL BASIS; SURFACE REGIONS; PROTEIN; ANTIBODIES; SUBTYPES; H5	Background: Influenza A viral surface protein, hemagglutinin, is the major target of neutralizing antibody response and hence a main constituent of all vaccine formulations. But due to its marked evolutionary variability, vaccines have to be reformulated so as to include the hemagglutinin protein from the emerging new viral strain. With the constant fear of a pandemic, there is critical need for the development of anti-viral strategies that can provide wider protection against any Influenza A pathogen. An anti-viral approach that is directed against the conserved regions of the hemaggutinin protein has a potential to protect against any current and new Influenza A virus and provide a solution to this ever-present threat to public health. Methodology/Principal Findings: Influenza A human hemagglutinin protein sequences available in the NCBI database, corresponding to H1, H2, H3 and H5 subtypes, were used to identify highly invariable regions of the protein. Nine such regions were identified and analyzed for structural properties like surface exposure, hydrophilicity and residue type to evaluate their suitability for targeting an anti-peptide antibody/anti-viral response. Conclusion/Significance: This study has identified nine conserved regions in the hemagglutinin protein, five of which have the structural characteristics suitable for an anti-viral/anti-peptide response. This is a critical step in the design of efficient anti-peptide antibodies as novel anti-viral agents against any Influenza A pathogen. In addition, these anti-peptide antibodies will provide broadly cross-reactive immunological reagents and aid the rapid development of vaccines against new and emerging Influenza A strains.	[Sahini, Leepakshi; Agarwal, Ritu] ChimericBio Inc, Dept Proc & Analyt Biochem, Long Isl City, NY USA; [Tempczyk-Russell, Anna] Accelrys Inc, Dept Computat Biol & Chem, San Diego, CA USA	BIOVIA	Sahini, L (corresponding author), ChimericBio Inc, Dept Proc & Analyt Biochem, Long Isl City, NY USA.	agarwalr@chimericbio.com			Chimericbio Incorporated	Chimericbio Incorporated	This work was supported by Chimericbio Incorporated, and software expertise was provided by Accelrys Incorporated as a collaborative effort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; BERZOFSKY JA, 1985, SCIENCE, V229, P932, DOI 10.1126/science.2410982; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LERNER RA, 1982, NATURE, V299, P592, DOI 10.1038/299592a0; MULLER GM, 1982, P NATL ACAD SCI-BIOL, V79, P569, DOI 10.1073/pnas.79.2.569; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; SCHMITZ HE, 1983, IMMUNOL COMMUN, V12, P161, DOI 10.3109/08820138309066866; Smirnov YA, 1999, ACTA VIROL, V43, P237; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; VANREGENMORTEL MHV, 1992, STRUCTURE ANTIGENS, P277; WANG CY, 1991, SCIENCE, V254, P285, DOI 10.1126/science.1925584; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHITE JM, 1997, STRUCTURAL BIOL VIRU, P80; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514	37	15	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9268	10.1371/journal.pone.0009268	http://dx.doi.org/10.1371/journal.pone.0009268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174650	Green Submitted, Green Published, gold			2022-12-25	WOS:000274590600021
J	Gong, S; Blundell, TL				Gong, Sungsam; Blundell, Tom L.			Structural and Functional Restraints on the Occurrence of Single Amino Acid Variations in Human Proteins	PLOS ONE			English	Article							PHYTANOYL-COA HYDROXYLASE; NUCLEOTIDE POLYMORPHISMS; STABILITY CHANGES; MOLECULAR-BASIS; GENOME SEQUENCE; REFSUM-DISEASE; PREDICTION; MUTATIONS; DATABASE; CONSTRAINTS	Human genetic variation is the incarnation of diverse evolutionary history, which reflects both selectively advantageous and selectively neutral change. In this study, we catalogue structural and functional features of proteins that restrain genetic variation leading to single amino acid substitutions. Our variation dataset is divided into three categories: i) Mendelian disease-related variants, ii) neutral polymorphisms and iii) cancer somatic mutations. We characterize structural environments of the amino acid variants by the following properties: i) side-chain solvent accessibility, ii) main-chain secondary structure, and iii) hydrogen bonds from a side chain to a main chain or other side chains. To address functional restraints, amino acid substitutions in proteins are examined to see whether they are located at functionally important sites involved in protein-protein interactions, protein-ligand interactions or catalytic activity of enzymes. We also measure the likelihood of amino acid substitutions and the degree of residue conservation where variants occur. We show that various types of variants are under different degrees of structural and functional restraints, which affect their occurrence in human proteome.	[Gong, Sungsam; Blundell, Tom L.] Univ Cambridge, Dept Biochem, Biocomp Grp, Cambridge CB2 1QW, England	University of Cambridge	Gong, S (corresponding author), Univ Cambridge, Dept Biochem, Biocomp Grp, Tennis Court Rd, Cambridge CB2 1QW, England.	tom@cryst.bioc.cam.ac.uk	Gong, Sungsam/AAW-6501-2020	Gong, Sungsam/0000-0001-5796-4423	Wellcome Trust [GR079281RR]	Wellcome Trust(Wellcome TrustEuropean Commission)	TLB acknowledges support from the Wellcome Trust (GR079281RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bao L, 2006, FEBS LETT, V580, P1231, DOI 10.1016/j.febslet.2006.01.035; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Dayhoff MO, 1968, ATLAS PROTEIN SEQUEN, P33; Deane CM, 1999, PROTEIN ENG, V12, P1025, DOI 10.1093/protein/12.12.1025; DEHOUCK Y, 2009, BIOINFORMATICS; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Ferrer-Costa C, 2007, J MOL BIOL, V365, P249, DOI 10.1016/j.jmb.2006.09.053; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gong SS, 2009, BIOCHEM SOC T, V37, P727, DOI 10.1042/BST0370727; Gong S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000179; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; HUBBARD TJP, 1987, PROTEIN ENG, V1, P159, DOI 10.1093/protein/1.3.159; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jansen GA, 2000, HUM MOL GENET, V9, P1195, DOI 10.1093/hmg/9.8.1195; Jansen GA, 1997, NAT GENET, V17, P190, DOI 10.1038/ng1097-190; Jansen GA, 1999, ADV EXP MED BIOL, V466, P371; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Lee S, 2009, BIOINFORMATICS, V25, P1976, DOI 10.1093/bioinformatics/btp300; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Masso M, 2008, BIOINFORMATICS, V24, P2002, DOI 10.1093/bioinformatics/btn353; Mihalik SJ, 1997, NAT GENET, V17, P185, DOI 10.1038/ng1097-185; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; OVERINGTON J, 1990, P ROY SOC B-BIOL SCI, V241, P132, DOI 10.1098/rspb.1990.0077; OVERINGTON J, 1992, PROTEIN SCI, V1, P216; SHENKIN PS, 1991, PROTEINS, V11, P297, DOI 10.1002/prot.340110408; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Steward RE, 2003, TRENDS GENET, V19, P505, DOI 10.1016/S0168-9525(03)00195-1; Sunyaev S, 1999, J MOL MED-JMM, V77, P754, DOI 10.1007/s001099900059; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; TALAVERA D, 2009, PROTEINS; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Worth Catherine L, 2007, J Bioinform Comput Biol, V5, P1297, DOI 10.1142/S0219720007003120; Worth CL, 2009, NAT REV MOL CELL BIO, V10, P709, DOI 10.1038/nrm2762; Worth CL, 2009, PROTEINS, V75, P413, DOI 10.1002/prot.22248; Yip YL, 2008, HUM MUTAT, V29, P361, DOI 10.1002/humu.20671; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	57	32	32	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9186	10.1371/journal.pone.0009186	http://dx.doi.org/10.1371/journal.pone.0009186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169194	Green Submitted, Green Published, gold			2022-12-25	WOS:000274474600007
J	Ma, HX; Zheng, L; Liu, YB; Zhao, CY; Harrison, TJ; Ma, YY; Sun, SH; Zhang, JG; Wang, YC				Ma, Hongxia; Zheng, Lin; Liu, Yunbo; Zhao, Chenyan; Harrison, Tim J.; Ma, Yuyuan; Sun, Shuhua; Zhang, Jingang; Wang, Youchun			Experimental Infection of Rabbits with Rabbit and Genotypes 1 and 4 Hepatitis E Viruses	PLOS ONE			English	Article							RT-PCR ASSAY; SWINE; HEV; SEQUENCE; PIGS; PREVALENCE; DEER; PATHOGENESIS; CHINA; TRANSMISSION	Background: A recent study provided evidence that farmed rabbits in China harbor a novel hepatitis E virus (HEV) genotype. Although the rabbit HEV isolate had 77-79% nucleotide identity to the mammalian HEV genotypes 1 to 4, their genomic organization is very similar. Since rabbits are used widely experimentally, including as models of infection, we investigated whether they constitute an appropriate animal model for human HEV infection. Methods: Forty-two SPF rabbits were divided randomly into eleven groups and inoculated with six different isolates of rabbit HEV, two different doses of a second-passage rabbit HEV, and with genotype 1 and 4 HEV. Sera and feces were collected weekly after inoculation. HEV antigen, RNA, antibody and alanine aminotransferase in sera and HEV RNA in feces were detected. The liver samples were collected during necropsy subject to histopathological examination. Findings: Rabbits inoculated with rabbit HEV became infected with HEV, with viremia, fecal virus shedding and high serum levels of viral antigens, and developed hepatitis, with elevation of the liver enzyme, ALT. The severity of disease corresponded to the infectious dose (genome equivalents), with the most severe hepatic disease caused by strain GDC54-18. However, only two of nine rabbits infected with HEV genotype 4, and none infected with genotype 1, developed hepatitis although six of nine rabbits inoculated with the genotype 1 HEV and in all rabbits inoculated with the genotype 4 HEV seroconverted to be positive for anti-HEV IgG antibody by 14 weeks post-inoculation. Conclusions: These data indicate that rabbits are an appropriate model for rabbit HEV infection but are not likely to be useful for the study of human HEV. The rabbit HEV infection of rabbits may provide an appropriate parallel animal model to study HEV pathogenesis.	[Ma, Hongxia; Zhao, Chenyan; Wang, Youchun] Natl Inst Control Pharmaceut & Biol Prod, Dept Cellular Biol, Beijing, Peoples R China; [Zheng, Lin; Ma, Yuyuan; Zhang, Jingang] Acad Mil Med Sci, Inst Transfus Med, Natl Ctr Biomed Anal, Lab Viral Detect, Beijing, Peoples R China; [Liu, Yunbo; Sun, Shuhua] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100037, Peoples R China; [Liu, Yunbo; Sun, Shuhua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Hongxia] Henan Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Harrison, Tim J.] UCL, Sch Med, Div Med, London W1N 8AA, England	National Institute of Food & Drug Control - China; Academy of Military Medical Sciences - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of London; University College London; UCL Medical School	Ma, HX (corresponding author), Natl Inst Control Pharmaceut & Biol Prod, Dept Cellular Biol, Beijing, Peoples R China.	wychun3@yahoo.com	Harrison, Tim J/C-6550-2009		Ministry of Science and Technology, China [2006AA02Z453]	Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This study was supported by the 863 project (grant: 2006AA02Z453) from the Ministry of Science and Technology, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 1997, Trop Gastroenterol, V18, P49; Aggarwal R, 2001, J INFECT DIS, V184, P1380, DOI 10.1086/324376; Arankalle VA, 2001, J VIRAL HEPATITIS, V8, P223, DOI 10.1046/j.1365-2893.2001.00290.x; Billam P, 2005, J VIROL, V79, P3429, DOI 10.1128/JVI.79.6.3429-3437.2005; Bouwknegt M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-7; Chandra V, 2008, J BIOSCIENCES, V33, P451, DOI 10.1007/s12038-008-0064-1; Emerson SU, 2003, REV MED VIROL, V13, P145, DOI 10.1002/rmv.384; Emerson SU, 2001, P NATL ACAD SCI USA, V98, P15270, DOI 10.1073/pnas.251555098; Favorov MO, 2000, J INFECT DIS, V181, P449, DOI 10.1086/315273; Graff J, 2006, J VIROL, V80, P5919, DOI 10.1128/JVI.00046-06; Halbur PG, 2001, J CLIN MICROBIOL, V39, P918, DOI 10.1128/JCM.39.3.918-923.2001; Huang FF, 2004, J GEN VIROL, V85, P1609, DOI 10.1099/vir.0.79841-0; Huang WJ, 2008, J MED VIROL, V80, P824, DOI 10.1002/jmv.21140; Huang YW, 2007, J VIROL, V81, P3018, DOI 10.1128/JVI.02259-06; Inoue J, 2006, J VIROL METHODS, V137, P325, DOI 10.1016/j.jviromet.2006.07.004; Kasorndorkbua C, 2002, J VIROL METHODS, V101, P71, DOI 10.1016/S0166-0934(01)00420-7; Panda SK, 2007, REV MED VIROL, V17, P151, DOI 10.1002/rmv.522; Lee YH, 2009, VET J, V179, P417, DOI 10.1016/j.tvjl.2007.10.028; Li WG, 2009, J MED VIROL, V81, P1591, DOI 10.1002/jmv.21573; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; MA H, 2009, ARCH VIROL; Ma HX, 2009, J MED VIROL, V81, P1052, DOI 10.1002/jmv.21484; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Nakamura M, 2006, HEPATOL RES, V34, P137, DOI 10.1016/j.hepres.2005.10.010; Purcell R H, 2001, ILAR J, V42, P161; Saad MD, 2007, INFECT GENET EVOL, V7, P368, DOI 10.1016/j.meegid.2006.07.007; Sonoda H, 2004, J CLIN MICROBIOL, V42, P5371, DOI 10.1128/JCM.42.11.5371-5374.2004; Takahashi K, 2004, VIROLOGY, V330, P501, DOI 10.1016/j.virol.2004.10.006; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Tei S, 2004, J MED VIROL, V74, P67, DOI 10.1002/jmv.20147; TSAREV SA, 1993, J INFECT DIS, V167, P1302, DOI 10.1093/infdis/167.6.1302; Wang YC, 2000, J GEN VIROL, V81, P1675, DOI 10.1099/0022-1317-81-7-1675; Wang YC, 2002, J MED VIROL, V67, P516, DOI 10.1002/jmv.10131; Williams TPE, 2001, J CLIN MICROBIOL, V39, P3040, DOI 10.1128/JCM.39.9.3040-3046.2001; Worm HC, 2002, MICROBES INFECT, V4, P657, DOI 10.1016/S1286-4579(02)01584-8; Zhang F, 2006, J MED VIROL, V78, P1441, DOI 10.1002/jmv.20717; Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523; Zhao CY, 2007, J MED VIROL, V79, P1966, DOI 10.1002/jmv.21040; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536; Zhao CY, 2009, J GASTROENTEROL, V44, P139, DOI 10.1007/s00535-008-2281-7	42	77	81	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9160	10.1371/journal.pone.0009160	http://dx.doi.org/10.1371/journal.pone.0009160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161794	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442800006
J	Crossett, A; Lauter, N; Love, TM				Crossett, Andrew; Lauter, Nick; Love, Tanzy M.			An Empirical Method for Establishing Positional Confidence Intervals Tailored for Composite Interval Mapping of QTL	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENETIC DISSECTION; MAIZE; MAP; ARCHITECTURE; LOCATION; GENOMICS; LINKAGE	Background: Improved genetic resolution and availability of sequenced genomes have made positional cloning of moderate-effect QTL realistic in several systems, emphasizing the need for precise and accurate derivation of positional confidence intervals (CIs) for QTL. Support interval (SI) methods based on the shape of the QTL likelihood curve have proven adequate for standard interval mapping, but have not been shown to be appropriate for use with composite interval mapping (CIM), which is one of the most commonly used QTL mapping methods. Results: Based on a non-parametric confidence interval (NPCI) method designed for use with the Haley-Knott regression method for mapping QTL, a CIM-specific method (CIM-NPCI) was developed to appropriately account for the selection of background markers during analysis of bootstrap-resampled data sets. Coverage probabilities and interval widths resulting from use of the NPCI, SI, and CIM-NPCI methods were compared in a series of simulations analyzed via CIM, wherein four genetic effects were simulated in chromosomal regions with distinct marker densities while heritability was fixed at 0.6 for a population of 200 isolines. CIM-NPCIs consistently capture the simulated QTL across these conditions while slightly narrower SIs and NPCIs fail at unacceptably high rates, especially in genomic regions where marker density is high, which is increasingly common for real studies. The effects of a known CIM bias toward locating QTL peaks at markers were also investigated for each marker density case. Evaluation of sub-simulations that varied according to the positions of simulated effects relative to the nearest markers showed that the CIM-NPCI method overcomes this bias, offering an explanation for the improved coverage probabilities when marker densities are high. Conclusions: Extensive simulation studies herein demonstrate that the QTL confidence interval methods typically used to positionally evaluate CIM results can be dramatically improved by accounting for the procedural complexity of CIM via an empirical approach, CIM-NPCI. Confidence intervals are a critical measure of QTL utility, but have received inadequate treatment due to a perception that QTL mapping is not sufficiently precise for procedural improvements to matter. Technological advances will continue to challenge this assumption, creating even more need for the current improvement to be refined.	[Crossett, Andrew; Love, Tanzy M.] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Lauter, Nick] Iowa State Univ, Dept Plant Pathol, Ames, IA USA; [Lauter, Nick] Iowa State Univ, Dept Agron, Ames, IA USA; [Lauter, Nick] USDA ARS, Corn Insects & Crop Genet Res Unit, Ames, IA USA	Carnegie Mellon University; Iowa State University; Iowa State University; United States Department of Agriculture (USDA)	Crossett, A (corresponding author), Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA.	Tanzy_Love@urmc.rochester.edu	Love, Tanzy M T/F-3954-2010	Love, Tanzy M T/0000-0002-7154-0229	Department of Statistics at Carnegie Mellon University [3625-21000049- 00D]; National Science Foundation [DMS-0240019]; National Institutes of Health [T32 ES007271]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007271] Funding Source: NIH RePORTER	Department of Statistics at Carnegie Mellon University; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the Department of Statistics at Carnegie Mellon University, by the USDA Agricultural Research Service (CRIS# 3625-21000049- 00D), by the National Science Foundation (DMS-0240019), and by the National Institutes of Health (T32 ES007271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint-Kurti PJ, 2007, GENETICS, V176, P645, DOI 10.1534/genetics.106.067892; Basten C. J., 2003, QTL CARTOGRAPHER VER; Chen LS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r219; DARVASI A, 1993, GENETICS, V134, P943; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Dupuis J, 1999, GENETICS, V151, P373; Fu Y, 2006, GENETICS, V174, P1671, DOI 10.1534/genetics.106.060376; Hussain T, 2007, J PLANT REGIST, V1, P81, DOI 10.3198/jpr2005.11.0414crs; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jookim J, 2002, GENET RES, V79, P259, DOI 10.1017/S001667230200561X; LANDER ES, 1989, GENETICS, V121, P185; Lauter N, 2008, PLANT GENOME-US, V1, P99, DOI 10.3835/plantgenome2008.06.0385; Lebreton CM, 1998, GENETICS, V148, P525; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Luo ZW, 2007, GENETICS, V176, P789, DOI 10.1534/genetics.106.067843; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; MANGIN B, 1994, GENETICS, V138, P1301; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Sharopova N, 2002, PLANT MOL BIOL, V48, P463, DOI 10.1023/A:1014868625533; Visscher PM, 1996, GENETICS, V143, P1013; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	24	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9039	10.1371/journal.pone.0009039	http://dx.doi.org/10.1371/journal.pone.0009039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161743	Green Submitted, Green Published, gold			2022-12-25	WOS:000274442600003
J	Baima, ET; Guzova, JA; Mathialagan, S; Nagiec, EE; Hardy, MM; Song, LR; Bonar, SL; Weinberg, RA; Selness, SR; Woodard, SS; Chrencik, J; Hood, WF; Schindler, JF; Kishore, N; Mbalaviele, G				Baima, Eric T.; Guzova, Julia A.; Mathialagan, Sumathy; Nagiec, Eva E.; Hardy, Medora M.; Song, Lily R.; Bonar, Sheri L.; Weinberg, Robin A.; Selness, Shaun R.; Woodard, Scott S.; Chrencik, Jill; Hood, William F.; Schindler, John F.; Kishore, Nandini; Mbalaviele, Gabriel			Novel Insights into the Cellular Mechanisms of the Anti-inflammatory Effects of NF-kappa B Essential Modulator Binding Domain Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERE LIVER DEGENERATION; KINASE IKK INHIBITOR; SELECTIVE-INHIBITION; IN-VIVO; BLOCKS OSTEOCLASTOGENESIS; MURINE COLITIS; NEMO; ACTIVATION; BETA; PHOSPHORYLATION	The classical nuclear factor kappa B (NF-kappa B) signaling pathway is under the control of the I kappa B kinase (IKK) complex, which consists of IKK-1, IKK-2, and NF-kappa B essential modulator (NEMO). This complex is responsible for the regulation of cell proliferation, survival, and differentiation. Dysregulation of this pathway is associated with several human diseases, and as such, its inhibition offers an exciting opportunity for therapeutic intervention. NEMO-binding domain (NBD) peptides inhibit the binding of recombinant NEMO to IKK-2 in vitro. However, direct evidence of disruption of this binding by NBD peptides in biological systems has not been provided. Using a cell system, we expanded on previous observations to show that NBD peptides inhibit inflammation-induced but not basal cytokine production. We report that these peptides cause the release of IKK-2 from an IKK complex and disrupt NEMO-IKK2 interactions in cells. We demonstrate that by interfering with NEMO-IKK-2 interactions, NBD peptides inhibit IKK-2 phosphorylation, without affecting signaling intermediates upstream of the IKK complex of the NF-kappa B pathway. Furthermore, in a cell-free system of IKK complex activation by TRAF6 (TNF receptor-associated factor 6), we show that these peptides inhibit the ability of this complex to phosphorylate downstream substrates, such as p65 and inhibitor of kappa B alpha (I kappa B alpha). Thus, consistent with the notion that NEMO regulates IKK-2 catalytic activity by serving as a scaffold, appropriately positioning IKK-2 for activation by upstream kinase(s), our findings provide novel insights into the molecular mechanisms by which NBD peptides exert their anti-inflammatory effects in cells.	[Baima, Eric T.; Guzova, Julia A.; Mathialagan, Sumathy; Nagiec, Eva E.; Hardy, Medora M.; Song, Lily R.; Bonar, Sheri L.; Weinberg, Robin A.; Selness, Shaun R.; Woodard, Scott S.; Chrencik, Jill; Hood, William F.; Schindler, John F.; Kishore, Nandini; Mbalaviele, Gabriel] Pfizer Inc, Dept Inflammat, Chesterfield, MO 63017 USA	Pfizer	Mbalaviele, G (corresponding author), Washington Univ, Sch Med, Div Bone & Mineral Dis, 660 S Euclid Ave,Campus Box 8301, St Louis, MO 63110 USA.	mbalaviele@yahoo.com						Agou F, 2004, J BIOL CHEM, V279, P54248, DOI 10.1074/jbc.M406423200; Buckley GM, 2008, BIOORG MED CHEM LETT, V18, P3656, DOI 10.1016/j.bmcl.2008.04.042; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; Dave SH, 2007, J IMMUNOL, V179, P7852, DOI 10.4049/jimmunol.179.11.7852; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; Drew D, 2007, BIOCHEMISTRY-US, V46, P12482, DOI 10.1021/bi701137a; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li XH, 2001, J BIOL CHEM, V276, P4494, DOI 10.1074/jbc.M008353200; Lo YC, 2008, BIOCHEMISTRY-US, V47, P3109, DOI 10.1021/bi702312c; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mbalaviele G, 2009, J PHARMACOL EXP THER, V329, P14, DOI 10.1124/jpet.108.143800; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Palkowitsch L, 2008, J BIOL CHEM, V283, P76, DOI 10.1074/jbc.M708856200; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Rudolph D, 2000, GENE DEV, V14, P854; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Shibata W, 2007, J IMMUNOL, V179, P2681, DOI 10.4049/jimmunol.179.5.2681; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Solt LA, 2009, J BIOL CHEM, V284, P27596, DOI 10.1074/jbc.M109.047563; Sommers CD, 2009, J PHARMACOL EXP THER, V330, P377, DOI 10.1124/jpet.108.147538; Strnad J, 2006, J MOL RECOGNIT, V19, P227, DOI 10.1002/jmr.766; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	33	38	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13498	13506		10.1074/jbc.M109.099895	http://dx.doi.org/10.1074/jbc.M109.099895			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20167598	Green Published, hybrid			2022-12-25	WOS:000276987700022
J	Kim, Y; Kim, BS; Park, YJ; Choi, WC; Hwang, J; Kang, BS; Oh, TK; Choi, SH; Kim, MH				Kim, Yoonjeong; Kim, Byoung Sik; Park, Yu Jin; Choi, Won-Chan; Hwang, Jungwon; Kang, Beom Sik; Oh, Tae-Kwang; Choi, Sang Ho; Kim, Myung Hee			Crystal Structure of SmcR, a Quorum-sensing Master Regulator of Vibrio vulnificus, Provides Insight into Its Regulation of Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; EXPRESSION; LUXR; ELASTASE; GENE; TRAR; IDENTIFICATION; DIMERIZATION; RECOGNITION; RESISTANCE	Quorum sensing has been implicated as an important global regulatory system controlling the expression of numerous virulence factors in bacterial pathogens. SmcR, a homologue of Vibrio harveyi LuxR, has been proposed as a quorum-sensing master regulator of Vibrio vulnificus, an opportunistic human pathogen. Previous studies demonstrated that SmcR is essential for the survival and pathogenesis of V. vulnificus, indicating that inhibiting SmcR is an attractive approach to combat infections by the bacteria. Here, we determined the crystal structure of SmcR at 2.1 angstrom resolution. The protein structure reveals a typical TetR superfamily fold consisting of an N-terminal DNA binding domain and a C-terminal dimerization domain. In vivo and in vitro functional analysis of the dimerization domain suggested that dimerization of SmcR is vital for its biological regulatory function. The N-terminal DNA recognition and binding residues were assigned based on the protein structure and the results of in vivo and in vitro mutagenesis experiments. Furthermore, protein-DNA interaction experiments suggested that SmcR may have a sophisticated mechanism that enables the protein to recognize each of its many target operators with different affinities.	[Kim, Byoung Sik; Park, Yu Jin; Choi, Sang Ho] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Kim, Yoonjeong; Choi, Won-Chan; Hwang, Jungwon; Oh, Tae-Kwang; Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Kim, Yoonjeong; Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Hwang, Jungwon] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Kim, Myung Hee] Univ Sci & Technol, Biosyst & Bioengn Program, Taejon 305333, South Korea	Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kyungpook National University; Korea Advanced Institute of Science & Technology (KAIST)	Choi, SH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	choish@snu.ac.kr; mhk8n@kribb.re.kr	Kim, Byoungsik/AAE-6239-2021	Choi, Sang Ho/0000-0003-3865-1039; Kim, Byoung Sik/0000-0001-9820-6071	Ministry of Education, Science, and Technology, Republic of Korea [R0A-2007-000-200390]	Ministry of Education, Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the 21st Century Frontier Microbial Genomics and Applications Center Program (to M. H. K.) and from the National Research Laboratory Program (R0A-2007-000-200390 to S. H. C.) funded by the Ministry of Education, Science, and Technology, Republic of Korea.	Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; De Silva RS, 2007, J BACTERIOL, V189, P5683, DOI 10.1128/JB.01807-06; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Jeong HS, 2001, J BIOL CHEM, V276, P13875, DOI 10.1074/jbc.M010567200; Jeong KC, 2000, INFECT IMMUN, V68, P5096, DOI 10.1128/IAI.68.9.5096-5106.2000; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kim MH, 2008, J BIOL CHEM, V283, P31981, DOI 10.1074/jbc.M804092200; Kim SY, 2003, MOL MICROBIOL, V48, P1647, DOI 10.1046/j.1365-2958.2003.03536.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee DH, 2008, J BIOL CHEM, V283, P23610, DOI 10.1074/jbc.M801480200; McDougald D, 2001, J BACTERIOL, V183, P758, DOI 10.1128/JB.183.2.758-762.2001; McDougald D, 2000, GENE, V248, P213, DOI 10.1016/S0378-1119(00)00117-7; MILLER JH, 1976, EXPT MOL GENETICS, P352; Milton DL, 2006, INT J MED MICROBIOL, V296, P61, DOI 10.1016/j.ijmm.2006.01.044; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinto UM, 2009, MOL MICROBIOL, V73, P32, DOI 10.1111/j.1365-2958.2009.06730.x; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Qin YP, 2000, EMBO J, V19, P5212, DOI 10.1093/emboj/19.19.5212; Roh JB, 2006, J BIOL CHEM, V281, P34775, DOI 10.1074/jbc.M607844200; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Shao CP, 2001, J BACTERIOL, V183, P1369, DOI 10.1128/JB.183.4.1369-1375.2001; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valiente E, 2009, FEMS MICROBIOL ECOL, V69, P16, DOI 10.1111/j.1574-6941.2009.00691.x; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507	38	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					14020	14030		10.1074/jbc.M109.100248	http://dx.doi.org/10.1074/jbc.M109.100248			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20178981	Green Published, hybrid			2022-12-25	WOS:000276987700075
J	Irimia, JM; Meyer, CM; Peper, CL; Zhai, LM; Bock, CB; Previs, SF; McGuinness, OP; DePaoli-Roach, A; Roach, PJ				Irimia, Jose M.; Meyer, Catalina M.; Peper, Caron L.; Zhai, Lanmin; Bock, Cheryl B.; Previs, Stephen F.; McGuinness, Owen P.; DePaoli-Roach, Anna; Roach, Peter J.			Impaired Glucose Tolerance and Predisposition to the Fasted State in Liver Glycogen Synthase Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID-METABOLISM; MUSCLE GLYCOGEN; HEPATIC GLUCONEOGENESIS; GENE-EXPRESSION; MIXED MEAL; STORAGE; LACKING; CARBOHYDRATE; HOMEOSTASIS	Conversion to glycogen is a major fate of ingested glucose in the body. A rate-limiting enzyme in the synthesis of glycogen is glycogen synthase encoded by two genes, GYS1, expressed in muscle and other tissues, and GYS2, primarily expressed in liver (liver glycogen synthase). Defects in GYS2 cause the inherited monogenic disease glycogen storage disease 0. We have generated mice with a liver-specific disruption of the Gys2 gene (liver glycogen synthase knock-out (LGSKO) mice), using Lox-P/Cre technology. Conditional mice carrying floxed Gys2 were crossed with mice expressing Cre recombinase under the albumin promoter. The resulting LGSKO mice are viable, develop liver glycogen synthase deficiency, and have a 95% reduction in fed liver glycogen content. They have mild hypoglycemia but dispose glucose less well in a glucose tolerance test. Fed, LGSKO mice also have a reduced capacity for exhaustive exercise compared with mice carrying floxed alleles, but the difference disappears after an overnight fast. Upon fasting, LGSKO mice reach within 4 h decreased blood glucose levels attained by control floxed mice only after 24 h of food deprivation. The LGSKO mice maintain this low blood glucose for at least 24 h. Basal gluconeogenesis is increased in LGSKO mice, and insulin suppression of endogenous glucose production is impaired as assessed by euglycemic-hyperinsulinemic clamp. This observation correlates with an increase in the liver gluconeogenic enzyme phosphoenolpyruvate carboxykinase expression and activity. This mouse model mimics the pathophysiology of glycogen storage disease 0 patients and highlights the importance of liver glycogen stores in whole body glucose homeostasis.	[DePaoli-Roach, Anna; Roach, Peter J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Ctr Diabet Res, Indianapolis, IN 46202 USA; [Bock, Cheryl B.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Previs, Stephen F.] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [McGuinness, Owen P.] Vanderbilt Univ, Sch Med, Metab Pathophysiol Core Mouse Metab Phenotyping, Nashville, TN 37232 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Duke University; Case Western Reserve University; Vanderbilt University	Roach, PJ (corresponding author), 635 Barnhill Dr,MS405A, Indianapolis, IN 46202 USA.	proach@iupui.edu			National Institutes of Health [DK27221, DK59637, DK082376]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, U2CDK059637, R25DK082376, R01DK027221, R56DK027221, R37DK027221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK27221 (to P. J. R.), DK59637 (to the Vanderbilt Mouse Metabolic Phenotyping Center), and DK082376 (to the Case Western Reserve University Mouse Metabolic Phenotyping Center).	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; ANTWI D, 1988, AM J PHYSIOL, V254, pE720, DOI 10.1152/ajpendo.1988.254.6.E720; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; BALLET F, 1990, PHARMACOL THERAPEUT, V47, P281, DOI 10.1016/0163-7258(90)90091-F; BHAVNANI BR, 1983, CAN J BIOCHEM CELL B, V61, P191, DOI 10.1139/o83-027; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; CALDER PC, 1992, INT J BIOCHEM, V24, P71, DOI 10.1016/0020-711X(92)90231-O; Capaldo B, 1999, DIABETES, V48, P958, DOI 10.2337/diabetes.48.5.958; CHEN C, 1992, HORM METAB RES, V24, P161, DOI 10.1055/s-2007-1003285; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fueger PT, 2005, J PHYSIOL-LONDON, V562, P925, DOI 10.1113/jphysiol.2004.076158; Gastaldelli A, 2001, DIABETES, V50, P1807, DOI 10.2337/diabetes.50.8.1807; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hribal ML, 2002, AM J PHYSIOL-ENDOC M, V282, pE977, DOI 10.1152/ajpendo.00561.2001; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; LUDVIK B, 1995, J CLIN INVEST, V95, P2232, DOI 10.1172/JCI117913; Marliss E B, 1974, Horm Metab Res, VSuppl 4, P93; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Nuttall FQ, 2008, DIABETES-METAB RES, V24, P438, DOI 10.1002/dmrr.863; Ozen H, 2007, WORLD J GASTROENTERO, V13, P2541; Orho M, 1998, J CLIN INVEST, V102, P507, DOI 10.1172/JCI2890; Parker GE, 2006, BIOCHEM J, V395, P137, DOI 10.1042/BJ20051456; Pederson BA, 2005, DIABETES, V54, P3466, DOI 10.2337/diabetes.54.12.3466; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Pederson BA, 2005, BIOCHEM BIOPH RES CO, V331, P491, DOI 10.1016/j.bbrc.2005.03.206; Pederson BA, 2004, MOL CELL BIOL, V24, P7179, DOI 10.1128/MCB.24.16.7179-7187.2004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PREVIS SF, 1995, J BIOL CHEM, V270, P19806, DOI 10.1074/jbc.270.34.19806; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rajas F, 2000, DIABETES, V49, P1165, DOI 10.2337/diabetes.49.7.1165; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Taylor R, 1996, J CLIN INVEST, V97, P126, DOI 10.1172/JCI118379; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806; Weinstein DA, 2006, MOL GENET METAB, V87, P284, DOI 10.1016/j.ymgme.2005.10.006; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	47	55	56	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12851	12861		10.1074/jbc.M110.106534	http://dx.doi.org/10.1074/jbc.M110.106534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178984	hybrid, Green Published			2022-12-25	WOS:000276787800043
J	Kaysser, L; Eitel, K; Tanino, T; Siebenberg, S; Matsuda, A; Ichikawa, S; Gust, B				Kaysser, Leonard; Eitel, Kornelia; Tanino, Tetsuya; Siebenberg, Stefanie; Matsuda, Akira; Ichikawa, Satoshi; Gust, Bertolt			A New Arylsulfate Sulfotransferase Involved in Liponucleoside Antibiotic Biosynthesis in Streptomycetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOFURANOSYL NUCLEOSIDE MOIETY; HUMAN INTESTINAL BACTERIUM; ASTA GENE; PEPTIDOGLYCAN SYNTHESIS; ESCHERICHIA-COLI; EUBACTERIUM A-44; CELL-WALL; LIPOSIDOMYCINS; ANALOGS; CLONING	Sulfotransferases are involved in a variety of physiological processes and typically use 3'-phosphoadenosine 5'-phosphosulfate (PAPS) as the sulfate donor substrate. In contrast, microbial arylsulfate sulfotransferases (ASSTs) are PAPS-independent and utilize arylsulfates as sulfate donors. Yet, their genuine acceptor substrates are unknown. In this study we demonstrate that Cpz4 from Streptomyces sp. MK730-62F2 is an ASST-type sulfotransferase responsible for the formation of sulfated liponucleoside antibiotics. Gene deletion mutants showed that cpz4 is required for the production of sulfated caprazamycin derivatives. Cloning, overproduction, and purification of Cpz4 resulted in a 58-kDa soluble protein. The enzyme catalyzed the transfer of a sulfate group from p-nitrophenol sulfate (K-m 48.1 mu M, k(cat) 0.14 s(-1)) and methyl umbelliferone sulfate (K-m 34.5 mu M, k(cat) 0.15 s(-1)) onto phenol (K-m 25.9 and 29.7 mM, respectively). The Cpz4 reaction proceeds by a ping pong bi-bi mechanism. Several structural analogs of intermediates of the caprazamycin biosynthetic pathway were synthesized and tested as substrates of Cpz4. Des-N-methyl-acyl-caprazol was converted with highest efficiency 100 times faster than phenol. The fatty acyl side chain and the uridyl moiety seem to be important for substrate recognition by Cpz4. Liponucleosides, partially purified from various mutant strains, were readily sulfated by Cpz4 using p-nitrophenol sulfate. No product formation could be observed with PAPS as the donor substrate. Sequence homology of Cpz4 to the previously examined ASSTs is low. However, numerous orthologs are encoded in microbial genomes and represent interesting subjects for future investigations.	[Gust, Bertolt] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany; [Tanino, Tetsuya; Matsuda, Akira; Ichikawa, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0650812, Japan	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Hokkaido University	Gust, B (corresponding author), Univ Tubingen, Inst Pharmazeut, Auf Morgenstelle 8, D-72076 Tubingen, Germany.	bertolt.gust@uni-tuebingen.de	Kaysser, Leonard/Q-2091-2019; Ichikawa, Satoshi S/F-6915-2012; Matsuda, Akira/D-5477-2012	Kaysser, Leonard/0000-0002-3943-993X; 	European Commission [IP005224]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission Grant IP005224 (ActinoGEN).	Baek MC, 1996, MICROBIOL IMMUNOL, V40, P531, DOI 10.1111/j.1348-0421.1996.tb01105.x; BURNS GRJ, 1977, BIOCHEM J, V167, P223, DOI 10.1042/bj1670223; Chapman E, 2004, ANGEW CHEM INT EDIT, V43, P3526, DOI 10.1002/anie.200300631; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P188; Cronan GE, 2004, J BACTERIOL, V186, P4168, DOI 10.1128/JB.186.13.4168-4176.2004; Dini C, 2001, BIOORG MED CHEM LETT, V11, P533, DOI 10.1016/S0960-894X(00)00714-9; Dini C, 2001, BIOORG MED CHEM LETT, V11, P529, DOI 10.1016/S0960-894X(00)00715-0; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Funabashi M, 2010, CHEMBIOCHEM, V11, P184, DOI 10.1002/cbic.200900665; Goldstein A, 1944, J GEN PHYSIOL, V27, P529, DOI 10.1085/jgp.27.6.529; GOREN MB, 1974, INFECT IMMUN, V9, P142, DOI 10.1128/IAI.9.1.142-149.1974; Gu LC, 2009, J AM CHEM SOC, V131, P16033, DOI 10.1021/ja9071578; HARADA K, 1994, TOXICON, V32, P73, DOI 10.1016/0041-0101(94)90023-X; Hirano S, 2008, BIOORGAN MED CHEM, V16, P5123, DOI 10.1016/j.bmc.2008.03.020; Hirano S, 2008, J ORG CHEM, V73, P569, DOI 10.1021/jo702264e; Hirano S, 2007, TETRAHEDRON, V63, P2798, DOI 10.1016/j.tet.2007.01.055; Hirano S, 2008, BIOORGAN MED CHEM, V16, P428, DOI 10.1016/j.bmc.2007.09.022; Igarashi M, 2005, J ANTIBIOT, V58, P327, DOI 10.1038/ja.2005.41; ISONO K, 1985, J ANTIBIOT, V38, P1617, DOI 10.7164/antibiotics.38.1617; IWAMOTO T, 1994, J ANTIBIOT, V47, P1084; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kang JW, 2001, BIOL PHARM BULL, V24, P570, DOI 10.1248/bpb.24.570; Kang JW, 2001, ARCH PHARM RES, V24, P316, DOI 10.1007/BF02975099; Kaysser L, 2010, CHEMBIOCHEM, V11, P191, DOI 10.1002/cbic.200900637; Kaysser L, 2009, J BIOL CHEM, V284, P14987, DOI 10.1074/jbc.M901258200; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim B, 2007, BIOL PHARM BULL, V30, P11, DOI 10.1248/bpb.30.11; KIM DH, 1991, J BIOCHEM-TOKYO, V109, P45; Kimura K, 2003, NAT PROD REP, V20, P252, DOI 10.1039/b202149h; KIMURA K, 1989, AGR BIOL CHEM TOKYO, V53, P1811, DOI 10.1080/00021369.1989.10869560; KIMURA K, 2002, Patent No. 6455694; KONISHIIMAMURA L, 1994, BIOL PHARM BULL, V17, P1018; Kwon AR, 2001, BIOCHEM BIOPH RES CO, V285, P526, DOI 10.1006/bbrc.2001.5185; Kwon AR, 1999, PROTEIN EXPRES PURIF, V17, P366, DOI 10.1006/prep.1999.1129; Lamb SS, 2006, CHEM BIOL, V13, P171, DOI 10.1016/j.chembiol.2005.12.003; Malojcic G, 2008, P NATL ACAD SCI USA, V105, P19217, DOI 10.1073/pnas.0806997105; Sambrook J., 2002, MOL CLONING LAB MANU; SCHNEIDER H, 1993, J ORG CHEM, V58, P683, DOI 10.1021/jo00055a022; Shi R, 2007, J BIOL CHEM, V282, P13073, DOI 10.1074/jbc.M611912200; TAKEUCHI T, 2002, Patent No. 6780616; UBUKATA M, 1992, J ORG CHEM, V57, P6392, DOI 10.1021/jo00050a009	41	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12684	12694		10.1074/jbc.M109.094490	http://dx.doi.org/10.1074/jbc.M109.094490			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20157116	Green Published, hybrid			2022-12-25	WOS:000276787800027
J	Moynihan, PJ; Clarke, AJ				Moynihan, Patrick J.; Clarke, Anthony J.			O-Acetylation of Peptidoglycan in Gram-negative Bacteria IDENTIFICATION AND CHARACTERIZATION OF PEPTIDOGLYCAN O-ACETYLTRANSFERASE IN NEISSERIA GONORRHOEAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; NEISSERIA-GONORRHOEAE; GONOCOCCAL PEPTIDOGLYCAN; LYTIC TRANSGLYCOSYLASES; ACETYLPEPTIDOGLYCAN ESTERASE; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; LYSOZYME SENSITIVITY; PROTEUS-MIRABILIS; CRYSTAL-STRUCTURE	The ape2 gene encoding a hypothetical O-acetylpeptidoglycan esterase was amplified from genomic DNA of Neisseria gonorrhoeae FA1090 and cloned to encode either the full-length protein or a truncated version lacking its hypothetical signal sequence. Expression trials revealed that production of the full-length version possessing either an N-terminal or C-terminal His(6) tag was toxic to Escherichia coli transformants and that the host rapidly degraded the small amount of protein that was produced. An N-terminally truncated protein could be produced in sufficient yields for purification only if it possessed an N-terminal His(6) tag. This form of the protein was isolated and purified to apparent homogeneity, and its enzymatic properties were characterized. Whereas the protein could bind to insoluble peptidoglycan, it did not function as an esterase. Phenotypic characterization of E. coli transformants producing various forms of the protein revealed that it functions instead to O-acetylate peptidoglycan within the periplasm, and it was thus renamed peptidoglycan O-acetyltransferase B. This activity was found to be dependent upon a second protein, which functions to translocate acetate from the cytoplasm to the periplasm, demonstrating that the O-acetylation of peptidoglycan in N. gonorrhoeae, and other Gram-negative bacteria, requires a two component system.	[Moynihan, Patrick J.; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Clarke, AJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	aclarke@uoguelph.ca	Moynihan, Patrick J/I-3393-2013	Moynihan, Patrick J/0000-0003-4182-6223	Canadian Institutes for Health Research [MOP81223]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Grant MOP81223 (to A.J.C.).	Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; BLACK WJ, 1984, INFECT IMMUN, V45, P453, DOI 10.1128/IAI.45.2.453-457.1984; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; BLUNDELL JK, 1980, FEMS MICROBIOL LETT, V9, P259, DOI 10.1111/j.1574-6968.1980.tb05648.x; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; CLARKE AJ, 1992, CAN J MICROBIOL, V38, P85, DOI 10.1139/m92-014; Clarke AJ, 2000, GLYCOMICROBIOLOGY, P187; Clarke J. H, 1996, GREAT MIGHTY WALK; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; DEUTSCHER MP, 1974, J BACTERIOL, V118, P633, DOI 10.1128/JB.118.2.633-639.1974; Dillard JP, 2005, INFECT IMMUN, V73, P5697, DOI 10.1128/IAI.73.9.5697-5705.2005; DUPONT C, 1991, J BACTERIOL, V173, P4618, DOI 10.1128/jb.173.15.4618-4624.1991; DUPONT C, 1991, EUR J BIOCHEM, V195, P763, DOI 10.1111/j.1432-1033.1991.tb15764.x; Franklin MJ, 1996, J BACTERIOL, V178, P2186, DOI 10.1128/jb.178.8.2186-2195.1996; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; HOLMQUIST M, 2000, CURR OPIN STRUC BIOL, V9, P209; HOLTJE JV, 1975, J BACTERIOL, V124, P1067; HOYLE BD, 1984, CAN J MICROBIOL, V30, P204, DOI 10.1139/m84-031; Kajimura J, 2006, J BACTERIOL, V188, P7542, DOI 10.1128/JB.00783-06; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Koraimann G, 2003, CELL MOL LIFE SCI, V60, P2371, DOI 10.1007/s00018-003-3056-1; LAEMMLI UK, 1970, NATURE, V227, P685; Mirza IA, 2005, BIOCHEMISTRY-US, V44, P15768, DOI 10.1021/bi051951y; Pagotto FJ, 2000, GENE, V244, P13, DOI 10.1016/S0378-1119(99)00557-0; Payie KG, 1996, MICROB DRUG RESIST, V2, P135, DOI 10.1089/mdr.1996.2.135; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; ROSENTHAL RS, 1982, INFECT IMMUN, V37, P826, DOI 10.1128/IAI.37.2.826-829.1982; ROSENTHAL RS, 1983, INFECT IMMUN, V40, P903, DOI 10.1128/IAI.40.3.903-911.1983; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Scheurwater EM, 2008, J BIOL CHEM, V283, P8363, DOI 10.1074/jbc.M710135200; SNOWDEN MA, 1989, J GEN MICROBIOL, V135, P3015; SWIM SC, 1983, INFECT IMMUN, V42, P446, DOI 10.1128/IAI.42.2.446-452.1983; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Wang M, 2007, BIOCHEM BIOPH RES CO, V363, P1050, DOI 10.1016/j.bbrc.2007.08.153; Weadge JT, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-49; Weadge JT, 2006, BIOCHEMISTRY-US, V45, P839, DOI 10.1021/bi051679s	42	53	53	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13264	13273		10.1074/jbc.M110.107086	http://dx.doi.org/10.1074/jbc.M110.107086			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178982	Green Published, hybrid			2022-12-25	WOS:000276787800081
J	Major, B; Kardos, J; Kekesi, KA; Lorincz, Z; Zavodszky, P; Gal, P				Major, Balazs; Kardos, Jozsef; Kekesi, Katalin Adrienna; Lorincz, Zsolt; Zavodszky, Peter; Gal, Peter			Calcium-dependent Conformational Flexibility of a CUB Domain Controls Activation of the Complement Serine Protease C1r	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC DOMAIN; CRYSTAL-STRUCTURE; ENERGY CONTENT; PROTEINS; REVEALS; REGION; RECOGNITION; COMPLEXES; MECHANISM; INSIGHTS	C1, the first component of the complement system, is a Ca2+-dependent heteropentamer complex of C1q and two modular serine proteases, C1r and C1s. Current functional models assume significant flexibility of the subcomponents. Noncatalytic modules in C1r have been proposed to provide the flexibility required for function. Using a recombinant CUB2-CCP1 domain pair and the individual CCP1 module, we showed that binding of Ca2+ induces the folding of the CUB2 domain and stabilizes its structure. In the presence of Ca2+, CUB2 shows a compact, folded structure, whereas in the absence of Ca2+, it has a flexible, disordered conformation. CCP1 module is Ca2+-in-sensitive. Isothermal titration calorimetry revealed that CUB2 binds a single Ca2+ with a relatively high K-D (430 mu M). In blood, the CUB2 domain of C1r is only partially (74%) saturated by Ca2+, therefore the disordered, Ca2+-free form could provide the flexibility required for C1 activation. In accordance with this assumption, the effect of Ca2+ on the autoactivation of native, isolated C1r zymogen was proved. In the case of infection-inflammation when the local Ca2+ concentration decreases, this property of CUB2 domain could serve as subtle means to trigger the activation of the classical pathway of complement. The CUB2 domain of C1r is a novel example for globular protein domains with marginal stability, high conformational flexibility, and proteolytic sensitivity. The physical nature of the behavior of this domain is similar to that of intrinsically unstructured proteins, providing a further example of functionally relevant ligand-induced reorganization of a polypeptide chain.	[Major, Balazs; Kardos, Jozsef; Lorincz, Zsolt; Zavodszky, Peter; Gal, Peter] Hungarian Acad Sci, Inst Enzymol, H-1113 Budapest, Hungary; [Kardos, Jozsef] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Kekesi, Katalin Adrienna] Eotvos Lorand Univ, Lab Proteom, H-1117 Budapest, Hungary; [Kekesi, Katalin Adrienna] Eotvos Lorand Univ, Dept Physiol & Neurobiol, Inst Biol, H-1117 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand University	Kardos, J (corresponding author), Hungarian Acad Sci, Inst Enzymol, Karolina Ut 29-31, H-1113 Budapest, Hungary.	kardos@elte.hu; gal@enzim.hu	Kékesi, Katalin Adrienna A/H-3484-2017; Gal, Peter/B-5886-2011; Kardos, József/J-1035-2017	Kékesi, Katalin Adrienna A/0000-0003-3042-4878; Kardos, József/0000-0002-2135-2932	Hungarian Scientific Research Fund [68464, 81950, NK77978]; National Development Agency [KMOP-1.1.2-07/1-2008-0003];  [NKFP_07_1-MASPOK07]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency; 	This work was supported by Hungarian Scientific Research Fund Grants 68464, 81950, and NK77978, Anyos Jedlik Grant NKFP_07_1-MASPOK07, and National Development Agency Grant KMOP-1.1.2-07/1-2008-0003.	Arlaud GJ, 2007, MOL IMMUNOL, V44, P3809, DOI 10.1016/j.molimm.2007.06.147; ARLAUD GJ, 1993, METHOD ENZYMOL, V223, P61; ARLAUD GJ, 1986, BIOCHEMISTRY-US, V25, P5177, DOI 10.1021/bi00366a029; Bally I, 2009, J BIOL CHEM, V284, P19340, DOI 10.1074/jbc.M109.004473; Bersch B, 1998, BIOCHEMISTRY-US, V37, P1204, DOI 10.1021/bi971851v; Budayova-Spano M, 2002, STRUCTURE, V10, P1509, DOI 10.1016/S0969-2126(02)00881-X; Budayova-Spano M, 2002, EMBO J, V21, P231, DOI 10.1093/emboj/21.3.231; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Dobo J, 2006, J BIOL CHEM, V281, P38781, DOI 10.1074/jbc.M605151200; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; FINN BE, 1995, STRUCTURE, V3, P7, DOI 10.1016/S0969-2126(01)00130-7; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; Gaboriaud C, 2007, IMMUNOBIOLOGY, V212, P279, DOI 10.1016/j.imbio.2006.11.007; GAL P, 1989, COMPLEMENT INFLAMMAT, V6, P433; Gal P, 2009, MOL IMMUNOL, V46, P2745, DOI 10.1016/j.molimm.2009.04.026; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; Hazy E, 2009, CHEMPHYSCHEM, V10, P1415, DOI 10.1002/cphc.200900205; Kardos J, 2001, J IMMUNOL, V167, P5202, DOI 10.4049/jimmunol.167.9.5202; Kardos J, 2008, MOL IMMUNOL, V45, P1752, DOI 10.1016/j.molimm.2007.09.031; Lacroix M, 2001, J BIOL CHEM, V276, P36233, DOI 10.1074/jbc.M105688200; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; MONKOVIC DD, 1992, BIOCHEM BIOPH RES CO, V189, P233, DOI 10.1016/0006-291X(92)91549-6; MOORE E W, 1970, Journal of Clinical Investigation, V49, P318, DOI 10.1172/JCI106241; Phillips AE, 2009, J IMMUNOL, V182, P7708, DOI 10.4049/jimmunol.0900666; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; SCHUMAKER VN, 1989, BEHRING I MITT, V84, P102; THIELENS NM, 1994, BIOCHEM J, V301, P509, DOI 10.1042/bj3010509; Thielens NM, 1999, J BIOL CHEM, V274, P9149, DOI 10.1074/jbc.274.14.9149; THIELENS NM, 1990, J BIOL CHEM, V265, P14469; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Yamniuk AP, 2007, BIOCHEMISTRY-US, V46, P7088, DOI 10.1021/bi700200z; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282	40	16	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11863	11869		10.1074/jbc.M109.098541	http://dx.doi.org/10.1074/jbc.M109.098541			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20178990	Green Published, hybrid			2022-12-25	WOS:000276787100014
J	Lee, KY; Yang, K; Cohn, MA; Sikdar, N; D'Andrea, AD; Myung, K				Lee, Kyoo-young; Yang, Kailin; Cohn, Martin A.; Sikdar, Nilabja; D'Andrea, Alan D.; Myung, Kyungjae			Human ELG1 Regulates the Level of Ubiquitinated Proliferating Cell Nuclear Antigen (PCNA) through Its Interactions with PCNA and USP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-FACTOR-C; DNA-POLYMERASE-ETA; GENOME STABILITY; COHESION ESTABLISHMENT; MONOUBIQUITINATED PCNA; COMPLEX-FORMATION; S-PHASE; INSTABILITY; DAMAGE; FORMS	The level of monoubiquitinated proliferating cell nuclear antigen (PCNA) is closely linked with DNA damage bypass to protect cells from a high level of mutagenesis. However, it remains unclear how the level of monoubiquitinated PCNA is regulated. Here, we demonstrate that human ELG1 protein, which comprises an alternative replication factor C (RFC) complex and plays an important role in preserving genomic stability, as an interacting partner for the USP1 (ubiquitin-specific protease 1)-UAF1 (USP1-associated factor 1) complex, a deubiquitinating enzyme complex for PCNA and FANCD2. ELG1 protein interacts with PCNAs that are localized at stalled replication forks. ELG1 knockdown specifically resulted in an increase in the level of PCNA monoubiquitination without affecting the level of FANCD2 ubiquitination. It is a novel function of ELG1 distinct from its role as an alternative RFC complex because knockdowns of any other RFC subunits or other alternative RFCs did not affect PCNA monoubiquitination. Lastly, we identified a highly conserved N-terminal domain in ELG1 that was responsible for the USP1-UAF1 interaction as well as the activity to down-regulate PCNA monoubiquitination. Taken together, ELG1 specifically directs USP1-UAF1 complex for PCNA deubiquitination.	[Lee, Kyoo-young; Sikdar, Nilabja; Myung, Kyungjae] NHGRI, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Yang, Kailin; Cohn, Martin A.; D'Andrea, Alan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Myung, K (corresponding author), NHGRI, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, Bldg 49,Rm 4A22, Bethesda, MD 20892 USA.	kmyung@nhgri.nih.gov	Yang, Kailin/L-2205-2013; Classen, Scott/AAY-8176-2020; Lee, Kyoo-young/AAG-3144-2019; Yang, Kailin/D-7966-2013	Yang, Kailin/0000-0001-5968-6738; Cohn, Martin/0000-0002-2988-3009	National Institutes of Health [RO1-HL52725, RO1-DK43889, PO1-CA092584]; National Institutes of Health, National Human Genome Research Institute, Intramural Research Program [HG012003-07]; Korean Government [KRF-2007-357C00092]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052725] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG012003, Z01HG012003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Human Genome Research Institute, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Korean Government(Korean Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL52725, RO1-DK43889, and PO1-CA092584 (to A. D.) and National Institutes of Health, National Human Genome Research Institute, Intramural Research Program Grant HG012003-07 (to K. M.). This work was also supported by Korea Research Foundation Grant KRF-2007-357C00092 funded by the Korean Government (to K. Y. L.).	Banerjee S, 2004, EUKARYOT CELL, V3, P1557, DOI 10.1128/EC.3.6.1557-1566.2004; Banerjee S, 2007, BIOCHEM BIOPH RES CO, V362, P546, DOI 10.1016/j.bbrc.2007.07.126; Bellaoui M, 2003, EMBO J, V22, P4304, DOI 10.1093/emboj/cdg406; Ben-Aroya S, 2003, P NATL ACAD SCI USA, V100, P9906, DOI 10.1073/pnas.1633757100; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Brown S, 2009, CELL CYCLE, V8, P689, DOI 10.4161/cc.8.5.7707; Bylund GO, 2005, MOL CELL BIOL, V25, P5445, DOI 10.1128/MCB.25.13.5445-5455.2005; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Davidson MB, 2008, DNA REPAIR, V7, P1221, DOI 10.1016/j.dnarep.2008.04.001; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Ishizaki K, 1996, MUTAT RES-DNA REPAIR, V364, P43, DOI 10.1016/0921-8777(96)00020-1; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kanellis P, 2003, CURR BIOL, V13, P1583, DOI 10.1016/S0960-9822(03)00578-5; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; Lee KY, 2008, MOL CELLS, V26, P5; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Merkle CJ, 2003, J BIOL CHEM, V278, P30051, DOI 10.1074/jbc.M211591200; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Sikdar N, 2009, CELL CYCLE, V8, P3199, DOI 10.4161/cc.8.19.9752; Uhlmann F, 1997, J BIOL CHEM, V272, P10065; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	34	105	107	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10362	10369		10.1074/jbc.M109.092544	http://dx.doi.org/10.1074/jbc.M109.092544			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20147293	hybrid, Green Published			2022-12-25	WOS:000276264600021
J	Gonzalvez, F; Pariselli, F; Jalmar, O; Dupaigne, P; Sureau, F; Dellinger, M; Hendrickson, EA; Bernard, S; Petit, PX				Gonzalvez, Francois; Pariselli, Fabrizio; Jalmar, Olivier; Dupaigne, Pauline; Sureau, Franck; Dellinger, Marc; Hendrickson, Eric A.; Bernard, Sophie; Petit, Patrice X.			Mechanistic Issues of the Interaction of the Hairpin-Forming Domain of tBid with Mitochondrial Cardiolipin	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; INDUCED APOPTOSIS; BCL-2 FAMILY; RAT-LIVER; X-RAY; BAX; MEMBRANE; DEATH; PATHWAY; PROTEIN	Background: The pro-apoptotic effector Bid induces mitochondrial apoptosis in synergy with Bax and Bak. In response to death receptors activation, Bid is cleaved by caspase-8 into its active form, tBid (truncated Bid), which then translocates to the mitochondria to trigger cytochrome c release and subsequent apoptosis. Accumulating evidence now indicate that the binding of tBid initiates an ordered sequences of events that prime mitochondria from the action of Bax and Bak: (1) tBid interacts with mitochondria via a specific binding to cardiolipin (CL) and immediately disturbs mitochondrial structure and function idependently of its BH3 domain; (2) Then, tBid activates through its BH3 domain Bax and/or Bak and induces their subsequent oligomerization in mitochondrial membranes. To date, the underlying mechanism responsible for targeting tBid to mitochondria and disrupting mitochondrial bioenergetics has yet be elucidated. Principal Findings: The present study investigates the mechanism by which tBid interacts with mitochondria issued from mouse hepatocytes and perturbs mitochondrial function. We show here that the helix alpha H6 is responsible for targeting tBid to mitochondrial CL and disrupting mitochondrial bioenergetics. In particular, alpha H6 interacts with mitochondria through electrostatic interactions involving the lysines 157 and 158 and induces an inhibition of state-3 respiration and an uncoupling of state-4 respiration. These changes may represent a key event that primes mitochondria for the action of Bax and Bak. In addition, we also demonstrate that tBid required its helix alpha H6 to efficiently induce cytochrome c release and apoptosis. Conclusions: Our findings provide new insights into the mechanism of action of tBid, and particularly emphasize the importance of the interaction of the helix alpha H6 with CL for both mitochondrial targeting and pro-apoptotic activity of tBid. These support the notion that tBid acts as a bifunctional molecule: first, it binds to mitochondrial CL via its helix alpha H6 and destabilizes mitochondrial structure and function, and then it promotes through its BH3 domain the activation and oligomerization of Bax and/or Bak, leading to cytochrome c release and execution of apoptosis. Our findings also imply an active role of the membrane in modulating the interactions between Bcl-2 proteins that has so far been underestimated.	[Gonzalvez, Francois; Pariselli, Fabrizio; Jalmar, Olivier; Petit, Patrice X.] Univ Paris 05, INSERM, UMR8104, Inst Cochin,CNRS,U567, Paris, France; [Dupaigne, Pauline] Univ Paris 05, CNRS, UPR2228, Paris, France; [Sureau, Franck] Univ Paris 08, Univ Paris 06, CNRS, UMR7033,BioMoCeti,GENOPOLE Campus 1, Evry, France; [Dellinger, Marc] Museum Natl Hist Nat, USM Biol Fonct Protozoaires 504, F-75231 Paris, France; [Hendrickson, Eric A.] Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Bernard, Sophie] Univ Paris 05, IFR 95, CNRS, UPR 2228, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Genopole; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-VIII; Museum National d'Histoire Naturelle (MNHN); University of Minnesota System; University of Minnesota Twin Cities; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Gonzalvez, F (corresponding author), Univ Paris 05, INSERM, UMR8104, Inst Cochin,CNRS,U567, Paris, France.	patrice.petit@inserm.fr	Petit, Patrice X./A-3692-2009; Dupaigne, Pauline/C-6873-2019; Petit, patrice/AAF-6774-2020	Petit, Patrice X./0000-0002-5038-9101; Dupaigne, Pauline/0000-0001-7033-4055	Centre national de la Recherche Scientifique (CNRS); Association de recherche contre le Cancer [4493]; AFM [11557/2005, 13313/2008]	Centre national de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association de recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); AFM(Association Francaise contre les Myopathies)	This work was supported by grants from the Centre national de la Recherche Scientifique (CNRS), Association de recherche contre le Cancer (ARC 4493 to PXP) and AFM 11557/2005 and 13313/2008 to PXP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Ahmad KA, 2004, CANCER RES, V64, P7867, DOI 10.1158/0008-5472.CAN-04-0648; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; DELACOSTE A, 1998, AM J PHYSIOL, V59, P5017; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Esposti MD, 2002, BBA-BIOENERGETICS, V1553, P331, DOI 10.1016/S0005-2728(02)00187-1; Etienne F, 2008, CHEM PHYS LIPIDS, V152, P13, DOI 10.1016/j.chemphyslip.2007.12.002; Gabriel B, 2003, EXP CELL RES, V289, P195, DOI 10.1016/S0014-4827(03)00255-6; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Hu X, 2003, APOPTOSIS, V8, P277, DOI 10.1023/A:1023676906857; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lacronique V, 1996, NAT MED, V2, P80, DOI 10.1038/nm0196-80; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu J, 2004, APOPTOSIS, V9, P533, DOI 10.1023/B:APPT.0000038034.16230.ea; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; PETIT PX, 1990, EUR J BIOCHEM, V194, P389, DOI 10.1111/j.1432-1033.1990.tb15632.x; Petit PX, 2001, BIOCHEM J, V353, P357, DOI 10.1042/0264-6021:3530357; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	39	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9342	10.1371/journal.pone.0009342	http://dx.doi.org/10.1371/journal.pone.0009342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179769	Green Published, gold, Green Submitted			2022-12-25	WOS:000274923900009
J	Guo, G; Cai, TJ; Guo, R; Wang, HY; Harris, KM				Guo, Guang; Cai, Tianji; Guo, Rui; Wang, Hongyu; Harris, Kathleen Mullan			The Dopamine Transporter Gene, a Spectrum of Most Common Risky Behaviors, and the Legal Status of the Behaviors	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; GENOME-WIDE ASSOCIATION; NONINVASIVE METHOD; SMOKING-BEHAVIOR; VARIABLE NUMBER; YOUTH ACCESS; DAT1; POLYMORPHISMS; AVAILABILITY; ALCOHOL	This study tests the specific hypothesis that the 9R/9R genotype in the VNTR of the dopamine transporter gene (DAT1) exerts a general protective effect against a spectrum of risky behaviors in comparison to the 10R/9R and 10R/10R genotypes, drawing on three-time repeated measures of risky behaviors in adolescence and young adulthood on about 822 non-Hispanic white males from the Add Health study. Our data have established two empirical findings. The first is a protective main effect in the DAT1 gene against risky behaviors. The second finding is that the protective effect varies over age, with the effect prominent at ages when a behavior is illegal and the effect largely vanished at ages when the behavior becomes legal or more socially tolerated. Both the protective main effect and the gene-lifecourse interaction effect are replicated across a spectrum of most common risky behaviors: delinquency, variety of sexual partners, binge drinking, drinking quantity, smoking quantity, smoking frequency, marijuana use, cocaine use, other illegal drug use, and seatbelt non-wearing. We also compared individuals with the protective genotype and individuals without it in terms of age, physical maturity, verbal IQ, GPA, received popularity, sent popularity, church attendance, two biological parents, and parental education. These comparisons indicate that the protective effect of DAT1*9R/9R cannot be explained away by these background characteristics. Our work demonstrates how legal/social contexts can enhance or reduce a genetic effect on risky behaviors.	[Guo, Guang; Cai, Tianji; Harris, Kathleen Mullan] Univ N Carolina, Dept Sociol, Chapel Hill, NC 27515 USA; [Guo, Guang; Harris, Kathleen Mullan] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Guo, Guang; Harris, Kathleen Mullan] Univ N Carolina, Caroline Populat Ctr, Chapel Hill, NC USA; [Guo, Rui] N Carolina Cent Univ, Sch Lib & Informat Sci, Durham, NC 27707 USA; [Wang, Hongyu] Univ Macau, Dept Sociol, Taipa, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina Central University; University of Macau	Guo, G (corresponding author), Univ N Carolina, Dept Sociol, Chapel Hill, NC 27515 USA.	guang_guo@unc.edu	Cai, Tianji/R-8697-2019	Cai, Tianji/0000-0002-8962-2660	National Institute of Child Health and Human Development [P01-HD31921]; National Institutes of Health (NIH) [P01-HD31921, R03 HD042490-02, R03 HD053385-01]; NSF [SES-0210389]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921, R24HD050924] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD042490, R03HD053385] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research uses data from Add Health, a program project designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris, and funded by a grant P01-HD31921 from the National Institute of Child Health and Human Development, with cooperative funding from 17 other agencies (www.cpc. unc.edu/addhealth/contract. html). The authors gratefully acknowledge support from National Institutes of Health (NIH): P01-HD31921 to Add Health, R03 HD042490-02 to Guang Guo, R03 HD053385-01 to Guang Guo; and support from NSF, SES-0210389 to Guang Guo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, HEALTH POLICY, V75, P74, DOI 10.1016/j.healthpol.2005.02.004; Ahmad S, 2007, HEALTH POLICY, V80, P378, DOI 10.1016/j.healthpol.2006.04.001; BANNON MJ, 1995, CAN J PHYSIOL PHARM, V73, P866, DOI 10.1139/y95-119; Barkley RA, 2006, AM J MED GENET B, V141B, P487, DOI 10.1002/ajmg.b.30326; Barr CL, 2001, BIOL PSYCHIAT, V49, P333, DOI 10.1016/S0006-3223(00)01053-2; Bressan RA, 2005, ACTA PSYCHIAT SCAND, V111, P14, DOI 10.1111/j.1600-0447.2005.00540.x; Chen CK, 2003, MOL PSYCHIATR, V8, P393, DOI 10.1038/sj.mp.4001238; Cheuk DKL, 2006, AM J MED GENET B, V141B, P123, DOI 10.1002/ajmg.b.30280; COOK EH, 1995, AM J HUM GENET, V56, P993; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; Curran S, 2001, MOL PSYCHIATR, V6, P425, DOI 10.1038/sj.mp.4000914; Daly G, 1999, MOL PSYCHIATR, V4, P192, DOI 10.1038/sj.mp.4000510; Des Jarlais DC, 1999, LANCET, V353, P1657, DOI 10.1016/S0140-6736(98)07026-3; Dick DM, 2006, BEHAV GENET, V36, P577, DOI 10.1007/s10519-005-9041-8; DOUCETTESTAMM LA, 1995, GENET EPIDEMIOL, V12, P303, DOI 10.1002/gepi.1370120307; Feng Y, 2005, AM J MED GENET B, V139B, P1, DOI 10.1002/ajmg.b.30190; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freeman B, 1997, BEHAV GENET, V27, P251, DOI 10.1023/A:1025614231190; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; Goode E., 2008, DRUGS AM SOC; Gottfredson M. R., 1990, GEN THEORY CRIME; Guo G, 2008, AM SOCIOL REV, V73, P543, DOI 10.1177/000312240807300402; Guo G, 2007, EUR J HUM GENET, V15, P279, DOI 10.1038/sj.ejhg.5201763; Guo G, 2007, HUM GENET, V121, P125, DOI 10.1007/s00439-006-0244-8; Haddley K, 2008, NEUROCHEM RES, V33, P652, DOI 10.1007/s11064-007-9521-8; Harris K.M., 2003, NATL LONGITUDINAL ST; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Hirschi T., 1969, CAUSES DELINQUENCY; Jacobsen LK, 2000, AM J PSYCHIAT, V157, P1700, DOI 10.1176/appi.ajp.157.10.1700; JOHNSTON LD, 2003, NIH PUB; Kalivas P. W, 2002, NEUROPSYCHOPHARMACOL; LENCH N, 1988, LANCET, V1, P1356; Lerman C, 1999, HEALTH PSYCHOL, V18, P14, DOI 10.1037/0278-6133.18.1.14; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; LUBIN B, 1984, AM PSYCHOL, V39, P451, DOI 10.1037/0003-066X.39.4.451; Lynch DR, 2003, MOVEMENT DISORD, V18, P804, DOI 10.1002/mds.10430; Martinez D, 2001, NEUROPSYCHOPHARMACOL, V24, P553, DOI 10.1016/S0893-133X(00)00216-5; MAXSON S, HDB BEHAV G IN PRESS; MEULENBELT I, 1995, AM J HUM GENET, V57, P1252; Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x; MOONEY LA, 1992, DEVIANT BEHAV, V13, P59, DOI 10.1080/01639625.1992.9967898; Munafo MR, 2004, NICOTINE TOB RES, V6, P583, DOI 10.1080/14622200410001734030; Newman JC, 2002, AM J PUBLIC HEALTH, V92, P294, DOI 10.2105/AJPH.92.2.294; RICE JA, 1967, AM J MENT DEF, V71, P602; Sabol SZ, 1999, HEALTH PSYCHOL, V18, P7, DOI 10.1037/0278-6133.18.1.7; Sander T, 1997, AM J MED GENET, V74, P483, DOI 10.1002/(SICI)1096-8628(19970919)74:5<483::AID-AJMG5>3.0.CO;2-P; Schmidt LG, 1998, AM J PSYCHIAT, V155, P474, DOI 10.1176/ajp.155.4.474; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sieminska A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-92; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Swanson JM, 2000, NEUROSCI BIOBEHAV R, V24, P21, DOI 10.1016/S0149-7634(99)00062-7; Thornberry T. P., 2000, CRIMINAL JUSTICE, V4, P33, DOI DOI 10.2307/1141583; Timberlake DS, 2006, HEALTH PSYCHOL, V25, P190, DOI 10.1037/0278-6133.25.2.190; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; van Dyck CH, 2005, J NUCL MED, V46, P745; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	58	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9352	10.1371/journal.pone.0009352	http://dx.doi.org/10.1371/journal.pone.0009352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179766	Green Published, gold			2022-12-25	WOS:000274923900016
J	Ben-Zvi, I; Aranow, C; Mackay, M; Stanevsky, A; Kamen, DL; Marinescu, LM; Collins, CE; Gilkeson, GS; Diamond, B; Hardin, JA				Ben-Zvi, Ilan; Aranow, Cynthia; Mackay, Meggan; Stanevsky, Anfisa; Kamen, Diane L.; Marinescu, L. Manuela; Collins, Christopher E.; Gilkeson, Gary S.; Diamond, Betty; Hardin, John A.			The Impact of Vitamin D on Dendritic Cell Function in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							INDUCIBLE GENE-EXPRESSION; INTERFERON-ALPHA ACTIVITY; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; 1,25-DIHYDROXYVITAMIN D-3; D DEFICIENCY; IFN-ALPHA; RHEUMATOID-ARTHRITIS; MICROARRAY ANALYSIS; AUTOIMMUNE-DISEASE; D-RECEPTOR	Background: Excessive activity of dendritic cells (DCs) is postulated as a central disease mechanism in Systemic Lupus Erythematosus (SLE). Vitamin D is known to reduce responsiveness of healthy donor DCs to the stimulatory effects of Type I IFN. As vitamin D deficiency is reportedly common in SLE, we hypothesized that vitamin D might play a regulatory role in the IFN alpha amplification loop in SLE. Our goals were to investigate the relationship between vitamin D levels and disease activity in SLE patients and to investigate the effects of vitamin D on DC activation and expression of IFN alpha-regulated genes in vitro. Methodology/Principal Findings: In this study, 25-OH vitamin D (25-D) levels were measured in 198 consecutively recruited SLE patients. Respectively, 29.3% and 11.8% of African American and Hispanic SLE patient had 25-D levels <10 ng/ml. The degree of vitamin D deficiency correlated inversely with disease activity; R = -.234, p = .002. In 19 SLE patients stratified by 25-D levels, there were no differences between circulating DC number and phenotype. Monocyte-derived DCs (MDDCs) of SLE patients were normally responsive to the regulatory effects of vitamin D in vitro as evidenced by decreased activation in response to LPS stimulation in the presence of 1,25-D. Additionally, vitamin D conditioning reduced expression of IFN alpha-regulated genes by healthy donor and SLE MDDCs in response to factors in activating SLE plasma. Conclusions/Significance: We report on severe 25-D deficiency in a substantial percentage of SLE patients tested and demonstrate an inverse correlation with disease activity. Our results suggest that vitamin D supplementation will contribute to restoring immune homeostasis in SLE patients through its inhibitory effects on DC maturation and activation. We are encouraged to support the importance of adequate vitamin D supplementation and the need for a clinical trial to assess whether vitamin D supplementation affects IFN alpha activity in vivo and, most importantly, improves clinical outcome.	[Ben-Zvi, Ilan; Aranow, Cynthia; Mackay, Meggan; Stanevsky, Anfisa; Diamond, Betty] Feinstein Inst Med Res, Div Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA; [Marinescu, L. Manuela; Hardin, John A.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Kamen, Diane L.; Gilkeson, Gary S.] Med Univ S Carolina, Div Rheumatol, Charleston, SC 29425 USA; [Collins, Christopher E.; Gilkeson, Gary S.] Ralph H Johnson Vet Adm Med Ctr, Dept Med, Charleston, SC USA; [Hardin, John A.] NIAID, NIH, Washington, DC USA	Northwell Health; Yeshiva University; Albert Einstein College of Medicine; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ben-Zvi, I (corresponding author), Feinstein Inst Med Res, Div Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA.	johnhardin@arthritis.org	Ben-Zvi, Ilan/ABE-7114-2021	Ben-Zvi, Ilan/0000-0002-9160-3098; Collins, Christopher/0000-0002-3136-7767	National Institutes of Health [P60 AR049459, RR01070, AR052364]; National Institutes of Health (National Institute of Allergy and Infectious Disease) and the Autoimmunity Centers of Excellence; Autoimmunity Centers of Excellence; American College of Rheumatology Research and Education Foundation; Alliance for Lupus Research; NIAMS; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882, M01RR001070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR052364, P60AR049459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (National Institute of Allergy and Infectious Disease) and the Autoimmunity Centers of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Autoimmunity Centers of Excellence; American College of Rheumatology Research and Education Foundation; Alliance for Lupus Research; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported by grants from the National Institutes of Health to GSG (P60 AR049459) and DLK (General Clinical Research Center grant #RR01070); by grants from the National Institutes of Health (National Institute of Allergy and Infectious Disease) and the Autoimmunity Centers of Excellence to BD, MM, CA, and JAH; by an American College of Rheumatology Research and Education Foundation award to DLK; and by a grant from the Alliance for Lupus Research to JAH. Additional support for DLK: K23 Award from NIAMS: NIH K23 AR052364. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE J, 1990, J NUTR SCI VITAMINOL, V36, P21, DOI 10.3177/jnsv.36.21; Andjelkovic Z, 1999, CLIN EXP RHEUMATOL, V17, P453; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Becker A, 2001, Z RHEUMATOL, V60, P352, DOI 10.1007/s003930170035; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Borba VZC, 2009, OSTEOPOROSIS INT, V20, P427, DOI 10.1007/s00198-008-0676-1; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; BRENNAN A, 1987, IMMUNOLOGY, V61, P457; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Cantorna MT, 2000, J NUTR, V130, P2648, DOI 10.1093/jn/130.11.2648; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Carvalho JF, 2007, ANN NY ACAD SCI, V1109, P550, DOI 10.1196/annals.1398.061; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Crow MK, 2007, CURR TOP MICROBIOL, V316, P359; Crow MK, 2004, CURR OPIN RHEUMATOL, V16, P541, DOI 10.1097/01.bor.0000135453.70424.1b; Crow MK, 2003, AUTOIMMUNITY, V36, P481, DOI 10.1080/08916930310001625952; Crow MK, 2003, ARTHRITIS RES THER, V5, P279, DOI 10.1186/ar1015; Dong XY, 2005, P NATL ACAD SCI USA, V102, P16007, DOI 10.1073/pnas.0506516102; Dusso AS, 1997, J CLIN ENDOCR METAB, V82, P2222, DOI 10.1210/jc.82.7.2222; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Gaal J, 2009, ACTA DERM-VENEREOL, V89, P140, DOI 10.2340/00015555-0555; Gauzzi MC, 2005, J IMMUNOL, V174, P270, DOI 10.4049/jimmunol.174.1.270; Gill MA, 2002, HUM IMMUNOL, V63, P1172, DOI 10.1016/S0198-8859(02)00756-5; Gregori S, 2001, J IMMUNOL, V167, P1945, DOI 10.4049/jimmunol.167.4.1945; Griffin MD, 2004, J STEROID BIOCHEM, V89-90, P443, DOI 10.1016/j.jsbmb.2004.03.039; Han GM, 2003, GENES IMMUN, V4, P177, DOI 10.1038/sj.gene.6363966; Hardin JA, 2003, J EXP MED, V197, P681, DOI 10.1084/jem.20030130; Hewison M, 2004, MOL CELL ENDOCRINOL, V215, P31, DOI 10.1016/j.mce.2003.11.017; Hewison M, 2003, J IMMUNOL, V170, P5382, DOI 10.4049/jimmunol.170.11.5382; Huisman AM, 2001, J RHEUMATOL, V28, P2535; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Kamen DL, 2006, AUTOIMMUN REV, V5, P114, DOI 10.1016/j.autrev.2005.05.009; KAMEN DL, 2005, ARTHRITIS RHEUM, V48; Kariuki SN, 2008, ARTHRITIS RHEUM, V58, P2818, DOI 10.1002/art.23728; Kariuki SN, 2009, J IMMUNOL, V182, P34, DOI 10.4049/jimmunol.182.1.34; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; KOIZUMI T, 1985, INT ARCH ALLER A IMM, V77, P396, DOI 10.1159/000233815; Koller M, 2004, INT IMMUNOL, V16, P1595, DOI 10.1093/intimm/dxh160; LEMIRE JM, 1992, AUTOIMMUNITY, V12, P143, DOI 10.3109/08916939209150321; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Mahon BD, 2003, J NEUROIMMUNOL, V134, P128, DOI 10.1016/S0165-5728(02)00396-X; Merlino LA, 2004, ARTHRITIS RHEUM-US, V50, P72, DOI 10.1002/art.11434; MULLER K, 1995, CLIN RHEUMATOL, V14, P397, DOI 10.1007/BF02207671; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Niewold TB, 2007, GENES IMMUN, V8, P492, DOI 10.1038/sj.gene.6364408; Niewold TB, 2005, CLIN RHEUMATOL, V24, P178, DOI 10.1007/s10067-004-1024-2; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; OREGAN S, 1979, ACTA PAEDIATR SCAND, V68, P109, DOI 10.1111/j.1651-2227.1979.tb04969.x; Overbergh L, 2000, DIABETES, V49, P1301, DOI 10.2337/diabetes.49.8.1301; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Platzer B, 2004, BLOOD, V104, P3655, DOI 10.1182/blood-2004-02-0412; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; Ruiz-Irastorza G, 2008, RHEUMATOLOGY, V47, P920, DOI 10.1093/rheumatology/ken121; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Scheinecker C, 2001, ARTHRITIS RHEUM, V44, P856, DOI 10.1002/1529-0131(200104)44:4<856::AID-ANR142>3.0.CO;2-A; Shoenfeld N, 2009, NAT CLIN PRACT RHEUM, V5, P99, DOI 10.1038/ncprheum0989; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Thudi A, 2008, AM J MED SCI, V335, P99, DOI 10.1097/MAJ.0b013e318134eeb6; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; ZADSHIR A, 2005, ETHN DIS S5, V15, DOI DOI 10.1136/JMG.2004.024083	66	110	121	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9193	10.1371/journal.pone.0009193	http://dx.doi.org/10.1371/journal.pone.0009193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169063	Green Published, Green Submitted, gold			2022-12-25	WOS:000274590500003
J	Merendino, AM; Bucchieri, F; Campanella, C; Marciano, V; Ribbene, A; David, S; Zummo, G; Burgio, G; Corona, DFV; de Macario, EC; Macario, AJL; Cappello, F				Merendino, Anna M.; Bucchieri, Fabio; Campanella, Claudia; Marciano, Vito; Ribbene, Anna; David, Sabrina; Zummo, Giovanni; Burgio, Giosalba; Corona, Davide F. V.; de Macario, Everly Conway; Macario, Alberto J. L.; Cappello, Francesco			Hsp60 Is Actively Secreted by Human Tumor Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; STRESS-PROTEINS; EPITHELIAL-CELLS; K562 CELLS; T-CELLS; EXOSOMES; HEAT-SHOCK-PROTEIN-60; EXPRESSION; PATHWAY; SURFACE	Background: Hsp60, a Group I mitochondrial chaperonin, is classically considered an intracellular chaperone with residence in the mitochondria; nonetheless, in the last few years it has been found extracellularly as well as in the cell membrane. Important questions remain pertaining to extracellular Hsp60 such as how generalized is its occurrence outside cells, what are its extracellular functions and the translocation mechanisms that transport the chaperone outside of the cell. These questions are particularly relevant for cancer biology since it is believed that extracellular chaperones, like Hsp70, may play an active role in tumor growth and dissemination. Methodology/Principal Findings: Since cancer cells may undergo necrosis and apoptosis, it could be possible that extracellular Hsps are chiefly the result of cell destruction but not the product of an active, physiological process. In this work, we studied three tumor cells lines and found that they all release Hsp60 into the culture media by an active mechanism independently of cell death. Biochemical analyses of one of the cell lines revealed that Hsp60 secretion was significantly reduced, by inhibitors of exosomes and lipid rafts. Conclusions/Significance: Our data suggest that Hsp60 release is the result of an active secretion mechanism and, since extracellular release of the chaperone was demonstrated in all tumor cell lines investigated, our observations most likely reflect a general physiological phenomenon, occurring in many tumors.	[Merendino, Anna M.; Bucchieri, Fabio; Campanella, Claudia; Marciano, Vito; Ribbene, Anna; David, Sabrina; Zummo, Giovanni; Cappello, Francesco] Univ Palermo, Dipartimento Biomed Sperimentale & Neurosci Clin, Palermo, Italy; [Burgio, Giosalba; Corona, Davide F. V.] Univ Palermo, Dipartimento Biol Cellulare & Sviluppo, Palermo, Italy; [Burgio, Giosalba; Corona, Davide F. V.] Dulbecco Telethon Inst, Palermo, Italy; [de Macario, Everly Conway; Macario, Alberto J. L.] Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, Baltimore, MD 21202 USA; [Cappello, Francesco] Ist EuroMEditerraneo Sci & Tecnol, Palermo, Italy	University of Palermo; University of Palermo; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University System of Maryland; University of Maryland Baltimore	Merendino, AM (corresponding author), Univ Palermo, Dipartimento Biomed Sperimentale & Neurosci Clin, Palermo, Italy.	francapp@hotmail.com	Bucchieri, Fabio/F-8877-2012; Corona, Davide F.V./H-8467-2012; Cappello, Francesco/F-9153-2012	BUCCHIERI, Fabio/0000-0002-0209-8668; Cappello, Francesco/0000-0001-9288-1148; DAVID, Sabrina/0000-0003-4106-6826	MIUR; Istituto EuroMEditerraneo di Scienza e Tecnologia (IEMEST); Federazione Italiana Ricerca Cancro (FIRC); Fondazione Telethon; Armenise-Harvard Foundation; Associazione Italiana Ricerca Cancro (AIRC); Fondo per gli investimenti per la Ricerca di Base (FIRB)	MIUR(Ministry of Education, Universities and Research (MIUR)); Istituto EuroMEditerraneo di Scienza e Tecnologia (IEMEST); Federazione Italiana Ricerca Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Telethon(Fondazione TelethonEuropean Commission); Armenise-Harvard Foundation; Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondo per gli investimenti per la Ricerca di Base (FIRB)(Ministry of Education, Universities and Research (MIUR))	This work was supported by funds from MIUR ex-60% (F. C., S. D. and G. Z.), Istituto EuroMEditerraneo di Scienza e Tecnologia (IEMEST) (F. C.), Federazione Italiana Ricerca Cancro (FIRC) fellowship (G. B.), and Fondazione Telethon, Armenise-Harvard Foundation, Associazione Italiana Ricerca Cancro (AIRC) and Fondo per gli investimenti per la Ricerca di Base (FIRB) (D. F. V. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Campanella C, 2008, EUR J HISTOCHEM, V52, P221; Cappello F, 2008, CANCER BIOL THER, V7, P801, DOI 10.4161/cbt.7.6.6281; Cappello F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000552; Chen WL, 2006, EUR J IMMUNOL, V36, P1598, DOI 10.1002/eji.200535501; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Dziewanowska K, 2000, INFECT IMMUN, V68, P6321, DOI 10.1128/IAI.68.11.6321-6328.2000; Feng HP, 2002, BLOOD, V100, P4108, DOI 10.1182/blood-2002-05-1389; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Horvath I, 2008, BBA-BIOMEMBRANES, V1778, P1653, DOI 10.1016/j.bbamem.2008.02.012; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Merendino AM, 2006, AM J RESP CELL MOL, V35, P155, DOI 10.1165/rcmb.2005-0433OC; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Osterloh A, 2004, J BIOL CHEM, V279, P47906, DOI 10.1074/jbc.M408440200; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Savina A, 2002, J CELL SCI, V115, P2505; Schiera G, 2007, J CELL MOL MED, V11, P1384, DOI 10.1111/j.1582-4934.2007.00100.x; Shamaei-Tousi A, 2007, CELL STRESS CHAPERON, V12, P384, DOI 10.1379/CSC-300.1; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Soltys BJ, 1997, CELL BIOL INT, V21, P315, DOI 10.1006/cbir.1997.0144; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I	30	125	129	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9247	10.1371/journal.pone.0009247	http://dx.doi.org/10.1371/journal.pone.0009247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169074	Green Submitted, Green Published, gold			2022-12-25	WOS:000274590500025
J	Wang, SM; Lu, B; Girman, S; Duan, J; McFarland, T; Zhang, QS; Grompe, M; Adamus, G; Appukuttan, B; Lund, R				Wang, Shaomei; Lu, Bin; Girman, Sergei; Duan, Jie; McFarland, Trevor; Zhang, Qing-shuo; Grompe, Markus; Adamus, Grazyna; Appukuttan, Binoy; Lund, Raymond			Non-Invasive Stem Cell Therapy in a Rat Model for Retinal Degeneration and Vascular Pathology	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; RCS RAT; SUBRETINAL TRANSPLANTATION; PHOTORECEPTOR DEGENERATION; PROMOTING MIGRATION; VISUAL FUNCTION; ANIMAL-MODELS; GENE-TRANSFER; CONE VISION; RESCUE	Background: Retinitis pigmentosa (RP) is characterized by progressive night blindness, visual field loss, altered vascular permeability and loss of central vision. Currently there is no effective treatment available except gene replacement therapy has shown promise in a few patients with specific gene defects. There is an urgent need to develop therapies that offer generic neuro- and vascular-protective effects with non-invasive intervention. Here we explored the potential of systemic administration of pluripotent bone marrow-derived mesenchymal stem cells (MSCs) to rescue vision and associated vascular pathology in the Royal College Surgeons (RCS) rat, a well-established animal model for RP. Methodology/Principal Findings: Animals received syngeneic MSCs (1 x 10(6) cells) by tail vein at an age before major photoreceptor loss. Principal results: both rod and cone photoreceptors were preserved (5-6 cells thick) at the time when control animal has a single layer of photoreceptors remained; Visual function was significantly preserved compared with controls as determined by visual acuity and luminance threshold recording from the superior colliculus; The number of pathological vascular complexes (abnormal vessels associated with migrating pigment epithelium cells) and area of vascular leakage that would ordinarily develop were dramatically reduced; Semi-quantitative RT-PCR analysis indicated there was upregulation of growth factors and immunohistochemistry revealed that there was an increase in neurotrophic factors within eyes of animals that received MSCs. Conclusions/Significance: These results underscore the potential application of MSCs in treating retinal degeneration. The advantages of this non-invasive cell-based therapy are: cells are easily isolated and can be expanded in large quantity for autologous graft; hypoimmunogenic nature as allogeneic donors; less controversial in nature than other stem cells; can be readministered with minor discomfort. Therefore, MSCs may prove to be the ideal cell source for auto-cell therapy for retinal degeneration and other ocular vascular diseases.	[Wang, Shaomei; Lu, Bin; Girman, Sergei; Duan, Jie; McFarland, Trevor; Adamus, Grazyna; Appukuttan, Binoy; Lund, Raymond] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Zhang, Qing-shuo; Grompe, Markus] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Wang, SM (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	wangsha@ohsu.edu		Grompe, Markus/0000-0002-6616-4345; Zhang, Qing-shuo/0000-0002-4407-6053	Foundation Fighting Blindness, Research Prevent Blindness; Lincy Foundation; NATIONAL EYE INSTITUTE [P30EY010572] Funding Source: NIH RePORTER	Foundation Fighting Blindness, Research Prevent Blindness; Lincy Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This work was supported by grants of Foundation Fighting Blindness, Research Prevent Blindness and Lincy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Arnhold S, 2006, INVEST OPHTH VIS SCI, V47, P4121, DOI 10.1167/iovs.04-1501; Bainbridge JWB, 2006, GENE THER, V13, P1191, DOI 10.1038/sj.gt.3302812; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Cayouette M, 1998, J NEUROSCI, V18, P9282; CHAITIN MH, 1983, INVEST OPHTH VIS SCI, V24, P812; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Dorrell M, 2007, SURV OPHTHALMOL, V52, pS3, DOI 10.1016/j.survophthal.2006.10.017; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Farrar GJ, 2002, EMBO J, V21, P857, DOI 10.1093/emboj/21.5.857; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Frasson M, 1999, NAT MED, V5, P1183, DOI 10.1038/13508; Fukuda Keiichi, 2003, Hum Cell, V16, P83, DOI 10.1111/j.1749-0774.2003.tb00138.x; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Girman S, 2005, VISION RES, V45, P343, DOI 10.1016/j.visres.2004.08.023; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; Guo Y, 2006, STEM CELLS, V24, P850, DOI 10.1634/stemcells.2005-0457; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hatch Heather M., 2002, Cloning and Stem Cells, V4, P339, DOI 10.1089/153623002321025014; Hauk TG, 2010, INVEST OPHTH VIS SCI, V51, P459, DOI 10.1167/iovs.09-4203; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Inoue Y, 2007, EXP EYE RES, V85, P234, DOI 10.1016/j.exer.2007.04.007; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Lennon DP, 2006, EXP HEMATOL, V34, P1606, DOI 10.1016/j.exphem.2006.07.015; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; LI ZY, 1995, OPHTHALMOLOGY, V102, P805, DOI 10.1016/S0161-6420(95)30953-0; LU B, 2009, STEM CELLS; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Lund RD, 2001, P NATL ACAD SCI USA, V98, P9942, DOI 10.1073/pnas.171266298; MacDonald IM, 2007, CAN J OPHTHALMOL, V42, P399, DOI 10.3129/i07-039; MILAM AH, 1995, RETINAL PATHOLOGY RE; Neuhuber B, 2008, EXP HEMATOL, V36, P1176, DOI 10.1016/j.exphem.2008.03.019; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; Sasahara M, 2008, AM J PATHOL, V172, P1693, DOI 10.2353/ajpath.2008.080024; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; Smith LEH, 2002, ACTA PAEDIATR, V91, P26, DOI 10.1080/08035250260095771; Smith TC, 2007, AUST FAM PHYSICIAN, V36, P359; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Steinberg Roy H., 1994, Current Opinion in Neurobiology, V4, P515, DOI 10.1016/0959-4388(94)90052-3; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; Wang S, 2003, CURR EYE RES, V27, P183, DOI 10.1076/ceyr.27.3.183.16053; Wang SM, 2008, INVEST OPHTH VIS SCI, V49, P3201, DOI 10.1167/iovs.08-1831; Wang SM, 2005, INVEST OPHTH VIS SCI, V46, P2552, DOI 10.1167/iovs.05-0279; Wang SM, 2005, J COMP NEUROL, V491, P400, DOI 10.1002/cne.20695; Williams DS, 2008, VISION RES, V48, P433, DOI 10.1016/j.visres.2007.08.015; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475	57	102	110	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9200	10.1371/journal.pone.0009200	http://dx.doi.org/10.1371/journal.pone.0009200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169166	Green Submitted, Green Published, gold			2022-12-25	WOS:000274474700004
J	Wood, NI; Carta, V; Milde, S; Skillings, EA; McAllister, CJ; Ang, YLM; Duguid, A; Wijesuriya, N; Afzal, SM; Fernandes, JX; Leong, TW; Morton, J				Wood, Nigel I.; Carta, Valentina; Milde, Stefan; Skillings, Elizabeth A.; McAllister, Catherine J.; Ang, Y. L. Mabel; Duguid, Alasdair; Wijesuriya, Nadeev; Afzal, Samira Mohd; Fernandes, Joe X.; Leong, T. W.; Morton, Jennifer			Responses to Environmental Enrichment Differ with Sex and Genotype in a Transgenic Mouse Model of Huntington's Disease	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; MICE; BEHAVIOR; STRESS; GENE; SURVIVAL; DEFICITS; CONSEQUENCES; HIPPOCAMPAL; EXPRESSION	Background: Environmental enrichment (EE) in laboratory animals improves neurological function and motor/cognitive performance, and is proposed as a strategy for treating neurodegenerative diseases. EE has been investigated in the R6/2 mouse model of Huntington's disease (HD), where increased social interaction, sensory stimulation, exploration, and physical activity improved survival. We have also shown previously that HD patients and R6/2 mice have disrupted circadian rhythms, treatment of which may improve cognition, general health, and survival. Methodology/Principal Findings: We examined the effects of EE on the behavioral phenotype and circadian activity of R6/2 mice. Our mice are typically housed in an "enriched'' environment, so the EE that the mice received was in addition to these enhanced housing conditions. Mice were either kept in their home cages or exposed daily to the EE (a large playground box containing running wheels and other toys). The "home cage'' and "playground'' groups were subdivided into "handling'' (stimulated throughout the experimental period) and "no-handling'' groups. All mice were assessed for survival, body weight, and cognitive performance in the Morris water maze (MWM). Mice in the playground groups were more active throughout the enrichment period than home cage mice. Furthermore, R6/2 mice in the EE/no-handling groups had better survival than those in the home cage/no-handling groups. Sex differences were seen in response to EE. Handling was detrimental to R6/2 female mice, but EE increased the body weight of male R6/2 and WT mice in the handling group. EE combined with handling significantly improved MWM performance in female, but not male, R6/2 mice. Conclusions/Significance: We show that even when mice are living in an enriched home cage, further EE had beneficial effects. However, the improvements in cognition and survival vary with sex and genotype. These results indicate that EE may improve the quality of life of HD patients, but we suggest that EE as a therapy should be tailored to individuals.	[Wood, Nigel I.; Carta, Valentina; Milde, Stefan; Skillings, Elizabeth A.; McAllister, Catherine J.; Ang, Y. L. Mabel; Duguid, Alasdair; Wijesuriya, Nadeev; Afzal, Samira Mohd; Fernandes, Joe X.; Leong, T. W.; Morton, Jennifer] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Wood, NI (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	niw20@cam.ac.uk	Longo, Kenneth A/A-5631-2010	Leong, Tian Weng/0000-0001-6090-7163; McAllister, Catherine/0000-0001-6147-6449	CHDI Foundation	CHDI Foundation	This work was supported by grants to AJM from CHDI Foundation (www.highqfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avital A, 2005, INT J NEUROPSYCHOPH, V8, P163, DOI 10.1017/S1461145704004808; Baudic S, 2006, DEMENT GERIATR COGN, V21, P316, DOI 10.1159/000091523; Bode FJ, 2009, BEHAV BRAIN RES, V205, P175, DOI 10.1016/j.bbr.2009.06.031; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Buchanan JB, 2008, PSYCHONEUROENDOCRINO, V33, P755, DOI 10.1016/j.psyneuen.2008.02.013; Carter RJ, 2000, MOVEMENT DISORD, V15, P925, DOI 10.1002/1531-8257(200009)15:5<925::AID-MDS1025>3.0.CO;2-Z; Cummings J L, 1995, Adv Neurol, V65, P179; Dorner JL, 2007, BEHAV BRAIN RES, V178, P90, DOI 10.1016/j.bbr.2006.12.004; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Kim JJ, 2007, P NATL ACAD SCI USA, V104, P18297, DOI 10.1073/pnas.0708644104; Kitraki E, 2004, ANN NY ACAD SCI, V1018, P323, DOI 10.1196/annals.1296.039; Lione LA, 1999, J NEUROSCI, V19, P10428; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maei HR, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.004.2009; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martinez-Cue C, 2002, BEHAV BRAIN RES, V134, P185, DOI 10.1016/S0166-4328(02)00026-8; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; Orr AL, 2008, J BIOL CHEM, V283, P16027, DOI 10.1074/jbc.M710606200; Pallier PN, 2007, J NEUROSCI, V27, P7869, DOI 10.1523/JNEUROSCI.0649-07.2007; Pallier PN, 2009, BRAIN RES, V1279, P90, DOI 10.1016/j.brainres.2009.03.072; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Paulsen JS, 2001, NEUROLOGY, V57, P658, DOI 10.1212/WNL.57.4.658; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x; Schilling G, 2004, EXP NEUROL, V187, P137, DOI 10.1016/j.expneurol.2004.01.003; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Sullivan F R, 2001, J Neurosci Nurs, V33, P136; Thompson JC, 2002, J NEUROPSYCH CLIN N, V14, P37, DOI 10.1176/appi.neuropsych.14.1.37; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Wood NI, 2003, BRAIN RES BULL, V61, P375, DOI 10.1016/S0361-9230(03)00141-2; Wood NI, 2008, BRAIN RES BULL, V76, P70, DOI 10.1016/j.brainresbull.2007.12.007; Wood NI, 2007, NEUROBIOL DIS, V25, P342, DOI 10.1016/j.nbd.2006.09.015; Zinzi P, 2007, CLIN REHABIL, V21, P603, DOI 10.1177/0269215507075495; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	39	72	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9077	10.1371/journal.pone.0009077	http://dx.doi.org/10.1371/journal.pone.0009077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20174443	Green Submitted, gold, Green Published			2022-12-25	WOS:000274474600002
J	Wang, NZ; Gates, KL; Trejo, H; Favoreto, S; Schleimer, RP; Sznajder, JI; Beitel, GJ; Sporn, PHS				Wang, Naizhen; Gates, Khalilah L.; Trejo, Humberto; Favoreto, Silvio, Jr.; Schleimer, Robert P.; Sznajder, Jacob I.; Beitel, Greg J.; Sporn, Peter H. S.			Elevated CO2 selectively inhibits interleukin-6 and tumor necrosis factor expression and decreases phagocytosis in the macrophage	FASEB JOURNAL			English	Article						monocytes; lipopolysaccharide; cytokines; phagocytosis; lung	NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; CARBON-DIOXIDE AVOIDANCE; INDUCED LUNG INJURY; TOLL-LIKE RECEPTORS; HYPERCAPNIC ACIDOSIS; FACTOR-ALPHA; ALVEOLAR MACROPHAGES; HOST-DEFENSE; TNF-ALPHA	Elevated blood and tissue CO2, or hypercapnia, is common in severe lung disease. Patients with hypercapnia often develop lung infections and have an increased risk of death following pneumonia. To explore whether hypercapnia interferes with host defense, we studied the effects of elevated P-CO2 on macrophage innate immune responses. In differentiated human THP-1 macrophages and human and mouse alveolar macrophages stimulated with lipopolysaccharide (LPS) and other Toll-like receptor ligands, hypercapnia inhibited expression of tumor necrosis factor and interleukin (IL)-6, nuclear factor (NF)-kappa B-dependent cytokines critical for antimicrobial host defense. Inhibition of IL-6 expression by hypercapnia was concentration dependent, rapid, reversible, and independent of extracellular and intracellular acidosis. In contrast, hypercapnia did not down-regulate IL-10 or interferon-beta, which do not require NF-kappa B. Notably, hypercapnia did not affect LPS-induced degradation of I kappa B alpha, nuclear translocation of RelA/p65, or activation of mitogen-activated protein kinases, but it did block IL-6 promoter-driven luciferase activity in mouse RAW 264.7 macrophages. Elevated P-CO2 also decreased phagocytosis of opsonized polystyrene beads and heat-killed bacteria in THP-1 and human alveolar macrophages. By interfering with essential innate immune functions in the macrophage, hypercapnia may cause a previously unrecognized defect in resistance to pulmonary infection in patients with advanced lung disease.-Wang, N., Gates, K. L., Trejo, H., Favoreto, Jr., S., Schleimer, R. P., Sznajder, J. I., Beitel, G. J., Sporn, P. H. S. Elevated CO2 selectively inhibits interleukin-6 and tumor necrosis factor expression and decreases phagocytosis in the macrophage. FASEB J. 24, 2178-2190 (2010). www.fasebj.org	[Wang, Naizhen; Gates, Khalilah L.; Trejo, Humberto; Sznajder, Jacob I.; Sporn, Peter H. S.] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Favoreto, Silvio, Jr.; Schleimer, Robert P.] Northwestern Univ, Div Allergy Immunol, Feinberg Sch Med, Chicago, IL 60611 USA; [Beitel, Greg J.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL USA; [Sporn, Peter H. S.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Sporn, PHS (corresponding author), Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, 240 E Huron St,McGaw M-300, Chicago, IL 60611 USA.	p-sporn@northwestern.edu		Sporn, Peter/0000-0002-1006-9437	National Institutes of Health [HL068546, HL078860, HL085534, HL072891]; American Heart Association [0855686G]; Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068546, R01HL085534, R01HL072891, R37HL068546, R01HL078860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Y. Gruenbaum, R. M. Pope, A. Kato, P. J. Bryce, and S. C. Shin for helpful discussions, and Aisha Nair for technical assistance. This work was supported by grants from the National Institutes of Health (HL068546 and HL078860 to R. P. S., HL085534 to J. I. S., and HL072891 to P. H. S. S.), the American Heart Association (grant-in-aid 0855686G to G. J. B.), and the Department of Veterans Affairs (Merit Review to P. H. S. S.).	Abolhassani M, 2009, AM J PHYSIOL-LUNG C, V296, pL657, DOI 10.1152/ajplung.90460.2008; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Belkin RA, 2006, AM J RESP CRIT CARE, V173, P659, DOI 10.1164/rccm.200410-1369OC; Bigatello L M, 2001, Curr Opin Crit Care, V7, P34, DOI 10.1097/00075198-200102000-00006; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bondeson J, 1999, J IMMUNOL, V162, P2939; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Briva A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001238; Broccard AF, 2001, AM J RESP CRIT CARE, V164, P802, DOI 10.1164/ajrccm.164.5.2007060; BURET A, 1994, INFECT IMMUN, V62, P5335, DOI 10.1128/IAI.62.12.5335-5343.1994; Chonghaile MN, 2008, ANESTHESIOLOGY, V109, P837, DOI 10.1097/ALN.0b013e3181895fb7; Chonghaile MN, 2008, CRIT CARE MED, V36, P3135, DOI 10.1097/CCM.0b013e31818f0d13; Costello R, 1997, AM J MED, V102, P239, DOI 10.1016/S0002-9343(97)00017-X; D'Addario M, 2000, J MOL BIOL, V298, P765, DOI 10.1006/jmbi.2000.3717; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; Goel A, 2003, J GEN INTERN MED, V18, P824, DOI 10.1046/j.1525-1497.2003.20615.x; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Groenewegen KH, 2003, CHEST, V124, P459, DOI 10.1378/chest.124.2.459; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Harrison RE, 2002, BIOCHEM CELL BIOL, V80, P509, DOI 10.1139/O02-142; Helenius IT, 2009, P NATL ACAD SCI USA, V106, P18710, DOI 10.1073/pnas.0905925106; Iregui MG, 2001, SEMIN RESP CRIT CARE, V22, P317, DOI 10.1055/s-2001-15788; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kim HY, 2002, INFECT IMMUN, V70, P4132, DOI 10.1128/IAI.70.8.4132-4141.2002; Laffey JG, 2004, AM J RESP CRIT CARE, V169, P46, DOI 10.1164/rccm.200205-394OC; Laichalk LL, 1996, INFECT IMMUN, V64, P5211, DOI 10.1128/IAI.64.12.5211-5218.1996; Lang CJ, 2005, AM J PHYSIOL-LUNG C, V289, pL96, DOI 10.1152/ajplung.00394.2004; Lee JH, 2003, AM J RESP CRIT CARE, V168, P1462, DOI 10.1164/rccm.200302-303OC; Lu H, 2005, MOL BIOL CELL, V16, P4954, DOI 10.1091/mbc.E05-05-0426; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; MARTINU T, 2003, CAN RESPIR J, V10, P301; Mehrad B, 1999, J IMMUNOL, V162, P1633; MOSER KM, 1973, JAMA-J AM MED ASSOC, V255, P705; MULLEN PG, 1995, J SURG RES, V58, P124, DOI 10.1006/jsre.1995.1020; *NAT HEART LUNG BL, 2007, MORB MORT 2007 CHART; O'Croinin DF, 2008, CRIT CARE MED, V36, P2128, DOI 10.1097/CCM.0b013e31817d1b59; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; O'Reilly PJ, 2003, AM J RESP CELL MOL, V28, P443, DOI 10.1165/rcmb.2002-0153OC; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rai S, 2004, PEDIATR RES, V55, P42, DOI 10.1203/01.PDR.0000098502.72182.55; Roilides E, 1998, INFECT IMMUN, V66, P5999, DOI 10.1128/IAI.66.12.5999-6003.1998; Rutault K, 2001, J BIOL CHEM, V276, P6666, DOI 10.1074/jbc.M005486200; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Sethi Sanjay, 2004, Proc Am Thorac Soc, V1, P109, DOI 10.1513/pats.2306029; Sharabi K, 2009, P NATL ACAD SCI USA, V106, P4024, DOI 10.1073/pnas.0900309106; Shirai R, 1997, CLIN EXP IMMUNOL, V109, P73, DOI 10.1046/j.1365-2249.1997.4211317.x; Siddiqui AA, 2006, INFECT IMMUN, V74, P5302, DOI 10.1128/IAI.00661-06; Sin DD, 2005, AM J MED, V118, P145, DOI 10.1016/j.amjmed.2004.10.014; Sinclair SE, 2002, AM J RESP CRIT CARE, V166, P403, DOI 10.1164/rccm.200112-117OC; Son YH, 2008, J CARDIOVASC PHARM, V51, P71, DOI 10.1097/FJC.0b013e31815bd23d; Srivastava S, 1999, J CLIN INVEST, V104, P503, DOI 10.1172/JCI7094; Standiford TJ, 1999, HUM GENE THER, V10, P899, DOI 10.1089/10430349950018300; Suzuki E, 2006, BIOMED PHARMACOTHER, V60, P578, DOI 10.1016/j.biopha.2006.07.089; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Takeshita K, 2003, AM J RESP CELL MOL, V29, P124, DOI 10.1165/rcmb.2002-0126OC; TUDER RM, 1995, J CLIN INVEST, V95, P1798, DOI 10.1172/JCI117858; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; West MA, 1996, J SURG RES, V63, P269, DOI 10.1006/jsre.1996.0259; Williams DM, 1998, INFECT IMMUN, V66, P4564; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zhu S, 2000, AM J PHYSIOL-LUNG C, V278, pL1025, DOI 10.1152/ajplung.2000.278.5.L1025	67	86	89	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2010	24	7					2178	2190		10.1096/fj.09-136895	http://dx.doi.org/10.1096/fj.09-136895			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20181940	Green Published			2022-12-25	WOS:000279343600005
J	Furuita, K; Jee, J; Fukada, H; Mishima, M; Kojima, C				Furuita, Kyoko; Jee, JunGoo; Fukada, Harumi; Mishima, Masaki; Kojima, Chojiro			Electrostatic Interaction between Oxysterol-binding Protein and VAMP-associated Protein A Revealed by NMR and Mutagenesis Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTOPICALLY ENRICHED PROTEINS; AMYOTROPHIC-LATERAL-SCLEROSIS; CELLULAR LIPID-METABOLISM; TORSION ANGLE DYNAMICS; OSBP-RELATED PROTEINS; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; VESICLE TRANSPORT; ENERGY CONTENT; FFAT MOTIF	Oxysterol-binding protein (OSBP), a cytosolic receptor of cholesterol and oxysterols, is recruited to the endoplasmic reticulum by binding to the cytoplasmic major sperm protein (MSP) domain of integral endoplasmic reticulum protein VAMP-associated protein-A (VAP-A), a process essential for the stimulation of sphingomyelin synthesis by 25-hydroxycholesterol. To delineate the interaction mechanism between VAP-A and OSBP, we determined the complex structure between the VAP-A MSP domain (VAP-A(MSP)) and the OSBP fragment containing a VAP-A binding motif FFAT (OSBPF) by NMR. This solution structure explained that five of six conserved residues in the FFAT motif are required for the stable complex formation, and three of five, including three critical intermolecular electrostatic interactions, were not explained before. By combining NMR relaxation and titration, isothermal titration calorimetry, and mutagenesis experiments with structural information, we further elucidated the detailed roles of the FFAT motif and underlying motions of VAP-A(MSP), OSBPF, and the complex. Our results show that OSBPF is disordered in the free state, and VAP-A(MSP) and OSBPF form a final complex by means of intermediates, where electrostatic interactions through acidic residues, including an acid patch preceding the FFAT motif, probably play a collective role. Additionally, we report that the mutation that causes the familial motor neuron disease decreases the stability of the MSP domain.	[Furuita, Kyoko; Jee, JunGoo; Mishima, Masaki; Kojima, Chojiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Jee, JunGoo] Tokyo Metropolitan Univ, Ctr Prior Areas, Tokyo 1920397, Japan; [Fukada, Harumi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka 5998531, Japan; [Mishima, Masaki] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Tokyo 1920397, Japan	Nara Institute of Science & Technology; Tokyo Metropolitan University; Osaka Metropolitan University; Tokyo Metropolitan University	Kojima, C (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kojima@protein.osaka-u.ac.jp	Kojima, Chojiro/AFV-4592-2022	Furuita, Kyoko/0000-0002-9272-0026; Kojima, Chojiro/0000-0003-2723-8249	Ministry of Education, Culture, Sports and Technology (Japan)	Ministry of Education, Culture, Sports and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports and Technology (Japan) through Target Proteins Research Program, Global Centers of Excellence Program, and grants-in-aid for scientific research.	Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; ARCHER SJ, 1991, J MAGN RESON, V95, P636, DOI 10.1016/0022-2364(91)90182-S; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P679, DOI 10.1016/B978-012164491-8/50010-5; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Furuita K, 2006, J BIOMOL NMR, V36, P69, DOI 10.1007/s10858-006-9057-2; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; GRZESIEK S, 1992, J MAGN RESON, V96, P215, DOI 10.1016/0022-2364(92)90307-S; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hu JS, 1997, J BIOMOL NMR, V9, P323, DOI 10.1023/A:1018691228238; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kovrigin EL, 2006, BIOCHEMISTRY-US, V45, P2636, DOI 10.1021/bi0525066; Lapierre LA, 1999, J CELL SCI, V112, P3723; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lehto M, 2004, CELL TISSUE RES, V315, P39, DOI 10.1007/s00441-003-0817-y; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Lehto M, 2001, J LIPID RES, V42, P1203; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Olkkonen VM, 2006, BIOCHEM SOC T, V34, P389, DOI 10.1042/BST0340389; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; PALMER AG, 1991, CHEM PHYS LETT, V185, P41, DOI 10.1016/0009-2614(91)80136-L; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; RIDGWAY ND, 1995, J LIPID RES, V36, P1345; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Salerno WJ, 2004, NUCLEIC ACIDS RES, V32, pW566, DOI 10.1093/nar/gkh434; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tarr DEK, 2005, TRENDS PARASITOL, V21, P224, DOI 10.1016/j.pt.2005.03.009; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Weir ML, 2001, BIOCHEM BIOPH RES CO, V286, P616, DOI 10.1006/bbrc.2001.5437; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Xu YQ, 2001, J BIOL CHEM, V276, P18407, DOI 10.1074/jbc.M101204200; Yang HY, 2006, TRENDS CELL BIOL, V16, P427, DOI 10.1016/j.tcb.2006.07.002	55	52	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12961	12970		10.1074/jbc.M109.082602	http://dx.doi.org/10.1074/jbc.M109.082602			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178991	Green Published, hybrid			2022-12-25	WOS:000276787800054
J	Kenoth, R; Simanshu, DK; Kamlekar, RK; Pike, HM; Molotkovsky, JG; Benson, LM; Bergen, HR; Prendergast, FG; Malinina, L; Venyaminov, SY; Patel, DJ; Brown, RE				Kenoth, Roopa; Simanshu, Dhirendra K.; Kamlekar, Ravi Kanth; Pike, Helen M.; Molotkovsky, Julian G.; Benson, Linda M.; Bergen, H. Robert, III; Prendergast, Franklyn G.; Malinina, Lucy; Venyaminov, Sergei Y.; Patel, Dinshaw J.; Brown, Rhoderick E.			Structural Determination and Tryptophan Fluorescence of Heterokaryon Incompatibility C2 Protein (HET-C2), a Fungal Glycolipid Transfer Protein (GLTP), Provide Novel Insights into Glycolipid Specificity and Membrane Interaction by the GLTP Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; SECONDARY STRUCTURE; EXTINCTION COEFFICIENTS; CRYSTAL-STRUCTURES; FILAMENTOUS FUNGI; BINDING PROTEINS; BILAYER VESICLES; CELL-DEATH; RECOGNITION; GLYCOSPHINGOLIPIDS	HET-C2 is a fungal protein that transfers glycosphingolipids between membranes and has limited sequence homology with human glycolipid transfer protein (GLTP). The human GLTP fold is unique among lipid binding/transfer proteins, defining the GLTP superfamily. Herein, GLTP fold formation by HET-C2, its glycolipid transfer specificity, and the functional role(s) of its two Trp residues have been investigated. X-ray diffraction (1.9 angstrom) revealed a GLTP fold with all key sugar headgroup recognition residues (Asp(66), Asn(70), Lys(73), Trp(109), and His(147)) conserved and properly oriented for glycolipid binding. Far-UV CD showed secondary structure dominated by alpha-helices and a cooperative thermal unfolding transition of 49 degrees C, features consistent with a GLTP fold. Environmentally induced optical activity of Trp/Tyr/Phe (2: 4: 12) detected by near-UV CD was unaffected by membranes containing glycolipid but was slightly altered by membranes lacking glycolipid. Trp fluorescence was maximal at similar to 355 nm and accessible to aqueous quenchers, indicating free exposure to the aqueous milieu and consistent with surface localization of the two Trps. Interaction with membranes lacking glycolipid triggered significant decreases in Trp emission intensity but lesser than decreases induced by membranes containing glycolipid. Binding of glycolipid (confirmed by electro-spray injection mass spectrometry) resulted in a blue-shifted emission wavelength maximum (similar to 6 nm) permitting determination of binding affinities. The unique positioning of Trp(208) at the HET-C2 C terminus revealed membrane-induced conformational changes that precede glycolipid uptake, whereas key differences in residues of the sugar headgroup recognition center accounted for altered glycolipid specificity and suggested evolutionary adaptation for the simpler glycosphingolipid compositions of filamentous fungi.	[Prendergast, Franklyn G.; Venyaminov, Sergei Y.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Simanshu, Dhirendra K.; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Molotkovsky, Julian G.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Benson, Linda M.; Bergen, H. Robert, III] Mayo Clin, Coll Med, Mayo Prote Res Ctr, Rochester, MN 55905 USA; [Malinina, Lucy] Ctr Invest Cooperat Biociencias, Derio 48160, Spain; [Kenoth, Roopa; Kamlekar, Ravi Kanth; Pike, Helen M.; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	Mayo Clinic; Memorial Sloan Kettering Cancer Center; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Mayo Clinic; University of Minnesota System	Venyaminov, SY (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	venyaminov.sergei@mayo.edu; pateld@mskcc.org; reb@umn.edu	Malinina, Lucy/B-8161-2013; Kenoth, Roopa/F-3942-2010; Kamlekar, Ravikanth/B-9447-2009; Simanshu, Dhirendra/B-3361-2008; Kenoth, Roopa/ABH-5650-2020	Kenoth, Roopa/0000-0003-1992-3465; Kamlekar, Ravikanth/0000-0003-1627-122X; Simanshu, Dhirendra/0000-0002-9717-4618; Brown, Rhoderick/0000-0002-7337-3604; Malinina, Lucy/0000-0001-7973-1831	National Institutes of Health [GM45928, GM34847, CA121493]; Russian Foundation for Basic Research [09-04-00313]; Abby Rockefeller Mauze Trust; Dewitt Wallace, Maloris, Mayo, and Hormel Foundations; NATIONAL CANCER INSTITUTE [R01CA121493] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928, R01GM034847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Abby Rockefeller Mauze Trust; Dewitt Wallace, Maloris, Mayo, and Hormel Foundations; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grants GM45928 and GM34847 and National Institutes of Health, NCI, Grant CA121493. This work was also supported by Russian Foundation for Basic Research Grant 09-04-00313, the Abby Rockefeller Mauze Trust, and the Dewitt Wallace, Maloris, Mayo, and Hormel Foundations.	ABE A, 1989, BIOCHIM BIOPHYS ACTA, V985, P38, DOI 10.1016/0005-2736(89)90100-4; Ahn VE, 2006, PROTEIN SCI, V15, P1849, DOI 10.1110/ps.062256606; Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; Aoki K, 2004, BIOCHEM J, V378, P461, DOI 10.1042/BJ20031307; BASHFORD CL, 1979, BIOPHYS J, V25, P63, DOI 10.1016/S0006-3495(79)85278-9; BLOJ B, 1981, J BIOL CHEM, V256, P5988; BROWN RE, 1990, BIOCHIM BIOPHYS ACTA, V1044, P77, DOI 10.1016/0005-2760(90)90221-I; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorova ND, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-177; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; Hoh F, 2005, ACTA CRYSTALLOGR D, V61, P397, DOI 10.1107/S0907444905000417; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kolter T, 2005, J BIOL CHEM, V280, P41125, DOI 10.1074/jbc.R500015200; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P278; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li XM, 2004, BIOCHEMISTRY-US, V43, P10285, DOI 10.1021/bi0495432; Lin X, 2000, J BIOL CHEM, V275, P5104, DOI 10.1074/jbc.275.7.5104; Lomize AL, 2006, PROTEIN SCI, V15, P1318, DOI 10.1110/ps.062126106; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; Martin I, 1996, EUR J BIOCHEM, V239, P156, DOI 10.1111/j.1432-1033.1996.0156u.x; Mattjus P, 2003, BIOCHEMISTRY-US, V42, P535, DOI 10.1021/bi026896x; Mattjus P, 2002, BIOCHEMISTRY-US, V41, P266, DOI 10.1021/bi015718l; Mattjus P, 1999, ANAL BIOCHEM, V268, P297, DOI 10.1006/abio.1998.3065; Mattjus P, 2000, BIOCHEMISTRY-US, V39, P1067, DOI 10.1021/bi991810u; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIHALYI E, 1968, J CHEM ENG DATA, V13, P179, DOI 10.1021/je60037a011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Neumann S, 2008, ADV ENZYME REGUL, V48, P137, DOI 10.1016/j.advenzreg.2007.11.009; Nylund M, 2005, BBA-BIOMEMBRANES, V1669, P87, DOI 10.1016/j.bbamem.2004.12.014; Olsen I, 2001, ANAEROBE, V7, P103, DOI 10.1006/anae.2001.0376; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paoletti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000283; Park C, 2005, J LIPID RES, V46, P759, DOI 10.1194/jlr.M400457-JLR200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; Rao CS, 2005, BIOPHYS J, V89, P4017, DOI 10.1529/biophysj.105.070631; Rossmann M, 2008, STRUCTURE, V16, P809, DOI 10.1016/j.str.2008.02.016; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; SAUPE S, 1994, P NATL ACAD SCI USA, V91, P5927, DOI 10.1073/pnas.91.13.5927; Saupe SJ, 2000, MICROBIOL MOL BIOL R, V64, P489, DOI 10.1128/MMBR.64.3.489-502.2000; Snook CF, 2006, BBA-MOL CELL BIOL L, V1761, P927, DOI 10.1016/j.bbalip.2006.06.004; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Tilley SJ, 2004, STRUCTURE, V12, P317, DOI 10.1016/j.str.2004.01.013; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; VENYAMINOV SY, 1994, ANAL BIOCHEM, V222, P176, DOI 10.1006/abio.1994.1470; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; West G, 2008, FEBS J, V275, P3421, DOI 10.1111/j.1742-4658.2008.06498.x; West G, 2006, BBA-BIOMEMBRANES, V1758, P1732, DOI 10.1016/j.bbamem.2006.06.020; Yeats TH, 2008, PROTEIN SCI, V17, P191, DOI 10.1110/ps.073300108; Zhai XH, 2009, J BIOL CHEM, V284, P13620, DOI 10.1074/jbc.M809089200	65	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13066	13078		10.1074/jbc.M109.093203	http://dx.doi.org/10.1074/jbc.M109.093203			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20164530	Green Published, hybrid			2022-12-25	WOS:000276787800064
J	Ni, YG; Condra, JH; Orsatti, L; Shen, X; Di Marco, S; Pandit, S; Bottomley, MJ; Ruggeri, L; Cummings, RT; Cubbon, RM; Santoro, JC; Ehrhardt, A; Lewis, D; Fisher, TS; Ha, S; Njimoluh, L; Wood, DD; Hammond, HA; Wisniewski, D; Volpari, C; Noto, A; Lo Surdo, P; Hubbard, B; Carfi, A; Sitlani, A				Ni, Yan G.; Condra, Jon H.; Orsatti, Laura; Shen, Xun; Di Marco, Stefania; Pandit, Shilpa; Bottomley, Matthew J.; Ruggeri, Lionello; Cummings, Richard T.; Cubbon, Rose M.; Santoro, Joseph C.; Ehrhardt, Anka; Lewis, Dale; Fisher, Timothy S.; Ha, Sookhee; Njimoluh, Leila; Wood, Dana D.; Hammond, Holly A.; Wisniewski, Douglas; Volpari, Cinzia; Noto, Alessia; Lo Surdo, Paola; Hubbard, Brian; Carfi, Andrea; Sitlani, Ayesha			A Proprotein Convertase Subtilisin-like/Kexin Type 9 (PCSK9) C-terminal Domain Antibody Antigen-binding Fragment Inhibits PCSK9 Internalization and Restores Low Density Lipoprotein Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; LDL-CHOLESTEROL; FAMILIAL HYPERCHOLESTEROLEMIA; NONHUMAN-PRIMATES; RECEPTOR; MUTATIONS; MICE; MUTANTS; DISEASE; GENE	PCSK9 binds to the low density lipoprotein receptor (LDLR) and leads to LDLR degradation and inhibition of plasma LDL cholesterol clearance. Consequently, the role of PCSK9 in modulating circulating LDL makes it a promising therapeutic target for treating hypercholesterolemia and coronary heart disease. Although the C-terminal domain of PCSK9 is not involved in LDLR binding, the location of several naturally occurring mutations within this region suggests that it has an important role for PCSK9 function. Using a phage display library, we identified an anti-PCSK9 Fab (fragment antigen binding), 1G08, with subnanomolar affinity for PCSK9. In an assay measuring LDL uptake in HEK293 and HepG2 cells, 1G08 Fab reduced 50% the PCSK9-dependent inhibitory effects on LDL uptake. Importantly, we found that 1G08 did not affect the PCSK9-LDLR interaction but inhibited the internalization of PCSK9 in these cells. Furthermore, proteolysis and site-directed mutagenesis studies demonstrated that 1G08 Fab binds a region of beta-strands encompassing Arg-549, Arg-580, Arg-582, Glu-607, Lys-609, and Glu-612 in the PCSK9 C-terminal domain. Consistent with these results, 1G08 fails to bind PCSK9 Delta C, a truncated form of PCSK9 lacking the C-terminal domain. Additional studiesrevealed that lack of the C-terminal domain compromised the ability of PCSK9 to internalize into cells, and to inhibit LDL uptake. Together, the present study demonstrate that the PCSK9 C-terminal domain contribute to its inhibition of LDLR function mainly through its role in the cellular uptake of PCSK9 and LDLR complex. 1G08 Fab represents a useful new tool for delineating the mechanism of PCSK9 uptake and LDLR degradation.	[Ni, Yan G.; Shen, Xun; Pandit, Shilpa; Cummings, Richard T.; Cubbon, Rose M.; Santoro, Joseph C.; Fisher, Timothy S.; Njimoluh, Leila; Hubbard, Brian; Sitlani, Ayesha] Merck Res Labs, Dept Cardiovasc Dis, Rahway, NJ 07065 USA; [Wisniewski, Douglas] Merck Res Labs, Dept Infect Dis, Rahway, NJ 07065 USA; [Lewis, Dale] Merck Res Labs, Dept Vitro Sci, Rahway, NJ 07065 USA; [Ehrhardt, Anka; Ha, Sookhee] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA; [Condra, Jon H.; Wood, Dana D.; Hammond, Holly A.] Merck Res Labs, Dept Biol, West Point, PA 19486 USA; [Orsatti, Laura; Di Marco, Stefania; Bottomley, Matthew J.; Ruggeri, Lionello; Volpari, Cinzia; Noto, Alessia; Lo Surdo, Paola; Carfi, Andrea] IRBM P Angeletti & Merck Res Labs, Dept Biochem & Mol Biol, I-00040 Rome, Italy	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Ni, YG (corresponding author), 126 E Lincoln Ave, Rahway, NJ 07065 USA.	yan_ni@merck.com; andrea.carfi@novartis.com; ayesha_sitlani@merck.com	Fisher, Timothy S/D-8517-2011; Wisniewski, Douglas/AAT-9198-2021	Fisher, Timothy S/0000-0002-8909-313X; 				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; Cameron J, 2009, ATHEROSCLEROSIS, V203, P161, DOI 10.1016/j.atherosclerosis.2008.10.007; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Costet P, 2008, TRENDS BIOCHEM SCI, V33, P426, DOI 10.1016/j.tibs.2008.06.005; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Duff CJ, 2009, BIOCHEM J, V419, P577, DOI 10.1042/BJ20082407; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Pandit S, 2008, J LIPID RES, V49, P1333, DOI 10.1194/jlr.M800049-JLR200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Rauchenberger R, 2003, J BIOL CHEM, V278, P38194, DOI 10.1074/jbc.M303164200; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Schmidt RJ, 2008, BIOCHEM BIOPH RES CO, V370, P634, DOI 10.1016/j.bbrc.2008.04.004; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105	30	87	100	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12882	12891		10.1074/jbc.M110.113035	http://dx.doi.org/10.1074/jbc.M110.113035			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20172854	hybrid, Green Published			2022-12-25	WOS:000276787800046
J	Shepherd, M; Barynin, V; Lu, CY; Bernhardt, PV; Wu, GH; Yeh, SR; Egawa, T; Sedelnikova, SE; Rice, DW; Wilson, JL; Poole, RK				Shepherd, Mark; Barynin, Vladimir; Lu, Changyuan; Bernhardt, Paul V.; Wu, Guanghui; Yeh, Syun-Ru; Egawa, Tsuyoshi; Sedelnikova, Svetlana E.; Rice, David W.; Wilson, Jayne Louise; Poole, Robert K.			The Single-domain Globin from the Pathogenic Bacterium Campylobacter jejuni NOVEL D-HELIX CONFORMATION, PROXIMAL HYDROGEN BONDING THAT INFLUENCES LIGAND BINDING, AND PEROXIDASE-LIKE REDOX PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; VITREOSCILLA HEMOGLOBIN VHB; TRUNCATED HEMOGLOBIN; ESCHERICHIA-COLI; FUNCTIONAL-PROPERTIES; NITROSATIVE STRESS; NITRIC-OXIDE; MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; FLAVOHEMOGLOBIN	The food-borne pathogen Campylobacter jejuni possesses a single-domain globin (Cgb) whose role in detoxifying nitric oxide has been unequivocally demonstrated through genetic and molecular approaches. The x-ray structure of cyanide-bound Cgb has been solved to a resolution of 1.35 angstrom. The overall fold is a classic three-on-three alpha-helical globin fold, similar to that of myoglobin and Vgb from Vitreoscilla stercoraria. However, the D region (defined according to the standard globin fold nomenclature) of Cgb adopts a highly ordered alpha-helical conformation unlike any previously characterized members of this globin family, and the GlnE7 residue has an unexpected role in modulating the interaction between the ligand and the TyrB10 residue. The proximal hydrogen bonding network in Cgb demonstrates that the heme cofactor is ligated by an imidazolate, a characteristic of peroxidase-like proteins. Mutation of either proximal hydrogen-bonding residue (GluH23 or TyrG5) results in the loss of the high frequency nu(Fe-His) stretching mode (251 cm(-1)), indicating that both residues are important for maintaining the anionic character of the proximal histidine ligand. Cyanide binding kinetics for these proximal mutants demonstrate for the first time that proximal hydrogen bonding in globins can modulate ligand binding kinetics at the distal site. A low redox midpoint for the ferrous/ferric couple (-134 mV versus normal hydrogen electrode at pH 7) is consistent with the peroxidase-like character of the Cgb active site. These data provide a new insight into the mechanism via which Campylobacter may survive host-derived nitrosative stress.	[Shepherd, Mark; Barynin, Vladimir; Sedelnikova, Svetlana E.; Rice, David W.; Wilson, Jayne Louise; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Lu, Changyuan; Yeh, Syun-Ru; Egawa, Tsuyoshi] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Bernhardt, Paul V.] Univ Queensland, Dept Chem, Brisbane, Qld 4072, Australia; [Wu, Guanghui] Vet Labs Agcy, Dept Food & Environm Safety, Addlestone KT15 3NB, Surrey, England	University of Sheffield; Yeshiva University; Albert Einstein College of Medicine; University of Queensland; Veterinary Laboratories Agency	Shepherd, M (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	m.shepherd@sheffield.ac.uk	Wu, Guanghui/A-3757-2016; Bernhardt, Paul V/J-8008-2013	Wu, Guanghui/0000-0002-9374-3190; Bernhardt, Paul V/0000-0001-6839-1763; Yeh, Syun-Ru/0000-0002-9858-386X; Shepherd, Mark/0000-0002-7472-2300	Biotechnology and Biological Sciences Research Council [BB/EO10504/1]; BBSRC [BB/E010504/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E010504/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/EO10504/1 (to R. K. P.).	Arcovito A, 2007, P NATL ACAD SCI USA, V104, P6211, DOI 10.1073/pnas.0608411104; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernhardt PV, 2006, J BIOL INORG CHEM, V11, P930, DOI 10.1007/s00775-006-0148-z; Bolognesi M, 1999, J MOL BIOL, V291, P637, DOI 10.1006/jmbi.1999.2975; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; COOPER CE, 1994, BIOCHEM SOC T, V22, P709, DOI 10.1042/bst0220709; Dou Y, 1996, BIOCHEMISTRY-US, V35, P7107, DOI 10.1021/bi9600299; Egawa T, 2005, J INORG BIOCHEM, V99, P72, DOI 10.1016/j.jinorgbio.2004.10.017; Elvers KT, 2004, J BACTERIOL, V186, P5332, DOI 10.1128/JB.186.16.5332-5341.2004; Elvers KT, 2005, MOL MICROBIOL, V57, P735, DOI 10.1111/j.1365-2958.2005.04723.x; Ermler U, 1995, EMBO J, V14, P6067, DOI 10.1002/j.1460-2075.1995.tb00297.x; ERMLER U, 1995, PROTEINS, V21, P351, DOI 10.1002/prot.340210408; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Ilari A, 2002, J BIOL CHEM, V277, P23725, DOI 10.1074/jbc.M202228200; Iovine NM, 2008, INFECT IMMUN, V76, P986, DOI 10.1128/IAI.01063-07; JAKOB W, 1992, ARCH BIOCHEM BIOPHYS, V292, P29, DOI 10.1016/0003-9861(92)90046-Y; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOSHI M, 1994, BIOCHEM BIOPH RES CO, V202, P535, DOI 10.1006/bbrc.1994.1961; Kaur R, 2002, APPL ENVIRON MICROB, V68, P152, DOI 10.1128/AEM.68.1.152-160.2002; Kaur R, 2008, FEBS LETT, V582, P3494, DOI 10.1016/j.febslet.2008.09.018; KEILIN D, 1953, NATURE, V172, P390, DOI 10.1038/172390a0; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SY, 2004, BIOCHEM BIOPH RES CO, V316, P1101, DOI 10.1016/j.bbrc.2004.02.154; Lu CY, 2007, J BIOL CHEM, V282, P25917, DOI 10.1074/jbc.M704415200; Lu CY, 2007, J BIOL CHEM, V282, P13627, DOI 10.1074/jbc.M609397200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Membrillo-Hernandez J, 1999, J BIOL CHEM, V274, P748, DOI 10.1074/jbc.274.2.748; Monk CE, 2008, J BIOL CHEM, V283, P28413, DOI 10.1074/jbc.M801016200; Mukai M, 2001, J BIOL CHEM, V276, P7272, DOI 10.1074/jbc.M009280200; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424; Poole RK, 2000, MOL MICROBIOL, V36, P775, DOI 10.1046/j.1365-2958.2000.01889.x; Poulos TL, 1996, J BIOL INORG CHEM, V1, P356, DOI 10.1007/s007750050064; Rayner BS, 2004, BIOCHEM J, V381, P365, DOI 10.1042/BJ20031924; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; Tari C, 1998, BIOTECHNOL BIOENG, V59, P673, DOI 10.1002/(SICI)1097-0290(19980920)59:6&lt;673::AID-BIT3&gt;3.0.CO;2-C; Tarricone C, 1997, PROTEINS, V27, P154, DOI 10.1002/(SICI)1097-0134(199701)27:1<154::AID-PROT15>3.0.CO;2-M; Tarricone C, 1997, STRUCTURE, V5, P497, DOI 10.1016/S0969-2126(97)00206-2; VASUDEVAN SG, 1991, MOL GEN GENET, V226, P49, DOI 10.1007/BF00273586; Verma S, 2005, BIOCHEM BIOPH RES CO, V326, P290, DOI 10.1016/j.bbrc.2004.11.025; Wainwright LM, 2005, MICROBIOL-SGM, V151, P4079, DOI 10.1099/mic.0.28266-0; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; YAMADA H, 1975, ARCH BIOCHEM BIOPHYS, V169, P344, DOI 10.1016/0003-9861(75)90350-1	48	20	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12747	12754		10.1074/jbc.M109.084509	http://dx.doi.org/10.1074/jbc.M109.084509			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20164176	hybrid, Green Published			2022-12-25	WOS:000276787800033
J	Berger, A; Munk, C; Schweizer, M; Cichutek, K; Schule, S; Flory, E				Berger, Andre; Muenk, Carsten; Schweizer, Matthias; Cichutek, Klaus; Schuele, Silke; Flory, Egbert			Interaction of Vpx and Apolipoprotein B mRNA-editing Catalytic Polypeptide 3 Family Member A (APOBEC3A) Correlates with Efficient Lentivirus Infection of Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-2 VPX; CELL-CYCLE ARREST; CD4(+) T-CELLS; NUCLEAR IMPORT; PREINTEGRATION COMPLEX; REVERSE TRANSCRIPTION; PAPILLOMAVIRUS DNA; UBIQUITIN LIGASE; PROTEINS; HIV-1	The accessory protein Vpx is encoded by lentiviruses of the human immunodeficiency virus type 2 (HIV-2) and the simian immunodeficiency SIVsm/SIVmac lineage. It is packaged into virions and is indispensable in early steps of monocyte infection. HIV-1, which does not encode Vpx, is not able to infect human monocytes, but Vpx enables infection with HIV-1. The underlying mechanism is not completely understood. In this work, we focus on Vpx-mediated intracellular postentry events as counteraction of host cell proteins. We found that Vpx binds to apolipoprotein B mRNA-editing catalytic polypeptide 3 family member A (APOBEC3A; A3A), a member of the family of cytidine deaminases, present in monocytes. This interaction led to a reduction of the steady-state protein level of A3A. A single-point mutation in Vpx (H82A) abrogated binding to A3A and single-round infection of monocytes by HIV-1. Taken together, our data indicate that lentiviral Vpx counteracts A3A in human monocytes.	[Berger, Andre; Schweizer, Matthias; Cichutek, Klaus; Schuele, Silke; Flory, Egbert] Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany; [Muenk, Carsten] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany	Paul Ehrlich Institute; Heinrich Heine University Dusseldorf	Flory, E (corresponding author), Paul Ehrlich Inst, Div Med Biotechnol, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.	floeg@pei.de			Ansmann Foundation for AIDS Research; European Comission [LSHB-CT-2006-018933]; German Research Foundation [SPP1230]	Ansmann Foundation for AIDS Research; European Comission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation(German Research Foundation (DFG))	Supported by the Ansmann Foundation for AIDS Research.; Supported by the CliniGene Network of Excellence funded by the European Comission FP6 Research Programme under Contract LSHB-CT-2006-018933 and by German Research Foundation Grant SPP1230.	Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Belshan M, 2003, VIROLOGY, V311, P7, DOI 10.1016/S0042-6822(03)00093-X; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Cheng XG, 2008, J VIROL, V82, P1229, DOI 10.1128/JVI.00540-07; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; de Sio FRS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006571; DEWHURST S, 1990, NATURE, V345, P636, DOI 10.1038/345636a0; Fletcher TM, 1996, EMBO J, V15, P6155, DOI 10.1002/j.1460-2075.1996.tb01003.x; Fritz JV, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-87; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; HIGGINS JR, 1992, J MED PRIMATOL, V21, P265; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; HORTON R, 1994, VIROLOGY, V199, P453, DOI 10.1006/viro.1994.1144; Kamata M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000342; KAPPES JC, 1993, VIROLOGY, V193, P222, DOI 10.1006/viro.1993.1118; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Kumar PR, 2005, J BIOL CHEM, V280, P8553, DOI 10.1074/jbc.M407863200; Kurg R, 2009, VIROLOGY, V386, P353, DOI 10.1016/j.virol.2009.01.025; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Muckenfuss H, 2007, NUCLEIC ACIDS RES, V35, P3784, DOI 10.1093/nar/gkm340; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Muhlebach MD, 2005, MOL THER, V12, P1206, DOI 10.1016/j.ymthe.2005.06.483; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Neil S, 2001, J VIROL, V75, P5448, DOI 10.1128/JVI.75.12.5448-5456.2001; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Pancio HA, 2000, J VIROL, V74, P6162, DOI 10.1128/JVI.74.13.6162-6167.2000; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Perkovic M, 2009, J BIOL CHEM, V284, P5819, DOI 10.1074/jbc.M808853200; Schule S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007098; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sleigh R, 1998, VIROLOGY, V245, P338, DOI 10.1006/viro.1998.9159; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wolfrum N, 2007, VIROLOGY, V364, P330, DOI 10.1016/j.virol.2007.03.008	43	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12248	12254		10.1074/jbc.M109.090977	http://dx.doi.org/10.1074/jbc.M109.090977			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20178977	Green Published, hybrid			2022-12-25	WOS:000276787100054
J	Kang, LS; Bondensgaard, K; Li, TK; Hartmann, R; Hjorth, SA				Kang, Lishan; Bondensgaard, Kent; Li, Tengkun; Hartmann, Rune; Hjorth, Siv A.			Rational Design of Interleukin-21 Antagonist through Selective Elimination of the gamma C Binding Epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING; STRUCTURAL BASIS; IL-21 RECEPTOR; T-CELLS; CHAIN; AFFINITY; COMPLEX; REQUIREMENTS; BIOLOGY; GROWTH	The cytokine interleukin (IL)-21 exerts pleiotropic effects acting through innate as well as adaptive immune responses. The activities of IL-21 are mediated through binding to its cognate receptor complex composed of the IL-21 receptor private chain (IL-21R alpha) and thecommon gamma-chain (gamma C), the latter being shared by IL-2, IL-4, IL-7, IL-9, and IL-15. The binding energy of the IL-21 ternary complex is predominantly provided by the high affinity interaction between IL-21 and IL-21R alpha, whereas the interaction between IL-21 and gamma C, albeit essential for signaling, is rather weak. The design of IL-21 analogues, which have lost most or all affinity toward the signaling gamma C chain, while simultaneously maintaining a tight interaction with the private chain, would in theory represent candidates for IL-21 antagonists. We predicted the IL-21 residues, which compose the gamma C binding epitope using homology modeling and alignment with the related cytokines, IL-2 and IL-4. Next we systematically analyzed the predicted binding epitope by a mutagenesis study. Indeed two mutants, which have significantly impaired gamma C affinity with undiminished IL-21R alpha affinity, were successfully identified. Functional studies confirmed that these two novel hIL-21 double mutants do act as hIL-21 antagonists.	[Kang, Lishan] Novo Nordisk China R&D, Beijing 102206, Peoples R China; [Bondensgaard, Kent; Hjorth, Siv A.] Novo Nordisk AS, Biopharmaceut Res Unit, DK-2760 Malov, Denmark; [Hartmann, Rune] Aarhus Univ, Struct Biol Ctr, Dept Mol Biol, DK-8000 Aarhus C, Denmark	Novo Nordisk; Novo Nordisk; Aarhus University	Kang, LS (corresponding author), Novo Nordisk China R&D, 29 Life Sci Pk Rd, Beijing 102206, Peoples R China.	LshK@novonordisk.com		Hjorth, Siv Annegrethe/0000-0002-6470-650X; Hartmann, Rune/0000-0003-1159-066X				Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bondensgaard K, 2007, J BIOL CHEM, V282, P23326, DOI 10.1074/jbc.M701313200; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DUSCHL A, 1995, EUR J BIOCHEM, V228, P305; Habib T, 2002, BIOCHEMISTRY-US, V41, P8725, DOI 10.1021/bi0202023; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; KRUSE N, 1992, EMBO J, V11, P3237, DOI 10.1002/j.1460-2075.1992.tb05401.x; KRUSE N, 1993, EMBO J, V12, P5121, DOI 10.1002/j.1460-2075.1993.tb06207.x; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Letzelter F, 1998, EUR J BIOCHEM, V257, P11, DOI 10.1046/j.1432-1327.1998.2570011.x; MULLER T, 1994, J MOL BIOL, V237, P423, DOI 10.1006/jmbi.1994.1245; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Olosz F, 2002, J BIOL CHEM, V277, P12047, DOI 10.1074/jbc.M110520200; Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008; PRESNELL SR, 2007, Patent No. 7186805; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; TONY HP, 1994, EUR J BIOCHEM, V225, P659, DOI 10.1111/j.1432-1033.1994.00659.x; Toomey JA, 2003, J LEUKOCYTE BIOL, V74, P233, DOI 10.1189/jlb.0303097; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wang YH, 1997, P NATL ACAD SCI USA, V94, P1657, DOI 10.1073/pnas.94.5.1657; Zhang JL, 2003, BIOCHEM BIOPH RES CO, V300, P291, DOI 10.1016/S0006-291X(02)02836-X; Zhang JL, 2002, EUR J BIOCHEM, V269, P1490, DOI 10.1046/j.1432-1033.2002.02796.x	24	11	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12223	12231		10.1074/jbc.M110.101444	http://dx.doi.org/10.1074/jbc.M110.101444			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20167599	hybrid, Green Published			2022-12-25	WOS:000276787100051
J	Santiago, MF; Alcami, P; Striedinger, KM; Spray, DC; Scemes, E				Santiago, Marcelo F.; Alcami, Pepe; Striedinger, Katharine M.; Spray, David C.; Scemes, Eliana			The Carboxyl-terminal Domain of Connexin43 Is a Negative Modulator of Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL PROGENITOR CELLS; GAP-JUNCTION BLOCKAGE; NTERA2/CLONE D1 CELLS; NERVOUS-SYSTEM; NEOCORTICAL DEVELOPMENT; ASTROCYTE PROGENITORS; CORTICAL DEVELOPMENT; TEMPORAL EXPRESSION; P2Y(1) RECEPTORS; IN-VITRO	Connexin43 (Cx43) is widely expressed in embryonic brain, and its expression becomes restricted mainly to astrocytes as the central nervous system matures. Recent studies have indicated that Cx43 plays important, nonchannel, roles during central nervous system development by affecting neuronal cell migration. Here, we evaluated the effects of Cx43 on neuronal differentiation. For that we used an in vitro model of neural cell development (neurospheres) to evaluate, through immunocytochemistry, electrophysiology, and molecular biology, the degree of neuronal maturation from neurospheres derived from wild-type (WT) and Cx43-null mice. Our results indicate that Cx43 is a negative modulator of neuronal differentiation. The percent neurospheres containing differentiated neurons and the number of cells displaying inward currents were significantly higher in Cx43-null than in WT littermate neurospheres. Knockdown of Cx43 with small interfering RNA increased the number of WT neurospheres generating differentiated neurons. Blockade of gap junctional communication with carbenoxolone did not induce neuronal differentiation in WT neurospheres. Transfection of Cx43-null neurospheres with Cx43 mutants revealed that Cx43 carboxyl terminus prevents neuronal maturation. In agreement with these in vitro data, in situ analysis of embryonic day 16 brains revealed increased beta-III-tubulin expression in germinal zones of Cx43-null compared with that of WT littermates. These results indicate that Cx43, and specifically its carboxyl terminus, is crucial for signaling mechanisms preventing premature neuronal differentiation during embryonic brain development.	Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY 10461 USA; [Santiago, Marcelo F.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil; [Alcami, Pepe] Ecole Normale Super, Dept Biol, F-75005 Paris, France; [Striedinger, Katharine M.] Accuray Inc, Sunnyvale, CA 94089 USA	Yeshiva University; Universidade Federal do Rio de Janeiro; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Scemes, E (corresponding author), Kennedy Ctr, 1410 Pelham Pkwy,Rm 203, Bronx, NY 10461 USA.	scemes@aecom.yu.edu	Santiago, Marcelo Felippe/AAZ-3553-2020; Alcami, Pepe/T-2242-2018; Santiago, Marcelo F/H-3943-2011; Scemes, Eliana/K-6257-2019	Santiago, Marcelo Felippe/0000-0003-2428-9606; Alcami, Pepe/0000-0003-0023-7377; Santiago, Marcelo F/0000-0003-2428-9606; Scemes, Eliana/0000-0002-6650-3976; Spray, David/0000-0001-8368-5073	NINDS/National Institutes of Health [NS052245, NS041282]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041282, R01NS052245] Funding Source: NIH RePORTER	NINDS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS/National Institutes of Health Grants NS052245 (to E. S.) and NS041282 (to D. C. S.).	Agresti C, 2005, GLIA, V50, P132, DOI 10.1002/glia.20160; Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bani-Yaghoub M, 1999, DEV GENET, V24, P69, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<69::AID-DVG8>3.0.CO;2-M; Bani-Yaghoub M, 1999, EXP NEUROL, V156, P16, DOI 10.1006/exnr.1998.6950; BaniYaghoub M, 1997, J NEUROSCI RES, V49, P19, DOI 10.1002/(SICI)1097-4547(19970701)49:1<19::AID-JNR3>3.0.CO;2-G; Belliveau DJ, 2006, J BIOL CHEM, V281, P20920, DOI 10.1074/jbc.M600026200; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Bittman K, 1997, J NEUROSCI, V17, P7037; Bittman KS, 1999, CEREB CORTEX, V9, P188, DOI 10.1093/cercor/9.2.188; Chao DL, 2008, MOL CELL NEUROSCI, V39, P248, DOI 10.1016/j.mcn.2008.07.001; Cina C, 2007, J COMP NEUROL, V504, P298, DOI 10.1002/cne.21426; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; CONNORS BW, 1983, J NEUROSCI, V3, P773; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Duval N, 2002, J CELL SCI, V115, P3241; Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Fushiki S, 2003, J NEUROPATH EXP NEUR, V62, P304, DOI 10.1093/jnen/62.3.304; GOODMAN CS, 1979, NATURE, V280, P208, DOI 10.1038/280208a0; Gulisano M, 2000, NEUROREPORT, V11, P3823, DOI 10.1097/00001756-200011270-00045; Iacobas DA, 2008, CELL COMMUN ADHES, V15, P195, DOI 10.1080/15419060802014222; Iacobas DA, 2007, GENOMICS, V89, P113, DOI 10.1016/j.ygeno.2006.09.007; INGRAHAM CA, 1989, MOL CHEM NEUROPATHOL, V10, P1, DOI 10.1007/BF02969481; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; Kreuzberg MM, 2008, MOL CELL NEUROSCI, V37, P119, DOI 10.1016/j.mcn.2007.09.003; Kunze A, 2009, P NATL ACAD SCI USA, V106, P11336, DOI 10.1073/pnas.0813160106; Li W, 2005, J BIOL CHEM, V280, P7941, DOI 10.1074/jbc.M410548200; Loo LWM, 1999, MOL CARCINOGEN, V25, P187, DOI 10.1002/(SICI)1098-2744(199907)25:3<187::AID-MC5>3.3.CO;2-F; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; MIENVILLE JM, 1994, DEV BRAIN RES, V77, P89, DOI 10.1016/0165-3806(94)90216-X; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nadarajah B, 1997, J NEUROSCI, V17, P3096; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; PEINADO A, 1993, CEREB CORTEX, V3, P488, DOI 10.1093/cercor/3.5.488; ROZENTAL R, 1995, DEV BIOL, V167, P350, DOI 10.1006/dbio.1995.1029; Rozental R, 1998, J NEUROSCI, V18, P1753; Rozental R, 2000, BRAIN RES REV, V32, P57, DOI 10.1016/S0165-0173(99)00096-X; Scemes E, 2003, J NEUROSCI, V23, P11444; Scemes E, 2008, GLIA, V56, P145, DOI 10.1002/glia.20598; Scemes Eliana, 2009, P107, DOI 10.1007/978-0-387-79492-1_5; Shamekh R, 2006, EXP BRAIN RES, V170, P277, DOI 10.1007/s00221-005-0212-x; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Striedinger K, 2008, J NEUROIMMUNOL, V196, P116, DOI 10.1016/j.jneuroim.2008.03.014; Striedinger K, 2007, GLIA, V55, P652, DOI 10.1002/glia.20494; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Wiencken-Barger AE, 2007, GLIA, V55, P675, DOI 10.1002/glia.20484; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379	49	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11836	11845		10.1074/jbc.M109.058750	http://dx.doi.org/10.1074/jbc.M109.058750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164188	Green Published, hybrid			2022-12-25	WOS:000276787100011
J	Saita, E; Iino, R; Suzuki, T; Feniouk, BA; Kinosita, K; Yoshida, M				Saita, Ei-ichiro; Iino, Ryota; Suzuki, Toshiharu; Feniouk, Boris A.; Kinosita, Kazuhiko, Jr.; Yoshida, Masasuke			Activation and Stiffness of the Inhibited States of F-1-ATPase Probed by Single-molecule Manipulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON MOTIVE FORCE; COLI ATP SYNTHASE; C-TERMINAL DOMAIN; EPSILON-SUBUNIT; ESCHERICHIA-COLI; THERMOPHILIC F-1-ATPASE; F0F1-ATP SYNTHASE; MITOCHONDRIAL F1-ATPASE; ENDOGENOUS INHIBITOR; NUCLEOTIDE-BINDING	F-1-ATPase (F-1), a soluble portion of FoF1-ATP synthase (FoF1), is an ATP-driven motor in which gamma epsilon subunits rotate in the alpha(3)beta(3) cylinder. Activity of F1 and FoF1 from Bacillus PS3 is attenuated by the epsilon subunit in an inhibitory extended form. In this study we observed ATP-dependent transition of epsilon in single F-1 molecules from extended form to hairpin form by fluorescence resonance energy transfer. The results justify the previous bulk experiments and ensure that fraction of F-1 with hairpin epsilon directly determines the fraction of active F-1 at any ATP concentration. Next, mechanical activation and stiffness of epsilon-inhibited F-1 were examined by the forced rotation of magnetic beads attached to epsilon. Compared with ADP inhibition, which is another manner of inhibition, rotation by a larger angle was required for the activation from epsilon inhibition when the beads were forced to rotate to ATP hydrolysis direction, and more torque was required to reach the same rotation angle when beads were forced to rotate to ATP synthesis direction. The results imply that if FoF1 is resting in the epsilon-inhibited state, F-o motor must transmit to gamma a torque larger than expected from thermodynamic equilibrium to initiate ATP synthesis.	[Saita, Ei-ichiro; Suzuki, Toshiharu; Feniouk, Boris A.; Yoshida, Masasuke] Japan Sci & Technol Corp, ICORP ATP Synth Regulat Project, Tokyo 1350064, Japan; [Iino, Ryota] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Kinosita, Kazuhiko, Jr.] Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan; [Yoshida, Masasuke] Kyoto Sangyo Univ, Fac Engn, Kyoto 6038555, Japan	Japan Science & Technology Agency (JST); Osaka University; Waseda University; Kyoto Sangyo University	Yoshida, M (corresponding author), Japan Sci & Technol Corp, ICORP ATP Synth Regulat Project, Aomi 2-3-6, Tokyo 1350064, Japan.	myoshida@res.titech.ac.jp	Iino, Ryota/B-7746-2011; Feniouk, Boris/F-2380-2012	Iino, Ryota/0000-0003-0110-5704; Feniouk, Boris/0000-0003-0474-7411				Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Bandyopadhyay S, 2005, BIOCHEMISTRY-US, V44, P2441, DOI 10.1021/bi047694z; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Bulygin VV, 2004, J BIOL CHEM, V279, P35616, DOI 10.1074/jbc.M405012200; Bulygin VV, 1998, J BIOL CHEM, V273, P31765, DOI 10.1074/jbc.273.48.31765; CARMELI C, 1972, BIOCHIM BIOPHYS ACTA, V267, P86, DOI 10.1016/0005-2728(72)90140-5; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; DROBINSKAYA IY, 1985, FEBS LETT, V182, P419, DOI 10.1016/0014-5793(85)80346-X; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; DUNHAM KR, 1981, J BIOL CHEM, V256, P44; Feniouk Boris A., 2008, V45, P279, DOI 10.1007/400_2007_043; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Fischer S, 2000, J BIOL CHEM, V275, P30157, DOI 10.1074/jbc.275.39.30157; FUNG DC, 1995, NATURE, V375, P809, DOI 10.1038/375809a0; Gabel CV, 2003, P NATL ACAD SCI USA, V100, P8748, DOI 10.1073/pnas.1533395100; Ganti S, 2007, J BIOENERG BIOMEMBR, V39, P99, DOI 10.1007/s10863-006-9066-6; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; JAULT JM, 1993, J BIOL CHEM, V268, P1558; JUNGE W, 1970, EUR J BIOCHEM, V14, P582, DOI 10.1111/j.1432-1033.1970.tb00327.x; Kato S, 2007, J BIOL CHEM, V282, P37618, DOI 10.1074/jbc.M707509200; Kato Y, 1997, J BIOL CHEM, V272, P24906, DOI 10.1074/jbc.272.40.24906; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Kato-Yamada Y, 2003, J BIOL CHEM, V278, P36013, DOI 10.1074/jbc.M306140200; Kato-Yamada Y, 1998, J BIOL CHEM, V273, P19375, DOI 10.1074/jbc.273.31.19375; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; Kinosita K Jr, 2000, Essays Biochem, V35, P3; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 2001, J BIOL CHEM, V276, P25480, DOI 10.1074/jbc.M102200200; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Tsumuraya M, 2009, FEBS LETT, V583, P1121, DOI 10.1016/j.febslet.2009.02.038; Tsunoda SP, 1999, J BIOL CHEM, V274, P5701, DOI 10.1074/jbc.274.9.5701; Turina P, 2003, EMBO J, V22, P418, DOI 10.1093/emboj/cdg073; TURINA P, 1992, J BIOL CHEM, V267, P11057; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; VanWalraven HS, 1996, FEBS LETT, V379, P309, DOI 10.1016/0014-5793(95)01536-1; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; Wilkens S, 1998, J BIOL CHEM, V273, P26645, DOI 10.1074/jbc.273.41.26645; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zharova TV, 2006, BIOCHEMISTRY-US, V45, P14552, DOI 10.1021/bi061520v	56	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11411	11417		10.1074/jbc.M109.099143	http://dx.doi.org/10.1074/jbc.M109.099143			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154086	hybrid, Green Published			2022-12-25	WOS:000276286200047
J	Soto, T; Villar-Tajadura, MA; Madrid, M; Vicente, J; Gacto, M; Perez, P; Cansado, J				Soto, Teresa; Antonia Villar-Tajadura, Maria; Madrid, Marisa; Vicente, Jero; Gacto, Mariano; Perez, Pilar; Cansado, Jose			Rga4 Modulates the Activity of the Fission Yeast Cell Integrity MAPK Pathway by Acting as a Rho2 GTPase-activating Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; REGULATES MORPHOGENESIS; NUCLEOTIDE EXCHANGE; S-POMBE; KINASE; LOCALIZATION; STRESS; POLARITY; CDC42P; FAMILY	Rho GTPase-activating proteins ( GAPs) are responsible for the inactivation of Rho GTPases, which are involved in the regulation of critical biological responses in eukaryotic cells, ranging from cell cycle control to cellular morphogenesis. The genome of fission yeast Schizosaccharomyces pombe contains six genes coding for putative Rho GTPases, whereas nine genes code for predicted Rho GAPs (Rga1 to Rga9). One of them, Rga4, has been recently described as a Cdc42 GAP, involved in the control of cell diameter and symmetry in fission yeast. In this work we show that Rga4 is also a Rho2 GAP that negatively modulates the activity of the cell integrity pathway and its main effector, MAPK Pmk1. The DYRK-type protein kinase Pom1, which regulates both the localization and phosphorylation state of Rga4, is also a negative regulator of the Pmk1 pathway, but this control is not dependent upon the Rga4 role as a Rho2-GAP. Hence, two subsets of Rga4 negatively regulate Cdc42 and Rho2 functions in a specific and unrelated way. Finally, we show that Rga7, another Rho2 GAP, down-regulates the Pmk1 pathway in addition to Rga4. These results reinforce the notion of the existence of complex mechanisms determining the selectivity of Rho GAPs toward Rho GTPases and their functions.	[Soto, Teresa; Madrid, Marisa; Vicente, Jero; Gacto, Mariano; Cansado, Jose] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Yeast Physiol Grp, E-30071 Murcia, Spain; [Antonia Villar-Tajadura, Maria; Perez, Pilar] Univ Salamanca, CSIC, Dept Microbiol & Genet, Inst Microbiol Bioquim, Salamanca 30007, Spain	University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Gacto, M (corresponding author), Univ Murcia, Fac Biol, Dept Genet & Microbiol, Yeast Physiol Grp, E-30071 Murcia, Spain.	maga@um.es; jcansado@um.es	Perez, Pilar/B-4948-2010; Madrid, Marisa/K-7755-2014; Madrid, Marisa/AAV-2154-2020; Vicente-Soler, Jerónima/ABF-6293-2020; Cansado, Jose/ABC-6872-2020; Cansado, Jose/K-5212-2014; Pino, Teresa Soto/AAC-6096-2020	Perez, Pilar/0000-0003-3557-2247; Madrid, Marisa/0000-0002-7970-2587; Madrid, Marisa/0000-0002-7970-2587; Vicente-Soler, Jerónima/0000-0001-8759-6545; Cansado, Jose/0000-0002-2342-8152; Pino, Teresa Soto/0000-0003-2965-318X	Ministerio de Cienicia e Innovacion [BFU2007-60675, BFU2008-01653]; Junta de Castilla y Leon, Spain [GR231]; Fundacion Seneca (Region de Murcia), Spain [08725/PI/08]	Ministerio de Cienicia e Innovacion; Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); Fundacion Seneca (Region de Murcia), Spain(Fundacion Seneca)	This work was supported by Grants BFU2007-60675 from Ministerio de Cienicia e Innovacion and GR231 from Junta de Castilla y Leon, Spain (to P. P.) and Grants BFU2008-01653 from Ministerio de Cienicia e Innovacion and 08725/PI/08 from Fundacion Seneca (Region de Murcia), Spain (to J.C.).	Alfa C., 1993, EXPT FISSION YEAST; Villar-Tajadura MA, 2008, MOL MICROBIOL, V70, P867, DOI 10.1111/j.1365-2958.2008.06447.x; Arellano M, 1999, J CELL SCI, V112, P3569; Arellano M, 1996, EMBO J, V15, P4584, DOI 10.1002/j.1460-2075.1996.tb00836.x; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barba G, 2008, CELL SIGNAL, V20, P748, DOI 10.1016/j.cellsig.2007.12.017; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Calonge TM, 2003, MOL MICROBIOL, V47, P507, DOI 10.1046/j.1365-2958.2003.03312.x; Calonge TM, 2000, MOL BIOL CELL, V11, P4393, DOI 10.1091/mbc.11.12.4393; Coll PM, 2003, MOL BIOL CELL, V14, P313, DOI 10.1091/mbc.E02-07-0400; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Das M, 2007, MOL BIOL CELL, V18, P2090, DOI 10.1091/mbc.E06-09-0883; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Hirata D, 1998, J CELL SCI, V111, P149; Katayama S, 1999, J CELL BIOL, V144, P1173, DOI 10.1083/jcb.144.6.1173; Loewith R, 2000, J CELL SCI, V113, P153; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Madrid M, 2007, MOL BIOL CELL, V18, P4405, DOI 10.1091/mbc.E07-05-0484; Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Nakano K, 1997, GENES CELLS, V2, P679, DOI 10.1046/j.1365-2443.1997.1540352.x; Nakano K, 2001, GENES CELLS, V6, P1031, DOI 10.1046/j.1365-2443.2001.00485.x; OTTILIE S, 1995, EMBO J, V14, P5908, DOI 10.1002/j.1460-2075.1995.tb00278.x; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Rincon SA, 2009, MOL BIOL CELL, V20, P4390, DOI 10.1091/mbc.E09-03-0207; Schmidt A, 2002, MOL MICROBIOL, V45, P1433, DOI 10.1046/j.1365-2958.2002.03110.x; SELF AJ, 1995, METHOD ENZYMOL, V256, P67; Sengar AS, 1997, MOL CELL BIOL, V17, P3508, DOI 10.1128/MCB.17.7.3508; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Soto T, 2002, EUR J BIOCHEM, V269, P5056, DOI 10.1046/j.1432-1033.2002.03214.x; Sugiura R, 1999, NATURE, V399, P479, DOI 10.1038/20951; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Toda T, 1996, MOL CELL BIOL, V16, P6752; Yang PR, 2003, J BIOL CHEM, V278, P48821, DOI 10.1074/jbc.M306819200; ZaitsevskayaCarter T, 1997, EMBO J, V16, P1318, DOI 10.1093/emboj/16.6.1318	47	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11516	11525		10.1074/jbc.M109.071027	http://dx.doi.org/10.1074/jbc.M109.071027			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20164182	hybrid, Green Published			2022-12-25	WOS:000276286200058
J	Vonlaufen, N; Naguleswaran, A; Coppens, I; Sullivan, WJ				Vonlaufen, Nathalie; Naguleswaran, Arunasalam; Coppens, Isabelle; Sullivan, William J., Jr.			MYST Family Lysine Acetyltransferase Facilitates Ataxia Telangiectasia Mutated (ATM) Kinase-mediated DNA Damage Response in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASES; POSTTRANSLATIONAL MODIFICATIONS; ACTIVATES ATM; PROTOZOAN; ACETYLATION; TIP60; PROTEIN; EXPRESSION; GENE; STABILITY	The MYST family of lysine acetyltransferases (KATs) function in a wide variety of cellular operations, including gene regulation and the DNA damage response. Here we report the characterization of the second MYST family KAT in the protozoan parasite Toxoplasma gondii (TgMYST-B). Toxoplasma causes birth defects and is an opportunistic pathogen in the immuno-compromised, the latter due to its ability to convert into a latent cyst (bradyzoite). We demonstrate that TgMYST-B can gain access to the parasite nucleus and acetylate histones. Overexpression of recombinant, tagged TgMYST-B reduces growth rate in vitro and confers protection from a DNA-alkylating agent. Expression of mutant TgMYST-B produced no growth defect and failed to protect against DNA damage. We demonstrate that cells overexpressing TgMYST-B have increased levels of ataxia telangiectasia mutated (ATM) kinase and phosphorylated H2AX and that TgMYST-B localizes to the ATM kinase gene. Pharmacological inhibitors of ATM kinase or KATs reverse the slow growth phenotype seen in parasites overexpressing TgMYST-B. These studies are the first to show that a MYST KAT contributes to ATM kinase gene expression, further illuminating the mechanism of how ATM kinase is up-regulated to respond to DNA damage.	[Vonlaufen, Nathalie; Naguleswaran, Arunasalam; Sullivan, William J., Jr.] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Coppens, Isabelle] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sullivan, WJ (corresponding author), Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr,MS A-525, Indianapolis, IN 46202 USA.	wjsulliv@iupui.edu			National Institutes of Health, NIAID [R21AI083732]; American Heart Association [0725725Z]; Swiss National Foundation [PBBSA-115870]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083732] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); Swiss National Foundation(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Award R21AI083732 (to W. J. S.). This work was also supported by American Heart Association Grant 0725725Z (to A. N.) and Swiss National Foundation Grant PBBSA-115870 (to N. V.).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bhatti MM, 2006, EUKARYOT CELL, V5, P62, DOI 10.1128/EC.5.1.62-76.2006; Bhatti MM, 2005, J BIOL CHEM, V280, P5902, DOI 10.1074/jbc.M410656200; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; CAPPAI R, 1992, MOL BIOCHEM PARASIT, V54, P117, DOI 10.1016/0166-6851(92)90103-Q; Costa JM, 2000, J CLIN MICROBIOL, V38, P2929, DOI 10.1128/JCM.38.8.2929-2932.2000; Dalmasso MC, 2009, J MOL BIOL, V392, P33, DOI 10.1016/j.jmb.2009.07.017; Decker PV, 2008, GENETICS, V178, P1209, DOI 10.1534/genetics.107.080135; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Donald RGK, 2002, MOL BIOCHEM PARASIT, V120, P165, DOI 10.1016/S0166-6851(01)00451-0; Escargueil AE, 2008, MUTAT RES-REV MUTAT, V658, P259, DOI 10.1016/j.mrrev.2008.01.004; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Lavin MF, 2005, MUTAT RES-FUND MOL M, V569, P123, DOI 10.1016/j.mrfmmm.2004.04.020; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Ran QT, 2000, GENE, V258, P141, DOI 10.1016/S0378-1119(00)00410-8; Rios-Doria J, 2009, CANCER BIOL THER, V8, P422, DOI 10.4161/cbt.8.5.7592; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Smith AT, 2005, EUKARYOT CELL, V4, P2057, DOI 10.1128/EC.4.12.2057-2065.2005; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Sullivan WJ, 2006, CELL MICROBIOL, V8, P1850, DOI 10.1111/j.1462-5822.2006.00818.x; Sullivan WJ, 2005, ANTIMICROB AGENTS CH, V49, P2172, DOI 10.1128/AAC.49.6.2172-2179.2005; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2006, FEBS LETT, V580, P4353, DOI 10.1016/j.febslet.2006.06.092; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2007, MOL CELL BIOCHEM, V303, P1, DOI 10.1007/s11010-007-9449-y	32	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11154	11161		10.1074/jbc.M109.066134	http://dx.doi.org/10.1074/jbc.M109.066134			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20159970	Green Published, hybrid			2022-12-25	WOS:000276286200020
J	Bradford, J; Shin, JY; Roberts, M; Wang, CE; Sheng, GQ; Li, SH; Li, XJ				Bradford, Jennifer; Shin, Ji-Yeon; Roberts, Meredith; Wang, Chuan-En; Sheng, Guoqing; Li, Shihua; Li, Xiao-Jiang			Mutant Huntingtin in Glial Cells Exacerbates Neurological Symptoms of Huntington Disease Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOSODIUM-L-GLUTAMATE; INTRANUCLEAR INCLUSIONS; MOUSE MODEL; EXPRESSION; ASTROCYTES; NEURODEGENERATION; ACCUMULATION; PATHOGENESIS; PROTEIN; RATS	Huntington disease (HD) is caused by an expansion of the polyglutamine (polyQ) repeat (> 37Q) in huntingtin (htt), and age of onset is inversely correlated with the length of the polyQ repeat. Mutant htt with expanded polyQ is ubiquitously expressed in various types of cells, including glia, but causes selective neurodegeneration. Our recent study demonstrated that expression of the N-terminal mutant htt with a large polyQ repeat (160Q) in astrocytes is sufficient to induce neurological symptoms in mice (Bradford, J., Shin, J. Y., Roberts, M., Wang, C. E., Li, X.-J., and Li, S. H. (2009) Proc. Natl. Acad. Sci. U. S. A. 106, 22480-22485). Because glia-neuron interactions are critical for maintaining the normal function and survival of neurons in the brain and because mutant htt is more abundant in neurons than in glial cells, it is important to investigate whether glial htt can still contribute to HD pathology when mutant htt is abundantly expressed in neuronal cells. We generated transgenic mice that express mutant htt with 98Q in astrocytes. Unlike our recently generated htt-160Q transgenic mice, htt-98Q mice do not show obvious neurological phenotypes, suggesting that the length of the polyQ repeat determines the severity of glial dysfunction. However, htt-98Q mice show increased susceptibility to glutamate-induced seizure. Mice expressing mutant htt in astrocytes were mated with N171-82Q mice that express mutant htt primarily in neuronal cells. Double transgenic mice expressing mutant htt in both neuronal and glial cells display more severe neurological symptoms and earlier death than N171-82Q mice. These findings indicate a role of glial mutant htt in exacerbating HD neuropathology and underscore the importance of improving glial function in treating HD.	[Bradford, Jennifer; Shin, Ji-Yeon; Roberts, Meredith; Wang, Chuan-En; Sheng, Guoqing; Li, Shihua; Li, Xiao-Jiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Emory University	Li, XJ (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	xli2@emory.edu			National Institutes of Health [NS36232, AG19206, AG031153, NS045016]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041669, R01NS045016, R01NS036232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019206, R01AG031153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS36232 (to X.-J.L.), AG19206 (to X.-J.L.), AG031153 (to S. H. L.), and NS045016 (to S. H. L.).	ARAUZCONTRERAS J, 1984, GEN PHARMACOL-VASC S, V15, P391, DOI 10.1016/0306-3623(84)90036-3; Arzberger T, 1997, J NEUROPATH EXP NEUR, V56, P440, DOI 10.1097/00005072-199704000-00013; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Brenner Michael, 1996, Methods (Orlando), V10, P351, DOI 10.1006/meth.1996.0113; Chou SY, 2008, J NEUROSCI, V28, P3277, DOI 10.1523/JNEUROSCI.0116-08.2008; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; FeriaVelasco A, 1995, ARCH MED RES, V26, pS127; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Gu XF, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-8; Hassel B, 2008, NEUROCHEM RES, V33, P232, DOI 10.1007/s11064-007-9463-1; Hayase T, 2001, J PHARM PHARMACOL, V53, P1525, DOI 10.1211/0022357011777891; Hebb MO, 1999, FASEB J, V13, P1099, DOI 10.1096/fasebj.13.9.1099; Heng MY, 2008, NEUROBIOL DIS, V32, P1, DOI 10.1016/j.nbd.2008.06.005; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Li SH, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-19; Lievens JC, 2005, HUM MOL GENET, V14, P713, DOI 10.1093/hmg/ddi067; Lievens JC, 2001, NEUROBIOL DIS, V8, P807, DOI 10.1006/nbdi.2001.0430; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; MYERS RH, 1991, J NEUROPATH EXP NEUR, V50, P729, DOI 10.1097/00005072-199111000-00005; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Singhrao SK, 1998, EXP NEUROL, V150, P213, DOI 10.1006/exnr.1998.6778; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Yu ZX, 2003, J NEUROSCI, V23, P2193	34	108	114	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10653	10661		10.1074/jbc.M109.083287	http://dx.doi.org/10.1074/jbc.M109.083287			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20145253	hybrid, Green Published			2022-12-25	WOS:000276264600052
J	Zhang, H; Fagan, DH; Zeng, X; Freeman, KT; Sachdev, D; Yee, D				Zhang, H.; Fagan, D. H.; Zeng, X.; Freeman, K. T.; Sachdev, D.; Yee, D.			Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation	ONCOGENE			English	Article						insulin receptor; angiogenesis; lymphangiogenesis; metastasis	GROWTH-FACTOR-RECEPTOR; HUMAN-BREAST-CANCER; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; IGF-I RECEPTORS; M14 MELANOMA; VIVO; EXPRESSION; LINES; MICE; ACTIVATION	Insulin receptor (IR) and the type I IGF receptor (IGF1R) are structurally and functionally related. The function of IGF1R in cancer has been well documented and anti-IGF1R strategies to treat cancer have shown initial positive results. However, the role of IR in tumor biology, independent of IGF1R, is less clear. To address this issue, short hairpin RNA (shRNA) was used to specifically downregulate IR in two cancer cell lines, LCC6 and T47D. Cells with reduced IR showed reduced insulin-stimulated Akt activation, without affecting IGF1R activation. Cells with reduced IR formed fewer colonies in anchorage-independent conditions. LCC6 IR shRNA xenograft tumors in mice had reduced growth, angiogenesis and lymphangiogensis when compared with LCC6 wild-type cells. Accordingly, LCC6 IR shRNA clones produced less hypoxia-inducible factor-1 alpha, vascular endothelial growth factor (VEGF)-A and VEGF-D. Furthermore, LCC6 IR shRNA cells formed fewer pulmonary metastases when compared with LCC6 wild-type cells. Using in vivo luciferase imaging, we have shown that LCC6 IR shRNA cells have less seeding and colonization potential in the lung and liver of mice than LCC6 cells. In conclusion, downregulation of IR inhibited cancer cell proliferation, angiogenesis, lymphangiogenesis and metastasis. Our data argue that IR should also be targeted in cancer therapy. Oncogene (2010) 29, 2517-2527; doi:10.1038/onc.2010.17; published online 15 February 2010	[Zhang, H.; Freeman, K. T.; Sachdev, D.; Yee, D.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Fagan, D. H.; Zeng, X.; Yee, D.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Sachdev, D.; Yee, D.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Yee, D (corresponding author), Univ Minnesota, Masonic Canc Ctr, MMC 806,420 Delaware St SE, Minneapolis, MN 55455 USA.	yeexx006@umn.edu		Yee, Douglas/0000-0002-3387-4009	Department of Defense [BC050548]; National Institutes of Health [R01CA74285]; National Cancer Institute Cancer Center [P30 077598]; NATIONAL CANCER INSTITUTE [P30CA077598, R01CA074285] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Colleen Forster for the technical service on immunohistochemistry staining of tumor and lung tissue. We thank Dr Ilze Matise from the Masonic Cancer Center Comparative Pathology Shared Resource for valuable advice. We thank Dr Yunfang Li and Dr Kalpna Gupta from Masonic Cancer Center for detailed protocol of LYVE-1 and CD31 staining in tumor samples. We appreciate Dr Minghai Shao and Dr Daniela E Matei from Indiana University School of Medicine for providing the retroviral vector expressing luciferase. We acknowledge the assistance of the Flow Cytometry Core Shared Resource of the Masonic Cancer Center. Animal imaging was performed at the Biomedical Image Processing laboratory at University of Minnesota. This work was supported by Department of Defense Breast Cancer Research Program post-doctoral Grant BC050548 to HZ, National Institutes of Health R01CA74285 to DY and National Cancer Institute Cancer Center Support Grant P30 077598.	Ademuyiwa FO, 2008, CLIN BREAST CANCER, V8, pS151, DOI 10.3816/CBC.2008.s.011; Avnet S, 2009, CANCER RES, V69, P2443, DOI 10.1158/0008-5472.CAN-08-2645; Bjorndahl M, 2005, P NATL ACAD SCI USA, V102, P15593, DOI 10.1073/pnas.0507865102; Byron SA, 2006, BRIT J CANCER, V95, P1220, DOI 10.1038/sj.bjc.6603354; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Dillon RL, 2009, CANCER RES, V69, P5057, DOI 10.1158/0008-5472.CAN-08-4287; Dunn SE, 1998, CANCER RES, V58, P3353; Eccles S, 2007, CLIN EXP METASTAS, V24, P619, DOI 10.1007/s10585-007-9123-5; Feldser D, 1999, CANCER RES, V59, P3915; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Frasca Francesco, 2003, Breast Dis, V17, P73; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Goodwin PJ, 2002, J CLIN ONCOL, V20, P42, DOI 10.1200/JCO.20.1.42; Haluska P, 2006, CANCER RES, V66, P362, DOI 10.1158/0008-5472.CAN-05-1107; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HEUSON JC, 1972, CANCER RES, V32, P226; Hewish M, 2009, RECENT PAT ANTI-CANC, V4, P54, DOI 10.2174/157489209787002515; Ji QS, 2007, MOL CANCER THER, V6, P2158, DOI 10.1158/1535-7163.MCT-07-0070; KAREY KP, 1988, CANCER RES, V48, P4083; KASUYA J, 1993, BIOCHEMISTRY-US, V32, P13531, DOI 10.1021/bi00212a019; Leonessa F, 1996, BRIT J CANCER, V73, P154, DOI 10.1038/bjc.1996.29; Li JG, 2006, PHYSIOL GENOMICS, V25, P450, DOI 10.1152/physiolgenomics.00293.2005; Ma J, 2008, LANCET ONCOL, V9, P1039, DOI 10.1016/S1470-2045(08)70235-3; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; NANDI S, 1995, P NATL ACAD SCI USA, V92, P3650, DOI 10.1073/pnas.92.9.3650; Novosyadlyy R, 2009, ONCOGENE, V28, P3477, DOI 10.1038/onc.2009.209; OSBORNE CK, 1976, P NATL ACAD SCI USA, V73, P4536, DOI 10.1073/pnas.73.12.4536; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Sachdev D, 2001, ENDOCR-RELAT CANCER, V8, P197, DOI 10.1677/erc.0.0080197; Sachdev D, 2004, J BIOL CHEM, V279, P5017, DOI 10.1074/jbc.M305403200; Sachdev D, 2003, CANCER RES, V63, P627; Sachdev D, 2006, J MAMMARY GLAND BIOL, V11, P27, DOI 10.1007/s10911-006-9010-8; Stoeltzing O, 2003, AM J PATHOL, V163, P1001, DOI 10.1016/S0002-9440(10)63460-8; Tang YC, 2003, CANCER RES, V63, P1166; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Wang JQ, 2006, BIOORG MED CHEM LETT, V16, P331, DOI 10.1016/j.bmcl.2005.09.082; Weroha S, 2008, J MAMMARY GLAND BIOL, V13, P471, DOI 10.1007/s10911-008-9104-6; Zhang H, 2007, CANCER RES, V67, P391, DOI 10.1158/0008-5472.CAN-06-1712; Zhang H, 2006, CLIN CANCER RES, V12, P6323, DOI 10.1158/1078-0432.CCR-06-1707	43	97	106	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	17					2517	2527		10.1038/onc.2010.17	http://dx.doi.org/10.1038/onc.2010.17			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	589RB	20154728	Green Accepted			2022-12-25	WOS:000277169400007
J	Braun, E; Geurten, B; Egelhaaf, M				Braun, Elke; Geurten, Bart; Egelhaaf, Martin			Identifying Prototypical Components in Behaviour Using Clustering Algorithms	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; OPTIC FLOW; BLOWFLY FLIGHT; PRIMITIVES; DROSOPHILA; MOVEMENT; CLASSIFICATION; VALIDATION; PHENOTYPES; DYNAMICS	Quantitative analysis of animal behaviour is a requirement to understand the task solving strategies of animals and the underlying control mechanisms. The identification of repeatedly occurring behavioural components is thereby a key element of a structured quantitative description. However, the complexity of most behaviours makes the identification of such behavioural components a challenging problem. We propose an automatic and objective approach for determining and evaluating prototypical behavioural components. Behavioural prototypes are identified using clustering algorithms and finally evaluated with respect to their ability to represent the whole behavioural data set. The prototypes allow for a meaningful segmentation of behavioural sequences. We applied our clustering approach to identify prototypical movements of the head of blowflies during cruising flight. The results confirm the previously established saccadic gaze strategy by the set of prototypes being divided into either predominantly translational or rotational movements, respectively. The prototypes reveal additional details about the saccadic and intersaccadic flight sections that could not be unravelled so far. Successful application of the proposed approach to behavioural data shows its ability to automatically identify prototypical behavioural components within a large and noisy database and to evaluate these with respect to their quality and stability. Hence, this approach might be applied to a broad range of behavioural and neural data obtained from different animals and in different contexts.	[Braun, Elke; Geurten, Bart; Egelhaaf, Martin] Univ Bielefeld, Ctr Excellence Cognit Interact Technol, Bielefeld, Germany	University of Bielefeld	Braun, E (corresponding author), Univ Bielefeld, Ctr Excellence Cognit Interact Technol, Bielefeld, Germany.	elke.braun@uni-bielefeld.de	Geurten, Bart/I-2037-2019; Egelhaaf, Martin/A-9824-2010	Geurten, Bart/0000-0002-1816-3241; Egelhaaf, Martin/0000-0002-9336-4270	Deutsche Forschungsgemeinschaft (DFG); Studienstiftung des deutschen Volkes	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	This work was funded by the Deutsche Forschungsgemeinschaft (DFG) and by a PhD grant of the Studienstiftung des deutschen Volkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2002, J NEUROSCI METH, V118, P9, DOI 10.1016/S0165-0270(02)00117-6; Ben-Hur Asa, 2002, Pac Symp Biocomput, P6; Bobick AF, 1998, PROC CVPR IEEE, P196, DOI 10.1109/CVPR.1998.698609; Boeddeker N, 2005, J EXP BIOL, V208, P1563, DOI 10.1242/jeb.01558; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; COGGINS JM, 1985, PATTERN RECOGN LETT, V3, P195, DOI 10.1016/0167-8655(85)90053-4; Del Vecchio D, 2003, AUTOMATICA, V39, P2085, DOI 10.1016/S0005-1098(03)00250-4; DUDA RO, 2001, PATTERN CLASSIFICATI, pR20; Dudoit S, 2002, GENOME BIOL, V3; Everitt B., 2001, CLUSTER ANAL, pviii; FENTRESS JC, 1973, NATURE, V244, P52, DOI 10.1038/244052a0; Flash T, 2005, CURR OPIN NEUROBIOL, V15, P660, DOI 10.1016/j.conb.2005.10.011; Fod A, 2002, AUTON ROBOT, V12, P39, DOI 10.1023/A:1013254724861; FUKUNAGA K, 1990, INTRO STAT PATTERN R, pR13; Fussnecker BL, 2006, J INSECT PHYSIOL, V52, P1083, DOI 10.1016/j.jinsphys.2006.07.008; Geng W, 2003, GENETICS, V165, P1117; Ghahramani Z, 2000, NATURE, V407, P682, DOI 10.1038/35037690; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Hardle W. K., 2003, APPL MULTIVARIATE ST; Hoshi K, 2006, J NEUROSCI METH, V157, P355, DOI 10.1016/j.jneumeth.2006.05.002; JAIN AK, 1988, ALGORITHMS CLUSTERIN, pR14; JAMBU M, 1983, CLUSTER ANAL DATA AN, pR24; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Kern R, 2005, PLOS BIOL, V3, P1130, DOI 10.1371/journal.pbio.0030171; Lange T, 2004, NEURAL COMPUT, V16, P1299, DOI 10.1162/089976604773717621; LEHNER PN, 1998, HDB ETHOLOGICAL METH, pR19; Levine E, 2001, NEURAL COMPUT, V13, P2573, DOI 10.1162/089976601753196030; Lindemann JP, 2003, VISION RES, V43, P779, DOI 10.1016/S0042-6989(03)00039-7; MARTIN P, 2002, MEASURING BEHAV, pR16; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; NIEMANN H, 1990, SPRINGER SERIES INFO, V4, pR14; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Panuccio A., 2002, Structural, Syntactic, and Statistical Pattern Recognition. Joint IAPR International Workshops SSPR 2002 and SPR 2002 (Lecture Notes in Computer Science Vol. 2396), P734; POMPLUN M, 2001, IRIS02410 U SO CAL I; SARASWATI S, J NEUROBIOLOGY, V58; Schack T., 2004, J SPORT EXERCISE PSY, V2, P403, DOI [10.1080/1612197x.2004.9671753, DOI 10.1080/1612197X.2004.9671753, 10.1080/1612197X.2004.9671753]; Schilstra C, 1998, J NEUROSCI METH, V83, P125, DOI 10.1016/S0165-0270(98)00069-7; Schilstra C, 1999, J EXP BIOL, V202, P1481; Smyth P, 2000, STAT COMPUT, V10, P63, DOI 10.1023/A:1008940618127; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Suster ML, 2004, GENES BRAIN BEHAV, V3, P273, DOI 10.1111/j.1601-183X.2004.00082.x; Thurau C, 2004, LECT NOTES COMPUT SC, V3175, P179; Van Hateren JH, 1999, J EXP BIOL, V202, P1491; WEST DB, 2001, INTRO GRAPH THEORY, pR19	46	51	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9361	10.1371/journal.pone.0009361	http://dx.doi.org/10.1371/journal.pone.0009361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179763	Green Published, Green Submitted, gold			2022-12-25	WOS:000274923900021
J	Rohan, LC; Moncla, BJ; Ayudhya, RPKN; Cost, M; Huang, Y; Gai, F; Billitto, N; Lynam, JD; Pryke, K; Graebing, P; Hopkins, N; Rooney, JF; Friend, D; Dezzutti, CS				Rohan, Lisa C.; Moncla, Bernard J.; Ayudhya, Ratiya Pamela Kunjara Na; Cost, Marilyn; Huang, Yunda; Gai, Fang; Billitto, Nicole; Lynam, J. D.; Pryke, Kara; Graebing, Phillip; Hopkins, Nicole; Rooney, James F.; Friend, David; Dezzutti, Charlene S.			In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide	PLOS ONE			English	Article							NONOXYNOL-9 VAGINAL GEL; PLACEBO-CONTROLLED TRIAL; FEMALE SEX WORKERS; TOPICAL MICROBICIDES; NEISSERIA-GONORRHOEAE; RECTAL TRANSMISSION; EXPLANT CULTURE; CLINICAL-TRIALS; SOUTH-AFRICA; DOUBLE-BLIND	Background: Tenofovir gel has entered into clinical trials for use as a topical microbicide to prevent HIV-1 infection but has no published data regarding pre-clinical testing using in vitro and ex vivo models. To validate our findings with on-going clinical trial results, we evaluated topical tenofovir gel for safety and efficacy. We also modeled systemic application of tenofovir for efficacy. Methods and Findings: Formulation assessment of tenofovir gel included osmolality, viscosity, in vitro release, and permeability testing. Safety was evaluated by measuring the effect on the viability of vaginal flora, PBMCs, epithelial cells, and ectocervical and colorectal explant tissues. For efficacy testing, PBMCs were cultured with tenofovir or vehicle control gels and HIV-1 representing subtypes A, B, and C. Additionally, polarized ectocervical and colorectal explant cultures were treated apically with either gel. Tenofovir was added basolaterally to simulate systemic application. All tissues were challenged with HIV-1 applied apically. Infection was assessed by measuring p24 by ELISA on collected supernatants and immunohistochemistry for ectocervical explants. Formulation testing showed the tenofovir and vehicle control gels were >10 times isosmolar. Permeability through ectocervical tissue was variable but in all cases the receptor compartment drug concentration reached levels that inhibit HIV-1 infection in vitro. The gels were non-toxic toward vaginal flora, PBMCs, or epithelial cells. A transient reduction in epithelial monolayer integrity and epithelial fracture for ectocervical and colorectal explants was noted and likely due to the hyperosmolar nature of the formulation. Tenofovir gel prevented HIV-1 infection of PBMCs regardless of HIV-1 subtype. Topical and systemic tenofovir were effective at preventing HIV-1 infection of explant cultures. Conclusions: These studies provide a mechanism for pre-clinical prediction of safety and efficacy of formulated microbicides. Tenofovir was effective against HIV-1 infection in our algorithm. These data support the use of tenofovir for pre-exposure prophylaxis.	[Rohan, Lisa C.; Moncla, Bernard J.; Ayudhya, Ratiya Pamela Kunjara Na; Cost, Marilyn; Billitto, Nicole; Lynam, J. D.; Pryke, Kara; Graebing, Phillip; Hopkins, Nicole; Dezzutti, Charlene S.] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15260 USA; [Huang, Yunda; Gai, Fang] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Rooney, James F.] Gilead Sci Inc, Foster City, CA 94404 USA; [Friend, David] CONRAD, Arlington, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Fred Hutchinson Cancer Center; Gilead Sciences	Rohan, LC (corresponding author), Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15260 USA.	cdezzutti@mwri.magee.edu		Huang, Yunda/0000-0003-1546-6172; Dezzutti, Charlene/0000-0001-5902-5841	National Institute of Allergy and Infectious Diseases [U01 AI068633]; National Institute of Child Health and Development; National Institute of Mental Health; United States National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068633] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Microbicide Trials Network funded by the National Institute of Allergy and Infectious Diseases (U01 AI068633), the National Institute of Child Health and Development, and the National Institute of Mental Health, all of the United States National Institutes of Health. The NIH had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; ANTON P, 2009, STRONG SUPPRESSION H; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; AYUDHYA RPK, KEYST S PREV HIV AID; Beer BE, 2006, ANTIMICROB AGENTS CH, V50, P713, DOI 10.1128/AAC.50.2.713-723.2006; Carballo-Dieguez A, 2006, ARCH SEX BEHAV, V35, P473, DOI 10.1007/s10508-006-9078-7; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Cosentino LA, 2003, J CLIN MICROBIOL, V41, P3592, DOI 10.1128/JCM.41.8.3592-3596.2003; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; Fletcher PS, 2006, AIDS, V20, P1237, DOI 10.1097/01.aids.0000232230.96134.80; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Fuchs EJ, 2007, J INFECT DIS, V195, P703, DOI 10.1086/511279; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Gray Ronald H, 2008, Curr Infect Dis Rep, V10, P121, DOI 10.1007/s11908-008-0022-y; Greig FE, 2003, AIDS BEHAV, V7, P195, DOI 10.1023/A:1023954526639; Harwood B, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.020; Herrera C, 2009, ANTIMICROB AGENTS CH, V53, P1797, DOI 10.1128/AAC.01096-08; Hillier SL, 2008, SAFETY ACCEPTABILITY; JENNINGS R, 1993, J ANTIMICROB CHEMOTH, V32, P71, DOI 10.1093/jac/32.1.71; Kalichman SC, 1998, J WOMENS HEALTH, V7, P371, DOI 10.1089/jwh.1998.7.371; KARIM SA, 2009, SAFETY EFFECTIVENESS; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; KURAMOTO H, 1972, Acta Obstetrica et Gynaecologica Japonica (English Edition), V19, P47; MALKOVSKY M, 1988, LANCET, V1, P645; Martin HL, 1997, SEX TRANSM DIS, V24, P279, DOI 10.1097/00007435-199705000-00008; Mayer KH, 2006, AIDS, V20, P543, DOI 10.1097/01.aids.0000210608.70762.c3; Microbicides Development Programme, 2009, HIV PREV GEL PRO 200; Mills E, 2008, HIV MED, V9, P332, DOI 10.1111/j.1468-1293.2008.00596.x; Moncla BJ, 2008, ANTIMICROB AGENTS CH, V52, P1577, DOI 10.1128/AAC.01023-07; Moncla BJ, 2005, SEX TRANSM DIS, V32, P491, DOI 10.1097/01.olq.0000170444.13666.e9; MONCLA BJ, 1991, J CLIN MICROBIOL, V29, P1955, DOI 10.1128/JCM.29.9.1955-1958.1991; Moszynski P, 2007, BRIT MED J, V334, P276, DOI 10.1136/bmj.39118.473356.DB; NIRUTHISARD S, 1992, LANCET, V339, P1371, DOI 10.1016/0140-6736(92)91195-E; NIRUTHISARD S, 1991, SEX TRANSM DIS, V18, P176, DOI 10.1097/00007435-199107000-00010; Olmsted SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-79; Palmer S, 2001, AIDS RES HUM RETROV, V17, P1167, DOI 10.1089/088922201316912772; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Patel S, 2007, J INFECT DIS, V196, P1394, DOI 10.1086/522606; Patton DL, 2002, SEX TRANSM DIS, V29, P581, DOI 10.1097/00007435-200210000-00004; Phillips DM, 2004, CONTRACEPTION, V70, P107, DOI 10.1016/j.contraception.2004.04.008; Phillips DM, 2000, CONTRACEPTION, V62, P149, DOI 10.1016/S0010-7824(00)00156-6; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Rustomjee R, 1999, AIDS, V13, P1511, DOI 10.1097/00002030-199908200-00011; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Steinbrook R, 2007, NEW ENGL J MED, V357, P2653, DOI 10.1056/NEJMp0708117; Tabet SR, 1999, SEX TRANSM DIS, V26, P564, DOI 10.1097/00007435-199911000-00005; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; Tuyama ACG, 2006, J INFECT DIS, V194, P795, DOI 10.1086/506948; *UNAIDS WHO, 2008, REP GLOB AIDS EP; Van Damme L, 2000, AIDS, V14, P85, DOI 10.1097/00002030-200001070-00010; Van Damme L, 1998, AIDS, V12, P433, DOI 10.1097/00002030-199804000-00013; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957	55	154	159	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9310	10.1371/journal.pone.0009310	http://dx.doi.org/10.1371/journal.pone.0009310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174579	Green Accepted, Green Published, gold			2022-12-25	WOS:000274923700014
J	Gao, XL; Wang, SH; Fan, YJ; Bai, H; Yang, J; Yang, X				Gao, Xiaoling; Wang, Shuhe; Fan, Yijun; Bai, Hong; Yang, Jie; Yang, Xi			CD8(+) DC, but Not CD8(-)DC, Isolated from BCG-Infected Mice Reduces Pathological Reactions Induced by Mycobacterial Challenge Infection	PLOS ONE			English	Article							DENDRITIC CELL SUBSETS; REGULATORY T-CELLS; IN-VIVO; TUBERCULOSIS INFECTION; CYTOKINE PRODUCTION; IMMUNE-RESPONSE; CD8-ALPHA(+); SPLEEN; SUBPOPULATION; MACROPHAGES	Background: Tuberculosis is a mycobacterial infection causing worldwide public health problems but the available vaccine is far from ideal. Type-1 T cell immunity has been shown to be critical for host defence against tuberculosis infection, but the role of dendritic cell (DC) subsets in pathogenesis of mycobacterial infection remains unclear. Methodology/Principal Findings: We examined the effectiveness of dendritic cell (DC) subsets in BCG-infected mice in generating immune responses beneficial for pathogen clearance and reduction of pathological reactions in the tissues following challenge infection. Our data showed that only the adoptive transfer of the subset of CD8 alpha(+) DC isolated from infected mice (iCD8(+) DC) generated significant protection, demonstrated by less mycobacterial growth and pathological changes in the lung and liver tissues in iCD8(+) DC recipients than sham-treated control mice. The adoptive transfer of the CD8 alpha-DC from the infected mice (iCD8(-) DC) not only failed to reduce bacterial growth, but enhanced inflammation characterized by diffuse heavy cellular infiltration. Notably, iCD8(-)DC produced significantly higher levels of IL-10 than iCD8(+) DC and promoted more Th2 cytokine responses in in vitro DC-T cell co-culture and in vivo adoptive transfer experiments. Conclusions/Significance: The data indicate that in vivo BCG-primed CD8(+)DC is the dominant DC subset in inducing protective immunity especially for reducing pathological reactions in infected tissues. The finding has implications for the rational improvement of the prophylactic and therapeutic approaches for controlling tuberculosis infection and related diseases.	[Gao, Xiaoling; Wang, Shuhe; Fan, Yijun; Bai, Hong; Yang, Jie; Yang, Xi] Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Infect & Immun, Winnipeg, MB, Canada; [Bai, Hong; Yang, Xi] Tianjin Med Univ, Dept Immunol, Tianjin, Peoples R China	University of Manitoba; Tianjin Medical University	Gao, XL (corresponding author), Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Infect & Immun, Winnipeg, MB, Canada.	yangxi@cc.umanitoba.ca	Gao, xiao ling/GQI-2790-2022	Yang, Xi/0000-0002-8831-7488	Canadian Institutes of Health Research (CIHR) [MT16480]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR) to X. Y. (MT16480). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SS, 1999, J IMMUNOL, V163, P3890; Bajana S, 2007, IMMUNOLOGY, V122, P381, DOI 10.1111/j.1365-2567.2007.02650.x; Bilenki L, 2006, J IMMUNOL, V177, P7067, DOI 10.4049/jimmunol.177.10.7067; Britton WJ, 2003, IMMUNOL CELL BIOL, V81, P34, DOI 10.1046/j.0818-9641.2002.01143.x; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Demangel C, 1999, EUR J IMMUNOL, V29, P1972, DOI 10.1002/(SICI)1521-4141(199906)29:06<1972::AID-IMMU1972>3.0.CO;2-1; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gonzalez-Juarrero M, 2002, CELL IMMUNOL, V220, P13, DOI 10.1016/S0008-8749(03)00010-8; Grohmann U, 2003, J IMMUNOL, V171, P2581, DOI 10.4049/jimmunol.171.5.2581; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Joyee AG, 2008, AM J RESP CRIT CARE, V178, P745, DOI 10.1164/rccm.200804-517OC; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kamijo R, 1994, Hokkaido Igaku Zasshi, V69, P1332; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Lagranderie M, 2003, IMMUNOLOGY, V108, P352, DOI 10.1046/j.1365-2567.2003.01609.x; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Mahnke K, 2005, CURR TOP MICROBIOL, V293, P133, DOI 10.1007/3-540-27702-1_7; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Maldonado-Lopez R, 2001, J IMMUNOL, V167, P4345, DOI 10.4049/jimmunol.167.8.4345; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Mitchison DA, 2005, EUR RESPIR J, V25, P376, DOI 10.1183/09031936.05.00075704; North RJ, 1998, CLIN EXP IMMUNOL, V113, P55, DOI 10.1046/j.1365-2249.1998.00636.x; Orme IA, 2005, MICROBES INFECT, V7, P905, DOI 10.1016/j.micinf.2005.03.008; Peinnequin Andre, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-3; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Pulendran B, 1997, J IMMUNOL, V159, P2222; Pulendran B, 2008, CURR OPIN IMMUNOL, V20, P61, DOI 10.1016/j.coi.2007.10.009; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Walls T, 2007, ARCH DIS CHILD, V92, P726, DOI 10.1136/adc.2006.102889; World Health Organization, 2004, TB HIV CLIN MAN, V2nd	39	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9281	10.1371/journal.pone.0009281	http://dx.doi.org/10.1371/journal.pone.0009281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174628	Green Submitted, Green Published, gold			2022-12-25	WOS:000274654700015
J	Sverrisdottir, YB; Jansson, LM; Hagg, U; Gan, LM				Sverrisdottir, Yrsa Bergmann; Jansson, Linda Marie; Hagg, Ulrika; Gan, Li-Ming			Muscle Sympathetic Nerve Activity Is Related to a Surrogate Marker of Endothelial Function in Healthy Individuals	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; CORONARY-ARTERY-DISEASE; NITRIC-OXIDE; HEART-FAILURE; NORADRENALINE SPILLOVER; ESSENTIAL-HYPERTENSION; VASCULAR-TONE; EXERCISE; HUMANS; REST	Background: Evidence from animal studies indicates the importance of an interaction between the sympathetic nervous system and the endothelium for cardiovascular regulation. However the interaction between these two systems remains largely unexplored in humans. The aim of this study was to investigate whether directly recorded sympathetic vasoconstrictor outflow is related to a surrogate marker of endothelial function in healthy individuals. Methods and Results: In 10 healthy normotensive subjects (3 f/7 m), (age 37+/-11 yrs), (BMI 24+/-3 kg/m(2)) direct recordings of sympathetic action potentials to the muscle vascular bed (MSNA) were performed and endothelial function estimated with the Reactive Hyperaemia-Peripheral Arterial Tonometry (RH-PAT) technique. Blood samples were taken and time spent on leisure-time physical activities was estimated. In all subjects the rate between resting flow and the maximum flow, the Reactive Hyperemic index (RH-PAT index), was within the normal range (1,9 -3,3) and MSNA was as expected for age and gender (13-44 burst/minute). RH-PAT index was inversely related to MSNA (r = -0.8, p = 0.005). RH-PAT index and MSNA were reciprocally related to time (h/week) spent on physical activity (p = 0.005 and p = 0.006 respectively) and platelet concentration (PLT) (p = 0.02 and p = 0.004 respectively). Conclusions: Our results show that sympathetic nerve activity is related to a surrogate marker of endothelial function in healthy normotensive individuals, indicating that sympathetic outflow may be modulated by changes in endothelial function. In this study time spent on physical activity is identified as a predictor of sympathetic nerve activity and endothelial function in a group of healthy individuals. The results are of importance in understanding mechanisms underlying sympathetic activation in conditions associated with endothelial dysfunction and emphasise the importance of a daily exercise routine for maintenance of cardiovascular health.	[Sverrisdottir, Yrsa Bergmann; Jansson, Linda Marie; Hagg, Ulrika; Gan, Li-Ming] Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Sverrisdottir, YB (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	yrsa.sverrisdottir@neuro.gu.se			Swedish Medical Research Council [15105-01A]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This study was supported by grants from the Swedish Medical Research Council (Project No. 15105-01A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boger R H, 1999, J Endocrinol Invest, V22, P75; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; Bonetti PO, 2003, J AM COLL CARDIOL, V41, P1761, DOI 10.1016/S0735-1097(03)00329-2; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Elherik K, 2002, CLIN SCI, V102, P547, DOI 10.1042/CS20010278; Esler M, 2000, J CARDIOVASC PHARM, V35, pS1, DOI 10.1097/00005344-200000004-00001; Fagius J, 1993, Clin Auton Res, V3, P201; FitzGerald SP, 2005, CLIN CHEM, V51, P1165, DOI 10.1373/clinchem.2005.049429; Forte P, 1998, HYPERTENSION, V32, P730, DOI 10.1161/01.HYP.32.4.730; Fraga R, 2007, EUR J HEART FAIL, V9, P630, DOI 10.1016/j.ejheart.2007.03.003; Franzoni F, 2004, CLIN SCI, V106, P329, DOI 10.1042/CS20030229; Fukai T, 2000, J CLIN INVEST, V105, P1631, DOI 10.1172/JCI9551; Gao L, 2004, CIRC RES, V95, P937, DOI 10.1161/01.RES.0000146676.04359.64; Gao L, 2007, CIRCULATION, V115, P3095, DOI 10.1161/CIRCULATIONAHA.106.677989; GRASSI G, 1994, HYPERTENSION, V23, P294, DOI 10.1161/01.HYP.23.3.294; Hagg U, 2005, AM J PHYSIOL-HEART C, V289, pH1627, DOI 10.1152/ajpheart.00135.2005; Haller MJ, 2007, PEDIATR DIABETES, V8, P193, DOI 10.1111/j.1399-5448.2007.00246.x; Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702; HARADA S, 1993, CIRC RES, V72, P511, DOI 10.1161/01.RES.72.3.511; Hedblad B, 2001, CIRCULATION, V103, P1721, DOI 10.1161/01.CIR.103.13.1721; Hijmering ML, 2002, J AM COLL CARDIOL, V39, P683, DOI 10.1016/S0735-1097(01)01786-7; KAYE DM, 1994, J AM COLL CARDIOL, V23, P570, DOI 10.1016/0735-1097(94)90738-2; Kingwell BA, 2000, FASEB J, V14, P1685, DOI 10.1096/fj.99-0896rev; Kojda G, 1999, CARDIOVASC RES, V43, P562, DOI 10.1016/S0008-6363(99)00169-8; KUBO SH, 1991, CIRCULATION, V84, P1589, DOI 10.1161/01.CIR.84.4.1589; Lowenstein L, 2007, EUR J OBSTET GYN R B, V134, P208, DOI 10.1016/j.ejogrb.2007.02.011; Marsh SA, 2005, INT J CARDIOL, V99, P165, DOI 10.1016/j.ijcard.2004.02.005; MORRIS JN, 1980, LANCET, V2, P1207; NG AV, 1993, HYPERTENSION, V21, P498, DOI 10.1161/01.HYP.21.4.498; Nohria A, 2006, J APPL PHYSIOL, V101, P545, DOI 10.1152/japplphysiol.01285.2005; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003; Otto ME, 2004, CIRCULATION, V109, P2507, DOI 10.1161/01.CIR.0000128207.26863.C4; Owlya R, 1997, CIRCULATION, V96, P3897; Panza JA, 1997, CLIN CARDIOL, V20, P26; PARATI G, 1989, HYPERTENSION, V13, P647, DOI 10.1161/01.HYP.13.6.647; Ray CA, 1998, MED SCI SPORT EXER, V30, P387, DOI 10.1097/00005768-199803000-00008; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sartori C, 2005, PHARMACOL THERAPEUT, V106, P209, DOI 10.1016/j.pharmthera.2004.11.009; SOMERS VK, 1993, NEW ENGL J MED, V328, P303, DOI 10.1056/NEJM199302043280502; Stener-Victorin E, 2009, AM J PHYSIOL-REG I, V297, pR387, DOI 10.1152/ajpregu.00197.2009; Sverrisdottir YB, 2003, J HYPERTENS, V21, P1905, DOI 10.1097/01.hjh.0000084757.37215.55; Sverrisdottir YB, 1998, J CLIN ENDOCR METAB, V83, P1881, DOI 10.1210/jc.83.6.1881; Sverrisdottir YB, 2001, J HYPERTENS, V19, P2019, DOI 10.1097/00004872-200111000-00012; SVERRISDOTTIR YB, 2008, AM J PHYSIOL-ENDOC M; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; TSUKAHARA H, 1994, KIDNEY INT, V45, P598, DOI 10.1038/ki.1994.78; VALLBO AB, 1979, PHYSIOL REV, V59, P919, DOI 10.1152/physrev.1979.59.4.919; Wallin BG, 2007, MUSCLE NERVE, V36, P595, DOI 10.1002/mus.20831; Wallin BG, 1996, J PHYSIOL-LONDON, V491, P881, DOI 10.1113/jphysiol.1996.sp021265; WALLIN BG, 1992, J PHYSIOL-LONDON, V453, P45, DOI 10.1113/jphysiol.1992.sp019217; ZANZINGER J, 1994, CIRC RES, V75, P1073, DOI 10.1161/01.RES.75.6.1073; Zoppini G, 2007, DIABETIC MED, V24, P370, DOI 10.1111/j.1464-5491.2007.02076.x	52	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9257	10.1371/journal.pone.0009257	http://dx.doi.org/10.1371/journal.pone.0009257			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174639	Green Published, Green Submitted, gold			2022-12-25	WOS:000274590600014
J	Daniau, AL; d'Errico, F; Goni, MFS				Daniau, Anne-Laure; d'Errico, Francesco; Goni, Maria Fernanda Sanchez			Testing the Hypothesis of Fire Use for Ecosystem Management by Neanderthal and Upper Palaeolithic Modern Human Populations	PLOS ONE			English	Article							SCALE CLIMATIC VARIABILITY; MODERN HUMAN ORIGINS; PLANKTONIC-FORAMINIFERA; HUMAN OCCUPATIONS; ORGANIC-MATTER; FOREST-FIRES; BLACK CARBON; HUMAN IMPACT; ARNHEM-LAND; 000 YR	Background: It has been proposed that a greater control and more extensive use of fire was one of the behavioral innovations that emerged in Africa among early Modern Humans, favouring their spread throughout the world and determining their eventual evolutionary success. We would expect, if extensive fire use for ecosystem management were a component of the modern human technical and cognitive package, as suggested for Australia, to find major disturbances in the natural biomass burning variability associated with the colonisation of Europe by Modern Humans. Methodology/Principal Findings: Analyses of microcharcoal preserved in two deep-sea cores located off Iberia and France were used to reconstruct changes in biomass burning between 70 and 10 kyr cal BP. Results indicate that fire regime follows the Dansgaard-Oeschger climatic variability and its impacts on fuel load. No major disturbance in natural fire regime variability is observed at the time of the arrival of Modern Humans in Europe or during the remainder of the Upper Palaeolithic (40-10 kyr cal BP). Conclusions/Significance: Results indicate that either Neanderthals and Modern humans did not influence fire regime or that, if they did, their respective influence was comparable at a regional scale, and not as pronounced as that observed in the biomass burning history of Southeast Asia.	[Daniau, Anne-Laure; Goni, Maria Fernanda Sanchez] Univ Bordeaux 1, EPHE, CNRS, EPOC,UMR5805, F-33405 Talence, France; [Daniau, Anne-Laure; d'Errico, Francesco] Univ Bordeaux 1, CNRS, UMR5199, PACEA, F-33405 Talence, France; [d'Errico, Francesco] Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of Witwatersrand	Daniau, AL (corresponding author), Univ Bordeaux 1, EPHE, CNRS, EPOC,UMR5805, F-33405 Talence, France.	al.daniau@bristol.ac.uk	DANIAU, Anne-Laure/O-2379-2017; Goñi, Maria Fernanda Sanchez/R-3699-2019	DANIAU, Anne-Laure/0000-0002-1621-3911; Goñi, Maria Fernanda Sanchez/0000-0001-8238-7488	RESOLuTION (ESF-Eurocores-Euroclimate); OMLL (ESF-Eurocores); ARTEMIS programmes [20040206003N]	RESOLuTION (ESF-Eurocores-Euroclimate)(European Science Foundation (ESF)); OMLL (ESF-Eurocores); ARTEMIS programmes	The work of A.-L. Daniau was funded by a BDI-CNRS- Region Aquitaine fellowship. This study was supported by the RESOLuTION (ESF-Eurocores-Euroclimate), the OMLL (ESF-Eurocores) and ARTEMIS programmes, Region Aquitaine project 20040206003N and the Universite Bordeaux1 BQR/RAMSEMAR (Reconnaissance Automatique des Micro-objets contenus dans les SEdiments MARins)/project 2003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Anderson MK, 1999, HUM ECOL, V27, P79, DOI 10.1023/A:1018757317568; [Anonymous], 1994, PALYNOLOGY SEDIMENTA; [Anonymous], 1977, PREHISTOIRE FEU; [Anonymous], 1994, SEDIMENTATION ORGANI, DOI DOI 10.1017/CBO9780511524875.018; [Anonymous], 1994, SEDIMENTATION ORGANI; Baena Preysler J., 2005, MONOGRAFIAS MUSEO NA, V20, P461; Bailey SE, 2006, J HUM EVOL, V50, P485, DOI 10.1016/j.jhevol.2005.11.008; Banks WE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003972; Bard E, 2004, QUATERNARY RES, V61, P204, DOI 10.1016/j.yqres.2003.11.006; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Beaufort L, 2003, MAR GEOL, V201, P53, DOI 10.1016/S0025-3227(03)00208-1; Bird RB, 2008, P NATL ACAD SCI USA, V105, P14796, DOI 10.1073/pnas.0804757105; Bocquet-Appel JP, 2005, J ARCHAEOL SCI, V32, P1656, DOI 10.1016/j.jas.2005.05.006; BON F, 2006, DEFINITION AURIGNACI, P133; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bos JAA, 2003, VEG HIST ARCHAEOBOT, V12, P19, DOI 10.1007/s00334-003-0006-7; Bowman DMJS, 1998, NEW PHYTOL, V140, P385, DOI [10.1046/j.1469-8137.1998.00289.x, 10.1111/j.1469-8137.1998.00289.x]; Bowman DMJS, 2004, J BIOGEOGR, V31, P207, DOI 10.1046/j.0305-0270.2003.00997.x; BRADSHAW RHW, 1997, SEDIMENT RECORDS BIO, P341; BRAIN CK, 1988, NATURE, V336, P464, DOI 10.1038/336464a0; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; BURROWS ND, 2006, BUSHF C 2006 LIF FIR, P1; Caldararo N, 2002, SCI TOTAL ENVIRON, V292, P141, DOI 10.1016/S0048-9697(01)01067-1; Carcaillet C, 2001, J ECOL, V89, P930, DOI 10.1111/j.1365-2745.2001.00614.x; Carcaillet C, 1998, J ECOL, V86, P384, DOI 10.1046/j.1365-2745.1998.00267.x; Carmona-Moreno C, 2005, GLOBAL CHANGE BIOL, V11, P1537, DOI 10.1111/j.1365-2486.2005.01003.x; Cayre O, 1999, PALEOCEANOGRAPHY, V14, P384, DOI 10.1029/1998PA900027; Chmura GL, 1999, PALAEOGEOGR PALAEOCL, V149, P257, DOI 10.1016/S0031-0182(98)00205-3; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; Clark JD, 1985, AFR ARCHAEOL REV, V3, P3, DOI DOI 10.1007/BF01117453; Clark JS, 1996, HOLOCENE, V6, P129, DOI 10.1177/095968369600600201; d'Errico F, 2003, QUATERNARY SCI REV, V22, P769, DOI 10.1016/S0277-3791(03)00009-X; Daniau AL, 2007, QUATERNARY SCI REV, V26, P1369, DOI 10.1016/j.quascirev.2007.02.005; Daniau AL, 2009, QUATERNARY RES, V71, P385, DOI 10.1016/j.yqres.2009.01.007; Delcourt HR, 1997, CONSERV BIOL, V11, P1010, DOI 10.1046/j.1523-1739.1997.96338.x; Dodson JR, 2005, AUSTRAL ECOL, V30, P592, DOI 10.1111/j.1442-9993.2005.01490.x; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Goni MFS, 2008, QUATERNARY SCI REV, V27, P1136, DOI 10.1016/j.quascirev.2008.03.003; Goni MFS, 2000, QUATERNARY RES, V54, P394, DOI 10.1006/qres.2000.2176; Goren-Inbar N, 2004, SCIENCE, V304, P725, DOI 10.1126/science.1095443; Gravina B, 2005, NATURE, V438, P51, DOI 10.1038/nature04006; GRIFFIN JJ, 1975, LIMNOL OCEANOGR, V20, P456, DOI 10.4319/lo.1975.20.3.0456; Grunberg JM, 2002, ANTIQUITY, V76, P15, DOI 10.1017/S0003598X00089638; Hill R, 2003, HUM ECOL, V31, P27, DOI 10.1023/A:1022830123349; Hockaday WC, 2006, ORG GEOCHEM, V37, P501, DOI 10.1016/j.orggeochem.2005.11.003; HOOGHIEMSTRA H, 1992, REV PALAEOBOT PALYNO, V74, P1, DOI 10.1016/0034-6667(92)90137-6; Hu F. S., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P829, DOI 10.1007/s11027-005-9015-4; Hublin JJ, 2007, RETHINKING HUMAN REV, P235; Hughen KA, 2004, RADIOCARBON, V46, P1059, DOI 10.1017/S0033822200033002; Hunt CO, 2007, J ARCHAEOL SCI, V34, P1953, DOI 10.1016/j.jas.2007.02.023; JAMES SR, 1989, CURR ANTHROPOL, V30, P1, DOI 10.1086/203705; Johnson BJ, 1999, SCIENCE, V284, P1150, DOI 10.1126/science.284.5417.1150; JONES TP, 1997, SEDIMENT RECORDS BIO, P9; Jouanneau JM, 1998, PROG OCEANOGR, V42, P233, DOI 10.1016/S0079-6611(98)00036-6; Jouanneau JM, 1999, DEEP-SEA RES PT II, V46, P2205, DOI 10.1016/S0967-0645(99)00060-0; Karkanas P, 2007, J HUM EVOL, V53, P197, DOI 10.1016/j.jhevol.2007.04.002; Kershaw A. P., 2002, Flammable Australia: the fire regimes and biodiversity of a continent, punknown; Kershaw P, 2003, FRESHWATER BIOL, V48, P1274, DOI 10.1046/j.1365-2427.2003.01085.x; Koller J., 2001, EUR J ARCHAEOL, V4, P385, DOI DOI 10.3346/jkms.2014.29.12.1597; Lebel S, 2001, P NATL ACAD SCI USA, V98, P11097, DOI 10.1073/pnas.181353998; Lezine AM, 1997, GEOLOGY, V25, P119, DOI 10.1130/0091-7613(1997)025<0119:EACITE>2.3.CO;2; MAGRI D, 1994, REV PALAEOBOT PALYNO, V81, P313, DOI 10.1016/0034-6667(94)90115-5; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; Marshall AG, 2006, J QUATERNARY SCI, V21, P789, DOI 10.1002/jqs.1063; Mason SLR, 2000, PALAEOGEOGR PALAEOCL, V164, P139, DOI 10.1016/S0031-0182(00)00181-4; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Meignen L, 2000, EXEMPLE PROCHE ORIEN, V26, P9; Mellars P, 1999, CURR ANTHROPOL, V40, P341, DOI 10.1086/200024; Meyn A, 2007, PROG PHYS GEOG, V31, P287, DOI 10.1177/0309133307079365; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; Miller GH, 2005, SCIENCE, V309, P287, DOI 10.1126/science.1111288; Millspaugh SH, 2000, GEOLOGY, V28, P211, DOI 10.1130/0091-7613(2000)28<211:VIFFAC>2.0.CO;2; MORENO E, 2000, PROPRIETES MAGNETIQU; Movius HL, 1950, SOUTHWEST J ANTHROP, V6, P139, DOI 10.1086/soutjanth.6.2.3628638; Nichols GJ, 2000, PALAEOGEOGR PALAEOCL, V164, P43, DOI 10.1016/S0031-0182(00)00174-7; Pailler D, 2002, PALAEOGEOGR PALAEOCL, V181, P431, DOI 10.1016/S0031-0182(01)00444-8; Palmer TY., 1975, FIRE TECHNOL, V11, P111, DOI [10.1007/BF02589941, DOI 10.1007/BF02589941]; Pereira MG, 2005, AGR FOREST METEOROL, V129, P11, DOI 10.1016/j.agrformet.2004.12.007; Perez B, 2003, FOREST ECOL MANAG, V182, P273, DOI 10.1016/S0378-1127(03)00069-0; Polunin O., 1985, GUIDE VEGETATION BRI, P320; Quenea K, 2006, ORG GEOCHEM, V37, P1185, DOI 10.1016/j.orggeochem.2006.05.010; RussellSmith J, 1997, HUM ECOL, V25, P159, DOI 10.1023/A:1021970021670; Sanchez-Goni MF, 2006, QUATERNAIRE, V17, P3; Sanchezgoni MF, 2002, CLIM DYNAM, V19, P95, DOI 10.1007/s00382-001-0212-x; Sepulchre P, 2007, EARTH PLANET SC LETT, V258, P283, DOI 10.1016/j.epsl.2007.03.041; Shackleton NJ, 2004, QUATERNARY SCI REV, V23, P1513, DOI 10.1016/j.quascirev.2004.03.006; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; SHACKLETON NJ, 2000, IGBP PAGES WORLD DAT; Simmons IG, 1996, J ARCHAEOL SCI, V23, P193, DOI 10.1006/jasc.1996.0017; Singh G., 1981, FIRE AUSTR BIOTA, P23; Smith E. F., 1972, Proceedings, Annual Tall Timbers Fire Ecology Conference, P9; Smith FH, 2005, QUATERN INT, V137, P7, DOI 10.1016/j.quaint.2004.11.016; Stevenson J, 2005, QUATERNARY RES, V64, P372, DOI 10.1016/j.yqres.2005.08.011; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Teichmuller M., 1982, 1982 COAL PETROLOGY, P5; THERYPARISOT I, 1998, EC COMBUSTIBLE PALEO; Thevenon F, 2004, PALAEOGEOGR PALAEOCL, V213, P83, DOI 10.1016/j.palaeo.2004.07.003; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Thouveny N, 2000, EARTH PLANET SC LETT, V180, P61, DOI 10.1016/S0012-821X(00)00155-2; TOSCANO LGV, 1990, PALEOLITHIQUE MOYEN, P169; Trinkaus E, 2007, P NATL ACAD SCI USA, V104, P7367, DOI 10.1073/pnas.0702214104; Turney CSM, 2001, J QUATERNARY SCI, V16, P767, DOI 10.1002/jqs.643; Vallverdu J, 2005, J HUM EVOL, V48, P157, DOI 10.1016/j.jhevol.2004.10.004; Vaquero M., 2006, NEANDERTHALS MODERN, P419; Verardo DJ, 1997, LIMNOL OCEANOGR, V42, P192, DOI 10.4319/lo.1997.42.1.0192; WALSH PM, 1997, FUEL EN ABSTR, V38, P172; Whitlock C, 2004, DEV QUA SCI, V1, P479; Whitlock C, 1996, HOLOCENE, V6, P7, DOI 10.1177/095968369600600102; Whitlock Cathy, 2001, Biology and Environment, V101B, P65; WILLIAMS GW, 2002, WILDERNESS POLITICAL; WYNN T, 2004, J HUMAN EVOLUTION, V46; WYNN T, 2003, FARMING, V2, P1; Wynn T, 2008, AM SCI, V96, P44, DOI 10.1511/2008.69.44; Zilhao J, 1999, J WORLD PREHIST, V13, P1, DOI 10.1023/A:1022348410845; ZILHAO J, 2006, J W MEDITERRANEAN PR, V1, P7; Zilhao J, 2003, TRABALHOS ARQUEOLOGI, P313, DOI DOI 10.1007/S10814-006-9008-1; Zilhao J, 2006, EVOL ANTHROPOL, V15, P183, DOI 10.1002/evan.20110; Zilhao J, 2006, P NATL ACAD SCI USA, V103, P12643, DOI 10.1073/pnas.0605128103	119	42	43	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9157	10.1371/journal.pone.0009157	http://dx.doi.org/10.1371/journal.pone.0009157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554NX	20161786	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442800004
J	Niino, Y; Hotta, K; Oka, K				Niino, Yusuke; Hotta, Kohji; Oka, Kotaro			Blue Fluorescent cGMP Sensor for Multiparameter Fluorescence Imaging	PLOS ONE			English	Article							CYCLIC-AMP; PROTEIN; FRET; BIOSENSORS; EVENTS; CELLS; PAIRS; CAMP; CA2+	Cyclic GMP (cGMP) regulates many physiological processes by cooperating with the other signaling molecules such as cyclic AMP (cAMP) and Ca(2+). Genetically encoded sensors for cGMP have been developed based on fluorescence resonance energy transfer (FRET) between fluorescent proteins. However, to analyze the dynamic relationship among these second messengers, combined use of existing sensors in a single cell is inadequate because of the significant spectral overlaps. A single wavelength indicator is an effective alternative to avoid this problem, but color variants of a single fluorescent protein-based biosensor are limited. In this study, to construct a new color fluorescent sensor, we converted the FRET-based sensor into a single wavelength indicator using a dark FRET acceptor. We developed a blue fluorescent cGMP biosensor, which is spectrally compatible with a FRET-based cAMP sensor using cyan and yellow fluorescent proteins (CFP/YFP). We cotransfected them and loaded a red fluorescent probe for Ca(2+) into cells, and accomplished triple-parameter fluorescence imaging of these cyclic nucleotides and Ca(2+), confirming the applicability of this combination to individually monitor their dynamics in a single cell. This blue fluorescent sensor and the approach using this FRET pair would be useful for multiparameter fluorescence imaging to understand complex signal transduction networks.	[Niino, Yusuke; Hotta, Kohji; Oka, Kotaro] Keio Univ, Ctr Biosci & Informat, Sch Fundamental Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 223, Japan	Keio University	Niino, Y (corresponding author), Keio Univ, Ctr Biosci & Informat, Sch Fundamental Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 223, Japan.	niino@bpni.bio.keio.ac.jp; oka@bio.keio.ac.jp	Oka, Kotaro/C-4918-2014; Hotta, Kohji/D-1162-2014	Hotta, Kohji/0000-0003-4614-7473	Japan Ministry of Education, Culture, Sports, Science and Technology [21300112]; Nakatani Foundation of Electronic Measuring Technology Advancement; The Naito Foundation	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakatani Foundation of Electronic Measuring Technology Advancement; The Naito Foundation	This work was supported in part by Grants-in-Aid for Scientific Research 21300112 from the Japan Ministry of Education, Culture, Sports, Science and Technology, by Nakatani Foundation of Electronic Measuring Technology Advancement and by The Naito Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Canossa M, 2002, P NATL ACAD SCI USA, V99, P3282, DOI 10.1073/pnas.042504299; Carlson HJ, 2009, CURR OPIN BIOTECH, V20, P19, DOI 10.1016/j.copbio.2009.01.003; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; GATTI G, 1988, BIOCHEM J, V255, P753, DOI 10.1042/bj2550753; Grant DM, 2008, BIOPHYS J, V95, pL69, DOI 10.1529/biophysj.108.139204; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Niino Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006036; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Pelligrino DA, 1998, PROG NEUROBIOL, V56, P1, DOI 10.1016/S0301-0082(98)00009-4; Piljic A, 2008, ACS CHEM BIOL, V3, P156, DOI 10.1021/cb700247q; Schultz C, 2005, CHEMBIOCHEM, V6, P1323, DOI 10.1002/cbic.200500012; Souslova EA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P683, DOI 10.1134/S0006297907070012; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Tomosugi W, 2009, NAT METHODS, V6, P351, DOI [10.1038/NMETH.1317, 10.1038/nmeth.1317]; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501	24	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9164	10.1371/journal.pone.0009164	http://dx.doi.org/10.1371/journal.pone.0009164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161796	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442800010
J	Zughaier, S; Karna, P; Stephens, D; Aneja, R				Zughaier, Susu; Karna, Prasanthi; Stephens, David; Aneja, Ritu			Potent Anti-Inflammatory Activity of Novel Microtubule-Modulating Brominated Noscapine Analogs	PLOS ONE			English	Article							CANCER-CELLS; UNDERGO APOPTOSIS; IMMUNE-RESPONSES; PERTURB MITOSIS; BREAST-CANCER; AUTOPHAGY; AGENT; MACROPHAGES; BINDING; INNATE	Noscapine, a plant-derived, non-toxic, over-the-counter antitussive alkaloid has tubulin-binding properties. Based upon the structural resemblance of noscapine to colchicine, a tubulin-binding anti-inflammatory drug, noscapine and its semisynthetic brominated analogs were examined for in vitro anti-inflammatory activity. Brominated noscapine analogs were found to inhibit cytokine and chemokine release from macrophage cell lines but did not affect cell viability. Brominated noscapine analogs demonstrated anti-inflammatory properties in both TLR- and non-TLR induced in vitro innate immune pathway inflammation models, mimicking septic and sterile infection respectively. In addition, electron microscopy and immunoblotting data indicated that these analogs induced robust autophagy in human macrophages. This study is the first report to identify brominated noscapines as innate immune pathway anti-inflammatory molecules.	[Zughaier, Susu; Stephens, David] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA; [Karna, Prasanthi; Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA USA	Emory University; University System of Georgia; Georgia State University	Zughaier, S (corresponding author), Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA.	szughai@emory.edu; raneja@gsu.edu	Zughaier, Susu/GLQ-9288-2022; Zughaier, Susu/N-3185-2019	Zughaier, Susu/0000-0001-7487-8770	Department of Defense [PC073104]; National Cancer Institute [K99 CA131489]; NIH [R01 AI033517]; NATIONAL CANCER INSTITUTE [K99CA131489, R00CA131489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033517] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants to RA from the Department of Defense (PC073104), and National Cancer Institute (K99 CA131489); and to DS from NIH (R01 AI033517). SZ, DS and RA acknowledge financial support from Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja R, 2006, CANCER RES, V66, P3782, DOI 10.1158/0008-5472.CAN-05-2962; Aneja R, 2006, BLOOD, V107, P2486, DOI 10.1182/blood-2005-08-3516; ANEJA R, 2009, INT J CANC; Aneja R, 2008, CANCER RES, V68, P1495, DOI 10.1158/0008-5472.CAN-07-1874; Aneja R, 2007, MOL CANCER THER, V6, P2891, DOI 10.1158/1535-7163.MCT-07-0359; Aneja R, 2007, CANCER CHEMOTH PHARM, V60, P831, DOI 10.1007/s00280-007-0430-y; Aneja R, 2006, BIOCHEM PHARMACOL, V72, P415, DOI 10.1016/j.bcp.2006.05.004; Aneja R, 2006, MOL CANCER THER, V5, P2366, DOI 10.1158/1535-7163.MCT-06-0205; AZAD MB, 2008, ANTIOXID REDOX SIGNA; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; DING AH, 1990, J EXP MED, V171, P715, DOI 10.1084/jem.171.3.715; Heidemann S, 2006, BLOOD, V107, P2216, DOI 10.1182/blood-2005-12-5142; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Jayaprakash Vikram, 2007, N Z Med J, V120, pU2402; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kakkar P, 2007, MOL CELL BIOCHEM, V305, P235, DOI 10.1007/s11010-007-9520-8; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Ke Y, 2000, CANCER IMMUNOL IMMUN, V49, P217, DOI 10.1007/s002620000109; Landen JW, 2002, CANCER RES, V62, P4109; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Oh SH, 2008, AUTOPHAGY, V4, P1009, DOI 10.4161/auto.6886; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PRISE KM, 1986, BIOCHIM BIOPHYS ACTA, V887, P13, DOI 10.1016/0167-4889(86)90116-3; ROWINSKY E K, 1991, Current Opinion in Oncology, V3, P1060, DOI 10.1097/00001622-199112000-00015; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Zhou J, 2005, CANCER CHEMOTH PHARM, V55, P461, DOI 10.1007/s00280-004-0903-1; Zhou J, 2003, MOL PHARMACOL, V63, P799, DOI 10.1124/mol.63.4.799; Zimmer SM, 2008, J BIOL CHEM, V283, P27916, DOI 10.1074/jbc.M802826200; Zughaier SM, 2005, CELL MICROBIOL, V7, P1251, DOI 10.1111/j.1462-5822.2005.00549.x; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; Zughaier SM, 1999, INFECT IMMUN, V67, P908, DOI 10.1128/IAI.67.2.908-913.1999; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	36	36	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9165	10.1371/journal.pone.0009165	http://dx.doi.org/10.1371/journal.pone.0009165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161797	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442800011
J	Erridge, C; Duncan, SH; Bereswill, S; Heimesaat, MM				Erridge, Clett; Duncan, Sylvia H.; Bereswill, Stefan; Heimesaat, Markus M.			The Induction of Colitis and Ileitis in Mice Is Associated with Marked Increases in Intestinal Concentrations of Stimulants of TLRs 2, 4, and 5	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; CROHNS-DISEASE; ESCHERICHIA-COLI; IMMUNE-RESPONSE; BACTERIAL FLAGELLIN; MUCOSAL FLORA; CPG MOTIFS; LIPOPOLYSACCHARIDE; LIGANDS	Background: Inflammatory bowel diseases (IBDs) appear to be modulated by the interaction of pathogen-associated molecular patterns (PAMPs) derived from intestinal bacteria with their respective innate immune receptors, including Toll-like receptors (TLRs). We aimed to establish if intestinal concentrations of proinflammatory bacterial ligands of TLR2, TLR4, or TLR5 may be altered in murine IBD models, and to characterize which of the major bacterial groups may contribute to each signal. Methodology/Principal Findings: PAMPs specific for TLR2 (lipopeptide equivalents), TLR4 (lipopolysaccharide equivalents), and TLR5 (flagellin equivalents) in human and murine fecal and intestinal samples were quantified using HEK-293 cells transfected with respective TLRs and calibrated with defined standard PAMPs. The induction of colitis in mice by dextran-sodium-sulphate treatment significantly increased colonic lipopeptide (fourfold) and LPS equivalent (550-fold) concentrations, while flagellin equivalent concentrations remained similar. The induction of ileitis by oral infection with Toxoplasma gondii dramatically increased ileal concentrations of lipopeptide (370-fold), LPS (3,300-fold), and flagellin equivalents (38-fold), all P < 0.01. Analysis of representative strains of the major bacterial groups of the human intestine revealed that enterobacterial species are likely to be more significant contributors of soluble TLR2 and TLR4 stimulants to the intestinal milieu than Bacteroides species or Gram-positive Firmicutes. Conclusions/Significance: We conclude that the induction of colitis or ileitis in mice is associated with significant disease-specific alterations to the PAMP profile of the gut microbiota.	[Erridge, Clett] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Duncan, Sylvia H.] Rowett Inst Nutr & Hlth, Microbial Ecol Grp, Aberdeen, Scotland; [Bereswill, Stefan; Heimesaat, Markus M.] Charite, Inst Mikrobiol & Hyg, D-13353 Berlin, Germany	University of Leicester; University of Aberdeen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Erridge, C (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	ce55@le.ac.uk		Duncan, Sylvia/0000-0002-4903-0978; Heimesaat, Markus/0000-0001-6399-651X; Erridge, Clett/0000-0003-2978-346X	Leicester University College of Medicine Fellowship; Scottish Government Rural and Environment Research and Analysis Directorate; German Research Foundation [DFG; SFB633, TP A7, DFG; SFB633, TP B6]	Leicester University College of Medicine Fellowship; Scottish Government Rural and Environment Research and Analysis Directorate; German Research Foundation(German Research Foundation (DFG))	This study was supported by a Leicester University College of Medicine Fellowship awarded to CE. The Rowett Institute receives financial support from the Scottish Government Rural and Environment Research and Analysis Directorate. S. B. and M. M. H. were supported by grants from the German Research Foundation (DFG; SFB633, TP A7 and DFG; SFB633, TP B6, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Deininger S, 2003, J IMMUNOL, V170, P4134, DOI 10.4049/jimmunol.170.8.4134; DELAHOOKE D, 1996, INFECT IMMUN, V63, P840; Dionne S, 2003, CLIN EXP IMMUNOL, V133, P108, DOI 10.1046/j.1365-2249.2003.02191.x; Erridge C, 2008, EUR J CLIN INVEST, V38, P713, DOI 10.1111/j.1365-2362.2008.02010.x; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Erridge C, 2007, ATHEROSCLEROSIS, V193, P77, DOI 10.1016/j.atherosclerosis.2006.08.032; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Hashimoto M, 2007, INFECT IMMUN, V75, P1926, DOI 10.1128/IAI.02083-05; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; HOTTA T, 1986, RES EXP MED, V186, P61, DOI 10.1007/BF01851834; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Lange S, 1996, APMIS, V104, P823, DOI 10.1111/j.1699-0463.1996.tb04948.x; Levin A, 2008, WORLD J GASTROENTERO, V14, P5149, DOI 10.3748/wjg.14.5149; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Masseret E, 2001, GUT, V48, P320, DOI 10.1136/gut.48.3.320; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Obermeier F, 2005, GASTROENTEROLOGY, V129, P913, DOI 10.1053/j.gastro.2005.06.061; Obermeier F, 2002, EUR J IMMUNOL, V32, P2084, DOI 10.1002/1521-4141(200207)32:7<2084::AID-IMMU2084>3.0.CO;2-Q; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Sanders CJ, 2006, J IMMUNOL, V177, P2810, DOI 10.4049/jimmunol.177.5.2810; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345	39	94	99	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9125	10.1371/journal.pone.0009125	http://dx.doi.org/10.1371/journal.pone.0009125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161736	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442600023
J	Kocher, SD; Ayroles, JF; Stone, EA; Grozinger, CM				Kocher, Sarah D.; Ayroles, Julien F.; Stone, Eric A.; Grozinger, Christina M.			Individual Variation in Pheromone Response Correlates with Reproductive Traits and Brain Gene Expression in Worker Honey Bees	PLOS ONE			English	Article							APIS-MELLIFERA L.; DIVISION-OF-LABOR; QUEEN MANDIBULAR PHEROMONE; SOCIAL-BEHAVIOR; OVARY DEVELOPMENT; JUVENILE-HORMONE; COLONIES; DIVERSITY; CASTE; GENOMICS	Background: Variation in individual behavior within social groups can affect the fitness of the group as well as the individual, and can be caused by a combination of genetic and environmental factors. However, the molecular factors associated with individual variation in social behavior remain relatively unexplored. We used honey bees (Apis mellifera) as a model to examine differences in socially-regulated behavior among individual workers, and used transcriptional profiling to determine if specific gene expression patterns are associated with these individual differences. In honey bees, the reproductive queen produces a pheromonal signal that regulates many aspects of worker behavior and physiology and maintains colony organization. Methodology/Principal Findings: Here, we demonstrate that there is substantial natural variation in individual worker attraction to queen pheromone (QMP). Furthermore, worker attraction is negatively correlated with ovariole number-a trait associated with reproductive potential in workers. We identified transcriptional differences in the adult brain associated with individual worker attraction to QMP, and identified hundreds of transcripts that are organized into statistically-correlated gene networks and associated with this response. Conclusions/Significance: Our studies demonstrate that there is substantial variation in worker attraction to QMP among individuals, and that this variation is linked with specific differences in physiology and brain gene expression patterns. This variation in individual response thresholds may reveal underlying variation in queen-worker reproductive conflict, and may mediate colony function and productivity by creating variation in individual task performance.	[Kocher, Sarah D.; Ayroles, Julien F.; Stone, Eric A.; Grozinger, Christina M.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Stone, Eric A.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Grozinger, Christina M.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Kocher, Sarah D.; Ayroles, Julien F.; Stone, Eric A.; Grozinger, Christina M.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Kocher, SD (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	skocher@gmail.com; cmgrozinger@psu.edu	Stone, Eric/Q-7840-2016	Stone, Eric/0000-0002-2725-4209	National Institutes of Health Training; North Carolina State University; National Science Foundation CAREER [0746338]	National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina State University; National Science Foundation CAREER(National Science Foundation (NSF))	This work is supported by a National Institutes of Health Training Grant and a Sigma XI Grant in Aid of Research to SDK, funding from North Carolina State University to CMG, and a National Science Foundation CAREER grant (IOS 0746338) to CMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp MH, 2003, BEHAV ECOL SOCIOBIOL, V54, P555, DOI 10.1007/s00265-003-0666-4; Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Ayroles JF, 2006, METHOD ENZYMOL, V411, P214, DOI 10.1016/S0076-6879(06)11011-3; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Bloch Guy, 2002, P195; BLUM MS, 1978, J APICULT RES, V17, P218, DOI 10.1080/00218839.1978.11099929; Calis JNM, 2002, APIDOLOGIE, V33, P193, DOI 10.1051/apido:2002009; Carde R.T., 1984, P355; Cnaani J, 2000, BEHAV ECOL SOCIOBIOL, V47, P346, DOI 10.1007/s002650050675; Cummings ME, 2008, P ROY SOC B-BIOL SCI, V275, P393, DOI 10.1098/rspb.2007.1454; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Evans JD, 2001, GENOME BIOL, V2; Grozinger CM, 2007, MOL ECOL, V16, P4837, DOI 10.1111/j.1365-294X.2007.03545.x; Grozinger CM, 2007, J COMP PHYSIOL A, V193, P461, DOI 10.1007/s00359-006-0202-x; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Hoover SER, 2006, J COMP PHYSIOL B, V176, P55, DOI 10.1007/s00360-005-0032-0; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; Hunt GJ, 1998, GENETICS, V148, P1203; Hunt GJ, 2007, NATURWISSENSCHAFTEN, V94, P247, DOI 10.1007/s00114-006-0183-1; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Kocher SD, 2009, BEHAV ECOL, V20, P1007, DOI 10.1093/beheco/arp090; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; LE CONTE Y, 1990, NATURWISSENSCHAFTEN, V77, P334, DOI 10.1007/BF01138390; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Linksvayer TA, 2009, AM NAT, V173, pE99, DOI 10.1086/596527; Makert GR, 2006, BEHAV ECOL SOCIOBIOL, V60, P815, DOI 10.1007/s00265-006-0225-x; Martin CG, 2004, BEHAV ECOL SOCIOBIOL, V56, P42, DOI 10.1007/s00265-004-0755-z; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Melathopoulos AP, 1996, CAN ENTOMOL, V128, P263, DOI 10.4039/Ent128263-2; Moritz RFA, 2002, INSECT SOC, V49, P86, DOI 10.1007/s00040-002-8284-0; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Oldroyd BP, 2008, TRENDS ECOL EVOL, V23, P59, DOI 10.1016/j.tree.2007.10.012; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; PAGE RE, 1988, BEHAV ECOL SOCIOBIOL, V23, P117, DOI 10.1007/BF00299895; PAGE RE, 1994, BEHAV ECOL SOCIOBIOL, V35, P99, DOI 10.1007/BF00171499; Page RE, 2007, BIOESSAYS, V29, P334, DOI 10.1002/bies.20549; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; Pankiw T, 1997, CAN ENTOMOL, V129, P679, DOI 10.4039/Ent129679-4; Pankiw T, 2000, NATURWISSENSCHAFTEN, V87, P487, DOI 10.1007/s001140050764; PANKIW T, 1994, J INSECT BEHAV, V7, P1, DOI 10.1007/BF01989823; PHAMDELEGUE MH, 1993, APIDOLOGIE, V24, P267, DOI 10.1051/apido:19930307; Phelps SM, 2003, J COMP NEUROL, V466, P564, DOI 10.1002/cne.10902; PICKETT JA, 1980, J CHEM ECOL, V6, P1561; Renn SCP, 2008, J EXP BIOL, V211, P3041, DOI 10.1242/jeb.018242; Richard FJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000980; Robinson GE, 2002, GENES BRAIN BEHAV, V1, P197, DOI 10.1034/j.1601-183X.2002.10401.x; ROBINSON GE, 1990, BEHAV ECOL SOCIOBIOL, V26, P315, DOI 10.1007/BF00171096; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Schulz DJ, 2001, J COMP PHYSIOL A, V187, P53, DOI 10.1007/s003590000177; Schulz DJ, 2002, HORM BEHAV, V42, P222, DOI 10.1006/hbeh.2002.1806; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; Stone EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000479; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tarpy DR, 2006, NATURWISSENSCHAFTEN, V93, P195, DOI 10.1007/s00114-006-0091-4; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; Wang J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000127; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Winston M. L. L., 1991, BIOL HONEY BEE; WIRTZ P, 1972, INDUCTION CASTE DIFF, P517; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520	72	40	40	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9116	10.1371/journal.pone.0009116	http://dx.doi.org/10.1371/journal.pone.0009116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161742	Green Submitted, gold, Green Published			2022-12-25	WOS:000274442600014
J	Smaers, JB; Schleicher, A; Zilles, K; Vinicius, L				Smaers, Jeroen Bert; Schleicher, Axel; Zilles, Karl; Vinicius, Lucio			Frontal White Matter Volume Is Associated with Brain Enlargement and Higher Structural Connectivity in Anthropoid Primates	PLOS ONE			English	Article							BASAL-GANGLIA; PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; SOCIAL BRAIN; GREAT APES; EVOLUTION; HUMANS; ORGANIZATION; PROJECTIONS; PATTERNS	Previous research has indicated the importance of the frontal lobe and its `executive' connections to other brain structures as crucial in explaining primate neocortical adaptations. However, a representative sample of volumetric measurements of frontal connective tissue (white matter) has not been available. In this study, we present new volumetric measurements of white and grey matter in the frontal and non-frontal neocortical lobes from 18 anthropoid species. We analyze this data in the context of existing theories of neocortex, frontal lobe and white versus grey matter hyperscaling. Results indicate that the `universal scaling law' of neocortical white to grey matter applies separately for frontal and non-frontal lobes; that hyperscaling of both neocortex and frontal lobe to rest of brain is mainly due to frontal white matter; and that changes in frontal (but not non-frontal) white matter volume are associated with changes in rest of brain and basal ganglia, a group of subcortical nuclei functionally linked to `executive control'. Results suggest a central role for frontal white matter in explaining neocortex and frontal lobe hyperscaling, brain size variation and higher neural structural connectivity in anthropoids.	[Smaers, Jeroen Bert; Vinicius, Lucio] Univ Cambridge, Dept Biol Anthropol, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 3DZ, England; [Schleicher, Axel; Zilles, Karl] Univ Dusseldorf, Cecile & Oskar Vogt Inst Brain Res, Dusseldorf, Germany	University of Cambridge; Heinrich Heine University Dusseldorf	Smaers, JB (corresponding author), Univ Cambridge, Dept Biol Anthropol, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 3DZ, England.	jbs32@cam.ac.uk	Zilles, Karl/J-9704-2013; Zilles, Karl/Y-3784-2019	Zilles, Karl/0000-0001-9296-9959; Zilles, Karl/0000-0002-4705-4175; Smaers, Jeroen/0000-0003-1741-9839	Cambridge European Trust; Leverhulme Trust	Cambridge European Trust; Leverhulme Trust(Leverhulme Trust)	This work was supported by the Cambridge European Trust and the Leverhulme Trust. JBS is partly funded by the Cambridge European Trust: http://www.admin.cam.ac.uk/univ/gsprospectus/funding/overseas/. LVC is funded by the Leverhulme Trust: http://www.leverhulme.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Allman J.M., 1999, EVOLVING BRAINS; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Bush EC, 2004, P NATL ACAD SCI USA, V101, P3962, DOI 10.1073/pnas.0305760101; CAVADA C, 1991, NEUROSCIENCE, V42, P683, DOI 10.1016/0306-4522(91)90037-O; Cavalieri B, 1635, GEOMETRIA INDIVISIBI; CHKLOVSKII D, 2000, ADV NEURAL INFORM PR; Doyon J, 1997, BRAIN COGNITION, V34, P218, DOI 10.1006/brcg.1997.0899; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; Exner C, 2002, LEARN MEMORY, V9, P376, DOI 10.1101/lm.48402; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FITZPATRICK KA, 1982, J COMP NEUROL, V204, P296, DOI 10.1002/cne.902040308; FOGASSI L, 1994, BEHAV BRAIN RES, V60, P91, DOI 10.1016/0166-4328(94)90067-1; Geyer S, 2000, ANAT EMBRYOL, V202, P443, DOI 10.1007/s004290000127; GOLDMAN PS, 1977, J COMP NEUROL, V171, P369, DOI 10.1002/cne.901710305; GOLDMANRAKIC PS, 1984, TRENDS NEUROSCI, V7, P419, DOI 10.1016/S0166-2236(84)80146-0; Grey L.J., 1994, BRODMANNS LOCALIZATI; Gurney K, 2001, BIOL CYBERN, V84, P401, DOI 10.1007/PL00007984; HOFMAN MA, 1989, PROG NEUROBIOL, V32, P137, DOI 10.1016/0301-0082(89)90013-0; Hollerman JR, 2000, PROG BRAIN RES, V126, P193; Howard C, 1998, UNBIASED STEREOLOGY; Joffe TH, 1997, P ROY SOC B-BIOL SCI, V264, P1303, DOI 10.1098/rspb.1997.0180; JOHNSON TN, 1968, EXP NEUROL, V21, P20, DOI 10.1016/0014-4886(68)90030-7; Kaas JH, 2006, CURR BIOL, V16, pR910, DOI 10.1016/j.cub.2006.09.057; Kolb B, 1996, FUNDAMENTALS HUMAN N; MacLeod CE, 2003, J HUM EVOL, V44, P401, DOI 10.1016/S0047-2484(03)00028-9; Martins E. P., 2004, COMPARE VERSION 4 6B; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Middleton FA, 2001, FRONTAL-SUBCORTICAL CIRCUITS IN PSYCHIATRIC AND NEUROLOGICAL DISORDERS, P44; Middleton FA, 2002, CEREB CORTEX, V12, P926, DOI 10.1093/cercor/12.9.926; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; MITCHISON G, 1992, TRENDS NEUROSCI, V15, P122, DOI 10.1016/0166-2236(92)90352-9; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; Rivara CB, 2003, ANAT REC PART A, V270A, P137, DOI 10.1002/ar.a.10015; Sanides F., 1967, Journal fuer Hirnforschung, V9, P225; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394; SCHULTZ W, 1992, EXP BRAIN RES, V91, P363; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Semendeferi K, 1997, J HUM EVOL, V32, P375, DOI 10.1006/jhev.1996.0099; Semendeferi K, 2002, NAT NEUROSCI, V5, P272, DOI 10.1038/nn814; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.0.CO;2-I; Sherwood CC, 2005, NAT NEUROSCI, V8, P537, DOI 10.1038/nn0505-537; Sherwood CC, 2004, BRAIN BEHAV EVOLUT, V63, P61, DOI 10.1159/000075672; Sherwood CC, 2003, BRAIN BEHAV EVOLUT, V61, P28, DOI 10.1159/000068879; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; SMITH RJ, 2002, INT J PRIMATOL, V23; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; Stephan H., 1980, BRAIN COMMON MARMOSE; STEPNIEWSKA I, 1993, J COMP NEUROL, V330, P238, DOI 10.1002/cne.903300207; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; WEINBERGER DR, 1993, J NEUROPSYCH CLIN N, V5, P241; Whiting BA, 2003, J HUM EVOL, V44, P3, DOI 10.1016/S0047-2484(02)00162-8; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; ZILLES K, 1982, MICROSC ACTA, V86, P339	61	58	58	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9123	10.1371/journal.pone.0009123	http://dx.doi.org/10.1371/journal.pone.0009123			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161758	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442600021
J	Tillo, D; Kaplan, N; Moore, IK; Fondufe-Mittendorf, Y; Gossett, AJ; Field, Y; Lieb, JD; Widom, J; Segal, E; Hughes, TR				Tillo, Desiree; Kaplan, Noam; Moore, Irene K.; Fondufe-Mittendorf, Yvonne; Gossett, Andrea J.; Field, Yair; Lieb, Jason D.; Widom, Jonathan; Segal, Eran; Hughes, Timothy R.			High Nucleosome Occupancy Is Encoded at Human Regulatory Sequences	PLOS ONE			English	Article							CHIP-SEQ DATA; HIGH-RESOLUTION; HUMAN GENOME; BINDING-SITES; TRANSCRIPTION FACTOR; DNA-SEQUENCE; CPG ISLANDS; CHROMATIN; ORGANIZATION; PROMOTERS	Active eukaryotic regulatory sites are characterized by open chromatin, and yeast promoters and transcription factor binding sites (TFBSs) typically have low intrinsic nucleosome occupancy. Here, we show that in contrast to yeast, DNA at human promoters, enhancers, and TFBSs generally encodes high intrinsic nucleosome occupancy. In most cases we examined, these elements also have high experimentally measured nucleosome occupancy in vivo. These regions typically have high G+C content, which correlates positively with intrinsic nucleosome occupancy, and are depleted for nucleosome-excluding poly-A sequences. We propose that high nucleosome preference is directly encoded at regulatory sequences in the human genome to restrict access to regulatory information that will ultimately be utilized in only a subset of differentiated cells.	[Tillo, Desiree; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Kaplan, Noam; Field, Yair; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Moore, Irene K.; Fondufe-Mittendorf, Yvonne; Widom, Jonathan] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL USA; [Gossett, Andrea J.; Lieb, Jason D.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	University of Toronto; Weizmann Institute of Science; Northwestern University; University of North Carolina; University of North Carolina Chapel Hill	Tillo, D (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	t.hughes@utoronto.ca	Segal, Eran/AAF-4855-2019; Kaplan, Noam/A-3544-2011; Kaplan, Noam/K-4383-2019	Kaplan, Noam/0000-0001-9940-1987; Kaplan, Noam/0000-0001-9940-1987; Gossett, Andrea/0000-0002-9471-3970; Segal, Eran/0000-0002-6859-1164; Lieb, Jason/0000-0001-7601-8061	Alexander Graham Bell Canada; Canadian Institutes of Health Research (CIHR) [MOP-86705]; Genome Canada; Howard Hughes Medical Institute; Canadian Institute for Advanced Research	Alexander Graham Bell Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	D.T. holds an Alexander Graham Bell Canada Graduate Scholarship (http://www.nserc-crsng.gc.ca/). This work was supported by a Canadian Institutes of Health Research (CIHR) Operating Grant MOP-86705 to T. R. H. and C. Nislow (http://www.cihr-irsc.gc.ca/e/193.html), by Genome Canada through the Ontario Genomics Institute and the Ontario Research Fund, the Howard Hughes Medical Institute, and the Canadian Institute for Advanced Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Di Filippo M, 2008, GENE, V419, P62, DOI 10.1016/j.gene.2008.02.012; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Johnson BV, 2004, MOL CELL BIOL, V24, P7914, DOI 10.1128/MCB.24.18.7914-7930.2004; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim A, 2003, MOL CELL BIOL, V23, P8099, DOI 10.1128/MCB.23.22.8099-8109.2003; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LOHR D, 1979, P NATL ACAD SCI USA, V76, P6326, DOI 10.1073/pnas.76.12.6326; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; LUTTER LC, 1989, METHOD ENZYMOL, V170, P264; MIRNY L, 2009, NUCLEOSOME MEDIATED; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Perry RP, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-15; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Rozenberg JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-67; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Segal MR, 2008, STAT APPL GENET MOL, V7; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Steger DJ, 1997, EMBO J, V16, P2463, DOI 10.1093/emboj/16.9.2463; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Voss TC, 2008, BBA-MOL CELL RES, V1783, P2044, DOI 10.1016/j.bbamcr.2008.06.022; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136	40	136	137	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9129	10.1371/journal.pone.0009129	http://dx.doi.org/10.1371/journal.pone.0009129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161746	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442600026
J	Tomonaga, M; Imura, T				Tomonaga, Masaki; Imura, Tomoko			Visual Search for Human Gaze Direction by a Chimpanzee (Pan troglodytes)	PLOS ONE			English	Article							EXPERIMENTER-GIVEN CUES; SUPERIOR TEMPORAL SULCUS; OBJECT-CHOICE TASKS; EYE CONTACT; INFANT CHIMPANZEES; SPECIES FOLLOW; FACES; PERCEPTION; ATTENTION; MONKEYS	Background: Humans detect faces with direct gazes among those with averted gazes more efficiently than they detect faces with averted gazes among those with direct gazes. We examined whether this "stare-in-the-crowd" effect occurs in chimpanzees (Pan troglodytes), whose eye morphology differs from that of humans (i.e., low-contrast eyes, dark sclera). Methodology/Principal Findings: An adult female chimpanzee was trained to search for an odd-item target (front view of a human face) among distractors that differed from the target only with respect to the direction of the eye gaze. During visual-search testing, she performed more efficiently when the target was a direct-gaze face than when it was an averted-gaze face. This direct-gaze superiority was maintained when the faces were inverted and when parts of the face were scrambled. Subsequent tests revealed that gaze perception in the chimpanzee was controlled by the contrast between iris and sclera, as in humans, but that the chimpanzee attended only to the position of the iris in the eye, irrespective of head direction. Conclusion/Significance: These results suggest that the chimpanzee can discriminate among human gaze directions and are more sensitive to direct gazes. However, limitations in the perception of human gaze by the chimpanzee are suggested by her inability to completely transfer her performance to faces showing a three-quarter view.	[Tomonaga, Masaki; Imura, Tomoko] Kyoto Univ, Primate Res Inst, Aichi, Japan	Kyoto University	Tomonaga, M (corresponding author), Kyoto Univ, Primate Res Inst, Aichi, Japan.	tomonaga@pri.kyoto-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) [12002009, 13610086, 16002001, 16300084, 19300091, 20002001]; MEXT [A14, D10]; global COE [A06, D07]	Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); global COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan Society for the Promotion of Science (JSPS) (12002009, 13610086, 16002001, 16300084, 19300091, 20002001); and by MEXT Grants-in-Aid for the 21st Century COE Programs (A14 and D10) and global COE Programs (A06 and D07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JR, 1995, ANIM BEHAV, V49, P201, DOI 10.1016/0003-3472(95)80168-5; Anderson JR, 1999, FOLIA PRIMATOL, V70, P17, DOI 10.1159/000021670; Ando S, 2002, PERCEPTION, V31, P657, DOI 10.1068/p3332; ANSTIS SM, 1969, AM J PSYCHOL, V82, P474, DOI 10.2307/1420441; Bard KA, 2005, DEV PSYCHOL, V41, P616, DOI 10.1037/0012-1649.41.4.616; Baron-Cohen Simon, 1995, MINDBLINDNESS ESSAY; Brauer J, 2005, J COMP PSYCHOL, V119, P145, DOI 10.1037/0735-7036.119.2.145; Brown V, 1997, PERCEPTION, V26, P1555, DOI 10.1068/p261555; CAMPBELL R, 1990, NEUROPSYCHOLOGIA, V28, P1123, DOI 10.1016/0028-3932(90)90050-X; CLINE MG, 1967, AM J PSYCHOL, V80, P41, DOI 10.2307/1420539; Coss RG, 2002, PRIMATES, V43, P217, DOI 10.1007/BF02629649; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; EACOTT MJ, 1993, NEUROPSYCHOLOGIA, V31, P609, DOI 10.1016/0028-3932(93)90055-5; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Fagot J, 1999, J COMP PSYCHOL, V113, P3, DOI 10.1037/0735-7036.113.1.3; Ferrari PF, 2000, P NATL ACAD SCI USA, V97, P13997, DOI 10.1073/pnas.250241197; GIBSON JJ, 1963, AM J PSYCHOL, V76, P386, DOI 10.2307/1419779; Goodall J., 1986, CHIMPANZEES GOMBE PA; HEYWOOD CA, 1992, PHILOS T ROY SOC B, V335, P31, DOI 10.1098/rstb.1992.0004; IDANI G, 1995, PRIMATES, V36, P377, DOI 10.1007/BF02382860; Itakura S, 1998, J COMP PSYCHOL, V112, P119, DOI 10.1037/0735-7036.112.2.119; Itakura S, 1996, JPN PSYCHOL RES, V38, P174, DOI 10.1111/j.1468-5884.1996.tb00022.x; Kano F, 2010, ANIM BEHAV, V79, P227, DOI 10.1016/j.anbehav.2009.11.003; Kano F, 2009, P R SOC B, V276, P1949, DOI 10.1098/rspb.2008.1811; Kaplan G, 2002, INT J PRIMATOL, V23, P501, DOI 10.1023/A:1014913532057; KEATING CF, 1993, J COMP PSYCHOL, V107, P131, DOI 10.1037/0735-7036.107.2.131; Kirk RE, 1995, EXPT DESIGN; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Matsuno T, 2006, BEHAV BRAIN RES, V172, P219, DOI 10.1016/j.bbr.2006.05.004; Matsuzawa T, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P3, DOI 10.1007/4-431-30248-4_1; MENDELSON MJ, 1982, DEV PSYCHOL, V18, P222, DOI 10.1037/0012-1649.18.2.222; Myowa-Yamakoshi M, 2003, COGNITION, V89, pB53, DOI 10.1016/S0010-0277(03)00071-4; Myowa-Yamakoshi M, 2001, PSYCHOLOGIA, V44, P24; Nahm FKD, 1997, J COGNITIVE NEUROSCI, V9, P611, DOI 10.1162/jocn.1997.9.5.611; Nakato E, 2009, INFANT BEHAV DEV, V32, P422, DOI 10.1016/j.infbeh.2009.07.006; NOTHDURFT HC, 1993, PERCEPTION, V22, P1287, DOI 10.1068/p221287; Okamoto S, 2002, ANIM COGN, V5, P107, DOI 10.1007/s10071-002-0133-z; Okamoto S, 2004, JPN PSYCHOL RES, V46, P236, DOI 10.1111/j.1468-5584.2004.00255.x; Okamoto-Barth S, 2008, DEVELOPMENTAL SCI, V11, P98, DOI 10.1111/j.1467-7687.2007.00658.x; Povinelli DJ, 1996, PSYCHOL SCI, V7, P129, DOI 10.1111/j.1467-9280.1996.tb00345.x; Ricciardelli P, 2000, COGNITION, V77, pB1, DOI 10.1016/S0010-0277(00)00092-5; Sato N, 2001, J COMP PSYCHOL, V115, P115, DOI 10.1037/0735-7036.115.2.115; Senju A, 2003, COGNITION, V89, pB43, DOI 10.1016/S0010-0277(03)00081-7; Shepherd SV, 2009, P NATL ACAD SCI USA, V106, P9489, DOI 10.1073/pnas.0900419106; THOMSEN CE, 1974, ANIM BEHAV, V22, P144, DOI 10.1016/S0003-3472(74)80063-1; Tomasello M, 1999, ANIM BEHAV, V58, P769, DOI 10.1006/anbe.1999.1192; Tomasello M, 1998, ANIM BEHAV, V55, P1063, DOI 10.1006/anbe.1997.0636; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Tomonaga M, 1999, PRIMATES, V40, P417, DOI 10.1007/BF02557579; TOMONAGA M, 1993, PERCEPT MOTOR SKILL, V76, P1287, DOI 10.2466/pms.1993.76.3c.1287; Tomonaga M., 1998, ANIM COGN, V1, P25, DOI [10.1007/s100710050004, DOI 10.1007/S100710050004]; Tomonaga M, 2007, J COMP PSYCHOL, V121, P156, DOI 10.1037/0735-7036.121.2.156; Tomonaga M, 2007, PRIMATES, V48, P1, DOI 10.1007/s10329-006-0011-4; Tomonaga M, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-14; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; vonGrunau M, 1995, PERCEPTION, V24, P1297, DOI 10.1068/p241297; Wilson HR, 2000, VISION RES, V40, P459, DOI 10.1016/S0042-6989(99)00195-9; Wollaston W.H., 1824, PHILOS T R SOC LOND, V114, P247; YAMAGIWA J, 1992, PRIMATES, V33, P523, DOI 10.1007/BF02381153	60	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9131	10.1371/journal.pone.0009131	http://dx.doi.org/10.1371/journal.pone.0009131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554NV	20161750	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442600028
J	Osada, M; Jardine, L; Misir, R; Andl, T; Millar, SE; Pezzano, M				Osada, Masako; Jardine, Logan; Misir, Ruth; Andl, Thomas; Millar, Sarah E.; Pezzano, Mark			DKK1 Mediated Inhibition of Wnt Signaling in Postnatal Mice Leads to Loss of TEC Progenitors and Thymic Degeneration	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; MEDULLARY EPITHELIAL-CELLS; BETA-CATENIN; SELF-RENEWAL; THYMOCYTE DEVELOPMENT; TRANSCRIPTION FACTORS; SMALL-INTESTINE; EXPRESSION; P63; DIFFERENTIATION	Background: Thymic epithelial cell (TEC) microenvironments are essential for the recruitment of T cell precursors from the bone marrow, as well as the subsequent expansion and selection of thymocytes resulting in a mature self-tolerant T cell repertoire. The molecular mechanisms, which control both the initial development and subsequent maintenance of these critical microenvironments, are poorly defined. Wnt signaling has been shown to be important to the development of several epithelial tissues and organs. Regulation of Wnt signaling has also been shown to impact both early thymocyte and thymic epithelial development. However, early blocks in thymic organogenesis or death of the mice have prevented analysis of a role of canonical Wnt signaling in the maintenance of TECs in the postnatal thymus. Methodology/Principal Findings: Here we demonstrate that tetracycline-regulated expression of the canonical Wnt inhibitor DKK1 in TECs localized in both the cortex and medulla of adult mice, results in rapid thymic degeneration characterized by a loss of Delta NP63(+) Foxn1(+) and Aire(+) TECs, loss of K5K8DP TECs thought to represent or contain an immature TEC progenitor, decreased TEC proliferation and the development of cystic structures, similar to an aged thymus. Removal of DKK1 from DKK1-involuted mice results in full recovery, suggesting that canonical Wnt signaling is required for the differentiation or proliferation of TEC populations needed for maintenance of properly organized adult thymic epithelial microenvironments. Conclusions/Significance: Taken together, the results of this study demonstrate that canonical Wnt signaling within TECs is required for the maintenance of epithelial microenvironments in the postnatal thymus, possibly through effects on TEC progenitor/stem cell populations. Downstream targets of Wnt signaling, which are responsible for maintenance of these TEC progenitors may provide useful targets for therapies aimed at counteracting age associated thymic involution or the premature thymic degeneration associated with cancer therapy and bone marrow transplants.	[Osada, Masako; Jardine, Logan; Misir, Ruth; Pezzano, Mark] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Andl, Thomas] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Millar, Sarah E.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Millar, Sarah E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	City University of New York (CUNY) System; City College of New York (CUNY); Vanderbilt University; University of Pennsylvania; University of Pennsylvania	Osada, M (corresponding author), CUNY City Coll, Dept Biol, 138Th St & Convent Ave, New York, NY 10031 USA.	mpezzano@sci.ccny.cuny.edu		Andl, Thomas/0000-0002-5555-468X; Millar, Sarah/0000-0001-8792-6890	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [1SC1AI081527]; NIH/NCI [1U56 CA96299, U54 1U54CA137788-01, PSCREG-39-1051, RO1-AR47709, RO1-DE015342, RO1-HD053829]; National Center for Research Resources Research Centers in Minority Institutions [G12RR03060]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053829] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA137788, U54CA132378, U56CA096299] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI104994, SC1AI081527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR047709, R01AR047709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015342] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources Research Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding: This work was supported by grants from National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) 1SC1AI081527 NIH/NCI 1U56 CA96299, NIH/NCI U54 1U54CA137788-01 and PSCREG-39-1051 to M. P. and RO1-AR47709, RO1-DE015342, RO1-HD053829 to S. E. M. Infrastructure support for core facilities and technical staff was provided by a grant to The City College of New York from the National Center for Research Resources Research Centers in Minority Institutions program grant # G12RR03060. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Aw D, 2008, AGING CELL, V7, P158, DOI 10.1111/j.1474-9726.2007.00365.x; Baba Y, 2006, J IMMUNOL, V177, P2294, DOI 10.4049/jimmunol.177.4.2294; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; BARCLAY AN, 1981, J EXP MED, V153, P1666, DOI 10.1084/jem.153.6.1666; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Chilosi M, 2003, VIRCHOWS ARCH, V443, P175, DOI 10.1007/s00428-003-0857-4; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Dooley J, 2008, J IMMUNOL, V181, P5225, DOI 10.4049/jimmunol.181.8.5225; Dotto J, 2007, AM J CLIN PATHOL, V127, P415, DOI 10.1309/2GAYKPDDM85P2VEW; FERRICK DA, 1989, CELL, V57, P483, DOI 10.1016/0092-8674(89)90923-9; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Flores KG, 1999, J CLIN INVEST, V104, P1031, DOI 10.1172/JCI7558; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Gillard GO, 2007, J IMMUNOL, V178, P3007, DOI 10.4049/jimmunol.178.5.3007; Gillard GO, 2006, J IMMUNOL, V176, P5815, DOI 10.4049/jimmunol.176.10.5815; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Grotewold L, 2002, INT J DEV BIOL, V46, P943; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; Hattori N, 1996, J EXP MED, V184, P1901, DOI 10.1084/jem.184.5.1901; Heng TSP, 2005, J IMMUNOL, V175, P2982, DOI 10.4049/jimmunol.175.5.2982; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; HIROKAWA K, 1994, IMMUNOL LETT, V40, P269, DOI 10.1016/0165-2478(94)00065-4; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Irifune T, 2004, ARCH HISTOL CYTOL, V67, P149, DOI 10.1679/aohc.67.149; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Itoi M, 2007, INT IMMUNOL, V19, P953, DOI 10.1093/intimm/dxm060; Jenkinson WE, 2007, BLOOD, V109, P954, DOI 10.1182/blood-2006-05-023143; Kikuchi T, 2004, INT IMMUNOL, V16, P831, DOI 10.1093/intimm/dxh087; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Kwack MH, 2008, J INVEST DERMATOL, V128, P262, DOI 10.1038/sj.jid.5700999; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Millar JBA, 2002, GENOME BIOL, V3; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Min D, 2007, BLOOD, V109, P2529, DOI 10.1182/blood-2006-08-043794; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Mulroy T, 2003, INT IMMUNOL, V15, P1485, DOI 10.1093/intimm/dxg146; Mulroy T, 2002, EUR J IMMUNOL, V32, P967, DOI 10.1002/1521-4141(200204)32:4<967::AID-IMMU967>3.0.CO;2-6; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; Osada M, 2006, CLIN DEV IMMUNOL, V13, P299, DOI 10.1080/17402520600935097; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Pongracz J, 2003, EUR J IMMUNOL, V33, P1949, DOI 10.1002/eji.200323564; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Savage PA, 2001, IMMUNITY, V14, P243, DOI 10.1016/S1074-7613(01)00106-6; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Schilham MW, 1998, J IMMUNOL, V161, P3984; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; Takeoka Y, 1996, INT ARCH ALLERGY IMM, V111, P5, DOI 10.1159/000237337; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; UTSUYAMA M, 1995, MECH AGEING DEV, V81, P107, DOI 10.1016/0047-6374(95)01589-R; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; van Ewijk W, 1999, SEMIN IMMUNOL, V11, P57, DOI 10.1006/smim.1998.0158; Weerkamp F, 2006, P NATL ACAD SCI USA, V103, P3322, DOI 10.1073/pnas.0511299103; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459; Zuklys S, 2009, J IMMUNOL, V182, P2997, DOI 10.4049/jimmunol.0713723	93	47	51	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9062	10.1371/journal.pone.0009062	http://dx.doi.org/10.1371/journal.pone.0009062			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161711	Green Published, gold			2022-12-25	WOS:000274442500002
J	Oussedik, K; Francois, JC; Halby, L; Senamaud-Beaufort, C; Toutirais, G; Dallavalle, S; Pommier, Y; Pisano, C; Arimondo, PB				Oussedik, Kahina; Francois, Jean-Christophe; Halby, Ludovic; Senamaud-Beaufort, Catherine; Toutirais, Geraldine; Dallavalle, Sabrina; Pommier, Yves; Pisano, Claudio; Arimondo, Paola B.			Sequence-specific targeting of IGF-I and IGF-IR genes by camptothecins	FASEB JOURNAL			English	Article						DNA regulation; specific DNA cleavage; topoisomerase I poisons; triplex-forming oligonucleotides; anticancer agents	TRIPLEX-FORMING OLIGONUCLEOTIDES; GROWTH-FACTOR RECEPTOR; C-MYC GENE; TOPOISOMERASE-I; PROSTATE-CANCER; DNA CLEAVAGE; CELL-LINES; INSULIN; DERIVATIVES; INHIBITION	We and others have clearly demonstrated that a topoisomerase I (Top1) inhibitor, such as camptothecin (CPT), coupled to a triplex-forming oligonucleotide (TFO) through a suitable linker can be used to cause site-specific cleavage of the targeted DNA sequence in in vitro models. Here we evaluated whether these molecular tools induce sequence-specific DNA damage in a genome context. We targeted the insulin-like growth factor (IGF)-I axis and in particular promoter 1 of IGF-I and intron 2 of type 1 insulin-like growth factor receptor (IGF-IR) in cancer cells. The IGF axis molecules represent important targets for anticancer strategies, because of their central role in oncogenic maintenance and metastasis processes. We chemically attached 2 CPT derivatives to 2 TFOs. Both conjugates efficiently blocked gene expression in cells, reducing the quantity of mRNA transcribed by 70-80%, as measured by quantitative RT-PCR. We confirmed that the inhibitory mechanism of these TFO conjugates was mediated by Top1-induced cleavage through the use of RNA interference experiments and a camptothecin-resistant cell line. In addition, induction of phospho-H2AX foci supports the DNA-damaging activity of TFO-CPT conjugates at specific sites. The evaluated conjugates induce a specific DNA damage at the target gene mediated by Top1.-Oussedik, K., Francois, J.-C., Halby, L., Senamaud-Beaufort, C., Toutirais, G., Dallavalle, S., Pommier, Y., Pisano, C., Arimondo, P. B. Sequence-specific targeting of IGF-I and IGF-IR genes by camptothecins. FASEB J. 24, 2235-2244 (2010). www.fasebj.org	[Oussedik, Kahina; Francois, Jean-Christophe; Halby, Ludovic; Senamaud-Beaufort, Catherine; Toutirais, Geraldine; Arimondo, Paola B.] Museum Natl Hist Nat, F-75231 Paris, France; [Oussedik, Kahina; Francois, Jean-Christophe; Halby, Ludovic; Senamaud-Beaufort, Catherine; Toutirais, Geraldine; Arimondo, Paola B.] INSERM, U565, Paris, France; [Oussedik, Kahina] Univ Paris 06, Paris, France; [Dallavalle, Sabrina] Univ Milan, Dipartimento Sci Mol Agroalimentari, Milan, Italy; [Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Pisano, Claudio] Sigma Tau Pharmaceut Co, Pomezia, Italy	Museum National d'Histoire Naturelle (MNHN); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Milan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Leadiant Biosciences	Arimondo, PB (corresponding author), CNRS, UMR7196, 43 Rue Cuvier, F-75231 Paris 05, France.	arimondo@mnhn.fr	Arimondo, Paola B/R-9095-2017; Dallavalle, Sabrina/AGY-7086-2022; FRANCOIS, Jean-Christophe/O-1659-2018	Arimondo, Paola B/0000-0001-5175-4396; FRANCOIS, Jean-Christophe/0000-0003-4480-1822; pisano, claudio/0000-0001-8624-2980; Dallavalle, Sabrina/0000-0002-8813-8922; Halby, Ludovic/0000-0002-7988-7542	Ligue Nationale Contre le Cancer; Sigma Tau; Center for Cancer Research, National Cancer Institute, U.S. National Institutes of Health; Assocation pour la Recherche sur les Tumeurs de la Prostate; Association pour la Recherche sur le Cancer; NATIONAL CANCER INSTITUTE [ZIABC006150, ZIABC006161] Funding Source: NIH RePORTER	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Sigma Tau; Center for Cancer Research, National Cancer Institute, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Assocation pour la Recherche sur les Tumeurs de la Prostate; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Tiphanie Durfort and Frederic Chapuis for technical help, Dr. Jean-Louis Mergny and Lucio Merlini for suggestions and useful discussions, Dr. P. Rotwein (Oregon Health and Science University, Portland, OR, USA) for providing IGF-I plasmids, Christophe Chamot for help with the fluorescence microscopy, and Dr F. Morel (Service de Cytogenetique Cytologie et Biologie de la Reproduction, Center Hospitalier Universitaire Morvan, Brest, France) for providing IGF-IR probes. This work was supported by grants from Ligue Nationale Contre le Cancer; a Sigma Tau collaboration grant; a Center for Cancer Research, National Cancer Institute, U. S. National Institutes of Health grant to Y.P.; and fellowships to K.O. from Assocation pour la Recherche sur les Tumeurs de la Prostate and Association pour la Recherche sur le Cancer.	Alexia C, 2004, BIOCHEM PHARMACOL, V68, P1003, DOI 10.1016/j.bcp.2004.05.029; Arianayagam M, 2007, AUST FAM PHYSICIAN, V36, P737; Arimondo PB, 2006, MOL CELL BIOL, V26, P324, DOI 10.1128/MCB.26.1.324-333.2006; Arimondo PB, 2005, BIOCHEMISTRY-US, V44, P4171, DOI 10.1021/bi048031k; Arimondo PB, 2002, J BIOL CHEM, V277, P3132, DOI 10.1074/jbc.M110181200; Arimondo PB, 2001, ANGEW CHEM INT EDIT, V40, P3045, DOI 10.1002/1521-3773(20010817)40:16<3045::AID-ANIE3045>3.0.CO;2-A; Baserga R, 2005, EXPERT OPIN THER TAR, V9, P753, DOI 10.1517/14728222.9.4.753; Bohula EA, 2003, J BIOL CHEM, V278, P15991, DOI 10.1074/jbc.M300714200; Carbone GM, 2004, NUCLEIC ACIDS RES, V32, P2396, DOI 10.1093/nar/gkh527; Ciampolillo A, 2007, CURR PHARM DESIGN, V13, P729, DOI 10.2174/138161207780249209; Dallavalle S, 2001, J MED CHEM, V44, P3264, DOI 10.1021/jm0108092; Davies M, 2006, INT J COLORECTAL DIS, V21, P201, DOI 10.1007/s00384-005-0776-8; Dong AQ, 2008, ACTA BIOCH BIOPH SIN, V40, P497, DOI 10.1111/j.1745-7270.2008.00429.x; Francois JC, 2000, METHOD ENZYMOL, V313, P74; Guo N, 2003, GROWTH HORM IGF RES, V13, P44, DOI 10.1016/S1096-6374(02)00121-1; HALL LJ, 1992, DNA CELL BIOL, V11, P301, DOI 10.1089/dna.1992.11.301; Hamel Y, 1999, BIOCHEM J, V339, P547, DOI 10.1042/0264-6021:3390547; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hofmann F, 2005, DRUG DISCOV TODAY, V10, P1041, DOI 10.1016/S1359-6446(05)03512-9; Karamouzis MV, 2006, TRENDS MOL MED, V12, P595, DOI 10.1016/j.molmed.2006.10.003; Kawada M, 2006, CANCER RES, V66, P4419, DOI 10.1158/0008-5472.CAN-05-4239; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Lacoste J, 1997, NUCLEIC ACIDS RES, V25, P1991, DOI 10.1093/nar/25.10.1991; Lacroix L, 1999, BIOCHEMISTRY-US, V38, P1893, DOI 10.1021/bi982290q; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lee YJ, 2007, LUNG CANCER, V55, P279, DOI 10.1016/j.lungcan.2006.10.020; LeRoith D, 2004, CANCER CELL, V5, P201, DOI 10.1016/S1535-6108(04)00054-6; Liao YD, 2005, HUM PATHOL, V36, P1186, DOI 10.1016/j.humpath.2005.07.023; Macris MA, 2003, J BIOL CHEM, V278, P3357, DOI 10.1074/jbc.M206542200; Marchand C, 2006, MOL CANCER THER, V5, P287, DOI 10.1158/1535-7163.MCT-05-0456; Matteucci M, 1997, J AM CHEM SOC, V119, P6939, DOI 10.1021/ja9702475; Meinbach DS, 2006, UROL ONCOL-SEMIN ORI, V24, P294, DOI 10.1016/j.urolonc.2005.12.004; Mignet N, 2000, NUCLEIC ACIDS RES, V28, P3134, DOI 10.1093/nar/28.16.3134; Monti S, 2007, CURR PHARM DESIGN, V13, P719, DOI 10.2174/138161207780249128; Napoli S, 2006, NUCLEIC ACIDS RES, V34, P734, DOI 10.1093/nar/gkj473; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rao VA, 2007, CANCER RES, V67, P9971, DOI 10.1158/0008-5472.CAN-07-0804; Resnik JL, 1998, CANCER RES, V58, P1159; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sordet O, 2004, J BIOL CHEM, V279, P50499, DOI 10.1074/jbc.M410277200; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stierle V, 2008, MOL PHARMACOL, V73, P1568, DOI 10.1124/mol.107.042010; Tao Y, 2007, NAT CLIN PRACT ONCOL, V4, P591, DOI 10.1038/ncponc0934; Trojan J, 2007, NEUROSCIENCE, V145, P795, DOI 10.1016/j.neuroscience.2007.01.021; Urasaki Y, 2001, CANCER RES, V61, P1964; Vasquez KM, 2000, SCIENCE, V290, P530, DOI 10.1126/science.290.5491.530; Vekhoff P, 2009, BIOCONJUGATE CHEM, V20, P666, DOI 10.1021/bc800494y; Yee D, 2007, Br J Cancer, V96 Suppl, pR7; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI 10.1517/14728222.12.5.589 	52	15	15	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2235	2244		10.1096/fj.09-132324	http://dx.doi.org/10.1096/fj.09-132324			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20179147	Green Published			2022-12-25	WOS:000279343600010
J	Xu, L; Nilsson, MB; Saintigny, P; Cascone, T; Herynk, MH; Du, Z; Nikolinakos, PG; Yang, Y; Prudkin, L; Liu, D; Lee, JJ; Johnson, FM; Wong, KK; Girard, L; Gazdar, AF; Minna, JD; Kurie, JM; Wistuba, II; Heymach, JV				Xu, L.; Nilsson, M. B.; Saintigny, P.; Cascone, T.; Herynk, M. H.; Du, Z.; Nikolinakos, P. G.; Yang, Y.; Prudkin, L.; Liu, D.; Lee, J. J.; Johnson, F. M.; Wong, K-K; Girard, L.; Gazdar, A. F.; Minna, J. D.; Kurie, J. M.; Wistuba, I. I.; Heymach, J. V.			Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1 alpha in non-small cell lung cancer cells	ONCOGENE			English	Article						EGFR; MET; non-small cell lung cancer; HIF-1 alpha; invasiveness	PREVIOUSLY TREATED PATIENTS; KINASE DOMAIN MUTATIONS; FACTOR SCATTER FACTOR; IN-VITRO INVASION; C-MET; TYROSINE KINASE; FACTOR-ALPHA; CROSS-TALK; SIGNALING PATHWAY; EGF RECEPTOR	Recent studies have established that amplification of the MET proto-oncogene can cause resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC) cell lines with EGFR-activating mutations. The role of non-amplified MET in EGFR-dependent signaling before TKI resistance, however, is not well understood. Using NSCLC cell lines and transgenic models, we demonstrate here that EGFR activation by either mutation or ligand binding increases MET gene expression and protein levels. Our analysis of 202 NSCLC patient specimens was consistent with these observations: levels of MET were significantly higher in NSCLC with EGFR mutations than in NSCLC with wild-type EGFR. EGFR regulation of MET levels in cell lines occurred through the hypoxia-inducible factor (HIF)-1 alpha pathway in a hypoxia-independent manner. This regulation was lost, however, after MET gene amplification or overexpression of a constitutively active form of HIF-1 alpha. EGFR- and hypoxia-induced invasiveness of NSCLC cells, but not cell survival, were found to be MET dependent. These findings establish that, absent MET amplification, EGFR signaling can regulate MET levels through HIF-1 alpha and that MET is a key downstream mediator of EGFR- induced invasiveness in EGFR- dependent NSCLC cells. Oncogene (2010) 29, 2616-2627; doi:10.1038/onc.2010.16; published online 15 February 2010	[Xu, L.; Nilsson, M. B.; Saintigny, P.; Cascone, T.; Herynk, M. H.; Nikolinakos, P. G.; Yang, Y.; Johnson, F. M.; Kurie, J. M.; Heymach, J. V.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Du, Z.; Wistuba, I. I.; Heymach, J. V.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Prudkin, L.; Wistuba, I. I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Liu, D.; Lee, J. J.] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA; [Wong, K-K] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Girard, L.; Gazdar, A. F.; Minna, J. D.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Hamon Ctr Therapeut Oncol Res, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Minna, J. D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Heymach, JV (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, 1515 Holcombe Blvd,Unit 432, Houston, TX 77030 USA.	jheymach@mdanderson.org	Lee, Jack/P-7331-2019; Heymach, John/AAG-2361-2019; Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Yang, Yanan/F-1592-2010	Lee, Jack/0000-0002-4584-929X; Heymach, John/0000-0001-9068-8942; Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Saintigny, Pierre/0000-0002-8090-9323	NIH [P50 CA70907, P01 CA06294]; Department of Defense [W81XWH-07-1-0306 01]; Metastasis Foundation; Physician-Scientist Program; American Society for Clinical Oncology Career Development Award; Damon Runyon Cancer Research Foundation [CI 24-04]; NATIONAL CANCER INSTITUTE [P50CA070907, P01CA006294] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Metastasis Foundation; Physician-Scientist Program; American Society for Clinical Oncology Career Development Award; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Mien-Chie Hung, Scott Lippman, and Kian Ang for their critical review, Dr Jeffrey Engelman for the EGFR-transfected NIH 3T3 cell lines, and Joseph Munch for editorial assistance. Supported in part by the NIH Lung Cancer SPORE grant P50 CA70907, NIH Grant P01 CA06294, Department of Defense Grant W81XWH-07-1-0306 01, awards from the Metastasis Foundation, the Physician-Scientist Program, and the American Society for Clinical Oncology Career Development Award (JVH). JVH is a Damon Runyon-Lilly Clinical Investigator supported in part by the Damon Runyon Cancer Research Foundation (CI 24-04).	Beadsmoore CJ, 2003, EUR J RADIOL, V45, P8, DOI 10.1016/S0720-048X(02)00287-5; Bergstrom JD, 2000, EXP CELL RES, V259, P293, DOI 10.1006/excr.2000.4967; Bredin CG, 2003, ANTICANCER RES, V23, P4877; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; COOPER CS, 1986, EMBO J, V5, P2623, DOI 10.1002/j.1460-2075.1986.tb04543.x; Cuvier C, 1997, CLIN EXP METASTAS, V15, P19; Damstrup L, 1998, BRIT J CANCER, V78, P631, DOI 10.1038/bjc.1998.553; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; HAMADA J, 1995, CANCER LETT, V89, P161, DOI 10.1016/0304-3835(95)03686-Q; Hirami Y, 2004, CANCER LETT, V214, P157, DOI 10.1016/j.canlet.2004.04.028; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Ichimura E, 1996, JPN J CANCER RES, V87, P1063, DOI 10.1111/j.1349-7006.1996.tb03111.x; Ide T, 2006, INT J CANCER, V119, P2750, DOI 10.1002/ijc.22178; Janne PA, 2005, J CLIN ONCOL, V23, P3227, DOI 10.1200/JCO.2005.09.985; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; LIU C, 1993, AM J PATHOL, V142, P1155; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Luwor RB, 2005, ONCOGENE, V24, P4433, DOI 10.1038/sj.onc.1208625; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Nakamura Y, 2007, CANCER SCI, V98, P1006, DOI 10.1111/j.1349-7006.2007.00493.x; Olivero M, 1996, BRIT J CANCER, V74, P1862, DOI 10.1038/bjc.1996.646; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pai R, 2003, FASEB J, V17, P1640, DOI 10.1096/fj.02-1011com; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2005, J CLIN ONCOL, V23, P2556, DOI 10.1200/JCO.2005.07.799; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Pore N, 2006, CANCER RES, V66, P3197, DOI 10.1158/0008-5472.CAN-05-3090; Qiao H, 2002, J CELL BIOCHEM, V86, P665, DOI 10.1002/jcb.10239; Rosario M, 2003, TRENDS CELL BIOL, V13, P328, DOI 10.1016/S0962-8924(03)00104-1; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Scheving LA, 2002, BIOCHEM BIOPH RES CO, V290, P197, DOI 10.1006/bbrc.2001.6157; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Shimazaki K, 2003, BRAIN RES, V962, P105, DOI 10.1016/S0006-8993(02)03975-6; Siegfried JM, 1998, ANN THORAC SURG, V66, P1915, DOI 10.1016/S0003-4975(98)01165-5; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Stabile LP, 2004, GENE THER, V11, P325, DOI 10.1038/sj.gt.3302169; Swinson DEB, 2006, CLIN LUNG CANCER, V7, P250, DOI 10.3816/CLC.2006.n.002; Swinson DEB, 2004, INT J CANCER, V111, P43, DOI 10.1002/ijc.20052; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Weinberger PM, 2005, ARCH OTOLARYNGOL, V131, P707, DOI 10.1001/archotol.131.8.707; Yang Y, 2008, MOL CANCER THER, V7, P952, DOI 10.1158/1535-7163.MCT-07-2045; Yi S, 1998, BRIT J CANCER, V77, P2162, DOI 10.1038/bjc.1998.361; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603; Zhong H, 2000, CANCER RES, V60, P1541; Zhou QC, 2006, ZEBRAFISH, V3, P39, DOI 10.1089/zeb.2006.3.39	60	69	71	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2010	29	18					2616	2627		10.1038/onc.2010.16	http://dx.doi.org/10.1038/onc.2010.16			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	592DC	20154724	Green Accepted			2022-12-25	WOS:000277354600002
J	Han, Y; Huang, C; Sun, XX; Xiang, BG; Wang, M; Yeh, ETH; Chen, YY; Li, H; Shi, GY; Cang, H; Sun, YP; Wang, J; Wang, W; Gao, F; Yi, J				Han, Yan; Huang, Chao; Sun, Xuxu; Xiang, Binggang; Wang, Ming; Yeh, Edward T. H.; Chen, Yuying; Li, Hui; Shi, Guiying; Cang, Hui; Sun, Yueping; Wang, Jian; Wang, Wei; Gao, Fei; Yi, Jing			SENP3-mediated De-conjugation of SUMO2/3 from Promyelocytic Leukemia Is Correlated with Accelerated Cell Proliferation under Mild Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PML NUCLEAR-BODIES; NF-KAPPA-B; PROTEIN SUMOYLATION; TYROSINE KINASES; CEREBRAL-ISCHEMIA; BODY FORMATION; CANCER; ACTIVATION; SENP3; ND10	Small ubiquitin-like modifier (SUMO) 2/3 is known to conjugate to substrates in response to a variety of cellular stresses. However, whether and how SUMO2/3-specific proteases are involved in de-conjugation under cell stress is unclear. Here, we show that low doses of hydrogen peroxide (H2O2) induce an increase of the SENP3 protein, which removes SUMO2/3 from promyelocytic leukemia (PML). Low dose H2O2 causes SENP3 to co-localize with PML bodies and reduces the number of PML bodies in a SENP3-dependent manner. Furthermore, de-conjugation of SUMO2/3 from PML is responsible for the accelerated cell proliferation caused by low dose H2O2. Knocking down PML promotes basal cell proliferation as expected. This can be reversed by reconstitution with wild-type PML but not its mutant lacking SUMOylation, indicating that only the SUMOylated PML can play an inhibitory role for cell proliferation. Thus, SENP3 appears to be a key mediator in mild oxidative stress-induced cell proliferation via regulation of the SUMOylation status of PML. Furthermore, SENP3 is over-accumulated in a variety of primary human cancers including colon adenocarcinoma in which PML is hypo-SUMOylated. These results reveal an important role of SENP3 and the SUMOylation status of PML in the regulation of cell proliferation under oxidative stress.	[Han, Yan; Huang, Chao; Sun, Xuxu; Xiang, Binggang; Wang, Ming; Chen, Yuying; Li, Hui; Shi, Guiying; Cang, Hui; Sun, Yueping; Gao, Fei; Yi, Jing] Shanghai Jiao Tong Univ, Sch Med, Dept Cell Biol,Inst Med Sci, Key Lab Educ Minist Cell Differentiat & Apoptosis, Shanghai 200025, Peoples R China; [Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; [Wang, Jian; Wang, Wei] Shanghai Jiao Tong Univ, Sch Med, Dept Surg, Ren Ji Hosp, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University	Yi, J (corresponding author), 280 S Chongqing Rd, Shanghai 200025, Peoples R China.	yijing@shsmu.edu.cn	Xiang, Binggang/N-6494-2013	huang, chao/0000-0002-4913-921X; Wang, Jian/0000-0002-5335-8845	National Natural Science Foundation of China [30971437]; Ministry of Science and Technology of China [2006CB910104]; Shanghai Municipal Science and Technology Commission [08JC1413800]; Shanghai Municipal Education Commission [J50201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by grants from the National Natural Science Foundation of China (30971437), the Ministry of Science and Technology of China (2006CB910104), Shanghai Municipal Science and Technology Commission (08JC1413800), and Shanghai Municipal Education Commission (J50201).	Beech SJ, 2005, EXP CELL RES, V307, P109, DOI 10.1016/j.yexcr.2005.03.012; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; BIANCHINI L, 1993, J BIOL CHEM, V268, P3357; Boddy MN, 1996, ONCOGENE, V13, P971; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Di Bacco A, 2006, CELL CYCLE, V5, P2310, DOI 10.4161/cc.5.20.3367; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Ding XJ, 2008, ONCOL REP, V20, P1041, DOI 10.3892/or_00000107; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Galaris D, 2008, CANCER LETT, V266, P21, DOI 10.1016/j.canlet.2008.02.038; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Huang XZ, 2008, CANCER BIOL THER, V7, P468, DOI 10.4161/cbt.7.3.5457; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Kamei H, 1997, EXP CELL RES, V237, P207, DOI 10.1006/excr.1997.3790; Klein UR, 2009, MOL BIOL CELL, V20, P410, DOI 10.1091/mbc.E08-05-0511; Kuo ML, 2008, CELL CYCLE, V7, P3378, DOI 10.4161/cc.7.21.6930; Laviano A, 2007, CURR OPIN CLIN NUTR, V10, P449, DOI 10.1097/MCO.0b013e328122db94; Le XF, 1996, J BIOL CHEM, V271, P130, DOI 10.1074/jbc.271.1.130; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; Li TW, 2006, J BIOL CHEM, V281, P36221, DOI 10.1074/jbc.M608236200; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Maul GG, 1995, J CELL BIOCHEM, V59, P498, DOI 10.1002/jcb.240590410; MESSINA MJ, 1991, FREE RADICAL BIO MED, V10, P175, DOI 10.1016/0891-5849(91)90072-B; MU ZM, 1994, MOL CELL BIOL, V14, P6858, DOI 10.1128/MCB.14.10.6858; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Natarajan R, 2002, FREE RADICAL BIO MED, V33, P962, DOI 10.1016/S0891-5849(02)00990-5; Nefkens I, 2003, J CELL SCI, V116, P513, DOI 10.1242/jcs.00253; Nishida T, 2000, EUR J BIOCHEM, V267, P6423, DOI 10.1046/j.1432-1327.2000.01729.x; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V371, P823, DOI 10.1016/j.bbrc.2008.04.179; Qin SF, 1996, EUR J BIOCHEM, V236, P443, DOI 10.1111/j.1432-1033.1996.00443.x; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; SCHIEVEN GL, 1993, BLOOD, V82, P1212, DOI 10.1182/blood.V82.4.1212.bloodjournal8241212; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Wang FB, 2008, EXP CELL RES, V314, P213, DOI 10.1016/j.yexcr.2007.09.022; Wang RY, 2009, ANAT REC, V292, P777, DOI 10.1002/ar.20904; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	55	81	92	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12906	12915		10.1074/jbc.M109.071431	http://dx.doi.org/10.1074/jbc.M109.071431			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20181954	Green Published, hybrid			2022-12-25	WOS:000276787800049
J	Li, YJ; Xu, FFL; Lu, J; Saunders, WS; Prochownik, EV				Li, Youjun; Xu, Fengfeng L.; Lu, Jie; Saunders, William S.; Prochownik, Edward V.			Widespread Genomic Instability Mediated by a Pathway Involving Glycoprotein Ib alpha and Aurora B Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; C-MYC TARGET; DNA-DAMAGE; CHROMOSOME SEGREGATION; PROMOTES TUMORIGENESIS; ENDOPLASMIC-RETICULUM; CELL-DIVISION; IN-VITRO; CYTOKINESIS; REPAIR	c-Myc (Myc) oncoprotein induction of genomic instability (GI) contributes to its initial transforming function and subsequent tumor cell evolution. We describe here a pathway by which Myc, via its target protein glycoprotein Ib alpha (GpIb alpha), mediates GI. Proteomic profiling revealed that the serine/threonine kinase Aurora B is down-regulated by GpIb alpha in p53-deficient primary human fibroblasts. The phenotypes of Aurora B deficiency are strikingly reminiscent of Myc or GpIb alpha overexpression and include double-stranded DNA breaks, altered nuclear size and morphology, chromatin bridges, cleavage furrow regression, and tetraploidy. During mitosis, GpIb alpha and Aurora B redistribute to the cleavage furrow along with other cleavage furrow proteins. GpIb alpha overexpression at levels comparable with those seen in some tumor cells causes the dispersal of these proteins but not Aurora B, resulting in furrow regression and cytokinesis failure. Aurora B normalization redirects the mislocalized furrow proteins to their proper location, corrects the cleavage furrow abnormalities, and restores genomic stability. Aurora B thus appears necessary for a previously unrecognized function in guiding and positioning a number of key proteins, including GpIb alpha to the cleavage furrow. These findings underscore the importance of maintaining a delicate balance among cleavage furrow-associated proteins during mitosis. Suppression of Aurora B via GpIb alpha provides a unifying and mechanistic explanation for several types of Myc-mediated GI.	Univ Pittsburgh, Hematol Oncol Sect, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15201 USA; [Xu, Fengfeng L.; Saunders, William S.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15201 USA; [Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Dept Microbiol & Mol Genet, Pittsburgh, PA 15201 USA; [Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), Childrens Hosp Pittsburgh, Hematol Oncol Sect, Res Ctr, Rm 5124,530 45th St, Pittsburgh, PA 15201 USA.	prochownikev@upmc.edu			National Institutes of Health [RO1 CA105033, ROI DE 016086]; NATIONAL CANCER INSTITUTE [R01CA105033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA105033 (to E. V. P.) and ROI DE 016086 (to W. S. S.).	Acilan C, 2007, GENE CHROMOSOME CANC, V46, P522, DOI 10.1002/gcc.20425; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cimini D, 2003, MOL BIOL CELL, V14, P3821, DOI 10.1091/mbc.E03-01-0860; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Doxsey SJ, 2005, MOL CELL, V20, P170, DOI 10.1016/j.molcel.2005.10.010; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Eilers M, 1999, MOL CELLS, V9, P1; Engels WR, 2007, CELL CYCLE, V6, P131, DOI 10.4161/cc.6.2.3758; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Geddis AE, 2007, CELL CYCLE, V6, P455, DOI 10.4161/cc.6.4.3836; Ghiorghi YK, 2007, J BIOL CHEM, V282, P8150, DOI 10.1074/jbc.M610648200; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Kanaji T, 2004, BLOOD, V104, P3161, DOI 10.1182/blood-2004-03-0893; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kuo LJ, 2008, IN VIVO, V22, P305; Kuttler F, 2006, GENOME DYN, V1, P171, DOI 10.1159/000092507; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Li Y, 2008, ONCOGENE, V27, P1599, DOI 10.1038/sj.onc.1210794; Li YJ, 2007, P NATL ACAD SCI USA, V104, P3490, DOI 10.1073/pnas.0610163104; Li YJ, 2009, J BIOL CHEM, V284, P1410, DOI 10.1074/jbc.M806222200; Lopez J A, 1997, Curr Opin Hematol, V4, P323; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; Mendoza M, 2008, BIOCHEM SOC T, V36, P387, DOI 10.1042/BST0360387; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nair JS, 2009, MOL BIOL CELL, V20, P2218, DOI 10.1091/mbc.E08-08-0885; Natarajan AT, 2008, MUTAT RES-GEN TOX EN, V657, P3, DOI 10.1016/j.mrgentox.2008.08.017; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Neiman PE, 2006, ONCOGENE, V25, P6325, DOI 10.1038/sj.onc.1209646; Nguyen HG, 2009, FASEB J, V23, P2741, DOI 10.1096/fj.09-130963; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; Pellman D, 2007, NATURE, V446, P38, DOI 10.1038/446038a; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Rogulski KR, 2005, P NATL ACAD SCI USA, V102, P18968, DOI 10.1073/pnas.0507902102; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sallmyr A, 2008, CANCER LETT, V270, P1, DOI 10.1016/j.canlet.2008.03.036; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shields BJ, 2008, CANCER CELL, V14, P166, DOI 10.1016/j.ccr.2008.06.003; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tsuno T, 2007, J NEURO-ONCOL, V83, P249, DOI 10.1007/s11060-007-9335-1; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Weaver BAA, 2006, NATURE, V442, pE9, DOI 10.1038/nature05139; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yin XY, 2002, J BIOL CHEM, V277, P19998, DOI 10.1074/jbc.M200860200; Yin XY, 2001, CANCER RES, V61, P6487; Zhou ZQ, 2001, TRENDS CELL BIOL, V11, pS10, DOI 10.1016/S0962-8924(01)02121-3	75	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13183	13192		10.1074/jbc.M109.084913	http://dx.doi.org/10.1074/jbc.M109.084913			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20157117	Green Published, hybrid			2022-12-25	WOS:000276787800073
J	Sobczak, K; Michlewski, G; de Mezer, M; Kierzek, E; Krol, J; Olejniczak, M; Kierzek, R; Krzyzosiak, WJ				Sobczak, Krzysztof; Michlewski, Gracjan; de Mezer, Mateusz; Kierzek, Elzbieta; Krol, Jacek; Olejniczak, Marta; Kierzek, Ryszard; Krzyzosiak, Wlodzimierz J.			Structural Diversity of Triplet Repeat RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO TRANSLATION; TRINUCLEOTIDE REPEATS; G-QUADRUPLEX; CAG REPEATS; MYOTONIC-DYSTROPHY; MESSENGER-RNA; CUG REPEATS; FORM; DNA; GENE	Tandem repeats of various trinucleotide motifs are present in the human transcriptome, but the functions of these regular sequences, which likely depend on the structures they form, are still poorly understood. To gain new insight into the structural and functional properties of triplet repeats in RNA, we have performed a biochemical structural analysis of the complete set of triplet repeat transcripts, each composed of a single sequence repeated 17 times. We show that these transcripts fall into four structural classes. The repeated CAA, UUG, AAG, CUU, CCU, CCA, and UAA motifs did not form any higher order structure under any analyzed conditions. The CAU, CUA, UUA, AUG, and UAG repeats are ordered according to their increasing tendency to form semistable hairpins. The repeated CGA, CGU, and all CNG motifs form fairly stable hairpins, whereas AGG and UGG repeats fold into stable G-quadruplexes. The triplet a repeats that formed the most stable structures were characterized further by biophysical methods. UV-monitored structure melting revealed that CGG and CCG repeats form, respectively, the most and least stable hairpins of all CNG repeats. Circular dichroism spectra showed that the AGG and UGG repeat quadruplexes are formed by parallel RNA strands. Furthermore, we demonstrated that the different susceptibility of various triplet repeat transcripts to serum nucleases can be explained by the sequence and structural features of the tested RNAs. The results of this study provide a comprehensive structural foundation for the functional analysis of triplet repeats in transcripts.	[Sobczak, Krzysztof; Michlewski, Gracjan; de Mezer, Mateusz; Krol, Jacek; Olejniczak, Marta; Krzyzosiak, Wlodzimierz J.] Polish Acad Sci, Inst Bioorgan Chem, Canc Genet Lab, PL-61704 Poznan, Poland; [Kierzek, Elzbieta; Kierzek, Ryszard] Polish Acad Sci, Inst Bioorgan Chem, Lab RNA Chem, PL-61704 Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Krzyzosiak, WJ (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Canc Genet Lab, Noskowskiego 12-14 St, PL-61704 Poznan, Poland.	wlodkrzy@ibch.poznan.pl	de Mezer, Mateusz/B-2060-2012; Michlewski, Gracjan/J-1264-2019; de Mezer, Mateusz/GQP-6125-2022; Olejniczak, Marta/W-2610-2018; Olejniczak, Marta/AAU-5704-2020	Michlewski, Gracjan/0000-0002-7409-9619; de Mezer, Mateusz/0000-0003-4718-9747; Olejniczak, Marta/0000-0001-8471-6302; Olejniczak, Marta/0000-0001-8471-6302; Kierzek, Elzbieta/0000-0002-5563-003X; Sobczak, Krzysztof/0000-0001-8352-9812; Kierzek, Ryszard/0000-0002-7644-0016	European Union [LSHB-CT-2004- 005276]; Ministry of Science and Higher Education [PBZ-MNil-2/1/2005, N301-112-32/3910, N302 278937, N N301 284837]; Operational Programme "Innovative economy" [POIG.01.03.01-00-098/08]	European Union(European Commission); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Operational Programme "Innovative economy"	This work was supported by grants from the Sixth Research Framework Programme of the European Union, Project RIGHT (Grant LSHB-CT-2004- 005276) and the Ministry of Science and Higher Education, Grants PBZ-MNil-2/1/2005, N301-112-32/3910, N302 278937, and N N301 284837, and Operational Programme "Innovative economy" Grant POIG.01.03.01-00-098/08.	Arora A, 2008, RNA, V14, P1290, DOI 10.1261/rna.1001708; Bonnal S, 2003, J BIOL CHEM, V278, P39330, DOI 10.1074/jbc.M305580200; Broda M, 2005, BIOCHEMISTRY-US, V44, P10873, DOI 10.1021/bi0502339; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; Chen LS, 2003, HUM MOL GENET, V12, P3067, DOI 10.1093/hmg/ddg331; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; GIEGE R, 2001, RNA, P71; Gomez D, 2004, NUCLEIC ACIDS RES, V32, P371, DOI 10.1093/nar/gkh181; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Huppert JL, 2008, BIOCHIMIE, V90, P1140, DOI 10.1016/j.biochi.2008.01.014; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jasinska A, 2003, NUCLEIC ACIDS RES, V31, P5463, DOI 10.1093/nar/gkg767; KETTANI A, 1995, J MOL BIOL, V254, P638, DOI 10.1006/jmbi.1995.0644; Khateb S, 2004, NUCLEIC ACIDS RES, V32, P4145, DOI 10.1093/nar/gkh745; Khateb S, 2007, NUCLEIC ACIDS RES, V35, P5775, DOI 10.1093/nar/gkm636; Kierzek R, 1999, BIOCHEMISTRY-US, V38, P14214, DOI 10.1021/bi991186l; Kiliszek A, 2009, NUCLEIC ACIDS RES, V37, P4149, DOI 10.1093/nar/gkp350; Kozlowski P, 2010, NUCLEIC ACIDS RES, V38, P4027, DOI 10.1093/nar/gkq127; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Krzyzosiak W.J., 2006, GENETIC INSTABILITIE, P705; KRZYZOSIAK WJ, 1988, BIOCHEMISTRY-US, V27, P5771, DOI 10.1021/bi00415a056; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lee MM, 2009, J AM CHEM SOC, V131, P17464, DOI 10.1021/ja906877y; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Matsugami A, 2003, J BIOL CHEM, V278, P28147, DOI 10.1074/jbc.M303694200; Matsugami A, 2001, J MOL BIOL, V313, P255, DOI 10.1006/jmbi.2001.5047; MATSUGAMI A, 2008, NUCL ACIDS S SER, V52, P179; MATSUGAMI A, 2002, NUCLEIC ACIDS RES, V2, P49; McDowell JA, 1996, BIOCHEMISTRY-US, V35, P14077, DOI 10.1021/bi9615710; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, P81, DOI 10.1093/nar/gki148; Michalowski S, 1999, NUCLEIC ACIDS RES, V27, P3534, DOI 10.1093/nar/27.17.3534; Michlewski G, 2004, J MOL BIOL, V340, P665, DOI 10.1016/j.jmb.2004.05.021; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mooers BHM, 2005, P NATL ACAD SCI USA, V102, P16626, DOI 10.1073/pnas.0505873102; Napierala M, 1997, J BIOL CHEM, V272, P31079, DOI 10.1074/jbc.272.49.31079; Napierala M, 2005, NUCLEIC ACIDS RES, V33, P451, DOI 10.1093/nar/gki186; Nishikawa F, 2009, OLIGONUCLEOTIDES, V19, P179, DOI 10.1089/oli.2008.0167; O'Rourke JR, 2009, J BIOL CHEM, V284, P7419, DOI 10.1074/jbc.R800025200; Ofer N, 2009, NUCLEIC ACIDS RES, V37, P2712, DOI 10.1093/nar/gkp130; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pushechnikov A, 2009, J AM CHEM SOC, V131, P9767, DOI 10.1021/ja9020149; Qiu L, 1998, MOL GEN GENET, V258, P352, DOI 10.1007/s004380050741; Rozanska M, 2007, HUM MUTAT, V28, P451, DOI 10.1002/humu.20466; SHIDA T, 1997, NUCL ACIDS S SER, V37, P129; Shin J, 2009, NEUROSCI LETT, V466, P99, DOI 10.1016/j.neulet.2009.07.079; Sobczak K, 2005, J BIOL CHEM, V280, P3898, DOI 10.1074/jbc.M409984200; Sobczak K, 2004, J BIOL CHEM, V279, P41563, DOI 10.1074/jbc.M405130200; Sobczak K, 2003, NUCLEIC ACIDS RES, V31, P5469, DOI 10.1093/nar/gkg766; Sorrentino S, 1998, CELL MOL LIFE SCI, V54, P785, DOI 10.1007/s000180050207; Sorrentino S, 1997, FEBS LETT, V404, P1, DOI 10.1016/S0014-5793(97)00086-0; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Usdin K, 2008, GENOME RES, V18, P1011, DOI 10.1101/gr.070409.107; Vieregg J, 2007, J AM CHEM SOC, V129, P14966, DOI 10.1021/ja074809o; Wieland M, 2007, CHEM BIOL, V14, P757, DOI 10.1016/j.chembiol.2007.06.005; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zanotti KJ, 2006, BIOCHEMISTRY-US, V45, P8319, DOI 10.1021/bi060209a; Zumwalt M, 2007, RNA BIOL, V4, P93, DOI 10.4161/rna.4.2.5039	61	90	91	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12755	12764		10.1074/jbc.M109.078790	http://dx.doi.org/10.1074/jbc.M109.078790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20159983	Green Published, hybrid			2022-12-25	WOS:000276787800034
J	Mora-Montes, HM; Bates, S; Netea, MG; Castillo, L; Brand, A; Buurman, ET; Diaz-Jimenez, DF; Kullberg, BJ; Brown, AJP; Odds, FC; Gow, NAR				Mora-Montes, Hector M.; Bates, Steven; Netea, Mihai G.; Castillo, Luis; Brand, Alexandra; Buurman, Ed T.; Diaz-Jimenez, Diana F.; Kullberg, Bart Jan; Brown, Alistair J. P.; Odds, Frank C.; Gow, Neil A. R.			A Multifunctional Mannosyltransferase Family in Candida albicans Determines Cell Wall Mannan Structure and Host-Fungus Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN MANNOSYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; MANNOSYLPHOSPHATE TRANSFER; ANTIFUNGAL RESISTANCE; IMMUNE RECOGNITION; MOLECULAR ANALYSIS; SEROTYPE-B; VIRULENCE; GLYCOSYLATION	The cellwall proteins of fungi are modified by N- and O-linked mannosylation and phosphomannosylation, resulting in changes to the physical and immunological properties of the cell. Glycosylation of cell wall proteins involves the activities of families of endoplasmic reticulum and Golgi-located glycosyl transferases whose activities are difficult to infer through bioinformatics. The Candida albicans MNT1/KRE2 mannosyl transferase family is represented by five members. We showed previously that Mnt1 and Mnt2 are involved in O-linked mannosylation and are required for virulence. Here, the role of C. albicans MNT3, MNT4, and MNT5 was determined by generating single andmultiple MnT Delta null mutants and by functional complementation experiments in Saccharomyces cerevisiae. CaMnt3, CaMnt4, and CaMnt5 did not participate in O-linked mannosylation, but CaMnt3 and CaMnt5 had redundant activities in phosphomannosylation and were responsible for attachment of approximately half of the phosphomannan attached to N-linked mannans. CaMnt4 and CaMnt5 participated in N-mannan branching. Deletion of CaMNT3, CaMNT4, and CaMNT5 affected the growth rate and virulence of C. albicans, affected the recognition of the yeast by human monocytes and cytokine stimulation, and led to increased cell wall chitin content and exposure of beta-glucan at the cell wall surface. Therefore, the MNT1/KRE2 gene family participates in three types of protein mannosylation in C. albicans, and these modifications play vital roles in fungal cell wall structure and cell surface recognition by the innate immune system.	[Mora-Montes, Hector M.; Bates, Steven; Castillo, Luis; Brand, Alexandra; Buurman, Ed T.; Brown, Alistair J. P.; Odds, Frank C.; Gow, Neil A. R.] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Netea, Mihai G.; Kullberg, Bart Jan] Radboud Univ Nijmegen, Dept Med, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Diaz-Jimenez, Diana F.] Univ Guanajuato, Dept Biol, Div Ciencias Nat & Exactas, Guanajuato 6000, Mexico	University of Aberdeen; Radboud University Nijmegen; Universidad de Guanajuato	Gow, NAR (corresponding author), Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen AB25 2ZD, Scotland.	n.gow@abdn.ac.uk	Netea, Mihai/N-5155-2014; Montes, Hector Manuel Mora/H-1729-2014; Kullberg, BJ/C-8520-2013; Brown, Alistair J.P./B-6627-2014; GOW, Neil/AAS-5323-2021; Brand, Alexandra/P-7493-2018	Montes, Hector Manuel Mora/0000-0001-6973-0595; Kullberg, BJ/0000-0002-6813-8167; GOW, Neil/0000-0002-2776-5850; Bates, Steven/0000-0003-0489-5705; Brown, Alistair JP/0000-0003-1406-4251; Brand, Alexandra/0000-0002-7381-131X	Wellcome Trust [080088]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Programme Grant 080088 (to N.A.R.G., A.J.P.B., and F.C.O.).	Bai C, 2006, EUKARYOT CELL, V5, P238, DOI 10.1128/EC.5.2.238-247.2006; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Buurman ET, 1998, P NATL ACAD SCI USA, V95, P7670, DOI 10.1073/pnas.95.13.7670; Calderone Richard A., 1993, Trends in Microbiology, V1, P55, DOI 10.1016/0966-842X(93)90033-N; Cambi A, 2008, J BIOL CHEM, V283, P20590, DOI 10.1074/jbc.M709334200; de Nobel H, 2000, TRENDS MICROBIOL, V8, P344, DOI 10.1016/S0966-842X(00)01805-9; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; FONZI WA, 1993, GENETICS, V134, P717; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; Jigami Y, 1999, BBA-GEN SUBJECTS, V1426, P335, DOI 10.1016/S0304-4165(98)00134-2; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lussier M, 1997, J BIOL CHEM, V272, P15527, DOI 10.1074/jbc.272.24.15527; Lussier M, 1996, J BIOL CHEM, V271, P11001, DOI 10.1074/jbc.271.18.11001; Lussier M, 1999, BBA-GEN SUBJECTS, V1426, P323, DOI 10.1016/S0304-4165(98)00133-0; Mora-Montes HM, 2007, EUKARYOT CELL, V6, P2184, DOI 10.1128/EC.00350-07; Munro CA, 2005, J BIOL CHEM, V280, P1051, DOI 10.1074/jbc.M411413200; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nakayama K, 1998, BBA-GEN SUBJECTS, V1425, P255, DOI 10.1016/S0304-4165(98)00078-6; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Nishikawa A, 2002, J BACTERIOL, V184, P29, DOI 10.1128/JB.184.1.29-42.2002; Odani T, 1996, GLYCOBIOLOGY, V6, P805, DOI 10.1093/glycob/6.8.805; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Plaine A, 2008, FUNGAL GENET BIOL, V45, P1404, DOI 10.1016/j.fgb.2008.08.003; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; Rieg G, 1999, INFECT IMMUN, V67, P3193, DOI 10.1128/IAI.67.7.3193-3198.1999; Rouabhia M, 2005, INFECT IMMUN, V73, P4571, DOI 10.1128/IAI.73.8.4571-4580.2005; SHIBATA N, 1992, INFECT IMMUN, V60, P4100, DOI 10.1128/IAI.60.10.4100-4110.1992; Singleton DR, 2005, EUKARYOT CELL, V4, P639, DOI 10.1128/EC.4.4.639-648.2005; Southard SB, 1999, J BACTERIOL, V181, P7439, DOI 10.1128/JB.181.24.7439-7448.1999; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Thomson LM, 2000, J BIOL CHEM, V275, P18933, DOI 10.1074/jbc.M909699199; Timpel C, 2000, J BACTERIOL, V182, P3063, DOI 10.1128/JB.182.11.3063-3071.2000; Timpel C, 1998, J BIOL CHEM, V273, P20837, DOI 10.1074/jbc.273.33.20837; Trinel PA, 1997, FEBS LETT, V416, P203, DOI 10.1016/S0014-5793(97)01205-2; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Wang XH, 1997, J BIOL CHEM, V272, P18117, DOI 10.1074/jbc.272.29.18117; Wang YY, 1998, INFECT IMMUN, V66, P1384, DOI 10.1128/IAI.66.4.1384-1391.1998; Warit S, 2000, MOL MICROBIOL, V36, P1156, DOI 10.1046/j.1365-2958.2000.01944.x; Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1&lt;65::AID-YEA508&gt;3.0.CO;2-M	46	88	94	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12087	12095		10.1074/jbc.M109.081513	http://dx.doi.org/10.1074/jbc.M109.081513			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164191	hybrid, Green Published			2022-12-25	WOS:000276787100038
J	Henderson, MJ; Vij, N; Zeitlin, PL				Henderson, Mark J.; Vij, Neeraj; Zeitlin, Pamela L.			Ubiquitin C-terminal Hydrolase-L1 Protects Cystic Fibrosis Transmembrane Conductance Regulator from Early Stages of Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; GREEN FLUORESCENT PROTEIN; CELL-CYCLE ANALYSIS; DEUBIQUITINATING ENZYMES; DOWN-REGULATION; QUALITY-CONTROL; L1 GENE; CFTR; DISEASE; UCH-L1	Delta F508 cystic fibrosis transmembrane conductance regulator (CFTR) degradation involves ubiquitin modification and efficient proteasomal targeting of the nascent misfolded protein. We show that a deubiquitinating enzyme, ubiquitin C-terminal hydrolase-L1 (UCH-L1), is highly expressed in cystic fibrosis (CF) airway epithelial cells in vitro and in vivo. We hypothesized that the elevation in UCH-L1 in CF cells represents a cellular adaptation to counterbalance excessive proteasomal degradation. The bronchial epithelial cell lines IB3-1 (CF, high UCH-L1 expression) and S9 (non-CF, low UCH-L1 expression) were transiently transfected with wild type (WT) or Delta F508 CFTR, WTUCH-L1 or small interfering RNA-UCH-L1, and a variety of ubiquitin mutants. We observed a positive correlation between UCH-L1 expression and steady state levels of WT- or Delta F508CFTR, and this stabilizing effect was confined to the early stages of CFTR synthesis. Immunolocalization of UCH-L1 by confocal microscopy revealed a partial co-localization with a ribosomal subunit and the endoplasmic reticulum. The UCH-L1-associated increase in CFTR levels was correlated with an increase in ubiquitinated CFTR (CFTR-Ub). Co-transfection with mutant ubiquitins and treatment with proteasome inhibitors suggested that UCH-L1 was reducing the proteasomal targeting of CFTR during synthesis by shortening conjugated polyubiquitin chains. Although not sufficient by itself to rescue mutant CFTR therapeutically, the elevation of UCH-L1 and its effect on CFTR processing provides insight into its potential roles in CF and other diseases.	[Henderson, Mark J.; Vij, Neeraj; Zeitlin, Pamela L.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Zeitlin, PL (corresponding author), 200 N wolfe St,Rm 3051, Baltimore, MD 21287 USA.	pzeitlin@jhmi.edu		Henderson, Mark/0000-0001-8590-7338; Zeitlin, Pamela/0000-0002-2719-1834	National Institutes of Health [R01 HL59410, BAA-HL-0204]; CTSA [UL1 RR 025005]; Cystic Fibrosis Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059410, R03HL096931] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL59410, BAA-HL-0204, and CTSA UL1 RR 025005 (to P.L.Z.). This work was also supported by a Cystic Fibrosis Foundation grant (to N.V.).	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Ardley HC, 2004, J NEUROCHEM, V90, P379, DOI 10.1111/j.1471-4159.2004.02485.x; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; GRUENERT DC, 1988, P NATL ACAD SCI USA, V85, P5951, DOI 10.1073/pnas.85.16.5951; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kalejta RF, 1999, EXP CELL RES, V248, P322, DOI 10.1006/excr.1999.4427; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Liu ZH, 2009, P NATL ACAD SCI USA, V106, P4635, DOI 10.1073/pnas.0806474106; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Maraganore DM, 1999, NEUROLOGY, V53, P1858, DOI 10.1212/WNL.53.8.1858; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Miyoshi Y, 2006, CANCER SCI, V97, P523, DOI 10.1111/j.1349-7006.2006.00202.x; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Naze P, 2002, NEUROSCI LETT, V328, P1, DOI 10.1016/S0304-3940(02)00231-8; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pollard HB, 2006, MOL CELL PROTEOMICS, V5, P1628, DOI 10.1074/mcp.M600091-MCP200; Qu BH, 1997, J BIOENERG BIOMEMBR, V29, P483, DOI 10.1023/A:1022439108101; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rolen U, 2006, MOL CARCINOGEN, V45, P260, DOI 10.1002/mc.20177; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Singh OV, 2008, MOL CELL PROTEOMICS, V7, P1099, DOI 10.1074/mcp.M700303-MCP200; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tokumaru Y, 2008, INT J CANCER, V123, P753, DOI 10.1002/ijc.23354; Tokunaga Fuminori, 2009, Tanpakushitsu Kakusan Koso, V54, P635; Van Oene M, 2000, J BIOL CHEM, V275, P19577, DOI 10.1074/jbc.M002186200; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Xue SF, 2006, BRAIN RES, V1087, P28, DOI 10.1016/j.brainres.2006.02.121; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; ZEITLIN PL, 1992, P NATL ACAD SCI USA, V89, P344, DOI 10.1073/pnas.89.1.344; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	61	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11314	11325		10.1074/jbc.M109.044057	http://dx.doi.org/10.1074/jbc.M109.044057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147297	Green Published, hybrid			2022-12-25	WOS:000276286200038
J	Marat, AL; McPherson, PS				Marat, Andrea L.; McPherson, Peter S.			The Connecdenn Family, Rab35 Guanine Nucleotide Exchange Factors Interfacing with the Clathrin Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA; SYNAPTIC VESICLE ENDOCYTOSIS; BETA-2 APPENDAGE; RAB6-INTERACTING PROTEIN-1; ALPHA-APPENDAGE; BINDING-PROTEIN; ADAPTER PROTEIN; LDL RECEPTOR; DENN DOMAIN; AP-2	Rabs constitute the largest family of monomeric GTPases, yet for the majority of Rabs relatively little is known about their activation and recruitment to vesicle-trafficking pathways. We recently identified connecdenn (DENND1A), which contains an N-terminal DENN (differentially expressed in neoplastic versus normal cells) domain, a common and evolutionarily ancient protein module. Through its DENN domain, connecdenn functions enzymatically as a guanine-nucleotide exchange factor (GEF) for Rab35. Here we identify two additional connecdenn family members and demonstrate that all connecdenns function as Rab35 GEFs, albeit with different levels of activity. The DENN domain of connecdenn 1 and 2 binds Rab35, whereas connecdenn 3 does not, indicating that Rab35 binding and activation are separable functions. Through their highly divergent C termini, each of the connecdenns binds to clathrin and to the clathrin adaptor AP-2. Interestingly, all three connecdenns use different mechanisms to bind AP-2. Characterization of connecdenn 2 reveals binding to the beta 2-ear of AP-2 on a site that overlaps with that used by the autosomal recessive hypercholesterolemia protein and beta arrestin, although the sequence used by connecdenn 2 is unique. Loss of connecdenn 2 function through small interference RNA knockdown results in an enlargement of early endosomes, similar to what is observed upon loss of Rab35 activity. Our studies reveal connecdenn DENN domains as generalized GEFs for Rab35 and identify a new AP-2-binding motif, demonstrating a complex link between the clathrin machinery and Rab35 activation.	[Marat, Andrea L.; McPherson, Peter S.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	McPherson, PS (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	peter.mcpherson@mcgill.ca		Marat, Andrea/0000-0001-8571-4253	Natural Sciences and Engineering Research Council [197316]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Grant 197316 from the Natural Sciences and Engineering Research Council (to P. S. M.).	Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; Burtey A, 2007, TRAFFIC, V8, P914, DOI 10.1111/j.1600-0854.2007.00578.x; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; Drake MT, 2001, J BIOL CHEM, V276, P28700, DOI 10.1074/jbc.M104226200; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Esters H, 2001, J MOL BIOL, V310, P141, DOI 10.1006/jmbi.2001.4735; Falbel TG, 2003, DEVELOPMENT, V130, P4011, DOI 10.1242/dev.00619; Fessart D, 2007, J CELL SCI, V120, P1723, DOI 10.1242/jcs.03444; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Girard Martine, 2005, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0313s26; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Harsay E, 2007, MOL BIOL CELL, V18, P1203, DOI 10.1091/mbc.E06-11-1035; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Kang DS, 2009, J BIOL CHEM, V284, P29860, DOI 10.1074/jbc.M109.023366; Katoh M, 2004, INT J ONCOL, V24, P743; Kim YM, 2002, J BIOL CHEM, V277, P30760, DOI 10.1074/jbc.M204528200; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Liao YH, 1999, J BIOL CHEM, V274, P37815, DOI 10.1074/jbc.274.53.37815; Liao YH, 2001, J BIOL CHEM, V276, P28478, DOI 10.1074/jbc.M101737200; LICHY JH, 1992, CELL GROWTH DIFFER, V3, P541; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Miserey-Lenkei S, 2007, TRAFFIC, V8, P1385, DOI 10.1111/j.1600-0854.2007.00612.x; Mishra SK, 2005, J BIOL CHEM, V280, P19270, DOI 10.1074/jbc.M501029200; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; Morgan JR, 2000, J NEUROSCI, V20, P8667; Nakano-Kobayashi A, 2007, EMBO J, V26, P1105, DOI 10.1038/sj.emboj.7601573; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Ritter B, 2004, TOP CURR GENET, V10, P9; Ritter B, 2004, EMBO J, V23, P3701, DOI 10.1038/sj.emboj.7600378; Ritter B, 2003, EMBO REP, V4, P1089, DOI 10.1038/sj.embor.7400004; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Santini F, 2000, J CELL SCI, V113, P2463; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Soutar AK, 2003, ARTERIOSCL THROM VAS, V23, P1963, DOI 10.1161/01.ATV.0000094410.66558.9A; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thieman JR, 2009, J BIOL CHEM, V284, P13924, DOI 10.1074/jbc.M901017200; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921	59	65	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10627	10637		10.1074/jbc.M109.050930	http://dx.doi.org/10.1074/jbc.M109.050930			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20154091	Green Published, hybrid			2022-12-25	WOS:000276264600050
J	Bosco, EE; Nakai, Y; Hennigan, RF; Ratner, N; Zheng, Y				Bosco, E. E.; Nakai, Y.; Hennigan, R. F.; Ratner, N.; Zheng, Y.			NF2-deficient cells depend on the Rac1-canonical Wnt signaling pathway to promote the loss of contact inhibition of proliferation	ONCOGENE			English	Article						Rac1; NF2/merlin; neurofibromatosis type 2; Wnt signaling; contact inhibition; proliferation	NF2 TUMOR-SUPPRESSOR; BETA-CATENIN; EXCHANGE FACTOR; INCREASED EXPRESSION; SCHWANNOMA CELLS; GENE-PRODUCT; RHO-GTPASES; MERLIN; COMPLEX; GROWTH	The neuro. bromatosis type 2 (NF2) tumor suppressor gene encodes merlin, a membrane/cytoskeleton protein necessary for the maintenance of contact inhibition of growth in cells. Bi-allelic inactivation of NF2 is known to cause multiple cancers in both humans and mice. However, the mechanism through which merlin exerts its tumor-suppressive function remains obscure. In this report, we show that NF2 knockout mouse embryonic fibroblasts lost contact inhibition of cell proliferation and contained significantly increased canonical Wnt signaling. Inhibition of Rac1, the activity of which is inversely regulated by NF2, through the use of a dominant-negative mutant, small hairpin RNA or a small molecule inhibitor in NF2-deficient cells, was able to suppress elevated Wnt signals as shown by reduced activity of the T-cell factor 4 (TCF4) transcription factor. Dominant-negative TCF4 or Rac1 mutant, as well as a small molecule inhibition of Wnt, were able to curb NF2 deficiency-elicited cell proliferation at the confluent state. Thus, Rac1-mediated canonical Wnt signaling is essential for the loss of contact inhibition in NF2-deficient cells. Oncogene (2010) 29, 2540-2549; doi:10.1038/onc.2010.20; published online 15 February 2010	[Bosco, E. E.; Nakai, Y.; Ratner, N.; Zheng, Y.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH USA; [Hennigan, R. F.] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Zheng, Y (corresponding author), Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Yi.Zheng@cchmc.org	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074; RATNER, NANCY/0000-0001-5030-9354; Nakai-Futatsugi, Yoko/0000-0003-4187-6060	NIH [R01 CA125658, R01 CA118032, T32 CA117846]; NATIONAL CANCER INSTITUTE [T32CA117846, R01CA118032, R01CA141341, R01CA125658] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all members of the Zheng laboratory for thought-provoking discussions. This study was supported by NIH R01 CA125658 (YZ), NIH R01 CA118032 (NR) and NIH T32 CA117846 (EEB). EEB and YN performed experiments, analyzed results and made the figures; RFH provided key reagents, NR collaborated on experimental design, EEB and YZ designed the research and wrote the paper.	Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Ammoun S, 2008, CANCER RES, V68, P5236, DOI 10.1158/0008-5472.CAN-07-5849; Bosco EE, 2004, NUCLEIC ACIDS RES, V32, P25, DOI 10.1093/nar/gkg919; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Chadee DN, 2006, P NATL ACAD SCI USA, V103, P4463, DOI 10.1073/pnas.0510651103; Colomba A, 2008, ONCOGENE, V27, P2728, DOI 10.1038/sj.onc.1210921; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Esufali S, 2004, ONCOGENE, V23, P8260, DOI 10.1038/sj.onc.1208007; Fernandez-Valle C, 2002, NAT GENET, V31, P354, DOI 10.1038/ng930; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Giovannini M, 2000, GENE DEV, V14, P1617; Gutmann DH, 1999, HUM MOL GENET, V8, P267, DOI 10.1093/hmg/8.2.267; Johnson KC, 2002, ONCOGENE, V21, P5990, DOI 10.1038/sj.onc.1205693; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Kaempchen K, 2003, HUM MOL GENET, V12, P1211, DOI 10.1093/hmg/ddg146; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Lau YKI, 2008, CANCER RES, V68, P5733, DOI 10.1158/0008-5472.CAN-08-0190; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Lyons LS, 2006, MOL ENDOCRINOL, V20, P1061, DOI 10.1210/me.2005-0346; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; Minke KS, 2009, EUR J HAEMATOL, V82, P165, DOI 10.1111/j.1600-0609.2008.01188.x; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Nakai Y, 2006, J NEUROSCI, V26, P3390, DOI 10.1523/JNEUROSCI.4865-05.2006; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sampietro J, 2006, MOL CELL, V24, P293, DOI 10.1016/j.molcel.2006.09.001; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200	35	39	41	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	17					2540	2549		10.1038/onc.2010.20	http://dx.doi.org/10.1038/onc.2010.20			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	589RB	20154721	Green Accepted			2022-12-25	WOS:000277169400009
J	Spinner, JL; Seo, KS; O'Loughlin, JL; Cundiff, JA; Minnich, SA; Bohach, GA; Kobayashi, SD				Spinner, Justin L.; Seo, Keun Seok; O'Loughlin, Jason L.; Cundiff, Jennifer A.; Minnich, Scott A.; Bohach, Gregory A.; Kobayashi, Scott D.			Neutrophils Are Resistant to Yersinia YopJ/P-Induced Apoptosis and Are Protected from ROS-Mediated Cell Death by the Type III Secretion System	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; UNDERGO APOPTOSIS; IMMUNE CELLS; ENTEROCOLITICA; MACROPHAGES; PESTIS; VIRULENCE; YOPP; ACTIVATION; CYTOTOXICITY	Background: The human innate immune system relies on the coordinated activity of macrophages and polymorphonuclear leukocytes (neutrophils or PMNs) for defense against bacterial pathogens. Yersinia spp. subvert the innate immune response to cause disease in humans. In particular, the Yersinia outer protein YopJ (Y. pestis and Y. pseudotuberculosis) and YopP (Y. enterocolitica) rapidly induce apoptosis in murine macrophages and dendritic cells. However, the effects of Yersinia Yop J/P on neutrophil fate are not clearly defined. Methodology/Principal Findings: In this study, we utilized wild-type and mutant strains of Yersinia to test the contribution of YopJ and YopP on induction of apoptosis in human monocyte-derived macrophages (HMDM) and neutrophils. Whereas YopJ and YopP similarly induced apoptosis in HMDMs, interaction of human neutrophils with virulence plasmid-containing Yersinia did not result in PMN caspase activation, release of LDH, or loss of membrane integrity greater than PMN controls. In contrast, interaction of human PMNs with the virulence plasmid-deficient Y. pestis strain KIM6 resulted in increased surface exposure of phosphatidylserine (PS) and cell death. PMN reactive oxygen species (ROS) production was inhibited in a virulence plasmid-dependent but YopJ/YopP-independent manner. Following phagocytic interaction with Y. pestis strain KIM6, inhibition of PMN ROS production with diphenyleneiodonium chloride resulted in a reduction of PMN cell death similar to that induced by the virulence plasmid-containing strain Y. pestis KIM5. Conclusions: Our findings showed that Yersinia YopJ and/or YopP did not induce pronounced apoptosis in human neutrophils. Furthermore, robust PMN ROS production in response to virulence plasmid-deficient Yersinia was associated with increased PMN cell death, suggesting that Yersinia inhibition of PMN ROS production plays a role in evasion of the human innate immune response in part by limiting PMN apoptosis.	[Spinner, Justin L.; Seo, Keun Seok; O'Loughlin, Jason L.; Cundiff, Jennifer A.; Minnich, Scott A.; Bohach, Gregory A.; Kobayashi, Scott D.] Univ Idaho, Dept Microbiol Mol Biol & Biochem, Moscow, ID 83843 USA	Idaho; University of Idaho	Spinner, JL (corresponding author), Univ Idaho, Dept Microbiol Mol Biol & Biochem, Moscow, ID 83843 USA.	kobayashis@niaid.nih.gov		Kobayashi, Scott/0000-0002-5705-1381; Seo, Keun Seok/0000-0001-9280-9680	NIH [1K22AI6274, P20RR015587, P20RR016454]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454, P20RR015587] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this research was provided by NIH awards 1K22AI6274 and P20RR015587 to S. D. Kobayashi, and P20RR016454 to S. A. Minnich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brodsky IE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000067; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLeo FR, 2004, APOPTOSIS, V9, P399, DOI 10.1023/B:APPT.0000031448.64969.fa; Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200; Erfurth SE, 2004, INFECT IMMUN, V72, P7045, DOI 10.1128/IAI.72.12.7045-7054.2004; Fadeel B, 1998, BLOOD, V92, P4808, DOI 10.1182/blood.V92.12.4808.424k01_4808_4818; GOGUEN JD, 1986, INFECT IMMUN, V51, P788, DOI 10.1128/IAI.51.3.788-794.1986; Grobner S, 2007, APOPTOSIS, V12, P1813, DOI 10.1007/s10495-007-0100-x; Grobner S, 2006, APOPTOSIS, V11, P1959, DOI 10.1007/s10495-006-0189-3; Hampton MB, 2002, J LEUKOCYTE BIOL, V71, P775; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Kobayashi SD, 2004, J IMMUNOL, V172, P636, DOI 10.4049/jimmunol.172.1.636; Kobayashi SD, 2003, MICROBES INFECT, V5, P1337, DOI 10.1016/j.micinf.2003.09.013; Lemaitre N, 2006, INFECT IMMUN, V74, P5126, DOI 10.1128/IAI.00219-06; Lundqvist-Gustafsson H, 1999, J LEUKOCYTE BIOL, V65, P196, DOI 10.1002/jlb.65.2.196; Maianski NA, 2003, ACTA HAEMATOL-BASEL, V111, P56, DOI 10.1159/000074486; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; NAUSEEF WM, 2005, BASIC PRINCIPLES DIA, P93; O'Loughlin JL, 2010, INFECT IMMUN, V78, P773, DOI 10.1128/IAI.00718-09; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Ruckdeschel K, 1996, INFECT IMMUN, V64, P724, DOI 10.1128/IAI.64.3.724-733.1996; Ruckdeschel K, 1997, INFECT IMMUN, V65, P4813, DOI 10.1128/IAI.65.11.4813-4821.1997; Ruckdeschel K, 2001, INFECT IMMUN, V69, P7652, DOI 10.1128/IAI.69.12.7652-7662.2001; Sanmun D, 2009, AM J PHYSIOL-CELL PH, V297, pC621, DOI 10.1152/ajpcell.00651.2008; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; SEO KS, 2009, J LEUKOCYTE BIOL, V85, P1; Shao F, 2008, CURR OPIN MICROBIOL, V11, P21, DOI 10.1016/j.mib.2008.01.005; Spinner JL, 2008, INFECT IMMUN, V76, P3754, DOI 10.1128/IAI.00385-08; van den Berg JM, 2001, J LEUKOCYTE BIOL, V69, P467; Watson RWG, 1996, J IMMUNOL, V156, P3986; Wilkie RP, 2007, INFECT IMMUN, V75, P3256, DOI 10.1128/IAI.01984-06; Zauberman A, 2006, INFECT IMMUN, V74, P3239, DOI 10.1128/IAI.00097-06; Zauberman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005938; Zhang B, 2003, J BIOL CHEM, V278, P28443, DOI 10.1074/jbc.M210727200; Zhang Y, 2005, J IMMUNOL, V174, P7939, DOI 10.4049/jimmunol.174.12.7939; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194	44	40	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9279	10.1371/journal.pone.0009279	http://dx.doi.org/10.1371/journal.pone.0009279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174624	Green Submitted, Green Published, gold			2022-12-25	WOS:000274654700013
J	Herrera, EA; Verkerk, MM; Derks, JB; Giussani, DA				Herrera, Emilio A.; Verkerk, Misha M.; Derks, Jan B.; Giussani, Dino A.			Antioxidant Treatment Alters Peripheral Vascular Dysfunction Induced by Postnatal Glucocorticoid Therapy in Rats	PLOS ONE			English	Article							INDUCED HYPERTENSION; ENDOCRINE RESPONSES; LUNG-DISEASE; DEXAMETHASONE; MECHANISMS; VASORELAXATION; PROLIFERATION; BAROREFLEX; EXPRESSION; SYNTHASE	Background: Postnatal glucocorticoid therapy in premature infants diminishes chronic lung disease, but it also increases the risk of hypertension in adulthood. Since glucocorticoid excess leads to overproduction of free radicals and endothelial dysfunction, this study tested the hypothesis that adverse effects on cardiovascular function of postnatal glucocorticoids are secondary to oxidative stress. Therefore, combined postnatal treatment of glucocorticoids with antioxidants may diminish unwanted effects. Methodology/Principal Findings: Male rat pups received a course of dexamethasone (Dex), or Dex with vitamins C and E (DexCE), on postnatal days 1-6 (P1-6). Controls received vehicle (Ctrl) or vehicle with vitamins (CtrlCE). At P21, femoral vascular reactivity was determined via wire myography. Dex, but not DexCE or CtrlCE, increased mortality relative to Ctrl (81.3 versus 96.9 versus 90.6 versus 100% survival, respectively; P< 0.05). Constrictor responses to phenylephrine (PE) and thromboxane were enhanced in Dex relative to Ctrl (84.7+/-4.8 versus 67.5+/-5.7 and 132.7+/-4.9 versus 107.0+/-4.9% Kmax, respectively; P<0.05); effects that were diminished in DexCE (58.3+/-7.5 and 121.1+/-4.3% Kmax, respectively; P<0.05). Endothelium-dependent dilatation was depressed in Dex relative to Ctrl (115.3+/-11.9 versus 216.9+/-18.9, AUC; P<0.05); however, this effect was not restored in DexCE (68.3+/-8.3, AUC). Relative to Ctrl, CtrlCE alone diminished PE-induced constriction (43.4+/-3.7% Kmax) and the endothelium-dependent dilatation (74.7+/-8.7 AUC; P<0.05). Conclusions/Significance: Treatment of newborn rats with dexamethasone has detrimental effects on survival and peripheral vasoconstrictor function. Coadministration of dexamethasone with antioxidant vitamins improves survival and partially restores vascular dysfunction. Antioxidant vitamins alone affect peripheral vascular function.	[Herrera, Emilio A.; Verkerk, Misha M.; Giussani, Dino A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Derks, Jan B.] Univ Med Ctr Utrecht, Dept Perinatol, Utrecht, Netherlands	University of Cambridge; Utrecht University; Utrecht University Medical Center	Herrera, EA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	dag26@cam.ac.uk	Herrera, Emilio A/H-5992-2018	Herrera, Emilio A/0000-0002-6342-085X; Giussani, Dino/0000-0002-1308-1204	British Heart Foundation [PMAG/148]; Biotechnology and Biological Sciences Research Council [PMAG/095]	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by the British Heart Foundation (PMAG/148) and the Biotechnology and Biological Sciences Research Council (PMAG/095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER AR, 2009, NEONATOLOGY IN PRESS; Bal MP, 2005, PEDIATR RES, V58, P46, DOI 10.1203/01.PDR.0000163617.01673.9A; BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; BENEDIKTSSON R, 1993, LANCET, V341, P339, DOI 10.1016/0140-6736(93)90138-7; Bennet L, 1999, BRIT J OBSTET GYNAEC, V106, P331, DOI 10.1111/j.1471-0528.1999.tb08270.x; Bensky AS, 1996, PEDIATRICS, V97, P818; BERK BC, 1988, J CELL PHYSIOL, V137, P391, DOI 10.1002/jcp.1041370302; BIAN XP, 1993, TERATOLOGY, V47, P109, DOI 10.1002/tera.1420470203; Carr AC, 2000, CIRC RES, V87, P349, DOI 10.1161/01.RES.87.5.349; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Chen Y, 2004, NITRIC OXIDE-BIOL CH, V11, P121; de Vries WB, 2006, BASIC RES CARDIOL, V101, P36, DOI 10.1007/s00395-005-0557-0; De Vries WB, 2002, PEDIATR RES, V52, P900, DOI 10.1203/01.PDR.0000036281.74804.27; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Gunnett CA, 2001, ARTERIOSCL THROM VAS, V21, P1281, DOI 10.1161/hq0801.093509; Halliday HL, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001145.pub2, 10.1002/14651858.CD001146.pub2]; HANDA M, 1984, HYPERTENSION, V6, P236, DOI 10.1161/01.HYP.6.2_Pt_1.236; HAYASHI T, 1991, AM J PHYSIOL, V261, pC106, DOI 10.1152/ajpcell.1991.261.1.C106; He J, 2004, AM J PHYSIOL-REG I, V287, pR198, DOI 10.1152/ajpregu.00349.2003; Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C; Jellyman JK, 2005, J PHYSIOL-LONDON, V567, P673, DOI 10.1113/jphysiol.2005.089805; Katusic ZS, 1996, FREE RADICAL BIO MED, V20, P443, DOI 10.1016/0891-5849(96)02116-8; Molnar J, 2003, J PHYSIOL-LONDON, V547, P61, DOI 10.1113/jphysiol.2002.032565; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Oncu M, 2002, HUM EXP TOXICOL, V21, P223, DOI 10.1191/0960327102ht225oa; PIRPIRIS M, 1992, HYPERTENSION, V19, P567, DOI 10.1161/01.HYP.19.6.567; Porter JP, 2000, AM J PHYSIOL-REG I, V279, pR1386, DOI 10.1152/ajpregu.2000.279.4.R1386; Roghair RD, 2005, AM J PHYSIOL-REG I, V288, pR46, DOI 10.1152/ajpregu.00165.2004; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; SAKAUE M, 1991, J CLIN INVEST, V88, P385, DOI 10.1172/JCI115315; Schafer SC, 2005, AM J PHYSIOL-HEART C, V288, pH436, DOI 10.1152/ajpheart.00587.2004; Segar JL, 2006, AM J PHYSIOL-REG I, V291, pR481, DOI 10.1152/ajpregu.00677.2005; Simmons WW, 1996, J BIOL CHEM, V271, P23928, DOI 10.1074/jbc.271.39.23928; Stark AR, 2001, NEW ENGL J MED, V344, P95, DOI 10.1056/NEJM200101113440203; Suzuki T, 2003, MICROSC RES TECHNIQ, V60, P76, DOI 10.1002/jemt.10246; TANGALAKIS K, 1992, EXP PHYSIOL, V77, P709, DOI 10.1113/expphysiol.1992.sp003637; THIBEAULT DW, 1993, PEDIATR PULM, V16, P81, DOI 10.1002/ppul.1950160202; TSENG YT, 1995, EUR J PHARM-MOLEC PH, V289, P353, DOI 10.1016/0922-4106(95)90113-2; VILLA AE, 1994, J CLIN INVEST, V93, P1243, DOI 10.1172/JCI117078; Wallerath T, 1999, P NATL ACAD SCI USA, V96, P13357, DOI 10.1073/pnas.96.23.13357; Whitworth JA, 2002, J HYPERTENS, V20, P1035, DOI 10.1097/00004872-200206000-00003; WHITWORTH JA, 1995, STEROIDS, V60, P76, DOI 10.1016/0039-128X(94)00033-9; Wise GE, 2001, CLIN ANAT, V14, P204, DOI 10.1002/ca.1034; Yamashita T, 2000, HYPERTENSION, V36, P97, DOI 10.1161/01.HYP.36.1.97; Yang Shumei, 2004, Current Vascular Pharmacology, V2, P1, DOI 10.2174/1570161043476483; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Zhou XB, 2001, J BIOL CHEM, V276, P43239, DOI 10.1074/jbc.M104202200	49	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9250	10.1371/journal.pone.0009250	http://dx.doi.org/10.1371/journal.pone.0009250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174656	Green Published, gold, Green Submitted			2022-12-25	WOS:000274590600010
J	Dere, R; Wilson, PD; Sandford, RN; Walker, CL				Dere, Ruhee; Wilson, Patricia D.; Sandford, Richard N.; Walker, Cheryl Lyn			Carboxy Terminal Tail of Polycystin-1 Regulates Localization of TSC2 to Repress mTOR	PLOS ONE			English	Article							SLOWS DISEASE PROGRESSION; KIDNEY-DISEASE; GENE-PRODUCT; C-JUN; MEMBRANE LOCALIZATION; CELL-GROWTH; PATHOGENESIS; PROTEIN; KINASE; PHOSPHORYLATION	Autosomal dominant polycystic kidney disease (ADPKD) is a commonly inherited renal disorder caused by defects in the PKD1 or PKD2 genes. ADPKD is associated with significant morbidity, and is a major underlying cause of end-stage renal failure (ESRF). Commonly, treatment options are limited to the management of hypertension, cardiovascular risk factors, dialysis, and transplantation when ESRF develops, although several new pharmacotherapies, including rapamycin, have shown early promise in animal and human studies. Evidence implicates polycystin-1 (PC-1), the gene product of the PKD1 gene, in regulation of the mTOR pathway. Here we demonstrate a mechanism by which the intracellular, carboxy-terminal tail of polycystin-1 (CP1) regulates mTOR signaling by altering the subcellular localization of the tuberous sclerosis complex 2 (TSC2) tumor suppressor, a gatekeeper for mTOR activity. Phosphorylation of TSC2 at S939 by AKT causes partitioning of TSC2 away from the membrane, its GAP target Rheb, and its activating partner TSC1 to the cytosol via 14-3-3 protein binding. We found that TSC2 and a C-terminal polycystin-1 peptide (CP1) directly interact and that a membrane-tethered CP1 protects TSC2 from AKT phosphorylation at S939, retaining TSC2 at the membrane to inhibit the mTOR pathway. CP1 decreased binding of 14-3-3 proteins to TSC2 and increased the interaction between TSC2 and its activating partner TSC1. Interestingly, while membrane tethering of CP1 was required to activate TSC2 and repress mTOR, the ability of CP1 to inhibit mTOR signaling did not require primary cilia and was independent of AMPK activation. These data identify a unique mechanism for modulation of TSC2 repression of mTOR signaling via membrane retention of this tumor suppressor, and identify PC-1 as a regulator of this downstream component of the PI3K signaling cascade.	[Dere, Ruhee; Walker, Cheryl Lyn] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX 78957 USA; [Wilson, Patricia D.] Med Coll Wisconsin, Dept Pediat, Childrens Res Inst, Milwaukee, WI 53226 USA; [Sandford, Richard N.] Univ Cambridge, Dept Med Genet, Cambridge, England	University of Texas System; UTMD Anderson Cancer Center; Medical College of Wisconsin; University of Cambridge	Dere, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX 78957 USA.	cwalker@wotan.mdacc.tmc.edu	Wilson, Patricia/AAW-8481-2021	Wilson, Patricia/0000-0003-0902-188X	Polycystic Kidney Disease (PKD) Foundation [157b2f]; David H. Koch Center for Applied Research of Genitourinary Cancers; National Institutes of Health (NIH) [DK062345]; National Institute of Health Research Cambridge Biomedical Research Center; National Institute for Environmental Health Sciences (NIEHS) Center [ES007784]; PKD/TSC Collaborative Research Initiative; NATIONAL CANCER INSTITUTE [R01CA143811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK062345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	Polycystic Kidney Disease (PKD) Foundation; David H. Koch Center for Applied Research of Genitourinary Cancers; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health Research Cambridge Biomedical Research Center(National Institute for Health Research (NIHR)); National Institute for Environmental Health Sciences (NIEHS) Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PKD/TSC Collaborative Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by post-doctoral fellowships awarded to R. D. by the Polycystic Kidney Disease (PKD) Foundation (157b2f) and the David H. Koch Center for Applied Research of Genitourinary Cancers, a National Institutes of Health (NIH) grant (DK062345) awarded to P. D. W., a National Institute of Health Research Cambridge Biomedical Research Center awarded to R.N.S., a National Institute for Environmental Health Sciences (NIEHS) Centfer Grant (ES007784), and a PKD/TSC Collaborative Research Initiative grant (from the PKD foundation and the Tuberous Sclerosis (TS) Alliance) awarded to C. L. W., R.N.S. and P.D.W.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER A, 2010, ATM SIGNALS IN PRESS; Arnould T, 1998, J BIOL CHEM, V273, P6013, DOI 10.1074/jbc.273.11.6013; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Bonnet CS, 2009, HUM MOL GENET, V18, P2166, DOI 10.1093/hmg/ddp149; Braun WE, 2009, CLEV CLIN J MED, V76, P97, DOI 10.3949/ccjm.76a.gr001; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chang MY, 2008, NEPHRON PHYSIOL, V108, P1, DOI 10.1159/000112495; Deane JA, 2007, NEPHROLOGY, V12, P559, DOI 10.1111/j.1440-1797.2007.00869.x; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fischer DC, 2009, NEPHROL DIAL TRANSPL, V24, P1819, DOI 10.1093/ndt/gfn744; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; GOMEZ MR, 1991, ANN NY ACAD SCI, V615, P1; Guay-Woodford LM, 2003, AM J PHYSIOL-RENAL, V285, pF1034, DOI 10.1152/ajprenal.00195.2003; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hartman TR, 2009, HUM MOL GENET, V18, P151, DOI 10.1093/hmg/ddn325; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hooper KM, 2003, CLIN SCI, V104, P217, DOI 10.1042/CS20020239; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Kleymenova E, 2001, MOL CELL, V7, P823, DOI 10.1016/S1097-2765(01)00226-X; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Le NH, 2005, J AM SOC NEPHROL, V16, P2724, DOI 10.1681/ASN.2004110913; Le NH, 2004, J BIOL CHEM, V279, P27472, DOI 10.1074/jbc.M312183200; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Meijer E, 2008, J NEPHROL, V21, P133; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; NEAME SJ, 1992, EMBO J, V11, P4733, DOI 10.1002/j.1460-2075.1992.tb05578.x; Nims N, 2003, BIOCHEMISTRY-US, V42, P13035, DOI 10.1021/bi035074c; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; PETERS DJM, 1993, NAT GENET, V5, P359, DOI 10.1038/ng1293-359; Pollizzi K, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-38; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Serra Andreas L, 2007, BMC Nephrol, V8, P13, DOI 10.1186/1471-2369-8-13; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Streets AJ, 2003, J AM SOC NEPHROL, V14, P1804, DOI 10.1097/01.ASN.0000076075.49819.9B; Sutters M, 2003, J LAB CLIN MED, V141, P91, DOI 10.1067/mlc.2003.13; Sutters M, 2006, NEPHRON EXP NEPHROL, V103, pE149, DOI 10.1159/000093216; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Wahl PR, 2006, NEPHROL DIAL TRANSPL, V21, P598, DOI 10.1093/ndt/gfi181; Weston BS, 2003, FEBS LETT, V538, P8, DOI 10.1016/S0014-5793(03)00130-3; Wilson PD, 2007, ANNU REV PATHOL-MECH, V2, P341, DOI 10.1146/annurev.pathol.2.010506.091850; Wilson PD, 2008, CURR TOP DEV BIOL, V84, P311, DOI 10.1016/S0070-2153(08)00606-6; Wilson PD, 1999, LAB INVEST, V79, P1311; Wilson PD, 2004, INT J BIOCHEM CELL B, V36, P1868, DOI 10.1016/j.biocel.2004.03.012; Wu M, 2007, KIDNEY BLOOD PRESS R, V30, P253, DOI 10.1159/000104818; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	56	74	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9239	10.1371/journal.pone.0009239	http://dx.doi.org/10.1371/journal.pone.0009239			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169078	gold, Green Published, Green Submitted			2022-12-25	WOS:000274590500020
J	Coppe, JP; Patil, CK; Rodier, F; Krtolica, A; Beausejour, CM; Parrinello, S; Hodgson, JG; Chin, KE; Desprez, PY; Campisi, J				Coppe, Jean-Philippe; Patil, Christopher K.; Rodier, Francis; Krtolica, Ana; Beausejour, Christian M.; Parrinello, Simona; Hodgson, J. Graeme; Chin, Koei; Desprez, Pierre-Yves; Campisi, Judith			A Human-Like Senescence-Associated Secretory Phenotype Is Conserved in Mouse Cells Dependent on Physiological Oxygen	PLOS ONE			English	Article							CELLULAR SENESCENCE; DNA-DAMAGE; GENE-EXPRESSION; REPLICATIVE SENESCENCE; TRIGGERS SENESCENCE; HUMAN FIBROBLASTS; GROWTH-FACTOR; IN-VIVO; CANCER; IMMORTALIZATION	Cellular senescence irreversibly arrests cell proliferation in response to oncogenic stimuli. Human cells develop a senescence-associated secretory phenotype (SASP), which increases the secretion of cytokines and other factors that alter the behavior of neighboring cells. We show here that "senescent'' mouse fibroblasts, which arrested growth after repeated passage under standard culture conditions (20% oxygen), do not express a human-like SASP, and differ from similarly cultured human cells in other respects. However, when cultured in physiological (3%) oxygen and induced to senesce by radiation, mouse cells more closely resemble human cells, including expression of a robust SASP. We describe two new aspects of the human and mouse SASPs. First, cells from both species upregulated the expression and secretion of several matrix metalloproteinases, which comprise a conserved genomic cluster. Second, for both species, the ability to promote the growth of premalignant epithelial cells was due primarily to the conserved SASP factor CXCL-1/KC/GRO-alpha. Further, mouse fibroblasts made senescent in 3%, but not 20%, oxygen promoted epithelial tumorigenesis in mouse xenographs. Our findings underscore critical mouse-human differences in oxygen sensitivity, identify conditions to use mouse cells to model human cellular senescence, and reveal novel conserved features of the SASP.	[Coppe, Jean-Philippe; Patil, Christopher K.; Rodier, Francis; Krtolica, Ana; Parrinello, Simona; Desprez, Pierre-Yves; Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Coppe, Jean-Philippe; Patil, Christopher K.; Rodier, Francis; Desprez, Pierre-Yves; Campisi, Judith] Buck Inst Age Res, Novato, CA USA; [Beausejour, Christian M.] Univ Montreal, CHU Ste Justine, Ctr Rech, Montreal, PQ, Canada; [Beausejour, Christian M.] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Hodgson, J. Graeme; Chin, Koei] Univ Calif San Francisco, Dept Lab Med, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Desprez, Pierre-Yves] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Buck Institute for Research on Aging; Universite de Montreal; Universite de Montreal; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; California Pacific Medical Center; California Pacific Medical Center Research Institute	Coppe, JP (corresponding author), Dynam Throughput Inc, Berkeley, CA USA.	jcampisi@buckinstitute.org		Rodier, Francis/0000-0003-2523-309X	National Institutes of Health [AG09909, AG017242, CA126540, AG000266, AG0025708]; Larry L. Hillblom Foundation; California Breast Cancer Research Program [8KB-0100]; US Department of Energy [DE-AC03-76SF00098]; NATIONAL CANCER INSTITUTE [U54CA126540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG009909, P01AG017242, R01AG009909, P30AG025708, R37AG009909, T32AG000266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; California Breast Cancer Research Program; US Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institutes of Health (research grants AG09909, AG017242 and CA126540 to JC; training grant AG000266; center grant AG0025708), Larry L. Hillblom Foundation (to CKP), California Breast Cancer Research Program (8KB-0100 to AK) and the US Department of Energy under contract DE-AC03-76SF00098 (JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Beliveau A, 2007, P NATL ACAD SCI USA, V104, P4431, DOI 10.1073/pnas.0700260104; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Di Micco R, 2008, CELL CYCLE, V7, P3601, DOI 10.4161/cc.7.22.7152; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Gray JW, 2000, CARCINOGENESIS, V21, P443, DOI 10.1093/carcin/21.3.443; Hampel B, 2006, EXP GERONTOL, V41, P474, DOI 10.1016/j.exger.2006.03.001; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; HORNSBY PJ, 2003, SCI AGING KNOWLEDGE, pPE21; Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Jiang H, 2008, P NATL ACAD SCI USA, V105, P11299, DOI 10.1073/pnas.0801457105; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Krtolica A, 2002, CYTOMETRY, V49, P73, DOI 10.1002/cyto.10149; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014; Mason DX, 2004, ONCOGENE, V23, P9238, DOI 10.1038/sj.onc.1208172; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Roberts S, 2006, EUR SPINE J, V15, pS312, DOI 10.1007/s00586-006-0126-8; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680; Shay JW, 2007, CANCER CELL, V12, P100, DOI 10.1016/j.ccr.2007.07.012; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wang B, 2006, CANCER RES, V66, P3071, DOI 10.1158/0008-5472.CAN-05-2871; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Yaswen P, 2002, INT J BIOCHEM CELL B, V34, P1382, DOI 10.1016/S1357-2725(02)00047-X; Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	54	280	289	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9188	10.1371/journal.pone.0009188	http://dx.doi.org/10.1371/journal.pone.0009188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169192	gold, Green Published, Green Submitted			2022-12-25	WOS:000274474600009
J	Hecht, MM; Nitz, N; Araujo, PF; Sousa, AO; Rosa, AD; Gomes, DA; Leonardecz, E; Teixeira, ARL				Hecht, Mariana M.; Nitz, Nadjar; Araujo, Perla F.; Sousa, Alessandro O.; Rosa, Ana de Cassia; Gomes, Dawidson A.; Leonardecz, Eduardo; Teixeira, Antonio R. L.			Inheritance of DNA Transferred from American Trypanosomes to Human Hosts	PLOS ONE			English	Article							CHAGAS-DISEASE; GENE-EXPRESSION; CRUZI; EVOLUTION; AMPLIFICATION; GENOME; SEQUENCES; PCR; IDENTIFICATION; MINICIRCLES	Interspecies DNA transfer is a major biological process leading to the accumulation of mutations inherited by sexual reproduction among eukaryotes. Lateral DNA transfer events and their inheritance has been challenging to document. In this study we modified a thermal asymmetric interlaced PCR by using additional targeted primers, along with Southern blots, fluorescence techniques, and bioinformatics, to identify lateral DNA transfer events from parasite to host. Instances of naturally occurring human infections by Trypanosoma cruzi are documented, where mitochondrial minicircles integrated mainly into retrotransposable LINE-1 of various chromosomes. The founders of five families show minicircle integrations that were transferred vertically to their progeny. Microhomology end-joining of 6 to 22 AC-rich nucleotide repeats in the minicircles and host DNA mediates foreign DNA integration. Heterogeneous minicircle sequences were distributed randomly among families, with diversity increasing due to subsequent rearrangement of inserted fragments. Mosaic recombination and hitchhiking on retrotransposition events to different loci were more prevalent in germ line as compared to somatic cells. Potential new genes, pseudogenes, and knockouts were identified. A pathway of minicircle integration and maintenance in the host genome is suggested. Thus, infection by T. cruzi has the unexpected consequence of increasing human genetic diversity, and Chagas disease may be a fortuitous share of negative selection. This demonstration of contemporary transfer of eukaryotic DNA to the human genome and its subsequent inheritance by descendants introduces a significant change in the scientific concept of evolutionary biology and medicine.	[Hecht, Mariana M.; Nitz, Nadjar; Araujo, Perla F.; Sousa, Alessandro O.; Rosa, Ana de Cassia; Leonardecz, Eduardo; Teixeira, Antonio R. L.] Univ Brasilia, Fac Med, Chagas Dis Multidisciplinary Res Lab, Brasilia, DF, Brazil; [Gomes, Dawidson A.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil	Universidade de Brasilia; Universidade Federal de Minas Gerais	Hecht, MM (corresponding author), Univ Brasilia, Fac Med, Chagas Dis Multidisciplinary Res Lab, Brasilia, DF, Brazil.	ateixeir@unb.br	de Araújo, Nadjar Nitz Silva Lociks/O-4052-2019; Sousa, Alessandro/F-2983-2012; Nitz, Nadjar/J-5794-2014; Gomes, Dawidson Assis/O-1372-2013; Leonardecz, Eduardo/E-9164-2012	de Araújo, Nadjar Nitz Silva Lociks/0000-0001-7820-0027; Nitz, Nadjar/0000-0001-7820-0027; Gomes, Dawidson Assis/0000-0001-7714-991X; Leonardecz, Eduardo/0000-0002-4654-5159	National Research Council for Scientific and Technological Development; CNPq/MCT; Financiadora de Estudos e Projetos; FINEP, Brazil	National Research Council for Scientific and Technological Development; CNPq/MCT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); FINEP, Brazil(Financiadora de Inovacao e Pesquisa (Finep))	This work received financial support from the National Research Council for Scientific and Technological Development, CNPq/MCT, and by Financiadora de Estudos e Projetos, FINEP, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LO, 2005, NAT REV MICROBIOL, V3, P819, DOI 10.1038/nrmicro1249; Andrews NW, 2002, J CELL BIOL, V158, P389, DOI 10.1083/jcb.200205110; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Beiko RG, 2008, SYST BIOL, V57, P844, DOI 10.1080/10635150802559265; Blaxter M, 2007, CELL HOST MICROBE, V2, P211, DOI 10.1016/j.chom.2007.09.008; Bohne A, 2008, CHROMOSOME RES, V16, P203, DOI 10.1007/s10577-007-1202-6; Carter KL, 2000, MOL ECOL, V9, P2149, DOI 10.1046/j.1365-294X.2000.01114.x; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; CRANE MSJ, 1979, J PROTOZOOL, V26, P599, DOI 10.1111/j.1550-7408.1979.tb04203.x; DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4; Doolittle WF, 2007, P NATL ACAD SCI USA, V104, P2043, DOI 10.1073/pnas.0610699104; Fantaccione S, 2008, GENOMICS, V91, P178, DOI 10.1016/j.ygeno.2007.10.008; Fassot C, 2008, J HYPERTENS, V26, P747, DOI 10.1097/HJH.0b013e3282f4b3d0; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; HANCOCK K, 1990, J BIOL CHEM, V265, P19208; Hazkani-Covo E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000237; Hines JC, 2008, NUCLEIC ACIDS RES, V36, P444, DOI 10.1093/nar/gkm1061; Januszyk K, 2007, J BIOL CHEM, V282, P24893, DOI 10.1074/jbc.M702023200; JONES DH, 1992, NUCLEIC ACIDS RES, V20, P595, DOI 10.1093/nar/20.3.595; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kirchhoff LV, 1996, J CLIN MICROBIOL, V34, P1171, DOI 10.1128/JCM.34.5.1171-1175.1996; Klein J, 2007, ANNU REV GENET, V41, P281, DOI 10.1146/annurev.genet.41.110306.130137; KRESS Y, 1975, NATURE, V257, P394, DOI 10.1038/257394a0; Kurland CG, 2006, SCIENCE, V312, P1011, DOI 10.1126/science.1121674; Kynast RG, 2004, P NATL ACAD SCI USA, V101, P9921, DOI 10.1073/pnas.0403421101; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lauria-Pires L, 2000, AM J TROP MED HYG, V63, P111, DOI 10.4269/ajtmh.2000.63.111; Le Rouzic A, 2007, P NATL ACAD SCI USA, V104, P19375, DOI 10.1073/pnas.0705238104; Liu YN, 2007, MOL MICROBIOL, V64, P676, DOI 10.1111/j.1365-2958.2007.05686.x; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; LIU YG, 1998, GENOMICS, V25, P175; Lucchinetti E, 2006, PHYSIOL GENOMICS, V25, P314, DOI 10.1152/physiolgenomics.00251.2005; Lukes J, 2002, EUKARYOT CELL, V1, P495, DOI 10.1128/EC.1.4.495-502.2002; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Marri PR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S8; MAZARS GR, 1991, NUCLEIC ACIDS RES, V19, P4783, DOI 10.1093/nar/19.17.4783; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; MINAMI M, 1995, GENOMICS, V29, P403, DOI 10.1006/geno.1995.9004; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; MOSER DR, 1989, J CLIN MICROBIOL, V27, P1477, DOI 10.1128/JCM.27.7.1477-1482.1989; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; Munguia-Vega A, 2007, MOL ECOL, V16, P4051, DOI 10.1111/j.1365-294X.2007.03319.x; Musova Z, 2006, BIOCHEM BIOPH RES CO, V347, P145, DOI 10.1016/j.bbrc.2006.06.071; Nonacs P, 2007, J EVOLUTION BIOL, V20, P2253, DOI 10.1111/j.1420-9101.2007.01418.x; O'Malley MA, 2005, STUD HIST PHI PART C, V36, P183, DOI 10.1016/j.shpsc.2004.12.002; OCHMAN H, 1988, GENETICS, V120, P621; Ogiwara I, 1999, MOL BIOL EVOL, V16, P1238, DOI 10.1093/oxfordjournals.molbev.a026214; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Rogers K, 2007, J BIOL CHEM, V282, P29073, DOI 10.1074/jbc.M704551200; ROSENTHAL A, 1990, NUCLEIC ACIDS RES, V18, P3095, DOI 10.1093/nar/18.10.3095; Rudi K, 1999, BIOTECHNIQUES, V27, P1170, DOI 10.2144/99276st03; Sambrook J, 2001, MOL CLONING LAB MANU; Simoes-Barbosa A, 1999, MEM I OSWALDO CRUZ, V94, P249, DOI 10.1590/S0074-02761999000700041; Simoes-Barbosa A, 2006, MEM I OSWALDO CRUZ, V101, P833, DOI 10.1590/S0074-02762006000800003; Simonson AB, 2005, P NATL ACAD SCI USA, V102, P6608, DOI 10.1073/pnas.0501996102; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Song MZ, 2007, GENE, V390, P206, DOI 10.1016/j.gene.2006.09.033; Stanhope MJ, 2001, NATURE, V411, P940, DOI 10.1038/35082058; Sturm Nancy R., 2009, P63; STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0; Teixeira ARL, 2006, POSTGRAD MED J, V82, P788, DOI 10.1136/pgmj.2006.047357; Teixeira A.R.L., 1991, Revista da Sociedade Brasileira de Medicina Tropical, V24, P55, DOI 10.1590/S0037-86821991000100010; Teixeira ARL, 2006, MEM I OSWALDO CRUZ, V101, P463, DOI 10.1590/S0074-02762006000500001; Teixeira Antonio R. L., 2009, P104; TEIXEIRA ARL, 1986, AM J PATHOL, V124, P363; TEIXEIRA ARL, 1983, AM J TROP MED HYG, V32, P258, DOI 10.4269/ajtmh.1983.32.258; TEIXEIRA ARL, 1990, AM J TROP MED HYG, V43, P146, DOI 10.4269/ajtmh.1990.43.146; Teixeira ARL, 2001, EMERG INFECT DIS, V7, P100, DOI 10.3201/eid0701.010115; TEIXEIRA ARL, 1994, MUTAT RES, V305, P197, DOI 10.1016/0027-5107(94)90240-2; Thomas S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-133; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Vanhamme L, 2008, CURR DRUG TARGETS, V9, P979, DOI 10.2174/138945008786786064; Virreira M, 2003, AM J TROP MED HYG, V68, P574, DOI 10.4269/ajtmh.2003.68.574; World Health Organization, 2002, 2 WHO, P1; Ziegler A, 2002, AM J REPROD IMMUNOL, V48, P34, DOI 10.1034/j.1600-0897.2002.01097.x	78	52	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9181	10.1371/journal.pone.0009181	http://dx.doi.org/10.1371/journal.pone.0009181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169193	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474600004
J	Sawasdidoln, C; Taweechaisupapong, S; Sermswan, RW; Tattawasart, U; Tungpradabkul, S; Wongratanacheewin, S				Sawasdidoln, Chakrit; Taweechaisupapong, Suwimol; Sermswan, Rasana W.; Tattawasart, Unchalee; Tungpradabkul, Sumalee; Wongratanacheewin, Surasakdi			Growing Burkholderia pseudomallei in Biofilm Stimulating Conditions Significantly Induces Antimicrobial Resistance	PLOS ONE			English	Article							QUORUM-SENSING SYSTEM; PSEUDOMONAS-AERUGINOSA BIOFILMS; BETA-LACTAM ANTIBIOTICS; IN-VITRO; PERMEABILITY BARRIERS; POLYACRYLAMIDE GELS; LIPOPOLYSACCHARIDE; SUSCEPTIBILITY; MELIOIDOSIS; VIRULENCE	Background: Burkholderia pseudomallei, a Gram-negative bacterium that causes melioidosis, was reported to produce biofilm. As the disease causes high relapse rate when compared to other bacterial infections, it therefore might be due to the reactivation of the biofilm forming bacteria which also provided resistance to antimicrobial agents. However, the mechanism on how biofilm can provide tolerance to antimicrobials is still unclear. Methodology/Principal Findings: The change in resistance of B. pseudomallei to doxycycline, ceftazidime, imipenem, and trimethoprim/sulfamethoxazole during biofilm formation were measured as minimum biofilm elimination concentration (MBEC) in 50 soil and clinical isolates and also in capsule, flagellin, LPS and biofilm mutants. Almost all planktonic isolates were susceptible to all agents studied. In contrast, when they were grown in the condition that induced biofilm formation, they were markedly resistant to all antimicrobial agents even though the amount of biofilm production was not the same. The capsule and O-side chains of LPS mutants had no effect on biofilm formation whereas the flagellin-defective mutant markedly reduced in biofilm production. No alteration of LPS profiles was observed when susceptible form was changed to resistance. The higher amount of N-acyl homoserine lactones (AHLs) was detected in the high biofilm-producing isolates. Interestingly, the biofilm mutant which produced a very low amount of biofilm and was sensitive to antimicrobial agents significantly resisted those agents when grown in biofilm inducing condition. Conclusions/Significance: The possible drug resistance mechanism of biofilm mutants and other isolates is not by having biofilm but rather from some factors that up-regulated when biofilm formation genes were stimulated. The understanding of genes related to this situation may lead us to prevent B. pseudomallei biofilms leading to the relapse of melioidosis.	[Sawasdidoln, Chakrit; Taweechaisupapong, Suwimol; Sermswan, Rasana W.; Tattawasart, Unchalee; Wongratanacheewin, Surasakdi] Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand; [Sawasdidoln, Chakrit; Tattawasart, Unchalee; Wongratanacheewin, Surasakdi] Khon Kaen Univ, Dept Microbiol, Khon Kaen, Thailand; [Sermswan, Rasana W.] Khon Kaen Univ, Dept Biochem, Khon Kaen, Thailand; [Taweechaisupapong, Suwimol] Khon Kaen Univ, Dept Oral Diag, Khon Kaen, Thailand; [Tungpradabkul, Sumalee] Mahidol Univ, Dept Biochem, Bangkok 10700, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Mahidol University	Sawasdidoln, C (corresponding author), Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand.	sura_wng@kku.ac.th	Wongratanacheewin, Surasakdi/F-7324-2010; Taweechaisupapong, suwimol/F-6759-2010	Wongratanacheewin, Surasakdi/0000-0003-2921-2536; 	Commission on Higher Education (CHE)(CHE-RG), Thailand	Commission on Higher Education (CHE)(CHE-RG), Thailand(Office of Higher Education Commission (OHEC))	This study received financial supports from The Commission on Higher Education (CHE)(CHE-RG), Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuntagool N, 2006, AM J TROP MED HYG, V74, P348, DOI 10.4269/ajtmh.2006.74.348; Bagge N, 2000, APMIS, V108, P589, DOI 10.1034/j.1600-0463.2000.d01-102.x; Banemann A, 1998, INFECT IMMUN, V66, P5607, DOI 10.1128/IAI.66.12.5607-5612.1998; Byers JT, 2002, J BACTERIOL, V184, P1163, DOI 10.1128/jb.184.4.1163-1171.2002; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; CHAOWAGUL W, 1993, J INFECT DIS, V168, P1181, DOI 10.1093/infdis/168.5.1181; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; DEBEER D, 1994, BIOTECHNOL BIOENG, V43, P1131, DOI 10.1002/bit.260431118; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Driffield K, 2008, J ANTIMICROB CHEMOTH, V61, P1053, DOI 10.1093/jac/dkn044; Farnaud S, 2004, FEMS MICROBIOL LETT, V233, P193, DOI 10.1016/j.femsle.2004.01.039; FLEMING MP, 1972, BMJ-BRIT MED J, V1, P726, DOI 10.1136/bmj.1.5802.726; Gilbert P, 1997, Adv Dent Res, V11, P160; GIWERCMAN B, 1991, ANTIMICROB AGENTS CH, V35, P1008, DOI 10.1128/AAC.35.5.1008; GODFREY AJ, 1991, ANTIMICROB AGENTS CH, V35, P1635, DOI 10.1128/AAC.35.8.1635; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Ishida H, 1998, ANTIMICROB AGENTS CH, V42, P1641, DOI 10.1128/AAC.42.7.1641; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM J, 1980, INFECT IMMUN, V28, P546; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Matsuura M, 1996, FEMS MICROBIOL LETT, V137, P79, DOI 10.1111/j.1574-6968.1996.tb08086.x; NIKAIDO H, 1985, PHARMACOL THERAPEUT, V27, P197, DOI 10.1016/0163-7258(85)90069-5; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Olson ME, 2002, CAN J VET RES, V66, P86; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; RUSSELL AD, 1986, J HOSP INFECT, V8, P47, DOI 10.1016/0195-6701(86)90104-0; Skurnik M, 1999, MOL MICROBIOL, V31, P1443, DOI 10.1046/j.1365-2958.1999.01285.x; Song Y, 2005, J BACTERIOL, V187, P785, DOI 10.1128/JB.187.2.785-790.2005; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Tanaka G, 1999, CHEMOTHERAPY, V45, P28, DOI 10.1159/000007162; Taweechaisupapong S, 2005, MICROB PATHOGENESIS, V39, P77, DOI 10.1016/j.micpath.2005.06.001; Tomlin KL, 2005, APPL ENVIRON MICROB, V71, P5208, DOI 10.1128/AEM.71.9.5208-5218.2005; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Ulrich RL, 2004, J MED MICROBIOL, V53, P1053, DOI 10.1099/jmm.0.45661-0; Valade E, 2004, J BACTERIOL, V186, P2288, DOI 10.1128/JB.186.8.2288-2294.2004; Vorachit M, 1995, J TROP MED HYG, V98, P379; VORACHIT M, 1993, ANTIMICROB AGENTS CH, V37, P2000, DOI 10.1128/AAC.37.9.2000; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wuthiekanun Vanaporn, 2006, Expert Rev Anti Infect Ther, V4, P445, DOI 10.1586/14787210.4.3.445	45	63	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9196	10.1371/journal.pone.0009196	http://dx.doi.org/10.1371/journal.pone.0009196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169199	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474600016
J	Tang, ED; Wang, CY				Tang, Eric D.; Wang, Cun-Yu			TRAF5 Is a Downstream Target of MAVS in Antiviral Innate Immune Signaling	PLOS ONE			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; RIG-I; IKK-EPSILON; ACTIVATION; RESPONSES; ADAPTER; RECOGNITION; PROTEIN; IRF3	The recognition of nucleic acids by the innate immune system during viral infection results in the production of type I interferons and the activation of antiviral immune responses. The RNA helicases RIG-I and MDA-5 recognize distinct types of cytosolic RNA species and signal through the mitochondrial protein MAVS to stimulate the phosphorylation and activation of the transcription factors IRF3 and IRF7, thereby inducing type I interferon expression. Alternatively, the activation of NF-kappa B leads to proinflammatory cytokine production. The function of MAVS is dependent on both its C-terminal transmembrane (TM) domain and N-terminal caspase recruitment domain (CARD). The TM domain mediates MAVS dimerization in response to viral RNA, allowing the CARD to bind to and activate the downstream effector TRAF3. Notably, dimerization of the MAVS CARD alone is sufficient to activate IRF3, IRF7, and NF-kappa B. However, TRAF3-deficient cells display only a partial reduction in interferon production in response to RNA virus infection and are not defective in NF-kappa B activation. Here we find that the related ubiquitin ligase TRAF5 is a downstream target of MAVS that mediates both IRF3 and NF-kappa B activation. The TM domain of MAVS allows it to dimerize and thereby associate with TRAF5 and induce its ubiquitination in a CARD-dependent manner. Also, NEMO is recruited to the dimerized MAVS CARD domain in a TRAF3 and TRAF5-dependent manner. Thus, our findings reveal a possible function for TRAF5 in mediating the activation of IRF3 and NF-kappa B downstream of MAVS through the recruitment of NEMO. TRAF5 may be a key molecule in the innate response against viral infection.	[Tang, Eric D.; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Mol Signalling Lab, Div Oral Biol & Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Tang, ED (corresponding author), Univ Calif Los Angeles, Sch Dent, Mol Signalling Lab, Div Oral Biol & Med, Los Angeles, CA 90024 USA.	cwang@dentistry.ucla.edu			National Institutes of Health [DE13848, DE15964]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE013848, R01DE015964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants DE13848 and DE15964 to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui XF, 2004, BIOCHEM CELL BIOL, V82, P401, DOI 10.1139/O04-041; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; He LS, 2006, J BIOL CHEM, V281, P11235, DOI 10.1074/jbc.M508779200; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; MacCorkle RA, 1998, P NATL ACAD SCI USA, V95, P3655, DOI 10.1073/pnas.95.7.3655; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oganesyan G, 2008, J BIOL CHEM, V283, P802, DOI 10.1074/jbc.M704755200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saito T, 2008, J EXP MED, V205, P1523, DOI 10.1084/jem.20081210; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tang ED, 2003, J BIOL CHEM, V278, P38566, DOI 10.1074/jbc.M304374200; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	41	62	65	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9172	10.1371/journal.pone.0009172	http://dx.doi.org/10.1371/journal.pone.0009172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161788	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442800018
J	Tao, YG; Xi, SC; Briones, V; Muegge, K				Tao, Yongguang; Xi, Sichuan; Briones, Victorino; Muegge, Kathrin			Lsh Mediated RNA Polymerase II Stalling at HoxC6 and HoxC8 Involves DNA Methylation	PLOS ONE			English	Article							DE-NOVO METHYLATION; TRANSCRIPTIONAL ELONGATION; CHROMATIN-STRUCTURE; HUMAN GENOME; CPG ISLAND; GENE; CELLS; NUCLEOSOMES; EXPRESSION; PROMOTERS	DNA cytosine methylation is an important epigenetic mechanism that is involved in transcriptional silencing of developmental genes. Several molecular pathways have been described that interfere with Pol II initiation, but at individual genes the molecular mechanism of repression remains uncertain. Here, we study the molecular mechanism of transcriptional regulation at Hox genes in dependence of the epigenetic regulator Lsh that controls CpG methylation at selected Hox genes. Wild type cells show a nucleosomal deprived region around the transcriptional start site at methylated Hox genes and mediate gene silencing via Pol II stalling. Hypomethylation in Lsh-/- cells is associated with efficient transcriptional elongation and splicing, in part mediated by the chromodomain protein Chd1. Dynamic modulation of DNA methylation in Lsh-/- and wild type cells demonstrates that catalytically active DNA methyltransferase activity is required for Pol II stalling. Taken together, the data suggests that DNA methylation can be compatible with Pol II binding at selected genes and Pol II stalling can act as alternate mechanism to explain transcriptional silencing associated with DNA methylation.	[Tao, Yongguang; Xi, Sichuan; Briones, Victorino; Muegge, Kathrin] NCI, Lab Canc Prevent, SAIC Frederick, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Tao, YG (corresponding author), NCI, Lab Canc Prevent, SAIC Frederick, Frederick, MD 21701 USA.	muegge@ncifcrf.gov			National Cancer Institute; National Institutes of Health [HHSN261200800001E]; Intramural Research Program of NIH; National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010014] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported by the Intramural Research Program of NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Belting HG, 1998, J EXP ZOOL, V282, P196, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;196::AID-JEZ22&gt;3.0.CO;2-R; Brand M, 2008, NAT PROTOC, V3, P398, DOI 10.1038/nprot.2008.8; Choi JK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r89; Chopra VS, 2009, CURR BIOL, V19, P688, DOI 10.1016/j.cub.2009.02.055; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Erfurth FE, 2008, P NATL ACAD SCI USA, V105, P7517, DOI 10.1073/pnas.0800090105; Fan T, 2005, DEVELOPMENT, V132, P635, DOI 10.1242/dev.01612; Fan T, 2003, CANCER RES, V63, P4677; Fan T, 2008, EPIGENETICS-US, V3, P134, DOI 10.4161/epi.3.3.6252; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hess JL, 2004, CRIT REV EUKAR GENE, V14, P235, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.10; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Huang JQ, 2004, NUCLEIC ACIDS RES, V32, P5019, DOI 10.1093/nar/gkh821; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Juan AH, 2006, ANN NY ACAD SCI, V1068, P87, DOI 10.1196/annals.1346.046; Kharchenko PV, 2008, GENOME RES, V18, P1554, DOI 10.1101/gr.075952.107; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Latham T, 2008, CELL TISSUE RES, V331, P31, DOI 10.1007/s00441-007-0537-9; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Muegge K, 2005, BIOCHEM CELL BIOL, V83, P548, DOI 10.1139/O05-119; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Okitsu CY, 2007, MOL CELL BIOL, V27, P2746, DOI 10.1128/MCB.02291-06; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Ordway JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001314; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Pennings Sari, 2005, Briefings in Functional Genomics & Proteomics, V3, P351, DOI 10.1093/bfgp/3.4.351; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Strathdee G, 2007, CLIN CANCER RES, V13, P5048, DOI 10.1158/1078-0432.CCR-07-0919; Strathdee G, 2007, CARCINOGENESIS, V28, P299, DOI 10.1093/carcin/bgl133; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wu XD, 2008, NUCLEIC ACIDS RES, V36, P3590, DOI 10.1093/nar/gkn243; XI S, 2009, STEM CELLS; Xi SC, 2007, P NATL ACAD SCI USA, V104, P14366, DOI 10.1073/pnas.0703669104; Yan QS, 2003, MOL CELL BIOL, V23, P8416, DOI 10.1128/MCB.23.23.8416-8428.2003; Yan QS, 2003, EMBO J, V22, P5154, DOI 10.1093/emboj/cdg493; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhu HM, 2006, EMBO J, V25, P335, DOI 10.1038/sj.emboj.7600925	60	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9163	10.1371/journal.pone.0009163	http://dx.doi.org/10.1371/journal.pone.0009163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161795	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442800009
J	Beck, L; Leroy, C; Beck-Cormier, S; Forand, A; Salaun, C; Paris, N; Bernier, A; Urena-Torres, P; Prie, D; Ollero, M; Coulombel, L; Friedlander, G				Beck, Laurent; Leroy, Christine; Beck-Cormier, Sarah; Forand, Anne; Salauen, Christine; Paris, Nadine; Bernier, Adeline; Urena-Torres, Pablo; Prie, Dominique; Ollero, Mario; Coulombel, Laure; Friedlander, Gerard			The Phosphate Transporter PiT1 (Slc20a1) Revealed As a New Essential Gene for Mouse Liver Development	PLOS ONE			English	Article							APE LEUKEMIA-VIRUS; EMBRYONIC LETHALITY; RETROVIRUS RECEPTOR; CELLULAR RECEPTOR; MESSENGER-RNA; MICE LACKING; FETAL LIVER; EXPRESSION; COTRANSPORTER; GROWTH	Background: PiT1 (or SLC20a1) encodes a widely expressed plasma membrane protein functioning as a high-affinity Na+-phosphate (Pi) cotransporter. As such, PiT1 is often considered as a ubiquitous supplier of Pi for cellular needs regardless of the lack of experimental data. Although the importance of PiT1 in mineralizing processes have been demonstrated in vitro in osteoblasts, chondrocytes and vascular smooth muscle cells, in vivo evidence is missing. Methodology/Principal Findings: To determine the in vivo function of PiT1, we generated an allelic series of PiT1 mutations in mice by combination of wild-type, hypomorphic and null PiT1 alleles expressing from 100% to 0% of PiT1. In this report we show that complete deletion of PiT1 results in embryonic lethality at E12.5. PiT1-deficient embryos display severely hypoplastic fetal livers and subsequent reduced hematopoiesis resulting in embryonic death from anemia. We show that the anemia is not due to placental, yolk sac or vascular defects and that hematopoietic progenitors have no cell-autonomous defects in proliferation and differentiation. In contrast, mutant fetal livers display decreased proliferation and massive apoptosis. Animals carrying two copies of hypomorphic PiT1 alleles (resulting in 15% PiT1 expression comparing to wild-type animals) survive at birth but are growth-retarded and anemic. The combination of both hypomorphic and null alleles in heterozygous compounds results in late embryonic lethality (E14.5-E16.5) with phenotypic features intermediate between null and hypomorphic mice. In the three mouse lines generated we could not evidence defects in early skeleton formation. Conclusion/Significance: This work is the first to illustrate a specific in vivo role for PiT1 by uncovering it as being a critical gene for normal developmental liver growth.	[Beck, Laurent; Leroy, Christine; Forand, Anne; Salauen, Christine; Paris, Nadine; Bernier, Adeline; Urena-Torres, Pablo; Prie, Dominique; Ollero, Mario; Friedlander, Gerard] INSERM, U845, Ctr Rech Croissance & Signalisat, Paris, France; [Beck, Laurent; Leroy, Christine; Forand, Anne; Salauen, Christine; Paris, Nadine; Bernier, Adeline; Urena-Torres, Pablo; Prie, Dominique; Ollero, Mario; Friedlander, Gerard] Univ Paris 05, Fac Med, Paris, France; [Beck-Cormier, Sarah] Inst Pasteur, Unite Genet Fonct Souris, Paris, France; [Beck-Cormier, Sarah] CNRS, URA2578, Unite Genet Fonct Souris, Paris, France; [Coulombel, Laure] INSERM, U935, Villejuif, France; [Coulombel, Laure] Hop Paul Brousse, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Beck, L (corresponding author), INSERM, U845, Ctr Rech Croissance & Signalisat, Paris, France.	laurent.beck@inserm.fr	Ollero, Mario/AAJ-3545-2020; Beck-Cormier, Sarah/P-3091-2014; BECK, Laurent/P-2952-2014; Ollero, Mario/Q-6147-2018	Beck-Cormier, Sarah/0000-0001-5258-1933; BECK, Laurent/0000-0002-6730-2762; Bernier, Adeline/0000-0003-3023-429X; Forand, Anne/0000-0003-4970-2372; Friedlander, Gerard/0000-0002-6854-4261; Ollero, Mario/0000-0003-3590-706X; Salaun, Christine/0000-0003-3002-6810	INSERM; CNRS; Institut Pasteur; Paris Descartes University; Association Laboratoire de Recherches Physiologiques; ANR (Agence Nationale pour la Recherche)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); Paris Descartes University; Association Laboratoire de Recherches Physiologiques; ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR))	This study was supported by grants from INSERM, CNRS, Institut Pasteur, Paris Descartes University, Association Laboratoire de Recherches Physiologiques and ANR (Agence Nationale pour la Recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1; Beck L, 2000, J BIOL CHEM, V275, P11880, DOI 10.1074/jbc.275.16.11880; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; ESCOUBET B, 1992, J ENDOCRINOL, V133, P301, DOI 10.1677/joe.0.1330301; Festing MH, 2009, GENESIS, V47, P858, DOI 10.1002/dvg.20577; Frei P, 2005, AM J PHYSIOL-GASTR L, V288, pG771, DOI 10.1152/ajpgi.00272.2004; Ganiatsas S, 1998, P NATL ACAD SCI USA, V95, P6881, DOI 10.1073/pnas.95.12.6881; Giachelli CM, 2009, KIDNEY INT, V75, P890, DOI 10.1038/ki.2008.644; GOHEEN SC, 1982, LIPIDS, V17, P594, DOI 10.1007/BF02535364; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Isern J, 2008, P NATL ACAD SCI USA, V105, P6662, DOI 10.1073/pnas.0802032105; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JOHANN SV, 1992, J VIROL, V66, P1635, DOI 10.1128/JVI.66.3.1635-1640.1992; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGrath K, 2008, CURR TOP DEV BIOL, V82, P1, DOI 10.1016/S0070-2153(07)00001-4; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; MILLER DG, 1994, J VIROL, V68, P8270, DOI 10.1128/JVI.68.12.8270-8276.1994; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Nielsen LB, 2001, BONE, V28, P160, DOI 10.1016/S8756-3282(00)00418-X; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; OLAH Z, 1994, J BIOL CHEM, V269, P25426; Ollero M, 2006, METABOLISM, V55, P1192, DOI 10.1016/j.metabol.2006.05.002; Palmer G, 2000, ENDOCRINOLOGY, V141, P2236, DOI 10.1210/en.141.6.2236; Palmer G, 1997, ENDOCRINOLOGY, V138, P5202, DOI 10.1210/en.138.12.5202; Palmer G, 1999, BONE, V24, P1, DOI 10.1016/S8756-3282(98)00151-3; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Suzuki A, 2006, J BONE MINER RES, V21, P674, DOI 10.1359/JBMR.020603; Suzuki A, 2001, BONE, V28, P589, DOI 10.1016/S8756-3282(01)00459-8; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; Uckert W, 1998, HUM GENE THER, V9, P2619, DOI 10.1089/10430349850019454; Villa-Bellosta R, 2007, ARTERIOSCL THROM VAS, V27, P1030, DOI 10.1161/ATVBAHA.106.132266; Villa-Bellosta R, 2009, PFLUG ARCH EUR J PHY, V458, P1151, DOI 10.1007/s00424-009-0688-5; Villa-Bellosta R, 2009, ARTERIOSCL THROM VAS, V29, P761, DOI 10.1161/ATVBAHA.108.183384; Vincent F, 2009, CANCER RES, V69, P2853, DOI 10.1158/0008-5472.CAN-08-2484; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wang Cecilia C Low, 2007, Atherosclerosis, V195, pe65, DOI 10.1016/j.atherosclerosis.2007.02.032; Wang DS, 2001, J BIOL CHEM, V276, P33995, DOI 10.1074/jbc.M007757200; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07; Zoidis E, 2004, J ENDOCRINOL, V181, P531, DOI 10.1677/joe.0.1810531	52	79	80	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9148	10.1371/journal.pone.0009148	http://dx.doi.org/10.1371/journal.pone.0009148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161774	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442700012
J	Becquart, P; Wauquier, N; Mahlakoiv, T; Nkoghe, D; Padilla, C; Souris, M; Ollomo, B; Gonzalez, JP; De Lamballerie, X; Kazanji, M; Leroy, EM				Becquart, Pierre; Wauquier, Nadia; Mahlakoiv, Tanel; Nkoghe, Dieudonne; Padilla, Cindy; Souris, Marc; Ollomo, Benjamin; Gonzalez, Jean-Paul; De Lamballerie, Xavier; Kazanji, Mirdad; Leroy, Eric M.			High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; ANTIBODY PREVALENCE; NONHUMAN-PRIMATES; VIRUS-INFECTION; IGG ANTIBODIES; MEMORY; RESPONSES; PROTECTION; SMALLPOX; OUTBREAK	To better understand Zaire ebolavirus (ZEBOV) circulation and transmission to humans, we conducted a large serological survey of rural populations in Gabon, a country characterized by both epidemic and non epidemic regions. The survey lasted three years and covered 4,349 individuals from 220 randomly selected villages, representing 10.7% of all villages in Gabon. Using a sensitive and specific ELISA method, we found a ZEBOV-specific IgG seroprevalence of 15.3% overall, the highest ever reported. The seroprevalence rate was significantly higher in forested areas (19.4%) than in other ecosystems, namely grassland (12.4%), savannah (10.5%), and lakeland (2.7%). No other risk factors for seropositivity were found. The specificity of anti-ZEBOV IgG was confirmed by Western blot in 138 individuals, and CD8 T cells from seven IgG+ individuals were shown to produce IFN-gamma after ZEBOV stimulation. Together, these findings show that a large fraction of the human population living in forested areas of Gabon has both humoral and cellular immunity to ZEBOV. In the absence of identified risk factors, the high prevalence of "immune'' persons suggests a common source of human exposure such as fruits contaminated by bat saliva. These findings provide significant new insights into ZEBOV circulation and human exposure, and raise important questions as to the human pathogenicity of ZEBOV and the existence of natural protective immunization.	[Becquart, Pierre; Wauquier, Nadia; Mahlakoiv, Tanel; Nkoghe, Dieudonne; Padilla, Cindy; Ollomo, Benjamin; Gonzalez, Jean-Paul; Kazanji, Mirdad; Leroy, Eric M.] Ctr Int Rech Med Franceville, Unite Malad Virales Emergentes, Franceville, Gabon; [Becquart, Pierre; Souris, Marc; De Lamballerie, Xavier; Leroy, Eric M.] Univ Aix Marseille 2, Emergence Pathol Virales UMR190, Marseille, France; [Becquart, Pierre; Souris, Marc; De Lamballerie, Xavier; Leroy, Eric M.] Inst Rech Dev, Marseille, France; [Souris, Marc] Mahidol Univ Salaya, Nakhonpathon, Thailand	UDICE-French Research Universities; Aix-Marseille Universite; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Mahidol University	Becquart, P (corresponding author), Ctr Int Rech Med Franceville, Unite Malad Virales Emergentes, BP 769, Franceville, Gabon.	eric.leroy@ird.fr	Gonzalez, J-P/C-3077-2013; Becquart, Pierre/GLT-0845-2022; LEROY, Eric M/I-4347-2016; SOURIS, Marc/K-2506-2016	Gonzalez, J-P/0000-0003-3063-1770; LEROY, Eric M/0000-0003-0022-0890; SOURIS, Marc/0000-0002-2933-3488; Mahlakoiv, Tanel/0000-0001-9059-0486; Wauquier, Nadia/0000-0002-2874-7574; Becquart, Pierre/0000-0002-0980-1678	Agence Nationale pour la Recherche [ANR-06-MIME-022-01]; Ministere des Affaires Etrangeres de la France [2002005700]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ministere des Affaires Etrangeres de la France	This work was funded by a grant from Agence Nationale pour la Recherche (# ANR-06-MIME-022-01) and a Fonds de Solidarite Prioritaire grant from the Ministere des Affaires Etrangeres de la France (# 2002005700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; [Anonymous], 2005, SURVEYOFCLUSTERINGAL, V16, DOI [DOI 10.1086/503836, 10.1109/TNN.2005, DOI 10.1109/TNN.2005]; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; BARON RC, 1983, B WORLD HEALTH ORGAN, V61, P997; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; BOUREE P, 1983, AM J TROP MED HYG, V32, P1465, DOI 10.4269/ajtmh.1983.32.1465; Brehm MA, 2004, CELL MICROBIOL, V6, P411, DOI 10.1111/j.1462-5822.2004.00390.x; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Busico KM, 1999, J INFECT DIS, V179, pS102, DOI 10.1086/514309; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P73; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Combadiere B, 2004, J EXP MED, V199, P1585, DOI 10.1084/jem.20032083; Deng IM, 1978, B WORLD HEALTH ORGAN, V56, P247; Feldmann H, 2007, FIELDS VIROLOGY, P1409; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Georges AJ, 1999, J INFECT DIS, V179, pS65, DOI 10.1086/514290; Gonzalez JP, 2000, MICROBES INFECT, V2, P39, DOI 10.1016/S1286-4579(00)00287-2; GONZALEZ JP, 1989, RES VIROLOGY, V140, P319, DOI 10.1016/S0923-2516(89)80112-8; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Heffernan RT, 2005, J INFECT DIS, V191, P964, DOI 10.1086/427994; IVANOFF B, 1982, T ROY SOC TROP MED H, V76, P719, DOI 10.1016/0035-9203(82)90089-X; JAHRLING PB, 1990, LANCET, V335, P502, DOI 10.1016/0140-6736(90)90737-P; JOHNSON BK, 1986, LANCET, V1, P1160; JOHNSON ED, 1993, T ROY SOC TROP MED H, V87, P536, DOI 10.1016/0035-9203(93)90077-4; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; KINGDOM J, 1984, E AFRICAN MAMMALS; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; LED J, 2004, GRANDS ENSEMBLES VEG; LEGUENNO B, 1995, LANCET, V345, P1271, DOI 10.1016/S0140-6736(95)90925-7; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; MOE JB, 1981, J CLIN MICROBIOL, V13, P791, DOI 10.1128/JCM.13.4.791-793.1981; Okware SI, 2002, TROP MED INT HEALTH, V7, P1068, DOI 10.1046/j.1365-3156.2002.00944.x; Olinger GG, 2005, J VIROL, V79, P14189, DOI 10.1128/JVI.79.22.14189-14196.2005; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547; Richardson JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005308; Rollin PE, 1999, J INFECT DIS, V179, pS108, DOI 10.1086/514303; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Warfield KL, 2005, J IMMUNOL, V175, P1184, DOI 10.4049/jimmunol.175.2.1184; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001; Wittmann TJ, 2007, P NATL ACAD SCI USA, V104, P17123, DOI 10.1073/pnas.0704076104; [No title captured]	58	107	112	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9126	10.1371/journal.pone.0009126	http://dx.doi.org/10.1371/journal.pone.0009126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161740	gold, Green Published			2022-12-25	WOS:000274442600024
J	Collombet, JM; Elias, M; Gotthard, G; Four, E; Renault, F; Joffre, A; Baubichon, D; Rochu, D; Chabriere, E				Collombet, Jean-Marc; Elias, Mikael; Gotthard, Guillaume; Four, Elise; Renault, Frederique; Joffre, Aurelie; Baubichon, Dominique; Rochu, Daniel; Chabriere, Eric			Eukaryotic DING Proteins Are Endogenous: An Immunohistological Study in Mouse Tissues	PLOS ONE			English	Article							ST-JOHNS-WORT; HUMAN PARAOXONASE; HIV-1 EXPRESSION; T-CELLS; SEQUENCE; P27(SJ); CRYSTALLIZATION; DISCOVERY; MICE; HPBP	Background: DING proteins encompass an intriguing protein family first characterized by their conserved N-terminal sequences. Some of these proteins seem to have key roles in various human diseases, e. g., rheumatoid arthritis, atherosclerosis, HIV suppression. Although this protein family seems to be ubiquitous in eukaryotes, their genes are consistently lacking from genomic databases. Such a lack has considerably hampered functional studies and has fostered therefore the hypothesis that DING proteins isolated from eukaryotes were in fact prokaryotic contaminants. Principal Findings: In the framework of our study, we have performed a comprehensive immunological detection of DING proteins in mice. We demonstrate that DING proteins are present in all tissues tested as isoforms of various molecular weights (MWs). Their intracellular localization is tissue-dependant, being exclusively nuclear in neurons, but cytoplasmic and nuclear in other tissues. We also provide evidence that germ-free mouse plasma contains as much DING protein as wildtype. Significance: Hence, data herein provide a valuable basis for future investigations aimed at eukaryotic DING proteins, revealing that these proteins seem ubiquitous in mouse tissue. Our results strongly suggest that mouse DING proteins are endogenous. Moreover, the determination in this study of the precise cellular localization of DING proteins constitute a precious evidence to understand their molecular involvements in their related human diseases.	[Collombet, Jean-Marc; Four, Elise; Renault, Frederique; Baubichon, Dominique; Rochu, Daniel] Ctr Rech, Serv Sante Armees, Dept Toxicol, Inst Rech Biomed Armees, La Tronche, France; [Elias, Mikael; Gotthard, Guillaume; Chabriere, Eric] Aix Marseille Univ, CNRS, Marseille, France; [Joffre, Aurelie] Ctr Rech, Serv Sante Armees, Serv Microscopie & Imagerie Med, Inst Rech Biomed Armees, La Tronche, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Collombet, JM (corresponding author), Ctr Rech, Serv Sante Armees, Dept Toxicol, Inst Rech Biomed Armees, La Tronche, France.	eric.chabriere@afmb.univ-mrs.fr	Elias, Mikael/C-8484-2011; Elias, Mikael/AAH-9385-2021	Elias, Mikael/0000-0003-0406-7539; Elias, Mikael/0000-0003-0406-7539	Delegation Generale pour l'Armement [010807/03-10]; C.N.R.S.D.R.; German Bundesministerium der Verteidigung [M/SABX/8A001]; F.E.B.S.	Delegation Generale pour l'Armement; C.N.R.S.D.R.; German Bundesministerium der Verteidigung; F.E.B.S.	Funding: This research was supported by grants to E.C. by Delegation Generale pour l'Armement (CO n degrees 010807/03-10) and by the C.N.R.S.D.R. is under contract with the German Bundesministerium der Verteidigung (M/SABX/8A001). M. E. is a post-doctoral fellow supported by the F.E.B.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams L, 2002, BBA-MOL BASIS DIS, V1586, P254, DOI 10.1016/S0925-4439(01)00104-1; Ahn S, 2007, FEBS LETT, V581, P3455, DOI 10.1016/j.febslet.2007.06.050; Belenky M, 2003, J NUTR, V133, p2497S, DOI 10.1093/jn/133.7.2497S; Berna A, 2002, FEBS LETT, V524, P6, DOI 10.1016/S0014-5793(02)03053-3; BERNA A, 2009, CELL MOL LIFE SCI; Berna A, 2008, INT J BIOCHEM CELL B, V40, P170, DOI 10.1016/j.biocel.2007.02.004; Berna A, 2009, BIOESSAYS, V31, P570, DOI 10.1002/bies.200800174; Collombet JM, 2006, NEUROSCI LETT, V398, P337, DOI 10.1016/j.neulet.2006.01.029; Collombet JM, 2005, TOXICOLOGY, V208, P319, DOI 10.1016/j.tox.2004.11.036; Contreras-Martel C, 2006, ACTA CRYSTALLOGR F, V62, P67, DOI 10.1107/S1744309105041461; Darbinian N, 2008, ANTIVIR RES, V79, P136, DOI 10.1016/j.antiviral.2007.11.006; Darbinian N, 2009, J CELL BIOCHEM, V107, P400, DOI 10.1002/jcb.22135; Darbinian-Sarkissian N, 2006, GENE THER, V13, P288, DOI 10.1038/sj.gt.3302649; Diemer H, 2008, PROTEINS, V71, P1708, DOI 10.1002/prot.21866; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Fokine A, 2003, ACTA CRYSTALLOGR D, V59, P2083, DOI 10.1107/S0907444903017682; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; HAIN N, 1990, RHEUMATOL INT, V10, P203, DOI 10.1007/BF02274834; Hain NAK, 1996, J IMMUNOL, V157, P1773; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kumar V, 2004, AM J PHYSIOL-RENAL, V287, pF373, DOI 10.1152/ajprenal.00418.2003; Lesner A, 2005, J IMMUNOL, V175, P2548, DOI 10.4049/jimmunol.175.4.2548; LESNER A, 2009, BIOCH BIOPHYS RES CO; Lewis AP, 2005, FEMS MICROBIOL LETT, V252, P215, DOI 10.1016/j.femsle.2005.08.047; Liebschner D, 2009, J AM CHEM SOC, V131, P7879, DOI 10.1021/ja901900y; Lillie R. D., 1976, HISTOPATHOLOGIC TECH, P208; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moniot S, 2007, ACTA CRYSTALLOGR F, V63, P590, DOI 10.1107/S1744309107028102; Morales R., 2007, ANNALES PHARMACEUTIQUES FRANCAISES, V65, P98, DOI 10.1016/S0003-4509(07)90023-1; Morales R, 2006, STRUCTURE, V14, P601, DOI 10.1016/j.str.2005.12.012; Mukerjee R, 2008, MOL IMMUNOL, V45, P4028, DOI 10.1016/j.molimm.2008.06.001; PANTAZAKI AA, 2007, DING PHOSPHATASE THE; Perera T, 2008, PHYTOCHEMISTRY, V69, P865, DOI 10.1016/j.phytochem.2007.10.001; Renault F, 2006, J CHROMATOGR B, V836, P15, DOI 10.1016/j.jchromb.2006.03.029; Riah O, 2000, CELL MOL NEUROBIOL, V20, P653, DOI 10.1023/A:1007094623775; Rochu D, 2007, BIOCHEM SOC T, V35, P1616, DOI 10.1042/BST0351616; ROCHU D, 2008, STABILISATION ACTIVE, P171; ROCHU D, 2007, TOXICOLOGY, V142; Scott K, 2005, BBA-MOL CELL RES, V1744, P234, DOI 10.1016/j.bbamcr.2005.02.003; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; STREIT WJ, 1990, J HISTOCHEM CYTOCHEM, V38, P1683, DOI 10.1177/38.11.2212623	41	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9099	10.1371/journal.pone.0009099	http://dx.doi.org/10.1371/journal.pone.0009099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161715	gold, Green Submitted, Green Published			2022-12-25	WOS:000274442500008
J	Kara, FM; Chitu, V; Sloane, J; Axelrod, M; Fredholm, BB; Stanley, ER; Cronstein, BN				Kara, Firas M.; Chitu, Violeta; Sloane, Jennifer; Axelrod, Matthew; Fredholm, Bertil B.; Stanley, E. Richard; Cronstein, Bruce N.			Adenosine A(1) receptors (A(1)Rs) play a critical role in osteoclast formation and function	FASEB JOURNAL			English	Article						P1 receptors; osteoporosis	NF-KAPPA-B; SMOOTH-MUSCLE-CELLS; DEFECTIVE INTERLEUKIN-1; BONE-RESORPTION; ION CHANNELS; K+ CHANNELS; RELEASE; ACTIVATION; DIFFERENTIATION; PRECURSORS	Adenosine regulates a wide variety of physiological processes via interaction with one or more G-protein-coupled receptors (A(1)R, A(2A)R, A(2B)R, and A(3)R). Because A(1)R occupancy promotes fusion of human monocytes to form giant cells in vitro, we determined whether A(1)R occupancy similarly promotes osteoclast function and formation. Bone marrow cells (BMCs) were harvested from C57Bl/6 female mice or A(1)R-knockout mice and their wild-type (WT) littermates and differentiated into osteoclasts in the presence of colony stimulating factor-1 and receptor activator of NF-kappa B ligand in the presence or absence of the A(1)R antagonist 1,3-dipropyl-8-cyclopentyl xanthine (DPCPX). Osteoclast morphology was analyzed in tartrate-resistant acid phosphatase or F-actin-stained samples, and bone resorption was evaluated by toluidine blue staining of dentin. BMCs from A(1)R-knockout mice form fewer osteoclasts than BMCs from WT mice, and the A(1)R antagonist DPCPX inhibits osteoclast formation (IC50 = 1 nM), with altered morphology and reduced ability to resorb bone. A(1)R blockade increased ubiquitination and degradation of TRAF6 in RAW264.7 cells induced to differentiate into osteoclasts. These studies suggest a critical role for adenosine in bone homeostasis via interaction with adenosine A(1)R and further suggest that A(1)R may be a novel pharmacologic target to prevent the bone loss associated with inflammatory diseases and menopause.-Kara, F. M., Chitu, V., Sloane, J., Axelrod, M., Fredholm, B. B., Stanley, R., Cronstein, B. N. Adenosine A(1) receptors (A(1)Rs) play a critical role in osteoclast formation and function. FASEB J. 24, 2325-2333 (2010). www.fasebj.org	[Kara, Firas M.; Sloane, Jennifer; Axelrod, Matthew; Cronstein, Bruce N.] NYU, Sch Med, Div Clin Pharmacol, Dept Med, New York, NY 10016 USA; [Chitu, Violeta; Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Fredholm, Bertil B.] Karolinska Inst, Dept Physiol, S-10401 Stockholm, Sweden; [Fredholm, Bertil B.] Karolinska Inst, Dept Pharmacol, S-10401 Stockholm, Sweden	New York University; Yeshiva University; Albert Einstein College of Medicine; Karolinska Institutet; Karolinska Institutet	Cronstein, BN (corresponding author), NYU, Sch Med, Div Clin Pharmacol, Dept Med, 550 1st Ave,NBV16N1, New York, NY 10016 USA.	cronsb01@med.nyu.edu	Cronstein, Bruce N/D-4678-2011; Stanley, Evan R/J-9154-2013	Cronstein, Bruce N/0000-0002-4295-7383; Stanley, Evan R/0000-0002-2910-2065; Chitu, Violeta/0000-0001-6641-1564	U.S. National Institutes of Health [AR54897, AR41911, AA13336, RO1 CA25604, K01 AR054486-02]; NYU-HHC Clinical and Translational Science Institute [UL1RR029893]; New York Community Trust; Albert Einstein College of Medicine Cancer Center [P30 CA13330]; Kaplan Cancer Center of New York University School of Medicine; NATIONAL CANCER INSTITUTE [R37CA026504, P30CA013330, R01CA032551] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR054486, R01AR041911, R01AR054897, P30AR046121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013336] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYU-HHC Clinical and Translational Science Institute; New York Community Trust; Albert Einstein College of Medicine Cancer Center; Kaplan Cancer Center of New York University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors thank Dr. Kevin McHugh (Beth Israel Deaconess Medical Center, Boston, MA, USA) for providing the RAW264.7 cell line. This work was supported by grants from the U.S. National Institutes of Health (AR54897, AR41911, and AA13336 to B.N.C.; RO1 CA25604 to E. R. S.; and K01 AR054486-02 to V. C.), the NYU-HHC Clinical and Translational Science Institute (UL1RR029893), a New York Community Trust blood diseases grant (V. C.), the Albert Einstein College of Medicine Cancer Center (P30 CA13330; to E. R. S.), and the Kaplan Cancer Center of New York University School of Medicine. In addition, the Musculoskeletal Repair and Regeneration Core Center at the Hospital for Special Surgery (AR046121) provided technical assistance. B.N.C. holds or has filed applications for patents on the use of adenosine A<INF>2A</INF>R agonists to promote wound healing and use of A<INF>2A</INF>R antagonists to inhibit fibrosis; use of adenosine A<INF>1</INF>R antagonists to treat osteoporosis and other diseases of bone; use of adenosine A<INF>1</INF>R and A<INF>2B</INF>R antagonists to treat fatty liver; and use of adenosine A<INF>2A</INF>R agonists to prevent prosthesis loosening. Consultancies (within past 2 yr): King Pharmaceutical (licensee of patents on wound healing and fibrosis above), CanFite Biopharmaceuticals, Savient Pharmaceuticals, Bristol-Myers Squibb, Roche Pharmaceuticals, Cellzome, Tap (Takeda) Pharmaceuticals, Prometheus Laboratories, Regeneron (Westat, DSMB), Sepracor, Amgen, Endocyte, Protalex, Allos, Inc., Combinatorx, Kyowa Hakka. Honoraria/speaker bureaus: Tap (Takeda) Pharmaceuticals. Stock: CanFite Biopharmaceuticals, received for membership on Scientific Advisory Board.	AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; Baron R, 1995, ACTA ORTHOP SCAND, V66, P66, DOI 10.3109/17453679509157650; BERNE RM, 1985, ACTA MED SCAND, P9; Blay J, 1997, CANCER RES, V57, P2602; BORST MM, 1991, CIRC RES, V68, P797, DOI 10.1161/01.RES.68.3.797; Bosche LI, 2003, J PHYSIOL-LONDON, V550, P707, DOI 10.1113/jphysiol.2003.041962; Brubaker KD, 1999, J BONE MINER RES, V14, P1861, DOI 10.1359/jbmr.1999.14.11.1861; CHAMBERS TJ, 1993, P NATL ACAD SCI USA, V90, P5578, DOI 10.1073/pnas.90.12.5578; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chitu V, 2005, MOL BIOL CELL, V16, P2947, DOI 10.1091/mbc.e04-10-0914; DART C, 1993, J PHYSIOL-LONDON, V471, P767, DOI 10.1113/jphysiol.1993.sp019927; DEUSSEN A, 1986, PFLUG ARCH EUR J PHY, V406, P608, DOI 10.1007/BF00584028; DUNWIDDIE TV, 1989, J PHARMACOL EXP THER, V249, P31; Evans BAJ, 2006, J BONE MINER RES, V21, P228, DOI 10.1359/JBMR.051021; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Finkelstein JS, 2000, CECIL TXB MED, P1366; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fredholm BB, 2000, N-S ARCH PHARMACOL, V362, P364, DOI 10.1007/s002100000313; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; Galvin RJS, 1999, BIOCHEM BIOPH RES CO, V265, P233, DOI 10.1006/bbrc.1999.1632; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; Heymann D, 1998, CYTOKINE, V10, P155, DOI 10.1006/cyto.1997.0277; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; Jones SJ, 1997, BONE, V21, P393, DOI 10.1016/S8756-3282(97)00174-9; Kara FM, 2010, ARTHRITIS RHEUM-US, V62, P534, DOI 10.1002/art.27219; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Khoa ND, 2006, MOL PHARMACOL, V69, P1311, DOI 10.1124/mol.105.016857; Khoa ND, 2003, J IMMUNOL, V171, P3991, DOI 10.4049/jimmunol.171.8.3991; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Kim EY, 1997, AM J PHYSIOL-HEART C, V272, pH325, DOI 10.1152/ajpheart.1997.272.1.H325; Komarova SV, 2003, CALCIFIED TISSUE INT, V73, P265, DOI 10.1007/s00223-002-1051-4; Komarova SV, 2001, CURR PHARM DESIGN, V7, P637, DOI 10.2174/1381612013397799; LAKKAKORPI PT, 1991, J BONE MINER RES, V6, P817; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Lennon PF, 1998, J EXP MED, V188, P1433, DOI 10.1084/jem.188.8.1433; Liu AMF, 2004, J BIOL CHEM, V279, P53196, DOI 10.1074/jbc.M410196200; LOHSE MJ, 1987, N-S ARCH PHARMACOL, V336, P204, DOI 10.1007/BF00165806; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; MADARA JL, 1993, J CLIN INVEST, V91, P2320, DOI 10.1172/JCI116462; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MEININGER CJ, 1988, AM J PHYSIOL, V255, pH554, DOI 10.1152/ajpheart.1988.255.3.H554; Merrill JT, 1997, ARTHRITIS RHEUM, V40, P1308, DOI 10.1002/1529-0131(199707)40:7<1308::AID-ART16>3.0.CO;2-M; MOONGA BS, 1992, J ENDOCRINOL, V132, P241, DOI 10.1677/joe.0.1320241; Morabito L, 1998, J CLIN INVEST, V101, P295, DOI 10.1172/JCI1554; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Okada Y, 2000, J CLIN INVEST, V105, P823, DOI 10.1172/JCI8195; PEARSON JD, 1979, NATURE, V281, P384, DOI 10.1038/281384a0; Peng Z, 2009, J CLIN INVEST, V119, P582, DOI 10.1172/JCI37409; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Sitaraman SV, 2001, J CLIN INVEST, V107, P861, DOI 10.1172/JCI11783; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takagi H, 1996, INVEST OPHTH VIS SCI, V37, P1311; TAKAHASHI N, 1994, DEV BIOL, V163, P212, DOI 10.1006/dbio.1994.1137; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; TUCKER AL, 1993, CARDIOVASC RES, V27, P62, DOI 10.1093/cvr/27.1.62; VAANANEN HK, 1995, J CELL SCI, V108, P2729; Wani MR, 1999, ENDOCRINOLOGY, V140, P1927, DOI 10.1210/en.140.4.1927; Weidema AF, 2000, BONE, V27, P5, DOI 10.1016/S8756-3282(00)00287-8; Weidema AF, 1997, J PHYSIOL-LONDON, V503, P303, DOI 10.1111/j.1469-7793.1997.303bh.x; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Yang M, 2001, J IMMUNOL, V166, P6885, DOI 10.4049/jimmunol.166.11.6885; Yasuda H, 1999, BONE, V25, P109, DOI 10.1016/S8756-3282(99)00121-0; Ye RD, 2001, J LEUKOCYTE BIOL, V70, P839	66	62	64	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2325	2333		10.1096/fj.09-147447	http://dx.doi.org/10.1096/fj.09-147447			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20181934	Green Published			2022-12-25	WOS:000279343600019
J	Rom, S; Rom, I; Passiatore, G; Pacifici, M; Radhakrishnan, S; Del Valle, L; Pina-Oviedo, S; Khalili, K; Eletto, D; Peruzzi, F				Rom, Slava; Rom, Inna; Passiatore, Giovanni; Pacifici, Marco; Radhakrishnan, Sujatha; Del Valle, Luis; Pina-Oviedo, Sergio; Khalili, Kamel; Eletto, Davide; Peruzzi, Francesca			CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells	FASEB JOURNAL			English	Article						microRNA; chronic inflammation; brain	CELLULAR MICRORNA MIR-146A; NORMAL IMMUNE FUNCTION; KAPPA-B; CHEMOATTRACTANT PROTEIN-1; HUMAN NEURONS; HUMAN CANCERS; HUMAN BRAIN; HIV-1 TAT; EXPRESSION; DISEASE	MicroRNA-mediated regulation of gene expression appears to be involved in a variety of cellular processes, including development, differentiation, proliferation, and apoptosis. Mir-146a is thought to be involved in the regulation of the innate immune response, and its expression is increased in tissues associated with chronic inflammation. Among the predicted gene targets for mir-146a, the chemokine CCL8/MCP-2 is a ligand for the CCR5 chemokine receptor and a potent inhibitor of CD4/CCR5-mediated HIV-1 entry and replication. In the present study, we have analyzed changes in the expression of mir-146a in primary human fetal microglial cells upon infection with HIV-1 and found increased expression of mir-146a. We further show that CCL8/MCP-2 is a target for mir-146a in HIV-1 infected microglia, as overexpression of mir-146a prevented HIV-induced secretion of MCP-2 chemokine. The clinical relevance of our findings was evaluated in HIV-encephalitis (HIVE) brain samples in which decreased levels of MCP-2 and increased levels of mir-146a were observed, suggesting a role for mir-146a in the maintenance of HIV-mediated chronic inflammation of the brain.-Rom, S., Rom, I., Passiatore, G., Pacifici, M., Radhakrishnan, S., Del Valle, L., Pina-Oviedo, S., Khalili, K., Eletto, D., Peruzzi, F. CCL8/MCP-2 is a target for mir-146a in HIV-1 infected human microglial cells. FASEB J. 24, 2292-2300 (2010). www.fasebj.org	[Rom, Slava; Rom, Inna; Passiatore, Giovanni; Pacifici, Marco; Radhakrishnan, Sujatha; Del Valle, Luis; Pina-Oviedo, Sergio; Khalili, Kamel; Peruzzi, Francesca] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Rom, Slava; Rom, Inna; Passiatore, Giovanni; Pacifici, Marco; Radhakrishnan, Sujatha; Del Valle, Luis; Pina-Oviedo, Sergio; Khalili, Kamel; Peruzzi, Francesca] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA; [Eletto, Davide] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Eletto, Davide] Univ Penn, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Peruzzi, F (corresponding author), Temple Univ, Sch Med, Dept Neurosci, 1900 N 12th St, Philadelphia, PA 19122 USA.	fperuzzi@temple.edu	Del Valle, Luis/J-4085-2015; Oviedo, Sergio Pina/AAV-8814-2021; Rom, Slava/AAF-6872-2020; Peruzzi, Francesca/M-9804-2014	Del Valle, Luis/0000-0003-3894-9206; Rom, Slava/0000-0002-1050-1955	NIH [MH071162, MH079751];  [P01 NS30916]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS030916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Martyn White for editorial assistance. The work was supported by NIH grants MH071162 and MH079751, awarded to F. P. The parts of this work related to HIV-1 infection and immunohistochemistry were partially supported by grant P01 NS30916, awarded to L. D. V., S. A., and K. K. The authors thank Susan Morgello (Director of the Manhattan Brain Bank at Mt. Sinai School of Medicine, New York, NY, USA) for providing HIVE clinical samples.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Bagasra O, 2004, J MOL HISTOL, V35, P545; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bell MD, 1996, NEUROSCIENCE, V74, P283, DOI 10.1016/0306-4522(96)00083-8; Borgmann Kathleen, 2005, Methods Mol Biol, V304, P49; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Coughlan CM, 2000, NEUROSCIENCE, V97, P591, DOI 10.1016/S0306-4522(00)00024-5; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; D'Aversa TG, 2005, J NEUROSCI RES, V81, P436, DOI 10.1002/jnr.20486; DECOCK B, 1990, BIOCHEM BIOPH RES CO, V167, P904, DOI 10.1016/0006-291X(90)90609-Q; Del Valle L, 2006, FRONT BIOSCI-LANDMRK, V11, P718, DOI 10.2741/1830; Dollard SC, 1995, NEUROPATH APPL NEURO, V21, P518, DOI 10.1111/j.1365-2990.1995.tb01098.x; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Eletto D, 2008, J CELL PHYSIOL, V216, P764, DOI 10.1002/jcp.21452; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gong WH, 1998, J BIOL CHEM, V273, P4289, DOI 10.1074/jbc.273.8.4289; Gong XQ, 1997, J BIOL CHEM, V272, P11682, DOI 10.1074/jbc.272.18.11682; Gu L, 1999, Chem Immunol, V72, P7, DOI 10.1159/000058723; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Huppi K, 2007, SEMIN CANCER BIOL, V17, P65, DOI 10.1016/j.semcancer.2006.10.004; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Ke XS, 2003, CURR OPIN CHEM BIOL, V7, P516, DOI 10.1016/S1367-5931(03)00075-9; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; McManus C, 1998, J NEUROIMMUNOL, V86, P20, DOI 10.1016/S0165-5728(98)00002-2; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Motsch N, 2007, RNA BIOL, V4, P131, DOI 10.4161/rna.4.3.5206; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Proost P, 1996, J LEUKOCYTE BIOL, V59, P67, DOI 10.1002/jlb.59.1.67; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; van der Meer P, 2000, EXP MOL PATHOL, V69, P192, DOI 10.1006/exmp.2000.2336; VANDAMME J, 1992, J EXP MED, V176, P59, DOI 10.1084/jem.176.1.59; Wang JB, 2006, J NEUROVIROL, V12, P472, DOI 10.1080/13550280601039659; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yang OO, 2002, J INFECT DIS, V185, P1174, DOI 10.1086/339678; Zink MC, 2001, J INFECT DIS, V184, P1015, DOI 10.1086/323478	52	94	97	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2010	24	7					2292	2300		10.1096/fj.09-143503	http://dx.doi.org/10.1096/fj.09-143503			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20181935	Green Published			2022-12-25	WOS:000279343600016
J	Li, Z; Zhang, Q; Mao, JH; Weise, A; Mrasek, K; Fan, X; Zhang, X; Liehr, T; Lu, KH; Balmain, A; Cai, WW				Li, Z.; Zhang, Q.; Mao, J-H; Weise, A.; Mrasek, K.; Fan, X.; Zhang, X.; Liehr, T.; Lu, K. H.; Balmain, A.; Cai, W-W			An HDAC1-binding domain within FATS bridges p21 turnover to radiation-induced tumorigenesis	ONCOGENE			English	Article						radiation; p21; acetylation; carcinogenesis	HISTONE-DEACETYLASE INHIBITORS; FRAGILE SITE FRA16D; REPEAT INSTABILITY; IONIZING-RADIATION; BREAST-CANCER; DEGRADATION; EXPRESSION; COMMON; ATM; P53	There is a gap between the initial formation of cells carrying radiation-induced genetic damage and their contribution to cancer development. Herein, we reveal a previously uncharacterized gene FATS through a genome-wide approach and demonstrate its essential role in regulating the abundance of p21 in surveillance of genome integrity. A large exon coding the NH2-terminal domain of FATS, deleted in spontaneous mouse lymphomas, is much more frequently deleted in radiation-induced mouse lymphomas. Its human counterpart is a fragile site gene at a previously identified loss of heterozygosity site. FATS is essential for maintaining steady-state level of p21 protein and sustaining DNA damage checkpoint. Furthermore, the NH2-terminal FATS physically interacts with histone deacetylase 1 (HDAC1) to enhance the acetylation of endogenous p21, leading to the stabilization of p21. Our results reveal a molecular linkage between p21 abundance and radiation-induced carcinogenesis. Oncogene (2010) 29, 2659-2671; doi:10.1038/onc.2010.19; published online 15 February 2010	[Li, Z.; Fan, X.; Zhang, X.; Liehr, T.] Tianjin Med Univ, Canc Inst & Hosp, Dept Biochem & Mol Biol, Key Lab,Minist Educ Breast Canc Prevent & Treatme, Tianjin 300030, Peoples R China; [Zhang, Q.; Lu, K. H.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Mao, J-H; Balmain, A.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Weise, A.; Mrasek, K.; Liehr, T.] Inst Human Genet & Anthropol, Jena, Germany; [Cai, W-W] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Tianjin Medical University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; Baylor College of Medicine	Li, Z (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Biochem & Mol Biol, Key Lab,Minist Educ Breast Canc Prevent & Treatme, Huan Hu Xi Rd, Tianjin 300030, Peoples R China.	zhengli@tijmu.edu.cn	Liehr, Thomas/H-2852-2019; Weise, Anja/H-6669-2019; Mao, Jian-Hua/EIZ-8595-2022	Liehr, Thomas/0000-0003-1672-3054; Weise, Anja/0000-0003-3988-8919; Mao, Jian-Hua/0000-0001-9320-6021	Tianjin Medical University Cancer Institute and Hospital [08Y01]; Ministry of Science and Technology of China 973 [2009CB526407]; Tianjin Municipal Science and Technology Foundation; Department of defense of United States [FG02-03ER63630]; IZKF Jena Start-up S16	Tianjin Medical University Cancer Institute and Hospital; Ministry of Science and Technology of China 973(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Tianjin Municipal Science and Technology Foundation; Department of defense of United States(United States Department of Defense); IZKF Jena Start-up S16	We are grateful to Mien-Chi Hung for critical discussions. We thank Xiangwei He and Qi Gao for assistance in microscopic imaging; Tao Jiang and Qian Li for technical assistance. This study was supported in part by the following grants: Tianjin Medical University Cancer Institute and Hospital Start-up 08Y01 (to Z Li); Ministry of Science and Technology of China 973-program Concept Award 2009CB526407 (to Z Li); Tianjin Municipal Science and Technology Foundation ( to Z Li); Department of defense of United States FG02-03ER63630 (to A Balmain); IZKF Jena Start-up S16 (to T Liehr).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Barboza JA, 2006, P NATL ACAD SCI USA, V103, P19842, DOI 10.1073/pnas.0606343104; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Bichara M, 2006, MUTAT RES-FUND MOL M, V598, P144, DOI 10.1016/j.mrfmmm.2006.01.020; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Buttel I, 2004, ANN NY ACAD SCI, V1028, P14, DOI 10.1196/annals.1322.002; Cai WW, 2002, NAT BIOTECHNOL, V20, P393, DOI 10.1038/nbt0402-393; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cen B, 2008, CANCER RES, V68, P5355, DOI 10.1158/0008-5472.CAN-07-6869; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Efeyan A, 2007, ONCOGENE, V26, P1645, DOI 10.1038/sj.onc.1209972; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; HOLM LE, 1990, INT J RADIAT ONCOL, V19, P1303, DOI 10.1016/0360-3016(90)90249-J; HOPPESEYLER F, 1993, J VIROL, V67, P3111, DOI 10.1128/JVI.67.6.3111-3117.1993; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Kim GD, 1999, J BIOL CHEM, V274, P31127, DOI 10.1074/jbc.274.44.31127; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Li Z, 2004, CANCER RES, V64, P9080, DOI 10.1158/0008-5472.CAN-04-2419; Liehr Thomas, 2002, Expert Rev Mol Diagn, V2, P217, DOI 10.1586/14737159.2.3.217; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Magrath IT, 1997, ANN ONCOL, V8, P7, DOI 10.1023/A:1008225127815; Maier D, 1997, ONCOGENE, V15, P997, DOI 10.1038/sj.onc.1201209; Mangelsdorf M, 2000, CANCER RES, V60, P1683; Mao JH, 2005, ONCOGENE, V24, P7924, DOI 10.1038/sj.onc.1208926; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Nagase S, 1997, CANCER RES, V57, P1630; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Schellong G, 1998, ANN ONCOL, V9, P115, DOI 10.1023/A:1008482728545; Schwartz M, 2006, CANCER LETT, V232, P13, DOI 10.1016/j.canlet.2005.07.039; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Varshavsky A, 2000, BIOL CHEM, V381, P779, DOI 10.1515/BC.2000.101; Wei Q, 2003, MOL CELL BIOL, V23, P4035, DOI 10.1128/MCB.23.12.4035-4045.2003; Winters ZE, 2003, BREAST CANCER RES, V5, pR242, DOI 10.1186/bcr654; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527; Zhang H, 2007, MOL CELL, V27, P367, DOI 10.1016/j.molcel.2007.06.012; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	58	16	22	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2010	29	18					2659	2671		10.1038/onc.2010.19	http://dx.doi.org/10.1038/onc.2010.19			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	592DC	20154723				2022-12-25	WOS:000277354600006
J	Omi, R; Kurokawa, S; Mihara, H; Hayashi, H; Goto, M; Miyahara, I; Kurihara, T; Hirotsu, K; Esaki, N				Omi, Rie; Kurokawa, Suguru; Mihara, Hisaaki; Hayashi, Hideyuki; Goto, Masaru; Miyahara, Ikuko; Kurihara, Tatsuo; Hirotsu, Ken; Esaki, Nobuyoshi			Reaction Mechanism and Molecular Basis for Selenium/Sulfur Discrimination of Selenocysteine Lyase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE DESULFURASE ACTIVITY; ESCHERICHIA-COLI COUNTERPART; NIFS-LIKE PROTEIN; CRYSTAL-STRUCTURE; SULFUR TRANSFER; GENE CLONING; TRANSFER-RNA; MOUSE-LIVER; BETA-LYASE; BIOSYNTHESIS	Selenocysteine lyase (SCL) catalyzes the pyridoxal 5'-phosphate-dependent removal of selenium from L-selenocysteine to yield L-alanine. The enzyme is proposed to function in the recycling of the micronutrient selenium from degraded selenoproteins containing selenocysteine residue as an essential component. The enzyme exhibits strict substrate specificity toward L-selenocysteine and no activity to its cognate L-cysteine. However, it remains unclear how the enzyme distinguishes between selenocysteine and cysteine. Here, we present mechanistic studies of selenocysteine lyase from rat. ESI-MS analysis of wild-type and C375A mutant SCL revealed that the catalytic reaction proceeds via the formation of an enzyme-bound selenopersulfide intermediate on the catalytically essential Cys-375 residue. UV-visible spectrum analysis and the crystal structure of SCL complexed with L-cysteine demonstrated that the enzyme reversibly forms a nonproductive adduct with L-cysteine. Cys-375 on the flexible loop directed L-selenocysteine, but not L-cysteine, to the correct position and orientation in the active site to initiate the catalytic reaction. These findings provide, for the first time, the basis for understanding how trace amounts of a selenium-containing substrate is distinguished from excessive amounts of its cognate sulfur-containing compound in a biological system.	[Mihara, Hisaaki] Ritsumeikan Univ, Dept Biotechnol, Inst Sci & Engn, Coll Life Sci, Shiga 5258577, Japan; [Omi, Rie; Kurokawa, Suguru; Kurihara, Tatsuo; Esaki, Nobuyoshi] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Goto, Masaru; Miyahara, Ikuko; Hirotsu, Ken] Osaka City Univ, Dept Chem, Grad Sch Sci, Osaka 5588585, Japan; [Hayashi, Hideyuki] Osaka Med Coll, Dept Biochem, Takatsuki, Osaka 5698686, Japan	Ritsumeikan University; Kyoto University; Osaka Metropolitan University; Osaka Medical College	Mihara, H (corresponding author), Ritsumeikan Univ, Dept Biotechnol, Inst Sci & Engn, Coll Life Sci, Shiga 5258577, Japan.	mihara@fc.ritsumei.ac.jp; hirotsu@spring8.or.jp; esakin@SCL.kyoto-u.ac.jp	Mihara, Hisaaki/F-2172-2010	Mihara, Hisaaki/0000-0002-5153-4403	Ministry of Education, Culture, Sports, Science, and Technology of Japan [19370040]; Japan Society for the Promotion of Science [21780094]; National Project on Protein Structural and Functional Analyses; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research on Priority Areas (B) 19370040 (to N. E.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by Grant-in-aid for Encouragement of Young Scientists 21780094 (to H. M.) from the Japan Society for the Promotion of Science, by the National Project on Protein Structural and Functional Analyses, and by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21st Century COE on Kyoto University Alliance for Chemistry) (to N. E.).	ALLEN FH, 1999, INT TABLES CRYSTALLO, VC, P782; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; CHOCAT P, 1985, J BACTERIOL, V163, P669, DOI 10.1128/JB.163.2.669-676.1985; Clausen T, 2000, P NATL ACAD SCI USA, V97, P3856, DOI 10.1073/pnas.97.8.3856; COMBS GF, 1984, ANNU REV NUTR, V4, P257, DOI 10.1146/annurev.nu.04.070184.001353; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Delano W. L., 2001, PYMOL MOL GRAPHICS S; ESAKI N, 1981, BIOCHEMISTRY-US, V20, P4492, DOI 10.1021/bi00518a039; ESAKI N, 1982, J BIOL CHEM, V257, P4386; ESAKI N, 1987, METHOD ENZYMOL, V143, P415; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; Ganichkin OM, 2008, J BIOL CHEM, V283, P5849, DOI 10.1074/jbc.M709342200; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hatfield D. L., 2001, SELENIUM ITS MOL BIO; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Kambampati R, 2000, J BIOL CHEM, V275, P10727, DOI 10.1074/jbc.275.15.10727; Kim IY, 1997, P NATL ACAD SCI USA, V94, P418, DOI 10.1073/pnas.94.2.418; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MEHTA PK, 1993, EUR J BIOCHEM, V214, P549, DOI 10.1111/j.1432-1033.1993.tb17953.x; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Mihara H, 2000, J BIOL CHEM, V275, P6195, DOI 10.1074/jbc.275.9.6195; Mihara H, 2002, METHOD ENZYMOL, V347, P198; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Momany C, 2004, BIOCHEMISTRY-US, V43, P1193, DOI 10.1021/bi035744e; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; SCHWARZ K, 1965, FED PROC, V24, P58; Small-Howard AL, 2005, BIOCHEM SOC T, V33, P1493, DOI 10.1042/BST0331493; Smith AD, 2005, FEBS LETT, V579, P5236, DOI 10.1016/j.febslet.2005.08.046; Tirupati B, 2004, BIOCHEMISTRY-US, V43, P12210, DOI 10.1021/bi0491447; Tormay P, 1998, EUR J BIOCHEM, V254, P655, DOI 10.1046/j.1432-1327.1998.2540655.x; URSINI F, 1987, CHEM PHYS LIPIDS, V44, P255, DOI 10.1016/0009-3084(87)90053-3; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Xu XM, 2007, BIOCHEM J, V404, P115, DOI 10.1042/BJ20070165; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	48	27	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12133	12139		10.1074/jbc.M109.084475	http://dx.doi.org/10.1074/jbc.M109.084475			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164179	Green Published, hybrid			2022-12-25	WOS:000276787100043
J	Tay, YD; Wu, L				Tay, Ye Dee; Wu, Leonard			Overlapping Roles for Yen1 and Mus81 in Cellular Holliday Junction Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; IN-VIVO; ENDONUCLEASE; RESOLVASE; RECOMBINATION; CROSSOVERS; RESOLUTION; YEAST; REPLICATION	Eukaryotic Holliday junction (HJ) resolvases have attracted much attention recently with the identification of at least three distinct proteins that can cleave model HJs in vitro. However, the specificDNAstructure(s) that these proteins act upon in the cell is unknown. Here, we describe a system in budding yeast to directly and quantitatively monitor in vivo HJ resolution. We found that Yen1 acts redundantly with Mus81, but not Slx1, to resolve a model HJ in vivo. This functional overlap specifically extends to the repair/bypass of lesions that impede the progression of replication forks but not to the repair of double-strand breaks induced by ionizing radiation. Together, these results suggest a direct role for Yen1 in the response to DNA damage and implicate overlapping HJ resolution functions of Yen1 with Mus81 during replication fork repair.	[Tay, Ye Dee; Wu, Leonard] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Wu, L (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	leonard.wu@imm.ox.ac.uk		TAY, YE DEE/0000-0002-7031-7789	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK.	Andersen SL, 2009, MOL CELL, V35, P128, DOI 10.1016/j.molcel.2009.06.019; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Chan SN, 1997, J BIOL CHEM, V272, P14873, DOI 10.1074/jbc.272.23.14873; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Cote AG, 2008, MOL CELL, V31, P800, DOI 10.1016/j.molcel.2008.08.025; de los Santos T, 2003, GENETICS, V164, P81; Doe CL, 2002, J BIOL CHEM, V277, P32753, DOI 10.1074/jbc.M202120200; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Fricke WM, 2005, DNA REPAIR, V4, P243, DOI 10.1016/j.dnarep.2004.10.001; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lorenz A, 2010, NUCLEIC ACIDS RES, V38, P1866, DOI 10.1093/nar/gkp1179; MCCULLOCH R, 1994, EMBO J, V13, P1844, DOI 10.1002/j.1460-2075.1994.tb06453.x; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Rouse J, 2009, BIOCHEM SOC T, V37, P495, DOI 10.1042/BST0370495; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105	24	56	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11427	11432		10.1074/jbc.M110.108399	http://dx.doi.org/10.1074/jbc.M110.108399			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20178992	Green Published, hybrid			2022-12-25	WOS:000276286200049
J	Morris, MR; Ricketts, C; Gentle, D; Abdulrahman, M; Clarke, N; Brown, M; Kishida, T; Yao, M; Latif, F; Maher, ER				Morris, M. R.; Ricketts, C.; Gentle, D.; Abdulrahman, M.; Clarke, N.; Brown, M.; Kishida, T.; Yao, M.; Latif, F.; Maher, E. R.			Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma	ONCOGENE			English	Article						renal cell carcinoma; methylation; epigenetics	HIPPEL-LINDAU-DISEASE; CLEAR-CELL; PROMOTER HYPERMETHYLATION; ABERRANT METHYLATION; TARGET GENES; EPIGENETIC INACTIVATION; BASEMENT-MEMBRANE; DNA METHYLATION; POOR-PROGNOSIS; MULTIPLE GENES	Promoter region hyermethylation and transcriptional silencing is a frequent cause of tumour suppressor gene (TSG) inactivation in many types of human cancers. Functional epigenetic studies, in which gene expression is induced by treatment with demethylating agents, may identify novel genes with tumour-specific methylation. We used high-density gene expression microarrays in a functional epigenetic study of 11 renal cell carcinoma (RCC) cell lines. Twenty-eight genes were then selected for analysis of promoter methylation status in cell lines and primary RCC. Eight genes (BNC1, PDLIM4, RPRM, CST6, SFRP1, GREM1, COL14A1 and COL15A1) showed frequent (>30% of RCC tested) tumour-specific promoter region methylation. Hypermethylation was associated with transcriptional silencing. Re-expression of BNC1, CST6, RPRM and SFRP1 suppressed the growth of RCC cell lines and RNA interference knock-down of BNC1, SFRP1 and COL14A1 increased the growth of RCC cell lines. Methylation of BNC1 or COL14A1 was associated with a poorer prognosis independent of tumour size, stage or grade. The identification of these epigenetically inactivated candidate RCC TSGs can provide insights into renal tumourigenesis and a basis for developing novel therapies and biomarkers for prognosis and detection. Oncogene (2010) 29, 2104-2117; doi: 10.1038/onc.2009.493; published online 15 February 2010	[Morris, M. R.; Ricketts, C.; Gentle, D.; Abdulrahman, M.; Latif, F.; Maher, E. R.] Univ Birmingham, Dept Med & Mol Genet, Inst Biomedi Res W, Sch Clin & Expt Med,Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Morris, M. R.; Ricketts, C.; Gentle, D.; Latif, F.; Maher, E. R.] Univ Birmingham, Canc Res UK Renal Mol Oncol Grp, Birmingham B15 2TT, W Midlands, England; [Clarke, N.; Brown, M.] Univ Manchester, Genito Urinary Canc Res Grp, Paterson Inst Canc Res, Manchester, Lancs, England; [Kishida, T.; Yao, M.] Yokohama City Univ, Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan; [Maher, E. R.] Birmingham Womens Hosp, W Midlands Reg Gent Serv, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; Paterson Institute for Cancer Research; University of Manchester; Yokohama City University; Birmingham Women's Hospital	Maher, ER (corresponding author), Univ Birmingham, Dept Med & Mol Genet, Inst Biomedi Res W, Sch Clin & Expt Med,Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England.	E.R.Maher@bham.ac.uk	MAHER, EAMONN R/A-9507-2008; Brown, Mick/A-1308-2012; Brown, Mick D/N-6521-2015; Morris, Mark/C-6413-2008; Ricketts, Christopher/AAV-9580-2020	MAHER, EAMONN R/0000-0002-6226-6918; Brown, Mick D/0000-0003-1322-4671; Morris, Mark/0000-0002-0700-355X; Clarke, Noel/0000-0001-7776-8059; Abdulrahman, Mahera/0000-0001-6271-3776	Cancer Research UK; MRC [G0900871] Funding Source: UKRI; Medical Research Council [G0900871] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Cancer Research UK for financial support.	Ai LB, 2006, CANCER RES, V66, P7899, DOI 10.1158/0008-5472.CAN-06-0576; Amenta PS, 2005, J HISTOCHEM CYTOCHEM, V53, P165, DOI 10.1369/jhc.4A6376.2005; Awakura Y, 2008, ONCOL REP, V20, P1257, DOI 10.3892/or_00000138; Battagli C, 2003, CANCER RES, V63, P8695; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bernal C, 2008, CLIN CANCER RES, V14, P6264, DOI 10.1158/1078-0432.CCR-07-4522; Bishop T, 2004, PLOS BIOL, V2, P1549, DOI 10.1371/journal.pbio.0020289; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; Brandan E, 2006, J BIOL CHEM, V281, P31562, DOI 10.1074/jbc.M602919200; Breault JE, 2005, CLIN CANCER RES, V11, P557; Bromme D, 2002, CURR PHARM DESIGN, V8, P1639, DOI 10.2174/1381612023394179; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Chowdhury S, 2008, EUR J CANCER, V44, P2152, DOI 10.1016/j.ejca.2008.06.028; Christoph F, 2006, CLIN CANCER RES, V12, P5040, DOI 10.1158/1078-0432.CCR-06-0144; Clifford SC, 1998, GENE CHROMOSOME CANC, V22, P200, DOI 10.1002/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Costa VL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-133; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; Dallol A, 2002, ONCOGENE, V21, P3020, DOI 10.1038/sj.onc.1205421; Ehnis T, 1997, J BIOL CHEM, V272, P20414, DOI 10.1074/jbc.272.33.20414; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; Gonzalgo ML, 2004, CLIN CANCER RES, V10, P7276, DOI 10.1158/1078-0432.CCR-03-0692; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Harris A, 2007, MOL CANCER RES, V5, P1241, DOI 10.1158/1541-7786.MCR-07-0200; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hoque MO, 2004, CANCER RES, V64, P5511, DOI 10.1158/0008-5472.CAN-04-0799; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lodygin D, 2005, CANCER RES, V65, P4218, DOI 10.1158/0008-5472.CAN-04-4407; Mancini V, 2008, UROL ONCOL-SEMIN ORI, V26, P225, DOI 10.1016/j.urolonc.2007.05.017; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McRonald FE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-31; Morris MR, 2008, BRIT J CANCER, V98, P496, DOI 10.1038/sj.bjc.6604180; Morris MR, 2005, CANCER RES, V65, P4598, DOI 10.1158/0008-5472.CAN-04-3371; Morris MR, 2003, ONCOGENE, V22, P6794, DOI 10.1038/sj.onc.1206914; Morrissey C, 2001, CANCER RES, V61, P7277; Nomoto S, 2007, BRIT J CANCER, V97, P1260, DOI 10.1038/sj.bjc.6604016; Ohki R, 2000, J BIOL CHEM, V275, P22627, DOI 10.1074/jbc.C000235200; Qiu J, 2008, LAB INVEST, V88, P910, DOI 10.1038/labinvest.2008.66; Ramchandran R, 1999, BIOCHEM BIOPH RES CO, V255, P735, DOI 10.1006/bbrc.1999.0248; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; Sato N, 2003, CANCER RES, V63, P3735; Sato N, 2006, CANCER-AM CANCER SOC, V107, P251, DOI 10.1002/cncr.21977; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; SCHUPPAN D, 1990, J BIOL CHEM, V265, P8823; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Shridhar R, 2004, ONCOGENE, V23, P2206, DOI 10.1038/sj.onc.1207340; Smits KM, 2008, CLIN CANCER RES, V14, P782, DOI 10.1158/1078-0432.CCR-07-1753; Suzuki M, 2005, BRIT J CANCER, V93, P1029, DOI 10.1038/sj.bjc.6602837; Takahashi T, 2005, INT J CANCER, V115, P503, DOI 10.1002/ijc.20910; Urakami S, 2006, CLIN CANCER RES, V12, P6989, DOI 10.1158/1078-0432.CCR-06-1194; Wang JW, 2006, BIOCHEM BIOPH RES CO, V348, P1261, DOI 10.1016/j.bbrc.2006.07.198; Wistuba II, 2007, CURR MOL MED, V7, P3, DOI 10.2174/156652407779940468; Yamada D, 2006, INT J CANCER, V118, P916, DOI 10.1002/ijc.21450; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5	57	120	128	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2010	29	14					2104	2117		10.1038/onc.2009.493	http://dx.doi.org/10.1038/onc.2009.493			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	579UX	20154727	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000276402800009
J	Blanco-Aparicio, C; Canamero, M; Cecilia, Y; Pequeno, B; Renner, O; Ferrer, I; Carnero, A				Blanco-Aparicio, Carmen; Canamero, Marta; Cecilia, Yolanda; Pequeno, Belen; Renner, Oliver; Ferrer, Irene; Carnero, Amancio			Exploring the Gain of Function Contribution of AKT to Mammary Tumorigenesis in Mouse Models	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; PROTEIN-KINASE-B; BREAST-CANCER; PIK3CA GENE; PHOSPHATIDYLINOSITOL 3-KINASE; MOLECULAR CHARACTERIZATION; MEMBRANE LOCALIZATION; GERMLINE MUTATIONS; ORAL EPITHELIUM; HIGH-FREQUENCY	Elevated expression of AKT has been noted in a significant percentage of primary human breast cancers, mainly as a consequence of the PTEN/PI3K pathway deregulation. To investigate the mechanistic basis of the AKT gain of function-dependent mechanisms of breast tumorigenesis, we explored the phenotype induced by activated AKT transgenes in a quantitative manner. We generated several transgenic mice lines expressing different levels of constitutively active AKT in the mammary gland. We thoroughly analyzed the preneoplastic and neoplastic mammary lesions of these mice and correlated the process of tumorigenesis to AKT levels. Finally, we analyzed the impact that a possible senescent checkpoint might have in the tumor promotion inhibition observed, crossing these lines to mammary specific p53(R172H) mutant expression, and to p27 knock-out mice. We analyzed the benign, premalignant and malignant lesions extensively by pathology and at molecular level analysing the expression of proteins involved in the PI3K/AKT pathway and in cellular senescence. Our findings revealed an increased preneoplastic phenotype depending upon AKT signaling which was not altered by p27 or p53 loss. However, p53 inactivation by R172H point mutation combined with myrAKT transgenic expression significantly increased the percentage and size of mammary carcinoma observed, but was not sufficient to promote full penetrance of the tumorigenic phenotype. Molecular analysis suggest that tumors from double myrAKT; p53(R172H) mice result from acceleration of initiated p53(R172H) tumors and not from bypass of AKT-induced oncogenic senescence. Our work suggests that tumors are not the consequence of the bypass of senescence in MIN. We also show that AKT-induced oncogenic senescence is dependent of pRb but not of p53. Finally, our work also suggests that the cooperation observed between mutant p53 and activated AKT is due to AKT-induced acceleration of mutant p53-induced tumors. Finally, our work shows that levels of activated AKT are not essential in the induction of benign or premalignant tumors, or in the cooperation of AKT with other tumorigenic signal such as mutant p53, once AKT pathway is activated, the relative level of activity seems not to determine the phenotype.	[Blanco-Aparicio, Carmen; Pequeno, Belen; Renner, Oliver; Ferrer, Irene; Carnero, Amancio] Spanish Natl Canc Res Ctr, Expt Therapeut Programme, Madrid, Spain; [Canamero, Marta; Cecilia, Yolanda] Spanish Natl Canc Res Ctr, Biotechnol Programme, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Blanco-Aparicio, C (corresponding author), Spanish Natl Canc Res Ctr, Expt Therapeut Programme, Madrid, Spain.	acarnero@ibis-sevilla.es	Ferrer, Irene/C-9418-2015; Renner, Oliver/M-7002-2015; IBIS, CANCER/P-3323-2015; Blanco-Aparicio, Carmen/I-3162-2015; /AAI-3238-2021	Ferrer, Irene/0000-0002-2748-2607; Renner, Oliver/0000-0002-4046-0517; Blanco-Aparicio, Carmen/0000-0002-3249-6595; Carnero, Amancio/0000-0003-4357-3979	Spanish Ministry of Science and Innovation [SAF2009-08605]; Consejeria de Salud, Junta de Andalucia [PI-0142]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia)	This work was supported by grants from the Spanish Ministry of Science and Innovation (SAF2009-08605) and Consejeria de Salud, Junta de Andalucia (PI-0142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Albrektsen G, 2005, BRIT J CANCER, V92, P167, DOI 10.1038/sj.bjc.6602302; Asano T, 2004, ONCOGENE, V23, P8571, DOI 10.1038/sj.onc.1207902; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Barnes DM, 1998, BREAST CANCER RES TR, V52, P1, DOI 10.1023/A:1006103831990; Beaty MW, 2005, INT J SURG PATHOL, V13, P9, DOI 10.1177/106689690501300102; Berns EMJJ, 2000, CANCER RES, V60, P2155; Bisogna M, 2001, CANCER GENET CYTOGEN, V125, P131, DOI 10.1016/S0165-4608(00)00367-8; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P584, DOI 10.1093/carcin/bgl190; Britt K, 2007, ENDOCR-RELAT CANCER, V14, P907, DOI 10.1677/ERC-07-0137; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Butt S, 2009, EJSO-EUR J SURG ONC, V35, P702, DOI 10.1016/j.ejso.2008.03.017; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; CARNERO A, 2009, CURRENT PHARM DESIGN, V17, P1435; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carver BS, 2006, CLIN CANCER RES, V12, P5305, DOI 10.1158/1078-0432.CCR-06-0482; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Colozza M, 2005, ANN ONCOL, V16, P1723, DOI 10.1093/annonc/mdi352; Cowell JK, 2005, CANCER GENET CYTOGEN, V163, P23, DOI 10.1016/j.cancergencyto.2005.04.019; D'Amico M, 2003, CANCER RES, V63, P3395; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; DUMITRESCU RG, 2009, J CELL MOL MED; Garcia-Rostan G, 2005, CANCER RES, V65, P10199, DOI 10.1158/0008-5472.CAN-04-4259; Geisler S, 2003, CLIN CANCER RES, V9, P5582; Gorgoulis VG, 1998, MOL MED, V4, P807, DOI 10.1007/BF03401773; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hui R, 2000, CLIN CANCER RES, V6, P2777; Hutchinson J, 2001, MOL CELL BIOL, V21, P2203, DOI 10.1128/MCB.21.6.2203-2212.2001; Iwakuma T, 2007, ONCOGENE, V26, P2177, DOI 10.1038/sj.onc.1210278; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kirkegaard T, 2005, J PATHOL, V207, P139, DOI 10.1002/path.1829; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Li G, 2002, DEVELOPMENT, V129, P4159; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Link W, 2005, J CELL BIOCHEM, V95, P979, DOI 10.1002/jcb.20479; Liu W, 2007, FRONT BIOSCI-LANDMRK, V12, P4011, DOI 10.2741/2367; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Marchio C, 2008, J PATHOL, V216, P399, DOI 10.1002/path.2423; Maroulakou IG, 2008, J CELL PHYSIOL, V217, P468, DOI 10.1002/jcp.21518; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Moral M, 2009, IN VIVO, V23, P653; Moral M, 2009, CANCER RES, V69, P1099, DOI 10.1158/0008-5472.CAN-08-3240; Nakayama K, 2006, CANCER BIOL THER, V5, P779, DOI 10.4161/cbt.5.7.2751; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; Okano Jun-ichi, 2003, Methods Mol Biol, V222, P131; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Reddy HKDL, 2005, CANCER RES, V65, P10174, DOI 10.1158/0008-5472.CAN-05-2639; Renner O, 2008, CLIN TRANSL ONCOL, V10, P618, DOI 10.1007/s12094-008-0262-1; Renner O, 2008, CANCER RES, V68, P9643, DOI 10.1158/0008-5472.CAN-08-1539; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Ruiz L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003230; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schade B, 2009, J BIOL CHEM, V284, P19018, DOI 10.1074/jbc.M109.018937; Schrager CA, 1998, HUM PATHOL, V29, P47, DOI 10.1016/S0046-8177(98)90389-6; Sharpless NE, 2005, NATURE, V436, P636, DOI 10.1038/436636a; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WRIGHT RW, 1981, J ANIM SCI, V52, P115, DOI 10.2527/jas1981.521115x; Xing DY, 2005, P NATL ACAD SCI USA, V102, P6936, DOI 10.1073/pnas.0502256102; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012	73	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9305	10.1371/journal.pone.0009305	http://dx.doi.org/10.1371/journal.pone.0009305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174572	Green Published, Green Submitted, gold			2022-12-25	WOS:000274923700011
J	Chen, L; Shi, WL; Li, H; Sun, XL; Fan, XL; LeSage, G; Li, H; Li, Y; Zhang, Y; Zhang, XM; Zhang, Y; Yin, DL				Chen, Lin; Shi, Wanliang; Li, Hui; Sun, Xiuli; Fan, Xionglin; LeSage, Gene; Li, Hui; Li, Yi; Zhang, Yi; Zhang, Xiumei; Zhang, Ying; Yin, Deling			Critical Role of Toll-Like Receptor 9 in Morphine and Mycobacterium tuberculosis-Induced Apoptosis in Mice	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; INNATE IMMUNITY; CELL APOPTOSIS; INFECTION; TLR2; EXPRESSION; REGULATIONS; RECOGNITION; PROTEINS; FAMILY	Background: Although it is established that opioid and Mycobacterium tuberculosis are both public health problems, the mechanisms by which they affect lung functions remain elusive. Methodology/Principal Findings: We report here that mice subjected to chronic morphine administration and M. tuberculosis infection exhibited significant apoptosis in the lung in wild type mice as demonstrated by the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling assay. Morphine and M. tuberculosis significantly induced the expression of Toll-like receptor 9 (TLR9), a key mediator of innate immunity and inflammation. Interestingly, deficiency in TLR9 significantly inhibited the morphine and M. tuberculosis induced apoptosis in the lung. In addition, chronic morphine treatment and M. tuberculosis infection enhanced the levels of cytokines (TNF-alpha, IL-1 beta, and IL-6) in wild type mice, but not in TLR9 knockout (KO) mice. The bacterial load was much lower in TLR9 KO mice compared with that in wild type mice following morphine and M. tuberculosis treatment. Morphine alone did not alter the bacterial load in either wild type or TLR9 KO mice. Moreover, administration of morphine and M. tuberculosis decreased the levels of phosphorylation of Akt and GSK3 beta in the wild type mice, but not in TLR9 KO mice, suggesting an involvement of Akt/GSK3 beta in morphine and M. tuberculosis-mediated TLR9 signaling. Furthermore, administration of morphine and M. tuberculosis caused a dramatic decrease in Bcl-2 level but increase in Bax level in wild type mice, but not in TLR9 KO mice, indicating a role of Bcl-2 family in TLR9-mediated apoptosis in the lung following morphine and M. tuberculosis administration. Conclusions/Significance: These data reveal a role for TLR9 in the immune response to opioids during M. tuberculosis infection.	[Chen, Lin; Li, Hui; Sun, Xiuli; LeSage, Gene; Li, Yi; Zhang, Yi; Yin, Deling] E Tennessee State Univ, Coll Med, Dept Internal Med, Johnson City, TN 37614 USA; [Chen, Lin; Zhang, Xiumei] Shandong Univ, Sch Med, Dept Pharmacol, Jinan 250100, Peoples R China; [Shi, Wanliang; Fan, Xionglin; Li, Hui; Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Sun, Xiuli] Peking Univ, Peoples Hosp, Dept Obstet & Gynecol, Beijing 100871, Peoples R China	East Tennessee State University; Shandong University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Peking University	Chen, L (corresponding author), E Tennessee State Univ, Coll Med, Dept Internal Med, Johnson City, TN 37614 USA.	zhangxiumei@yahoo.com; yzhang@jhsph.edu; yin@etsu.edu	Fan, Xionglin/E-2747-2015	Fan, Xionglin/0000-0001-9754-372X	National Institutes of Health [DA020120-03A1]; East Tennessee State University Research Development Committee; Changjiang Scholars Program;  [AI44063]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA020120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); East Tennessee State University Research Development Committee; Changjiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health grant DA020120-03A1 and East Tennessee State University Research Development Committee grant to D. Yin. Y. Zhang was supported by AI44063 and Changjiang Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Boronat MA, 2001, BRIT J PHARMACOL, V134, P1263, DOI 10.1038/sj.bjp.0704364; Chen L, 2009, BIOORGAN MED CHEM, V17, P4378, DOI 10.1016/j.bmc.2009.05.029; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Durante AJ, 1998, ADDICTION, V93, P1393, DOI 10.1046/j.1360-0443.1998.939139310.x; Gan L, 2006, IMMUNOL RES, V35, P295, DOI 10.1385/IR:35:3:295; Holscher C, 2008, EUR J IMMUNOL, V38, P680, DOI 10.1002/eji.200736458; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jozsef L, 2004, FASEB J, V18, P1776, DOI 10.1096/fj.04-2048fje; Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Li Y, 2009, BIOCHEM BIOPH RES CO, V378, P857, DOI 10.1016/j.bbrc.2008.12.001; Lin X, 2009, FEBS J, V276, P2022, DOI 10.1111/j.1742-4658.2009.06938.x; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; MACGREGOR RR, 1994, CLIN INFECT DIS, V19, P1100, DOI 10.1093/clinids/19.6.1100; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; MEDZHITOV R, 1997, NATURE, V388, P397; Moorman J, 2009, BBA-MOL CELL RES, V1793, P1366, DOI 10.1016/j.bbamcr.2009.05.007; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Shaw-Lutchman TZ, 2002, J NEUROSCI, V22, P3663; Singh RP, 2008, LIFE SCI, V82, P308, DOI 10.1016/j.lfs.2007.11.024; Wang J, 2008, ARCH IMMUNOL THER EX, V56, P299, DOI 10.1007/s00005-008-0035-0; Wang JH, 2008, J IMMUNOL, V180, P3594, DOI 10.4049/jimmunol.180.5.3594; Yin DL, 2006, J NEUROIMMUNOL, V174, P101, DOI 10.1016/j.jneuroim.2006.02.001; Yin DL, 1999, NATURE, V397, P218, DOI 10.1038/16612; Yin DL, 1999, J IMMUNOL, V163, P4328; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423	35	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9205	10.1371/journal.pone.0009205	http://dx.doi.org/10.1371/journal.pone.0009205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174568	gold, Green Published, Green Submitted			2022-12-25	WOS:000274923700001
J	Stevenson, IH; Kording, KP				Stevenson, Ian H.; Koerding, Konrad P.			On the Similarity of Functional Connectivity between Neurons Estimated across Timescales	PLOS ONE			English	Article							GRANGER CAUSALITY; FIELD POTENTIALS; VISUAL-CORTEX; MOTOR CORTEX; FIRING RATE; TELL US; MODELS; FMRI; BRAIN; NETWORK	A central objective in neuroscience is to understand how neurons interact. Such functional interactions have been estimated using signals recorded with different techniques and, consequently, different temporal resolutions. For example, spike data often have sub-millisecond resolution while some imaging techniques may have a resolution of many seconds. Here we use multi-electrode spike recordings to ask how similar functional connectivity inferred from slower timescale signals is to the one inferred from fast timescale signals. We find that functional connectivity is relatively robust to low-pass filtering-dropping by about 10% when low pass filtering at 10 hz and about 50% when low pass filtering down to about 1 Hz-and that estimates are robust to high levels of additive noise. Moreover, there is a weak correlation for physiological filters such as hemodynamic or Ca2+ impulse responses and filters based on local field potentials. We address the origin of these correlations using simulation techniques and find evidence that the similarity between functional connectivity estimated across timescales is due to processes that do not depend on fast pair-wise interactions alone. Rather, it appears that connectivity on multiple timescales or common-input related to stimuli or movement drives the observed correlations. Despite this qualification, our results suggest that techniques with intermediate temporal resolution may yield good estimates of the functional connections between individual neurons.	[Stevenson, Ian H.; Koerding, Konrad P.] Rehabil Inst Chicago, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Koerding, Konrad P.] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Feinberg School of Medicine	Stevenson, IH (corresponding author), Rehabil Inst Chicago, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	i-stevenson@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Stevenson, Ian/0000-0002-1428-5946	Chicago Community Trust; National Institutes of Health [T32 AG020418]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020418] Funding Source: NIH RePORTER	Chicago Community Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Chicago Community Trust. IHS was supported by National Institutes of Health T32 AG020418. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTIAS H, 1997, ADV NEURAL INFORM PR, V9; Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Averbeck BB, 2003, J NEUROSCI, V23, P7630; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Botvinick MM, 2008, TRENDS COGN SCI, V12, P201, DOI 10.1016/j.tics.2008.02.009; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; BROWN EN, 2002, TIME RESCALING THEOR, P325; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Callahan CA, 1998, CURR OPIN NEUROBIOL, V8, P582, DOI 10.1016/S0959-4388(98)80084-6; Chen CC, 2008, NEUROIMAGE, V41, P1293, DOI 10.1016/j.neuroimage.2008.03.026; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Ding M, 2006, QBIO0608035 ARXIV; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 2005, ANNU REV PSYCHOL, V56, P57, DOI 10.1146/annurev.psych.56.091103.070311; Friston KJ, 2000, PHILOS T R SOC B, V355, P215, DOI 10.1098/rstb.2000.0560; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Guo SX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000087; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hatsopoulos N, 2004, J NEUROPHYSIOL, V92, P1165, DOI 10.1152/jn.01245.2003; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Hoover JE, 1999, J NEUROSCI, V19, P1446; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Kulkarni JE, 2007, NETWORK-COMP NEURAL, V18, P375, DOI 10.1080/09548980701625173; KUYPERS HGJM, 1990, TRENDS NEUROSCI, V13, P71, DOI 10.1016/0166-2236(90)90071-H; Kwan AC, 2008, J NEUROPHYSIOL, V100, P2977, DOI 10.1152/jn.91037.2008; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; LIPSKI J, 1981, J NEUROSCI METH, V4, P1, DOI 10.1016/0165-0270(81)90015-7; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pillow J. W., 2007, BAYESIAN BRAIN PROBA, P53, DOI [DOI 10.7551/MITPRESS/9780262042383.003.0003, 10.7551/mitpress/9780262042383.003.0003]; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; REICH DS, 2001, INDEPENDENT REDUNDAN, P2566; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; SMETTERS D, 1999, ENZYMOL, V2, P215; Stephan KE, 2004, CURR OPIN NEUROBIOL, V14, P629, DOI 10.1016/j.conb.2004.08.006; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; Stevenson IH, 2008, CURR OPIN NEUROBIOL, V18, P582, DOI 10.1016/j.conb.2008.11.005; Tetzlaff T, 2008, NEURAL COMPUT, V20, P2133, DOI 10.1162/neco.2008.05-07-525; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; VOGELSTEIN J, 2008, BIOPHYS J IN PRESS; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874	55	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9206	10.1371/journal.pone.0009206	http://dx.doi.org/10.1371/journal.pone.0009206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174620	gold, Green Submitted, Green Published			2022-12-25	WOS:000274654700007
J	Kotelnikova, E; Ivanikova, N; Kalinin, A; Yuryev, A; Daraselia, N				Kotelnikova, Ekaterina; Ivanikova, Natalia; Kalinin, Andrey; Yuryev, Anton; Daraselia, Nikolai			Atlas of Signaling for Interpretation of Microarray Experiments	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; GENE-EXPRESSION; CELL-TYPE; PATHWAYS; MODULATION; APOPTOSIS; NETWORKS; GAMMA; MICE	Microarray-based expression profiling of living systems is a quick and inexpensive method to obtain insights into the nature of various diseases and phenotypes. A typical microarray profile can yield hundreds or even thousands of differentially expressed genes and finding biologically plausible themes or regulatory mechanisms underlying these changes is a nontrivial and daunting task. We describe a novel approach for systems-level interpretation of microarray expression data using a manually constructed "overview'' pathway depicting the main cellular signaling channels (Atlas of Signaling). Currently, the developed pathway focuses on signal transduction from surface receptors to transcription factors and further transcriptional regulation of cellular "workhorse'' proteins. We show how the constructed Atlas of Signaling in combination with an enrichment analysis algorithm allows quick identification and visualization of the main signaling cascades and cellular processes affected in a gene expression profiling experiment. We validate our approach using several publicly available gene expression datasets.	[Kotelnikova, Ekaterina; Ivanikova, Natalia; Kalinin, Andrey; Yuryev, Anton; Daraselia, Nikolai] Ariadne Genom Inc, Rockville, MD USA		Kotelnikova, E (corresponding author), Ariadne Genom Inc, Rockville, MD USA.	nikolai@ariadnegenomics.com	Ivanikova, Natalia/M-9003-2013; Kotelnikova, Elena/N-8496-2013	Kotelnikova, Ekaterina/0000-0002-8026-078X; Yuryev, Anton/0000-0003-1021-4849; Kalinin, Andrei/0000-0002-6059-4344				Daraselia N, 2004, BIOINFORMATICS, V20, P604, DOI 10.1093/bioinformatics/btg452; DARASELIA N, 2004, DAT MIN TEXT MIN BIO; Duan RS, 2006, EXP NEUROL, V202, P373, DOI 10.1016/j.expneurol.2006.06.013; Franco R, 2006, J MEMBRANE BIOL, V209, P43, DOI 10.1007/s00232-005-0837-5; Kirwan RP, 2005, GLIA, V52, P309, DOI 10.1002/glia.20247; Lee J, 2001, J BIOL CHEM, V276, P32956, DOI 10.1074/jbc.M104700200; Levi G, 1998, BIOCHIMIE, V80, P899, DOI 10.1016/S0300-9084(00)88886-0; Maezawa I, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-10; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; OHMORI Y, 1993, AM J PATHOL, V142, P861; Panayiotidis MI, 2006, ACTA PHYSIOL, V187, P205, DOI 10.1111/j.1748-1716.2006.01562.x; Rogove AD, 2002, CELL DEATH DIFFER, V9, P801, DOI 10.1038/sj.cdd.4401041; Sivachenko AY, 2007, J BIOINF COMPUT BIOL, V5, P429, DOI 10.1142/S0219720007002795; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takagi K, 2005, J IMMUNOL, V174, P1801, DOI 10.4049/jimmunol.174.4.1801; Townsend KP, 2004, J NEUROSCI RES, V78, P167, DOI 10.1002/jnr.20234; van Boxel-Dezaire AHH, 2007, CURR TOP MICROBIOL, V316, P119; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Wajant H, 2004, PROG MOLEC, V34, P47; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Xu Q, 2000, J BIOL CHEM, V275, P31770, DOI 10.1074/jbc.M002796200; Yuryev A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-171	22	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9256	10.1371/journal.pone.0009256	http://dx.doi.org/10.1371/journal.pone.0009256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174649	gold, Green Published, Green Submitted			2022-12-25	WOS:000274590600013
J	Park, CJ; Bart, R; Chern, M; Canlas, PE; Bai, W; Ronald, PC				Park, Chang-Jin; Bart, Rebecca; Chern, Mawsheng; Canlas, Patrick E.; Bai, Wei; Ronald, Pamela C.			Overexpression of the Endoplasmic Reticulum Chaperone BiP3 Regulates XA21-Mediated Innate Immunity in Rice	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TOLL-LIKE RECEPTORS; ORYZAE PV. ORYZAE; QUALITY-CONTROL; DISEASE RESISTANCE; NEGATIVE REGULATOR; STRESS; PERCEPTION; DOMAIN; GENE	Recognition of pathogen-associated molecular patterns by pattern recognition receptors (PRRs) activates the innate immune response. Although PRR-mediated signaling events are critical to the survival of plants and animals, secretion and localization of PRRs have not yet been clearly elucidated. Here we report the in vivo interaction of the endoplasmic reticulum (ER) chaperone BiP3 with the rice XA21 PRR, which confers resistance to the Gram negative bacterium, Xanthomonas oryzae pv. oryzae (Xoo). We show that XA21 is glycosylated and is primarily localized to the ER and also to the plasma membrane (PM). In BiP3-overexpressing rice plants, XA21-mediated immunity is compromised, XA21 stability is significantly decreased, and XA21 proteolytic cleavage is inhibited. BiP3 overexpression does not affect the general rice defense response, cell death or brassinolide-induced responses. These results indicate that BiP3 regulates XA21 protein stability and processing and that this regulation is critical for resistance to Xoo.	[Park, Chang-Jin; Bart, Rebecca; Chern, Mawsheng; Canlas, Patrick E.; Bai, Wei; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Park, CJ (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	pcronald@ucdavis.edu	Park, Chang-Jin/AAX-1867-2021; Ronald, Pamela/AAK-7664-2020; Bart, Rebecca S/M-2838-2013	Park, Chang-Jin/0000-0002-2586-8856; Bart, Rebecca/0000-0003-1378-3481	NIH [GM55962]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055962] Funding Source: NIH RePORTER; Direct For Biological Sciences [0943352] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NIH GM55962 to PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Andaya CB, 2003, PHYSIOL MOL PLANT P, V62, P203, DOI 10.1016/S0885-5765(03)00060-2; Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Cai B, 1998, J CELL PHYSIOL, V177, P282, DOI 10.1002/(SICI)1097-4652(199811)177:2<282::AID-JCP10>3.0.CO;2-C; Chern M, 2005, PLANT J, V43, P623, DOI 10.1111/j.1365-313X.2005.02485.x; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Davis SJ, 1998, PLANT MOL BIOL, V36, P521, DOI 10.1023/A:1005991617182; Ditt RF, 2006, MOL PLANT MICROBE IN, V19, P665, DOI 10.1094/MPMI-19-0665; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fleck MW, 2006, NEUROSCIENTIST, V12, P232, DOI 10.1177/1073858405283828; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hegde NR, 2006, J BIOL CHEM, V281, P20910, DOI 10.1074/jbc.M602989200; HONG Z, 2008, PLANT CELL; Hornef MW, 2008, CURR OPIN INFECT DIS, V21, P304, DOI 10.1097/QCO.0b013e3282f88ba3; Jin H, 2007, MOL CELL, V26, P821, DOI 10.1016/j.molcel.2007.05.015; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lang T, 2007, IMMUNOL CELL BIOL, V85, P425, DOI 10.1038/sj.icb.7100094; Leborgne-Castel N, 1999, PLANT CELL, V11, P459, DOI 10.1105/tpc.11.3.459; Lee SW, 2006, P NATL ACAD SCI USA, V103, P18395, DOI 10.1073/pnas.0605508103; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; LEE SW, 2009, SCIENCE IN PRESS; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; LI J, 2009, P NATL ACAD SCI US; Liu G, 2006, MUTAT RES-FUND MOL M, V596, P12, DOI 10.1016/j.mrfmmm.2005.10.015; Mayer M, 2003, J MOL BIOL, V330, P137, DOI 10.1016/S0022-2836(03)00556-4; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mimura N, 2007, CELL DEATH DIFFER, V14, P1475, DOI 10.1038/sj.cdd.4402151; Min MK, 2007, PLANT PHYSIOL, V143, P1601, DOI 10.1104/pp.106.095091; Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Peng Y, 2008, MOL PLANT, V1, P446, DOI 10.1093/mp/ssn024; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ponciano G, 2006, PHYSIOL MOL PLANT P, V69, P131, DOI 10.1016/j.pmpp.2007.03.002; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang GL, 1998, PLANT CELL, V10, P765, DOI 10.1105/tpc.10.5.765; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Xu WH, 2006, PLANT J, V45, P740, DOI 10.1111/j.1365-313X.2005.02638.x; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zhang XM, 2007, PFLUG ARCH EUR J PHY, V454, P143, DOI 10.1007/s00424-006-0179-x; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	60	90	105	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9262	10.1371/journal.pone.0009262	http://dx.doi.org/10.1371/journal.pone.0009262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174657	Green Published, gold			2022-12-25	WOS:000274590600017
J	Hone, DWE; Tischlinger, H; Xu, X; Zhang, FC				Hone, David W. E.; Tischlinger, Helmut; Xu, Xing; Zhang, Fucheng			The Extent of the Preserved Feathers on the Four-Winged Dinosaur Microraptor gui under Ultraviolet Light	PLOS ONE			English	Article							CHINA; EVOLUTION; BIRDS	Background: The holotype of the theropod non-avian dinosaur Microraptor gui from the Early Cretaceous of China shows extensive preservation of feathers in a halo around the body and with flight feathers associated with both the fore and hindlimbs. It has been questioned as to whether or not the feathers did extend into the halo to reach the body, or had disassociated and moved before preservation. This taxon has important implications for the origin of flight in birds and the possibility of a four-winged gliding phase. Methodology/Principal Findings: Examination of the specimen under ultraviolet light reveals that these feathers actually reach the body of the animal and were not disassociated from the bones. Instead they may have been chemically altered by the body tissues of the animal meaning that they did not carbonise close into the animal or more likely were covered by other decaying tissue, though evidence of their presence remains. Conclusions/Significance: These UV images show that the feathers preserved on the slab are genuinely associated with the skeleton and that their arrangement and orientation is likely correct. The methods used here to reveal hidden features of the specimen may be applicable to other specimens from the fossil beds of Liaoning that produced Microraptor.	[Hone, David W. E.; Xu, Xing; Zhang, Fucheng] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Hone, DWE (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China.	dwe_hone@yahoo.com	Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824	Chinese Academy of Sciences [202102]; Ministry of Science and Technology [2006CB806400]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	Funding: This work was supported by a grant from the Chinese Academy of Sciences (http://english.cas.cn/) Number 202102 and the Ministry of Science and Technology 2006CB806400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEBE CW, 1915, ZOOLOGICA, V2, P38; Bennett SC, 2007, PALAEONTOL Z, V81, P376, DOI 10.1007/BF02990250; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; Davis PG, 1998, PALAIOS, V13, P3, DOI 10.2307/3515277; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Frey Eberhard, 2003, Geological Society Special Publication, V217, P233, DOI 10.1144/GSL.SP.2003.217.01.14; GILL FB, 2003, ORNITHOLOGY; Gohlich UB, 2006, ARCHAEOPTERYX, V24, P1; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Kellner AWA, 2010, P ROY SOC B-BIOL SCI, V277, P321, DOI 10.1098/rspb.2009.0846; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; LUCAS AM, 1972, AGR HDB, V362, P340; Padian K, 2005, NATURE, V438, pE3, DOI 10.1038/nature04354; Padian K, 2003, BIOSCIENCE, V53, P450; Schafer W., 1972, ECOLOGY PALAEOECOLOG; Tischlinger H., 2005, ZITTELIANA B, V26, P26; Tischlinger Helmut, 2002, Archaeopteryx, V20, P21; Tischlinger Helmut, 2004, Archaeopteryx, V22, P17; Tischlinger Helmut, 2005, Archaeopteryx, V23, P33; Turner AH, 2007, SCIENCE, V317, P1721, DOI 10.1126/science.1145076; Wellnhofer P., 2009, ARCHAEOPTERYX ICON E, P208; Xing X, 2006, GEOL J, V41, P419, DOI 10.1002/gj.1044; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; XU X, 2009, P NAT ACAD, V106; Xu X, 2006, INTEGR ZOOL, V1, P4, DOI 10.1111/j.1749-4877.2006.00004.x; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; YALDEN DW, 1985, BEGINNINGS BIRDS, P91; Zhang FC, 2001, CHINESE SCI BULL, V46, P945, DOI 10.1007/BF02900473; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhang FC, 2008, SCI CHINA SER D, V51, P625, DOI 10.1007/s11430-008-0050-3; Zhou ZH, 2002, NATURE, V420, P285, DOI 10.1038/420285a; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P455, DOI 10.1007/s00114-004-0570-4; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P111; Zhou Zhong-He, 2006, Vertebrata Palasiatica, V44, P74; Zhou ZY, 2002, P SOC PHOTO-OPT INS, V4928, P160, DOI 10.1117/12.483166	39	42	43	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9223	10.1371/journal.pone.0009223	http://dx.doi.org/10.1371/journal.pone.0009223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169153	Green Submitted, Green Published, gold			2022-12-25	WOS:000274474700017
J	Koirala, S; Corfas, G				Koirala, Samir; Corfas, Gabriel			Identification of Novel Glial Genes by Single-Cell Transcriptional Profiling of Bergmann Glial Cells from Mouse Cerebellum	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; STEM-CELLS; SYNAPSE FORMATION; EXPRESSION PATTERNS; PURKINJE NEURONS; RADIAL MIGRATION; RAT CEREBELLUM; NERVOUS-SYSTEM; D-SERINE; BRAIN	Bergmann glial cells play critical roles in the structure and function of the cerebellum. During development, their radial processes serve as guides for migrating granule neurons and their terminal endfeet tile to form the glia limitans. As the cerebellum matures, Bergmann glia perform important roles in synaptic transmission and synapse maintenance, while continuing to serve as essential structural elements. Despite growing evidence of the diverse functions of Bergmann glia, the molecular mechanisms that mediate these functions have remained largely unknown. As a step toward identifying the molecular repertoire underlying Bergmann glial function, here we examine global gene expression in individual Bergmann glia from developing (P6) and mature (P30) mouse cerebellum. When we select for developmentally regulated genes, we find that transcription factors and ribosomal genes are particularly enriched at P6 relative to P30; whereas synapse associated molecules are enriched at P30 relative to P6. We also analyze genes expressed at high levels at both ages. In all these categories, we find genes that were not previously known to be expressed in glial cells, and discuss novel functions some of these genes may potentially play in Bergmann glia. We also show that Bergmann glia, even in the adult, express a large set of genes thought to be specific to stem cells, suggesting that Bergmann glia may retain neural precursor potential as has been proposed. Finally, we highlight several genes that in the cerebellum are expressed in Bergmann glia but not astrocytes, and may therefore serve as new, specific markers for Bergmann glia.	[Koirala, Samir; Corfas, Gabriel] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA; [Koirala, Samir; Corfas, Gabriel] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Corfas, Gabriel] Harvard Univ, Sch Med, Dept Otolaryngol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Koirala, S (corresponding author), Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA.	gabriel.corfas@childrens.harvard.edu	Corfas, Gabriel/AAH-2378-2020	Corfas, Gabriel/0000-0001-5412-9473	National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS35884]; National Institutes of Health (NIH) Mental Retardation Research Center [P30-HD 18655]; Fundamental Neurobiology National Institutes of Health (NIH) [T32 NS007484-06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484, R01NS035884] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NIH) Mental Retardation Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundamental Neurobiology National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) grant R01 NS35884 (to G. C.), National Institutes of Health (NIH) Mental Retardation Research Center grant P30-HD 18655 (to G. C.), and a Fundamental Neurobiology National Institutes of Health (NIH) training grant T32 NS007484-06 (to S. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J, 2007, MED HYPOTHESES, V69, P341, DOI 10.1016/j.mehy.2007.01.006; Altman J, 1997, DEV CEREBELLAR SYSTE; Ango F, 2008, PLOS BIOL, V6, P739, DOI 10.1371/journal.pbio.0060103; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bagri A, 2002, ADV EXP MED BIOL, V515, P13; Bellamy TC, 2006, CEREBELLUM, V5, P116, DOI 10.1080/14734220600724569; Belvindrah R, 2006, MOL CELL NEUROSCI, V33, P109, DOI 10.1016/j.mcn.2006.06.013; Bermingham JR, 2006, NAT NEUROSCI, V9, P76, DOI 10.1038/nn1598; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Bordey A, 2003, J NEUROPHYSIOL, V89, P979, DOI 10.1152/jn.00904.2002; Brockhaus J, 2002, J PHYSIOL-LONDON, V545, P581, DOI 10.1113/jphysiol.2002.028423; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Cui W, 2001, GLIA, V34, P272, DOI 10.1002/glia.1061; CUNNINGHAM NS, 1995, GROWTH FACTORS, V12, P99, DOI 10.3109/08977199509028956; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Dolter KE, 2001, BIOTECHNIQUES, V30, P1358, DOI 10.2144/01306pf01; Dulac C, 1998, CURR TOP DEV BIOL, V36, P245; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Eichele G, 1997, TRENDS GENET, V13, P343, DOI 10.1016/S0168-9525(97)01218-3; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HAUSMANN B, 1985, J COMP NEUROL, V241, P50, DOI 10.1002/cne.902410105; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; JORGENSEN JR, 2009, J MOL NEUROSCI; Klein C, 2005, DEVELOPMENT, V132, P4497, DOI 10.1242/dev.02037; Koirala S, 2009, J NEUROSCI, V29, P7439, DOI 10.1523/JNEUROSCI.1182-09.2009; Komine O, 2007, DEV BIOL, V311, P238, DOI 10.1016/j.ydbio.2007.08.042; Krizhanovsky V, 2006, MECH DEVELOP, V123, P67, DOI 10.1016/j.mod.2005.09.005; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Lippman JJ, 2008, GLIA, V56, P1463, DOI 10.1002/glia.20712; Lopez-Bayghen E, 2007, NEURON GLIA BIOL, V3, P155, DOI 10.1017/S1740925X0700066X; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; MAGER WH, 1988, BIOCHIM BIOPHYS ACTA, V949, P1, DOI 10.1016/0167-4781(88)90048-6; Magistretti PJ, 1999, NEWS PHYSIOL SCI, V14, P177, DOI 10.1152/physiologyonline.1999.14.5.177; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Muller T, 1995, INT REV NEUROBIOL, V38, P341, DOI 10.1016/S0074-7742(08)60530-9; Mustafa AK, 2004, NEURON GLIA BIOL, V1, P275, DOI 10.1017/S1740925X05000141; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Nishino J, 2004, EMBO J, V23, P1998, DOI 10.1038/sj.emboj.7600202; Ottersen OP, 1997, PROG BRAIN RES, V114, P97; OTTERSEN OP, 1992, NEUROSCIENCE, V46, P519, DOI 10.1016/0306-4522(92)90141-N; Pan PY, 2009, NEURON, V61, P412, DOI 10.1016/j.neuron.2008.12.029; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Park WJ, 2008, NEUROSCI LETT, V444, P240, DOI 10.1016/j.neulet.2008.08.044; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Roubelakis MG, 2007, J CELL BIOCHEM, V102, P955, DOI 10.1002/jcb.21334; SASSOON D, 1993, METHOD ENZYMOL, V225, P384; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schoch S, 2006, EMBO J, V25, P5852, DOI 10.1038/sj.emboj.7601425; Schousboe A, 1997, GLIA, V21, P99; Shima Y, 2004, DEV CELL, V7, P205, DOI 10.1016/j.devcel.2004.07.007; SIEVERS J, 1986, ANAT EMBRYOL, V175, P91, DOI 10.1007/BF00315459; SIEVERS J, 1981, J COMP NEUROL, V203, P751, DOI 10.1002/cne.902030412; SOTELO C, 1994, J NEUROSCI, V14, P124; Soto D, 2009, NAT NEUROSCI, V12, P277, DOI 10.1038/nn.2266; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; TEICHBERG VI, 1991, FASEB J, V5, P3086, DOI 10.1096/fasebj.5.15.1660422; THIERRYMIEG D, 2006, GENOME BIOL S1, V7, pS1211; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Tournell CE, 2006, NEUROSCIENCE, V141, P1327, DOI 10.1016/j.neuroscience.2006.05.004; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; TUSHINSKI RJ, 1982, J CELL PHYSIOL, V112, P128, DOI 10.1002/jcp.1041120119; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Weller M, 2006, DEV NEUROSCI-BASEL, V28, P70, DOI 10.1159/000090754; Yamada K, 2000, J COMP NEUROL, V418, P106; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Zhao RB, 1999, DEV BIOL, V212, P68, DOI 10.1006/dbio.1999.9326; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	92	61	61	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9198	10.1371/journal.pone.0009198	http://dx.doi.org/10.1371/journal.pone.0009198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169146	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474600018
J	Rioux, JB; Philippe, N; Pereira, S; Pignol, D; Wu, LF; Ginet, N				Rioux, Jean-Baptiste; Philippe, Nadege; Pereira, Sandrine; Pignol, David; Wu, Long-Fei; Ginet, Nicolas			A Second Actin-Like MamK Protein in Magnetospirillum magneticum AMB-1 Encoded Outside the Genomic Magnetosome Island	PLOS ONE			English	Article							MAGNETOTACTIC BACTERIA; GRYPHISWALDENSE; SEQUENCE; BIOMINERALIZATION; COMPLEX; REGION; DOMAIN	Magnetotactic bacteria are able to swim navigating along geomagnetic field lines. They synthesize ferromagnetic nanocrystals that are embedded in cytoplasmic membrane invaginations forming magnetosomes. Regularly aligned in the cytoplasm along cytoskeleton filaments, the magnetosome chain effectively forms a compass needle bestowing on bacteria their magnetotactic behaviour. A large genomic island, conserved among magnetotactic bacteria, contains the genes potentially involved in magnetosome formation. One of the genes, mamK has been described as encoding a prokaryotic actin-like protein which when it polymerizes forms in the cytoplasm filamentous structures that provide the scaffold for magnetosome alignment. Here, we have identified a series of genes highly similar to the mam genes in the genome of Magnetospirillum magneticum AMB-1. The newly annotated genes are clustered in a genomic islet distinct and distant from the known magnetosome genomic island and most probably acquired by lateral gene transfer rather than duplication. We focused on a mamK-like gene whose product shares 54.5% identity with the actin-like MamK. Filament bundles of polymerized MamK-like protein were observed in vitro with electron microscopy and in vivo in E. coli cells expressing MamK-like-Venus fusions by fluorescence microscopy. In addition, we demonstrate that mamK-like is transcribed in AMB-1 wild-type and DmamK mutant cells and that the actin-like filamentous structures observed in the DmamK strain are probably MamK-like polymers. Thus MamK-like is a new member of the prokaryotic actin-like family. This is the first evidence of a functional mam gene encoded outside the magnetosome genomic island.	[Rioux, Jean-Baptiste; Pignol, David; Ginet, Nicolas] CEA, Inst Biol Environm & Biotechnol, Lab Bioenerget Cellulaire, St Paul Les Durance, France; [Rioux, Jean-Baptiste; Pignol, David; Ginet, Nicolas] CNRS, UMR Biol Vegetale & Microbiol Environm 6191, St Paul Les Durance, France; [Rioux, Jean-Baptiste; Pignol, David; Ginet, Nicolas] Aix Marseille Univ, St Paul Les Durance, France; [Philippe, Nadege; Wu, Long-Fei] CNRS, UPR 9043, Chim Bacterienne Lab, Marseille, France; [Pereira, Sandrine] Inst Radioprotect & Surete Nucl, Lab Radiotoxicol & Ecotoxicol, St Paul Les Durance, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Rioux, JB (corresponding author), CEA, Inst Biol Environm & Biotechnol, Lab Bioenerget Cellulaire, St Paul Les Durance, France.	nicolas.ginet@cea.fr	Ginet, Nicolas/AEB-2370-2022	Philippe, Nadege/0000-0001-9154-0341; PIGNOL, David/0000-0002-8070-0319; Ginet, Nicolas/0000-0002-5544-4376	Le Commissariat a l'Energie Atomique; Le Centre National de la Recherche Scientifique; Aix-Marseille II Universite; Institut de Radioprotection et de Surete Nucleaire	Le Commissariat a l'Energie Atomique(French Atomic Energy Commission); Le Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille II Universite; Institut de Radioprotection et de Surete Nucleaire	This work was supported by Le Commissariat a l'Energie Atomique (http://www.cea.fr), Le Centre National de la Recherche Scientifique (http://www.cnrs.fr), Aix-Marseille II Universite (http://www.univmed.fr) and Institut de Radioprotection et de Surete Nucleaire (http://www.irsn.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya Y, 2007, BIOMATERIALS, V28, P5381, DOI 10.1016/j.biomaterials.2007.07.051; ARAKAKI A, 2009, J COLLOID INTERFACE; Bates PA, 1999, PROTEINS, P47; Bazylinski D.A., 2006, MAGNETOSOMES MAGNETO, P37; Bellini S, 2009, CHIN J OCEANOL LIMN, V27, P3, DOI 10.1007/s00343-009-0003-5; Bellini S, 2009, CHIN J OCEANOL LIMN, V27, P6, DOI 10.1007/s00343-009-0006-2; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frankel R B, 2007, MICROBIOL MONOGR, V3, DOI DOI 10.1007/7171_2006_036; Frankel RB, 2006, TRENDS MICROBIOL, V14, P329, DOI 10.1016/j.tim.2006.06.004; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Graumann PL, 2007, ANNU REV MICROBIOL, V61, P589, DOI 10.1146/annurev.micro.61.080706.093236; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Jogler C, 2009, ENVIRON MICROBIOL, V11, P1267, DOI 10.1111/j.1462-2920.2009.01854.x; Jogler C, 2009, APPL ENVIRON MICROB, V75, P3972, DOI 10.1128/AEM.02701-08; Komeili A, 2004, P NATL ACAD SCI USA, V101, P3839, DOI 10.1073/pnas.0400391101; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Komelli A, 2007, ANNU REV BIOCHEM, V76, P351, DOI 10.1146/annurev.biochem.74.082803.133444; Lang C, 2007, MACROMOL BIOSCI, V7, P144, DOI 10.1002/mabi.200600235; Matsunaga T, 2007, TRENDS BIOTECHNOL, V25, P182, DOI 10.1016/j.tibtech.2007.02.002; Matsunaga T, 2005, DNA RES, V12, P157, DOI 10.1093/dnares/dsi002; McInerney JO, 1998, BIOINFORMATICS, V14, P372, DOI 10.1093/bioinformatics/14.4.372; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakazawa H, 2009, GENOME RES, V19, P1801, DOI 10.1101/gr.088906.108; Pradel N, 2006, P NATL ACAD SCI USA, V103, P17485, DOI 10.1073/pnas.0603760103; Richter M, 2007, J BACTERIOL, V189, P4899, DOI 10.1128/JB.00119-07; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Scheffel A, 2008, J BACTERIOL, V190, P377, DOI 10.1128/JB.01371-07; Scheffel A, 2007, J BACTERIOL, V189, P6437, DOI 10.1128/JB.00421-07; Schubbe S, 2009, APPL ENVIRON MICROB, V75, P4835, DOI 10.1128/AEM.02874-08; Schuler D, 2008, FEMS MICROBIOL REV, V32, P654, DOI 10.1111/j.1574-6976.2008.00116.x; Skorko-Glonek J, 1999, MOL GEN GENET, V262, P342, DOI 10.1007/s004380051092; Sternberg MJE, 1999, CURR OPIN STRUC BIOL, V9, P368, DOI 10.1016/S0959-440X(99)80050-5; Taoka A, 2007, J BACTERIOL, V189, P8737, DOI 10.1128/JB.00899-07; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ullrich S, 2005, J BACTERIOL, V187, P7176, DOI 10.1128/JB.187.21.7176-7184.2005; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Yang CD, 2001, ENZYME MICROB TECH, V29, P13, DOI 10.1016/S0141-0229(01)00343-X	41	61	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9151	10.1371/journal.pone.0009151	http://dx.doi.org/10.1371/journal.pone.0009151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161777	Green Submitted, gold, Green Published			2022-12-25	WOS:000274442700015
J	Navaroli, DM; Melikian, HE				Navaroli, Deanna M.; Melikian, Haley E.			Insertion of Tetracysteine Motifs into Dopamine Transporter Extracellular Domains	PLOS ONE			English	Article							NEUROTRANSMITTER TRANSPORTERS; PLASMA-MEMBRANE; TRANSMEMBRANE SEGMENT; FUNCTIONAL REGULATION; COCAINE ANALOGS; CROSS-LINKING; TRAFFICKING; INTERNALIZATION; ENDOCYTOSIS; PROTEINS	The neuronal dopamine transporter (DAT) is a major determinant of extracellular dopamine (DA) levels and is the primary target for a variety of addictive and therapeutic psychoactive drugs. DAT is acutely regulated by protein kinase C (PKC) activation and amphetamine exposure, both of which modulate DAT surface expression by endocytic trafficking. In order to use live imaging approaches to study DAT endocytosis, methods are needed to exclusively label the DAT surface pool. The use of membrane impermeant, sulfonated biarsenic dyes holds potential as one such approach, and requires introduction of an extracellular tetracysteine motif (tetraCys; CCPGCC) to facilitate dye binding. In the current study, we took advantage of intrinsic proline-glycine (Pro-Gly) dipeptides encoded in predicted DAT extracellular domains to introduce tetraCys motifs into DAT extracellular loops 2, 3, and 4. [(3)H]DA uptake studies, surface biotinylation and fluorescence microscopy in PC12 cells indicate that tetraCys insertion into the DAT second extracellular loop results in a functional transporter that maintains PKC-mediated downregulation. Introduction of tetraCys into extracellular loops 3 and 4 yielded DATs with severely compromised function that failed to mature and traffic to the cell surface. This is the first demonstration of successful introduction of a tetracysteine motif into a DAT extracellular domain, and may hold promise for use of biarsenic dyes in live DAT imaging studies.	[Navaroli, Deanna M.; Melikian, Haley E.] Univ Massachusetts, Sch Med, Interdisciplinary Grad Program, Worcester, MA 01605 USA; [Melikian, Haley E.] Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Navaroli, DM (corresponding author), Univ Massachusetts, Sch Med, Interdisciplinary Grad Program, Worcester, MA 01605 USA.	haley.melikian@umassmed.edu	Melikian, Haley/S-8301-2016	Melikian, Haley/0000-0002-9694-5556	National Institutes of Health [DA15169]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by National Institutes of Health grant # DA15169 to H. E. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Adams SR, 2008, NAT PROTOC, V3, P1527, DOI 10.1038/nprot.2008.144; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; ANJAN KB, 2007, CHEMBIOCHEM, V8, P1642; Beckman ML, 1998, J MEMBRANE BIOL, V164, P1; Blakely RD, 2001, J NEUROSCI, V21, P8319, DOI 10.1523/JNEUROSCI.21-21-08319.2001; Boudanova E, 2008, MOL CELL NEUROSCI, V39, P211, DOI 10.1016/j.mcn.2008.06.011; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Daws LC, 2002, BIOCHEM BIOPH RES CO, V290, P1545, DOI 10.1006/bbrc.2002.6384; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Furman CA, 2009, J NEUROSCI, V29, P3328, DOI 10.1523/JNEUROSCI.5386-08.2009; Gainetdinov RR, 1998, BRAIN RES REV, V26, P148, DOI 10.1016/S0165-0173(97)00063-5; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hearps AC, 2007, J FLUORESC, V17, P593, DOI 10.1007/s10895-007-0225-x; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Jayanthi LD, 2005, AAPS J, V7, pE728, DOI 10.1208/aapsj070373; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Little KY, 2002, MOL PHARMACOL, V61, P436, DOI 10.1124/mol.61.2.436; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Machleidt T, 2007, METH MOL B, V356, P209; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Melikian HE, 1999, J NEUROSCI, V19, P7699; Orun O, 2009, ACTA BIOL HUNG, V60, P15, DOI 10.1556/ABiol.60.2009.1.2; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Robertson SD, 2009, MOL NEUROBIOL, V39, P73, DOI 10.1007/s12035-009-8053-4; Robinson MB, 2002, J NEUROCHEM, V80, P1, DOI 10.1046/j.0022-3042.2001.00698.x; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Taguchi Y, 2009, MOL BIOL CELL, V20, P233, DOI 10.1091/mbc.E08-06-0635; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Zahniser NR, 2004, NEUROPHARMACOLOGY, V47, P80, DOI 10.1016/j.neuropharm.2004.07.010; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9113	10.1371/journal.pone.0009113	http://dx.doi.org/10.1371/journal.pone.0009113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161733	Green Submitted, gold, Green Published			2022-12-25	WOS:000274442600011
J	Shoemaker, LD; Orozco, NM; Geschwind, DH; Whitelegge, JP; Faull, KF; Kornblum, HI				Shoemaker, Lorelei D.; Orozco, Nicholas M.; Geschwind, Daniel H.; Whitelegge, Julian P.; Faull, Kym F.; Kornblum, Harley I.			Identification of Differentially Expressed Proteins in Murine Embryonic and Postnatal Cortical Neural Progenitors	PLOS ONE			English	Article							REPULSIVE GUIDANCE MOLECULE; STEM-CELLS; NEURONAL DIFFERENTIATION; SUBVENTRICULAR ZONE; MULTIPLE ROLES; TUBE CLOSURE; ADULT-MOUSE; NEOGENIN; RGM; GROWTH	Background: The central nervous system (CNS) develops from a heterogeneous pool of neural stem and progenitor cells (NSPC), the underlying differences among which are poorly understood. The study of NSPC would be greatly facilitated by the identification of additional proteins that mediate their function and that would distinguish amongst different progenitor populations. Methodology/Principal Findings: To identify membrane and membrane-associated proteins expressed by NSPC, we used a proteomics approach to profile NSPC cultured as neurospheres (NS) isolated from the murine cortex during a period of neurogenesis (embryonic day 11.5, E11.5), as compared to NSPC isolated at a peak of gliogenesis (postnatal day 1, P0) and to differentiated E11.5 NS. 54 proteins were identified with high expression in E11.5 NS, including the TrkC receptor, several heterotrimeric G proteins, and the Neogenin receptor. 24 proteins were identified with similar expression in E11.5 and P0 NS over differentiated E11.5 NS, and 13 proteins were identified with high expression specifically in P0 NS compared to E11.5 NS. To illustrate the potential relevance of these identified proteins to neural stem cell biology, the function of Neogenin was further studied. Using Fluorescence Activated Cell Sorting (FACS) analysis, expression of Neogenin was associated with a self-renewing population present in both E11.5 and adult subventricular zone (SVZ) NS but not in P0 NS. E11.5 NS expressed a putative Neogenin ligand, RGMa, and underwent apoptosis when exposed to a ligand-blocking antibody. Conclusions/Significance: There are fundamental differences between the continuously self-renewing and more limited progenitors of the developing cortex. We identified a subset of differentially expressed proteins that serve not only as a set of functionally important proteins, but as a useful set of markers for the subsequent analysis of NSPC. Neogenin is associated with the continuously self-renewing and neurogenic cells present in E11.5 cortical and adult SVZ NS, and the Neogenin/RGMa receptor/ligand pair may regulate cell survival during development.	[Shoemaker, Lorelei D.; Whitelegge, Julian P.; Faull, Kym F.] Univ Calif Los Angeles, David Geffen Sch Med, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Shoemaker, Lorelei D.; Orozco, Nicholas M.; Geschwind, Daniel H.; Whitelegge, Julian P.; Faull, Kym F.; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Neuropsychiat, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Shoemaker, Lorelei D.; Orozco, Nicholas M.; Geschwind, Daniel H.; Whitelegge, Julian P.; Faull, Kym F.; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Shoemaker, Lorelei D.; Orozco, Nicholas M.; Geschwind, Daniel H.; Whitelegge, Julian P.; Faull, Kym F.; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Shoemaker, LD (corresponding author), Stanford Med Sch, Dept Neurosurg, Stanford, CA USA.	harley@ucla.edu		Shoemaker, Lorelei/0000-0002-2208-0537	National Institute of Mental Health [68649, 65756]; National Institutes of Health Shared Instrument [S10 RR16793: 010, S10 RR15952: 01]; University of California Los Angeles Graduate Division; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015952, S10RR016793] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health Shared Instrument(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Los Angeles Graduate Division; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by National Institute of Mental Health grants 68649 and 65756 (to HIK), National Institutes of Health Shared Instrument Grant award S10 RR16793: 010 and S10 RR15952: 01 (to KFF), and by University of California Los Angeles Graduate Division (to LDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramova N, 2005, DEV BIOL, V283, P269, DOI 10.1016/j.ydbio.2005.03.040; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Costa MR, 2009, CEREB CORTEX, V19, pI135, DOI 10.1093/cercor/bhp046; De Vries M, 2008, J NEUROCHEM, V106, P1483, DOI 10.1111/j.1471-4159.2008.05485.x; Desai AR, 2000, DEVELOPMENT, V127, P2863; EASTERDAY MC, 2003, DEV BIOL IN PRESS; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Fitzgerald DP, 2006, NEUROSCIENCE, V142, P703, DOI 10.1016/j.neuroscience.2006.06.041; Fitzgerald DP, 2007, GENE EXPR PATTERNS, V7, P784, DOI 10.1016/j.modgep.2007.05.004; Fuja TJ, 2004, J NEUROSCI RES, V75, P782, DOI 10.1002/jnr.10874; Fujita Y, 2008, CELL DEATH DIFFER, V15, P1593, DOI 10.1038/cdd.2008.92; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Henion PD, 1995, DEV BIOL, V172, P602, DOI 10.1006/dbio.1995.8054; Hoffrogge R, 2006, PROTEOMICS, V6, P1833, DOI 10.1002/pmic.200500556; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kee N, 2008, J NEUROSCI, V28, P12643, DOI 10.1523/JNEUROSCI.4265-08.2008; Keeling SL, 1997, ONCOGENE, V15, P691, DOI 10.1038/sj.onc.1201225; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Kornblum HI, 1998, J NEUROSCI RES, V53, P697, DOI 10.1002/(SICI)1097-4547(19980915)53:6<697::AID-JNR8>3.3.CO;2-M; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2004, DEV GROWTH DIFFER, V46, P481; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Maurer MH, 2007, J PROTEOME RES, V6, P1198, DOI 10.1021/pr0605825; Maurer MH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-7; Maurer MH, 2004, NEUROCHEM RES, V29, P1129, DOI 10.1023/B:NERE.0000023600.25994.11; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Salim K, 2007, STEM CELLS DEV, V16, P143, DOI 10.1089/scd.2006.00100; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Seaberg RM, 2005, DEV BIOL, V278, P71, DOI 10.1016/j.ydbio.2004.10.017; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shin GJ, 2008, J MOL HISTOL, V39, P105, DOI 10.1007/s10735-007-9138-x; Skalnikova H, 2007, PROTEOMICS, V7, P1825, DOI 10.1002/pmic.200600867; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Unwin RD, 2006, BLOOD, V107, P4687, DOI 10.1182/blood-2005-12-4995; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5; Willaime-Morawek S, 2006, J CELL BIOL, V175, P159, DOI 10.1083/jcb.200604123; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	55	6	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9121	10.1371/journal.pone.0009121	http://dx.doi.org/10.1371/journal.pone.0009121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161753	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442600019
J	Wan, XY; Ji, W; Mei, X; Zhou, JG; Liu, JX; Fang, CC; Xiao, WH				Wan, Xiaoyang; Ji, Wei; Mei, Xue; Zhou, Jiangang; Liu, Jing-xia; Fang, Chengchi; Xiao, Wuhan			Negative Feedback Regulation of Wnt4 Signaling by EAF1 and EAF2/U19	PLOS ONE			English	Article							EXTENSION MOVEMENTS; ELL; EXPRESSION; CONVERGENCE; ACTIVATION; PROSTATE; PROTEIN; GENE	Previous studies indicated that EAF (ELL-associated factor) family members, EAF1 and EAF2/U19, play a role in cancer and embryogenesis. For example, EAF2/U19 may serve as a tumor suppressor in prostate cancer. At the same time, EAF2/U19 is a downstream factor in the non-canonical Wnt4 signaling pathway required for eye development in Xenopus laevis, and along with EAF1, contributes to convergence and extension movements in zebrafish embryos through Wnt maintenance. Here, we used zebrafish embryos and mammalian cells to show that both EAF1 and EAF2/U19 were up-regulated by Wnt4 (Wnt4a). Furthermore, we found that EAF1 and EAF2/U19 suppressed Wnt4 expression by directly binding to the Wnt4 promoter as seen in chromatin immunoprecipitation assays. These findings indicate that an auto-regulatory negative feedback loop occurs between Wnt4 and the EAF family, which is conserved between zebrafish and mammalian. The rescue experiments in zebrafish embryos showed that early embryonic development required the maintenance of the appropriate levels of Wnt4a through the feedback loop. Others have demonstrated that the tumor suppressors p63, p73 and WT1 positively regulate Wnt4 expression while p21 has the opposite effect, suggesting that maintenance of appropriate Wnt4 expression may also be critical for adult tissue homeostasis and prevention against tumor initiation. Thus, the autoregulatory negative feedback loop that controls expression of Wnt4 and EAF proteins may play an important role in both embryonic development and tumor suppression. Our findings provide the first convincing line of evidence that EAF and Wnt4 form an auto-regulatory negative feedback loop in vivo.	[Wan, Xiaoyang; Ji, Wei; Mei, Xue; Zhou, Jiangang; Liu, Jing-xia; Fang, Chengchi; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan, Peoples R China.	w-xiao@ihb.ac.cn	Xiao, Wuhan/GLU-7352-2022	Wan, Xiaoyang/0000-0002-8871-2015	NSFC [30671037, 30971667, 30700440, 20890113]; National Transgene Project [2009ZX08010-021B];  [2010CB126306];  [2007CB815705];  [2004CB117404]	NSFC(National Natural Science Foundation of China (NSFC)); National Transgene Project; ; ; 	WX is supported by 973 grant 2010CB126306, 2007CB815705, 2004CB117404, NSFC grant 30671037, 30971667 and National Transgene Project 2009ZX08010-021B. JL is supported by NSFC grant (Youth Foundation) 30700440 and NSFC grant 20890113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Jordan BK, 2003, P NATL ACAD SCI USA, V100, P10866, DOI 10.1073/pnas.1834480100; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Liu AP, 2000, MECH DEVELOP, V91, P409, DOI 10.1016/S0925-4773(99)00308-1; Liu JX, 2009, J BIOL CHEM, V284, P16679, DOI 10.1074/jbc.M109.009654; Luo RT, 2001, MOL CELL BIOL, V21, P5678, DOI 10.1128/MCB.21.16.5678-5687.2001; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Maurus D, 2005, EMBO J, V24, P1181, DOI 10.1038/sj.emboj.7600603; Mitani K, 2000, BIOCHEM BIOPH RES CO, V279, P563, DOI 10.1006/bbrc.2000.3970; Osada M, 2006, BIOCHEM BIOPH RES CO, V339, P1120, DOI 10.1016/j.bbrc.2005.11.118; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Sim EUH, 2002, ONCOGENE, V21, P2948, DOI 10.1038/sj.onc.1205373; Simone F, 2003, BLOOD, V101, P2355, DOI 10.1182/blood-2002-06-1664; Simone F, 2001, BLOOD, V98, P201, DOI 10.1182/blood.V98.1.201; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Torban E, 2006, J BIOL CHEM, V281, P12705, DOI 10.1074/jbc.M513181200; UNGAR AR, 1995, MECH DEVELOP, V52, P153, DOI 10.1016/0925-4773(95)00386-F; Wang Z, 1997, P NATL ACAD SCI USA, V94, P12999, DOI 10.1073/pnas.94.24.12999; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Xiao WH, 2006, PROSTATE, V66, P1, DOI 10.1002/pros.20309; Xiao WH, 2003, CANCER RES, V63, P4698; Xiao WH, 2009, CANCER RES, V69, P2599, DOI 10.1158/0008-5472.CAN-08-2595	24	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9118	10.1371/journal.pone.0009118	http://dx.doi.org/10.1371/journal.pone.0009118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161747	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442600016
J	Kunzli, N; Jerrett, M; Garcia-Esteban, R; Basagana, X; Beckermann, B; Gilliland, F; Medina, M; Peters, J; Hodis, HN; Mack, WJ				Kuenzli, Nino; Jerrett, Michael; Garcia-Esteban, Raquel; Basagana, Xavier; Beckermann, Bernardo; Gilliland, Frank; Medina, Merce; Peters, John; Hodis, Howard N.; Mack, Wendy J.			Ambient Air Pollution and the Progression of Atherosclerosis in Adults	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; RANDOMIZED CONTROLLED-TRIAL; SUBCLINICAL ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; HORMONE-THERAPY; CAROTID-ARTERY; LOS-ANGELES; EXPOSURE; PREVENTION; EVENTS	Background: Cross-sectional studies suggest an association between exposure to ambient air pollution and atherosclerosis. We investigated the association between outdoor air quality and progression of subclinical atherosclerosis (common carotid artery intima-media thickness, CIMT). Methodology/Principal Findings: We examined data from five double-blind randomized trials that assessed effects of various treatments on the change in CIMT. The trials were conducted in the Los Angeles area. Spatial models and land-use data were used to estimate the home outdoor mean concentration of particulate matter up to 2.5 micrometer in diameter (PM2.5), and to classify residence by proximity to traffic-related pollution (within 100 m of highways). PM2.5 and traffic proximity were positively associated with CIMT progression. Adjusted coefficients were larger than crude associations, not sensitive to modelling specifications, and statistically significant for highway proximity while of borderline significance for PM2.5 (P = 0.08). Annual CIMT progression among those living within 100 m of a highway was accelerated (5.5 micrometers/yr [95% CI: 0.13-10.79; p = 0.04]) or more than twice the population mean progression. For PM2.5, coefficients were positive as well, reaching statistical significance in the socially disadvantaged; in subjects reporting lipid lowering treatment at baseline; among participants receiving on-trial treatments; and among the pool of four out of the five trials. Conclusion: Consistent with cross-sectional findings and animal studies, this is the first study to report an association between exposure to air pollution and the progression of atherosclerosis - indicated with CIMT change - in humans. Ostensibly, our results suggest that air pollution may contribute to the acceleration of cardiovascular disease development the main causes of morbidity and mortality in many countries. However, the heterogeneity of the volunteering populations across the five trials, the limited sample size within trials and other relevant subgroups, and the fact that some key findings reached statistical significance in subgroups rather than the sample precludes generalizations to the general population.	[Kuenzli, Nino] Swiss Trop & Publ Hlth Inst Swiss TPH, Basel, Switzerland; [Kuenzli, Nino; Garcia-Esteban, Raquel; Basagana, Xavier; Medina, Merce] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Jerrett, Michael; Beckermann, Bernardo] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Gilliland, Frank; Peters, John; Mack, Wendy J.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Hodis, Howard N.] Univ So Calif, Dept Med, Atherosclerosis Res Unit, Los Angeles, CA 90089 USA	University of Basel; Swiss Tropical & Public Health Institute; Pompeu Fabra University; University of California System; University of California Berkeley; University of Southern California; University of Southern California	Kunzli, N (corresponding author), Swiss Trop & Publ Hlth Inst Swiss TPH, Basel, Switzerland.	Nino.Kuenzli@unibas.ch	Jerrett, Michael/CAA-2482-2022; Basagaña, Xavier/C-3901-2017; Kuenzli, Nino/F-7195-2014	Basagaña, Xavier/0000-0002-8457-1489; Kuenzli, Nino/0000-0001-8360-080X; Garcia, Raquel/0000-0002-5663-6388	NIH National Institute on Aging [R01AG-13860, R01AG-17160, R01AG-18798]; National Health Lung and Blood Institute [U01HL-49298]; Office of Dietary Supplements; Office of Research on Minority Health; National Institute of Environmental Health Sciences [5 P30 ES07048]; Parke-Davis Pharmaceutical Research (TART); Wright Foundation; Hastings Foundation; Health Effects Institute; Catalan Institute for Research and Advanced studies (ICREA), Barcelona, Spain; Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Spanish Ministry of Science and Innovation Program Juan de la Cierva [JCI-2007-47-767]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL049298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013860, R01AG018798, R01AG017160] Funding Source: NIH RePORTER	NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Health Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research on Minority Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Parke-Davis Pharmaceutical Research (TART); Wright Foundation; Hastings Foundation; Health Effects Institute; Catalan Institute for Research and Advanced studies (ICREA), Barcelona, Spain(ICREA); Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Spanish Ministry of Science and Innovation Program Juan de la Cierva; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The main author and data analyst (RG) had full access to the data and takes responsibility for the integrity of the data and the accuracy of the data analysis. NIH National Institute on Aging (grants R01AG-13860 (VEAPS); R01AG-17160 (BVAIT); R01AG-18798 (EPAT); National Health Lung and Blood Institute (U01HL-49298) (WELL-HART); Office of Dietary Supplements (VEAPS, BVAIT) and Office of Research on Minority Health (WELL-HART); National Institute of Environmental Health Sciences (5 P30 ES07048); Parke-Davis Pharmaceutical Research (TART); Wright Foundation; Hastings Foundation; Health Effects Institute; Catalan Institute for Research and Advanced studies (ICREA), Barcelona, Spain; Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Spanish Ministry of Science and Innovation Program Juan de la Cierva (JCI-2007-47-767).	ABE KC, 2009, ENV RES; Allen RW, 2009, EPIDEMIOLOGY, V20, P254, DOI 10.1097/EDE.0b013e31819644cc; Araujo JA, 2008, CIRC RES, V102, P589, DOI 10.1161/CIRCRESAHA.107.164970; Bailey T, 1995, INTERACTIVE SPATIAL; Beelen R, 2009, OCCUP ENVIRON MED, V66, P243, DOI 10.1136/oem.2008.042358; BLANKENHORN DH, 1994, ARTERIOSCLER THROMB, V14, P177, DOI 10.1161/01.ATV.14.2.177; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2008, CLIN SCI, V115, P175, DOI 10.1042/CS20070444; Burrough P., 1998, PRINCIPLES GEOGRAPHI; Chambless LE, 2002, AM J EPIDEMIOL, V155, P38, DOI 10.1093/aje/155.1.38; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Health Effects Institute, 2009, 17 HEI; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hodis HN, 2003, NEW ENGL J MED, V349, P535, DOI 10.1056/NEJMoa030830; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hodis HN, 1999, CURR PRACT MED, V2, P171; Hodis HN, 2008, CLIN OBSTET GYNECOL, V51, P564, DOI 10.1097/GRF.0b013e318181de86; Hodis HN, 2006, DIABETES CARE, V29, P1545, DOI 10.2337/dc05-2462; Hodis Howard N, 2008, Cleve Clin J Med, V75 Suppl 4, pS3; Hodis HN, 2009, STROKE, V40, P730, DOI 10.1161/STROKEAHA.108.526798; Hoek G, 2001, J EXPO ANAL ENV EPID, V11, P459, DOI 10.1038/sj.jea.7500189; Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Jerrett M, 2009, ENVIRON HEALTH PERSP, V117, P772, DOI 10.1289/ehp.11533; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Kunzli N, 2005, SWISS MED WKLY, V135, P697; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; RUBIN DB, 1996, J AM STAT ASSOC, V91, P473, DOI DOI 10.2307/2291635; SELZER RH, 1994, ATHEROSCLEROSIS, V111, P1, DOI 10.1016/0021-9150(94)90186-4; Selzer RH, 2001, ATHEROSCLEROSIS, V154, P185, DOI 10.1016/S0021-9150(00)00461-5; Sharman JE, 2002, ARCH ENVIRON HEALTH, V57, P536, DOI 10.1080/00039890209602085; Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; Yamawaki H, 2006, CIRC J, V70, P129, DOI 10.1253/circj.70.129; Yanez ND, 1998, STAT MED, V17, P2597, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2597::AID-SIM940>3.0.CO;2-G; Zhu YF, 2002, J AIR WASTE MANAGE, V52, P1032, DOI 10.1080/10473289.2002.10470842	42	188	192	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9096	10.1371/journal.pone.0009096	http://dx.doi.org/10.1371/journal.pone.0009096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161713	Green Published, gold			2022-12-25	WOS:000274442500007
J	Hara, K; Hashimoto, H; Murakumo, Y; Kobayashi, S; Kogame, T; Unzai, S; Akashi, S; Takeda, S; Shimizu, T; Sato, M				Hara, Kodai; Hashimoto, Hiroshi; Murakumo, Yoshiki; Kobayashi, Shunsuke; Kogame, Toshiaki; Unzai, Satoru; Akashi, Satoko; Takeda, Shunichi; Shimizu, Toshiyuki; Sato, Mamoru			Crystal Structure of Human REV7 in Complex with a Human REV3 Fragment and Structural Implication of the Interaction between DNA Polymerase zeta and REV1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; EMBRYONIC LETHALITY; CATALYTIC SUBUNIT; YEAST REV1; MOLECULAR GRAPHICS; MULTIPLE ROLES; C-TERMINUS; Y-FAMILY; PROTEIN; DISRUPTION	DNA polymerase zeta (Pol zeta) is an error-prone DNA polymerase involved in translesion DNA synthesis. Pol zeta consists of two sub-units: the catalytic REV3, which belongs to B family DNA polymerase, and the noncatalytic REV7. REV7 also interacts with REV1 polymerase, which is an error-prone Y family DNA polymerase and is also involved in translesion DNA synthesis. Cells deficient in one of the three REV proteins and those deficient in all three proteins show similar phenotype, indicating the functional collaboration of the three REV proteins. REV7 interacts with both REV3 and REV1 polymerases, but the structure of REV7 or REV3, as well as the structural and functional basis of the REV1-REV7 and REV3-REV7 interactions, remains unknown. Here we show the first crystal structure of human REV7 in complex with a fragment of human REV3 polymerase (residues 1847-1898) and reveal the mechanism underlying REV7-REV3 interaction. The structure indicates that the interaction between REV7 and REV3 creates a structural interface for REV1 binding. Furthermore, we show that the REV7-mediated interactions are responsible for DNA damage tolerance. Our results highlight the function of REV7 as an adapter protein to recruit Pol zeta to a lesion site. REV7 is alternatively called MAD2B or MAD2L2 and also involved in various cellular functions such as signal transduction and cell cycle regulation. Our results will provide a general structural basis for understanding the REV7 interaction.	[Hara, Kodai; Hashimoto, Hiroshi; Unzai, Satoru; Akashi, Satoko; Shimizu, Toshiyuki; Sato, Mamoru] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Murakumo, Yoshiki] Nagoya Univ, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kobayashi, Shunsuke; Kogame, Toshiaki; Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Yokohama City University; Nagoya University; Kyoto University	Hashimoto, H (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	hash@tsurumi.yokohama-cu.ac.jp		Kogame, Toshiaki/0000-0002-0683-719X; hara, kodai/0000-0002-1586-6312; Hashimoto, Hiroshi/0000-0003-1503-6789; Akashi, Satoko/0000-0002-8978-6358	KAKENHI; Target Protein Research Programs; Yokohama Academic Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Target Protein Research Programs; Yokohama Academic Foundation	This work was supported by funding from KAKENHI, the Protein 3000 Project, and the Target Protein Research Programs (to H. H., T. S., and M. S.), and by a grant from the Yokohama Academic Foundation (to H. H.).	Acharya N, 2005, MOL CELL BIOL, V25, P9734, DOI 10.1128/MCB.25.21.9734-9740.2005; Acharya N, 2007, MOL CELL BIOL, V27, P8401, DOI 10.1128/MCB.01478-07; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; D'Souza S, 2008, DNA REPAIR, V7, P1455, DOI 10.1016/j.dnarep.2008.05.009; D'Souza S, 2006, MOL CELL BIOL, V26, P8173, DOI 10.1128/MCB.00202-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito G, 2000, CURR BIOL, V10, P1221, DOI 10.1016/S0960-9822(00)00726-0; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Hara K, 2009, ACTA CRYSTALLOGR F, V65, P1302, DOI 10.1107/S1744309109046181; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Hong CF, 2009, J BIOL CHEM, V284, P19613, DOI 10.1074/jbc.M109.005017; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAWRENCE CW, 1979, GENETICS, V92, P397; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; LAWRENCE CW, 1985, MOL GEN GENET, V200, P80, DOI 10.1007/BF00383316; LAWRENCE CW, 1982, MOL GEN GENET, V186, P1, DOI 10.1007/BF00422904; Lin WS, 1999, NUCLEIC ACIDS RES, V27, P4468, DOI 10.1093/nar/27.22.4468; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Masuda Y, 2003, J BIOL CHEM, V278, P12356, DOI 10.1074/jbc.M211765200; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Murakumo Y, 2002, MUTAT RES-FUND MOL M, V510, P37, DOI 10.1016/S0027-5107(02)00250-6; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Ohmori H, 2004, ADV PROTEIN CHEM, V69, P265; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Okada T, 2005, MOL CELL BIOL, V25, P6103, DOI 10.1128/MCB.25.14.6103-6111.2005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaisman A, 2004, ADV PROTEIN CHEM, V69, P205; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Zhang L, 2007, MOL CELL BIOL, V27, P2861, DOI 10.1128/MCB.02276-06	55	91	95	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12299	12307		10.1074/jbc.M109.092403	http://dx.doi.org/10.1074/jbc.M109.092403			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164194	hybrid, Green Published			2022-12-25	WOS:000276787100059
J	Osakabe, A; Tachiwana, H; Matsunaga, T; Shiga, T; Nozawa, RS; Obuse, C; Kurumizaka, H				Osakabe, Akihisa; Tachiwana, Hiroaki; Matsunaga, Takaaki; Shiga, Tatsuya; Nozawa, Ryu-Suke; Obuse, Chikashi; Kurumizaka, Hitoshi			Nucleosome Formation Activity of Human Somatic Nuclear Autoantigenic Sperm Protein (sNASP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 VARIANTS; XENOPUS-LAEVIS OOCYTES; ASSEMBLY FACTOR-I; CENP-A; STRUCTURAL BASIS; CELL-CYCLE; MAMMALIAN-CELLS; BINDING PROTEIN; DNA-SYNTHESIS; CHROMATIN	NASP (nuclear autoantigenic sperm protein) is a member of the N1/N2 family, which is widely conserved among eukaryotes. Human NASP reportedly prefers to bind to histones H3.H4 and the linker histone H1, as compared with H2A.H2B, and is anticipated to function as an H3.H4 chaperone for nucleosome assembly. However, the direct nucleosome assembly activity of human NASP has not been reported so far. In humans, two spliced isoforms, somatic and testicular NASPs (sNASP and tNASP, respectively) were identified. In the present study we purified human sNASP and found that sNASP efficiently promoted the assembly of nucleosomes containing the conventional H3.1, H3.2, H3.3, or centromere-specific CENP-A. On the other hand, sNASP inefficiently promoted nucleosome assembly with H3T, a testis-specific H3 variant. Mutational analyses revealed that the Met-71 residue of H3T is responsible for this inefficient nucleosome formation by sNASP. Tetrasomes, composed of the H3.H4 tetramer and DNA without H2A.H2B, were efficiently formed by the sNASP-mediated nucleosome-assembly reaction. A deletion analysis of sNASP revealed that the central region, amino acid residues 26-325, of sNASP is responsible for nucleosome assembly in vitro. These experiments are the first demonstration that human NASP directly promotes nucleosome assembly and provide compelling evidence that sNASP is a bona fide histone chaperone for H3.H4.	[Nozawa, Ryu-Suke; Obuse, Chikashi] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan; [Kurumizaka, Hitoshi] Waseda Univ, Struct Biol Lab, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan	Hokkaido University; Waseda University	Kurumizaka, H (corresponding author), Waseda Res Inst Sci & Engn, Tokyo, Japan.	kurumizaka@waseda.jp	Tachiwana, Hiroaki/AHB-3091-2022; Obuse, Chikashi/F-5273-2011	Tachiwana, Hiroaki/0000-0001-9227-7653; Osakabe, Akihisa/0000-0002-2526-3398; Kurumizaka, Hitoshi/0000-0001-7412-3722	Japanese Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid from the Japanese Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology, Japan.; Supported by Japanese Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists (a JSPS Research Fellow).	Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Alekseev OM, 2003, J BIOL CHEM, V278, P8846, DOI 10.1074/jbc.M210352200; Andrews AJ, 2008, J BIOL CHEM, V283, P32412, DOI 10.1074/jbc.M805918200; Antczak AJ, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-26; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Finn RM, 2008, BIOPHYS J, V95, P1314, DOI 10.1529/biophysj.108.130021; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Hu RJ, 1996, HUM MOL GENET, V5, P1743, DOI 10.1093/hmg/5.11.1743; ISHIMI Y, 1984, EUR J BIOCHEM, V142, P431, DOI 10.1111/j.1432-1033.1984.tb08305.x; ISHIMI Y, 1983, J BIOCHEM-TOKYO, V94, P735, DOI 10.1093/oxfordjournals.jbchem.a134414; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jin JJ, 2005, TRENDS BIOCHEM SCI, V30, P680, DOI 10.1016/j.tibs.2005.10.003; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Kamakaka RT, 1996, MOL CELL BIOL, V16, P810; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; KLEINSCHMIDT J, 1986, EMBO J, V5, P3547, DOI 10.1002/j.1460-2075.1986.tb04681.x; KLEINSCHMIDT JA, 1982, CELL, V29, P799, DOI 10.1016/0092-8674(82)90442-1; KLEINSCHMIDT JA, 1985, J BIOL CHEM, V260, P1166; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; McBryant SJ, 2003, J BIOL CHEM, V278, P44574, DOI 10.1074/jbc.M305636200; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Okuwaki M, 2005, MOL CELL BIOL, V25, P10639, DOI 10.1128/MCB.25.23.10639-10651.2005; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Polo SE, 2006, CURR OPIN GENET DEV, V16, P104, DOI 10.1016/j.gde.2006.02.011; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Richardson RT, 2006, J BIOL CHEM, V281, P21526, DOI 10.1074/jbc.M603816200; Richardson RT, 2000, J BIOL CHEM, V275, P30378, DOI 10.1074/jbc.M003781200; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Tachiwana H, 2008, NUCLEIC ACIDS RES, V36, P2208, DOI 10.1093/nar/gkn060; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; Wang HY, 2008, NUCLEIC ACIDS RES, V36, P5763, DOI 10.1093/nar/gkn574	54	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11913	11921		10.1074/jbc.M109.083238	http://dx.doi.org/10.1074/jbc.M109.083238			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20167597	Green Published, hybrid			2022-12-25	WOS:000276787100019
J	Cornu, M; Modi, H; Kawamori, D; Kulkarni, RN; Joffraud, M; Thorens, B				Cornu, Marion; Modi, Honey; Kawamori, Dan; Kulkarni, Rohit N.; Joffraud, Magali; Thorens, Bernard			Glucagon-like Peptide-1 Increases beta-Cell Glucose Competence and Proliferation by Translational Induction of Insulin-like Growth Factor-1 Receptor Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CAMP; SECRETION; EXOCYTOSIS; HORMONES; MASS; SURVIVAL; LOCALIZATION; PANCREAS; RELEASE	Glucagon-like peptide-1 (GLP-1) protects beta-cells against apoptosis, increases their glucose competence, and induces their proliferation. We previously demonstrated that the antiapoptotic effect was mediated by an increase in insulin-like growth factor-1 receptor (IGF-1R) expression and signaling, which was dependent on autocrine secretion of insulin-like growth factor 2 (IGF-2). Here, we further investigated how GLP-1 induces IGF-1R expression and whether the IGF-2/IGF-1R autocrine loop is also involved in mediating GLP-1-increase in glucose competence and proliferation. We show that GLP-1 up-regulated IGF-1R expression by a protein kinase Adependent translational control mechanism, whereas isobutylmethylxanthine, which led to higher intracellular accumulation of cAMP than GLP-1, increased both IGF-1R transcription and translation. We then demonstrated, using MIN6 cells and primary islets, that the glucose competence of these cells was dependent on the level of IGF-1R expression and on IGF-2 secretion. We showed that GLP-1-induced primary beta-cell proliferation was suppressed by Igf-1r gene inactivation and by IGF-2 immunoneutralization or knockdown. Together our data show that regulation of beta-cell number and function by GLP-1 depends on the cAMP/protein kinase A mediated-induction of IGF-1R expression and the increased activity of an IGF-2/ IGF-1R autocrine loop.	[Cornu, Marion; Modi, Honey; Joffraud, Magali; Thorens, Bernard] Univ Lausanne, Dept Physiol, CH-1015 Lausanne, Switzerland; [Cornu, Marion; Modi, Honey; Joffraud, Magali; Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Kawamori, Dan; Kulkarni, Rohit N.] Joslin Diabet Ctr, Dept Cellular & Mol Physiol, Boston, MA 02215 USA; [Kawamori, Dan; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Boston, MA 02139 USA	University of Lausanne; University of Lausanne; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Thorens, B (corresponding author), Univ Lausanne, Dept Physiol, Genopode Bldg, CH-1015 Lausanne, Switzerland.	Bernard.Thorens@unil.ch			National Institutes of Health [RO1 DK67536]; Swiss National Science Foundation [31003A-113525]; Juvenile Diabetes Research Foundation [7-2005-1158]; European Community [LSHM-CT-2006 518153]; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Community(European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK67536 (to R. N. K.). This work was also supported by Swiss National Science Foundation Grant 31003A-113525, Juvenile Diabetes Research Foundation Program Project 7-2005-1158, the Integrated Project Eurodia LSHM-CT-2006 518153 Framework Programme 6 of the European Community (to B. T.), and a Juvenile Diabetes Research Foundation Fellowship (to D. K.).	Abderrahmani A, 2006, EMBO J, V25, P977, DOI 10.1038/sj.emboj.7601008; Arnette D, 2003, J BIOL CHEM, V278, P32517, DOI 10.1074/jbc.M301174200; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buchanan CM, 2001, BIOCHEM J, V360, P431, DOI 10.1042/0264-6021:3600431; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Buteau J, 2006, DIABETES, V55, P1190, DOI 10.2337/db05-0825; CHRISTOFORI G, 1995, NAT GENET, V10, P196, DOI 10.1038/ng0695-196; Cornu M, 2009, DIABETES, V58, P1816, DOI 10.2337/db09-0063; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Egan JM, 2003, DIABETES-METAB RES, V19, P115, DOI 10.1002/dmrr.357; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Hoog A, 1997, ULTRASTRUCT PATHOL, V21, P457, DOI 10.3109/01913129709021946; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Klinger S, 2008, DIABETES, V57, P584, DOI 10.2337/db07-1414; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; MAAKE C, 1993, CELL TISSUE RES, V273, P249, DOI 10.1007/BF00312826; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Perfetti R, 2000, ENDOCRINOLOGY, V141, P4600, DOI 10.1210/en.141.12.4600; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P824, DOI 10.1210/endo-117-3-824; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; SCHUIT FC, 1985, ENDOCRINOLOGY, V117, P834, DOI 10.1210/endo-117-3-834; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; WIDMANN C, 1994, MOL PHARMACOL, V45, P1029; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276	36	68	77	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10538	10545		10.1074/jbc.M109.091116	http://dx.doi.org/10.1074/jbc.M109.091116			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20145256	hybrid, Green Published			2022-12-25	WOS:000276264600040
J	Ferencko, L; Rotman, B				Ferencko, Linda; Rotman, Boris			Constructing Fluorogenic Bacillus Spores (F-Spores) via Hydrophobic Decoration of Coat Proteins	PLOS ONE			English	Article							GERMINATION; SUBTILIS	Background: Bacterial spores are protected by a coat consisting of about 60 different proteins assembled as a biochemically complex structure with intriguing morphological and mechanical properties. Historically, the coat has been considered a static structure providing rigidity and mainly acting as a sieve to exclude exogenous large toxic molecules, such as lytic enzymes. Over recent years, however, new information about the coat's architecture and function have emerged from experiments using innovative tools such as automated scanning microscopy, and high resolution atomic force microscopy. Principal Findings: Using thin-section electron microscopy, we found that the coat of Bacillus spores has topologically specific proteins forming a layer that is identifiable because it spontaneously becomes decorated with hydrophobic fluorogenic probes from the milieu. Moreover, spores with decorated coat proteins (termed F-spores) have the unexpected attribute of responding to external germination signals by generating intense fluorescence. Fluorescence data from diverse experimental designs, including F-spores constructed from five different Bacilli species, indicated that the fluorogenic ability of F-spores is under control of a putative germination-dependent mechanism. Conclusions: This work uncovers a novel attribute of spore-coat proteins that we exploited to decorate a specific layer imparting germination-dependent fluorogenicity to F-spores. We expect that F-spores will provide a model system to gain new insights into structure/function dynamics of spore-coat proteins.	[Ferencko, Linda; Rotman, Boris] BCR Diagnost, Jamestown, RI USA; [Rotman, Boris] Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02912 USA	Brown University	Ferencko, L (corresponding author), BCR Diagnost, Jamestown, RI USA.	b_rotman@brown.edu			National Institutes of Health [HL070360]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL070360, R43HL070360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a National Institutes of Health Grant HL070360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chada VGR, 2003, J BACTERIOL, V185, P6255, DOI 10.1128/JB.185.21.6255-6261.2003; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; DOYLE RJ, 1984, CURR MICROBIOL, V10, P329, DOI 10.1007/BF01626560; Driks A, 2003, P NATL ACAD SCI USA, V100, P3007, DOI 10.1073/pnas.0730807100; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; Ferencko L, 2004, BIOCHEM BIOPH RES CO, V319, P854, DOI 10.1016/j.bbrc.2004.05.062; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; HACHISUKA YOETSU, 1955, JOUR BACT, V69, P399; Haugland R.P., 2005, INVITROGEN MOL PROBE, V10th; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Jagtap P, 2006, PROTEOMICS, V6, P5199, DOI 10.1002/pmic.200600314; Kim H, 2006, MOL MICROBIOL, V59, P487, DOI 10.1111/j.1365-2958.2005.04968.x; Lavis LD, 2008, ACS CHEM BIOL, V3, P203, DOI 10.1021/cb800065s; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Magge A, 2009, J APPL MICROBIOL, V106, P814, DOI 10.1111/j.1365-2672.2008.04048.x; Moir A, 2006, J APPL MICROBIOL, V101, P526, DOI 10.1111/j.1365-2672.2006.02885.x; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Paidhungat M, 2001, J BACTERIOL, V183, P4886, DOI 10.1128/JB.183.16.4886-4893.2001; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Piggot P, 2002, BACILLUS SUBTILIS IT, P483; Plomp M, 2007, P NATL ACAD SCI USA, V104, P9644, DOI 10.1073/pnas.0610626104; Ricca Ezio, 2003, J Nanobiotechnology, V1, P6, DOI 10.1186/1477-3155-1-6; ROBINOW CF, 1953, J BACTERIOL, V66, P300, DOI 10.1128/JB.66.3.300-311.1953; ROTMAN B, 1963, P NATL ACAD SCI USA, V50, P1; ROTMAN B, 1966, P NATL ACAD SCI USA, V55, P134, DOI 10.1073/pnas.55.1.134; ROTMAN B, 1995, CELL VISION, V2, P145; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; SETLOW P, 1969, J BACTERIOL, V100, P1155, DOI 10.1128/JB.100.3.1155-1160.1969; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Wang R, 2007, LANGMUIR, V23, P10230, DOI 10.1021/la701788d; Westphal AJ, 2003, P NATL ACAD SCI USA, V100, P3461, DOI 10.1073/pnas.232710999; WIENCEK KM, 1990, APPL ENVIRON MICROB, V56, P2600, DOI 10.1128/AEM.56.9.2600-2605.1990; Xu ZH, 1998, J STRUCT BIOL, V124, P129, DOI 10.1006/jsbi.1998.4060; ZHANG J, 1993, J BACTERIOL, V175, P3757, DOI 10.1128/JB.175.12.3757-3766.1993	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9283	10.1371/journal.pone.0009283	http://dx.doi.org/10.1371/journal.pone.0009283			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174569	Green Submitted, gold, Green Published			2022-12-25	WOS:000274923700004
J	Radhika, V; Kost, C; Boland, W; Heil, M				Radhika, Venkatesan; Kost, Christian; Boland, Wilhelm; Heil, Martin			The Role of Jasmonates in Floral Nectar Secretion	PLOS ONE			English	Article							BEAN PHASEOLUS-LUNATUS; BRASSICA-NAPUS L; ARABIDOPSIS-THALIANA; MACARANGA-TANARIUS; PLANT-RESPONSES; WOUND RESPONSE; ACID TREATMENT; GENE ENCODES; INDUCTION; DEFENSE	Plants produce nectar in their flowers as a reward for their pollinators and most of our crops depend on insect pollination, but little is known on the physiological control of nectar secretion. Jasmonates are well-known for their effects on senescence, the development and opening of flowers and on plant defences such as extrafloral nectar. Their role in floral nectar secretion has, however, not been explored so far. We investigated whether jasmonates have an influence on floral nectar secretion in oil-seed rape, Brassica napus. The floral tissues of this plant produced jasmonic acid (JA) endogenously, and JA concentrations peaked shortly before nectar secretion was highest. Exogenous application of JA to flowers induced nectar secretion, which was suppressed by treatment with phenidone, an inhibitor of JA synthesis. This effect could be reversed by additional application of JA. Jasmonoyl-isoleucine and its structural mimic coronalon also increased nectar secretion. Herbivory or addition of JA to the leaves did not have an effect on floral nectar secretion, demonstrating a functional separation of systemic defence signalling from reproductive nectar secretion. Jasmonates, which have been intensively studied in the context of herbivore defences and flower development, have a profound effect on floral nectar secretion and, thus, pollination efficiency in B. napus. Our results link floral nectar secretion to jasmonate signalling and thereby integrate the floral nectar secretion into the complex network of oxylipid-mediated developmental processes of plants.	[Radhika, Venkatesan; Kost, Christian; Boland, Wilhelm] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany; [Heil, Martin] CINVESTAV, Dept Ingn Genet, Guanajuato, Mexico	Max Planck Society; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Radhika, V (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany.	mheil@ira.cinvestav.mx	Heil, Martin/I-1797-2012; Heil, Martin/AAC-2730-2022; Kost, Christian/N-1553-2014	Kost, Christian/0000-0002-7870-7343; Heil, Martin/0000-0001-8036-8697	Max Planck Society; International Max Planck Research School (IMPRS); CONACYT (Consejo Nacional de Ciencia y Tecnologi-a de Mexico)	Max Planck Society(Max Planck Society); International Max Planck Research School (IMPRS); CONACYT (Consejo Nacional de Ciencia y Tecnologi-a de Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Financial support came from the Max Planck Society, the International Max Planck Research School (IMPRS) and CONACYT (Consejo Nacional de Ciencia y Tecnologi-a de Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHTOVA JTP, 1994, BIOL PLANTARUM, V36, P317, DOI 10.1007/BF02921108; Baker H.G., 1983, P117; BARENDSE GWM, 1985, BIOL PLANTARUM, V27, P408, DOI 10.1007/BF02879889; Bruinsma M, 2008, ENTOMOL EXP APPL, V128, P109, DOI 10.1111/j.1570-7458.2008.00695.x; Bruinsma M, 2010, OECOLOGIA, V162, P393, DOI 10.1007/s00442-009-1459-x; Castellanos MC, 2002, AM J BOT, V89, P111, DOI 10.3732/ajb.89.1.111; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2009, FEBS J, V276, P4682, DOI 10.1111/j.1742-4658.2009.07194.x; CUCUROU C, 1991, BIOCHEMISTRY-US, V30, P8964, DOI 10.1021/bi00101a008; Davis SJ, 2009, PLANT CELL ENVIRON, V32, P1201, DOI 10.1111/j.1365-3040.2009.01968.x; Devoto A, 2003, ANN BOT-LONDON, V92, P329, DOI 10.1093/aob/mcg151; EISIKOWITCH D, 1981, J AGR SCI, V96, P321, DOI 10.1017/S0021859600066107; Farkas A., 2007, EUR J PLANT SCI BIOT, V1, P125; Fischer E., 2006, Braz. J. Biol., V66, P747, DOI 10.1590/S1519-69842006000400019; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Gols R, 2003, J CHEM ECOL, V29, P2651, DOI 10.1023/B:JOEC.0000008010.40606.b0; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Hause B, 2000, PLANT J, V24, P113, DOI 10.1046/j.1365-313x.2000.00861.x; Heil M, 2004, J ECOL, V92, P527, DOI 10.1111/j.0022-0477.2004.00890.x; Heil M, 2001, P NATL ACAD SCI USA, V98, P1083, DOI 10.1073/pnas.031563398; Heil M, 2000, FUNCT ECOL, V14, P749, DOI 10.1046/j.1365-2435.2000.00480.x; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Higginson AD, 2006, ECOL ENTOMOL, V31, P269, DOI 10.1111/j.1365-2311.2006.00789.x; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Izaguirre MM, 2006, P NATL ACAD SCI USA, V103, P7170, DOI 10.1073/pnas.0509805103; KEVAN PG, 1990, EUPHYTICA, V45, P39; Krajncic B, 2006, PLANT PHYSIOL BIOCH, V44, P752, DOI 10.1016/j.plaphy.2006.10.029; Krumm T, 1995, FEBS LETT, V377, P523, DOI 10.1016/0014-5793(95)01398-9; Maciejewska BD, 2004, PLANT GROWTH REGUL, V43, P1, DOI 10.1023/B:GROW.0000038241.00771.bd; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Moreno JE, 2009, P NATL ACAD SCI USA, V106, P4935, DOI 10.1073/pnas.0900701106; Nepi M, 2001, INT J PLANT SCI, V162, P353, DOI 10.1086/319581; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Pacini E, 2003, PLANT SYST EVOL, V238, P7, DOI 10.1007/s00606-002-0277-y; Pacini Ettore, 2007, P167, DOI 10.1007/978-1-4020-5937-7_4; Pak HS, 2009, PLANTA, V231, P79, DOI 10.1007/s00425-009-1029-9; Pierre J, 1999, PLANT BREEDING, V118, P471, DOI 10.1046/j.1439-0523.1999.00421.x; Ruhlmann JM, 2010, J EXP BOT, V61, P395, DOI 10.1093/jxb/erp309; Sanders PM, 2000, PLANT CELL, V12, P1041, DOI 10.1105/tpc.12.7.1041; Schilmiller AL, 2005, CURR OPIN PLANT BIOL, V8, P369, DOI 10.1016/j.pbi.2005.05.008; Schuler G, 2004, FEBS LETT, V563, P17, DOI 10.1016/S0014-5793(04)00239-X; Schulze B, 2006, ANAL BIOCHEM, V348, P269, DOI 10.1016/j.ab.2005.10.021; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thorpe MR, 2007, PLANTA, V226, P541, DOI 10.1007/s00425-007-0503-5; van Poecke RMP, 2004, PLANT BIOLOGY, V6, P387, DOI 10.1055/s-2004-820887; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wasternack C, 2006, J PLANT PHYSIOL, V163, P297, DOI 10.1016/j.jplph.2005.10.014; WEILER EW, 1994, FEBS LETT, V345, P9, DOI 10.1016/0014-5793(94)00411-0; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; [No title captured]	51	57	57	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9265	10.1371/journal.pone.0009265	http://dx.doi.org/10.1371/journal.pone.0009265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174464	gold, Green Published, Green Submitted			2022-12-25	WOS:000274923700002
J	Yu, H; Yuan, Q; Ge, SX; Wang, HY; Zhang, YL; Chen, QR; Zhang, J; Chen, PJ; Xia, NS				Yu, Hai; Yuan, Quan; Ge, Sheng-Xiang; Wang, Hurng-Yi; Zhang, Ya-Li; Chen, Qing-Rui; Zhang, Jun; Chen, Pei-Jer; Xia, Ning-Shao			Molecular and Phylogenetic Analyses Suggest an Additional Hepatitis B Virus Genotype "I''	PLOS ONE			English	Article							SURFACE-ANTIGEN; MOUSE MODEL; VIRAL-DNA; STRAINS; SUBTYPE; GENOMES	A novel hepatitis B virus (HBV) strain (W29) was isolated from serum samples in the northwest of China. Phylogenetic and distance analyses indicate that this strain is grouped with a series of distinct strains discovered in Vietnam and Laos that have been proposed to be a new genotype I. TreeOrderScan and GroupScan methods were used to study the intergenotype recombination of this special group. Recombination plots and tree maps of W29 and these putative genotype I strains exhibit distinct characteristics that are unexpected in typical genotype C strains of HBV. The amino acids of P gene, S gene, X gene, and C gene of all genotypes (including subtypes) were compared, and eight unique sites were found in genotype I. In vitro and in vivo experiments were also conducted to determine phenotypic characteristics between W29 and other representative strains of different genotypes obtained from China. Secretion of HBsAg in Huh7 cells is uniformly abundant among genotypes A, B, C, and I (W29), but not genotype D. HBeAg secretion is low in genotype I (W29), whose level is close to genotype A and much lower than genotypes B, C, and D. Results from the acute hydrodynamic injection mouse model also exhibit a similar pattern. From an overview of the results, the viral markers of W29 (I1) in Huh7 cells and mice had a more similar level to genotype A than genotype C, although the latter was closer to W29 in distance analysis. All evidence suggests that W29, together with other related strains found in Vietnam and Laos, should be classified into a new genotype.	[Yu, Hai; Yuan, Quan; Ge, Sheng-Xiang; Zhang, Ya-Li; Chen, Qing-Rui; Zhang, Jun; Xia, Ning-Shao] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China; [Wang, Hurng-Yi; Chen, Pei-Jer] Natl Taiwan Univ & Hosp, Grad Inst Clin Med, Taipei, Taiwan	Xiamen University; National Taiwan University; National Taiwan University Hospital	Yu, H (corresponding author), Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China.	zhangj@xmu.edu.cn	Xia, NS/G-4647-2010; Zhang, Jun/G-4598-2010; Ge, Shengxiang/Q-2256-2019	Zhang, Jun/0000-0002-6601-9180; Ge, Shengxiang/0000-0002-7165-3004; WANG, HURNG-YI/0000-0003-1708-8734; yuan, quan/0000-0001-5487-561X; Chen, Pei-Jer/0000-0001-8316-3785; Xia, Ningshao/0000-0003-0179-5266	National Scientific and Technological Major Project [2008ZX10002-012]; Excellent Youth Foundation of Fujian Province [2009J06020]	National Scientific and Technological Major Project; Excellent Youth Foundation of Fujian Province	This work was supported by a grant from the National Scientific and Technological Major Project (2008ZX10002-012), and a grant from the Excellent Youth Foundation of Fujian Province (2009J06020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS G, 1987, P NATL ACAD SCI USA, V84, P4641, DOI 10.1073/pnas.84.13.4641; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Colson P, 2009, J CLIN VIROL, V45, P165, DOI 10.1016/j.jcv.2009.03.007; GERBER MA, 1988, LAB INVEST, V59, P173; GUNTHER S, 1995, J VIROL, V69, P5437; Hannoun C, 2000, J GEN VIROL, V81, P2267, DOI 10.1099/0022-1317-81-9-2267; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurbanov F, 2008, J VIROL, V82, P8241, DOI 10.1128/JVI.00793-08; NORDER H, 1992, J GEN VIROL, V73, P3141, DOI 10.1099/0022-1317-73-12-3141; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; OKAMOTO H, 1987, J VIROL, V61, P3030, DOI 10.1128/JVI.61.10.3030-3034.1987; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Olinger CM, 2008, EMERG INFECT DIS, V14, P1777, DOI 10.3201/eid1411.080437; Schaefer S, 2005, J VIRAL HEPATITIS, V12, P111, DOI 10.1111/j.1365-2893.2005.00584.x; Schaefer S, 2009, INTERVIROLOGY, V52, P323, DOI 10.1159/000242353; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Stuyver L, 2000, J GEN VIROL, V81, P67, DOI 10.1099/0022-1317-81-1-67; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599	26	103	110	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9297	10.1371/journal.pone.0009297	http://dx.doi.org/10.1371/journal.pone.0009297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174575	Green Submitted, Green Published, gold			2022-12-25	WOS:000274923700008
J	Ben Hamida-Rebai, M; Robert, CH				Ben Hamida-Rebai, Meriam; Robert, Charles H.			A Computational Study of a Recreated G Protein-GEF Reaction Intermediate Competent for Nucleotide Exchange: Fate of the Mg Ion	PLOS ONE			English	Article							ELONGATION-FACTOR TU; MOLECULAR-DYNAMICS; ADP-RIBOSYLATION; SEC7 DOMAINS; FREE-ENERGY; CONFORMATIONAL STATES; ARF ACTIVATION; ATOMIC RADII; BREFELDIN-A; FACTOR ARNO	Small G-proteins of the superfamily Ras function as molecular switches, interacting with different cellular partners according to their activation state. G-protein activation involves the dissociation of bound GDP and its replacement by GTP, in an exchange reaction that is accelerated and regulated in the cell by guanine-nucleotide exchange factors (GEFs). Large conformational changes accompany the exchange reaction, and our understanding of the mechanism is correspondingly incomplete. However, much knowledge has been derived from structural studies of blocked or inactive mutant GEFs, which presumably closely represent intermediates in the exchange reaction and yet which are by design incompetent for carrying out the nucleotide exchange reaction. In this study we have used comparative modelling to recreate an exchange-competent form of a late, pre-GDP-ejection intermediate species in Arf1, a well-characterized small G-protein. We extensively characterized three distinct models of this intermediate using molecular dynamics simulations, allowing us to address ambiguities related to the mutant structural studies. We observed in particular the unfavorable nature of Mg2+ associated forms of the complex and the establishment of closer Arf1-GEF contacts in its absence. The results of this study shed light on GEF-mediated activation of this small G protein and on predicting the fate of the Mg ion at a critical point in the exchange reaction. The structural models themselves furnish additional targets for interfacial inhibitor design, a promising direction for exploring potentially druggable targets with high biological specificity.	[Ben Hamida-Rebai, Meriam; Robert, Charles H.] Univ Paris 11, CNRS, IBBMC, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Ben Hamida-Rebai, M (corresponding author), Univ Paris 11, CNRS, IBBMC, F-91405 Orsay, France.	robert@ibpc.fr		Robert, Charles/0000-0003-0337-1504	French Centre Nationale de la Recherche Scientifique (CNRS); French Ministry of Education; IDRIS facility of the CNRS; Universite Paris Sud 11 (Orsay) Pluriformation Project DEMAIN	French Centre Nationale de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Education; IDRIS facility of the CNRS; Universite Paris Sud 11 (Orsay) Pluriformation Project DEMAIN	Funding for this study was provided by the French Centre Nationale de la Recherche Scientifique (CNRS) and the French Ministry of Education. Computational resources were provided by the IDRIS facility of the CNRS and by the Universite Paris Sud 11 (Orsay) Pluriformation Project DEMAIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov A, 2008, BIOCHEMISTRY-US, V47, P13594, DOI 10.1021/bi801726q; Alto NM, 2008, CELL MICROBIOL, V10, P566, DOI 10.1111/j.1462-5822.2007.01110.x; AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301; Banavali NK, 2002, J PHYS CHEM B, V106, P11026, DOI 10.1021/jp025852v; Beck DAC, 2005, BIOCHEMISTRY-US, V44, P609, DOI 10.1021/bi0486381; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Carlson HA, 1999, J MED CHEM, V42, P109, DOI 10.1021/jm980351c; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cavalli A, 2001, PROTEINS, V45, P478, DOI 10.1002/prot.10013; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; Faure J, 2004, CURR BIOL, V14, P1056, DOI 10.1016/j.cub.2004.06.021; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Grubmuller H., 1996, SOLVATE 1 0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; KAHN RA, 1984, J BIOL CHEM, V259, P6228; Kremer W, 2004, J BIOL CHEM, V279, P17004, DOI 10.1074/jbc.M312780200; Liao JC, 2004, EUR BIOPHYS J BIOPHY, V33, P29, DOI 10.1007/s00249-003-0339-2; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; Mayaan E, 2007, J COMPUT CHEM, V28, P495, DOI 10.1002/jcc.20474; Menetrey J, 2000, NAT STRUCT BIOL, V7, P466; Mori K, 2005, J AM CHEM SOC, V127, P15127, DOI 10.1021/ja0467972; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Nina M, 1999, BIOPHYS CHEM, V78, P89, DOI 10.1016/S0301-4622(98)00236-1; Pan JY, 1996, J BIOL CHEM, V271, P1322, DOI 10.1074/jbc.271.3.1322; Peng YY, 2005, J MOL GRAPH MODEL, V24, P72, DOI 10.1016/j.jmgm.2005.06.002; Pommier Y, 2005, TRENDS PHARMACOL SCI, V26, P138, DOI 10.1016/j.tips.2005.01.008; Reblova K, 2006, BIOPOLYMERS, V82, P504, DOI 10.1002/bip.20503; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Renault L, 2002, BIOCHEMISTRY-US, V41, P3605, DOI 10.1021/bi012123h; Robert CH, 2004, J MOL BIOL, V337, P969, DOI 10.1016/j.jmb.2004.01.052; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schimmoller F, 1997, CURR BIOL, V7, pR235, DOI 10.1016/S0960-9822(06)00109-6; Schummer T, 2007, BIOCHEMISTRY-US, V46, P4977, DOI 10.1021/bi602486c; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wong S, 2009, J CHEM THEORY COMPUT, V5, P422, DOI 10.1021/ct8003707; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200; Zeeh JC, 2008, METHOD ENZYMOL, V438, P41, DOI 10.1016/S0076-6879(07)38004-X	56	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9142	10.1371/journal.pone.0009142	http://dx.doi.org/10.1371/journal.pone.0009142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174625	Green Published, gold, Green Submitted			2022-12-25	WOS:000274654700005
J	Kujjo, LL; Laine, T; Pereira, RJG; Kagawa, W; Kurumizaka, H; Yokoyama, S; Perez, GI				Kujjo, Loro L.; Laine, Tiina; Pereira, Ricardo J. G.; Kagawa, Wataru; Kurumizaka, Hitoshi; Yokoyama, Shigeyuki; Perez, Gloria I.			Enhancing Survival of Mouse Oocytes Following Chemotherapy or Aging by Targeting Bax and Rad51	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; GENE-EXPRESSION; DNA-DAMAGE; GERM-CELLS; AGED MICE; IN-VITRO; C-ABL; APOPTOSIS; DEATH; OVEREXPRESSION	Background: Therapeutic approaches to preserve fertility in females undergoing cancer treatments are currently ineffective. This is partly due to limited knowledge of the molecular mechanisms that injured germ cells elicit to repair damage and survive or to abort repair and activate biochemical pathways leading to death. So far, we know that following spontaneously occurring or drug-induced DNA damage, the efficiency of DNA repair is a critical determinant of the cell's fate. The protein encoded by the Rad51 gene is one of several components recruited for homologous recombination-dependent DNA double-strand break repair in both somatic cells and germ cells. Recently, we showed that microinjection of recombinant Rad51 into AKR/J mouse oocytes decreased the extent of spontaneous DNA double-strand breaks, suppressed apoptosis, and restored the developmental competence in AKR/J embryos. Herein we characterized the nature of chemotherapy-induced lesions in oocytes, and the associated individual components of the DNA damage sensor and repair apparatus. For comparison, we also assessed parallel spontaneous changes in aging oocytes. Methods: Data collected were derived from: analysis of apoptosis; immunodepletion; oocyte microinjections; immunocytochemistry; immunofluorescence; and CHIP-like assays. Results: Our data show that: (i) DNA damage in oocytes can be induced by both chemotherapy and spontaneously by the aging process; (ii) oocytes possess the machinery and capability for repairing such DNA damage; (iii) Rad51 is a critical player in the repair of both chemotherapy-induced and spontaneously-sustained DNA damage; and (iv) in response to damage, oocytes exhibit an inverse functional relationship between presence of Bax and activity of Rad51. Conclusion/Significance: Our results establish Rad51 and/or Bax as potential candidates that can be targeted for development of individualized chemotherapeutic interventions that are effective, but minimal in toxicity. The use of Rad51 and Bax modulating compounds could offer women the opportunity to maintain fully functional germ cells despite cancer treatments or aging.	[Kujjo, Loro L.; Pereira, Ricardo J. G.; Perez, Gloria I.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Laine, Tiina] Univ Helsinki, Childrens Hosp, Program Dev & Reprod Biol, Helsinki, Finland; [Kagawa, Wataru; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Tokyo, Japan; [Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan	Michigan State University; University of Helsinki; Waseda University; RIKEN	Kujjo, LL (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	perezg@msu.edu	Perez, Gloria I/GMX-1286-2022; Pereira, Ricardo/C-7200-2012; Yokoyama, Shigeyuki/N-6911-2015	Pereira, Ricardo/0000-0003-3908-1007; Yokoyama, Shigeyuki/0000-0003-3133-7338; Kurumizaka, Hitoshi/0000-0001-7412-3722; Kagawa, Wataru/0000-0002-8801-6589	Department of Physiology at Michigan State University [05-IRGP-400 MSU]	Department of Physiology at Michigan State University	This work was supported by 05-IRGP-400 MSU and the Department of Physiology at Michigan State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Chen G, 1999, J BIOL CHEM, V274, P12748, DOI 10.1074/jbc.274.18.12748; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Dumay A, 2006, ONCOGENE, V25, P3196, DOI 10.1038/sj.onc.1209344; Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Fujino Y, 1996, HUM REPROD, V11, P1480; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Henning W, 2003, TOXICOLOGY, V193, P91, DOI 10.1016/S0300-483X(03)00291-9; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jurisicova A, 2006, CELL DEATH DIFFER, V13, P1466, DOI 10.1038/sj.cdd.4401819; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Matikainen T, 2001, ENDOCRINOLOGY, V142, P2468, DOI 10.1210/en.142.6.2468; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; Matikainen TM, 2002, ENDOCRINOLOGY, V143, P615, DOI 10.1210/en.143.2.615; Miyagawa K, 2008, CANCER SCI, V99, P187, DOI 10.1111/j.1349-7006.2007.00644.x; Morita Y, 1999, MOL ENDOCRINOL, V13, P841, DOI 10.1210/me.13.6.841; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Perez GI, 2007, CELL DEATH DIFFER, V14, P524, DOI 10.1038/sj.cdd.4402050; Perez GI, 1997, HUM REPROD, V12, P2781, DOI 10.1093/humrep/12.12.2781; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Perez GI, 1999, MOL HUM REPROD, V5, P414, DOI 10.1093/molehr/5.5.414; Perez GI, 2005, FASEB J, V19, P860, DOI 10.1096/fj.04-2903fje; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Perez GI, 2007, P NATL ACAD SCI USA, V104, P5229, DOI 10.1073/pnas.0608557104; Takai Y, 2007, APOPTOSIS, V12, P791, DOI 10.1007/s10495-006-0022-z; Tarin JJ, 2001, BIOL REPROD, V65, P141, DOI 10.1095/biolreprod65.1.141; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Tatone C, 2006, BIOL REPROD, V74, P395, DOI 10.1095/biolreprod.105.046169; Wu L, 2008, BIOESSAYS, V30, P291, DOI 10.1002/bies.20735; Yuan SSF, 2003, MUTAT RES-FUND MOL M, V525, P85, DOI 10.1016/S0027-5107(03)00009-5; Yuan ZM, 1998, J BIOL CHEM, V273, P3799, DOI 10.1074/jbc.273.7.3799	34	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9204	10.1371/journal.pone.0009204	http://dx.doi.org/10.1371/journal.pone.0009204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169201	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474600019
J	Yang, JW; Xu, J; Chen, XY; Zhang, YX; Jiang, XC; Guo, XK; Zhao, GP				Yang, Junwei; Xu, Jing; Chen, Xiaoying; Zhang, Yixuan; Jiang, Xucheng; Guo, Xiaokui; Zhao, Guoping			Decrease of Plasma Platelet-Activating Factor Acetylhydrolase Activity in Lipopolysaccharide Induced Mongolian Gerbil Sepsis Model	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ANIMAL-MODELS; EXPRESSION; LEPTOSPIROSIS; MULTICENTER; MORTALITY; MICE	Platelet-activating factor (PAF) plays an important role in the pathogenesis of sepsis, and the level of plasma PAF acetylhydrolase (pPAF-AH), which inactivates PAF, decreases in sepsis patients except for the sepsis caused by severe leptospirosis. Usually, increase of pPAF-AH activity was observed in lipopolysaccharide (LPS)-induced Syrian hamster and rat sepsis models, while contradictory effects were reported for mouse model in different studies. Here, we demonstrated the in vivo effects of LPS upon the change of pPAF-AH activity in C57BL/6 mice and Mongolian gerbils. After LPS-treatment, the clinical manifestations of Mongolian gerbil model were apparently similar to that of C57BL/6 mouse sepsis model. The pPAF-AH activity increased in C57BL/6 mice after LPS induction, but decreased in Mongolian gerbils, which was similar to that of the human sepsis. It thus suggests that among the LPS-induced rodent sepsis models, only Mongolian gerbil could be used for the study of pPAF-AH related to the pathogenesis of human sepsis. Proper application of this model might enable people to clarify the underline mechanism accounted for the contradictory results between the phase II and phase III clinical trials for the administration of recombinant human pPAF-AH in the sepsis therapy.	[Yang, Junwei; Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Yang, Junwei; Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Xu, Jing] Shanghai Inst Hlth Sci, Shanghai, Peoples R China; [Xu, Jing; Jiang, Xucheng; Guo, Xiaokui] Shanghai Jiao Tong Univ, Sch Med, Dept Med Microbiol & Parasitol, Shanghai 200030, Peoples R China; [Xu, Jing; Jiang, Xucheng; Guo, Xiaokui] Shanghai Jiao Tong Univ, Sch Med, Dept Pathol, Shanghai 200030, Peoples R China; [Chen, Xiaoying; Zhang, Yixuan] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China; [Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Lab Synthet Biol, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shenyang Pharmaceutical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yang, JW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	gpzhao@sibs.ac.cn		Zhao, Guo-Ping/0000-0002-7621-6620; Guo, Xiao-Kui/0000-0002-1595-9965	National Natural Science Foundation of China [30830002, 30970077, 30900051, 30970125, 30770111, 30770820]; National Key Program for Infectious Diseases of China [2008ZX10004-002, 2008ZX10004-009, 2009ZX10004-712]; Shanghai Leading Academic Discipline [T0206]; Shanghai Natural Science Foundation of China [062R14056]; Shanghai Municipal Education Commission and Shanghai Education Development Foundation [2007CGB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Program for Infectious Diseases of China; Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project); Shanghai Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission and Shanghai Education Development Foundation(Shanghai Municipal Education Commission (SHMEC))	This work was supported in part by grants from the National Natural Science Foundation of China (No. 30830002, 30970077, 30900051, 30970125, 30770111 and 30770820), the National Key Program for Infectious Diseases of China (No. 2008ZX10004-002, 2008ZX10004-009 and 2009ZX10004-712), and Shanghai Leading Academic Discipline Project (T0206), Shanghai Natural Science Foundation of China (No. 062R14056), Shanghai Municipal Education Commission and Shanghai Education Development Foundation ("Chen Guang'' project, 2007CGB06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Cao Y, 1998, J BIOL CHEM, V273, P4012, DOI 10.1074/jbc.273.7.4012; CHANG SW, 1987, J CLIN INVEST, V79, P1498, DOI 10.1172/JCI112980; CHAO W, 1993, BIOCHEM J, V292, P617, DOI 10.1042/bj2920617; Claus RA, 2005, CRIT CARE MED, V33, P1416, DOI 10.1097/01.CCM.0000165807.26485.ED; Fink MP, 2008, KIDNEY INT, V74, P991, DOI 10.1038/ki.2008.442; Gomes RN, 2006, SHOCK, V26, P41, DOI 10.1097/01.shk.0000209562.00070.1a; GRAHAM RM, 1994, CRIT CARE MED, V22, P204, DOI 10.1097/00003246-199402000-00009; Howard KM, 2000, J BIOL CHEM, V275, P19891, DOI 10.1074/jbc.M001462200; Howard KM, 1997, J BIOL CHEM, V272, P27543, DOI 10.1074/jbc.272.44.27543; Jeong YI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006503; Marshall JC, 2003, NAT REV DRUG DISCOV, V2, P391, DOI 10.1038/nrd1084; Memon RA, 1999, AM J PHYSIOL-REG I, V277, pR94, DOI 10.1152/ajpregu.1999.277.1.R94; Metzler M, 1999, CRIT CARE MED, V27, pA85, DOI 10.1097/00003246-199901001-00201; Opal S, 2004, CRIT CARE MED, V32, P332, DOI 10.1097/01.CCM.0000108867.87890.6D; Partrick DA, 1997, SHOCK, V7, P170, DOI 10.1097/00024382-199703000-00003; Schuster DP, 2003, CRIT CARE MED, V31, P1612, DOI 10.1097/01.CCM.0000063267.79824.DB; Stafforini DM, 1997, J BIOL CHEM, V272, P17895, DOI 10.1074/jbc.272.29.17895; Svetlov SI, 1999, HEPATOLOGY, V30, P128, DOI 10.1002/hep.510300122; Yang JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004181; Zimmerman GA, 2002, CRIT CARE MED, V30, pS294, DOI 10.1097/00003246-200205001-00020	22	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9190	10.1371/journal.pone.0009190	http://dx.doi.org/10.1371/journal.pone.0009190			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169191	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474600011
J	Naumann, U; Cameroni, E; Pruenster, M; Mahabaleshwar, H; Raz, E; Zerwes, HG; Rot, A; Thelen, M				Naumann, Ulrike; Cameroni, Elisabetta; Pruenster, Monika; Mahabaleshwar, Harsha; Raz, Erez; Zerwes, Hans-Guenter; Rot, Antal; Thelen, Marcus			CXCR7 Functions as a Scavenger for CXCL12 and CXCL11	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; CELL-MIGRATION; ENDOTHELIAL-CELLS; ACTIVATION; LIGAND; SDF-1; RDC1; INTERNALIZATION; LYMPHOPOIESIS; HEMATOPOIESIS	Background: CXCR7 (RDC1), the recently discovered second receptor for CXCL12, is phylogenetically closely related to chemokine receptors, but fails to couple to G-proteins and to induce typical chemokine receptor mediated cellular responses. The function of CXCR7 is controversial. Some studies suggest a signaling activity in mammalian cells and zebrafish embryos, while others indicate a decoy activity in fish. Here we investigated the two propositions in human tissues. Methodology/Principal Findings: We provide evidence and mechanistic insight that CXCR7 acts as specific scavenger for CXCL12 and CXCL11 mediating effective ligand internalization and targeting of the chemokine cargo for degradation. Consistently, CXCR7 continuously cycles between the plasma membrane and intracellular compartments in the absence and presence of ligand, both in mammalian cells and in zebrafish. In accordance with the proposed activity as a scavenger receptor CXCR7-dependent chemokine degradation does not become saturated with increasing ligand concentrations. Active CXCL12 sequestration by CXCR7 is demonstrated in adult mouse heart valves and human umbilical vein endothelium. Conclusions/Significance: The finding that CXCR7 specifically scavenges CXCL12 suggests a critical function of the receptor in modulating the activity of the ubiquitously expressed CXCR4 in development and tumor formation. Scavenger activity of CXCR7 might also be important for the fine tuning of the mobility of hematopoietic cells in the bone marrow and lymphoid organs.	[Naumann, Ulrike; Cameroni, Elisabetta; Thelen, Marcus] Biomed Res Inst, Bellinzona, Switzerland; [Pruenster, Monika] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Mahabaleshwar, Harsha; Raz, Erez] Univ Munster, Inst Cell Biol, Munster, Germany; [Zerwes, Hans-Guenter] Novartis Inst Biomed Res Autoimmun Transplantat &, Basel, Switzerland; [Rot, Antal] Univ Birmingham, MRC, Ctr Immune Regulat, Inst Biomed Res, Birmingham, W Midlands, England	Universita della Svizzera Italiana; University of Munich; University of Munster; Novartis; University of Birmingham	Naumann, U (corresponding author), Biomed Res Inst, Bellinzona, Switzerland.	marcus.thelen@irb.unisi.ch	Pruenster, Monika/AAV-4694-2020	Rot, Antal/0000-0002-9730-6166	Helmut Horten Foundation; Swiss National Science Foundation; European Community Framework Program 6-Network of Excellence [LSHG-CT-2003-502935]; Novartis Foundation; Roche Research Foundation; MRC [G0802838] Funding Source: UKRI; Medical Research Council [G0802838] Funding Source: researchfish	Helmut Horten Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community Framework Program 6-Network of Excellence; Novartis Foundation(Novartis); Roche Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Helmut Horten Foundation, the Swiss National Science Foundation (M.T.), and the European Community Framework Program 6-Network of Excellence Grant LSHG-CT-2003-502935. E.C. was supported by the Novartis Foundation and the Roche Research Foundation, and the Fondazione Ticinese per la Ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Comerford I, 2006, EUR J IMMUNOL, V36, P1904, DOI 10.1002/eji.200535716; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Cubedo N, 2009, MOL CELL NEUROSCI, V40, P474, DOI 10.1016/j.mcn.2009.01.003; Damaj BB, 1996, FASEB J, V10, P1426, DOI 10.1096/fasebj.10.12.8903513; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; De CE, 1994, ANTIMICROB AGENTS CH, V38, P668; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; FAGHIHI SM, 1982, J CELL SCI, V57, P115; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gerrits H, 2008, GENESIS, V46, P235, DOI 10.1002/dvg.20387; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Infantino S, 2006, J IMMUNOL, V176, P2197, DOI 10.4049/jimmunol.176.4.2197; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kayali AG, 2003, J CELL BIOL, V163, P859, DOI 10.1083/jcb.200304153; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Miyasaka N, 2007, DEVELOPMENT, V134, P2459, DOI 10.1242/dev.001958; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nibbs RJB, 2009, METHOD ENZYMOL, V460, P245, DOI 10.1016/S0076-6879(09)05212-4; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Proost P, 1998, FEBS LETT, V432, P73, DOI 10.1016/S0014-5793(98)00830-8; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Raggo C, 2005, CANCER RES, V65, P5084, DOI 10.1158/0008-5472.CAN-04-2822; Rot A, 2005, CYTOKINE GROWTH F R, V16, P687, DOI 10.1016/j.cytogfr.2005.05.011; Salcedo R, 2000, FASEB J, V14, P2055, DOI 10.1096/fj.99-0963com; Schultze-Lutter F, 2007, CLIN NEUROPSYCHIATR, V4, P11; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; SUN YX, 2008, CLIN EXP METASTASIS; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Thoma G, 2008, J MED CHEM, V51, P7915, DOI 10.1021/jm801065q; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Wolff B, 1997, ANAL BIOCHEM, V244, P33, DOI 10.1006/abio.1996.9881; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200; Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	56	343	354	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9175	10.1371/journal.pone.0009175	http://dx.doi.org/10.1371/journal.pone.0009175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161793	Green Submitted, Green Published, gold			2022-12-25	WOS:000274442800021
J	Tourino, C; Zimmer, A; Valverde, O				Tourino, Clara; Zimmer, Andreas; Valverde, Olga			THC Prevents MDMA Neurotoxicity in Mice	PLOS ONE			English	Article							RECEPTOR KNOCKOUT MICE; CORE BODY-TEMPERATURE; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; SUBSTITUTED AMPHETAMINES; CLINICAL-PHARMACOLOGY; CANNABINOID RECEPTOR; AMBIENT-TEMPERATURE; ACUTE HYPERTHERMIA; CB2 RECEPTORS; RAT-BRAIN	The majority of MDMA (ecstasy) recreational users also consume cannabis. Despite the rewarding effects that both drugs have, they induce several opposite pharmacological responses. MDMA causes hyperthermia, oxidative stress and neuronal damage, especially at warm ambient temperature. However, THC, the main psychoactive compound of cannabis, produces hypothermic, anti-inflammatory and antioxidant effects. Therefore, THC may have a neuroprotective effect against MDMAinduced neurotoxicity. Mice receiving a neurotoxic regimen of MDMA (20 mg/kg64) were pretreated with THC (3 mg/kg 64) at room (21 degrees C) and at warm (26 degrees C) temperature, and body temperature, striatal glial activation and DA terminal loss were assessed. To find out the mechanisms by which THC may prevent MDMA hyperthermia and neurotoxicity, the same procedure was carried out in animals pretreated with the CB1 receptor antagonist AM251 and the CB2 receptor antagonist AM630, as well as in CB1, CB2 and CB1/CB2 deficient mice. THC prevented A-induced-hyperthermia and glial activation in animals housed at both room and warm temperature. Surprisingly, MDMA-induced DA terminal loss was only observed in animals housed at warm but not at room temperature, and this neurotoxic effect was reversed by THC administration. However, THC did not prevent MDMA-induced hyperthermia, glial activation, and DA terminal loss in animals treated with the CB1 receptor antagonist AM251, neither in CB1 and CB1/CB2 knockout mice. On the other hand, THC prevented MDMA-induced hyperthermia and DA terminal loss, but only partially suppressed glial activation in animals treated with the CB2 cannabinoid antagonist and in CB2 knockout animals. Our results indicate that THC protects against MDMA neurotoxicity, and suggest that these neuroprotective actions are primarily mediated by the reduction of hyperthermia through the activation of CB1 receptor, although CB2 receptors may also contribute to attenuate neuroinflammation in this process.	[Tourino, Clara; Valverde, Olga] Univ Pompeu Fabra, GRNC, Dept Ciencies Expt & Salut, Barcelona, Spain; [Zimmer, Andreas] Univ Bonn, Dept Mol Psychiat, Bonn, Germany	Pompeu Fabra University; University of Bonn	Tourino, C (corresponding author), Univ Pompeu Fabra, GRNC, Dept Ciencies Expt & Salut, Barcelona, Spain.	clara.tourino@upf.edu; olga.valverde@upf.edu	Zimmer, Andreas/B-8357-2009; Valverde, Olga/D-8654-2012	Valverde, Olga/0000-0003-2264-7852	Spanish Ministry of Science and Innovation [SAF2007/60249]; Spanish Ministry of Health [RD06/0001/1001]; Department of Education and Universities from Generalitat de Catalunya; Social European Fund	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Department of Education and Universities from Generalitat de Catalunya; Social European Fund(European Social Fund (ESF))	This work was supported by the Spanish Ministry of Science and Innovation (SAF2007/60249), the Spanish Ministry of Health (PNSD and RD06/0001/1001) to OV. CT was funded with a fellowship supported by the Department of Education and Universities from Generalitat de Catalunya and by the Social European Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Cadet JL, 2007, NEUROTOX RES, V11, P183, DOI 10.1007/BF03033567; Chen YQ, 2000, J PHARMACOL EXP THER, V293, P807; Colado MI, 1997, BRIT J PHARMACOL, V121, P889, DOI 10.1038/sj.bjp.0701213; Daumann J, 2003, NEUROREPORT, V14, P1983, DOI 10.1097/00001756-200310270-00021; Di Forti M, 2007, CURR OPIN PSYCHIATR, V20, P228; Dissing-Olesen L, 2007, NEUROSCIENCE, V149, P112, DOI 10.1016/j.neuroscience.2007.06.037; FORMUKONG EA, 1988, INFLAMMATION, V12, P361, DOI 10.1007/BF00915771; Goni-Allo B, 2008, PSYCHOPHARMACOLOGY, V197, P263, DOI 10.1007/s00213-007-1027-1; Green AR, 2004, EUR J PHARMACOL, V500, P3, DOI 10.1016/j.ejphar.2004.07.006; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; GREEN AR, 1995, PSYCHOPHARMACOLOGY, V119, P247, DOI 10.1007/BF02246288; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; HEWITT KE, 1994, NEUROPHARMACOLOGY, V33, P1589, DOI 10.1016/0028-3908(94)90134-1; Indlekofer F, 2009, J PSYCHOPHARMACOL, V23, P495, DOI 10.1177/0269881108091076; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Karlsen SN, 2008, BASIC CLIN PHARMACOL, V102, P15, DOI 10.1111/j.1742-7843.2007.00159.x; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; LOGAN BJ, 1988, EUR J PHARMACOL, V152, P227, DOI 10.1016/0014-2999(88)90717-0; Malberg JE, 1998, J NEUROSCI, V18, P5086; Milani RM, 2005, HUM PSYCHOPHARM CLIN, V20, P249, DOI 10.1002/hup.684; Morley KC, 2004, NEUROPHARMACOLOGY, V46, P954, DOI 10.1016/j.neuropharm.2004.01.002; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; O'Shea E, 2001, NEUROPHARMACOLOGY, V40, P65, DOI 10.1016/S0028-3908(00)00106-4; O'Shea E, 2006, BRIT J PHARMACOL, V148, P778, DOI 10.1038/sj.bjp.0706783; OCALLAGHAN JP, 1994, J PHARMACOL EXP THER, V270, P741; Orio L, 2004, J NEUROCHEM, V89, P1445, DOI 10.1111/j.1471-4159.2004.02443.x; Parrott AC, 2007, J NEURAL TRANSM, V114, P959, DOI 10.1007/s00702-007-0715-7; Parrott AC, 2004, J PSYCHOPHARMACOL, V18, pA7, DOI 10.1177/0269881104047286; Racz I, 2008, J NEUROSCI, V28, P12125, DOI 10.1523/JNEUROSCI.3400-08.2008; Rawls SM, 2002, J PHARMACOL EXP THER, V301, P963, DOI 10.1124/jpet.301.3.963; Robledo P, 2007, PSYCHOPHARMACOLOGY, V195, P255, DOI 10.1007/s00213-007-0879-8; Sarne Y, 2005, CNS NEUROL DISORD-DR, V4, P677, DOI 10.2174/156800705774933005; SCHMIDT CJ, 1987, J PHARMACOL EXP THER, V240, P1; Strote J, 2002, J ADOLESCENT HEALTH, V30, P64, DOI 10.1016/S1054-139X(01)00315-9; Thomas DM, 2004, NEUROSCI LETT, V367, P349, DOI 10.1016/j.neulet.2004.06.065; Tourino C, 2008, BIOL PSYCHIAT, V63, P1030, DOI 10.1016/j.biopsych.2007.09.003; Tourino C, 2007, PSYCHOPHARMACOLOGY, V193, P75, DOI 10.1007/s00213-007-0772-5; Winstock AR, 2001, DRUG ALCOHOL DEPEN, V64, P9, DOI 10.1016/S0376-8716(00)00215-5; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	42	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9143	10.1371/journal.pone.0009143	http://dx.doi.org/10.1371/journal.pone.0009143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20174577	Green Published, gold			2022-12-25	WOS:000274442700019
J	Wang, HY; Leavitt, L; Ramaswamy, R; Rapraeger, AC				Wang, Haiyao; Leavitt, LuAnn; Ramaswamy, Ravishankar; Rapraeger, Alan C.			Interaction of Syndecan and alpha 6 beta 4 Integrin Cytoplasmic Domains REGULATION OF ErbB2-MEDIATED INTEGRIN ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; PHOSPHOINOSITIDE 3-OH KINASE; MAMMARY EPITHELIAL-CELLS; ALPHA(6)BETA(4) INTEGRIN; CARCINOMA INVASION; KERATINOCYTE MIGRATION; EXTRACELLULAR DOMAINS; LAMININ-5 LAMININ-332; BIOLOGICAL-ACTIVITY; BINDING DOMAIN	The alpha 6 beta 4 integrin is a laminin 332 (LN332) receptor central to the formation of hemidesmosomes in epithelial layers. However, the integrin becomes phosphorylated by keratinocytes responding to epidermal growth factor in skin wounds or by squamous cell carcinomas that overexpress/hyperactivate the tyrosine kinase ErbB2, epidermal growth factor receptor, or c-Met. We show here that the beta 4-dependent signaling in A431 human squamous carcinoma cells is dependent on the syndecan family of matrix receptors. Yeast two-hybrid analysis identifies an interaction within the distal third (amino acids 1473-1752) of the beta 4 cytoplasmic domain and the conserved C2 region of the syndecan cytoplasmic domain. Via its C2 region, Sdc1 forms a complex with the alpha 6 beta 4 integrin along with the receptor tyrosine kinase ErbB2 and the cytoplasmic kinase Fyn in A431 cells. Engagement of LN332 or clustering of the alpha 6 beta 4 integrin with integrin-specific antibodies causes phosphorylation of ErbB2, Fyn, and the beta 4 subunit as well as activation of phosphatidylinositol 3-kinase and Akt and their assimilation into this complex. This leads to phosphatidylinositol 3-kinase-dependent cell spreading and Akt-dependent protection from apoptosis. This is disrupted by RNA interference silencing of Sdc1 but can be rescued by mouse Sdc1 or Sdc4 but not by syndecan mutants lacking their C-terminal C2 region. This disruption does not prevent the phosphorylation of ErbB2 or Fyn but blocks the Fyn-mediated phosphorylation of the beta 4 tail. We propose that syndecans engage the distal region of the beta 4 cytoplasmic domain and bring it to the plasma membrane, where it can be acted upon by Src family kinases.	[Wang, Haiyao; Leavitt, LuAnn; Ramaswamy, Ravishankar; Rapraeger, Alan C.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Rapraeger, AC (corresponding author), Wisconsin Inst Med Res, 1111 Highland Ave, Madison, WI 53706 USA.	acraprae@wisc.edu	Ramaswamy, Ravishankar/I-2789-2019	Ramaswamy, Ravishankar/0000-0001-5253-9508	National Institutes of Health [R01-CA109010]; NATIONAL CANCER INSTITUTE [R01CA109010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA109010 (to A. C. R.).	Aumailley M, 1999, MATRIX BIOL, V18, P19, DOI 10.1016/S0945-053X(98)00004-3; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Bachelder RE, 1999, J CELL BIOL, V147, P1063, DOI 10.1083/jcb.147.5.1063; Bachy S, 2008, J CELL PHYSIOL, V214, P238, DOI 10.1002/jcp.21184; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; CLARKE AS, 1995, J BIOL CHEM, V270, P22673, DOI 10.1074/jbc.270.39.22673; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Dutta U, 2008, CANCER RES, V68, P8779, DOI 10.1158/0008-5472.CAN-08-2125; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Gagnoux-Palacios L, 2003, J CELL BIOL, V162, P1189, DOI 10.1083/jcb.200305006; GAIETTA G, 1994, J CELL SCI, V107, P3339; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hintermann E, 2005, J BIOL CHEM, V280, P8004, DOI 10.1074/jbc.M406301200; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Humphries MJ, 1996, CURR OPIN CELL BIOL, V8, P632, DOI 10.1016/S0955-0674(96)80104-9; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lebakken CS, 2000, EXP CELL RES, V259, P315, DOI 10.1006/excr.2000.4981; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; Lipscomb EA, 2005, CANCER RES, V65, P10970, DOI 10.1158/0008-5472.CAN-05-2327; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; McQuade KJ, 2003, J BIOL CHEM, V278, P46607, DOI 10.1074/jbc.M304775200; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; Merdek KD, 2007, J BIOL CHEM, V282, P30322, DOI 10.1074/jbc.M703156200; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Ogawa T, 2004, J CELL BIOCHEM, V92, P701, DOI 10.1002/jcb.20112; Ogawa T, 2007, MOL BIOL CELL, V18, P1621, DOI 10.1091/mbc.E06-09-0806; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; RAPRAEGER A, 1986, J CELL BIOL, V103, P2683, DOI 10.1083/jcb.103.6.2683; Raymond K, 2007, MOL BIOL CELL, V18, P4210, DOI 10.1091/mbc.E06-08-0720; Rousselle P, 1997, J CELL BIOL, V138, P719, DOI 10.1083/jcb.138.3.719; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Schaapveld RQJ, 1998, J CELL BIOL, V142, P271, DOI 10.1083/jcb.142.1.271; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Sigle RO, 2004, J CELL SCI, V117, P4481, DOI 10.1242/jcs.01310; Sulka B, 2009, J BIOL CHEM, V284, P10659, DOI 10.1074/jbc.M807643200; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tran M, 2008, CANCER RES, V68, P2885, DOI 10.1158/0008-5472.CAN-07-6160; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Yamashita Y, 1999, J IMMUNOL, V162, P5940; Yoon SO, 2005, CANCER RES, V65, P2761, DOI 10.1158/0008-5472.CAN-04-4122; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	66	55	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13569	13579		10.1074/jbc.M110.102137	http://dx.doi.org/10.1074/jbc.M110.102137			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20181947	hybrid, Green Published			2022-12-25	WOS:000276987700030
J	Li, Y; Hu, J; Hofer, K; Wong, AMS; Cooper, JD; Birnbaum, SG; Hammer, RE; Hofmann, SL				Li, Yi; Hu, Jie; Hoefer, Klemens; Wong, Andrew M. S.; Cooper, Jonathan D.; Birnbaum, Shari G.; Hammer, Robert E.; Hofmann, Sandra L.			DHHC5 Interacts with PDZ Domain 3 of Post-synaptic Density-95 (PSD-95) Protein and Plays a Role in Learning and Memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PALMITOYL TRANSFERASE; MENTAL-RETARDATION; SACCHAROMYCES-CEREVISIAE; DIFFERENTIAL REGULATION; ACYLATED PROTEINS; GABA(A) RECEPTORS; MAMMALIAN-CELLS; MOUSE MODEL; TRAFFICKING; HUNTINGTIN	A family of integral membrane proteins containing a signature DHHC motif has been shown to display protein S-acyltransferase activity, modifying cysteine residues in proteins with fatty acids. The physiological roles of these proteins have largely been unexplored. Here we report that mice homozygous for a hypomorphic allele of a previously uncharacterized member, DHHC5, are born at half the expected rate, and survivors show a marked deficit in contextual fear conditioning, an indicator of defective hippocampal-dependent learning. DHHC5 is highly enriched in a post-synaptic density preparation and co-immunoprecipitates with post-synaptic density protein-95 (PSD-95), an interaction that is mediated through binding of the carboxyl terminus of DHHC5 and the PDZ3 domain of PSD-95. Immunohistochemistry demonstrated that DHHC5 is expressed in the CA3 and dentate gyrus in the hippocampus. These findings point to a previously unsuspected role for DHHC5 in post-synaptic function affecting learning and memory.	[Li, Yi; Hu, Jie; Hofmann, Sandra L.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Hammer, Robert E.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Hofmann, Sandra L.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Birnbaum, Shari G.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Hoefer, Klemens; Wong, Andrew M. S.; Cooper, Jonathan D.] Kings Coll London, Pediat Storage Disorders Lab, Ctr Cellular Basis Behav,MRC,Inst Psychiat, Dept Neurosci,Ctr Neurodegenerat,James Black Ctr, London SE5 9NU, England	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of London; King's College London	Hofmann, SL (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	sandra.hofmann@utsouthwestern.edu	Cooper, Jonathan/C-8117-2009; Cooper, Jonathan/V-9962-2019	Cooper, Jonathan/0000-0003-1339-4750; Cooper, Jonathan/0000-0003-1339-4750; Hammer, Robert E./0000-0001-5487-7551	National Institutes of Health [NS36867, NS41930]; Robert A. Welch Foundation [I-1187]; Wellcome Trust [GR079491MA]; Erasmus Studentship; Batten Disease Support and Research Association; Batten Disease Family Association; Natalie Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036867, R37NS036867, R21NS041930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Erasmus Studentship; Batten Disease Support and Research Association; Batten Disease Family Association; Natalie Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS36867 (to S. L. H.) and NS41930 (to J. D. C.). This work was also supported by Robert A. Welch Foundation Grant I-1187 (to S. L. H.), Wellcome Trust Grant GR079491MA (to J. D. C.), an Erasmus Studentship (to K. H.), the Batten Disease Support and Research Association (to J. D. C.), the Batten Disease Family Association (to J. D. C.), and the Natalie Fund (to J. D. C.).	Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Bouvier D, 2008, J NEUROCHEM, V106, P682, DOI 10.1111/j.1471-4159.2008.05416.x; Chen WY, 2004, HUM MOL GENET, V13, P2991, DOI 10.1093/hmg/ddh322; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Dalva MB, 2009, J CELL BIOL, V186, P7, DOI 10.1083/jcb.200906101; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Goytain A, 2008, J BIOL CHEM, V283, P33365, DOI 10.1074/jbc.M801469200; Hang HC, 2007, J AM CHEM SOC, V129, P2744, DOI 10.1021/ja0685001; Harris BZ, 2001, J CELL SCI, V114, P3219; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hines RM, 2010, J BIOL CHEM, V285, P4621, DOI 10.1074/jbc.M109.069849; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Klemmer P, 2009, J PROTEOMICS, V72, P82, DOI 10.1016/j.jprot.2008.10.005; Kostiuk MA, 2008, FASEB J, V22, P721, DOI 10.1096/fj.07-9199com; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Mansouri MR, 2005, EUR J HUM GENET, V13, P970, DOI 10.1038/sj.ejhg.5201445; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Putilina T, 1999, MOL CELL BIOCHEM, V195, P219, DOI 10.1023/A:1006932522197; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Saitoh F, 2004, J BIOL CHEM, V279, P29461, DOI 10.1074/jbc.M401471200; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Witzmann FA, 2005, PROTEOMICS, V5, P2177, DOI 10.1002/pmic.200401102; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang SH, 2005, J BIOL CHEM, V280, P18990, DOI 10.1074/jbc.M412917200; Yang SH, 2009, TRANSGENIC RES, V18, P483, DOI 10.1007/s11248-008-9237-9; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200	57	58	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13022	13031		10.1074/jbc.M109.079426	http://dx.doi.org/10.1074/jbc.M109.079426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20178993	Green Published, hybrid			2022-12-25	WOS:000276787800060
J	Safavi-Hemami, H; Bulaj, G; Olivera, BM; Williamson, NA; Purcell, AW				Safavi-Hemami, Helena; Bulaj, Grzegorz; Olivera, Baldomero M.; Williamson, Nicholas A.; Purcell, Anthony W.			Identification of Conus Peptidylprolyl Cis-Trans Isomerases (PPIases) and Assessment of Their Role in the Oxidative Folding of Conotoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; HUMAN CYCLOPHILIN; CYCLOSPORINE-A; POSTTRANSLATIONAL MODIFICATIONS; FK506-BINDING PROTEIN; CHEMICAL-SYNTHESIS; PROLYL ISOMERASE; BINDING-PROTEIN; VENOM DUCT; PEPTIDES	Peptidylprolyl cis-trans isomerases (PPIases) are ubiquitous proteins that catalyze the cis-trans isomerization of prolines. A number of proteins, such as Drosophila rhodopsin and the human immunodeficiency viral protein HIV-1 Gag, have been identified as endogenous substrates for PPIases. However, very little is known about the interaction of PPIases with small, disulfide-rich peptides. Marine cone snails synthesize a wide array of cysteine-rich peptides, called conotoxins, many of which contain one or more prolines or hydroxyprolines. To identify whether PPIase-associated cis-trans isomerization of these residues affects the oxidative folding of conotoxins, we identified, sequenced, and expressed three functionally active isoforms of PPIase from the venom gland of Conus novaehollandiae, and we characterized their ability to facilitate oxidative folding of conotoxins in vitro. Three conotoxins, namely mu-GIIIA, mu-SIIIA, and omega-MVIIC, derived from two distinct toxin gene families were assayed. Conus PPIase significantly increased the rate of appearance of the native form of mu-GIIIA, a peptide containing three hydroxyprolines. In contrast, the presence of PPIase had no effect on the folding of mu-SIIIA and omega-MVIIC, peptides containing no or one proline residue, respectively. We further showed that an endoplasmic reticulum-resident PPIase isoform facilitated folding of mu-GIIIA more efficiently than two cytosolic isoforms. This is the first study to demonstrate PPIase-assisted folding of conotoxins, small disulfide-rich peptides with unique structural properties.	[Safavi-Hemami, Helena; Williamson, Nicholas A.; Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Bulaj, Grzegorz] Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA; [Olivera, Baldomero M.] Univ Utah, Dept Biol, Salt Lake City, UT 84108 USA	University of Melbourne; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Purcell, AW (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia.	apurcell@unimelb.edu.au	Williamson, Nicholas A/O-9812-2016; Safavi-Hemami, Helena/E-7624-2015; Purcell, Anthony/AAH-1942-2019	Williamson, Nicholas A/0000-0002-2173-3452; Safavi-Hemami, Helena/0000-0002-1984-2721; Purcell, Anthony/0000-0003-0532-8331				Arevalo-Rodriguez M, 2004, FRONT BIOSCI-LANDMRK, V9, P2420, DOI 10.2741/1405; Armishaw C, 2009, J BIOL CHEM, V284, P9498, DOI 10.1074/jbc.M806136200; ATHERTON E, 1989, SOLID PHASE PEPTIDE, P134; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; Balbach J., 2000, MECH PROTEIN FOLDING, P212; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Buczek O, 2004, BIOCHEMISTRY-US, V43, P1093, DOI 10.1021/bi0354233; Buczek O, 2005, J BIOL CHEM, V280, P4247, DOI 10.1074/jbc.M405835200; Bugli F, 1998, PROTEIN EXPRES PURIF, V12, P340, DOI 10.1006/prep.1997.0852; Bulaj G, 2006, BIOCHEMISTRY-US, V45, P7404, DOI 10.1021/bi060159+; Bulaj G, 2003, P NATL ACAD SCI USA, V100, P14562, DOI 10.1073/pnas.2335845100; Bulaj G, 2008, ANTIOXID REDOX SIGN, V10, P141, DOI 10.1089/ars.2007.1856; BUSH KT, 1994, BIOCHEM J, V303, P705, DOI 10.1042/bj3030705; Craig AG, 2001, TOXICON, V39, P809, DOI 10.1016/S0041-0101(00)00211-7; DAVIS JM, 1989, J BIOL CHEM, V264, P8956; DeLa Cruz R, 2003, J PEPT RES, V61, P202, DOI 10.1034/j.1399-3011.2003.t01-1-00048.x; di Luccio E, 2001, BIOCHEM J, V358, P681, DOI 10.1042/0264-6021:3580681; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Fuller E, 2005, FEBS J, V272, P1727, DOI 10.1111/j.1742-4658.2005.04602.x; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Gourlay LJ, 2007, J BIOL CHEM, V282, P24851, DOI 10.1074/jbc.M702714200; Gowd KH, 2007, MOL BIOSYST, V3, P554, DOI 10.1039/b705382g; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; HARRISON RK, 1992, J AM CHEM SOC, V114, P3464, DOI 10.1021/ja00035a046; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; Hill JM, 1996, BIOCHEMISTRY-US, V35, P8824, DOI 10.1021/bi960073o; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Jakubowski JA, 2006, TOXICON, V47, P688, DOI 10.1016/j.toxicon.2006.01.021; KALLEN J, 1991, NATURE, V353, P276, DOI 10.1038/353276a0; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KE HM, 1991, P NATL ACAD SCI USA, V88, P9483, DOI 10.1073/pnas.88.21.9483; Kim J, 2008, J CELL SCI, V121, P3636, DOI 10.1242/jcs.028654; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; Laxa M, 2007, BIOCHEM J, V401, P287, DOI 10.1042/BJ20061092; Le Gall F, 1999, TOXICON, V37, P985, DOI 10.1016/S0041-0101(98)00227-X; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Loughnan ML, 2004, J MED CHEM, V47, P1234, DOI 10.1021/jm031010o; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Motohashi K, 2003, J BIOL CHEM, V278, P31848, DOI 10.1074/jbc.M304258200; NIGAM SK, 1993, BIOCHEM J, V294, P511, DOI 10.1042/bj2940511; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Olivera BM, 1997, MOL BIOL CELL, V8, P2101, DOI 10.1091/mbc.8.11.2101; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PANTIN CFA, 1946, NOTES MICROSCOPICAL, P75; Pisarewicz K, 2005, J AM CHEM SOC, V127, P6207, DOI 10.1021/ja050088m; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; RASSOW J, 1995, MOL CELL BIOL, V15, P2654; Rycyzyn MA, 2002, P NATL ACAD SCI USA, V99, P6790, DOI 10.1073/pnas.092160699; Schindler T, 1996, EUR J BIOCHEM, V241, P516, DOI 10.1111/j.1432-1033.1996.00516.x; SCHONBRUNNER ER, 1992, P NATL ACAD SCI USA, V89, P4510, DOI 10.1073/pnas.89.10.4510; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; Stanley TB, 1997, FEBS LETT, V407, P85, DOI 10.1016/S0014-5793(97)00299-8; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Townsend A, 2009, INT J PEPT RES THER, V15, P195, DOI 10.1007/s10989-009-9173-4; Walewska A, 2009, ANGEW CHEM INT EDIT, V48, P2221, DOI 10.1002/anie.200806085; Wang ZQ, 2007, FEBS J, V274, P4778, DOI 10.1111/j.1742-4658.2007.06003.x; YANG WM, 1995, J BIOL CHEM, V270, P15187, DOI 10.1074/jbc.270.25.15187	68	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12735	12746		10.1074/jbc.M109.078691	http://dx.doi.org/10.1074/jbc.M109.078691			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20147296	Green Published, hybrid			2022-12-25	WOS:000276787800032
J	Ishizuka, T; Fujimori, I; Kato, M; Noji-Sakikawa, C; Saito, M; Yoshigae, Y; Kubota, K; Kurihara, A; Izumi, T; Ikeda, T; Okazaki, O				Ishizuka, Tomoko; Fujimori, Izumi; Kato, Mitsunori; Noji-Sakikawa, Chisa; Saito, Motoko; Yoshigae, Yasushi; Kubota, Kazuishi; Kurihara, Atsushi; Izumi, Takashi; Ikeda, Toshihiko; Okazaki, Osamu			Human Carboxymethylenebutenolidase as a Bioactivating Hydrolase of Olmesartan Medoxomil in Liver and Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIENELACTONE HYDROLASE; CARBOXYLESTERASE ISOZYMES; HUMAN VALACYCLOVIRASE; CATALYTIC-PROPERTIES; PRODRUG; ACTIVATION; PROTEIN; IDENTIFICATION; HYDROLYSIS; STABILITY	Olmesartan medoxomil (OM) is a prodrug type angiotensin II type 1 receptor antagonist widely prescribed as an antihypertensive agent. Herein, we describe the identification and characterization of the OM bioactivating enzyme that hydrolyzes the prodrug and converts to its pharmacologically active metabolite olmesartan in human liver and intestine. The protein was purified from human liver cytosol by successive column chromatography and was identified by mass spectrometry to be a carboxymethylenebutenolidase (CMBL) homolog. Human CMBL, whose endogenous function has still not been reported, is a human homolog of Pseudomonas dienelactone hydrolase involved in the bacterial halocatechol degradation pathway. The ubiquitous expression of human CMBL gene transcript in various tissues was observed. The recombinant human CMBL expressed in mammalian cells was clearly shown to activate OM. By comparing the enzyme kinetics and chemical inhibition properties between the recombinant protein and human tissue preparations, CMBL was demonstrated to be the primary OM bioactivating enzyme in the liver and intestine. The recombinant CMBL also converted other prodrugs having the same ester structure as OM, faropenem medoxomil and lenampicillin, to their active metabolites. CMBL exhibited a unique sensitivity to chemical inhibitors, thus, being distinguishable from other known esterases. Site-directed mutagenesis on the putative active residue Cys(132) of the recombinant CMBL caused a drastic reduction of the OM-hydrolyzing activity. We report for the first time that CMBL serves as a key enzyme in the bioactivation of OM, hydrolyzing the ester bond of the prodrug type xenobiotics.	[Ishizuka, Tomoko; Kurihara, Atsushi; Izumi, Takashi; Okazaki, Osamu] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; [Fujimori, Izumi] Daiichi Sankyo Co Ltd, R&D Operat Dept, Tokyo 1408710, Japan; [Ikeda, Toshihiko] Yokohama Coll Pharm, Kanagawa 2450066, Japan; [Kato, Mitsunori; Noji-Sakikawa, Chisa; Kubota, Kazuishi] Daiichi Sankyo Co Ltd, Translat Med & Clin Pharmacol Dept, Tokyo 1408710, Japan	Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited	Ishizuka, T (corresponding author), Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	ishizuka.tomoko.xx@daiichisankyo.co.jp						Beaumont K, 2003, CURR DRUG METAB, V4, P461, DOI 10.2174/1389200033489253; BEVERIDGE AJ, 1995, PROTEIN ENG, V8, P135, DOI 10.1093/protein/8.2.135; Carr PD, 2009, PROTEIN PEPTIDE LETT, V16, P1137; CHEAH E, 1993, PROTEINS, V16, P64, DOI 10.1002/prot.340160108; Chrysant SG, 2008, DRUG TODAY, V44, P443, DOI [10.1358/dot.2008.44.6.1223895, 10.1358/dot.2008.44.6.1219543]; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; Easthope SE, 2002, DRUGS, V62, P1253, DOI 10.2165/00003495-200262080-00016; Ettmayer P, 2004, J MED CHEM, V47, P2393, DOI 10.1021/jm0303812; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412; Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173; James RW, 2004, FREE RADICAL BIO MED, V37, P1986, DOI 10.1016/j.freeradbiomed.2004.08.012; Kim I, 2003, J BIOL CHEM, V278, P25348, DOI 10.1074/jbc.M302055200; Kubota K, 2003, PROTEOMICS, V3, P616, DOI 10.1002/pmic.200300410; Laeis Petra, 2001, Journal of Hypertension, V19, pS21; Lai LS, 2008, J BIOL CHEM, V283, P9318, DOI 10.1074/jbc.M709530200; Liederer BM, 2006, J PHARM SCI-US, V95, P1177, DOI 10.1002/jps.20542; Ma SF, 2005, DRUG METAB DISPOS, V33, P1911, DOI 10.1124/dmd.105.006163; NGAI KL, 1987, J BACTERIOL, V169, P699, DOI 10.1128/jb.169.2.699-703.1987; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PATHAK D, 1988, J MOL BIOL, V204, P435, DOI 10.1016/0022-2836(88)90587-6; PATHAK D, 1990, J MOL BIOL, V214, P497, DOI 10.1016/0022-2836(90)90196-S; PATHAK D, 1991, PROTEINS, V9, P267, DOI 10.1002/prot.340090405; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Redon Josep, 2009, J Renin Angiotensin Aldosterone Syst, V10, P147, DOI 10.1177/1470320309342735; Reyns T, 2008, J CHROMATOGR B, V861, P108, DOI 10.1016/j.jchromb.2007.11.007; SAARI WS, 1984, J MED CHEM, V27, P713, DOI 10.1021/jm00372a002; SAITO A, 1986, ANTIMICROB AGENTS CH, V29, P948, DOI 10.1128/AAC.29.5.948; SAKAMOTO F, 1984, CHEM PHARM BULL, V32, P2241; Satoh T, 2006, CHEM-BIOL INTERACT, V162, P195, DOI 10.1016/j.cbi.2006.07.001; Satoh Tetsuo, 2005, Toxicol Appl Pharmacol, V207, P11, DOI 10.1016/j.taap.2005.01.046; SCHMIDT E, 1980, BIOCHEM J, V192, P339, DOI 10.1042/bj1920339; Schurek KN, 2007, EXPERT REV ANTI-INFE, V5, P185, DOI 10.1586/14787210.5.2.185; Scott LJ, 2008, DRUGS, V68, P1239, DOI 10.2165/00003495-200868090-00005; TAYLOR P, 1991, J BIOL CHEM, V266, P4025; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Testa B, 2004, BIOCHEM PHARMACOL, V68, P2097, DOI 10.1016/j.bcp.2004.07.005; TESTA B, 2003, HYDROLYSIS DRUG PROD, P1; Tougou K, 1998, DRUG METAB DISPOS, V26, P355	40	41	43	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11892	11902		10.1074/jbc.M109.072629	http://dx.doi.org/10.1074/jbc.M109.072629			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177059	Green Published, hybrid			2022-12-25	WOS:000276787100017
J	Siskind, LJ; Mullen, TD; Rosales, KR; Clarke, CJ; Hernandez-Corbacho, MJ; Edinger, AL; Obeid, LM				Siskind, Leah J.; Mullen, Thomas D.; Rosales, Kimberly Romero; Clarke, Christopher J.; Hernandez-Corbacho, Maria Jose; Edinger, Aimee L.; Obeid, Lina M.			The BCL-2 Protein BAK Is Required for Long-chain Ceramide Generation during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; SPHINGOSINE KINASE-1; PROAPOPTOTIC BAX; MITOCHONDRIAL APOPTOSIS; ACID SPHINGOMYELINASE; ENDOPLASMIC-RETICULUM; CANCER-CELLS; ER STRESS; ACTIVATION; RESISTANCE	The BCL-2 family members BAK and BAX are required for apoptosis and trigger mitochondrial outer membrane permeabilization (MOMP). Here we identify a MOMP-independent function of BAK as a required factor for long-chain ceramide production in response to pro-apoptotic stress. UV-C irradiation of wild-type (WT) cells increased long-chain ceramides; blocking ceramide generation prevented caspase activation and cell death, demonstrating that long-chain ceramides play a key role in UV-C-induced apoptosis. In contrast, UV-C irradiation did not increase long-chain ceramides in BAK and BAX double knock-out cells. Notably, this was not specific to the cell type (baby mouse kidney cells, hematopoietic) nor the apoptotic stimulus employed (UV-C, cisplatin, and growth factor withdrawal). Importantly, long-chain ceramide generation was dependent on the presence of BAK, but not BAX. However, ceramide generation was independent of the known downstream actions of BAK in apoptosis(MOMP or caspase activation), suggesting a novel role for BAK in apoptosis. Finally, enzymatic assays identified ceramide synthase as the mechanism by which BAK regulates ceramide metabolism. There was no change in CerS expression at the message or protein level, indicating regulation at the post-translational level. Moreover, CerS activity in BAK KO microsomes can be reactivated upon addition of BAK-containing microsomes. The data presented indicate that ceramide-induced apoptosis is dependent upon BAK and identify a novel role for BAK during apoptosis. By establishing a unique role for BAK in long-chain ceramide metabolism, these studies further demonstrate that the seemingly redundant proteins BAK and BAX have distinct mechanisms of action during apoptosis induction.	[Siskind, Leah J.; Mullen, Thomas D.; Hernandez-Corbacho, Maria Jose; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Div Gen Internal Med Geriatr, Charleston, SC 29425 USA; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Rosales, Kimberly Romero; Edinger, Aimee L.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Clarke, Christopher J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; University of California System; University of California Irvine; Medical University of South Carolina	Siskind, LJ (corresponding author), Med Univ S Carolina, Dept Med, Div Gen Internal Med Geriatr, 114 Doughty St,MSC 779, Charleston, SC 29425 USA.	siskind@musc.edu		Siskind, Leah/0000-0001-5026-5187; obeid, lina/0000-0002-0734-0847	NIEHS [1F30 ES016975-01]; NIA [F31 CA126494, K08 CA100526, R01 AG016583]; NCI [P01 CA097132]; Veterans Administration; American Cancer Society [IRG-97-219-11]; Cancer Center Support Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [F31CA126494, K08CA100526, P01CA097132, P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES016975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Administration(US Department of Veterans Affairs); American Cancer Society(American Cancer Society); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 1F30 ES016975-01 (to T. D. M.) from NIEHS, F31 CA126494 (to K. R. R.), K08 CA100526 (to A. L. E.), and R01 AG016583 from NIA and P01 CA097132 from NCI (to L. M. O.). This work was also supported by a Veterans Administration Career Development Award-2 (to L. J. S.), pilot project funding from a Veterans Administration REAP (to L. J. S. and L. M. O.), and American Cancer Society Institutional Research Grant IRG-97-219-11 (sub-award to L. J. S.). The shared resources of the Hollings Cancer Center were supported in part by a Cancer Center Support Grant (P30 CA138313).	Alphonse G, 2004, ONCOGENE, V23, P2703, DOI 10.1038/sj.onc.1207357; Alphonse G, 2002, INT J RADIAT BIOL, V78, P821, DOI 10.1080/09553000210153943; Bektas M, 2005, ONCOGENE, V24, P178, DOI 10.1038/sj.onc.1208019; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Charruyer A, 2007, BIOCHEM J, V405, P77, DOI 10.1042/BJ20061528; Chatterjee M, 2001, MOL CELL BIOCHEM, V219, P21, DOI 10.1023/A:1011083818452; Chmura SJ, 1997, CANCER RES, V57, P1270; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; DBAIBO GS, 1995, P NATL ACAD SCI USA, V92, P1347, DOI 10.1073/pnas.92.5.1347; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heath-Engel HM, 2006, CELL DEATH DIFFER, V13, P1277, DOI 10.1038/sj.cdd.4401961; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Holopainen JM, 2000, BIOPHYS J, V78, P830, DOI 10.1016/S0006-3495(00)76640-9; Jin JF, 2008, J BIOL CHEM, V283, P26509, DOI 10.1074/jbc.M801597200; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; Kepp O, 2007, EMBO J, V26, P825, DOI 10.1038/sj.emboj.7601533; Klee M, 2009, EMBO J, V28, P1757, DOI 10.1038/emboj.2009.90; Kroesen BJ, 2003, J BIOL CHEM, V278, P14723, DOI 10.1074/jbc.M210756200; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2006, CELL DEATH DIFFER, V13, P1272, DOI 10.1038/sj.cdd.4401953; Liu YY, 2004, J LIPID RES, V45, P933, DOI 10.1194/jlr.M300486-JLR200; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Min JX, 2007, MOL CANCER RES, V5, P801, DOI 10.1158/1541-7786.MCR-07-0100; Mousley CJ, 2008, MOL BIOL CELL, V19, P4785, DOI 10.1091/mbc.E08-04-0426; Muriel MP, 2000, J COMP NEUROL, V426, P297, DOI 10.1002/1096-9861(20001016)426:2<297::AID-CNE10>3.0.CO;2-O; Noda S, 2001, J NEURO-ONCOL, V52, P11, DOI 10.1023/A:1010624823158; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Rodriguez-Lafrasse C, 2002, INT J CANCER, V101, P589, DOI 10.1002/ijc.10652; Ruiz-Vela A, 2005, EMBO REP, V6, P379, DOI 10.1038/sj.embor.7400375; Sautin Y, 2000, THYROID, V10, P733, DOI 10.1089/thy.2000.10.733; Selzner M, 2001, CANCER RES, V61, P1233; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	46	89	96	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11818	11826		10.1074/jbc.M109.078121	http://dx.doi.org/10.1074/jbc.M109.078121			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20172858	Green Published, hybrid			2022-12-25	WOS:000276787100009
J	Han, WN; Ming, M; He, TC; He, YY				Han, Weinong; Ming, Mei; He, Tong-Chuan; He, Yu-Ying			Immunosuppressive Cyclosporin A Activates AKT in Keratinocytes through PTEN Suppression IMPLICATIONS IN SKIN CARCINOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; CANCER-RISK; TRANSPLANT RECIPIENTS; RAPAMYCIN; GROWTH; TRANSFORMATION; INDUCTION; SIROLIMUS; APOPTOSIS; KIDNEY	Non-melanoma skin cancer, the most common neoplasia after solid organ transplantation, causes serious morbidity and mortality and is related to sun exposure. Cyclosporin A (CsA) has been used widely to prevent rejection in organ transplantation. The mechanism of CsA action in causing cancer was thought to be well understood via immunosuppression. Here, we show that CsA promotes primary skin tumor growth in immune-deficient mice and keratinocyte growth in vitro. In addition, CsA enhances keratinocyte survival from removal of extracellular matrix or UVB radiation. At the molecular level, CsA increases AKT activation after serum treatment and UVB irradiation. Furthermore we found that expression of PTEN, the negative regulator of AKT activation, is significantly reduced post-CsA in human HaCaT and A431 cells and in mouse skin in vivo. CsA-induced PTEN down-regulation occurs at the transcription level and is epidermal growth factor receptor-dependent. Such PTEN suppression is required for increased AKT activation. Inhibition of AKT activation abolishes CsA-promoted growth and survival, indicating that AKT hyperactivation is essential for both growth and survival of CsA-treated cells. In addition, mTOR signaling as a known AKT downstream pathway is required for CsA-enhanced growth and survival. Taken together, we have identified the PTEN/AKT pathway as new molecular targets of CsA in epidermal keratinocytes, suggesting a previously unknown mechanism in CsA-enhanced skin carcinogenesis. Our findings challenge assumptions about how CsA-associated tumors arise in skin.	[Han, Weinong; Ming, Mei; He, Yu-Ying] Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA; [He, Tong-Chuan] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	University of Chicago; University of Chicago	He, YY (corresponding author), Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu			American Skin Association; Wendy Will Case Cancer Fund; University of Chicago Comprehensive Cancer Center [P30 CA014599]; Clinical and Translational Science Award [UL1RR024999]; University of Chicago; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016936] Funding Source: NIH RePORTER	American Skin Association; Wendy Will Case Cancer Fund; University of Chicago Comprehensive Cancer Center; Clinical and Translational Science Award; University of Chicago(University of Chicago); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the American Skin Association, the Wendy Will Case Cancer Fund, University of Chicago Comprehensive Cancer Center Grant P30 CA014599, Clinical and Translational Science Award UL1RR024999, and the University of Chicago "Friends of Dermatology" endowment fund.	Allardice GM, 2003, BRIT J CANCER, V89, P505, DOI 10.1038/sj.bjc.6601139; Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; BODE AM, 2003, SCI STKE, pRE2; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Dal Maso L, 2009, BRIT J CANCER, V100, P840, DOI 10.1038/sj.bjc.6604923; Dantal J, 1998, LANCET, V351, P623, DOI 10.1016/S0140-6736(97)08496-1; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dean PG, 2004, TRANSPLANTATION, V77, P1555, DOI 10.1097/01.TP.0000123082.31092.53; DEGRUIJL FR, 1993, CANCER RES, V53, P53; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Ekici Y, 2007, TRANSPL P, V39, P1201, DOI 10.1016/j.transproceed.2007.04.013; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Goren I, 2009, J INVEST DERMATOL, V129, P752, DOI 10.1038/jid.2008.230; Groetzner J, 2004, J HEART LUNG TRANSPL, V23, P632, DOI 10.1016/S1053-2498(03)00309-7; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; He YY, 2008, PHOTOCHEM PHOTOBIOL, V84, P69, DOI 10.1111/j.1751-1097.2007.00199.x; He YY, 2008, CANCER RES, V68, P3752, DOI 10.1158/0008-5472.CAN-07-6138; He YY, 2006, ONCOGENE, V25, P3680, DOI 10.1038/sj.onc.1209384; He YY, 2006, ONCOGENE, V25, P1521, DOI 10.1038/sj.onc.1209184; He YY, 2004, J INVEST DERMATOL, V122, P533, DOI 10.1046/j.0022-202X.2003.22123.x; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Jensen P, 1999, J AM ACAD DERMATOL, V40, P177, DOI 10.1016/S0190-9622(99)70185-4; Kim HK, 2008, NEOPLASIA, V10, P1411, DOI 10.1593/neo.08804; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Luan FL, 2003, KIDNEY INT, V63, P917, DOI 10.1046/j.1523-1755.2003.00805.x; Luan FL, 2002, TRANSPLANTATION, V73, P1565, DOI 10.1097/00007890-200205270-00008; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; NAKAZAWA H, 1994, P NATL ACAD SCI USA, V91, P360, DOI 10.1073/pnas.91.1.360; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; SETLOW RB, 1993, P NATL ACAD SCI USA, V90, P6666, DOI 10.1073/pnas.90.14.6666; Shair KHY, 2008, CANCER RES, V68, P6997, DOI 10.1158/0008-5472.CAN-08-1178; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Suzuki A, 2003, CANCER RES, V63, P674; Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008; Vasudevan KM, 2007, CANCER RES, V67, P10343, DOI 10.1158/0008-5472.CAN-07-1827; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Wulff BC, 2008, J INVEST DERMATOL, V128, P2467, DOI 10.1038/jid.2008.121; Yarosh DB, 2005, J INVEST DERMATOL, V125, P1020, DOI 10.1111/j.0022-202X.2005.23858.x	50	51	52	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11369	11377		10.1074/jbc.M109.028142	http://dx.doi.org/10.1074/jbc.M109.028142			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154081	Green Published, hybrid			2022-12-25	WOS:000276286200043
J	Jung, HJ; Shim, JS; Lee, J; Song, YM; Park, KC; Choi, SH; Kim, ND; Yoon, JH; Mungai, PT; Schumacker, PT; Kwon, HJ				Jung, Hye Jin; Shim, Joong Sup; Lee, Jiyong; Song, Young Mi; Park, Ki Chung; Choi, Seung Hoon; Kim, Nam Doo; Yoon, Jeong Hyeok; Mungai, Paul T.; Schumacker, Paul T.; Kwon, Ho Jeong			Terpestacin Inhibits Tumor Angiogenesis by Targeting UQCRB of Mitochondrial Complex III and Suppressing Hypoxia-induced Reactive Oxygen Species Production and Cellular Oxygen Sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; ELECTRON-TRANSFER; ENANTIOSELECTIVE SYNTHESIS; SUPEROXIDE-PRODUCTION; HEART-MITOCHONDRIA; DOMAIN MOVEMENT; 14-KDA SUBUNIT; CANCER-CELLS; Q-CYCLE; IDENTIFICATION	Cellular oxygen sensing is required for hypoxia-inducible factor-1 alpha stabilization, which is important for tumor cell survival, proliferation, and angiogenesis. Here we find that terpestacin, a small molecule previously identified in a screen of microbial extracts, binds to the 13.4-kDa subunit (UQCRB) of mitochondrial Complex III, resulting in inhibition of hypoxia-induced reactive oxygen species generation. Consequently, such inhibition blocks hypoxia-inducible factor activation and tumor angiogenesis in vivo, without inhibiting mitochondrial respiration. Overexpression of UQCRB or its suppression using RNA interference demonstrates that it plays a crucial role in the oxygen sensing mechanism that regulates responses to hypoxia. These findings provide a novel molecular basis of terpestacin targeting UQCRB of Complex III in selective suppression of tumor progression.	[Jung, Hye Jin; Shim, Joong Sup; Lee, Jiyong; Song, Young Mi; Kwon, Ho Jeong] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea; [Park, Ki Chung; Choi, Seung Hoon] Yonsei Univ, Coll Med, Dept Surg, Seoul 120752, South Korea; [Kim, Nam Doo; Yoon, Jeong Hyeok] Equispharm Inc, Drug Design Team, Gyeonggi, South Korea; [Mungai, Paul T.; Schumacker, Paul T.] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA	Yonsei University; Yonsei University; Yonsei University Health System; Northwestern University	Kwon, HJ (corresponding author), Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, 134 Shinchon Dong, Seoul 120749, South Korea.	kwonhj@yonsei.ac.kr	Lee, Jiyong/B-4894-2017; Park, Ki Cheong/ABD-3136-2020; Shim, Joong Sup/G-8383-2011; 권, 호정/AAS-3642-2021; Shim, Joong Sup/O-2848-2016	Shim, Joong Sup/0000-0003-0167-7307; Shim, Joong Sup/0000-0003-0167-7307; Park, Ki Cheong/0000-0002-3435-3985; Lee, Jiyong/0000-0002-4455-3358; Schumacker, Paul T/0000-0001-9591-2034	National R & D Program for Cancer Control, Ministry of Health Welfare; Translational Research Center for Protein Function Control, KRF [2009-0083522]; Korean Government [2009-0092964]; Brain Korea 21 project of the Republic of Korea; National Institutes of Health [HL35440, HL079650]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079650, R01HL035440] Funding Source: NIH RePORTER	National R & D Program for Cancer Control, Ministry of Health Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); Translational Research Center for Protein Function Control, KRF(National Research Foundation of Korea); Korean Government(Korean Government); Brain Korea 21 project of the Republic of Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National R & D Program for Cancer Control, Ministry of Health & Welfare, the Translational Research Center for Protein Function Control, KRF Grant 2009-0083522, the National Research Foundation of Korea Grant funded by Korean Government Grant 2009-0092964, and the Brain Korea 21 project of the Republic of Korea. This work was supported, in whole or in part, by National Institutes of Health Grants HL35440 and HL079650 (to P. T. S. and P. T. M.).	Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Borisov Vitaliy B, 2004, Ital J Biochem, V53, P34; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Chan J, 2004, J AM CHEM SOC, V126, P10682, DOI 10.1021/ja0470968; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Folkman J, 1992, Semin Cancer Biol, V3, P65; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0; HEMRIKA W, 1994, EUR J BIOCHEM, V220, P569, DOI 10.1111/j.1432-1033.1994.tb18657.x; Hong Soon-Sun, 2004, Cancer Res Treat, V36, P343, DOI 10.4143/crt.2004.36.6.343; Hwang KY, 2008, NEUROSCI LETT, V444, P264, DOI 10.1016/j.neulet.2008.08.057; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jia HL, 2007, CLIN CANCER RES, V13, P1133, DOI 10.1158/1078-0432.CCR-06-1025; Jung HJ, 2003, J ANTIBIOT, V56, P492, DOI 10.7164/antibiotics.56.492; Kwon HJ, 2003, CURR MED CHEM, V10, P717, DOI 10.2174/0929867033457755; Lin X, 2008, P NATL ACAD SCI USA, V105, P174, DOI 10.1073/pnas.0706585104; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; MULDER W, 1994, BBA-GENE STRUCT EXPR, V1219, P719, DOI 10.1016/0167-4781(94)90235-6; Myers AG, 2002, J AM CHEM SOC, V124, P4230, DOI 10.1021/ja020072l; OKA M, 1993, J ANTIBIOT, V46, P367, DOI 10.7164/antibiotics.46.367; Park HJ, 2005, J BIOCHEM MOL BIOL, V38, P232, DOI 10.5483/BMBRep.2005.38.2.232; Piggott AM, 2008, CHEMBIOCHEM, V9, P524, DOI 10.1002/cbic.200700608; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; Satake S, 1998, BIOL CELL, V90, P161, DOI 10.1016/S0248-4900(98)80337-7; Schreiber SL, 1998, BIOORGAN MED CHEM, V6, P1127, DOI 10.1016/S0968-0896(98)00126-6; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shim JS, 2004, CHEM BIOL, V11, P1455, DOI 10.1016/j.chembiol.2004.08.015; Shim JS, 2005, EXP MOL MED, V37, P365, DOI 10.1038/emm.2005.46; Spector JA, 2001, AM J PHYSIOL-CELL PH, V280, pC72, DOI 10.1152/ajpcell.2001.280.1.C72; SUZUKI H, 1988, BIOCHEM BIOPH RES CO, V156, P987, DOI 10.1016/S0006-291X(88)80941-0; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Ulanovskaya OA, 2008, NAT CHEM BIOL, V4, P418, DOI 10.1038/nchembio.94; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	42	83	88	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11584	11595		10.1074/jbc.M109.087809	http://dx.doi.org/10.1074/jbc.M109.087809			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145250	Green Published, hybrid			2022-12-25	WOS:000276286200064
J	Nair, U; Cao, Y; Xie, ZP; Klionsky, DJ				Nair, Usha; Cao, Yang; Xie, Zhiping; Klionsky, Daniel J.			Roles of the Lipid-binding Motifs of Atg18 and Atg21 in the Cytoplasm to Vacuole Targeting Pathway and Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PROTEIN-ACTIVATING ENZYME; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; VESICLE FORMATION; BUDDING YEAST; PREAUTOPHAGOSOMAL STRUCTURE; NONSPECIFIC AUTOPHAGY; MEMBRANE RECRUITMENT; SELECTIVE AUTOPHAGY; SECRETORY PATHWAY	Atg18 and Atg21 are homologous WD-40 repeat proteins that bind phosphoinositides via a novel conserved Phe-Arg-Arg-Gly motif and function in autophagy-related pathways. Atg18 is required for the cytoplasm to vacuole targeting (Cvt) pathway and autophagy, whereas Atg21 is only required for the Cvt pathway. Currently, the functions of both proteins are poorly understood. Here, we examined the relationship between the phosphatidylinositol 3-phosphate (PtdIns(3)P)-binding abilities of Atg18 and Atg21 and autophagy by expressing variants of these proteins that have mutations in their phosphoinositide-binding motifs. Cells expressing PtdIns(3)P-binding mutants of both these proteins showed highly reduced autophagy. Furthermore, the localization of components of two related ubiquitin-like protein conjugation systems, Atg8 and Atg16, to the phagophore assembly site is affected. Consistent with the aberrant localization of the above Atg proteins, precursor Ape1, a cargo of the Cvt pathway and autophagy, is partially protease-sensitive in starvation conditions. This finding suggests a requirement for the PtdIns( 3) P binding capability of Atg18 and Atg21 in efficient completion of the sequestering autophagic vesicles. Finally, using a multiple knock-out strain, we found that Atg18 and Atg21 facilitate the recruitment of Atg8-PE to the site of autophagosome formation and protect it from premature cleavage by Atg4, which represents a key aspect of post-translational autophagy regulation. Taken together, our results suggest that PtdIns( 3) P binding by at least Atg18 or Atg21 is required for robust autophagic activity and that the PtdIns(3)P-binding motifs of Atg18 and Atg21 can compensate for one another in the recruitment of Atg components that are dependent on PtdIns( 3) P for their phagophore assembly site association.	[Nair, Usha; Cao, Yang; Xie, Zhiping; Klionsky, Daniel J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Nair, Usha; Cao, Yang; Xie, Zhiping; Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Klionsky, Daniel J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	klionsky@umich.edu	Xie, Zhiping/A-1306-2015	Xie, Zhiping/0000-0001-5816-6159	National Institutes of Health [GM53396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53396 (to D.J.K.).	Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; Barth H, 2002, FEBS LETT, V512, P173, DOI 10.1016/S0014-5793(02)02252-4; Barth H, 2001, FEBS LETT, V508, P23, DOI 10.1016/S0014-5793(01)03016-2; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Cao Y, 2008, J CELL BIOL, V182, P703, DOI 10.1083/jcb.200801035; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Denisenko ON, 1997, MOL CELL BIOL, V17, P4707, DOI 10.1128/MCB.17.8.4707; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Guan J, 2001, MOL BIOL CELL, V12, P3821, DOI 10.1091/mbc.12.12.3821; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; He CC, 2006, J CELL BIOL, V175, P925, DOI 10.1083/jcb.200606084; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; James P, 1996, GENETICS, V144, P1425; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Krick R, 2008, AUTOPHAGY, V4, P896, DOI 10.4161/auto.6801; Krick R, 2006, FEBS LETT, V580, P4632, DOI 10.1016/j.febslet.2006.07.041; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; LI QW, 1994, J BIOL CHEM, V269, P31777; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Meiling-Wesse K, 2004, J BIOL CHEM, V279, P37741, DOI 10.1074/jbc.M401066200; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Obara K, 2008, J BIOL CHEM, V283, P23972, DOI 10.1074/jbc.M803180200; Obara K, 2008, GENES CELLS, V13, P537, DOI 10.1111/j.1365-2443.2008.01188.x; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Reggiori F, 2005, MOL BIOL CELL, V16, P5843, DOI 10.1091/mbc.E05-07-0629; Reggiori F, 2004, MOL BIOL CELL, V15, P2189, DOI 10.1091/mbc.E03-07-0479; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292	61	92	100	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11476	11488		10.1074/jbc.M109.080374	http://dx.doi.org/10.1074/jbc.M109.080374			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154084	Green Published, hybrid			2022-12-25	WOS:000276286200054
J	Zhang, W; Zeng, X; Briggs, KJ; Beaty, R; Simons, B; Yen, RWC; Tyler, MA; Tsai, HC; Ye, Y; Gesell, GS; Herman, JG; Baylin, SB; Watkins, DN				Zhang, W.; Zeng, X.; Briggs, K. J.; Beaty, R.; Simons, B.; Yen, R-W Chiu; Tyler, M. A.; Tsai, H-C; Ye, Y.; Gesell, G. S.; Herman, J. G.; Baylin, S. B.; Watkins, D. N.			A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1	ONCOGENE			English	Article						Hic1; ephrin-A1; EphA2; EphA4	MILLER-DIEKER-SYNDROME; EPHA2 RECEPTOR; CELL-MIGRATION; COLORECTAL-CANCER; GENE; EXPRESSION; LIGAND; MICE; HYPERMETHYLATED-IN-CANCER-1; PROGRESSION	The tumor suppressor gene hypermethylated in cancer 1 (HIC1), which encodes a transcriptional repressor, is epigenetically inactivated in various human cancers. In this study, we show that HIC1 is a direct transcriptional repressor of the gene encoding ephrin-A1, a cell surface ligand implicated in the pathogenesis of epithelial cancers. We also show that mouse embryos lacking both Hic1 alleles manifest developmental defects spatially associated with the misexpression of ephrin-A1, and that overexpression of ephrin-A1 is a feature of tumors arising in Hic1 heterozygous mice in which the remaining wild-type allele is epigenetically silenced. In breast cancer, we find that ephrin-A1 expression is common in vivo, but that in cell culture, expression of the EphA receptors is predominant. Restoration of HIC1 function in breast cancer cells leads to a reduction in tumor growth in vivo, an effect that can be partially rescued by co-overexpression of ephrin-A1. Interestingly, overexpression of ephrin-A1 in vitro triggers downregulation of EphA2 and EphA4 levels, resulting in an expression pattern similar to that seen in vivo. We conclude that Hic1 spatially restricts ephrin-A1 expression in development, and that upregulated expression of ephrin-A1 resulting from epigenetic silencing of HIC1 in cancer cells may be an important mechanism in epithelial malignancy. Oncogene (2010) 29, 2467-2476; doi:10.1038/onc.2010.12; published online 15 February 2010	[Zhang, W.; Zeng, X.; Briggs, K. J.; Beaty, R.; Simons, B.; Yen, R-W Chiu; Tyler, M. A.; Tsai, H-C; Ye, Y.; Gesell, G. S.; Herman, J. G.; Baylin, S. B.; Watkins, D. N.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Zhang, W.; Zeng, X.; Briggs, K. J.; Beaty, R.; Simons, B.; Yen, R-W Chiu; Tyler, M. A.; Tsai, H-C; Ye, Y.; Gesell, G. S.; Herman, J. G.; Baylin, S. B.; Watkins, D. N.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; [Zeng, X.; Briggs, K. J.; Tsai, H-C] Johns Hopkins Univ, Sch Med, Grad Training Program Cellular & Mol Med, Baltimore, MD 21231 USA; [Watkins, D. N.] Monash Univ, Ctr Canc Res, Monash Inst Med Res, Clayton, Vic, Australia	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Monash University	Watkins, DN (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St,CRB I 541, Baltimore, MD 21231 USA.	sbaylin@jhmi.edu; neil.watkins@med.monash.edu.au	Tsai, Hsing-Chen/AAE-7530-2021; zhang, wei/A-7015-2011; Simons, Brian W./G-7352-2015; Watkins, David N/I-6113-2013	Tsai, Hsing-Chen/0000-0002-7057-9084; Simons, Brian W./0000-0003-0644-211X; 	National Cancer Institute [R01 CA43318]; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA043318] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute Grant R01 CA43318 (SB Baylin) and an American Cancer Society Postdoctoral Fellowship (W Zhang). We thank Craig D Peacock, Leslie Meszler and Lillian Dasko-Vincent for technical assistance, Leander Van Neste for biostatistical support and Kathy Bender for the preparation and submission of this paper.	Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Briggs KJ, 2008, GENE DEV, V22, P770, DOI 10.1101/gad.1640908; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Deltour S, 1998, BBA-GENE STRUCT EXPR, V1443, P230, DOI 10.1016/S0167-4781(98)00219-X; Easty DJ, 1999, INT J CANCER, V84, P494, DOI 10.1002/(SICI)1097-0215(19991022)84:5<494::AID-IJC8>3.3.CO;2-F; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Guo H, 2006, CANCER RES, V66, P7050, DOI 10.1158/0008-5472.CAN-06-0004; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herath NI, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-144; Hirotsune S, 1997, GENOME RES, V7, P625, DOI 10.1101/gr.7.6.625; Holder N, 1999, DEVELOPMENT, V126, P2033; Iida H, 2005, GUT, V54, P843, DOI 10.1136/gut.2004.049486; Jenal M, 2009, MOL CANCER RES, V7, P916, DOI 10.1158/1541-7786.MCR-08-0359; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Nakamura R, 2005, CANCER SCI, V96, P42, DOI 10.1111/j.1349-7006.2005.00007.x; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Potla L, 2002, CANCER LETT, V175, P187, DOI 10.1016/S0304-3835(01)00613-9; Shi L, 2008, ONCOGENE, V27, P3265, DOI 10.1038/sj.onc.1210992; Takai N, 2001, ONCOL REP, V8, P567; Tang XX, 1999, CLIN CANCER RES, V5, P1491; Van Rechem C, 2009, J BIOL CHEM, V284, P20927, DOI 10.1074/jbc.M109.022350; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wykosky J, 2008, ONCOGENE, V27, P7260, DOI 10.1038/onc.2008.328; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Zhang W, 2008, CANCER RES, V68, P2764, DOI 10.1158/0008-5472.CAN-07-6349	44	35	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	17					2467	2476		10.1038/onc.2010.12	http://dx.doi.org/10.1038/onc.2010.12			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	589RB	20154726	Green Accepted			2022-12-25	WOS:000277169400002
J	Douglas, DN; Kawahara, T; Sis, B; Bond, D; Fischer, KP; Tyrrell, DLJ; Lewis, JT; Kneteman, NM				Douglas, Donna N.; Kawahara, Toshiyasu; Sis, Banu; Bond, David; Fischer, Karl P.; Tyrrell, D. Lorne J.; Lewis, Jamie T.; Kneteman, Norman M.			Therapeutic Efficacy of Human Hepatocyte Transplantation in a SCID/uPA Mouse Model with Inducible Liver Disease	PLOS ONE			English	Article							THYMIDINE KINASE GENE; SIMPLEX-VIRUS TYPE-1; EXPERIMENTAL BRAIN-TUMORS; HSV-TK EXPRESSION; IN-VITRO; TRANSGENIC MICE; GAP-JUNCTIONS; CLINICAL-IMPLICATIONS; NONSENSE MUTATION; CATALYTIC SUBUNIT	Background: Severe Combined Immune Deficient (SCID)/Urokinase-type Plasminogen Activator (uPA) mice undergo liver failure and are useful hosts for the propagation of transplanted human hepatocytes (HH) which must compete with recipient-derived hepatocytes for replacement of the diseased liver parenchyma. While partial replacement by HH has proven useful for studies with Hepatitis C virus, complete replacement of SCID/uPA mouse liver by HH has never been achieved and limits the broader application of these mice for other areas of biomedical research. The herpes simplex virus type-1 thymidine kinase (HSVtk)/ganciclovir (GCV) system is a powerful tool for cell-specific ablation in transgenic animals. The aim of this study was to selectively eliminate murine-derived parenchymal liver cells from humanized SCID/uPA mouse liver in order to achieve mice with completely humanized liver parenchyma. Thus, we reproduced the HSVtk (vTK)/GCV system of hepatic failure in SCID/uPA mice. Methodology/Principal Findings: In vitro experiments demonstrated efficient killing of vTK expressing hepatoma cells after GCV treatment. For in vivo experiments, expression of vTK was targeted to the livers of FVB/N and SCID/uPA mice. Hepatic sensitivity to GCV was first established in FVB/N mice since these mice do not undergo liver failure inherent to SCID/uPA mice. Hepatic vTK expression was found to be an integral component of GCV-induced pathologic and biochemical alterations and caused death due to liver dysfunction in vTK transgenic FVB/N and non-transplanted SCID/uPA mice. In SCID/uPA mice with humanized liver, vTK/GCV caused death despite extensive replacement of the mouse liver parenchyma with HH (ranging from 32-87%). Surprisingly, vTK/GCV-dependent apoptosis and mitochondrial aberrations were also localized to bystander vTK-negative HH. Conclusions/Significance: Extensive replacement of mouse liver parenchyma by HH does not provide a secure therapeutic advantage against vTK/GCV-induced cytotoxicity targeted to residual mouse hepatocytes. Functional support by engrafted HH may be secured by strategies aimed at limiting this bystander effect.	[Douglas, Donna N.; Kawahara, Toshiyasu; Tyrrell, D. Lorne J.; Lewis, Jamie T.; Kneteman, Norman M.] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Bond, David; Fischer, Karl P.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Sis, Banu] Univ Alberta Hosp, Dept Lab Med & Pathol, Edmonton, AB T6G 2R7, Canada; [Tyrrell, D. Lorne J.; Kneteman, Norman M.] KMT Hepatech Inc, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Douglas, DN (corresponding author), Univ Alberta, Dept Surg, Edmonton, AB, Canada.	donnad@ualberta.ca		Sis, Banu/0000-0001-9215-2535	Canadian Institutes of Health Research [G019000018]; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by Canadian Institutes of Health Research Grant # G019000018 and Alberta Heritage Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSHAWI R, 1988, MOL CELL BIOL, V8, P4821, DOI 10.1128/MCB.8.11.4821; ALSHAWI R, 1991, MOL CELL BIOL, V11, P4207, DOI 10.1128/MCB.11.8.4207; Araki R, 1997, P NATL ACAD SCI USA, V94, P2438, DOI 10.1073/pnas.94.6.2438; Asklund T, 2003, EXP CELL RES, V284, P185, DOI 10.1016/S0014-4827(02)00052-6; BARBA D, 1994, P NATL ACAD SCI USA, V91, P4348, DOI 10.1073/pnas.91.10.4348; BARRY M, 1990, PHARMACOL THERAPEUT, V48, P71, DOI 10.1016/0163-7258(90)90019-X; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; BI WL, 1993, HUM GENE THER, V4, P725, DOI 10.1089/hum.1993.4.6-725; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; Brand T, 1997, MECH DEVELOP, V64, P53, DOI 10.1016/S0925-4773(97)00044-0; Braun KM, 2000, NAT MED, V6, P320; BRAUN RE, 1990, BIOL REPROD, V43, P684, DOI 10.1095/biolreprod43.4.684; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; CARUSO M, 1993, P NATL ACAD SCI USA, V90, P7024, DOI 10.1073/pnas.90.15.7024; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; Dilber MS, 1997, CANCER RES, V57, P1523; ELLISON AR, 1995, MOL REPROD DEV, V41, P425, DOI 10.1002/mrd.1080410405; Elshami AA, 1996, GENE THER, V3, P85; Fausto N, 2005, J HEPATO-BILIARY-PAN, V12, P181, DOI 10.1007/s00534-005-0979-y; Fausto N, 2001, LIVER TRANSPLANT, V7, P835, DOI 10.1053/jlts.2001.27865; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; FICK J, 1995, P NATL ACAD SCI USA, V92, P11071, DOI 10.1073/pnas.92.24.11071; Fillat C., 2003, Current Gene Therapy, V3, P13, DOI 10.2174/1566523033347426; FREEMAN SM, 1993, CANCER RES, V53, P5274; Freeman SM, 1996, SEMIN ONCOL, V23, P31; Gomez-Lechon MJ, 2003, CURR DRUG METAB, V4, P292, DOI 10.2174/1389200033489424; Graham L, 2007, NAT PROTOC, V2, P2439, DOI 10.1038/nprot.2007.304; Hamel W, 1996, CANCER RES, V56, P2697; HUTTNER KM, 1993, BIOL REPROD, V49, P251, DOI 10.1095/biolreprod49.2.251; Izquierdo M, 1996, GENE THER, V3, P491; KANEKO Y, 1995, CANCER LETT, V96, P105, DOI 10.1016/0304-3835(95)03919-N; Klatzmann D, 1998, HUM GENE THER, V9, P2595, DOI 10.1089/hum.1998.9.17-2595; Kneteman NM, 2006, HEPATOLOGY, V43, P1346, DOI 10.1002/hep.21209; LEE WM, 1995, NEW ENGL J MED, V333, P1118, DOI 10.1056/NEJM199510263331706; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Mesnil M, 1996, P NATL ACAD SCI USA, V93, P1831, DOI 10.1073/pnas.93.5.1831; Meuleman P, 2003, BIOCHEM BIOPH RES CO, V308, P375, DOI 10.1016/S0006-291X(03)01388-3; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MOOLTEN FL, 1986, CANCER RES, V46, P5276; Myronovych A, 2008, J HEPATOL, V49, P363, DOI 10.1016/j.jhep.2008.04.019; Naritomi Y, 2001, DRUG METAB DISPOS, V29, P1316; OLDFIELD EH, 1993, HUM GENE THER, V4, P39, DOI 10.1089/hum.1993.4.1-39; PARK BK, 1981, CLIN PHARMACOKINET, V6, P1, DOI 10.2165/00003088-198106010-00001; RAM Z, 1993, CANCER RES, V53, P83; RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734; Rodrigues A D, 1997, Adv Pharmacol, V43, P65, DOI 10.1016/S1054-3589(08)60202-1; Rodrigues AD, 2002, CURR DRUG METAB, V3, P289, DOI 10.2174/1389200023337522; RODRIGUES AD, 1994, ANAL BIOCHEM, V219, P309, DOI 10.1006/abio.1994.1271; RODRIGUES AD, 1994, BIOCHEM PHARMACOL, V48, P197; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; SANDGREN EP, 1992, P NATL ACAD SCI USA, V89, P11523, DOI 10.1073/pnas.89.23.11523; SHIOTA G, 1995, RES COMMUN MOL PATH, V89, P259; Sterman DH, 1998, HEMATOL ONCOL CLIN N, V12, P553, DOI 10.1016/S0889-8588(05)70008-3; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Thust R, 2000, MUTAGENESIS, V15, P177, DOI 10.1093/mutage/15.2.177; van der Eb MM, 1998, GENE THER, V5, P451, DOI 10.1038/sj.gt.3300637; van der Eb MM, 2003, J GENE MED, V5, P1018, DOI 10.1002/jgm.450; Wallace H, 1996, ONCOGENE, V13, P55; Zhang Y, 2005, FEBS J, V272, P2207, DOI 10.1111/j.1742-4658.2005.04644.x	59	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9209	10.1371/journal.pone.0009209	http://dx.doi.org/10.1371/journal.pone.0009209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174638	Green Published, Green Submitted, gold			2022-12-25	WOS:000274654700008
J	Suzuki, K; Okada, K; Wakuda, T; Shinmura, C; Kameno, Y; Iwata, K; Takahashi, T; Suda, S; Matsuzaki, H; Iwata, Y; Hashimoto, K; Mori, N				Suzuki, Katsuaki; Okada, Kyoko; Wakuda, Tomoyasu; Shinmura, Chie; Kameno, Yosuke; Iwata, Keiko; Takahashi, Taro; Suda, Shiro; Matsuzaki, Hideo; Iwata, Yasuhide; Hashimoto, Kenji; Mori, Norio			Destruction of Dopaminergic Neurons in the Midbrain by 6-Hydroxydopamine Decreases Hippocampal Cell Proliferation in Rats: Reversal by Fluoxetine	PLOS ONE			English	Article							PARKINSONS-DISEASE; ANTIDEPRESSANT TREATMENT; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; STIMULATION PROMOTES; OPEN-LABEL; DEPRESSION; SYMPTOMS; PROJECTIONS; MANAGEMENT	Background: Non-motor symptoms (e. g., depression, anxiety, and cognitive deficits) in patients with Parkinson disease (PD) precede the onset of the motor symptoms. Although these symptoms do not respond to pharmacological dopamine replacement therapy, their precise pathological mechanisms are currently unclear. The present study was undertaken to examine whether the unilateral 6-hydroxydopamine (6-OHDA) lesion to the substantia nigra pars compacta (SNc), which represents a model of long-term dopaminergic neurotoxicity, could affect cell proliferation in the adult rat brain. Furthermore, we examined the effects of the selective serotonin reuptake inhibitor (SSRI) fluoxetine and the selective noradrenaline reuptake inhibitor maprotiline on the reduction in cell proliferation in the subgranular zone (SGZ) by the unilateral 6-OHDA lesion. Methodology/Principal Findings: A single unilateral injection of 6-OHDA into the rat SNc resulted in an almost complete loss of tyrosine hydroxylase (TH) immunoreactivity in the striatum and SNc, as well as in reductions of TH-positive cells and fibers in the ventral tegmental area (VTA). On the other hand, an injection of vehicle alone showed no overt change in TH immunoreactivity. A unilateral 6-OHDA lesion to SNc significantly decreased cell proliferation in the SGZ ipsilateral to the 6-OHDA lesion, but not in the contralateral SGZ or the subventricular zone (SVZ), of rats. Furthermore, subchronic (14 days) administration of fluoxetine (5 mg/kg/day), but not maprotiline significantly attenuated the reduction in cell proliferation in the SGZ by unilateral 6-OHDA lesion. Conclusions/Significance: The present study suggests that cell proliferation in the SGZ of the dentate gyrus might be, in part, under dopaminergic control by SNc and VTA, and that subchronic administration of fluoxetine reversed the reduction in cell proliferation in the SGZ by 6-OHDA. Therefore, SSRIs such as fluoxetine might be potential therapeutic drugs for non-motor symptoms as well as motor symptoms in patients with PD, which might be associated with the reduction in cell proliferation in the SGZ.	[Suzuki, Katsuaki; Iwata, Keiko; Takahashi, Taro; Suda, Shiro] Hamamatsu Univ Sch Med, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4312102, Japan; [Okada, Kyoko; Wakuda, Tomoyasu; Shinmura, Chie; Kameno, Yosuke; Iwata, Yasuhide; Mori, Norio] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka 4312102, Japan; [Matsuzaki, Hideo] Osaka Univ, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Grad Sch Med, Suita, Osaka, Japan; [Hashimoto, Kenji] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Osaka University; Chiba University	Suzuki, K (corresponding author), Hamamatsu Univ Sch Med, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4312102, Japan.	k-suzuki@hama-med.ac.jp; hashimoto@faculty.chiba-u.jp	MATSUZAKI, HIDEO/AAE-5246-2020; Hashimoto, Kenji/I-5800-2015	MATSUZAKI, HIDEO/0000-0002-6869-1261; Wakuda, Tomoyasu/0000-0002-1924-8167; Hashimoto, Kenji/0000-0002-8892-0439; Suzuki, Katsuaki/0000-0003-0446-3355	Ministry of Education, Culture, Sports, Science, and Technology of Japan [19209039, 19591347]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to Drs. N. Mori (# 19209039) and T. Wakuda (# 19591347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMALRIC M, 1993, PROG BRAIN RES, V99, P209; Baker SA, 2004, EUR J NEUROSCI, V20, P575, DOI 10.1111/j.1460-9568.2004.03486.x; Beauquis J, 2006, EUR J NEUROSCI, V23, P1539, DOI 10.1111/j.1460-9568.2006.04691.x; Berendse HW, 2001, ANN NEUROL, V50, P34, DOI 10.1002/ana.1049; Borta A, 2007, J NEUROCHEM, V100, P587, DOI 10.1111/j.1471-4159.2006.04241.x; Brandstadter D, 2003, ADV NEUROL, V91, P371; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Coronas V, 2004, J NEUROCHEM, V91, P1292, DOI 10.1111/j.1471-4159.2004.02823.x; Dell'Agnello G, 2001, CLIN NEUROPHARMACOL, V24, P221, DOI 10.1097/00002826-200107000-00005; Devos D, 2008, MOVEMENT DISORD, V23, P850, DOI 10.1002/mds.21966; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Duman RS, 2001, NEUROPSYCHOPHARMACOL, V25, P836, DOI 10.1016/S0893-133X(01)00358-X; EHRINGER H, 1960, KLIN WOCHENSCHR, V38, P1236, DOI 10.1007/BF01485901; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Freundlieb N, 2006, J NEUROSCI, V26, P2321, DOI 10.1523/JNEUROSCI.4859-05.2006; Gasbarri A, 1997, PROG NEURO-PSYCHOPH, V21, P1, DOI 10.1016/S0278-5846(96)00157-1; Gesi M, 2000, NEUROSCI BIOBEHAV R, V24, P655, DOI 10.1016/S0149-7634(00)00028-2; Gonera EG, 1997, MOVEMENT DISORD, V12, P871, DOI 10.1002/mds.870120607; GREENFIELD JG, 1953, J NEUROL NEUROSUR PS, V16, P213, DOI 10.1136/jnnp.16.4.213; Grote HE, 2005, EUR J NEUROSCI, V22, P2081, DOI 10.1111/j.1460-9568.2005.04365.x; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Hiramoto T, 2007, NEUROREPORT, V18, P659, DOI 10.1097/WNR.0b013e3280bef9d3; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Ishihara L, 2006, ACTA NEUROL SCAND, V113, P211, DOI 10.1111/j.1600-0404.2006.00579.x; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; Lemke MR, 2008, EUR J NEUROL, V15, P21, DOI 10.1111/j.1468-1331.2008.02058.x; Loughlin S.E., 1985, RAT NERVOUS SYSTEM H, V2, P79; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manev H, 2001, EUR J PHARMACOL, V411, P67, DOI 10.1016/S0014-2999(00)00904-3; Oertel WH, 2001, ADV NEUROL, V86, P373; Perera TD, 2008, NEUROSCIENTIST, V14, P326, DOI 10.1177/1073858408317242; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2004, BIOL PSYCHIAT, V56, P137, DOI 10.1016/j.biopsych.2004.04.012; SCATTON B, 1980, NEUROSCI LETT, V18, P125, DOI 10.1016/0304-3940(80)90314-6; Schrag A, 2006, LANCET NEUROL, V5, P355, DOI 10.1016/S1474-4422(06)70411-2; Schrag A, 2006, J NEUROL SCI, V248, P151, DOI 10.1016/j.jns.2006.05.030; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; Vajda FJE, 2005, J CLIN NEUROSCI, V12, P739, DOI 10.1016/j.jocn.2005.03.008; Wakuda T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003648; Weintraub D, 2008, AM J MANAG CARE, V14, pS59; Weintraub D, 2008, AM J MANAG CARE, V14, pS40; Weintraub D, 2006, J NEUROPSYCH CLIN N, V18, P377, DOI 10.1176/appi.neuropsych.18.3.377; Winner B, 2006, EXP NEUROL, V197, P113, DOI 10.1016/j.expneurol.2005.08.028; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	48	45	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9260	10.1371/journal.pone.0009260	http://dx.doi.org/10.1371/journal.pone.0009260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174647	Green Published, Green Submitted, gold			2022-12-25	WOS:000274590600015
J	Shehadeh, LA; Yu, K; Wang, LY; Guevara, A; Singer, C; Vance, J; Papapetropoulos, S				Shehadeh, Lina A.; Yu, Kristine; Wang, Liyong; Guevara, Alexandra; Singer, Carlos; Vance, Jeffery; Papapetropoulos, Spyridon			SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GENE-EXPRESSION; SUBSTANTIA-NIGRA; AXON GUIDANCE; FRONTOTEMPORAL DEMENTIA; GLUTAMATE TRANSPORTER; ALZHEIMERS-DISEASE; IN-VITRO; RNA; PROTEINS	Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects about five million people worldwide. Diagnosis remains clinical, based on phenotypic patterns. The discovery of laboratory markers that will enhance diagnostic accuracy, allow pre-clinical detection and tracking of disease progression is critically needed. These biomarkers may include transcripts with different isoforms. Methodology/Principal Findings: We performed extensive analysis on 3 PD microarray experiments available through GEO and found that the RNA splicing gene SRRM2 (or SRm300), sereine/arginine repetitive matrix 2, was the only gene differentially upregulated among all the three PD experiments. SRRM2 expression was not changed in the blood of other neurological diseased patients versus the healthy controls. Using real-time PCR, we report that the shorter transcript of SRRM2 was 1.7 fold (p = 0.008) upregulated in the substantia nigra of PDs vs controls while the longer transcript was 0.4 downregulated in both the substantia nigra (p = 0.03) and amygdala (p = 0.003). To validate our results and test for the possibility of alternative splicing in PD, we performed independent microarray scans, using Affymetrix Exon_ST1 arrays, from peripheral blood of 28 individuals (17 PDs and 11 Ctrls) and found a significant upregulation of the upstream (5') exons of SRRM2 and a downregulation of the downstream exons, causing a total of 0.7 fold down regulation (p = 0.04) of the long isoform. In addition, we report novel information about hundreds of genes with significant alternative splicing (differential exonic expression) in PD blood versus controls. Conclusions/Significance: The consistent dysregulation of the RNA splicing factor SRRM2 in two different PD neuronal sources and in PD blood but not in blood of other neurologically diseased patients makes SRRM2 a strong candidate gene for PD and draws attention to the role of RNA splicing in the disease.	[Shehadeh, Lina A.] Univ Miami, Dept Mol & Cellular Pharmacol, Leonard M Miller Sch Med, Miami, FL 33152 USA; [Yu, Kristine; Wang, Liyong; Vance, Jeffery] Univ Miami, Dept Human Genet, Leonard M Miller Sch Med, Miami, FL USA; [Guevara, Alexandra; Singer, Carlos; Papapetropoulos, Spyridon] Univ Miami, Dept Neurol, Leonard M Miller Sch Med, Miami, FL USA	University of Miami; University of Miami; University of Miami	Shehadeh, LA (corresponding author), Univ Miami, Dept Mol & Cellular Pharmacol, Leonard M Miller Sch Med, Miami, FL 33152 USA.	lshehadeh@med.miami.edu	Singer, Carlos/AAI-6643-2020; Pinheiro, Maísa/E-7424-2012	Vance, Jeffery/0000-0003-3815-8199	University of Miami Miller School of Medicine; National Institutes of Health National Institute of Neurological Disorders and Stroke (NIH/NINDS); Morris K. Udall Parkinson Disease Research Center of Excellence (JV); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL083673] Funding Source: NIH RePORTER	University of Miami Miller School of Medicine; National Institutes of Health National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Morris K. Udall Parkinson Disease Research Center of Excellence (JV); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This study was partly supported by an intramural Scientific Awards Committee (SAC) grant from the University of Miami Miller School of Medicine (SP and LAS) and a National Institutes of Health National Institute of Neurological Disorders and Stroke (NIH/NINDS) Morris K. Udall Parkinson Disease Research Center of Excellence (JV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBARIAN S, 1995, BRAIN RES, V699, P297, DOI 10.1016/0006-8993(95)00922-D; Beyer K, 2008, NEUROGENETICS, V9, P15, DOI 10.1007/s10048-007-0106-0; Bossers K, 2009, BRAIN PATHOL, V19, P91, DOI 10.1111/j.1750-3639.2008.00171.x; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Catania MV, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-11-j0002.2001; Chisa JL, 2007, GENETICS, V175, P1079, DOI 10.1534/genetics.106.066183; D'Agata V, 2004, NEUROCHEM RES, V29, P1715, DOI 10.1023/B:NERE.0000035807.25370.5e; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Davies RC, 1998, GENE DEV, V12, P3217, DOI 10.1101/gad.12.20.3217; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Dubey D, 2008, HUM MOL GENET, V17, P3010, DOI 10.1093/hmg/ddn199; Duke DC, 2006, NEUROGENETICS, V7, P139, DOI 10.1007/s10048-006-0033-5; Gloor GB, 2000, GENETICS, V155, P1821; Greene JG, 2008, NEUROSCIENCE, V152, P198, DOI 10.1016/j.neuroscience.2007.11.029; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Lesnick TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001449; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Lynch KW, 2001, J BIOL CHEM, V276, P24341, DOI 10.1074/jbc.M102175200; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; McLean PJ, 2002, NEUROSCI LETT, V323, P219, DOI 10.1016/S0304-3940(02)00154-4; Miller RM, 2006, NEUROBIOL DIS, V21, P305, DOI 10.1016/j.nbd.2005.07.010; Mukherji M, 2006, BIOCHEMISTRY-US, V45, P15529, DOI 10.1021/bi060971c; Papapetropoulos S, 2007, FUTUR NEUROL, V2, P29, DOI 10.2217/14796708.2.1.29; Papapetropoulos S, 2006, GENE EXPRESSION, V13, P205, DOI 10.3727/000000006783991827; Potashkin JA, 2007, BRAIN RES, V1182, P1, DOI 10.1016/j.brainres.2007.08.080; Sato N, 1999, J NEUROCHEM, V72, P2498, DOI 10.1046/j.1471-4159.1999.0722498.x; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Tan EK, 2005, NEUROGENETICS, V6, P179, DOI 10.1007/s10048-005-0001-5; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59	38	66	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9104	10.1371/journal.pone.0009104	http://dx.doi.org/10.1371/journal.pone.0009104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161708	gold, Green Submitted, Green Published			2022-12-25	WOS:000274442500011
J	Garcia-Marcos, M; Ghosh, P; Ear, J; Farquhar, MG				Garcia-Marcos, Mikel; Ghosh, Pradipta; Ear, Jason; Farquhar, Marilyn G.			A Structural Determinant That Renders G alpha(i) Sensitive to Activation by GIV/Girdin Is Required to Promote Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; RECEPTOR-MEDIATED ACTIVATION; PROTEIN SIGNALING PROTEINS; ENDOGENOUS RGS PROTEINS; BREAST-CANCER CELLS; ADENYLYL-CYCLASE; LYSOPHOSPHATIDIC ACID; ALPHA-SUBUNITS; GTP HYDROLYSIS; CRYSTAL-STRUCTURE	Although several non-receptor activators of heterotrimeric G proteins have been identified, the structural features of G proteins that determine their interaction with such activators and the subsequent biological effects are poorly understood. Here we investigated the structural determinants in G alpha i(3) necessary for its regulation by GIV/girdin, a guanine-nucleotide exchange factor (GEF) that activates G alpha(i) subunits. Using G protein activity and in vitro pulldown assays we demonstrate that G alpha i(3) is a better substrate for GIV than the highly homologous G alpha(o). We identified Trp-258 in the G alpha(i) subunit as a novel structural determinant for GIV binding by comparing GIV binding to G alpha(i3)/G alpha(o) chimeras. Mutation of Trp-258 to the corresponding Phe in G alpha(o) decreased GIV binding in vitro and in cultured cells but did not perturb interaction with other G alpha-binding partners, i.e. G beta gamma, AGS3 (a guanine nucleotide dissociation inhibitor), GAIP/RGS19 (a GTPase-activating protein), and LPAR1 (a G protein-coupled receptor). Activation of G alpha(i3) by GIV was also dramatically reduced when Trp-258 was replaced with Tyr, Leu, Ser, His, Asp, or Ala, highlighting that Trp is required for maximal activation. Moreover, when mutant G alpha(i3) W258F was expressed in HeLa cells they failed to undergo cell migration and to enhance Akt signaling after growth factor or G protein-coupled receptor stimulation. Thus activation of G alpha(i3) by GIV is essential for biological functions associated with G alpha(i3) activation. In conclusion, we have discovered a novel structural determinant on G alpha(i) that plays a key role in defining the selectivity and efficiency of the GEF activity of GIV on G alpha(i) and that represents an attractive target site for designing small molecules to disrupt the G alpha(i)-GIV interface for therapeutic purposes.	[Farquhar, Marilyn G.] Univ Calif San Diego, Dept Cellular & Mol Med, George Palade Labs Cellular & Mol Med, La Jolla, CA 92093 USA; [Ghosh, Pradipta; Ear, Jason] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Farquhar, MG (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, George Palade Labs Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mfarquhar@ucsd.edu		Garcia-Marcos, Mikel/0000-0001-9513-4826	National Institutes of Health [DKI7780, CA100768]; Basque Government [BFI06.300]; Susan G. Komen Postdoctoral Fellowship [KG080079]; American Gastroenterology Association [T32 DK07202]; McNair Student Research Scholarship; NATIONAL CANCER INSTITUTE [R01CA100768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basque Government(Basque Government); Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); American Gastroenterology Association; McNair Student Research Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DKI7780 and CA100768 (to M. G. F.).; Supported by Basque Government Postdoctoral Fellowship BFI06.300 and Susan G. Komen Postdoctoral Fellowship KG080079.; Supported by a Research Scholar Award from the American Gastroenterology Association and by Training Grant T32 DK07202.; Recipient of a McNair Student Research Scholarship.	Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Cavalli A, 2000, J BIOL CHEM, V275, P23693, DOI 10.1074/jbc.M910395199; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Clark MJ, 2003, J BIOL CHEM, V278, P9418, DOI 10.1074/jbc.M208885200; Clark MJ, 2004, J PHARMACOL EXP THER, V310, P215, DOI 10.1124/jpet.103.064824; CODINA J, 1994, J BIOL CHEM, V269, P29339; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DeVries L, 1996, P NATL ACAD SCI USA, V93, P15203, DOI 10.1073/pnas.93.26.15203; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; Fu Y, 2004, METHOD ENZYMOL, V389, P229; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Grishina G, 1998, J BIOL CHEM, V273, P15053, DOI 10.1074/jbc.273.24.15053; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; Huang XY, 2008, DIABETES, V57, P77, DOI 10.2337/db07-0599; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; Krumins AM, 2002, METHOD ENZYMOL, V344, P673; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Lane JR, 2008, J PHARMACOL EXP THER, V325, P319, DOI 10.1124/jpet.107.134296; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Malik S, 2005, MOL PHARMACOL, V68, P129, DOI 10.1124/mol.104.010116; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Mukhopadhyay S, 2002, METHOD ENZYMOL, V344, P350; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Nishimura A, 2006, GENES CELLS, V11, P487, DOI 10.1111/j.1365-2443.2006.00959.x; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Qiao M, 2007, CANCER RES, V67, P5293, DOI 10.1158/0008-5472.CAN-07-0877; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Slep KC, 2008, P NATL ACAD SCI USA, V105, P6243, DOI 10.1073/pnas.0801569105; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Vazquez-Prado J, 2004, J BIOL CHEM, V279, P54283, DOI 10.1074/jbc.M410594200; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Warner DR, 1999, P NATL ACAD SCI USA, V96, P4268, DOI 10.1073/pnas.96.8.4268; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200; Wise A, 1999, BIOCHEMISTRY-US, V38, P2272, DOI 10.1021/bi982054f; Ye XQ, 2002, BBA-MOL CELL BIOL L, V1585, P108, DOI 10.1016/S1388-1981(02)00330-X	61	59	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12765	12777		10.1074/jbc.M109.045161	http://dx.doi.org/10.1074/jbc.M109.045161			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20157114	Green Published, hybrid			2022-12-25	WOS:000276787800035
J	Crawford, J; Lamb, E; Wasmuth, J; Grujic, O; Grigg, ME; Boulanger, MJ				Crawford, Joanna; Lamb, Erika; Wasmuth, James; Grujic, Ognjen; Grigg, Michael E.; Boulanger, Martin J.			Structural and Functional Characterization of SporoSAG A SAG2-RELATED SURFACE ANTIGEN FROM TOXOPLASMA GONDII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII INFECTION; SURFACE-ANTIGEN; WATERBORNE TOXOPLASMOSIS; SWINE FARMS; PROTEIN; OUTBREAK; ENCEPHALITIS; SUPERFAMILY; ANTIBODIES; HUMANS	Toxoplasma gondii, the etiological agent of toxoplasmosis, utilizes stage-specific expression of antigenically distinct glycosylphosphatidylinositol-tethered surface coat proteins to promote and establish chronic infection. Of the three infective stages of T. gondii, sporozoites are encapsulated in highly infectious oocysts that have been linked to large scale outbreaks of toxoplasmosis. SporoSAG (surface antigen glycoprotein) is the dominant surface coat protein expressed on the surface of sporozoites. Using a bioinformatic approach, we show that SporoSAG clusters with the SAG2 subfamily of the SAG1-related superfamily (SRS) and is non-polymorphic among the 11 haplogroups of T. gondii strains. In contrast to the immunodominant SAG1 protein expressed on tachyzoites, SporoSAG is non-immunogenic during natural infection. We report the 1.60 angstrom resolution crystal structure of SporoSAG solved using cadmium single anomalous dispersion. SporoSAG crystallized as a monomer and displays unique features of the SRS beta-sandwich fold relative to SAG1 and BSR4. Intriguingly, the structural diversity is localized to the upper sheets of the beta-sandwich fold and may have important implications for multimerization and host cell ligand recognition. The structure of SporoSAG also reveals an unexpectedly acidic surface that contrasts with the previously determined SAG1 and BSR4 structures where a basic surface is predicted to play a role in binding negatively charged glycosaminoglycans. Our structural and functional characterization of SporoSAG provides a rationale for the evolutionary divergence of this key SRS family member.	[Lamb, Erika; Grigg, Michael E.] NIAID, Mol Parasitol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Crawford, Joanna; Grujic, Ognjen; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Wasmuth, James] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1L7, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Victoria; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Grigg, ME (corresponding author), NIAID, Mol Parasitol Unit, Parasit Dis Lab, NIH, 4 Ctr Dr, Bethesda, MD 20892 USA.	griggm@niaid.nih.gov; mboulang@uvic.ca	Crawford, Joanna/F-9135-2013	Crawford, Joanna/0000-0003-0786-6889; Wasmuth, James/0000-0002-9516-212X	Canadian Institutes of Health Research (CIHR) [MOP82915]; National Institutes of Health through the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001017] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Research Grant MOP82915 from the Canadian Institutes of Health Research (CIHR) (to M. J. B.). This work was also supported by the Intramural Research Program of the National Institutes of Health (to M. E. G.) through the NIAID.	Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENENSON MW, 1982, NEW ENGL J MED, V307, P666, DOI 10.1056/NEJM198209093071107; BESSIERES MH, 1992, PARASITOL RES, V78, P222, DOI 10.1007/BF00931730; Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Crawford J, 2009, J BIOL CHEM, V284, P9192, DOI 10.1074/jbc.M808714200; de Moura L, 2006, EMERG INFECT DIS, V12, P326, DOI 10.3201/eid1202.041115; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DRUMMOND AJ, 2006, GENEIOUS VERSION 2 5; Dubey JP, 2007, VET PARASITOL, V145, P352, DOI 10.1016/j.vetpar.2006.12.016; Dubey JP, 2004, VET PARASITOL, V126, P57, DOI 10.1016/j.vetpar.2004.09.005; DUBEY JP, 1995, J PARASITOL, V81, P723, DOI 10.2307/3283961; Dubey JP, 2002, J PARASITOL, V88, P802, DOI 10.1645/0022-3395(2002)088[0802:POTGAI]2.0.CO;2; DUBEY JP, 1981, AM J VET RES, V42, P1007; Dzierszinski F, 2000, MOL MICROBIOL, V37, P574, DOI 10.1046/j.1365-2958.2000.02014.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Grimwood J, 1996, INT J PARASITOL, V26, P169, DOI 10.1016/0020-7519(95)00103-4; Grujic O, 2008, ACTA CRYSTALLOGR F, V64, P425, DOI 10.1107/S1744309108010920; He XL, 2002, NAT STRUCT BIOL, V9, P606, DOI 10.1038/nsb819; Jackson M. H., 1989, Advances in Parasitology, V28, P55, DOI 10.1016/S0065-308X(08)60331-0; Jones JL, 2003, EMERG INFECT DIS, V9, P1371, DOI 10.3201/eid0911.030098; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; KHAN IA, 1988, J INFECT DIS, V157, P979, DOI 10.1093/infdis/157.5.979; Kong JT, 2003, J INFECT DIS, V187, P1484, DOI 10.1086/374647; Lau YL, 2008, EXP PARASITOL, V119, P373, DOI 10.1016/j.exppara.2008.03.016; LUFT BJ, 1984, JAMA-J AM MED ASSOC, V252, P913, DOI 10.1001/jama.252.7.913; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MCCABE RE, 1983, EUR J CLIN MICROBIOL, V2, P95, DOI 10.1007/BF02001573; MCDONALD JC, 1990, J INFECT DIS, V161, P769, DOI 10.1093/infdis/161.4.769; MINEO JR, 1994, EXP PARASITOL, V79, P11, DOI 10.1006/expr.1994.1054; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NUSSENBLATT RB, 1994, JAMA-J AM MED ASSOC, V271, P304, DOI 10.1001/jama.271.4.304; PARTANEN P, 1984, J CLIN MICROBIOL, V20, P133, DOI 10.1128/JCM.20.1.133-135.1984; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Prigione I, 2000, J IMMUNOL, V164, P3741, DOI 10.4049/jimmunol.164.7.3741; Radke JR, 2004, MOL MICROBIOL, V52, P93, DOI 10.1111/j.1365-2958.2003.03967.x; Sharif M, 2009, TROP ANIM HEALTH PRO, V41, P183, DOI 10.1007/s11250-008-9173-y; SILVEIRA C, 1988, AM J OPHTHALMOL, V106, P362, DOI 10.1016/0002-9394(88)90382-0; SMITH KE, 1992, VET PARASITOL, V42, P199, DOI 10.1016/0304-4017(92)90062-E; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; TEUTSCH SM, 1979, NEW ENGL J MED, V300, P695, DOI 10.1056/NEJM197903293001302; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	48	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12063	12070		10.1074/jbc.M109.054866	http://dx.doi.org/10.1074/jbc.M109.054866			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164173	Green Published, hybrid			2022-12-25	WOS:000276787100035
J	Ippagunta, SK; Brand, DD; Luo, JW; Boyd, KL; Calabrese, C; Stienstra, R; Van de Veerdonk, FL; Netea, MG; Joosten, LAB; Lamkanfi, M; Kanneganti, TD				Ippagunta, Sirish K.; Brand, David D.; Luo, Jiwen; Boyd, Kelli L.; Calabrese, Christopher; Stienstra, Rinke; Van de Veerdonk, Frank L.; Netea, Mihai G.; Joosten, Leo A. B.; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			Inflammasome-independent Role of Apoptosis-associated Speck-like Protein Containing a CARD (ASC) in T Cell Priming Is Critical for Collagen-induced Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-1; AUTOIMMUNITY; ACTIVATION; IL-1-BETA; CARTILAGE; RELEASE; ENZYME; ALPHA; BETA; MICE	Rheumatoid arthritis is an autoimmune disease with 1% prevalence in the industrialized world. The contributions of the inflammasome components Nlrp3, ASC, and caspase-1 in the pathogenesis of collagen-induced arthritis have not been characterized. Here, we show that ASC(-/-) mice were protected from arthritis, whereas Nlrp3(-/-) and caspase-1(-/-) mice were susceptible to collagen-induced arthritis. Unlike Nlrp3(-/-) and caspase-1(-/-) mice, the production of collagen-specific antibodies was abolished in ASC(-/-) mice. This was due to a significantly reduced antigen-specific activation of lymphocytes by ASC(-/-) dendritic cells. Antigen-induced proliferation of purified ASC(-/-) T cells was restored upon incubation with wild type dendritic cells, but not when cultured with ASC(-/-) dendritic cells. Moreover, direct T cell receptor ligation with CD3 and CD28 antibodies induced a potent proliferation of ASC(-/-) T cells, indicating that ASC is specifically required in dendritic cells for antigen-induced T cell activation. Therefore, ASC fulfills a hitherto unrecognized inflammasome-independent role in dendritic cells that is crucial for T cell priming and the induction of antigen-specific cellular and humoral immunity and the onset of collagen-induced arthritis.	[Ippagunta, Sirish K.; Boyd, Kelli L.; Calabrese, Christopher; Kanneganti, Thirumala-Devi] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; [Brand, David D.; Luo, Jiwen] Univ Tennessee, Vet Affairs Med Ctr, Res Serv, Memphis, TN 38104 USA; [Stienstra, Rinke; Van de Veerdonk, Frank L.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HB Nijmegen, Netherlands; [Lamkanfi, Mohamed] Univ Ghent VIB, Dept Med Prot Res, Dept Biochem, B-9000 Ghent, Belgium	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Radboud University Nijmegen; Flanders Institute for Biotechnology (VIB); Ghent University	Kanneganti, TD (corresponding author), St Jude Childrens Hosp, Dept Immunol, MS 351,570 St Jude Pl,Suite E7004, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Joosten, Leo AB/H-3138-2015; Kanneganti, Thirumala-Devi/M-9435-2018; Netea, Mihai/N-5155-2014; Stienstra, Rinke/A-4763-2015; van de Veerdonk, Frank L/C-7256-2008	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Joosten, Leo AB/0000-0001-6166-9830; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Stienstra, Rinke/0000-0001-6729-7193; van de Veerdonk, Frank L/0000-0002-1121-4894; Ippagunta, Sirish Kumar/0000-0002-7449-0511; Brand, David/0000-0002-9260-7963	National Institutes of Health [AR056296]; American Lebanese and Syrian Associated Charities; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese and Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant AR056296. This work was also supported by the American Lebanese and Syrian Associated Charities (to T.-D.K.).	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; HAQQI TM, 1990, J AUTOIMMUN, V3, P113, DOI 10.1016/0896-8411(90)90135-F; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; HOLMDAHL R, 1993, ANN MED, V25, P251, DOI 10.3109/07853899309147871; HOLMDAHL R, 1990, IMMUNOL REV, V118, P193, DOI 10.1111/j.1600-065X.1990.tb00817.x; IRMLER M, 1995, J EXP MED, V181, P1917, DOI 10.1084/jem.181.5.1917; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Lamkanfi M, 2009, J BIOL CHEM, V284, P20574, DOI 10.1074/jbc.M109.023689; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132715; MILLER EJ, 1971, BIOCHEMISTRY-US, V10, P1652, DOI 10.1021/bi00785a024; Sutterwala FS, 2006, J ENDOTOXIN RES, V12, P251, DOI 10.1179/096805106X118771; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Wannamaker W, 2007, J PHARMACOL EXP THER, V321, P509, DOI 10.1124/jpet.106.111344	25	73	76	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12454	12462		10.1074/jbc.M109.093252	http://dx.doi.org/10.1074/jbc.M109.093252			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177071	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000276787100073
J	Wang, J; Peng, QS; Lin, Q; Childress, C; Carey, D; Yang, WN				Wang, Jian; Peng, Qisheng; Lin, Qiong; Childress, Chandra; Carey, David; Yang, Wannian			Calcium Activates Nedd4 E3 Ubiquitin Ligases by Releasing the C2 Domain-mediated Auto-inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; INDUCIBLE KINASE ISOFORMS; GROWTH-FACTOR RECEPTOR; SODIUM-CHANNEL; INOSITOL 1,4,5-TRISPHOSPHATE; PROTEIN UBIQUITYLATION; ENDOPLASMIC-RETICULUM; FUNCTIONAL DIVERSITY; RNA INTERFERENCE; PHOSPHOLIPASE-C	Nedd4 E3 ligases are members of the HECT E3 ubiquitin ligase family and regulate ubiquitination-mediated protein degradation. In this report, we demonstrate that calcium releases the C2 domain-mediated auto-inhibition in both Nedd4-1 and Nedd4-2. Calcium disrupts binding of the C2 domain to the HECT domain. Consistent with this, calcium activates the E3 ubiquitin ligase activity of Nedd4. Elevation of intracellular calcium by ionomycin treatment, or activation of acetylcholine receptor or epidermal growth factor receptor by carbachol or epidermal growth factor stimulation induced activation of endogenous Nedd4 in vivo evaluated by assays of either Nedd4 E3 ligase activity or ubiquitination of Nedd4 substrate ENaC-beta. The activation effect of calcium on Nedd4 E3 ligase activity was dramatically enhanced by a membrane-rich fraction, suggesting that calcium-mediated membrane translocation through the C2 domain might be an activation mechanism of Nedd4 in vivo. Our studies have revealed an activation mechanism of Nedd4 E3 ubiquitin ligases and established a connection of intracellular calcium signaling to regulation of protein ubiquitination.	[Yang, Wannian] Geisinger Med Clin, Weis Ctr Res, Danville, PA 17822 USA; [Wang, Jian] Beijing Inst Biotechnol, Lab Mol Biol Med, Beijing 100850, Peoples R China; [Peng, Qisheng] Jilin Univ, Coll Vet Med, Changchun 130062, Peoples R China	Geisinger Medical Center; Jilin University	Yang, WN (corresponding author), Geisinger Med Clin, Weis Ctr Res, 100 N Acad Ave, Danville, PA 17822 USA.	wyang1@geisinger.edu	Yang, Wannian/K-4836-2019	Lin, Qiong/0000-0002-4393-2495	American Cancer Society [ACS-RSG TBE-110602]	American Cancer Society(American Cancer Society)	This work was supported by American Cancer Society Grant ACS-RSG TBE-110602 (to W. Y.).	Aoh QL, 2009, MOL BIOL CELL, V20, P1816, DOI 10.1091/mbc.E08-09-0894; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Boehmer C, 2003, J NEUROCHEM, V86, P1181, DOI 10.1046/j.1471-4159.2003.01937.x; Boehmer C, 2003, BIOCHEM BIOPH RES CO, V306, P156, DOI 10.1016/S0006-291X(03)00921-5; Boehmer C, 2003, CARDIOVASC RES, V57, P1079, DOI 10.1016/S0008-6363(02)00837-4; Busjahn A, 2002, HYPERTENSION, V40, P256, DOI 10.1161/01.HYP.0000030153.19366.26; Chen HM, 2001, EUR J HUM GENET, V9, P922, DOI 10.1038/sj.ejhg.5200747; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; KEIZER J, 1995, MOL BIOL CELL, V6, P945, DOI 10.1091/mbc.6.8.945; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; LUO JH, 1993, J BIOL CHEM, V268, P23580; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Pearce D, 2001, TRENDS ENDOCRIN MET, V12, P341, DOI 10.1016/S1043-2760(01)00439-8; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; PRENTKI M, 1984, J BIOL CHEM, V259, P3777; PRENTKI M, 1985, J BIOL CHEM, V260, P9185; QIAN NX, 1993, P NATL ACAD SCI USA, V90, P4077, DOI 10.1073/pnas.90.9.4077; Russo CJ, 2005, HYPERTENSION, V46, P488, DOI 10.1161/01.HYP.0000178594.63193.c0; Sanchez-Perez A, 2007, BIOCHEM BIOPH RES CO, V359, P611, DOI 10.1016/j.bbrc.2007.05.134; Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200; SEUWEN K, 1990, J BIOL CHEM, V265, P22292; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 2001, J BIOL CHEM, V276, P28321, DOI 10.1074/jbc.M011487200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Vana ML, 2004, J VIROL, V78, P13943, DOI 10.1128/JVI.78.24.13943-13953.2004; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu LL, 2003, CANCER RES, V63, P4299; Yang WN, 2001, J BIOL CHEM, V276, P17468, DOI 10.1074/jbc.M010893200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	57	91	92	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12279	12288		10.1074/jbc.M109.086405	http://dx.doi.org/10.1074/jbc.M109.086405			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20172859	Green Published, hybrid			2022-12-25	WOS:000276787100057
J	Wang, K; Long, B; Zhou, J; Li, PF				Wang, Kun; Long, Bo; Zhou, Jing; Li, Pei-Feng			miR-9 and NFATc3 Regulate Myocardin in Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; CASPASE RECRUITMENT DOMAIN; CARDIOMYOCYTE HYPERTROPHY; IN-VIVO; CALCINEURIN INHIBITION; OXIDATIVE MODIFICATION; OVERLOAD HYPERTROPHY; APOPTOSIS REPRESSOR; PRESSURE-OVERLOAD; DOWN-REGULATION	Myocardial hypertrophy is frequently associated with poor clinical outcomes including the development of cardiac systolic and diastolic dysfunction and ultimately heart failure. To prevent cardiac hypertrophy and heart failure, it is necessary to identify and characterize molecules that may regulate the hypertrophic program. Our present study reveals that nuclear factor of activated T cells c3 (NFATc3) and myocardin constitute a hypertrophic pathway that can be targeted by miR-9. Our results show that myocardin expression is elevated in response to hypertrophic stimulation with isoproterenol and aldosterone. In exploring the molecular mechanism by which myocardin expression is elevated, we identified that NFATc3 can bind to the promoter region of myocardin and transcriptionally activate its expression. Knockdown of myocardin can attenuate hypertrophic responses triggered by NFATc3, suggesting that myocardin can be a downstream mediator of NFATc3 in the hypertrophic cascades. MicroRNAs are a class of small noncoding RNAs that mediate post-transcriptional gene silencing. Our data reveal that miR-9 can suppress myocardin expression. However, the hypertrophic stimulation with isoproterenol and aldosterone leads to a decrease in the expression levels of miR-9. Administration of miR-9 could attenuate cardiac hypertrophy and ameliorate cardiac function. Taken together, our data demonstrate that NFATc3 can promote myocardin expression, whereas miR-9 is able to suppress myocardin expression, thereby regulating cardiac hypertrophy.	[Wang, Kun; Long, Bo; Zhou, Jing; Li, Pei-Feng] Chinese Acad Sci, Natl Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Div Cardiovasc Res, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Li, PF (corresponding author), Chinese Acad Sci, Natl Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Div Cardiovasc Res, Beijing 100101, Peoples R China.	peifli@ioz.ac.cn	Li, Peifeng/ABD-5663-2021; Long, Bo/AGX-8013-2022; Long, Bo/GQH-5131-2022; Li, Peifeng/AHE-6906-2022	Li, Peifeng/0000-0002-0969-9407	National Natural Science Foundation of China [30730045, 30871243]; National Basic Research Program of China [2007CB512000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30730045 and 30871243 and by National Basic Research Program of China Program 973 Grant 2007CB512000.	Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2009, J CELL SCI, V122, P13, DOI 10.1242/jcs.041723; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; DOLBER PC, 1994, AM J PHYSIOL-HEART C, V267, pH1279, DOI 10.1152/ajpheart.1994.267.4.H1279; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Kuster GM, 2005, CIRCULATION, V111, P1192, DOI 10.1161/01.CIR.0000157148.59308.F5; Kuwahara K, 2007, J CLIN INVEST, V117, P1324, DOI 10.1172/JCI31240; Langenickel TH, 2006, P NATL ACAD SCI USA, V103, P4735, DOI 10.1073/pnas.0510019103; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Lim HW, 2000, CIRCULATION, V101, P2431, DOI 10.1161/01.CIR.101.20.2431; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Luo XB, 2008, J BIOL CHEM, V283, P20045, DOI 10.1074/jbc.M801035200; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 2000, CIRC RES, V87, P731, DOI 10.1161/01.RES.87.9.731; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Olson EN, 1999, CIRC RES, V84, P623, DOI 10.1161/01.RES.84.6.623; Reinhold MI, 2004, J BIOL CHEM, V279, P38209, DOI 10.1074/jbc.M404855200; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Sugden PH, 2003, CIRC RES, V93, P1179, DOI 10.1161/01.RES.0000106132.04301.F5; Takeda Y, 2002, CIRCULATION, V105, P677, DOI 10.1161/hc0602.104675; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang JX, 2009, CANCER RES, V69, P492, DOI 10.1158/0008-5472.CAN-08-2962; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Wollert KC, 2000, CIRCULATION, V101, P1172, DOI 10.1161/01.CIR.101.10.1172; Xia Y, 2000, J BIOL CHEM, V275, P1855, DOI 10.1074/jbc.275.3.1855; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhu WD, 2000, J BIOL CHEM, V275, P15239, DOI 10.1074/jbc.275.20.15239; Zou YZ, 1999, J BIOL CHEM, V274, P9760, DOI 10.1074/jbc.274.14.9760	51	128	142	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11903	11912		10.1074/jbc.M109.098004	http://dx.doi.org/10.1074/jbc.M109.098004			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177053	Green Published, hybrid			2022-12-25	WOS:000276787100018
J	Choi, HS; Han, GS; Carman, GM				Choi, Hyeon-Son; Han, Gil-Soo; Carman, George M.			Phosphorylation of Yeast Phosphatidylserine Synthase by Protein Kinase A IDENTIFICATION OF SER46 AND SER47 AS MAJOR SITES OF PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID BIOSYNTHESIS; TRANSCRIPTIONAL REGULATION; COORDINATE REGULATION; MEMBRANE INSERTION; GENETIC-REGULATION; STRUCTURAL GENE; MUTANT; INOSITOL	The CHO1-encoded phosphatidylserine synthase from Saccharomyces cerevisiae is phosphorylated and inhibited by protein kinase A in vitro. CHO1 alleles bearing Ser(46) -> Ala and/or Ser(47) -> Ala mutations were constructed and expressed in a cho1 Delta mutant lacking phosphatidylserine synthase. In vitro, the S46A/S47A mutation reduced the total amount of phosphorylation by 90% and abolished the inhibitory effect protein kinase A had on phosphatidylserine synthase activity. The enzyme phosphorylation by protein kinase A, which was time- and dose-dependent and dependent on the concentration of ATP, caused a electrophoretic mobility shift from a 27-kDa form to a 30-kDa form. The two electrophoretic forms of phosphatidylserine synthase were present in exponential phase cells, whereas only the 27-kDa form was present in stationary phase cells. In vivo labeling with P-32(i) and immune complex analysis showed that the 30-kDa form was predominantly phosphorylated when compared with the 27-kDa form. However, the S46A/S47A mutations abolished the protein kinase A-mediated electrophoretic mobility shift. The S46A/S47A mutations also caused a 55% reduction in the total amount of phosphatidylserine synthase in exponential phase cells and a 66% reduction in the amount of enzyme in stationary phase cells. In phospholipid composition analysis, cells expressing the S46A/S47A mutant enzyme exhibited a 57% decrease in phosphatidylserine and a 40% increase in phosphatidylinositol. These results indicate that phosphatidylserine synthase is phosphorylated on Ser(46) and Ser(47) by protein kinase A, which results in a higher amount of enzyme for the net effect of stimulating the synthesis of phosphatidylserine.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			National Institutes of Health [GM-50679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-50679.	ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; BAELEE M, 1990, J BIOL CHEM, V265, P7221; BAELEE MS, 1984, J BIOL CHEM, V259, P857; BAILIS AM, 1992, NUCLEIC ACIDS RES, V20, P1411, DOI 10.1093/nar/20.6.1411; BAILIS AM, 1987, MOL CELL BIOL, V7, P167, DOI 10.1128/MCB.7.1.167; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broach J R, 1990, Adv Cancer Res, V54, P79, DOI 10.1016/S0065-230X(08)60809-X; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; CARMAN GM, 1992, METHOD ENZYMOL, V209, P298; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Choi HS, 2004, J BIOL CHEM, V279, P12081, DOI 10.1074/jbc.M400297200; Choi HS, 2007, J BIOL CHEM, V282, P31217, DOI 10.1074/jbc.M705098200; CULBERTSON MR, 1975, GENETICS, V80, P23; Greenberg ML, 1996, MICROBIOL REV, V60, P1; HAID A, 1983, METHOD ENZYMOL, V96, P192; Harlow E., 1988, ANTIBODIES LAB MANUA; Henry S. A., 1982, MOL BIOL YEAST SACCH, P101; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HOMANN MJ, 1987, J BACTERIOL, V169, P533, DOI 10.1128/jb.169.2.533-539.1987; HOMANN MJ, 1987, J BACTERIOL, V169, P3276, DOI 10.1128/jb.169.7.3276-3280.1987; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; KINNEY AJ, 1988, P NATL ACAD SCI USA, V85, P7962, DOI 10.1073/pnas.85.21.7962; KIYONO K, 1987, J BIOCHEM-TOKYO, V102, P1089, DOI 10.1093/oxfordjournals.jbchem.a122147; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; KOHLWEIN SD, 1988, J BACTERIOL, V170, P3778, DOI 10.1128/jb.170.8.3778-3781.1988; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPING E, 1994, GENETICS, V137, P55; LARSON TJ, 1976, BIOCHEMISTRY-US, V15, P5212, DOI 10.1021/bi00669a003; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; LIEBERMAN I, 1956, J BIOL CHEM, V222, P765; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MCDONOUGH VM, 1995, J BIOL CHEM, V270, P18774, DOI 10.1074/jbc.270.32.18774; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; NIKAWA J, 1987, EUR J BIOCHEM, V167, P7, DOI 10.1111/j.1432-1033.1987.tb13297.x; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oshiro J, 2003, J BIOL CHEM, V278, P31495, DOI 10.1074/jbc.M305452200; PALTAUF F, 1992, MOL CELLULAR BIOL YE, P415; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; POOLE MA, 1986, J BACTERIOL, V168, P668, DOI 10.1128/jb.168.2.668-672.1986; RATTRAY JBM, 1975, BACTERIOL REV, V39, P197, DOI 10.1128/MMBR.39.3.197-231.1975; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SIKORSKI RS, 1989, GENETICS, V122, P19; SPERKAGOTTLIEB C, 1990, YEAST, V6, P331, DOI 10.1002/yea.320060406; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Vance JE, 1998, TRENDS BIOCHEM SCI, V23, P423, DOI 10.1016/S0968-0004(98)01297-3; Wang Q, 2009, J VIROL, V83, P3668, DOI 10.1128/JVI.02063-08; Williams JG, 1998, J BIOL CHEM, V273, P13482, DOI 10.1074/jbc.273.22.13482; Yamashita S, 1997, BBA-LIPID LIPID MET, V1348, P228, DOI 10.1016/S0005-2760(97)00102-1; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Yang WL, 1996, J BIOL CHEM, V271, P28777, DOI 10.1074/jbc.271.46.28777	65	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11526	11536		10.1074/jbc.M110.100727	http://dx.doi.org/10.1074/jbc.M110.100727			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145252	hybrid, Green Published			2022-12-25	WOS:000276286200059
J	Peng, Y; Lee, J; Zhu, CF; Sun, ZJ				Peng, Yue; Lee, Jane; Zhu, Chunfang; Sun, Zijie			A Novel Role for Protein Inhibitor of Activated STAT (PIAS) Proteins in Modulating the Activity of Zimp7, a Novel PIAS-like Protein, in Androgen Receptor-mediated Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 TUMOR-SUPPRESSOR; INTERACTING PROTEIN-3; GENE-EXPRESSION; NUCLEAR-BODIES; SUMO LIGASES; SP-RING; COACTIVATOR; COMPLEX; HZIMP10; FAMILY	The PIAS proteins ( protein inhibitor of activated STAT) were originally identified as inhibitors of the JAK-STAT pathway. Subsequently, their roles on transcriptional regulation have been identified in modulation of the androgen receptor (AR) and other nuclear hormone receptor-mediated actions. Zimp7, also named Zmiz2, is a novel PIAS-like protein and functions as a transcriptional co-activator. In this study, we demonstrate an interaction between Zimp7 and PIAS proteins with higher preference for PIAS3. A modified mammalian one-hybrid assay showed that the NH2-terminal proline-rich domain of Zimp7 and the region spanning amino acids 321-486 of PIAS3 were the primary interaction segments. The interaction between Zimp7 and PIAS3 proteins was further confirmed by in vitro protein pull-down and co-immunoprecipitation assays with both exogenous and endogenous proteins. Expression of exogenous PIAS3 further enhances Zimp7-mediated augmentation of AR transcription. Knockdown of the endogenous PIAS3 protein using a specific PIAS3 small hairpin RNA reduced the augmentation of Zimp7 on AR-mediated transcription. Co-localization of Zimp7 and PIAS3 proteins was observed in the nuclei of cells by immunostaining. Exogenous PIAS3 expression enhances the stability of the Zimp7 protein. Using chromatin immunoprecipitation assays, we showed that PIAS3 is involved in the AR- and Zimp7-formed protein complex(es) in the AR downstream target promoter to facilitate androgen-induced transcription. Finally, we further demonstrated that loss of Zimp7 significantly impaired PIAS3-mediated enhancement on AR activity in mouse Zimp7 null (zimp7(-/-)) embryonic fibroblasts. Taken together, these results demonstrate a novel interaction between PIAS and PIAS-like proteins and elucidate a novel regulatory mechanism for PIAS proteins in AR- mediated transcription.	[Sun, Zijie] Stanford Univ, Dept Urol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Sun, ZJ (corresponding author), Stanford Univ, Dept Urol, Sch Med, Stanford, CA 94305 USA.	zsun@stanford.edu			National Institutes of Health [CA70297]; NATIONAL CANCER INSTITUTE [R29CA070297, R01CA070297, R01CA087767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061002, R56DK061002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant CA70297.	Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Beliakoff J, 2008, MOL CELL BIOL, V28, P282, DOI 10.1128/MCB.00771-07; Beliakoff Jason, 2006, Nucl Recept Signal, V4, pe017; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; Delenda C, 2004, J GENE MED, V6, pS125, DOI 10.1002/jgm.501; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Huang CY, 2005, MOL ENDOCRINOL, V19, P2915, DOI 10.1210/me.2005-0097; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; James P, 1996, GENETICS, V144, P1425; Jimenez-Lara AM, 2002, FEBS LETT, V526, P142, DOI 10.1016/S0014-5793(02)03154-X; Kotaja N, 2000, MOL ENDOCRINOL, V14, P1986, DOI 10.1210/me.14.12.1986; Kotaja N, 2002, J BIOL CHEM, V277, P17781, DOI 10.1074/jbc.M106354200; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; Lee H, 2006, GENE DEV, V20, P784, DOI 10.1101/gad.1392006; Lee J, 2007, NUCLEIC ACIDS RES, V35, P4523, DOI 10.1093/nar/gkm476; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Megidish T, 2002, J BIOL CHEM, V277, P8255, DOI 10.1074/jbc.C200001200; Moilanen AM, 1999, J BIOL CHEM, V274, P3700, DOI 10.1074/jbc.274.6.3700; Nelson V, 2001, APOPTOSIS, V6, P221, DOI 10.1023/A:1011392811628; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Shuai K, 2006, CELL RES, V16, P196, DOI 10.1038/sj.cr.7310027; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; SUN ZJ, 1995, J BIOL CHEM, V270, P1462, DOI 10.1074/jbc.270.3.1462; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Wu L, 1997, MECH DEVELOP, V65, P3, DOI 10.1016/S0925-4773(97)00032-4; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200	37	19	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11465	11475		10.1074/jbc.M109.079327	http://dx.doi.org/10.1074/jbc.M109.079327			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20159969	hybrid, Green Published			2022-12-25	WOS:000276286200053
J	Xie, HDQ; Liang, D; Leung, KW; Chen, VP; Zhu, KY; Chan, WKB; Choi, RCY; Massoulie, J; Tsim, KWK				Xie, Heidi Q.; Liang, Dong; Leung, K. Wing; Chen, Vicky P.; Zhu, Kevin Y.; Chan, Wallace K. B.; Choi, Roy C. Y.; Massoulie, Jean; Tsim, Karl W. K.			Targeting Acetylcholinesterase to Membrane Rafts A FUNCTION MEDIATED BY THE PROLINE-RICH MEMBRANE ANCHOR (PRiMA) IN NEURONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBULAR FORM ACETYLCHOLINESTERASE; CHARACTERIZING FAST MUSCLES; TERMINAL T-PEPTIDE; LIPID RAFTS; TRANSCRIPTIONAL REGULATION; DEPENDENT RECRUITMENT; GENE-EXPRESSION; MOLECULAR-FORMS; BRAIN; PROTEINS	In the mammalian brain, acetylcholinesterase (AChE) is anchored in cell membranes by a transmembrane protein PRiMA (proline-rich membrane anchor). We present evidence that at least part of the PRiMA-linked AChE is integrated in membrane microdomains called rafts. A significant proportion of PRiMA-linked AChE tetramers from rat brain was recovered in raft fractions; this proportion was markedly higher at low rather than at high concentrations of cold Triton X-100. The detergent-resistant fraction increased during brain development. In NG108-15 neuroblastoma cells transfected with cDNAs encoding AChE(T) and PRiMA, PRiMA-linked G(4) AChE was found in membrane rafts and showed the same sensitivity to cold Triton X-100 extraction as in the brain. The association of PRiMA-linked AChE with rafts was weaker than that of glycosylphosphatidylinositol-anchored G(2) AChE or G(4) Q(N)-H-C-linked AChE. It was found to depend on the presence of a cholesterol-binding motif, called CRAC ( cholesterol recognition/interaction amino acid consensus), located at the junction of transmembrane and cytoplasmic domains of both PRiMA I and II isoforms. The cytoplasmic domain of PRiMA, which differs between PRiMA I and PRiMA II, appeared to play some role in stabilizing the raft localization of G(4) AChE, because the Triton X-100-resistant fraction was smaller with the shorter PRiMA II isoform than that with the longer PRiMA I isoform.	[Xie, Heidi Q.; Leung, K. Wing; Chen, Vicky P.; Zhu, Kevin Y.; Chan, Wallace K. B.; Choi, Roy C. Y.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China; [Xie, Heidi Q.; Leung, K. Wing; Chen, Vicky P.; Zhu, Kevin Y.; Chan, Wallace K. B.; Choi, Roy C. Y.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Kowloon, Hong Kong, Peoples R China; [Liang, Dong; Massoulie, Jean] Ecole Normale Super, CNRS, Neurobiol Lab, UMR 8544, F-75005 Paris, France	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China.	botsim@ust.hk	CHEN, VICKY/C-9223-2016	CHEN, VICKY/0000-0003-3753-7170; Tsim, Karl/0000-0003-4808-1674; Leung, Ka Wing/0000-0002-6137-3877	Research Grants Council of Hong Kong [N_HKUST629/07, 662407, 662608, F-HK21/06T]; Croucher Foundation [CAS-CF07/08.SC03]; CNRS; Ecole Normale Superieure; Association Francais Contre les Myopathies; French Ministry of Foreign Affairs	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Croucher Foundation; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure; Association Francais Contre les Myopathies(Association Francaise contre les Myopathies); French Ministry of Foreign Affairs	This work was supported by Research Grants Council of Hong Kong Grants N_HKUST629/07, 662407, 662608, and F-HK21/06T, Croucher Foundation Grant CAS-CF07/08.SC03 (to K. W. K. T.), CNRS, Ecole Normale Superieure, Association Francais Contre les Myopathies, and French Ministry of Foreign Affairs (to J.M.).	Belbeoc'h S, 2003, EMBO J, V22, P3536, DOI 10.1093/emboj/cdg360; Brimijoin S, 1996, NEUROSCIENCE, V71, P555, DOI 10.1016/0306-4522(95)00457-2; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; CHATEL JM, 1993, P NATL ACAD SCI USA, V90, P2476, DOI 10.1073/pnas.90.6.2476; Choi RCY, 1997, NEUROSCI LETT, V236, P167, DOI 10.1016/S0304-3940(97)00789-1; Descarries L, 1997, PROG NEUROBIOL, V53, P603, DOI 10.1016/S0301-0082(97)00050-6; DUVAL N, 1992, EMBO J, V11, P3255, DOI 10.1002/j.1460-2075.1992.tb05403.x; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Falasca C, 2005, J BIOL CHEM, V280, P878, DOI 10.1074/jbc.M409201200; GISIGER V, 1988, J NEUROSCI RES, V19, P62, DOI 10.1002/jnr.490190110; Grifman M, 1998, P NATL ACAD SCI USA, V95, P13935, DOI 10.1073/pnas.95.23.13935; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Hering H, 2003, J NEUROSCI, V23, P3262; INESTROSA NC, 1994, NEUROSCI LETT, V173, P155, DOI 10.1016/0304-3940(94)90172-4; Inestrosa NC, 1998, J PHYSIOLOGY-PARIS, V92, P341, DOI 10.1016/S0928-4257(99)80002-3; JASMIN BJ, 1990, J NEUROSCI, V10, P1444; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEGAY C, 1993, J NEUROCHEM, V60, P337, DOI 10.1111/j.1471-4159.1993.tb05856.x; Leung KW, 2009, FEBS J, V276, P3031, DOI 10.1111/j.1742-4658.2009.07022.x; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Ma L, 2003, J NEUROSCI, V23, P3164; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Massoulie J, 2006, J MOL NEUROSCI, V30, P233, DOI 10.1385/JMN:30:1:233; Mok MKW, 2009, NEUROSCI LETT, V461, P202, DOI 10.1016/j.neulet.2009.06.015; Mukherjee A, 2003, J BIOL CHEM, V278, P40806, DOI 10.1074/jbc.M306440200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Noureddine H, 2008, J BIOL CHEM, V283, P20722, DOI 10.1074/jbc.M801364200; Noureddine H, 2007, J BIOL CHEM, V282, P3487, DOI 10.1074/jbc.M607221200; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Perrier NA, 2005, J NEUROCHEM, V94, P629, DOI 10.1111/j.1471-4159.2005.03140.x; Perrier NA, 2003, EUR J NEUROSCI, V18, P1837, DOI 10.1046/j.1460-9568.2003.02914.x; Perry C, 2002, ONCOGENE, V21, P8428, DOI 10.1038/sj.onc.1205945; Pick M, 2004, ANN NY ACAD SCI, V1018, P85, DOI 10.1196/annals.1296.010; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; Saslowsky DE, 2002, J BIOL CHEM, V277, P26966, DOI 10.1074/jbc.M204669200; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Shogomori H, 2003, BIOL CHEM, V384, P1259, DOI 10.1515/BC.2003.139; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014; Simon S, 1998, EMBO J, V17, P6178, DOI 10.1093/emboj/17.21.6178; Siow NL, 2005, CHEM-BIOL INTERACT, V157, P423, DOI 10.1016/j.cbi.2005.10.088; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Sternfeld M, 1998, J NEUROSCI, V18, P1240; STYA M, 1983, J CELL BIOL, V97, P48, DOI 10.1083/jcb.97.1.48; Suzuki T, 2008, J NEUROCHEM, V104, P596, DOI 10.1111/j.1471-4159.2007.05035.x; WALLACE BG, 1995, J CELL BIOL, V128, P1121, DOI 10.1083/jcb.128.6.1121; Xie HQ, 2007, J BIOL CHEM, V282, P11765, DOI 10.1074/jbc.M608265200; Xie HQ, 2009, BRAIN RES, V1265, P13, DOI 10.1016/j.brainres.2009.01.065	53	45	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11537	11546		10.1074/jbc.M109.038711	http://dx.doi.org/10.1074/jbc.M109.038711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147288	hybrid, Green Published			2022-12-25	WOS:000276286200060
J	Ingerslev, HC; Ossum, CG; Lindenstrom, T; Nielsen, ME				Ingerslev, Hans-Christian; Ossum, Carlo Gunnar; Lindenstrom, Thomas; Nielsen, Michael Engelbrecht			Fibroblasts Express Immune Relevant Genes and Are Important Sentinel Cells during Tissue Damage in Rainbow Trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							TOLL-LIKE-RECEPTOR; HUMAN GINGIVAL FIBROBLASTS; SALMON SALMO-SALAR; ATLANTIC SALMON; TELEOST FISH; IFN-GAMMA; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; MX1 PROMOTER; RESPONSES	Fibroblasts have shown to be an immune competent cell type in mammals. However, little is known about the immunological functions of this cell-type in lower vertebrates. A rainbow trout hypodermal fibroblast cell-line (RTHDF) was shown to be responsive to PAMPs and DAMPs after stimulation with LPS from E. coli, supernatant and debris from sonicated RTHDF cells. LPS was overall the strongest inducer of IL-1 beta, IL-8, IL-10, TLR-3 and TLR-9. IL-1 beta and IL-8 were already highly up regulated after 1 hour of LPS stimulation. Supernatant stimuli significantly increased the expression of IL-1 beta, TLR-3 and TLR-9, whereas the debris stimuli only increased expression of IL-1 beta. Consequently, an in vivo experiment was further set up. By mechanically damaging the muscle tissue of rainbow trout, it was shown that fibroblasts in the muscle tissue of rainbow trout contribute to electing a highly local inflammatory response following tissue injury. The damaged muscle tissue showed a strong increase in the expression of the immune genes IL-1 beta, IL-8 and TGF-beta already 4 hours post injury at the site of injury while the expression in non-damaged muscle tissue was not influenced. A weaker, but significant response was also seen for TLR-9 and TLR-22. Rainbow trout fibroblasts were found to be highly immune competent with a significant ability to express cytokines and immune receptors. Thus fish fibroblasts are believed to contribute significantly to local inflammatory reactions in concert with the traditional immune cells.	[Ingerslev, Hans-Christian; Nielsen, Michael Engelbrecht] DTU Food, Natl Food Inst, Div Seafood Res, Sect Aquat Prot Biochem, Lyngby, Denmark; [Ossum, Carlo Gunnar] Univ Copenhagen, August Krogh Inst, Dept Biochem, DK-2100 Copenhagen, Denmark; [Lindenstrom, Thomas] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen; Statens Serum Institut	Ingerslev, HC (corresponding author), DTU Food, Natl Food Inst, Div Seafood Res, Sect Aquat Prot Biochem, Lyngby, Denmark.	hci@aqua.dtu.dk	Nielsen, Michael Canova Engelbrecht/L-4911-2019; Lindenstrøm, Thomas/ABE-4203-2020; Ingerslev, Hans-Christian/AAP-6079-2020	Nielsen, Michael Canova Engelbrecht/0000-0001-5044-4441; Lindenstrøm, Thomas/0000-0002-7162-8124; Ingerslev, Hans-Christian/0000-0002-9761-7474	Directorate for Food, Fisheries and Agri Business [3310-06-00116]; Strategic Research Council [2101-08-0017]	Directorate for Food, Fisheries and Agri Business; Strategic Research Council	This work was supported by The Directorate for Food, Fisheries and Agri Business Grant 3310-06-00116 and the Strategic Research Council grant 2101-08-0017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham LC, 2007, EXP CELL RES, V313, P1045, DOI 10.1016/j.yexcr.2006.12.019; Alberts B., 1989, MOL BIOL CELL; Alberts B, 2008, MOL BIOL CELL; Arora S, 2009, TOXICOL APPL PHARM, V236, P310, DOI 10.1016/j.taap.2009.02.020; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; Campo GM, 2006, MOL CELL BIOCHEM, V292, P169, DOI 10.1007/s11010-006-9230-7; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chen BL, 2005, J IMMUNOL, V175, P1310, DOI 10.4049/jimmunol.175.2.1310; Collet B, 2004, DEV COMP IMMUNOL, V28, P793, DOI 10.1016/j.dci.2003.12.005; Collet B, 2001, EUR J BIOCHEM, V268, P1577, DOI 10.1046/j.1432-1033.2001.02021.x; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Dziarski R, 2000, J ENDOTOXIN RES, V6, P401, DOI 10.1179/096805100101532243; Ganassin RC, 1998, FISH SHELLFISH IMMUN, V8, P457, DOI 10.1006/fsim.1998.0153; Ganassin RC, 1996, FISH SHELLFISH IMMUN, V6, P17, DOI 10.1006/fsim.1996.0003; Gonzalez SF, 2007, DEV COMP IMMUNOL, V31, P244, DOI 10.1016/j.dci.2006.06.010; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Hatakeyama J, 2003, ORAL MICROBIOL IMMUN, V18, P14, DOI 10.1034/j.1399-302X.2003.180103.x; HORDVIK I, 1993, IMMUNOGENETICS, V37, P437, DOI 10.1007/BF00222467; Hosokawa Y, 2005, CLIN EXP IMMUNOL, V142, P285, DOI 10.1111/j.1365-2249.2005.02912.x; Iliev DB, 2007, MOL IMMUNOL, V44, P1803, DOI 10.1016/j.molimm.2006.07.297; Ingerslev HC, 2006, MOL IMMUNOL, V43, P1194, DOI 10.1016/j.molimm.2005.07.009; Jault C, 2004, MOL IMMUNOL, V40, P759, DOI 10.1016/j.molimm.2003.10.001; Kaiser P, 2004, DEV COMP IMMUNOL, V28, P375, DOI 10.1016/j.dci.2003.09.004; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kumagai Y, 2008, ADV DRUG DELIVER REV, V60, P795, DOI 10.1016/j.addr.2007.12.004; Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516; Kyburz D, 2003, ARTHRITIS RHEUM-US, V48, P642, DOI 10.1002/art.10848; Laing KJ, 2001, EUR J BIOCHEM, V268, P1315, DOI 10.1046/j.1432-1327.2001.01996.x; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Chunguang, 1999, Methods in Cell Science, V21, P39, DOI 10.1023/A:1009824303498; Magor BG, 2001, DEV COMP IMMUNOL, V25, P651, DOI 10.1016/S0145-305X(01)00029-5; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; MURPHY KP, 2008, JANCWAYS IMMUNOBIOLO, pR21; Nemoto E, 2000, J IMMUNOL, V165, P5807, DOI 10.4049/jimmunol.165.10.5807; Nielsen AR, 2007, APPL PHYSIOL NUTR ME, V32, P833, DOI 10.1139/H07-054; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Ohtani M, 2008, IMMUNOGENETICS, V60, P383, DOI 10.1007/s00251-008-0299-x; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; Ossum CG, 2004, J FISH BIOL, V64, P1103, DOI 10.1111/j.1095-8649.2004.0378.x; Peatman E, 2007, IMMUNOGENETICS, V59, P613, DOI 10.1007/s00251-007-0228-4; Purcell MK, 2006, COMP BIOCHEM PHYS D, V1, P77, DOI 10.1016/j.cbd.2005.07.003; Rebl A, 2007, DEV COMP IMMUNOL, V31, P499, DOI 10.1016/j.dci.2006.08.007; Rodriguez MF, 2005, IMMUNOGENETICS, V57, P510, DOI 10.1007/s00251-005-0013-1; Ruiz C, 2007, J BONE MINER METAB, V25, P286, DOI 10.1007/s00774-007-0767-7; Sangrador-Vegas A, 2002, CYTOKINE, V17, P66, DOI 10.1006/cyto.2001.0991; Secombes C. J., 1996, The fish immune system: organism, pathogen, and environment, P63; Secombes CJ, 1999, FISH SHELLFISH IMMUN, V9, P335, DOI 10.1006/fsim.1998.0193; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; SHAN X, 2009, COLLOIDS SURF B; Skaleric U, 2000, EUR J ORAL SCI, V108, P130, DOI 10.1034/j.1600-0722.2000.90771.x; Skjaeveland I, 2008, DEV COMP IMMUNOL, V32, P603, DOI 10.1016/j.dci.2007.10.011; Smith RS, 1997, AM J PATHOL, V151, P317; Strandskog G, 2008, VACCINE, V26, P4704, DOI 10.1016/j.vaccine.2008.06.054; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Sugawara S, 1998, INFECT IMMUN, V66, P3043, DOI 10.1128/IAI.66.7.3043-3049.1998; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; TROBRIDGE GD, 1995, J INTERF CYTOK RES, V15, P691, DOI 10.1089/jir.1995.15.691; Uehara A, 2007, J DENT RES, V86, P249, DOI 10.1177/154405910708600310; Wang TH, 2002, BBA-GENE STRUCT EXPR, V1575, P108, DOI 10.1016/S0167-4781(02)00235-X; Wang TH, 2008, J IMMUNOL, V181, P3310, DOI 10.4049/jimmunol.181.5.3310; WARR GW, 1995, DEV COMP IMMUNOL, V19, P1, DOI 10.1016/0145-305X(94)00052-H; WOLF K, 1962, SCIENCE, V135, P1065, DOI 10.1126/science.135.3508.1065; Yoshiura Y, 2003, IMMUNOGENETICS, V55, P296, DOI 10.1007/s00251-003-0582-9; Zhang DC, 2005, J BIOCHEM MOL BIOL, V38, P571; Zhang Wensheng, 2002, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V19, P697; Zou J, 2005, J IMMUNOL, V175, P2484, DOI 10.4049/jimmunol.175.4.2484; Zou J, 2004, EUR J BIOCHEM, V271, P1913, DOI 10.1111/j.1432-1033.2004.04101.x; Zou J, 1999, CYTOKINE, V11, P552, DOI 10.1006/cyto.1998.0470	74	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9304	10.1371/journal.pone.0009304	http://dx.doi.org/10.1371/journal.pone.0009304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174584	Green Submitted, Green Published, gold			2022-12-25	WOS:000274654700026
J	Pereira, JP; Cyster, JG; Xu, Y				Pereira, Joao Pedro; Cyster, Jason G.; Xu, Ying			A Role for S1P and S1P1 in Immature-B Cell Egress from Mouse Bone Marrow	PLOS ONE			English	Article							ANTI-IGM ANTIBODY; SPHINGOSINE-1-PHOSPHATE RECEPTOR; LYMPHOCYTE EGRESS; ENDOTHELIAL-CELLS; INVIVO PERFUSION; LOCALIZATION; TRAFFICKING; 2-ARACHIDONOYLGLYCEROL; ACTIVATION; PRECURSORS	B lymphocyte egress from secondary lymphoid organs requires sphingosine-1-phosphate (S1P) and S1P receptor-1 (S1P1). However, whether S1P contributes to immature-B cell egress from the bone marrow (BM) has not been fully assessed. Here we report that in S1P- and S1P1-conditionally deficient mice, the number of immature-B cells in the BM parenchyma increased, while it decreased in the blood. Moreover, a slower rate of bromodeoxyuridine incorporation suggested immature-B cells spent longer in the BM of mice in which S1P1-S1P signaling was genetically or pharmacologically impaired. Transgenic expression of S1P1 in developing B cells was sufficient to mobilize pro- and pre-B cells from the BM. We conclude that the S1P1-S1P pathway contributes to egress of immature-B cells from BM, and that this mechanism is partially redundant with other undefined pathways.	[Pereira, Joao Pedro; Cyster, Jason G.; Xu, Ying] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Pereira, JP (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	Joao.Pereira@ucsf.edu; Jason.Cyster@ucsf.edu		Pereira, Joao/0000-0002-5694-4938	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Supported by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTEN SJ, 1984, J IMMUNOL METHODS, V72, P381, DOI 10.1016/0022-1759(84)90007-3; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Donati C, 2007, STEM CELLS, V25, P1713, DOI 10.1634/stemcells.2006-0725; DONOVAN EE, 2009, EUR J IMMUNOL; Girkontaite I, 2004, J EXP MED, V200, P1491, DOI 10.1084/jem.20041483; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Halin C, 2005, BLOOD, V106, P1314, DOI 10.1182/blood-2004-09-3687; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; KIMURA Y, 2000, PHYS LOW DIMENS SEMI, V1, P1; Kohno T, 2002, FASEB J, V16, P983, DOI 10.1096/fj.01-0809com; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kwon YG, 2001, J BIOL CHEM, V276, P10627, DOI 10.1074/jbc.M011449200; Le Y, 2007, IMMUNITY, V27, P811, DOI 10.1016/j.immuni.2007.09.011; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mechoulam R, 1998, EUR J PHARMACOL, V362, pR1, DOI 10.1016/S0014-2999(98)00777-8; OSMOND DG, 1984, AM J ANAT, V170, P349, DOI 10.1002/aja.1001700310; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pelanda R, 2002, GENESIS, V32, P154, DOI 10.1002/gene.10070; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sugiura T, 2000, CHEM PHYS LIPIDS, V108, P89, DOI 10.1016/S0009-3084(00)00189-4; Sugiura T, 1998, BIOCHEM BIOPH RES CO, V243, P838, DOI 10.1006/bbrc.1998.8187; TAVASSOLI M, 1983, BONE MARROW STRUCTUR, pR12; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523	33	72	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9277	10.1371/journal.pone.0009277	http://dx.doi.org/10.1371/journal.pone.0009277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174580	gold, Green Published, Green Submitted			2022-12-25	WOS:000274654700012
J	Zhou, Y; Murthy, JN; Zeng, DW; Belardinelli, L; Blackburn, MR				Zhou, Yang; Murthy, Jayasimha N.; Zeng, Dewan; Belardinelli, Luiz; Blackburn, Michael R.			Alterations in Adenosine Metabolism and Signaling in Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							DEAMINASE-DEFICIENT MICE; MAST-CELLS; INDUCED BRONCHOCONSTRICTION; AIRWAY INFLAMMATION; ASTHMATIC SUBJECTS; RECEPTOR AGONISTS; GENE-EXPRESSION; CYSTIC-FIBROSIS; A(2B) RECEPTORS; A(1) RECEPTOR	Background: Adenosine is generated in response to cellular stress and damage and is elevated in the lungs of patients with chronic lung disease. Adenosine signaling through its cell surface receptors serves as an amplifier of chronic lung disorders, suggesting adenosine-based therapeutics may be beneficial in the treatment of lung diseases such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). Previous studies in mouse models of chronic lung disease demonstrate that the key components of adenosine metabolism and signaling are altered. Changes include an up-regulation of CD73, the major enzyme of adenosine production and down-regulation of adenosine deaminase (ADA), the major enzyme for adenosine metabolism. In addition, adenosine receptors are elevated. Methodology/Principal Findings: The focus of this study was to utilize tissues from patients with COPD or IPF to examine whether changes in purinergic metabolism and signaling occur in human disease. Results demonstrate that the levels of CD73 and A2BR are elevated in surgical lung biopsies from severe COPD and IPF patients. Immunolocalization assays revealed abundant expression of CD73 and the A2BR in alternatively activated macrophages in both COPD and IPF samples. In addition, mediators that are regulated by the A2BR, such as IL-6, IL-8 and osteopontin were elevated in these samples and activation of the A2BR on cells isolated from the airways of COPD and IPF patients was shown to directly induce the production of these mediators. Conclusions/Significance: These findings suggest that components of adenosine metabolism and signaling are altered in a manner that promotes adenosine production and signaling in the lungs of patients with COPD and IPF, and provide proof of concept information that these disorders may benefit from adenosine-based therapeutics. Furthermore, this study provides the first evidence that A2BR signaling can promote the production of inflammatory and fibrotic mediators in patients with these disorders.	[Zhou, Yang; Blackburn, Michael R.] Univ Texas Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Murthy, Jayasimha N.] Univ Texas Houston Med Sch, Div Pulm Crit Care & Sleep Med, Houston, TX USA; [Zhou, Yang; Blackburn, Michael R.] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA; [Zeng, Dewan; Belardinelli, Luiz] Gilead Sci Inc, Palo Alto, CA USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Gilead Sciences	Zhou, Y (corresponding author), Univ Texas Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	michael.r.blackburn@uth.tmc.edu	ZHou, Yang/D-3320-2012	Blackburn, Michael/0000-0002-1394-9966	National Institutes of Health (NIH) [HL095401, HL70952]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL095401, R01HL070952] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant numbers HL095401 and HL70952 to M. R. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI S, 1994, J PHARMACOL EXP THER, V268, P1328; BERKVENS TM, 1988, NUCLEIC ACIDS RES, V16, P3255, DOI 10.1093/nar/16.8.3255; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; Blackburn MR, 2003, J CLIN INVEST, V112, P332, DOI 10.1172/JCI200316815; Blackburn MR, 2003, TRENDS PHARMACOL SCI, V24, P66, DOI 10.1016/S0165-6147(02)00045-7; Brown RA, 2008, EUR RESPIR J, V31, P311, DOI 10.1183/09031936.00003707; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; Chunn JL, 2001, J IMMUNOL, V167, P4676, DOI 10.4049/jimmunol.167.8.4676; CUSHLEY MJ, 1983, BRIT J CLIN PHARMACO, V15, P161, DOI 10.1111/j.1365-2125.1983.tb01481.x; DRIVER AG, 1993, AM REV RESPIR DIS, V148, P91, DOI 10.1164/ajrccm/148.1.91; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; FEOKTISTOV I, 1995, J CLIN INVEST, V96, P1979, DOI 10.1172/JCI118245; Feoktistov I, 1997, PHARMACOL REV, V49, P381; Fozard JR, 1999, PULM PHARMACOL THER, V12, P111, DOI 10.1006/pupt.1999.0191; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Hasko G, 1996, J IMMUNOL, V157, P4634; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Huszar E, 2002, EUR RESPIR J, V20, P1393, DOI 10.1183/09031936.02.00005002; JOHNSON HG, 1985, BRIT J PHARMACOL, V86, P63, DOI 10.1111/j.1476-5381.1985.tb09435.x; Li Y, 2006, AM J RESP CELL MOL, V34, P600, DOI 10.1165/rcmb.2005-0421OC; Lupher ML, 2006, ADV IMMUNOL, V89, P245, DOI 10.1016/S0065-2776(05)89006-6; Ma B, 2006, J CLIN INVEST, V116, P1274, DOI 10.1172/JCI26372; MANN JS, 1986, CLIN SCI, V70, P461, DOI 10.1042/cs0700461; MANN JS, 1986, J APPL PHYSIOL, V61, P1667, DOI 10.1152/jappl.1986.61.5.1667; MARQUARDT DL, 1978, J IMMUNOL, V120, P871; Mohsenin A, 2007, FASEB J, V21, P1026, DOI 10.1096/fj.06-7301com; OOSTERHOFF Y, 1993, AM REV RESPIR DIS, V147, P553, DOI 10.1164/ajrccm/147.3.553; Picher M, 2004, J BIOL CHEM, V279, P20234, DOI 10.1074/jbc.M400305200; Roman J, 2006, AM J PHYSIOL-LUNG C, V290, pL317, DOI 10.1152/ajplung.00118.2005; Ryzhov S, 2004, J IMMUNOL, V172, P7726, DOI 10.4049/jimmunol.172.12.7726; Ryzhov S, 2008, J IMMUNOL, V180, P7212, DOI 10.4049/jimmunol.180.11.7212; Ryzhov S, 2008, J PHARMACOL EXP THER, V324, P694, DOI 10.1124/jpet.107.131540; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Strieter Robert M, 2008, Proc Am Thorac Soc, V5, P305, DOI 10.1513/pats.200710-160DR; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Sun CX, 2005, J CLIN INVEST, V115, P35, DOI 10.1172/JCI200522656; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Varani K, 2006, AM J RESP CRIT CARE, V173, P398, DOI 10.1164/rccm.200506-869OC; Vizi E, 2002, J ALLERGY CLIN IMMUN, V109, P446, DOI 10.1067/mai.2002.121955; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; Walker BAM, 1997, AM J RESP CELL MOL, V16, P531, DOI 10.1165/ajrcmb.16.5.9160835; Ward PA, 1998, AM J RESP CRIT CARE, V157, pS123, DOI 10.1164/ajrccm.157.4.nhlbi-10; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Young HWJ, 2004, J IMMUNOL, V173, P1380, DOI 10.4049/jimmunol.173.2.1380; ZAYNAGETDINOV R, 2009, AM J RESP CELL MOL B; Zhong HY, 2005, AM J RESP CELL MOL, V32, P2, DOI 10.1165/rcmb.2004-0103OC; Zhong HY, 2004, AM J RESP CELL MOL, V30, P118, DOI 10.1165/rcmb.2003-0118OC; Zhou Y, 2009, PHARMACOL THERAPEUT, V123, P105, DOI 10.1016/j.pharmthera.2009.04.003	51	89	92	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9224	10.1371/journal.pone.0009224	http://dx.doi.org/10.1371/journal.pone.0009224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169073	Green Published, Green Submitted, gold			2022-12-25	WOS:000274590500006
J	Estes, LJ; Lloyd, LE; Teti, M; Raja, S; Bowleg, L; Allgood, KL; Glick, N				Estes, Larissa J.; Lloyd, Linda E.; Teti, Michelle; Raja, Sheela; Bowleg, Lisa; Allgood, Kristi L.; Glick, Nancy			Perceptions of Audio Computer-Assisted Self-Interviewing (ACASI) among Women in an HIV-Positive Prevention Program	PLOS ONE			English	Article							HEALTH; INTERVENTION; PEOPLE; STIGMA	Background: Audio Computer-Assisted Self Interviewing (ACASI) has improved the reliability and accuracy of self-reported HIV health and risk behavior data, yet few studies account for how participants experience the data collection process. Methodology/Principal Findings: This exploratory qualitative analysis aimed to better understand the experience and implications of using ACASI among HIV-positive women participating in sexual risk reduction interventions in Chicago (n = 12) and Philadelphia (n = 18). Strategies of Grounded Theory were used to explore participants' ACASI experiences. Conclusion/Significance: Key themes we identified included themes that could be attributed to the ACASI and other methods of data collection (e. g., paper-based self-administered questionnaire or face-to-face interviews). The key themes were usability; privacy and honesty; socially desirable responses and avoiding judgment; and unintentional discomfort resulting from recalling risky behavior using the ACASI. Despite both positive and negative findings about the ACASI experience, we conclude that ACASI is in general an appropriate method for collecting sensitive data about HIV/AIDS risk behaviors among HIV-positive women because it seemed to ensure privacy in the study population allowing for more honest responses, minimize socially desirable responses, and help participants avoid actual or perceived judgment.	[Estes, Larissa J.; Lloyd, Linda E.] Univ Texas Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Teti, Michelle; Bowleg, Lisa] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Raja, Sheela] Univ Illinois, Coll Dent, Chicago, IL USA; [Allgood, Kristi L.; Glick, Nancy] Sinai Hlth Syst, Sinai Urban Hlth Inst, Chicago, IL USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Drexel University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Estes, LJ (corresponding author), Univ Texas Houston, Sch Publ Hlth, Houston, TX 77030 USA.	Larissa.J.Estes@uth.tmc.edu		Bowleg, Lisa/0000-0003-4677-8195; Teti, Michelle/0000-0002-3943-3810; , Sheela/0000-0001-5297-362X; Estes, Larissa/0000-0002-0601-2681; Allgood, Kristi/0000-0002-5056-3069	U.S. Department of Health and Human Services [03048]; Health Resources and Services Administration (HRSA); National Significance (SPNS) Program	U.S. Department of Health and Human Services; Health Resources and Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Significance (SPNS) Program	This research is supported by grant number 03048 from the U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) Special Projects of National Significance (SPNS) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This manuscript's contents are solely the responsibility of the authors and do not represent the official view of HRSA or the SPNS program.	ALMEIDA L, 2006, J CLIN PHARM, V46, P1077; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Bowleg L, 2004, PSYCHOL WOMEN QUART, V28, P70, DOI 10.1111/j.1471-6402.2004.00124.x; Brewer NT, 2004, MED CARE, V42, P875, DOI 10.1097/01.mlr.0000135817.31355.6b; Bunting SM, 1996, ADV NURS SCI, V19, P64, DOI 10.1097/00012272-199612000-00008; Burt RS, 2005, BROKERAGE CLOSURE IN; Denzin N., 2005, SAGE HDB QUALITATIVE, V3rd, DOI DOI 10.4135/9781849208550.N1; Edwards SL, 2007, AM J EPIDEMIOL, V165, P1336, DOI 10.1093/aje/kwm019; Eide P, 2008, NURS ETHICS, V15, P199, DOI 10.1177/0969733007086018; ELLIOTT DM, 1995, J TRAUMA STRESS, V8, P629, DOI 10.1007/BF02102892; Evans M, 2002, J MED ETHICS, V28, P41, DOI 10.1136/jme.28.1.41; Ghanem KG, 2005, SEX TRANSM INFECT, V81, P421, DOI 10.1136/sti.2004.013193; Green J., 2018, QUALITATIVE METHODS, VFourth; Griffin MG, 2003, J TRAUMA STRESS, V16, P221, DOI 10.1023/A:1023735821900; Guba EG., 1994, HDB QUALITATIVE RES, P105; Jacomb PA, 1999, SOC PSYCH PSYCH EPID, V34, P80, DOI 10.1007/s001270050115; Jones R, 2003, WESTERN J NURS RES, V25, P349, DOI 10.1177/0193945902250423; Kahn DL, 1999, QUAL HEALTH RES, V9, P119, DOI 10.1177/104973299129121631; Kim JH, 2008, IEEJ T ELECTR ELECTR, V3, P255, DOI 10.1002/tee.20264; Kurth AE, 2004, SEX TRANSM DIS, V31, P719, DOI 10.1097/01.olq.0000145855.36181.13; Kvale S., 2008, INTERVIEWS LEARNING; Kvale S., 1996, INTERVIEWS INTRO QUA; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Malitz FE, 2007, AIDS BEHAV, V11, pS1, DOI 10.1007/s10461-007-9252-5; Metzger DS, 2000, AM J EPIDEMIOL, V152, P99, DOI 10.1093/aje/152.2.99; Minnis AM, 2007, CONTRACEPTION, V75, P59, DOI 10.1016/j.contraception.2006.07.002; Newman PA, 2008, J HEALTH CARE POOR U, V19, P829, DOI 10.1353/hpu.0.0043; NIMH Multisite HIV STD Prevent Tri, 2008, JAIDS-J ACQ IMM DEF, V49, pS52, DOI 10.1097/QAI.0b013e318184481a; Nunkoosing K, 2005, QUAL HEALTH RES, V15, P698, DOI 10.1177/1049732304273903; Pluhar E, 2007, J ASSOC NURSE AIDS C, V18, P51, DOI 10.1016/j.jana.2007.05.002; Raja S, 2007, AIDS BEHAV, V11, pS127, DOI 10.1007/s10461-007-9226-7; Sandelowski M, 2006, QUAL HEALTH RES, V16, P1350, DOI 10.1177/1049732306294274; Schneider S.J., 2000, J OFFICIAL STAT STOC, V16, P255; TETI M, 2009, MIXED METHODS EVALUA; Teti M, 2007, AIDS BEHAV, V11, pS106, DOI 10.1007/s10461-007-9275-y; *U CA SAN FRANC, 2008, ENH PREV POS EV CTR; van de Wijgert J, 2000, INT J EPIDEMIOL, V29, P885, DOI 10.1093/ije/29.5.885; Walker EA, 1997, GEN HOSP PSYCHIAT, V19, P403, DOI 10.1016/S0163-8343(97)00061-3; Waruru Anthony K, 2005, BMC Med Inform Decis Mak, V5, P24, DOI 10.1186/1472-6947-5-24; Wu Y, 2007, J SCHOOL HEALTH, V77, P23, DOI 10.1111/j.1746-1561.2007.00158.x	40	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9149	10.1371/journal.pone.0009149	http://dx.doi.org/10.1371/journal.pone.0009149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554NW	20161771	Green Published, gold			2022-12-25	WOS:000274442700013
J	Dong, HJ; Zhang, YP; Dai, ZJ; Li, Y				Dong, Hongjun; Zhang, Yanping; Dai, Zongjie; Li, Yin			Engineering Clostridium Strain to Accept Unmethylated DNA	PLOS ONE			English	Article							INTRON TARGETRON VECTOR; ESCHERICHIA-COLI; GENETIC-TRANSFORMATION; TRANSFER EFFICIENCY; RESTRICTION; INACTIVATION; METHYLTRANSFERASE; DISRUPTION; OVEREXPRESSION; CYANOBACTERIUM	It is difficult to genetically manipulate the medically and biotechnologically important genus Clostridium due to the existence of the restriction and modification (RM) systems. We identified and engineered the RM system of a model clostridial species, C. acetobutylicum, with the aim to allow the host to accept the unmethylated DNA efficiently. A gene CAC1502 putatively encoding the type II restriction endonuclease Cac8241 was identified from the genome of C. acetobutylicum DSM1731, and disrupted using the ClosTron system based on group II intron insertion. The resulting strain SMB009 lost the type II restriction endonuclease activity, and can be transformed with unmethylated DNA as efficiently as with methylated DNA. The strategy reported here makes it easy to genetically modify the clostridial species using unmethylated DNA, which will help to advance the understanding of the clostridial physiology from the molecular level.	[Dong, Hongjun; Zhang, Yanping; Dai, Zongjie; Li, Yin] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Dong, Hongjun] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Dai, Zongjie] Univ Sci & Technol China, Dept Biochem & Mol Biol, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Dong, HJ (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.	yli@im.ac.cn	Li, Yin/C-6644-2009; Zhang, Yanping/C-7114-2009	Li, Yin/0000-0003-0995-3070; 	National High Technology Research and Development Program of China [2006AA02Z237]; National Basic Research Program of China [2007CB707803]; Knowledge Innovation Program of CAS [KSCXZ-YW-G-007]; Hundreds Talents Program of the Chinese Academy of Sciences	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Knowledge Innovation Program of CAS(Knowledge Innovation Program of the Chinese Academy of Sciences); Hundreds Talents Program of the Chinese Academy of Sciences	This work was supported by the National High Technology Research and Development Program of China (863 Project, # 2006AA02Z237), National Basic Research Program of China (973 Project, # 2007CB707803), Knowledge Innovation Program of CAS (# KSCXZ-YW-G-007), and Hundreds Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZEDDOUG H, 1989, FEMS MICROBIOL LETT, V65, P323, DOI 10.1016/0378-1097(89)90239-5; Bartlett JG, 2006, ANN INTERN MED, V145, P758, DOI 10.7326/0003-4819-145-10-200611210-00008; Bayliss CD, 2006, NUCLEIC ACIDS RES, V34, P4046, DOI 10.1093/nar/gkl568; Berndt C, 2003, MICROBIOL-SGM, V149, P895, DOI 10.1099/mic.0.26033-0; Brenner J., 2005, PROBACTERIA A, P27; Desai RP, 1999, APPL ENVIRON MICROB, V65, P936; Durre P., 2005, HDB CLOSTRIDIA; Edwards RA, 1999, BIOTECHNIQUES, V26, P892, DOI 10.2144/99265st02; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; Green EM, 1998, BIOTECHNOL BIOENG, V58, P215, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<215::AID-BIT14>3.3.CO;2-I; Green EM, 1996, MICROBIOL-SGM, V142, P2079, DOI 10.1099/13500872-142-8-2079; Green EM, 1996, APPL BIOCHEM BIOTECH, V57-8, P213, DOI 10.1007/BF02941702; Harris LM, 2002, J BACTERIOL, V184, P3586, DOI 10.1128/JB.184.13.3586-3597.2002; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Hillmann F, 2009, J BACTERIOL, V191, P6082, DOI 10.1128/JB.00351-09; HIRSCH A, 1954, J DAIRY RES, V21, P101, DOI 10.1017/S0022029900007196; Iwai M, 2004, PLANT CELL PHYSIOL, V45, P171, DOI 10.1093/pcp/pch015; JONES DT, 1986, MICROBIOL REV, V50, P484, DOI 10.1128/MMBR.50.4.484-524.1986; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; Kennedy CL, 2005, MOL MICROBIOL, V57, P1357, DOI 10.1111/j.1365-2958.2005.04774.x; LEE SY, 1992, ANN NY ACAD SCI, V665, P39, DOI 10.1111/j.1749-6632.1992.tb42572.x; Lewis TA, 1996, APPL ENVIRON MICROB, V62, P4669, DOI 10.1128/AEM.62.12.4669-4674.1996; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; MERMELSTEIN LD, 1993, APPL ENVIRON MICROB, V59, P1077, DOI 10.1128/AEM.59.4.1077-1081.1993; MERMELSTEIN LD, 1992, BIO-TECHNOL, V10, P190, DOI 10.1038/nbt0292-190; Minton NP, 1989, INTRO PHYSL BIOCH GE, P27; MOSER DP, 1993, ARCH MICROBIOL, V160, P229; Murray NE, 2002, MICROBIOL-SGM, V148, P3, DOI 10.1099/00221287-148-1-3; Nikolajewa S, 2005, NUCLEIC ACIDS RES, V33, P2726, DOI 10.1093/nar/gki575; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Ohshima H, 2002, J BACTERIOL, V184, P381, DOI 10.1128/JB.184.2.381-389.2002; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Roberts RJ, 2007, NUCLEIC ACIDS RES, V35, pD269, DOI 10.1093/nar/gkl891; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; ROOD JI, 1983, CAN J MICROBIOL, V29, P1241, DOI 10.1139/m83-193; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; Sambrook J, 2001, MOL CLONING LAB MANU; SCOTT PT, 1989, GENE, V82, P327, DOI 10.1016/0378-1119(89)90059-0; Shao L, 2007, CELL RES, V17, P963, DOI 10.1038/cr.2007.91; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; TRANBETCKE A, 1986, GENE, V42, P89, DOI 10.1016/0378-1119(86)90153-8; Tummala SB, 2003, J BACTERIOL, V185, P3644, DOI 10.1128/JB.185.12.3644-3653.2003; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06; Yasui K, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn884; Zhong J, 2003, NUCLEIC ACIDS RES, V31, P1656, DOI 10.1093/nar/gkg248	48	60	68	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9038	10.1371/journal.pone.0009038	http://dx.doi.org/10.1371/journal.pone.0009038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161730	Green Submitted, gold, Green Published			2022-12-25	WOS:000274442600002
J	Gopal, S; Bober, A; Whiteford, JR; Multhaupt, HAB; Yoneda, A; Couchman, JR				Gopal, Sandeep; Bober, Adam; Whiteford, James R.; Multhaupt, Hinke A. B.; Yoneda, Atsuko; Couchman, John R.			Heparan Sulfate Chain Valency Controls Syndecan-4 Function in Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTIONAL MIGRATION; CYTOPLASMIC DOMAIN; PKC-ALPHA; BINDING; PROTEIN; KINASE; PROTEOGLYCANS; LOCALIZATION; ACTIVATION; ACTIN	Fibroblasts null for the transmembrane proteoglycan, syndecan-4, have an altered actin cytoskeleton, compared with matching wild-type cells. They do not organize alpha-smooth muscle actin into bundles, but will do so when full-length syndecan-4 is re-expressed. This requires the central V region of the core protein cytoplasmic domain, though not interactions with PDZ proteins. A second key requirement is multiple heparan sulfate chains. Mutant syndecan-4 with no chains, or only one chain, failed to restore the wild-type phenotype, whereas those expressing two or three were competent. However, clustering of one-chain syndecan-4 forms with antibodies overcame the block, indicating that valency of interactions with ligands is a key component of syndecan-4 function. Measurements of focal contact/adhesion size and focal adhesion kinase phosphorylation correlated with syndecan-4 status and alpha-smooth muscle actin organization, being reduced where syndecan-4 function was compromised by a lack of multiple heparan sulfate chains.	[Couchman, John R.] Univ Copenhagen, Dept Biomed Sci, Bioctr, DK-2200 Copenhagen N, Denmark; [Bober, Adam; Whiteford, James R.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London SW7 2AZ, England	University of Copenhagen; Imperial College London	Couchman, JR (corresponding author), Univ Copenhagen, Dept Biomed Sci, Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	john.couchman@bric.ku.dk		Gopal, Sandeep/0000-0002-6706-6747; Whiteford, James/0000-0002-8967-7389	Wellcome Trust [065940]; Danish National Research Foundation; Haensch Foundation; Wilhelm Pedersen Fonden through the Novo Nordisk Fonden; Department of Biomedical Sciences at the University of Copenhagen; Molecular Medicine Ph.D. program at the University of Copenhagen; Medical Research Council UK (MRC); Versus Arthritis [19207] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Haensch Foundation; Wilhelm Pedersen Fonden through the Novo Nordisk Fonden; Department of Biomedical Sciences at the University of Copenhagen; Molecular Medicine Ph.D. program at the University of Copenhagen; Medical Research Council UK (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Versus Arthritis(Versus Arthritis)	This work was supported initially by Wellcome Trust Programme Grant 065940 (to J. R. C.), then by the Danish National Research Foundation, Haensch Foundation, Wilhelm Pedersen Fonden through the Novo Nordisk Fonden, and the Department of Biomedical Sciences at the University of Copenhagen (to J. R. C.).; Supported by the Molecular Medicine Ph.D. program at the University of Copenhagen.; Supported by a Medical Research Council UK (MRC) studentship.	Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020; Echtermeyer F, 1999, J CELL SCI, V112, P3433; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Ishiguro K, 2000, J BIOL CHEM, V275, P5249, DOI 10.1074/jbc.275.8.5249; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; Longley RL, 1999, J CELL SCI, V112, P3421; Mahalingam Y, 2007, J BIOL CHEM, V282, P3221, DOI 10.1074/jbc.M604938200; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176; Okina E, 2009, SCAND J MED SCI SPOR, V19, P479, DOI 10.1111/j.1600-0838.2009.00941.x; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; Shin J, 2001, BIOCHEMISTRY-US, V40, P8471, DOI 10.1021/bi002750r; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; SHWORAK NW, 1994, J BIOL CHEM, V269, P21204; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tumova S, 2000, J BIOL CHEM, V275, P9410, DOI 10.1074/jbc.275.13.9410; Whiteford JR, 2008, J BIOL CHEM, V283, P29322, DOI 10.1074/jbc.M803505200; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Whiteford JR, 2006, J BIOL CHEM, V281, P32156, DOI 10.1074/jbc.M605553200; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Yamada S, 2007, GLYCOBIOLOGY, V17, P886, DOI 10.1093/glycob/cwm051; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	36	56	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14247	14258		10.1074/jbc.M109.056945	http://dx.doi.org/10.1074/jbc.M109.056945			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20154082	hybrid, Green Published			2022-12-25	WOS:000277299700021
J	Peterson, SB; Liu, J				Peterson, Sherket B.; Liu, Jian			Unraveling the Specificity of Heparanase Utilizing Synthetic Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN HEPARANASE; EXTRACELLULAR-MATRIX; TUMOR PROGRESSION; SULFATE GLYCOSAMINOGLYCANS; CAPSULAR POLYSACCHARIDE; CANCER METASTASIS; GROWTH-FACTOR; EXPRESSION; HEPARIN; CLONING	Heparanase is a promising anticancer target because of its involvement in cancer invasion and metastasis. Heparanase cleaves heparan sulfate (HS), a sulfated polysaccharide, and activates a series of HS-mediated cell proliferation and angiogenesis processes. Understanding the substrate specificity of heparanase will aid the discovery of heparanase inhibitors. Here, we sought to determine the specificity of heparanase using synthetic polysaccharide substrates. The substrates were prepared using purified HS biosynthetic enzymes. Using these substrates, we were able to dissect the structural moieties required for heparanase. Our data suggest that heparanase cleaves the linkage between a GlcA unit and an N-sulfo glucosamine unit carrying either a 3-O-sulfo or a 6-O-sulfo group. In addition, heparanase cleaves the linkage of a GlcA unit and N-sulfo glucosamine unit with a 2-O-sulfated GlcA residue, not a 2-O-sulfated IdoA residue, in proximity. We also discovered that the polysaccharide with repeating disaccharide units of IdoA2S-GlcNS inhibits the activity of heparanase. Our findings advance the understanding of the substrate specificity of heparanase and identify a lead compound for developing polysaccharide-based heparanase inhibitors.	[Peterson, Sherket B.; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Liu, J (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Med Chem & Nat Prod, 303 Beard Hall, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu			National Institutes of Health [R01AI050050, R01HL094463, R21AI074775]; American Heart Association, Mid-Atlantic Affiliate [0855424E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050, R21AI074775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM090647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Mid-Atlantic Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01AI050050, R01HL094463, and R21AI074775. This work was also supported by Grant-in-aid 0855424E from the American Heart Association, Mid-Atlantic Affiliate.	Abboud-Jarrous G, 2005, J BIOL CHEM, V280, P13568, DOI 10.1074/jbc.M413370200; BAME KJ, 1993, J BIOL CHEM, V268, P19956; Bame KJ, 2001, GLYCOBIOLOGY, V11, p91R, DOI 10.1093/glycob/11.6.91R; BARNER M, 1987, BLOOD, V70, P551; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Davidson D, 2007, GYNECOL ONCOL, V104, P311, DOI 10.1016/j.ygyno.2006.08.045; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; Duncan MB, 2006, BIOCHEM BIOPH RES CO, V339, P1232, DOI 10.1016/j.bbrc.2005.11.142; Feyerabend TB, 2006, NAT CHEM BIOL, V2, P195, DOI 10.1038/nchembio777; Friedmann Y, 2000, AM J PATHOL, V157, P1167, DOI 10.1016/S0002-9440(10)64632-9; Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ikuta M, 2001, ORAL ONCOL, V37, P177, DOI 10.1016/S1368-8375(00)00077-4; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; ISHAIMICHAELI R, 1992, BIOCHEMISTRY-US, V31, P2080, DOI 10.1021/bi00122a027; Koliopanos A, 2001, CANCER RES, V61, P4655; Kussie PH, 1999, BIOCHEM BIOPH RES CO, V261, P183, DOI 10.1006/bbrc.1999.0962; Li K, 2010, J BIOL CHEM, V285, P11106, DOI 10.1074/jbc.M109.081059; Lindahl U, 2005, J MED CHEM, V48, P349, DOI 10.1021/jm049812m; Liu J, 1996, J BIOL CHEM, V271, P27072, DOI 10.1074/jbc.271.43.27072; Marchetti D, 2001, ADV ENZYME REGUL, V41, P343, DOI 10.1016/S0065-2571(00)00016-9; McDowell LM, 2006, J BIOL CHEM, V281, P6924, DOI 10.1074/jbc.M512932200; Mikami S, 2001, JPN J CANCER RES, V92, P1062, DOI 10.1111/j.1349-7006.2001.tb01061.x; Naggi A, 2005, J BIOL CHEM, V280, P12103, DOI 10.1074/jbc.M414217200; Ogishima T, 2005, CLIN CANCER RES, V11, P1028; OGREN S, 1975, J BIOL CHEM, V250, P2690; Okada Y, 2002, J BIOL CHEM, V277, P42488, DOI 10.1074/jbc.M206510200; Parish CR, 2001, BIOCHIM BIOPHYS ACTA, V1471, P99, DOI DOI 10.1016/S0304-419X(01)00017-8; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Quiros RM, 2006, CANCER-AM CANCER SOC, V106, P532, DOI 10.1002/cncr.21648; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Shinyo Y, 2003, ANN ONCOL, V14, P1505, DOI 10.1093/annonc/mdg407; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Simizu S, 2004, CANCER SCI, V95, P553, DOI 10.1111/j.1349-7006.2004.tb02485.x; Toyoshima M, 1999, J BIOL CHEM, V274, P24153, DOI 10.1074/jbc.274.34.24153; Uno F, 2001, CANCER RES, V61, P7855; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Xiao Y, 2003, HEPATOL RES, V26, P192, DOI 10.1016/S1386-6346(03)00107-4	47	55	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14504	14513		10.1074/jbc.M110.104166	http://dx.doi.org/10.1074/jbc.M110.104166			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20181948	Green Published, hybrid			2022-12-25	WOS:000277299700047
J	Sevrioukova, IF; Poulos, TL; Churbanova, IY				Sevrioukova, Irina F.; Poulos, Thomas L.; Churbanova, Inna Y.			Crystal Structure of the Putidaredoxin Reductase.Putidaredoxin Electron Transfer Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P450CAM MONOOXYGENASE; REDOX PARTNERS; ADRENODOXIN REDUCTASE; CYTOCHROME P450CAM; ASSOCIATIONS; COMPONENT; SYSTEM; ROLES	In the camphor monooxygenase system from Pseudomonas putida, the [2Fe-2S]-containing putidaredoxin (Pdx) shuttles electrons between the NADH-dependent putidaredoxin reductase (Pdr) and cytochrome P450(cam). The mechanism of the Pdr.Pdx redox couple has been investigated by a variety of techniques. One of the exceptions is x-ray crystallography as the native partners associate weakly and resist co-crystallization. Here, we present the 2.6-angstrom x-ray structure of a catalytically active complex between Pdr and Pdx C73S/C85S chemically cross-linked via the Lys(409Pdr)-Glu(72Pdx) pair. The 365 angstrom(2) Pdr-Pdx interface is predominantly hydrophobic with one central Arg(310Pdr)-Asp(38Pdx) salt bridge, likely assisting docking and orienting the partners optimally for electron transfer, and a few peripheral hydrogen bonds. A predicted 12-angstrom-long electron transfer route between FAD and [2Fe-2S] includes flavin flanking Trp(330Pdr) and the iron ligand Cys(39Pdx). The x-ray model agrees well with the experimental and theoretical results and suggests that the linked Pdx must undergo complex movements during turnover to accommodate P450(cam), which could limit the Pdx-to-P450(cam) electron transfer reaction.	[Sevrioukova, Irina F.; Poulos, Thomas L.; Churbanova, Inna Y.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Chem & Pharmaceut Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Sevrioukova, IF (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 3205 McGaugh Hall, Irvine, CA 92697 USA.	sevrioui@uci.edu			National Institutes of Health [GM67637, GM33688]; U. S. Dept. of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067637, R01GM033688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Dept. of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM67637 (to I. F. S.) and GM33688 (to T. L. P.). This work was based on research conducted at the Advanced Light Source, which is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U. S. Dept. of Energy under Contract DE-AC02-05CH11231.	Aoki M, 1998, BBA-PROTEIN STRUCT M, V1386, P168, DOI 10.1016/S0167-4838(98)00091-0; Aoki M, 1998, BBA-PROTEIN STRUCT M, V1386, P157, DOI 10.1016/S0167-4838(98)00094-6; Aoki M, 1998, BBA-PROTEIN STRUCT M, V1384, P180, DOI 10.1016/S0167-4838(98)00017-X; Aoki M, 1998, INORG CHIM ACTA, V272, P80, DOI 10.1016/S0020-1693(97)05946-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Churbanova IY, 2010, BIOCHEMISTRY-US, V49, P58, DOI 10.1021/bi901872s; Corbett MC, 2007, ACTA CRYSTALLOGR D, V63, P951, DOI 10.1107/S0907444907035160; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Grinberg AV, 2000, PROTEINS, V40, P590, DOI 10.1002/1097-0134(20000901)40:4<590::AID-PROT50>3.0.CO;2-P; HINTZ MJ, 1982, J BIOL CHEM, V257, P4324; Holden M, 1997, J BIOL CHEM, V272, P21720, DOI 10.1074/jbc.272.35.21720; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KATAGIRI M, 1968, J BIOL CHEM, V243, P3543; KIMBARA K, 1989, J BACTERIOL, V171, P2740, DOI 10.1128/jb.171.5.2740-2747.1989; Kurnikov I, 2000, HARLEM VERSION 1 0; Kuznetsov VY, 2006, BIOCHEMISTRY-US, V45, P11934, DOI 10.1021/bi0611154; Kuznetsov VY, 2005, J BIOL CHEM, V280, P16135, DOI 10.1074/jbc.M500771200; Muller JJ, 2001, J BIOL CHEM, V276, P2786, DOI 10.1074/jbc.M008501200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Purdy MM, 2004, BIOCHEMISTRY-US, V43, P271, DOI 10.1021/bi0356045; ROOME PW, 1988, ARCH BIOCHEM BIOPHYS, V266, P32, DOI 10.1016/0003-9861(88)90233-0; ROOME PW, 1988, ARCH BIOCHEM BIOPHYS, V266, P41, DOI 10.1016/0003-9861(88)90234-2; Senda M, 2007, J MOL BIOL, V373, P382, DOI 10.1016/j.jmb.2007.08.002; Sevrioukova IF, 2004, J MOL BIOL, V336, P889, DOI 10.1016/j.jmb.2003.12.067; Sevrioukova IF, 2003, J MOL BIOL, V333, P377, DOI 10.1016/j.jmb.2003.08.028; Sevrioukova IF, 2002, J BIOL CHEM, V277, P25831, DOI 10.1074/jbc.M201110200; Sevrioukova IF, 2001, BIOCHEMISTRY-US, V40, P10592, DOI 10.1021/bi010874d; Smith N, 2004, ACTA CRYSTALLOGR D, V60, P816, DOI 10.1107/S0907444904003348; Ziegler GA, 1999, J MOL BIOL, V289, P981, DOI 10.1006/jmbi.1999.2807	31	27	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13616	13620		10.1074/jbc.M110.104968	http://dx.doi.org/10.1074/jbc.M110.104968			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20179327	hybrid, Green Published			2022-12-25	WOS:000276987700035
J	Mierke, CT; Kollmannsberger, P; Zitterbart, DP; Diez, G; Koch, TM; Marg, S; Ziegler, WH; Goldmann, WH; Fabry, B				Mierke, Claudia T.; Kollmannsberger, Philip; Zitterbart, Daniel Paranhos; Diez, Gerold; Koch, Thorsten M.; Marg, Susanna; Ziegler, Wolfgang H.; Goldmann, Wolfgang H.; Fabry, Ben			Vinculin Facilitates Cell Invasion into Three-dimensional Collagen Matrices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA-CELLS; MIGRATION; ADHESION; LOCOMOTION; F9; PROTEOLYSIS; INTEGRINS; DYNAMICS; SURVIVAL; MOTILITY	The cytoskeletal protein vinculin contributes to the mechanical link of the contractile actomyosin cytoskeleton to the extracellular matrix (ECM) through integrin receptors. In addition, vinculin modulates the dynamics of cell adhesions and is associated with decreased cell motility on two-dimensional ECM substrates. The effect of vinculin on cell invasion through dense three-dimensional ECM gels is unknown. Here, we report how vinculin expression affects cell invasion into three-dimensional collagen matrices. Cell motility was investigated in vinculin knockout and vinculin expressing wild-type mouse embryonic fibroblasts. Vinculin knockout cells were 2-fold more motile on two-dimensional collagen-coated substrates compared with wild-type cells, but 3-fold less invasive in 2.4 mg/ml three-dimensional collagen matrices. Vinculin knockout cells were softer and remodeled their cytoskeleton more dynamically, which is consistent with their enhanced two-dimensional motility but does not explain their reduced three-dimensional invasiveness. Importantly, vinculin-expressing cells adhered more strongly to collagen and generated 3-fold higher traction forces compared with vinculin knockout cells. Moreover, vinculin-expressing cells were able to migrate into dense (5.8 mg/ml) three-dimensional collagen matrices that were impenetrable for vinculin knockout cells. These findings suggest that vinculin facilitates three-dimensional matrix invasion through up-regulation or enhanced transmission of traction forces that are needed to overcome the steric hindrance of ECMs.	[Goldmann, Wolfgang H.; Fabry, Ben] Univ Erlangen Nurnberg, Ctr Med Phys & Technol, Biophys Grp, D-91052 Erlangen, Germany; [Marg, Susanna; Ziegler, Wolfgang H.] Univ Leipzig, Fac Med, Interdisziplinares Zentrum Klin Forsch Leipzig, D-404103 Leipzig, Germany	University of Erlangen Nuremberg; Leipzig University	Mierke, CT (corresponding author), Univ Erlangen Nurnberg, Ctr Med Phys & Technol, Biophys Grp, Henkestr 91, D-91052 Erlangen, Germany.	claudia.mierke@t-online.de	Goldmann, Wolfgang H/H-5572-2013; Fabry, Ben/AAT-5717-2020; Fabry, Ben/C-5496-2013; Kollmannsberger, Philip/D-7925-2011; Zitterbart, Daniel/N-7489-2013; Mierke, Claudia Tanja/L-5293-2018	Fabry, Ben/0000-0003-1737-0465; Fabry, Ben/0000-0003-1737-0465; Kollmannsberger, Philip/0000-0002-8049-6186; Mierke, Claudia Tanja/0000-0002-6622-335X; Ziegler, Wolfgang H./0000-0003-4529-1916	National Institutes of Health [HL65960]; Deutsche Forschungsgemeinschaft [FA336/2-1, GO598/13-1]; Deutsche Krebshilfe [107384]; Deutscher Akademischer Austausch Dienst; Bavaria California Technology Center; Bayerisch-Franzo-Sisches Hochschulzentrum; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065960] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Bavaria California Technology Center; Bayerisch-Franzo-Sisches Hochschulzentrum; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL65960. This work was also supported by Deutsche Forschungsgemeinschaft Grants FA336/2-1 and GO598/13-1, the Cluster of Excellence "Engineering of Advanced Materials" Program, Deutsche Krebshilfe Grant 107384, Deutscher Akademischer Austausch Dienst, Bavaria California Technology Center, and Bayerisch-Franzo-Sisches Hochschulzentrum.	Baciu PC, 2003, EXP CELL RES, V291, P167, DOI 10.1016/S0014-4827(03)00387-2; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; Davidson B, 1999, CLIN EXP METASTAS, V17, P799, DOI 10.1023/A:1006723011835; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451; Fabry B, 2003, RESP PHYSIOL NEUROBI, V137, P109, DOI 10.1016/S1569-9048(03)00141-1; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170; GOLDMANN WH, 1995, EXP CELL RES, V221, P311, DOI 10.1006/excr.1995.1380; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Kollmannsberger P, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2804771; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; McNulty AL, 2009, CLIN ORTHOP RELAT R, V467, P1557, DOI 10.1007/s11999-008-0596-6; Mierke CT, 2008, EUR J CELL BIOL, V87, P669, DOI 10.1016/j.ejcb.2008.01.002; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Mohl CC, 2009, CELL MOTIL CYTOSKEL, V66, P350, DOI 10.1002/cm.20375; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Raupach C, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011918; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Webb DJ, 2003, CURR OPIN CELL BIOL, V15, P614, DOI 10.1016/S0955-0674(03)00105-4; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Xu WM, 1998, J CELL SCI, V111, P1535; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	31	147	148	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13121	13130		10.1074/jbc.M109.087171	http://dx.doi.org/10.1074/jbc.M109.087171			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20181946	hybrid, Green Published			2022-12-25	WOS:000276787800068
J	Jennewein, C; von Knethen, A; Schmid, T; Brune, B				Jennewein, Carla; von Knethen, Andreas; Schmid, Tobias; Bruene, Bernhard			MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) mRNA Destabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; HALF-LIFE; KAPPA-B; EXPRESSION; INFLAMMATION; MACROPHAGES; NUCLEAR; ALPHA; TRANSLOCATION; STIMULATION	Peroxisome proliferator-activated receptor gamma (PPAR gamma) gained considerable interest as a therapeutic target during chronic inflammatory diseases. Remarkably, the pathogenesis of diseases such as multiple sclerosis or Alzheimer is associated with impaired PPAR gamma expression. Considering that regulation of PPAR gamma expression during inflammation is largely unknown, we were interested in elucidating underlying mechanisms. To this end, we initiated an inflammatory response by exposing primary human macrophages to lipopolysaccharide (LPS) and observed a rapid decline of PPAR gamma 1 expression. Because promoter activities were not affected by LPS, we focused on mRNA stability and noticed a decreased mRNA half-life. As RNA stability is often regulated via 3'-untranslated regions (UTRs), we analyzed the impact of the PPAR gamma-3'-UTR by reporter assays using specific constructs. LPS significantly reduced luciferase activity of the pGL3-PPAR gamma-3'-UTR, suggesting that PPAR gamma 1 mRNA is destabilized. Deletion or mutation of a potential microRNA-27a/b (miR-27a/b) binding site within the 3'-UTR restored luciferase activity. Moreover, inhibition of miR-27b, which was induced upon LPS exposure, partially reversed PPAR gamma 1 mRNA decay, whereas miR-27b overexpression decreased PPAR gamma 1 mRNA content. In addition, LPS further reduced this decay. The functional relevance of miR-27b-dependent PPAR gamma 1 decrease was proven by inhibition or overexpression of miR-27b, which affected LPS-induced expression of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF alpha) and interleukin (IL)-6. We provide evidence that LPS-induced miR-27b contributes to destabilization of PPAR gamma 1 mRNA. Understanding molecular mechanisms decreasing PPAR gamma might help to better appreciate inflammatory diseases.	[Jennewein, Carla; von Knethen, Andreas; Schmid, Tobias; Bruene, Bernhard] Goethe Univ Frankfurt, Fac Med, Inst Biochem I ZAFES, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Brune, B (corresponding author), Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	bruene@pathobiochemie1.de	Jennewein, Carla/C-2199-2013	Schmid, Tobias/0000-0002-1952-5259	Deutsche Forschungsgemeinschaft [Br 999, FOG 784]; Sander Foundation; LOEWE	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sander Foundation; LOEWE	This work was supported by grants from Deutsche Forschungsgemeinschaft (Br 999, FOG 784, Excellence Cluster Cardiopulmonary System), Sander Foundation, and LOEWE (LiFF and OSF).	Drew PD, 2008, PPAR RES, V2008, DOI 10.1155/2008/627463; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Dushkin MI, 2009, B EXP BIOL MED+, V147, P345, DOI 10.1007/s10517-009-0505-3; Elbrecht A, 1996, BIOCHEM BIOPH RES CO, V224, P431, DOI 10.1006/bbrc.1996.1044; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fajas L, 1998, FEBS LETT, V438, P55, DOI 10.1016/S0014-5793(98)01273-3; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; HARROLD S, 1991, ANAL BIOCHEM, V198, P19, DOI 10.1016/0003-2697(91)90500-S; Johann AM, 2006, CELL DEATH DIFFER, V13, P1533, DOI 10.1038/sj.cdd.4401832; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kim D, 2001, MOL CELLS, V11, P267; Klotz L, 2005, J IMMUNOL, V175, P4948, DOI 10.4049/jimmunol.175.8.4948; Kobayashi M, 2005, ANN ALLERG ASTHMA IM, V95, P468, DOI 10.1016/S1081-1206(10)61173-8; Landreth G, 2007, CURR ALZHEIMER RES, V4, P159, DOI 10.2174/156720507780362092; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Mendes SD, 2009, CELL SIGNAL, V21, P1109, DOI 10.1016/j.cellsig.2009.02.025; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Necela BM, 2008, IMMUNOLOGY, V125, P344, DOI 10.1111/j.1365-2567.2008.02849.x; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sertznig P, 2008, AM J CLIN DERMATOL, V9, P15, DOI 10.2165/00128071-200809010-00002; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Von Knethen A, 2001, FASEB J, V15, P535, DOI 10.1096/fj.00-0187com; von Knethen A, 2007, J CELL BIOL, V176, P681, DOI 10.1083/jcb.200605038; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhou M, 2008, AM J PHYSIOL-REG I, V294, pR84, DOI 10.1152/ajpregu.00340.2007	45	150	159	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11846	11853		10.1074/jbc.M109.066399	http://dx.doi.org/10.1074/jbc.M109.066399			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164187	Green Published, hybrid			2022-12-25	WOS:000276787100012
J	Zavialov, AV; Yu, XD; Spillmann, D; Lauvau, G; Zavialov, AV				Zavialov, Anton V.; Yu, Xiaodi; Spillmann, Dorothe; Lauvau, Gregoire; Zavialov, Andrey V.			Structural Basis for the Growth Factor Activity of Human Adenosine Deaminase ADA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGE; CELL-SURFACE; DROSOPHILA; FAMILY; GENE; PURIFICATION; RECEPTORS; REVEALS; BINDING	Two distinct adenosine deaminases, ADA1 and ADA2, are found in humans. ADA1 has an important role in lymphocyte function and inherited mutations in ADA1 result in severe combined immunodeficiency. The recently isolated ADA2 belongs to the novel family of adenosine deaminase growth factors (ADGFs), which play an important role in tissue development. The crystal structures of ADA2 and ADA2 bound to a transition state analogue presented here reveal the structural basis of the catalytic/signaling activity of ADGF/ ADA2 proteins. In addition to the catalytic domain, the structures discovered two ADGF/ADA2-specific domains of novel folds that mediate the protein dimerization and binding to the cell surface receptors. This complex architecture is in sharp contrast with that of monomeric single domain ADA1. An extensive glycosylation and the presence of a conserved disulfide bond and a signal peptide in ADA2 strongly suggest that ADA2, in contrast to ADA1, is specifically designed to act in the extracellular environment. The comparison of catalytic sites of ADA2 and ADA1 demonstrates large differences in the arrangement of the substrate-binding pockets. These structural differences explain the substrate and inhibitor specificity of adenosine deaminases and provide the basis for a rational design of ADA2-targeting drugs to modulate the immune system responses in pathophysiological conditions.	Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Mol Biol, SE-75324 Uppsala, Sweden; [Spillmann, Dorothe] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Lauvau, Gregoire] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, INSERM, U924, F-06560 Valbonne, France; [Lauvau, Gregoire] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Zavialov, Andrey V.] Singapore Immunol Network SIgN, Lab Immune Regulat, Singapore 138648, Singapore	Swedish University of Agricultural Sciences; Uppsala University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Yeshiva University; Albert Einstein College of Medicine; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)		anton.zavialov@molbio.slu.se; Andrey_Zaviyalov@immunol.a-star.edu.sg	Zavialov, Anton V./C-7664-2015	Zavialov, Anton V./0000-0001-6191-5931	Swedish Research Council [K2008-58X-20689-01-3]; FORMAS [221-2007-1057]; European Molecular Biology Organization [ALT-978-2005]; Human Frontier of Science Program (HFSP) [LT00395-2006-L]; INSERM (Avenir); HFSP [CDA0040-2005C]	Swedish Research Council(Swedish Research CouncilEuropean Commission); FORMAS(Swedish Research Council Formas); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier of Science Program (HFSP)(Human Frontier Science Program); INSERM (Avenir)(Institut National de la Sante et de la Recherche Medicale (Inserm)); HFSP(Human Frontier Science Program)	This work was supported by grants from the Swedish Research Council (K2008-58X-20689-01-3) and FORMAS (221-2007-1057) (to Ant. V. Z.), European Molecular Biology Organization Grant ALT-978-2005 and Human Frontier of Science Program (HFSP) Long Term Fellowship LT00395-2006-L (to And. V. Z.), and grants from INSERM (Avenir) and HFSP carrier development award (CDA0040-2005C) (to G. L.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Canals M, 2004, J NEUROCHEM, V88, P726, DOI 10.1046/j.1471-4159.2003.02200.x; Charlab R, 2001, GENE, V267, P13, DOI 10.1016/S0378-1119(01)00393-6; Dillman Robert O, 2004, Expert Rev Anticancer Ther, V4, P27, DOI 10.1586/14737140.4.1.27; Dolezal T, 2005, PLOS BIOL, V3, P1213, DOI 10.1371/journal.pbio.0030201; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Franco R, 2007, CRIT REV IMMUNOL, V27, P495, DOI 10.1615/CritRevImmunol.v27.i6.10; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hershfield MS, 2005, EUR J IMMUNOL, V35, P25, DOI 10.1002/eji.200425738; Homma K, 1996, J BIOL CHEM, V271, P13770, DOI 10.1074/jbc.271.23.13770; Homma KJ, 2001, J BIOL CHEM, V276, P43761, DOI 10.1074/jbc.M105088200; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Iijima R, 2008, J BIOL CHEM, V283, P2255, DOI 10.1074/jbc.M709279200; Iwaki-Egawa S, 2004, COMP BIOCHEM PHYS B, V137, P247, DOI 10.1016/j.cbpc.2003.11.010; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kinoshita T, 2005, BIOCHEMISTRY-US, V44, P10562, DOI 10.1021/bi050529e; Kinoshita T, 2008, BIOCHEM BIOPH RES CO, V373, P53, DOI 10.1016/j.bbrc.2008.05.180; Larson ET, 2008, J MOL BIOL, V381, P975, DOI 10.1016/j.jmb.2008.06.048; Maier SA, 2005, J MOL EVOL, V61, P776, DOI 10.1007/s00239-005-0046-y; Maier SA, 2001, GENE, V280, P27, DOI 10.1016/S0378-1119(01)00762-4; Matsushita T, 2000, J BIOL CHEM, V275, P36934, DOI 10.1074/jbc.M003455200; Meins M, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e62; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NIEDZWICKI JG, 1991, J ACQ IMMUN DEF SYND, V4, P178; Petersen F, 1999, J BIOL CHEM, V274, P12376, DOI 10.1074/jbc.274.18.12376; Riazi MA, 2000, GENOMICS, V64, P277, DOI 10.1006/geno.1999.6099; Sachchidanand, 2002, J BIOL CHEM, V277, P50629, DOI 10.1074/jbc.M208956200; UNGERER JPJ, 1992, CLIN CHEM, V38, P1322; Weihofen WA, 2004, J BIOL CHEM, V279, P43330, DOI 10.1074/jbc.M405001200; WILSON DK, 1993, BIOCHEMISTRY-US, V32, P1689, DOI 10.1021/bi00058a001; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zavialov AV, 2005, BIOCHEM J, V391, P51, DOI 10.1042/BJ20050683; Zurovec M, 2002, P NATL ACAD SCI USA, V99, P4403, DOI 10.1073/pnas.062059699	36	79	83	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12367	12377		10.1074/jbc.M109.083527	http://dx.doi.org/10.1074/jbc.M109.083527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20147294	hybrid, Green Published			2022-12-25	WOS:000276787100065
J	Wang, S; Poon, K; Oswald, RE; Chuang, HH				Wang, Shu; Poon, Kinning; Oswald, Robert E.; Chuang, Huai-hu			Distinct Modulations of Human Capsaicin Receptor by Protons and Magnesium through Different Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID RECEPTOR-1; TRP CHANNELS; POTENTIAL VANILLOID-1; ION-CHANNEL; NEURONS; HYPERALGESIA; ACTIVATION; ANANDAMIDE; DETERMINANTS; SENSITIVITY	The capsaicin receptor (TRPV1) is a nonselective cation channel that integrates multiple painful stimuli, including capsaicin, protons, and heat. Protons facilitate the capsaicin- and heat-induced currents by decreasing thermal threshold or increasing agonist potency for TRPV1 activation (Tominaga, M., Caterina, M. J., Malmberg, A. B., Rosen, T. A., Gilbert, H., Skinner, K., Raumann, B. E., Basbaum, A. I., and Julius, D. ( 1998) Neuron 21, 531-543). In the presence of saturating capsaicin, rat TRPV1 (rTRPV1) reaches full activation, with no further stimulation by protons. Human TRPV1 (hTRPV1), a species ortholog with high homology to rTRPV1, is potentiated by extracellular protons and magnesium, even at saturating capsaicin. We investigated the structural basis for protons and magnesium modulation of fully capsaicin- bound human receptors. By analysis of chimeric channels between hTRPV1 and rTRPV1, we found that transmembrane domain 1-4 (TM1-4) of TRPV1 determines whether protons can further open the fully capsaicin- bound receptors. Mutational analysis identified a titratable glutamate residue (Glu-536) in the linker between TM3 and TM4 critical for further stimulation of fully liganded hTRPV1. In contrast, hTRPV1 TM5-6 is required for magnesium augmentation of capsaicin efficacy. Our results demonstrate that capsaicin efficacy of hTRPV1 correlates with the extracellular ion milieu and unravel the relevant structural basis of modulation by protons and magnesium.	[Wang, Shu; Chuang, Huai-hu] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Poon, Kinning; Oswald, Robert E.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University; Cornell University	Chuang, HH (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA.	huai-hu.chuang@cornell.edu	Wang, Shu/F-2976-2011	Poon, Kinning/0000-0001-5671-9194	Cornell University Startup Funds; American Heart Association	Cornell University Startup Funds; American Heart Association(American Heart Association)	This work was supported by Cornell University Startup Funds and a scientist development grant from the American Heart Association (to H.-h.C.).	Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Cornett PM, 2008, MOL PHARMACOL, V74, P1261, DOI 10.1124/mol.108.049684; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Gavva NR, 2008, PAIN, V136, P202, DOI 10.1016/j.pain.2008.01.024; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jahnel R, 2001, EUR J BIOCHEM, V268, P5489, DOI 10.1046/j.1432-1033.2001.02500.x; Johnson DM, 2006, MOL PHARMACOL, V70, P1005, DOI 10.1124/mol.106.023945; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Olah Z, 2001, J BIOL CHEM, V276, P31163, DOI 10.1074/jbc.M101607200; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pareek TK, 2007, P NATL ACAD SCI USA, V104, P660, DOI 10.1073/pnas.0609916104; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Sprague J, 2001, EUR J PHARMACOL, V423, P121, DOI 10.1016/S0014-2999(01)01123-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Trevisani M, 2002, NAT NEUROSCI, V5, P546, DOI 10.1038/nn852; Vannier B, 1998, J BIOL CHEM, V273, P8675, DOI 10.1074/jbc.273.15.8675; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Zhang H, 2007, J NEUROSCI, V27, P12067, DOI 10.1523/JNEUROSCI.0496-07.2007; Zhang N, 2005, P NATL ACAD SCI USA, V102, P4536, DOI 10.1073/pnas.0406030102; Zhu WG, 2007, J NEUROSCI, V27, P13770, DOI 10.1523/JNEUROSCI.3822-07.2007	34	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11547	11556		10.1074/jbc.M109.058727	http://dx.doi.org/10.1074/jbc.M109.058727			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145248	hybrid, Green Published			2022-12-25	WOS:000276286200061
J	Yu, YB; Dosanjh, L; Lao, LX; Tan, M; Shim, BS; Luo, Y				Yu, Young-Beob; Dosanjh, Laura; Lao, Lixing; Tan, Ming; Shim, Bum Sang; Luo, Yuan			Cinnamomum cassia Bark in Two Herbal Formulas Increases Life Span in Caenorhabditis elegans via Insulin Signaling and Stress Response Pathways	PLOS ONE			English	Article							BILOBA EXTRACT EGB-761; JUZEN-TAIHO-TO; POSTPRANDIAL BLOOD-GLUCOSE; EXPRESSION; MEDICINE; RESISTANCE; MICE; BEHAVIORS; TOLERANCE; INGESTION	Background: Proving the efficacy and corresponding mode of action of herbal supplements is a difficult challenge for evidence-based herbal therapy. A major hurdle is the complexity of herbal preparations, many of which combine multiple herbs, particularly when the combination is assumed to be vitally important to the effectiveness of the herbal therapy. This issue may be addressed through the use of contemporary methodology and validated animal models. Methods and Principal Findings: In this study, two commonly used traditional herbal formulas, Shi Quan Da Bu Tang (SQDB) and Huo Luo Xiao Ling Dan (HLXL) were evaluated using a survival assay and oxidative stress biomarkers in a well-established C. elegans model of aging. HLXL is an eleven herb formula modified from a top-selling traditional herbal formula for the treatment of arthritic joint pain. SQDB consists of ten herbs often used for fatigue and energy, particularly in the aged. We demonstrate here that SQDB significantly extend life span in a C. elegans model of aging. Among all individual herbs tested, two herbs Cinnamomum cassia bark (Chinese pharmaceutical name: Cinnamomi Cortex, CIN) and Panax ginseng root (Chinese pharmaceutical name: Ginseng Radix, GS) significantly extended life span in C. elegans. CIN in both SQDB and HLXL formula extended life span via modulation of multiple longevity assurance genes, including genes involved in insulin signaling and stress response pathways. All the life-span-extending herbs (SQDB, CIN and GS) also attenuated levels of H2O2 and enhanced small heat shock protein expression. Furthermore, the life span-extending herbs significantly delayed human amyloid beta (A beta)-induced toxicity in transgenic C. elegans expressing human A beta. Conclusion/Significance: These results validate an invertebrate model for rapid, systematic evaluation of commonly used Chinese herbal formulations and may provide insight for designing future evidence-based herbal therapy(s).	[Yu, Young-Beob; Dosanjh, Laura; Luo, Yuan] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Lao, Lixing; Luo, Yuan] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA; [Tan, Ming] Univ Maryland, Sch Med, Div Biostat, Baltimore, MD 21201 USA; [Yu, Young-Beob] Korea Inst Oriental Med, Brain Dis Res Ctr, Taejon, South Korea; [Yu, Young-Beob] Nambu Univ, Dept Med Plant Resources, Kwangju, South Korea; [Shim, Bum Sang] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Korea Institute of Oriental Medicine (KIOM); Nambu University; Kyung Hee University	Yu, YB (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.	yluo@rx.umaryland.edu	Shim, Bum-sang/AAH-9081-2020; Lao, Lixing/I-7979-2013; Lao, Lixing/P-9107-2019	Lao, Lixing/0000-0003-0198-9714; Yu, Young-Bob/0000-0001-7785-5988	NIH [AT001928]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT001928] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	NIH AT001928 http://nccam.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin KA, 2009, INT J CLIN EXP MED, V2, P254; Antebi A, 2007, NATURE, V447, P536, DOI 10.1038/447536a; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blumenthal M, 2000, HERBAL MED; Boyd-Kimball D, 2006, NEUROBIOL AGING, V27, P1239, DOI 10.1016/j.neurobiolaging.2005.07.001; Brown MK, 2006, PHARMACOL BIOCHEM BE, V85, P620, DOI 10.1016/j.pbb.2006.10.017; Brown MK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-62; BURNS JJ, 2009, TOXICOLOGY      1007; Cao ZM, 2007, J GERONTOL A-BIOL, V62, P1337, DOI 10.1093/gerona/62.12.1337; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Collins JJ, 2006, EXP GERONTOL, V41, P1032, DOI 10.1016/j.exger.2006.06.038; DOSANJH LE, 2009, J ALZHEIMERS DI 1105; Dragland S, 2003, J NUTR, V133, P1286; Drake J, 2003, NEUROBIOL AGING, V24, P415, DOI 10.1016/S0197-4580(02)00225-7; DUDONNE S, 2009, J AGR FOOD CHEM; Dugasani S, 2010, J ETHNOPHARMACOL, V127, P515, DOI 10.1016/j.jep.2009.10.004; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Farooqui T, 2009, MECH AGEING DEV, V130, P203, DOI 10.1016/j.mad.2008.11.006; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; Hasani-Ranjbar Shirin, 2009, Inflammation & Allergy Drug Targets, V8, P2; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hlebowicz J, 2007, AM J CLIN NUTR, V85, P1552, DOI 10.1093/ajcn/85.6.1552; Hlebowicz J, 2009, AM J CLIN NUTR, V89, P815, DOI 10.3945/ajcn.2008.26807; HU Y, 2009, IMMUNOPHARMACOL IMMU; Jitomir J, 2009, J MED FOOD, V12, P467, DOI 10.1089/jmf.2008.0128; Kamiyama H, 2005, BIOL PHARM BULL, V28, P2111, DOI 10.1248/bpb.28.2111; Kato M, 2007, WORLD J GASTROENTERO, V13, P2289, DOI 10.3748/wjg.v13.i16.2289; Kim SH, 2006, J ETHNOPHARMACOL, V104, P119, DOI 10.1016/j.jep.2005.08.059; Kirkham S, 2009, DIABETES OBES METAB, V11, P1100, DOI 10.1111/j.1463-1326.2009.01094.x; Kogure T, 2005, PHYTOMEDICINE, V12, P327, DOI 10.1016/j.phymed.2004.05.002; Kwon HK, 2009, CANCER LETT, V278, P174, DOI 10.1016/j.canlet.2009.01.015; Lao LX, 2006, AM J CHINESE MED, V34, P833, DOI 10.1142/S0192415X06004326; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; Link CD, 2003, NEUROBIOL AGING, V24, P397, DOI 10.1016/S0197-4580(02)00224-5; Luo Y., 2003, Current Topics in Nutraceutical Research, V1, P49; Luo Y, 2004, REDOX REP, V9, P65, DOI 10.1179/135100004225004733; Mettler S, 2009, NUTR RES, V29, P723, DOI 10.1016/j.nutres.2009.10.002; Morimoto RI, 2006, NEW ENGL J MED, V355, P2254, DOI 10.1056/NEJMcibr065573; Panickar KS, 2009, EXP NEUROL, V216, P420, DOI 10.1016/j.expneurol.2008.12.024; Peterson DW, 2009, J ALZHEIMERS DIS, V17, P585, DOI 10.3233/JAD-2009-1083; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Qin B, 2009, HORM METAB RES, V41, P516, DOI 10.1055/s-0029-1202813; QIN B, 2009, HORM METAB RES; Qin BL, 2003, DIABETES RES CLIN PR, V62, P139, DOI 10.1016/S0168-8227(03)00173-6; Qin BL, 2009, J NUTR BIOCHEM, V20, P901, DOI 10.1016/j.jnutbio.2008.08.005; Rajaiah R, 2009, J ETHNOPHARMACOL, V123, P40, DOI 10.1016/j.jep.2009.02.032; Riedlinger JE, 2001, ANN PHARMACOTHER, V35, P228, DOI 10.1345/aph.10122; Satoh H, 2002, J ALTERN COMPLEM MED, V8, P107, DOI 10.1089/107555302317371370; SMITH JV, 2003, J ALZ DIS, V4; Solomon TPJ, 2007, DIABETES OBES METAB, V9, P895, DOI 10.1111/j.1463-1326.2006.00694.x; Solomon TPJ, 2009, EUR J APPL PHYSIOL, V105, P969, DOI 10.1007/s00421-009-0986-9; Srivastava D, 2008, BIOGERONTOLOGY, V9, P309, DOI 10.1007/s10522-008-9139-5; Strayer A, 2003, FASEB J, V17, P2305, DOI 10.1096/fj.03-0376fje; Tagami K, 2004, BIOL PHARM BULL, V27, P156, DOI 10.1248/bpb.27.156; Tsuchiya M, 2008, INT J CANCER, V123, P2503, DOI 10.1002/ijc.23828; Tsunemi A, 2005, NEUROCHEM RES, V30, P75, DOI 10.1007/s11064-004-9688-1; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wilson Mark A., 2008, BMC Pharmacology, V8, P15, DOI 10.1186/1471-2210-8-15; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; WU Y, 2008, NEUROBIOL AGING, V10, P1016; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Wu ZX, 2002, CELL MOL BIOL, V48, P725; Yang M, 2010, J ETHNOPHARMACOL, V127, P264, DOI 10.1016/j.jep.2009.11.010; YAO CJ, 2009, EVID BASED COMP 1123; Zarse K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004062; Zee-Cheng Robert K.-Y, 1992, Methods and Findings in Experimental and Clinical Pharmacology, V14, P725; Zhang LZ, 2009, FREE RADICAL BIO MED, V46, P414, DOI 10.1016/j.freeradbiomed.2008.10.041; Zhang RX, 2009, J ETHNOPHARMACOL, V121, P366, DOI 10.1016/j.jep.2008.11.018	74	50	54	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9339	10.1371/journal.pone.0009339	http://dx.doi.org/10.1371/journal.pone.0009339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179756	Green Submitted, Green Published, gold			2022-12-25	WOS:000274923900008
J	Buffin, E; Gho, M				Buffin, Eulalie; Gho, Michel			Laser Microdissection of Sensory Organ Precursor Cells of Drosophila Microchaetes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; EXPRESSION; GENES; TRANSFORMATION; SPECIFICATION; SENSELESS; PROTEINS; DIVISION	Background: In Drosophila, each external sensory organ originates from the division of a unique precursor cell (the sensory organ precursor cell or SOP). Each SOP is specified from a cluster of equivalent cells, called a proneural cluster, all of them competent to become SOP. Although, it is well known how SOP cells are selected from proneural clusters, little is known about the downstream genes that are regulated during SOP fate specification. Methodology/Principal Findings: In order to better understand the mechanism involved in the specification of these precursor cells, we combined laser microdissection, toisolate SOP cells, with transcriptome analysis, to study their RNA profile. Using this procedure, we found that genes that exhibit a 2-fold or greater expression in SOPs versus epithelial cells were mainly associated with Gene Ontology (GO) terms related with cell fate determination and sensory organ specification. Furthermore, we found that several genes such as pebbled/hindsight, scabrous, miranda, senseless, or cut, known to be expressed in SOP cells by independent procedures, are particularly detected in laser microdissected SOP cells rather than in epithelial cells. Conclusions/Significance: These results confirm the feasibility and the specificity of our laser microdissection based procedure. We anticipate that this analysis will give new insight into the selection and specification of neural precursor cells.	[Buffin, Eulalie; Gho, Michel] Univ Paris 06, UMR 7622, Paris, France; [Buffin, Eulalie; Gho, Michel] CNRS, UMR 7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Buffin, E (corresponding author), Univ Paris 06, UMR 7622, Paris, France.	Michel.Gho@snv.jussieu.fr		Buffin, Eulalie/0000-0002-0471-7258	ARC [3291]; CNRS; UPMC	ARC(Australian Research Council); CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC	This work was supported by ARC (Grant 3291, www.arc.asso.fr), CNRS (www.cnrs.fr) and UPMC (www.UPMC.fr). E. B. was supported by a CNRS postdoctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelilah-Seyfried S, 2000, GENETICS, V155, P733; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; Erickson Heidi S., 2008, V424, P433, DOI 10.1007/978-1-60327-064-9_34; Fichelson P, 2004, DEV BIOL, V276, P367, DOI 10.1016/j.ydbio.2004.08.043; Gho M, 1999, DEVELOPMENT, V126, P3573; Inbal A, 2003, DEVELOPMENT, V130, P2467, DOI 10.1242/dev.00475; Jafar-Nejad H, 2003, GENE DEV, V17, P2966, DOI 10.1101/gad.1122403; Li YX, 2003, DEVELOPMENT, V130, P2819, DOI 10.1242/dev.00495; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Miller AC, 2008, DEVELOPMENT, V135, P707, DOI 10.1242/dev.016386; Miller SW, 2009, DEV BIOL, V329, P386, DOI 10.1016/j.ydbio.2009.02.009; Mollinari C, 2002, BIOL CELL, V94, P1, DOI 10.1016/S0248-4900(02)01181-4; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Pi H, 2007, J BIOMED SCI, V14, P467, DOI 10.1007/s11373-007-9156-4; Pi HW, 2001, DEVELOPMENT, V128, P2699; Pickup AT, 2009, DEVELOPMENT, V136, P975, DOI 10.1242/dev.027318; Reeves N, 2005, DEV CELL, V8, P413, DOI 10.1016/j.devcel.2005.01.020; ROARK M, 1995, GENE DEV, V9, P2384, DOI 10.1101/gad.9.19.2384; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Sawamoto K, 1996, NEUROSCI RES, V26, P205, DOI 10.1016/S0168-0102(96)01110-8; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Wildonger J, 2005, DEV BIOL, V286, P507, DOI 10.1016/j.ydbio.2005.08.026; Yamada T, 2003, DEVELOPMENT, V130, P4085, DOI 10.1242/dev.00624; Yeh E, 2000, EMBO J, V19, P4827, DOI 10.1093/emboj/19.17.4827	30	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9285	10.1371/journal.pone.0009285	http://dx.doi.org/10.1371/journal.pone.0009285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174573	Green Submitted, gold, Green Published			2022-12-25	WOS:000274923700006
J	Leoni, AL; Gavillet, B; Rougier, JS; Marionneau, C; Probst, V; Le Scouarnec, S; Schott, JJ; Demolombe, S; Bruneval, P; Huang, CLH; Colledge, WH; Grace, AA; Le Marec, H; Wilde, AA; Mohler, PJ; Escande, D; Abriel, H; Charpentier, F				Leoni, Anne-Laure; Gavillet, Bruno; Rougier, Jean-Sebastien; Marionneau, Celine; Probst, Vincent; Le Scouarnec, Solena; Schott, Jean-Jacques; Demolombe, Sophie; Bruneval, Patrick; Huang, Christopher L. H.; Colledge, William H.; Grace, Andrew A.; Le Marec, Herve; Wilde, Arthur A.; Mohler, Peter J.; Escande, Denis; Abriel, Hugues; Charpentier, Flavien			Variable Na(v)1.5 Protein Expression from the Wild-Type Allele Correlates with the Penetrance of Cardiac Conduction Disease in the Scn5a(+/-) Mouse Model	PLOS ONE			English	Article							BRUGADA-SYNDROME; SODIUM-CHANNEL; TARGETED DISRUPTION; MUTATION; ANKYRIN; HEART; PHENOTYPE; GENE; MICE; CARDIOMYOCYTES	Background: Loss-of-function mutations in SCN5A, the gene encoding Na(v)1.5 Na+ channel, are associated with inherited cardiac conduction defects and Brugada syndrome, which both exhibit variable phenotypic penetrance of conduction defects. We investigated the mechanisms of this heterogeneity in a mouse model with heterozygous targeted disruption of Scn5a (Scn5a(+/-) mice) and compared our results to those obtained in patients with loss-of-function mutations in SCN5A. Methodology/Principal Findings: Based on ECG, 10-week-old Scn5a(+/-) mice were divided into 2 subgroups, one displaying severe ventricular conduction defects (QRS interval>18 ms) and one a mild phenotype (QRS <= 18 ms; QRS in wild-type littermates: 10-18 ms). Phenotypic difference persisted with aging. At 10 weeks, the Na+ channel blocker ajmaline prolonged QRS interval similarly in both groups of Scn5a(+/-) mice. In contrast, in old mice (>53 weeks), ajmaline effect was larger in the severely affected subgroup. These data matched the clinical observations on patients with SCN5A loss-of-function mutations with either severe or mild conduction defects. Ventricular tachycardia developed in 5/10 old severely affected Scn5a(+/-) mice but not in mildly affected ones. Correspondingly, symptomatic SCN5A-mutated Brugada patients had more severe conduction defects than asymptomatic patients. Old severely affected Scn5a(+/-) mice but not mildly affected ones showed extensive cardiac fibrosis. Mildly affected Scn5a(+/-) mice had similar Na(v)1.5 mRNA but higher Na(v)1.5 protein expression, and moderately larger I-Na current than severely affected Scn5a(+/-) mice. As a consequence, action potential upstroke velocity was more decreased in severely affected Scn5a(+/-) mice than in mildly affected ones. Conclusions: Scn5a(+/-) mice show similar phenotypic heterogeneity as SCN5A-mutated patients. In Scn5a(+/-) mice, phenotype severity correlates with wild-type Na(v)1.5 protein expression.	[Leoni, Anne-Laure; Marionneau, Celine; Probst, Vincent; Le Scouarnec, Solena; Schott, Jean-Jacques; Demolombe, Sophie; Le Marec, Herve; Escande, Denis; Charpentier, Flavien] INSERM, UMR915, Inst Thorax, Nantes, France; [Probst, Vincent; Le Scouarnec, Solena; Schott, Jean-Jacques; Demolombe, Sophie; Le Marec, Herve; Charpentier, Flavien] CNRS, ERL3147, Nantes, France; [Leoni, Anne-Laure; Marionneau, Celine; Probst, Vincent; Le Scouarnec, Solena; Schott, Jean-Jacques; Demolombe, Sophie; Le Marec, Herve; Escande, Denis; Charpentier, Flavien] Univ Nantes, Nantes, France; [Probst, Vincent; Schott, Jean-Jacques; Le Marec, Herve; Escande, Denis; Charpentier, Flavien] CHU Nantes, Inst Thorax, F-44035 Nantes 01, France; [Rougier, Jean-Sebastien; Abriel, Hugues] Univ Bern, Dept Clin Res, Bern, Switzerland; [Bruneval, Patrick] Univ Paris 05, INSERM, U652, Paris, France; [Wilde, Arthur A.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Huang, Christopher L. H.; Colledge, William H.; Grace, Andrew A.] Univ Cambridge, Dept Biochem, Sect Cardiovasc Biol, Cambridge CB2 1QW, England; [Huang, Christopher L. H.; Colledge, William H.; Grace, Andrew A.] Univ Cambridge, Dept Physiol, Cambridge CB2 1QW, England; [Mohler, Peter J.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Gavillet, Bruno] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Nantes Universite; CHU de Nantes; University of Bern; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Amsterdam; Academic Medical Center Amsterdam; University of Cambridge; University of Cambridge; University of Iowa; University of Lausanne	Leoni, AL (corresponding author), INSERM, UMR915, Inst Thorax, Nantes, France.	flavien.charpentier@nantes.inserm.fr	Le Marec, Hervé/D-2718-2015; Schott, jean-Jacques/F-8842-2013; Charpentier, Flavien/D-3586-2015; Marionneau, Céline/D-4011-2015; Abriel, Hugues/B-9800-2009; Le Scouarnec, Solena/D-3547-2015; Colledge, William/X-4976-2019; Rougier, Jean-Sébastien/AAX-5038-2021	Le Marec, Hervé/0000-0002-8288-8693; Schott, jean-Jacques/0000-0002-9578-9475; Charpentier, Flavien/0000-0002-5057-0998; Marionneau, Céline/0000-0003-0962-9756; Abriel, Hugues/0000-0003-0465-5138; Le Scouarnec, Solena/0000-0003-3444-2125; Colledge, William/0000-0002-9603-4429; ROUGIER, Jean-Sebastien/0000-0002-8710-0260	Agence Nationale de la Recherche, Paris, France [ANR-05-PCOD-037-01, ANR-05-MRAR-028]; Fondation Leducq, Paris, France; Netherlands Heart Foundation, Den Haag, The Netherlands [2003/B195]; National Institutes of Health, Bethesda, Maryland, United States of America (NIH) [R01 HL083422]; Swiss National Science Foundation, Bern, Switzerland [310000-120707]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083422] Funding Source: NIH RePORTER	Agence Nationale de la Recherche, Paris, France(French National Research Agency (ANR)); Fondation Leducq, Paris, France(Leducq Foundation); Netherlands Heart Foundation, Den Haag, The Netherlands(Netherlands Heart FoundationNetherlands Government); National Institutes of Health, Bethesda, Maryland, United States of America (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation, Bern, Switzerland(Swiss National Science Foundation (SNSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Agence Nationale de la Recherche, Paris, France (ANR-05-PCOD-037-01 for FC; ANR-05-MRAR-028 for JJS and DE), the Fondation Leducq, Paris, France (DE, JJS, AAW), the Netherlands Heart Foundation, Den Haag, The Netherlands (2003/B195 for AAW), the National Institutes of Health, Bethesda, Maryland, United States of America (NIH R01 HL083422 for PJM) and the Swiss National Science Foundation, Bern, Switzerland (310000-120707 for HA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2005, TRENDS CARDIOVAS MED, V15, P35, DOI 10.1016/j.tcm.2005.01.001; Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Balasubramaniam R, 2003, J PHYSIOL-LONDON, V552, P535, DOI 10.1113/jphysiol.2003.048249; Bezzina CR, 2003, CIRC RES, V92, P159, DOI 10.1161/01.RES.0000052672.97759.36; Boixel C, 2006, AM J PHYSIOL-HEART C, V290, pH2257, DOI 10.1152/ajpheart.01060.2005; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; Chauhan VS, 2000, CIRC RES, V86, P441, DOI 10.1161/01.RES.86.4.441; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; Clancy CE, 2002, J CLIN INVEST, V110, P1075, DOI 10.1172/JCI200216945; Cohen SA, 1996, CIRCULATION, V94, P3083, DOI 10.1161/01.CIR.94.12.3083; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; Frustaci A, 2005, CIRCULATION, V112, P3680, DOI 10.1161/CIRCULATIONAHA.105.520999; Herfst LJ, 2004, J MOL CELL CARDIOL, V36, P185, DOI 10.1016/j.yjmcc.2003.11.014; Junttila MJ, 2008, J CARDIOVASC ELECTR, V19, P380, DOI 10.1111/j.1540-8167.2007.01050.x; Kaab S, 2005, CARDIOVASC RES, V67, P397, DOI 10.1016/j.cardiores.2005.04.005; Kupershmidt S, 1999, CIRC RES, V84, P146, DOI 10.1161/01.RES.84.2.146; Kyndt F, 2001, CIRCULATION, V104, P3081, DOI 10.1161/hc5001.100834; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; Meregalli PG, 2005, CARDIOVASC RES, V67, P367, DOI 10.1016/j.cardiores.2005.03.005; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Probst V, 2006, J CARDIOVASC ELECTR, V17, P270, DOI 10.1111/j.1540-8167.2006.00349.x; Probst V, 2003, J AM COLL CARDIOL, V41, P643, DOI 10.1016/S0735-1097(02)02864-4; Royer A, 2005, CIRCULATION, V111, P1738, DOI 10.1161/01.CIR.0000160853.19867.61; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Smits JPP, 2002, J AM COLL CARDIOL, V40, P350, DOI 10.1016/S0735-1097(02)01962-9; Tan HL, 2003, CARDIOVASC RES, V57, P961, DOI 10.1016/S0008-6363(02)00714-9; Tukkie R, 2004, CIRCULATION, V109, P1272, DOI 10.1161/01.CIR.0000118467.53182.D1; van Veen TAB, 2005, CIRCULATION, V112, P1927, DOI 10.1161/CIRCULATIONAHA.105.539072; van Veen TAB, 2006, ADV CARDIOL, V42, P18, DOI 10.1159/000092560	33	54	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9298	10.1371/journal.pone.0009298	http://dx.doi.org/10.1371/journal.pone.0009298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174578	Green Published, gold, Green Submitted			2022-12-25	WOS:000274923700009
J	Cotter, CR; Nguyen, ML; Yount, JS; Lopez, CB; Blaho, JA; Moran, TM				Cotter, Christopher R.; Nguyen, Marie L.; Yount, Jacob S.; Lopez, Carolina B.; Blaho, John A.; Moran, Thomas M.			The Virion Host Shut-Off (vhs) Protein Blocks a TLR-Independent Pathway of Herpes Simplex Virus Type 1 Recognition in Human and Mouse Dendritic Cells	PLOS ONE			English	Article							LATENCY-ASSOCIATED TRANSCRIPT; WILD-TYPE; ADAPTIVE IMMUNITY; RNA DEGRADATION; GLYCOPROTEIN-D; INFECTION; GENE; APOPTOSIS; INTERFERON; ACTIVATION	Molecular pathways underlying the activation of dendritic cells (DCs) in response to Herpes Simplex Virus type 1 (HSV-1) are poorly understood. Removal of the HSV virion host shut-off (vhs) protein relieves a block to DC activation observed during wild-type infection. In this study, we utilized a potent DC stimulatory HSV-1 recombinant virus lacking vhs as a tool to investigate the mechanisms involved in the activation of DCs by HSV-1. We report that the release of pro-inflammatory cytokines by conventional DC (cDC) during HSV-1 infection is triggered by both virus replication-dependent and replication-independent pathways. Interestingly, while vhs is capable of inhibiting the release of cytokines during infection of human and mouse cDCs, the secretion of cytokines by plasmacytoid DC (pDC) is not affected by vhs. These data prompted us to postulate that infection of cDCs by HSV triggers a TLR independent pathway for cDC activation that is susceptible to blockage by the vhs protein. Using cDCs isolated from mice deficient in both the TLR adaptor protein MyD88 and TLR3, we show that HSV-1 and the vhs-deleted virus can activate cDCs independently of TLR signaling. In addition, virion-associated vhs fails to block cDC activation in response to treatment with TLR agonists, but it efficiently blocked cDC activation triggered by the paramyxoviruses Sendai Virus (SeV) and Newcastle Disease Virus (NDV). This block to SeV- and NDV induced activation of cDC resulted in elevated SeV and NDV viral gene expression indicating that infection with HSV-1 enhances the cell's susceptibility to other pathogens through the action of vhs. Our results demonstrate for the first time that a viral protein contained in the tegument of HSV-1 can block the induction of DC activation by TLR-independent pathways of viral recognition.	[Cotter, Christopher R.; Nguyen, Marie L.; Yount, Jacob S.; Lopez, Carolina B.; Blaho, John A.; Moran, Thomas M.] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Cotter, Christopher R.; Nguyen, Marie L.; Yount, Jacob S.; Lopez, Carolina B.; Blaho, John A.; Moran, Thomas M.] Mt Sinai Sch Med, Inst Immunol, New York, NY USA; [Nguyen, Marie L.] Des Moines Univ, Dept Microbiol & Immunol, Des Moines, IA USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Cotter, CR (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY USA.	thomas.moran@mssm.edu	Lopez, Carolina/A-8887-2008; Yount, Jacob/F-9905-2014	Lopez, Carolina/0000-0002-7669-6572; Yount, Jacob/0000-0002-6128-4575	United States Public Health Service National Institutes of Health [AI48582, AI38873, AI07647, CA88796, R21AI077007, RO1AI041111]; National Institute of Allergy and Infectious Disease; NATIONAL CANCER INSTITUTE [T32CA088796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038873, R21AI038873, R01AI041111, R21AI077007, R01AI038873, R01AI048582] Funding Source: NIH RePORTER	United States Public Health Service National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AI48582 and AI38873 to John A. Blaho provided by United States Public Health Service National Institutes of Health; AI07647 to Christopher R. Cotter provided by United States Public Health Service National Institutes of Health; AI07647 and CA88796 to Marie L. Nyugen provided by United States Public Health Service National Institutes of Health; and R21AI077007 and RO1AI041111 to Thomas M. Moran provided by National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2005, J IMMUNOL, V175, P4189, DOI 10.4049/jimmunol.175.7.4189; Aubert M, 1999, J VIROL, V73, P10359, DOI 10.1128/JVI.73.12.10359-10370.1999; BenMohamed L, 2003, J VIROL, V77, P9463, DOI 10.1128/JVI.77.17.9463-9473.2003; Bettahi I, 2007, INVEST OPHTH VIS SCI, V48, P4643, DOI 10.1167/iovs.07-0356; Caselli E, 2003, INTERVIROLOGY, V46, P141, DOI 10.1159/000071454; Caselli E, 2005, BLOOD, V106, P2790, DOI 10.1182/blood-2005-04-1390; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; Esclatine A, 2004, P NATL ACAD SCI USA, V101, P18165, DOI 10.1073/pnas.0408272102; Esclatine A, 2004, P NATL ACAD SCI USA, V101, P3603, DOI 10.1073/pnas.0400354101; Everly DN, 1997, J VIROL, V71, P7157, DOI 10.1128/JVI.71.10.7157-7166.1997; Everly DN, 2002, J VIROL, V76, P8560, DOI 10.1128/JVI.76.17.8560-8571.2002; FENWICK ML, 1984, J GEN VIROL, V65, P1225, DOI 10.1099/0022-1317-65-7-1225; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Geiss BJ, 2000, J VIROL, V74, P11137, DOI 10.1128/JVI.74.23.11137-11144.2000; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Jin L, 2005, J VIROL, V79, P12286, DOI 10.1128/JVI.79.19.12286-12295.2005; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100; KWONG AD, 1988, J VIROL, V62, P912, DOI 10.1128/JVI.62.3.912-921.1988; Lee GE, 2003, J VIROL, V77, P2038, DOI 10.1128/JVI.77.3.2038-2045.2003; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Lopez CB, 2004, J IMMUNOL, V173, P6882, DOI 10.4049/jimmunol.173.11.6882; Lopez CB, 2003, J INFECT DIS, V187, P1126, DOI 10.1086/368381; Martinez EH, 2001, REV MED VIROL, V11, P253, DOI 10.1002/rmv.323; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; Miles DH, 2004, CURR EYE RES, V29, P79, DOI 10.1080/02713680490504669; Nguyen ML, 2005, VIROLOGY, V336, P274, DOI 10.1016/j.virol.2005.03.026; Nichol P F, 1994, Neurobiol Dis, V1, P83, DOI 10.1006/nbdi.1994.0011; NIEMIALTOWSKI MG, 1992, J IMMUNOL, V149, P3035; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Peri P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-140; Perng GC, 2002, J VIROL, V76, P1224, DOI 10.1128/JVI.76.3.1224-1235.2002; Pollara G, 2004, J IMMUNOL, V173, P4108, DOI 10.4049/jimmunol.173.6.4108; Pollara G, 2003, J INFECT DIS, V187, P165, DOI 10.1086/367675; Prechtel AT, 2005, J GEN VIROL, V86, P1645, DOI 10.1099/vir.0.80852-0; Rasmussen SB, 2007, J VIROL, V81, P13315, DOI 10.1128/JVI.01167-07; Rasmussen SB, 2009, J GEN VIROL, V90, P74, DOI 10.1099/vir.0.005389-0; READ GS, 1983, J VIROL, V46, P498, DOI 10.1128/JVI.46.2.498-512.1983; READ GS, 1993, J VIROL, V67, P7149, DOI 10.1128/JVI.67.12.7149-7160.1993; Reske A, 2008, J IMMUNOL, V180, P7525, DOI 10.4049/jimmunol.180.11.7525; Roizman B, 2007, FIELDS VIROLOGY, V2, P2501, DOI DOI 10.1148/RADIOL.14144045; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sabri F, 2006, J NEUROIMMUNOL, V171, P171, DOI 10.1016/j.jneuroim.2005.10.003; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Samady L, 2003, J VIROL, V77, P3768, DOI 10.1128/JVI.77.6.3768-3776.2003; Sanfilippo CM, 2004, J VIROL, V78, P224, DOI 10.1128/JVI.78.1.224-239.2004; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; SCHEK N, 1985, J VIROL, V55, P601, DOI 10.1128/JVI.55.3.601-610.1985; Schillinger JA, 2004, SEX TRANSM DIS, V31, P753, DOI 10.1097/01.olq.0000145852.43262.c3; SMIBERT CA, 1990, J VIROL, V64, P3882, DOI 10.1128/JVI.64.8.3882-3894.1990; SMIBERT CA, 1994, J VIROL, V68, P2339, DOI 10.1128/JVI.68.4.2339-2346.1994; Strand SS, 2004, J VIROL, V78, P13562, DOI 10.1128/JVI.78.24.13562-13572.2004; Strand SS, 2004, J VIROL, V78, P8400, DOI 10.1128/jvi.78.15.8400-8403.2004; Strelow L, 1997, VIROLOGY, V231, P28, DOI 10.1006/viro.1997.8497; STRELOW LI, 1995, J VIROL, V69, P6779, DOI 10.1128/JVI.69.11.6779-6786.1995; STROM T, 1987, J VIROL, V61, P2198, DOI 10.1128/JVI.61.7.2198-2207.1987; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Westra DF, 2000, J GEN VIROL, V81, P2011, DOI 10.1099/0022-1317-81-8-2011; Yount JS, 2008, J IMMUNOL, V180, P4910, DOI 10.4049/jimmunol.180.7.4910; Yount JS, 2006, J IMMUNOL, V177, P4503, DOI 10.4049/jimmunol.177.7.4503; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhang Z, 2005, CELL MOL IMMUNOL, V2, P411; Zheng XD, 2001, INVEST OPHTH VIS SCI, V42, P120	69	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e8684	10.1371/journal.pone.0008684	http://dx.doi.org/10.1371/journal.pone.0008684			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174621	Green Published, gold, Green Submitted			2022-12-25	WOS:000274654700001
J	Freeman, R; Dennis, T; Landers, T; Thompson, D; Bell, E; Walker, M; Guilford, T				Freeman, Robin; Dennis, Todd; Landers, Todd; Thompson, David; Bell, Elizabeth; Walker, Mike; Guilford, Tim			Black Petrels (Procellaria parkinsoni) Patrol the Ocean Shelf-Break: GPS Tracking of a Vulnerable Procellariiform Seabird	PLOS ONE			English	Article							FORAGING BEHAVIOR; POSITIONAL ENTROPY; PELAGIC SEABIRD; CAPE GANNETS; ALBATROSSES; SYSTEM; MIGRATION; PENGUINS; PACIFIC; ECOLOGY	Background: Determining the foraging movements of pelagic seabirds is fundamental for their conservation. However, the vulnerability and elusive lifestyles of these animals have made them notoriously difficult to study. Recent developments in satellite telemetry have enabled tracking of smaller seabirds during foraging excursions. Methodology/Principal Findings: Here, we report the first successful precision tracking of a c. 700 g seabird, the vulnerable Black Petrel, Procellaria parkinsoni, foraging at sea during the breeding season, using miniature GPS-logging technology. Employing a combination of high-resolution fixes and low-power duty-cycles, we present data from nine individual foraging excursions tracked during the chick-rearing period in February 2006. Conclusions/Significance: We provide a snapshot of the species' foraging range and behaviour in relation to detailed underlying bathymetry off the coast of New Zealand, finding a significant relationship between foraging movements and regions of the shelf-break. We also highlight the potential of more sophisticated analyses to identify behavioural phenomena from position data alone.	[Freeman, Robin] Microsoft Res, Computat Ecol & Environm Sci, Cambridge, England; [Freeman, Robin; Guilford, Tim] Univ Oxford, Dept Zool, Anim Behav Res Grp, Oxford OX1 3PS, England; [Dennis, Todd; Landers, Todd; Walker, Mike] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Landers, Todd] Auckland War Mem Museum, Auckland, New Zealand; [Thompson, David] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand; [Bell, Elizabeth] Wildlife Management Int Ltd, Rapaura, Blenheim, New Zealand	Microsoft; University of Oxford; University of Auckland; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Freeman, R (corresponding author), Microsoft Res, Computat Ecol & Environm Sci, Cambridge, England.	robin.freeman@microsoft.com	Thompson, David R/E-2431-2018	Thompson, David R/0000-0001-8518-6307; Walker, Michael/0000-0001-9631-9128	Engineering and Physical Sciences Research Council [GR/S58119/01]; Microsoft Research; Merton College, Oxford	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Microsoft Research(Microsoft); Merton College, Oxford	Financial support was kindly provided by the Engineering and Physical Sciences Research Council ( grant number: GR/S58119/01, http://www.epsrc.ac.uk), Microsoft Research (http://research.microsoft.com) and Merton College, Oxford (http://www.merton.ox.ac.uk). The corresponding author is currently employed at Microsoft Research as a post-doctoral researcher, but aside from this none of these funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ACAP, 2006, AGR CONS ALB PETR; Afanasyev Vsevolod, 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P227; Baduini Cheryl L., 2003, Marine Ornithology, V31, P101; BELL E, 2005, 200304 DEP CONS; BirdLife International, 2004, TRACK OC WAND GLOB D; Bishop C.M., 2006, PATTERN RECOGNITION; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Guilford T, 2004, J THEOR BIOL, V227, P25, DOI 10.1016/j.jtbi.2003.07.003; Guilford TC, 2008, IBIS, V150, P462, DOI 10.1111/j.1474-919X.2008.00805.x; HUNTER C, 2001, DEP CONSERVATION INT, V2; Hyrenbach KD, 2006, FISH OCEANOGR, V15, P95, DOI 10.1111/j.1365-2419.2005.00350.x; Mattern T, 2007, MAR ECOL PROG SER, V343, P295, DOI 10.3354/meps06954; Nevitt GA, 2000, BIOL BULL-US, V198, P245, DOI 10.2307/1542527; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Phalan B, 2007, MAR ECOL PROG SER, V340, P271, DOI 10.3354/meps340271; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; PITMAN RL, 1992, CONDOR, V94, P825, DOI 10.2307/1369280; Roberts S, 2004, J THEOR BIOL, V227, P39, DOI 10.1016/j.jtbi.2003.07.002; Ryan PG, 2004, MAR BIOL, V145, P215, DOI 10.1007/s00227-004-1328-4; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Steiner I, 2000, PHYSIOL BEHAV, V71, P589, DOI 10.1016/S0031-9384(00)00409-1; von Hunerbein K, 2000, NATURWISSENSCHAFTEN, V87, P278, DOI 10.1007/s001140050721; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034; [No title captured]	28	38	39	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9236	10.1371/journal.pone.0009236	http://dx.doi.org/10.1371/journal.pone.0009236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174652	Green Published, Green Submitted, gold			2022-12-25	WOS:000274590600008
J	Kubo, Y; Takeuchi, T; Okano, K; Okano, T				Kubo, Yoko; Takeuchi, Takahiro; Okano, Keiko; Okano, Toshiyuki			Cryptochrome Genes Are Highly Expressed in the Ovary of the African Clawed Frog, Xenopus tropicalis	PLOS ONE			English	Article							CIRCADIAN CLOCK; LIGHT; DROSOPHILA; CRY1; ZEBRAFISH; GENETICS; EMBRYOS; RHYTHMS; FAMILY	Cryptochromes (CRYs) are flavoproteins sharing high homology with photolyases. Some of them have function(s) including transcription regulation in the circadian clock oscillation, blue-light photoreception for resetting the clock phase, and light-dependent magnetoreception. Vertebrates retain multiple sets of CRY or CRY-related genes, but their functions are yet unclear especially in the lower vertebrates. Although CRYs and the other circadian clock components have been extensively studied in the higher vertebrates such as mice, only a few model species have been studied in the lower vertebrates. In this study, we identified two CRYs, XtCRY1 and XtCRY2 in Xenopus tropicalis, an excellent experimental model species. Examination of tissue specificity of their mRNA expression by real-time PCR analysis revealed that both the XtCRYs showed extremely high mRNA expression levels in the ovary. The mRNA levels in the ovary were about 28-fold (XtCry1) and 48-fold (XtCry2) higher than levels in the next abundant tissues, the retina and kidney, respectively. For the functional analysis of the XtCRYs, we cloned circadian positive regulator XtCLOCK and XtBMAL1, and found circadian enhancer E-box in the upstream of XtPer1 gene. XtCLOCK and XtBMAL1 exhibited strong transactivation from the XtPer1 E-box element, and both the XtCRYs inhibited the XtCLOCK: XtBMAL1-mediated transactivation, thereby suggesting this element to drive the circadian transcription. These results revealed a conserved main feedback loop in the X. tropicalis circadian clockwork and imply a possible physiological importance of CRYs in the ovarian functions such as synthesis of steroid hormones and/or control of estrus cycles via the transcription regulation.	[Kubo, Yoko; Takeuchi, Takahiro; Okano, Keiko; Okano, Toshiyuki] Waseda Univ, Dept Elect Engn & Biosci, Grad Sch Adv Sci & Engn, Tokyo, Japan; [Okano, Toshiyuki] Japan Sci & Technol Agcy, Tokyo, Japan	Waseda University; Japan Science & Technology Agency (JST)	Kubo, Y (corresponding author), Waseda Univ, Dept Elect Engn & Biosci, Grad Sch Adv Sci & Engn, Tokyo, Japan.	okano@waseda.jp		Okano, Toshiyuki/0000-0001-6740-6265	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the High-Tech Research Center Project for Private Universities: matching fund subsidy from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2009, BIOL REPROD, V80, P473, DOI 10.1095/biolreprod.108.069542; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Besharse JC, 2004, EUR J NEUROSCI, V20, P167, DOI 10.1111/j.1460-9568.2004.03479.x; BISBEE CA, 1977, SCIENCE, V195, P785, DOI 10.1126/science.65013; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Delaunay F, 2000, SCIENCE, V289, P297, DOI 10.1126/science.289.5477.297; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Green CB, 2003, J NEUROENDOCRINOL, V15, P350, DOI 10.1046/j.1365-2826.2003.00999.x; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hirayama J, 2003, J BIOL CHEM, V278, P35620, DOI 10.1074/jbc.M305028200; Hirsch N, 2002, DEV DYNAM, V225, P422, DOI 10.1002/dvdy.10178; Johnsen S, 2007, J EXP BIOL, V210, P3171, DOI 10.1242/jeb.007567; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; LEUCHT T, 1990, J EXP BIOL, V148, P325; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109; Tu DC, 2004, SCIENCE, V306, P129, DOI 10.1126/science.1101484; Yamamoto K, 2001, NEUROSCI LETT, V313, P13, DOI 10.1016/S0304-3940(01)02227-3; Zhu HS, 2001, CURR BIOL, V11, P1945, DOI 10.1016/S0960-9822(01)00601-7	22	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9273	10.1371/journal.pone.0009273	http://dx.doi.org/10.1371/journal.pone.0009273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174658	Green Published, Green Submitted, gold			2022-12-25	WOS:000274590600026
J	Selig, ER; Bruno, JF				Selig, Elizabeth R.; Bruno, John F.			A Global Analysis of the Effectiveness of Marine Protected Areas in Preventing Coral Loss	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; PHASE-SHIFTS; RESERVE; FISH; RESILIENCE; FISHERIES; IMPACTS; SCALE; CONSERVATION	Background: A variety of human activities have led to the recent global decline of reef-building corals [1,2]. The ecological, social, and economic value of coral reefs has made them an international conservation priority [2,3]. The success of Marine Protected Areas (MPAs) in restoring fish populations [4] has led to optimism that they could also benefit corals by indirectly reducing threats like overfishing, which cause coral degradation and mortality [2,5]. However, the general efficacy of MPAs in increasing coral reef resilience has never been tested. Methodology/Principal Findings: We compiled a global database of 8534 live coral cover surveys from 1969-2006 to compare annual changes in coral cover inside 310 MPAs to unprotected areas. We found that on average, coral cover within MPAs remained constant, while coral cover on unprotected reefs declined. Although the short-term differences between unprotected and protected reefs are modest, they could be significant over the long-term if the effects are temporally consistent. Our results also suggest that older MPAs were generally more effective in preventing coral loss. Initially, coral cover continued to decrease after MPA establishment. Several years later, however, rates of coral cover decline slowed and then stabilized so that further losses stopped. Conclusions/Significance: These findings suggest that MPAs can be a useful tool not only for fisheries management, but also for maintaining coral cover. Furthermore, the benefits of MPAs appear to increase with the number of years since MPA establishment. Given the time needed to maximize MPA benefits, there should be increased emphasis on implementing new MPAs and strengthening the enforcement of existing MPAs.	[Selig, Elizabeth R.] Univ N Carolina, Curriculum Ecol, Chapel Hill, NC USA; [Selig, Elizabeth R.; Bruno, John F.] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Selig, ER (corresponding author), Conservat Int, Ctr Appl Biodivers Sci, Arlington, VA USA.	e.selig@conservation.org			EPA STAR; UNC Dissertation Completion Fellowship; NSF [OCE-0326705]	EPA STAR(United States Environmental Protection Agency); UNC Dissertation Completion Fellowship; NSF(National Science Foundation (NSF))	This research was supported through an EPA STAR and UNC Dissertation Completion Fellowship to E. R. S. and NSF # OCE-0326705 to J. F. B.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Airame S, 2003, ECOL APPL, V13, pS170; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Aronson RB, 2004, ECOLOGY, V85, P1876, DOI 10.1890/03-0108; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Ault JS, 2005, B MAR SCI, V76, P595; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cinner JE, 2009, J APPL ECOL, V46, P724, DOI 10.1111/j.1365-2664.2009.01648.x; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Edgar GJ, 2004, ENVIRON CONSERV, V31, P212, DOI 10.1017/S0376892904001584; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Edmunds PJ, 1996, MAR ECOL PROG SER, V143, P165, DOI 10.3354/meps143165; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Halpern BS, 2003, ECOL APPL, V13, pS117; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jameson SC, 2002, MAR POLLUT BULL, V44, P1177, DOI 10.1016/S0025-326X(02)00258-8; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jones PJS, 2001, REV FISH BIOL FISHER, V11, P197, DOI 10.1023/A:1020327007975; Keller BD, 2005, OCEAN COAST MANAGE, V48, P869, DOI 10.1016/j.ocecoaman.2005.03.008; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kramer KL, 2007, MAR ECOL PROG SER, V349, P111, DOI 10.3354/meps07083; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Maliao RJ, 2004, FISH RES, V66, P343, DOI 10.1016/s0165-7836(03)00181-4; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2001, CORAL REEFS, V19, P367, DOI 10.1007/s003380000131; McClanahan TR, 1999, CORAL REEFS, V18, P321, DOI 10.1007/s003380050205; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; McMahon SM, 2007, ECOL LETT, V10, P437, DOI 10.1111/j.1461-0248.2007.01036.x; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; OSENBERG CW, 1994, ECOL APPL, V4, P16, DOI 10.2307/1942111; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 2000, B MAR SCI, V66, P581; SEBENS KP, 1994, AM ZOOL, V34, P115; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; Willis TJ, 2003, ENVIRON CONSERV, V30, P97, DOI 10.1017/S0376892903000092	50	223	227	5	205	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9278	10.1371/journal.pone.0009278	http://dx.doi.org/10.1371/journal.pone.0009278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174644	gold, Green Published			2022-12-25	WOS:000274590600030
J	Lucas, G; Du, J; Romeas, T; Mnie-Filali, O; Haddjeri, N; Pineyro, G; Debonnel, G				Lucas, Guillaume; Du, Jenny; Romeas, Thomas; Mnie-Filali, Ouissame; Haddjeri, Nasser; Pineyro, Graciela; Debonnel, Guy			Selective Serotonin Reuptake Inhibitors Potentiate the Rapid Antidepressant-Like Effects of Serotonin(4) Receptor Agonists in the Rat	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; POSTSYNAPTIC 5-HT1A RECEPTORS; ELECTROPHYSIOLOGICAL EVIDENCE; NEURONAL-ACTIVITY; TONIC ACTIVATION; IN-VITRO; DEPRESSION; BINDING; CITALOPRAM; PINDOLOL	Background: We have recently reported that serotonin(4) (5-HT4) receptor agonists have a promising potential as fast-acting antidepressants. Here, we assess the extent to which this property may be optimized by the concomitant use of conventional antidepressants. Methodology/Principal Findings: We found that, in acute conditions, the 5-HT4 agonist prucalopride was able to counteract the inhibitory effect of the selective serotonin reuptake inhibitors (SSRI) fluvoxamine and citalopram on 5-HT neuron impulse flow, in Dorsal Raphe Nucleus (DRN) cells selected for their high (>1.8 Hz) basal discharge. The co-administration of both prucalopride and RS 67333 with citalopram for 3 days elicited an enhancement of DRN 5-HT neuron average firing rate, very similar to what was observed with either 5-HT4 agonist alone. At the postsynaptic level, this translated into the manifestation of a tonus on hippocampal postsynaptic 5-HT1A receptors, that was two to three times stronger when the 5-HT4 agonist was combined with citalopram. Similarly, co-administration of citalopram synergistically potentiated the enhancing effect of RS 67333 on CREB protein phosphorylation within the hippocampus. Finally, in the Forced Swimming Test, the combination of RS 67333 with various SSRIs (fluvoxamine, citalopram and fluoxetine) was more effective to reduce time of immobility than the separate administration of each compound. Conclusions/Significance: These findings strongly suggest that the adjunction of an SSRI to a 5-HT4 agonist may help to optimize the fast-acting antidepressant efficacy of the latter.	[Lucas, Guillaume; Du, Jenny; Romeas, Thomas; Mnie-Filali, Ouissame; Pineyro, Graciela] Univ Montreal, Dept Psychiat, Ctr Rech Fernand Seguin, Montreal, PQ H3C 3J7, Canada; [Mnie-Filali, Ouissame; Haddjeri, Nasser] Univ Lyon 1, CNRS, EAC 3006, ISPB,Fac Pharm, F-69365 Lyon, France; [Debonnel, Guy] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; McGill University	Lucas, G (corresponding author), Univ Montreal, Dept Psychiat, Ctr Rech Fernand Seguin, Montreal, PQ H3C 3J7, Canada.	guillaume.lucas@gmail.com	Lucas, Guillaume/N-6993-2017; Haddjeri, Nasser/M-6377-2014; Romeas, Thomas/S-6034-2019	Lucas, Guillaume/0000-0003-0647-9756; Haddjeri, Nasser/0000-0002-2161-2204; Romeas, Thomas/0000-0002-3298-5719; Pineyro, Graciela/0000-0001-9709-651X	Instituts de Recherche en Sant du Canada (IRSC/CIHR); Wyeth Ayerst Canada	Instituts de Recherche en Sant du Canada (IRSC/CIHR)(Canadian Institutes of Health Research (CIHR)); Wyeth Ayerst Canada	This work was supported by grants from the Instituts de Recherche en Sant du Canada (IRSC/CIHR). GL was a fellowship recipient from Wyeth Ayerst Canada in partnership with the IRSC/CIHR during the accomplishment of a part of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAJANIAN GK, 1978, ESSAYS NEUROCHEMISTR, P1; Arborelius L, 1999, EUR J PHARMACOL, V382, P133, DOI 10.1016/S0014-2999(99)00592-0; Artigas F, 2006, CURR DRUG TARGETS, V7, P139, DOI 10.2174/138945006775515446; ARTIGAS F, 1994, ARCH GEN PSYCHIAT, V51, P248; Artigas Francesc, 2002, Psychopharmacol Bull, V36 Suppl 2, P123; Beique JC, 2000, NEUROPSYCHOPHARMACOL, V23, P294; Besson A, 2000, EUR NEUROPSYCHOPHARM, V10, P177, DOI 10.1016/S0924-977X(00)00069-9; Blier P, 1999, NEUROPSYCHOPHARMACOL, V21, pS91, DOI 10.1016/S0893-133X(99)00036-6; Blier P, 2001, J CLIN PSYCHIAT, V62, P7; BLIER P, 1994, TRENDS PHARMACOL SCI, V15, P220, DOI 10.1016/0165-6147(94)90315-8; Blier P, 2003, BIOL PSYCHIAT, V53, P193, DOI 10.1016/S0006-3223(02)01643-8; Briejer MR, 2001, EUR J PHARMACOL, V423, P71, DOI 10.1016/S0014-2999(01)01087-1; CHAPUT Y, 1986, N-S ARCH PHARMACOL, V333, P342, DOI 10.1007/BF00500007; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Duman RS, 2007, NEURON, V55, P679, DOI 10.1016/j.neuron.2007.08.011; Duman RS, 1998, BIOL PSYCHIAT, V44, P324, DOI 10.1016/S0006-3223(98)00031-6; EGLEN RM, 1995, BRIT J PHARMACOL, V115, P1387, DOI 10.1111/j.1476-5381.1995.tb16628.x; Fujita M, 2000, BIOL PSYCHIAT, V48, P801, DOI 10.1016/S0006-3223(00)00960-4; Furukawa TA, 2007, CAN J PSYCHIAT, V52, P545, DOI 10.1177/070674370705200902; Haddjeri N, 1998, J NEUROSCI, V18, P10150; Haddjeri N, 2004, NEUROPSYCHOPHARMACOL, V29, P1800, DOI 10.1038/sj.npp.1300489; Hajos M, 1999, BRIT J PHARMACOL, V126, P1741, DOI 10.1038/sj.bjp.0702510; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Kapur S, 1996, AM J PSYCHIAT, V153, P466; Lengyel K, 2008, NEUROPHARMACOLOGY, V55, P63, DOI 10.1016/j.neuropharm.2008.04.014; Lucas G, 2005, BIOL PSYCHIAT, V57, P918, DOI 10.1016/j.biopsych.2004.12.023; Lucas G, 2002, EUR J NEUROSCI, V16, P817, DOI 10.1046/j.1460-9568.2002.02150.x; Lucas G, 2007, NEURON, V55, P712, DOI 10.1016/j.neuron.2007.07.041; Lucas Guillaume, 2008, Expert Rev Neurother, V8, P1, DOI 10.1586/14737175.8.1.1; Lucas G, 2008, INT J NEUROPSYCHOPH, V11, P485, DOI 10.1017/S1461145708008547; Martin-Ruiz R, 2001, NEUROPHARMACOLOGY, V41, P72, DOI 10.1016/S0028-3908(01)00050-8; Martinez D, 2001, NEUROPSYCHOPHARMACOL, V24, P209, DOI 10.1016/S0893-133X(00)00187-1; Michelsen KA, 2007, BRAIN RES REV, V55, P329, DOI 10.1016/j.brainresrev.2007.01.002; Nibuya M, 1996, J NEUROSCI, V16, P2365; Pineyro G, 2001, MOL PHARMACOL, V60, P816; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Sanchez C, 1999, CELL MOL NEUROBIOL, V19, P467, DOI 10.1023/A:1006986824213; Sanchez C, 2003, PSYCHOPHARMACOLOGY, V167, P353, DOI 10.1007/s00213-002-1364-z; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Shelton RC, 2008, ACTA PSYCHIAT SCAND, V117, P253, DOI 10.1111/j.1600-0447.2007.01130.x; Sprouse J, 2001, SYNAPSE, V41, P49, DOI 10.1002/syn.1059; Thase ME, 2002, J CLIN PSYCHIAT, V63, P95, DOI 10.4088/JCP.v63n0202; Thome J, 2000, J NEUROSCI, V20, P4030; Tiraboschi E, 2004, NEUROPSYCHOPHARMACOL, V29, P1831, DOI 10.1038/sj.npp.1300488; Trivedi Madhukar H, 2003, Ann Clin Psychiatry, V15, P59; Wong EHF, 2000, BIOL PSYCHIAT, V47, P818, DOI 10.1016/S0006-3223(99)00291-7	46	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9253	10.1371/journal.pone.0009253	http://dx.doi.org/10.1371/journal.pone.0009253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169084	Green Submitted, gold, Green Published			2022-12-25	WOS:000274590500028
J	Alexiou, P; Maragkakis, M; Papadopoulos, GL; Simmosis, VA; Zhang, L; Hatzigeorgiou, AG				Alexiou, Panagiotis; Maragkakis, Manolis; Papadopoulos, Giorgio L.; Simmosis, Victor A.; Zhang, Lin; Hatzigeorgiou, Artemis G.			The DIANA-mirExTra Web Server: From Gene Expression Data to MicroRNA Function	PLOS ONE			English	Article							KEGG	Background: High-throughput gene expression experiments are widely used to identify the role of genes involved in biological conditions of interest. MicroRNAs (miRNA) are regulatory molecules that have been functionally associated with several developmental programs and their deregulation with diverse diseases including cancer. Methodology/Principal Findings: Although miRNA expression levels may not be routinely measured in high-throughput experiments, a possible involvement of miRNAs in the deregulation of gene expression can be computationally predicted and quantified through analysis of overrepresented motifs in the deregulated genes 3' untranslated region (3'UTR) sequences. Here, we introduce a user-friendly web-server, DIANA-mirExTra (www.microrna.gr/mirextra) that allows the comparison of frequencies of miRNA associated motifs between sets of genes that can lead to the identification of miRNAs responsible for the deregulation of large numbers of genes. To this end, we have investigated different approaches and measures, and have practically implemented them on experimental data. Conclusions/Significance: On several datasets of miRNA overexpression and repression experiments, our proposed approaches have successfully identified the deregulated miRNA. Beyond the prediction of miRNAs responsible for the deregulation of transcripts, the web-server provides extensive links to DIANA-mirPath, a functional analysis tool incorporating miRNA targets in biological pathways. Additionally, in case information about miRNA expression changes is provided, the results can be filtered to display the analysis for miRNAs of interest only.	[Alexiou, Panagiotis; Maragkakis, Manolis; Papadopoulos, Giorgio L.; Simmosis, Victor A.; Hatzigeorgiou, Artemis G.] Biomed Sci Res Ctr Alexander Fleming, Inst Mol Oncol, Varkiza, Greece; [Alexiou, Panagiotis] Aristotle Univ Thessaloniki, Sch Biol, GR-54006 Thessaloniki, Greece; [Maragkakis, Manolis] Univ Halle Wittenberg, Inst Comp Sci, Halle, Germany; [Zhang, Lin] Univ Penn, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA	Alexander Fleming Biomedical Sciences Research Center; Aristotle University of Thessaloniki; Martin Luther University Halle Wittenberg; University of Pennsylvania	Alexiou, P (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Mol Oncol, Varkiza, Greece.	hatzigeorgiou@fleming.gr	Maragkakis, Emmanouil/F-5427-2010; Hatzigeorgiou, Artemis/Z-1976-2019; Zhang, Lin/K-8478-2012; Maragkakis, Manolis/AAN-3407-2020; Alexiou, Panagiotis/ABB-6698-2020; ALEXIOU, PANAGIOTIS/C-8906-2011	Maragkakis, Emmanouil/0000-0002-3158-1763; Maragkakis, Manolis/0000-0002-3158-1763; Alexiou, Panagiotis/0000-0003-3437-7482; ALEXIOU, PANAGIOTIS/0000-0003-3437-7482; Papadopoulos, Giorgio Lucio/0000-0003-0199-0256	General Secretary Research and Technology, Greece	General Secretary Research and Technology, Greece	Aristeia Award from General Secretary Research and Technology, Greece. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Elkon R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000189; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karolchik Donna, 2007, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s17; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; SELBACH M, 2008, NATURE; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Zhang JJ, 2009, J CHEM CRYSTALLOGR, V39, P1, DOI 10.1007/s10870-008-9423-x; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	22	68	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9171	10.1371/journal.pone.0009171	http://dx.doi.org/10.1371/journal.pone.0009171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161787	Green Submitted, Green Published, gold			2022-12-25	WOS:000274442800017
J	Matsumura, N; Tsuji, T; Sumida, T; Kokubo, M; Onimaru, M; Doi, N; Takashima, H; Miyamoto-Sato, E; Yanagawa, H				Matsumura, Nobutaka; Tsuji, Toru; Sumida, Takeshi; Kokubo, Masahito; Onimaru, Michiko; Doi, Nobuhide; Takashima, Hideaki; Miyamoto-Sato, Etsuko; Yanagawa, Hiroshi			mRNA display selection of a high-affinity, Bcl-X-L-specific binding peptide	FASEB JOURNAL			English	Article						Bcl-2 family; BH3 domain; therapeutic peptide	IN-VITRO SELECTION; BH3-ONLY PROTEINS; INDUCE APOPTOSIS; BH3 PEPTIDES; FAMILY-MEMBERS; CELL-DEATH; BAX; ACTIVATION; BCL-X(L); DOMAINS	Bcl-X-L, an antiapoptotic member of the Bcl-2 family, is a mitochondrial protein that inhibits activation of Bax and Bak, which commit the cell to apoptosis, and it therefore represents a potential target for drug discovery. Peptides have potential as therapeutic molecules because they can be designed to engage a larger portion of the target protein with higher specificity. In the present study, we selected 16-mer peptides that interact with Bcl-X-L from random and degenerate peptide libraries using mRNA display. The selected peptides have sequence similarity with the Bcl-2 family BH3 domains, and one of them has higher affinity (IC50 = 0.9 mu M) than Bak BH3 (IC50 = 11.8 mu M) for Bcl-X-L in vitro. We also found that GFP fusions of the selected peptides specifically interact with Bcl-X-L, localize in mitochondria, and induce cell death. Further, a chimeric molecule, in which the BH3 domain of Bak protein was replaced with a selected peptide, retained the ability to bind specifically to Bcl-X-L. These results demonstrate that this selected peptide specifically antagonizes the function of Bcl-X-L and overcomes the effects of Bcl-X-L in intact cells. We suggest that mRNA display is a powerful technique to identify peptide inhibitors with high affinity and specificity for disease-related proteins.-Matsumura, N., Tsuji, T., Sumida, T., Kokubo, M., Onimaru, M., Doi, N., Takashima, H., Miyamoto-Sato, E., Yanagawa, H. mRNA display selection of a high-affinity, Bcl-X-L-specific binding peptide. FASEB J. 24, 2201-2210 (2010). www.fasebj.org	[Yanagawa, Hiroshi] Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Keio University	Yanagawa, H (corresponding author), Keio Univ, Dept Biosci & Informat, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	hyana@bio.keio.ac.jp	Doi, Nobuhide/C-4481-2014	Doi, Nobuhide/0000-0002-2402-6390	Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT); New Energy and Industrial Technology Development Organization (NEDO) of Japan	Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO))	The authors thank Junko Shimizu for technical help in preparation of GFP-fusion plasmids. This work was supported, in part, by a grant-in-aid for scientific research, a Special Coordination Fund grant from the Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT), and a grant for practical application of university R&D results under the Matching Fund Method from the New Energy and Industrial Technology Development Organization (NEDO) of Japan.	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Aouacheria A, 2001, ONCOGENE, V20, P5846, DOI 10.1038/sj.onc.1204740; Arai R, 2004, PROTEINS, V57, P829, DOI 10.1002/prot.20244; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Frankel A, 2003, CHEM BIOL, V10, P1043, DOI 10.1016/j.chembiol.2003.11.004; Geyer CR, 2000, METHOD ENZYMOL, V328, P171, DOI 10.1016/S0076-6879(00)28398-5; Hammond PW, 2001, J BIOL CHEM, V276, P20898, DOI 10.1074/jbc.M011641200; Holinger EP, 1999, J BIOL CHEM, V274, P13298, DOI 10.1074/jbc.274.19.13298; Horisawa K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh167; Hunter JJ, 1996, J BIOL CHEM, V271, P8521, DOI 10.1074/jbc.271.15.8521; Josephson K, 2005, J AM CHEM SOC, V127, P11727, DOI 10.1021/ja0515809; Juin P, 2002, MOL CELL BIOL, V22, P6158, DOI 10.1128/MCB.22.17.6158-6169.2002; Ke N, 2001, J BIOL CHEM, V276, P12481, DOI 10.1074/jbc.C000871200; Kim H, 2005, ONCOGENE, V24, P1252, DOI 10.1038/sj.onc.1208282; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Krajewska M, 1996, CANCER RES, V56, P2422; Lama D, 2008, PROTEINS, V73, P492, DOI 10.1002/prot.22075; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; LU PJ, 1995, J CELL BIOL, V129, P1363, DOI 10.1083/jcb.129.5.1363; Miyamoto-Sato E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng078; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Saito H, 2007, NUCLEIC ACIDS RES, V35, P6357, DOI 10.1093/nar/gkm692; Saito H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm017; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schimmer AD, 2001, CELL DEATH DIFFER, V8, P725, DOI 10.1038/sj.cdd.4400870; Shangary S, 2004, MOL CANCER THER, V3, P1343; Shangary S, 2002, BIOCHEMISTRY-US, V41, P9485, DOI 10.1021/bi025605h; Shibasaki F, 1997, NATURE, V386, P728, DOI 10.1038/386728a0; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Tateyama S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj025; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001	40	9	9	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2010	24	7					2201	2210		10.1096/fj.09-143008	http://dx.doi.org/10.1096/fj.09-143008			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20181936				2022-12-25	WOS:000279343600007
J	de Zoete, MR; Keestra, AM; Wagenaar, JA; van Putten, JPM				de Zoete, Marcel R.; Keestra, A. Marijke; Wagenaar, Jaap A.; van Putten, Jos P. M.			Reconstitution of a Functional Toll-like Receptor 5 Binding Site in Campylobacter jejuni Flagellin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; BACTERIAL FLAGELLIN; CARBOHYDRATE MODIFICATIONS; SALMONELLA FLAGELLIN; SIGNAL-TRANSDUCTION; ACTIVATION; TOLL-LIKE-RECEPTOR-5; GENE; IDENTIFICATION	Bacterial flagellin is important for intestinal immune homeostasis. Flagellins from most species activate Toll-like receptor 5 (TLR5). The principal bacterial food-borne pathogen Campylobacter jejuni escapes TLR5 recognition, probably due to an alternate flagellin subunit structure. We investigated the molecular basis of TLR5 evasion by aiming to reconstitute TLR5 stimulating activity in live C. jejuni. Both native glycosylated C. jejuni flagellins (FlaA and FlaB) and recombinant proteins purified from Escherichia coli failed to activate NF-kappa B in HEK293 cells expressing TLR5. Introduction of multiple defined regions from Salmonella flagellin into C. jejuni FlaA via a recombinatorial approach revealed three regions critical for the activation of human and mouse TLR5, including a beta-hairpin structure not previously implicated in TLR5 recognition. Surprisingly, this domain was not required for the activation of chicken TLR5, indicating a selective requirement for the beta-hairpin in the recognition of mammalian TLR5. Expression of the active chimeric protein in C. jejuni resulted in secreted glycosylated flagellin that induced a potent TLR5 response. Overall, our results reveal a novel structural requirement for TLR5 recognition of bacterial flagellin and exclude flagellin glycosylation as an additional mechanism of bacterial evasion of the TLR5 response.	[de Zoete, Marcel R.; Keestra, A. Marijke; Wagenaar, Jaap A.; van Putten, Jos P. M.] Univ Utrecht, Dept Infect Dis & Immunol, NL-3508 TD Utrecht, Netherlands; [Wagenaar, Jaap A.; van Putten, Jos P. M.] WHO Collaborating Ctr Campylobacter, OIE Reference Lab Campylobacteriosis Utrecht Lely, NL-8200 AB Lelystad, Netherlands	Utrecht University	van Putten, JPM (corresponding author), Yalelaan 1, NL-3584 CL Utrecht, Netherlands.	j.vanputten@uu.nl	Keestra-Gounder, A. Marijke/H-4394-2012; de Zoete, Marcel/C-1164-2011; de Zoete, Marcel R/O-3012-2014; de Zoete, Marcel/ABA-7918-2021	Keestra-Gounder, A. Marijke/0000-0002-2231-652X; de Zoete, Marcel/0000-0002-6561-5810; van Putten, Jos/0000-0002-4126-8172	Dutch Ministry of Agriculture, Nature, and Food Quality	Dutch Ministry of Agriculture, Nature, and Food Quality	The work was supported by the Dutch Ministry of Agriculture, Nature, and Food Quality.	Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Auvray F, 2001, J MOL BIOL, V308, P221, DOI 10.1006/jmbi.2001.4597; Bargieri DY, 2008, VACCINE, V26, P6132, DOI 10.1016/j.vaccine.2008.08.070; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; Donnelly MA, 2002, J BIOL CHEM, V277, P40456, DOI 10.1074/jbc.M206851200; Eaves-Pyles TD, 2001, J IMMUNOL, V167, P7009, DOI 10.4049/jimmunol.167.12.7009; Evdokimov AG, 2003, NAT STRUCT BIOL, V10, P789, DOI 10.1038/nsb982; Galkin VE, 2008, SCIENCE, V320, P382, DOI 10.1126/science.1155307; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Goon S, 2003, MOL MICROBIOL, V50, P659, DOI 10.1046/j.1365-2958.2003.03725.x; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; IBRAHIM GF, 1985, J CLIN MICROBIOL, V22, P1040, DOI 10.1128/JCM.22.6.1040-1044.1985; Jacchieri SG, 2003, J BACTERIOL, V185, P4243, DOI 10.1128/JB.185.14.4243-4247.2003; Johanesen PA, 2006, INFECT IMMUN, V74, P3437, DOI 10.1128/IAI.01740-05; Karlyshev AV, 2002, MICROBIOL-SGM, V148, P473, DOI 10.1099/00221287-148-2-473; Keestra AM, 2008, MOL IMMUNOL, V45, P1298, DOI 10.1016/j.molimm.2007.09.013; Le Moigne V, 2008, MOL IMMUNOL, V45, P2499, DOI 10.1016/j.molimm.2008.01.005; Lee SK, 2003, MICROBES INFECT, V5, P1345, DOI 10.1016/j.micinf.2003.09.018; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; LOGAN SM, 1983, INFECT IMMUN, V42, P675, DOI 10.1128/IAI.42.2.675-682.1983; Logan SM, 2002, MOL MICROBIOL, V46, P587, DOI 10.1046/j.1365-2958.2002.03185.x; Logan SM, 2009, FEBS J, V276, P1014, DOI 10.1111/j.1742-4658.2008.06840.x; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; Meinersmann RJ, 2000, MICROBIOL-UK, V146, P2283, DOI 10.1099/00221287-146-9-2283; Miao EA, 2007, SEMIN IMMUNOPATHOL, V29, P275, DOI 10.1007/s00281-007-0078-z; Murthy KGK, 2004, J BIOL CHEM, V279, P5667, DOI 10.1074/jbc.M307759200; Neish AS, 2007, AM J PHYSIOL-GASTR L, V292, pG462, DOI 10.1152/ajpgi.00274.2006; NUIJTEN PJM, 1991, INFECT IMMUN, V59, P1100, DOI 10.1128/IAI.59.3.1100-1105.1991; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Sanders CJ, 2006, J IMMUNOL, V177, P2810, DOI 10.4049/jimmunol.177.5.2810; SKOUNTZOU I, 2009, VACCINE IN PRESS; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; Steeghs L, 2008, INFECT IMMUN, V76, P3801, DOI 10.1128/IAI.00005-08; Szymanski CM, 2003, TRENDS MICROBIOL, V11, P233, DOI 10.1016/S0966-842X(03)00079-9; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; van Alphen LB, 2008, MICROBIOL-SGM, V154, P3385, DOI 10.1099/mic.0.2008/019919-0; Van Asten FJAM, 2000, FEMS MICROBIOL LETT, V185, P175, DOI 10.1111/j.1574-6968.2000.tb09058.x; van Aubel RAMH, 2007, MOL IMMUNOL, V44, P3702, DOI 10.1016/j.molimm.2007.04.001; van Mourik A, 2008, MICROBIOL-SGM, V154, P584, DOI 10.1099/mic.0.2007/012120-0; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; Vegh BM, 2006, BIOCHEM BIOPH RES CO, V345, P93, DOI 10.1016/j.bbrc.2006.04.055; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; Vijay-Kumar M, 2008, SEMIN IMMUNOPATHOL, V30, P11, DOI 10.1007/s00281-007-0100-5; WASSENAAR TM, 1993, GENE, V132, P131, DOI 10.1016/0378-1119(93)90525-8; Watson RO, 2005, CELL MICROBIOL, V7, P655, DOI 10.1111/j.1462-5822.2004.00498.x; Way SS, 2004, CELL MICROBIOL, V6, P235, DOI 10.1046/j.1462-5822.2004.00360.x; Winter SE, 2008, CELL MICROBIOL, V10, P247, DOI 10.1111/j.1462-5822.2007.01037.x; Wosten MMSM, 2004, J BIOL CHEM, V279, P16214, DOI 10.1074/jbc.M400357200; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	56	41	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12149	12158		10.1074/jbc.M109.070227	http://dx.doi.org/10.1074/jbc.M109.070227			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164175	Green Published, hybrid			2022-12-25	WOS:000276787100045
J	Hu, GQ; Wang, XB; Saunders, DN; Henderson, M; Russell, AJ; Herring, BP; Zhou, JL				Hu, Guoqing; Wang, Xiaobo; Saunders, Darren N.; Henderson, Michelle; Russell, Amanda J.; Herring, B. Paul; Zhou, Jiliang			Modulation of Myocardin Function by the Ubiquitin E3 Ligase UBR5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL DIFFERENTIATION; SERUM RESPONSE FACTOR; TUMOR-SUPPRESSOR GENE; DNA-DAMAGE RESPONSE; HYPERPLASTIC-DISCS; PHENOTYPIC MODULATION; INDUCED ACTIVATION; BINDING-PROTEIN; SMOOTH; EXPRESSION	Fully differentiated mature smooth muscle cells (SMCs) are characterized by the presence of a unique repertoire of smooth muscle-specific proteins. Although previous studies have shown myocardin to be a critical transcription factor for stimulating expression of smooth muscle-specific genes, the mechanisms regulating myocardin activity are still poorly understood. We used a yeast two-hybrid screen with myocardin as bait to search for factors that may regulate the transcriptional activity of the myocardin. From this screen we identified a HECT domain-containing protein UBR5 (ubiquitin protein ligase E3 component n-recognin 5) as a myocardin-binding protein. Previous studies have shown that HECT domain-containing proteins are ubiquitin E3 ligases that play an important role in protein degradation. UBR5 has, however, also been shown to regulate transcription independent of its E3 ligase activity. In the current study we demonstrated that UBR5 localized in the nuclei of SMCs and forms a complex with myocardin in vivo and in vitro. We also show that UBR5 specifically enhanced trans-activation of smooth muscle-specific promoters by the myocardin family of proteins. In addition, UBR5 significantly augmented the ability of myocardin to induce expression of endogenous SMC marker genes independent on its E3 ligase function. Conversely, depletion of endogenous UBR5 by small interfering RNA in fibroblast cells attenuated myocardin-induced smooth muscle-specific gene expression, and UBR5 knockdown in SMCs resulted in down-regulation of smooth muscle-specific genes. Furthermore, we found that UBR5 can attenuate myocardin protein degradation resulting in increased myocardin protein expression without affecting myocardin mRNA expression. The effects of UBR5 on myocardin requires only the HECT and UBR1 domains of UBR5. This study reveals an unexpected role for the ubiquitin E3 ligase UBR5 as an activator of smooth muscle differentiation through its ability to stabilize myocardin protein.	[Zhou, Jiliang] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Saunders, Darren N.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1L3, Canada; [Saunders, Darren N.] British Columbia Canc Res Ctr, Mol Oncol & Breast Canc Program, Vancouver, BC V5Z 1L3, Canada; [Henderson, Michelle; Russell, Amanda J.] Childrens Canc Inst Australia Med Res, Expt Therapeut Program, Randwick, NSW 2031, Australia; [Herring, B. Paul] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Albany Medical College; University of British Columbia; British Columbia Cancer Agency; Children's Cancer Institute; Indiana University System; Indiana University-Purdue University Indianapolis	Zhou, JL (corresponding author), 47 New Scotland Ave, Albany, NY 12208 USA.	zhouj1@mail.amc.edu	Wang, Xiaobo/S-2476-2019; henderson, Michelle/G-6657-2012; Saunders, Darren/B-7677-2008; Wang, Xiaobo/J-4312-2014	Wang, Xiaobo/0000-0001-6044-914X; Saunders, Darren/0000-0003-0924-0513	National Institutes of Health [DK61130]; Albany Medical College; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albany Medical College; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK61130 (to B. P. H.) and a Albany Medical College start up grant and a Scientist Development Grant from the American Heart Association (to J. Z.).	Aikawa M, 1995, J Atheroscler Thromb, V2, P14; BENDITT EP, 1973, P NATL ACAD SCI USA, V70, P1753, DOI 10.1073/pnas.70.6.1753; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Doherty TM, 2003, FASEB J, V17, P592, DOI 10.1096/fj.02-0913hyp; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; GLUKHOVA MA, 1988, P NATL ACAD SCI USA, V85, P9542, DOI 10.1073/pnas.85.24.9542; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; Hinson JS, 2008, AM J PHYSIOL-HEART C, V295, pH1067, DOI 10.1152/ajpheart.91421.2007; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; MAJESKY MW, 1992, CIRC RES, V71, P759, DOI 10.1161/01.RES.71.4.759; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Mori Y, 2002, CANCER RES, V62, P3641; Ohshima R, 2007, GENES CELLS, V12, P1339, DOI 10.1111/j.1365-2443.2007.01138.x; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; PENN A, 1990, MUTAT RES, V239, P149, DOI 10.1016/0165-1110(90)90003-T; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Saunders DN, 2004, MOL CELL BIOL, V24, P7225, DOI 10.1128/MCB.24.16.7225-7234.2004; UEKI N, 1987, P NATL ACAD SCI USA, V84, P9049, DOI 10.1073/pnas.84.24.9049; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229; Zhou JL, 2008, J BIOL CHEM, V283, P35383, DOI 10.1074/jbc.M805489200; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200	37	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11800	11809		10.1074/jbc.M109.079384	http://dx.doi.org/10.1074/jbc.M109.079384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20167605	Green Published, hybrid			2022-12-25	WOS:000276787100007
J	An, S; Kyoung, M; Allen, JJ; Shokat, KM; Benkovic, SJ				An, Songon; Kyoung, Minjoung; Allen, Jasmina J.; Shokat, Kevan M.; Benkovic, Stephen J.			Dynamic Regulation of a Metabolic Multi-enzyme Complex by Protein Kinase CK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC-SUBUNIT; ENZYME COMPLEX; INHIBITORS; PURIFICATION; CHEMOTHERAPY; CANCER; TUMORS; KEY	The reversible association and dissociation of a metabolic multi-enzyme complex participating in de novo purine biosynthesis, the purinosome, was demonstrated in live cells to respond to the levels of purine nucleotides in the culture media. We also took advantage of in vitro proteomic scale studies of cellular substrates of human protein kinases (e.g. casein kinase II (CK2) and Akt), that implicated several de novo purine biosynthetic enzymes as kinase substrates. Here, we successfully identified that purinosome formation in vivo was significantly promoted in HeLa cells by the addition of small-molecule CK2-specific inhibitors (i.e. 4,5,6,7-tetrabromo-1H-benzimidazole, 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole, tetrabromocinammic acid, 4,4',5,5',6,6'-hexahydroxydiphenic acid 2,2',6,6'-dilactone (ellagic acid) as well as by silencing the endogenous human CK2 alpha catalytic subunit with small interfering RNA. However, 4,5,6,7-tetrabromobenzotriazole, another CK2-specific inhibitor, triggered the dissociation of purinosome clusters in HeLa cells. Although the mechanism by which 4,5,6,7-tetrabromobenzotriazole affects purinosome clustering is not clear, we were capable of chemically reversing purinosome formation in cells by the sequential addition of two CK2 inhibitors. Collectively, we provide compelling cellular evidence that CK2-mediated pathways reversibly regulate purinosome assembly, and thus the purinosome may be one of the ultimate targets of kinase inhibitors.	[An, Songon; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Kyoung, Minjoung] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Allen, Jasmina J.] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94158 USA; [Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Benkovic, SJ (corresponding author), 413 Wartik Lab, University Pk, PA 16802 USA.	sjb1@psu.edu	An, Songon/A-6714-2009	An, Songon/0000-0003-2189-7374	National Institutes of Health [GM24129, RO1 EB0001987]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024129, R37GM024129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM24129 (to S. J. B.) and RO1 EB0001987 (to K. M. S.).	ALLEN JJ, 2008, THESIS U CALIFORNIA; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Boccalatte FE, 2009, BLOOD, V113, P2776, DOI 10.1182/blood-2008-06-161018; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Dominguez I, 2009, CELL MOL LIFE SCI, V66, P1850, DOI 10.1007/s00018-009-9153-z; Duncan JS, 2008, MOL CELL PROTEOMICS, V7, P1077, DOI 10.1074/mcp.M700559-MCP200; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Field MS, 2009, ARCH BIOCHEM BIOPHYS, V481, P145, DOI 10.1016/j.abb.2008.11.001; Filhol O, 2009, CELL MOL LIFE SCI, V66, P1830, DOI 10.1007/s00018-009-9151-1; Lou DY, 2008, MOL CELL BIOL, V28, P131, DOI 10.1128/MCB.01119-07; Luo Y, 2005, MOL CANCER THER, V4, P977, DOI 10.1158/1535-7163.MCT-05-0005; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; Raaf J, 2009, J MOL BIOL, V386, P1212, DOI 10.1016/j.jmb.2009.01.033; RISCOE MK, 1989, BLOOD REV, V3, P162, DOI 10.1016/0268-960X(89)90013-1; ROWE PB, 1978, J BIOL CHEM, V253, P7711; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; SMITH GK, 1980, BIOCHEMISTRY-US, V19, P4313, DOI 10.1021/bi00559a026; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; VANGORP AG, 2007, THESIS PROEFSCHRIFT; Wang W, 2009, J BIOL CHEM, V284, P3521, DOI 10.1074/jbc.M806707200; Wilson LK, 1997, J BIOL CHEM, V272, P12961, DOI 10.1074/jbc.272.20.12961	31	49	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11093	11099		10.1074/jbc.M110.101139	http://dx.doi.org/10.1074/jbc.M110.101139			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20157113	Green Published, hybrid			2022-12-25	WOS:000276286200013
J	Liu, C; van Dyk, D; Xu, P; Choe, V; Pan, HH; Peng, JM; Andrews, B; Rao, H				Liu, Chang; van Dyk, Dewald; Xu, Ping; Choe, Vitnary; Pan, Haihui; Peng, Junmin; Andrews, Brenda; Rao, Hai			Ubiquitin Chain Elongation Enzyme Ufd2 Regulates a Subset of Doa10 Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGRADATION; LIGASE; RETICULUM; MEMBRANE; MULTIUBIQUITYLATION; MUTATIONS; MECHANISM; PROTEINS; REVEALS; PATHWAY	Ufd2 is the founding member of E4 enzymes that are specifically involved in ubiquitin chain elongation but whose roles in proteolysis remain scarce. Here, using a genome-wide screen, we identified one cellular target of yeast Ufd2 as the membrane protein Pex29. The ubiquitin chains assembled on Pex29 in vivo by Ufd2 mainly contain Lys-48 linkages. We found that the ubiquitin-protein E3 ligase for overexpressed Pex29 is Doa10, which is known to be involved in protein quality control. Interestingly, not all Doa10 substrates are regulated by Ufd2, suggesting that E4 involvement is not specific to a particular E3, but may depend on the spatial arrangement of the E3-substrate interaction. Cells lacking UFD2 elicit an unfolded protein response, expanding the physiological function of Ufd2. Our results lead to novel insights into the biological role of Ufd2 and further underscore the significance of Ufd2 in proteolysis.	[Liu, Chang; Choe, Vitnary; Pan, Haihui; Rao, Hai] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; [van Dyk, Dewald; Andrews, Brenda] Univ Toronto, Dept Mol & Med Genet, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Xu, Ping; Peng, Junmin] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA	University of Texas System; University of Texas Health San Antonio; University of Toronto; Emory University	Rao, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.	raoh@uthscsa.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; RAO, HAI/0000-0002-4235-2210	National Institutes of Health [GM 078085]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 078085 (to H. R.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Apodaca J, 2006, BIOCHEM BIOPH RES CO, V347, P319, DOI 10.1016/j.bbrc.2006.06.078; Eckert JH, 2003, J CELL SCI, V116, P3623, DOI 10.1242/jcs.00678; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hosoda M, 2005, ONCOGENE, V24, P7156, DOI 10.1038/sj.onc.1208872; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kaneko-Oshikawa C, 2005, MOL CELL BIOL, V25, P10953, DOI 10.1128/MCB.25.24.10953-10964.2005; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Krona C, 2003, ONCOGENE, V22, P2343, DOI 10.1038/sj.onc.1206324; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Measday V, 2002, METHOD ENZYMOL, V350, P316, DOI 10.1016/S0076-6879(02)50971-X; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Smith JJ, 2009, CURR OPIN CELL BIOL, V21, P119, DOI 10.1016/j.ceb.2009.01.009; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vizeacoumar FJ, 2003, J CELL BIOL, V161, P321, DOI 10.1083/jcb.200210130; Williams C, 2008, BIOCHEM BIOPH RES CO, V374, P620, DOI 10.1016/j.bbrc.2008.07.054; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041	35	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10265	10272		10.1074/jbc.M110.110551	http://dx.doi.org/10.1074/jbc.M110.110551			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20159987	Green Published, hybrid			2022-12-25	WOS:000276264600010
J	Haubner, BJ; Neely, GG; Voelkl, JGJ; Damilano, F; Kuba, K; Imai, Y; Komnenovic, V; Mayr, A; Pachinger, O; Hirsch, E; Penninger, JM; Metzler, B				Haubner, Bernhard J.; Neely, G. Gregory; Voelkl, Jakob G. J.; Damilano, Federico; Kuba, Keiji; Imai, Yumiko; Komnenovic, Vukoslav; Mayr, Agnes; Pachinger, Otmar; Hirsch, Emilio; Penninger, Josef M.; Metzler, Bernhard			PI3K gamma Protects from Myocardial Ischemia and Reperfusion Injury through a Kinase-Independent Pathway	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE GAMMA; HEART-FAILURE; PRESSURE-OVERLOAD; INFARCTION; MICE; INFLAMMATION; INHIBITION; ACTIVATION; PI3K-DELTA; REGULATOR	Background: PI3K gamma functions in the immune compartment to promote inflammation in response to G-protein-coupled receptor (GPCR) agonists and PI3K gamma also acts within the heart itself both as a negative regulator of cardiac contractility and as a pro-survival factor. Thus, PI3K gamma has the potential to both promote and limit M I/R injury. Methodology/Principal Findings: Complete PI3K gamma(-/-) mutant mice, catalytically inactive PI3K gamma(KD/KD) (KD) knock-in mice, and control wild type (WT) mice were subjected to in vivo myocardial ischemia and reperfusion (M I/R) injury. Additionally, bone-marrow chimeric mice were constructed to elucidate the contribution of the inflammatory response to cardiac damage. PI3K gamma(-/-) mice exhibited a significantly increased infarction size following reperfusion. Mechanistically, PI3K gamma is required for activation of the Reperfusion Injury Salvage Kinase (RISK) pathway (AKT/ERK1/2) and regulates phospholamban phosphorylation in the acute injury response. Using bone marrow chimeras, the cardioprotective role of PI3K gamma was mapped to non-haematopoietic cells. Importantly, this massive increase in M I/R injury in PI3K gamma(-/-) mice was rescued in PI3K gamma kinase-dead (PI3K gamma(KD/KD)) knock-in mice. However, PI3K gamma(KD/KD) mice exhibited a cardiac injury similar to wild type animals, suggesting that specific blockade of PI3K gamma catalytic activity has no beneficial effects. Conclusions/Significance: Our data show that PI3K gamma is cardioprotective during M I/R injury independent of its catalytic kinase activity and that loss of PI3K gamma function in the hematopoietic compartment does not affect disease outcome. Thus, clinical development of specific PI3K gamma blockers should proceed with caution.	[Haubner, Bernhard J.; Voelkl, Jakob G. J.; Mayr, Agnes; Pachinger, Otmar; Metzler, Bernhard] Innsbruck Med Univ, Dept Internal Med Cardiol 3, Innsbruck, Austria; [Neely, G. Gregory; Kuba, Keiji; Imai, Yumiko; Komnenovic, Vukoslav; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Damilano, Federico; Hirsch, Emilio] Univ Turin, Dept Genet Biol & Biochem, Ctr Mol Biotechnol, Turin, Italy	Medical University of Innsbruck; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Turin	Haubner, BJ (corresponding author), Innsbruck Med Univ, Dept Internal Med Cardiol 3, Innsbruck, Austria.	josef.penninger@oeaw.ac.at	Neely, Greg/AAB-4642-2020; Voelkl, Jakob/T-4298-2019; Imai, Yumiko/GXW-1144-2022; Hirsch, Emilio/F-4848-2013; neely, graham/A-6511-2011; Penninger, Josef M/I-6860-2013	Neely, Greg/0000-0002-1957-9732; Hirsch, Emilio/0000-0002-9073-6024; Penninger, Josef M/0000-0002-8194-3777; Metzler, Bernhard/0000-0002-5240-2453; , Agnes Mayr/0000-0001-9363-873X	EU; Osterreichische Kardiologische Gesellschaft and Medizinischer Forschungsfond Tirol	EU(European Commission); Osterreichische Kardiologische Gesellschaft and Medizinischer Forschungsfond Tirol	Supported by grants from IMBA and EuGeneHeart (EU grant) to J M.P. and from the Osterreichische Kardiologische Gesellschaft and Medizinischer Forschungsfond Tirol to B. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Ban K, 2008, CIRC RES, V103, P643, DOI 10.1161/CIRCRESAHA.108.175018; BRODDE OE, 1992, J HEART LUNG TRANSPL, V11, pS164; Chang JD, 2007, P NATL ACAD SCI USA, V104, P8077, DOI 10.1073/pnas.0702663104; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Cross HR, 2003, AM J PHYSIOL-HEART C, V284, pH683, DOI 10.1152/ajpheart.00567.2002; Curcio A, 2006, AM J PHYSIOL-HEART C, V291, pH1754, DOI 10.1152/ajpheart.01199.2005; Del Prete A, 2004, EMBO J, V23, P3505, DOI 10.1038/sj.emboj.7600361; Doukas J, 2007, BIOCHEM SOC T, V35, P204, DOI 10.1042/BST0350204; FISHER TC, 1994, THROMB RES, V74, pS21, DOI 10.1016/S0049-3848(10)80004-0; GRISWOLD DE, 1988, J PHARMACOL METHOD, V20, P225, DOI 10.1016/0160-5402(88)90065-4; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hawkins PT, 2007, SCIENCE, V318, P64, DOI 10.1126/science.1145420; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Kerfant BG, 2007, CIRC RES, V101, P400, DOI 10.1161/CIRCRESAHA.107.156422; Liu LX, 2007, BLOOD, V110, P1191, DOI 10.1182/blood-2006-11-060103; MAROKO PR, 1971, CIRCULATION, V43, P67, DOI 10.1161/01.CIR.43.1.67; Metzler B, 2001, CARDIOVASC RES, V49, P399, DOI 10.1016/S0008-6363(00)00261-3; MUSIOLIK J, 2009, CARDIOVASC RES; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Oudit GY, 2003, CIRCULATION, V108, P2147, DOI 10.1161/01.CIR.0000091403.62293.2B; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Skyschally A, 2009, CIRC RES, V104, P15, DOI 10.1161/CIRCRESAHA.108.186429; Stuhlinger MC, 2007, CARDIOVASC RES, V75, P417, DOI 10.1016/j.cardiores.2007.04.030; Yaoita H, 2000, CARDIOVASC RES, V45, P630, DOI 10.1016/S0008-6363(99)00349-1	31	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9350	10.1371/journal.pone.0009350	http://dx.doi.org/10.1371/journal.pone.0009350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179753	Green Published, Green Submitted, gold			2022-12-25	WOS:000274923900015
J	Cao, PX; Yuan, YY; Pehek, EA; Moise, AR; Huang, Y; Palczewski, K; Feng, ZY				Cao, Pengxiu; Yuan, Yiyuan; Pehek, Elizabeth A.; Moise, Alex R.; Huang, Ying; Palczewski, Krzysztof; Feng, Zhaoyang			Alpha-Synuclein Disrupted Dopamine Homeostasis Leads to Dopaminergic Neuron Degeneration in Caenorhabditis elegans	PLOS ONE			English	Article							PARKINSONS-DISEASE; C-ELEGANS; DROSOPHILA MODEL; NEURITE OUTGROWTH; GENE; NEUROTOXICITY; PATHOGENESIS; MECHANISMS; STORAGE; PHOSPHORYLATION	Disruption of dopamine homeostasis may lead to dopaminergic neuron degeneration, a proposed explanation for the specific vulnerability of dopaminergic neurons in Parkinson's disease. While expression of human alpha-synuclein in C. elegans results in dopaminergic neuron degeneration, the effects of alpha-synuclein on dopamine homeostasis and its contribution to dopaminergic neuron degeneration in C. elegans have not been reported. Here, we examined the effects of alpha-synuclein overexpression on worm dopamine homeostasis. We found that alpha-synuclein expression results in upregulation of dopamine synthesis and content, and redistribution of dopaminergic synaptic vesicles, which significantly contribute to dopaminergic neuron degeneration. These results provide in vivo evidence supporting a critical role for dopamine homeostasis in supporting dopaminergic neuron integrity.	[Cao, Pengxiu; Yuan, Yiyuan; Moise, Alex R.; Huang, Ying; Palczewski, Krzysztof; Feng, Zhaoyang] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Pehek, Elizabeth A.] Case Western Reserve Univ, Sch Med, Dept Psychiat, Cleveland, OH 44106 USA; [Pehek, Elizabeth A.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Pehek, Elizabeth A.] Louis Stokes Cleveland Vet Affairs Med Ctr, Dept Vet Affairs, Cleveland, OH USA; [Feng, Zhaoyang] Xi An Jiao Tong Univ, Coll Med, Dept Physiol, Xian 710049, Shaanxi, Peoples R China	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Xi'an Jiaotong University	Cao, PX (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.	john.feng@case.edu	Cao, Pengxiu/I-5378-2012; AR, Moise/P-2474-2019; Moise, Alexander R/C-9498-2009	AR, Moise/0000-0003-2307-6035; Moise, Alexander R/0000-0003-2307-6035; CAO, PENGXIU/0000-0002-5900-5645	Mt. Sinai Healthcare Foundation; Department of Veterans Affairs	Mt. Sinai Healthcare Foundation; Department of Veterans Affairs(US Department of Veterans Affairs)	This work is partially supported by Mt. Sinai Healthcare Scholarship from Mt. Sinai Healthcare Foundation (www.mtsinaifoundation.org/) to ZF and a MERIT Review grant of the Department of Veterans Affairs (www.research.va.gov/) to EAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bozzi Y, 2006, TRENDS NEUROSCI, V29, P167, DOI 10.1016/j.tins.2006.01.002; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Caudle WM, 2008, TRENDS NEUROSCI, V31, P303, DOI 10.1016/j.tins.2008.02.010; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dawson TM, 2002, NAT NEUROSCI, V5, P1058, DOI 10.1038/nn941; Duerr Janet S, 2006, WormBook, P1; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Hobert O, 1999, DEVELOPMENT, V126, P1547; HSU AL, 2008, NEUROBIOL AGING; KEHR W, 1972, J PHARM PHARMACOL, V24, P744, DOI 10.1111/j.2042-7158.1972.tb09104.x; Kuwahara T, 2006, J BIOL CHEM, V281, P334, DOI 10.1074/jbc.M504860200; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lints R, 1999, DEVELOPMENT, V126, P5819; Lints R, 2002, GENE DEV, V16, P2390, DOI 10.1101/gad.1012602; Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Mosharov EV, 2006, J NEUROSCI, V26, P9304, DOI 10.1523/JNEUROSCI.0519-06.2006; Nussbaum RL, 1997, HUM MOL GENET, V6, P1687, DOI 10.1093/hmg/6.10.1687; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Park SS, 2007, EUR J NEUROSCI, V26, P3104, DOI 10.1111/j.1460-9568.2007.05929.x; Park SS, 2006, EUR J NEUROSCI, V23, P2908, DOI 10.1111/j.1460-9568.2006.04844.x; Pezzella A, 1997, J MED CHEM, V40, P2211, DOI 10.1021/jm970099t; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; Spencer JPE, 1998, J NEUROCHEM, V71, P2112; Stiernagle Theresa, 2006, WormBook, P1; Sze JY, 2002, DEVELOPMENT, V129, P3901; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Wei G, 2004, IEEE T BIO-MED ENG, V51, P1811, DOI 10.1109/TBME.2004.831532; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088	49	31	31	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9312	10.1371/journal.pone.0009312	http://dx.doi.org/10.1371/journal.pone.0009312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174477	Green Published, gold			2022-12-25	WOS:000274923700016
J	Crews, L; Spencer, B; Desplats, P; Patrick, C; Paulino, A; Rockenstein, E; Hansen, L; Adame, A; Galasko, D; Masliah, E				Crews, Leslie; Spencer, Brian; Desplats, Paula; Patrick, Christina; Paulino, Amy; Rockenstein, Edward; Hansen, Lawrence; Adame, Anthony; Galasko, Douglas; Masliah, Eliezer			Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of alpha-Synucleinopathy	PLOS ONE			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; AGGREGATE-PRONE PROTEINS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; TRANSGENIC MICE; MOUSE MODEL; WILD-TYPE; FRONTOTEMPORAL DEMENTIA; NEURONAL EXPRESSION; GAUCHER-DISEASE	Background: Lewy body disease is a heterogeneous group of neurodegenerative disorders characterized by alpha-synuclein accumulation that includes dementia with Lewy bodies (DLB) and Parkinson's Disease (PD). Recent evidence suggests that impairment of lysosomal pathways (i.e. autophagy) involved in alpha-synuclein clearance might play an important role. For this reason, we sought to examine the expression levels of members of the autophagy pathway in brains of patients with DLB and Alzheimer's Disease (AD) and in alpha-synuclein transgenic mice. Methodology/Principal Findings: By immunoblot analysis, compared to controls and AD, in DLB cases levels of mTor were elevated and Atg7 were reduced. Levels of other components of the autophagy pathway such as Atg5, Atg10, Atg12 and Beclin-1 were not different in DLB compared to controls. In DLB brains, mTor was more abundant in neurons displaying alpha-synuclein accumulation. These neurons also showed abnormal expression of lysosomal markers such as LC3, and ultrastructural analysis revealed the presence of abundant and abnormal autophagosomes. Similar alterations were observed in the brains of alpha-synuclein transgenic mice. Intra-cerebral infusion of rapamycin, an inhibitor of mTor, or injection of a lentiviral vector expressing Atg7 resulted in reduced accumulation of alpha-synuclein in transgenic mice and amelioration of associated neurodegenerative alterations. Conclusions/Significance: This study supports the notion that defects in the autophagy pathway and more specifically in mTor and Atg7 are associated with neurodegeneration in DLB cases and alpha-synuclein transgenic models and supports the possibility that modulators of the autophagy pathway might have potential therapeutic effects.	[Crews, Leslie; Hansen, Lawrence; Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Spencer, Brian; Desplats, Paula; Patrick, Christina; Paulino, Amy; Rockenstein, Edward; Hansen, Lawrence; Adame, Anthony; Galasko, Douglas; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Crews, L (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	emasliah@UCSD.edu	Crews, Leslie/B-7584-2014; Desplats, Paula/AFW-5030-2022	Crews, Leslie/0000-0003-0704-0067; Desplats, Paula/0000-0002-4758-4280	NIH [AG18440, AG5131]; NATIONAL INSTITUTE ON AGING [P50AG005131, R01AG018440, R37AG018440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants AG18440 and AG5131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2004, J GERIATR PSYCH NEUR, V17, P137, DOI 10.1177/0891988704267470; Bahr BA, 2002, J NEUROCHEM, V83, P481, DOI 10.1046/j.1471-4159.2002.01192.x; Bendiske J, 2003, J NEUROPATH EXP NEUR, V62, P451, DOI 10.1093/jnen/62.5.451; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Braak H, 2000, J NEUROL, V247, P3; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Burn DJ, 2006, CURR OPIN NEUROL, V19, P572, DOI 10.1097/01.wco.0000247607.34697.a2; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Crews L, 2009, NEUROTOX RES, V16, P306, DOI 10.1007/s12640-009-9073-6; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Dickson DW, 2001, CURR OPIN NEUROL, V14, P423, DOI 10.1097/00019052-200108000-00001; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; HANSEN L, 1998, JNEUROLNEUROSURGPSYC; HANSEN L, 1997, J NEURAL TRANSM, V51, P111; HANSEN LA, 1991, NEUROSCI LETT, V129, P269, DOI 10.1016/0304-3940(91)90478-C; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Hashimoto M, 2003, J NEUROCHEM, V85, P1468, DOI 10.1046/j.1471-4159.2003.01791.x; Hashimoto M, 2002, J BIOL CHEM, V277, P32985, DOI 10.1074/jbc.M202803200; Janvin CC, 2006, MOVEMENT DISORD, V21, P337, DOI 10.1002/mds.20726; Jellinger KA, 1998, J NEURAL TRANSM-SUPP, P77; Jellinger KA, 2006, ACTA NEUROPATHOL, V112, P253, DOI 10.1007/s00401-006-0088-2; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Lippa CF, 2007, NEUROLOGY, V68, P812, DOI 10.1212/01.wnl.0000256715.13907.d3; Litvan I, 1998, ARCH NEUROL-CHICAGO, V55, P969, DOI 10.1001/archneur.55.7.969; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Marr RA, 2003, J NEUROSCI, V23, P1992; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2003, NEUROLOGY, V61, P206, DOI 10.1212/01.WNL.0000073987.79060.4B; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McKeith IG, 2006, J ALZHEIMERS DIS, V9, P417, DOI 10.1212/wnl.47.5.1113; McKeith IG, 2000, NEUROL CLIN, V18, P865, DOI 10.1016/S0733-8619(05)70230-9; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MUCKE L, 1995, J EXP MED, V181, P1551, DOI 10.1084/jem.181.4.1551; Nakajima T, 2005, BRAIN RES, V1040, P73, DOI 10.1016/j.brainres.2005.01.099; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P323, DOI 10.1093/jnen/63.4.323; Sarkar S, 2008, MOL BIOSYST, V4, P895, DOI 10.1039/b804606a; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Takenouchi T, 2001, MOL CELL NEUROSCI, V17, P141, DOI 10.1006/mcne.2000.0923; Tayebi N, 2001, MOL GENET METAB, V73, P313, DOI 10.1006/mgme.2001.3201; Tiscornia G, 2006, NAT PROTOC, V1, P234, DOI 10.1038/nprot.2006.36; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Uchikado H, 2006, J NEUROPATH EXP NEUR, V65, P685, DOI 10.1097/01.jnen.0000225908.90052.07; van Kats JP, 2001, J HYPERTENS, V19, P583, DOI 10.1097/00004872-200103001-00010; Varkonyi J, 2003, AM J MED GENET A, V116A, P348, DOI 10.1002/ajmg.a.10028; Veinbergs I, 2001, EXP NEUROL, V170, P15, DOI 10.1006/exnr.2001.7684; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	89	267	280	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9313	10.1371/journal.pone.0009313	http://dx.doi.org/10.1371/journal.pone.0009313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174468	Green Published, Green Submitted, gold			2022-12-25	WOS:000274923700017
J	Calmettes, G; Deschodt-Arsac, V; Gouspillou, G; Miraux, S; Muller, B; Franconi, JM; Thiaudiere, E; Diolez, P				Calmettes, Guillaume; Deschodt-Arsac, Veronique; Gouspillou, Gilles; Miraux, Sylvain; Muller, Bernard; Franconi, Jean-Michel; Thiaudiere, Eric; Diolez, Philippe			Improved Energy Supply Regulation in Chronic Hypoxic Mouse Counteracts Hypoxia-Induced Altered Cardiac Energetics	PLOS ONE			English	Article							HIGH-ALTITUDE HYPOXIA; METABOLIC-CONTROL ANALYSIS; MODULAR CONTROL ANALYSIS; FAILING HEART; TIME-COURSE; RAT-HEART; ADAPTATION; ATP; PERFORMANCE; MYOCARDIUM	Background: Hypoxic states of the cardiovacular system are undoubtedly associated with the most frequent diseases of modern time. Therefore, understanding hypoxic resistance encountered after physiological adaptation such as chronic hypoxia, is crucial to better deal with hypoxic insult. In this study, we examine the role of energetic modifications induced by chronic hypoxia (CH) in the higher tolerance to oxygen deprivation. Methodology/Principal Findings: Swiss mice were exposed to a simulated altitude of 5500 m in a barochamber for 21 days. Isolated perfused hearts were used to study the effects of a decreased oxygen concentration in the perfusate on contractile performance (RPP) and phosphocreatine (PCr) concentration (assessed by P-31-NMR), and to describe the integrated changes in cardiac energetics regulation by using Modular Control Analysis (MoCA). Oxygen reduction induced a concomitant decrease in RPP (-46%) and in [PCr] (-23%) in Control hearts while CH hearts energetics was unchanged. MoCA demonstrated that this adaptation to hypoxia is the direct consequence of the higher responsiveness (elasticity) of ATP production of CH hearts compared with Controls (-1.88 +/- 0.38 vs -0.89 +/- 0.41, p < 0.01) measured under low oxygen perfusion. This higher elasticity induces an improved response of energy supply to cellular energy demand. The result is the conservation of a healthy control pattern of contraction in CH hearts, whereas Control hearts are severely controlled by energy supply. C Conclusions/Significance: As suggested by the present study, the mechanisms responsible for this increase in elasticity and the consequent improved ability of CH heart metabolism to respond to oxygen deprivation could participate to limit the damages induced by hypoxia.	[Calmettes, Guillaume; Deschodt-Arsac, Veronique; Gouspillou, Gilles; Miraux, Sylvain; Franconi, Jean-Michel; Thiaudiere, Eric; Diolez, Philippe] Univ Bordeaux 2, CNRS, UMR 5536, Lab Resonance Magnet Syst Biol, F-33076 Bordeaux, France; [Muller, Bernard] Univ Bordeaux 2, INSERM, U885, Pharmacol Lab, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Calmettes, G (corresponding author), Univ Bordeaux 2, CNRS, UMR 5536, Lab Resonance Magnet Syst Biol, F-33076 Bordeaux, France.	guillaume.calmettes@rmsb.u-bordeaux2.fr; philippe.diolez@rmsb.u-bordeaux2.fr	Miraux, Sylvain/AAF-1023-2019; Calmettes, Guillaume/A-6916-2010	Gouspillou, Gilles/0000-0002-8543-3619; Diolez, Philippe/0000-0002-7548-2070; Miraux, Sylvain/0000-0002-3642-2390; Thiaudiere, Eric/0000-0002-9993-4035; Deschodt-Arsac, Veronique/0000-0002-9244-9862	"Centre National de la Recherche Scientifique, France''; "Region Aquitaine, France''; "Universite Bordeaux 2''	"Centre National de la Recherche Scientifique, France''(Centre National de la Recherche Scientifique (CNRS)); "Region Aquitaine, France''(Region Nouvelle-Aquitaine); "Universite Bordeaux 2''	This work was supported by the "Centre National de la Recherche Scientifique, France'', the "Region Aquitaine, France'', and the "Universite Bordeaux 2''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsac LM, 2008, BIOCHEM J, V414, P391, DOI 10.1042/BJ20080280; Asemu G, 2000, PHYSIOL RES, V49, P597; BALABAN RS, 1990, AM J PHYSIOL, V258, pC377, DOI 10.1152/ajpcell.1990.258.3.C377; BEUSTE C, 2009, BIOCHEM J; BITTL JA, 1987, CIRC RES, V60, P871, DOI 10.1161/01.RES.60.6.871; Brand MD, 1997, J EXP BIOL, V200, P193; Calmettes G, 2008, AM J PHYSIOL-REG I, V295, pR1891, DOI 10.1152/ajpregu.90548.2008; Corbucci G G, 2005, Minerva Anestesiol, V71, P727; Diolez P, 2007, AM J PHYSIOL-REG I, V293, pR13, DOI 10.1152/ajpregu.00189.2006; Dos Santos P, 2000, J MOL CELL CARDIOL, V32, P1703, DOI 10.1006/jmcc.2000.1207; Dzeja P P, 2000, Curr Cardiol Rep, V2, P212, DOI 10.1007/s11886-000-0071-9; Essop MF, 2007, J PHYSIOL-LONDON, V584, P715, DOI 10.1113/jphysiol.2007.143511; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Gibbs JSR, 2007, ADV EXP MED BIOL, V618, P13; Ingwall JS, 2006, CURR HYPERTENS REP, V8, P457, DOI 10.1007/s11906-006-0023-x; Itoh A, 2009, ACTA MED OKAYAMA, V63, P87; Kolar F, 2004, PHYSIOL RES, V53, pS3; Korzeniewski B, 2008, BIOCHEM J, V413, P343, DOI 10.1042/BJ20080162; McFalls EO, 2006, J MOL CELL CARDIOL, V41, P980, DOI 10.1016/j.yjmcc.2006.07.008; MEERSON FZ, 1973, AM J CARDIOL, V31, P30, DOI 10.1016/0002-9149(73)90806-0; Merati G, 1996, AM J PHYSIOL-HEART C, V271, pH2300, DOI 10.1152/ajpheart.1996.271.6.H2300; Miraux S, 2009, MAGN RESON MED, V62, P1099, DOI 10.1002/mrm.22139; Morris-Thurgood J A, 2000, Heart Fail Rev, V5, P307, DOI 10.1023/A:1026555012135; Nakanishi I, 1995, J PHYSIOL-LONDON, V489, P869, DOI 10.1113/jphysiol.1995.sp021099; Neckar J, 2002, CARDIOVASC RES, V55, P567, DOI 10.1016/S0008-6363(02)00456-X; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nouette-Gaulain K, 2005, CARDIOVASC RES, V66, P132, DOI 10.1016/j.cardiores.2004.12.023; Ostadal B, 2007, RESP PHYSIOL NEUROBI, V158, P224, DOI 10.1016/j.resp.2007.03.005; Pei JM, 2003, AM J PHYSIOL-CELL PH, V285, pC1420, DOI 10.1152/ajpcell.00534.2002; POIZAT C, 1994, BASIC RES CARDIOL, V89, P535, DOI 10.1007/BF00794953; Reboul C, 2005, J APPL PHYSIOL, V98, P83, DOI 10.1152/japplphysiol.00214.2004; Rossi A, 1996, CARDIOVASC RES, V31, P163, DOI 10.1016/S0008-6363(95)00183-2; SAMAJA M, 1994, J APPL PHYSIOL, V77, P2530, DOI 10.1152/jappl.1994.77.6.2530; Srere PA., 1969, METHODS ENZYMOLOGY, P3, DOI DOI 10.1016/0076-6879(69)13005-0; TAJIMA M, 1994, CARDIOVASC RES, V28, P312, DOI 10.1093/cvr/28.3.312; Vogt AM, 2002, J BIOL CHEM, V277, P24411, DOI 10.1074/jbc.M201138200; Weiss JN, 2006, J LIPID RES, V47, P2355, DOI 10.1194/jlr.R600023-JLR200; Weiss JN, 2003, FASEB J, V17, P1, DOI 10.1096/fj.02-0408rev	38	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9306	10.1371/journal.pone.0009306	http://dx.doi.org/10.1371/journal.pone.0009306			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174637	Green Published, gold, Green Submitted			2022-12-25	WOS:000274654700027
J	Krishnamoorthy, J; Yu, VCK; Mok, YK				Krishnamoorthy, Janarthanan; Yu, Victor C. K.; Mok, Yu-Keung			Auto-FACE: An NMR Based Binding Site Mapping Program for Fast Chemical Exchange Protein-Ligand Systems	PLOS ONE			English	Article							NUCLEAR MAGNETIC RESONANCE; AQUEOUS-SOLUTION; THERMODYNAMICAL ANALYSIS; SHIFT PERTURBATIONS; COMPLETE RELAXATION; GENETIC ALGORITHM; ESCHERICHIA-COLI; DRUG DISCOVERY; AB-INITIO; DYNAMICS	Background: Nuclear Magnetic Resonance (NMR) spectroscopy offers a variety of experiments to study protein-ligand interactions at atomic resolution. Among these experiments, N-15 Heteronuclear Single Quantum Correlation (HSQC) experiment is simple, less time consuming and highly informative in mapping the binding site of the ligand. The interpretation of N-15 HSQC becomes ambiguous when the chemical shift perturbations are caused by non-specific interactions like allosteric changes and local structural rearrangement. Under such cases, detailed chemical exchange analysis based on chemical shift perturbation will assist in locating the binding site accurately. Methodology/Principal Findings: We have automated the mapping of binding sites for fast chemical exchange systems using information obtained from N-15 HSQC spectra of protein serially titrated with ligand of increasing concentrations. The automated program Auto-FACE (Auto-FAst Chemical Exchange analyzer) determines the parameters, e. g. rate of change of perturbation, binding equilibrium constant and magnitude of chemical shift perturbation to map the binding site residues. Interestingly, the rate of change of perturbation at lower ligand concentration is highly sensitive in differentiating the binding site residues from the non-binding site residues. To validate this program, the interaction between the protein hBcl(XL) and the ligand BH3I-1 was studied. Residues in the hydrophobic BH3 binding groove of hBcl(XL) were easily identified to be crucial for interaction with BH3I-1 from other residues that also exhibited perturbation. The geometrically averaged equilibrium constant (3.0 x 10(4)) calculated for the residues present at the identified binding site is consistent with the values obtained by other techniques like isothermal calorimetry and fluorescence polarization assays (12:8 x 10(4)). Adjacent to the primary site, an additional binding site was identified which had an affinity of 3.8 times weaker than the former one. Further NMR based model fitting for individual residues suggest single site model for residues present at these binding sites and two site model for residues present between these sites. This implies that chemical shift perturbation can represent the local binding event much more accurately than the global binding event. Conclusion/Significance: Detail NMR chemical shift perturbation analysis enabled binding site residues to be distinguished from non-binding site residues for accurate mapping of interaction site in complex fast exchange system between small molecule and protein. The methodology is automated and implemented in a program called "Auto-FACE'',which also allowed quantitative information of each interaction site and elucidation of binding mechanism.	[Krishnamoorthy, Janarthanan; Mok, Yu-Keung] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Yu, Victor C. K.] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Krishnamoorthy, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsmokh@nus.edu.sg	Yu, Victor/A-7899-2015; Mok, Yu Keung/H-8019-2012	Yu, Victor/0000-0003-3270-4734; Mok, Yu Keung/0000-0002-2829-4878; Krishnamoorthy, Janarthanan/0000-0002-9931-8187	A*Star Biomedical Research Council of Singapore [04/1/21/19/320]	A*Star Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a grant from the A*Star Biomedical Research Council of Singapore, 04/1/21/19/320, to Y.K.M and V.C.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Bain AD, 1996, CAN J CHEM, V74, P819, DOI 10.1139/v96-090; Bain AD, 2003, PROG NUCL MAG RES SP, V43, P63, DOI 10.1016/j.pnmrs.2003.08.001; Bain AD, 1998, BIOCHEM CELL BIOL, V76, P171, DOI 10.1139/bcb-76-2-3-171; BAIN AD, 2002, MEXICO 3 1 MCMASTER; Beach H, 2005, J AM CHEM SOC, V127, P9167, DOI 10.1021/ja0514949; Berghella AM, 1998, CANCER BIOTHER RADIO, V13, P225, DOI 10.1089/cbr.1998.13.225; BINSCH G, 1969, J AM CHEM SOC, V91, P1304, DOI 10.1021/ja01034a007; BOWDEN AEC, 1977, J BIOCH, V165, P55; Carlomagno T, 2005, ANNU REV BIOPH BIOM, V34, P245, DOI 10.1146/annurev.biophys.34.040204.144419; Cavanagh J., 1996, PROTEIN NMR SPECTROS; DALLAKYAN S, MGLTOOLS 1 5 2; Davies DB, 2000, J BIOMOL STRUCT DYN, V17, P887, DOI 10.1080/07391102.2000.10506577; Davies DB, 1996, J CHEM SOC FARADAY T, V92, P3545, DOI 10.1039/ft9969203545; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FERRIN T, CHIMERA 1 3 2577; Goddard P. E., 1903, U CALIFORNIA PUBLICA, V1, P1; Gorecki A, 2009, INT J BIOL MACROMOL, V44, P262, DOI 10.1016/j.ijbiomac.2008.12.015; GUTOWSKY HS, 1956, J CHEM PHYS, V25, P1228, DOI 10.1063/1.1743184; Harding S. E., 2001, PROTEIN LIGAND INTER; Huang C Y, 1979, Methods Enzymol, V63, P54; Huang ZW, 2000, ONCOGENE, V19, P6627, DOI 10.1038/sj.onc.1204087; Jayalakshmi V, 2004, J MAGN RESON, V168, P36, DOI 10.1016/j.jmr.2004.01.017; Jayalakshmi V, 2002, J MAGN RESON, V155, P106, DOI 10.1006/jmre.2001.2499; JOHNSON CS, 1965, ADV MAGN RESON, V1, P33; Keeler J., 2010, UNDERSTANDING NMR SP, V2; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; Kovrigin EL, 2006, J MAGN RESON, V180, P93, DOI 10.1016/j.jmr.2006.01.010; Kovrigin EL, 2006, J AM CHEM SOC, V128, P7724, DOI 10.1021/ja061435a; Lama D, 2008, PROTEINS, V73, P492, DOI 10.1002/prot.22075; Le HB, 1996, J PHYS CHEM-US, V100, P16423, DOI 10.1021/jp9606164; Lugovskoy AA, 2002, J AM CHEM SOC, V124, P1234, DOI 10.1021/ja011239y; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; McCoy MA, 2002, J AM CHEM SOC, V124, P11758, DOI 10.1021/ja026166c; McCoy MA, 2002, J AM CHEM SOC, V124, P2104, DOI 10.1021/ja017242z; MERRITT E, GNUPLOT 4 2 4; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Moseley HNB, 1997, BIOCHEMISTRY-US, V36, P5293, DOI 10.1021/bi970242k; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; OSAPAY K, 1991, J AM CHEM SOC, V113, P9436, DOI 10.1021/ja00025a002; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Roberts GCK, 2000, DRUG DISCOV TODAY, V5, P230, DOI 10.1016/S1359-6446(00)01479-3; Segel H, 1975, ENZYME KINETICS; Sharma Y, 2002, J AM CHEM SOC, V124, P327, DOI 10.1021/ja016859d; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; TJELVAR SG, 2008, J MOL BIOL, V384, P1002; van Dongen M, 2002, DRUG DISCOV TODAY, V7, P471, DOI 10.1016/S1359-6446(02)02233-X; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; Veselkov AN, 2004, J MOL STRUCT, V701, P31, DOI 10.1016/j.molstruc.2004.05.014; Zhang YH, 2006, J MOL BIOL, V364, P536, DOI 10.1016/j.jmb.2006.09.023; NMRPIPE 9	53	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e8943	10.1371/journal.pone.0008943	http://dx.doi.org/10.1371/journal.pone.0008943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174626	gold, Green Submitted, Green Published			2022-12-25	WOS:000274654700002
J	Latawiec, D; Herrera, F; Bek, A; Losasso, V; Candotti, M; Benetti, F; Carlino, E; Kranjc, A; Lazzarino, M; Gustincich, S; Carloni, P; Legname, G				Latawiec, Diane; Herrera, Fernando; Bek, Alpan; Losasso, Valeria; Candotti, Michela; Benetti, Federico; Carlino, Elvio; Kranjc, Agata; Lazzarino, Marco; Gustincich, Stefano; Carloni, Paolo; Legname, Giuseppe			Modulation of Alpha-Synuclein Aggregation by Dopamine Analogs	PLOS ONE			English	Article							PARKINSONS-DISEASE; MOLECULAR-DYNAMICS; LEWY BODIES; INHIBITION; BINDING; FIBRILLIZATION; PATHOGENESIS; FIBRILLATION; OLIGOMERIZATION; CATECHOLS	The action of dopamine on the aggregation of the unstructured alpha-synuclein (alpha-syn) protein may be linked to the pathogenesis of Parkinson's disease. Dopamine and its oxidation derivatives may inhibit alpha-syn aggregation by non-covalent binding. Exploiting this fact, we applied an integrated computational and experimental approach to find alternative ligands that might modulate the fibrillization of alpha-syn. Ligands structurally and electrostatically similar to dopamine were screened from an established library. Five analogs were selected for in vitro experimentation from the similarity ranked list of analogs. Molecular dynamics simulations showed they were, like dopamine, binding non-covalently to alpha-syn and, although much weaker than dopamine, they shared some of its binding properties. In vitro fibrillization assays were performed on these five dopamine analogs. Consistent with our predictions, analyses by atomic force and transmission electron microscopy revealed that all of the selected ligands affected the aggregation process, albeit to a varying and lesser extent than dopamine, used as the control ligand. The in silico/in vitro approach presented here emerges as a possible strategy for identifying ligands interfering with such a complex process as the fibrillization of an unstructured protein.	[Latawiec, Diane; Benetti, Federico; Gustincich, Stefano; Legname, Giuseppe] Scuola Int Super Studi Avanzati, Scuola Int Super Studi Avanzati, Dept Neurobiol, Trieste, Italy; [Herrera, Fernando; Losasso, Valeria; Candotti, Michela; Kranjc, Agata; Carloni, Paolo] Scuola Int Super Studi Avanzati, Scuola Int Super Studi Avanzati, Dept Stat & Biol Phys, Trieste, Italy; [Latawiec, Diane; Herrera, Fernando; Candotti, Michela; Benetti, Federico; Kranjc, Agata; Gustincich, Stefano; Carloni, Paolo; Legname, Giuseppe] Italian Inst Technol, SISSA Unit, Trieste, Italy; [Bek, Alpan; Lazzarino, Marco] Ctr Mol Biomed CBM Scrl, Consorzio Ctr Biomed Mol, Trieste, Italy; [Carlino, Elvio; Lazzarino, Marco] TASC INFM Natl Lab, Trieste, Italy; [Legname, Giuseppe] Sincrotrone Trieste SCpA, ELETTRA Lab, Trieste, Italy	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; Elettra Sincrotrone Trieste	Latawiec, D (corresponding author), Scuola Int Super Studi Avanzati, Scuola Int Super Studi Avanzati, Dept Neurobiol, Trieste, Italy.	carloni@sissa.it; legname@sissa.it	Carlino, Elvio/C-3607-2015; Legname, Giuseppe/C-1723-2012; Bek, Alpan/A-4847-2010; Lazzarino, Marco/AAC-3446-2022; Carloni, Paolo/H-8736-2013	Carlino, Elvio/0000-0003-0285-7297; Legname, Giuseppe/0000-0003-0716-4393; Bek, Alpan/0000-0002-0190-7945; Lazzarino, Marco/0000-0003-1077-6569; Herrera, Fernando E./0000-0002-8595-3382; Benetti, Federico/0000-0001-6491-4715; Gustincich, Stefano/0000-0002-2749-2514	Italian Institute of Technology; FP6; Bio-Nano European Infrastructure (BINASP) [SSA 011936]	Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); FP6(European Commission); Bio-Nano European Infrastructure (BINASP)	This work was supported by grants from the Italian Institute of Technology to PC and GL and by FP6, Bio-Nano European Infrastructure (BINASP) - SSA 011936 grant to AB and ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 1998, AM J PATHOL, V152, P879; Bisaglia M, 2007, J BIOL CHEM, V282, P15597, DOI 10.1074/jbc.M610893200; Bostrom J, 2006, J MED CHEM, V49, P6716, DOI 10.1021/jm060167o; Burke WJ, 2008, ACTA NEUROPATHOL, V115, P193, DOI 10.1007/s00401-007-0303-9; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Dawson TM, 2003, J CLIN INVEST, V111, P145, DOI 10.1172/JCI200317575; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Fountaine TM, 2007, J NEUROSCI RES, V85, P351, DOI 10.1002/jnr.21125; Goedert M, 2001, CLIN CHEM LAB MED, V39, P308, DOI 10.1515/CCLM.2001.047; Herrera FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003394; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Kaylor J, 2005, J MOL BIOL, V353, P357, DOI 10.1016/j.jmb.2005.08.046; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lewy F., 1912, HDB NEUROLOGIE; Li HT, 2005, FEBS J, V272, P3661, DOI 10.1111/j.1742-4658.2005.04792.x; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Muchmore SW, 2006, CHEM BIOL DRUG DES, V67, P174, DOI 10.1111/j.1747-0285.2006.00341.x; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Slutzki M, 2006, J MOL BIOL, V360, P1019, DOI 10.1016/j.jmb.2006.05.069; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stratmann R.E., 2001, GAUSSIAN 98 REVISION; Tanimoto T.T., 1957, NOV, V17, P1957; Tashiro M, 2008, BIOCHEM BIOPH RES CO, V369, P910, DOI 10.1016/j.bbrc.2008.02.127; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; van Raaij ME, 2008, BIOPHYS J, V95, P4871, DOI 10.1529/biophysj.107.127464; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; von Grotthuss M, 2004, COMB CHEM HIGH T SCR, V7, P757; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Wright JA, 2008, J NEUROSCI RES, V86, P496, DOI 10.1002/jnr.21461; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600	47	36	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9234	10.1371/journal.pone.0009234	http://dx.doi.org/10.1371/journal.pone.0009234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169066	Green Published, Green Submitted, gold			2022-12-25	WOS:000274590500016
J	Ghosh, HS; McBurney, M; Robbins, PD				Ghosh, Hiyaa Singhee; McBurney, Michael; Robbins, Paul D.			SIRT1 Negatively Regulates the Mammalian Target of Rapamycin	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; CALORIE RESTRICTION; SACCHAROMYCES-CEREVISIAE; DOWN-REGULATION; CELL-GROWTH; MTOR; TOXICITY; DISEASE; MICE; NAD	The IGF/mTOR pathway, which is modulated by nutrients, growth factors, energy status and cellular stress regulates aging in various organisms. SIRT1 is a NAD+ dependent deacetylase that is known to regulate caloric restriction mediated longevity in model organisms, and has also been linked to the insulin/IGF signaling pathway. Here we investigated the potential regulation of mTOR signaling by SIRT1 in response to nutrients and cellular stress. We demonstrate that SIRT1 deficiency results in elevated mTOR signaling, which is not abolished by stress conditions. The SIRT1 activator resveratrol reduces, whereas SIRT1 inhibitor nicotinamide enhances mTOR activity in a SIRT1 dependent manner. Furthermore, we demonstrate that SIRT1 interacts with TSC2, a component of the mTOR inhibitory-complex upstream to mTORC1, and regulates mTOR signaling in a TSC2 dependent manner. These results demonstrate that SIRT1 negatively regulates mTOR signaling potentially through the TSC1/2 complex.	[Ghosh, Hiyaa Singhee; Robbins, Paul D.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [McBurney, Michael] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada; [McBurney, Michael] Univ Ottawa, Dept Med & Biochem, Ottawa, ON, Canada; [McBurney, Michael] Univ Ottawa, Dept Microbiol, Ottawa, ON, Canada; [McBurney, Michael] Univ Ottawa, Dept Immunol, Ottawa, ON, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Ghosh, HS (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.	probb@pitt.edu			Department of Defense (DOD) [17-03-1-0488, 17-03-0412]	Department of Defense (DOD)(United States Department of Defense)	Funding: This work was supported in part by Department of Defense (DOD) grants 17-03-1-0488 and 17-03-0412 to P. D. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; Bedalov A, 2004, SCIENCE, V305, P954, DOI 10.1126/science.1102497; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen D, 2007, TRENDS MOL MED, V13, P64, DOI 10.1016/j.molmed.2006.12.004; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Demidenko ZN, 2009, CELL CYCLE, V8, P1901, DOI 10.4161/cc.8.12.8810; GHOSH HS, 2007, BIOCH J; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; LEE IH, 2008, P NATL ACAD SCI US; Li X, 2005, FEBS J, V272, P4211, DOI 10.1111/j.1742-4658.2005.04833.x; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Narala SR, 2008, MOL BIOL CELL; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sommer M, 2006, CELL CYCLE, V5, P2005, DOI 10.4161/cc.5.17.3194; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Yang YP, 2005, ACTA PHARMACOL SIN, V26, P1421, DOI 10.1111/j.1745-7254.2005.00235.x; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977; 2009, AGING, V1, P511	43	276	290	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9199	10.1371/journal.pone.0009199	http://dx.doi.org/10.1371/journal.pone.0009199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169165	Green Published, Green Accepted, gold			2022-12-25	WOS:000274474700003
J	Joubert, BR; Franceschini, N; Mwapasa, V; North, KE; Meshnick, SR				Joubert, Bonnie R.; Franceschini, Nora; Mwapasa, Victor; North, Kari E.; Meshnick, Steven R.			Regulation of CCR5 Expression in Human Placenta: Insights from a Study of Mother-to-Child Transmission of HIV in Malawi	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR 5; CELL-SURFACE; HEPARAN-SULFATE; PROMOTER POLYMORPHISM; DISEASE PROGRESSION; ENDOTHELIAL-CELLS; GENE; PROTEOGLYCANS; INFECTION	Background: Human promoter polymorphisms in the chemokine co-receptor 5 gene (CCR5) have been noted for association with mother-to-child transmission of HIV (HIV MTCT) as well as reduced receptor expression in vitro, but have not been clearly associated with CCR5 expression in vivo. Placental expression of CCR5 may be influenced by such polymorphisms as well as other in vivo regulatory factors. Methodology/Principal Findings: We evaluated the associations between infant CCR5 polymorphisms, measures of maternal infection, and placental expression of CCR5 among mother-infant pairs in Blantyre, Malawi. RNA was extracted from placental tissue and used in multiplex real-time PCR to quantify gene expression. Through linear regression, we observed that CCR5-2554T (beta = -0.67, 95% CI = -1.23, -0.11) and -2132T (beta = -0.75, 95% CI = -0.131, -0.18) were significantly associated with reduced placental expression of CCR5. An incremental increase in CCR5 expression was observed for incremental increases in expression of two heparan sulfate genes involved in viral infection, HS3ST3A1 (beta = 0.27, 95% CI = 0.18, 0.35) and HS3ST3B1 (beta = 0.11, 95% CI = 0.06, 0.18). Among HIV infected mothers, an incremental increase in maternal HIV viral load was also associated with higher CCR5 expression (beta = 0.76, 95% CI = 0.12, 1.39). Maternal HIV status had no overall effect (beta = 0.072, 95% CI = -0.57, -0.72). Higher CCR5 expression was observed for mothers with malaria but was not statistically significant (beta = 0.37, 95% CI = -0.43, 1.18). Conclusions/Significance: These results provide in vivo evidence for genetic and environmental factors involved in the regulation of CCR5 expression in the placenta. Our findings also suggest that the measurement of placental expression of CCR5 alone is not an adequate indicator of the risk of mother-to-child transmission of HIV.	[Joubert, Bonnie R.; Franceschini, Nora; North, Kari E.; Meshnick, Steven R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Mwapasa, Victor] Univ Malawi, Coll Med, Blantyre, Malawi; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Malawi; University of North Carolina; University of North Carolina Chapel Hill	Joubert, BR (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	joubert.bonnie@epa.gov		Joubert, Bonnie/0000-0001-7952-1180; Mwapasa, Victor/0000-0002-2748-8902	Centers for Disease Control and Prevention Dissertation [PAR 07-231]; NIH [T32 AI007419]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007419] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention Dissertation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This research was supported by the Centers for Disease Control and Prevention Dissertation Award (PAR 07-231, 2008) and the NIH Virology Training Grant (T32 AI007419, 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], REP GLOB AIDS EP 200; Argyris EG, 2003, J VIROL, V77, P12140, DOI 10.1128/JVI.77.22.12140-12151.2003; Behbahani H, 2000, AM J PATHOL, V157, P1811, DOI 10.1016/S0002-9440(10)64819-5; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bobardt MD, 2004, J VIROL, V78, P6567, DOI 10.1128/JVI.78.12.6567-6584.2004; BRUSE S, 2006, MULTIPLEX LIGASE DET; Burns JC, 2005, J INFECT DIS, V192, P344, DOI 10.1086/430953; Cladera J, 2001, EMBO J, V20, P19, DOI 10.1093/emboj/20.1.19; Clegg AO, 2000, AIDS, V14, P103, DOI 10.1097/00002030-200001280-00004; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Fernandez Elias J., 2001, Antiviral Chemistry and Chemotherapy, V12, P43; GALLAGHER JT, 1986, BIOCHEM J, V236, P313, DOI 10.1042/bj2360313; Gatignol A, 2000, Adv Pharmacol, V48, P209; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Hladik F, 2005, J VIROL, V79, P11677, DOI 10.1128/JVI.79.18.11677-11684.2005; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; Knudsen TB, 2001, J MED VIROL, V65, P441, DOI 10.1002/jmv.2054.abs; Kostrikis LG, 1999, J VIROL, V73, P10264, DOI 10.1128/JVI.73.12.10264-10271.1999; MAIONE TE, 1991, CANCER RES, V51, P2077; Martin L, 2001, BIOCHEMISTRY-US, V40, P6303, DOI 10.1021/bi002670n; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Murooka TT, 2006, J BIOL CHEM, V281, P25184, DOI 10.1074/jbc.M603912200; Mwapasa V, 2004, AIDS, V18, P1051, DOI 10.1097/00002030-200404300-00014; Mwapasa V, 2006, AIDS, V20, P1869, DOI 10.1097/01.aids.0000244206.41500.27; Pedersen BR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000838; RAZI N, 1995, J BIOL CHEM, V270, P11267, DOI 10.1074/jbc.270.19.11267; Rothman K., 1998, MODERN EPIDEMIOLOGY; Salkowitz JR, 2003, CLIN IMMUNOL, V108, P234, DOI 10.1016/S1521-6616(03)00147-5; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Slimani H, 2003, BBA-BIOMEMBRANES, V1617, P80, DOI 10.1016/j.bbamem.2003.09.006; Slimani H, 2003, GLYCOBIOLOGY, V13, P623, DOI 10.1093/glycob/cwg083; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Ugolini S, 1999, TRENDS MICROBIOL, V7, P144, DOI 10.1016/S0966-842X(99)01474-2; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665	46	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9212	10.1371/journal.pone.0009212	http://dx.doi.org/10.1371/journal.pone.0009212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169157	Green Submitted, Green Published, gold			2022-12-25	WOS:000274474700009
J	Sheldon, IM; Rycroft, AN; Dogan, B; Craven, M; Bromfield, JJ; Chandler, A; Roberts, MH; Price, SB; Gilbert, RO; Simpson, KW				Sheldon, I. Martin; Rycroft, Andrew N.; Dogan, Belgin; Craven, Melanie; Bromfield, John J.; Chandler, Alyssa; Roberts, Mark H.; Price, Sian B.; Gilbert, Robert O.; Simpson, Kenneth W.			Specific Strains of Escherichia coli Are Pathogenic for the Endometrium of Cattle and Cause Pelvic Inflammatory Disease in Cattle and Mice	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; EPITHELIAL-CELLS; URINARY-TRACT; BACTERIAL-CONTAMINATION; GENOTYPIC DIVERSITY; VIRULENCE FACTORS; CROHNS-DISEASE; STROMAL CELLS; DAIRY-COWS; INNATE	Background: Escherichia coli are widespread in the environment and pathogenic strains cause diseases of mucosal surfaces including the female genital tract. Pelvic inflammatory disease (PID; metritis) or endometritis affects similar to 40% of cattle after parturition. We tested the expectation that multiple genetically diverse E. coli from the environment opportunistically contaminate the uterine lumen after parturition to establish PID. Methodology/Principal Findings: Distinct clonal groups of E. coli were identified by Random Amplification of Polymorphic DNA (RAPD) and Multilocus sequence typing (MLST) from animals with uterine disease and these differed from known diarrhoeic or extra-intestinal pathogenic E. coli. The endometrial pathogenic E. coli (EnPEC) were more adherent and invasive for endometrial epithelial and stromal cells, compared with E. coli isolated from the uterus of clinically unaffected animals. The endometrial epithelial and stromal cells produced more prostaglandin E-2 and interleukin-8 in response to lipopolysaccharide (LPS) purified from EnPEC compared with non-pathogenic E. coli. The EnPEC or their LPS also caused PID when infused into the uterus of mice with accumulation of neutrophils and macrophages in the endometrium. Infusion of EnPEC was only associated with bacterial invasion of the endometrium and myometrium. Despite their ability to invade cultured cells, elicit host cell responses and establish PID, EnPEC lacked sixteen genes commonly associated with adhesion and invasion by enteric or extraintestinal pathogenic E. coli, though the ferric yersiniabactin uptake gene (fyuA) was present in PID-associated EnPEC. Endometrial epithelial or stromal cells from wild type but not Toll-like receptor 4 (TLR4) null mice secreted prostaglandin E-2 and chemokine (C-X-C motif) ligand 1 (CXCL1) in response to LPS from EnPEC, highlighting the key role of LPS in PID. Conclusions/Significance: The implication arising from the discovery of EnPEC is that development of treatments or vaccines for PID should focus specifically on EnPEC and not other strains of E. coli.	[Sheldon, I. Martin; Bromfield, John J.; Roberts, Mark H.] Swansea Univ, Sch Med, Inst Life Sci, Swansea, W Glam, Wales; [Rycroft, Andrew N.; Price, Sian B.] Univ London Royal Vet Coll, Hatfield, Herts, England; [Dogan, Belgin; Craven, Melanie; Chandler, Alyssa; Gilbert, Robert O.; Simpson, Kenneth W.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	Swansea University; University of London; University of London Royal Veterinary College; Cornell University	Sheldon, IM (corresponding author), Swansea Univ, Sch Med, Inst Life Sci, Singleton Pk, Swansea, W Glam, Wales.	I.M.Sheldon@swansea.ac.uk	Bromfield, John/A-8830-2014; Sheldon, I Martin/E-1567-2013; Gilbert, Robert/J-9107-2012	Bromfield, John/0000-0001-5438-2137; Sheldon, I Martin/0000-0001-7902-5558; Gilbert, Robert/0000-0002-1528-243X	Biotechnology and Biological Sciences Research Council Research Development Fellowship [BB/D02028X/1]; Biotechnology and Biological Sciences Research Council [S19795, BB/D02028X/1, BB/D02028X/2] Funding Source: researchfish; BBSRC [BB/D02028X/1, BB/D02028X/2] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council Research Development Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk/)Research Development Fellowship (BB/D02028X/1 to I. M. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe CM, 2008, FEMS IMMUNOL MED MIC, V52, P397, DOI 10.1111/j.1574-695X.2008.00388.x; Aisemberg J, 2007, P NATL ACAD SCI USA, V104, P7534, DOI 10.1073/pnas.0702279104; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barrow GI, 1993, COWAN STEEL IS MANUA, V3rd; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Bettelheim KA, 2005, J APPL MICROBIOL, V98, P699, DOI 10.1111/j.1365-2672.2004.02501.x; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Deb Kaushik, 2005, Infect Dis Obstet Gynecol, V13, P125, DOI 10.1080/10647440500147885; Deb Kaushik, 2004, Archives of Gynecology and Obstetrics, V270, P133, DOI 10.1007/s00404-004-0623-0; DebRoy Chitrita, 2001, Animal Health Research Reviews, V2, P129; Dogan B, 2006, VET MICROBIOL, V116, P270, DOI 10.1016/j.vetmic.2006.04.023; Dohmen MJW, 2000, THERIOGENOLOGY, V54, P1019, DOI 10.1016/S0093-691X(00)00410-6; Duncan MJ, 2005, J BIOL CHEM, V280, P37707, DOI 10.1074/jbc.M501249200; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Fahey JV, 2008, MUCOSAL IMMUNOL, V1, P317, DOI 10.1038/mi.2008.20; FORTIER MA, 1988, J REPROD FERTIL, V83, P239, DOI 10.1530/jrf.0.0830239; Grant KS, 2003, BIOL REPROD, V69, P1091, DOI 10.1095/biolreprod.103.015495; Hancock V, 2008, MICROBIOL-SGM, V154, P167, DOI 10.1099/mic.0.2007/011981-0; Herath S, 2006, ENDOCRINOLOGY, V147, P562, DOI 10.1210/en.2005-1113; Herath S, 2009, ENDOCRINOLOGY, V150, P1912, DOI 10.1210/en.2008-1379; Houser BA, 2008, FOODBORNE PATHOG DIS, V5, P41, DOI 10.1089/fpd.2007.0036; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; IRELAND JJ, 1980, J DAIRY SCI, V63, P155, DOI 10.3168/jds.S0022-0302(80)82901-8; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; KIM JJ, 1995, J REPROD FERTIL, V103, P239; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lewis Gregory S, 2003, Reprod Biol Endocrinol, V1, P117; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Moulin-Schouleur M, 2006, J CLIN MICROBIOL, V44, P3484, DOI 10.1128/JCM.00548-06; *NCCLS, NCCLS PERF STAND ANT; POYSER NL, 1987, J REPROD FERTIL, V81, P269, DOI 10.1530/jrf.0.0810269; Rinaldi M, 2008, VET IMMUNOL IMMUNOP, V126, P199, DOI 10.1016/j.vetimm.2008.07.001; Ross JDC, 2002, SEX TRANSM INFECT, V78, P18, DOI 10.1136/sti.78.1.18; Runciman DJ, 2009, AUST VET J, V87, P369, DOI 10.1111/j.1751-0813.2009.00469.x; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; Silva E, 2009, J DAIRY SCI, V92, P6000, DOI 10.3168/jds.2009-2358; Son I, 2009, FOODBORNE PATHOG DIS, V6, P837, DOI 10.1089/fpd.2008.0201; Torres AG, 2005, INFECT IMMUN, V73, P18, DOI 10.1128/IAI.73.1.18-29.2005; WANG G, 1993, NUCLEIC ACIDS RES, V21, P5930, DOI 10.1093/nar/21.25.5930; Wellens A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002040; Williams EJ, 2007, THERIOGENOLOGY, V68, P549, DOI 10.1016/j.theriogenology.2007.04.056; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; Wira CR, 2004, IMMUNOLOGY, V111, P13, DOI 10.1111/j.1365-2567.2004.01796.x; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; Zerbe H, 2003, THERIOGENOLOGY, V60, P209, DOI 10.1016/S0093-691X(02)01376-6	50	199	207	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9192	10.1371/journal.pone.0009192	http://dx.doi.org/10.1371/journal.pone.0009192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169203	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474600013
J	Morine, KJ; Bish, LT; Pendrak, K; Sleeper, MM; Barton, ER; Sweeney, HL				Morine, Kevin J.; Bish, Lawrence T.; Pendrak, Klara; Sleeper, Meg M.; Barton, Elisabeth R.; Sweeney, H. Lee			Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; DUCHENNE MUSCULAR-DYSTROPHY; BETA SUPERFAMILY MEMBER; MDX MICE; DEFICIENT CARDIOMYOPATHY; MURINE MODEL; EXPRESSION; GROWTH; MOUSE; PROPEPTIDE	Background: Myostatin inhibition is a promising therapeutic strategy to maintain muscle mass in a variety of disorders, including the muscular dystrophies, cachexia, and sarcopenia. Previously described approaches to blocking myostatin signaling include injection delivery of inhibitory propeptide domain or neutralizing antibodies. Methodology/Principal Findings: Here we describe a unique method of myostatin inhibition utilizing recombinant adeno-associated virus to overexpress a secretable dominant negative myostatin exclusively in the liver of mice. Systemic myostatin inhibition led to increased skeletal muscle mass and strength in control C57 Bl/6 mice and in the dystrophin-deficient mdx model of Duchenne muscular dystrophy. The mdx soleus, a mouse muscle more representative of human fiber type composition, demonstrated the most profound improvement in force production and a shift toward faster myosin-heavy chain isoforms. Unexpectedly, the 11-month-old mdx diaphragm was not rescued by long-term myostatin inhibition. Further, mdx mice treated for 11 months exhibited cardiac hypertrophy and impaired function in an inhibitor dose-dependent manner. Conclusions/Significance: Liver-targeted gene transfer of a myostatin inhibitor is a valuable tool for preclinical investigation of myostatin blockade and provides novel insights into the long-term effects and shortcomings of myostatin inhibition on striated muscle.	[Morine, Kevin J.; Bish, Lawrence T.; Pendrak, Klara; Sweeney, H. Lee] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Sleeper, Meg M.] Univ Penn, Sch Vet Med, Cardiol Sect, Philadelphia, PA 19104 USA; [Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Morine, KJ (corresponding author), Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	km446@drexel.edu	Sweeney, H Lee/F-1862-2010		Wellstone Muscular Dystrophy Cooperative Center [U54-AR052646]	Wellstone Muscular Dystrophy Cooperative Center	This work was supported by a Wellstone Muscular Dystrophy Cooperative Center Grant (U54-AR052646) to H.L.S.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755; Artaza JN, 2007, J ENDOCRINOL, V194, P63, DOI 10.1677/JOE-07-0072; Bartoli M, 2007, GENE THER, V14, P733, DOI 10.1038/sj.gt.3302928; Barton ER, 2006, AM J PHYSIOL-CELL PH, V290, pC411, DOI 10.1152/ajpcell.00192.2005; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; BISH LT, 2008, HUM GENE THER; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Bogdanovich S, 2008, MUSCLE NERVE, V37, P308, DOI 10.1002/mus.20920; Bostick B, 2008, CIRC RES, V102, P121, DOI 10.1161/CIRCRESAHA.107.162982; Cohn RD, 2007, NEUROMUSCULAR DISORD, V17, P290, DOI 10.1016/j.nmd.2007.01.011; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; Durieux AC, 2007, ENDOCRINOLOGY, V148, P3140, DOI 10.1210/en.2006-1500; Earnshaw JC, 2002, HISTOCHEM CELL BIOL, V118, P19, DOI 10.1007/s00418-002-0428-9; Forbes D, 2006, J CELL PHYSIOL, V206, P264, DOI 10.1002/jcp.20477; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Garg RR, 1999, MOL CELL ENDOCRINOL, V153, P169, DOI 10.1016/S0303-7207(99)00044-1; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Grobet L, 2003, GENESIS, V35, P227, DOI 10.1002/gene.10188; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Harding TC, 2004, GENE THER, V11, P204, DOI 10.1038/sj.gt.3302142; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Huang ZQ, 2007, CELL SIGNAL, V19, P2286, DOI 10.1016/j.cellsig.2007.07.002; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; Lee SJ, 2007, TRENDS GENET, V23, P475, DOI 10.1016/j.tig.2007.08.008; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Li ZF, 2005, AM J PATHOL, V166, P491, DOI 10.1016/S0002-9440(10)62271-7; Li ZB, 2008, J BIOL CHEM, V283, P19371, DOI 10.1074/jbc.M802585200; MARSHALL PA, 1989, MUSCLE NERVE, V12, P528, DOI 10.1002/mus.880120703; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mingozzi F, 2007, BLOOD, V110, P2334, DOI 10.1182/blood-2007-03-080093; Morissette MR, 2009, AM J PHYSIOL-CELL PH, V297, pC1124, DOI 10.1152/ajpcell.00043.2009; Nakatani M, 2008, FASEB J, V22, P477, DOI 10.1096/fj.07-8673com; NIGRO G, 1990, INT J CARDIOL, V26, P271, DOI 10.1016/0167-5273(90)90082-G; Pacak Christina A, 2008, Genet Vaccines Ther, V6, P14, DOI 10.1186/1479-0556-6-14; Parsons SA, 2006, AM J PATHOL, V168, P1975, DOI 10.2353/ajpath.2006.051316; Philip B, 2005, CELL SIGNAL, V17, P365, DOI 10.1016/j.cellsig.2004.08.003; Qiao CP, 2008, HUM GENE THER, V19, P241, DOI 10.1089/hum.2007.159; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Salerno MS, 2004, AM J PHYSIOL-CELL PH, V287, pC1031, DOI 10.1152/ajpcell.00492.2003; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Shimatsu Y, 2003, EXP ANIM TOKYO, V52, P93, DOI 10.1538/expanim.52.93; Shimatsu Yoshiki, 2005, Acta Myol, V24, P145; Shyu KG, 2006, EUR J CLIN INVEST, V36, P713, DOI 10.1111/j.1365-2362.2006.01718.x; Silcocks PB, 1997, HEART, V78, P237, DOI 10.1136/hrt.78.3.237; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Van Erp C, 2006, MUSCLE NERVE, V34, P327, DOI 10.1002/mus.20590; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Wagner KR, 2002, ANN NEUROL, V52, P832, DOI 10.1002/ana.10385; Wagner KR, 2005, P NATL ACAD SCI USA, V102, P2519, DOI 10.1073/pnas.0408729102; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Yang W, 2006, CANCER RES, V66, P1320, DOI 10.1158/0008-5472.CAN-05-3060; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200	62	46	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9176	10.1371/journal.pone.0009176	http://dx.doi.org/10.1371/journal.pone.0009176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161803	Green Published, gold			2022-12-25	WOS:000274442800022
J	Tracht, SM; Del Valle, SY; Hyman, JM				Tracht, Samantha M.; Del Valle, Sara Y.; Hyman, James M.			Mathematical Modeling of the Effectiveness of Facemasks in Reducing the Spread of Novel Influenza A (H1N1)	PLOS ONE			English	Article							FACEPIECE RESPIRATORS; PERFORMANCE; TRANSMISSION	On June 11, 2009, the World Health Organization declared the outbreak of novel influenza A (H1N1) a pandemic. With limited supplies of antivirals and vaccines, countries and individuals are looking at other ways to reduce the spread of pandemic (H1N1) 2009, particularly options that are cost effective and relatively easy to implement. Recent experiences with the 2003 SARS and 2009 H1N1 epidemics have shown that people are willing to wear facemasks to protect themselves against infection; however, little research has been done to quantify the impact of using facemasks in reducing the spread of disease. We construct and analyze a mathematical model for a population in which some people wear facemasks during the pandemic and quantify impact of these masks on the spread of influenza. To estimate the parameter values used for the effectiveness of facemasks, we used available data from studies on N95 respirators and surgical facemasks. The results show that if N95 respirators are only 20% effective in reducing susceptibility and infectivity, only 10% of the population would have to wear them to reduce the number of influenza A (H1N1) cases by 20%. We can conclude from our model that, if worn properly, facemasks are an effective intervention strategy in reducing the spread of pandemic (H1N1) 2009.	[Tracht, Samantha M.; Del Valle, Sara Y.] Los Alamos Natl Lab, Decis Applicat Div, Energy & Infrastruct Anal Grp, Los Alamos, NM USA; [Tracht, Samantha M.] Capital Univ, Dept Math Comp Sci & Phys, Columbus, OH USA; [Hyman, James M.] Los Alamos Natl Lab, Div Theoret, Math Modeling & Anal Grp, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Capital University; United States Department of Energy (DOE); Los Alamos National Laboratory	Tracht, SM (corresponding author), Los Alamos Natl Lab, Decis Applicat Div, Energy & Infrastruct Anal Grp, Los Alamos, NM USA.	samantha.tracht@gmail.com	Hyman, James M/AAF-7389-2020; Del Valle, Sara/AAG-5148-2021	Hyman, James M/0000-0001-5247-5794; Del Valle, Sara/0000-0002-0159-1952	Los Alamos National Security, LLC (LANS) [DE-AC52-06NA25396]; U.S. Department of Energy (DOE)	Los Alamos National Security, LLC (LANS); U.S. Department of Energy (DOE)(United States Department of Energy (DOE))	This research was prepared by Los Alamos National Security, LLC (LANS) under Contract DE-AC52-06NA25396 with the U.S. Department of Energy (DOE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO A, 2008, 48 ANN INT C ANT AG; [Anonymous], INTERIM RECOMMENDATI; [Anonymous], 2009, MORBIDITY MORTALITY, V58, P467; Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; Balazy A, 2006, ANN OCCUP HYG, V50, P259, DOI 10.1093/annhyg/mei058; Balazy A, 2006, AM J INFECT CONTROL, V34, P51, DOI 10.1016/j.ajic.2005.08.018; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Chowell G, 2006, J THEOR BIOL, V241, P193, DOI 10.1016/j.jtbi.2005.11.026; CHOWELL G, 2006, TRANSMISSION CONTROL; Del Valle S, 2005, MATH BIOSCI, V195, P228, DOI 10.1016/j.mbs.2005.03.006; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; Eninger RM, 2008, ANN OCCUP HYG, V52, P385, DOI 10.1093/annhyg/men019; FRASER EA, 2009, SCI EXPRESS, V324, P1557; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Lee SA, 2008, ANN OCCUP HYG, V52, P177, DOI 10.1093/annhyg/men005; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; LO JYC, 2005, EMERGING INFECT DIS, V11; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; MCSHANE L, 2009, DAILY NEWS; Nishiura H, 2009, EUROSURVEILLANCE, V14; PASTEUR S, 2007, DO THEY MAKE INFLUEN; STROUD PD, 2006, EPISIMS LOS ANGELES; Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032; TANG JW, 2009, J ROYAL SOC INTERFAC; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; 2009, GLOBAL ALERT RESPONS; 2009, QUESTIONS ANSWERS RE; 2009, MORBIDITY MORTALITY, V58, P431; 2009, H1N1 FLU; 2009, TEMP SENSOR NEWS; HHS PANDEMIC INFLUEN; 2009, INTERIM GUIDANCE CLI; 2009, NOVEL H1N1 FLU SITUA	35	97	99	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9018	10.1371/journal.pone.0009018	http://dx.doi.org/10.1371/journal.pone.0009018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161764	Green Submitted, Green Published, gold			2022-12-25	WOS:000274442700002
J	Matsuo, R; Kobayashi, S; Murakami, J; Ito, E				Matsuo, Ryota; Kobayashi, Suguru; Murakami, Jun; Ito, Etsuro			Spontaneous Recovery of the Injured Higher Olfactory Center in the Terrestrial Slug Limax	PLOS ONE			English	Article							ADULT NEUROGENESIS; STEM-CELLS; NEURAL PROGENITORS; BULBECTOMIZED RATS; TRAVELING-WAVES; IN-VITRO; MOLLUSK; REGENERATION; PROCEREBRUM; SNAIL	Background: Of all organs and tissues in adult mammals, the brain shows the most limited regeneration and recovery after injury. This is one reason why treating neurological damage such as ischemic injury after stroke presents such a challenge. Here we report a novel mode of regeneration which the slug's cognitive center, the procerebrum, shows after surgical lesioning in the adult. It is well known that the land slug Limax possesses the capacity to demonstrate conditioned food aversion. This learning ability critically depends on the procerebrum, which is the higher olfactory center in the brain of the terrestrial mollusk. Principal Findings: In the present study, after a 1-month recovery period post-surgical lesioning of the procerebrum we investigated whether the brain of the slug shows recovery from damage. We found that learning ability, local field potential oscillation, and the number of cells in the procerebrum (PC) all recovered spontaneously within 1 month of bilateral lesioning of the PC. Moreover, neurogenesis was enhanced in the lesioned PC. However, memory acquired before the surgery could not be retrieved 1 month after surgery although the procerebrum had recovered from injury by this time, consistent with the notion that the procerebrum is the storage site of odor-aversion memory, or deeply involved in the memory recall process. Significance: Our findings are the first to demonstrate that a brain region responsible for the associative memory of an adult organism can spontaneously reconstitute itself, and can recover its function following injury.	[Matsuo, Ryota; Kobayashi, Suguru; Murakami, Jun; Ito, Etsuro] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Kagawa, Japan	Tokushima Bunri University	Matsuo, R (corresponding author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Kagawa, Japan.	matsuor@kph.bunri-u.ac.jp	Kobayashi, Suguru/AAN-9001-2021		Ministry of Education, Culture, Sports, Science, and Technology [17790054]; Japan Society for the Promotion of Science [19370030, 21657022]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding: This study was partly supported by Grants-in-Aid for KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology (No. 17790054 to RM, http://www.mext.go.jp/) and from the Japan Society for the Promotion of Science (No. 19370030 and 21657022 to EI, http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS TW, 1988, TRENDS NEUROSCI, V11, P128, DOI 10.1016/0166-2236(88)90137-3; Agata K, 2008, PHILOS T R SOC B, V363, P2071, DOI 10.1098/rstb.2008.2260; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BUTLER AB, 1984, NEUROSCI LETT, V48, P247, DOI 10.1016/0304-3940(84)90046-6; Chabaud P, 2000, CHEM SENSES, V25, P561, DOI 10.1093/chemse/25.5.561; CHASE R, 1993, MICROSC RES TECHNIQ, V24, P214, DOI 10.1002/jemt.1070240303; CHASE R, 1989, J COMP NEUROL, V283, P143, DOI 10.1002/cne.902830112; CHASE R, 1983, J NEUROBIOL, V14, P43, DOI 10.1002/neu.480140106; Chase R, 2000, MICROSC RES TECHNIQ, V49, P511, DOI 10.1002/1097-0029(20000615)49:6<511::AID-JEMT2>3.0.CO;2-L; EAKIN RM, 1973, J EXP ZOOL, V184, P81, DOI 10.1002/jez.1401840107; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GELPERIN A, 1975, SCIENCE, V189, P567, DOI 10.1126/science.1145215; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; Gelperin A, 1999, J EXP BIOL, V202, P1855; Gheusi G, 2007, CHEM SENSES, V32, P397, DOI 10.1093/chemse/bjm012; GRAZIADEI PPC, 1978, P NATL ACAD SCI USA, V75, P5230, DOI 10.1073/pnas.75.10.5230; Inoue T, 2004, J NEUROPHYSIOL, V91, P372, DOI 10.1152/jn.00247.2003; Inoue T, 2006, J NEUROPHYSIOL, V95, P3898, DOI 10.1152/jn.00853.2005; Kasai Y, 2006, LEARN MEMORY, V13, P482, DOI 10.1101/lm.257606; Kawahara S, 1997, J EXP BIOL, V200, P1851; Kennard MA, 1942, ARCH NEURO PSYCHIATR, V48, P227, DOI 10.1001/archneurpsyc.1942.02290080073002; Kimura T, 1998, LEARN MEMORY, V4, P376, DOI 10.1101/lm.4.5.376; Kimura T, 1998, LEARN MEMORY, V4, P365, DOI 10.1101/lm.4.5.365; Kirschenbaum B, 1999, J NEUROSCI, V19, P2171; KLEINFELD D, 1994, J NEUROPHYSIOL, V72, P1402, DOI 10.1152/jn.1994.72.3.1402; KOLB B, 1993, BEHAV NEUROSCI, V107, P799, DOI 10.1037/0735-7044.107.5.799; Levenson J, 2000, J COMP NEUROL, V423, P121, DOI 10.1002/1096-9861(20000717)423:1<121::AID-CNE10>3.0.CO;2-E; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Matsuo R, 2008, ACTA BIOL HUNG, V59, P73, DOI 10.1556/ABiol.59.2008.Suppl.11; Matsuo R, 2002, NEUROSCI LETT, V334, P201, DOI 10.1016/S0304-3940(02)01089-3; MATSUO R, 2009, NEUROBIOL L IN PRESS; Matsuo R, 2009, J NEUROSCI RES, V87, P3011, DOI 10.1002/jnr.22130; Matsuo R, 2009, BIOCHEM BIOPH RES CO, V386, P724, DOI 10.1016/j.bbrc.2009.06.112; MEREDITH M, 1983, SCIENCE, V222, P1254, DOI 10.1126/science.6648533; MOFFETT SB, 1995, PROG NEUROBIOL, V46, P289, DOI 10.1016/0301-0082(95)00007-I; Myohara M, 1999, DEV GROWTH DIFFER, V41, P549; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nakaya T, 2001, GENES CELLS, V6, P43, DOI 10.1046/j.1365-2443.2001.00397.x; Ravel N, 2003, EUR J NEUROSCI, V17, P350, DOI 10.1046/j.1460-9568.2003.02445.x; SAHLEY C, 1981, P NATL ACAD SCI-BIOL, V78, P640, DOI 10.1073/pnas.78.1.640; Shimozono S, 2001, BRAIN RES, V921, P98, DOI 10.1016/S0006-8993(01)03096-7; Shirahata T, 2006, LEARN MEMORY, V13, P267, DOI 10.1101/lm.133906; Sirko S, 2009, BRAIN, V132, P2252, DOI 10.1093/brain/awp043; Slotnick B, 2004, J NEUROSCI, V24, P9195, DOI 10.1523/JNEUROSCI.1936-04.2004; SNYDER KA, 1990, COMP BIOCHEM PHYS A, V96, P407, DOI 10.1016/0300-9629(90)90104-Z; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Takamori S, 2006, NEUROSCI RES, V55, P343, DOI 10.1016/j.neures.2006.04.016; Watanabe S, 2003, J NEUROSCI, V23, P2932; Watanabe S, 2008, LEARN MEMORY, V15, P633, DOI 10.1101/lm920908; WRIGHT JW, 1982, SCIENCE, V216, P322, DOI 10.1126/science.7063891; Yamagishi M, 2008, J EXP BIOL, V211, P1841, DOI 10.1242/jeb.018028; Zakharov IS, 1998, J NEUROBIOL, V35, P271, DOI 10.1002/(SICI)1097-4695(19980605)35:3<271::AID-NEU4>3.0.CO;2-W; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	56	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9054	10.1371/journal.pone.0009054	http://dx.doi.org/10.1371/journal.pone.0009054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161701	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442500001
J	Zhao, JS; Deng, YH; Manno, D; Hawari, J				Zhao, Jian-Shen; Deng, Yinghai; Manno, Dominic; Hawari, Jalal			Shewanella spp. Genomic Evolution for a Cold Marine Lifestyle and In-Situ Explosive Biodegradation	PLOS ONE			English	Article							OUTER-MEMBRANE CYTOCHROMES; AMINO-ACID-RESIDUES; CENTRAL BALTIC SEA; C-TYPE CYTOCHROME; SP-NOV.; SP. NOV.; ONEIDENSIS MR-1; HEXAHYDRO-1,3,5-TRINITRO-1,3,5-TRIAZINE RDX; EXTRACELLULAR RESPIRATION; LOCAL FLEXIBILITY	Shewanella halifaxensis and Shewanella sediminis were among a few aquatic gamma-proteobacteria that were psychrophiles and the first anaerobic bacteria that degraded hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX). Although many mesophilic or psychrophilic strains of Shewanella and gamma-proteobacteria were sequenced for their genomes, the genomic evolution pathways for temperature adaptation were poorly understood. On the other hand, the genes responsible for anaerobic RDX mineralization pathways remain unknown. To determine the unique genomic properties of bacteria responsible for both cold-adaptation and RDX degradation, the genomes of S. halifaxensis and S. sediminis were sequenced and compared with 108 other gamma-proteobacteria including Shewanella that differ in temperature and Na(+) requirements, as well as RDX degradation capability. Results showed that for coping with marine environments their genomes had extensively exchanged with deep sea bacterial genomes. Many genes for Na(+)-dependent nutrient transporters were recruited to use the high Na(+) content as an energy source. For coping with low temperatures, these two strains as well as other psychrophilic strains of Shewanella and gamma-proteobacteria were found to decrease their genome G+C content and proteome alanine, proline and arginine content (p-value < 0.01) to increase protein structural flexibility. Compared to poorer RDX-degrading strains, S. halifaxensis and S. sediminis have more number of genes for cytochromes and other enzymes related to RDX metabolic pathways. Experimentally, one cytochrome was found induced in S. halifaxensis by RDX when the chemical was the sole terminal electron acceptor. The isolated protein degraded RDX by mono-denitration and was identified as a multiheme 52 kDa cytochrome using a proteomic approach. The present analyses provided the first insight into divergent genomic evolution of bacterial strains for adaptation to the specific cold marine conditions and to the degradation of the pollutant RDX. The present study also provided the first evidence for the involvement of a specific c-type cytochrome in anaerobic RDX metabolism.	[Zhao, Jian-Shen; Deng, Yinghai; Manno, Dominic; Hawari, Jalal] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	National Research Council Canada	Zhao, JS (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	jianszhao@yahoo.ca; jalal.hawari@nrc.ca			University of California; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; Office of Naval Research [N000140610251]; Defense Research and Development Canada, Canada; US SERDP [ER1609];  [Zhao 0180 051115]	University of California(University of California System); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Office of Naval Research(Office of Naval Research); Defense Research and Development Canada, Canada; US SERDP; 	Funding: Genome sequencing and annotation were performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The user agreement number is Zhao 0180 051115 for Dr. Jian-Shen Zhao as a principal collaborator. Financial support was also received from the Office of Naval Research (grant N000140610251) and Defense Research and Development Canada, Canada, and US SERDP (project ER1609). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGAWAMATSUSHITA M, 1992, INT J SYST BACTERIOL, V42, P621, DOI 10.1099/00207713-42-4-621; Beddington J., 2005, MUNITIONS DUMPED SEA; Bhushan B, 2003, APPL ENVIRON MICROB, V69, P1347, DOI 10.1128/AEM.69.3.1347-1351.2003; Bowman JP, 1997, INT J SYST BACTERIOL, V47, P1040, DOI 10.1099/00207713-47-4-1040; Brettar I, 2002, INT J SYST EVOL MICR, V52, P2211, DOI 10.1099/00207713-52-6-2211; Brettar I, 2001, MICROB ECOL, V42, P295, DOI 10.1007/s00248-001-0011-2; BRYANT C, 1991, J BIOL CHEM, V266, P4119; Crocker FH, 2006, APPL MICROBIOL BIOT, V73, P274, DOI 10.1007/s00253-006-0588-y; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darrach MR, 1998, ENVIRON SCI TECHNOL, V32, P1354, DOI 10.1021/es970992h; DEMING JW, 1988, SYST APPL MICROBIOL, V10, P152, DOI 10.1016/S0723-2020(88)80030-4; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Gao HC, 2006, INT J SYST EVOL MICR, V56, P1911, DOI 10.1099/ijs.0.64354-0; GAUTHIER G, 1995, INT J SYST BACTERIOL, V45, P755, DOI 10.1099/00207713-45-4-755; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; Gianese G, 2001, PROTEIN ENG, V14, P141, DOI 10.1093/protein/14.3.141; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Gralnick JA, 2007, MOL MICROBIOL, V65, P1, DOI 10.1111/j.1365-2958.2007.05778.x; Hartshorne RS, 2007, J BIOL INORG CHEM, V12, P1083, DOI 10.1007/s00775-007-0278-y; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Jackson RG, 2007, P NATL ACAD SCI USA, V104, P16822, DOI 10.1073/pnas.0705110104; Jain R, 2003, MOL BIOL EVOL, V20, P1598, DOI 10.1093/molbev/msg154; Keigwin LD, 2003, CLIM DYNAM, V21, P53, DOI 10.1007/s00382-003-0316-6; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kitts CL, 2000, CAN J MICROBIOL, V46, P278, DOI 10.1139/cjm-46-3-278; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwon MJ, 2006, APPL ENVIRON MICROB, V72, P5933, DOI 10.1128/AEM.00660-06; LAUSSERMAIR E, 1989, J BIOL CHEM, V264, P14710; Leiros HKS, 2007, J BIOL CHEM, V282, P21973, DOI 10.1074/jbc.M610174200; Leonardo MR, 1999, INT J SYST BACTERIOL, V49, P1341, DOI 10.1099/00207713-49-4-1341; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Makemson JC, 1997, INT J SYST BACTERIOL, V47, P1034, DOI 10.1099/00207713-47-4-1034; MAKEMSON JC, 1979, APPL ENVIRON MICROB, V38, P178, DOI 10.1128/AEM.38.1.178-180.1979; Marshall MJ, 2006, PLOS BIOL, V4, P1324, DOI 10.1371/journal.pbio.0040268; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Myers CR, 2004, LETT APPL MICROBIOL, V39, P466, DOI 10.1111/j.1472-765X.2004.01611.x; Myers CR, 1997, J BACTERIOL, V179, P1143, DOI 10.1128/jb.179.4.1143-1152.1997; Myers CR, 2003, LETT APPL MICROBIOL, V37, P254, DOI 10.1046/j.1472-765X.2003.01389.x; NEALSON KH, 2005, PROKARYOTES HDB BIOL, V6, P1133; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nogi Y, 1998, EXTREMOPHILES, V2, P1, DOI 10.1007/s007920050036; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Perl D, 2000, NAT STRUCT BIOL, V7, P380; PFENNIG N, 1971, International Journal of Systematic Bacteriology, V21, P19; PICARDAL FW, 1993, APPL ENVIRON MICROB, V59, P3763, DOI 10.1128/AEM.59.11.3763-3770.1993; Robidoux PY, 2000, ENVIRON TOXICOL CHEM, V19, P1764, DOI [10.1002/etc.5620190709, 10.1897/1551-5028(2000)019&lt;1764:CTOECI&gt;2.3.CO;2]; ROSEMOND ZA, 1998, TOXICOLOGICAL PROFIL; ROSENBERG IM, 1996, PROTEIN ANAL PURIFIC; Schleheck D, 2004, INT J SYST EVOL MICR, V54, P1489, DOI 10.1099/ijs.0.03020-0; Shi L, 2008, J BACTERIOL, V190, P5512, DOI 10.1128/JB.00514-08; Simonson AB, 2005, P NATL ACAD SCI USA, V102, P6608, DOI 10.1073/pnas.0501996102; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Talmage Sylvia S., 1999, Reviews of Environmental Contamination and Toxicology, V161, P1; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; *USEPA, 2000, EPA505R0001 OFF SOL; Venkateswaran K, 1998, INT J SYST BACTERIOL, V48, P965, DOI 10.1099/00207713-48-3-965; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; WATANABE K, 1991, J BIOL CHEM, V266, P24287; Wiebe CA, 2001, BIOCHEM J, V357, P1, DOI 10.1042/0264-6021:3570001; Williams RE, 2004, APPL ENVIRON MICROB, V70, P3566, DOI 10.1128/AEM.70.6.3566-3574.2004; Xiong YJ, 2006, J AM CHEM SOC, V128, P13978, DOI 10.1021/ja063526d; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yang H, 2009, J APPL MICROBIOL, V107, P1799, DOI 10.1111/j.1365-2672.2009.04366.x; Zhao JS, 2008, MICROBIOL-SGM, V154, P1026, DOI 10.1099/mic.0.2007/013409-0; Zhao JS, 2006, INT J SYST EVOL MICR, V56, P205, DOI 10.1099/ijs.0.63829-0; Zhao JS, 2005, INT J SYST EVOL MICR, V55, P1511, DOI 10.1099/ijs.0.63604-0; Zhao JS, 2004, FEMS MICROBIOL ECOL, V49, P349, DOI 10.1016/j.femsec.2004.04.008; Zhu GP, 1999, PROTEIN ENG, V12, P635, DOI 10.1093/protein/12.8.635	71	44	46	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9109	10.1371/journal.pone.0009109	http://dx.doi.org/10.1371/journal.pone.0009109			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20174598	Green Published, gold, Green Accepted			2022-12-25	WOS:000274442500015
J	Bromer, JG; Zhou, YP; Taylor, MB; Doherty, L; Taylor, HS				Bromer, Jason G.; Zhou, Yuping; Taylor, Melissa B.; Doherty, Leo; Taylor, Hugh S.			Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response	FASEB JOURNAL			English	Article						BPA; DNA methylation; HOXA10/Hoxa10; epigenetics; developmental programming	DNA METHYLATION; GENE-EXPRESSION; HOX GENES; DIETHYLSTILBESTROL DES; PROMOTER METHYLATION; ABERRANT EXPRESSION; HOMEOBOX GENE; CANCER; ENDOMETRIOSIS; IMPLANTATION	Bisphenol-A (BPA) is a nonsteroidal estrogen that is ubiquitous in the environment. The homeobox gene Hoxa10 controls uterine organogenesis, and its expression is affected by in utero BPA exposure. We hypothesized that an epigenetic mechanism underlies BPA-mediated alterations in Hoxa10 expression. We analyzed the expression pattern and methylation profile of Hoxa10 after in utero BPA exposure. Pregnant CD-1 mice were treated with BPA (5 mg/kg IP) or vehicle control on d 9-16 of pregnancy. Hoxa10 mRNA and protein expression were increased by 25% in the reproductive tract of mice exposed in utero. Bisulfite sequencing revealed that cytosine-guanine dinucleotide methylation was decreased from 67 to 14% in the promoter and from 71 to 3% in the intron of Hoxa10 after in utero BPA exposure. Decreased DNA methylation led to an increase in binding of ER-alpha to the Hoxa10 ERE both in vitro as and in vivo as determined by EMSA and chromatin immunoprecipitation, respectively. Diminished methylation of the ERE-containing promoter sequence resulted in an increase in ERE-driven gene expression in reporter assays. We identify altered methylation as a novel mechanism of BPA-induced altered developmental programming. Permanent epigenetic alteration of ERE sensitivity to estrogen may be a general mechanism through which endocrine disruptors exert their action.-Bromer, J. G., Zhou, Y., Taylor, M. B., Doherty, L., Taylor, H. S.. Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB J. 24, 2273-2280 (2010). www.fasebj.org	[Bromer, Jason G.; Zhou, Yuping; Taylor, Melissa B.; Doherty, Leo; Taylor, Hugh S.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA	Yale University	Taylor, HS (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, 333 Cedar St,POB 208068, New Haven, CT 06520 USA.	hugh.taylor@yale.edu			U.S. National Institutes of Health [ES10610, HD052668]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD052668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010610] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Hongling Du for technical advice and assistance. This research was supported by U.S. National Institutes of Health grants ES10610 and HD052668.	Akbas GE, 2004, J MOL BIOL, V340, P1013, DOI 10.1016/j.jmb.2004.05.052; Ballestar E, 2003, EMBO J, V22, P6335, DOI 10.1093/emboj/cdg604; Block K, 2000, FASEB J, V14, P1101, DOI 10.1096/fasebj.14.9.1101; Bromer JG, 2009, ENDOCRINOLOGY, V150, P3376, DOI 10.1210/en.2009-0071; BROTONS JA, 1995, ENVIRON HEALTH PERSP, V103, P608, DOI 10.2307/3432439; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; Chu MC, 2004, CANCER BIOL THER, V3, P568, DOI 10.4161/cbt.3.6.848; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Daftary GS, 2000, SEMIN REPROD MED, V18, P311, DOI 10.1055/s-2000-12568; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Du HL, 2004, ANN NY ACAD SCI, V1034, P152, DOI 10.1196/annals.1335.018; Enokida H, 2005, CLIN CANCER RES, V11, P6582, DOI 10.1158/1078-0432.CCR-05-0658; Greathouse KL, 2008, REPROD SCI, V15, P765, DOI 10.1177/1933719108322440; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Issa JP, 2002, J NUTR, V132, p2388S, DOI 10.1093/jn/132.8.2388S; Kwon HE, 2004, ANN NY ACAD SCI, V1034, P1, DOI 10.1196/annals.1335.001; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lee B, 2009, BIOL REPROD, V80, P79, DOI 10.1095/biolreprod.108.070391; Lee TS, 2006, ANN NY ACAD SCI, V1091, P218, DOI 10.1196/annals.1378.068; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033; Markey CM, 2001, BIOL REPROD, V65, P1215, DOI 10.1093/biolreprod/65.4.1215; Martin R, 2007, J CLIN ENDOCR METAB, V92, P1920, DOI 10.1210/jc.2006-1694; Morrison AG, 2003, DOMEST ANIM ENDOCRIN, V25, P329, DOI 10.1016/j.domaniend.2003.06.004; Mountfort KA, 1997, FOOD ADDIT CONTAM, V14, P737, DOI 10.1080/02652039709374584; Newell-Price J, 2000, TRENDS ENDOCRIN MET, V11, P142, DOI 10.1016/S1043-2760(00)00248-4; Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Sakuma M, 2007, CANCER SCI, V98, P380, DOI 10.1111/j.1349-7006.2007.00394.x; Sheehan DM, 2000, P SOC EXP BIOL MED, V224, P57, DOI 10.1046/j.1525-1373.2000.22401.x; Smith CC, 2007, FASEB J, V21, P239, DOI 10.1096/fj.06-6635com; Takahashi O, 2000, ENVIRON HEALTH PERSP, V108, P931, DOI 10.2307/3435050; Taylor HS, 1998, J CLIN INVEST, V101, P1379, DOI 10.1172/JCI1057; Whitcomb BP, 2003, CLIN CANCER RES, V9, P2277; Wu Y, 2005, AM J OBSTET GYNECOL, V193, P371, DOI 10.1016/j.ajog.2005.01.034; Wu Y, 2007, FERTIL STERIL, V87, P24, DOI 10.1016/j.fertnstert.2006.05.077; Yoshida HY, 2006, CANCER RES, V66, P889, DOI 10.1158/0008-5472.CAN-05-2828	39	196	213	0	40	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2273	2280		10.1096/fj.09-140533	http://dx.doi.org/10.1096/fj.09-140533			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20181937	Green Published			2022-12-25	WOS:000279343600014
J	Gitik, M; Reichert, F; Rotshenker, S				Gitik, Miri; Reichert, Fanny; Rotshenker, Shlomo			Cytoskeleton plays a dual role of activation and inhibition in myelin and zymosan phagocytosis by microglia	FASEB JOURNAL			English	Article						Wallerian degeneration; axonal injury; complement receptor-3; actin; myosin	PERIPHERAL-NERVE INJURY; FC-GAMMA-R; SCAVENGER-RECEPTOR; WALLERIAN DEGENERATION; MEDIATED PHAGOCYTOSIS; APOPTOTIC CELLS; DISTINCT ROLES; STRESS FIBERS; SPINAL-CORD; RHO GTPASES	A major innate immune function of microglia in the central nervous system is receptor-mediated phagocytosis of tissue debris and pathogens. We studied how phagocytosis of degenerated myelin (i.e., tissue debris) and zymosan (i.e., yeast pathogen) is regulated by the cytoskeleton through myosin light chain kinase (MLCK) and the small GTPase Rho and its effector Rho-kinase (ROCK) in primary mouse microglia. Our observations suggest a dual role of activation and inhibition of phagocytosis by MLCK and Rho/ROCK signaling. MLCK activated, whereas Rho/ROCK down-regulated complement receptor-3 (CR3) mediated, phagocytosis of C3bi-opsonized and nonopsonized myelin. These opposing roles of MLCK and Rho/ROCK depended on the preferential spatial localization of their distinctive functions. MLCK further activated, and Rho/ROCK down-regulated, phagocytosis of nonopsonized zymosan by nonopsonic receptors (e. g., Dectin-1). In contrast, MLCK down-regulated, but Rho/ROCK activated, CR3-mediated phagocytosis of C3bi-opsonized zymosan. Thus MLCK and Rho/ROCK can each activate or inhibit phagocytosis but always act in opposition. Whether activation or inhibition occurs depends on the nature of the phagocytosed particle (C3bi-opsonized or nonopsonized myelin or zymosan) and the receptors mediating each phagocytosis.-Gitik, M., Reichert, F., Rotshenker, S. Cytoskeleton plays a dual role of activation and inhibition in myelin and zymosan phagocytosis by microglia. FASEB J. 24, 2211-2221 (2010). www.fasebj.org	[Rotshenker, Shlomo] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Med Neurobiol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel; Eric Roland Ctr Neurodegenerat Dis, Jerusalem, Israel	Hebrew University of Jerusalem	Rotshenker, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Med Neurobiol, Inst Med Res Israel Canada, POB 12272, IL-91120 Jerusalem, Israel.	shlomor@ekmd.huji.ac.il			Israel Science Foundation [11/06]	Israel Science Foundation(Israel Science Foundation)	This study was supported by the Israel Science Foundation (grant 11/06 to S. R.). The authors thank Dr. Carlo Laudana (University of Verona, Verona, Italy) for providing cell-permeable fusion protein P1(75-92).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Be'eri M, 1998, EUR J NEUROSCI, V10, P2707; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; Cohen G, 2006, GLIA, V53, P538, DOI 10.1002/glia.20304; da Costa CC, 1997, EUR J NEUROSCI, V9, P2650, DOI 10.1111/j.1460-9568.1997.tb01694.x; Dewitt S, 2006, J CELL SCI, V119, P443, DOI 10.1242/jcs.02756; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; GIAIMIS J, 1993, J LEUKOCYTE BIOL, V54, P564, DOI 10.1002/jlb.54.6.564; GRIFFIN JW, 1992, J NEUROIMMUNOL, V40, P153, DOI 10.1016/0165-5728(92)90129-9; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hannila SS, 2007, INT REV NEUROBIOL, V77, P57, DOI 10.1016/S0074-7742(06)77003-9; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; KAPLAN G, 1977, SCAND J IMMUNOL, V6, P797, DOI 10.1111/j.1365-3083.1977.tb02153.x; Kuhlmann T, 2002, J NEUROSCI RES, V67, P185, DOI 10.1002/jnr.10104; LE CV, 2002, J IMMUNOL, V169, P2003; Lukas TJ, 1999, J MED CHEM, V42, P910, DOI 10.1021/jm980573a; McKerracher L, 2006, J NEUROTRAUM, V23, P309, DOI 10.1089/neu.2006.23.309; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; REICHERT F, 1994, J NEUROSCI, V14, P3231; Reichert F, 2003, NEUROBIOL DIS, V12, P65, DOI 10.1016/S0969-9961(02)00008-6; Reichert F, 1996, J NEUROIMMUNOL, V70, P153, DOI 10.1016/S0165-5728(96)00112-9; Reichert F, 2001, NEUROBIOL DIS, V8, P504, DOI 10.1006/nbdi.2001.0383; Reichert F, 1999, EXP NEUROL, V160, P508, DOI 10.1006/exnr.1999.7229; RIOHORTEGA P, 1932, CYTOLOGY CELLULAR PA, P481; Rotshenker S, 2003, J MOL NEUROSCI, V21, P65, DOI 10.1385/JMN:21:1:65; Rotshenker S., 2007, ENCY PAIN, P2659; Rotshenker S, 2009, J MOL NEUROSCI, V39, P99, DOI 10.1007/s12031-009-9186-7; SCHENKEIN HA, 1981, J IMMUNOL, V126, P7; Slobodov U, 2001, EXP NEUROL, V167, P401, DOI 10.1006/exnr.2000.7559; SPEERT DP, 1985, J LEUKOCYTE BIOL, V38, P655, DOI 10.1002/jlb.38.5.655; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tosello-Trampont AC, 2003, J BIOL CHEM, V278, P49911, DOI 10.1074/jbc.M306079200; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; vanderLaan LJW, 1996, J NEUROIMMUNOL, V70, P145, DOI 10.1016/S0165-5728(96)00110-5; VANGURI P, 1982, P NATL ACAD SCI-BIOL, V79, P3290, DOI 10.1073/pnas.79.10.3290; Xia Y, 1999, J IMMUNOL, V162, P2281	47	29	30	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2211	2221		10.1096/fj.09-146118	http://dx.doi.org/10.1096/fj.09-146118			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20179145				2022-12-25	WOS:000279343600008
J	Sierra, MI; Wright, MH; Nash, PD				Sierra, Maria I.; Wright, Michelle H.; Nash, Piers D.			AMSH Interacts with ESCRT-0 to Regulate the Stability and Trafficking of CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; UBIQUITIN ISOPEPTIDASE; DOWN-REGULATION; SH3 DOMAIN; FLUORESCENCE COMPLEMENTATION; MEMBRANE TRAFFICKING; SIGNAL-TRANSDUCTION; PROGENITOR CELLS; STRUCTURAL BASIS; CHEMOKINE SDF-1	Reversible ubiquitination is essential for the endocytic sorting and down-regulation of G protein-coupled receptors, such as the chemokine receptor CXCR4. The deubiquitinating enzyme AMSH has been implicated in the endocytic sorting of both G protein-coupled receptors and receptor-tyrosine kinases. Herein, we examine the role of AMSH in the regulation of CXCR4 stability and trafficking and characterize protein-protein interactions critical for this function. Loss of AMSH catalytic activity or depletion by RNAi results in increased steady-state levels of CXCR4 under basal conditions. Analysis of truncation and point mutation of AMSH reveal the importance of an RXXK motif for CXCR4 degradation. The RXXK motif of AMSH interacts with the SH3 domains of the STAM and Grb2 families of adaptor proteins with high affinity. Cells expressing a catalytically inactive mutant of AMSH show basal hyperubiquitination, but not increased degradation, of the ESCRT-0 components STAM1 and Hrs. This is dependent on the RXXK motif of AMSH. Ubiquitination of endocytic machinery modulates their activity, suggesting that AMSH may directly regulate endocytic adaptor protein function. This is reflected in CXCR4 trafficking and provides a mechanism by which AMSH specifies the fate of endocytosed receptors. Taken together, these studies implicate AMSH as a key modulator of receptor fate determination through its action on components of the endocytic machinery.	[Sierra, Maria I.; Wright, Michelle H.; Nash, Piers D.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Chicago	Nash, PD (corresponding author), 929 E 57th St,W432, Chicago, IL 60637 USA.	pdnash@uchicago.edu			Leukemia Research Foundation; Edward Mallinckrodt, Jr. Foundation; Concern Foundation; National Institutes of Health [T32HL07237, F31AI073227]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI073227] Funding Source: NIH RePORTER	Leukemia Research Foundation; Edward Mallinckrodt, Jr. Foundation; Concern Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This was work was supported by grants from the Leukemia Research Foundation, the Edward Mallinckrodt, Jr. Foundation, and a Concern Foundation CONquer canCER Now Award (to P. D. N.).; Supported by National Institutes of Health Grants T32HL07237 and F31AI073227.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Diaz GA, 2005, IMMUNOL REV, V203, P235, DOI 10.1111/j.0105-2896.2005.00226.x; Diaz GA, 2005, CURR ALLERGY ASTHM R, V5, P350, DOI 10.1007/s11882-005-0005-0; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Futahashi Y, 2007, CANCER SCI, V98, P373, DOI 10.1111/j.1349-7006.2007.00388.x; Gulino AV, 2003, CURR OPIN ALLERGY CL, V3, P443, DOI 10.1097/01.all.0000104449.09202.d8; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harkiolaki M, 2003, EMBO J, V22, P2571, DOI 10.1093/emboj/cdg258; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Herrera-Vigenor F, 2006, BIOCHEM BIOPH RES CO, V347, P924, DOI 10.1016/j.bbrc.2006.06.169; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Holler D, 2004, BIOCHEM PHARMACOL, V67, P1013, DOI 10.1016/j.bcp.2004.01.003; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kikuchi K, 2003, BIOCHEM BIOPH RES CO, V306, P637, DOI 10.1016/S0006-291X(03)01009-X; Kim MS, 2006, BIOCHEM BIOPH RES CO, V351, P612, DOI 10.1016/j.bbrc.2006.10.068; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Komada Masayuki, 2008, Curr Drug Discov Technol, V5, P78, DOI 10.2174/157016308783769469; Kyuuma M, 2006, CELL STRUCT FUNCT, V31, P159, DOI 10.1247/csf.06023; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; Ma YM, 2007, J BIOL CHEM, V282, P9805, DOI 10.1074/jbc.M611635200; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mines MA, 2009, J BIOL CHEM, V284, P5742, DOI 10.1074/jbc.M808507200; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakamura M, 2006, GENES CELLS, V11, P593, DOI 10.1111/j.1365-2443.2006.00963.x; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Raiborg C, 2002, CELL STRUCT FUNCT, V27, P403, DOI 10.1247/csf.27.403; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rasband W. S., 1997, IMAGEJ SOFTWARE; Reyes-Ibarra AP, 2007, MOL ENDOCRINOL, V21, P1394, DOI 10.1210/me.2006-0523; Roland J, 2003, BLOOD, V101, P399, DOI 10.1182/blood-2002-03-0978; Row PE, 2007, J BIOL CHEM, V282, P30929, DOI 10.1074/jbc.M704009200; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Song L, 2008, CURR OPIN CELL BIOL, V20, P156, DOI 10.1016/j.ceb.2008.01.012; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tanaka N, 1999, J BIOL CHEM, V274, P19129, DOI 10.1074/jbc.274.27.19129; Tsang HTH, 2006, GENOMICS, V88, P333, DOI 10.1016/j.ygeno.2006.04.003; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; Urbe S, 2006, BIOCHEM SOC T, V34, P754, DOI 10.1042/BST0340754; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wojcik Cezary, 2002, Trends Cell Biol, V12, P549, DOI 10.1016/S0962-8924(02)02398-X; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	69	53	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13990	14004		10.1074/jbc.M109.061309	http://dx.doi.org/10.1074/jbc.M109.061309			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20159979	Green Published, hybrid			2022-12-25	WOS:000276987700073
J	Arenas, I; Bravo, A; Soberon, M; Gomez, I				Arenas, Ivan; Bravo, Alejandra; Soberon, Mario; Gomez, Isabel			Role of Alkaline Phosphatase from Manduca sexta in the Mechanism of Action of Bacillus thuringiensis Cry1Ab Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; AMINOPEPTIDASE-N-RECEPTOR; OLIGOMERIC PRE-PORE; DELTA-ENDOTOXIN; DOMAIN-II; HELIOTHIS-VIRESCENS; BINDING-PROTEINS; LYMANTRIA-DISPAR; LARVAL MIDGUT; CYT TOXINS	Cry toxins produced by Bacillus thuringiensis have been recognized as pore-forming toxins whose primary action is to lyse midgut epithelial cells in their target insect. In the case of the Cry1A toxins, a prepore oligomeric intermediate is formed after interaction with cadherin receptor. The Cry1A oligomer then interacts with glycosylphosphatidylinositol-anchored receptors. Two Manduca sexta glycosylphosphatidylinositol-anchored proteins, aminopeptidase (APN) and alkaline phosphatase (ALP), have been shown to bind Cry1Ab, although their role in toxicity remains to be determined. Detection of Cry1Ab binding proteins by ligand blot assay revealed that ALP is preferentially expressed earlier during insect development, because it was found in the first larval instars, whereas APN is induced later after the third larval instar. The binding of Cry1Ab oligomer to pure preparations of APN and ALP showed that this toxin structure interacts with both receptors with high affinity (apparent K-d = 0.6 nM), whereas the monomer showed weaker binding (apparent K-d = 101.6 and 267.3 nM for APN and ALP, respectively). Several Cry1Ab nontoxic mutants located in the exposed loop 2 of domain II or in beta-16 of domain III were affected in binding to APN and ALP, depending on their oligomeric state. In particular monomers of the nontoxic domain III, the L511A mutant did not bind ALP but retained APN binding, suggesting that initial interaction with ALP is critical for toxicity. Our data suggest that APN and ALP fulfill two roles. First APN and ALP are initial receptors promoting the localization of toxin monomers in the midgut microvilli before interaction with cadherin. Then APN and ALP function as secondary receptors mediating oligomer insertion into the membrane. However, the expression pattern of these receptors and the phenotype of L511A mutant suggest that ALP may have a predominant role in toxin action because Cry toxins are highly effective against the neonate larvae that is the target for pest control programs.	[Arenas, Ivan; Bravo, Alejandra; Soberon, Mario; Gomez, Isabel] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Gomez, I (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62250, Morelos, Mexico.	isabelg@ibt.unam.mx	de la Parra, Maria Alejandra Bravo/R-6740-2017	Bravo, Alejandra/0000-0002-7573-7475; ARENAS, IVAN/0000-0003-0384-7437	National Institutes of Health [1R01 AI066014]; Consejo Nacional de Ciencia y Tecnologia [83135, 81639]; Direccion General de Asuntos del Personal Academico-UNAM [IN218608, IN210208]; United States Department of Agriculture [2207-35607-17780]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico-UNAM(Universidad Nacional Autonoma de Mexico); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01 AI066014. This work was also supported by Consejo Nacional de Ciencia y Tecnologia Grants 83135 and 81639, Direccion General de Asuntos del Personal Academico-UNAM Grants IN218608 and IN210208, and United States Department of Agriculture Grant 2207-35607-17780.	Asgeirsson B, 2007, BBA-PROTEINS PROTEOM, V1774, P679, DOI 10.1016/j.bbapap.2007.03.016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Bravo A, 2002, BBA-BIOMEMBRANES, V1562, P63, DOI 10.1016/S0005-2736(02)00360-7; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Chen J, 2005, CELL TISSUE RES, V321, P123, DOI 10.1007/s00441-005-1124-6; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; Gazit E, 1998, P NATL ACAD SCI USA, V95, P12289, DOI 10.1073/pnas.95.21.12289; Gill M, 2002, INSECT MOL BIOL, V11, P619, DOI 10.1046/j.1365-2583.2002.00373.x; Gomez I, 2007, PEPTIDES, V28, P169, DOI 10.1016/j.peptides.2006.06.013; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Griko N, 2008, COMP BIOCHEM PHYS B, V151, P59, DOI 10.1016/j.cbpb.2008.05.016; GROCHULSKI P, 1995, J MOL BIOL, V254, P447, DOI 10.1006/jmbi.1995.0630; Guo SY, 2009, J STRUCT BIOL, V168, P259, DOI 10.1016/j.jsb.2009.07.004; Herrero S, 2004, BIOCHEM J, V384, P507, DOI 10.1042/BJ20041094; Jenkins J L, 2000, Genet Eng (N Y), V22, P33; Jenkins JL, 1999, FEBS LETT, V462, P373, DOI 10.1016/S0014-5793(99)01559-8; Jenkins JL, 2000, J BIOL CHEM, V275, P14423, DOI 10.1074/jbc.275.19.14423; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Jurat-Fuentes JL, 2006, J INVERTEBR PATHOL, V92, P166, DOI 10.1016/j.jip.2006.01.010; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; Krishnamoorthy M, 2007, INSECT BIOCHEM MOLEC, V37, P189, DOI 10.1016/j.ibmb.2006.10.004; LANDT M, 1978, BIOCHEMISTRY-US, V17, P915, DOI 10.1021/bi00598a027; Lee MK, 2000, MOL MICROBIOL, V38, P289, DOI 10.1046/j.1365-2958.2000.02109.x; LERECLUS D, 1989, FEMS MICROBIOL LETT, V60, P211, DOI 10.1016/0378-1097(89)90511-9; McNall RJ, 2003, INSECT BIOCHEM MOLEC, V33, P999, DOI 10.1016/S0965-1748(03)00114-0; Nair MS, 2008, BIOCHEMISTRY-US, V47, P5814, DOI 10.1021/bi7014234; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Pacheco S, 2009, PEPTIDES, V30, P583, DOI 10.1016/j.peptides.2008.08.006; Pardo-Lopez L, 2006, BIOCHEMISTRY-US, V45, P10329, DOI 10.1021/bi060297z; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rajamohan F, 1998, PROG NUCLEIC ACID RE, V60, P1, DOI 10.1016/S0079-6603(08)60887-9; Rausell C, 2004, J BIOL CHEM, V279, P55168, DOI 10.1074/jbc.M406279200; Rodriguez-Almazan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005545; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schwartz JL, 1997, FEBS LETT, V412, P270, DOI 10.1016/S0014-5793(97)00801-6; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Valaitis AP, 1995, INSECT BIOCHEM MOLEC, V25, P1143, DOI 10.1016/0965-1748(95)00050-X; WOLFERSBERGER MG, 1993, ARCH INSECT BIOCHEM, V24, P139, DOI 10.1002/arch.940240304; You Taek H, 2008, BMC Biochem, V9, P3, DOI 10.1186/1471-2091-9-3; Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200	43	130	148	1	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12497	12503		10.1074/jbc.M109.085266	http://dx.doi.org/10.1074/jbc.M109.085266			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177063	Green Published, hybrid			2022-12-25	WOS:000276787800006
J	Heneberg, P; Draberova, L; Bambouskova, M; Pompach, P; Draber, P				Heneberg, Petr; Draberova, Lubica; Bambouskova, Monika; Pompach, Petr; Draber, Petr			Down-regulation of Protein-tyrosine Phosphatases Activates an Immune Receptor in the Absence of Its Translocation into Lipid Rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; AFFINITY IGE RECEPTOR; DETERGENT-RESISTANT MEMBRANES; OXYGEN SPECIES GENERATION; MAST-CELL DEGRANULATION; REACTIVE OXYGEN; NEGATIVE REGULATION; IMMUNOGLOBULIN-E; REDOX REGULATION; SIGNAL-TRANSDUCTION	The earliest known biochemical step that occurs after ligand binding to the multichain immune recognition receptor is tyrosine phosphorylation of the receptor subunits. In mast cells and basophils activated by multivalent antigen-IgE complexes, this step is mediated by Src family kinase Lyn, which phosphorylates the high affinity IgE receptor (Fc epsilon RI). However, the exact molecular mechanism of this phosphorylation step is incompletely understood. In this study, we tested the hypothesis that changes in activity and/ or topography of protein-tyrosine phosphatases (PTPs) could play a major role in the Fc epsilon RI triggering. We found that exposure of rat basophilic leukemia cells or mouse bone marrow-derived mast cells to PTP inhibitors, H2O2 or pervanadate, induced phosphorylation of the Fc epsilon RI subunits, similarly as Fc epsilon RI triggering. Interestingly, and in sharp contrast to antigen-induced activation, neither H2O2 nor pervanadate induced any changes in the association of Fc epsilon RI with detergent-resistant membranes and in the topography of Fc epsilon RI detectable by electron microscopy on isolated plasma membrane sheets. In cells stimulated with pervanadate, H2O2 or antigen, enhanced oxidation of active site cysteine of several PTPs was detected. Unexpectedly, most of oxidized phosphatases bound to the plasma membrane were associated with the actin cytoskeleton. Several PTPs (SHP-1, SHP-2, hematopoietic PTP, and PTP-MEG2) showed changes in their enzymatic activity and/or oxidation state during activation. Based on these and other data, we propose that down-regulation of enzymatic activity of PTPs and/or changes in their accessibility to the substrates play a key role in initial tyrosine phosphorylation of the Fc epsilon RI and other multichain immune receptors.	[Heneberg, Petr; Draberova, Lubica; Bambouskova, Monika; Draber, Petr] Acad Sci Czech Republ, Lab Signal Transduct, Inst Mol Genet, CZ-14220 Prague 4, Czech Republic; [Pompach, Petr] Acad Sci Czech Republ, Inst Microbiol, CZ-14220 Prague 4, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Draber, P (corresponding author), Acad Sci Czech Republ, Lab Signal Transduct, Inst Mol Genet, Videnska 1083, CZ-14220 Prague 4, Czech Republic.	draberpe@img.cas.cz	Draber, Petr/G-3412-2014; Heneberg, Petr/C-1881-2012; Draberova, Lubica/G-3505-2014; Pompach, Petr/J-6209-2014; Draber, Petr/E-1119-2018	Draber, Petr/0000-0002-3986-2025; Heneberg, Petr/0000-0002-0703-951X; Draberova, Lubica/0000-0002-2459-4435; Pompach, Petr/0000-0002-0606-0851; Draber, Petr/0000-0002-3986-2025	Grant Agency of the Czech Republic [301/09/1826, P302/10/1759]; Center of Molecular and Cellular Immunology [1M0506]; Ministry of Education, Youth, and Sports of the Czech Republic [LC-545, 1M0505]; Academy of Sciences of the Czech Republic [KAN200520701, M200520901]; Institutional Project [AVOZ50520514]; 3rd Faculty of Medicine [MSM0021620814]; Charles University; Prague; Canadian Institute of Health	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Center of Molecular and Cellular Immunology; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Institutional Project; 3rd Faculty of Medicine; Charles University; Prague; Canadian Institute of Health(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Projects 301/09/1826 and P302/10/1759 from Grant Agency of the Czech Republic, Center of Molecular and Cellular Immunology 1M0506, Projects LC-545 and 1M0505 from the Ministry of Education, Youth, and Sports of the Czech Republic, Grants KAN200520701 and M200520901 from the Academy of Sciences of the Czech Republic, and Institutional Project AVOZ50520514.; Supported by Research Goal MSM0021620814 from the 3rd Faculty of Medicine, Charles University, Prague, Czech Republic, and by a Canadian Institute of Health Research fellowship.	Amoui M, 1997, EUR J IMMUNOL, V27, P321, DOI 10.1002/eji.1830270146; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0; Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Chen CH, 2006, MOL PHARMACOL, V69, P1347, DOI 10.1124/mol.105.017558; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; den Hertog J, 2005, ARCH BIOCHEM BIOPHYS, V434, P11, DOI 10.1016/j.abb.2004.05.024; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Draber P, 2007, CELL SIGNAL, V19, P2400, DOI 10.1016/j.cellsig.2007.07.018; Draberova L, 2004, EUR J IMMUNOL, V34, P2209, DOI 10.1002/eji.200322663; Draberova L, 2003, J IMMUNOL, V171, P3585, DOI 10.4049/jimmunol.171.7.3585; Draberova L, 1996, IMMUNOLOGY, V87, P141; EISEMAN E, 1992, NATURE, V355, P78; Field KA, 1999, J BIOL CHEM, V274, P1753, DOI 10.1074/jbc.274.3.1753; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gulati P, 2004, EMBO REP, V5, P812, DOI 10.1038/sj.embor.7400190; HEFFETZ D, 1990, J BIOL CHEM, V265, P2896; Heneberg P, 2002, INT ARCH ALLERGY IMM, V128, P253, DOI 10.1159/000063864; Heneberg P, 2005, CURR MED CHEM, V12, P1859, DOI 10.2174/0929867054546636; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Keilhack H, 2001, J CELL BIOL, V152, P325, DOI 10.1083/jcb.152.2.325; Kimura T, 1997, J IMMUNOL, V159, P4426; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; LACHAPELLE M, 1988, J HISTOCHEM CYTOCHEM, V36, P1197, DOI 10.1177/36.9.3403970; Lebduska P, 2007, J IMMUNOL METHODS, V328, P139, DOI 10.1016/j.jim.2007.08.015; LIU FT, 1980, J IMMUNOL, V124, P2728; Lou YW, 2008, FEBS J, V275, P69, DOI 10.1111/j.1742-4658.2007.06173.x; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mikalsen SO, 1998, J BIOL CHEM, V273, P10036, DOI 10.1074/jbc.273.16.10036; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nakata K, 2008, J IMMUNOL, V181, P5414, DOI 10.4049/jimmunol.181.8.5414; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Peirce M, 2000, J BIOL CHEM, V275, P34976, DOI 10.1074/jbc.M005819200; Persson C, 2005, METHODS, V35, P37, DOI 10.1016/j.ymeth.2004.07.006; Persson C, 2004, P NATL ACAD SCI USA, V101, P1886, DOI 10.1073/pnas.0304403101; Philimonenko AA, 2000, J STRUCT BIOL, V132, P201, DOI 10.1006/jsbi.2000.4326; PRIBLUDA VS, 1994, P NATL ACAD SCI USA, V91, P11246, DOI 10.1073/pnas.91.23.11246; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; Sil D, 2007, ACS CHEM BIOL, V2, P674, DOI 10.1021/cb7001472; Simoneau M, 2008, J BIOL CHEM, V283, P25544, DOI 10.1074/jbc.M804177200; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stauffer TP, 1997, J CELL BIOL, V139, P1447, DOI 10.1083/jcb.139.6.1447; Steinmetz MO, 1998, J MOL BIOL, V276, P1, DOI 10.1006/jmbi.1997.1529; Surviladze Z, 2007, J LIPID RES, V48, P1325, DOI 10.1194/jlr.M600485-JLR200; Suzuki Y, 2003, J IMMUNOL, V171, P6119, DOI 10.4049/jimmunol.171.11.6119; SWIETER M, 1995, J BIOL CHEM, V270, P21902, DOI 10.1074/jbc.270.37.21902; Swindle EJ, 2004, J BIOL CHEM, V279, P48751, DOI 10.1074/jbc.M409738200; Swindle EJ, 2002, J IMMUNOL, V169, P5866, DOI 10.4049/jimmunol.169.10.5866; Swindle EJ, 2007, J IMMUNOL, V179, P7059, DOI 10.4049/jimmunol.179.10.7059; TESHIMA R, 1994, BIOCHEM J, V302, P867, DOI 10.1042/bj3020867; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Tolarova H, 2004, EUR J IMMUNOL, V34, P1627, DOI 10.1002/eji.200424991; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Vonakis BM, 2005, J IMMUNOL, V175, P4543, DOI 10.4049/jimmunol.175.7.4543; Weibrecht I, 2007, FREE RADICAL BIO MED, V43, P100, DOI 10.1016/j.freeradbiomed.2007.03.021; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wilson BS, 2002, MOL IMMUNOL, V38, P1259, DOI 10.1016/S0161-5890(02)00073-1; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Xie ZH, 2000, J IMMUNOL, V164, P1521, DOI 10.4049/jimmunol.164.3.1521; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; ZICK Y, 1990, BIOCHEMISTRY-US, V29, P10240, DOI 10.1021/bi00496a013	74	41	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12787	12802		10.1074/jbc.M109.052555	http://dx.doi.org/10.1074/jbc.M109.052555			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20157115	hybrid, Green Published			2022-12-25	WOS:000276787800037
J	Krahn, MP; Rizk, S; Alfalah, M; Behrendt, M; Naim, HY				Krahn, Michael P.; Rizk, Sandra; Alfalah, Marwan; Behrendt, Marc; Naim, Hassan Y.			Protocadherin of the Liver, Kidney, and Colon Associates with Detergent-resistant Membranes during Cellular Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CADHERIN SUPERFAMILY; TUMOR-SUPPRESSOR; APICAL MEMBRANE; O-GLYCOSYLATION; ADHESION; FAMILY; IDENTIFICATION; EXPRESSION; RECEPTORS; BIOSYNTHESIS	Protocadherin LKC (PLKC) is a member of the heterogeneous subgroup of protocadherins that was identified and described as a potential tumor-suppressor gene involved in contact inhibition (Okazaki, N., Takahashi, N., Kojima, S., Masuho, Y., and Koga, H. (2002) Carcinogenesis 23, 1139-1148 and Ose, R., Yanagawa, T., Ikeda, S., Ohara, O., and Koga, H. (2009) Mol. Oncol. 3, 54-66). Several aspects of the structure, posttranslational processing, targeting, and function of this new protocadherin are still not known. Here, we demonstrate that the expression of PLKC at the apical membrane domain and its concentration at regions of cell-cell contacts occur concomitantly with significant elevation of PLKC-mRNA levels. Furthermore, it can be found within the adherens junctions, but it does not colocalize with tight junctions proteins ZO-1 and occludin, respectively. Additionally, unlike E-cadherin, PLKC is not redistributed upon Ca2+ removal. Biosynthetic labeling revealed N- and O-glycosylation as posttranslational modifications as well as a fast transport to the cell surface and a low turnover rate. During differentiation, PLKC associates with detergent-resistant membranes that trigger its redistribution from intracellular membranes to the cell surface. This association occurs concomitant with alterations in the glycosylation pattern. We propose a role for PLKC in the establishment of a proper epithelial cell polarity that requires O-linked glycosylation and association of the protein with detergent-resistant membranes.	[Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, D-30559 Hannover, Germany; [Rizk, Sandra] Lebanese Amer Univ, Dept Nat Sci, Beirut, Lebanon	University of Veterinary Medicine Hannover, Foundation; Lebanese American University	Naim, HY (corresponding author), Univ Vet Med Hannover, Dept Physiol Chem, Bunteweg 17, D-30559 Hannover, Germany.	hassan.naim@tiho-hannover.de	Rizk-Jamati, Sandra/AAG-3457-2019; Krahn, Michael/AAD-4476-2022	Rizk-Jamati, Sandra/0000-0002-4405-5703; Krahn, Michael/0000-0001-7718-9890	Deutsche Forschungsgemeinschaft, Bonn, Germany [SFB 621]; Lebanese American University Research Council [URC-s-2009-04]	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); Lebanese American University Research Council	This work was supported by the Deutsche Forschungsgemeinschaft, Bonn, Germany (SFB 621, Project C8 (to H. Y. N.)) and the Lebanese American University Research Council (URC-s-2009-04 (to S. R.)).	Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Alfalah M, 1999, CURR BIOL, V9, P593, DOI 10.1016/S0960-9822(99)80263-2; Alfalah M, 2002, J BIOL CHEM, V277, P10683, DOI 10.1074/jbc.M109357200; Bradley RS, 1998, CURR BIOL, V8, P325, DOI 10.1016/S0960-9822(98)70132-0; Breuza L, 2002, EXP CELL RES, V273, P178, DOI 10.1006/excr.2001.5442; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Castelletti D, 2008, BIOCHEM J, V409, P149, DOI 10.1042/BJ20070396; Dejana E, 1999, EXP CELL RES, V252, P13, DOI 10.1006/excr.1999.4601; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Goldberg M, 2000, J BIOL CHEM, V275, P24622, DOI 10.1074/jbc.M000234200; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Hirano S, 1999, J NEUROSCI, V19, P995; Hirayama T, 2006, CURR OPIN NEUROBIOL, V16, P336, DOI 10.1016/j.conb.2006.05.003; Jacob R, 2000, J BIOL CHEM, V275, P6566, DOI 10.1074/jbc.275.9.6566; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kuzmenko YS, 1998, FEBS LETT, V434, P183, DOI 10.1016/S0014-5793(98)00977-6; Leve F, 2008, J PHARMACOL EXP THER, V327, P777, DOI 10.1124/jpet.108.140798; Lindner R, 2009, EXP CELL RES, V315, P2871, DOI 10.1016/j.yexcr.2009.07.020; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; NAIM HY, 1987, BIOCHEM J, V241, P427, DOI 10.1042/bj2410427; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Okazaki N, 2002, CARCINOGENESIS, V23, P1139, DOI 10.1093/carcin/23.7.1139; Ose R, 2009, MOL ONCOL, V3, P54, DOI 10.1016/j.molonc.2008.10.005; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Proszynski TJ, 2004, MOL BIOL CELL, V15, P1533, DOI 10.1091/mbc.E03-07-0511; Sambrook J, 2001, MOL CLONING LAB MANU; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; SHORE EM, 1991, J BIOL CHEM, V266, P19672; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Takeda H, 2004, BIOCHEM BIOPH RES CO, V316, P822, DOI 10.1016/j.bbrc.2004.02.123; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Telo P, 1998, J BIOL CHEM, V273, P17565, DOI 10.1074/jbc.273.28.17565; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; VOLBERG T, 1986, J CELL BIOL, V102, P1832, DOI 10.1083/jcb.102.5.1832; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Yamamoto A, 1998, DEVELOPMENT, V125, P3389; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0	42	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13193	13200		10.1074/jbc.M109.080051	http://dx.doi.org/10.1074/jbc.M109.080051			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20159971	Green Published, hybrid			2022-12-25	WOS:000276787800074
J	Shimada, H; Rajagopalan, LE				Shimada, Hideaki; Rajagopalan, Lakshman E.			Rho Kinase-2 Activation in Human Endothelial Cells Drives Lysophosphatidic Acid-mediated Expression of Cell Adhesion Molecules via NF-kappa B p65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHATASE; RHEUMATOID-ARTHRITIS; MYOSIN PHOSPHATASE; SERINE/THREONINE KINASE; AIRWAY INFLAMMATION; DEPENDENT MECHANISM; ICAM-1 EXPRESSION; RHO/RHO-KINASE; ROCK-II; PHOSPHORYLATION	Endothelial cells play an important role in the recruitment of immune cells to a disease locus through the induced expression of chemokines and cell adhesion molecules (CAMs). The proinflammatory lysophospholipid, lysophosphatidic acid (LPA), which is elevated in multiple inflammatory diseases, is a potent activator of the RhoA/Rho kinase signaling pathway and has been shown to induce the expression of CAMs in endothelial cells. The present study was undertaken to map signal transduction downstream of LPA and to investigate the contributions of the Rho kinase isoforms ROCK1 and ROCK2 to adhesion molecule expression in human umbilical vein endothelial cells. LPA activated Rho kinase within minutes and subsequently the NF-kappa B pathway through phosphorylation of the p65 subunit. The lipid also induced the late expression of intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). Pharmacologic inhibition of Rho kinase signaling blocked LPA-induced p65 phosphorylation and suppressed ICAM-1 and VCAM-1 expression. Inhibition of the NF-kappa B pathway had no impact on LPA-induced Rho kinase activation, but inhibited adhesion molecule expression. Small interfering RNA-facilitated knockdown of each isoform identified ROCK2 as the mediator of LPA-driven phosphorylation of NF-kappa B p65 and of ICAM-1 and VCAM-1 mRNA and protein induction. Taken collectively, our data are consistent with Rho kinase being upstream of NF-kappa B in driving LPA-mediated adhesion molecule expression. This study also provides the first evidence of the critical involvement of ROCK2 in LPA-induced CAM expression through activation of the NF-kappa B pathway in human endothelial cells.	[Shimada, Hideaki; Rajagopalan, Lakshman E.] Pfizer Global Res & Dev, Inflammat Res Unit, Chesterfield, MO 63017 USA	Pfizer	Rajagopalan, LE (corresponding author), 700 Chesterfield Pkwy W, Chesterfield, MO 63017 USA.	leraja22@gmail.com			Pfizer, Inc	Pfizer, Inc(Pfizer)	This work was supported by Pfizer, Inc.	Aihara M, 2003, INT IMMUNOPHARMACOL, V3, P1619, DOI 10.1016/S1567-5769(03)00184-X; ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Boerma M, 2008, BLOOD COAGUL FIBRIN, V19, P709, DOI 10.1097/MBC.0b013e32830b2891; Cook-Mills JM, 2005, J LEUKOCYTE BIOL, V77, P487, DOI 10.1189/jlb.0904554; Essler M, 1999, J BIOL CHEM, V274, P30361, DOI 10.1074/jbc.274.43.30361; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Garton AJ, 2008, METHOD ENZYMOL, V439, P491, DOI 10.1016/S0076-6879(07)00433-8; Hashimoto T, 2003, J PHARMACOL SCI, V91, P8, DOI 10.1254/jphs.91.8; He Y, 2008, ARTHRITIS RHEUM-US, V58, P3366, DOI 10.1002/art.23986; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kitazawa T, 2000, J BIOL CHEM, V275, P9897, DOI 10.1074/jbc.275.14.9897; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Lee HY, 2004, AM J PHYSIOL-CELL PH, V287, pC1657, DOI 10.1152/ajpcell.00172.2004; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Lin CI, 2006, J CELL BIOCHEM, V99, P1216, DOI 10.1002/jcb.20963; Lin CL, 2007, BIOCHEM BIOPH RES CO, V363, P1001, DOI 10.1016/j.bbrc.2007.09.081; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Maruta T, 2008, J NEUROCHEM, V105, P401, DOI 10.1111/j.1471-4159.2007.05143.x; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nochi H, 2008, J IMMUNOL, V181, P5111, DOI 10.4049/jimmunol.181.7.5111; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Ohkita M, 2002, JPN J PHARMACOL, V89, P81, DOI 10.1254/jjp.89.81; Rahman A, 1999, J IMMUNOL, V162, P5466; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Sebbagh M, 2005, J EXP MED, V201, P465, DOI 10.1084/jem.20031877; Amerongen GPV, 2008, AM J PHYSIOL-CELL PH, V294, pC1234, DOI 10.1152/ajpcell.00551.2007; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wang YP, 2009, CIRC RES, V104, P531, DOI 10.1161/CIRCRESAHA.108.188524; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2; Wu XY, 2009, AM J PHYSIOL-RENAL, V297, pF316, DOI 10.1152/ajprenal.00089.2009; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Zhao CQ, 2008, MOL PHARMACOL, V73, P587, DOI 10.1124/mol.107.038216; Zhao YT, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-114; Zhao YT, 2009, CELL SIGNAL, V21, P367, DOI 10.1016/j.cellsig.2008.10.010	41	83	85	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12536	12542		10.1074/jbc.M109.099630	http://dx.doi.org/10.1074/jbc.M109.099630			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20164172	Green Published, hybrid			2022-12-25	WOS:000276787800010
J	Andreasson, C; Rampelt, H; Fiaux, J; Druffel-Augustin, S; Bukau, B				Andreasson, Claes; Rampelt, Heike; Fiaux, Jocelyne; Druffel-Augustin, Silke; Bukau, Bernd			The Endoplasmic Reticulum Grp170 Acts as a Nucleotide Exchange Factor of Hsp70 via a Mechanism Similar to That of the Cytosolic Hsp110	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMIDE HYDROGEN-EXCHANGE; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL-CHANGES; TRANSMEMBRANE PROTEIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; YEAST; CHAPERONES; TRANSLOCATION; BINDING	Grp170 and Hsp110 proteins constitute two evolutionary distinct branches of the Hsp70 family that share the ability to function as nucleotide exchange factors (NEFs) for canonical Hsp70s. Although the NEF mechanism of the cytoplasmic Hsp110s is well understood, little is known regarding the mechanism used by Grp170s in the endoplasmic reticulum. In this study, we compare the yeast Grp170 Lhs1 with the yeast Hsp110 Sse1. We find that residues important for Sse1 NEF activity are conserved in Lhs1 and that mutations in these residues in Lhs1 compromise NEF activity. As previously reported for Sse1, Lhs1 requires ATP to trigger nucleotide exchange in its cognate Hsp70 partner Kar2. Using site-specific cross-linking, we show that the nucleotide-binding domain (NBD) of Lhs1 interacts with the NBD of Kar2 face to face, and that Lhs1 contacts the side of the Kar2 NBD via its protruding C-terminal alpha-helical domain. To directly address the mechanism of nucleotide exchange, we have compared the hydrogen-exchange characteristics of a yeast Hsp70NBD(Ssa1) in complex with either Sse1 or Lhs1. We find that Lhs1 and Sse1 induce very similar changes in the conformational dynamics in the Hsp70. Thus, our findings demonstrate that despite some differences between Hsp110 and Grp170 proteins, they use a similar mechanism to trigger nucleotide exchange.	[Andreasson, Claes; Rampelt, Heike; Fiaux, Jocelyne; Druffel-Augustin, Silke; Bukau, Bernd] Univ Heidelberg, DKFZ ZMBH Alliance, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Andreasson, C (corresponding author), Stockholm Univ, Wenner Gren Inst, Svante Arrheniusvag 16-18 E5, SE-10691 Stockholm, Sweden.	claes.andreasson@cellbio.su.se		Bukau, Bernd/0000-0003-0521-7199; Rampelt, Heike/0000-0002-5458-5652; Andreasson, Claes/0000-0001-8948-0685	Deutsche Forschungsgemeinschaft [SFB638]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported in part by Deutsche Forschungsgemeinschaft Grant SFB638 and a grant from the Fonds der Chemischen Industrie (to B. B.).	Andreasson C, 2008, P NATL ACAD SCI USA, V105, P16519, DOI 10.1073/pnas.0804187105; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Baxter BK, 1996, MOL CELL BIOL, V16, P6444; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; CRAIG EA, 2005, PROTEIN FOLDING HDB, P490; Craven RA, 1996, EMBO J, V15, P2640, DOI 10.1002/j.1460-2075.1996.tb00624.x; de Keyzer J, 2009, J BIOL CHEM, V284, P31564, DOI 10.1074/jbc.M109.055160; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hamilton TG, 1996, J BIOL CHEM, V271, P30610, DOI 10.1074/jbc.271.48.30610; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MORI K, 1993, CELL, V74, P743; MUKAI H, 1993, GENE, V132, P57; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rist W, 2005, PROTEIN SCI, V14, P626, DOI 10.1110/ps.041098305; Rist W, 2003, J BIOL CHEM, V278, P51415, DOI 10.1074/jbc.M307160200; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; SIKORSKI RS, 1989, GENETICS, V122, P19; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518	34	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12445	12453		10.1074/jbc.M109.096735	http://dx.doi.org/10.1074/jbc.M109.096735			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177057	Green Published, hybrid			2022-12-25	WOS:000276787100072
J	Cole, LK; Vance, DE				Cole, Laura K.; Vance, Dennis E.			A Role for Sp1 in Transcriptional Regulation of Phosphatidylethanolamine N-Methyltransferase in Liver and 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; HORMONE RECEPTOR GENE; CELL-CYCLE; RAT-LIVER; FACTOR-BINDING; S-PHASE; EXPRESSION; ESTROGEN; PHOSPHATIDYLCHOLINE; ALPHA	Phosphatidylcholine is made in all nucleated mammalian cells via the CDP-choline pathway. Another major pathway for phosphatidylcholine biosynthesis in liver is catalyzed by phosphatidylethanolamine N-methyltransferase (PEMT). We have now identified 3T3-L1 adipocytes as a cell culture model that expresses PEMT endogenously. We have found that PEMT mRNA and protein levels increased dramatically in 3T3-L1 cells upon differentiation to adipocytes. 5'-Deletion analysis of the PEMT promoter-luciferase constructs stably expressed in 3T3-L1 adipocytes identified a regulatory region between -471 and -371 bp (relative to the transcriptional start site). Competitive and supershift assays demonstrated binding sites for transcription factors Sp1, Sp3 (-408 to -413), and YY1 (-417 to -420). During differentiation of 3T3-L1 cells to adipocytes, the amount of Sp1 protein decreased by similar to 50% just prior to activation of PEMT. Transduction of 3T3-L1 adipocytes with retrovirus containing Sp1 cDNA demonstrated that Sp1 inhibited PEMT transcriptional activity. Similarly, short hairpin RNA directed against Sp1 in 3T3-L1 adipocytes enhanced PEMT transcriptional activation. Chromatin immunoprecipitation assays confirmed that Sp1 binds to the PEMT promoter, and this interaction decreases upon differentiation to adipocytes. These experiments directly link increased PEMT expression in adipocytes to decreased transcriptional expression of Sp1. In addition, our data established that Sp1 binding was required for tamoxifen-mediated inhibition of Pemt promoter activity.	Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB TG6 2S2, Canada; Univ Alberta, Dept Biochem, Edmonton, AB TG6 2S2, Canada	University of Alberta; University of Alberta		dennis.vance@ualberta.ca			Canadian Institutes of Health Research [MOP 5182]; Alberta Heritage Foundation for Medical Research; Natural Science and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Canadian Institutes of Health Research Grant MOP 5182.; Recipient of a studentship award from the Alberta Heritage Foundation for Medical Research and the Natural Science and Engineering Research Council of Canada.	Aoyama C, 2007, BBA-MOL CELL BIOL L, V1771, P1148, DOI 10.1016/j.bbalip.2007.07.003; Baker TK, 2001, CHEM RES TOXICOL, V14, P1218, DOI 10.1021/tx015518a; Banchio C, 2004, J BIOL CHEM, V279, P40220, DOI 10.1074/jbc.M406468200; Banchio C, 2003, J BIOL CHEM, V278, P32457, DOI 10.1074/jbc.M304810200; BREMER J, 1960, BIOCHIM BIOPHYS ACTA, V37, P173, DOI 10.1016/0006-3002(60)90104-9; Chang YC, 2001, MOL CELL BIOL, V21, P1121, DOI 10.1128/MCB.21.4.1121-1131.2001; Cui Z, 1997, BBA-LIPID LIPID MET, V1346, P10, DOI 10.1016/S0005-2760(97)00012-X; CUI Z, 1993, J BIOL CHEM, V268, P16655; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; DERYCKERE F, 1994, BIOTECHNIQUES, V16, P405; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Dong J, 2006, J BIOL CHEM, V281, P18825, DOI 10.1074/jbc.M512826200; Dong S, 2007, MOL ENDOCRINOL, V21, P1617, DOI 10.1210/me.2006-0550; Douglas DN, 2001, J BIOL CHEM, V276, P25621, DOI 10.1074/jbc.M103874200; Feng DX, 2005, P NATL ACAD SCI USA, V102, P9896, DOI 10.1073/pnas.0502041102; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Houweling M, 1997, BBA-LIPID LIPID MET, V1346, P1, DOI 10.1016/S0005-2760(97)00011-8; Ince TA, 1995, J BIOL CHEM, V270, P30249, DOI 10.1074/jbc.270.51.30249; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Kutoh E, 1999, CANCER LETT, V136, P187, DOI 10.1016/S0304-3835(98)00321-8; Lai KD, 2003, J BIOL CHEM, V278, P36418, DOI 10.1074/jbc.M303913200; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; Lelliott CJ, 2005, FASEB J, V19, P1108, DOI 10.1096/fj.04-3196com; Levy N, 2008, MOL ENDOCRINOL, V22, P287, DOI 10.1210/me.2007-0340; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Li ZY, 2005, J BIOL CHEM, V280, P37798, DOI 10.1074/jbc.M508575200; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Loria P, 2008, CLIN SCI, V115, P1, DOI 10.1042/CS20070311; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Ngwenya S, 2003, ENDOCRINOLOGY, V144, P1675, DOI 10.1210/en.2002-0009; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; PELECH SL, 1983, CAN J BIOCHEM CELL B, V61, P1147, DOI 10.1139/o83-147; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Qin CH, 2004, MOL CARCINOGEN, V40, P160, DOI 10.1002/mc.20030; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; Resseguie M, 2007, FASEB J, V21, P2622, DOI 10.1096/fj.07-8227com; Roer K, 2002, BIOCHEM BIOPH RES CO, V294, P63, DOI 10.1016/S0006-291X(02)00440-0; Saadeh S, 2007, NUTR CLIN PRACT, V22, P1, DOI 10.1177/011542650702200101; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Sesca E, 1996, BIOCHEM BIOPH RES CO, V229, P158, DOI 10.1006/bbrc.1996.1773; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Shields DJ, 2003, J BIOL CHEM, V278, P2956, DOI 10.1074/jbc.M210904200; Singh MN, 2008, MED SCI MONITOR, V14, pRA144; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; SUNDLER R, 1975, J BIOL CHEM, V250, P3359; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Vance D.E., 2008, BIOCH LIPIDS LIPOPRO, P214; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; Walkey CJ, 1996, J LIPID RES, V37, P2341; YOU JS, 2006, BIOCHEM BIOPH RES CO, V342, P1168; Zhang DP, 2006, COMP BIOCHEM PHYS A, V144, P306, DOI 10.1016/j.cbpa.2006.01.025; Zhang Y, 2003, MOL CELL BIOL, V23, P6958, DOI 10.1128/MCB.23.19.6958-6972.2003; Zhang Y, 2006, MOL CELL BIOL, V26, P6748, DOI 10.1128/MCB.00560-06; Zhao Y, 2009, ARTERIOSCL THROM VAS, V29, P1349, DOI 10.1161/ATVBAHA.109.188672	58	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11880	11891		10.1074/jbc.M110.109843	http://dx.doi.org/10.1074/jbc.M110.109843			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20150657	Green Published, hybrid			2022-12-25	WOS:000276787100016
J	Perrera, C; Colombo, R; Valsasina, B; Carpinelli, P; Troiani, S; Modugno, M; Gianellini, L; Cappella, P; Isacchi, A; Moll, J; Rusconi, L				Perrera, Claudia; Colombo, Riccardo; Valsasina, Barbara; Carpinelli, Patrizia; Troiani, Sonia; Modugno, Michele; Gianellini, Laura; Cappella, Paolo; Isacchi, Antonella; Moll, Jurgen; Rusconi, Luisa			Identification of Myb-binding Protein 1A (MYBBP1A) as a Novel Substrate for Aurora B Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PASSENGER COMPLEX; HUMAN MITOTIC SPINDLE; C-MYB; SACCHAROMYCES-CEREVISIAE; PHOSPHOPROTEOME ANALYSIS; PROTEOMIC ANALYSIS; NUCLEOLAR PROTEIN; CELL-DIVISION; MISU NSUN2; PHOSPHORYLATION	Aurora kinases are mitotic enzymes involved in centrosome maturation and separation, spindle assembly and stability, and chromosome condensation, segregation, and cytokinesis and represent well known targets for cancer therapy because their deregulation has been linked to tumorigenesis. The availability of suitable markers is of crucial importance to investigate the functions of Auroras and monitor kinase inhibition in in vivo models and in clinical trials. Extending the knowledge on Aurora substrates could help to better understand their biology and could be a source for clinical biomarkers. Using biochemical, mass spectrometric, and cellular approaches, we identified MYBBP1A as a novel Aurora B substrate and serine 1303 as the major phosphorylation site. MYBBP1A is phosphorylated in nocodazole-arrested cells and is dephosphorylated upon Aurora B silencing or by treatment with Danusertib, a small molecule inhibitor of Aurora kinases. Furthermore, we show that MYBBP1A depletion by RNA interference causes mitotic progression delay and spindle assembly defects. MYBBP1A has until now been described as a nucleolar protein, mainly involved in transcriptional regulation. The results presented herein show MYBBP1A as a novel Aurora B kinase substrate and reveal a not yet recognized link of this nucleolar protein to mitosis.	[Perrera, Claudia; Colombo, Riccardo; Valsasina, Barbara; Carpinelli, Patrizia; Troiani, Sonia; Modugno, Michele; Gianellini, Laura; Cappella, Paolo; Isacchi, Antonella; Moll, Jurgen; Rusconi, Luisa] Nerviano Med Sci SRL, I-20014 Nerviano, MI, Italy	Nerviano Medical Sciences S.r.l	Perrera, C (corresponding author), Nerviano Med Sci SRL, Viale L Pasteur 10, I-20014 Nerviano, MI, Italy.	Claudia.Perrera@nervianoms.com	Cappella, Paolo/ABI-2298-2020; Cappella, Paolo/L-5857-2016	Cappella, Paolo/0000-0002-3401-4246; Cappella, Paolo/0000-0002-7476-5618				Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; ANDERSON DF, 2002, INT J COMMUTATIVE RI, V1, P11; ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; BADING H, 1989, EXP CELL RES, V185, P50, DOI 10.1016/0014-4827(89)90036-0; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brittle AL, 2007, EXP CELL RES, V313, P2780, DOI 10.1016/j.yexcr.2007.04.038; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; CARPINELLI P, 2009, J CURR OPIN DRUG DIS, V12, P533; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Costa A, 2008, BIOCHEM SOC T, V36, P136, DOI 10.1042/BST0360136; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Delacour-Larose M, 2007, CELL CYCLE, V6, P1878, DOI 10.4161/cc.6.15.4482; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Diaz VM, 2007, MOL CELL BIOL, V27, P7981, DOI 10.1128/MCB.01290-07; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; FAVIER D, 1994, ONCOGENE, V9, P305; Frye M, 2010, CANCER LETT, V289, P71, DOI 10.1016/j.canlet.2009.08.004; Gambe AE, 2009, FEBS LETT, V583, P1951, DOI 10.1016/j.febslet.2009.05.033; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; Hara Y, 2009, NUCLEIC ACIDS RES, V37, P1115, DOI 10.1093/nar/gkn1013; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; Imami K, 2008, ANAL SCI, V24, P161, DOI 10.2116/analsci.24.161; Jones LC, 2002, J BIOL CHEM, V277, P22515, DOI 10.1074/jbc.M200740200; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Kelly AE, 2009, CURR OPIN CELL BIOL, V21, P51, DOI 10.1016/j.ceb.2009.01.004; Keough RA, 2003, EXP CELL RES, V289, P108, DOI 10.1016/S0014-4827(03)00262-3; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Kollareddy M, 2008, BIOMED PAP, V152, P27, DOI 10.5507/bp.2008.004; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Morrison C, 2002, NUCLEIC ACIDS RES, V30, P5318, DOI 10.1093/nar/gkf665; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Owen HR, 2007, J MOL BIOL, V366, P725, DOI 10.1016/j.jmb.2006.11.099; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pollard JR, 2009, J MED CHEM, V52, P2629, DOI 10.1021/jm8012129; Rodriguez JA, 2006, ONCOGENE, V25, P4867, DOI 10.1038/sj.onc.1209499; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sakita-Suto S, 2007, MOL BIOL CELL, V18, P1107, DOI 10.1091/mbc.E06-11-1021; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Shimizu K, 2002, P NATL ACAD SCI USA, V99, P9133, DOI 10.1073/pnas.142277999; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Tavner FJ, 1998, MOL CELL BIOL, V18, P989, DOI 10.1128/MCB.18.2.989; Troiani S, 2005, J PROTEOME RES, V4, P1296, DOI 10.1021/pr050018e; Tsuno A, 2000, MOL CELL BIOL, V20, P2066, DOI 10.1128/MCB.20.6.2066-2074.2000; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Van Hooser AA, 2005, CHROMOSOMA, V114, P377, DOI 10.1007/s00412-005-0021-9; Venoux M, 2008, HUM MOL GENET, V17, P215, DOI 10.1093/hmg/ddm298; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807; Yang W, 2003, CELL CYCLE, V2, P120, DOI 10.4161/cc.2.2.329; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	74	22	22	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11775	11785		10.1074/jbc.M109.068312	http://dx.doi.org/10.1074/jbc.M109.068312			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177074	hybrid, Green Published			2022-12-25	WOS:000276787100004
J	Zhou, Y; Wang, S; Ma, JW; Lei, Z; Zhu, HF; Lei, P; Yang, ZS; Zhang, B; Yao, XX; Shi, C; Sun, LF; Wu, XW; Ning, Q; Shen, GX; Huang, B				Zhou, Yu; Wang, Shuo; Ma, Jing-Wei; Lei, Zhang; Zhu, Hui-Fen; Lei, Ping; Yang, Zhuo-Shun; Zhang, Biao; Yao, Xin-Xin; Shi, Chuan; Sun, Li-Fang; Wu, Xiong-Wen; Ning, Qin; Shen, Guan-Xin; Huang, Bo			Hepatitis B Virus Protein X-induced Expression of the CXC Chemokine IP-10 Is Mediated through Activation of NF-kappa B and Increases Migration of Leukocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-INDUCIBLE PROTEIN-10; HBX PROTEIN; IN-VIVO; KINASE; TRANSCRIPTION; INDUCTION; GENE; DNA; INFLAMMATION; SPECIFICITY	Interferon-gamma inducible protein 10 (IP-10) involves inflammatory cell recruitment and cellular immune damage during virus infection. Although an increase of the peripheral IP-10 level is known in HBV-infected patients, the molecular basis of HBV infection inducing IP-10 expression has remained elusive. In the present study, we demonstrate that hepatitis B virus protein X (HBx) increases IP-10 expression in a dose-dependent manner. Transfection of the HBx-expressing vector into HepG2 cells results in nuclear translocation of NF-kappa B, which directly binds the promoter of IP-10 at positions from -122 to -113, thus facilitating transcription. The addition of the NF-kappa B inhibitor blocks the effect of HBx on IP-10 induction. In parallel, increase of NF-kappa B subunits p65 and p50 in HepG2 cells also augments IP-10 expression. Furthermore, we show that HBx induces activation of NF-kappa B through the TRAF2/TAK1 signaling pathway, leading to up-regulation of IP-10 expression. As a consequence, up-regulation of IP-10 may mediate the migration of peripheral blood leukocytes in a NF-kappa B-dependent manner. In conclusion, we report a novel molecular mechanism of HBV infection inducing IP-10 expression, which involves viral protein HBx affecting NF-kappa B pathway, leading to transactivation of the IP-10 promoter. Our study provides insight into the migration of leukocytes in response to HBV infection, thus causing immune pathological injury of liver.	[Zhou, Yu; Ma, Jing-Wei; Zhu, Hui-Fen; Lei, Ping; Yao, Xin-Xin; Shi, Chuan; Sun, Li-Fang; Wu, Xiong-Wen; Shen, Guan-Xin] Huazhong Univ Sci & Technol, Dept Immunol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Lei, Zhang; Yang, Zhuo-Shun; Zhang, Biao; Huang, Bo] Huazhong Univ Sci & Technol, Dept Biochem & Mol Biol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Ning, Qin] Huazhong Univ Sci & Technol, Dept Infect Dis, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Wang, Shuo] McGill Univ, Lady Davis Inst, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Lady Davis Institute; McGill University	Shen, GX (corresponding author), 13 Hangkong Rd, Wuhan 430030, Peoples R China.	guanxin_shen@yahoo.com.cn; tjhuangbo@hotmail.com	shen, Guanxin/F-7441-2011		National Key and Basic Research Development Program of China [2007CB512900]; State Project on Major Infectious Diseases Prevention [2008ZX10002-009]; Program for New Century Excellent Talents in University [NCET-08-0219]; Special Research Foundation for Universities affiliated with China Ministry of Education [Z2009005]	National Key and Basic Research Development Program of China(National Basic Research Program of China); State Project on Major Infectious Diseases Prevention; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Special Research Foundation for Universities affiliated with China Ministry of Education	This work was supported by the National Key and Basic Research Development Program of China Grant 2007CB512900, State Project on Major Infectious Diseases Prevention Grant 2008ZX10002-009, Program for New Century Excellent Talents in University Grant NCET-08-0219, and Special Research Foundation for Universities affiliated with China Ministry of Education Grant Z2009005.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Asensio VC, 2001, J VIROL, V75, P7067, DOI 10.1128/JVI.75.15.7067-7077.2001; Benn J, 1996, J VIROL, V70, P4978, DOI 10.1128/JVI.70.8.4978-4985.1996; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Diao JY, 2001, J BIOL CHEM, V276, P8328, DOI 10.1074/jbc.M006026200; Diao JY, 2001, CYTOKINE GROWTH F R, V12, P189, DOI 10.1016/S1359-6101(00)00034-4; DORIA M, 1995, EMBO J, V14, P4747, DOI 10.1002/j.1460-2075.1995.tb00156.x; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Feldmann M, 2001, ADV EXP MED BIOL, V490, P119; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Harousseau Jean-Luc, 2004, Hematology Am Soc Hematol Educ Program, P237; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Horie R, 2006, DRUG NEWS PERSPECT, V19, P201, DOI 10.1358/dnp.2006.19.4.985934; Kakimi K, 2001, J EXP MED, V194, P1755, DOI 10.1084/jem.194.12.1755; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; Kim HT, 2001, BIOCHEM BIOPH RES CO, V286, P886, DOI 10.1006/bbrc.2001.5496; Kim SJ, 2005, LUNG CANCER, V49, P325, DOI 10.1016/j.lungcan.2005.03.036; Kim WH, 2001, FASEB J, V15, P2551, DOI 10.1096/fj.01-0217; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; Law AHY, 2007, J VIROL, V81, P416, DOI 10.1128/JVI.02336-05; Le Goffic R, 2002, ENDOCRINOLOGY, V143, P1434, DOI 10.1210/en.143.4.1434; Lee YH, 1998, J BIOL CHEM, V273, P25510, DOI 10.1074/jbc.273.39.25510; Liu MT, 2000, J IMMUNOL, V165, P2327, DOI 10.4049/jimmunol.165.5.2327; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Mahalingam S, 1999, J VIROL, V73, P1479, DOI 10.1128/JVI.73.2.1479-1491.1999; Moon EJ, 2003, FASEB J, V17, P382, DOI 10.1096/fj.03-0153fje; Nakamichi K, 2005, J VIROL, V79, P11801, DOI 10.1128/JVI.79.18.11801-11812.2005; Narumi S, 1997, J IMMUNOL, V158, P5536; Nazar ASMI, 1997, J NEUROIMMUNOL, V77, P116, DOI 10.1016/S0165-5728(97)00070-2; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Nishioji K, 2001, CLIN EXP IMMUNOL, V123, P271, DOI 10.1046/j.1365-2249.2001.01391.x; Park SR, 2001, EUR J IMMUNOL, V31, P1706, DOI 10.1002/1521-4141(200106)31:6<1706::AID-IMMU1706>3.0.CO;2-Z; ROBINSON WS, 1974, J VIROL, V14, P384, DOI 10.1128/JVI.14.2.384-391.1974; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rotondi M, 2003, J ENDOCRINOL INVEST, V26, P177, DOI 10.1007/BF03345149; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shamay M, 2002, J BIOL CHEM, V277, P9982, DOI 10.1074/jbc.M111354200; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; TAKENAKA M, 1994, J BIOL CHEM, V269, P29379; TIOLLAIS P, 1981, SCIENCE, V213, P406, DOI 10.1126/science.6264599; Wang J, 2008, HEPATOB PANCREAT DIS, V7, P45; Weil R, 1999, MOL CELL BIOL, V19, P6345; Wenzel J, 2009, ARCH DERMATOL RES, V301, P83, DOI 10.1007/s00403-008-0892-8; WILLIAMS JS, 1995, P NATL ACAD SCI USA, V92, P3819, DOI 10.1073/pnas.92.9.3819	50	45	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12159	12168		10.1074/jbc.M109.067629	http://dx.doi.org/10.1074/jbc.M109.067629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20164184	hybrid, Green Published			2022-12-25	WOS:000276787100046
J	Fujiwara, T; Maisonneuve, S; Isshiki, M; Mizutani, M; Chen, LT; Wong, HL; Kawasaki, T; Shimamoto, K				Fujiwara, Tadashi; Maisonneuve, Sylvie; Isshiki, Masayuki; Mizutani, Masaharu; Chen, Letian; Wong, Hann Ling; Kawasaki, Tsutomu; Shimamoto, Ko			Sekiguchi Lesion Gene Encodes a Cytochrome P450 Monooxygenase That Catalyzes Conversion of Tryptamine to Serotonin in Rice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEIN; SMALL GTPASE RAC; CELL-DEATH; DISEASE RESISTANCE; BIOSYNTHESIS; FUNGUS; ACCUMULATION; INDUCTION; RESPONSES; OXIDASE	Serotonin is a well known neurotransmitter in mammals and plays an important role in various mental functions in humans. In plants, the serotonin biosynthesis pathway and its function are not well understood. The rice sekiguchi lesion (sl) mutants accumulate tryptamine, a candidate substrate for serotonin biosynthesis. We isolated the SL gene by map-based cloning and found that it encodes CYP71P1 in a cytochrome P450 monooxygenase family. A recombinant SL protein exhibited tryptamine 5-hydroxylase enzyme activity and catalyzed the conversion of tryptamine to serotonin. This pathway is novel and has not been reported in mammals. Expression of SL was induced by the N-acetylchitooligosaccharide (chitin) elicitor and by infection with Magnaporthe grisea, a causal agent for rice blast disease. Exogenously applied serotonin induced defense gene expression and cell death in rice suspension cultures and increased resistance to rice blast infection in plants. We also found that serotonin-induced defense gene expression is mediated by the RacGTPase pathway and by the G alpha subunit of the heterotrimeric G protein. These results suggest that serotonin plays an important role in rice innate immunity.	[Fujiwara, Tadashi; Maisonneuve, Sylvie; Isshiki, Masayuki; Chen, Letian; Wong, Hann Ling; Kawasaki, Tsutomu; Shimamoto, Ko] Nara Inst Sci & Technol, Plant Mol Genet Lab, Ikoma 6300192, Japan; [Mizutani, Masaharu] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan	Nara Institute of Science & Technology; Kobe University	Shimamoto, K (corresponding author), Nara Inst Sci & Technol, Plant Mol Genet Lab, 8916-5 Takayama, Ikoma 6300192, Japan.	simamoto@bs.naist.jp	Chen, Letian/B-1263-2015; Wong, Hann Ling/S-8148-2017	Chen, Letian/0000-0001-6413-636X; Wong, Hann Ling/0000-0001-8903-1812; Mizutani, Masaharu/0000-0002-4321-0644	Ministry of Agriculture, Forestry, and Fisheries of Japan [IP4001]; Japan Society for Promotion of Science [13G0023]; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	This work was supported by grants-in-aid from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Rice Genome Project IP4001), the Japan Society for Promotion of Science Grant 13G0023 (to K. S.), and the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) (to T. K.).	Arase S, 2001, J PHYTOPATHOL, V149, P409, DOI 10.1046/j.1439-0434.2001.00646.x; Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Fitzpatrick PF, 2003, BIOCHEMISTRY-US, V42, P14083, DOI 10.1021/bi035656u; Geyer MA, 2008, TRENDS PHARMACOL SCI, V29, P445, DOI 10.1016/j.tips.2008.06.006; Gingrich JA, 2001, PSYCHOPHARMACOLOGY, V155, P1, DOI 10.1007/s002130000573; HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; Hayashi M, 2005, P NATL ACAD SCI USA, V102, P7020, DOI 10.1073/pnas.0502556102; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; Ishihara A, 2008, PLANT J, V54, P481, DOI 10.1111/j.1365-313X.2008.03441.x; Kang K, 2009, PLANT PHYSIOL, V150, P1380, DOI 10.1104/pp.109.138552; Kawasaki T, 1999, P NATL ACAD SCI USA, V96, P10922, DOI 10.1073/pnas.96.19.10922; Keller H, 1996, PHYTOCHEMISTRY, V42, P389, DOI 10.1016/0031-9422(95)00866-7; Lieberherr D, 2005, PLANT PHYSIOL, V138, P1644, DOI 10.1104/pp.104.057414; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Midoh N, 1996, PLANT CELL PHYSIOL, V37, P9, DOI 10.1093/oxfordjournals.pcp.a028918; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Miyagawa H, 1995, BIOSCI BIOTECH BIOCH, V59, P2305, DOI 10.1271/bbb.59.2305; Mizutani M, 1998, PLANT PHYSIOL, V116, P357, DOI 10.1104/pp.116.1.357; Mockus SM, 1998, J MOL NEUROSCI, V10, P163, DOI 10.1007/BF02761772; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Roshchina VV, 2001, NEUROTRANSMITTERS PL, P4; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; SATOH H, 1979, J FAC AGR KYUSHU U, V24, P165; Suharsono U, 2002, P NATL ACAD SCI USA, V99, P13307, DOI 10.1073/pnas.192244099; Thao NP, 2007, PLANT CELL, V19, P4035, DOI 10.1105/tpc.107.055517; Ueno M, 2003, PLANT J, V36, P215, DOI 10.1046/j.1365-313X.2003.01875.x; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Yamaguchi T, 2000, PLANT CELL, V12, P817, DOI 10.1105/tpc.12.5.817	33	145	169	4	56	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11308	11313		10.1074/jbc.M109.091371	http://dx.doi.org/10.1074/jbc.M109.091371			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20150424	hybrid, Green Published			2022-12-25	WOS:000276286200037
J	Vendruscolo, LF; Gueye, AB; Darnaudery, M; Ahmed, SH; Cador, M				Vendruscolo, Leandro F.; Gueye, Aliou B.; Darnaudery, Muriel; Ahmed, Serge H.; Cador, Martine			Sugar Overconsumption during Adolescence Selectively Alters Motivation and Reward Function in Adult Rats	PLOS ONE			English	Article							DRUG-ADDICTION; COCAINE; FOOD; DOPAMINE; INTERMITTENT; SENSITIVITY; CONSUMPTION; ESCALATION; BEHAVIORS; BEVERAGES	Background: There has been a dramatic escalation in sugar intake in the last few decades, most strikingly observed in the adolescent population. Sugar overconsumption has been associated with several adverse health consequences, including obesity and diabetes. Very little is known, however, about the impact of sugar overconsumption on mental health in general, and on reward-related behavioral disorders in particular. This study examined in rats the effects of unlimited access to sucrose during adolescence on the motivation for natural and pharmacological rewards in adulthood. Methodology/Principal Findings: Adolescent rats had free access to 5% sucrose or water from postnatal day 30 to 46. The control group had access to water only. In adulthood, rats were tested for self-administration of saccharin (sweet), maltodextrin (non-sweet), and cocaine (a potent drug of abuse) using fixed-and progressive-ratio schedules, and a concentration-response curve for each substance. Adult rats, exposed or not exposed to sucrose, were tested for saccharin self-administration later in life to verify the specificity of adolescence for the sugar effects. Sugar overconsumption during adolescence, but not during adulthood, reduced the subsequent motivation for saccharin and maltodextrin, but not cocaine. This selective decrease in motivation is more likely due to changes in brain reward processing than changes in gustatory perception. Conclusions/Significance: Sugar overconsumption induces a developmental stage-specific chronic depression in reward processing that may contribute to an increase in the vulnerability to reward-related psychiatric disorders.	[Vendruscolo, Leandro F.; Gueye, Aliou B.; Ahmed, Serge H.; Cador, Martine] Univ Bordeaux, CNRS, UMR5227, Bordeaux, France; [Darnaudery, Muriel] Univ Bordeaux, CNRS, UMR5226, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Vendruscolo, LF (corresponding author), Univ Bordeaux, CNRS, UMR5227, Bordeaux, France.	vendruscolo@hotmail.com	Kauk, Rachel C/H-3622-2012; AHMED, Serge H/D-5236-2014; LE MOINE, Catherine/E-2671-2014	DARNAUDERY, Muriel/0000-0003-0209-3880; Ahmed, Serge/0000-0002-1225-9234	Fondation Fyssen, France; Mission Interministerielle de la Lutte contre les Drogues et la Toxicomanie (MILDT), France [0901]; CNRS; University of Lille 1; University Bordeaux 2; Conseil regional d'aquitaine; IREB (Institut de Recherche sur les Boissons)	Fondation Fyssen, France; Mission Interministerielle de la Lutte contre les Drogues et la Toxicomanie (MILDT), France; CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lille 1; University Bordeaux 2; Conseil regional d'aquitaine(Region Nouvelle-Aquitaine); IREB (Institut de Recherche sur les Boissons)	LFV received financial support from Fondation Fyssen, France. ABG received financial support from Mission Interministerielle de la Lutte contre les Drogues et la Toxicomanie (MILDT #0901), France. SHA and MC were financially supported by CNRS and MD by University of Lille 1. Research was supported by CNRS, University Bordeaux 2, Conseil regional d'aquitaine, MILDT, IREB (Institut de Recherche sur les Boissons). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2005, PSYCHOPHARMACOLOGY, V180, P473, DOI 10.1007/s00213-005-2180-z; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Barbano MF, 2007, PSYCHOPHARMACOLOGY, V191, P497, DOI 10.1007/s00213-006-0521-1; Baunez C, 2005, NAT NEUROSCI, V8, P484, DOI 10.1038/nn1429; Berkey CS, 2004, OBES RES, V12, P778, DOI 10.1038/oby.2004.94; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Carelli RM, 2002, PHYSIOL BEHAV, V76, P379, DOI 10.1016/S0031-9384(02)00760-6; Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66; Davis C, 2002, COMPR PSYCHIAT, V43, P189, DOI 10.1053/comp.2002.32356; Davis CA, 2009, OBESITY, V17, P1220, DOI 10.1038/oby.2009.52; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Diergaarde L, 2009, BEHAV NEUROSCI, V123, P794, DOI 10.1037/a0016504; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Drewnowski A, 2007, NUTR BULL, V32, P52, DOI 10.1111/j.1467-3010.2007.00604.x; Frary CD, 2004, J ADOLESCENT HEALTH, V34, P56, DOI 10.1016/S1054-139X(03)00248-9; Frazier CRM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003221; Goeders JE, 2009, PHARMACOL BIOCHEM BE, V93, P67, DOI 10.1016/j.pbb.2009.04.008; Grimm JW, 2007, PSYCHOPHARMACOLOGY, V194, P537, DOI 10.1007/s00213-007-0868-y; Guthrie JF, 2000, J AM DIET ASSOC, V100, P43, DOI 10.1016/S0002-8223(00)00018-3; Hayward MD, 2002, J NEUROSCI, V22, P8251; Iniguez SD, 2009, NEUROPSYCHOPHARMACOL, V34, P1609, DOI 10.1038/npp.2008.220; JACOBSON MF, 2005, LIQUID CANDY SOFT DR; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Le Merrer J, 2006, J NEUROSCI, V26, P7163, DOI 10.1523/JNEUROSCI.5345-05.2006; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Mintz S W, 1979, Marx Perspect, V2, P56; Moore SC, 2009, BRIT J PSYCHIAT, V195, P366, DOI 10.1192/bjp.bp.108.061820; Mormede P, 2004, ALCOHOL ALCOHOLISM, V39, P183, DOI 10.1093/alcalc/agh037; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Popkin BM, 2003, OBES RES, V11, P1325, DOI 10.1038/oby.2003.179; Realini N, 2009, PHARMACOL RES, V60, P132, DOI 10.1016/j.phrs.2009.03.006; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Smith RF, 2003, NEUROTOXICOL TERATOL, V25, P291, DOI 10.1016/S0892-0362(02)00349-5; Spangler R, 2004, MOL BRAIN RES, V124, P134, DOI 10.1016/j.molbrainres.2004.02.013; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stafford D, 1998, PSYCHOPHARMACOLOGY, V139, P169, DOI 10.1007/s002130050702; Thomsen M, 2009, J NEUROSCI, V29, P1087, DOI 10.1523/JNEUROSCI.4037-08.2009; Torrey EF, 2001, INVISIBLE PLAGUE RIS; Vendruscolo LF, 2008, BEHAV PHARMACOL, V19, P21, DOI 10.1097/FBP.0b013e3282f3cfbe; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; White AA, 2004, J NUTR EDUC BEHAV, V36, P266, DOI 10.1016/S1499-4046(06)60390-4; WHO, 2003, DIET NUTR PREVENTION, V916; WURTMAN JJ, 1979, SCIENCE, V205, P321, DOI 10.1126/science.451607; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zukerman S, 2009, AM J PHYSIOL-REG I, V296, pR866, DOI 10.1152/ajpregu.90870.2008	49	73	73	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9296	10.1371/journal.pone.0009296	http://dx.doi.org/10.1371/journal.pone.0009296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560SS	20174565	Green Published, Green Submitted, gold			2022-12-25	WOS:000274923700007
J	Kawaguchi, C; Isojima, Y; Shintani, N; Hatanaka, M; Guo, XH; Okumura, N; Nagai, K; Hashimoto, H; Baba, A				Kawaguchi, Chihiro; Isojima, Yasushi; Shintani, Norihito; Hatanaka, Michiyoshi; Guo, Xiaohong; Okumura, Nobuaki; Nagai, Katsuya; Hashimoto, Hitoshi; Baba, Akemichi			PACAP-Deficient Mice Exhibit Light Parameter-Dependent Abnormalities on Nonvisual Photoreception and Early Activity Onset	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; INDUCED PHASE-SHIFT; GANGLION-CELLS; CIRCADIAN-RHYTHM; MASKING RESPONSES; MELANOPSIN; LACKING; CLOCK; IRRADIANCE; PEPTIDE	Background: The photopigment melanopsin has been suggested to act as a dominant photoreceptor in nonvisual photoreception including resetting of the circadian clock (entrainment), direct tuning or masking of vital status (activity, sleep/wake cycles, etc.), and the pupillary light reflex (PLR). Pituitary adenylate cyclase-activating polypeptide (PACAP) is exclusively coexpressed with melanopsin in a small subset of retinal ganglion cells and is predicted to be involved extensively in these responses; however, there were inconsistencies in the previous reports, and its functional role has not been well understood. Methodology/Principal Findings: Here we show that PACAP-deficient mice exhibited severe dysfunctions of entrainment in a time-dependent manner. The abnormalities in the mutant mice were intensity-dependent in phase delay and duration-dependent in phase advance. The knockout mice also displayed blunted masking, which was dependent on lighting conditions, but not completely lost. The dysfunctions of masking in the mutant mice were recovered by infusion of PACAP-38. By contrast, these mutant mice show a normal PLR. We examined the retinal morphology and innervations in the mutant mice, and no apparent changes were observed in melanopsin-immunoreactive cells. These data suggest that the dysfunctions of entrainment and masking were caused by the loss of PACAP, not by the loss of light input itself. Moreover, PACAP-deficient mice express an unusually early onset of activities, from approximately four hours before the dark period, without influencing the phase of the endogenous circadian clock. Conclusions/Significance: Although some groups including us reported the abnormalities in photic entrainments in PACAP-and PAC(1)-knockout mice, there were inconsistencies in their results [1,2,3,4]. The time-dependent dysfunctions of photic entrainment in the PACAP-knockout mice described in this paper can integrate the incompatible data in previous reports. The recovery of impaired masking by infusion of PACAP-38 in the mutant mice is the first direct evidence of the relationship between PACAP and masking. These results indicate that PACAP regulates particular nonvisual light responses by conveying parametric light information-that is, intensity and duration. The "early-bird'' phenotype in the mutant mice originally reported in this paper supposed that PACAP also has a critical role in daily behavioral patterns, especially during the light-to-dark transition period.	[Kawaguchi, Chihiro; Shintani, Norihito; Hatanaka, Michiyoshi; Guo, Xiaohong; Hashimoto, Hitoshi; Baba, Akemichi] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan; [Isojima, Yasushi; Okumura, Nobuaki; Nagai, Katsuya] Osaka Univ, Inst Prot Res, Osaka, Japan; [Isojima, Yasushi] RIKEN, Genom Sci Ctr, Yokohama, Kanagawa, Japan; [Hashimoto, Hitoshi] Osaka Univ, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Osaka, Japan; [Hashimoto, Hitoshi] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Osaka, Japan; [Hashimoto, Hitoshi] Hamamatsu Univ Sch Med, Osaka, Japan	Osaka University; Osaka University; RIKEN; Osaka University; Kanazawa University; Osaka University; Hamamatsu University School of Medicine	Kawaguchi, C (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan.	isojima@gsc.riken.jp	Shintani, Norihito/N-1600-2019; Hashimoto, Hitoshi/D-1209-2010; Shintani, Norihito/D-5860-2014	Shintani, Norihito/0000-0002-7850-9064; Hashimoto, Hitoshi/0000-0001-6548-4016; Shintani, Norihito/0000-0002-7850-9064	Japan Society for the Promotion of Science; Sankyo Foundation of Life Science; Uehara Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sankyo Foundation of Life Science; Uehara Memorial Foundation(Uehara Memorial Foundation)	This research was partly supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science, the Sankyo Foundation of Life Science, and the Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAHARA H, 2008, FUTURE SYSTEMS EARHQ, P67; Aschoff J, 1999, JPN J PHYSIOL, V49, P11, DOI 10.2170/jjphysiol.49.11; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; BAUER MS, 1992, AM J PHYSIOL, V263, pR1110, DOI 10.1152/ajpregu.1992.263.5.R1110; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Borba JC, 2005, DEV BRAIN RES, V156, P193, DOI 10.1016/j.devbrainres.2005.02.016; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Colwell CS, 2004, AM J PHYSIOL-REG I, V287, pR1194, DOI 10.1152/ajpregu.00268.2004; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Doyle S, 2007, COLD SPRING HARB SYM, V72, P499, DOI 10.1101/sqb.2007.72.003; Doyle SE, 2006, P NATL ACAD SCI USA, V103, P10432, DOI 10.1073/pnas.0600934103; FANG JD, 1995, BRAIN RES, V686, P23, DOI 10.1016/0006-8993(95)00443-T; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Guler AD, 2007, COLD SPRING HARB SYM, V72, P509, DOI 10.1101/sqb.2007.72.074; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hannibal J, 2001, J NEUROSCI, V21, P4883, DOI 10.1523/JNEUROSCI.21-13-04883.2001; Hannibal J, 2008, AM J PHYSIOL-REG I, V295, pR2050, DOI 10.1152/ajpregu.90563.2008; Harrington ME, 1999, J NEUROSCI, V19, P6637; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hashimoto H, 2009, J NEUROCHEM, V110, P595, DOI 10.1111/j.1471-4159.2009.06168.x; Hatanaka M, 2008, NEUROSCI LETT, V444, P153, DOI 10.1016/j.neulet.2008.08.030; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Kawaguchi C, 2003, BIOCHEM BIOPH RES CO, V310, P169, DOI 10.1016/j.bbrc.2003.09.004; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Mabuchi T, 2004, J NEUROSCI, V24, P7283, DOI 10.1523/JNEUROSCI.0983-04.2004; Michel S, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-15; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; MROSOVSKY N, 1994, CHRONOBIOL INT, V11, P343, DOI 10.3109/07420529409057251; Mrosovsky N, 1999, J COMP PHYSIOL A, V184, P423, DOI 10.1007/s003590050341; Mrosovsky N, 2000, VISION RES, V40, P575, DOI 10.1016/S0042-6989(99)00207-2; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Redlin U, 2001, CHRONOBIOL INT, V18, P737, DOI 10.1081/CBI-100107511; Silveira MS, 2002, J BIOL CHEM, V277, P16075, DOI 10.1074/jbc.M110106200; Smale L, 2003, J BIOL RHYTHM, V18, P356, DOI 10.1177/0748730403256651; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370	43	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9286	10.1371/journal.pone.0009286	http://dx.doi.org/10.1371/journal.pone.0009286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174586	Green Published, gold, Green Submitted			2022-12-25	WOS:000274654700016
J	Curriero, FC; Kulldorff, M; Boscoe, FP; Klassen, AC				Curriero, Frank C.; Kulldorff, Martin; Boscoe, Francis P.; Klassen, Ann C.			Using Imputation to Provide Location Information for Nongeocoded Addresses	PLOS ONE			English	Article							POSITIONAL ACCURACY; CANCER; STAGE; ERROR; GRADE	Background: The importance of geography as a source of variation in health research continues to receive sustained attention in the literature. The inclusion of geographic information in such research often begins by adding data to a map which is predicated by some knowledge of location. A precise level of spatial information is conventionally achieved through geocoding, the geographic information system (GIS) process of translating mailing address information to coordinates on a map. The geocoding process is not without its limitations, though, since there is always a percentage of addresses which cannot be converted successfully (nongeocodable). This raises concerns regarding bias since traditionally the practice has been to exclude nongeocoded data records from analysis. Methodology/Principal Findings: In this manuscript we develop and evaluate a set of imputation strategies for dealing with missing spatial information from nongeocoded addresses. The strategies are developed assuming a known zip code with increasing use of collateral information, namely the spatial distribution of the population at risk. Strategies are evaluated using prostate cancer data obtained from the Maryland Cancer Registry. We consider total case enumerations at the Census county, tract, and block group level as the outcome of interest when applying and evaluating the methods. Multiple imputation is used to provide estimated total case counts based on complete data (geocodes plus imputed nongeocodes) with a measure of uncertainty. Results indicate that the imputation strategy based on using available population-based age, gender, and race information performed the best overall at the county, tract, and block group levels. Conclusions/Significance: The procedure allows for the potentially biased and likely under reported outcome, case enumerations based on only the geocoded records, to be presented with a statistically adjusted count (imputed count) with a measure of uncertainty that are based on all the case data, the geocodes and imputed nongeocodes. Similar strategies can be applied in other analysis settings.	[Curriero, Frank C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Curriero, Frank C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Kulldorff, Martin] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Kulldorff, Martin] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Boscoe, Francis P.] New York State Dept Hlth, New York State Canc Registry, Albany, NY USA; [Klassen, Ann C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Klassen, Ann C.] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; State University of New York (SUNY) System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Curriero, FC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA.	fcurrier@jhsph.edu	Kulldorff, Martin/H-4282-2011	Kulldorff, Martin/0000-0002-5284-2993	Centers for Disease Control and the Association of Schools of Public Health; Maryland Cigarette Restitution Fund; Department of Defense; Maryland Cancer Registry; Center for Cancer Surveillance and Control; Department of Health and Mental Hygiene; State of Maryland; National Program of Cancer Registries (NPCR); Centers for Disease Control and Prevention (CDC); NATIONAL CANCER INSTITUTE [R21CA124921] Funding Source: NIH RePORTER	Centers for Disease Control and the Association of Schools of Public Health; Maryland Cigarette Restitution Fund; Department of Defense(United States Department of Defense); Maryland Cancer Registry; Center for Cancer Surveillance and Control; Department of Health and Mental Hygiene; State of Maryland; National Program of Cancer Registries (NPCR); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this research was provided by the following sources: the Centers for Disease Control and the Association of Schools of Public Health, the Maryland Cigarette Restitution Fund, and the Department of Defense. Cancer incidence data have been provided by the Maryland Cancer Registry, Center for Cancer Surveillance and Control, Department of Health and Mental Hygiene, 201 W. Preston Street, Room 400, Baltimore, MD 21201, www.fha.state.md.us/cancer/registry/, 410-767-4055. The author's acknowledge the State of Maryland, the Maryland Cigarette Restitution Fund, and the National Program of Cancer Registries (NPCR) of the Centers for Disease Control and Prevention (CDC) for the funds that helped support the availability of the cancer registry data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERSTEIN KT, 2004, AM J EPIDEMIOL, V160, P51; Bonner MR, 2003, EPIDEMIOLOGY, V14, P408, DOI 10.1097/01.EDE.0000073121.63254.c5; Boscoe FP, 2008, GEOCODING HLTH DATA, P95; BOSCOE FP, 2002, J REGIST MANAG, V29, P117; Cayo Michael R, 2003, Int J Health Geogr, V2, P10, DOI 10.1186/1476-072X-2-10; Cressie N. A. C., 1993, STAT SPATIAL DATA WI; Elliot P., 2000, SPATIAL EPIDEMIOLOGY, P3; Fotheringham AS, 2009, SAGE HDB SPATIAL ANA; Gaffney SH, 2005, ENVIRON HEALTH PERSP, V113, P1712, DOI 10.1289/ehp.8154; *GEOL INC, 1998, CENS CD; Goldberg DW, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-60; Gregorio DI, 1999, HEALTH PLACE, V5, P173, DOI 10.1016/S1353-8292(99)00004-0; Henry KA, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-3; Hinrichsen VL, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-41; Huang L, 2008, STAT MED, V27, P5111, DOI 10.1002/sim.3342; Hurley SE, 2003, EPIDEMIOLOGY, V14, P386, DOI 10.1097/01.EDE.0000073161.66729.89; Jennings JM, 2005, AM J EPIDEMIOL, V161, P73, DOI 10.1093/aje/kwi012; Jung I, 2007, STAT MED, V26, P1594, DOI 10.1002/sim.2607; Klassen AC, 2006, AM J PREV MED, V30, pS77, DOI 10.1016/j.amepre.2005.09.010; Klassen AC, 2004, PREV MED, V39, P441, DOI 10.1016/j.ypmed.2004.04.031; Klassen Ann Carroll, 2005, Int J Health Geogr, V4, P1, DOI 10.1186/1476-072X-4-1; Kravets N, 2007, HEALTH PLACE, V13, P293, DOI 10.1016/j.healthplace.2005.08.006; Lawson, 2010, DIMAPPING RISK ASS; Lawson AB, 2004, GIS IN PUBLIC HEALTH PRACTICE, P31; Little R.J.A., 2002, STAT ANAL MISSING DA; Lovasi GS, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-12; Mazumdar S, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-13; Oliver M Norman, 2005, Int J Health Geogr, V4, P29, DOI 10.1186/1476-072X-4-29; Pickle Linda Williams, 2005, Int J Health Geogr, V4, P3, DOI 10.1186/1476-072X-4-3; Pollack LA, 2006, CANCER CAUSE CONTROL, V17, P449, DOI 10.1007/s10552-005-0505-1; R Development Core Team, 2009, R FDN STAT COMP; Rushton G, 2006, AM J PREV MED, V30, pS16, DOI 10.1016/j.amepre.2005.09.011; Rushton G, 2008, GEOCODING HLTH DATA; SHEEHAN TJ, 2004, INT J HEALTH GEOGR, V3, P1; Stillwell John, 2003, APPL GIS SPATIAL ANA; Strickland MJ, 2007, ENVIRON HEALTH-UK, V6, DOI 10.1186/1476-069X-6-10; Wakefield JC, 2000, SPATIAL EPIDEMIOLOGY, P128; Walter SD., 2000, SPATIAL EPIDEMIOLOGY, P223; Ward MH, 2005, EPIDEMIOLOGY, V16, P542, DOI 10.1097/01.ede.0000165364.54925.f3; Whitsel Eric A, 2006, Epidemiol Perspect Innov, V3, P8, DOI 10.1186/1742-5573-3-8; WIGGINS L, 2002, USING GEOGRAPHIC INF, P85; Wilson JP., 2007, HDB GEOGRAPHIC INFOR, V1st; Zandbergen PA, 2007, ENVIRON HEALTH PERSP, V115, P1363, DOI 10.1289/ehp.9668; Zhan FB, 2006, ANN EPIDEMIOL, V16, P842, DOI 10.1016/j.annepidem.2006.08.001; Zimmerman D.L., 2008, GEOCODING HLTH DATA, P165; Zimmerman DL, 2008, STAT MED, V27, P4254, DOI 10.1002/sim.3288; Zimmerman DL, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-1; Zimmerman DL, 2008, BIOMETRICS, V64, P262, DOI 10.1111/j.1541-0420.2007.00870.x	48	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e8998	10.1371/journal.pone.0008998	http://dx.doi.org/10.1371/journal.pone.0008998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161766	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442700001
J	Weber, CR; Raleigh, DR; Su, LP; Shen, L; Sullivan, EA; Wang, YM; Turner, JR				Weber, Christopher R.; Raleigh, David R.; Su, Liping; Shen, Le; Sullivan, Erika A.; Wang, Yingmin; Turner, Jerrold R.			Epithelial Myosin Light Chain Kinase Activation Induces Mucosal Interleukin-13 Expression to Alter Tight Junction Ion Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; INCREASED INTESTINAL PERMEABILITY; DIARRHEA IN-VIVO; NK-T-CELLS; CROHNS-DISEASE; ULCERATIVE-COLITIS; BARRIER DYSFUNCTION; CLAUDIN-2 EXPRESSION; PARACELLULAR PORES	Intestinal barrier function is reduced in inflammatory bowel disease (IBD). Tumor necrosis factor (TNF) and interleukin (IL)-13, which are up-regulated in IBD, induce barrier defects that are associated with myosin light chain kinase (MLCK) activation and increased claudin-2 expression, respectively, in cultured intestinal epithelial monolayers. Here we report that these independent signaling pathways have distinct effects on tight junction barrier properties and interact in vivo. MLCK activation alters size selectivity to enhance paracellular flux of uncharged macromolecules without affecting charge selectivity and can be rapidly reversed by MLCK inhibition. In contrast, IL-13-dependent claudin-2 expression increases paracellular cation flux in vitro and in vivo without altering tight junction size selectivity but is unaffected by MLCK inhibition in vitro. In vivo, MLCK activation increases paracellular flux of uncharged macromolecules and also triggers IL-13 expression, claudin-2 synthesis, and increased paracellular cation flux. We conclude that reversible, MLCK-dependent permeability increases cause mucosal immune activation that, in turn, feeds back on the tight junction to establish long-lasting barrier defects. Interactions between these otherwise distinct tight junction regulatory pathways may contribute to IBD pathogenesis.	[Weber, Christopher R.; Raleigh, David R.; Su, Liping; Shen, Le; Sullivan, Erika A.; Wang, Yingmin; Turner, Jerrold R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago	Turner, JR (corresponding author), 5841 S Maryland,MC 1089, Chicago, IL 60637 USA.	jturner@bsd.uchicago.edu	Turner, Jerrold R/A-6895-2009; wang, yingying/GRS-3058-2022; Turner, Jerrold/H-1502-2019; Shen, Le/E-7866-2010	Turner, Jerrold R/0000-0003-0627-9455; Weber, Christopher/0000-0002-2117-3184	National Institutes of Health [R01DK61931, R01DK68271, P01DK67887, F32DK082134, T32HL007237, T32GM07281]; University of Chicago Cancer Center [P30CA14599]; Crohn's and Colitis Foundation of America, Laura McAteer Hoffman; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068271, P01DK067887, F32DK082134, R56DK094954, R01DK061931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Cancer Center(University of Chicago); Crohn's and Colitis Foundation of America, Laura McAteer Hoffman; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK61931, R01DK68271, P01DK67887, F32DK082134, T32HL007237, and T32GM07281, University of Chicago Cancer Center Grant P30CA14599, and a research fellowship award from the Crohn's and Colitis Foundation of America sponsored by Laura McAteer Hoffman.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Angelow S, 2009, J BIOL CHEM, V284, P29205, DOI 10.1074/jbc.M109.043752; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Buhner S, 2006, GUT, V55, P342, DOI 10.1136/gut.2005.065557; Ceponis PJM, 2000, J BIOL CHEM, V275, P29132, DOI 10.1074/jbc.M003516200; Clayburgh DR, 2006, J CLIN INVEST, V116, P2682, DOI 10.1172/JCI29218; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; D'Inca R, 1999, AM J GASTROENTEROL, V94, P2956, DOI 10.1111/j.1572-0241.1999.01444.x; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Fihn BM, 2000, GASTROENTEROLOGY, V119, P1029, DOI 10.1053/gast.2000.18148; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Jarnerot G, 2005, GASTROENTEROLOGY, V128, P1805, DOI 10.1053/j.gastro.2005.03.003; Mackay F, 1998, GASTROENTEROLOGY, V115, P1464, DOI 10.1016/S0016-5085(98)70025-3; MADARA JL, 1988, AM J PHYSIOL, V254, P416; Marano CW, 1998, J MEMBRANE BIOL, V161, P263, DOI 10.1007/s002329900333; MAY GR, 1993, GASTROENTEROLOGY, V104, P1627, DOI 10.1016/0016-5085(93)90638-S; McGarry LC, 2004, ONCOGENE, V23, P5284, DOI 10.1038/sj.onc.1207687; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Scharl M, 2009, J BIOL CHEM, V284, P27952, DOI 10.1074/jbc.M109.046292; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Shiue H, 2005, J BIOL CHEM, V280, P1688, DOI 10.1074/jbc.M409471200; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Suenaert P, 2002, AM J GASTROENTEROL, V97, P2000; Targan SR, 2005, IMMUNOL REV, V206, P296, DOI 10.1111/j.0105-2896.2005.00286.x; Taylor CT, 1998, GASTROENTEROLOGY, V114, P657, DOI 10.1016/S0016-5085(98)70579-7; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Uribe JM, 1996, J BIOL CHEM, V271, P26588, DOI 10.1074/jbc.271.43.26588; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Watson CJ, 2005, J CELL SCI, V118, P5221, DOI 10.1242/jcs.02630; Weber CR, 2007, GUT, V56, P6, DOI 10.1136/gut.2006.104182; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Zhang CL, 2005, J INVEST DERMATOL, V125, P1045, DOI 10.1111/j.0022-202X.2005.23925.x; Zolotarevsky Y, 2002, GASTROENTEROLOGY, V123, P163, DOI 10.1053/gast.2002.34235	52	193	202	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12037	12046		10.1074/jbc.M109.064808	http://dx.doi.org/10.1074/jbc.M109.064808			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20177070	Green Published, hybrid			2022-12-25	WOS:000276787100032
J	Bayot, A; Gareil, M; Rogowska-Wrzesinska, A; Roepstorff, P; Friguet, B; Bulteau, AL				Bayot, Aurelien; Gareil, Monique; Rogowska-Wrzesinska, Adelina; Roepstorff, Peter; Friguet, Bertrand; Bulteau, Anne-Laure			Identification of Novel Oxidized Protein Substrates and Physiological Partners of the Mitochondrial ATP-dependent Lon-like Protease Pim1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-AAA PROTEASE; YEAST SACCHAROMYCES-CEREVISIAE; DNA NUCLEOIDS; MOLECULAR CHAPERONES; OXIDATIVE STRESS; QUALITY-CONTROL; MISFOLDED PROTEINS; MASS-SPECTROMETRY; ESCHERICHIA-COLI; INNER MEMBRANE	ATP-dependent proteases are currently emerging as key regulators of mitochondrial functions. Among these proteolytic systems, Pim1, a Lon-like serine protease in Saccharomyces cerevisiae, is involved in the control of selective protein turnover in the mitochondrial matrix. In the absence of Pim1, yeast cells have been shown to accumulate electron-dense inclusion bodies in the matrix space, to lose integrity of mitochondrial genome, and to be respiration-deficient. Because of the severity of phenotypes associated with the depletion of Pim1, this protease appears to be an essential component of the protein quality control machinery in mitochondria and to exert crucial functions during the biogenesis of this organelle. Nevertheless, its physiological substrates and partners are not fully characterized. Therefore, we used the combination of different proteomic techniques to assess the nature of oxidized protein substrates and physiological partners of Pim1 protease under non-repressing growth conditions. The results presented here supply evidence that Pim1-mediated proteolysis is required for elimination of oxidatively damaged proteins in mitochondria.	[Bayot, Aurelien; Gareil, Monique; Friguet, Bertrand; Bulteau, Anne-Laure] Univ Paris 06, Lab Biol Cellulaire Vieillissement, UR4, F-75252 Paris 05, France; [Rogowska-Wrzesinska, Adelina; Roepstorff, Peter] Univ So Denmark, Dept Biochem & Mol Biol, Prot Res Grp, DK-5230 Odense, Denmark	UDICE-French Research Universities; Sorbonne Universite; University of Southern Denmark	Friguet, B (corresponding author), Univ Paris 06, Lab Biol Cellulaire Vieillissement, UR4, Case Courrier 256,Batiment A,5eme Etage,7 Quai St, F-75252 Paris 05, France.	bertrand.friguet@snv.jussieu.fr; anne-laure.bulteau@upmc.fr	bulteau, anne-laure/AAN-4004-2020; Rogowska-Wrzesinska, Adelina/F-2888-2013	Rogowska-Wrzesinska, Adelina/0000-0002-9876-0061; Bayot, Aurelien/0000-0001-7236-9948; Friguet, Bertrand/0000-0001-8085-1961	Ministere de l'Education Nationale, de la Recherche, et de la Technologie (MENRT); Proteomage [LSHM-CT-518230]	Ministere de l'Education Nationale, de la Recherche, et de la Technologie (MENRT); Proteomage	This work was supported by funds from the Ministere de l'Education Nationale, de la Recherche, et de la Technologie (MENRT), and Proteomage Grant LSHM-CT-518230.	Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Bateman JM, 2002, J BIOL CHEM, V277, P47946, DOI 10.1074/jbc.M209071200; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017; Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Chen SH, 2008, NUCLEIC ACIDS RES, V36, P1273, DOI 10.1093/nar/gkm1140; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; FOX TD, 1991, METHOD ENZYMOL, V194, P149; Fu GK, 1998, BIOCHEMISTRY-US, V37, P1905, DOI 10.1021/bi970928c; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; KOBS G, 2001, PROMEGA NOTES, V68, P28; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Korbel D, 2004, EMBO REP, V5, P698, DOI 10.1038/sj.embor.7400186; Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605; Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007; Lefebvre-Legendre L, 2005, J BIOL CHEM, V280, P18386, DOI 10.1074/jbc.M410789200; Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200; Leidhold C, 2007, ANN NY ACAD SCI, V1113, P72, DOI 10.1196/annals.1391.011; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; LITSKE JG, 1986, NUCLEIC ACIDS RES, V14, P9631, DOI 10.1093/nar/14.24.9631; Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200; Lu B, 2003, GENE, V306, P45, DOI 10.1016/S0378-1119(03)00403-7; Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200; MacAlpine DM, 2000, EMBO J, V19, P767, DOI 10.1093/emboj/19.4.767; Major T, 2006, MOL CELL BIOL, V26, P762, DOI 10.1128/MCB.26.3.762-776.2006; Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; Ngo JK, 2007, ANN NY ACAD SCI, V1119, P78, DOI 10.1196/annals.1404.015; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Nomura K, 2004, J BIOL CHEM, V279, P34406, DOI 10.1074/jbc.M404725200; NORAIS N, 1991, J BIOL CHEM, V266, P16541; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Onder O, 2006, MOL CELL PROTEOMICS, V5, P1426, DOI 10.1074/mcp.M600099-MCP200; Ondrovicova G, 2005, J BIOL CHEM, V280, P25103, DOI 10.1074/jbc.M502796200; Osman C, 2007, MOL BIOL CELL, V18, P627, DOI 10.1091/mbc.E06-09-0839; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rep M, 1996, CURR GENET, V30, P367, DOI 10.1007/s002940050145; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; Rosen R, 2002, FEMS MICROBIOL LETT, V207, P9, DOI 10.1111/j.1574-6968.2002.tb11020.x; Rottgers K, 2002, J BIOL CHEM, V277, P45829, DOI 10.1074/jbc.M207152200; Savel'ev AS, 1998, J BIOL CHEM, V273, P20596, DOI 10.1074/jbc.273.32.20596; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5; Stahlberg H, 1999, P NATL ACAD SCI USA, V96, P6787, DOI 10.1073/pnas.96.12.6787; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; van Dijl JM, 1998, P NATL ACAD SCI USA, V95, P10584, DOI 10.1073/pnas.95.18.10584; van Dyck L, 1998, GENE DEV, V12, P1515, DOI 10.1101/gad.12.10.1515; VANDYCK L, 1994, J BIOL CHEM, V269, P238; von Janowsky B, 2005, BIOL CHEM, V386, P1307, DOI 10.1515/BC.2005.149; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Wagner I, 1997, EMBO J, V16, P7317, DOI 10.1093/emboj/16.24.7317; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; WANG N, 1993, P NATL ACAD SCI USA, V90, P11247, DOI 10.1073/pnas.90.23.11247; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200	73	74	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11445	11457		10.1074/jbc.M109.065425	http://dx.doi.org/10.1074/jbc.M109.065425			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20150421	Green Published, hybrid			2022-12-25	WOS:000276286200051
J	Chen, AC; Guo, LY; Ostaszewski, BL; Selkoe, DJ; LaVoie, MJ				Chen, Allen C.; Guo, Lucie Y.; Ostaszewski, Beth L.; Selkoe, Dennis J.; LaVoie, Matthew J.			Aph-1 Associates Directly with Full-length and C-terminal Fragments of gamma-Secretase Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSMEMBRANE DOMAIN-4; PRESENILIN COMPLEXES; ALZHEIMERS-DISEASE; NOTCH LIGANDS; BETA-PROTEIN; NICASTRIN; PEN-2; MEMBRANE; CLEAVAGE	gamma-Secretase is a ubiquitous, multiprotein enzyme composed of presenilin, nicastrin, Aph-1, and Pen-2. It mediates the intramembrane proteolysis of many type 1 proteins, plays an essential role in numerous signaling pathways, and helps drive the pathogenesis of Alzheimer disease by excising the hydrophobic, aggregation-prone amyloid beta-peptide from the beta-amyloid precursor protein. A central unresolved question is how its many substrates bind and enter the gamma-secretase complex. Here, we provide evidence that both the beta-amyloid precursor protein holoprotein and its C-terminal fragments, the immediate substrates of gamma-secretase, can associate with Aph-1 at overexpressed as well as endogenous protein levels. This association was observed using bi-directional co-immunoprecipitation in multiple systems and detergent conditions, and an beta-amyloid precursor protein-Aph-1 complex was specifically isolated following in situ cross-linking in living cells. In addition, another endogenous canonical gamma-substrate, Jagged, showed association of both its full-length and C-terminal fragment forms with Aph-1. We were also able to demonstrate that this interaction with substrates was conserved across the multiple isoforms of Aph-1 (beta, alpha S, and alpha L), as they were all able to bind beta-amyloid precursor protein with similar affinity. Finally, two highly conserved intramembrane histidines (His-171 and His-197) within Aph-1, which were recently shown to be important for gamma-secretase activity, are required for efficient binding of substrates. Taken together, our data suggest a dominant role for Aph-1 in interacting with gamma-secretase substrates prior to their processing by the proteolytic complex.	[LaVoie, Matthew J.] Brigham & Womens Hosp, Ctr Neurol Dis, Harvard Inst Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	LaVoie, MJ (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Harvard Inst Med, Rm 764, Boston, MA 02115 USA.	mlavoie@rics.bwh.harvard.edu		LaVoie, Matthew/0000-0002-2583-1578	National Institutes of Health [AG015379, AG023094]; Excellence in Biomedical Research; Smith Family and Ludke Family Foundations; NATIONAL INSTITUTE ON AGING [R37AG006173, K01AG023094, P01AG015379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Excellence in Biomedical Research; Smith Family and Ludke Family Foundations; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG015379 (to D.J.S.) and AG023094 (to M.J.L.). This work was also supported by an award for Excellence in Biomedical Research from The Smith Family and Ludke Family Foundations (to M.J.L.).	Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Berezovska O, 2003, J NEUROSCI, V23, P4560; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Coolen MW, 2005, FASEB J, V19, P175, DOI 10.1096/fj.05-4337fje; Coolen MW, 2005, NEURON, V45, P497, DOI 10.1016/j.neuron.2004.12.054; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fortna RR, 2004, J BIOL CHEM, V279, P3685, DOI 10.1074/jbc.M310505200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Futai E, 2009, J BIOL CHEM, V284, P13013, DOI 10.1074/jbc.M807653200; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hu Y, 2003, J CELL BIOL, V161, P685, DOI 10.1083/jcb.200304014; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Morais VA, 2003, J BIOL CHEM, V278, P43284, DOI 10.1074/jbc.M305685200; Pardossi-Piquard R, 2009, J BIOL CHEM, V284, P16298, DOI 10.1074/jbc.M109.000067; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Steiner H, 2008, J BIOL CHEM, V283, P34677, DOI 10.1074/jbc.M709067200; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	46	28	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11378	11391		10.1074/jbc.M109.088815	http://dx.doi.org/10.1074/jbc.M109.088815			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145246	hybrid, Green Published			2022-12-25	WOS:000276286200044
J	Xie, J; Litman, R; Wang, S; Peng, M; Guillemette, S; Rooney, T; Cantor, SB				Xie, J.; Litman, R.; Wang, S.; Peng, M.; Guillemette, S.; Rooney, T.; Cantor, S. B.			Targeting the FANCJ-BRCA1 interaction promotes a switch from recombination to pol eta-dependent bypass	ONCOGENE			English	Article						BRCA1; FANCJ; DNA repair	DNA-POLYMERASE-ETA; HOMOLOGY-DIRECTED REPAIR; FANCONI-ANEMIA PATHWAY; BREAST-CANCER; HELICASE BRIP1; PROTEIN; DAMAGE; BRCA1; CELLS; BACH1	BRCA1 and the DNA helicase FANCJ (also known as BACH1 or BRIP1) have common functions in breast cancer suppression and DNA repair. However, the functional significance of the direct interaction between BRCA1 and FANCJ remains unclear. Here, we have discovered that BRCA1 binding to FANCJ regulates DNA damage repair choice. Thus, when FANCJ binding to BRCA1 is ablated, the molecular mechanism chosen for the repair of damaged DNA is dramatically altered. Specifically, a FANCJ protein that cannot be phosphorylated at serine 990 or bind BRCA1 inhibits DNA repair via homologous recombination and promotes pol eta-dependent bypass. Furthermore, the pol eta-dependent bypass promoted by FANCJ requires the direct binding to the mismatch repair (MMR) protein, MLH1. Together, our findings implicate that in human cells BRCA1 binding to FANCJ is critical to regulate DNA repair choice and promote genomic stability. Moreover, unregulated FANCJ function could be associated with cancer and/or chemoresistance. Oncogene (2010) 29, 2499-2508; doi:10.1038/onc.2010.18; published online 22 February 2010	[Xie, J.; Litman, R.; Wang, S.; Peng, M.; Guillemette, S.; Rooney, T.; Cantor, S. B.] Univ Massachusetts, UMASS Mem Canc Ctr, Dept Canc Biol, Womens Cancers Program,Sch Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University Massachusetts Worcester Hospital	Cantor, SB (corresponding author), UMASS Med Sch, Dept Canc Biol, 364 Plantat St,LRB Rm 415, Worcester, MA 01605 USA.	Sharon.Cantor@umassmed.edu			NIH [R01 CA129514-01A1]; NATIONAL CANCER INSTITUTE [R01CA129514] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Larry Thompson, Alan Lehmann, and Roger Greenberg for critical comments. We also thank Maria Jasin for the DR-U2OS cells and Alan Lehmann for the XPV-vector and pol eta-complemented lines as well as pol eta-GFP construct, Hans Joenje for FA-J cells, and Claire Baldwin for readership comments. This study was supported by NIH R01 CA129514-01A1 and from charitable contributions from Mr and Mrs Edward T Vitone Jr.	Albertella MR, 2005, CANCER RES, V65, P9799, DOI 10.1158/0008-5472.CAN-05-1095; Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Barbour L, 2003, MUTAT RES-FUND MOL M, V532, P137, DOI 10.1016/j.mrfmmm.2003.08.014; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cantor SB, 2006, CELL CYCLE, V5, P164, DOI 10.4161/cc.5.2.2338; Delacote F, 2007, MUTAT RES-FUND MOL M, V615, P125, DOI 10.1016/j.mrfmmm.2006.11.028; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Eelen G, 2008, ONCOGENE, V27, P4233, DOI 10.1038/onc.2008.51; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Hinz JM, 2006, DNA REPAIR, V5, P875, DOI 10.1016/j.dnarep.2006.05.039; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kim HT, 2008, MOL CELLS, V25, P457; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shen X, 2009, MOL CELL, V35, P716, DOI 10.1016/j.molcel.2009.06.034; Sinclair CS, 2003, BREAST CANCER RES TR, V78, P313, DOI 10.1023/A:1023081624133; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zheng HY, 2003, MOL CELL BIOL, V23, P754, DOI 10.1128/MCB.23.2.754-761.2003	43	50	50	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	17					2499	2508		10.1038/onc.2010.18	http://dx.doi.org/10.1038/onc.2010.18			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	589RB	20173781	Green Accepted			2022-12-25	WOS:000277169400005
J	Chung, CAB; Boyd, VL; McKernan, KJ; Fu, YT; Monighetti, C; Peckham, HE; Barker, M				Chung, Christina A. Bormann; Boyd, Victoria L.; McKernan, Kevin J.; Fu, Yutao; Monighetti, Cinna; Peckham, Heather E.; Barker, Melissa			Whole Methylome Analysis by Ultra-Deep Sequencing Using Two-Base Encoding	PLOS ONE			English	Article							DNA METHYLATION; ESCHERICHIA-COLI; HUMAN GENOME; BISULFITE; ARABIDOPSIS; LIGATION; REVEALS; SITES; CELLS; WIDE	Methylation, the addition of methyl groups to cytosine (C), plays an important role in the regulation of gene expression in both normal and dysfunctional cells. During bisulfite conversion and subsequent PCR amplification, unmethylated Cs are converted into thymine (T), while methylated Cs will not be converted. Sequencing of this bisulfite-treated DNA permits the detection of methylation at specific sites. Through the introduction of next-generation sequencing technologies (NGS) simultaneous analysis of methylation motifs in multiple regions provides the opportunity for hypothesis-free study of the entire methylome. Here we present a whole methylome sequencing study that compares two different bisulfite conversion methods (in solution versus in gel), utilizing the high throughput of the SOLiD (TM) System. Advantages and disadvantages of the two different bisulfite conversion methods for constructing sequencing libraries are discussed. Furthermore, the application of the SOLiD (TM) bisulfite sequencing to larger and more complex genomes is shown with preliminary in silico created bisulfite converted reads.	[Chung, Christina A. Bormann; Boyd, Victoria L.; Monighetti, Cinna; Barker, Melissa] Life Technol, Foster City, CA USA; [McKernan, Kevin J.; Fu, Yutao; Peckham, Heather E.] Life Technol, Beverly, MA USA	Thermo Fisher Scientific; Thermo Fisher Scientific	Chung, CAB (corresponding author), Life Technol, Foster City, CA USA.	Christina.Chung@lifetech.com		McKernan, Kevin/0000-0002-3908-1122	Life Technologies	Life Technologies	This study was supported by Life Technologies. Data available upon request. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Chen JJ, 1998, NUCLEIC ACIDS RES, V26, P1546, DOI 10.1093/nar/26.6.1546; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; HODGES E, 2009, GENOME RES, DOI DOI 10.1101/GR.095190.109/; Homer N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-175; Korshunova Y, 2008, GENOME RES, V18, P19, DOI 10.1101/gr.6883307; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; MARINUS MG, 1987, ANNU REV GENET, V21, P113, DOI 10.1146/annurev.genet.21.1.113; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Pomraning KR, 2009, METHODS, V47, P142, DOI 10.1016/j.ymeth.2008.09.022; Ranade SS, 2009, ANAL BIOCHEM, V390, P126, DOI 10.1016/j.ab.2009.04.020; RINGQUIST S, 1992, P NATL ACAD SCI USA, V89, P4539, DOI 10.1073/pnas.89.10.4539; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	20	38	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9320	10.1371/journal.pone.0009320	http://dx.doi.org/10.1371/journal.pone.0009320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179767	gold, Green Submitted, Green Published			2022-12-25	WOS:000274923900005
J	Dharajiya, N; Vaidya, SV; Murai, H; Cardenas, V; Kurosky, A; Boldogh, I; Sur, SA				Dharajiya, Nilesh; Vaidya, Swapnil V.; Murai, Hiroki; Cardenas, Victor; Kurosky, Alexander; Boldogh, Istvan; Sur, Sanjiv A.			Fc gamma RIIb Inhibits Allergic Lung Inflammation in a Murine Model of Allergic Asthma	PLOS ONE			English	Article							INDUCED AIRWAY HYPERRESPONSIVENESS; BIFUNCTIONAL FUSION PROTEIN; CLASS-SWITCH RECOMBINATION; MAST-CELL ACTIVATION; DENDRITIC CELLS; IFN-GAMMA; RECEPTOR IIB; IN-VIVO; NEGATIVE REGULATION; IMMUNOGLOBULIN-E	Allergic asthma is characterized by airway eosinophilia, increased mucin production and allergen-specific IgE. Fc gamma receptor IIb (Fc gamma RIIb), an inhibitory IgG receptor, has recently emerged as a negative regulator of allergic diseases like anaphylaxis and allergic rhinitis. However, no studies to date have evaluated its role in allergic asthma. Our main objective was to study the role of Fc gamma RIIb in allergic lung inflammation. We used a murine model of allergic airway inflammation. Inflammation was quantified by BAL inflammatory cells and airway mucin production. Fc gamma RIIb expression was measured by qPCR and flow cytometry and the cytokines were quantified by ELISA. Compared to wild type animals, Fc gamma RIIb deficient mice mount a vigorous allergic lung inflammation characterized by increased bronchoalveolar lavage fluid cellularity, eosinophilia and mucin content upon ragweed extract (RWE) challenge. RWE challenge in sensitized mice upregulated Fc gamma RIIb in the lungs. Disruption of IFN-gamma gene abrogated this upregulation. Treatment of naive mice with the Th1-inducing agent CpG DNA increased Fc gamma RIIb expression in the lungs. Furthermore, treatment of sensitized mice with CpG DNA prior to RWE challenge induced greater upregulation of Fc gamma RIIb than RWE challenge alone. These observations indicated that RWE challenge upregulated Fc gamma RIIb in the lungs by IFN-gamma- and Th1-dependent mechanisms. RWE challenge upregulated Fc gamma RIIb on pulmonary CD14+/MHC II+ mononuclear cells and CD11c+ cells. Fc gamma RIIb deficient mice also exhibited an exaggerated RWE-specific IgE response upon sensitization when compared to wild type mice. We propose that Fc gamma RIIb physiologically regulates allergic airway inflammation by two mechanisms: 1) allergen challenge mediates upregulation of Fc gamma RIIb on pulmonary CD14+/MHC II+ mononuclear cells and CD11c+ cells by an IFN-gamma dependent mechanism; and 2) by attenuating the allergen specific IgE response during sensitization. Thus, stimulating Fc gamma RIIb may be a therapeutic strategy in allergic airway disorders.	[Dharajiya, Nilesh] Univ Texas Galveston, Med Branch, NHLBI, Prote Ctr,Dept Biochem & Mol Biol, Galveston, TX 77550 USA; [Vaidya, Swapnil V.; Murai, Hiroki; Cardenas, Victor; Sur, Sanjiv A.] Univ Texas Galveston, Med Branch, Dept Internal Med, Galveston, TX 77550 USA; [Kurosky, Alexander] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77550 USA; [Boldogh, Istvan] Univ Texas Galveston, Med Branch, Dept Microbiol, Galveston, TX 77550 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Dharajiya, N (corresponding author), Univ Texas Galveston, Med Branch, NHLBI, Prote Ctr,Dept Biochem & Mol Biol, Galveston, TX 77550 USA.	sasur@utmb.edu			National Institutes of Health (NIH) [RO1HL071163]; National Institute of Allergy and Infectious Disease (NIAID) [PO1AI062885-01]; National Heart, Lung, and Blood Institute (NHLBI) Proteomics Initiative [NO1HV-28184]; National Institute of Environmental Health Sciences (NIEHS) [EOS 006677]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028184] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676, R01ES018948] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute (NHLBI) Proteomics Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from National Institutes of Health (NIH) RO1HL071163 (S.S.), National Institute of Allergy and Infectious Disease (NIAID), PO1AI062885-01 (I.B., S.S.), National Heart, Lung, and Blood Institute (NHLBI) Proteomics Initiative, NO1HV-28184 (S.S.) and National Institute of Environmental Health Sciences (NIEHS) Center Grant, EOS 006677 (I.B., S.S.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Bruhns P, 2000, J BIOL CHEM, V275, P37357, DOI 10.1074/jbc.M003518200; Caron G, 2001, J IMMUNOL, V167, P3682, DOI 10.4049/jimmunol.167.7.3682; Choudhury BK, 2002, J IMMUNOL, V169, P5955, DOI 10.4049/jimmunol.169.10.5955; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; Dharajiya N, 2007, J ALLERGY CLIN IMMUN, V119, P646, DOI 10.1016/j.jaci.2006.11.634; Dharajiya N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008172; Flaishon L, 2002, J IMMUNOL, V168, P3707, DOI 10.4049/jimmunol.168.8.3707; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Fulkerson PC, 2004, P NATL ACAD SCI USA, V101, P1987, DOI 10.1073/pnas.0308544100; Gangur V, 1999, INT ARCH ALLERGY IMM, V118, P387, DOI 10.1159/000024144; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; GOSWAMI S, 2009, NAT IMMUNOL; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; Hoffmann PR, 2007, J IMMUNOL METHODS, V328, P21, DOI 10.1016/j.jim.2007.07.019; Huang TJ, 2001, J IMMUNOL, V166, P207, DOI 10.4049/jimmunol.166.1.207; Hunt LW, 2002, CLIN EXP ALLERGY, V32, P210, DOI 10.1046/j.1365-2222.2002.01228.x; HUNT LW, 1994, AM J RESP CRIT CARE, V149, P1471, DOI 10.1164/ajrccm.149.6.8004300; Jensen WA, 2001, BIOCHEM SOC T, V29, P840, DOI 10.1042/0300-5127:0290840; JOSEPH M, 1983, J CLIN INVEST, V71, P221, DOI 10.1172/JCI110762; Justice JP, 2001, AM J PHYSIOL-LUNG C, V280, pL363, DOI 10.1152/ajplung.2001.280.2.L363; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; Kepley CL, 2000, J ALLERGY CLIN IMMUN, V106, P337, DOI 10.1067/mai.2000.107931; Kitamura K, 2007, J IMMUNOL, V178, P480, DOI 10.4049/jimmunol.178.1.480; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Lee SH, 2004, J ALLERGY CLIN IMMUN, V113, P72, DOI 10.1016/j.jaci.2003.09.039; Li YH, 2006, J IMMUNOL, V177, P1679, DOI 10.4049/jimmunol.177.3.1679; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Manetz TS, 2001, MOL CELL BIOL, V21, P3763, DOI 10.1128/MCB.21.11.3763-3774.2001; Mertsching E, 2008, J ALLERGY CLIN IMMUN, V121, P441, DOI 10.1016/j.jaci.2007.08.051; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; Nakamura A, 2000, J EXP MED, V191, P899, DOI 10.1084/jem.191.5.899; Obayashi K, 2007, INT IMMUNOL, V19, P217, DOI 10.1093/intimm/dxl138; Passalacqua G, 2008, CLIN EXP IMMUNOL, V153, P12, DOI 10.1111/j.1365-2249.2008.03715.x; PHILLIPS NE, 1983, J IMMUNOL, V130, P602; Poulsen LK, 2007, ANN MED, V39, P440, DOI 10.1080/07853890701449354; Pricop L, 2001, J IMMUNOL, V166, P531, DOI 10.4049/jimmunol.166.1.531; Pritchard NR, 2000, CURR BIOL, V10, P227, DOI 10.1016/S0960-9822(00)00344-4; Qin DH, 2000, J IMMUNOL, V164, P6268, DOI 10.4049/jimmunol.164.12.6268; Rabinovitch N, 2004, INT ARCH ALLERGY IMM, V133, P285, DOI 10.1159/000076836; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rohr UP, 2002, J VIROL METHODS, V106, P81, DOI 10.1016/S0166-0934(02)00138-6; Saxon A, 2008, J ALLERGY CLIN IMMUN, V121, P320, DOI 10.1016/j.jaci.2007.10.017; Scheurer Michael E, 2007, Infect Agent Cancer, V2, P8, DOI 10.1186/1750-9378-2-8; Stefanescu RN, 2004, J CLIN IMMUNOL, V24, P315, DOI 10.1023/B:JOCI.0000029105.47772.04; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Sur S, 1999, J IMMUNOL, V162, P6284; Suzuki Y, 1998, KIDNEY INT, V54, P1166, DOI 10.1046/j.1523-1755.1998.00108.x; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Tridandapani S, 2002, J BIOL CHEM, V277, P5082, DOI 10.1074/jbc.M110277200; Ujike A, 1999, J EXP MED, V189, P1573, DOI 10.1084/jem.189.10.1573; Watanabe T, 2004, AM J RESP CRIT CARE, V169, P105, DOI 10.1164/rccm.200302-239OC; Wild JS, 2000, J IMMUNOL, V164, P2701, DOI 10.4049/jimmunol.164.5.2701; WILLIAMS J, 1992, J IMMUNOL, V149, P2823; Yamada T, 2003, J BIOL CHEM, V278, P32818, DOI 10.1074/jbc.M304590200; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187; Zhang K, 2004, J ALLERGY CLIN IMMUN, V114, P321, DOI 10.1016/j.jaci.2004.03.058; Zhang Y, 2009, J IMMUNOL, V182, P554, DOI 10.4049/jimmunol.182.1.554; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219; Zhu DC, 2002, NAT MED, V8, P518, DOI 10.1038/nm0502-518	71	23	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9337	10.1371/journal.pone.0009337	http://dx.doi.org/10.1371/journal.pone.0009337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179765	gold, Green Published, Green Submitted			2022-12-25	WOS:000274923900007
J	Azzopardi, PV; O'Young, J; Lajoie, G; Karttunen, M; Goldberg, HA; Hunter, GK				Azzopardi, Paul V.; O'Young, Jason; Lajoie, Gilles; Karttunen, Mikko; Goldberg, Harvey A.; Hunter, Graeme K.			Roles of Electrostatics and Conformation in Protein-Crystal Interactions	PLOS ONE			English	Article							CALCIUM-OXALATE CRYSTALLIZATION; BONE SIALOPROTEIN; IN-VITRO; HYDROXYAPATITE FORMATION; CONSTANT COMPOSITION; MOLECULAR-DYNAMICS; POSTTRANSLATIONAL MODIFICATIONS; ACIDIC PROTEINS; OSTEOPONTIN; GROWTH	In vitro studies have shown that the phosphoprotein osteopontin (OPN) inhibits the nucleation and growth of hydroxyapatite (HA) and other biominerals. In vivo, OPN is believed to prevent the calcification of soft tissues. However, the nature of the interaction between OPN and HA is not understood. In the computational part of the present study, we used molecular dynamics simulations to predict the adsorption of 19 peptides, each 16 amino acids long and collectively covering the entire sequence of OPN, to the {100} face of HA. This analysis showed that there is an inverse relationship between predicted strength of adsorption and peptide isoelectric point (P < 0.0001). Analysis of the OPN sequence by PONDR (Predictor of Naturally Disordered Regions) indicated that OPN sequences predicted to adsorb well to HA are highly disordered. In the experimental part of the study, we synthesized phosphorylated and non-phosphorylated peptides corresponding to OPN sequences 65-80 (pSHDHMDDDDDDDDDGD) and 220-235 (pSHEpSTEQSDAIDpSAEK). In agreement with the PONDR analysis, these were shown by circular dichroism spectroscopy to be largely disordered. A constant-composition/seeded growth assay was used to assess the HA-inhibiting potencies of the synthetic peptides. The phosphorylated versions of OPN65-80 (IC50 = 1.93 mu g/ml) and OPN220-235 (IC50 = 1.48 mu g/ml) are potent inhibitors of HA growth, as is the nonphosphorylated version of OPN65-80 (IC50 = 2.97 mu g/ml); the nonphosphorylated version of OPN220-235 has no measurable inhibitory activity. These findings suggest that the adsorption of acidic proteins to Ca2+-rich crystal faces of biominerals is governed by electrostatics and is facilitated by conformational flexibility of the polypeptide chain.	[Azzopardi, Paul V.; O'Young, Jason; Goldberg, Harvey A.; Hunter, Graeme K.] Univ Western Ontario, Sch Dent, London, ON, Canada; [Azzopardi, Paul V.; Lajoie, Gilles; Goldberg, Harvey A.; Hunter, Graeme K.] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Karttunen, Mikko] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Azzopardi, PV (corresponding author), Univ Western Ontario, Sch Dent, London, ON, Canada.	graeme.hunter@schulich.uwo.ca	Goldberg, Harvey/B-5742-2015; Azzopardi, Paul/C-5694-2013; Karttunen, Mikko/G-4531-2010	Azzopardi, Paul/0000-0001-7386-8191; Karttunen, Mikko/0000-0002-8626-3033	Canadian Institutes of Health Research [MOP-68827]; Natural Sciences and Engineering Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	These studies were funded by Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) operating grant MOP-68827 and by the Natural Sciences and Engineering Council of Canada (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Addadi L, 2001, Z Kardiol, V90 Suppl 3, P92; ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Almora-Barrios N, 2009, LANGMUIR, V25, P5018, DOI 10.1021/la803842g; ANDALORO G, 1988, CHEM PHYS LETT, V149, P201, DOI 10.1016/0009-2614(88)87222-1; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Berendsen H., 1981, INTERMOLECULAR FORCE, DOI DOI 10.1007/978-94-015-7658-1_21; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Buehler MJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/29/295102; Chen PH, 2008, J AM CHEM SOC, V130, P2862, DOI 10.1021/ja076607y; Clark RH, 1999, CALCIFIED TISSUE INT, V64, P516, DOI 10.1007/s002239900642; Dahlin S, 1998, EUR J ORAL SCI, V106, P239, DOI 10.1111/j.1600-0722.1998.tb02182.x; Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168; Dubey DK, 2009, J MECH PHYS SOLIDS, V57, P1702, DOI 10.1016/j.jmps.2009.07.002; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Elhadj S, 2006, P NATL ACAD SCI USA, V103, P19237, DOI 10.1073/pnas.0605748103; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Filgueiras MRT, 2006, J CRYST GROWTH, V294, P60, DOI 10.1016/j.jcrysgro.2006.05.077; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Fleet ME, 2004, AM MINERAL, V89, P1422; FRANK FC, 1949, DISCUSS FARADAY SOC, P48, DOI 10.1039/df9490500048; FUJISAWA R, 1991, BIOCHIM BIOPHYS ACTA, V1075, P56; FUREDIMILHOFER H, 1994, CONNECT TISSUE RES, V30, P251, DOI 10.3109/03008209409015041; Gauci S, 2008, PROTEOMICS, V8, P4898, DOI 10.1002/pmic.200800295; Gerbaud V, 2000, J BIOL CHEM, V275, P1057, DOI 10.1074/jbc.275.2.1057; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; GILMAN H, 1994, J INORG BIOCHEM, V55, P31, DOI 10.1016/0162-0134(94)85130-1; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; Grohe B, 2007, J AM CHEM SOC, V129, P14946, DOI 10.1021/ja0745613; Grohe B, 2009, LANGMUIR, V25, P11635, DOI 10.1021/la901145d; Harding JH, 2006, J MATER CHEM, V16, P1105, DOI 10.1039/b511650c; Harding JH, 2008, CHEM REV, V108, P4823, DOI 10.1021/cr078278y; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; Hincke M.T., 2000, CHEM BIOL MINERALIZE, P13; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Holt C, 1996, BIOCHEM J, V314, P1035, DOI 10.1042/bj3141035; Hoyer JR, 2001, KIDNEY INT, V60, P77, DOI 10.1046/j.1523-1755.2001.00772.x; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; Hunter GK, 2009, CELLS TISSUES ORGANS, V189, P44, DOI 10.1159/000151430; Huq NL, 2000, J MOL MODEL, V6, P35; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Jono S, 2000, J BIOL CHEM, V275, P20197, DOI 10.1074/jbc.M909174199; Karttunen M, 2008, CURR TOP MEMBR, V60, P49, DOI 10.1016/S1063-5823(08)00002-1; Keykhosravani M, 2005, BIOCHEMISTRY-US, V44, P6990, DOI 10.1021/bi050109p; KOUTSOUKOS P, 1980, J AM CHEM SOC, V102, P1553, DOI 10.1021/ja00525a015; Kumar V, 2006, CURR OPIN NEPHROL HY, V15, P374, DOI 10.1097/01.mnh.0000232877.12599.f4; LANGDON A, 2009, CALCIFIED T IN PRESS; LEE WK, 1981, J CHEM PHYS, V75, P3040, DOI 10.1063/1.442399; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mann S., 2001, BIOMINERALIZATION PR; Masica DL, 2009, BIOPHYS J, V96, P3082, DOI 10.1016/j.bpj.2009.01.033; Mo L, 2004, KIDNEY INT, V66, P1159, DOI 10.1111/j.1523-1755.2004.00867.x; Moravec M, 2003, FABULA, V44, P1; NANCOLLAS GH, 1970, ARCH ORAL BIOL, V15, P731, DOI 10.1016/0003-9969(70)90037-3; NANCOLLAS GH, 1984, INHIBITORS CRYSTALLI; O'Young J, 2009, CELLS TISSUES ORGANS, V189, P51, DOI 10.1159/000151724; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Pampena DA, 2004, BIOCHEM J, V378, P1083, DOI 10.1042/BJ20031150; Pan H., 2007, FRONTIERS CHEM CHINA, V2, P156, DOI DOI 10.1007/S11458-007-0032-6; Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2; Patra M, 2004, J COMPUT CHEM, V25, P678, DOI 10.1002/jcc.10417; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447; Qiu SR, 2004, P NATL ACAD SCI USA, V101, P1811, DOI 10.1073/pnas.0307900100; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; SMITH PE, 1991, J CHEM PHYS, V95, P8430, DOI 10.1063/1.461272; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; TOMSON MB, 1978, SCIENCE, V200, P1059, DOI 10.1126/science.200.4345.1059; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang LJ, 2008, J PHYS CHEM B, V112, P9151, DOI 10.1021/jp804282u; Wesson JA, 2003, J AM SOC NEPHROL, V14, P139, DOI 10.1097/01.ASN.0000040593.93815.9D; WORCESTER EM, 1992, J BONE MINER RES, V7, P1029; Zhang HP, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044110	79	62	62	6	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9330	10.1371/journal.pone.0009330	http://dx.doi.org/10.1371/journal.pone.0009330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174473	Green Published, Green Submitted, gold			2022-12-25	WOS:000274923700027
J	Marley, A; von Zastrow, M				Marley, Aaron; von Zastrow, Mark			Dysbindin Promotes the Post-Endocytic Sorting of G Protein-Coupled Receptors to Lysosomes	PLOS ONE			English	Article							ORGANELLES COMPLEX-1; SCHIZOPHRENIA; BLOC-1; INTERNALIZATION; TRAFFICKING; BIOGENESIS; ENDOSOMES; IDENTIFICATION; DEGRADATION; MECHANISMS	Background: Dysbindin, a cytoplasmic protein long known to function in the biogenesis of specialized lysosome-related organelles (LROs), has been reported to reduce surface expression of D2 dopamine receptors in neurons. Dysbindin is broadly expressed, and dopamine receptors are members of the large family of G protein-coupled receptors (GPCRs) that function in diverse cell types. Thus we asked if dysbindin regulates receptor number in non-neural cells, and further investigated the cellular basis of this regulation. Methodology/Principal Findings: We used RNA interference to deplete endogenous dysbindin in HEK293 and HeLa cells, then used immunochemical and biochemical methods to assess expression and endocytic trafficking of epitope-tagged GPCRs. Dysbindin knockdown up-regulated surface expression of D2 receptors compared to D1 receptors, as reported previously in neurons. This regulation was not mediated by a change in D2 receptor endocytosis. Instead, dysbindin knockdown specifically reduced the subsequent trafficking of internalized D2 receptors to lysosomes. This distinct post-endocytic sorting function explained the minimal effect of dysbindin depletion on D1 receptors, which recycle efficiently and traverse the lysosomal pathway to only a small degree. Moreover, dysbindin regulated the delta opioid receptor, a more distantly related GPCR that is also sorted to lysosomes after endocytosis. Dysbindin was not required for lysosomal trafficking of all signaling receptors, however, as its depletion did not detectably affect down-regulation of the EGF receptor tyrosine kinase. Dysbindin co-immunoprecipitated with GASP-1 (or GPRASP-1), a cytoplasmic protein shown previously to modulate lysosomal trafficking of D2 dopamine and delta opioid receptors by direct interaction, and with HRS that is a core component of the conserved ESCRT machinery mediating lysosome biogenesis and sorting. Conclusions/Significance: These results identify a distinct, and potentially widespread function of dysbindin in promoting the sorting of specific GPCRs to lysosomes after endocytosis.	[Marley, Aaron] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marley, A (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	mark.vonzastrow@ucsf.edu			National Institutes of Health [DA010711, DA012864]; NATIONAL INSTITUTE ON DRUG ABUSE [R29DA010711, R01DA012864, R01DA010711, R37DA010711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health DA010711, DA012864. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bhardwaj SK, 2009, BEHAV BRAIN RES, V197, P435, DOI 10.1016/j.bbr.2008.10.011; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chu P, 1997, J BIOL CHEM, V272, P27124, DOI 10.1074/jbc.272.43.27124; Cox MM, 2009, GENES BRAIN BEHAV, V8, P390, DOI 10.1111/j.1601-183X.2009.00477.x; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Hislop JN, 2004, J BIOL CHEM, V279, P22522, DOI 10.1074/jbc.M311062200; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; Ji YY, 2009, P NATL ACAD SCI USA, V106, P19593, DOI 10.1073/pnas.0904289106; Kumamoto N, 2006, BIOCHEM BIOPH RES CO, V345, P904, DOI 10.1016/j.bbrc.2006.04.163; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Pradhan AAA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005425; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Raiborg C, 2002, CELL STRUCT FUNCT, V27, P403, DOI 10.1247/csf.27.403; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Ryder PV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293pe66; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; van den Oord EJCG, 2003, MOL PSYCHIATR, V8, P499, DOI 10.1038/sj.mp.4001263; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Wei LN, 2002, CURR OPIN PHARMACOL, V2, P69, DOI 10.1016/S1471-4892(01)00123-0; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308	37	51	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9325	10.1371/journal.pone.0009325	http://dx.doi.org/10.1371/journal.pone.0009325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174469	gold, Green Submitted, Green Published			2022-12-25	WOS:000274923700023
J	Phillips, G; Reith, F; Qualls, C; Ali, AM; Spilde, M; Appenzeller, O				Phillips, Genevieve; Reith, Frank; Qualls, Clifford; Ali, Abdul-Mehdi; Spilde, Mike; Appenzeller, Otto			Bacterial Deposition of Gold on Hair: Archeological, Forensic and Toxicological Implications	PLOS ONE			English	Article							STABLE-ISOTOPE; GEOMICROBIOLOGY	Background: Trace metal analyses in hair are used in archeological, forensic and toxicological investigations as proxies for metabolic processes. We show metallophilic bacteria mediating the deposition of gold (Au), used as tracer for microbial activity in hair post mortem after burial, affecting results of such analyses. Methodology/Principal Findings: Human hair was incubated for up to six months in auriferous soils, in natural soil columns (Experiment 1), soils amended with mobile Au(III)-complexes (Experiment 2) and the Au-precipitating bacterium Cupriavidus metallidurans (Experiment 3), in peptone-meat-extract (PME) medium in a culture of C. metallidurans amended with Au(III)complexes (Experiment 4), and in non-auriferous soil (Experiment 5). Hair samples were analyzed using scanning electron microscopy, confocal microscopy and inductively coupled plasma-mass spectrometry. In Experiments 1-4 the Au content increased with time (P = 0.038). The largest increase was observed in Experiment 4 vs. Experiment 1 (mean = 1188 vs. 161 mu g Kg(-1), Fisher's least significance 0.001). The sulfur content, a proxy for hair metabolism, remained unchanged. Notably, the ratios of Au-to-S increased with time (linear trend P = 0.02) and with added Au and bacteria (linear trend, P = 0.005), demonstrating that larger populations of Au-precipitating bacteria and increased availability of Au increased the deposition of Au on the hair. Conclusion/Significance: Interactions of soil biota with hair post mortem may distort results of hair analyses, implying that metal content, microbial activities and the duration of burial must be considered in the interpretation of results of archeological, forensic and toxicological hair analyses, which have hitherto been proxies for pre-mortem metabolic processes.	[Phillips, Genevieve] Univ New Mexico, Canc Res & Treatment Ctr, Fluorescence Microscopy Facil, Albuquerque, NM 87131 USA; [Reith, Frank] Univ Adelaide, Sch Earth & Environm Sci, Ctr Tecton Resources & Explorat, Adelaide, SA, Australia; [Reith, Frank] CSIRO Land & Water, PMB2, Glen Osmond, SA, Australia; [Qualls, Clifford] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA; [Ali, Abdul-Mehdi] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Spilde, Mike] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; [Appenzeller, Otto] New Mexico Hlth Enhancement & Marathon Clin Res F, Albuquerque, NM USA	University of New Mexico; University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of New Mexico; University of New Mexico; University of New Mexico	Phillips, G (corresponding author), Univ New Mexico, Canc Res & Treatment Ctr, Fluorescence Microscopy Facil, Albuquerque, NM 87131 USA.	oarun@unm.edu	Reith, Frank/E-5542-2011		New Mexico Health Enhancement; Marathon Clinics Research Foundation; Albuquerque NM United States of America	New Mexico Health Enhancement; Marathon Clinics Research Foundation; Albuquerque NM United States of America	Funded by New Mexico Health Enhancement and Marathon Clinics Research Foundation, Albuquerque NM United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000636; BIANUCCI R, 2006, PLOS ONE, V3, pE2053, DOI DOI 10.1371/JOURNALPONE.0002053; Egeland GM, 2009, ENVIRON RES, V109, P281, DOI 10.1016/j.envres.2008.11.004; FIRESTEIN S, 2010, SCIENCE, V327, P146; Flanagan RJ, 2009, MED SCI LAW, V49, P153, DOI 10.1258/rsmmsl.49.3.153; Guibaud G, 2005, CHEMOSPHERE, V59, P629, DOI 10.1016/j.chemosphere.2004.10.028; Kintz P, 2006, J ANAL TOXICOL, V30, P621, DOI 10.1093/jat/30.8.621; Lader M, 2009, MED SCI LAW, V49, P1; Lin XL, 2004, ANAL BIOANAL CHEM, V379, P218, DOI 10.1007/s00216-004-2536-y; Mascarelli AL, 2009, NATURE, V459, P770, DOI 10.1038/459770a; NICHOLSON JK, 2010, NATURE, V463, P32; Pringle H, 2009, SCIENCE, V324, P1130, DOI 10.1126/science.324_1130; Reith F., 2008, REGOLITH SCI, P127; Reith F, 2007, ISME J, V1, P567, DOI 10.1038/ismej.2007.75; Reith F, 2006, SCIENCE, V313, P233, DOI 10.1126/science.1125878; Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106; Rogers G, 2009, EXP DERMATOL, V18, P541, DOI 10.1111/j.1600-0625.2008.00825.x; Srogi K, 2007, REV ENVIRON CONTAM T, V189, P107, DOI 10.1007/978-0-387-35368-5_5; Wilson AS, 2007, P NATL ACAD SCI USA, V104, P16456, DOI 10.1073/pnas.0704276104	19	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9335	10.1371/journal.pone.0009335	http://dx.doi.org/10.1371/journal.pone.0009335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560SS	20174476	Green Published, gold, Green Submitted			2022-12-25	WOS:000274923700028
J	Langendorf, CG; Key, TLG; Fenalti, G; Kan, WT; Buckle, AM; Caradoc-Davies, T; Tuck, KL; Law, RHP; Whisstock, JC				Langendorf, Christopher G.; Key, Trevor L. G.; Fenalti, Gustavo; Kan, Wan-Ting; Buckle, Ashley M.; Caradoc-Davies, Tom; Tuck, Kellie L.; Law, Ruby H. P.; Whisstock, James C.			The X-Ray Crystal Structure of Escherichia coli Succinic Semialdehyde Dehydrogenase; Structural Insights into NADP(+)/Enzyme Interactions	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; ALDEHYDE DEHYDROGENASE; NUCLEOTIDE-SEQUENCE; SSADH DEFICIENCY; MOLECULAR-BASIS; INBORN ERROR; GAB CLUSTER; HUMAN-BRAIN; GENE; IDENTIFICATION	Background: In mammals succinic semialdehyde dehydrogenase (SSADH) plays an essential role in the metabolism of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) to succinic acid (SA). Deficiency of SSADH in humans results in elevated levels of GABA and gamma-Hydroxybutyric acid (GHB), which leads to psychomotor retardation, muscular hypotonia, non-progressive ataxia and seizures. In Escherichia coli, two genetically distinct forms of SSADHs had been described that are essential for preventing accumulation of toxic levels of succinic semialdehyde (SSA) in cells. Methodology/Principal Findings: Here we structurally characterise SSADH encoded by the E coli gabD gene by X-ray crystallographic studies and compare these data with the structure of human SSADH. In the E. coli SSADH structure, electron density for the complete NADP(+) cofactor in the binding sites is clearly evident; these data in particular revealing how the nicotinamide ring of the cofactor is positioned in each active site. Conclusions/Significance: Our structural data suggest that a deletion of three amino acids in E. coli SSADH permits this enzyme to use NADP(+), whereas in contrast the human enzyme utilises NAD(+). Furthermore, the structure of E. coli SSADH gives additional insight into human mutations that result in disease.	[Langendorf, Christopher G.; Key, Trevor L. G.; Fenalti, Gustavo; Kan, Wan-Ting; Buckle, Ashley M.; Law, Ruby H. P.; Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Key, Trevor L. G.; Tuck, Kellie L.] Monash Univ, Sch Chem, Melbourne, Vic 3004, Australia; [Fenalti, Gustavo] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Kan, Wan-Ting; Law, Ruby H. P.; Whisstock, James C.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Melbourne, Vic 3004, Australia; [Caradoc-Davies, Tom] Australian Synchrotron, Clayton, Vic, Australia	Monash University; Monash University; Scripps Research Institute; Monash University	Langendorf, CG (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton Campus, Melbourne, Vic 3004, Australia.	Ruby.law@med.monash.edu.au; James.whisstock@med.monash.edu.au	Tuck, Kellie/AAV-2596-2020; Buckle, Ashley/P-8366-2016	Tuck, Kellie/0000-0002-9104-3158; Buckle, Ashley/0000-0003-2943-9044; law, ruby/0000-0001-5432-5781; Langendorf, Christopher/0000-0002-9049-5283; Whisstock, James/0000-0003-4200-5611	National Health and Medical Research Council of Australia; TLGK is an Australia Postgraduate Award scholarship; NHMRC; ARC	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); TLGK is an Australia Postgraduate Award scholarship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council)	CGL is a National Health and Medical Research Council of Australia biomedical postgraduate research scholarship student, TLGK is an Australia Postgraduate Award scholarship student, AMB is an NHMRC Senior Research Fellow. JCW is an Australian Research Council Federation Fellow and an honorary NHMRC Principal Research Fellow. The authors thank the NHMRC and the ARC for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaboshi S, 2003, HUM MUTAT, V22, P442, DOI 10.1002/humu.10288; Androulakis S, 2008, ACTA CRYSTALLOGR D, V64, P810, DOI 10.1107/S0907444908015540; Aoshima T, 2002, HUM HERED, V53, P42, DOI 10.1159/000048603; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTSCH K, 1990, J BACTERIOL, V172, P7035, DOI 10.1128/jb.172.12.7035-7042.1990; Bekri S, 2004, MOL GENET METAB, V81, P347, DOI 10.1016/j.ymgme.2004.01.012; BLANER WS, 1980, EUR J BIOCHEM, V109, P431, DOI 10.1111/j.1432-1033.1980.tb04812.x; Blasi P, 2002, MOL GENET METAB, V76, P348, DOI 10.1016/S1096-7192(02)00105-1; Blasi P, 2006, J MOL EVOL, V63, P54, DOI 10.1007/s00239-005-0154-8; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; CHAMBLISS KL, 1995, J BIOL CHEM, V270, P461, DOI 10.1074/jbc.270.1.461; CHAMBLISS KL, 1992, INT J BIOCHEM, V24, P1493, DOI 10.1016/0020-711X(92)90077-E; Chambliss KL, 1998, AM J HUM GENET, V63, P399, DOI 10.1086/301964; CHO SW, 1993, EUR J BIOCHEM, V211, P757, DOI 10.1111/j.1432-1033.1993.tb17606.x; Cobessi D, 1999, J MOL BIOL, V290, P161, DOI 10.1006/jmbi.1999.2853; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Di Costanzo L, 2007, J MOL BIOL, V366, P481, DOI 10.1016/j.jmb.2006.11.023; DONNELLY MI, 1981, J BACTERIOL, V145, P1425, DOI 10.1128/JB.145.3.1425-1427.1981; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Fuhrer T, 2007, J BACTERIOL, V189, P8073, DOI 10.1128/JB.01027-07; Gibson KM, 1998, NEUROPEDIATRICS, V29, P14, DOI 10.1055/s-2007-973527; Gibson KM, 2003, BIOL PSYCHIAT, V54, P763, DOI 10.1016/S0006-3223(03)00113-6; GIBSON KM, 1983, CLIN CHIM ACTA, V133, P33, DOI 10.1016/0009-8981(83)90018-9; Gruez A, 2004, J MOL BIOL, V343, P29, DOI 10.1016/j.jmb.2004.08.030; Hogema BM, 2001, NAT GENET, V29, P212, DOI 10.1038/ng727; Hogema BM, 2001, MOL GENET METAB, V72, P218, DOI 10.1006/mgme.2000.3145; Jaeger M, 2008, BIOCHEM BIOPH RES CO, V372, P400, DOI 10.1016/j.bbrc.2008.04.183; JAKOBY WB, 1959, J BIOL CHEM, V234, P937; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Johansson K, 1998, PROTEIN SCI, V7, P2106, DOI 10.1002/pro.5560071007; Kim YG, 2009, EMBO J, V28, P959, DOI 10.1038/emboj.2009.40; Knerr I, 2007, J INHERIT METAB DIS, V30, P279, DOI 10.1007/s10545-007-0574-2; KOH Y, 1994, J MOL BIOL, V27, P75; Law RHP, 2005, J BIOL CHEM, V280, P22356, DOI 10.1074/jbc.M412043200; Lee BR, 1995, MOL CELLS, V5, P611; LESLIE AGW, 1992, NEWSLETTER PROTEIN C, V26; Lorentzen E, 2004, J MOL BIOL, V341, P815, DOI 10.1016/j.jmb.2004.05.032; MALASPINA P, 2006, CLIN GENET, V69, P284; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; METZER E, 1990, J BACTERIOL, V172, P3250, DOI 10.1128/jb.172.6.3250-3256.1990; Moore SA, 1998, STRUCTURE, V6, P1541, DOI 10.1016/S0969-2126(98)00152-X; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NIEGEMANN E, 1993, ARCH MICROBIOL, V160, P454, DOI 10.1007/BF00245306; Novotny EJ, 2003, ANN NEUROL, V54, pS25, DOI 10.1002/ana.10697; Pearl PL, 2006, FUTUR NEUROL, V1, P631, DOI 10.2217/14796708.1.5.631; Pearl PL, 2003, ANN NEUROL, V54, pS73, DOI 10.1002/ana.10629; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; RYZLAK MT, 1988, ARCH BIOCHEM BIOPHYS, V266, P386, DOI 10.1016/0003-9861(88)90270-6; SANCHEZ M, 1989, BIOCHIM BIOPHYS ACTA, V990, P225, DOI 10.1016/S0304-4165(89)80038-8; Schaller M, 1999, EUR J BIOCHEM, V265, P1056, DOI 10.1046/j.1432-1327.1999.00826.x; SKINNER MA, 1982, ARCH MICROBIOL, V132, P270, DOI 10.1007/BF00407964; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Struys EA, 2006, MOL GENET METAB, V88, P53, DOI 10.1016/j.ymgme.2005.12.002; Terwilliger TC, 2007, ACTA CRYSTALLOGR D, V63, P101, DOI 10.1107/S0907444906046233; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Trettel F, 1997, ADV EXP MED BIOL, V414, P253; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; WEINER H, 2004, ENCY LIFE SCI, P1	61	27	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9280	10.1371/journal.pone.0009280	http://dx.doi.org/10.1371/journal.pone.0009280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174634	gold, Green Submitted, Green Published			2022-12-25	WOS:000274654700014
J	Suzuki, H; Saba, R; Sada, A; Saga, Y				Suzuki, Hitomi; Saba, Rie; Sada, Aiko; Saga, Yumiko			The Nanos3-3 ' UTR Is Required for Germ Cell Specific NANOS3 Expression in Mouse Embryos	PLOS ONE			English	Article							MESSENGER-RNA; TRANSLATIONAL REPRESSION; DROSOPHILA EMBRYOS; LOCALIZATION; PROTEIN; SMAUG; HOMOLOG; GENES; DIFFERENTIATION; IDENTIFICATION	Background: The regulation of gene expression via a 3' untranslated region (UTR) plays essential roles in the discrimination of the germ cell lineage from somatic cells during embryogenesis. This is fundamental to the continuation of a species. Mouse NANOS3 is an essential protein required for the germ cell maintenance and is specifically expressed in these cells. However, the regulatory mechanisms that restrict the expression of this gene in the germ cells is largely unknown at present. Methodology/Principal Findings: In our current study, we show that differences in the stability of Nanos3 mRNA between germ cells and somatic cells is brought about in a 3'UTR-dependent manner in mouse embryos. Although Nanos3 is transcribed in both cell lineages, it is efficiently translated only in the germ lineage. We also find that the translational suppression of NANOS3 in somatic cells is caused by a 3'UTR-mediated mRNA destabilizing mechanism. Surprisingly, even when under the control of the CAG promoter which induces strong ubiquitous transcription in both germ cells and somatic cells, the addition of the Nanos3-3'UTR sequence to the coding region of exogenous gene was effective in restricting protein expression in germ cells. Conclusions/Significance: Our current study thus suggests that Nanos3-3'UTR has an essential role in translational control in the mouse embryo.	[Suzuki, Hitomi; Saga, Yumiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Saba, Rie; Saga, Yumiko] Natl Inst Genet, Div Mammalian Dev, Shizuoka, Japan; [Sada, Aiko; Saga, Yumiko] Grad Univ Adv Studies Sokendai, Dept Genet, Shizuoka, Japan	University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Suzuki, H (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15260 USA.	ysaga@lab.nig.ac.jp	Sada, Aiko/B-1176-2019	Sada, Aiko/0000-0002-0984-4280	National BioResource Project (NBRP); Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science (JSPS)	National BioResource Project (NBRP)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by the National BioResource Project (NBRP) (http://www.nbrp.jp/); the Genome Network Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan; and Research Fellowships of the Japan Society for the Promotion of Science (JSPS) for Young Scientists to A. S. (http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baez MV, 2005, J BIOL CHEM, V280, P43131, DOI 10.1074/jbc.M508374200; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Crucs S, 2000, MOL CELL, V5, P457, DOI 10.1016/S1097-2765(00)80440-2; D'Agostino I, 2006, DEV BIOL, V292, P244, DOI 10.1016/j.ydbio.2005.11.046; Dahanukar A, 1996, GENE DEV, V10, P2610, DOI 10.1101/gad.10.20.2610; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; GAVIS ER, 1992, CELL, V71, P301, DOI 10.1016/0092-8674(92)90358-J; Gavis ER, 1996, DEV BIOL, V176, P36, DOI 10.1006/dbio.1996.9996; Gavis ER, 1996, DEVELOPMENT, V122, P2791; GAVIS ER, 1994, NATURE, V369, P315, DOI 10.1038/369315a0; Giorgini F, 2002, DEVELOPMENT, V129, P3669; Giorgini F, 2001, MOL CELL BIOL, V21, P7010, DOI 10.1128/MCB.21.20.7010-7019.2001; Kalifa Y, 2006, DEV CELL, V10, P291, DOI 10.1016/j.devcel.2006.01.001; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Koprunner M, 2001, GENE DEV, V15, P2877; Kosaka K, 2007, MECH DEVELOP, V124, P279, DOI 10.1016/j.mod.2007.01.003; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Kurokawa H, 2006, DEV GROWTH DIFFER, V48, P209, DOI 10.1111/j.1440-169x.2006.00858.x; Loya A, 2008, RNA, V14, P1352, DOI 10.1261/rna.867208; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Mochizuki K, 2000, DEV GENES EVOL, V210, P591, DOI 10.1007/s004270000105; MORALES CR, 1991, J CELL SCI, V100, P119; MOSQUERA L, 1993, DEVELOPMENT, V117, P377; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Oginuma M, 2008, MECH DEVELOP, V125, P432, DOI 10.1016/j.mod.2008.01.010; Okamura Y, 2008, MECH DEVELOP, V125, P663, DOI 10.1016/j.mod.2008.04.007; Pilon M, 1997, DEVELOPMENT, V124, P1771; Rangan P, 2009, CURR BIOL, V19, P72, DOI 10.1016/j.cub.2008.11.066; RONGO C, 1995, DEVELOPMENT, V121, P2737; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Smibert CA, 1996, GENE DEV, V10, P2600, DOI 10.1101/gad.10.20.2600; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Suzuki A, 2007, DEVELOPMENT, V134, P77, DOI 10.1242/dev.02697; Suzuki H, 2008, DEV BIOL, V318, P133, DOI 10.1016/j.ydbio.2008.03.020; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Tsuda M, 2006, MECH DEVELOP, V123, P440, DOI 10.1016/j.mod.2006.04.002; WANG C, 1994, DEV DYNAM, V199, P103, DOI 10.1002/aja.1001990204; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; YAMAJI M, 2009, REPRODUCTION; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Zaessinger S, 2006, DEVELOPMENT, V133, P4573, DOI 10.1242/dev.02649	46	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9300	10.1371/journal.pone.0009300	http://dx.doi.org/10.1371/journal.pone.0009300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174582	Green Published, gold, Green Submitted			2022-12-25	WOS:000274654700024
J	Chu, KM; Boulle, AM; Ford, N; Goemaere, E; Asselman, V; Van Cutsem, G				Chu, Kathryn M.; Boulle, Andrew M.; Ford, Nathan; Goemaere, Eric; Asselman, Valerie; Van Cutsem, Gilles			Nevirapine-Associated Early Hepatotoxicity: Incidence, Risk Factors, and Associated Mortality in a Primary Care ART Programme in South Africa	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; CONTAINING REGIMENS; PREGNANT-WOMEN; LIVER TOXICITY; EFAVIRENZ; SETTINGS; EVENTS; COHORT; COUNT	Background: The majority of antiretroviral treatment programmes in sub-Saharan Africa are scaling up antiretroviral treatment using a fixed dose first-line antiretroviral regimen containing stavudine, lamivudine, and nevirapine. One of the primary concerns with the use of this regimen is nevirapine-associated hepatotoxicity. Methodology/Principal Findings: Study participants were 1809 HIV-infected, antiretroviral naive adults initiating nevirapine-based antiretroviral therapy between November 2002 and December 2006. The primary outcome was early hepatotoxicity. Secondary outcomes were associations with hepatotoxicity and mortality at six months. The cumulative proportion of early hepatotoxicity ranged from 1.0-2.0% giving an incidence-rate at 102 days of 3.6-7.6 per 100 person-years. Median time to hepatotoxicity was 32 (IQR 28-58) days. At 12 weeks, only 8% of patients had alanine aminotransferase monitoring at all the time-points recommended by national guidelines. No association was found between age, gender, baseline CD4 count, concurrent tuberculosis infection, prior participation in a prevention of mother-to-child-transmission program, or baseline weight and early hepatotoxicity. There was no association between early hepatotoxicity and mortality. Conclusions: The cumulative proportion of early hepatotoxicity in nevirapine based antiretroviral therapy was low in this resource-constrained setting. Hepatotoxicity was not associated with mortality. Frequent routine monitoring of alanine aminotransferase proved difficult to implement in this public sector primary care programme. Focused monitoring in the first month may be a more cost-effective and pragmatic option in settings with limited resources. Correlation with clinical signs and symptoms may allow future alanine aminotransferase testing to be dictated by clinical criteria.	[Chu, Kathryn M.; Ford, Nathan] Med Sans Frontieres, S African Med Unit, Johannesburg, South Africa; [Boulle, Andrew M.; Ford, Nathan; Van Cutsem, Gilles] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Sch Publ Hlth & Family Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Goemaere, Eric; Van Cutsem, Gilles] Med Sans Frontieres, Cape Town, South Africa; [Asselman, Valerie] JF Jooste Hosp, Infect Dis Clin, Cape Town, South Africa	University of Cape Town	Chu, KM (corresponding author), Med Sans Frontieres, S African Med Unit, Johannesburg, South Africa.	kathryn.chu@joburg.msf.org	Van Cutsem, Gilles/ABB-1171-2021; Boulle, Andrew/C-1413-2008	Van Cutsem, Gilles/0000-0002-8972-4480; Boulle, Andrew/0000-0002-7713-8062	M�decins Sans Fronti�res [09_NAT_ERB_009] Funding Source: researchfish	M�decins Sans Fronti�res		[Anonymous], 2003, SCALING ANTIRETROVIR; Bartlett J, 2007, MED MANAGEMENT HIV I; *BOEH ING PHARM, VIR PACK INS; Calmy A, 2007, LANCET, V370, P12, DOI 10.1016/S0140-6736(07)61027-7; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Ena J, 2003, INT J STD AIDS, V14, P776, DOI 10.1258/09564620360719840; Firnhaber C, 2008, SAMJ S AFR MED J, V98, P541; Forna F, 2007, JAIDS-J ACQ IMM DEF, V44, P456, DOI 10.1097/QAI.0b013e318033ffa1; Hahn Judith A, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P83, DOI 10.1177/1545109707299356; Jamisse L, 2007, JAIDS-J ACQ IMM DEF, V44, P371, DOI 10.1097/QAI.0b013e318032bbee; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Kumarasamy N, 2008, AIDS PATIENT CARE ST, V22, P337, DOI 10.1089/apc.2007.0093; Law WP, 2003, AIDS, V17, P2191, DOI 10.1097/00002030-200310170-00007; Manfredi R, 2006, AIDS, V20, P2233, DOI 10.1097/QAD.0b013e3280110cae; Martinez E, 2001, AIDS, V15, P1261, DOI 10.1097/00002030-200107060-00007; Meyssonnier V, 2008, HIV MED, V9, P62, DOI 10.1111/j.1468-1293.2008.00516.x; *NIH, AIDS CLIN TRIALS GRO; Phanuphak N, 2007, HIV MED, V8, P357, DOI 10.1111/j.1468-1293.2007.00477.x; *PHARM BI, 2005, VIR PACK INS; Sanne I, 2005, J INFECT DIS, V191, P825, DOI 10.1086/428093; Stern JO, 2003, JAIDS-J ACQ IMM DEF, V34, pS21, DOI 10.1097/00126334-200309011-00005; Taiwo B, 2006, INT J STD AIDS, V17, P364, DOI 10.1258/095646206777323346; Torti C, 2007, DRUG SAFETY, V30, P1161, DOI 10.2165/00002018-200730120-00008; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Wooltorton E, 2004, CAN MED ASSOC J, V170, P1091, DOI 10.1503/cmaj.1040417; Zhou ML, 2006, JAIDS-J ACQ IMM DEF, V43, P501	26	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9183	10.1371/journal.pone.0009183	http://dx.doi.org/10.1371/journal.pone.0009183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174653	Green Published, gold, Green Submitted			2022-12-25	WOS:000274590600005
J	Uziel, O; Beery, E; Dronichev, V; Samocha, K; Gryaznov, S; Weiss, L; Slavin, S; Kushnir, M; Nordenberg, Y; Rabinowitz, C; Rinkevich, B; Zehavi, T; Lahav, M				Uziel, Orit; Beery, Einat; Dronichev, Vladimir; Samocha, Katty; Gryaznov, Sergei; Weiss, Lola; Slavin, Shimon; Kushnir, Michal; Nordenberg, Yardena; Rabinowitz, Claudette; Rinkevich, Baruch; Zehavi, Tania; Lahav, Meir			Telomere Shortening Sensitizes Cancer Cells to Selected Cytotoxic Agents: In Vitro and In Vivo Studies and Putative Mechanisms	PLOS ONE			English	Article							SMALL INTERFERING RNA; HUMAN MISMATCH REPAIR; OVARIAN-CANCER; IONIZING-RADIATION; THERAPEUTIC TARGET; INDUCED APOPTOSIS; MULTIPLE-MYELOMA; DRUG-RESISTANT; TUMOR-CELLS; INHIBITION	Background: Telomere/telomerase system has been recently recognized as an attractive target for anticancer therapy. Telomerase inhibition results in tumor regression and increased sensitivity to various cytotoxic drugs. However, it has not been fully established yet whether the mediator of these effects is telomerase inhibition per se or telomere shortening resulting from inhibition of telomerase activity. In addition, the characteristics and mechanisms of sensitization to cytotoxic drugs caused by telomerase inhibition has not been elucidated in a systematic manner. Methodology/Principal Findings: In this study we characterized the relative importance of telomerase inhibition versus telomere shortening in cancer cells. Sensitization of cancer cells to cytotoxic drugs was achieved by telomere shortening in a length dependent manner and not by telomerase inhibition per se. In our system this sensitization was related to the mechanism of action of the cytotoxic drug. In addition, telomere shortening affected also other cancer cell functions such as migration. Telomere shortening induced DNA damage whose repair was impaired after administration of cisplatinum while doxorubicin or vincristine did not affect the DNA repair. These findings were verified also in in vivo mouse model. The putative explanation underlying the phenotype induced by telomere shortening may be related to changes in expression of various microRNAs triggered by telomere shortening. Conclusions/Significance: To our best knowledge this is the first study characterizing the relative impact of telomerase inhibition and telomere shortening on several aspects of cancer cell phenotype, especially related to sensitivity to cytotoxic drugs and its putative mechanisms. The microRNA changes in cancer cells upon telomere shortening are novel information. These findings may facilitate the development of telomere based approaches in treatment of cancer.	[Uziel, Orit; Beery, Einat; Dronichev, Vladimir; Samocha, Katty; Nordenberg, Yardena; Lahav, Meir] Beilinson Med Ctr, Rabin Med Ctr, Felsenstein Med Res Ctr, Petah Tiqwa, Israel; [Nordenberg, Yardena] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Gryaznov, Sergei] Geron Corp, Menlo Pk, CA USA; [Weiss, Lola; Slavin, Shimon] Hadassah Univ Hosp, Dept Bone Marrow Transplantat & Canc Immunotherap, IL-91120 Jerusalem, Israel; [Kushnir, Michal] Rosetta Genom Ltd, Rehovot, Israel; [Rabinowitz, Claudette; Rinkevich, Baruch] Natl Inst Oceanog, IL-31080 Haifa, Israel; [Zehavi, Tania] Meir Med Ctr, Dept Pathol, Kefar Sava, Israel	Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Geron Corporation; Hebrew University of Jerusalem; Israel Oceanographic & Limnological Research Institute; Tel Aviv University; Sackler Faculty of Medicine	Uziel, O (corresponding author), Beilinson Med Ctr, Rabin Med Ctr, Felsenstein Med Res Ctr, Petah Tiqwa, Israel.	mlahav@post.tau.ac.il			Rabin Medical Center Research Authority; Sackler School of Medicine, Tel-Aviv University, Israel	Rabin Medical Center Research Authority; Sackler School of Medicine, Tel-Aviv University, Israel	This work was partially supported by research grants from Rabin Medical Center Research Authority and a research grant from Sackler School of Medicine, Tel-Aviv University, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Akiyama M, 2003, CANCER RES, V63, P6187; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; BAGHERI S, P NATL ACAD SCI US, V103, P11306; Boren T, 2009, GYNECOL ONCOL, V113, P249, DOI 10.1016/j.ygyno.2009.01.014; Boukamp P, 2007, EXP DERMATOL, V16, P71, DOI 10.1111/j.1600-0625.2006.00517.x; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Bu Y, 2009, ONCOL REP, V21, P13, DOI 10.3892/or_00000183; Cerone MA, 2006, ONCOGENE, V25, P7411, DOI 10.1038/sj.onc.1209727; Cerone MA, 2006, MOL CANCER THER, V5, P1669, DOI 10.1158/1535-7163.MCT-06-0033; Chen Z, 2003, CANCER RES, V63, P5917; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Cong YS, 2008, CELL RES, V18, P725, DOI 10.1038/cr.2008.74; Cookson JC, 2005, MOL PHARMACOL, V68, P1551, DOI 10.1124/mol.105.013300; Dikmen ZG, 2005, CANCER RES, V65, P7866, DOI 10.1158/0008-5472.CAN-05-1215; Duale N, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-53; El Daly Hesham, 2007, V405, P47, DOI 10.1007/978-1-60327-070-0_6; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; HERINGOVA P, 2009, J BIOL INORG CHEM; Kamer I, 2002, TOXICOL IN VITRO, V16, P177, DOI 10.1016/S0887-2333(01)00118-7; KIM S, J BIOL CHEM, V26, P18158; Kondo Y, 1998, ONCOGENE, V16, P2243, DOI 10.1038/sj.onc.1201754; Larson ED, 2001, J BIOL CHEM, V276, P9775, DOI 10.1074/jbc.M006390200; Lavelle F, 2000, CRIT REV ONCOL HEMAT, V34, P111, DOI 10.1016/S1040-8428(00)00057-3; Lee KH, 2001, P NATL ACAD SCI USA, V98, P3381, DOI 10.1073/pnas.051629198; Li S, 2004, CANCER RES, V64, P4833, DOI 10.1158/0008-5472.CAN-04-0953; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Massard C, 2006, ONCOGENE, V25, P4505, DOI 10.1038/sj.onc.1209487; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mu D, 1997, MOL CELL BIOL, V17, P760, DOI 10.1128/MCB.17.2.760; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nakagawa Y, 2007, BIOORGAN MED CHEM, V15, P5620, DOI 10.1016/j.bmc.2007.04.071; Nakamura M, 2005, HUM GENE THER, V16, P859, DOI 10.1089/hum.2005.16.859; O'Driscoll M, 1999, CARCINOGENESIS, V20, P799, DOI 10.1093/carcin/20.5.799; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Park YP, 2008, KOREAN J LAB MED, V28, P430, DOI 10.3343/kjlm.2008.28.6.430; Ram R, 2009, CLIN CANCER RES, V15, P914, DOI 10.1158/1078-0432.CCR-08-0792; Reischer D, 2007, BRIT J PHARMACOL, V150, P738, DOI 10.1038/sj.bjp.0707146; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; RUDD GN, 1995, CANCER CHEMOTH PHARM, V35, P323, DOI 10.1007/BF00689452; Sanceau J, 2003, J BIOL CHEM, V278, P36537, DOI 10.1074/jbc.M304300200; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Shammas MA, 2008, LEUKEMIA, V22, P1410, DOI 10.1038/leu.2008.81; Shammas MA, 1999, ONCOGENE, V18, P6191, DOI 10.1038/sj.onc.1203069; Shammas MA, 2004, CLIN CANCER RES, V10, P770, DOI 10.1158/1078-0432.CCR-0793-03; Shammas MA, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-24; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; Shay JW, 2001, RADIAT RES, V155, P188, DOI 10.1667/0033-7587(2001)155[0188:TATIFC]2.0.CO;2; Shen Y, 2008, CANCER BIOL THER, V7, P228, DOI 10.4161/cbt.7.2.5259; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Taylor EM, 1998, INT J RADIAT BIOL, V74, P277; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Ward RJ, 2005, MOL PHARMACOL, V68, P779, DOI 10.1124/mol.105.011494; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Zhang ZH, 2006, CLIN CANCER RES, V12, P4933, DOI 10.1158/1078-0432.CCR-05-2831	62	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9132	10.1371/journal.pone.0009132	http://dx.doi.org/10.1371/journal.pone.0009132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161752	Green Submitted, Green Published, gold			2022-12-25	WOS:000274442600029
J	St-Onge, M; Lagarde, S; Laflamme, C; Rollet-Labelle, E; Marois, L; Naccache, PH; Pouliot, M				St-Onge, Mireille; Lagarde, Stephanie; Laflamme, Cynthia; Rollet-Labelle, Emmanuelle; Marois, Louis; Naccache, Paul H.; Pouliot, Marc			Proteinase-activated receptor-2 up-regulation by Fc gamma-receptor activation in human neutrophils	FASEB JOURNAL			English	Article						inflammation; polymorphonuclear leukocytes; PARs; primary granules	EPITHELIAL-CELLS; PROINFLAMMATORY CYTOKINES; MEDIATED PHAGOCYTOSIS; ADHESION MOLECULES; GENE-EXPRESSION; URATE CRYSTALS; IN-VIVO; INFLAMMATION; MIGRATION; THROMBIN	We shed new light on the expression and function of the proteinase-activated receptor (PAR) family, associated with inflammation and hyperalgesia, in human granulocytes. Resting cells expressed constitutive levels of PAR-2 and PAR-3 mRNA but not PAR-1 or PAR-4. Based on flow cytometry, stimulation with opsonized bacteria (Bop) specifically up-regulated cell surface expression of PAR-2 in a concentration-dependent and time-dependent manner, independent of transcription or de novo protein synthesis. Primary granules were identified as a source of preformed PAR-2 that can readily be mobilized at the surface on fusion with the plasma membrane. Cellular response to PAR-2 activation, measured as changes in intracellular calcium concentration, was enhanced in PAR-2 up-regulated cells. Increase of cell-surface PAR-2 and of cell responsiveness were dependent specifically on the engagement of immunoglobulin (Ig)-binding receptors. Together, our results reveal that mobilization of intracellular granules, in response to Ig-receptor activation, up-regulates PAR-2 surface expression and makes neutrophils more responsive to proteinase activity. This enhanced response to PAR-2 activation indicates that molecular communication between pain and inflammation may be more important than previously believed.-St-Onge, M., Lagarde, S., Laflamme, C., Rollet-Labelle, E., Marois, L., Naccache, P. H., Pouliot, M. Proteinase-activated receptor-2 upregulation by Fc gamma-receptor activation in human neutrophils. FASEB J. 24, 2116-2125 (2010). www.fasebj.org	[St-Onge, Mireille; Lagarde, Stephanie; Laflamme, Cynthia; Rollet-Labelle, Emmanuelle; Marois, Louis; Naccache, Paul H.; Pouliot, Marc] Univ Laval, Ctr Rech Rhumatol & Immunol, CHU Quebec, Dept Microbiol Infectiol & Immunol,Fac Med, Quebec City, PQ G1K 7P4, Canada	Laval University	Pouliot, M (corresponding author), CHUL, Ctr Rech Rhumatol & Immunol, 2705 Laurier Blvd,Off T1-49, Quebec City, PQ G1V 4G2, Canada.	marc.pouliot@crchul.ulaval.ca	Dufrechou, Stephanie/W-8547-2019; Pouliot, Marc/G-4103-2016	Pouliot, Marc/0000-0002-2466-5424; Marois, Louis/0000-0002-1567-5583	Canadian Institutes of Health Research (CIHR) [MOP-64315]; U.S. National Institutes of Health [R01 AR052614]; Fonds de la Recherche en Sante du Quebec (FRSQ); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052614] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported by grants from the Canadian Institutes of Health Research (CIHR, MOP-64315; M. P.) and the U.S. National Institutes of Health (R01 AR052614). M.P. is a Senior Investigator Scholar of the Fonds de la Recherche en Sante du Quebec (FRSQ). M.S.O. is the recipient of a studentship from the FRSQ. The authors declare no conflicting financial interests.	Barabe F, 2002, J IMMUNOL, V168, P4042, DOI 10.4049/jimmunol.168.8.4042; BEAULIEU AD, 1992, J BIOL CHEM, V267, P426; BERGER M, 1989, J CLIN INVEST, V84, P1302, DOI 10.1172/JCI114298; Borregaard N, 1995, Clin Exp Immunol, V101 Suppl 1, P6; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Chin AC, 2008, J IMMUNOL, V181, P5702, DOI 10.4049/jimmunol.181.8.5702; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coughlin SR, 2003, J CLIN INVEST, V111, P25, DOI 10.1172/JCI200317564; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; de Boer Willem I, 2007, Int J Chron Obstruct Pulmon Dis, V2, P205; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Fernandes MJG, 2005, J LEUKOCYTE BIOL, V78, P524, DOI 10.1189/jlb.0804479; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Foster PS, 2008, CURR MOL MED, V8, P585, DOI 10.2174/156652408785748013; FUJISHIMA S, 1993, J CELL PHYSIOL, V154, P478, DOI 10.1002/jcp.1041540305; GARCIA JGN, 1993, J CELL PHYSIOL, V156, P541, DOI 10.1002/jcp.1041560313; Gilbert C, 2003, ARTHRITIS RHEUM-US, V48, P1137, DOI 10.1002/art.10851; Gopinath R, 1997, CYTOMETRY, V30, P313; Houle S, 2005, BRIT J PHARMACOL, V146, P670, DOI 10.1038/sj.bjp.0706371; Howells GL, 1997, J CELL SCI, V110, P881; Hyun E, 2008, GUT, V57, P1222, DOI 10.1136/gut.2008.150722; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Kato T, 2006, INT J HEMATOL, V84, P205, DOI 10.1532/IJH97.06141; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; LYNCH JP, 1985, AM J MED, V78, P691, DOI 10.1016/0002-9343(85)90416-4; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; MOVAT HZ, 1987, FASEB J, V46, P97; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nanda A, 1996, J BIOL CHEM, V271, P15963, DOI 10.1074/jbc.271.27.15963; O'SHEA JJ, 1985, J IMMUNOL, V134, P2580; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; POULIOT M, 1994, J EXP MED, V179, P1225, DOI 10.1084/jem.179.4.1225; Pouliot M, 2002, J IMMUNOL, V169, P5279, DOI 10.4049/jimmunol.169.9.5279; Roche N, 2003, RESP MED, V97, P228, DOI 10.1053/rmed.2003.1437; ROSALES C, 1991, J IMMUNOL, V146, P3937; Sawyer D W, 1989, Rev Infect Dis, V11 Suppl 7, pS1532; Seeliger S, 2003, FASEB J, V17, P1871, DOI 10.1096/fj.02-1112com; Sekiguchi F, 2005, YAKUGAKU ZASSHI, V125, P491, DOI 10.1248/yakushi.125.491; Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034; SHANLEY TP, 1995, MOL MED TODAY, V1, P40, DOI 10.1016/1357-4310(95)80019-0; Shpacovitch VM, 2007, EXP DERMATOL, V16, P799, DOI 10.1111/j.1600-0625.2007.00605.x; Shpacovitch VM, 2004, J LEUKOCYTE BIOL, V76, P388, DOI 10.1189/jlb.0503221; St-Onge M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004902; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Suzuki T, 2006, CELL RES, V16, P887, DOI 10.1038/sj.cr.7310103; TERKELTAUB R, 1983, ARTHRITIS RHEUM, V26, P775, DOI 10.1002/art.1780260612; Uehara A, 2004, J IMMUNOL, V173, P4179, DOI 10.4049/jimmunol.173.6.4179; Vergnolle N, 2001, TRENDS PHARMACOL SCI, V22, P146, DOI 10.1016/S0165-6147(00)01634-5; Vergnolle N, 1999, J IMMUNOL, V163, P5064; Wang HY, 2006, CELL BIOL INT, V30, P688, DOI 10.1016/j.cellbi.2006.04.007; Williams C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004936	55	13	15	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					2116	2125		10.1096/fj.09-146167	http://dx.doi.org/10.1096/fj.09-146167			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20154268	Green Accepted, Green Published			2022-12-25	WOS:000278200000044
J	Fernandez-Calotti, P; Pastor-Anglada, M				Fernandez-Calotti, Paula; Pastor-Anglada, Marcal			All-trans-retinoic Acid Promotes Trafficking of Human Concentrative Nucleoside Transporter-3 (hCNT3) to the Plasma Membrane by a TGF-beta 1-mediated Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; GROWTH-FACTOR-BETA; TGF-BETA; CELLS; DIFFERENTIATION; FLUDARABINE; ACTIVATION; RHO; EXPRESSION	Human concentrative nucleoside transporter-3 (hCNT3) is a sodium-coupled nucleoside transporter that exhibits high affinity and broad substrate selectivity, making it the most suitable candidate for mediating the uptake and cytotoxic action of most nucleoside-derived drugs. The drug of this class most commonly used in the treatment of chronic lymphocytic leukemia (CLL) is the pro-apoptotic nucleoside analog fludarabine (Flu), which enters CLL cells primarily through human equilibrative nucleoside transporters (hENTs). Although CLL cells lack hCNT3 activity, they do express this transporter protein, which is located mostly in the cytosol. The aim of our study was to identify agents and mechanisms capable of promoting hCNT3 trafficking to the plasma membrane. Here, we report that all-trans-retinoic acid (ATRA), currently used in the treatment of acute promyelocytic leukemia (APL), increases hCNT3-related activity through a mechanism that involves trafficking of pre-existing hCNT3 proteins to the plasma membrane. This effect is mediated by the autocrine action of transforming growth factor (TGF)-beta 1, which is transcriptionally activated by ATRA in ap38-dependent manner. TGF-beta 1 acts through activation of ERK1/2 and the small GTPase RhoA to promote plasma membrane trafficking of the hCNT3 protein.	[Pastor-Anglada, Marcal] Univ Barcelona, IBUB, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; Univ Barcelona, CIBER EHD, E-08028 Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona	Pastor-Anglada, M (corresponding author), Univ Barcelona, IBUB, Dept Bioquim & Biol Mol, Diagonal 645, E-08028 Barcelona, Spain.	mpastor@ub.edu	Pastor-Anglada, Marçal/C-3730-2017	Pastor-Anglada, Marçal/0000-0003-3712-1773	Ministerio de Ciencia e Innovacion [SAF2008-00577]; Generalitat de Catalunya [2005SGR00315]; Accion Transversal en Cancer (CIBER-Instituto de Salud Carlos III); Juan de la Cierva; Ministerio de Educacion y Ciencia, Spain; European Regional Development Fund (ERDF) [BFU2007-30688-E/BFI]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Accion Transversal en Cancer (CIBER-Instituto de Salud Carlos III); Juan de la Cierva(Instituto de Salud Carlos III); Ministerio de Educacion y Ciencia, Spain(Spanish Government); European Regional Development Fund (ERDF)(European Commission)	This work was supported by Grants SAF2008-00577 (Ministerio de Ciencia e Innovacion) and 2005SGR00315 (Generalitat de Catalunya) (to M. P.-A.). This work was also supported by the Accion Transversal en Cancer (CIBER-Instituto de Salud Carlos III) and by Juan de la Cierva (to P.F.-C.).; We thank Neus Abella and Maria Calvo from the Confocal Microscopy Facility of Serveis Cientificotecnics (Universitat de Barcelona-IDIBAPS) for support and advice with confocal techniques. This laboratory belongs to the Biomedical Research Institute Network-Liver and Gastrointestinal Diseases (CIBER EHD). CIBER is an initiative of the Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion). Our group is a member of the Network for Cooperative Research on Membrane Transport Proteins (REIT), co-funded by the Ministerio de Educacion y Ciencia, Spain, and the European Regional Development Fund (ERDF) (Grant BFU2007-30688-E/BFI).	Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; BONETKERRACHE A, 2005, BIOCHEM J, V15, P261; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; Calotti PF, 2008, BIOCHEM PHARMACOL, V75, P857, DOI 10.1016/j.bcp.2007.10.017; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; CHOMIENNE C, 1990, BLOOD, V76, P1710; Coe I, 2002, FEBS LETT, V517, P201, DOI 10.1016/S0014-5793(02)02622-4; Dai XJ, 2004, J INVEST DERMATOL, V123, P1078, DOI 10.1111/j.0022-202X.2004.23503.x; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Duflot S, 2004, MOL CELL BIOL, V24, P2710, DOI 10.1128/MCB.24.7.2710-2719.2004; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Elter T, 2006, EXPERT OPIN PHARMACO, V7, P1641, DOI 10.1517/14656566.7.12.1641; Errasti-Murugarren E, 2009, FASEB J, V23, P172, DOI 10.1096/fj.08-113902; Fernandez-Veledo S, 2006, BIOCHEM J, V395, P337, DOI 10.1042/BJ20051232; Flanagan SA, 1997, J BIOL CHEM, V272, P18026, DOI 10.1074/jbc.272.29.18026; Flanagan SA, 2003, CANCER CHEMOTH PHARM, V51, P363, DOI 10.1007/s00280-002-0561-0; Flanagan SA, 2007, LEUKEMIA RES, V31, P955, DOI 10.1016/j.leukres.2006.09.010; Freund A, 1999, ANN ONCOL, V10, P335, DOI 10.1023/A:1008365714942; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Gamberale R, 2001, LEUKEMIA, V15, P1860, DOI 10.1038/sj.leu.2402288; Glasow A, 2005, BLOOD, V105, P341, DOI 10.1182/blood-2004-03-1074; Imamichi Y, 2005, BIOL CHEM, V386, P225, DOI 10.1515/BC.2005.028; Kardassis D, 2009, FEBS J, V276, P2947, DOI 10.1111/j.1742-4658.2009.07031.x; KREMER JP, 1992, BRIT J HAEMATOL, V80, P480, DOI 10.1111/j.1365-2141.1992.tb04561.x; Lecuona E, 2003, MOL BIOL CELL, V14, P3888, DOI 10.1091/mbc.E02-12-0781; Lewandowski D, 2002, BRIT J HAEMATOL, V118, P535, DOI 10.1046/j.1365-2141.2002.03601.x; Mackey JR, 2005, BLOOD, V105, P767, DOI 10.1182/blood-2004-03-1046; Maeda A, 2002, BIOCHEM BIOPH RES CO, V297, P1231, DOI 10.1016/S0006-291X(02)02342-2; Mercader J, 1996, BIOCHEM J, V317, P835, DOI 10.1042/bj3170835; Molina-Arcas M, 2003, BLOOD, V101, P2328, DOI 10.1182/blood-2002-07-2236; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Norman JC, 1996, MOL BIOL CELL, V7, P1429, DOI 10.1091/mbc.7.9.1429; Nunes I, 1996, CANCER RES, V56, P495; Pastor-Anglada M, 2001, MOL MEMBR BIOL, V18, P81, DOI 10.1080/096876800110033783; Pedersen IM, 2004, LEUKEMIA LYMPHOMA, V45, P2365, DOI 10.1080/10428190412331272703; Pochynyuk O, 2007, J BIOL CHEM, V282, P14576, DOI 10.1074/jbc.M701348200; REN X, 2007, LIFE SCI, V96, P47; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Sullivan R, 1999, J BIOL CHEM, V274, P38140, DOI 10.1074/jbc.274.53.38140; Symons M, 2003, CURR BIOL, V13, pR409, DOI 10.1016/S0960-9822(03)00324-5; Tsang RY, 2008, MODERN PATHOL, V21, P1387, DOI 10.1038/modpathol.2008.110; WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002; Yang LM, 2001, ONCOGENE, V20, P8025, DOI 10.1038/sj.onc.1204911; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; Yue JB, 2000, METH MOL B, V142, P125; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	50	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13589	13598		10.1074/jbc.M109.055673	http://dx.doi.org/10.1074/jbc.M109.055673			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20172853	hybrid, Green Published			2022-12-25	WOS:000276987700032
J	Marchildon, F; St-Louis, C; Akter, R; Roodman, V; Wiper-Bergeron, NL				Marchildon, Francois; St-Louis, Catherine; Akter, Rahima; Roodman, Victoria; Wiper-Bergeron, Nadine L.			Transcription Factor Smad3 Is Required for the Inhibition of Adipogenesis by Retinoic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-BETA; GROWTH-FACTOR-BETA; C/EBP-BETA; ADIPOCYTE DIFFERENTIATION; TGF-BETA; MAMMARY-GLAND; PREADIPOCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; HEPATOCYTE PROLIFERATION; INSULIN SENSITIVITY	The process of adipocyte differentiation is driven by a highly coordinated cascade of transcriptional events that results in the development of the mature adipocyte and in lipid accumulation. One of the early events of differentiation is the up-regulation of CCAAT/enhancer-binding protein beta (C/EBP beta) expression. C/EBP beta then acts to up-regulate the expression of adipogenic factors such as C/EBP alpha, which control the late stage of adipogenesis. Retinoic acid (RA) is a potent inhibitor of adipogenesis, and its action appears to block C/EBP beta transcriptional potential early during differentiation. Using preadipocytes and mesenchymal stem cell models, we show that RA specifically blocks the occupancy of C/EBP beta of the Cebpa promoter, thereby abrogating the differentiation process. RA does not act directly on C/EBP beta but rather stimulates the expression of the transforming growth factor beta-effector protein Smad3, which can interact with C/EBP beta via its Mad homology 1 domain and can interfere with C/EBP beta DNA binding. The RA-induced increase in Smad3 expression results in increased cytoplasmic and nuclear Smad3, an important event as ectopic expression of Smad3 in preadipocytes in the absence of RA treatment only modestly inhibits adipogenesis and C/EBP beta DNA binding, suggesting that Smad3 alone is not sufficient to completely recapitulate the effects of retinoic acid treatment during differentiation. However, in the absence of Smad3, RA is not able to inhibit adipocyte differentiation or to elicit a decrease in C/EBP beta DNA occupancy suggesting that Smad3 is necessary to convey the inhibitory effects of retinoic acid during adipogenesis.	Univ Ottawa, Grad Program Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [St-Louis, Catherine; Akter, Rahima; Wiper-Bergeron, Nadine L.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa	Wiper-Bergeron, NL (corresponding author), 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	nadine.wiperbergeron@uottawa.ca	Wiper-Bergeron, Nadine/AAO-4370-2021	Wiper-Bergeron, Nadine/0000-0001-8448-3246; Marchildon, Francois/0000-0002-4846-3149	Heart and Stroke Foundation of Ontario [NA 6375]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by Heart and Stroke Foundation of Ontario Grant NA 6375.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312; BOYD AS, 1989, AM J MED, V86, P568, DOI 10.1016/0002-9343(89)90386-0; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cao ZH, 2003, BLOOD, V101, P498, DOI 10.1182/blood-2002-05-1549; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Gery S, 2004, BLOOD, V104, P3911, DOI 10.1182/blood-2003-10-3688; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; HATHCOCK JN, 1990, AM J CLIN NUTR, V52, P183, DOI 10.1093/ajcn/52.2.183; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Jefcoate Colin R., 2008, V456, P173, DOI 10.1007/978-1-59745-245-8_13; Jeyakumar SM, 2006, OBESITY, V14, P52, DOI 10.1038/oby.2006.7; KISTLER A, 1986, CARCINOGENESIS, V7, P1175, DOI 10.1093/carcin/7.7.1175; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; Ledda-Columbano GM, 2004, CARCINOGENESIS, V25, P2061, DOI 10.1093/carcin/bgh221; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Millward CA, 2007, DIABETES, V56, P161, DOI 10.2337/db06-0310; Ozeki A, 1999, BBA-MOL CELL RES, V1450, P308, DOI 10.1016/S0167-4889(99)00063-4; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; TRAUTWEIN C, 1994, J CLIN INVEST, V93, P2554, DOI 10.1172/JCI117266; Wang LQ, 2000, J BIOL CHEM, V275, P14173, DOI 10.1074/jbc.M000764200; Wang YA, 2005, DEV DYNAM, V234, P892, DOI 10.1002/dvdy.20570; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Wiper-Bergeron N, 2007, MOL ENDOCRINOL, V21, P2124, DOI 10.1210/me.2006-0452; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Zauberman A, 2001, J BIOL CHEM, V276, P24719, DOI 10.1074/jbc.M005813200; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	49	58	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13274	13284		10.1074/jbc.M109.054536	http://dx.doi.org/10.1074/jbc.M109.054536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20179325	Green Published, hybrid			2022-12-25	WOS:000276787800082
J	Salsi, E; Campanini, B; Bettati, S; Raboni, S; Roderick, SL; Cook, PF; Mozzarelli, A				Salsi, Enea; Campanini, Barbara; Bettati, Stefano; Raboni, Samanta; Roderick, Steven L.; Cook, Paul F.; Mozzarelli, Andrea			A Two-step Process Controls the Formation of the Bienzyme Cysteine Synthase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; ALPHA-AMINOACRYLATE INTERMEDIATE; ANION-BINDING SITE; SERINE ACETYLTRANSFERASE; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; ACTIVE-SITE; MOLECULAR-BASIS; CONFORMATIONAL-CHANGE; FUNCTIONAL-ANALYSIS	The regulation of enzyme activity through the transient formation of multiprotein assemblies plays an important role in the control of biosynthetic pathways. One of the first regulatory complexes to be discovered was cysteine synthase (CS), formed by the pyridoxal 5'-phosphate-dependent enzyme O-acetylserine sulfhydrylase (OASS) and serine acetyltransferase (SAT). These enzymes are at the branch point of the sulfur, carbon, and nitrogen assimilation pathways. Understanding the mechanism of complex formation helps to clarify the role played by CS in the regulation of sulfur assimilation in bacteria and plants. To this goal, stopped-flow fluorescence spectroscopy was used to characterize the interaction of SAT with OASS, at different temperatures and pH values, and in the presence of the physiological regulators cysteine and bisulfide. Results shed light on the mechanism of complex formation and regulation, so far poorly understood. Cysteine synthase assembly occurs via a two-step mechanism involving rapid formation of an encounter complex between the two enzymes, followed by a slow conformational change. The conformational change likely results from the closure of the active site of OASS upon binding of the SAT C-terminal peptide. Bisulfide, the second substrate and a feedback inhibitor of OASS, stabilizes the CS complex mainly by decreasing the back rate of the isomerization step. Cysteine, the product of the OASS reaction and a SAT inhibitor, slightly affects the kinetics of CS formation leading to destabilization of the complex.	[Mozzarelli, Andrea] Univ Parma, Dipartmento Biochim & Biol Mol, I-43100 Parma, Italy; [Bettati, Stefano; Mozzarelli, Andrea] Ist Nazl Biostrutture & Biosistemi, I-00136 Rome, Italy; [Roderick, Steven L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Cook, Paul F.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Parma; Yeshiva University; Albert Einstein College of Medicine; University of Oklahoma System; University of Oklahoma - Norman	Campanini, B (corresponding author), V GP Usberti 23-A, I-43100 Parma, Italy.	barbara.campanini@unipr.it; pcook@ou.edu	Bettati, Stefano/V-9975-2018; Campanini, Barbara/L-9723-2017; Mozzarelli, Andrea/C-3615-2014; RABONI, Samanta/P-7823-2018	Bettati, Stefano/0000-0001-6787-0594; Campanini, Barbara/0000-0003-0359-0627; Mozzarelli, Andrea/0000-0003-3762-0062; RABONI, Samanta/0000-0003-3068-3714	Italian Ministry of University and Research [COFIN2007]; International Exchange Program [2005]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); International Exchange Program	This work was supported by the Grayce B. Kerr endowment to the University of Oklahoma (to P. F. C.), by grants from the Italian Ministry of University and Research COFIN2007 (to A. M.), and by the International Exchange Program 2005 (to A. M. and P. F. C.).	BECKER MA, 1969, J BIOL CHEM, V244, P6023; BERNHARD SA, 1988, CELL BIOPHYS, V12, P119, DOI 10.1007/BF02918354; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Burkhard P, 2000, J MOL BIOL, V303, P279, DOI 10.1006/jmbi.2000.4109; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Campanini B, 2005, PROTEIN SCI, V14, P2115, DOI 10.1110/ps.051492805; COOK PF, 1976, J BIOL CHEM, V251, P2023; COOK PF, 1977, ARCH BIOCHEM BIOPHYS, V178, P293, DOI 10.1016/0003-9861(77)90194-1; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Feldman-Salit A, 2009, J MOL BIOL, V386, P37, DOI 10.1016/j.jmb.2008.08.075; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; GARLAND DL, 1978, BIOCHEMISTRY-US, V17, P4266, DOI 10.1021/bi00613a024; Gorman J, 2004, ACTA CRYSTALLOGR D, V60, P1600, DOI 10.1107/S0907444904015240; Hedderich R, 1998, FEMS MICROBIOL REV, V22, P353, DOI 10.1111/j.1574-6976.1998.tb00376.x; Hell R, 2001, CURR OPIN BIOTECH, V12, P161, DOI 10.1016/S0958-1669(00)00193-2; Hindson VJ, 2000, J BIOL CHEM, V275, P461, DOI 10.1074/jbc.275.1.461; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Johnson CM, 2004, ARCH BIOCHEM BIOPHYS, V429, P115, DOI 10.1016/j.abb.2004.06.006; Kopriva S, 2002, PLANT PHYSIOL, V130, P1406, DOI 10.1104/pp.007773; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; KREDICH NM, 1992, MOL MICROBIOL, V6, P2747, DOI 10.1111/j.1365-2958.1992.tb01453.x; KREDICH NM, 1996, ESCHERICHIA COLI SAL, V2, P514; Kumaran S, 2007, BIOCHEMISTRY-US, V46, P5586, DOI 10.1021/bi7001168; Kumaran S, 2009, J BIOL CHEM, V284, P10268, DOI 10.1074/jbc.M900154200; Li S, 2002, J BIOL CHEM, V277, P25992, DOI 10.1074/jbc.M201619200; MCCLURE GD, 1994, BIOCHEMISTRY-US, V33, P1674, DOI 10.1021/bi00173a009; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1628, DOI 10.1271/bbb.64.1628; Mino K, 1999, BIOSCI BIOTECH BIOCH, V63, P168, DOI 10.1271/bbb.63.168; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1874, DOI 10.1271/bbb.64.1874; O'Leary SE, 2008, BIOCHEMISTRY-US, V47, P11606, DOI 10.1021/bi8013664; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; OVADI J, 1991, J THEOR BIOL, V152, P1, DOI 10.1016/S0022-5193(05)80500-4; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; PERACCHI A, 1995, BIOCHEMISTRY-US, V34, P9459, DOI 10.1021/bi00029a022; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; Raboni S, 2003, BBA-PROTEINS PROTEOM, V1647, P157, DOI 10.1016/S1570-9639(03)00084-0; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Riek U, 2008, BIOTECHNIQUES, V45, P187, DOI 10.2144/000112830; SCHNACKERZ KD, 1995, BIOCHEMISTRY-US, V34, P12152, DOI 10.1021/bi00038a008; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; Sekowska A, 2000, J MOL MICROB BIOTECH, V2, P145; Soutourina O, 2009, MOL MICROBIOL, V73, P194, DOI 10.1111/j.1365-2958.2009.06760.x; TAI CH, 1993, BIOCHEMISTRY-US, V32, P6433, DOI 10.1021/bi00076a017; Tai CH, 2001, BIOCHEMISTRY-US, V40, P7446, DOI 10.1021/bi015511s; Tai CH, 2008, BBA-PROTEINS PROTEOM, V1784, P629, DOI 10.1016/j.bbapap.2007.12.017; Tanous C, 2008, J BIOL CHEM, V283, P35551, DOI 10.1074/jbc.M805951200; Wei J, 2002, BIOCHEMISTRY-US, V41, P8493, DOI 10.1021/bi025953j; Williams RAM, 2009, BIOCHEM J, V420, P451, DOI 10.1042/BJ20082441; Wirtz M, 2006, J PLANT PHYSIOL, V163, P273, DOI 10.1016/j.jplph.2005.11.013; Wirtz M, 2004, J EXP BOT, V55, P1785, DOI 10.1093/jxb/erh201; Woehl EU, 1996, BIOCHEMISTRY-US, V35, P4776, DOI 10.1021/bi952938o; Zhao CH, 2006, BIOCHEM BIOPH RES CO, V341, P911, DOI 10.1016/j.bbrc.2006.01.054	57	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12813	12822		10.1074/jbc.M109.075762	http://dx.doi.org/10.1074/jbc.M109.075762			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20164178	Green Published, hybrid			2022-12-25	WOS:000276787800039
J	Andersen, OS; Boisguerin, P; Glerup, S; Skeldal, S; Volkmer, R; Willnow, TE; Nykjaer, A; Andersen, OM				Andersen, Olga Serup; Boisguerin, Prisca; Glerup, Simon; Skeldal, Sune; Volkmer, Rudolf; Willnow, Thomas E.; Nykjaer, Anders; Andersen, Olav M.			Identification of a Linear Epitope in Sortilin That Partakes in Pro-neurotrophin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; SPINAL-CORD-INJURY; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; SPOT-SYNTHESIS; HUMAN BRAIN; CELL-DEATH; NEURONAL DEVELOPMENT; RECEPTOR SORTILIN; PEPTIDE ARRAYS	Sortilin acts as a cell surface receptor for pro-neurotrophins (pro-NT) that upon complex formation with the p75 neurotrophin receptor (p75(NTR)) is able to signal neuronal cell death. Here we screened a sortilin peptide library comprising 16-mer overlapping sequences for binding of the pro-domains of nerve growth factor and brain-derived neurotrophic factor. We find that a linear surface-exposed sequence, (163)RIFRSSDFAKNF(174), constitutes an important pro-NT binding epitope in sortilin. Systematic mutational analysis revealed residues Arg(163), Phe(165), Arg(166), and Phe(170) to be critical for the interaction. Expression of a sortilin mutant in which these four amino acids were substituted by alanines disrupted pro-NT binding without affecting receptor heterodimerization with p75(NTR) or binding of ligands that selectively engages the centrally located tunnel in the beta-propeller of sortilin. We furthermore demonstrate that a peptide comprising the ligand-binding epitope can prevent pro-NT-induced apoptosis in RN22 schwannoma cells.	[Glerup, Simon; Skeldal, Sune; Nykjaer, Anders; Andersen, Olav M.] Univ Aarhus, Dept Med Biochem, Membrane Receptors Neuronal Dis Ctr, DK-8000 Aarhus C, Denmark; [Andersen, Olga Serup] Univ Aarhus, Dept Mol Biol, Membrane Receptors Neuronal Dis Ctr, DK-8000 Aarhus C, Denmark; [Boisguerin, Prisca; Volkmer, Rudolf] Charite, Inst Med Immunol, D-10115 Berlin, Germany; [Willnow, Thomas E.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Aarhus University; Aarhus University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Andersen, OM (corresponding author), Univ Aarhus, Dept Med Biochem, Membrane Receptors Neuronal Dis Ctr, Ole Worms Alle 3,Bldg 1170, DK-8000 Aarhus C, Denmark.	o.andersen@biokemi.au.dk	Boisguerin, Prisca/AAG-6565-2020; Andersen, Olav/N-2777-2017	Boisguerin, Prisca/0000-0002-6955-1340; Nykjaer, Anders/0000-0001-6422-6736; Volkmer, Rudolf/0000-0003-4710-1143; Willnow, Thomas/0000-0001-9515-7921; Andersen, Olav/0000-0003-4226-3354	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	This work was supported in part by grants from the Danish Medical Research Council and the Lundbeck Foundation.	Al-Shawi R, 2008, EUR J NEUROSCI, V27, P2103, DOI 10.1111/j.1460-9568.2008.06152.x; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Arnett MG, 2007, BRAIN RES, V1183, P32, DOI 10.1016/j.brainres.2007.09.051; BANDTLOW C, 2004, SCI STKE, pPE24, DOI DOI 10.1126/STKE.2352004PE24; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; Bronfman FC, 2004, EMBO REP, V5, P867, DOI 10.1038/sj.embor.7400219; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Clee SM, 2006, NAT GENET, V38, P688, DOI 10.1038/ng1796; Copley RR, 2001, PROTEIN SCI, V10, P285, DOI 10.1110/ps.31901; Counts SE, 2004, ANN NEUROL, V56, P520, DOI 10.1002/ana.20233; Counts SE, 2005, J NEUROPATH EXP NEUR, V64, P263, DOI 10.1093/jnen/64.4.263; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; Domeniconi M, 2007, MOL CELL NEUROSCI, V34, P271, DOI 10.1016/j.mcn.2006.11.005; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Fan YJ, 2008, EUR J NEUROSCI, V27, P2380, DOI 10.1111/j.1460-9568.2008.06215.x; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; Frank R, 1996, Methods Mol Biol, V66, P149; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kaplan DR, 2004, NATURE, V427, P798, DOI 10.1038/427798a; Kichev A, 2009, AM J PATHOL, V175, P2574, DOI 10.2353/ajpath.2009.090018; KIM JS, 1993, PROTEIN SCI, V2, P348; Kliemannel M, 2007, PROTEIN SCI, V16, P411, DOI 10.1110/ps.062376207; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Michalski B, 2003, MOL BRAIN RES, V111, P148, DOI 10.1016/S0169-328X(03)00003-2; Nakamura K, 2007, CELL DEATH DIFFER, V14, P1552, DOI 10.1038/sj.cdd.4402173; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pagadala PC, 2006, P NATL ACAD SCI USA, V103, P17939, DOI 10.1073/pnas.0604139103; Palardini A, 2008, NEUROPEPTIDES, V42, P205, DOI 10.1016/j.npep.2007.11.004; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Paoletti F, 2006, BIOCHEM SOC T, V34, P605, DOI 10.1042/BST0340605; Paoli M, 1999, NAT STRUCT BIOL, V6, P926; Pedraza CE, 2005, AM J PATHOL, V166, P533, DOI 10.1016/S0002-9440(10)62275-4; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Podlesniy P, 2006, AM J PATHOL, V169, P119, DOI 10.2353/ajpath.2006.050787; Provenzano MJ, 2008, LARYNGOSCOPE, V118, P87, DOI 10.1097/MLG.0b013e31814b8d9f; Quistgaard EM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-46; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Scharn D, 2000, J COMB CHEM, V2, P361, DOI 10.1021/cc000012g; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Schweigreiter R, 2006, BIOESSAYS, V28, P583, DOI 10.1002/bies.20419; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Tauris J, 1998, FEBS LETT, V429, P27, DOI 10.1016/S0014-5793(98)00559-6; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Volosin M, 2008, J NEUROSCI, V28, P9870, DOI 10.1523/JNEUROSCI.2841-08.2008; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; Wei Y, 2007, NEUROSCI LETT, V429, P169, DOI 10.1016/j.neulet.2007.10.012; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yano H, 2009, J NEUROSCI, V29, P14790, DOI 10.1523/JNEUROSCI.2059-09.2009; Yune TY, 2007, J NEUROSCI, V27, P7751, DOI 10.1523/JNEUROSCI.1661-07.2007	72	16	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12210	12222		10.1074/jbc.M109.062364	http://dx.doi.org/10.1074/jbc.M109.062364			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20159974	Green Published, hybrid			2022-12-25	WOS:000276787100050
J	Burger, K; Muhl, B; Harasim, T; Rohrmoser, M; Malamoussi, A; Orban, M; Kellner, M; Gruber-Eber, A; Kremmer, E; Holzel, M; Eick, D				Burger, Kaspar; Muehl, Bastian; Harasim, Thomas; Rohrmoser, Michaela; Malamoussi, Anastassia; Orban, Mathias; Kellner, Markus; Gruber-Eber, Anita; Kremmer, Elisabeth; Hoelzel, Michael; Eick, Dirk			Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U2 SNRNA; 5-FLUOROURACIL TOXICITY; P53; TRANSCRIPTION; DISRUPTION; URACIL; YEAST; PSEUDOURIDYLATION; ACCUMULATION; DEPLETION	Drugs for cancer therapy belong to different categories of chemical substances. The cellular targets for the therapeutic efficacy are often not unambiguously identified. Here, we describe the process of ribosome biogenesis as a target of a large variety of chemotherapeutic drugs. We determined the inhibitory concentration of 36 chemotherapeutic drugs for transcription and processing of ribosomal RNA by in vivo labeling experiments. Inhibitory drug concentrations were correlated to the loss of nucleolar integrity. The synergism of drugs inhibiting ribosomal RNA synthesis at different levels was studied. Drugs inhibited ribosomal RNA synthesis either at the level of (i) rRNA transcription (e. g. oxaliplatin, doxorubicin, mitoxantrone, methotrexate), (ii) early rRNA processing (e. g. camptothecin, flavopiridol, roscovitine), or (iii) late rRNA processing (e. g. 5-fluorouracil, MG-132, homoharringtonine). Blockage of rRNA transcription or early rRNA processing steps caused nucleolar disintegration, whereas blockage of late rRNA processing steps left the nucleolus intact. Flavopiridol and 5-fluorouracil showed a strong synergism for inhibition of rRNA processing. We conclude that inhibition of ribosome biogenesis by chemotherapeutic drugs potentially may contribute to the efficacy of therapeutic regimens.	[Orban, Mathias; Kellner, Markus; Gruber-Eber, Anita; Hoelzel, Michael; Eick, Dirk] CIPSM, Inst Clin Mol Biol & Tumor Genet, D-81377 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, D-81377 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Eick, D (corresponding author), Marchioninistr 25, D-81377 Munich, Germany.	eick@helmholtz-muenchen.de	Orban, Mathias/AAS-8461-2020	Orban, Mathias/0000-0001-7846-8808	Deutsche Forschungsgemeinschaft [SFB684, SFB-Transregio]; Fonds der Chemischen Industrie; German Jose Carreras Leukemia Foundation (DJCLS) [F09/03]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); German Jose Carreras Leukemia Foundation (DJCLS)	This work was supported by the Deutsche Forschungsgemeinschaft (SFB684 and SFB-Transregio 5), Fonds der Chemischen Industrie, and German Jose Carreras Leukemia Foundation (DJCLS, Project F09/03).	Budde A, 1999, ONCOGENE, V18, P1119, DOI 10.1038/sj.onc.1202402; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Byrd JC, 2007, BLOOD, V109, P399, DOI 10.1182/blood-2006-05-020735; Carneiro T, 2007, MOL CELL BIOL, V27, P4157, DOI 10.1128/MCB.00120-07; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dornfeld K, 2005, NUCLEIC ACIDS RES, V33, P6644, DOI 10.1093/nar/gki975; Fang F, 2004, MOL CELL BIOL, V24, P10766, DOI 10.1128/MCB.24.24.10766-10776.2004; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; GHOSHAL K, 1994, CANCER RES, V54, P632; Grimm T, 2006, NUCLEIC ACIDS RES, V34, P3030, DOI 10.1093/nar/gkl378; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Hoskins J, 2008, GENETICS, V179, P323, DOI 10.1534/genetics.107.082727; Kouzminova EA, 2006, J MOL BIOL, V355, P20, DOI 10.1016/j.jmb.2005.10.044; Ladner RD, 2001, CURR PROTEIN PEPT SC, V2, P361, DOI 10.2174/1389203013380991; LENZ HJ, 1994, J BIOL CHEM, V269, P31962; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; PARKER WB, 1990, PHARMACOL THERAPEUT, V48, P381, DOI 10.1016/0163-7258(90)90056-8; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Seiple L, 2006, NUCLEIC ACIDS RES, V34, P140, DOI 10.1093/nar/gkj430; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Sirri V, 2002, J CELL BIOL, V156, P969, DOI 10.1083/jcb.200201024; Soos TJ, 2006, DRUG NEWS PERSPECT, V19, P325, DOI 10.1358/dnp.2006.19.6.985939; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Yu YT, 1998, EMBO J, V17, P5783, DOI 10.1093/emboj/17.19.5783; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000; Zhao XL, 2007, NUCLEIC ACIDS RES, V35, P550, DOI 10.1093/nar/gkl1084; Zhao XL, 2004, RNA, V10, P681, DOI 10.1261/rna.5159504	37	275	283	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12416	12425		10.1074/jbc.M109.074211	http://dx.doi.org/10.1074/jbc.M109.074211			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20159984	Green Published, hybrid			2022-12-25	WOS:000276787100069
J	Majerciak, V; Kruhlak, M; Dagur, PK; Mccoy, JP; Zheng, ZM				Majerciak, Vladimir; Kruhlak, Michael; Dagur, Pradeep K.; Mccoy, J. Philip, Jr.; Zheng, Zhi-Ming			Caspase-7 Cleavage of Kaposi Sarcoma-associated Herpesvirus ORF57 Confers a Cellular Function against Viral Lytic Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFUSION LYMPHOMA-CELLS; DNA-SEQUENCES; INDUCED APOPTOSIS; PROTEIN; VIRUS; HUMAN-HERPESVIRUS-8; PHOSPHORYLATION; ACTIVATION; PREDICTION; PATHWAYS	Kaposi sarcoma-associated herpesvirus (KSHV) ORF57 is a viral early protein essential for KSHV multiplication. We found that B cells derived from cavity-based B cell lymphoma with lytic KSHV infection display activation of caspase-8 and cleavage of ORF57 in the cytoplasm by caspase-7 at the aspartate residue at position 33 from the N terminus. Caspase-7 cleavage of ORF57 is prevented by pan-caspase inhibitor z-VAD, caspase-3 and caspase-7 inhibitor z-DEVD, and caspase-7 small interfering RNAs. The caspase-7 cleavage site (DETD33)-D-30 in ORF57 is not cleavable by caspase-3, although both enzymes use DEXD as a common cleavage site. B cells with lytic KSHV infection and caspase-7 activation exhibited a greatly reduced level of ORF57. A majority of the cells expressing active caspase-7 appeared to have no detectable ORF57 and vice versa. Upon cleavage with caspase-7, ORF57 was deficient in promoting the expression of viral lytic genes. Inhibiting caspase-7 cleavage of ORF57 in KSHV+ BCBL-1 cells by z-VAD, z-DEVD, or caspase-7 small interfering RNA led to increased expression of viral lytic genes and production of cell-free virus particles. Collectively, our data provide the first compelling evidence that caspase cleavage of ORF57 may represent a cellular function against lytic KSHV infection.	[Majerciak, Vladimir; Zheng, Zhi-Ming] NCI, HIV & AIDS Malignancy Branch, Bethesda, MD 20892 USA; [Kruhlak, Michael] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; [Dagur, Pradeep K.; Mccoy, J. Philip, Jr.] NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zheng, ZM (corresponding author), 10 Ctr Dr,Rm 6N106, Bethesda, MD 20892 USA.	zhengt@mail.nih.gov	Zheng, Zhi-Ming/L-6383-2019; mccoy, john philip/ABD-9348-2021	Zheng, Zhi-Ming/0000-0001-5547-7912; 	National Cancer Institute, Center for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZICBC010915, ZIASC010357] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005905] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, National Cancer Institute, Center for Cancer Research.	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Aragane Y, 1998, J CELL BIOL, V140, P171, DOI 10.1083/jcb.140.1.171; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boston-Howes W, 2006, J BIOL CHEM, V281, P14076, DOI 10.1074/jbc.M600653200; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Clarke CAL, 2005, J BIOL CHEM, V280, P35337, DOI 10.1074/jbc.M506460200; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Djerbi M, 1999, J EXP MED, V190, P1025, DOI 10.1084/jem.190.7.1025; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gausdal G, 2004, LEUKEMIA, V18, P1989, DOI 10.1038/sj.leu.2403508; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Han YC, 2006, CIRC RES, V99, P415, DOI 10.1161/01.RES.0000237387.05259.a5; Han Z, 2006, J VIROL, V80, P5251, DOI 10.1128/JVI.02570-05; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Huang HS, 2008, J BIOL CHEM, V283, P18135, DOI 10.1074/jbc.M709735200; Janicke RU, 2006, SCIENCE, V312, P1874; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Klass CM, 2005, BLOOD, V105, P4028, DOI 10.1182/blood-2004-09-3569; Kulms D, 2002, BIOCHEM PHARMACOL, V64, P837, DOI 10.1016/S0006-2952(02)01146-2; Kuribayashi K, 2006, CANCER BIOL THER, V5, P763, DOI 10.4161/cbt.5.7.3228; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Majerciak V, 2008, J VIROL, V82, P2792, DOI 10.1128/JVI.01856-07; Majerciak V, 2007, J VIROL, V81, P1062, DOI 10.1128/JVI.01558-06; Majerciak V, 2006, J VIROL, V80, P11968, DOI 10.1128/JVI.01394-06; Majerciak V, 2006, J BIOL CHEM, V281, P28365, DOI 10.1074/jbc.M603095200; Majerciak V, 2009, FRONT BIOSCI-LANDMRK, V14, P1516, DOI 10.2741/3322; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Medina-Palazon C, 2007, J VIROL, V81, P11850, DOI 10.1128/JVI.01421-07; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olson NE, 2003, J IMMUNOL, V170, P6065, DOI 10.4049/jimmunol.170.12.6065; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Schulz TF, 1998, J GEN VIROL, V79, P1573, DOI 10.1099/0022-1317-79-7-1573; Schweigreiter R, 2007, PROTEOMICS, V7, P4457, DOI 10.1002/pmic.200700499; Sharp TV, 2002, J VIROL, V76, P802, DOI 10.1128/JVI.76.2.802-816.2002; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Wang HW, 2002, EMBO J, V21, P2602, DOI 10.1093/emboj/21.11.2602; Wang YM, 2006, J BIOL CHEM, V281, P11887, DOI 10.1074/jbc.M511309200; Wee LJK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S14; Wies E, 2008, BLOOD, V111, P320, DOI 10.1182/blood-2007-05-092288; Yamanegi K, 2005, J VIROL, V79, P14207, DOI 10.1128/JVI.79.22.14207-14221.2005; Young JE, 2007, J BIOL CHEM, V282, P30150, DOI 10.1074/jbc.M705265200; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641; Zhu FX, 2003, J VIROL, V77, P4221, DOI 10.1128/JVI.77.7.4221-4230.2003	50	27	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11297	11307		10.1074/jbc.M109.068221	http://dx.doi.org/10.1074/jbc.M109.068221			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20159985	hybrid, Green Published			2022-12-25	WOS:000276286200036
J	Roussilhon, C; Brasseur, P; Agnamey, P; Perignon, JL; Druilhe, P				Roussilhon, Christian; Brasseur, Philippe; Agnamey, Patrice; Perignon, Jean-Louis; Druilhe, Pierre			Understanding Human-Plasmodium falciparum Immune Interactions Uncovers the Immunological Role of Worms	PLOS ONE			English	Article							GLUTAMATE-RICH PROTEIN; REGULATORY T-CELLS; PROTECTIVE IMMUNITY; SCHISTOSOMA-MANSONI; ASCARIS-LUMBRICOIDES; NEMATODE INFECTION; HUMAN MALARIA; RESPONSES; ANTIBODIES; DISEASES	Background: Former studies have pointed to a monocyte-dependant effect of antibodies in protection against malaria and thereby to cytophilic antibodies IgG1 and IgG3, which trigger monocyte receptors. Field investigations have further documented that a switch from non-cytophilic to cytophilic classes of antimalarial antibodies was associated with protection. The hypothesis that the non-cytophilic isotype imbalance could be related to concomittant helminthic infections was supported by several interventions and case-control studies. Methods and Findings: We investigated here the hypothesis that the delayed acquisition of immunity to malaria could be related to a worm-induced Th2 drive on antimalarial immune responses. IgG1 to IgG4 responses against 6 different parasite-derived antigens were analyzed in sera from 203 Senegalese children, half carrying intestinal worms, presenting 421 clinical malaria attacks over 51 months. Results show a significant correlation between the occurrence of malaria attacks, worm carriage (particularly that of hookworms) and a decrease in cytophilic IgG1 and IgG3 responses and an increase in non-cytophilic IgG4 response to the merozoite stage protein 3 (MSP3) vaccine candidate. Conclusion: The results confirm the association with protection of anti-MSP3 cytophilic responses, confirm in one additional setting that worms increase malaria morbidity and show a Th2 worm-driven pattern of anti-malarial immune responses. They document why large anthelminthic mass treatments may be worth being assessed as malaria control policies.	[Roussilhon, Christian; Perignon, Jean-Louis; Druilhe, Pierre] Inst Pasteur, Unite Parasitol Biomed, Paris, France; [Brasseur, Philippe] Inst Rech Dev, UMR 198, Dakar, Senegal; [Agnamey, Patrice] Hop Sud, CHU Amiens, Lab Parasitol Mycol, Amiens, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut de Recherche pour le Developpement (IRD); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Roussilhon, C (corresponding author), Inst Pasteur, Unite Parasitol Biomed, Paris, France.	druilhe@pasteur.fr			French Ministry of Foreign Affairs [FAC 2000]	French Ministry of Foreign Affairs	This work was in part supported by the French Ministry of Foreign Affairs - grant FAC 2000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnamey P, 2006, ANTIMICROB AGENTS CH, V50, P1531, DOI 10.1128/AAC.50.4.1531-1534.2006; Aribot G, 1996, AM J TROP MED HYG, V54, P449, DOI 10.4269/ajtmh.1996.54.449; BAILENGER J, 1970, ANN BIOL CLIN-PARIS, V28, P425; Basavaraju SV, 2006, MT SINAI J MED, V73, P1098; Bleay C, 2007, INT J PARASITOL, V37, P1501, DOI 10.1016/j.ijpara.2007.04.023; Borkow G, 2008, TRENDS PARASITOL, V24, P243, DOI 10.1016/j.pt.2008.02.009; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Cooper PJ, 2000, J INFECT DIS, V182, P1207, DOI 10.1086/315830; Cooper PJ, 2001, INFECT IMMUN, V69, P1574, DOI 10.1128/IAI.69.3.1574-1580.2001; de Souza B, 2008, MICROBES INFECT, V10, P916, DOI 10.1016/j.micinf.2008.04.015; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Druilhe P, 2006, VACCINE, V24, P4902, DOI 10.1016/j.vaccine.2006.03.018; Elias D, 2008, VACCINE, V26, P3897, DOI 10.1016/j.vaccine.2008.04.083; Elias D, 2007, EXPERT REV ANTI-INFE, V5, P475, DOI 10.1586/14787210.5.3.475; Hartgers FC, 2006, PARASITE IMMUNOL, V28, P497, DOI 10.1111/j.1365-3024.2006.00901.x; Hartgers FC, 2009, J INFECT DIS, V199, P1528, DOI 10.1086/598687; Helmby H, 1998, INFECT IMMUN, V66, P5167, DOI 10.1128/IAI.66.11.5167-5174.1998; Jackson JA, 2009, IMMUNOLOGY, V126, P18, DOI 10.1111/j.1365-2567.2008.03010.x; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Karp CL, 2007, CLIN INFECT DIS, V45, P1214, DOI 10.1086/522180; Khan WI, 2008, PARASITOLOGY, V135, P671, DOI 10.1017/S0031182008004381; MANSONBAHR PEC, 2002, MANSONS TROPICAL DIS; McGregor I. A., 1988, Malaria: principles and practice of malariology. Volume 1., P559; Moncayo AL, 2006, INT J BIOCHEM CELL B, V38, P1031, DOI 10.1016/j.biocel.2005.11.003; Mwangi TW, 2006, ANN TROP MED PARASIT, V100, P551, DOI 10.1179/136485906X118468; OEUVRAY C, 1994, MEM I OSWALDO CRUZ, V89, P77, DOI 10.1590/S0074-02761994000600018; Okech BA, 2001, AM J TROP MED HYG, V65, P912, DOI 10.4269/ajtmh.2001.65.912; PIERCE EJ, 1991, J EXP MED, V73, P159; PRITCHARD DI, 1992, PARASITE IMMUNOL, V14, P617, DOI 10.1111/j.1365-3024.1992.tb00034.x; Pullan R, 2008, PARASITOLOGY, V135, P783, DOI 10.1017/S0031182008000346; RHODESFEUILLETTE A, 1985, J INTERFERON RES, V5, P169, DOI 10.1089/jir.1985.5.169; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sarthou JL, 1997, INFECT IMMUN, V65, P3271, DOI 10.1128/IAI.65.8.3271-3276.1997; Sergent Ed., 1935, Arch Inst Pasteur Alger, V13, P279; Shin EH, 2007, J PARASITOL, V93, P1036, DOI 10.1645/GE-1203R.1; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Soe S, 2002, INFECT IMMUN, V70, P7182, DOI 10.1128/IAI.70.12.7182-7184.2002; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Su Z, 2005, INFECT IMMUN, V73, P3531, DOI 10.1128/IAI.73.6.3531-3539.2005; Theisen M, 2000, VACCINE, V19, P204, DOI 10.1016/S0264-410X(00)00181-X; Wilson MS, 2006, CHEM IMMUNOL ALLERGY, V90, P176, DOI 10.1159/000088892; Yoshida A, 2000, INT IMMUNOL, V12, P1117, DOI 10.1093/intimm/12.8.1117	46	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9309	10.1371/journal.pone.0009309	http://dx.doi.org/10.1371/journal.pone.0009309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174576	Green Published, Green Submitted, gold			2022-12-25	WOS:000274923700013
J	Tuch, BB; Laborde, RR; Xu, X; Gu, J; Chung, CB; Monighetti, CK; Stanley, SJ; Olsen, KD; Kasperbauer, JL; Moore, EJ; Broomer, AJ; Tan, RY; Brzoska, PM; Muller, MW; Siddiqui, AS; Asmann, YW; Sun, YM; Kuersten, S; Barker, MA; De La Vega, FM; Smith, DI				Tuch, Brian B.; Laborde, Rebecca R.; Xu, Xing; Gu, Jian; Chung, Christina B.; Monighetti, Cinna K.; Stanley, Sarah J.; Olsen, Kerry D.; Kasperbauer, Jan L.; Moore, Eric J.; Broomer, Adam J.; Tan, Ruoying; Brzoska, Pius M.; Muller, Matthew W.; Siddiqui, Asim S.; Asmann, Yan W.; Sun, Yongming; Kuersten, Scott; Barker, Melissa A.; De La Vega, Francisco M.; Smith, David I.			Tumor Transcriptome Sequencing Reveals Allelic Expression Imbalances Associated with Copy Number Alterations	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LASER CAPTURE MICRODISSECTION; GENE-EXPRESSION; RNA-SEQ; CANCER STATISTICS; CYCLIN D1; SUPPRESSOR; HEAD; AGGRESSIVENESS; IDENTIFICATION	Due to growing throughput and shrinking cost, massively parallel sequencing is rapidly becoming an attractive alternative to microarrays for the genome-wide study of gene expression and copy number alterations in primary tumors. The sequencing of transcripts (RNA-Seq) should offer several advantages over microarray-based methods, including the ability to detect somatic mutations and accurately measure allele-specific expression. To investigate these advantages we have applied a novel, strand-specific RNA-Seq method to tumors and matched normal tissue from three patients with oral squamous cell carcinomas. Additionally, to better understand the genomic determinants of the gene expression changes observed, we have sequenced the tumor and normal genomes of one of these patients. We demonstrate here that our RNA-Seq method accurately measures allelic imbalance and that measurement on the genome-wide scale yields novel insights into cancer etiology. As expected, the set of genes differentially expressed in the tumors is enriched for cell adhesion and differentiation functions, but, unexpectedly, the set of allelically imbalanced genes is also enriched for these same cancer-related functions. By comparing the transcriptomic perturbations observed in one patient to his underlying normal and tumor genomes, we find that allelic imbalance in the tumor is associated with copy number mutations and that copy number mutations are, in turn, strongly associated with changes in transcript abundance. These results support a model in which allele-specific deletions and duplications drive allele-specific changes in gene expression in the developing tumor.	[Tuch, Brian B.; Xu, Xing; Chung, Christina B.; Monighetti, Cinna K.; Stanley, Sarah J.; Broomer, Adam J.; Tan, Ruoying; Brzoska, Pius M.; Muller, Matthew W.; Siddiqui, Asim S.; Sun, Yongming; Barker, Melissa A.; De La Vega, Francisco M.] Life Technol Inc, Foster City, CA USA; [Laborde, Rebecca R.; Smith, David I.] Mayo Clin, Div Expt Pathol, Dept Lab Med & Pathol, Rochester, MN USA; [Gu, Jian; Kuersten, Scott] Life Technol Inc, Austin, TX USA; [Olsen, Kerry D.; Kasperbauer, Jan L.; Moore, Eric J.] Mayo Clin, Dept Otorhinolaryngol, Rochester, MN USA; [Asmann, Yan W.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA	Thermo Fisher Scientific; Mayo Clinic; Thermo Fisher Scientific; Mayo Clinic; Mayo Clinic	Tuch, BB (corresponding author), Life Technol Inc, Foster City, CA USA.	francisco.delavega@lifetech.com; smith.david@mayo.edu	Pillay, Nischalan/F-9536-2012; De La Vega, Francisco/H-3832-2011		Mayo Clinic and Life Technologies Inc.	Mayo Clinic and Life Technologies Inc.	This work was supported by the Mayo Clinic and Life Technologies Inc.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Al Moustafa AE, 2002, ONCOGENE, V21, P2634, DOI 10.1038/sj.onc.1205351; Alevizos I, 2001, ONCOGENE, V20, P6196, DOI 10.1038/sj.onc.1204685; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Belbin TJ, 2002, CANCER RES, V62, P1184; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bohen SP, 2003, P NATL ACAD SCI USA, V100, P1926, DOI 10.1073/pnas.0437875100; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chen CH, 2009, ONCOGENE, V28, P2723, DOI 10.1038/onc.2009.128; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Clement G, 2008, CANCER SCI, V99, P46, DOI 10.1111/j.1349-7006.2007.00663.x; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feinberg AP, 1999, CANCER RES, V59, p1743S; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Freier K, 2006, GENE CHROMOSOME CANC, V45, P118, DOI 10.1002/gcc.20270; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Herrick J, 2005, CANCER RES, V65, P1174, DOI 10.1158/0008-5472.CAN-04-2802; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Hosokawa Y, 1998, GENE CHROMOSOME CANC, V22, P66, DOI 10.1002/(SICI)1098-2264(199805)22:1<66::AID-GCC9>3.0.CO;2-5; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; Kang CJ, 2009, CANCER LETT, V284, P131, DOI 10.1016/j.canlet.2009.04.014; Kim J, 2009, NAT BIOTECHNOL, V27, P472, DOI 10.1038/nbt.1540; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Leethanakul C, 2000, ONCOGENE, V19, P3220, DOI 10.1038/sj.onc.1203703; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; LIOTTA LA, 1986, CANCER RES, V46, P1; LIPSON D, 2004, JOINT ANAL DNA COPY, P135; Lopez P, 1999, ONCOGENE, V18, P7303, DOI 10.1038/sj.onc.1203143; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Miyazawa J, 2004, CANCER RES, V64, P2024, DOI 10.1158/0008-5472.CAN-03-1855; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; *NEXTBIO, 2010, NEXTBIO PROF SYST; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; SCHUURING E, 1995, GENE, V159, P83, DOI 10.1016/0378-1119(94)00562-7; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Tsui IFL, 2009, INT J CANCER, V125, P2219, DOI 10.1002/ijc.24611; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Yoshinaga K, 2008, ANN SURG ONCOL, V15, P96, DOI 10.1245/s10434-007-9631-1; Yu YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003215; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	73	96	99	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9317	10.1371/journal.pone.0009317	http://dx.doi.org/10.1371/journal.pone.0009317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174472	gold, Green Published, Green Submitted			2022-12-25	WOS:000274923700019
J	Utge, SJ; Soronen, P; Loukola, A; Kronholm, E; Ollila, HM; Pirkola, S; Porkka-Heiskanen, T; Partonen, T; Paunio, T				Utge, Siddheshwar J.; Soronen, Pia; Loukola, Anu; Kronholm, Erkki; Ollila, Hanna M.; Pirkola, Sami; Porkka-Heiskanen, Tarja; Partonen, Timo; Paunio, Tiina			Systematic Analysis of Circadian Genes in a Population-Based Sample Reveals Association of TIMELESS with Depression and Sleep Disturbance	PLOS ONE			English	Article							BIPOLAR-I-DISORDER; CLOCK GENE; DIURNAL PREFERENCE; PHASE SYNDROME; METABOLIC SYNDROME; SUPRACHIASMATIC NUCLEUS; TRANSCRIPTION FACTOR; LINKAGE ANALYSES; MOOD DISORDERS; POLYMORPHISM	Disturbances in the circadian pacemaker system are commonly found in individuals with depression and sleep-related problems. We hypothesized that some of the canonical circadian clock genes would be associated with depression accompanied by signs of disturbed sleep, early morning awakening, or daytime fatigue. We tested this hypothesis in a population-based sample of the Health 2000 dataset from Finland, including 384 depressed individuals and 1270 controls, all with detailed information on sleep and daytime vigilance, and analyzed this set of individuals with regard to 113 single-nucleotide polymorphisms of 18 genes of the circadian system. We found significant association between TIMELESS variants and depression with fatigue (D+FAT+) (rs7486220: pointwise P = 0.000099, OR = 1.66; corrected empirical P for the model of D+FAT+ = 0.0056; haplotype 'C-A-A-C' of rs2291739-rs2291738-rs7486220-rs1082214: P = 0.0000075, OR = 1.72) in females, and association to depression with early morning awakening (D+EMA+) (rs1082214: pointwise P = 0.0009, OR = 2.70; corrected empirical P = 0.0374 for the model D+EMA+; haplotype 'G-T' of rs7486220 and rs1082214: P = 0.0001, OR = 3.01) in males. There was significant interaction of gender and TIMELESS (for example with rs1082214, P = 0.000023 to D+EMA+ and P = 0.005 to D+FAT+). We obtained supported evidence for involvement of TIMELESS in sleeping problems in an independent set of control individuals with seasonal changes in mood, sleep duration, energy level and social activity in females (P = 0.036, (R) = 0.123 for rs1082214) and with early morning awakening or fatigue in males (P = 0.038 and P = 0.0016, respectively, for rs1082214). There was also some evidence of interaction between TIMELESS and PER1 in females to D+FAT+ as well as between TIMELESS and ARNTL, RORA or NR1D1 in males to D+EMA+. These findings support a connection between circadian genes and gender-dependent depression and defective sleep regulation.	[Utge, Siddheshwar J.; Soronen, Pia; Loukola, Anu; Ollila, Hanna M.; Paunio, Tiina] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Utge, Siddheshwar J.; Ollila, Hanna M.; Porkka-Heiskanen, Tarja] Univ Helsinki, Dept Physiol, Helsinki, Finland; [Utge, Siddheshwar J.; Soronen, Pia; Pirkola, Sami; Paunio, Tiina] Univ Helsinki, Cent Hosp, Dept Psychiat, Helsinki, Finland; [Utge, Siddheshwar J.; Soronen, Pia; Loukola, Anu; Ollila, Hanna M.; Paunio, Tiina] Univ Helsinki, FIMM, Helsinki, Finland; [Kronholm, Erkki] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Populat Studies Unit, Turku, Finland; [Pirkola, Sami; Partonen, Timo] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Utge, SJ (corresponding author), Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland.	Tiina.Paunio@thl.fi	Partonen, Timo/G-1105-2012; Ollila, Hanna M/GQA-6308-2022; Ollila, Hanna M/I-8552-2017	Partonen, Timo/0000-0003-1951-2455; Ollila, Hanna M/0000-0002-5302-6429; Ollila, Hanna M/0000-0002-5302-6429; Loukola, Anu-Maria/0000-0003-0542-5967; Stenberg, Tarja/0000-0003-1843-7625; Pirkola, Sami/0000-0003-0138-3130	European Union [LSHM-CT-2005-518189, MCRTN-CT-2004-512362]; Centre for International Mobility [CIMO, TM-09-6095]; Helsinki University Central Hospital [EVO, TYH6254]; Academy of Finland post-doctoral research fellowship	European Union(European Commission); Centre for International Mobility; Helsinki University Central Hospital; Academy of Finland post-doctoral research fellowship(Academy of Finland)	This study was supported by grants from the European Union (LSHM-CT-2005-518189 and MCRTN-CT-2004-512362), Centre for International Mobility (CIMO, TM-09-6095), and Helsinki University Central Hospital (EVO, TYH6254), and this support is gratefully acknowledged. Dr. Anu Loukola and Dr. Timo Partonen were supported by an Academy of Finland post-doctoral research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst J, 2005, J AFFECT DISORDERS, V84, P149, DOI 10.1016/S0165-0327(03)00195-2; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benazzi F, 2002, COMPR PSYCHIAT, V43, P263, DOI 10.1053/comp.2002.33496; Benca R M, 1997, Sleep Med Rev, V1, P45, DOI 10.1016/S1087-0792(97)90005-8; Benedetti F, 2003, AM J MED GENET B, V123B, P23, DOI 10.1002/ajmg.b.20038; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Cardoso FRG, 2009, BRAZ J MED BIOL RES, V42, P122, DOI 10.1590/S0100-879X2009000100017; Carpen JD, 2005, J SLEEP RES, V14, P293, DOI 10.1111/j.1365-2869.2005.00471.x; Cermakian N, 2003, BRAIN RES REV, V42, P204, DOI 10.1016/S0165-0173(03)00171-1; Chang PP, 1997, AM J EPIDEMIOL, V146, P105; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Dunbar JA, 2008, DIABETES CARE, V31, P2368, DOI 10.2337/dc08-0175; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Emilien G, 1999, IRISH J PSYCHOL MED, V16, P18, DOI 10.1017/S0790966700004985; Franken P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-87; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; Hastings M, 1998, BRIT MED J, V317, P1704, DOI 10.1136/bmj.317.7174.1704; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Hochstrasser B, 1993, Ther Umsch, V50, P679; Jackson A, 2003, J AFFECT DISORDERS, V74, P209, DOI 10.1016/S0165-0327(02)00266-5; Johansson C, 2003, NEUROPSYCHOPHARMACOL, V28, P734, DOI 10.1038/sj.npp.1300121; Jones SH, 2005, BIPOLAR DISORD, V7, P176, DOI 10.1111/j.1399-5618.2005.00187.x; Katzenberg D, 1998, SLEEP, V21, P569, DOI 10.1093/sleep/21.6.569; KAWATO M, 1982, J THEOR BIOL, V98, P369, DOI 10.1016/0022-5193(82)90125-4; Kieseppa T, 2004, AM J PSYCHIAT, V161, P1814, DOI 10.1176/appi.ajp.161.10.1814; KISHI T, 2008, NEUROSCI RES; Klar J, 2005, EUR J HUM GENET, V13, P928, DOI 10.1038/sj.ejhg.5201433; Klinge CM, 1999, J STEROID BIOCHEM, V71, P1, DOI 10.1016/S0960-0760(99)00124-7; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; KUPFER DJ, 1990, ARCH GEN PSYCHIAT, V47, P1100; KUPPERMANN M, 1995, J GEN INTERN MED, V10, P25, DOI 10.1007/BF02599573; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; Lasky-Su J, 2008, AM J MED GENET B; Lichstein KL, 1997, BEHAV RES THER, V35, P733, DOI 10.1016/S0005-7967(97)00029-6; LIVINGSTON G, 1993, BRIT J GEN PRACT, V43, P445; Mansour HA, 2006, GENES BRAIN BEHAV, V5, P150, DOI 10.1111/j.1601-183X.2005.00147.x; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Naylor E, 2000, J NEUROSCI, V20, P8138; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; PAFFENBARGER RS, 1994, ACTA PSYCHIAT SCAND, V89, P16, DOI 10.1111/j.1600-0447.1994.tb05796.x; Pandi-Perumal SR, 2009, PROG NEUROBIOL, V88, P264, DOI 10.1016/j.pneurobio.2009.04.007; Partonen T, 2007, ANN MED, V39, P229, DOI 10.1080/07853890701278795; Paunio T, 2009, AM J EPIDEMIOL, V169, P206, DOI 10.1093/aje/kwn305; Perez-Calatayud J, 2005, MED PHYS, V32, P28, DOI 10.1118/1.1834835; Pirkola SP, 2005, SOC PSYCH PSYCH EPID, V40, P1, DOI 10.1007/s00127-005-0848-7; Pirovano A, 2005, GENET MED, V7, P455, DOI 10.1097/01.GIM.0000170996.58079.6D; Porkka-Heiskanen T, 2003, FRONT BIOSCI-LANDMRK, V8, pS421, DOI 10.2741/1073; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rintamaki R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001482; Riva A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-33; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Serretti A, 2003, AM J MED GENET B, V121B, P35, DOI 10.1002/ajmg.b.20053; Serretti A, 2005, AM J MED GENET B, V137B, P36, DOI 10.1002/ajmg.b.30130; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Shi JJ, 2008, AM J MED GENET B, V147B, P1047, DOI 10.1002/ajmg.b.30714; Shin K, 2005, J AFFECT DISORDERS, V86, P19, DOI 10.1016/j.jad.2004.11.010; Skilton MR, 2007, BIOL PSYCHIAT, V62, P1251, DOI 10.1016/j.biopsych.2007.01.012; Szczepankiewicz A, 2006, NEUROPSYCHOBIOLOGY, V53, P51, DOI 10.1159/000090704; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takano A, 2004, NEUROPSYCHOPHARMACOL, V29, P1901, DOI 10.1038/sj.npp.1300503; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254, DOI 10.4088/JCP.v66n1008; Turek FW, 2007, INT CLIN PSYCHOPHARM, V22, pS1, DOI 10.1097/01.yic.0000277956.93777.6a; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; UTGE S, 2009, AM J MED B IN PRESS; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; VOLLRATH M, 1989, EUR ARCH PSY CLIN N, V239, P113, DOI 10.1007/BF01759584; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; Wehr T., 1984, SEASONAL PATTERN ASS; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; NATURE, V437, P1299	89	73	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9259	10.1371/journal.pone.0009259	http://dx.doi.org/10.1371/journal.pone.0009259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174623	Green Submitted, Green Published, gold			2022-12-25	WOS:000274654700011
J	Nougairede, A; Ninove, L; Zandotti, C; Salez, N; Mantey, K; Resseguier, N; Gazin, C; Raoult, D; Charrel, RN; de Lamballerie, X				Nougairede, Antoine; Ninove, Laetitia; Zandotti, Christine; Salez, Nicolas; Mantey, Karine; Resseguier, Noemie; Gazin, Celine; Raoult, Didier; Charrel, Remi N.; de Lamballerie, Xavier			Novel Virus Influenza A (H1N1sw) in South-Eastern France, April-August 2009	PLOS ONE			English	Article							RAPID DETECTION; PCR ASSAY; INFECTION; DIAGNOSIS	Background: In April 2009, the first cases of pandemic (H1N1)-2009 influenza [H1N1sw] virus were detected in France. Virological surveillance was undertaken in reference laboratories of the seven French Defence Zones. Methodology/Principal Findings: We report results of virological analyses performed in the Public Hospitals of Marseille during the first months of the outbreak. (i) Nasal swabs were tested using rapid influenza diagnostic test (RIDT) and two RTPCR assays. Epidemiological characteristics of the 99 first suspected cases were analyzed, including detection of influenza virus and 18 other respiratory viruses. During three months, a total of 1,815 patients were tested (including 236 patients infected H1N1sw virus) and distribution in age groups and results of RIDT were analyzed. (ii) 600 sera received before April 2009 and randomly selected from in-patients were tested by a standard hemagglutination inhibition assay for antibody to the novel H1N1sw virus. (iii) One early (May 2009) and one late (July 2009) viral isolates were characterized by sequencing the complete hemagglutinine and neuraminidase genes. (iiii) Epidemiological characteristics of a cluster of cases that occurred in July 2009 in a summer camp were analyzed. Conclusions/Significance: This study presents new virological and epidemiological data regarding infection by the pandemic A/H1N1 virus in Europe. Distribution in age groups was found to be similar to that previously reported for seasonal H1N1. The first seroprevalence data made available for a European population suggest a previous exposure of individuals over 40 years old to influenza viruses antigenically related to the pandemic (H1N1)-2009 virus. Genomic analysis indicates that strains harbouring a new amino-acid pattern in the neuraminidase gene appeared secondarily and tended to supplant the first strains. Finally, in contrast with previous reports, our data support the use of RIDT for the detection of infection in children, especially in the context of the investigation of grouped cases.	[Nougairede, Antoine; Ninove, Laetitia; Salez, Nicolas; Charrel, Remi N.; de Lamballerie, Xavier] Univ Meditarranee, UMR 190, Unite Virus Emergents, Marseille, France; [Nougairede, Antoine; Ninove, Laetitia; Salez, Nicolas; Charrel, Remi N.; de Lamballerie, Xavier] Inst Rech Dev, Marseille, France; [Nougairede, Antoine; Ninove, Laetitia; Zandotti, Christine; Gazin, Celine; Raoult, Didier; Charrel, Remi N.; de Lamballerie, Xavier] Assistance Publ Hop Marseille, Lab Virol Pole Hosp Microbiol & Malad Infect, Marseille, France; [Mantey, Karine; Resseguier, Noemie] French Inst Publ Hlth Surveillance, S Interreg Epidemiol Unit, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institute of Public Health Surveillance	Nougairede, A (corresponding author), Univ Meditarranee, UMR 190, Unite Virus Emergents, Marseille, France.	xavier.de-lamballerie@univmed.fr	Resseguier, Noémie/E-8427-2017; RAOULT, Didier/A-8434-2008	Resseguier, Noémie/0000-0003-0816-4053; RAOULT, Didier/0000-0002-0633-5974; Charrel, Remi/0000-0002-7675-8251	AP-HM Public Hospital system; Universite de la Mediterranee	AP-HM Public Hospital system; Universite de la Mediterranee	This study has been partly funded by AP-HM Public Hospital system and by Universite de la Mediterranee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Benschop K, 2008, J CLIN VIROL, V41, P69, DOI 10.1016/j.jcv.2007.10.004; Dierssen U, 2008, J CLIN VIROL, V42, P58, DOI 10.1016/j.jcv.2007.11.016; Follin P, 2009, EUROSURVEILLANCE, V14; FRANK AL, 1981, J INFECT DIS, V144, P433, DOI 10.1093/infdis/144.5.433; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garbino J, 2004, AM J RESP CRIT CARE, V170, P1197, DOI 10.1164/rccm.200406-781OC; Gouarin S, 2008, J MED VIROL, V80, P1441, DOI 10.1002/jmv.21218; Griscelli F, 2001, J CLIN MICROBIOL, V39, P4362, DOI 10.1128/JCM.39.12.4362-4369.2001; Khiabanian H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006832; LEVYBRUHL D, 2009, EURO SURVEILL, V14; Lindau C, 2009, J CLIN VIROL, V44, P24, DOI 10.1016/j.jcv.2008.09.006; Mackay IM, 2003, J CLIN MICROBIOL, V41, P100, DOI 10.1128/JCM.41.1.100-105.2003; Maurer-Stroh S, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-18; Munoz Flor M, 2002, Semin Pediatr Infect Dis, V13, P72, DOI 10.1053/spid.2002.122992; NINOVE L, 2009, VECTOR BORNE ZOONOTI; NOUGAIREDE A, 2009, PLOSE CURRENTS INFLU; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tivejung-Lindell A, 2009, J MED VIROL, V81, P167, DOI 10.1002/jmv.21368; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; van Elden LJR, 2004, J INFECT DIS, V189, P652, DOI 10.1086/381207; van Elden LJR, 2003, J CLIN MICROBIOL, V41, P4378, DOI 10.1128/JCM.41.9.4378-4381.2003; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; WHO, 2009, SEQ PRIM PROT PAND H	26	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9214	10.1371/journal.pone.0009214	http://dx.doi.org/10.1371/journal.pone.0009214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174643	gold, Green Submitted, Green Published			2022-12-25	WOS:000274590600006
J	Thorborn, G; Pomeroy, L; Isohanni, H; Perry, M; Peters, B; Vyakarnam, A				Thorborn, Georgina; Pomeroy, Laura; Isohanni, Heidi; Perry, Melissa; Peters, Barry; Vyakarnam, Annapurna			Increased Sensitivity of CD4+T-Effector Cells to CD4+CD25+Treg Suppression Compensates for Reduced Treg Number in Asymptomatic HIV-1 Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL-BLOOD; VIRAL LOAD; SIV INFECTION; CD4(+); ACTIVATION; RESPONSES; DEPLETION; DISEASE	Background: In HIV infection, uncontrolled immune activation and disease progression is attributed to declining CD4+CD25+FoxP3+ regulatory T-cell (Treg) numbers. However, qualitative aspects of Treg function in HIV infection, specifically the balance between Treg cell suppressive potency versus suppressibility of effector cells, remain poorly understood. This report addresses this issue. Methodology/Principal Findings: A classic suppression assay to measure CD4+CD45RO+CD25hi Treg cells to suppress the proliferation of CD4+CD45RO+CD25 - effectors cells (E) following CD3/CD28 polyclonal stimulation was employed to compare the suppressive ability of healthy volunteers (N = 27) and chronic, asymptomatic, treatment naive, HIV-infected subjects (N = 14). HIV-infected subjects displayed significantly elevated Treg-mediated suppression compared to healthy volunteers (p = 0.0047). Cross-over studies comparing Treg cell potency from HIV-infected versus control subjects to suppress the proliferation of a given population of allogeneic effector cells demonstrated increased sensitivity of CD4+CD252 effector cells from HIV-infected subjects to be suppressed, associated with reduced production of the Treg counter-regulatory cytokine, IL-17, rather than an increase in the suppressive potential of their CD4+CD25+ Treg cells. However, compared to controls, HIV+ subjects had significantly fewer absolute numbers of circulating CD4+CD25+FoxP3+ Treg cells. In vitro studies highlighted that one mechanism for this loss could be the preferential infection of Treg cells by HIV. Conclusions/Significance: Together, novel data is provided to support the contention that elevated Treg-mediated suppression may be a natural host response to HIV infection	[Thorborn, Georgina; Vyakarnam, Annapurna] Kings Coll London, Dept Infect Dis, Guys Hosp, London WC2R 2LS, England; [Pomeroy, Laura; Isohanni, Heidi; Perry, Melissa; Peters, Barry] Kings Coll London, Dept Infect Dis, St Thomas Hosp, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Thorborn, G (corresponding author), Kings Coll London, Dept Infect Dis, Guys Hosp, London WC2R 2LS, England.	anna.Vyakarnam@kcl.ac.uk			National Institute for Health Research (NIHR)	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This work was partly supported by an educational grant from Gilead Pharmaceuticals and partly by the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Alvarez R, 2008, J VIROL, V82, P471, DOI 10.1128/JVI.00939-07; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; Antons AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002952; Baecher-Allan C, 2002, J IMMUNOL, V169, P6210, DOI 10.4049/jimmunol.169.11.6210; Becker C, 2009, BLOOD, V114, P1263, DOI 10.1182/blood-2009-02-206730; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Betti M, 2006, ANN ONCOL, V17, P235; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Chase AJ, 2007, J VIROL, V81, P12748, DOI 10.1128/JVI.00841-07; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Eggena MP, 2005, J INFECT DIS, V191, P694, DOI 10.1086/427516; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Holmes D, 2007, J BIOL CHEM, V282, P15973, DOI 10.1074/jbc.M702051200; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; JI J, 2009, INT IMMUNOL; Joshi A, 2004, VIROLOGY, V321, P307, DOI 10.1016/j.virol.2004.01.014; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; LAURENCE J, 1993, ANN INTERN MED, V119, P55, DOI 10.7326/0003-4819-119-1-199307010-00010; Lawson JM, 2008, CLIN EXP IMMUNOL, V154, P353, DOI 10.1111/j.1365-2249.2008.03810.x; Lenarczyk A, 2000, CLIN EXP IMMUNOL, V122, P41, DOI 10.1046/j.1365-2249.2000.01328.x; Maek-A-Nantawat W, 2007, VIRAL IMMUNOL, V20, P66, DOI 10.1089/vim.2006.0063; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; MONTES M, 2006, AIDS RES HUM RETROV; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; NAKAMURA Z, 1982, CLIN IMMUNOL IMMUNOP, V24, P72, DOI 10.1016/0090-1229(82)90090-3; Ndhlovu LC, 2008, AIDS, V22, P990, DOI 10.1097/QAD.0b013e3282ff884e; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Pereira LE, 2007, J VIROL, V81, P4445, DOI 10.1128/JVI.00026-07; Roberts AI, 2003, IMMUNOL RES, V28, P285, DOI 10.1385/IR:28:3:285; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Trindade CJ, 2008, FASEB J, V22; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Yates J, 2008, CLIN EXP IMMUNOL, V153, P44, DOI 10.1111/j.1365-2249.2008.03665.x; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Zhao Y, 2010, INT ARCH ALLERGY IMM, V151, P297, DOI 10.1159/000250438; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	57	20	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9254	10.1371/journal.pone.0009254	http://dx.doi.org/10.1371/journal.pone.0009254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174666	gold, Green Published, Green Submitted			2022-12-25	WOS:000274590600011
J	Williams, GJ; Aeby, GS; Cowie, ROM; Davy, SK				Williams, Gareth J.; Aeby, Greta S.; Cowie, Rebecca O. M.; Davy, Simon K.			Predictive Modeling of Coral Disease Distribution within a Reef System	PLOS ONE			English	Article							BLACK-BAND DISEASE; NORTHERN FLORIDA-KEYS; GREAT-BARRIER-REEF; US VIRGIN-ISLANDS; CLIMATE-CHANGE; INDO-PACIFIC; TRANSMISSION DYNAMICS; SCLERACTINIAN CORALS; NUTRIENT ENRICHMENT; REGRESSION TREES	Diseases often display complex and distinct associations with their environment due to differences in etiology, modes of transmission between hosts, and the shifting balance between pathogen virulence and host resistance. Statistical modeling has been underutilized in coral disease research to explore the spatial patterns that result from this triad of interactions. We tested the hypotheses that: 1) coral diseases show distinct associations with multiple environmental factors, 2) incorporating interactions (synergistic collinearities) among environmental variables is important when predicting coral disease spatial patterns, and 3) modeling overall coral disease prevalence (the prevalence of multiple diseases as a single proportion value) will increase predictive error relative to modeling the same diseases independently. Four coral diseases: Porites growth anomalies (PorGA), Porites tissue loss (PorTL), Porites trematodiasis (PorTrem), and Montipora white syndrome (MWS), and their interactions with 17 predictor variables were modeled using boosted regression trees (BRT) within a reef system in Hawaii. Each disease showed distinct associations with the predictors. Environmental predictors showing the strongest overall associations with the coral diseases were both biotic and abiotic. PorGA was optimally predicted by a negative association with turbidity, PorTL and MWS by declines in butterflyfish and juvenile parrotfish abundance respectively, and PorTrem by a modal relationship with Porites host cover. Incorporating interactions among predictor variables contributed to the predictive power of our models, particularly for PorTrem. Combining diseases (using overall disease prevalence as the model response), led to an average six-fold increase in cross-validation predictive deviance over modeling the diseases individually. We therefore recommend coral diseases to be modeled separately, unless known to have etiologies that respond in a similar manner to particular environmental conditions. Predictive statistical modeling can help to increase our understanding of coral disease ecology worldwide.	[Williams, Gareth J.; Cowie, Rebecca O. M.; Davy, Simon K.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Aeby, Greta S.] Hawaii Inst Marine Biol, Kaneohe, HI USA	Victoria University Wellington	Williams, GJ (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	info@garethjwilliams.net; simon.davy@vuw.ac.nz		Davy, Simon/0000-0003-3584-5356; Williams, Dr Gareth J./0000-0001-7837-1619	Victoria University Vice- Chancellor Strategic Research Scholarship; New Zealand International Doctoral Research Scholarship	Victoria University Vice- Chancellor Strategic Research Scholarship; New Zealand International Doctoral Research Scholarship	Gareth J. Williams is supported by a Victoria University Vice- Chancellor Strategic Research Scholarship and a New Zealand International Doctoral Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2007, B MAR SCI, V80, P209; Aeby GS, 2006, MAR ECOL PROG SER, V318, P103, DOI 10.3354/meps318103; Aeby GS, 1998, J PARASITOL, V84, P1259, DOI 10.2307/3284684; Altizer SM, 1997, P ROY SOC B-BIOL SCI, V264, P807, DOI 10.1098/rspb.1997.0113; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Baker DM, 2007, MAR ECOL PROG SER, V343, P123, DOI 10.3354/meps06937; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Begon M, 1998, ECOL LETT, V1, P82; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berthier K, 2000, P ROY SOC B-BIOL SCI, V267, P2049, DOI 10.1098/rspb.2000.1248; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Blanford S, 2003, ECOL LETT, V6, P2, DOI 10.1046/j.1461-0248.2003.00387.x; BLOESCH J, 1994, HYDROBIOLOGIA, V284, P13, DOI 10.1007/BF00005728; Borger JL, 2005, DIS AQUAT ORGAN, V67, P249, DOI 10.3354/dao067249; Boyett HV, 2007, MAR BIOL, V151, P1711, DOI 10.1007/s00227-006-0603-y; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; BREIMAN L., 1984, CRC PRESS; Brown CR, 2004, ECOLOGY, V85, P1619, DOI 10.1890/03-0206; Bruckner AW, 2006, DIS AQUAT ORGAN, V69, P67, DOI 10.3354/dao069067; Bruckner AW, 1997, CORAL REEFS, V16, P260, DOI 10.1007/s003380050081; Bruckner AW, 1998, CORAL REEFS, V17, P350, DOI 10.1007/s003380050138; BRUCKNER AW, 1997, P 8 INT COR REEF S, V1, P601; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Carslaw DC, 2009, ATMOS ENVIRON, V43, P3563, DOI 10.1016/j.atmosenv.2009.04.001; Cole AJ, 2009, CORAL REEFS, V28, P965, DOI 10.1007/s00338-009-0519-3; Coles SL, 1998, CORAL REEFS, V17, P195, DOI 10.1007/s003380050118; Colwell RR, 2004, INT MICROBIOL, V7, P285; COX EF, 1986, J EXP MAR BIOL ECOL, V101, P161, DOI 10.1016/0022-0981(86)90047-X; CRAFT CB, 1991, ESTUARIES, V14, P175, DOI 10.2307/1351691; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; EDMUNDS PJ, 1991, CORAL REEFS, V10, P161, DOI 10.1007/BF00572175; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; FRIEDLANDER AM, 2008, 11 NOAA NOS NCCOS CT, P219; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Ge Y, 2008, ISME J, V2, P254, DOI 10.1038/ismej.2008.2; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Idjadi JA, 2006, MAR ECOL PROG SER, V319, P117, DOI 10.3354/meps319117; Jackson JA, 2002, PARASITOL RES, V88, P632, DOI 10.1007/s00436-002-0629-0; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; Kaczmarsky LT, 2006, DIS AQUAT ORGAN, V69, P9, DOI 10.3354/dao069009; Kim Kiho, 2002, P813; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Kuta KG, 1996, CORAL REEFS, V15, P219, DOI 10.1007/BF01787455; Kuta KG, 2002, CORAL REEFS, V21, P393, DOI 10.1007/s00338-002-0261-6; Lafferty KD, 1999, LIMNOL OCEANOGR, V44, P925, DOI 10.4319/lo.1999.44.3_part_2.0925; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Leathwick JR, 2008, J BIOGEOGR, V35, P1481, DOI 10.1111/j.1365-2699.2008.01887.x; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; Lu YN, 2000, J AQUAT ANIM HEALTH, V12, P58, DOI [10.1577/1548-8667(2000)012<0058:DOGTHS>2.0.CO;2, 10.1577/1548-8667(2000)012&lt;0058:DOGTHS&gt;2.0.CO;2]; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McClanahan TR, 2009, GLOBAL CHANGE BIOL, V15, P1804, DOI 10.1111/j.1365-2486.2008.01799.x; Miller J, 2006, CORAL REEFS, V25, P418, DOI 10.1007/s00338-006-0125-6; Miller MW, 1998, OECOLOGIA, V113, P231, DOI 10.1007/s004420050373; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Nakhapakorn Kanchana, 2005, Int J Health Geogr, V4, P13; Nugues MM, 2002, MAR ECOL PROG SER, V229, P61, DOI 10.3354/meps229061; Ostfeld R. S. et al., 2008, INFECT DIS ECOLOGY E; Page CA, 2008, CORAL REEFS, V27, P257, DOI 10.1007/s00338-007-0317-8; Page CA, 2009, DIS AQUAT ORGAN, V87, P135, DOI 10.3354/dao02112; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; PETERS EC, 1986, JNCI-J NATL CANCER I, V76, P895; Ramsey D, 2002, J APPL ECOL, V39, P806, DOI 10.1046/j.1365-2664.2002.00760.x; Raymundo LJ, 2009, P NATL ACAD SCI USA, V106, P17067, DOI 10.1073/pnas.0900365106; Raymundo LJ, 2005, DIS AQUAT ORGAN, V64, P181, DOI 10.3354/dao064181; Richardson LL, 2005, MAR ECOL PROG SER, V297, P147, DOI 10.3354/meps297147; Richardson LL, 2004, CORAL HEALTH AND DISEASE, P325; Ridgeway G., 2006, GEN BOOSTED REGRESSI; Riegl B, 2002, MAR BIOL, V140, P29, DOI 10.1007/s002270100676; Rodriguez S, 2008, CORAL REEFS, V27, P381, DOI 10.1007/s00338-007-0341-8; Sokolow SH, 2009, J APPL ECOL, V46, P621, DOI 10.1111/j.1365-2664.2009.01649.x; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Voss JD, 2006, DIS AQUAT ORGAN, V69, P33, DOI 10.3354/dao069033; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Ward JR, 2007, MAR ECOL PROG SER, V329, P115, DOI 10.3354/meps329115; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Work TM, 2008, J EXP MAR BIOL ECOL, V362, P63, DOI 10.1016/j.jembe.2008.05.011; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155	93	67	69	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9264	10.1371/journal.pone.0009264	http://dx.doi.org/10.1371/journal.pone.0009264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174663	Green Submitted, gold, Green Published			2022-12-25	WOS:000274590600019
J	Brolin, KJM; Persson, KEM; Wahlgren, M; Rogerson, SJ; Chen, QJ				Brolin, Kim J. M.; Persson, Kristina E. M.; Wahlgren, Mats; Rogerson, Stephen J.; Chen, Qijun			Differential Recognition of P. falciparum VAR2CSA Domains by Naturally Acquired Antibodies in Pregnant Women from a Malaria Endemic Area	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; VARIANT SURFACE-ANTIGENS; SUB-SAHARAN AFRICA; PLASMODIUM-FALCIPARUM; INFECTED ERYTHROCYTES; STRUCTURAL BASIS; BINDING; PLACENTA; ADHESION; RECEPTOR	Background: Plasmodium falciparum infected red blood cells (iRBC) express variant surface antigens (VSA) of which VAR2CSA is involved in placental sequestration and causes pregnancy-associated malaria (PAM). Primigravidae are most susceptible to PAM whereas antibodies associated with protection are often present at higher levels in multigravid women. However, HIV co-infection with malaria has been shown to alter this parity-dependent acquisition of immunity, with more severe symptoms as well as more malaria episodes in HIV positive women versus HIV negative women of a similar parity. Methods: Using VAR2CSA DBL-domains expressed on the surface of CHO-745 cells we quantified levels of DBL-domain specific IgG in sera from pregnant Malawian women by flow cytometry. Dissociations constants of DBL5 epsilon specific antibodies were determined using a surface plasmon resonance technique, as an indication of antibody affinities. Results: VAR2CSA DBL5 epsilon was recognized in a gender and parity-dependent manner with anti-DBL5 epsilon IgG correlating significantly with IgG levels to VSA-PAM on the iRBC surface. HIV positive women had lower levels of anti-DBL5 epsilon IgG than HIV negative women of similar parity. In primigravidae, antibodies in HIV positive women also showed significantly lower affinity to VAR2CSA DBL5 epsilon. Conclusions: Pregnant women from a malaria-endemic area had increased levels of anti-DBL5 epsilon IgG by parity, indicating this domain of VAR2CSA to be a promising vaccine candidate against PAM. However, it is important to consider co-infection with HIV, as this seems to change the properties of antibody response against malaria. Understanding the characteristics of antibody response against VAR2CSA is undoubtedly imperative in order to design a functional and efficient vaccine against PAM.	[Brolin, Kim J. M.; Persson, Kristina E. M.; Wahlgren, Mats; Chen, Qijun] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Brolin, Kim J. M.; Persson, Kristina E. M.; Wahlgren, Mats; Chen, Qijun] Swedish Inst Infect Dis Control SMI, Dept Parasitol, Stockholm, Sweden; [Rogerson, Stephen J.] Univ Melbourne, Dept Med RMH WH, Melbourne, Vic, Australia; [Chen, Qijun] Minist Educ, Key Lab Zoonosis, Changchun, Peoples R China; [Chen, Qijun] Jilin Univ, Changchun 130023, Peoples R China; [Chen, Qijun] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100037, Peoples R China	Karolinska Institutet; Swedish Institute for Infectious Disease Control; University of Melbourne; Jilin University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Brolin, KJM (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	sroger@unimelb.edu.au; qijun.chen@smi.se		Rogerson, Stephen/0000-0003-4287-1982; Persson, Kristina E M/0000-0003-2661-3115	National Basic Research Program of China (973 Program) [2007CB513100]; SIDA/SAREC; EU; National Health and Medical Research Council of Australia; Boehringer Ingelheim Fonds; Kvinnor Kan; Wenner-Gren Foundations; O E and Edla Johanssons Foundation; Jeanssons Foundation	National Basic Research Program of China (973 Program)(National Basic Research Program of China); SIDA/SAREC; EU(European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Kvinnor Kan; Wenner-Gren Foundations; O E and Edla Johanssons Foundation; Jeanssons Foundation	Q.C. is supported by grants from the National Basic Research Program of China (973 Program, No. 2007CB513100), SIDA/SAREC (www.sida.se) and the EU malaria network of excellence (BioMalPar) program (www.biomalpar.org). S.J.R. is supported by the National Health and Medical Research Council of Australia (www.nhmrc.gov.au). K.J.M.B. was supported in part by a travel grant from Boehringer Ingelheim Fonds (www.bifonds.de) and by Kvinnor Kan (www.kvinnorkan.se). K. E. M. P. is supported by The Wenner-Gren Foundations (www.wennergren.org), Vinnova (www.vinnova.se), O E and Edla Johanssons Foundation (www.oejvetstift.se) and Jeanssons Foundation (www.jeanssonsstiftelser.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Beeson JG, 2002, INFECT IMMUN, V70, P5412, DOI 10.1128/IAI.70.10.5412-5415.2002; Bir N, 2006, INFECT IMMUN, V74, P5955, DOI 10.1128/IAI.00481-06; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Creasey AM, 2003, INFECT IMMUN, V71, P4767, DOI 10.1128/IAI.71.8.4767-4771.2003; Duffy MF, 2005, MOL MICROBIOL, V56, P774, DOI 10.1111/j.1365-2958.2005.04577.x; Feng GQ, 2009, J INFECT DIS, V200, P299, DOI 10.1086/599841; Filler SJ, 2006, J INFECT DIS, V194, P286, DOI 10.1086/505080; Flick K, 2001, SCIENCE, V293, P2098, DOI 10.1126/science.1062891; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gamain B, 2004, MOL MICROBIOL, V53, P445, DOI 10.1111/j.1365-2958.2004.04145.x; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Keen J, 2007, PLOS MED, V4, P912, DOI 10.1371/journal.pmed.0040181; Magistrado P, 2008, J INFECT DIS, V198, P1071, DOI 10.1086/591502; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Mwapasa V, 2004, AIDS, V18, P1051, DOI 10.1097/00002030-200404300-00014; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2004, J INFECT DIS, V190, P2001, DOI 10.1086/425521; Nielsen MA, 2007, EXP PARASITOL, V117, P1, DOI 10.1016/j.exppara.2007.03.002; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Oleinikov AV, 2007, J INFECT DIS, V196, P155, DOI 10.1086/518513; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Rasti N, 2006, P NATL ACAD SCI USA, V103, P13795, DOI 10.1073/pnas.0601519103; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Steketee RW, 1996, AM J TROP MED HYG, V55, P42, DOI 10.4269/ajtmh.1996.55.42; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Tebo AE, 2002, CLIN EXP IMMUNOL, V130, P300, DOI 10.1046/j.1365-2249.2002.01972.x; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; van Eijk AM, 2003, AIDS, V17, P595, DOI 10.1097/00002030-200303070-00015; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; WALTER PR, 1982, AM J PATHOL, V109, P330	43	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9230	10.1371/journal.pone.0009230	http://dx.doi.org/10.1371/journal.pone.0009230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169064	Green Published, gold			2022-12-25	WOS:000274590500012
J	Kaneko, K; Hori, S; Morimoto, MM; Nakaoka, T; Paul, RK; Fujiyuki, T; Shirai, K; Wakamoto, A; Tsuboko, S; Takeuchi, H; Kubo, T				Kaneko, Kumi; Hori, Sayaka; Morimoto, Mai M.; Nakaoka, Takayoshi; Paul, Rajib Kumar; Fujiyuki, Tomoko; Shirai, Kenichi; Wakamoto, Akiko; Tsuboko, Satomi; Takeuchi, Hideaki; Kubo, Takeo			In Situ Hybridization Analysis of the Expression of Futsch, Tau, and MESK2 Homologues in the Brain of the European Honeybee (Apis mellifera L.)	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; 1ST OPTIC GANGLION; DIVISION-OF-LABOR; MUSHROOM BODIES; CHROMATIC PROPERTIES; WORKER HONEYBEE; MONOPOLAR CELLS; INSECT BRAIN; BEE; DROSOPHILA	Background: The importance of visual sense in Hymenopteran social behavior is suggested by the existence of a Hymenopteran insect-specific neural circuit related to visual processing and the fact that worker honeybee brain changes morphologically according to its foraging experience. To analyze molecular and neural bases that underlie the visual abilities of the honeybees, we used a cDNA microarray to search for gene(s) expressed in a neural cell-type preferential manner in a visual center of the honeybee brain, the optic lobes (OLs). Methodology/Principal Findings: Expression analysis of candidate genes using in situ hybridization revealed two genes expressed in a neural cell-type preferential manner in the OLs. One is a homologue of Drosophila futsch, which encodes a microtubule-associated protein and is preferentially expressed in the monopolar cells in the lamina of the OLs. The gene for another microtubule-associated protein, tau, which functionally overlaps with futsch, was also preferentially expressed in the monopolar cells, strongly suggesting the functional importance of these two microtubule-associated proteins in monopolar cells. The other gene encoded a homologue of Misexpression Suppressor of Dominant-negative Kinase Suppressor of Ras 2 (MESK2), which might activate Ras/MAPK-signaling in Drosophila. MESK2 was expressed preferentially in a subclass of neurons located in the ventral region between the lamina and medulla neuropil in the OLs, suggesting that this subclass is a novel OL neuron type characterized by MESK2-expression. These three genes exhibited similar expression patterns in the worker, drone, and queen brains, suggesting that they function similarly irrespective of the honeybee sex or caste. Conclusions: Here we identified genes that are expressed in a monopolar cell (Amfutsch and Amtau) or ventral medulla-preferential manner (AmMESK2) in insect OLs. These genes may aid in visualizing neurites of monopolar cells and ventral medulla cells, as well as in analyzing the function of these neurons.	[Kaneko, Kumi; Hori, Sayaka; Morimoto, Mai M.; Nakaoka, Takayoshi; Paul, Rajib Kumar; Fujiyuki, Tomoko; Shirai, Kenichi; Tsuboko, Satomi; Takeuchi, Hideaki; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Wakamoto, Akiko] DNA Chip Res Inc, Tsurumi Ku, Kanagawa, Japan	University of Tokyo; DNA Chip Research Inc.	Kaneko, K (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	stkubo@biol.s.u-tokyo.ac.jp	Sayaka, Hori/AAU-7866-2020; Takeuchi, Hideaki/W-6739-2018; Fujiyuki, Tomoko Kaito/GYD-6398-2022; TAKEUCHI, HIDEAKI/G-4969-2014; KUBO, TAKEO/G-4951-2014; Tsuboko-Ishii, Satomi/J-2713-2019	Takeuchi, Hideaki/0000-0001-6610-3895; Fujiyuki, Tomoko Kaito/0000-0001-5533-4129; Tsuboko-Ishii, Satomi/0000-0003-4374-6200; Morimoto, Mai/0000-0002-9654-3960; Kubo, Takeo/0000-0002-5914-5269	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) and the Grant-in-Aid for Scientific Research on Innovative Areas "Systems Molecular Ethology'' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloch G, 2003, J COMP NEUROL, V464, P269, DOI 10.1002/cne.10778; Castella Claude, 2001, Invertebrate Neuroscience, V4, P85; Chang Q, 2000, NEURON, V26, P287, DOI 10.1016/S0896-6273(00)81161-7; Collett TS, 2002, NAT REV NEUROSCI, V3, P542, DOI 10.1038/nrn872; Dehmelt L, 2005, GENOME BIOL, V6; Ehmer B, 2002, J COMP NEUROL, V451, P362, DOI 10.1002/cne.10355; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; GRONENBERG W, 1986, J INSECT PHYSIOL, V32, P695, DOI 10.1016/0022-1910(86)90111-3; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Harris RA, 2007, CURR BIOL, V17, P93, DOI 10.1016/j.cub.2006.10.068; Heidary G, 2001, MECH DEVELOP, V108, P171, DOI 10.1016/S0925-4773(01)00487-7; Heisenberg M, 1998, LEARN MEMORY, V5, P1; HERTEL H, 1987, J EXP BIOL, V133, P283; HERTEL H, 1987, J EXP BIOL, V133, P301; HERTEL H, 1980, J COMP PHYSIOL, V137, P215, DOI 10.1007/BF00657117; Hori S, 2007, J COMP PHYSIOL A, V193, P825, DOI 10.1007/s00359-007-0234-x; Hori S, 2006, J COMP PHYSIOL A, V192, P691, DOI 10.1007/s00359-005-0091-4; Huang AM, 2000, GENETICS, V156, P1219; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Kamikouchi A, 1998, BIOCHEM BIOPH RES CO, V242, P181, DOI 10.1006/bbrc.1997.7870; Kamikouchi A, 2000, J COMP NEUROL, V417, P501, DOI 10.1002/(SICI)1096-9861(20000221)417:4&lt;501::AID-CNE8&gt;3.0.CO;2-4; KIEN J, 1977, J COMP PHYSIOL, V113, P17, DOI 10.1007/BF00610451; KIEN J, 1977, J COMP PHYSIOL, V113, P35, DOI 10.1007/BF00610452; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Kubo T, 1996, J BIOCHEM-TOKYO, V119, P291, DOI 10.1093/oxfordjournals.jbchem.a021237; KUBO T, 2003, GENES BEHAV EVOLUTIO, P3; Kuwabara M., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P458; Mobbs P.G., 1985, P299; Paul RK, 2006, ZOOL SCI, V23, P1085, DOI 10.2108/zsj.23.1085; Ribi W.A., 1975, Quarterly Review of Biology, V50, P1; RIBI WA, 1976, CELL TISSUE RES, V171, P359, DOI 10.1007/BF00224660; RIBI WA, 1981, CELL TISSUE RES, V221, P17, DOI 10.1007/BF00216567; RIBI WA, 1981, CELL TISSUE RES, V215, P443, DOI 10.1007/BF00233522; Rybak J, 1998, LEARN MEMORY, V5, P133; Sawata M, 2002, RNA, V8, P772, DOI 10.1017/S1355838202028790; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sen Sarma M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006408; SOUZA J D, 1992, Journal of Comparative Physiology A Sensory Neural and Behavioral Physiology, V170, P267; SOUZA JM, 1987, BRAZ J MED BIOL RES, V20, P851; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Takeuchi H, 2002, FEBS LETT, V513, P230, DOI 10.1016/S0014-5793(02)02319-0; Takeuchi H, 2001, INSECT MOL BIOL, V10, P487, DOI 10.1046/j.0962-1075.2001.00288.x; Uno Y, 2007, FEBS LETT, V581, P97, DOI 10.1016/j.febslet.2006.12.004; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang WQ, 2009, INT J CANCER, V124, P521, DOI 10.1002/ijc.23961; Winston, 1987, BIOL HONEYBEE; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; Yamazaki Y, 2006, FEBS LETT, V580, P2667, DOI 10.1016/j.febslet.2006.04.016; Yang EC, 2004, J INSECT PHYSIOL, V50, P913, DOI 10.1016/j.jinsphys.2004.06.010; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	56	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9213	10.1371/journal.pone.0009213	http://dx.doi.org/10.1371/journal.pone.0009213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169065	Green Published, Green Submitted, gold			2022-12-25	WOS:000274590500005
J	Osterstock, G; Escobar, P; Mitutsova, V; Gouty-Colomer, LA; Fontanaud, P; Molino, F; Fehrentz, JA; Carmignac, D; Martinez, J; Guerineau, NC; Robinson, ICAF; Mollard, P; Mery, PF				Osterstock, Guillaume; Escobar, Pauline; Mitutsova, Violeta; Gouty-Colomer, Laurie-Anne; Fontanaud, Pierre; Molino, Francois; Fehrentz, Jean-Alain; Carmignac, Danielle; Martinez, Jean; Guerineau, Nathalie C.; Robinson, Iain C. A. F.; Mollard, Patrice; Mery, Pierre-Francois			Ghrelin Stimulation of Growth Hormone-Releasing Hormone Neurons Is Direct in the Arcuate Nucleus	PLOS ONE			English	Article							REGULATING ENERGY HOMEOSTASIS; SECRETAGOGUE RECEPTOR 1A; PHARMACOLOGICAL IN-VITRO; STATIONARY POINT PROCESS; PROTEIN TRANSGENIC MICE; AGOUTI-RELATED PROTEIN; NEUROPEPTIDE-Y; GH SECRETAGOGUE; NITRIC-OXIDE; MESSENGER-RNA	Background: Ghrelin targets the arcuate nucleus, from where growth hormone releasing hormone (GHRH) neurones trigger GH secretion. This hypothalamic nucleus also contains neuropeptide Y (NPY) neurons which play a master role in the effect of ghrelin on feeding. Interestingly, connections between NPY and GHRH neurons have been reported, leading to the hypothesis that the GH axis and the feeding circuits might be co-regulated by ghrelin. Principal Findings: Here, we show that ghrelin stimulates the firing rate of identified GHRH neurons, in transgenic GHRHGFP mice. This stimulation is prevented by growth hormone secretagogue receptor-1 antagonism as well as by U-73122, a phospholipase C inhibitor and by calcium channels blockers. The effect of ghrelin does not require synaptic transmission, as it is not antagonized by c-aminobutyric acid, glutamate and NPY receptor antagonists. In addition, this hypothalamic effect of ghrelin is independent of somatostatin, the inhibitor of the GH axis, since it is also found in somatostatin knockout mice. Indeed, ghrelin does not modify synaptic currents of GHRH neurons. However, ghrelin exerts a strong and direct depolarizing effect on GHRH neurons, which supports their increased firing rate. Conclusion: Thus, GHRH neurons are a specific target for ghrelin within the brain, and not activated secondary to altered activity in feeding circuits. These results support the view that ghrelin related therapeutic approaches could be directed separately towards GH deficiency or feeding disorders.	[Osterstock, Guillaume; Escobar, Pauline; Mitutsova, Violeta; Gouty-Colomer, Laurie-Anne; Fontanaud, Pierre; Molino, Francois; Guerineau, Nathalie C.; Mollard, Patrice; Mery, Pierre-Francois] INSERM, U661, Montpellier, France; [Osterstock, Guillaume; Escobar, Pauline; Mitutsova, Violeta; Gouty-Colomer, Laurie-Anne; Fontanaud, Pierre; Molino, Francois; Guerineau, Nathalie C.; Mollard, Patrice; Mery, Pierre-Francois] Inst Genom Fonct, CNRS, UMR 5203, Montpellier, France; [Osterstock, Guillaume; Escobar, Pauline; Mitutsova, Violeta; Gouty-Colomer, Laurie-Anne; Fontanaud, Pierre; Molino, Francois; Fehrentz, Jean-Alain; Martinez, Jean; Guerineau, Nathalie C.; Mollard, Patrice; Mery, Pierre-Francois] Univ Montpellier 1, Montpellier, France; [Carmignac, Danielle; Robinson, Iain C. A. F.] MRC Natl Inst Med Res, Div Mol Neuroendocrinol, London, England; [Fehrentz, Jean-Alain; Martinez, Jean] Inst Biomol Max Mousseron, CNRS, UMR 5247, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; MRC National Institute for Medical Research; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Osterstock, G (corresponding author), INSERM, U661, Montpellier, France.	pierre-francois.mery@igf.cnrs.fr	Martinez, Jean/R-9421-2019; MERY, Pierre-François/C-5903-2019	Martinez, Jean/0000-0002-9267-4621; Mery, Pierre-Francois/0000-0001-6214-5422; Guerineau, Nathalie/0000-0003-2517-4210	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Universities of Montpellier 1 2; National Biophotonics and Imaging Platform (Ireland); Reseau National des Genopoles; Institut Federatif de Recherches 3; Medical Research Council (United Kingdom); Medical Research Council [MC_U117531708] Funding Source: researchfish; MRC [MC_U117531708] Funding Source: UKRI	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universities of Montpellier 1 2; National Biophotonics and Imaging Platform (Ireland); Reseau National des Genopoles; Institut Federatif de Recherches 3; Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, the Universities of Montpellier 1 & 2, National Biophotonics and Imaging Platform (Ireland), Reseau National des Genopoles, Institut Federatif de Recherches 3, Region Languedoc Roussillon and by core funding from the Medical Research Council (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2008, REGUL PEPTIDES, V149, P3, DOI 10.1016/j.regpep.2007.10.006; Alonso G, 2007, AGING CELL, V6, P197, DOI 10.1111/j.1474-9726.2007.00276.x; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Baccam N, 2007, J NEUROSCI, V27, P1631, DOI 10.1523/JNEUROSCI.2693-06.2007; Bailey ART, 1998, J NEUROENDOCRINOL, V10, P111; Balthasar N, 2003, ENDOCRINOLOGY, V144, P2728, DOI 10.1210/en.2003-0006; Banks WA, 2008, PEPTIDES, V29, P2061, DOI 10.1016/j.peptides.2008.07.001; Beedle AM, 2002, J MEMBRANE BIOL, V187, P225, DOI 10.1007/s00232-001-0166-2; Bennett PA, 1997, ENDOCRINOLOGY, V138, P4552, DOI 10.1210/en.138.11.4552; Bitran M, 1999, BRAIN RES, V851, P87, DOI 10.1016/S0006-8993(99)02123-X; BOWERS CY, 1984, ENDOCRINOLOGY, V114, P1537, DOI 10.1210/endo-114-5-1537; BRILLINGER DR, 1976, J ROY STAT SOC B MET, V38, P60; Broglio F, 2002, J ENDOCRINOL INVEST, V25, pRC26, DOI 10.1007/BF03345096; Casanueva FF, 2008, P NATL ACAD SCI USA, V105, P20452, DOI 10.1073/pnas.0811680106; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; COX DR, 1965, J ROY STAT SOC B, V27, P332; Dezaki K, 2007, DIABETES, V56, P2319, DOI 10.2337/db07-0345; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; DICKSON SL, 1993, BRAIN RES, V623, P95, DOI 10.1016/0006-8993(93)90015-F; Dickson SL, 1997, ENDOCRINOLOGY, V138, P771, DOI 10.1210/en.138.2.771; Dimaraki EV, 2006, REV ENDOCR METAB DIS, V7, P237, DOI 10.1007/s11154-006-9022-0; Farhy LS, 2007, AM J PHYSIOL-REG I, V292, pR1577, DOI 10.1152/ajpregu.00584.2006; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Gaskin FS, 2003, PEPTIDES, V24, P913, DOI 10.1016/S0196-9781(03)00160-8; Guerlavais V, 2003, J MED CHEM, V46, P1191, DOI 10.1021/jm020985q; GUILLAUME V, 1994, ENDOCRINOLOGY, V135, P1073, DOI 10.1210/en.135.3.1073; Hayashida T, 2002, J ENDOCRINOL, V173, P239, DOI 10.1677/joe.0.1730239; Hewson AK, 1999, J NEUROENDOCRINOL, V11, P919; Hewson AK, 2000, J NEUROENDOCRINOL, V12, P1047, DOI 10.1046/j.1365-2826.2000.00584.x; Hickey GJ, 1996, J ENDOCRINOL, V148, P371, DOI 10.1677/joe.0.1480371; Hosoda H, 2006, J PHARMACOL SCI, V100, P398, DOI 10.1254/jphs.CRJ06002X; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Jordani MC, 2000, MOL CELL BIOCHEM, V210, P153, DOI 10.1023/A:1007185825101; Kamegai J, 1999, J NEUROENDOCRINOL, V11, P299; Katayama M, 2000, NEUROENDOCRINOLOGY, V72, P333, DOI 10.1159/000054602; Kato M, 1999, J NEUROENDOCRINOL, V11, P795; King PJ, 2000, EUR J PHARMACOL, V396, pR1, DOI 10.1016/S0014-2999(00)00230-2; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kuramochi M, 2005, REGUL PEPTIDES, V126, P85, DOI 10.1016/j.regpep.2004.08.017; Lall S, 2004, ENDOCRINOLOGY, V145, P1602, DOI 10.1210/en.2003-1509; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lin S, 2007, ENDOCRINOLOGY, V148, P2056, DOI 10.1210/en.2006-1408; Liu XH, 2008, ENDOCRINOLOGY, V149, P4605, DOI 10.1210/en.2008-0321; Liu YL, 2002, MOL CELL ENDOCRINOL, V189, P97, DOI 10.1016/S0303-7207(01)00742-0; Low MJ, 2001, J CLIN INVEST, V107, P1571, DOI 10.1172/JCI11941; Luque RM, 2007, ENDOCRINOLOGY, V148, P300, DOI 10.1210/en.2006-0592; Morley JE, 1999, PEPTIDES, V20, P595, DOI 10.1016/S0196-9781(99)00012-1; Moulin A, 2008, J MED CHEM, V51, P689, DOI 10.1021/jm701292s; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; Mousseaux D, 2006, BRIT J PHARMACOL, V148, P350, DOI 10.1038/sj.bjp.0706727; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Pieraut S, 2007, J NEUROSCI, V27, P6751, DOI 10.1523/JNEUROSCI.1337-07.2007; Pinilla L, 2003, NEUROENDOCRINOLOGY, V77, P83, DOI 10.1159/000068652; Popovic V, 2003, J CLIN ENDOCR METAB, V88, P3450, DOI 10.1210/jc.2003-030211; Riediger T, 2003, NEUROSCI LETT, V341, P151, DOI 10.1016/S0304-3940(02)01381-2; Riediger T, 2006, BRAIN RES, V1125, P37, DOI 10.1016/j.brainres.2006.09.049; Rodriguez-Pacheco F, 2008, J NEUROENDOCRINOL, V20, P406, DOI 10.1111/j.1365-2826.2008.01645.x; Smith RG, 2005, ENDOCR REV, V26, P346, DOI 10.1210/er.2004-0019; Sun YX, 2007, ENDOCRINOLOGY, V148, P1323, DOI 10.1210/en.2006-0782; Tamura H, 2005, REGUL PEPTIDES, V125, P145, DOI 10.1016/j.regpep.2004.08.012; Tannenbaum GS, 1998, ENDOCRINOLOGY, V139, P4420, DOI 10.1210/en.139.10.4420; Tena-Sempere M, 2008, VITAM HORM, V77, P285, DOI 10.1016/S0083-6729(06)77012-1; Teruyama R, 2007, J NEUROPHYSIOL, V98, P2612, DOI 10.1152/jn.00599.2007; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Traebert M, 2002, J NEUROENDOCRINOL, V14, P580, DOI 10.1046/j.1365-2826.2002.00810.x; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Yanagida H, 2008, PEPTIDES, V29, P912, DOI 10.1016/j.peptides.2008.01.021; ZHENG LX, 1995, ENDOCRINOLOGY, V136, P1079, DOI 10.1210/en.136.3.1079	71	53	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9159	10.1371/journal.pone.0009159	http://dx.doi.org/10.1371/journal.pone.0009159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161791	gold, Green Submitted, Green Published			2022-12-25	WOS:000274442800005
J	Zhang, YH; Lin, XJ; Wang, GQ; Zhou, JF; Lu, J; Zhao, HL; Zhang, FW; Wu, J; Xu, CQ; Du, N; Li, Z; Zhang, Y; Wang, XY; Bi, SL; Shu, YL; Zhou, HN; Tan, WJ; Wu, XB; Chen, ZH; Wang, Y				Zhang, Yonghui; Lin, Xiaojing; Wang, Guoqin; Zhou, Jianfang; Lu, Jian; Zhao, Honglan; Zhang, Fengwei; Wu, Jia; Xu, Chunqiong; Du, Ning; Li, Zi; Zhang, Ye; Wang, Xiaoyi; Bi, Shengli; Shu, Yuelong; Zhou, Hongning; Tan, Wenjie; Wu, Xiaobing; Chen, Zhihui; Wang, Yue			Neuraminidase and Hemagglutinin Matching Patterns of a Highly Pathogenic Avian and Two Pandemic H1N1 Influenza A Viruses	PLOS ONE			English	Article							ORIGIN; INFECTION; TRANSMISSION; SPECIFICITY; EMERGENCE	Background: Influenza A virus displays strong reassortment characteristics, which enable it to achieve adaptation in human infection. Surveying the reassortment and virulence of novel viruses is important in the prevention and control of an influenza pandemic. Meanwhile, studying the mechanism of reassortment may accelerate the development of anti-influenza strategies. Methodology/Principal Findings: The hemagglutinin (HA) and neuraminidase (NA) matching patterns of two pandemic H1N1 viruses (the 1918 and current 2009 strains) and a highly pathogenic avian influenza A virus (H5N1) were studied using a pseudotyped particle (pp) system. Our data showed that four of the six chimeric HA/NA combinations could produce infectious pps, and that some of the chimeric pps had greater infectivity than did their ancestors, raising the possibility of reassortment among these viruses. The NA of H5N1 (A/Anhui/1/2005) could hardly reassort with the HAs of the two H1N1 viruses. Many biological characteristics of HA and NA, including infectivity, hemagglutinating ability, and NA activity, are dependent on their matching pattern. Conclusions/Significance: Our data suggest the existence of an interaction between HA and NA, and the HA NA matching pattern is critical for valid viral reassortment.	[Zhang, Yonghui; Zhou, Hongning] Dali Univ, Inst Pathogens & Vectors, Dali, Peoples R China; [Chen, Zhihui] Second Mil Med Univ, Dept Infect Dis, Changhai Hosp, Shanghai, Peoples R China; [Lin, Xiaojing; Zhou, Jianfang; Lu, Jian; Zhao, Honglan; Zhang, Fengwei; Wu, Jia; Xu, Chunqiong; Du, Ning; Li, Zi; Zhang, Ye; Wang, Xiaoyi; Bi, Shengli; Shu, Yuelong; Tan, Wenjie; Wu, Xiaobing; Wang, Yue] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Wang, Guoqin] Kitasato Univ, Sch Med, Kitasato Clin Res Ctr, Sagamihara, Kanagawa 228, Japan	Dali University; Naval Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Kitasato University	Zhang, YH (corresponding author), Dali Univ, Inst Pathogens & Vectors, Dali, Peoples R China.	hchzhi@126.com; euy-tokyo@umin.ac.jp		Bi, Shengli/0000-0002-0380-5790	863 Hi-Tech Research and Development Program of China [2007AA02Z157, 2007AA02Z417]; National Research Programs of China [2009ZX10004-711]	863 Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Research Programs of China	This study was supported by the 863 Hi-Tech Research and Development Program of China (2007AA02Z157, 2007AA02Z417) and the National Research Programs of China (2009ZX10004-711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gibbs MJ, 2006, NATURE, V440, pE8, DOI 10.1038/nature04823; HINSHAW VS, 1983, VIROLOGY, V128, P260, DOI 10.1016/0042-6822(83)90337-9; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Knipe DM, 2007, FIELD VIROLOGY, V5th; Kobasa D, 2001, J VIROL, V75, P11773, DOI 10.1128/JVI.75.23.11773-11780.2001; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lin XJ, 2009, BIOCHEM BIOPH RES CO, V390, P1305, DOI 10.1016/j.bbrc.2009.10.142; Lin XJ, 2009, BIOCHEM BIOPH RES CO, V385, P257, DOI 10.1016/j.bbrc.2009.05.068; Luo G, 1993, Virus Res, V29, P321; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ogata T, 2008, J EPIDEMIOL, V18, P160, DOI 10.2188/jea.JE2007446; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; ROGERS GN, 1983, VIROLOGY, V131, P394, DOI 10.1016/0042-6822(83)90507-X; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Tollis M, 2002, VET J, V164, P202, DOI 10.1053/tvjl.2002.0716; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang YH, 2009, BIOCHEM BIOPH RES CO, V387, P405, DOI 10.1016/j.bbrc.2009.07.040	31	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9167	10.1371/journal.pone.0009167	http://dx.doi.org/10.1371/journal.pone.0009167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161801	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442800013
J	Zhao, Y; Bretz, CA; Hawksworth, SA; Hirsh, J; Johnson, EC				Zhao, Yan; Bretz, Colin A.; Hawksworth, Shane A.; Hirsh, Jay; Johnson, Erik C.			Corazonin Neurons Function in Sexually Dimorphic Circuitry That Shape Behavioral Responses to Stress in Drosophila	PLOS ONE			English	Article							GENE-EXPRESSION; BIOGENIC-AMINES; DOPAMINE; HORMONE; RECEPTOR; IDENTIFICATION; ABLATION; MELANOGASTER; METABOLISM; MODULATION	All organisms are confronted with dynamic environmental changes that challenge homeostasis, which is the operational definition of stress. Stress produces adaptive behavioral and physiological responses, which, in the Metazoa, are mediated through the actions of various hormones. Based on its associated phenotypes and its expression profiles, a candidate stress hormone in Drosophila is the corazonin neuropeptide. We evaluated the potential roles of corazonin in mediating stress-related changes in target behaviors and physiologies through genetic alteration of corazonin neuronal excitability. Ablation of corazonin neurons confers resistance to metabolic, osmotic, and oxidative stress, as measured by survival. Silencing and activation of corazonin neurons lead to differential lifespan under stress, and these effects showed a strong dependence on sex. Additionally, altered corazonin neuron physiology leads to fundamental differences in locomotor activity, and these effects were also sex-dependent. The dynamics of altered locomotor behavior accompanying stress was likewise altered in flies with altered corazonin neuronal function. We report that corazonin transcript expression is altered under starvation and osmotic stress, and that triglyceride and dopamine levels are equally impacted in corazonin neuronal alterations and these phenotypes similarly show significant sexual dimorphisms. Notably, these sexual dimorphisms map to corazonin neurons. These results underscore the importance of central peptidergic processing within the context of stress and place corazonin signaling as a critical feature of neuroendocrine events that shape stress responses and may underlie the inherent sexual dimorphic differences in stress responses.	[Zhao, Yan; Bretz, Colin A.; Hawksworth, Shane A.; Johnson, Erik C.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Hirsh, Jay] Univ Virginia, Dept Biol, Charlottesville, VA USA	Wake Forest University; University of Virginia	Zhao, Y (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.	johnsoec@wfu.edu			Science Research Fund; Wake Forest University; NSF IOS [092931]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027318] Funding Source: NIH RePORTER	Science Research Fund; Wake Forest University; NSF IOS(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Science Research Fund, Wake Forest University, and NSF IOS 092931 to ECJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bazazi S, 2008, CURR BIOL, V18, P735, DOI 10.1016/j.cub.2008.04.035; BOERJAN B, 2009, GEN COMP ENDOCRINOL; BRAND AH, 1993, DEVELOPMENT, V118, P401; Breen KM, 2006, FRONT NEUROENDOCRIN, V27, P233, DOI 10.1016/j.yfrne.2006.03.335; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Cazzamali G, 2002, BIOCHEM BIOPH RES CO, V298, P31, DOI 10.1016/S0006-291X(02)02398-7; Chaudhuri A, 2007, J NEUROSCI, V27, P2457, DOI 10.1523/JNEUROSCI.4239-06.2007; Choi YJ, 2006, DEVELOPMENT, V133, P2223, DOI 10.1242/dev.02376; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Davis MM, 2007, DEVELOPMENT, V134, P4395, DOI 10.1242/dev.009902; Feng GP, 1996, J NEUROSCI, V16, P3925; Gatti S, 2000, CURR BIOL, V10, P667, DOI 10.1016/S0960-9822(00)00517-0; Gruntenko N, 2004, ARCH INSECT BIOCHEM, V55, P55, DOI 10.1002/arch.10123; Gruntenko NE, 2005, J INSECT PHYSIOL, V51, P417, DOI 10.1016/j.jinsphys.2005.01.007; Harbison ST, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r36; Hardie SL, 2006, J NEUROSCI METH, V153, P243, DOI 10.1016/j.jneumeth.2005.11.001; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Johnson E, 1997, J COMP PHYSIOL B, V167, P89, DOI 10.1007/s003600050051; Johnson EC, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1069; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; Kim YJ, 2004, P NATL ACAD SCI USA, V101, P6704, DOI 10.1073/pnas.0305291101; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee G, 2008, CELL TISSUE RES, V331, P659, DOI 10.1007/s00441-007-0549-5; Levavi-Sivan B, 2004, BIOL REPROD, V70, P1545, DOI 10.1095/biolreprod.103.021998; Li XF, 2004, ENDOCRINOLOGY, V145, P1556, DOI 10.1210/en.2003-1609; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Neckameyer WS, 1998, J NEUROGENET, V12, P101, DOI 10.3109/01677069809167259; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; Neckameyer WS, 2005, STRESS, V8, P117, DOI 10.1080/10253890500147381; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; RAUSCHENBACH IY, 1993, J INSECT PHYSIOL, V39, P761, DOI 10.1016/0022-1910(93)90051-R; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; RIVEST S, 1995, J NEUROENDOCRINOL, V7, P501, DOI 10.1111/j.1365-2826.1995.tb00788.x; Scaggiante M, 2006, HORM BEHAV, V50, P107, DOI 10.1016/j.yhbeh.2006.01.011; SELYE H, 1956, METABOLISM, V5, P525; SELYE H, 1950, BRIT MED J, V1, P1383, DOI 10.1136/bmj.1.4667.1383; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Sheeba V, 2008, J NEUROSCI, V28, P217, DOI 10.1523/JNEUROSCI.4087-07.2008; STEINMANNZWICKY M, 1994, DEVELOPMENT, V120, P707; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Tawfik AI, 1999, P NATL ACAD SCI USA, V96, P7083, DOI 10.1073/pnas.96.12.7083; Taylor MM, 2005, BRAIN RES, V1045, P199, DOI 10.1016/j.brainres.2005.03.034; van der Waaij EH, 2004, J ANIM SCI, V82, P973; VEENSTRA JA, 1989, FEBS LETT, V250, P231, DOI 10.1016/0014-5793(89)80727-6; VEENSTRA JA, 2009, INSETCT BIOCH MOL BI; Wang MH, 2004, AGING CELL, V3, P133, DOI 10.1111/j.1474-9728.2004.00098.x; Wise S, 2002, J COMP NEUROL, V447, P366, DOI 10.1002/cne.10242; Yellman C, 1997, P NATL ACAD SCI USA, V94, P4131, DOI 10.1073/pnas.94.8.4131	56	65	65	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9141	10.1371/journal.pone.0009141	http://dx.doi.org/10.1371/journal.pone.0009141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161767	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442700007
J	Yosef, I; Bochkareva, ES; Adler, J; Bibi, E				Yosef, Ido; Bochkareva, Elena S.; Adler, Julia; Bibi, Eitan			Membrane Protein Biogenesis in Ffh- or FtsY-Depleted Escherichia coli	PLOS ONE			English	Article							SIGNAL-RECOGNITION PARTICLE; MULTIDRUG TRANSPORTER MDFA; TARGETING PATHWAYS; RECEPTOR; SRP; RIBOSOMES; INSERTION; REVEAL; MUTANT; DOMAIN	Background: The Escherichia coli version of the mammalian signal recognition particle (SRP) system is required for biogenesis of membrane proteins and contains two essential proteins: the SRP subunit Ffh and the SRP-receptor FtsY. Scattered in vivo studies have raised the possibility that expression of membrane proteins is inhibited in cells depleted of FtsY, whereas Ffh-depletion only affects their assembly. These differential results are surprising in light of the proposed model that FtsY and Ffh play a role in the same pathway of ribosome targeting to the membrane. Therefore, we decided to evaluate these unexpected results systematically. Methodology/Principal Findings: We characterized the following aspects of membrane protein biogenesis under conditions of either FtsY- or Ffh-depletion: (i) Protein expression, stability and localization; (ii) mRNA levels; (iii) folding and activity. With FtsY, we show that it is specifically required for expression of membrane proteins. Since no changes in mRNA levels or membrane protein stability were detected in cells depleted of FtsY, we propose that its depletion may lead to specific inhibition of translation of membrane proteins. Surprisingly, although FtsY and Ffh function in the same pathway, depletion of Ffh did not affect membrane protein expression or localization. Conclusions: Our results suggest that indeed, while FtsY-depletion affects earlier steps in the pathway (possibly translation), Ffh-depletion disrupts membrane protein biogenesis later during the targeting pathway by preventing their functional assembly in the membrane.	[Yosef, Ido; Bochkareva, Elena S.; Adler, Julia; Bibi, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yosef, I (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.bibi@weizmann.ac.il		Bibi, Eitan/0000-0003-3700-2707	GIF; German-Israeli Foundation for Scientific Research and Development; Israel Science Foundation	GIF(German-Israeli Foundation for Scientific Research and Development); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation)	This work was supported by GIF, the German-Israeli Foundation for Scientific Research and Development, and by the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2004, BIOCHEMISTRY-US, V43, P518, DOI 10.1021/bi035485t; Adler J, 2002, J BACTERIOL, V184, P3313, DOI 10.1128/JB.184.12.3313-3320.2002; Bahari L, 2007, J BIOL CHEM, V282, P32168, DOI 10.1074/jbc.M705429200; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; Bernstein KD, 2001, J BACTERIOL, V183, P2187, DOI 10.1128/JB.183.7.2187-2197.2001; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Herskovits AA, 2001, EMBO REP, V2, P1040, DOI 10.1093/embo-reports/kve226; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; Koch HG, 2003, REV PHYSIOL BIOCH P, V146, P55, DOI 10.1007/s10254-002-0002-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; MACFARLANE J, 1995, EUR J BIOCHEM, V233, P766, DOI 10.1111/j.1432-1033.1995.766_3.x; Mircheva M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-76; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Park SK, 2002, J BACTERIOL, V184, P2642, DOI 10.1128/JB.184.10.2642-2653.2002; ROMISCH K, 1989, NATURE, V340, P478, DOI 10.1038/340478a0; Scotti PA, 1999, J BIOL CHEM, V274, P29883, DOI 10.1074/jbc.274.42.29883; Seluanov A, 1997, J BIOL CHEM, V272, P2053; Sigal N, 2006, J MOL MICROB BIOTECH, V11, P308, DOI 10.1159/000095633; Tian HP, 2000, P NATL ACAD SCI USA, V97, P4730, DOI 10.1073/pnas.090087297; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; Zelazny A, 1997, P NATL ACAD SCI USA, V94, P6025, DOI 10.1073/pnas.94.12.6025	27	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9130	10.1371/journal.pone.0009130	http://dx.doi.org/10.1371/journal.pone.0009130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161748	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442600027
J	Emelyanov, AV; Konev, AY; Vershilova, E; Fyodorov, DV				Emelyanov, Alexander V.; Konev, Alexander Y.; Vershilova, Elena; Fyodorov, Dmitry V.			Protein Complex of Drosophila ATRX/XNP and HP1a Is Required for the Formation of Pericentric Beta-heterochromatin in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THALASSEMIA-MENTAL-RETARDATION; ALPHA-THALASSEMIA; CENTRIC HETEROCHROMATIN; CHROMOSOME STRUCTURE; CHROMATIN-STRUCTURE; ATR-X; MELANOGASTER; DNA; TRANSCRIPTION; METHYLATION	ATRX belongs to the family of SWI2/SNF2-like ATP-dependent nucleosome remodeling molecular motor proteins. Mutations of the human ATRX gene result in a severe genetic disorder termed X-linked alpha-thalassemia mental retardation (ATR-X) syndrome. Here we perform biochemical and genetic analyses of the Drosophila melanogaster ortholog of ATRX. The loss of function allele of the Drosophila ATRX/XNP gene is semilethal. Drosophila ATRX is expressed throughout development in two isoforms, p185 and p125. ATRX185 and ATRX125 form distinct multisubunit complexes in fly embryo. The ATRX185 complex comprises p185 and heterochromatin protein HP1a. Consistently, ATRX185 but not ATRX125 is highly concentrated in pericentric beta-heterochromatin of the X chromosome in larval cells. HP1a strongly stimulates biochemical activities of ATRX185 in vitro. Conversely, ATRX185 is required for HP1a deposition in pericentric beta-heterochromatin of the X chromosome. The loss of function allele of the ATRX/XNP gene and mutant allele that does not express p185 are strong suppressors of position effect variegation. These results provide evidence for essential biological functions of Drosophila ATRX in vivo and establish ATRX as a major determinant of pericentric beta-heterochromatin identity.	[Emelyanov, Alexander V.; Konev, Alexander Y.; Vershilova, Elena; Fyodorov, Dmitry V.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Fyodorov, DV (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	dfyodoro@aecom.yu.edu	Konev, Alexander/J-4401-2015	Konev, Alexander/0000-0002-4497-6377	National Institutes of Health [GM074233]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074233 ( to D. V. F.).	Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; Bassett AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002099; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Cardoso C, 1998, HUM MOL GENET, V7, P679, DOI 10.1093/hmg/7.4.679; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; de Wit E, 2009, CHROMOSOMA, V118, P25, DOI 10.1007/s00412-008-0186-0; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Gibbons R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-15; GIBBONS RJ, 1991, J MED GENET, V28, P729, DOI 10.1136/jmg.28.11.729; GIBBONS RJ, 1995, AM J MED GENET, V55, P288, DOI 10.1002/ajmg.1320550309; Gibbons RJ, 2000, AM J MED GENET, V97, P204, DOI 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Guerrini R, 2000, ANN NEUROL, V47, P117; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Hong YK, 2009, BIOCHEM BIOPH RES CO, V384, P160, DOI 10.1016/j.bbrc.2009.04.112; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; KAMAKAKA RT, 1994, METHOD CELL BIOL, V44, P225, DOI 10.1016/S0091-679X(08)60916-4; Konev AY, 2003, GENETICS, V165, P2039; Lavrov S, 2004, METH MOL B, V247, P289; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lee NG, 2007, FEBS LETT, V581, P2625, DOI 10.1016/j.febslet.2007.05.005; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Lu XW, 2009, GENE DEV, V23, P452, DOI 10.1101/gad.1749309; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; MIKLOS GLG, 1990, BIOESSAYS, V12, P1, DOI 10.1002/bies.950120102; PAZIN MJ, 1994, SCIENCE, V266, P2007, DOI 10.1126/science.7801129; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Riddle NC, 2008, CURR TOP MICROBIOL, V320, P185; Ronsseray S, 2001, GENETICS, V159, P1631; Schneiderman JI, 2009, P NATL ACAD SCI USA, V106, P14472, DOI 10.1073/pnas.0905816106; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; WOLFFE AP, 1995, CURR BIOL, V5, P452, DOI 10.1016/S0960-9822(95)00088-1; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yan CM, 2002, GENETICS, V161, P217; Yasuhara JC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040016; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	49	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15027	15037		10.1074/jbc.M109.064790	http://dx.doi.org/10.1074/jbc.M109.064790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20154359	Green Published, hybrid			2022-12-25	WOS:000277399000024
J	Clark, JH; Kinnear, NP; Kalujnaia, S; Cramb, G; Fleischer, S; Jeyakumar, LH; Wuytack, F; Evans, AM				Clark, Jill H.; Kinnear, Nicholas P.; Kalujnaia, Svetlana; Cramb, Gordon; Fleischer, Sidney; Jeyakumar, Loice H.; Wuytack, Frank; Evans, A. Mark			Identification of Functionally Segregated Sarcoplasmic Reticulum Calcium Stores in Pulmonary Arterial Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; DISTINCT CA2+ STORES; CA2+-ATPASE SERCA; CYCLOPIAZONIC ACID; MOLECULAR-CLONING; CA-2+ ATPASE; TRIGGER ZONE; RYANODINE; EXPRESSION; ISOFORMS	In pulmonary arterial smooth muscle, Ca2+ release from the sarcoplasmic reticulum (SR) via ryanodine receptors (RyRs) may induce constriction and dilation in a manner that is not mutually exclusive. We show here that the targeting of different sarcoplasmic/endoplasmic reticulum Ca2+-ATPases (SERCA) and RyR subtypes to discrete SR regions explains this paradox. Western blots identified protein bands for SERCA2a and SERCA2b, whereas immunofluorescence labeling of isolated pulmonary arterial smooth muscle cells revealed striking differences in the spatial distribution of SERCA2a and SERCA2b and RyR1, RyR2, and RyR3, respectively. Almost all SERCA2a and RyR3 labeling was restricted to a region within 1.5 mu m of the nucleus. In marked contrast, SERCA2b labeling was primarily found within 1.5 mu m of the plasma membrane, where labeling for RyR1 was maximal. The majority of labeling for RyR2 lay in between these two regions of the cell. Application of the vasoconstrictor endothelin-1 induced global Ca2+ waves in pulmonary arterial smooth muscle cells, which were markedly attenuated upon depletion of SR Ca2+ stores by preincubation of cells with the SERCA inhibitor thapsigargin but remained unaffected after preincubation of cells with a second SERCA antagonist, cyclopiazonic acid. We conclude that functionally segregated SR Ca2+ stores exist within pulmonary arterial smooth muscle cells. One sits proximal to the plasma membrane, receives Ca2+ via SERCA2b, and likely releases Ca2+ via RyR1 to mediate vasodilation. The other is located centrally, receives Ca2+ via SERCA2a, and likely releases Ca2+ via RyR3 and RyR2 to initiate vasoconstriction.	[Clark, Jill H.; Kinnear, Nicholas P.; Evans, A. Mark] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Kalujnaia, Svetlana; Cramb, Gordon] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Fleischer, Sidney] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Fleischer, Sidney] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37235 USA; [Jeyakumar, Loice H.] Vanderbilt Univ, Sch Med, Dept Med Gastroenterol, Nashville, TN 37235 USA; [Wuytack, Frank] Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Transport ATPases Ca2, B-3000 Louvain, Belgium	University of Edinburgh; University of St Andrews; Vanderbilt University; Vanderbilt University; Vanderbilt University; KU Leuven	Evans, AM (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Hugh Robson Bldg,George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	mark.evans@ed.ac.uk			British Heart Foundation [PG/03/065, PG/05/128]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G.0646.08]; NERC [NE/F001401/1] Funding Source: UKRI; Natural Environment Research Council [NE/F001401/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by British Heart Foundation Project Grants PG/03/065 and PG/05/128 and by Grant G.0646.08 from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen ( to F. W.).	Bobe R, 2004, J BIOL CHEM, V279, P24297, DOI 10.1074/jbc.M314286200; BOBE R, 1994, J BIOL CHEM, V269, P1417; Boittin FX, 2003, J BIOL CHEM, V278, P9602, DOI 10.1074/jbc.M204891200; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; BURK SE, 1989, J BIOL CHEM, V264, P18561; CAMPBELL AM, 1991, J BIOL CHEM, V266, P16050; Dipp M, 2001, CIRC RES, V89, P77, DOI 10.1161/hh1301.093616; Dipp M, 2001, AM J PHYSIOL-LUNG C, V281, pL318, DOI 10.1152/ajplung.2001.281.2.L318; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; EGGERMONT JA, 1990, BIOCHEM J, V271, P649, DOI 10.1042/bj2710649; Ethier MF, 2001, AM J PHYSIOL-LUNG C, V281, pL126, DOI 10.1152/ajplung.2001.281.1.L126; Evans AM, 2005, PHARMACOL THERAPEUT, V107, P286, DOI 10.1016/j.pharmthera.2005.03.003; Fleischer S, 2008, BIOCHEM BIOPH RES CO, V369, P195, DOI 10.1016/j.bbrc.2007.12.119; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; GUNTESKIHAMBLIN AM, 1988, J BIOL CHEM, V263, P15032; Hauser K, 2007, BIOPHYS J, V93, P3259, DOI 10.1529/biophysj.107.109363; HERRMANNFRANK A, 1991, PFLUG ARCH EUR J PHY, V418, P353, DOI 10.1007/BF00550873; IINO M, 1988, BIOCHEM BIOPH RES CO, V152, P417, DOI 10.1016/S0006-291X(88)80730-7; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Janiak R, 2001, AM J PHYSIOL-CELL PH, V280, pC22, DOI 10.1152/ajpcell.2001.280.1.C22; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Jeyakumar LH, 2002, J MUSCLE RES CELL M, V23, P285, DOI 10.1023/A:1022091931677; Jeyakumar LH, 2001, BIOCHEM BIOPH RES CO, V281, P979, DOI 10.1006/bbrc.2001.4444; Jeyakumar LH, 1998, J BIOL CHEM, V273, P16011, DOI 10.1074/jbc.273.26.16011; Kargacin GJ, 2005, PFLUG ARCH EUR J PHY, V449, P356, DOI 10.1007/s00424-004-1345-7; Kinnear NP, 2008, CELL CALCIUM, V44, P190, DOI 10.1016/j.ceca.2007.11.003; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; KORCZAK B, 1988, J BIOL CHEM, V263, P4813; LINDEMANN JP, 1983, J BIOL CHEM, V258, P464; LYTTON J, 1988, J BIOL CHEM, V263, P15024; Ma HL, 1999, BIOCHEMISTRY-US, V38, P15522, DOI 10.1021/bi991523q; Mahmmoud YA, 2003, J BIOL CHEM, V278, P37427, DOI 10.1074/jbc.M305126200; Martin V, 2002, J BIOL CHEM, V277, P24442, DOI 10.1074/jbc.M202011200; McCarron JG, 2008, J BIOL CHEM, V283, P7206, DOI 10.1074/jbc.M708923200; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Nazer MA, 1998, CELL CALCIUM, V24, P275, DOI 10.1016/S0143-4160(98)90051-3; Nazer MA, 1998, AM J PHYSIOL-HEART C, V274, pH123, DOI 10.1152/ajpheart.1998.274.1.H123; NEYLON CB, 1995, BIOCHEM BIOPH RES CO, V215, P814, DOI 10.1006/bbrc.1995.2536; Odermatt A, 1996, J BIOL CHEM, V271, P14206, DOI 10.1074/jbc.271.24.14206; Poch E, 1998, AM J PHYSIOL-CELL PH, V275, pC1449, DOI 10.1152/ajpcell.1998.275.6.C1449; RAEYMAEKERS L, 1990, CELL CALCIUM, V11, P261, DOI 10.1016/0143-4160(90)90002-C; TRIBE RM, 1994, P NATL ACAD SCI USA, V91, P5908, DOI 10.1073/pnas.91.13.5908; VANBREEMEN C, 1995, TRENDS PHARMACOL SCI, V16, P98, DOI 10.1016/S0165-6147(00)88990-7; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; VERBOOMEN H, 1994, BIOCHEM J, V303, P979, DOI 10.1042/bj3030979; WUYTACK F, 1989, BIOCHEM J, V264, P765, DOI 10.1042/bj2640765; WUYTACK F, 1994, J BIOL CHEM, V269, P1410; YAMAGUCHI H, 1995, AM J PHYSIOL-CELL PH, V268, pC771, DOI 10.1152/ajpcell.1995.268.3.C771; Yang XR, 2005, AM J PHYSIOL-LUNG C, V289, pL338, DOI 10.1152/ajplung.00328.2004; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005	52	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13542	13549		10.1074/jbc.M110.101485	http://dx.doi.org/10.1074/jbc.M110.101485			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20177054	Green Published, hybrid			2022-12-25	WOS:000276987700027
J	Feinberg, H; Powlesland, AS; Taylor, ME; Weis, WI				Feinberg, Hadar; Powlesland, Alex S.; Taylor, Maureen E.; Weis, William I.			Trimeric Structure of Langerin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; RECEPTORS DC-SIGN; BIRBECK GRANULE; BINDING; CELLS; RECOGNITION	Langerin, an endocytic receptor of Langerhans cells, binds pathogens such as human immunodeficiency virus by recognition of surface glycoconjugates and mediates their internalization into Birbeck granules. Langerin has an extracellular region consisting of a C-type carbohydrate-recognition domain (CRD) and a neck region that stabilizes formation of trimers. As in many other C-type lectins, oligomerization is required for high affinity binding to glycan ligands and is also likely to be important for determining specificity. To facilitate structural analysis of the human langerin trimer, a truncated form of the extracellular region, consisting of part of the neck and the CRD, has been characterized. Like the full-length protein, truncated langerin exists as a stable trimer in solution. Glycan array screening with the trimeric fragment shows that high mannose oligosaccharides are the best ligands for langerin. Structural analysis of the trimeric fragment of langerin confirms that the neck region forms a coiled-coil of alpha-helices. Multiple interactions between the neck region and the CRDs make the trimer a rigid unit with the three CRDs in fixed positions and the primary sugar-binding sites separated by a distance of 42 angstrom. The fixed orientation of the sugar-binding sites in the trimer is likely to place constraints on the ligands that can be bound by langerin.	[Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94306 USA; [Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94306 USA; [Powlesland, Alex S.; Taylor, Maureen E.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Mol Biosci, London SW7 2AZ, England	Stanford University; Stanford University; Imperial College London	Weis, WI (corresponding author), Stanford Univ, Dept Biol Struct, 299 Campus Dr W, Stanford, CA 94305 USA.	bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Taylor, Maureen/0000-0001-8300-4987	Wellcome Trust [075565]; National Institutes of Health [GM62116]; Biotechnology and Biological Sciences Research Council; Dept. of Energy, Office of Biological and Environmental Research; National Institutes of Health; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dept. of Energy, Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 075565 from the Wellcome Trust (to M. E. T.). This work was also supported in part by National Institutes of Health Grant GM62116 (to the Consortium for Functional Glycomics). Analytical ultracentrifugation was performed in a facility supported by the Wellcome Trust and the Biotechnology and Biological Sciences Research Council. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the U. S. Dept. of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Dept. of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown JH, 1996, PROTEINS, V26, P134; Chatwell L, 2008, MOL IMMUNOL, V45, P1981, DOI 10.1016/j.molimm.2007.10.030; de Witte L, 2008, TRENDS MOL MED, V14, P12, DOI 10.1016/j.molmed.2007.11.001; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Idoyaga J, 2008, J IMMUNOL, V180, P3647, DOI 10.4049/jimmunol.180.6.3647; Kissenpfennig A, 2005, MOL CELL BIOL, V25, P88, DOI 10.1128/MCB.25.1.88-99.2005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDermott R, 2004, J INVEST DERMATOL, V123, P72, DOI 10.1111/j.0022-202X.2004.22728.x; Menon S, 2009, P NATL ACAD SCI USA, V106, P11524, DOI 10.1073/pnas.0901783106; Powlesland AS, 2008, J BIOL CHEM, V283, P593, DOI 10.1074/jbc.M706292200; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; Thepaut M, 2009, BIOCHEMISTRY-US, V48, P2684, DOI 10.1021/bi802151w; Tong L, 1996, ACTA CRYSTALLOGR A, V52, P782, DOI 10.1107/S010876739600548X; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Valladeau J, 1999, EUR J IMMUNOL, V29, P2695, DOI 10.1002/(SICI)1521-4141(199909)29:09<2695::AID-IMMU2695>3.0.CO;2-Q; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301	29	53	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13285	13293		10.1074/jbc.M109.086058	http://dx.doi.org/10.1074/jbc.M109.086058			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20181944	hybrid, Green Published			2022-12-25	WOS:000276787800083
J	Jaakola, VP; Lane, JR; Lin, JY; Katritch, V; IJzerman, AP; Stevens, RC				Jaakola, Veli-Pekka; Lane, J. Robert; Lin, Judy Y.; Katritch, Vsevolod; IJzerman, Adriaan P.; Stevens, Raymond C.			Ligand Binding and Subtype Selectivity of the Human A(2A) Adenosine Receptor IDENTIFICATION AND CHARACTERIZATION OF ESSENTIAL AMINO ACID RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; PROTEIN-COUPLED RECEPTORS; RECOGNITION; ANTAGONISTS; AGONISTS; DISCOVERY; DOCKING; DOMAINS	The crystal structure of the human A(2A) adenosine receptor bound to the A(2A) receptor-specific antagonist, ZM241385, was recently determined at 2.6-angstrom resolution. Surprisingly, the antagonist binds in an extended conformation, perpendicular to the plane of the membrane, and indicates a number of interactions unidentified before in ZM241385 recognition. To further understand the selectivity of ZM241385 for the human A2A adenosine receptor, we examined the effect of mutating amino acid residues within the binding cavity likely to have key interactions and that have not been previously examined. Mutation of Phe-168 to Ala abolishes both agonist and antagonist binding as well as receptor activity, whereas mutation of this residue to Trp or Tyr had only moderate effects. The Met-177 -> Ala mutation impeded antagonist but not agonist binding. Finally, the Leu-249 -> Ala mutant showed neither agonist nor antagonist binding affinity. From our results and previously published mutagenesis data, we conclude that conserved residues Phe-168( 5.29), Glu-169(5.30), Asn-253(6.55), and Leu-249(6.51) play a central role in coordinating the bicyclic core present in both agonists and antagonists. By combining the analysis of the mutagenesis data with a comparison of the sequences of different adenosine receptor subtypes from different species, we predict that the interactions that determine subtype selectivity reside in the more divergent "upper" region of the binding cavity while the "lower" part of the binding cavity is conserved across adenosine receptor subtypes.	[Jaakola, Veli-Pekka; Katritch, Vsevolod; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Stevens, Raymond C.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Jaakola, Veli-Pekka] Univ Oulu, Dept Biochem, Oulu 90014, Finland; [Jaakola, Veli-Pekka] Univ Oulu, Oulu Bioctr, Oulu 90014, Finland; [Lane, J. Robert; Lin, Judy Y.; IJzerman, Adriaan P.] Leiden Amsterdam Ctr Drug Res, Div Med Chem, NL-2300 RA Leiden, Netherlands	Scripps Research Institute; Scripps Research Institute; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; Leiden University; Leiden University - Excl LUMC	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,GAC-1200, La Jolla, CA 92037 USA.	stevens@scripps.edu	IJzerman, Ad/ABG-1353-2020; Katritch, Vsevolod/Q-8357-2016; Katritch, Vsevolod/Y-2721-2019; Stevens, Raymond/K-7272-2015	IJzerman, Ad/0000-0002-1182-2259; Katritch, Vsevolod/0000-0003-3883-4505; Stevens, Raymond/0000-0002-4522-8725; Jaakola, Veli-Pekka/0000-0003-2943-6417; Lane, J. Robert/0000-0002-7361-7875	Protein Structure Initiative [U54 GM074961]; Dutch Top Institute Pharma [D1-105]; Oulu Biocenter (Finland) [2009]; Sigrid Juselius Foundation (Finland) [2009]; Orion-Farmos Research Foundation (Finland) [2009]; Marie Curie European; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074961] Funding Source: NIH RePORTER	Protein Structure Initiative; Dutch Top Institute Pharma; Oulu Biocenter (Finland); Sigrid Juselius Foundation (Finland)(Sigrid Juselius Foundation); Orion-Farmos Research Foundation (Finland); Marie Curie European; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Protein Structure Initiative Grant U54 GM074961 (ATCG3D; to R. C. S.) and by the Dutch Top Institute Pharma, Project D1-105 (to J. R. L., J. Y. L., and A. P. IJ.).; Supported by the Oulu Biocenter (Finland, 2009), the Sigrid Juselius Foundation (Finland, 2009), the Orion-Farmos Research Foundation (Finland, 2009), and an FP7 Marie Curie European	Abagyan R, 2009, METHODS MOL BIOL, V575, P249, DOI 10.1007/978-1-60761-274-2_11; BALLESTEROS JA, 1995, RECEPTOR MOL BIOL, P366; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; de Zwart M, 1999, J MED CHEM, V42, P1384, DOI 10.1021/jm9804984; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P661, DOI 10.1016/S0006-2952(00)00357-9; Hanson MA, 2007, PROTEIN EXPRES PURIF, V56, P85, DOI 10.1016/j.pep.2007.06.003; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Ivanov AA, 2009, J MED CHEM, V52, P3284, DOI 10.1021/jm801533x; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jiang QL, 1996, MOL PHARMACOL, V50, P512; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; Kim JH, 1996, MOL PHARMACOL, V49, P683; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; Kim SK, 2003, J MED CHEM, V46, P4847, DOI 10.1021/jm0300431; Mantri M, 2008, J MED CHEM, V51, P4449, DOI 10.1021/jm701594y; Martinelli A, 2008, MED RES REV, V28, P247, DOI 10.1002/med.20106; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; Yuzlenko O, 2009, J COMPUT CHEM, V30, P14, DOI 10.1002/jcc.21001	22	77	79	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13032	13044		10.1074/jbc.M109.096974	http://dx.doi.org/10.1074/jbc.M109.096974			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20147292	hybrid, Green Published			2022-12-25	WOS:000276787800061
J	Maccario, H; Perera, NM; Gray, A; Downes, CP; Leslie, NR				Maccario, Helene; Perera, Nevin M.; Gray, Alexander; Downes, C. Peter; Leslie, Nick R.			Ubiquitination of PTEN (Phosphatase and Tensin Homolog) Inhibits Phosphatase Activity and Is Enhanced by Membrane Targeting and Hyperosmotic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; PROTEIN-KINASE CK2; C-TERMINUS; B-ALPHA; PHOSPHORYLATION; ACTIVATION; PROTEASOME; STABILITY; PATHWAY; CANCER	The PTEN (phosphatase and tensin homolog) tumor suppressor is a phosphatase that inhibits phosphoinositide 3-kinase-dependent signaling by metabolizing the phosphoinositide lipid phosphatidylinositol 3,4,5-trisphosphate (PtdInsP(3)) at the plasma membrane. PTEN can be mono-or polyubiquitinated, and this appears to control its nuclear localization and stability, respectively. Although PTEN phosphorylation at a cluster of C-terminal serine and threonine residues has been shown to stabilize the protein and inhibit polyubiquitination and plasma membrane localization, details of the regulation of ubiquitination are unclear. Here, we show that plasma membrane targeting of PTEN greatly enhances PTEN ubiquitination and that phosphorylation of PTEN in vitro does not affect subsequent ubiquitination. These data suggest that C-terminal phosphorylation indirectly regulates ubiquitination by controlling membrane localization. We also show that either mono-or polyubiquitination in vitro greatly reduces PTEN phosphatase activity. Finally, we show that hyperosmotic stress increases both PTEN ubiquitination and cellular PtdInsP(3) levels well before a reduction in PTEN protein levels is observed. Both PTEN ubiquitination and elevated PtdInsP(3) levels were reduced within 10 min after removal of the hyperosmotic stress. Our data indicate that ubiquitination may represent a regulated mechanism of direct reversible control over the PTEN enzyme.	[Maccario, Helene; Perera, Nevin M.; Gray, Alexander; Downes, C. Peter; Leslie, Nick R.] Univ Dundee, Coll Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland	University of Dundee	Maccario, H (corresponding author), Univ Dundee, Coll Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland.	h.maccario@dundee.ac.uk; n.r.leslie@dundee.ac.uk	Leslie, Nicholas/D-2699-2009	Gray, Alexander/0000-0001-9227-0363; LESLIE, Nicholas/0000-0001-5131-0541	MRC [G0801865, G9403619] Funding Source: UKRI; Medical Research Council [G9403619, G0801865] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Crockett DK, 2005, PROTEOMICS, V5, P1250, DOI 10.1002/pmic.200401046; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Leslie NR, 2001, BIOCHEM J, V357, P427, DOI 10.1042/0264-6021:3570427; Leslie NR, 2000, BIOCHEM J, V346, P827, DOI 10.1042/0264-6021:3460827; LESLIE NR, 2010, ADV ENZYME IN PRESS; Maccario H, 2007, BIOCHEM J, V405, P439, DOI 10.1042/BJ20061837; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Okahara F, 2006, MOL BIOL CELL, V17, P4888, DOI 10.1091/mbc.E06-04-0301; Ostrowska H, 2000, INT J BIOCHEM CELL B, V32, P747, DOI 10.1016/S1357-2725(00)00021-2; Pagano MA, 2004, J MED CHEM, V47, P6239, DOI 10.1021/jm049854a; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Tolkacheva T, 2001, CANCER RES, V61, P4985; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012	42	42	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12620	12628		10.1074/jbc.M109.072280	http://dx.doi.org/10.1074/jbc.M109.072280			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20177066	Green Published, hybrid			2022-12-25	WOS:000276787800020
J	Chavez, A; George, V; Agrawal, V; Johnson, FB				Chavez, Alejandro; George, Vanessa; Agrawal, Vishesh; Johnson, F. Brad			Sumoylation and the Structural Maintenance of Chromosomes (Smc) 5/6 Complex Slow Senescence through Recombination Intermediate Resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; TELOMERE MAINTENANCE; PROTEIN SUMOYLATION; REPLICATION FORKS; TOPOISOMERASE-III; SUMO PATHWAY; CELLS; LIGASE; RAD18	Telomeres are repetitive nucleoprotein structures that cap the ends of chromosomes. Without telomerase, telomeres shorten with replication and eventually signal cell cycle arrest (cell senescence). Homologous recombination (HR)-based mechanisms slow senescence, and distinct HR mechanisms support the growth of the rare survivors of senescence. Here, we report novel roles for the post-translational modification of small ubiquitin-like modifier (SUMO) in regulating the rate of senescence in Saccharomyces cerevisiae telomerase mutants. We identify Mms21 as the relevant SUMO E3 ligase and demonstrate that cells lacking Mms21-dependent sumoylation accumulate HR intermediates selectively at telomeres during senescence. One target of Mms21-dependent sumoylation is the cohesin-and condensin-related Smc5-Smc6 complex (Smc5/6). We show that hypomorphic smc5 or smc6 alleles exhibit phenotypes similar to mms21 sumoylation-deficient mutants with regard to senescence and the accumulation of unresolved HR intermediates. Further, we provide evidence that Mms21 and Smc5/6 prevent aberrant recombination between sister telomeres and also globally facilitate resolution of sister chromatid HR intermediates.	[Chavez, Alejandro; George, Vanessa; Agrawal, Vishesh; Johnson, F. Brad] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Chavez, Alejandro; Johnson, F. Brad] Univ Penn, Sch Med, Cell & Mol Biol Grp, Philadelphia, PA 19104 USA; [Chavez, Alejandro] Univ Penn, Sch Med, Med Scientist Training Program, Philadelphia, PA 19104 USA; [Johnson, F. Brad] Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Johnson, FB (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 405A Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.	johnsonb@mail.med.upenn.edu			National Institutes of Health [R01-AG021521, P01-AG031862, T32-AG000255]; NATIONAL INSTITUTE ON AGING [T32AG000255, P01AG031862, R01AG021521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AG021521 and P01-AG031862 (to F. B. J.) and T32-AG000255 (to A. C.).	Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Azam M, 2006, NUCLEIC ACIDS RES, V34, P506, DOI 10.1093/nar/gkj452; Bertuch AA, 2006, CURR OPIN CELL BIOL, V18, P247, DOI 10.1016/j.ceb.2006.04.005; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Chen XL, 2005, MOL CELL BIOL, V25, P4311, DOI 10.1128/MCB.25.10.4311-4320.2005; Cost GJ, 2006, GENETICS, V172, P2185, DOI 10.1534/genetics.105.053876; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Le S, 1999, GENETICS, V152, P143; Lee JY, 2007, PLOS BIOL, V5, P1334, DOI 10.1371/journal.pbio.0050160; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Liberi G, 2006, METHOD ENZYMOL, V409, P442, DOI 10.1016/S0076-6879(05)09026-9; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Martens UM, 2000, EXP CELL RES, V256, P291, DOI 10.1006/excr.2000.4823; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Potts PR, 2009, DNA REPAIR, V8, P499, DOI 10.1016/j.dnarep.2009.01.009; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Takahashi Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000215; Taylor EM, 2001, MOL BIOL CELL, V12, P1583, DOI 10.1091/mbc.12.6.1583; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Tsai HJ, 2006, J BIOL CHEM, V281, P13717, DOI 10.1074/jbc.M600649200; Tsalik EL, 1998, YEAST, V14, P847, DOI 10.1002/(SICI)1097-0061(19980630)14:9<847::AID-YEA285>3.0.CO;2-9; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	64	46	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11922	11930		10.1074/jbc.M109.041277	http://dx.doi.org/10.1074/jbc.M109.041277			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20159973	Green Published, hybrid			2022-12-25	WOS:000276787100020
J	Nichols, AS; Luetje, CW				Nichols, Andrew S.; Luetje, Charles W.			Transmembrane Segment 3 of Drosophila melanogaster Odorant Receptor Subunit 85b Contributes to Ligand-Receptor Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE TOPOLOGY; MODEL; EXPRESSION; PREDICTION; SYSTEM	The OR class insect odorant receptors are ligand-gated ion channels comprised of at least one common subunit (OR83b in Drosophila) and at least one putative odorant-binding subunit. However, little else is known about the molecular details of insect OR architecture. For example, nothing is known about how these receptors bind odorants, greatly limiting efforts to develop insect OR-targeted compounds for the control of insects involved in disease propagation and agricultural damage. Here we identify a portion of a Drosophila OR that is involved in odorant activation of the receptor. Using the substituted cysteine accessibility method, we identified residues 146150 of OR85b, located at the predicted interface between transmembrane segment 3 (TMS3) and extracellular loop 2 (ECL2), as playing a role in odorant (2-heptanone) activation. We found that occupation of the receptor by the competitive antagonist 2-nonanone protected the receptor from methanethiosulfonate action at position 148, placing this region close to the odorant-binding site. In addition, mutations at positions 142 and 143 within TMS3 altered odorant sensitivity. Our results identify the involvement of the extracellular half of TMS3 in Drosophila OR85b in odorant activation of the receptor. This finding can serve as a starting point for future detailed analysis of the molecular basis for odorant recognition by insect ORs, a novel class of ligand-gated channel.	[Nichols, Andrew S.; Luetje, Charles W.] Univ Miami, Dept Mol & Cellular Pharmacol, Miller Sch Med, Miami, FL 33101 USA	University of Miami	Luetje, CW (corresponding author), Univ Miami, Dept Mol & Cellular Pharmacol, Miller Sch Med, R-189,POB 016189, Miami, FL 33101 USA.	cluetje@med.miami.edu			National Institutes of Health [DC008119, T32 HL07188]; United States Department of Agriculture [2008-35302-18815]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008119, R01DC011091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC008119 (to C. W. L.). This work was also supported by United States Department of Agriculture Grant 2008-35302-18815.; Supported in part by National Institutes of Health Training Grant T32 HL07188.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906	28	59	65	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11854	11862		10.1074/jbc.M109.058321	http://dx.doi.org/10.1074/jbc.M109.058321			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20147286	Green Published, hybrid			2022-12-25	WOS:000276787100013
J	Basha, E; Jones, C; Wysocki, V; Vierling, E				Basha, Eman; Jones, Christopher; Wysocki, Vicki; Vierling, Elizabeth			Mechanistic Differences between Two Conserved Classes of Small Heat Shock Proteins Found in the Plant Cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE ACTIVITY; STRESS PROTEINS; ARABIDOPSIS-THALIANA; CLASS-II; IN-VIVO; COMPLEXES; SUBSTRATE; BINDING; DISSOCIATION; EXPRESSION	The small heat shock proteins (sHSPs) and alpha-crystallins are highly effective, ATP-independent chaperones that can bind denaturing client proteins to prevent their irreversible aggregation. One model of sHSP function suggests that the oligomeric sHSPs are activated to the client-binding form by dissociation at elevated temperatures to dimers or other sub-oligomeric species. Here we examine this model in a comparison of the oligomeric structure and chaperone activity of two conserved classes of cytosolic sHSPs in plants, the class I (CI) and class II (CII) proteins. Like the CI sHSPs, recombinant CII sHSPs from three divergent plant species, pea, wheat, and Arabidopsis, are dodecamers as determined by nano-electrospray mass spectrometry. While at 35 to 45 degrees C, all three CI sHSPs reversibly dissociate to dimers, the CII sHSPs retain oligomeric structure at high temperature. The CII dodecamers are, however, dynamic and rapidly exchange subunits, but unlike CI sHSPs, the exchange unit appears larger than a dimer. Differences in dodecameric structure are also reflected in the fact that the CII proteins do not hetero-oligomerize with CI sHSPs. Binding of the hydrophobic probe bis-ANS and limited proteolysis demonstrate CII proteins undergo significant, reversible structural changes at high temperature. All three recombinant CII proteins more efficiently protect firefly luciferase from insolubilization during heating than do the CI proteins. The CI and CII proteins behave strictly additively in client protection. In total, the results demonstrate that different sHSPs can achieve effective protection of client proteins by varied mechanisms.	[Basha, Eman; Jones, Christopher; Wysocki, Vicki; Vierling, Elizabeth] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Arizona	Vierling, E (corresponding author), Univ Arizona, Dept Chem & Biochem, 1007 E Lowell St, Tucson, AZ 85721 USA.	vierling@u.arizona.edu		Vierling, Elizabeth/0000-0002-0066-4881; Wysocki, Vicki/0000-0003-0495-2538	National Institutes of Health (NIH) [R01 GM42762, 5R01 GM051387]; National Science Foundation (NSF) [IBN-0213128]; NSF DBI [CHE 024447]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042762, R01GM051387] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF DBI(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R01 GM42762 and National Science Foundation (NSF) Grant IBN-0213128 (to E. V.). This work was also supported by NSF DBI Grant CHE 024447 for development of the QToF instrument and NIH Grant 5R01 GM051387 for support of experiments on protein fragmentation (to V. W.).	Basha E, 2004, EUR J BIOCHEM, V271, P1426, DOI 10.1111/j.1432-1033.2004.04033.x; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; CHEN Q, 1994, J BIOL CHEM, V269, P13216; Dafny-Yelin M, 2008, PLANT MOL BIOL, V67, P363, DOI 10.1007/s11103-008-9326-4; Galhena AS, 2008, ANAL CHEM, V80, P1425, DOI 10.1021/ac701782q; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Helm KW, 1997, PLANT PHYSIOL, V114, P1477, DOI 10.1104/pp.114.4.1477; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Kirschner M, 2000, PLANT J, V24, P397, DOI 10.1046/j.1365-313x.2000.00887.x; Koteiche HA, 2003, J BIOL CHEM, V278, P10361, DOI 10.1074/jbc.M211851200; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lee U, 2005, PLANT CELL, V17, P559, DOI 10.1105/tpc.104.027540; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Low D, 2000, PLANTA, V211, P575, DOI 10.1007/s004250000315; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; Painter AJ, 2008, CHEM BIOL, V15, P246, DOI 10.1016/j.chembiol.2008.01.009; Sathish HA, 2003, J BIOL CHEM, V278, P44214, DOI 10.1074/jbc.M307578200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Scharf KD, 2001, CELL STRESS CHAPERON, V6, P225, DOI 10.1379/1466-1268(2001)006<0225:TEFOAT>2.0.CO;2; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Siddique M, 2008, CELL STRESS CHAPERON, V13, P183, DOI 10.1007/s12192-008-0032-6; Sobott F, 2002, J BIOL CHEM, V277, P38921, DOI 10.1074/jbc.M206060200; Sun WN, 2001, PLANT J, V27, P407, DOI 10.1046/j.1365-313X.2001.01107.x; Tripp J, 2009, PLANT CELL ENVIRON, V32, P123, DOI 10.1111/j.1365-3040.2008.01902.x; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Waters ER, 1999, MOL BIOL EVOL, V16, P127, DOI 10.1093/oxfordjournals.molbev.a026033; Weber C, 2008, PLANT J, V56, P517, DOI 10.1111/j.1365-313X.2008.03623.x	32	70	71	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11489	11497		10.1074/jbc.M109.074088	http://dx.doi.org/10.1074/jbc.M109.074088			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145254	Green Published, hybrid			2022-12-25	WOS:000276286200055
J	Cairo, CW; Das, R; Albohy, A; Baca, QJ; Pradhan, D; Morrow, JS; Coombs, D; Golan, DE				Cairo, Christopher W.; Das, Raibatak; Albohy, Amgad; Baca, Quentin J.; Pradhan, Deepti; Morrow, Jon S.; Coombs, Daniel; Golan, David E.			Dynamic Regulation of CD45 Lateral Mobility by the Spectrin-Ankyrin Cytoskeleton of T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SINGLE-PARTICLE TRACKING; TYROSINE-PHOSPHATASE; BINDING DOMAIN; PROTEIN; MEMBRANE; ADHESION; MOLECULES; ERYTHROCYTES; ASSOCIATION	The leukocyte common antigen, CD45, is a critical immune regulator whose activity is modulated by cytoskeletal interactions. Components of the spectrin-ankyrin cytoskeleton have been implicated in the trafficking and signaling of CD45. We have examined the lateral mobility of CD45 in resting and activated T lymphocytes using single-particle tracking and found that the receptor has decreased mobility caused by increased cytoskeletal contacts in activated cells. Experiments with cells that have disrupted beta I spectrin interactions show decreased cytoskeletal contacts in resting cells and attenuation of receptor immobilization in activated cells. Applying two types of population analyses to single-particle tracking trajectories, we find good agreement between the diffusion coefficients obtained using either a mean squared displacement analysis or a hidden Markov model analysis. Hidden Markov model analysis also reveals the rate of association and dissociation of CD45-cytoskeleton contacts, demonstrating the importance of this analysis for measuring cytoskeleton binding events in live cells. Our findings are consistent with a model in which multiple cytoskeletal contacts, including those with spectrin and ankyrin, participate in the regulation of CD45 lateral mobility. These interactions are a major factor in CD45 immobilization in activated cells. Furthermore, cellular activation leads to CD45 immobilization by reduction of the CD45-cytoskeleton dissociation rate. Short peptides that mimic spectrin repeat domains alter the association rate of CD45 to the cytoskeleton and cause an apparent decrease in dissociation rates. We propose a model for CD45-cytoskeleton interactions and conclude that the spectrin-ankyrin-actin network is an essential determinant of immunoreceptor mobility.	[Cairo, Christopher W.; Albohy, Amgad] Univ Alberta, Dept Chem, Alberta Ingenu Ctr Carbohydrate Sci, Edmonton, AB T6G 2G2, Canada; [Das, Raibatak; Coombs, Daniel] Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z2, Canada; [Das, Raibatak; Coombs, Daniel] Univ British Columbia, Inst Appl Math, Vancouver, BC V6T 1Z2, Canada; [Baca, Quentin J.; Golan, David E.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Golan, David E.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Pradhan, Deepti; Morrow, Jon S.] Yale Univ, Dept Pathol, New Haven, CT 06510 USA; [Pradhan, Deepti; Morrow, Jon S.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06510 USA	University of Alberta; University of British Columbia; University of British Columbia; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Yale University; Yale University	Cairo, CW (corresponding author), Univ Alberta, Dept Chem, Alberta Ingenu Ctr Carbohydrate Sci, Edmonton, AB T6G 2G2, Canada.	ccairo@ualberta.ca	Albohy, Amgad/AAK-5421-2021; Cairo, Christopher W/B-5355-2009	Albohy, Amgad/0000-0003-3021-8767; Cairo, Christopher W/0000-0003-3363-8708; Coombs, Daniel/0000-0002-8038-6278; Pradhan, Deepti/0000-0003-3819-275X	National Institutes of Health [DEG R01-HL32854, QJB F31-GM78720, JSM R01-HL28560, R01-DK43812]; Natural Science and Engineering Research Council of Canada; Alberta Ingenuity Centre for Carbohydrate Science; Mathematics of Information Technology and Complex Systems; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032854, R01HL028560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, F31GM078720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity Centre for Carbohydrate Science; Mathematics of Information Technology and Complex Systems; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DEG R01-HL32854, QJB F31-GM78720, JSM R01-HL28560, and R01-DK43812. This work was also supported by funds from the Natural Science and Engineering Research Council of Canada (to C.W.C. and D.C.), the Alberta Ingenuity Centre for Carbohydrate Science (to C.W.C.), and Mathematics of Information Technology and Complex Systems (to D.C. and R.D.).	Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P31, DOI 10.1093/nar/25.1.31; Binz HK, 2006, PROTEINS, V65, P280, DOI 10.1002/prot.20930; Bruyns E, 1995, J BIOL CHEM, V270, P31372; Cairo CW, 2008, BIOPOLYMERS, V89, P409, DOI 10.1002/bip.20898; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Das R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000556; DE M, 2000, J CELL SCI, V113, P2331; Ding Y, 1996, J BIOL CHEM, V271, P22494, DOI 10.1074/jbc.271.37.22494; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Drbal K, 2007, INT IMMUNOL, V19, P675, DOI 10.1093/intimm/dxm032; Earl LA, 2008, IMMUNOL CELL BIOL, V86, P608, DOI 10.1038/icb.2008.46; Geng X, 2005, IMMUNOLOGY, V115, P347, DOI 10.1111/j.1365-2567.2005.02175.x; GOLDMAN SJ, 1992, J BIOL CHEM, V267, P6197; Greer SF, 2001, J IMMUNOL, V166, P7208, DOI 10.4049/jimmunol.166.12.7208; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Higgins D G, 1994, Methods Mol Biol, V25, P307; IIDA N, 1994, J BIOL CHEM, V269, P28576; Ipsaro JJ, 2009, BLOOD, V113, P5385, DOI 10.1182/blood-2008-10-184358; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Karnchanaphanurach P, 2009, J CLIN INVEST, V119, P788, DOI 10.1172/JCI36088; Kodippili GC, 2009, BLOOD, V113, P6237, DOI 10.1182/blood-2009-02-205450; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; LOKESHWAR VB, 1992, J BIOL CHEM, V267, P21551; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; LYNES MA, 1993, CELL IMMUNOL, V151, P65, DOI 10.1006/cimm.1993.1222; Mirchev R, 2001, BLOOD CELL MOL DIS, V27, P143, DOI 10.1006/bcmd.2000.0367; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pradhan D, 2002, IMMUNITY, V17, P303, DOI 10.1016/S1074-7613(02)00396-5; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SCHRAVEN B, 1990, NATURE, V345, P71, DOI 10.1038/345071a0; Stabach PR, 2009, BLOOD, V113, P5377, DOI 10.1182/blood-2008-10-184291; Street M, 2006, J CELL SCI, V119, P1528, DOI 10.1242/jcs.02872; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; ZHANG P, 1995, STRUCTURE, V3, P1185, DOI 10.1016/S0969-2126(01)00254-4; Zhu DM, 2006, ACS CHEM BIOL, V1, P649, DOI 10.1021/cb6002515; Zhu DM, 2007, BIOPHYS J, V92, P1022, DOI 10.1529/biophysj.106.089649	42	33	35	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11392	11401		10.1074/jbc.M109.075648	http://dx.doi.org/10.1074/jbc.M109.075648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20164196	Green Published, hybrid			2022-12-25	WOS:000276286200045
J	Jun, B; Kim, S				Jun, Bokkyoo; Kim, Sunyoung			Real-time Structural Transitions Are Coupled to Chemical Steps in ATP Hydrolysis by Eg5 Kinesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; FTIR DIFFERENCE SPECTROSCOPY; VIBRATIONAL SPECTROSCOPY; SPECTRAL SIGNATURES; PHOSPHATE-BINDING; PROTEIN-STRUCTURE; GAMMA-PHOSPHATE; CATALYTIC SITES; GTP HYDROLYSIS; MONASTROL	At the biochemical level, motor proteins are enzymatic molecules that function by converting chemical energy into mechanical motion. The key element for energy transduction and a major unresolved question common for all motor proteins is the coordination between the chemical and conformational steps in ATP hydrolysis. Here we show time-lapse monitoring of an in vitro ATP hydrolysis reaction by the motor domain of a human Kinesin-5 protein (Eg5) using difference Fourier transform infrared spectroscopy and UV photolysis of caged ATP. In this first continuous observation of a biological reaction coordinate from substrate to product, direct spectral markers for two catalytic events are measured: proton abstraction from nucleophilic water by the catalytic base and formation of the inorganic phosphate leaving group. Simultaneous examination of conformational switching in Eg5, in parallel with catalytic steps, shows structural transitions in solution consistent with published crystal structures of the prehydrolytic and ADP-bound states. In addition, we detect structural modifications in the Eg5 motor domain during bond cleavage between the beta- and gamma-phosphates of ATP. This conclusion challenges mechanochemical models for motor proteins that utilize only two stages of the catalytic cycle to drive force and motion.	[Jun, Bokkyoo; Kim, Sunyoung] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Kim, S (corresponding author), 1901 Perdido St, New Orleans, LA 70112 USA.	skim3@lsuhsc.edu			Louisiana Board of Regents	Louisiana Board of Regents	This work was supported by a grant from the Louisiana Board of Regents (to S. K.).	Ahmad Z, 2004, J BIOL CHEM, V279, P46057, DOI 10.1074/jbc.M407608200; Allin C, 2001, BIOCHEMISTRY-US, V40, P3037, DOI 10.1021/bi0017024; Asmis KR, 2003, SCIENCE, V299, P1375, DOI 10.1126/science.1081634; Baer M, 2008, CHEMPHYSCHEM, V9, P2703, DOI 10.1002/cphc.200800473; Barth A, 1996, J BIOL CHEM, V271, P30637, DOI 10.1074/jbc.271.48.30637; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; BRAIMAN MS, 1987, P NATL ACAD SCI USA, V84, P5221, DOI 10.1073/pnas.84.15.5221; Cepus V, 1998, Methods Enzymol, V291, P223; Cheng H, 2002, J AM CHEM SOC, V124, P11295, DOI 10.1021/ja026481z; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; DeBonis S, 2003, BIOCHEMISTRY-US, V42, P338, DOI 10.1021/bi026716j; Dittrich M, 2004, BIOPHYS J, V87, P2954, DOI 10.1529/biophysj.104.046128; Du XL, 2000, J BIOL CHEM, V275, P8492, DOI 10.1074/jbc.275.12.8492; FABIAN H, 2000, ENCY ANAL CHEM, P5779; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; Goormaghtigh E, 1994, Subcell Biochem, V23, P329; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Learman SS, 2009, BIOCHEMISTRY-US, V48, P1754, DOI 10.1021/bi801291q; Li GH, 2004, J PHYS CHEM B, V108, P3342, DOI 10.1021/jp0371783; Liu M, 2002, BIOPOLYMERS, V67, P267, DOI 10.1002/bip.10113; Maliga Z, 2002, CHEM BIOL, V9, P989, DOI 10.1016/S1074-5521(02)00212-0; Mathias G, 2007, P NATL ACAD SCI USA, V104, P6980, DOI 10.1073/pnas.0609229104; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; PRESTRELSKI SJ, 1991, INT J PEPT PROT RES, V37, P508; Scheidig AJ, 1999, STRUCTURE, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; White EM, 2008, BIOCHEMISTRY-US, V47, P84, DOI 10.1021/bi701723c; Wojcik EJ, 2004, BIOCHEMISTRY-US, V43, P9939, DOI 10.1021/bi048982y; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074	32	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11073	11077		10.1074/jbc.C110.103762	http://dx.doi.org/10.1074/jbc.C110.103762			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154092	Green Published, hybrid			2022-12-25	WOS:000276286200010
J	Manfrini, N; Guerini, I; Citterio, A; Lucchini, G; Longhese, MP				Manfrini, Nicola; Guerini, Ilaria; Citterio, Andrea; Lucchini, Giovanna; Longhese, Maria Pia			Processing of Meiotic DNA Double Strand Breaks Requires Cyclin-dependent Kinase and Multiple Nucleases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUDDING YEAST SAE2; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; END RESECTION; CHROMOSOME SEGREGATION; DAMAGE RESPONSE; HUMAN CTIP; MEIOSIS; REPAIR	Meiotic recombination requires the formation of programmed Spo11-dependent DNA double strand breaks (DSBs). In Saccharomyces cerevisiae, the Sae2 protein and the Mre11-Rad50-Xrs2 complex are necessary to remove the covalently attached Spo11 protein from the DNA ends, which are then resected by so far unknown nucleases. Here, we demonstrate that phosphorylation of Sae2 Ser-267 by cyclin-dependent kinase 1 (Cdk1) is required to initiate meiotic DSB resection by allowing Spo11 removal from DSB ends. This finding suggests that Cdk1 activity is required for the processing of Spo11-induced DSBs, thus providing a mechanism for coordinating DSB resection with progression through meiotic prophase. Furthermore, the helicase Sgs1 and the nucleases Exo1 and Dna2 participate in lengthening the 5'-3' resection tracts during meiosis by controlling a step subsequent to Spo11 removal.	[Manfrini, Nicola; Guerini, Ilaria; Citterio, Andrea; Lucchini, Giovanna; Longhese, Maria Pia] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, I-20126 Milan, Italy	University of Milano-Bicocca	Longhese, MP (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy.	mariapia.longhese@unimib.it	Manfrini, Nicola/A-1371-2019; Pia, Maria/AAK-2693-2020; Citterio, Andrea/K-4379-2016	Citterio, Andrea/0000-0003-4462-5646; Longhese, Maria Pia/0000-0003-1726-2034	Ministero dell'Universita et della Ricerca/Universita di Milano-Bicocca; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Ministero dell'Universita et della Ricerca/Universita di Milano-Bicocca; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from Associazione Italiana Ricerca sul Cancro and Cofinanziamento 2008 Ministero dell'Universita et della Ricerca/Universita di Milano-Bicocca (to M. P. L.).	ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Baroni E, 2004, MOL CELL BIOL, V24, P4151, DOI 10.1128/MCB.24.10.4151-4165.2004; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bonetti D, 2009, MOL CELL, V35, P70, DOI 10.1016/j.molcel.2009.05.015; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Cartagena-Lirola H, 2006, CELL CYCLE, V5, P1549, DOI 10.4161/cc.5.14.2916; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Longhese MP, 2009, DNA REPAIR, V8, P1127, DOI 10.1016/j.dnarep.2009.04.005; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; McKee AHZ, 1997, GENETICS, V146, P797; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moreau S, 1999, MOL CELL BIOL, V19, P556; Murakami H, 2003, NUCLEIC ACIDS RES, V31, P4085, DOI 10.1093/nar/gkg441; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Prieler S, 2005, GENE DEV, V19, P255, DOI 10.1101/gad.321105; Prinz S, 1997, GENETICS, V146, P781; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Viscardi V, 2007, MOL BIOL CELL, V18, P3047, DOI 10.1091/mbc.E07-03-0285; Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	38	39	42	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11628	11637		10.1074/jbc.M110.104083	http://dx.doi.org/10.1074/jbc.M110.104083			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20150422	Green Published, hybrid			2022-12-25	WOS:000276286200068
J	Mir, MA; Sheema, S; Haseeb, A; Haque, A				Mir, Mohammad A.; Sheema, Sheema; Haseeb, Abdul; Haque, Absarul			Hantavirus Nucleocapsid Protein Has Distinct m(7)G Cap- and RNA-binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-INDUCED ACTIVATION; HARE BUNYAVIRUS S; VIRUS N-PROTEIN; MESSENGER-RNA; 5 ENDS; P-PROTEINS; RECOGNITION; TRANSCRIPTION; GENOME; POLYMERASE	Hantaviruses, members of the Bunyaviridae family, are emerging category A pathogens that carry three negative stranded RNA molecules as their genome. Hantavirus nucleocapsid protein (N) is encoded by the smallest S segment genomic RNA(viral RNA). N specifically binds mRNA caps and requires four nucleotides adjacent to the cap for high affinity binding. We show that the N peptide has distinct cap-and RNA-binding sites that independently interact with mRNA cap and viral genomic RNA, respectively. In addition, N can simultaneously bind with both mRNA cap and vRNA. N undergoes distinct conformational changes after binding with either mRNA cap or vRNA or both mRNA cap and vRNA simultaneously. Hantavirus RNA-dependent RNA polymerase (RdRp) uses a capped RNA primer for transcription initiation. The capped RNA primer is generated from host cell mRNA by the cap-snatching mechanism and is supposed to anneal with the 3' terminus of vRNA template during transcription initiation by single G-C base pairing. We show that the capped RNA primer binds at the cap-binding site and induces a conformational change in N. The conformationally altered N with a capped primer loaded at the cap-binding site specifically binds the conserved 3' nine nucleotides of vRNA and assists the bound primer to anneal at the 3' terminus. We suggest that the cap-binding site of N, in conjunction with RdRp, plays a key role during the transcription and replication initiation of vRNA genome.	[Mir, Mohammad A.; Sheema, Sheema; Haseeb, Abdul; Haque, Absarul] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Mir, MA (corresponding author), 4022 Orr Major,3901 Rainbow Blvd, Kansas City, KS 66103 USA.	mmir@kumc.edu	HAQUE, ABSARUL/H-9610-2012; Haseeb, Abdul/Q-2788-2015; Haseeb, Abdul/I-5278-2017	Haseeb, Abdul/0000-0002-2623-1275; Mir, Sheema/0000-0001-7279-8734	National Institutes of Health [RAI083672Z]; Department of Microbiology, Molecular Genetics and Immunology, Kansas University Medical Center [P20 RR016443]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology, Molecular Genetics and Immunology, Kansas University Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Research Grant RAI083672Z. This work was also supported by COBRE Grant P20 RR016443 from the Department of Microbiology, Molecular Genetics and Immunology, Kansas University Medical Center.	Alfadhli A, 2002, J BIOL CHEM, V277, P27103, DOI 10.1074/jbc.M203395200; Alfadhli A, 2001, J VIROL, V75, P2019, DOI 10.1128/JVI.75.4.2019-2023.2001; BISHOP DHL, 1983, NUCLEIC ACIDS RES, V11, P6409, DOI 10.1093/nar/11.18.6409; Blakqori G, 2003, J GEN VIROL, V84, P1207, DOI 10.1099/vir.0.18876-0; Botten J, 2000, P NATL ACAD SCI USA, V97, P10578, DOI 10.1073/pnas.180197197; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; BOULOY M, 1990, VIROLOGY, V175, P50, DOI 10.1016/0042-6822(90)90185-T; BRAAM J, 1983, CELL, V34, P609; Bridgen A, 1996, P NATL ACAD SCI USA, V93, P15400, DOI 10.1073/pnas.93.26.15400; Cai A, 1999, BIOCHEMISTRY-US, V38, P8538, DOI 10.1021/bi9830213; CATON AJ, 1980, NUCLEIC ACIDS RES, V8, P2591, DOI 10.1093/nar/8.12.2591; DHAR R, 1980, CELL, V21, P495, DOI 10.1016/0092-8674(80)90486-9; Duijsings D, 2001, EMBO J, V20, P2545, DOI 10.1093/emboj/20.10.2545; ESHITA Y, 1985, J VIROL, V55, P681, DOI 10.1128/JVI.55.3.681-689.1985; GARCIN D, 1995, J VIROL, V69, P5754, DOI 10.1128/JVI.69.9.5754-5762.1995; GOTT P, 1993, VIROLOGY, V194, P332, DOI 10.1006/viro.1993.1263; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hodel AE, 1997, NAT STRUCT BIOL, V4, P350, DOI 10.1038/nsb0597-350; Hooker L, 2003, BIOCHEMISTRY-US, V42, P6234, DOI 10.1021/bi027081r; Hu GH, 1999, P NATL ACAD SCI USA, V96, P7149, DOI 10.1073/pnas.96.13.7149; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; JIN H, 1993, J GEN VIROL, V74, P2293, DOI 10.1099/0022-1317-74-10-2293; JIN H, 1993, J VIROL, V67, P1396, DOI 10.1128/JVI.67.3.1396-1404.1993; Jonsson CB, 2001, CURR TOP MICROBIOL, V256, P15; Jonsson CB, 2001, PROTEIN EXPRES PURIF, V23, P134, DOI 10.1006/prep.2001.1489; Kohl A, 2004, J VIROL, V78, P5679, DOI 10.1128/JVI.78.11.5679-5685.2004; Lakowitcz J.R, 1999, PRINCIPLES FLUORESCE, P237, DOI DOI 10.1007/978-1-4757-3061-6_8; Lockless SW, 1998, BIOCHEMISTRY-US, V37, P8564, DOI 10.1021/bi980178m; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Mazza C, 2001, MOL CELL, V8, P383, DOI 10.1016/S1097-2765(01)00299-4; Mir MA, 2006, J VIROL, V80, P11283, DOI 10.1128/JVI.00820-06; Mir MA, 2008, P NATL ACAD SCI USA, V105, P19294, DOI 10.1073/pnas.0807211105; Mir MA, 2006, RNA, V12, P272, DOI 10.1261/rna.2101906; Mir MA, 2005, J VIROL, V79, P1824, DOI 10.1128/JVI.79.3.1824-1835.2005; Mir MA, 2004, J VIROL, V78, P8281, DOI 10.1128/jvi.78.15.8281-8288.2004; Mir MA, 2001, BIOCHEMISTRY-US, V40, P11578, DOI 10.1021/bi010731r; Mir MA, 2008, EMBO J, V27, P3129, DOI 10.1038/emboj.2008.228; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; OBIJESKI JF, 1976, J VIROL, V19, P985, DOI 10.1128/JVI.19.3.985-997.1976; Osborne JC, 2000, J VIROL, V74, P9946, DOI 10.1128/JVI.74.21.9946-9952.2000; Padmanabhan U, 2001, J BIOL CHEM, V276, P43635, DOI 10.1074/jbc.M107531200; PATTERSON JL, 1984, J VIROL, V52, P215, DOI 10.1128/JVI.52.1.215-222.1984; PATTERSON JL, 1984, J VIROL, V49, P680, DOI 10.1128/JVI.49.3.680-685.1984; PETTERSSON RF, 1975, J VIROL, V15, P386, DOI 10.1128/JVI.15.2.386-392.1975; Pinschewer DD, 2003, J VIROL, V77, P3882, DOI 10.1128/JVI.77.6.3882-3887.2003; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; RAJU R, 1987, J VIROL, V61, P667, DOI 10.1128/JVI.61.3.667-672.1987; RAJU R, 1986, VIRUS RES, V5, P1, DOI 10.1016/0168-1702(86)90061-4; RAJU R, 1989, J VIROL, V63, P122, DOI 10.1128/JVI.63.1.122-128.1989; RAJU R, 1990, VIROLOGY, V174, P53, DOI 10.1016/0042-6822(90)90053-T; Schmaljohn C, 2001, FIELDS VIROLOGY, P1581; Schmidt R. R., 1996, FRONT NAT PROD RES, V1, P20, DOI DOI 10.1002/chin.199736318; Severson W, 2005, J VIROL, V79, P10032, DOI 10.1128/JVI.79.15.10032-10039.2005; Severson W, 1999, J BIOL CHEM, V274, P33732, DOI 10.1074/jbc.274.47.33732; Severson WE, 2001, J VIROL, V75, P2646, DOI 10.1128/JVI.75.6.2646-2652.2001; SIMONS JF, 1991, J VIROL, V65, P4741, DOI 10.1128/JVI.65.9.4741-4748.1991; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Taylor SL, 2009, ANN NY ACAD SCI, V1171, pE86, DOI 10.1111/j.1749-6632.2009.05049.x; Taylor SL, 2009, J VIROL, V83, P1271, DOI 10.1128/JVI.00986-08; ULMANEN I, 1981, P NATL ACAD SCI-BIOL, V78, P7355, DOI 10.1073/pnas.78.12.7355; WANG JL, 1971, J BIOL CHEM, V246, P1185; Wilson KF, 1999, J BIOL CHEM, V274, P4166, DOI 10.1074/jbc.274.7.4166; Xu XL, 2002, J VIROL, V76, P3301, DOI 10.1128/JVI.76.7.3301-3308.2002	63	37	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11357	11368		10.1074/jbc.M110.102459	http://dx.doi.org/10.1074/jbc.M110.102459			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20164193	Green Published, hybrid			2022-12-25	WOS:000276286200042
J	Srivastava, R; Burbach, BJ; Shimizu, Y				Srivastava, Rupa; Burbach, Brandon J.; Shimizu, Yoji			NF-kappa B Activation in T Cells Requires Discrete Control of I kappa B Kinase alpha/beta (IKK alpha/beta) Phosphorylation and IKK gamma Ubiquitination by the ADAP Adapter Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARMA1; TAK1; ANTIGEN; COMPLEX; MALT1; BCL10; TCR; ASSOCIATION; PLAYS	NF-kappa B activation following engagement of the antigen-specific T cell receptor involves protein kinase C-theta-dependent assembly of the CARMA1-BCL10-MALT1 (CBM) signalosome, which coordinates downstream activation of I kappa B kinase (IKK). We previously identified a novel role for the adhesion- and degranulation-promoting adapter protein (ADAP) in regulating the assembly of the CBM complex via an interaction of ADAP with CARMA1. In this study, we identify a novel site in ADAP that is critical for association with the TAK1 kinase. ADAP is critical for recruitment of TAK1 and the CBM complex, but not IKK, to protein kinase C-theta. ADAP is not required for TAK1 activation. Although both the TAK1 and the CARMA1 binding sites in ADAP are essential for I kappa B alpha phosphorylation and degradation and NF-kappa B nuclear translocation, only the TAK1 binding site in ADAP is necessary for IKK phosphorylation. In contrast, only the CARMA1 binding site in ADAP is required for ubiquitination of IKK gamma. Thus, distinct sites within ADAP control two key activation responses that are required for NF-kappa B activation in T cells.	[Srivastava, Rupa; Burbach, Brandon J.; Shimizu, Yoji] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Mason Canc Ctr,Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Shimizu, Y (corresponding author), Campus Code 2641,Rm 2-110 MBB,2101 6th St SE, Minneapolis, MN 55414 USA.	shimi002@umn.edu		Burbach, Brandon/0000-0003-0922-7722; Shimizu, Yoji/0000-0001-9760-0288	National Institutes of Health [R01 AI038474]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038474, R01AI031126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI038474 (to Y. S.).	Burbach BJ, 2008, J IMMUNOL, V181, P4840, DOI 10.4049/jimmunol.181.7.4840; Fostel LV, 2006, INT IMMUNOL, V18, P1305, DOI 10.1093/intimm/dxl063; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hurez Vincent, 2002, BMC Immunol, V3, P4, DOI 10.1186/1471-2172-3-4; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Medeiros RB, 2005, IMMUNITY, V23, P213, DOI 10.1016/j.immuni.2005.07.006; Medeiros RB, 2007, SCIENCE, V316, P754, DOI 10.1126/science.1137895; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	25	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11100	11105		10.1074/jbc.M109.068999	http://dx.doi.org/10.1074/jbc.M109.068999			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20164171	Green Published, hybrid			2022-12-25	WOS:000276286200014
J	Houshdaran, S; Hawley, S; Palmer, C; Campan, M; Olsen, MN; Ventura, AP; Knudsen, BS; Drescher, CW; Urban, ND; Brown, PO; Laird, PW				Houshdaran, Sahar; Hawley, Sarah; Palmer, Chana; Campan, Mihaela; Olsen, Mari N.; Ventura, Aviva P.; Knudsen, Beatrice S.; Drescher, Charles W.; Urban, Nicole D.; Brown, Patrick O.; Laird, Peter W.			DNA Methylation Profiles of Ovarian Epithelial Carcinoma Tumors and Cell Lines	PLOS ONE			English	Article							BRCA1 PROMOTER REGION; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; ESOPHAGEAL ADENOCARCINOMA; DRUG-RESISTANCE; CANCER-PATIENTS; X-INACTIVATION; CPG-ISLANDS; XIST GENE; IN-VITRO	Background: Epithelial ovarian carcinoma is a significant cause of cancer mortality in women worldwide and in the United States. Epithelial ovarian cancer comprises several histological subtypes, each with distinct clinical and molecular characteristics. The natural history of this heterogeneous disease, including the cell types of origin, is poorly understood. This study applied recently developed methods for high-throughput DNA methylation profiling to characterize ovarian cancer cell lines and tumors, including representatives of three major histologies. Methodology/Principal Findings: We obtained DNA methylation profiles of 1,505 CpG sites (808 genes) in 27 primary epithelial ovarian tumors and 15 ovarian cancer cell lines. We found that the DNA methylation profiles of ovarian cancer cell lines were markedly different from those of primary ovarian tumors. Aggregate DNA methylation levels of the assayed CpG sites tended to be higher in ovarian cancer cell lines relative to ovarian tumors. Within the primary tumors, those of the same histological type were more alike in their methylation profiles than those of different subtypes. Supervised analyses identified 90 CpG sites (68 genes) that exhibited 'subtype-specific' DNA methylation patterns (FDR, 1%) among the tumors. In ovarian cancer cell lines, we estimated that for at least 27% of analyzed autosomal CpG sites, increases in methylation were accompanied by decreases in transcription of the associated gene. Significance: The significant difference in DNA methylation profiles between ovarian cancer cell lines and tumors underscores the need to be cautious in using cell lines as tumor models for molecular studies of ovarian cancer and other cancers. Similarly, the distinct methylation profiles of the different histological types of ovarian tumors reinforces the need to treat the different histologies of ovarian cancer as different diseases, both clinically and in biomarker studies. These data provide a useful resource for future studies, including those of potential tumor progenitor cells, which may help illuminate the etiology and natural history of these cancers.	[Houshdaran, Sahar; Campan, Mihaela; Laird, Peter W.] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Hawley, Sarah; Palmer, Chana] Canary Fdn, Palo Alto, CA USA; [Campan, Mihaela; Laird, Peter W.] Univ So Calif, Dept Surg, Los Angeles, CA USA; [Olsen, Mari N.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Ventura, Aviva P.; Knudsen, Beatrice S.; Drescher, Charles W.; Urban, Nicole D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Laird, Peter W.] Univ So Calif, Univ So Calif Epigenome Ctr, Los Angeles, CA USA	University of Southern California; University of Southern California; Stanford University; Fred Hutchinson Cancer Center; University of Southern California	Houshdaran, S (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.	plaird@usc.edu	Laird, Peter W/G-8683-2012	Laird, Peter W/0000-0001-9117-3641	Canary Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P50CA083636, R01CA096958] Funding Source: NIH RePORTER	Canary Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a generous contribution from the Canary Foundation and by the Howard Hughes Medical Institute. The authors thank Don Listwin, founder of the Canary Foundation, for his continuing support and encouragement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2001, GYNECOL ONCOL, V82, P261, DOI 10.1006/gyno.2001.6291; [Anonymous], 2008, R LANGUAGE ENV STAT; Baldwin RL, 2000, CANCER RES, V60, P5329; Barr H, 2007, MOL CELL BIOL, V27, P3750, DOI 10.1128/MCB.02204-06; Barton CA, 2008, GYNECOL ONCOL, V109, P129, DOI 10.1016/j.ygyno.2007.12.017; BEHRENS BC, 1987, CANCER RES, V47, P414; BENARD J, 1985, CANCER RES, V45, P4970; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Boumil RM, 2006, MOL CELL BIOL, V26, P2109, DOI 10.1128/MCB.26.6.2109-2117.2006; Brock MV, 2003, CLIN CANCER RES, V9, P2912; Brown PO, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000114; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; BUICK RN, 1985, CANCER RES, V45, P3668; Campan Mihhaela, 2009, V507, P325, DOI 10.1007/978-1-59745-522-0_23; Catteau A, 1999, ONCOGENE, V18, P1957, DOI 10.1038/sj.onc.1202509; Cheng P, 1997, BRIT J CANCER, V75, P396, DOI 10.1038/bjc.1997.64; Chiang JW, 2006, GYNECOL ONCOL, V101, P403, DOI 10.1016/j.ygyno.2005.10.034; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; DISAIA PJ, 1972, AM J OBSTET GYNECOL, V114, P979, DOI 10.1016/0002-9378(72)90109-3; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Esteller M, 1999, CANCER RES, V59, P67; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fleischhacker M, 1999, Eur J Med Res, V4, P488; Fogh J., 1975, HUMAN TUMOR CELLS IN, VVolume 1, P115, DOI [10.1007/978-1-4757-1647-4_5, DOI 10.1007/978-1-4757-1647-4_5]; Furlong MT, 1999, J NATL CANCER I, V91, P1327, DOI 10.1093/jnci/91.15.1327; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goessl C, 2000, CANCER RES, V60, P5941; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hough CD, 2000, CANCER RES, V60, P6281; Houshdaran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001289; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Katari S, 2009, HUM MOL GENET, V18, P3769, DOI 10.1093/hmg/ddp319; Kawakami K, 2000, J NATL CANCER I, V92, P1805, DOI 10.1093/jnci/92.22.1805; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; LAU DHM, 1991, CANCER RES, V51, P5181; LEON SA, 1977, CANCER RES, V37, P646; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lowe KA, 2008, CANCER EPIDEM BIOMAR, V17, P2480, DOI 10.1158/1055-9965.EPI-08-0150; Lutz AM, 2008, PLOS MED, V5, P1287, DOI 10.1371/journal.pmed.0050170; Martinez R, 2009, EPIGENETICS-US, V4, P255, DOI 10.4161/epi.9130; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Pike BL, 2008, LEUKEMIA, V22, P1035, DOI 10.1038/leu.2008.18; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Roman-Gomez J, 2004, BLOOD, V104, P2492, DOI 10.1182/blood-2004-03-0954; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SCHILDER RJ, 1990, INT J CANCER, V45, P416, DOI 10.1002/ijc.2910450306; Shen Y, 2006, HUM MOL GENET, V15, P2623, DOI 10.1093/hmg/ddl188; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Strathdee G, 1999, ONCOGENE, V18, P2335, DOI 10.1038/sj.onc.1202540; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Weisenberger DJ, 2008, NUCLEIC ACIDS RES, V36, P4689, DOI 10.1093/nar/gkn455; WOLF CR, 1987, INT J CANCER, V39, P695, DOI 10.1002/ijc.2910390607; Wong IHN, 2000, CLIN CANCER RES, V6, P3516; Wong W, 1999, PC WEEK, V16, P73; Yu YH, 1999, P NATL ACAD SCI USA, V96, P214, DOI 10.1073/pnas.96.1.214; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508; ZUCCOTTI M, 1995, NAT GENET, V9, P316, DOI 10.1038/ng0395-316; 2009, STANFORD MICROARRAY; 2000, STANFORD FUNCTIONAL	69	72	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9359	10.1371/journal.pone.0009359	http://dx.doi.org/10.1371/journal.pone.0009359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179752	Green Published, gold, Green Submitted			2022-12-25	WOS:000274923900020
J	Timsit, Y; Varnai, P				Timsit, Youri; Varnai, Peter			Helical Chirality: a Link between Local Interactions and Global Topology in DNA	PLOS ONE			English	Article							POSITIVELY SUPERCOILED DNA; COLI TOPOISOMERASE-IV; II TOPOISOMERASES; ESCHERICHIA-COLI; STRUCTURAL BASIS; REVERSE GYRASE; NUCLEIC-ACIDS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; CHROMATIN FIBER	DNA supercoiling plays a major role in many cellular functions. The global DNA conformation is however intimately linked to local DNA-DNA interactions influencing both the physical properties and the biological functions of the supercoiled molecule. Juxtaposition of DNA double helices in ubiquitous crossover arrangements participates in multiple functions such as recombination, gene regulation and DNA packaging. However, little is currently known about how the structure and stability of direct DNA-DNA interactions influence the topological state of DNA. Here, a crystallographic analysis shows that due to the intrinsic helical chirality of DNA, crossovers of opposite handedness exhibit markedly different geometries. While right-handed crossovers are self-fitted by sequence-specific groove-backbone interaction and bridging Mg2+ sites, lefthanded crossovers are juxtaposed by groove-groove interaction. Our previous calculations have shown that the different geometries result in differential stabilisation in solution, in the presence of divalent cations. The present study reveals that the various topological states of the cell are associated with different inter-segmental interactions. While the unstable lefthanded crossovers are exclusively formed in negatively supercoiled DNA, stable right-handed crossovers constitute the local signature of an unusual topological state in the cell, such as the positively supercoiled or relaxed DNA. These findings not only provide a simple mechanism for locally sensing the DNA topology but also lead to the prediction that, due to their different tertiary intra-molecular interactions, supercoiled molecules of opposite signs must display markedly different physical properties. Sticky inter-segmental interactions in positively supercoiled or relaxed DNA are expected to greatly slow down the slithering dynamics of DNA. We therefore suggest that the intrinsic helical chirality of DNA may have oriented the early evolutionary choices for DNA topology.	[Timsit, Youri] CNRS, UPR2589, Inst Microbiol Mediterranee, Marseille, France; [Varnai, Peter] Univ Sussex, Sch Life Sci, Dept Chem & Biochem, Brighton, E Sussex, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Sussex	Timsit, Y (corresponding author), CNRS, UPR2589, Inst Microbiol Mediterranee, Parc Sci Luminy, Marseille, France.	Youri.Timsit@igs.cnrs-mrs.fr	Varnai, Peter/A-6870-2012; Timsit, Youri/AAL-2412-2021	Timsit, Youri/0000-0003-0601-7201; Varnai, Peter/0000-0003-4267-4671	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by grants to Y.T. from the Centre National de la Recherche Scientifique (CNRS) and the Agence Nationale de la Recherche (ANR) programme blanc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankhead T, 2006, MOL MICROBIOL, V62, P895, DOI 10.1111/j.1365-2958.2006.05423.x; Benham CJ, 2005, ANNU REV BIOMED ENG, V7, P21, DOI 10.1146/annurev.bioeng.6.062403.132016; BERMAN HM, 1992, BIOPHYS J, V63, P751, DOI 10.1016/S0006-3495(92)81649-1; Brochier-Armanet Celine, 2007, Archaea, V2, P83; CHARBONNIER F, 1994, J BACTERIOL, V176, P1251, DOI 10.1128/jb.176.5.1251-1259.1994; Charvin G, 2003, P NATL ACAD SCI USA, V100, P9820, DOI 10.1073/pnas.1631550100; Cherny DI, 2001, J MOL BIOL, V313, P295, DOI 10.1006/jmbi.2001.5031; Corbett KD, 2005, J MOL BIOL, V351, P545, DOI 10.1016/j.jmb.2005.06.029; Corbett KD, 2007, NAT STRUCT MOL BIOL, V14, P611, DOI 10.1038/nsmb1264; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Crisona NJ, 2000, GENE DEV, V14, P2881, DOI 10.1101/gad.838900; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Eichman BF, 2002, J MOL BIOL, V320, P1037, DOI 10.1016/S0022-2836(02)00540-5; Espeli O, 2004, MOL MICROBIOL, V52, P925, DOI 10.1111/j.1365-2958.2004.04047.x; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; Forterre P, 2009, NUCLEIC ACIDS RES, V37, P679, DOI 10.1093/nar/gkp032; Graille M, 2008, STRUCTURE, V16, P360, DOI 10.1016/j.str.2007.12.020; Guipaud O, 1997, P NATL ACAD SCI USA, V94, P10606, DOI 10.1073/pnas.94.20.10606; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inoue S, 2007, BIOCHEMISTRY-US, V46, P164, DOI 10.1021/bi061539y; Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683; KANAAR R, 1992, CURR OPIN STRUC BIOL, V2, P369, DOI DOI 10.1016/0959-440X(92)90227-X; Katritch V, 1996, NATURE, V384, P142, DOI 10.1038/384142a0; Kornyshev AA, 2007, REV MOD PHYS, V79, P943, DOI 10.1103/RevModPhys.79.943; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Liu ZR, 2006, J MOL BIOL, V361, P268, DOI 10.1016/j.jmb.2006.06.005; Lopez-Garcia P, 1999, J MOL EVOL, V49, P439, DOI 10.1007/PL00006567; Lopez-Garcia P, 2000, J BACTERIOL, V182, P4998, DOI 10.1128/JB.182.17.4998-5000.2000; MARGUET E, 1994, NUCLEIC ACIDS RES, V22, P1681, DOI 10.1093/nar/22.9.1681; MARKO JF, 1995, PHYS REV E, V52, P2912, DOI 10.1103/PhysRevE.52.2912; McClendon AK, 2005, J BIOL CHEM, V280, P39337, DOI 10.1074/jbc.M503320200; Minsky A, 2004, ANNU REV BIOPH BIOM, V33, P317, DOI 10.1146/annurev.biophys.33.110502.133328; Neuman KC, 2009, P NATL ACAD SCI USA, V106, P6986, DOI 10.1073/pnas.0900574106; Nollmann M, 2007, NAT STRUCT MOL BIOL, V14, P264, DOI 10.1038/nsmb1213; Olson WK, 2000, CURR OPIN STRUC BIOL, V10, P286, DOI 10.1016/S0959-440X(00)00086-5; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Pulleyblank DE, 1997, SCIENCE, V277, P648, DOI 10.1126/science.277.5326.648; Qiu XY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.038104; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Rybenkov VV, 1997, SCIENCE, V277, P690, DOI 10.1126/science.277.5326.690; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; SCHLICK T, 1992, SCIENCE, V257, P1110, DOI 10.1126/science.257.5073.1110; Shaw SY, 1997, P NATL ACAD SCI USA, V94, P1692, DOI 10.1073/pnas.94.5.1692; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P263, DOI 10.1016/S0304-3991(03)00051-2; Shlyakhtenko LS, 2000, J MOL BIOL, V296, P1169, DOI 10.1006/jmbi.2000.3542; Stasiak A, 1996, NATURE, V384, P122, DOI 10.1038/384122a0; Stone MD, 2003, P NATL ACAD SCI USA, V100, P8654, DOI 10.1073/pnas.1133178100; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; Stuchinskaya T, 2009, J MOL BIOL, V385, P1397, DOI 10.1016/j.jmb.2008.11.056; Stupina VA, 2004, P NATL ACAD SCI USA, V101, P8608, DOI 10.1073/pnas.0402849101; Tan ZJ, 2006, NUCLEIC ACIDS RES, V34, P6629, DOI 10.1093/nar/gkl810; TIMSIT Y, 1994, EMBO J, V13, P2737, DOI 10.1002/j.1460-2075.1994.tb06567.x; Timsit Y, 1999, J BIOMOL STRUCT DYN, V16, P775, DOI 10.1080/07391102.1999.10508292; TIMSIT Y, 1989, NATURE, V341, P459, DOI 10.1038/341459a0; TIMSIT Y, 1991, NATURE, V354, P167, DOI 10.1038/354167a0; Timsit Y, 1996, Q REV BIOPHYS, V29, P279, DOI 10.1017/S0033583500005862; TIMSIT Y, 1991, J MOL BIOL, V221, P919, DOI 10.1016/0022-2836(91)80184-V; Travers AA, 2004, PHILOS T R SOC A, V362, P1423, DOI 10.1098/rsta.2004.1390; Travers A, 2007, EMBO REP, V8, P147, DOI 10.1038/sj.embor.7400898; Trigueros S, 2004, J MOL BIOL, V335, P723, DOI 10.1016/j.jmb.2003.11.011; VARNAI P, 2010, NUCL ACIDS IN PRESS; Vetcher AA, 2002, J BIOL CHEM, V277, P39228, DOI 10.1074/jbc.M205210200; Vologodskii A, 1996, BIOPHYS J, V70, P2548, DOI 10.1016/S0006-3495(96)79826-0; VOLOGODSKII AV, 1994, ANNU REV BIOPH BIOM, V23, P609, DOI 10.1146/annurev.bb.23.060194.003141; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wong H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000877; Xu YC, 1997, NUCLEIC ACIDS RES, V25, P4067, DOI 10.1093/nar/25.20.4067; Yan J, 1999, NATURE, V401, P932, DOI 10.1038/44872; Zakharova SS, 2002, BIOPHYS J, V83, P1106, DOI 10.1016/S0006-3495(02)75234-X; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	74	31	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9326	10.1371/journal.pone.0009326	http://dx.doi.org/10.1371/journal.pone.0009326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174470	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000274923700024
J	MacLean, D; Studholme, DJ				MacLean, Daniel; Studholme, David J.			A Boolean Model of the Pseudomonas syringae hrp Regulon Predicts a Tightly Regulated System	PLOS ONE			English	Article							III PROTEIN SECRETION; PV. TOMATO DC3000; 2-COMPONENT SYSTEM; NETWORK MODEL; EXPRESSION; GENES; HRPX/HRPY; CASCADE; ACTS	The Type III secretion system (TTSS) is a protein secretion machinery used by certain gram-negative bacterial pathogens of plants and animals to deliver effector molecules to the host and is at the core of the ability to cause disease. Extensive molecular and biochemical study has revealed the components and their interactions within this system but reductive approaches do not consider the dynamical properties of the system as a whole. In order to gain a better understanding of these dynamical behaviours and to create a basis for the refinement of the experimentally derived knowledge we created a Boolean model of the regulatory interactions within the hrp regulon of Pseudomonas syringae pathovar tomato strain DC3000 Pseudomonas syringae. We compared simulations of the model with experimental data and found them to be largely in accordance, though the hrpV node shows some differences in state changes to that expected. Our simulations also revealed interesting dynamical properties not previously predicted. The model predicts that the hrp regulon is a biologically stable two-state system, with each of the stable states being strongly attractive, a feature indicative of selection for a tightly regulated and responsive system. The model predicts that the state of the GacS/GacA node confers control, a prediction that is consistent with experimental observations that the protein has a role as master regulator. Simulated gene "knock out" experiments with the model predict that HrpL is a central information processing point within the network.	[MacLean, Daniel; Studholme, David J.] John Innes Ctr, Sainsbury Lab, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	MacLean, D (corresponding author), John Innes Ctr, Sainsbury Lab, Norwich, Norfolk, England.	dan.maclean@tsl.ac.uk	Studholme, David/H-6790-2019; MacLean, Dan/C-7046-2013	Studholme, David/0000-0002-3010-6637; MacLean, Dan/0000-0003-1032-0887	Gatsby Charitable Foundation	Gatsby Charitable Foundation	Funding: D. M. and D. J. S. were supported by The Gatsby Charitable Foundation: www.gatsby.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alberts MJ, 2008, INT J STROKE, V3, P16, DOI 10.1111/j.1747-4949.2008.00174.x; ARNOLD DL, 2000, MOL PLANT PATHOL, V102, P407; Braunewell S, 2007, J THEOR BIOL, V245, P638, DOI 10.1016/j.jtbi.2006.11.012; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Chatterjee A, 2003, MOL PLANT MICROBE IN, V16, P1106, DOI 10.1094/MPMI.2003.16.12.1106; Chatterjee A, 2002, MOL PLANT MICROBE IN, V15, P971, DOI 10.1094/MPMI.2002.15.9.971; Chaves M, 2005, J THEOR BIOL, V235, P431, DOI 10.1016/j.jtbi.2005.01.023; CHAVES M, 2006, SYST BIOL STEVENAGE, V153, P155; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Fall CP., 2002, COMPUTATIONAL CELL B; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Fouts DE, 2002, P NATL ACAD SCI USA, V99, P2275, DOI 10.1073/pnas.032514099; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Hendrickson EL, 2000, J BACTERIOL, V182, P3508, DOI 10.1128/JB.182.12.3508-3516.2000; Hutcheson SW, 2001, J BACTERIOL, V183, P5589, DOI 10.1128/JB.183.19.5589-5598.2001; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Merighi M, 2003, MOL PLANT MICROBE IN, V16, P238, DOI 10.1094/MPMI.2003.16.3.238; Nizan-Koren R, 2003, MOL PLANT MICROBE IN, V16, P249, DOI 10.1094/MPMI.2003.16.3.249; Preston G, 1998, J BACTERIOL, V180, P4532, DOI 10.1128/JB.180.17.4532-4537.1998; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tang XY, 2006, MOL PLANT MICROBE IN, V19, P1159, DOI 10.1094/MPMI-19-1159; Thum KE, 2003, PLANT PHYSIOL, V132, P440, DOI 10.1104/pp.103.022780; Van Gijsegem F, 2000, MOL MICROBIOL, V36, P249, DOI 10.1046/j.1365-2958.2000.01851.x; Voit E. O., 2000, COMPUTATIONAL ANAL B; Wei WS, 2000, P NATL ACAD SCI USA, V97, P2247, DOI 10.1073/pnas.040570097; Wei ZM, 2000, MOL PLANT MICROBE IN, V13, P1251, DOI 10.1094/MPMI.2000.13.11.1251; Yuh Chiou-Hwa, 2001, P73	31	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9101	10.1371/journal.pone.0009101	http://dx.doi.org/10.1371/journal.pone.0009101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169167	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474700002
J	Nakazawa, T; Sakai, Y; Hsieh, CH; Koitabashi, T; Tayasu, I; Yamamura, N; Okuda, N				Nakazawa, Takefumi; Sakai, Yoichiro; Hsieh, Chih-hao; Koitabashi, Tadatoshi; Tayasu, Ichiro; Yamamura, Norio; Okuda, Noboru			Is the Relationship between Body Size and Trophic Niche Position Time-Invariant in a Predatory Fish? First Stable Isotope Evidence	PLOS ONE			English	Article							ONTOGENIC NICHE; PREY; PRESERVATION; DYNAMICS; SHIFTS; DIET	Characterizing relationships between individual body size and trophic niche position is essential for understanding how population and food-web dynamics are mediated by size-dependent trophic interactions. However, whether (and how) intraspecific size-trophic relationships (i.e., trophic ontogeny pattern at the population level) vary with time remains poorly understood. Using archival specimens of a freshwater predatory fish Gymnogobius isaza (Tanaka 1916) from Lake Biwa, Japan, we assembled a long-term (> 40 years) time-series of the size-dependence of trophic niche position by examining nitrogen stable isotope ratios (delta N-15) of the fish specimens. The size-dependence of trophic niche position was defined as the slope of the relationship between delta N-15 and log body size. Our analyses showed that the slope was significantly positive in about 60% of years and null in other years, changing through time. This is the first quantitative (i.e., stable isotope) evidence of long-term variability in the size-trophic relationship in a predatory fish. This finding had implications for the fish trophic dynamics, despite that about 60% of the yearly values were not statistically different from the long-term average. We proposed hypotheses for the underlying mechanism of the time-varying size-trophic relationship.	[Nakazawa, Takefumi; Sakai, Yoichiro; Koitabashi, Tadatoshi; Tayasu, Ichiro; Okuda, Noboru] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Nakazawa, Takefumi; Hsieh, Chih-hao] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan; [Yamamura, Norio] Res Inst Humanity & Nat, Kyoto, Japan	Kyoto University; National Taiwan University; National Taiwan University; Research Institute for Humanity & Nature (RIHN)	Nakazawa, T (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.	tknkzw@ntu.edu.tw	Tayasu, Ichiro/A-9924-2009; Hsieh, Chih-hao/B-3797-2008	Tayasu, Ichiro/0000-0002-3006-7973; Hsieh, Chih-hao/0000-0001-5935-7272	Global COE; National Science Council of Taiwan; Frontier and Innovative Research of National Taiwan University; Japan-Taiwan Interchange Association; Research Fellowship for Young Scientists [2103033]; Japan Society for the Promotion of Science [18770014]	Global COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Frontier and Innovative Research of National Taiwan University(National Taiwan University); Japan-Taiwan Interchange Association; Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Global COE Program A06 to Kyoto University, National Science Council of Taiwan, the grant for Frontier and Innovative Research of National Taiwan University, and Japan-Taiwan Interchange Association. T. N. and N. O. were supported by Research Fellowship for Young Scientists (2103033) and Grant-in Aid for Young Scientists (B) (18770014), respectively, from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badalamenti F, 2002, MAR BIOL, V141, P561, DOI 10.1007/s00227-002-0844-3; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; de Roos AM, 2002, ECOL MONOGR, V72, P271, DOI 10.1890/0012-9615(2002)072[0271:ONSAFB]2.0.CO;2; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Hildrew Alan G., 2007, P326; Jennings S, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P86; Jennings S, 2002, MAR BIOL, V141, P1085, DOI 10.1007/s00227-002-0905-7; Jennings S, 2007, J ANIM ECOL, V76, P72, DOI 10.1111/j.1365-2656.2006.01180.x; Kelly B, 2006, J FISH BIOL, V69, P1595, DOI 10.1111/j.1095-8649.2006.01226.x; Layman CA, 2005, ECOLOGY, V86, P2530, DOI 10.1890/04-1098; Mehner T, 1999, ENVIRON BIOL FISH, V56, P169, DOI 10.1023/A:1007532720226; MITTELBACH GG, 1981, ECOLOGY, V62, P1370, DOI 10.2307/1937300; Nagoshi M., 1966, RES POPUL ECOL, V8, P20, DOI [10.1007/BF02524743, DOI 10.1007/BF02524743]; NAKANISHI N, 1984, Japanese Journal of Limnology, V45, P279; Nakazawa T, 2007, ECOL FRESHW FISH, V16, P362, DOI 10.1111/j.1600-0633.2007.00234.x; Ogawa NO, 2001, LIMNOL OCEANOGR, V46, P1228, DOI 10.4319/lo.2001.46.5.1228; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Sarakinos HC, 2002, CAN J ZOOL, V80, P381, DOI 10.1139/z02-007; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Shiga Statistics and Information Office, 1962, ANN REP AGR FOR FISH; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Sweeting CJ, 2007, J EXP MAR BIOL ECOL, V340, P1, DOI 10.1016/j.jembe.2006.07.023; Takimoto G, 2003, AM NAT, V162, P93, DOI 10.1086/375540; Tuljapurkar S., 1997, STRUCTURED POPULATIO; Ward AJW, 2006, FISH FISH, V7, P231, DOI 10.1111/j.1467-2979.2006.00224.x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435; Woodward G, 2002, J ANIM ECOL, V71, P1063, DOI 10.1046/j.1365-2656.2002.00669.x; Yamada Yoshihiro, 1998, Japanese Journal of Limnology, V59, P409	33	30	32	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9120	10.1371/journal.pone.0009120	http://dx.doi.org/10.1371/journal.pone.0009120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161751	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442600018
J	Chen, HL; Yuh, CH; Wu, KK				Chen, Hua-Ling; Yuh, Chiou-Hwa; Wu, Kenneth K.			Nestin Is Essential for Zebrafish Brain and Eye Development through Control of Progenitor Cell Apoptosis	PLOS ONE			English	Article							EXPRESSION; PROTEIN; DEATH; CYTOSKELETON	Background: Nestin is expressed in neural progenitor cells (NPC) of developing brain. Despite its wide use as an NPC marker, the function of nestin in embryo development is unclear. Methodology/Principal Findings: As nestin is conserved in zebrafish and its predicted sequence is clustered with the mammalian nestin orthologue, we used zebrafish as a model to investigate its role in embryogenesis. Injection of nestin morpholino (MO) into fertilized eggs induced time-and dose-dependent brain and eye developmental defects. Nestin morphants exhibited characteristic morphological changes including small head, small eyes and hydrocephalus. Histological examinations show reduced hind-and mid-brain size, dilated ventricle, poorly organized retina and underdeveloped lens. Injection of control nestin MO did not induce brain or eye changes. Nestin MO injection reduced expression of ascl1b (achaete-scute complex-like 1b), a marker of NPCs, without affecting its distribution. Nestin MO did not influence Elavl3/4 (Embryonic lethal, abnormal vision, Drosophila-like 3/4) (a neuronal marker), or otx2 (a midbrain neuronal marker), but severely perturbed cranial motor nerve development and axon distribution. To determine whether the developmental defects are due to excessive NPC apoptosis and/or reduced NPC proliferation, we analyzed apoptosis by TUNEL assay and acridine orange staining and proliferation by BrdU incorporation, pcna and mcm5 expressions. Excessive apoptosis was noted in hindbrain and midbrain cells. Apoptotic signals were colocalized with ascl1b. Proliferation markers were not significantly altered by nestin MO. Conclusion/Significance: These results suggest that nestin is essential for zebrafish brain and eye development probably through control of progenitor cell apoptosis.	[Chen, Hua-Ling; Wu, Kenneth K.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Yuh, Chiou-Hwa] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Chen, HL (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	kkgo@nhri.org.tw	Yuh, Chiou-Hwa/AAL-2938-2020; Yuh, Chiou-Hwa/AAL-3531-2020; Yuh, Chiou-Hwa/E-3972-2010; Wu, Kenneth Kun-Yu/B-1070-2010; Chernyshev, Alexei/A-7195-2014	Yuh, Chiou-Hwa/0000-0002-2356-1551; Chernyshev, Alexei/0000-0002-2203-3001; Kajihara, Hiroshi/0000-0001-6510-9355	National Health Research Institutes, Taiwan; National Science Council, Taiwan	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institutes, Taiwan and National Science Council (Stem Cell Flagship Center Program), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieberich E, 2003, J CELL BIOL, V162, P469, DOI 10.1083/jcb.200212067; Cairns NJ, 2004, J PATHOL, V204, P438, DOI 10.1002/path.1650; Chan TM, 2009, DEV BIOL, V326, P456, DOI 10.1016/j.ydbio.2008.11.010; Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Gilbert S, 2008, APOPTOSIS, V13, P1479, DOI 10.1007/s10495-008-0274-x; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Gulati-Leekha A, 2006, DEV BIOL, V296, P29, DOI 10.1016/j.ydbio.2006.03.024; Hanington PC, 2008, DEV BIOL, V314, P250, DOI 10.1016/j.ydbio.2007.10.012; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Kageyama R, 1997, INT J BIOCHEM CELL B, V29, P1389, DOI 10.1016/S1357-2725(97)89968-2; Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Mahler J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-89; Marvin NJ, 1998, J CELL SCI, V111, P1951; Mokry J, 1998, Acta Medica (Hradec Kralove), V41, P73; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Qiu GT, 2007, EXP EYE RES, V84, P1047, DOI 10.1016/j.exer.2007.01.014; Rieske P, 2007, EUR J NEUROSCI, V25, P31, DOI 10.1111/j.1460-9568.2006.05254.x; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Shen Q, 2002, DEVELOPMENT, V129, P4843; SJOBERG G, 1994, EXP CELL RES, V214, P447, DOI 10.1006/excr.1994.1281; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6	26	104	111	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9318	10.1371/journal.pone.0009318	http://dx.doi.org/10.1371/journal.pone.0009318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174467	gold, Green Submitted, Green Published			2022-12-25	WOS:000274923700020
